Citrus Sinensis ID: 006810
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 630 | 2.2.26 [Sep-21-2011] | |||||||
| Q944Q0 | 563 | Serine/threonine-protein | yes | no | 0.868 | 0.971 | 0.549 | 1e-175 | |
| Q6EU49 | 612 | Probable serine/threonine | yes | no | 0.936 | 0.964 | 0.516 | 1e-162 | |
| Q8S8Y8 | 567 | Probable serine/threonine | no | no | 0.657 | 0.730 | 0.624 | 1e-151 | |
| Q8LST2 | 557 | Probable serine/threonine | no | no | 0.655 | 0.741 | 0.626 | 1e-150 | |
| Q8RXE5 | 524 | Probable serine/threonine | no | no | 0.650 | 0.782 | 0.662 | 1e-150 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.690 | 0.617 | 0.553 | 1e-137 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.690 | 0.617 | 0.553 | 1e-137 | |
| Q9CAV6 | 700 | Serine/threonine-protein | no | no | 0.666 | 0.6 | 0.531 | 1e-134 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.646 | 0.655 | 0.557 | 1e-133 | |
| Q8S8Y9 | 568 | Serine/threonine-protein | no | no | 0.738 | 0.818 | 0.492 | 1e-130 |
| >sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 616 bits (1588), Expect = e-175, Method: Compositional matrix adjust.
Identities = 353/642 (54%), Positives = 426/642 (66%), Gaps = 95/642 (14%)
Query: 1 MDCGSGFTK--SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV 58
M GSGF S EE +F+EKDPS RY RYD++LG+GAFKTVYK FDEVDGIEVAWN V
Sbjct: 1 MASGSGFLGQISSMEEADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLV 60
Query: 59 NIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-Y 117
+IEDVMQ P QLERLYSEVHLLK+LKHENIIK + SWVD+ N+TINMITELFTSGSLR Y
Sbjct: 61 SIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVY 120
Query: 118 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177
RKKH+ VD KAIKNWARQIL+GL+YLHS NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA
Sbjct: 121 RKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLA 180
Query: 178 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 237
V+QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPYNEC+N AQIY
Sbjct: 181 TVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIY 240
Query: 238 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP-- 295
KKVTS IKP SL KV DPQV+QFIEKC++PAS R ALEL KDPFL D KD
Sbjct: 241 KKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSALLASS 300
Query: 296 ------LRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTE 349
+R P L E PMD+D N K S + + W T+ELQR+ E
Sbjct: 301 STSSKYVRPPQL----------EHLPMDVDHNENK----SVSSNEDYPWSQTIELQRIAE 346
Query: 350 NNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHED 409
N EF LRGE++DD T S+ LRI D SG +HF FYL +DTA +IAEEMVE+L L+ ++
Sbjct: 347 NKEFRLRGERSDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEMVEELHLTSQE 406
Query: 410 VVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFA 469
VV IA++ID+ IM+L+ T+S N P +
Sbjct: 407 VVVIADMIDDFIMQLLSD------RTSSHHNQ------------------NSPRLTHEDH 442
Query: 470 EAVSQQGVLS--ELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVY 527
EA +QQ V S E A+G +S SDISA++ P + DG +A A
Sbjct: 443 EAANQQTVNSKDEEAAG------QSMKSDISADYYFPYSAN---------DGNAAMEAGR 487
Query: 528 DHGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDG 587
D ES+ +S++DSCS M S+I +LS++D ++ +
Sbjct: 488 D-------------AESM----------SSYLDSCSMM------STIYNLSISDNDYPED 518
Query: 588 LKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSV 629
LK EL+ I S++ Q FQ+LL+ +ED +ENA+++W+ +V
Sbjct: 519 LKTELNLIESQFNQSFQDLLKLKEDAIENAKRKWITKKQKAV 560
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 572 bits (1474), Expect = e-162, Method: Compositional matrix adjust.
Identities = 322/623 (51%), Positives = 417/623 (66%), Gaps = 33/623 (5%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
+ ++ E E DP+ RY RY+E+LG+GA KTVYK FDEV+GIEVAW+QV I++VMQSPD L
Sbjct: 9 KVDDAECVEVDPTRRYIRYNEVLGRGAMKTVYKAFDEVEGIEVAWSQVEIDEVMQSPDNL 68
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAI 129
ERLYSEVHLLKSLKHEN++KFYN WVDD +TIN+ITELFTSGSLR YR+KH VD+KAI
Sbjct: 69 ERLYSEVHLLKSLKHENVMKFYNYWVDDQKKTINVITELFTSGSLRQYRQKHPRVDLKAI 128
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 189
KNWARQ+LRGL YLH+H PPIIHRDLKCDNIFVNGN+GEVKIGDLGLA VM P A+SVI
Sbjct: 129 KNWARQVLRGLDYLHTHQPPIIHRDLKCDNIFVNGNHGEVKIGDLGLATVMLTPRAKSVI 188
Query: 190 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249
GTPEFMAPELY+E Y+ELVDIYSFGMC+LEM T EYPY+EC N AQI+KKV+ G+KPA+L
Sbjct: 189 GTPEFMAPELYDENYDELVDIYSFGMCMLEMFTLEYPYSECTNAAQIFKKVSKGVKPAAL 248
Query: 250 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLA 309
+K+T+ Q KQFI+KC+VPAS RL A ELL+DPFL +DN LV + P+ +P+ ++++
Sbjct: 249 AKITNIQAKQFIDKCLVPASERLSAKELLQDPFLCSDNSSVLV--GTKFPSSLPKSVDVS 306
Query: 310 HSEPHPMDIDLNHKKVSADSCAKSNTGTWFLT-LELQRLTENNEFTLRGEKNDDDTVSLT 368
H MD+D N ++ +C +++ G + LE R +N E L GEK DD++VSL
Sbjct: 307 LEALH-MDVDTNESMCTS-TCKRNDLGGPHRSVLEFTRTNKNTELKLTGEKLDDNSVSLV 364
Query: 369 LRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPS- 427
LRI D GH NIHF+FYL++DTA+S+A EMVEQL+L+ DV IA+ ID LI+ LVP
Sbjct: 365 LRIADLCGHARNIHFLFYLDSDTAMSVAAEMVEQLELADCDVTFIADFIDLLIVNLVPGQ 424
Query: 428 --WNPSLGSTASQQN-GLLKGSPVSQGNSISLK---CPGEPGSNNAFAEAVSQQGVLSEL 481
N ++ ST+S+ G + SQ + L E ++ A A + S L
Sbjct: 425 QLMNDAVMSTSSESKMGESEHVITSQQHPSELTHDYVLVEGMMHSKEANASPSDYIDSLL 484
Query: 482 ASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVS- 540
+ S SDIS + D KSL + Y V ++ E A + +
Sbjct: 485 NATNLGGPNSSEGSDISVQLDGS-------SKSL------SEYGVDEYRTLECGAYKGTD 531
Query: 541 -LGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKY 599
LG + + N +D S S+ + +S+S E+ D L EL I ++Y
Sbjct: 532 KLGCRHPLSNGSSNFAIFQMDQASHHSELVIGASVSI-----TENRDVLNGELGLIEAQY 586
Query: 600 QQCFQELLRQREDEMENARKRWL 622
+Q F+EL R RE+ +E ARK+WL
Sbjct: 587 EQWFRELTRMREEALEGARKKWL 609
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 536 bits (1381), Expect = e-151, Method: Compositional matrix adjust.
Identities = 269/431 (62%), Positives = 329/431 (76%), Gaps = 17/431 (3%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E + E E DP+ RY RY E++GKGAFKTVYK FDEVDGIEVAWNQV I+DV+QSP+ L
Sbjct: 12 EPPDPEVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCL 71
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAI 129
ERLYSEV LLKSLKH NII+FYNSW+DD N+T+N+ITELFTSGSLR YRKKH+ V+MKA+
Sbjct: 72 ERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAV 131
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 189
KNWARQIL GL YLH PPIIHRDLKCDNIF+NGN+GEVKIGDLGLA VM+Q A+SVI
Sbjct: 132 KNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVI 191
Query: 190 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249
GTPEFMAPELY+E YNEL DIYSFGMC+LEMVT +YPY ECKN AQIYKKV+SGIKPASL
Sbjct: 192 GTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASL 251
Query: 250 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV-PE---- 304
S+V DP+VKQFIEKC++PAS RL A ELL DPFL + + +PL LP++V P+
Sbjct: 252 SRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLT--MNNPLPLPDIVMPKEGAF 309
Query: 305 ----VMNLAHSEPHP---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRG 357
+M+ P + IDL+ N+G+ +E++R N F L+G
Sbjct: 310 GDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSGSR--CIEVRRAKRGNFFVLKG 367
Query: 358 EKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELI 417
E+ND+ +VSL LRI D++G V NIHF+FY DTA ++ EMVEQL+L+ ++V IAELI
Sbjct: 368 EENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTFIAELI 427
Query: 418 DNLIMKLVPSW 428
D L++ ++P+W
Sbjct: 428 DILLVNMIPTW 438
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 533 bits (1372), Expect = e-150, Method: Compositional matrix adjust.
Identities = 270/431 (62%), Positives = 335/431 (77%), Gaps = 18/431 (4%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E + E E DP+CRY RY E++GKGA KTV+KGFDEVDGIEVAWNQV I+D++QSPD L
Sbjct: 12 EPPDPEVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCL 71
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAI 129
ERLYSEV LLKSLKH+NII+FYNSW+DD N+T+N+ITELFTSGSLR YRKKH+ V+MKA+
Sbjct: 72 ERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAV 131
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 189
K WARQIL GL YLHS +PPIIHRD+KCDNIF+NGN+GEVKIGDLGLA VM+Q A+SVI
Sbjct: 132 KCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVI 191
Query: 190 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249
GTPEFMAPELY+E YNEL DIYSFGMC+LEMVT EYPY EC+N AQIYKKV+SGIKPASL
Sbjct: 192 GTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASL 251
Query: 250 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVC-DPLRLPNLV-PEVMN 307
SKV DP+V +FIEKC++PAS RL A ELL D FL N LV +PL LP++V P+ +
Sbjct: 252 SKVKDPEVMKFIEKCLLPASERLSAEELLLDSFL---NVNGLVMNNPLPLPDIVMPKEGS 308
Query: 308 LAH----SEPHP------MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRG 357
SE P M ++L+ + +N+GT +E++R N F L+G
Sbjct: 309 FGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSGTN--CIEVRRAKRGNFFVLKG 366
Query: 358 EKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELI 417
E+ND+++VSL LRI D++G V NIHF+F+ DTA +++ EMVEQL+L+ ++V IAELI
Sbjct: 367 EENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVKFIAELI 426
Query: 418 DNLIMKLVPSW 428
D L++ L+P+W
Sbjct: 427 DVLLVNLIPNW 437
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXE5|WNK10_ARATH Probable serine/threonine-protein kinase WNK10 OS=Arabidopsis thaliana GN=WNK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 532 bits (1370), Expect = e-150, Method: Compositional matrix adjust.
Identities = 275/415 (66%), Positives = 316/415 (76%), Gaps = 5/415 (1%)
Query: 13 EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
EE +F +KDP+ RY RY+++LG+GAFKTVYK FDEV+GIEVAWN ++IEDV+Q P QL+R
Sbjct: 2 EEADFVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDR 61
Query: 73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKN 131
LYSEVHLL SLKH+NIIK + SWVDD N++INMITELFTSGSL YRKKH+ VD KAI N
Sbjct: 62 LYSEVHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMN 121
Query: 132 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 191
WARQIL+GLHYLHS PP+IHRDLKCDNIFVNGN G+VKIGDLGLA VMQQPTARSVIGT
Sbjct: 122 WARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGT 181
Query: 192 PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251
PEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY EC+N AQIYKKVTSGIKP SLSK
Sbjct: 182 PEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSK 241
Query: 252 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 311
V DPQVKQFIEKC++PA R ALELLKD L D KD P +
Sbjct: 242 VDDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFKPAMP--PQC 299
Query: 312 EPHPMDIDL-NHKKVSADSCAKSNTGTWFL-TLELQRLTENNEFTLRGEKNDDDTVSLTL 369
E PMD++ + VS S AKS+ L T+E+QR+ E+ EF L GE+ DD S+ L
Sbjct: 300 EYRPMDVEYKKNTSVSICSSAKSSQECALLQTMEVQRVAESTEFKLSGERRDDVAASMAL 359
Query: 370 RIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 424
RI SG + F F L DTA ++ EMVE+LDLS +V IAE+ID LIMKL
Sbjct: 360 RIAGSSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKL 414
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1256), Expect = e-137, Method: Compositional matrix adjust.
Identities = 253/457 (55%), Positives = 313/457 (68%), Gaps = 22/457 (4%)
Query: 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
E++E DP+ RYGRY+++LGKGA KTVY+ FDE G+EVAWNQV + D +QSP+ LERLY
Sbjct: 16 EYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYC 75
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWAR 134
E+HLLK+LKH NI+KFY SWVD + R IN ITE+FTSG+LR YR+KH V++ A+K+W R
Sbjct: 76 EIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCR 135
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
QIL GL YLHSH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA ++++ A +GTPEF
Sbjct: 136 QILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEF 195
Query: 195 MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254
MAPE+YEEEYNELVDIYSFGMC+LEMVT EYPY+EC +P QIYKKV SG KP +L KV D
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255
Query: 255 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP----------LRLPNLVPE 304
P V+QF+EKC+ AS RL A ELLKDPFL D DLV P LR P L
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFLQVD---DLVFCPGDGDYSLMNYLRQPYLEHA 312
Query: 305 VMNLAH-----SEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEK 359
N++ SE D + D K++ F E + L N + T++G K
Sbjct: 313 YSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLG-NVDITIKGRK 371
Query: 360 NDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDN 419
++D ++ L LRI D GHV NI+F F + ADTA+S+A EMV +LD++ +V IAE+ID
Sbjct: 372 SEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDG 431
Query: 420 LIMKLVPSWNPSLGSTASQQNGLLK--GSPVSQGNSI 454
+ LVP W P G SQ GS VS S+
Sbjct: 432 EVSALVPDWRPGPGIEESQDTTYCHNCGSNVSSCGSL 468
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 488 bits (1255), Expect = e-137, Method: Compositional matrix adjust.
Identities = 253/457 (55%), Positives = 313/457 (68%), Gaps = 22/457 (4%)
Query: 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
E++E DP+ RYGRY+++LGKGA KTVY+ FDE G+EVAWNQV + D +QSP+ LERLY
Sbjct: 16 EYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYC 75
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWAR 134
E+HLLK+LKH NI+KFY SWVD + R IN ITE+FTSG+LR YR+KH V++ A+K+W R
Sbjct: 76 EIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCR 135
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
QIL GL YLHSH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA ++++ A +GTPEF
Sbjct: 136 QILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEF 195
Query: 195 MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254
MAPE+YEEEYNELVDIYSFGMC+LEMVT EYPY+EC +P QIYKKV SG KP +L KV D
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255
Query: 255 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP----------LRLPNLVPE 304
P V+QF+EKC+ AS RL A ELLKDPFL D DLV P LR P L
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFLQVD---DLVFCPGDGDYSLMNYLRQPYLEHA 312
Query: 305 VMNLAH-----SEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEK 359
N++ SE D + D K++ F E + L N + T++G K
Sbjct: 313 YSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLG-NVDITIKGRK 371
Query: 360 NDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDN 419
++D ++ L LRI D GHV NI+F F + ADTA+S+A EMV +LD++ +V IAE+ID
Sbjct: 372 SEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDG 431
Query: 420 LIMKLVPSWNPSLGSTASQQNGLLK--GSPVSQGNSI 454
+ LVP W P G SQ GS VS S+
Sbjct: 432 EVSALVPDWRPGPGIEESQDTTYCHNCGSNVSSCGSL 468
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 479 bits (1233), Expect = e-134, Method: Compositional matrix adjust.
Identities = 245/461 (53%), Positives = 309/461 (67%), Gaps = 41/461 (8%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E + EF E DP+ RYGRY+E+LGKGA KTVY+ FDE +GIEVAWNQV + D +QSP+ L
Sbjct: 8 EPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL 67
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAI 129
ERLY E+HLLK+LKH+NI+KFY SWVD NR IN +TELFTSG+LR YR +HK V+++A+
Sbjct: 68 ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAM 127
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 189
K+W RQILRGLHYLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++++ A +
Sbjct: 128 KHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
Query: 190 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249
GTPEFMAPE+YEE YNELVDIYSFGMCILEMVT +YPY+EC +PAQIYKKV SG KP +L
Sbjct: 188 GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDAL 247
Query: 250 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNP---------KDLVCDPLRLPN 300
KV DP+VK FIEKC+ SLR+ A ELL DPFL D+ +D V R P+
Sbjct: 248 YKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDMEDSVGPLYRQPH 307
Query: 301 LVPEVMNLAHSEP----------HPMD-IDLNHKKVSADSCAKSNTGTWFLT-------- 341
+P+ N + +P + LN + + + W
Sbjct: 308 HLPDYYNYPSNSSSLNRQYSNGNYPSNSSSLNRQYSNGYNSHHEYQNGWAYNPAETEETH 367
Query: 342 -LEL-----------QRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNA 389
+EL ++ + N + T++G++ DD + L LRI DK G V NI+F F +
Sbjct: 368 GIELFESRNNDDQEEEKKSGNVDITIKGKRRDDGGLFLRLRIADKEGRVRNIYFPFDIET 427
Query: 390 DTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNP 430
DTA+S+A EMV +LD+ V IA +ID I LVPSW P
Sbjct: 428 DTALSVATEMVAELDMDDHGVTKIANMIDGEISSLVPSWRP 468
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 476 bits (1225), Expect = e-133, Method: Compositional matrix adjust.
Identities = 238/427 (55%), Positives = 305/427 (71%), Gaps = 20/427 (4%)
Query: 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL 73
E EF+E DP+ RYGRY E+LGKGAFKTVYK FD+++G+EVAWNQ+ + D++++ D LERL
Sbjct: 15 EPEFAEVDPTARYGRYTEVLGKGAFKTVYKAFDQLEGLEVAWNQIKVGDILRNNDDLERL 74
Query: 74 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNW 132
SEV LLK+LKH+NIIKFYNSW+D N IN ITE+FTSG+LR YR KHK VD++A+K W
Sbjct: 75 RSEVRLLKTLKHKNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALKKW 134
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGT 191
+RQIL GL YLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++ +A S+IGT
Sbjct: 135 SRQILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARSAHSIIGT 194
Query: 192 PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251
PEFMAPELY+EEYNELVDIY+FGMC+LE+VT EYPY EC N AQIYKKV+ G KP+SL+K
Sbjct: 195 PEFMAPELYDEEYNELVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGEKPSSLAK 254
Query: 252 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 311
+ DP+V+ FIEKCI AS RL A ELL DPFL D K + PL+ + ++S
Sbjct: 255 IEDPEVRFFIEKCIAKASQRLSAQELLMDPFLRDDGEK--IFYPLQSNTKASDGAGSSNS 312
Query: 312 EPHPMDIDLNHKKVSADSCAKSNTGTW----------FLTLELQRLTENNEFTLRGEKND 361
+ + + ++ + +TG++ T++ Q T+ + D
Sbjct: 313 S-----MGYKYDRDASSMAIREHTGSFAEEHPSDRYIHSTMDPQ-AAAGRIITVESQMKD 366
Query: 362 DDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLI 421
+T+ L LRI D +GH NIHF F + ADT+IS+A EMV QLDL+ +DV +IAE+ID I
Sbjct: 367 LNTIFLKLRIADSTGHAQNIHFPFDIEADTSISVATEMVVQLDLTDQDVTAIAEMIDAEI 426
Query: 422 MKLVPSW 428
+P W
Sbjct: 427 RAHIPDW 433
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1200), Expect = e-130, Method: Compositional matrix adjust.
Identities = 240/487 (49%), Positives = 320/487 (65%), Gaps = 22/487 (4%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
F E DPS RYGRYDEILGKGA KTVY+ FDE +GIEVAWNQV + + ++P++LE+ + E
Sbjct: 14 FVEIDPSGRYGRYDEILGKGASKTVYRAFDEYEGIEVAWNQVKLRNFTRNPEELEKFFRE 73
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQ 135
+HLLK+L H+NI+KFY SWVD N +IN +TELFTSG+LR YR +H+ V+++A+K W +Q
Sbjct: 74 IHLLKTLNHQNIMKFYTSWVDTNNLSINFVTELFTSGTLRQYRLRHRRVNIRAVKQWCKQ 133
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 195
IL+GL YLHS +PPIIHRDLKCDNIF+NGN GEVKIGDLGLA ++++ A +GTPEFM
Sbjct: 134 ILKGLLYLHSRSPPIIHRDLKCDNIFINGNQGEVKIGDLGLAAILRKSHAVRCVGTPEFM 193
Query: 196 APELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255
APE+Y+EEYNELVD+Y+FGMC+LEMVT +YPY+EC +PAQIYKKVTSG KP + V DP
Sbjct: 194 APEVYDEEYNELVDVYAFGMCVLEMVTFDYPYSECTHPAQIYKKVTSGKKPEAFYLVKDP 253
Query: 256 QVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHP 315
+V++F+EKC+ + RL ALELL+DPFL DN V P+ N E HP
Sbjct: 254 EVREFVEKCLANVTCRLTALELLQDPFLQDDNMDGFVMRPIDYYNGYDETGVFLR---HP 310
Query: 316 M-DIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDK 374
+ D L H + + + + L ++ + +++G++N DD + L LRI D
Sbjct: 311 LIDDPLYHDQFESSQICE-------IDLFANDDEDHVDISIKGKRNGDDGIFLRLRISDA 363
Query: 375 SGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGS 434
G + NI+F F DTA S+A EMV +LD++++DV IAE+ID I LVP W
Sbjct: 364 EGRIRNIYFPFETAIDTAWSVAVEMVSELDITNQDVAKIAEMIDAEIAALVPDWK---ND 420
Query: 435 TASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSD 494
T S QN + + G GE SN E VS G S ++ +++ S
Sbjct: 421 TESSQNVNNNKNNNTAGFC------GECASNGYIQETVS-SGEKSHHNHHEFDSSEDKSC 473
Query: 495 SDISAEF 501
S + F
Sbjct: 474 SSVHGRF 480
|
Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 630 | ||||||
| 224072272 | 596 | predicted protein [Populus trichocarpa] | 0.933 | 0.986 | 0.652 | 0.0 | |
| 255555709 | 585 | kinase, putative [Ricinus communis] gi|2 | 0.920 | 0.991 | 0.633 | 0.0 | |
| 359474135 | 645 | PREDICTED: serine/threonine-protein kina | 0.977 | 0.955 | 0.635 | 0.0 | |
| 224058021 | 571 | predicted protein [Populus trichocarpa] | 0.893 | 0.985 | 0.642 | 0.0 | |
| 357462359 | 614 | Serine/threonine protein kinase WNK8 [Me | 0.966 | 0.991 | 0.610 | 0.0 | |
| 449452398 | 679 | PREDICTED: serine/threonine-protein kina | 0.971 | 0.901 | 0.583 | 0.0 | |
| 351724041 | 618 | with no lysine kinase 8 [Glycine max] gi | 0.946 | 0.964 | 0.596 | 0.0 | |
| 356547519 | 618 | PREDICTED: serine/threonine-protein kina | 0.949 | 0.967 | 0.592 | 0.0 | |
| 255564615 | 693 | kinase, putative [Ricinus communis] gi|2 | 0.971 | 0.883 | 0.541 | 1e-178 | |
| 225470964 | 625 | PREDICTED: probable serine/threonine-pro | 0.953 | 0.961 | 0.563 | 1e-178 |
| >gi|224072272|ref|XP_002303683.1| predicted protein [Populus trichocarpa] gi|222841115|gb|EEE78662.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1912), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/625 (65%), Positives = 468/625 (74%), Gaps = 37/625 (5%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI 60
MD GS SE G F+EKDP+ RY R DE LGKGAFKTVYK FDEVDGIEVAWNQVNI
Sbjct: 1 MDFGS---LSEDGGGVFAEKDPTGRYIRNDEFLGKGAFKTVYKAFDEVDGIEVAWNQVNI 57
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRK 119
EDV+QS QLERLYSEVHLLKSLKHENIIKFY+SWVDD N+TIN+ITELFTSGS+R YRK
Sbjct: 58 EDVLQSSQQLERLYSEVHLLKSLKHENIIKFYSSWVDDKNKTINIITELFTSGSMRQYRK 117
Query: 120 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179
KHK VDMKAIKNWARQILRGLHYLH+H+PPIIHRDLKCDNIFVNGN GEVKIGDLGLAIV
Sbjct: 118 KHKTVDMKAIKNWARQILRGLHYLHTHSPPIIHRDLKCDNIFVNGNTGEVKIGDLGLAIV 177
Query: 180 MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 239
MQQP ARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY+ECKNPAQIYKK
Sbjct: 178 MQQPIARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYSECKNPAQIYKK 237
Query: 240 VTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 299
V+SGIKPASL KV+D QVK FIEKC+VPAS RLPA+ELLKDPFL T+N K+LV L+LP
Sbjct: 238 VSSGIKPASLGKVSDHQVKVFIEKCLVPASTRLPAIELLKDPFLATENSKELVSSSLQLP 297
Query: 300 NLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGE 358
NL+ ++L SE H MDID KK+S SC KS N F TLEL R TENNEF LRG
Sbjct: 298 NLISRQVHLLQSESHLMDIDC--KKLSVGSCTKSINESPQFSTLELSRFTENNEFRLRGA 355
Query: 359 KNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELID 418
KN+D+TVSLTLRI D G NIHF FYL++DTA+ IAEEMVEQLDL EDV IAELID
Sbjct: 356 KNNDNTVSLTLRIADPCGRARNIHFTFYLDSDTAVLIAEEMVEQLDLLTEDVAVIAELID 415
Query: 419 NLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVL 478
NLI KLVPSWN SP + S L+ N++ +EAV + L
Sbjct: 416 NLIAKLVPSWNT---------------SPSVRNGSSELE-------NHSTSEAVKKPDFL 453
Query: 479 SELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADE 538
L + ++S +SDISAE+++ + D+ +KSL +YD E E
Sbjct: 454 P-LTNMTDLETKQSVNSDISAEYNMAIASDSGTNKSLGSSDCCLQSNMYD---LEFGMLE 509
Query: 539 VSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSK 598
+ + N+ST+NS S+I S SGMS+N S SSI SLSLADK+ S+ LK ELD+I+S
Sbjct: 510 DGISK---HNKSTRNSNDSYIGSFSGMSRNASMSSICSLSLADKDGSE-LKQELDSIDSH 565
Query: 599 YQQCFQELLRQREDEMENARKRWLA 623
Y QC QEL++ RE+ +ENA+KR +
Sbjct: 566 YNQCLQELMKMREEAIENAKKRGIT 590
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555709|ref|XP_002518890.1| kinase, putative [Ricinus communis] gi|223541877|gb|EEF43423.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 735 bits (1897), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/627 (63%), Positives = 460/627 (73%), Gaps = 47/627 (7%)
Query: 7 FTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS 66
F + ++ EF EKDP+ RY RYDE+LGKGAFKTVYK FDE++GIEVAWNQV++EDV+QS
Sbjct: 3 FCSRDDDDSEFEEKDPTGRYVRYDEVLGKGAFKTVYKAFDEINGIEVAWNQVSVEDVLQS 62
Query: 67 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVD 125
PDQLERLYSEVHLLKSLKHENI+KFYNSWVDD N+TINMITELFTSGSLR YRKKHKNVD
Sbjct: 63 PDQLERLYSEVHLLKSLKHENIMKFYNSWVDDNNKTINMITELFTSGSLRKYRKKHKNVD 122
Query: 126 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185
+KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN+FVNGNNGEVKIGDLGLA VMQQPTA
Sbjct: 123 IKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNVFVNGNNGEVKIGDLGLATVMQQPTA 182
Query: 186 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 245
RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPY+ECKNPAQIYKKVTSGIK
Sbjct: 183 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYSECKNPAQIYKKVTSGIK 242
Query: 246 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 305
PASL KV DP VK+FIEKCIVPAS+RLPALELLKDPFL T+NPK+LV L LP+L+ +
Sbjct: 243 PASLCKVNDPLVKRFIEKCIVPASMRLPALELLKDPFLATENPKELVFASLHLPDLMLKQ 302
Query: 306 MNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGEKNDDDT 364
++ SE +PMDID NHKK+S SC KS + F T E QRLT NEF LRGEKNDD+T
Sbjct: 303 VSRGQSESYPMDIDSNHKKLSVGSCTKSMDESLHFSTSEFQRLTVKNEFRLRGEKNDDNT 362
Query: 365 VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 424
+SLTLRI D+ G V NIHF FYL++DT +SIAEEMVEQLDLS+EDV IAELID LI+KL
Sbjct: 363 ISLTLRIVDRCGGVKNIHFTFYLDSDTTLSIAEEMVEQLDLSNEDVAIIAELIDALILKL 422
Query: 425 VPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASG 484
VP + S GST+S NG N+A + S+ L LA
Sbjct: 423 VPHLSQS-GSTSSMPNGF------------------SELHNDATFKVASKHDFLP-LADL 462
Query: 485 KYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGES 544
K Q Q+S S++S E + V DA +K L Y+ + Y+ G +D + G+
Sbjct: 463 KGQETQDSLLSELSTELPLTVASDASTNKPLGSSDYTIDFNTYEFG-----SDFMMHGDG 517
Query: 545 IL-FNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCF 603
+ + T++SE L A E D LKLELDAI+ +Y QCF
Sbjct: 518 TFKYGKYTKHSE-------------------KHLPSAKGEVQDDLKLELDAIDMQYNQCF 558
Query: 604 QELLRQREDEMENARKRWLAGSNVSVI 630
+EL RE+ +ENA+K+W+ V I
Sbjct: 559 RELSMMREEAIENAKKKWITRKKVPAI 585
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474135|ref|XP_002273005.2| PREDICTED: serine/threonine-protein kinase WNK8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1887), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/636 (63%), Positives = 479/636 (75%), Gaps = 20/636 (3%)
Query: 9 KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD 68
K ET++ +F EKDP+ RY RY+E LGKGAFKTVYK FDEVDGIEVAW QV IED++QSP
Sbjct: 5 KFETDDSDFEEKDPTGRYVRYNEFLGKGAFKTVYKAFDEVDGIEVAWGQVEIEDLLQSPQ 64
Query: 69 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMK 127
QLERLYSEVHLLKSLKH+NIIKFYNSWVDDTN+TIN+ITELFTSGSLR YRKKHKNVD+K
Sbjct: 65 QLERLYSEVHLLKSLKHDNIIKFYNSWVDDTNKTINLITELFTSGSLRQYRKKHKNVDLK 124
Query: 128 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 187
AIKNWA+QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS
Sbjct: 125 AIKNWAKQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 184
Query: 188 VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 247
VIGTPEFMAPELYEEEYNELVDIYSFGMCILE+VTCEYPYNECKNPAQIYKKV+SGIKPA
Sbjct: 185 VIGTPEFMAPELYEEEYNELVDIYSFGMCILELVTCEYPYNECKNPAQIYKKVSSGIKPA 244
Query: 248 SLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVC------DPLRLPNL 301
SL KV+DPQVKQFIEKC+VPASLRL A ELLKD F T+N K+ V D L+ N
Sbjct: 245 SLGKVSDPQVKQFIEKCLVPASLRLSAQELLKDAFFATENSKEPVYNHMHVDDSLQSSNF 304
Query: 302 VPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGT-WFLTLELQRLTENNEFTLRGEKN 360
+P +MNL E PMD+D N+KK+S + KS +GT F L+ +R +NN F LRGEK
Sbjct: 305 MPNLMNLPKPELQPMDMDPNYKKLSVSTHMKSISGTPHFRALQFERFNKNNLFKLRGEKI 364
Query: 361 DDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNL 420
DD+++S+TL I D G NIHF FYL++DTA+SIA EMVEQLDL +EDV IAELID +
Sbjct: 365 DDNSISMTLHIADPCGRAKNIHFAFYLDSDTALSIAGEMVEQLDLYNEDVAVIAELIDVM 424
Query: 421 IMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSE 480
I +LVP+W P+ S N + S V SL+ P + GS ++AV++ ++S
Sbjct: 425 ISELVPTWKPAFESMLCGANSSCEDSLVLHNGGTSLRHPSDSGSAKGTSDAVTEH-LISL 483
Query: 481 LASGKYQYNQESSDSDISAEFDVPVILDAHIDKSL-VPDG----------YSAHYAVYDH 529
A+G+ Q ES+ S +S + D V DA+ KSL PD ++ V DH
Sbjct: 484 SANGEEQSTVESALSGMSTKDDATVASDANDIKSLECPDDECYEASDRCCFNGDRQVLDH 543
Query: 530 GGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLK 589
H+ ++GE + N T++ E S I+SCSGMS +LS SSI SLSLADK+ SD LK
Sbjct: 544 ERHKEGRYNGNIGEPVAMNGFTKDWEISCIESCSGMSNSLSLSSICSLSLADKDPSDELK 603
Query: 590 LELDAINSKYQQCFQELLRQREDEMENARKRWLAGS 625
LE+D I+++Y QCFQELLR RE+ +E A+ RW+ S
Sbjct: 604 LEVDTIDTQYHQCFQELLRMREEAIEKAKNRWITKS 639
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224058021|ref|XP_002299436.1| predicted protein [Populus trichocarpa] gi|222846694|gb|EEE84241.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1883), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/626 (64%), Positives = 460/626 (73%), Gaps = 63/626 (10%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI 60
MD GS SE GEF+EKDP+ RY RYDEILGKGAFKTVYK FDEVDGIEVAWNQV+I
Sbjct: 1 MDFGSF---SEDGCGEFAEKDPTGRYVRYDEILGKGAFKTVYKAFDEVDGIEVAWNQVDI 57
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRK 119
EDV+QS QLERLYSEVHLLKSLKHENIIKFYNSWVDD N+TINMITEL TSG+LR YRK
Sbjct: 58 EDVLQSSQQLERLYSEVHLLKSLKHENIIKFYNSWVDDKNKTINMITELLTSGNLRQYRK 117
Query: 120 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179
KHK VDMKAIKNWARQILRGL YLH+ +P IIHRDLKCDNI VNGNNGEVKIGDLGLAIV
Sbjct: 118 KHKTVDMKAIKNWARQILRGLQYLHTRSPRIIHRDLKCDNILVNGNNGEVKIGDLGLAIV 177
Query: 180 MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 239
MQQP ARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY+ECKNPAQIYKK
Sbjct: 178 MQQPIARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYSECKNPAQIYKK 237
Query: 240 VTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 299
VTSGIKPASL KV D QVK+FIEKC+VPAS+RL A++LLKDPFL T+N K++V +LP
Sbjct: 238 VTSGIKPASLVKVNDLQVKEFIEKCLVPASVRLSAIDLLKDPFLATENSKEVVSSLSQLP 297
Query: 300 NLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGE 358
N++ + ++L SE H MDID K +S SC KS N FLTLEL+R TENNEF LR E
Sbjct: 298 NVICKQVHLPQSESHHMDIDC--KMLSLGSCPKSINESPQFLTLELRRFTENNEFRLRAE 355
Query: 359 KNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELID 418
KNDD+TVSLTLRI D G NIHF FYLN+DTA+SIAEEMVEQLDLS EDV IAELID
Sbjct: 356 KNDDNTVSLTLRIADPCGRARNIHFTFYLNSDTAVSIAEEMVEQLDLSSEDVAVIAELID 415
Query: 419 NLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPG-EPGSNNAFAEAVSQQGV 477
+LI+KLVP WN S +S +NG + S + K P P +N EA+
Sbjct: 416 SLIVKLVPCWNTS----SSVRNG--SSELENHATSETGKTPDFSPLTNITDHEAL----- 464
Query: 478 LSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKAD 537
+S +SDISAE+++ + DA +KSL S V+
Sbjct: 465 -------------QSVNSDISAEYNMAIASDASTNKSLGSSSCSLQSNVF---------- 501
Query: 538 EVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINS 597
IDSCSGMS+N S S I SL LADK+ S+ LKLELD+I+S
Sbjct: 502 --------------------HIDSCSGMSRNASLSIICSLFLADKDGSE-LKLELDSIDS 540
Query: 598 KYQQCFQELLRQREDEMENARKRWLA 623
Y QCFQEL++ RE+ +ENA++RW++
Sbjct: 541 HYNQCFQELMKTREEAIENAKRRWIS 566
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357462359|ref|XP_003601461.1| Serine/threonine protein kinase WNK8 [Medicago truncatula] gi|355490509|gb|AES71712.1| Serine/threonine protein kinase WNK8 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1804), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/624 (61%), Positives = 457/624 (73%), Gaps = 15/624 (2%)
Query: 10 SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
SE ++ EKDP+ RY RYDE+LGKGAFKTVYK FDEVDGIEVAWNQ++IEDVMQSP
Sbjct: 3 SEIDDVGVVEKDPTLRYARYDEMLGKGAFKTVYKAFDEVDGIEVAWNQISIEDVMQSPQN 62
Query: 70 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKA 128
LE+LYSEVHLLKSLKHENIIK Y+SWVD+ + INMITELFTSGSLR YRKKHKNVDMKA
Sbjct: 63 LEKLYSEVHLLKSLKHENIIKMYSSWVDEKSSNINMITELFTSGSLRQYRKKHKNVDMKA 122
Query: 129 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 188
IKNWARQILRGL +LHSHNPP+IHRDLKCDNIFVNGNNG+VKIGDLGLAIVMQQPTARSV
Sbjct: 123 IKNWARQILRGLCFLHSHNPPVIHRDLKCDNIFVNGNNGQVKIGDLGLAIVMQQPTARSV 182
Query: 189 IGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 248
IGTPEFMAPELYEEEYNELVD+YSFGMCILEM+TCEYPY+ECKNPAQIYKKVTSGIKPAS
Sbjct: 183 IGTPEFMAPELYEEEYNELVDVYSFGMCILEMITCEYPYSECKNPAQIYKKVTSGIKPAS 242
Query: 249 LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNL 308
L++V DP+VKQFIEKC+VPAS+RLPA ELLKDPFL T N K++ D L LPN + +N
Sbjct: 243 LARVNDPEVKQFIEKCLVPASMRLPASELLKDPFLATGNTKEIYHDNLLLPNPPSKSLNP 302
Query: 309 AHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTL--ELQRLTENNEFTLRGEKNDDDTVS 366
EPHPM+ID N K S S + + T ++ ++ R TENNEF LRGEKN D T+S
Sbjct: 303 PTCEPHPMEIDSNVKHTSPASTVERDKETSQVSSNHDILRKTENNEFRLRGEKNADRTIS 362
Query: 367 LTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVP 426
LTLRI D +G NIHF FY+++DT ISIAEEMVE L+L EDV IAELI N+I KLVP
Sbjct: 363 LTLRIADANGGARNIHFPFYIDSDTTISIAEEMVEHLELKDEDVAVIAELIHNMIFKLVP 422
Query: 427 SWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKY 486
W P L +S + L + P+ N L C GSNN +++ + S+L G+
Sbjct: 423 DWKP-LCENSSGTDNLYR--PLEPQNE-QLNCHWTLGSNNFDMKSMYEDLGHSQL-DGED 477
Query: 487 QYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESIL 546
Q QES SDISAE+ + DA K + + + H G D G+
Sbjct: 478 QDKQESVSSDISAEYGTVIATDA---KGVEQNCFILHECCKGSNGLNTNPDVRICGQE-- 532
Query: 547 FNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQEL 606
+ ++ SE S + CS S+NL S SL+ D++H D L+LE++AI +YQQ F+EL
Sbjct: 533 -DGNSNQSENSVVSCCSP-SENLDRLSKCSLTALDQDHLDELQLEIEAIEIQYQQSFREL 590
Query: 607 LRQREDEMENARKRWLAGSNVSVI 630
++ RE+ +EN +KRW + N+SV+
Sbjct: 591 MKMREEAIENVKKRWTSKKNISVM 614
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449452398|ref|XP_004143946.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus] gi|449529646|ref|XP_004171809.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1756), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/651 (58%), Positives = 456/651 (70%), Gaps = 39/651 (5%)
Query: 1 MDCGSGFT---KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQ 57
+ CGS SE ++ EKDPS RY RYDEILGKGAFKTVYK FDEV GIEVAW+Q
Sbjct: 47 LSCGSDLIMSGNSEADDRGIVEKDPSGRYIRYDEILGKGAFKTVYKAFDEVGGIEVAWSQ 106
Query: 58 VNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR- 116
V+IEDV+QSP+QL+RLYSEVHLLKSLKHENIIKFY+ WVDD ++TINMITELFTSGSLR
Sbjct: 107 VDIEDVLQSPEQLQRLYSEVHLLKSLKHENIIKFYSYWVDDKHKTINMITELFTSGSLRQ 166
Query: 117 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176
YRKKH+ VD+KA KNWARQILRGL YLH HNPPIIHRDLKCDNIFVNGN GEVKIGDLGL
Sbjct: 167 YRKKHRKVDLKAFKNWARQILRGLTYLHGHNPPIIHRDLKCDNIFVNGNTGEVKIGDLGL 226
Query: 177 AIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 236
AIVMQQPTARSVIGTPEFMAPELY+E+YNELVDIYSFGMC+LE+VTCEYPYNECKN AQI
Sbjct: 227 AIVMQQPTARSVIGTPEFMAPELYDEDYNELVDIYSFGMCMLEIVTCEYPYNECKNSAQI 286
Query: 237 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPL 296
+KKVTSGIKPASL KV DPQVKQFIEKC+VPAS RLPA ELLKDPFL ++PKD +
Sbjct: 287 FKKVTSGIKPASLEKVLDPQVKQFIEKCLVPASTRLPASELLKDPFLAAESPKDNSSELS 346
Query: 297 RLPNLVPEVMNLAHSEPHPMDIDLNHKKVSAD--SCAKSNTG-TWFLTLELQRLTENNEF 353
R N + +N HPM+ D N K+S S KSN G + F T ELQRLTENNE
Sbjct: 347 RSLNEHFKSVNPPLLGSHPMETDHNCTKLSGSVASSVKSNNGISHFSTQELQRLTENNEL 406
Query: 354 TLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSI 413
TL+G+ D +T+S LRI + G NIHF FYL++DT+++IA EMVEQL+LS+ED I
Sbjct: 407 TLKGDMTDHNTMSFHLRIAELYGKSRNIHFAFYLDSDTSLAIALEMVEQLELSNEDATII 466
Query: 414 AELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAV- 472
A+LID LI K VPSW P QQ SP +Q + + + F+E V
Sbjct: 467 AKLIDELIAKFVPSWKPCPNYCEEQQQN-TPHSPEAQEDKTFI--------SPFFSELVL 517
Query: 473 ------SQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLV------PDGY 520
+ + L+ LA + Q NQ+S S S E+ + D I K PD
Sbjct: 518 SSPMVAAARNNLTGLAKVEDQENQQSIISCASVEYIYSTVSDYSIGKGSECGEFGHPDCE 577
Query: 521 SAHYAVYDHGGHEVKADEV-SLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSL 579
A+ + G ++ A+ V SL +I F ++ S I SCS MSK LS SS S+LS+
Sbjct: 578 KAYIS---SGTIDLDAEAVGSLSTTIDF------AKPSLISSCSEMSKELSLSSFSTLSM 628
Query: 580 ADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSVI 630
+++H D LK+E+DAI+ +Y QC EL R RE+ +E+A+KRW++ + I
Sbjct: 629 EERDHQDELKMEIDAIDLQYHQCLCELSRMREEAIESAKKRWMSKKKATGI 679
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351724041|ref|NP_001236020.1| with no lysine kinase 8 [Glycine max] gi|225348645|gb|ACN87284.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 665 bits (1717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/604 (59%), Positives = 446/604 (73%), Gaps = 8/604 (1%)
Query: 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 78
EKDP+ RY RYDE+LGKGAFKTVYK FDEVDGIEVAWN++ +EDV+Q+P QL +LYSEVH
Sbjct: 8 EKDPTSRYARYDELLGKGAFKTVYKAFDEVDGIEVAWNRIGVEDVVQTPQQLGKLYSEVH 67
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQIL 137
LLKSLKH+N+IK YNSWVDDT TINMITELFTSGSLR YRKKHKNVDMKAIKNWARQIL
Sbjct: 68 LLKSLKHDNVIKLYNSWVDDTAGTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 127
Query: 138 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAP 197
RGL +LHS +PPI+HRDLKCDNIFVNGN+G VKIGDLGLAIVMQQPTARSVIGTPEFMAP
Sbjct: 128 RGLCFLHSQSPPIVHRDLKCDNIFVNGNSGLVKIGDLGLAIVMQQPTARSVIGTPEFMAP 187
Query: 198 ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257
ELYEEEYNELVDIYSFGMCILEMVTCEYPY+ECKNPAQIYKKVTSGIKPA+L+KV DP+V
Sbjct: 188 ELYEEEYNELVDIYSFGMCILEMVTCEYPYSECKNPAQIYKKVTSGIKPAALAKVNDPEV 247
Query: 258 KQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMD 317
KQFIEKC+VPAS+RL A ELLKDPFL T+N K++ D L+LPN +++NL EPHPM+
Sbjct: 248 KQFIEKCLVPASMRLSASELLKDPFLATENTKEINHDTLQLPNPHIKLVNLPKCEPHPME 307
Query: 318 IDLNHKKVS-ADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSG 376
ID ++ S S + + +L R+T+NN+ LRGEKN + T+SLTLRI D G
Sbjct: 308 IDSYSRRTSPGSSMGRIEETSQVSFFDLVRMTDNNKLMLRGEKNAESTISLTLRIPDACG 367
Query: 377 HVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTA 436
NIHF FY+++DTAISIAEEMVE L+L++EDV IAELI+++I KLVP+ P +
Sbjct: 368 GARNIHFPFYMDSDTAISIAEEMVEHLELTNEDVSVIAELINDMIAKLVPNSKPLCEKLS 427
Query: 437 SQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSD 496
S+ N L + S Q N C S++ +A+ + V S G Q QES SD
Sbjct: 428 SETNLLYRPSSEVQ-NGEQFNCHWPLQSSDYDMKAMYKDLVHSRPVDGDDQEKQESVMSD 486
Query: 497 ISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSET 556
ISA + + D+ K + PD + + + G +D G+ ++NS
Sbjct: 487 ISAACGITIASDS---KVVEPDIFI--FDEFWEGFFNSTSDIRFCGQEDGHKNQSENSVG 541
Query: 557 SFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMEN 616
S I+SC KN SSI SL+LADK+ S+GL+L+++AI++ + + F EL R++ +++
Sbjct: 542 SLINSCCCPFKNFDMSSICSLTLADKDPSEGLRLDIEAIDTYFDRRFLELEMMRQEAIKS 601
Query: 617 ARKR 620
A++R
Sbjct: 602 AKRR 605
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547519|ref|XP_003542159.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 657 bits (1695), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/604 (59%), Positives = 436/604 (72%), Gaps = 6/604 (0%)
Query: 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 78
EKD + RY RYDE+LGKGAFKTVYK FDEVDGIEVAWN +++EDV+Q+P QLE+LYSE+H
Sbjct: 8 EKDLTSRYARYDELLGKGAFKTVYKAFDEVDGIEVAWNMISVEDVVQTPQQLEKLYSEIH 67
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQIL 137
LLKSLKH+N+IK YNSWVDDT TINMITELFTSGSLR YR KHKNVDMKAIKNWARQIL
Sbjct: 68 LLKSLKHDNVIKLYNSWVDDTTGTINMITELFTSGSLRQYRNKHKNVDMKAIKNWARQIL 127
Query: 138 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAP 197
RGL +LH H+PPI+HRDLKCDNIFVNGN+G VKIGDLGLAIVMQQPTARSVIGTPEFMAP
Sbjct: 128 RGLCFLHCHSPPIVHRDLKCDNIFVNGNSGLVKIGDLGLAIVMQQPTARSVIGTPEFMAP 187
Query: 198 ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257
ELYEEEYNELVDIYSFGMCILEMVTCEYPY+EC NPAQIYKKVTSGIKPA+L+KV DP+V
Sbjct: 188 ELYEEEYNELVDIYSFGMCILEMVTCEYPYSECNNPAQIYKKVTSGIKPAALAKVNDPEV 247
Query: 258 KQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMD 317
KQFIEKC+VPAS+RL A ELLKDPFL T+N K++ D L LPN +++N EPHPM+
Sbjct: 248 KQFIEKCLVPASMRLSASELLKDPFLATENTKEINHDILELPNPHTKLVNPPTCEPHPME 307
Query: 318 IDLNHKKVS-ADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSG 376
ID ++ S S + + +L R+TENN+F LRGEKN + T+SLTLRI + G
Sbjct: 308 IDSKSRRTSPGSSMGRIEETSQVSFFDLVRMTENNKFMLRGEKNAESTISLTLRIANACG 367
Query: 377 HVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTA 436
NIHF FY+N+DTAISIAEEMVE L+L++EDV IAELI+++I KLVP+ P +
Sbjct: 368 GARNIHFPFYINSDTAISIAEEMVEHLELTNEDVSVIAELINDMIAKLVPNLKPLSEKLS 427
Query: 437 SQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSD 496
S + L + S Q N C S++ + V + V S G QES SD
Sbjct: 428 SGTDQLYRPSSEVQ-NGEQFNCHWPLQSSDYDMKPVFKDLVHSWPVDGDDLEKQESVMSD 486
Query: 497 ISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSET 556
IS E + V D+ K + PD + +D G+ ++NS
Sbjct: 487 ISVECGITVASDS---KVVEPDIFIFDEFWEGFDAFNSTSDVRFCGQEDGHKNQSENSSG 543
Query: 557 SFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMEN 616
S I+SC KN SSI SL+LADK+ S+GL+LE++AI++ ++Q F+EL R +E+
Sbjct: 544 SLINSCCCPFKNFDISSICSLTLADKDPSEGLRLEIEAIDTYFEQRFRELEMMRVAAIES 603
Query: 617 ARKR 620
++R
Sbjct: 604 LKRR 607
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255564615|ref|XP_002523302.1| kinase, putative [Ricinus communis] gi|223537390|gb|EEF39018.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1626), Expect = e-178, Method: Compositional matrix adjust.
Identities = 359/663 (54%), Positives = 448/663 (67%), Gaps = 51/663 (7%)
Query: 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL 73
+G+F E DP+ RY RYDE+LGKGAFKTVYKGFDEVDGIEVAWNQV I DV++SP LE+L
Sbjct: 28 KGDFVETDPTSRYVRYDEVLGKGAFKTVYKGFDEVDGIEVAWNQVRIADVLRSPKDLEKL 87
Query: 74 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNW 132
+SEVHLL+SLKHENI++ NSWVDD +TINMITELFTSG+LR YRKKHKNVDMKAIKNW
Sbjct: 88 HSEVHLLRSLKHENIMELCNSWVDDKKKTINMITELFTSGNLRQYRKKHKNVDMKAIKNW 147
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 192
ARQIL+GL YLH HNPPIIHRDLKCDNIFVNG+NG VKIGDLGLAI+MQQPTA SVIGTP
Sbjct: 148 ARQILQGLVYLHGHNPPIIHRDLKCDNIFVNGHNGVVKIGDLGLAIIMQQPTATSVIGTP 207
Query: 193 EFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 252
EFMA ELYEEEYNEL+DIYSFGMC+LEMVT EYPY+EC+NPAQIYKKVTSGIKPASL V
Sbjct: 208 EFMATELYEEEYNELIDIYSFGMCMLEMVTFEYPYSECRNPAQIYKKVTSGIKPASLGNV 267
Query: 253 TDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSE 312
+DPQVK+FI KC+VPAS RL A ELLKDPFL N + V DPL LPN P+ + S
Sbjct: 268 SDPQVKEFILKCLVPASERLSAKELLKDPFLQPQNLVEPVRDPLLLPNQYPKSSSATKSG 327
Query: 313 PHPMDIDLNHKKVSADSCAKSNT-GTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRI 371
P MDID ++K++S+ +C SN GT F E QR +N F L+G+++DD++VSLTLRI
Sbjct: 328 PLSMDIDADYKQISSSTCTGSNNEGTRFPVPEYQREHKNKVFKLKGKESDDNSVSLTLRI 387
Query: 372 GDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPS 431
D SG V NIHF+FYL++DTA+S+A EMV+QL+L+ DV IAE ID+LIMKL P W S
Sbjct: 388 ADSSGRVWNIHFLFYLDSDTALSVASEMVDQLELADHDVAFIAEFIDHLIMKLSPGWKLS 447
Query: 432 LGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLS---------ELA 482
+ ++ S + S+ CP + ++ +Q LS L
Sbjct: 448 SNYSLNELTSFYTASAALEN---SVACPWDSVLTTVLSQPAVEQEALSGMTTTPPEGSLQ 504
Query: 483 SGKYQYN--------------------QESSDSDISAEFDVPVILDAHIDKSL--VPD-- 518
+ + YN E DS S ++ V + D + +PD
Sbjct: 505 ADDFNYNDNRDGAVFHINYHSSPSFGYMEDQDSQTSGVSEILVEDVSSKDDRISELPDYN 564
Query: 519 ---------GYSAHYAVYD-HGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKN 568
GY++ + D + +++ ++ +GE I NE+ + SET F SG +
Sbjct: 565 TDGNCKYLNGYTSEPELRDSYSLRKLERNDSGVGECIPMNENAKVSETPF-PKLSGAPND 623
Query: 569 --LSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSN 626
++ SS SSL L K LKLELDAI ++YQ F++L R+RE+ +E+ +KRW A
Sbjct: 624 MSMTSSSSSSLYLVGKSMDTELKLELDAIEAQYQNWFRDLSRRREEALESTKKRWTAKKK 683
Query: 627 VSV 629
+ V
Sbjct: 684 LPV 686
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470964|ref|XP_002266888.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1624), Expect = e-178, Method: Compositional matrix adjust.
Identities = 357/633 (56%), Positives = 436/633 (68%), Gaps = 32/633 (5%)
Query: 13 EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
+E + EKDP+ RY R+ EILGKGAFKTVYK FDEVDGIE+AWNQV I+DV++SP+ LE+
Sbjct: 8 DEAAYVEKDPTGRYVRFKEILGKGAFKTVYKAFDEVDGIEIAWNQVKIDDVLRSPEDLEK 67
Query: 73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKN 131
LYSEVHLLKSLKHENIIKFYNSWVDD +T+NMITELFTSGSLR YRKKHKNVDMKAIKN
Sbjct: 68 LYSEVHLLKSLKHENIIKFYNSWVDDKKKTVNMITELFTSGSLRQYRKKHKNVDMKAIKN 127
Query: 132 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 191
WARQ+LRGL YLHSHNPPIIHRDLKCDNIFVNGN+GEVKIGDLGLAIVMQQPTARSVIGT
Sbjct: 128 WARQVLRGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIVMQQPTARSVIGT 187
Query: 192 PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251
PEFMAPELYEEEYNELVDIYSFGMC+LEMVT EYPYNECKNPAQIYKKVTSGIKPASL K
Sbjct: 188 PEFMAPELYEEEYNELVDIYSFGMCMLEMVTFEYPYNECKNPAQIYKKVTSGIKPASLCK 247
Query: 252 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 311
VTD Q+K+FI KC+ PAS RLPA ELLKDPF ++NPK+ + PL+LP+ P+ + L+ S
Sbjct: 248 VTDLQIKEFIVKCLAPASERLPAKELLKDPFFQSENPKEPIRVPLQLPSRSPKSIILSKS 307
Query: 312 EPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRI 371
P MDID +H ++S+ + ++N F LE QR+ +++EF LR +K +D+++SLTLR
Sbjct: 308 GPFSMDIDPDHPQLSSSTSTENNGSPDFPVLEFQRMYKSSEFRLRAKKINDNSISLTLRT 367
Query: 372 GDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNP- 430
D G V NIHF F L+ DT S+ EMVEQL+L+ +V IA+ ID +IM+L+P W P
Sbjct: 368 VDSYGPVKNIHFPFSLDTDTVHSVVGEMVEQLELAEHEVAFIADFIDYVIMRLLPGWKPP 427
Query: 431 ---SLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNA---FAEAVSQQGV------- 477
LG S P GN + C G N+ A A Q +
Sbjct: 428 RDDPLGGARSPN-----AEPPVLGNGNNHDCTISHGDGNSSPNLANAEDQDSLASAGLVT 482
Query: 478 LSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKAD 537
L+ AS K D +I + H + D Y H ++++ +
Sbjct: 483 LTVDASKKNDKTVGFGDYNIGGNYKGSN--GGHASEQESRDPY--------HEDYKLQRN 532
Query: 538 EVSLGESILFNESTQNSETSFIDSCSGMSK-NLSFSSISSLSLADKEHSDGLKLELDAIN 596
S+ E N+ +++ SF D SG+S S SSLSLAD + GLK ELDAI+
Sbjct: 533 NSSIEEFTPMNKFQKSTVLSF-DDLSGLSNVRSLTCSCSSLSLADIDQDPGLKQELDAID 591
Query: 597 SKYQQCFQELLRQREDEMENARKRWLAGSNVSV 629
+YQ FQEL R R + +E +KRW+ ++V
Sbjct: 592 LQYQHWFQELSRMRVEALEATKKRWMTKKKLAV 624
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 630 | ||||||
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.665 | 0.744 | 0.689 | 1.7e-166 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.657 | 0.730 | 0.624 | 1.8e-142 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.768 | 0.923 | 0.587 | 2.1e-141 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.655 | 0.741 | 0.626 | 4.6e-137 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.446 | 0.401 | 0.692 | 1.2e-128 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.434 | 0.531 | 0.700 | 1.1e-122 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.669 | 0.857 | 0.526 | 2.6e-118 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.460 | 0.528 | 0.641 | 1.4e-114 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.430 | 0.474 | 0.630 | 1.7e-105 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.460 | 0.923 | 0.577 | 1.2e-88 |
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1491 (529.9 bits), Expect = 1.7e-166, Sum P(3) = 1.7e-166
Identities = 295/428 (68%), Positives = 338/428 (78%)
Query: 1 MDCGSGFTK--SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV 58
M GSGF S EE +F+EKDPS RY RYD++LG+GAFKTVYK FDEVDGIEVAWN V
Sbjct: 1 MASGSGFLGQISSMEEADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLV 60
Query: 59 NIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-Y 117
+IEDVMQ P QLERLYSEVHLLK+LKHENIIK + SWVD+ N+TINMITELFTSGSLR Y
Sbjct: 61 SIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVY 120
Query: 118 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177
RKKH+ VD KAIKNWARQIL+GL+YLHS NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA
Sbjct: 121 RKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLA 180
Query: 178 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 237
V+QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPYNEC+N AQIY
Sbjct: 181 TVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIY 240
Query: 238 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLR 297
KKVTS IKP SL KV DPQV+QFIEKC++PAS R ALEL KDPFL D KD L
Sbjct: 241 KKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSAL--LA 298
Query: 298 LPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRG 357
+ + + E PMD+D N K S + + W T+ELQR+ EN EF LRG
Sbjct: 299 SSSTSSKYVRPPQLEHLPMDVDHNENK----SVSSNEDYPWSQTIELQRIAENKEFRLRG 354
Query: 358 EKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELI 417
E++DD T S+ LRI D SG +HF FYL +DTA +IAEEMVE+L L+ ++VV IA++I
Sbjct: 355 ERSDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEMVEELHLTSQEVVVIADMI 414
Query: 418 DNLIMKLV 425
D+ IM+L+
Sbjct: 415 DDFIMQLL 422
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1348 (479.6 bits), Expect = 1.8e-142, Sum P(2) = 1.8e-142
Identities = 269/431 (62%), Positives = 329/431 (76%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E + E E DP+ RY RY E++GKGAFKTVYK FDEVDGIEVAWNQV I+DV+QSP+ L
Sbjct: 12 EPPDPEVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCL 71
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAI 129
ERLYSEV LLKSLKH NII+FYNSW+DD N+T+N+ITELFTSGSLR YRKKH+ V+MKA+
Sbjct: 72 ERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAV 131
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 189
KNWARQIL GL YLH PPIIHRDLKCDNIF+NGN+GEVKIGDLGLA VM+Q A+SVI
Sbjct: 132 KNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVI 191
Query: 190 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249
GTPEFMAPELY+E YNEL DIYSFGMC+LEMVT +YPY ECKN AQIYKKV+SGIKPASL
Sbjct: 192 GTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASL 251
Query: 250 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV-PE---- 304
S+V DP+VKQFIEKC++PAS RL A ELL DPFL + + +PL LP++V P+
Sbjct: 252 SRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLT--MNNPLPLPDIVMPKEGAF 309
Query: 305 ----VMNLAHSEPHP---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRG 357
+M+ P + IDL+ N+G+ +E++R N F L+G
Sbjct: 310 GDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSGS--RCIEVRRAKRGNFFVLKG 367
Query: 358 EKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELI 417
E+ND+ +VSL LRI D++G V NIHF+FY DTA ++ EMVEQL+L+ ++V IAELI
Sbjct: 368 EENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTFIAELI 427
Query: 418 DNLIMKLVPSW 428
D L++ ++P+W
Sbjct: 428 DILLVNMIPTW 438
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1383 (491.9 bits), Expect = 2.1e-141, P = 2.1e-141
Identities = 293/499 (58%), Positives = 346/499 (69%)
Query: 13 EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
EE +F +KDP+ RY RY+++LG+GAFKTVYK FDEV+GIEVAWN ++IEDV+Q P QL+R
Sbjct: 2 EEADFVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDR 61
Query: 73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKN 131
LYSEVHLL SLKH+NIIK + SWVDD N++INMITELFTSGSL YRKKH+ VD KAI N
Sbjct: 62 LYSEVHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMN 121
Query: 132 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 191
WARQIL+GLHYLHS PP+IHRDLKCDNIFVNGN G+VKIGDLGLA VMQQPTARSVIGT
Sbjct: 122 WARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGT 181
Query: 192 PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251
PEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY EC+N AQIYKKVTSGIKP SLSK
Sbjct: 182 PEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSK 241
Query: 252 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 311
V DPQVKQFIEKC++PA R ALELLKD L D KD P +
Sbjct: 242 VDDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFKPAMP--PQC 299
Query: 312 EPHPMDIDLN-HKKVSADSCAKSNTGTWFL-TLELQRLTENNEFTLRGEKNDDDTVSLTL 369
E PMD++ + VS S AKS+ L T+E+QR+ E+ EF L GE+ DD S+ L
Sbjct: 300 EYRPMDVEYKKNTSVSICSSAKSSQECALLQTMEVQRVAESTEFKLSGERRDDVAASMAL 359
Query: 370 RIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWN 429
RI SG + F F L DTA ++ EMVE+LDLS +V IAE+ID LIMKL N
Sbjct: 360 RIAGSSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKLKA--N 417
Query: 430 PSLGSTASQQNGLLKGSPVSQGNSISL----KCPGEPGSN-NAFAEAVSQQGVLSELASG 484
SL + S + + S + IS + GS EAV + +LS
Sbjct: 418 RSLPNANSVYQSKDEEAGESMKSEISADYYHRVSSNEGSRLGCCCEAV--ESLLSSFLDS 475
Query: 485 KYQYNQESSDSDISAEFDV 503
+ + S+ D+ E +V
Sbjct: 476 CSMVSNKQSE-DLKTELNV 493
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1342 (477.5 bits), Expect = 4.6e-137, P = 4.6e-137
Identities = 270/431 (62%), Positives = 335/431 (77%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E + E E DP+CRY RY E++GKGA KTV+KGFDEVDGIEVAWNQV I+D++QSPD L
Sbjct: 12 EPPDPEVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCL 71
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAI 129
ERLYSEV LLKSLKH+NII+FYNSW+DD N+T+N+ITELFTSGSLR YRKKH+ V+MKA+
Sbjct: 72 ERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAV 131
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 189
K WARQIL GL YLHS +PPIIHRD+KCDNIF+NGN+GEVKIGDLGLA VM+Q A+SVI
Sbjct: 132 KCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVI 191
Query: 190 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249
GTPEFMAPELY+E YNEL DIYSFGMC+LEMVT EYPY EC+N AQIYKKV+SGIKPASL
Sbjct: 192 GTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASL 251
Query: 250 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD-PLRLPNLV-PEVMN 307
SKV DP+V +FIEKC++PAS RL A ELL D FL N LV + PL LP++V P+ +
Sbjct: 252 SKVKDPEVMKFIEKCLLPASERLSAEELLLDSFL---NVNGLVMNNPLPLPDIVMPKEGS 308
Query: 308 LAH----SEPHP------MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRG 357
SE P M ++L+ + +N+GT +E++R N F L+G
Sbjct: 309 FGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSGT--NCIEVRRAKRGNFFVLKG 366
Query: 358 EKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELI 417
E+ND+++VSL LRI D++G V NIHF+F+ DTA +++ EMVEQL+L+ ++V IAELI
Sbjct: 367 EENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVKFIAELI 426
Query: 418 DNLIMKLVPSW 428
D L++ L+P+W
Sbjct: 427 DVLLVNLIPNW 437
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1057 (377.1 bits), Expect = 1.2e-128, Sum P(3) = 1.2e-128
Identities = 196/283 (69%), Positives = 233/283 (82%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E + EF E DP+ RYGRY+E+LGKGA KTVY+ FDE +GIEVAWNQV + D +QSP+ L
Sbjct: 8 EPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL 67
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAI 129
ERLY E+HLLK+LKH+NI+KFY SWVD NR IN +TELFTSG+LR YR +HK V+++A+
Sbjct: 68 ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAM 127
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 189
K+W RQILRGLHYLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++++ A +
Sbjct: 128 KHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
Query: 190 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249
GTPEFMAPE+YEE YNELVDIYSFGMCILEMVT +YPY+EC +PAQIYKKV SG KP +L
Sbjct: 188 GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDAL 247
Query: 250 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL-VTDNPKDL 291
KV DP+VK FIEKC+ SLR+ A ELL DPFL + D DL
Sbjct: 248 YKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDL 290
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1039 (370.8 bits), Expect = 1.1e-122, Sum P(2) = 1.1e-122
Identities = 194/277 (70%), Positives = 234/277 (84%)
Query: 9 KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD 68
++ +EE EF E DP+ RYGRY E+LGKGAFK VY+ FD+++GIEVAWNQV ++D S +
Sbjct: 5 ENNSEE-EFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSE 63
Query: 69 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMK 127
L+RLYSEVHLLK+LKH++IIKFY SW+D + TIN+ITE+FTSG+LR YRKKHK VD++
Sbjct: 64 DLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLR 123
Query: 128 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TAR 186
A+K W+RQIL GL YLHSH+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++ + +A
Sbjct: 124 ALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAH 183
Query: 187 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 246
SVIGTPEFMAPELYEE+YN LVDIY+FGMC+LE+VT EYPY+EC N AQIY+KVTSGIKP
Sbjct: 184 SVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKP 243
Query: 247 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 283
A+L VTDPQV+ FIEKCI S RL A ELL DPFL
Sbjct: 244 AALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFL 280
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1165 (415.2 bits), Expect = 2.6e-118, P = 2.6e-118
Identities = 238/452 (52%), Positives = 310/452 (68%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E++ E+ E DP+ RYGRY+E+LGKG+ KTVY+GFDE GIEVAWNQV + D +QSP +L
Sbjct: 9 ESDYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQEL 68
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAI 129
ERLY E+HLLK+LKH++I+KFY SWVD NR IN +TE+FTSG+LR YR KHK V+++A+
Sbjct: 69 ERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAV 128
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 189
KNW RQILRGL+YLH+H+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA +Q A +
Sbjct: 129 KNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHCV 188
Query: 190 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249
GTPEFMAPE+Y+EEYN+LVDIYSFGMC+LEMVT +YPY+EC +PAQIYK+V SG KP L
Sbjct: 189 GTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDGL 248
Query: 250 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTD--------NPKDLVCD---PLRL 298
KV DP+V+ FIEKC+ SLRL A ELL D FL D + K L+ + PLR
Sbjct: 249 DKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCIDESDMRRVESEKGLIDEAGTPLRH 308
Query: 299 PNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNE------ 352
+P N +S + D N D +S+ LE Q + E
Sbjct: 309 SYHIPHYSNGYYSLYNQNQWDYN-----GDETVESHE---IDLLEFQNDDDEEEEDKRFG 360
Query: 353 ---FTLRGEKNDD-DTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHE 408
+++G++ D+ D + L L+ +K G V NI+F F + DTAIS+A EMVE+L++
Sbjct: 361 SVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDIETDTAISVAREMVEELEMDDR 420
Query: 409 DVVSIAELIDNLIMKLVPSWNPSLGSTASQQN 440
DV IA +ID I LVP+W+ S +++ +
Sbjct: 421 DVTKIANMIDGEIASLVPNWSIFCSSESNRSS 452
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 992 (354.3 bits), Expect = 1.4e-114, Sum P(2) = 1.4e-114
Identities = 190/296 (64%), Positives = 233/296 (78%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
+ E DPS RYGR+ E+LGKGA KTVYK FD+V G+EVAWNQV + +V +SP+ L+RLYSE
Sbjct: 15 YVETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRSPEPLQRLYSE 74
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQ 135
VHLLK+L HE+II++ SW+D RT N ITELFTSG+LR YR+K++ VD++AIK+WARQ
Sbjct: 75 VHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQ 134
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEF 194
IL GL YLH H+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA +++ A SVIGTPEF
Sbjct: 135 ILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEF 194
Query: 195 MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254
MAPELYEE+YNELVDIYSFGMC+LEM+T EYPY+EC NPAQIYKKVTSG P S +
Sbjct: 195 MAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQH 254
Query: 255 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLA 309
+ ++F+ KC+ S RLPA ELL DPFL + +DL PL RLP + + NLA
Sbjct: 255 TEAQRFVGKCLETVSRRLPAKELLADPFLAATDERDLA--PLFRLPQQLA-IQNLA 307
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 933 (333.5 bits), Expect = 1.7e-105, Sum P(2) = 1.7e-105
Identities = 172/273 (63%), Positives = 220/273 (80%)
Query: 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
E+ E DP+ RYGR+ EILG+GA KTVYK DE GIEVAW+QV +++V++S L+RLYS
Sbjct: 8 EYVETDPTGRYGRFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYS 67
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWAR 134
EVHLL +L H++II+FY SW+D N T+N ITELFTSG+LR Y+ K+ +D++AIK+WAR
Sbjct: 68 EVHLLSTLNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWAR 127
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPE 193
QIL GL YLH H+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA +++ +A S+IGTPE
Sbjct: 128 QILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPE 187
Query: 194 FMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253
FMAPELYEE YNEL+D+YSFGMC LEM+T E+PY+EC +PAQIYKKV G P + +V
Sbjct: 188 FMAPELYEENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVG 247
Query: 254 DPQVKQFIEKCIVPASLRLPALELLKDPFLVTD 286
D + ++FI KC+V AS R+ A ELL+DPFL +D
Sbjct: 248 DIEAQRFIGKCLVSASKRVSAKELLQDPFLASD 280
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 885 (316.6 bits), Expect = 1.2e-88, P = 1.2e-88
Identities = 172/298 (57%), Positives = 218/298 (73%)
Query: 1 MDCGSGF-TKSETEEGE--FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQ 57
M C S +SE ++ F E DP+ RYGRY E+LG GA K VY+ FD+ +GIEVAWNQ
Sbjct: 2 MTCASSDDNESEKDKDSESFVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQ 61
Query: 58 VNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR- 116
V + P ERLYSEV LLK+LK+ NII Y W D+ N T+N ITE+ TSG+LR
Sbjct: 62 VKLRCFSDDPAMTERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLRE 121
Query: 117 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176
YRKKH++V M+A+K W++QIL+GL YLH+H+P IIHRDL C NIFVNGN G+VKIGDLGL
Sbjct: 122 YRKKHRHVSMRALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGL 181
Query: 177 A-IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 235
A IV + A S++GTPEFMAPELYEE Y E+VDIYS+GMC+LE+V+ E PY+EC + A+
Sbjct: 182 AAIVGKNHLAHSILGTPEFMAPELYEENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAK 241
Query: 236 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPF---LVTDNPKD 290
IYK+V+ G+KP +L+KV DP+ K FIEKCI R A ELL DPF ++ D+ +D
Sbjct: 242 IYKRVSKGLKPEALNKVNDPEAKAFIEKCIAQPRARPSAAELLCDPFFDGILDDDDED 299
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6EU49 | WNK4_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5168 | 0.9365 | 0.9640 | yes | no |
| Q944Q0 | WNK8_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5498 | 0.8682 | 0.9715 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00031177 | hypothetical protein (596 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 630 | |||
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-69 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-68 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-61 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-55 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-54 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-52 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-50 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-50 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-45 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-41 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-40 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-40 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-39 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-38 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-38 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-37 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-36 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-36 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-36 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-35 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-35 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-34 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-34 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-34 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-33 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-32 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-32 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-32 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-30 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-30 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-30 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-29 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-28 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-28 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-28 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-28 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-28 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-27 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-26 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-24 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-24 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-24 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-24 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-23 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-22 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-22 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-22 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-20 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-19 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-18 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.001 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.002 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 6e-69
Identities = 96/260 (36%), Positives = 141/260 (54%), Gaps = 12/260 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E+LG+G+F +VY D+ G +A V + S ++LE L E+ +L SL+H NI++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSG--DSEEELEALEREIRILSSLQHPNIVR 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
+Y S D+ T+N+ E + GSL KK + I+ + RQIL GL YLHS+
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG-- 121
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEY 204
I+HRD+K NI V ++G VK+ D G A + SV GTP +MAPE+ EEY
Sbjct: 122 IVHRDIKGANILV-DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264
DI+S G ++EM T + P++E NP K+ S +P + + + K F+ KC
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240
Query: 265 IVP-ASLRLPALELLKDPFL 283
+ R A ELL+ PFL
Sbjct: 241 LRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 4e-68
Identities = 87/259 (33%), Positives = 132/259 (50%), Gaps = 15/259 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG+G+F VY D+ G VA + + + ER+ E+ +LK LKH NI++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI---KKDRERILREIKILKKLKHPNIVR 61
Query: 91 FYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
Y+ + D+ + ++ E G L KK + + + RQIL L YLHS
Sbjct: 62 LYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG-- 117
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPE-LYEEEYNEL 207
I+HRDLK +NI ++ +G VK+ D GLA + + +GTPE+MAPE L + Y +
Sbjct: 118 IVHRDLKPENILLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 208 VDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCI 265
VDI+S G IL E++T + P+ +++KK+ P + P+ K I K +
Sbjct: 177 VDIWSLG-VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235
Query: 266 VP-ASLRLPALELLKDPFL 283
V RL A E L+ PF
Sbjct: 236 VKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 6e-61
Identities = 80/263 (30%), Positives = 128/263 (48%), Gaps = 17/263 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G+F TVYK + G VA + + + + E+ +L+ L H NI++
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVR 62
Query: 91 FYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
+++ D + + ++ E G L Y + + K A QILRGL YLHS+
Sbjct: 63 LIDAFEDKDH--LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG-- 118
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE--LYEEEYN 205
IIHRDLK +NI ++ NG VKI D GLA + + + +GTP +MAPE L Y
Sbjct: 119 IIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 206 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASLSKVTD--PQVKQFI 261
VD++S G+ + E++T + P++ Q+ ++ K + + K I
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 262 EKCIVP-ASLRLPALELLKDPFL 283
+KC+ S R A E+L+ P+
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 1e-55
Identities = 79/256 (30%), Positives = 122/256 (47%), Gaps = 48/256 (18%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG+G F TVY D+ G +VA + ED S LE L E+ +LK L H NI+K Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED---SSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 93 NSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 150
+ D+ + + ++ E GSL+ ++ + I QIL GL YLHS+ I
Sbjct: 58 GVFEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--I 113
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNE 206
IHRDLK +NI ++ +NG+VK+ D GL+ ++ ++++GTP +MAPE+ Y+E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 207 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 266
DI+S G+ + E+ P++K I K +
Sbjct: 174 KSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199
Query: 267 P-ASLRLPALELLKDP 281
R A E+L+
Sbjct: 200 KDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 9e-54
Identities = 97/279 (34%), Positives = 145/279 (51%), Gaps = 19/279 (6%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
SE DP Y E +G+GA VYK D G EVA ++ + E + +E+
Sbjct: 13 SEGDPRELYKNL-EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-----QNKELIINEI 66
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKA--IKNWARQ 135
++K KH NI+ +Y+S++ + ++ E GSL V M I R+
Sbjct: 67 LIMKDCKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCRE 124
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 193
+L+GL YLHS N +IHRD+K DNI ++ +G VK+ D G A + ++ SV+GTP
Sbjct: 125 VLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPY 181
Query: 194 FMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSK 251
+MAPE+ + ++Y VDI+S G+ +EM E PY + P + ++ T GI P +
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIPPLKNPE 240
Query: 252 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 289
P+ K F+ KC+V R A ELL+ PFL PK
Sbjct: 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 4e-52
Identities = 94/262 (35%), Positives = 148/262 (56%), Gaps = 18/262 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-LERLYSEVHLLKSLKHENII 89
E+LG G+F +VY+G + DG A +V++ D Q+ + +++L E+ LL L+H NI+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 90 KFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
++ + ++ N + + EL GSL + KK+ + I+ + RQIL GL YLH N
Sbjct: 66 QYLGTEREEDN--LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN- 122
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELYEEE--YN 205
+HRD+K NI V+ NG VK+ D G+A V++ A+S G+P +MAPE+ ++ Y
Sbjct: 123 -TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 206 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIE 262
DI+S G +LEM T + P+++ + A ++K S P LS + K FI
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS----DEAKDFIL 236
Query: 263 KCI-VPASLRLPALELLKDPFL 283
KC+ SLR A ELL+ PF+
Sbjct: 237 KCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 1e-50
Identities = 78/267 (29%), Positives = 140/267 (52%), Gaps = 20/267 (7%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+Y+ I +GKG+F VY + DG ++++ + S + E +EV +LK L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNH 58
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSL-----RYRKKHKNVDMKAIKNWARQILRGL 140
NIIK+Y S+ + + ++ E G L + +K+ K + I +W Q+ L
Sbjct: 59 PNIIKYYESFEEKGK--LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE 198
YLHS I+HRD+K NIF+ +NG VK+GD G++ V+ A++V+GTP +++PE
Sbjct: 117 KYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173
Query: 199 LYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257
L + + YN DI+S G + E+ T ++P+ E +N ++ K+ G + + ++
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKG-QYPPIPSQYSSEL 231
Query: 258 KQFIEKCIVP-ASLRLPALELLKDPFL 283
+ + + R ++L+ PF+
Sbjct: 232 RNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-50
Identities = 88/258 (34%), Positives = 143/258 (55%), Gaps = 16/258 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +GKG F VYK + G EVA + +E S ++ E++ +E+ +LK KH NI+K
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKIINEIQILKKCKHPNIVK 61
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
+Y S++ I M E + GSL+ + ++ + I +++L+GL YLHS+
Sbjct: 62 YYGSYLKKDELWIVM--EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG- 118
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE-LYEEEYNE 206
IIHRD+K NI + ++GEVK+ D GL+ + AR +++GTP +MAPE + + Y+
Sbjct: 119 -IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 207 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCI 265
DI+S G+ +E+ + PY+E ++K T+G + K +D K F++KC+
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDE-FKDFLKKCL 235
Query: 266 VPA-SLRLPALELLKDPF 282
R A +LLK PF
Sbjct: 236 QKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 3e-45
Identities = 87/258 (33%), Positives = 141/258 (54%), Gaps = 14/258 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++G+GAF VYKG + G VA Q+++E + + L+ + E+ LLK+LKH NI+K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
+ S +T+ ++ +I E +GSLR KK + + Q+L+GL YLH
Sbjct: 64 YIGSI--ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG-- 119
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYEEE-YNE 206
+IHRD+K NI +G VK+ D G+A + SV+GTP +MAPE+ E +
Sbjct: 120 VIHRDIKAANILTTK-DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 207 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 266
DI+S G ++E++T PY + A +++ V P L + P++K F+ +C
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCFQ 236
Query: 267 P-ASLRLPALELLKDPFL 283
+LR A +LLK P++
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 82/265 (30%), Positives = 145/265 (54%), Gaps = 17/265 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +GKG+F TV K + DG + W +++ + M ++ ++L SEV++L+ LKH NI++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEK-QQLVSEVNILRELKHPNIVR 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSL-----RYRKKHKNVDMKAIKNWARQILRGLHYLHS 145
+Y+ +D +N+T+ ++ E G L + +K+ K ++ + I Q+L L+ H+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 146 HNPP---IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-L 199
+ P ++HRDLK NIF++ NN VK+GD GLA ++ + A++ +GTP +M+PE L
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 200 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
Y+E DI+S G I E+ P+ +N Q+ K+ G + ++ +
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASKIKEGKFR-RIPYRYSSELNE 240
Query: 260 FIEKCI-VPASLRLPALELLKDPFL 283
I+ + V R ELL+ P +
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-41
Identities = 91/267 (34%), Positives = 140/267 (52%), Gaps = 26/267 (9%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G G F VY + G +A ++ I+D P ++ + E+ +L+ LKH N++K+Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQD--NDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 93 NSWVDDTNRTINMITELFTSGSLRYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPII 151
V I M E + G+L +H + D I+ + Q+L GL YLHSH I+
Sbjct: 66 GVEVHREKVYIFM--EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IV 121
Query: 152 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGTPEFMAPELY----E 201
HRD+K NIF+ +NG +K+GD G A+ ++ T S+ GTP +MAPE+
Sbjct: 122 HRDIKPANIFL-DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 202 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVK 258
+ + DI+S G +LEM T + P++E N QI V +G KP SL P+ K
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL--SPEGK 238
Query: 259 QFIEKCIV--PASLRLPALELLKDPFL 283
F+++C+ P R A ELL+ PF+
Sbjct: 239 DFLDRCLESDP-KKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 90/264 (34%), Positives = 140/264 (53%), Gaps = 15/264 (5%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHE 86
R ++LG+GAF VY +D G E+A QV + D ++ ++ L E+ LLK+L+HE
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHS 145
I+++Y DD +I M E GS++ K + + + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDDETLSIFM--EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELY 200
+ I+HRD+K NI + + G VK+GD G + I +SV GTP +M+PE+
Sbjct: 123 NM--IVHRDIKGANI-LRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 201 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
E Y D++S G ++EM+T + P+ E + A I+K T P S V P +
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV-SPDARN 238
Query: 260 FIEKCIVPASLRLP-ALELLKDPF 282
F+ + V + + P A ELL+ F
Sbjct: 239 FLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 74/259 (28%), Positives = 133/259 (51%), Gaps = 16/259 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG+G+ VYK + G A +++++ + ++L E+ L+S + ++K Y
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDG---DEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 93 NSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPI 150
++ I+++ E GSL KK + + ARQIL+GL YLH+ + I
Sbjct: 66 GAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--I 121
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE-LYEEEYNEL 207
IHRD+K N+ +N + GEVKI D G++ V++ + +GT +M+PE + E Y+
Sbjct: 122 IHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180
Query: 208 VDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265
DI+S G+ +LE ++P+ + ++ + + G P+ ++ P+ + FI C+
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240
Query: 266 VP-ASLRLPALELLKDPFL 283
R A ELL+ PF+
Sbjct: 241 QKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 5e-40
Identities = 84/282 (29%), Positives = 135/282 (47%), Gaps = 30/282 (10%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+ + I GKG+F VYK D+ VA +++E+ + D++E + E+ L +
Sbjct: 2 LFTLLECI-GKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCR 57
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLH 144
I K+Y S++ + I M E GS K +D I R++L GL YLH
Sbjct: 58 SPYITKYYGSFLKGSKLWIIM--EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY-E 201
IHRD+K NI ++ G+VK+ D G++ + ++ + +GTP +MAPE+ +
Sbjct: 116 EEGK--IHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 202 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASL--SKVTDPQ 256
Y+E DI+S G+ +E+ E P ++ +P +V I P SL +K + P
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLSD-LHPM----RVLFLIPKNNPPSLEGNKFSKP- 226
Query: 257 VKQFIEKCIV--PASLRLPALELLKDPFL----VTDNPKDLV 292
K F+ C+ P R A ELLK F+ T L+
Sbjct: 227 FKDFVSLCLNKDPKE-RPSAKELLKHKFIKKAKKTSYLTLLI 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 5e-39
Identities = 78/244 (31%), Positives = 127/244 (52%), Gaps = 15/244 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+GKG F VYK +DG VA +V I ++M + E+ LLK L H N+IK+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 93 NSWVDDTNRTINMITELFTSGSLR-----YRKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
S+++ N +N++ EL +G L ++K+ + + + I + Q+ L ++HS
Sbjct: 69 ASFIE--NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEY 204
I+HRD+K N+F+ G VK+GDLGL T A S++GTP +M+PE ++E Y
Sbjct: 127 --IMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 205 NELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263
N DI+S G + EM + P Y + N + KK+ P + +++ + +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243
Query: 264 CIVP 267
CI P
Sbjct: 244 CINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 90/264 (34%), Positives = 144/264 (54%), Gaps = 12/264 (4%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHE 86
R ++LG+GAF VY +D G E+A QV + + ++ ++ L E+ LLK+L HE
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHS 145
I+++Y D RT+++ E GS++ + K + + + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELY 200
+ I+HRD+K NI + + G VK+GD G + I + +SV GTP +M+PE+
Sbjct: 125 NM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 201 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
E Y DI+S G ++EM+T + P+ E + A I+K T P V+D +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRD 240
Query: 260 FIEKCIVPASLRLPALELLKDPFL 283
F+++ V A LR A ELL+ F+
Sbjct: 241 FLKRIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 6e-38
Identities = 89/263 (33%), Positives = 142/263 (53%), Gaps = 12/263 (4%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHE 86
R ++LG+GAF VY +D G E+A QV + + ++ ++ L E+ LLK+L+HE
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHS 145
I+++Y D +T+ + E GS++ + K + + + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELY 200
+ I+HRD+K NI + + G VK+GD G + I M RSV GTP +M+PE+
Sbjct: 125 NM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 201 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
E Y D++S G ++EM+T + P+ E + A I+K T P S +++ +
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARD 240
Query: 260 FIEKCIVPASLRLPALELLKDPF 282
F+ V A R A ELL+ PF
Sbjct: 241 FLGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 85/265 (32%), Positives = 137/265 (51%), Gaps = 27/265 (10%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
E LG+G++ +VYK + G VA V +E+ +Q + E+ +LK I+
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE------IIKEISILKQCDSPYIV 61
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
K+Y S+ +T+ I M E +GS+ + +K + + I Q L+GL YLHS+
Sbjct: 62 KYYGSYFKNTDLWIVM--EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE-Y 204
IHRD+K NI +N G+ K+ D G++ + A+ +VIGTP +MAPE+ +E Y
Sbjct: 120 --KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PASLSKVTD--PQVKQ 259
N DI+S G+ +EM + PY++ I+ I P +LS P+
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNKPPPTLSDPEKWSPEFND 231
Query: 260 FIEKCIV-PASLRLPALELLKDPFL 283
F++KC+V R A++LL+ PF+
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 86/263 (32%), Positives = 142/263 (53%), Gaps = 12/263 (4%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHE 86
R ++LG+GAF VY +D G E+A QV + D ++ ++ L E+ LLK+L+H+
Sbjct: 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHS 145
I+++Y D + +++ E GS++ + K + + + + RQIL+G+ YLHS
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELY 200
+ I+HRD+K NI + + G VK+GD G + I M +SV GTP +M+PE+
Sbjct: 125 NM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 201 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
E Y D++S ++EM+T + P+ E + A I+K T KP V+D +
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRD 240
Query: 260 FIEKCIVPASLRLPALELLKDPF 282
F+++ V R A LL+ PF
Sbjct: 241 FLKQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 88/269 (32%), Positives = 132/269 (49%), Gaps = 24/269 (8%)
Query: 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLK 84
Y R E++G+GA+ VY+G G VA +N++ +P D + + EV LL L+
Sbjct: 3 YQRL-ELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLR 57
Query: 85 H---ENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLH 141
NI K+Y S++ I M E GS+R K + K I R++L L
Sbjct: 58 QSQPPNITKYYGSYLKGPRLWIIM--EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALK 115
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 199
Y+H +IHRD+K NI V N G VK+ D G+A ++ Q +++ + +GTP +MAPE+
Sbjct: 116 YIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV 172
Query: 200 YEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-KVTDPQ 256
E Y+ DI+S G+ I EM T PY A + KP L
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPY--SDVDAFRAMMLIPKSKPPRLEDNGYSKL 230
Query: 257 VKQFIEKCI--VPASLRLPALELLKDPFL 283
+++F+ C+ P RL A ELLK ++
Sbjct: 231 LREFVAACLDEEPKE-RLSAEELLKSKWI 258
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 63/229 (27%), Positives = 99/229 (43%), Gaps = 23/229 (10%)
Query: 28 RYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
+ LG+GAF VYKG E +VA + S ++ E E ++K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA---SEEEREEFLEEASIMKKL 58
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLH 141
H NI++ + ++TE G L + +KH + +K + A QI +G+
Sbjct: 59 SHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF-----MA 196
YL S N +HRDL N V N VKI D GL+ + MA
Sbjct: 117 YLESKN--FVHRDLAARNCLV-TENLVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWMA 172
Query: 197 PELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243
PE ++ ++ D++SFG+ + E+ T E PY N ++ + + G
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 84/260 (32%), Positives = 130/260 (50%), Gaps = 20/260 (7%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--EVHLLKSLKHENIIK 90
LGKG++ +VYK D A +V++ S Q ER + E+ +L S+ H NII
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDL----GSMSQKEREDAVNEIRILASVNHPNIIS 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRY----RKKHKN-VDMKAIKNWARQILRGLHYLHS 145
+ +++D I M E G L RKK + + + I Q+LRGL LH
Sbjct: 64 YKEAFLDGNKLCIVM--EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-Y 204
I+HRDLK NI + N VKIGDLG++ V+++ A++ IGTP +MAPE+++ Y
Sbjct: 122 QK--ILHRDLKSANILLV-ANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264
+ DI+S G + EM T P+ E ++ + KV G P + + ++ FI
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPP-IPPIYSQDLQNFIRSM 236
Query: 265 IVP-ASLRLPALELLKDPFL 283
+ LR ++L P +
Sbjct: 237 LQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 8e-36
Identities = 91/269 (33%), Positives = 132/269 (49%), Gaps = 32/269 (11%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
+LGKG + VY D + +A ++ D + L+ E+ L LKH NI+++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV----QPLHEEIALHSYLKHRNIVQY 70
Query: 92 YNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMK----AIKNWARQILRGLHYLHSHN 147
S D N + E GSL + K +K I + +QIL GL YLH +
Sbjct: 71 LGS--DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLG----LAIVMQQPTARSVIGTPEFMAPELYEE- 202
I+HRD+K DN+ VN +G VKI D G LA + P + GT ++MAPE+ ++
Sbjct: 129 --IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDKG 184
Query: 203 --EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYK----KVTSGIKPASLSKVTDP 255
Y DI+S G I+EM T + P+ E P A ++K K+ I P SLS
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI-PESLSA---- 239
Query: 256 QVKQFIEKCIVPASLRLP-ALELLKDPFL 283
+ K FI +C P + A +LL+DPFL
Sbjct: 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 70/246 (28%), Positives = 109/246 (44%), Gaps = 21/246 (8%)
Query: 30 DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+ LG+GAF VYKG +EVA V S Q+E E +++ L H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVA---VKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR-Y-RKKHKNVDMKAIKNWARQILRGLHYL 143
N++K ++ + ++ E G L Y RK + + + ++A QI RG+ YL
Sbjct: 61 PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE---FMAPE-L 199
S N IHRDL N V G N VKI D GL+ + G +MAPE L
Sbjct: 119 ESKN--FIHRDLAARNCLV-GENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 200 YEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258
E ++ D++SFG+ + E+ T E PY N ++ + + +G + +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLKNGYRLPQPPNCPPE-LY 233
Query: 259 QFIEKC 264
+ +C
Sbjct: 234 DLMLQC 239
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 79/260 (30%), Positives = 142/260 (54%), Gaps = 16/260 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+GKG+F V+K + D A Q+++ M ++ E + E +L L II+
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAI-DEARVLAKLDSSYIIR 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWAR--QILRGLHYLHSHN 147
+Y S++D +N++ E +G L K + + + W QIL GL +LHS
Sbjct: 64 YYESFLDK--GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-Y 204
I+HRD+K N+F++ + VKIGDLG+A ++ T A +++GTP +++PEL E++ Y
Sbjct: 122 --ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264
NE D+++ G+ + E T ++P+ + N + K+ G+ P +S++ Q+ Q I++C
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQC 236
Query: 265 IVPASLRLP-ALELLKDPFL 283
+ + P +LL++P L
Sbjct: 237 LTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 79/271 (29%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E++G GA VY + +VA ++++E + ++ L EV + H N++K
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLE---KCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSL----RYRKKHKNVDMKAIKNWARQILRGLHYLHSH 146
+Y S+V + M + GSL + +D I +++L+GL YLHS+
Sbjct: 64 YYTSFVVGDELWLVM--PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 147 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS------VIGTPEFMAPELY 200
IHRD+K NI + G +G VKI D G++ + R+ +GTP +MAPE+
Sbjct: 122 G--QIHRDIKAGNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 201 EEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV- 257
E+ Y+ DI+SFG+ +E+ T PY++ P ++ P SL D +
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQN-DPPSLETGADYKKY 236
Query: 258 ----KQFIEKCIV--PASLRLPALELLKDPF 282
++ I C+ P+ R A ELLK F
Sbjct: 237 SKSFRKMISLCLQKDPSK-RPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 72/247 (29%), Positives = 113/247 (45%), Gaps = 22/247 (8%)
Query: 30 DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+ LG+GAF VYKG + +EVA V S Q+E E +++ L H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVA---VKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIK--NWARQILRGLHY 142
NI+K ++ + ++ E G L Y +K++ ++ ++A QI RG+ Y
Sbjct: 61 PNIVKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE---FMAPE- 198
L S N IHRDL N V G N VKI D GL+ + V G +MAPE
Sbjct: 119 LESKN--FIHRDLAARNCLV-GENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 199 LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257
L E ++ D++SFG+ + E+ T E PY N A++ + + G + +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLKKGYRLPKPPNCPPE-L 233
Query: 258 KQFIEKC 264
+ + +C
Sbjct: 234 YKLMLQC 240
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 88/268 (32%), Positives = 142/268 (52%), Gaps = 23/268 (8%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-----LERLYSEVHLLKSLKHE 86
++G G+F +VY G + G +A QV + V S L+ L E+ LLK L+HE
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHS 145
NI+++ S +D + +N+ E GS+ + + ++N+ RQIL+GL+YLH+
Sbjct: 67 NIVQYLGSSLDADH--LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQQPTAR-SVIGTPEFMAP 197
IIHRD+K NI V+ N G +KI D G++ + + AR S+ G+ +MAP
Sbjct: 125 RG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 198 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256
E+ ++ Y DI+S G ++EM+T ++P+ +C I+ K+ P S ++ +
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASPEIPSNISS-E 239
Query: 257 VKQFIEKCIVP-ASLRLPALELLKDPFL 283
F+EK + R A ELLK PFL
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 78/264 (29%), Positives = 127/264 (48%), Gaps = 17/264 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLKHENI 88
+ LG GAF + Y+ D G +A QV + + +E L E+ L+ L H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHN 147
I+ + +D++ N+ E GS+ + K+ I N+ Q+LRGL YLH +
Sbjct: 66 IRMLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS------VIGTPEFMAPE-LY 200
IIHRD+K N+ ++ ++I D G A + + ++GT FMAPE L
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYPYN--ECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258
E+Y D++S G I+EM T + P+N + N + K+ S S+ + P ++
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241
Query: 259 QFIEKCI-VPASLRLPALELLKDP 281
+C+ + R P+ ELLK P
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 86/286 (30%), Positives = 149/286 (52%), Gaps = 24/286 (8%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
DP + +I G+G+ V D+ G +VA ++++ + + E L++EV
Sbjct: 13 DPGDPRSYLDNFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDL----RKQQRRELLFNEV 67
Query: 78 HLLKSLKHENIIKFYNSW-VDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQI 136
+++ +H NI++ Y+S+ V D + ++ E G+L H ++ + I +
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDE---LWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAV 124
Query: 137 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEF 194
L+ L +LH+ +IHRD+K D+I + ++G VK+ D G + + P +S++GTP +
Sbjct: 125 LKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 181
Query: 195 MAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKPAS--LS 250
MAPE+ Y VDI+S G+ ++EMV E PY NE P Q K++ + P L
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE--PPLQAMKRIRDNLPPKLKNLH 239
Query: 251 KVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 294
KV+ P+++ F+++ +V PA R A ELL PFL P +
Sbjct: 240 KVS-PRLRSFLDRMLVRDPAQ-RATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-33
Identities = 92/274 (33%), Positives = 145/274 (52%), Gaps = 18/274 (6%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP +Y R+++I G+GA TVY D G EVA Q+N++ Q P + E + +E+ ++
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKK-ELIINEILVM 70
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGL 140
+ KH NI+ + +S++ + ++ E GSL +D I R+ L+ L
Sbjct: 71 RENKHPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQAL 128
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE 198
+LHS+ +IHRD+K DNI + G +G VK+ D G I +Q +++GTP +MAPE
Sbjct: 129 EFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 199 LY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGIKPASLSKVTDP 255
+ + Y VDI+S G+ +EMV E PY NE NP + +Y T+G +
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLSA 243
Query: 256 QVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 288
+ F+ +C+ + R A ELL+ PFL P
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 80/269 (29%), Positives = 127/269 (47%), Gaps = 24/269 (8%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
Y+ I +G G + VYK D G VA + +E D E + E+ +LK +H
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRH 59
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYL 143
NI+ ++ S++ I M E GSL+ Y+ + I R+ L+GL YL
Sbjct: 60 PNIVAYFGSYLRRDKLWIVM--EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYE 201
H IHRD+K NI + +G+VK+ D G++ + A+ S IGTP +MAPE+
Sbjct: 118 HETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 202 EE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVT--D 254
E Y+ DI++ G+ +E+ + P + +P + ++ S P L
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPPPKLKDKEKWS 233
Query: 255 PQVKQFIEKCIVPASLRLP-ALELLKDPF 282
P FI+KC+ + P A +LL+ PF
Sbjct: 234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 94/295 (31%), Positives = 133/295 (45%), Gaps = 59/295 (20%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHE 86
E LG+G + VYK D+ G VA ++ +++ + E + S E+ LLK LKH
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN------EEEGIPSTALREISLLKELKHP 58
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLR-Y-RKKHKNVDMKAIKNWARQILRGLHYLH 144
NI+K + V T R + ++ E + L+ Y K+ + IK+ Q+LRGL Y H
Sbjct: 59 NIVKLLD--VIHTERKLYLVFE-YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPELY 200
SH I+HRDLK NI +N +G +K+ D GLA I ++ T V T + APE+
Sbjct: 116 SHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEIL 170
Query: 201 --EEEYNELVDIYSFGMCILEMVT--------CE------------YPYNE-----CKNP 233
+ Y+ VDI+S G EM+T E P E K P
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230
Query: 234 AQIYKKVTSGIKPASLSKVT---DPQVKQFIEK--CIVPASLRLPALELLKDPFL 283
YK P L KV DP+ + K PA R+ A E LK P+
Sbjct: 231 D--YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK-RISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (323), Expect = 2e-32
Identities = 82/372 (22%), Positives = 136/372 (36%), Gaps = 39/372 (10%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE- 86
R LG+G+F VY D VA + + ++ER E+ +L SL H
Sbjct: 3 RILRKLGEGSFGEVYLARDR---KLVALKVLAK-KLESKSKEVERFLREIQILASLNHPP 58
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSL----RYRKKHKNVDMKAIKNWARQILRGLHY 142
NI+K Y+ + D+ + + M E GSL + + + QIL L Y
Sbjct: 59 NIVKLYDFFQDEGSLYLVM--EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--------QQPTARSVIGTPEF 194
LHS IIHRD+K +NI ++ + VK+ D GLA ++ + +GTP +
Sbjct: 117 LHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 195 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPA 247
MAPE+ + DI+S G+ + E++T P+ +Q K + P+
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 248 SLSKV-------TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 299
S + ++K + RL + L L L L
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL---AHLKLKESDLSDL 291
Query: 300 NLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEK 359
+ L S P ++ ++ A S + + EL ++
Sbjct: 292 LKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSL 351
Query: 360 NDDDTVSLTLRI 371
S +
Sbjct: 352 LLSTASSKRSSL 363
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 62/238 (26%), Positives = 117/238 (49%), Gaps = 13/238 (5%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LGKG+F V + G A + + +++ ++E +E ++L + H I+K +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 93 NSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 151
++ + + ++ E G L K + + +A +I+ L YLHS II
Sbjct: 60 YAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--II 115
Query: 152 HRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 208
+RDLK +NI ++ +G +K+ D GLA + + + GTPE++APE L + Y + V
Sbjct: 116 YRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 209 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 266
D +S G+ + EM+T + P+ ++ +IY+K+ P + P+ + I +
Sbjct: 175 DWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQ 229
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 29/253 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---SPDQLERLYSEVHLLKSLKHEN 87
+ LG+GAF VYKG ++ G + +V ++ ++ S ++ + E ++K L H N
Sbjct: 1 KKLGEGAFGEVYKG--KLKGKDGKTTEVAVK-TLKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKN---------WARQIL 137
+++ V + ++ E G L Y +K + V K+ +A QI
Sbjct: 58 VVRLLG--VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 138 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPE--- 193
+G+ YL S +HRDL N V G + VKI D GL+ + R G
Sbjct: 116 KGMEYLASKK--FVHRDLAARNCLV-GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 194 FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 251
+MAPE L + + D++SFG+ + E+ T PY N ++ + + G +
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRKGYRLPKPEY 231
Query: 252 VTDPQVKQFIEKC 264
D ++ + + C
Sbjct: 232 CPD-ELYELMLSC 243
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 74/267 (27%), Positives = 126/267 (47%), Gaps = 46/267 (17%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ----LERLYSEVHLLKSLKHE 86
+I+G+G+F TV ++ E A ++ +++ +E+ EV L + H
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEK---EV-LTRLNGHP 62
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHS 145
IIK Y ++ D+ N + + E +G L +Y +K+ ++D K + +A +IL L YLHS
Sbjct: 63 GIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----------------------QQP 183
IIHRDLK +NI ++ + +KI D G A V+ +
Sbjct: 121 KG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 184 TARSVIGTPEFMAPELYEEEY-NELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVT 241
S +GT E+++PEL E+ + D+++ G CI+ +M+T + P+ N ++K
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFR-GSNEYLTFQK-- 233
Query: 242 SGIKPASLS--KVTDPQVKQFIEKCIV 266
I S P K IEK +V
Sbjct: 234 --ILKLEYSFPPNFPPDAKDLIEKLLV 258
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 92/274 (33%), Positives = 145/274 (52%), Gaps = 18/274 (6%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP +Y RY++I G+GA TV+ D G EVA Q+N +Q + E + +E+ ++
Sbjct: 16 DPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQIN----LQKQPKKELIINEILVM 70
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGL 140
K LK+ NI+ F +S++ + ++ E GSL +D I R+ L+ L
Sbjct: 71 KELKNPNIVNFLDSFL--VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQAL 128
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE 198
+LH++ +IHRD+K DN+ + G +G VK+ D G I +Q +++GTP +MAPE
Sbjct: 129 EFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 199 LYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGIKPASLSKVTDP 255
+ + Y VDI+S G+ +EMV E PY NE NP + +Y T+G + P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLSP 243
Query: 256 QVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 288
+ F+ +C+ + R A ELL+ PFL P
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 82/262 (31%), Positives = 140/262 (53%), Gaps = 15/262 (5%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
R ++ +G+G F VY+ +DG+ VA +V I D+M + + + + E+ LLK L H N
Sbjct: 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPN 63
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSL-----RYRKKHKNVDMKAIKNWARQILRGLHY 142
+IK+Y S+++D +N++ EL +G L ++K+ + + K + + Q+ L +
Sbjct: 64 VIKYYASFIEDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-L 199
+HS ++HRD+K N+F+ G VK+GDLGL T A S++GTP +M+PE +
Sbjct: 122 MHSRR--VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 200 YEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258
+E YN DI+S G + EM + P Y + N + KK+ P S +++
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
Query: 259 QFIEKCIVPASLRLPALELLKD 280
Q + CI P + P + + D
Sbjct: 239 QLVNMCINPDPEKRPDITYVYD 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 79/256 (30%), Positives = 137/256 (53%), Gaps = 14/256 (5%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
++G+GAF V+ + D V Q+ +E + + D+ +E +LK L H NII++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEY 64
Query: 92 YNSWVDDTNRTINMITELFTSGSL-RYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNP 148
Y ++++D I M E G+L Y +K N +D I ++ QIL LH++H+
Sbjct: 65 YENFLEDKALMIVM--EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELYE-EEYNE 206
I+HRDLK NI ++ + VKIGD G++ I+ + A +V+GTP +++PEL E + YN+
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 207 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI- 265
DI++ G + E+ + + + PA + K+ SG A +S P ++Q I +
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMSG-TFAPISDRYSPDLRQLILSMLN 238
Query: 266 VPASLRLPALELLKDP 281
+ S R +++ P
Sbjct: 239 LDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 86/279 (30%), Positives = 138/279 (49%), Gaps = 28/279 (10%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG GAF VYK + G+ A + IE ++LE E+ +L KH NI+ Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES----EEELEDFMVEIDILSECKHPNIVGLY 68
Query: 93 NSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 150
++ + ++ E G+L + + + I+ RQ+L L++LHSH +
Sbjct: 69 EAYFYENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--V 124
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE----- 203
IHRDLK NI + +G+VK+ D G++ + + + IGTP +MAPE+ E
Sbjct: 125 IHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 204 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQF 260
Y+ DI+S G+ ++E+ E P++E NP ++ K+ P SK + F
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSS-SFNDF 241
Query: 261 IEKCIVP-ASLRLPALELLKDPFL--VTDNP--KDLVCD 294
++ C+V R A ELLK PF+ +DN KDL+ +
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLLAE 280
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 95/278 (34%), Positives = 148/278 (53%), Gaps = 26/278 (9%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP +Y R+++I G+GA TVY D G EVA Q+N++ Q P + E + +E+ ++
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQ---QQPKK-ELIINEILVM 70
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGL 140
+ K+ NI+ + +S++ + ++ E GSL +D I R+ L+ L
Sbjct: 71 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQAL 128
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE 198
+LHS+ +IHRD+K DNI + G +G VK+ D G I +Q +++GTP +MAPE
Sbjct: 129 DFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 199 LY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPASLSK 251
+ + Y VDI+S G+ +EMV E PY NE NP + +Y T+G P LS
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPERLSA 243
Query: 252 VTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 288
V + F+ +C+ + R A ELL+ PFL P
Sbjct: 244 V----FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 85/267 (31%), Positives = 131/267 (49%), Gaps = 21/267 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKHENI 88
E+LGKGA+ TVY G G +A QV ++ +V+ + + E+L EV LLKSLKH NI
Sbjct: 6 EVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
+++ + +DD TI++ E GS+ + + + +QIL G+ YLH++
Sbjct: 65 VQYLGTCLDDN--TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--------VMQQPTARSVIGTPEFMAPEL 199
++HRD+K +N+ + NG +K+ D G A +S+ GTP +MAPE+
Sbjct: 123 --VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 200 YEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQV 257
E Y DI+S G + EM T + P A + Y G+ P L
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RLPDSFSAAA 238
Query: 258 KQFIEKCIVPASLRLP-ALELLKDPFL 283
F+ C+ P AL+LL+ FL
Sbjct: 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 18/201 (8%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLK 84
RY++ LG+G + VYK D+ G VA ++ + + ++ D + E+ LL+ LK
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKA--IKNWARQILRGLHY 142
H NII + + +N IN++ E F L K K++ + IK++ LRGL Y
Sbjct: 61 HPNIIGLLDVFGHKSN--INLVFE-FMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPEL 199
LHS+ I+HRDLK +N+ + ++G +K+ D GLA P + V+ T + APEL
Sbjct: 118 LHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPEL 173
Query: 200 Y--EEEYNELVDIYSFGMCIL 218
Y VD++S G CI
Sbjct: 174 LFGARHYGVGVDMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY+ + +G GA+ V D+ G +VA I +V +R+ E+ LL+ L+H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 86 ENIIKFYNSWVDDTN---RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHY 142
ENII + + + ++TEL + + K + + I+ + QILRGL Y
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKY 118
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM------- 195
LHS N +IHRDLK NI VN N ++KI D GLA + F+
Sbjct: 119 LHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDED-----EKGFLTEYVVTR 170
Query: 196 ---APE--LYEEEYNELVDIYSFGMCIL-EMVT 222
APE L Y + +DI+S G CI E++T
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 76/261 (29%), Positives = 133/261 (50%), Gaps = 20/261 (7%)
Query: 32 ILGKGAF--KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
+LGKGAF T+Y+ + D V W +VN+ + S + +E+ +L L+H NII
Sbjct: 7 VLGKGAFGEATLYRRTE--DDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNII 62
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLR---YRKKHKNVDMKAIKNWARQILRGLHYLHSH 146
+YN ++DD I M E G+L R+K + + + + + QI+ + Y+H
Sbjct: 63 AYYNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 147 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EE 203
I+HRD+K NIF+ G +K+GD G++ ++ A +V+GTP +M+PEL + +
Sbjct: 121 G--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 204 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263
YN DI++ G + E++T + + + NP + K+ G +S + ++ +
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPVVSVYSS-ELISLVHS 235
Query: 264 CI-VPASLRLPALELLKDPFL 283
+ R A E+L P L
Sbjct: 236 LLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 92/278 (33%), Positives = 147/278 (52%), Gaps = 26/278 (9%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP +Y R+++I G+GA TVY D G EVA Q+N++ Q P + E + +E+ ++
Sbjct: 17 DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 71
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGL 140
+ K+ NI+ + +S++ + ++ E GSL +D I R+ L+ L
Sbjct: 72 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQAL 129
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE 198
+LHS+ +IHRD+K DNI + G +G VK+ D G I +Q +++GTP +MAPE
Sbjct: 130 EFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 199 LY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPASLSK 251
+ + Y VDI+S G+ +EM+ E PY NE NP + +Y T+G P LS
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLSA 244
Query: 252 VTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 288
+ + F+ +C+ + R A ELL+ FL P
Sbjct: 245 I----FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIED-VMQSPDQLERLYSEVHLLKSLKHENII 89
+G+G + VYK ++ G VA ++ +E+ P R E+ LL+ L+H NI+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR---EIKLLQKLRHPNIV 61
Query: 90 KFYNSWVDDTNRTINMITELFT---SGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSH 146
+ +I M+ E +G L + K IK + +Q+L GL YLHS+
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLLD-SPEVK-FTESQIKCYMKQLLEGLQYLHSN 119
Query: 147 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS----VIGTPEFMAPELY-- 200
I+HRD+K NI +N N+G +K+ D GLA + + VI T + PEL
Sbjct: 120 G--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175
Query: 201 EEEYNELVDIYSFGMCIL-EMVT 222
Y VD++S G CIL E+
Sbjct: 176 ATRYGPEVDMWSVG-CILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 72/250 (28%), Positives = 132/250 (52%), Gaps = 15/250 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G+G F VY+ +D VA +V I ++M + + + E+ LLK L H N+IK+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPNVIKYL 68
Query: 93 NSWVDDTNRTINMITELFTSGSLR-----YRKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
+S+++D +N++ EL +G L ++K+ + + + + + Q+ + ++HS
Sbjct: 69 DSFIEDNE--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEY 204
++HRD+K N+F+ G VK+GDLGL T A S++GTP +M+PE ++E Y
Sbjct: 127 --VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 205 NELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263
N DI+S G + EM + P Y + N + +K+ P ++ ++++ +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243
Query: 264 CIVPASLRLP 273
CI P + P
Sbjct: 244 CIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 63/235 (26%), Positives = 107/235 (45%), Gaps = 10/235 (4%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G F V + A V + + Q E ++SE +L+ H I+K Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVK-KRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 93 NSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 151
++ D + I M+ E G L + D + + ++ YLH+ II
Sbjct: 60 RTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--II 115
Query: 152 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE-YNELVD 209
+RDLK +N+ ++ +NG VK+ D G A ++ + GTPE++APE+ + Y+ VD
Sbjct: 116 YRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVD 174
Query: 210 IYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263
+S G+ + E++T P+ E +P +IY + G D K I++
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 78/235 (33%), Positives = 128/235 (54%), Gaps = 17/235 (7%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIK 130
E L++EV +++ +HEN+++ YNS++ + ++ E G+L H ++ + I
Sbjct: 62 ELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA 119
Query: 131 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSV 188
+L+ L LH+ +IHRD+K D+I + ++G VK+ D G + + P +S+
Sbjct: 120 AVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSL 176
Query: 189 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP 246
+GTP +MAPEL Y VDI+S G+ ++EMV E PY NE P + K + + P
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPP 234
Query: 247 --ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 297
+L KV+ P +K F+++ +V PA R A ELLK PFL P + +R
Sbjct: 235 KLKNLHKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPSCIVPLMR 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 66/260 (25%), Positives = 123/260 (47%), Gaps = 15/260 (5%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G V K G +A + +E + +++ E+ +L I+ FY
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE---INEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 93 NSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 150
++ ++ + I++ E GSL ++ + + + A +L+GL YLH I
Sbjct: 66 GAFYNNGD--ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKI 122
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVD 209
IHRD+K NI VN + G++K+ D G++ + A++ +GT +MAPE + +Y+ D
Sbjct: 123 IHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSD 181
Query: 210 IYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265
I+S G+ ++E+ T +PY ++ + + + P S P + F+ C+
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCL 241
Query: 266 VPASLRLPAL-ELLKDPFLV 284
+ P+ ELL+ PF+
Sbjct: 242 IKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 87/273 (31%), Positives = 141/273 (51%), Gaps = 15/273 (5%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP + + ++I GKG+F V+KG D VA + I D+ ++ D++E + E+ +L
Sbjct: 1 DPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGL 140
+ K+Y S++ DT I I E GS + +D I R+IL+GL
Sbjct: 57 SQCDSPYVTKYYGSYLKDTKLWI--IMEYLGGGSALDLLEPGPLDETQIATILREILKGL 114
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE 198
YLHS IHRD+K N+ ++ +GEVK+ D G+A + Q + +GTP +MAPE
Sbjct: 115 DYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171
Query: 199 LYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257
+ ++ Y+ DI+S G+ +E+ E P++E +P ++ + P + P +
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNNPPTLEGNYSKP-L 229
Query: 258 KQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 289
K+F+E C+ S R A ELLK F+V K
Sbjct: 230 KEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 85/301 (28%), Positives = 145/301 (48%), Gaps = 21/301 (6%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
FS+ DP + EI G G+F VY D VA +++ QS ++ + + E
Sbjct: 8 FSKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKE 65
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWAR 134
V L+ L+H N I++ ++ + + M L ++ + ++K + V++ AI
Sbjct: 66 VRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI---CH 122
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
L+GL YLHSH IHRD+K NI + G VK+ D G A ++ A S +GTP +
Sbjct: 123 GALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVS--PANSFVGTPYW 177
Query: 195 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 250
MAPE+ E +Y+ VD++S G+ +E+ + P + +Y + +LS
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTLS 235
Query: 251 KVTDPQ-VKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMN 307
+ F++ C+ R + ELLK F++ + P ++ D + R + V E+ N
Sbjct: 236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRELDN 295
Query: 308 L 308
L
Sbjct: 296 L 296
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 25/271 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLLKSLK 84
E++GKG + VY + G +A QV + + D ++ L SE+ LK L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYL 143
H NI+++ + T +++ E GS+ + + + + ++ + Q+L GL YL
Sbjct: 67 HLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----AIVMQQPTARSVIGTPEFMAPE- 198
HS I+HRDLK DN+ V+ +G KI D G+ + S+ G+ +MAPE
Sbjct: 125 HSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 199 --LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK----KVTSGIKPASLSKV 252
Y + Y+ VDI+S G +LEM P+++ + A ++K + I P +
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241
Query: 253 TDPQVKQFIEKCIVPASLRLP-ALELLKDPF 282
+ P F+ C P A ELL+ PF
Sbjct: 242 S-PVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 78/272 (28%), Positives = 141/272 (51%), Gaps = 19/272 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G+G+ V ++ G +VA +++ ++ + E L++EV +++ HEN++ Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD----LRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 93 NSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 152
NS++ + ++ E G+L H ++ + I +LR L YLH+ +IH
Sbjct: 86 NSYL--VGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG--VIH 141
Query: 153 RDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEE-EYNELVD 209
RD+K D+I + ++G +K+ D G + + P +S++GTP +MAPE+ Y VD
Sbjct: 142 RDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 210 IYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV 266
I+S G+ ++EM+ E PY NE P Q +++ + P KV+ ++ F++ +V
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNE--PPLQAMRRIRDNLPPRVKDSHKVSS-VLRGFLDLMLV 257
Query: 267 -PASLRLPALELLKDPFLVTDNPKDLVCDPLR 297
S R A ELL+ PFL P + +R
Sbjct: 258 REPSQRATAQELLQHPFLKLAGPPSCIVPLMR 289
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 73/270 (27%), Positives = 132/270 (48%), Gaps = 22/270 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG+GA +V K + G+ A + +PD +++ E+ + KS K I+K
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTIT---TDPNPDLQKQILRELEINKSCKSPYIVK 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSL-----RYRKKHKNVDMKAIKNWARQILRGLHYLHS 145
+Y +++D+++ +I + E GSL + +K+ + K + A +L+GL YLHS
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEY 204
IIHRD+K NI + G+VK+ D G++ + A + GT +MAPE + + Y
Sbjct: 124 RK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPY 180
Query: 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD-PQV------ 257
+ D++S G+ +LE+ +P+ P ++ S I ++ D P
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240
Query: 258 --KQFIEKCIVPASLRLPA-LELLKDPFLV 284
K FI++C+ R P ++L+ P++
Sbjct: 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 83/291 (28%), Positives = 140/291 (48%), Gaps = 44/291 (15%)
Query: 20 KDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
DP+ G ++ E++G+G + VYK + G VA + I D++ D+ E + E
Sbjct: 2 PDPT---GIFELVEVIGEGTYGKVYKARHKKTGQLVA---IKIMDII--EDEEEEIKEEY 53
Query: 78 HLLKSL-KHENIIKFYNSWV--DDTNR--TINMITELFTSGSL-----RYRKKHKNVDMK 127
++L+ H NI FY +++ + + ++ EL GS+ RKK K + +
Sbjct: 54 NILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEE 113
Query: 128 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR- 186
I R+ LRGL YLH + +IHRD+K NI + N EVK+ D G++ + R
Sbjct: 114 WIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRR 170
Query: 187 -SVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA----- 234
+ IGTP +MAPE+ + Y+ D++S G+ +E+ + P C
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--CDMHPMRALF 228
Query: 235 QIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 283
+I + +K P + SK + FI +C++ + P ELL+ PF+
Sbjct: 229 KIPRNPPPTLKSPENWSK----KFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 66/267 (24%), Positives = 123/267 (46%), Gaps = 23/267 (8%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+ KGA+ V+ + G A + + M +Q++++ +E +L + ++K Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIK-KADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 93 NSWVDDTNRTINMITELFTSGSLRYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPII 151
S+ N + ++ E G L ++ D + + +I+ L YLHS+ II
Sbjct: 60 YSFQGKKN--LYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--II 115
Query: 152 HRDLKCDNIFVNGNNGEVKIGDLGL--------AIVMQQPTARS--VIGTPEFMAPE-LY 200
HRDLK DNI ++ +NG +K+ D GL I + ++GTP+++APE +
Sbjct: 116 HRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260
+ +++ VD +S G + E + P++ + P +I++ + +G +
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233
Query: 261 IEKCIVPASL-RLPAL---ELLKDPFL 283
I K +VP RL A E+ PF
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 70/241 (29%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G G F V+ D + A + I +V+ Q + +++E +LK + H II+ +
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 93 NSWVDDTNRTINMITELFTSGS----LRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
+ D + M+ E G LR + N +A +I+ L YLHS
Sbjct: 68 WTEHDQRF--LYMLMEYVPGGELFSYLRNSGRFSN---STGLFYASEIVCALEYLHSKE- 121
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNEL 207
I++RDLK +NI ++ G +K+ D G A ++ T ++ GTPE++APE+ + + +N+
Sbjct: 122 -IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTW-TLCGTPEYLAPEVIQSKGHNKA 178
Query: 208 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQFIEKCI 265
VD ++ G+ I EM+ P+ + NP IY+K+ +G ++ P L D K I+K +
Sbjct: 179 VDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLEFPRHL----DLYAKDLIKKLL 233
Query: 266 V 266
V
Sbjct: 234 V 234
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 82/268 (30%), Positives = 134/268 (50%), Gaps = 15/268 (5%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP + + + I GKG+F VYKG D VA + I D+ ++ D++E + E+ +L
Sbjct: 1 DPEELFTKLERI-GKGSFGEVYKGIDNRTKEVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGL 140
I ++Y S++ T I I E GS K ++ I R+IL+GL
Sbjct: 57 SQCDSPYITRYYGSYLKGTKLWI--IMEYLGGGSALDLLKPGPLEETYIATILREILKGL 114
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE 198
YLHS IHRD+K N+ ++ G+VK+ D G+A + Q + +GTP +MAPE
Sbjct: 115 DYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171
Query: 199 LYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257
+ ++ Y+ DI+S G+ +E+ E P ++ +P ++ + P + + P
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNSPPTLEGQYSKP-F 229
Query: 258 KQFIEKCI-VPASLRLPALELLKDPFLV 284
K+F+E C+ R A ELLK F+
Sbjct: 230 KEFVEACLNKDPRFRPTAKELLKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 83/273 (30%), Positives = 135/273 (49%), Gaps = 15/273 (5%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP + + + I GKG+F V+KG D VA + I D+ ++ D++E + E+ +L
Sbjct: 1 DPEELFTKLERI-GKGSFGEVFKGIDNRTQQVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGL 140
+ K+Y S++ T I I E GS + D I ++IL+GL
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWI--IMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGL 114
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE 198
YLHS IHRD+K N+ ++ G+VK+ D G+A + Q + +GTP +MAPE
Sbjct: 115 DYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171
Query: 199 LYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257
+ ++ Y+ DI+S G+ +E+ E P N +P ++ + P + +
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGE-PPNSDMHPMRVLFLIPKNNPPTLTGEFSK-PF 229
Query: 258 KQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 289
K+FI+ C+ S R A ELLK F+V + K
Sbjct: 230 KEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 71/262 (27%), Positives = 134/262 (51%), Gaps = 15/262 (5%)
Query: 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
+ ++GKG++ V DG + ++N+ + S + + E LL LKH NI
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNI 61
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDM---KAIKNWARQILRGLHYLHS 145
+ + SW + + + ++ G L ++ K + + + W QI L YLH
Sbjct: 62 VAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELYEEE 203
+ I+HRDLK N+F+ N +K+GDLG+A V+ Q A ++IGTP +M+PEL+ +
Sbjct: 121 KH--ILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177
Query: 204 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262
YN D+++ G C+ EM T ++ +N + +Y+ + + P + K P++ + I
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--MPKDYSPELGELIA 235
Query: 263 KCIVPASLRLPALE-LLKDPFL 283
+ + P+++ +L+ P++
Sbjct: 236 TMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 73/208 (35%), Positives = 107/208 (51%), Gaps = 25/208 (12%)
Query: 29 YDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNI---EDVMQSPDQLERLYSEVHLLKSL 83
Y+E+ +G+GA+ TVYK D G VA +V + E+ + P R E+ LLK L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI--PLSTLR---EIALLKQL 55
Query: 84 K---HENIIKFYN---SWVDDTNRTINMITELFTSGSLRYRKKH--KNVDMKAIKNWARQ 135
+ H NI++ + D + ++ E Y K + + IK+ RQ
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEF 194
+LRG+ +LHSH I+HRDLK NI V ++G+VKI D GLA + A SV+ T +
Sbjct: 116 LLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWY 172
Query: 195 MAPE-LYEEEYNELVDIYSFGMCIL-EM 220
APE L + Y VD++S G CI E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVG-CIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 24/264 (9%)
Query: 33 LGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
LGKG+F TVY K + ++V ++ + ++ +P++ + E LL L H I
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVL-KEIPVGEL--NPNETVQANQEAQLLSKLDHPAI 64
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSL-----RYRKKHKNVDMKAIKNWARQILRGLHYL 143
+KF+ S+++ I ITE L + K + + W Q+L G+HY+
Sbjct: 65 VKFHASFLERDAFCI--ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LY 200
H I+HRDLK NIF+ N +KIGD G++ ++ A + GTP +M+PE L
Sbjct: 123 HQRR--ILHRDLKAKNIFLKNN--LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260
+ Y+ DI+S G + EM + + E +N + ++ G P SL + Q+
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP-SLPETYSRQLNSI 236
Query: 261 IEKCIVP-ASLRLPALELLKDPFL 283
++ + SLR A E+L++PF+
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 74/265 (27%), Positives = 128/265 (48%), Gaps = 17/265 (6%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY+ + +G+G+F +Y + D ++++ + + + EV LL +KH
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMKH 58
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDM---KAIKNWARQILRGLHY 142
NI+ F+ S+ ++ I M E G L R + + I +W QI GL
Sbjct: 59 PNIVTFFASFQENGRLFIVM--EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK- 115
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY 200
H H+ I+HRD+K NIF++ N K+GD G+A + A + +GTP +++PE+
Sbjct: 116 -HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC 174
Query: 201 EEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
+ YN DI+S G + E+ T ++P+ E N Q+ K+ G A +S ++
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQG-YFAPISPNFSRDLRS 232
Query: 260 FIEKCIVPASLRLPAL-ELLKDPFL 283
I + + P++ +LK PFL
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
++GKGAF V A +N + + + + +E +L+ L H ++
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPFLVNL 65
Query: 92 YNSWVDDTNRTINMITELFTSGSLRYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPI 150
+ S+ D+ N + ++ +L G LRY K + +K W +I+ L YLHS I
Sbjct: 66 WYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--I 121
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELY-EEEYNELV 208
IHRD+K DNI ++ G V I D +A V S GTP +MAPE+ + Y+ V
Sbjct: 122 IHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAV 180
Query: 209 DIYSFGMCILEMVTCEYPYN 228
D +S G+ E + + PY
Sbjct: 181 DWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 83/278 (29%), Positives = 140/278 (50%), Gaps = 17/278 (6%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP Y +I G+G+ V ++ G +VA V + D ++ + E L++EV ++
Sbjct: 18 DPRSLLENYIKI-GEGSTGIVCIAREKHSGRQVA---VKMMD-LRKQQRRELLFNEVVIM 72
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGL 140
+ +H+N+++ Y S++ + ++ E G+L ++ + I +L+ L
Sbjct: 73 RDYQHQNVVEMYKSYL--VGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQAL 130
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE 198
YLHS +IHRD+K D+I + +G VK+ D G I P +S++GTP +MAPE
Sbjct: 131 CYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 187
Query: 199 LYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQ 256
+ Y VDI+S G+ ++EMV E PY +P Q K++ P + P
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISPV 246
Query: 257 VKQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 292
++ F+E+ + R A ELL PFL+ T P+ LV
Sbjct: 247 LRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLV 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 78/272 (28%), Positives = 139/272 (51%), Gaps = 24/272 (8%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG GAF VYK ++ G+ A ++ +S ++LE E+ +L S H NI+K
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVID----TKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 93 NSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 150
+++ + N I + E G++ + + + I+ +Q L L+YLH + I
Sbjct: 69 DAFYYENNLWI--LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--I 124
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY------EE 202
IHRDLK NI +G++K+ D G++ + R S IGTP +MAPE+ +
Sbjct: 125 IHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 203 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQF 260
Y+ D++S G+ ++EM E P++E NP ++ K+ +P +L++ + + K F
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKS-EPPTLAQPSRWSSEFKDF 241
Query: 261 IEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 291
++KC+ R +LL+ PF+ ++ K +
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 74/256 (28%), Positives = 131/256 (51%), Gaps = 35/256 (13%)
Query: 31 EILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
+ LG G+F V +KG + A ++ +++ Q+E + +E +L+S++H
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKY----YALKILSKAKIVKL-KQVEHVLNEKRILQSIRHP 61
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHS 145
++ Y S+ DD+N + ++ E G L + +K + +A Q++ L YLHS
Sbjct: 62 FLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-Y 204
+ I++RDLK +N+ + ++G +KI D G A ++ T ++ GTPE++APE+ + Y
Sbjct: 120 LD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGRT-YTLCGTPEYLAPEIILSKGY 175
Query: 205 NELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGIKPASLSKVT-----DPQV 257
+ VD ++ G+ I EM+ YP +++ NP QIY+K+ G KV P
Sbjct: 176 GKAVDWWALGILIYEML-AGYPPFFDD--NPIQIYEKILEG-------KVRFPSFFSPDA 225
Query: 258 KQFIEK-CIVPASLRL 272
K I V + RL
Sbjct: 226 KDLIRNLLQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 71/201 (35%), Positives = 108/201 (53%), Gaps = 18/201 (8%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---SPDQLERLYSEVHLLKS 82
RY ++ +G GAF V D++ G VA I+ +M+ +P +R Y E+ LLK
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVA-----IKKIMKPFSTPVLAKRTYRELKLLKH 65
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHY 142
L+HENII + ++ I +TEL + L + ++ + I+ + QILRGL Y
Sbjct: 66 LRHENIISLSDIFISPLE-DIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRGLKY 123
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LY 200
+HS ++HRDLK NI +N N ++KI D GLA + Q P + T + APE L
Sbjct: 124 VHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARI-QDPQMTGYVSTRYYRAPEIMLT 179
Query: 201 EEEYNELVDIYSFGMCILEMV 221
++Y+ VDI+S G EM+
Sbjct: 180 WQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 75/210 (35%), Positives = 106/210 (50%), Gaps = 29/210 (13%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM---QSPDQLERLYSEVHLLKS 82
RY + +G GA+ V FD G +VA I+ + QS +R Y E+ LLK
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVA-----IKKLSRPFQSAIHAKRTYRELRLLKH 70
Query: 83 LKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILR 138
+ HEN+I + + ++ + + ++T L + K K D I+ QILR
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDH-IQFLVYQILR 129
Query: 139 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFM 195
GL Y+HS IIHRDLK NI VN + E+KI D GLA + T + G T +
Sbjct: 130 GLKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA----RHTDDEMTGYVATRWYR 182
Query: 196 APE--LYEEEYNELVDIYSFGMCIL-EMVT 222
APE L YN+ VDI+S G CI+ E++T
Sbjct: 183 APEIMLNWMHYNQTVDIWSVG-CIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-23
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 17/200 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG+G + TVYKG + G VA +++++ +P R E+ L+K LKHENI++
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVR 62
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHKN---VDMKAIKNWARQILRGLHYLHSHN 147
++ V T + ++ E +Y H +D +K++ Q+L+G+ + H +
Sbjct: 63 LHD--VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEE 203
++HRDLK N+ +N GE+K+ D GLA P T + + T + AP+ L
Sbjct: 121 --VLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 204 YNELVDIYSFGMCIL-EMVT 222
Y+ +DI+S G CI+ EM+T
Sbjct: 178 YSTSIDIWSVG-CIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 18/198 (9%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G+G + VYK D++ G VA ++ + +S + E+ LLK L H NIIK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 93 NSWVDDTNRTINMITELFTSG---SLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
+ V + ++ E + ++ R++ + IK++ Q+L+GL + HSH
Sbjct: 65 D--VFRHKGDLYLVFEFMDTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCHSHG-- 118
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELY--EEEYN 205
I+HRDLK +N+ +N G +K+ D GLA + T + APEL ++ Y+
Sbjct: 119 ILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 206 ELVDIYSFGMCIL-EMVT 222
VDI+S G CI E+++
Sbjct: 178 TPVDIWSVG-CIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 68/212 (32%), Positives = 110/212 (51%), Gaps = 20/212 (9%)
Query: 24 CRYGRYDEILGKGAFKTVYKG-FDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
R+ ++ + LG+G F V +D + G +VA +N Q ER E+ +
Sbjct: 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEI 59
Query: 80 LKSLKHENIIKFYNSWVDDTN-RTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQI 136
L++L HENI+K Y + R++ +I E SGSLR Y ++H+ +++K + ++ QI
Sbjct: 60 LRTLDHENIVK-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118
Query: 137 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP 192
+G+ YL S IHRDL NI V + VKI D GLA V+ + + +P
Sbjct: 119 CKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 193 EF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 222
F APE L +++ D++SFG+ + E+ T
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 81/269 (30%), Positives = 133/269 (49%), Gaps = 21/269 (7%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+Y EILG G TVYK + + +A V + + + + +++ SE+ +L
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILA---VKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSH 146
II FY ++ + NR I++ TE GSL YRK ++V + A +++GL YL S
Sbjct: 61 IIGFYGAFFVE-NR-ISICTEFMDGGSLDVYRKIPEHV----LGRIAVAVVKGLTYLWSL 114
Query: 147 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYN 205
I+HRD+K N+ VN G+VK+ D G++ + A++ +GT +MAPE + E+Y
Sbjct: 115 K--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYG 171
Query: 206 ELVDIYSFGMCILEMVTCEYPY-----NECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
D++S G+ +E+ +PY N+ P Q+ + + P +
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231
Query: 260 FIEKCIVPASLRLPALELLKD-PFLVTDN 287
FI +C+ PA E L D PF+V N
Sbjct: 232 FITQCMRKQPKERPAPENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 3e-22
Identities = 78/270 (28%), Positives = 130/270 (48%), Gaps = 26/270 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENII 89
E++G G + VYKG G A + + DV + D+ E + E+++LK H NI
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAA---IKVMDV--TGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 90 KFYNSWVDDT----NRTINMITELFTSGS---LRYRKKHKNVDMKAIKNWARQILRGLHY 142
+Y +++ + + ++ E +GS L K + + I R+ILRGL +
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY 200
LH H +IHRD+K N+ + N EVK+ D G++ + + R + IGTP +MAPE+
Sbjct: 127 LHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 201 ------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254
+ Y+ D++S G+ +EM P + +P + + P SK
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKWS 242
Query: 255 PQVKQFIEKCIVPASLRLPALE-LLKDPFL 283
+ + FIE C+V + P E L+K PF+
Sbjct: 243 KKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-22
Identities = 82/270 (30%), Positives = 133/270 (49%), Gaps = 26/270 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NII 89
E++G G + VYKG G A + + DV + D+ E + E+++LK H NI
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTE--DEEEEIKLEINMLKKYSHHRNIA 76
Query: 90 KFYNSWVDDT----NRTINMITELFTSGSLR-YRKKHKNVDMKA--IKNWARQILRGLHY 142
+Y +++ + + + ++ E +GS+ K K +K I R+ILRGL +
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY 200
LH+H +IHRD+K N+ + N EVK+ D G++ + + R + IGTP +MAPE+
Sbjct: 137 LHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193
Query: 201 ------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254
+ Y+ DI+S G+ +EM P + +P + + P SK
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPPPKLKSKKWS 252
Query: 255 PQVKQFIEKCIVPASLRLPALE-LLKDPFL 283
+ FIE C+V L P+ E LLK PF+
Sbjct: 253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 7e-22
Identities = 88/302 (29%), Positives = 150/302 (49%), Gaps = 19/302 (6%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
F + DP + EI G G+F VY D + VA +++ QS ++ + + E
Sbjct: 8 FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKE 65
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWAR 134
V L+ L+H N I++ ++ + + M L ++ L ++K + V++ A+ + A
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA- 124
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
L+GL YLHSHN +IHRD+K NI ++ G VK+GD G A +M A +GTP +
Sbjct: 125 --LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA--PANXFVGTPYW 177
Query: 195 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 250
MAPE+ E +Y+ VD++S G+ +E+ + P + +Y + PA S
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQS 236
Query: 251 KVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNL 308
+ F++ C+ P E LLK F++ + P ++ D + R + V E+ NL
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNL 296
Query: 309 AH 310
+
Sbjct: 297 QY 298
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 30/213 (14%)
Query: 34 GKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERL----YSEVHLLKSLKHEN 87
G+G + VYK + DG E A I+ +Q + E+ LL+ LKHEN
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYA-----IKKFKGDKEQYTGISQSACREIALLRELKHEN 63
Query: 88 IIKFYNSWVDDTNRTINMITE-----LFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHY 142
++ +++ ++++ ++ + L+ + K ++ +K+ QIL G+HY
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP-----TARSVIGTPEF 194
LHS+ ++HRDLK NI V G G VKIGDLGLA + P V+ T +
Sbjct: 124 LHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 195 MAPELY--EEEYNELVDIYSFGMCIL-EMVTCE 224
APEL Y + +DI++ G CI E++T E
Sbjct: 182 RAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 88/303 (29%), Positives = 152/303 (50%), Gaps = 21/303 (6%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
F ++DP + EI G G+F VY D VA +++ QS ++ + + E
Sbjct: 18 FFKEDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKE 75
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWAR 134
V L+ +KH N I++ ++ + + M L ++ L ++K + V++ AI + A
Sbjct: 76 VKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA- 134
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
L+GL YLHSHN +IHRD+K NI + G+VK+ D G A + A S +GTP +
Sbjct: 135 --LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIAS--PANSFVGTPYW 187
Query: 195 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 250
MAPE+ E +Y+ VD++S G+ +E+ + P + +Y + P S
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPTLQS 246
Query: 251 KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMN 307
+ F++ C+ +P R + ELLK F++ + P+ ++ D + R + V E+ N
Sbjct: 247 NEWSDYFRNFVDSCLQKIPQD-RPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELDN 305
Query: 308 LAH 310
L +
Sbjct: 306 LQY 308
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 24/264 (9%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG GAF VYK ++ G A + +S ++LE E+ +L + H I+K
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIE----TKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 93 NSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 150
++ D I MI E G++ + + + I+ RQ+L L YLHS I
Sbjct: 76 GAFYWDGKLWI-MI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--I 131
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE------LYEE 202
IHRDLK N+ + +G++K+ D G++ + R S IGTP +MAPE + +
Sbjct: 132 IHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 203 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQF 260
Y+ DI+S G+ ++EM E P++E NP ++ K+ +P +LS+ + + + F
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKS-EPPTLSQPSKWSMEFRDF 248
Query: 261 IEKCIVP-ASLRLPALELLKDPFL 283
++ + R A +LL+ PF+
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFV 272
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-21
Identities = 87/302 (28%), Positives = 146/302 (48%), Gaps = 19/302 (6%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
F + DP + EI G G+F VY + VA +++ Q+ ++ + + E
Sbjct: 14 FYKDDPEEIFVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMSYSG-KQTNEKWQDIIKE 71
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWAR 134
V L+ LKH N I++ ++ + + M L ++ L ++K + V++ AI + A
Sbjct: 72 VKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA- 130
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
L+GL YLHSHN +IHRD+K NI + G+VK+ D G A A S +GTP +
Sbjct: 131 --LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSS--PANSFVGTPYW 183
Query: 195 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 250
MAPE+ E +Y+ VD++S G+ +E+ + P + +Y + P S
Sbjct: 184 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQS 242
Query: 251 KVTDPQVKQFIEKCIVPASLRLPA-LELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNL 308
+ F++ C+ PA ELL+ F+ D P ++ D + R + V E+ NL
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDNL 302
Query: 309 AH 310
+
Sbjct: 303 QY 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 29 YDEI--LGKGAFKTVYKGFDEVDGIEVAWNQV-----NIEDVMQSPDQLERLYSEVHLLK 81
Y I LG G F +VY ++ G VA ++ + E+ M EV L+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR--------EVKSLR 52
Query: 82 SLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRY----RKKHKNVDMKAIKNWARQI 136
L H NI+K + + N + + E + G+L Y +K K I++ QI
Sbjct: 53 KLNEHPNIVKLKEVFRE--NDELYFVFE-YMEGNL-YQLMKDRKGKPFSESVIRSIIYQI 108
Query: 137 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEFM 195
L+GL ++H H HRDLK +N+ V+G VKI D GLA + +P + T +
Sbjct: 109 LQGLAHIHKHG--FFHRDLKPENLLVSG-PEVVKIADFGLAREIRSRPPYTDYVSTRWYR 165
Query: 196 APE--LYEEEYNELVDIYSFGMCIL-EMVTCE 224
APE L Y+ VDI++ G CI+ E+ T
Sbjct: 166 APEILLRSTSYSSPVDIWALG-CIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 54/163 (33%), Positives = 91/163 (55%), Gaps = 11/163 (6%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKN-VD 125
+ + L E+ +L++L HENI+K+ +D I +I E SGSL+ Y ++KN ++
Sbjct: 48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN 107
Query: 126 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 183
+K +A QI +G+ YL S +HRDL N+ V + +VKIGD GL ++
Sbjct: 108 LKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKE 164
Query: 184 --TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 222
T + + +P F APE L + ++ D++SFG+ + E++T
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 84
RY + +G+GA V+K D G VA +V + + P+Q R E+ L++ +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR---EIKALQACQ 57
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSG-SLRYRKKHKNVDMKAIKNWARQILRGLHYL 143
H ++K + + + ++ E S S R + + + +K++ R +L+G+ Y+
Sbjct: 58 HPYVVKLLDVFPHGSG--FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV---IGTPEFMAPELY 200
H++ I+HRDLK N+ + +G +KI D GLA + + R + T + APEL
Sbjct: 116 HANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
Query: 201 --EEEYNELVDIYSFGMCIL-EMVTC 223
+Y+ VD+++ G CI E++
Sbjct: 173 YGARKYDPGVDLWAVG-CIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 19/210 (9%)
Query: 25 RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
R+ ++ + LGKG F +V Y + G VA ++ + + L E+ +L
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ----HSTAEHLRDFEREIEIL 59
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKN-VDMKAIKNWARQILR 138
KSL+H+NI+K+ R + ++ E GSLR Y +KH+ +D + + +A QI +
Sbjct: 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119
Query: 139 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----- 193
G+ YL S +HRDL NI V N VKIGD GL V+ Q + P
Sbjct: 120 GMEYLGSKR--YVHRDLATRNILVESEN-RVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 194 FMAPE-LYEEEYNELVDIYSFGMCILEMVT 222
+ APE L E +++ D++SFG+ + E+ T
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-21
Identities = 72/253 (28%), Positives = 125/253 (49%), Gaps = 22/253 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQSPDQLER------LYSEVHLLK-S 82
E LG GAF VYK + +G +A ++N+ + D+ ER + SEV ++K
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-----YRKKHKNVDMKAIKNWARQIL 137
L+H NI+++Y ++++ N + ++ +L L ++K + + I N Q++
Sbjct: 66 LRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 138 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFM 195
L YLH I+HRDL +NI + G + +V I D GLA +QP ++ SV+GT +
Sbjct: 124 LALRYLHKEKR-IVHRDLTPNNIML-GEDDKVTITDFGLA-KQKQPESKLTSVVGTILYS 180
Query: 196 APELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254
PE+ + E Y E D+++FG + +M T + P+ N + K+ + +
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYS 239
Query: 255 PQVKQFIEKCIVP 267
V I C+ P
Sbjct: 240 EDVTDVITSCLTP 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 77/286 (26%), Positives = 130/286 (45%), Gaps = 39/286 (13%)
Query: 30 DEI-----LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
DEI LGKG + +VYK G+ +A ++ +E + ++ E+ +L
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAV 57
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRY----RKKHKNVDMKAIKNWARQILRGL 140
I+ FY ++ + + M E +GSL + + ++ +++GL
Sbjct: 58 SPYIVDFYGAFFIEG--AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 141 HYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL 199
+L HN IIHRD+K N+ VNGN G+VK+ D G++ + A++ IG +MAPE
Sbjct: 116 KFLKEEHN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPER 172
Query: 200 YEEE-------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------P 246
+ Y D++S G+ ILEM YPY P + Y + + + P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANIFAQLSAIVDGDP 227
Query: 247 ASLSKVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKD 290
+L + F+ KC+ +P + R +LL+ P+LV D
Sbjct: 228 PTLPSGYSDDAQDFVAKCLNKIP-NRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 70/229 (30%), Positives = 117/229 (51%), Gaps = 17/229 (7%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+Y + +I G+G+F + DG + ++NI + SP + E EV +L ++K
Sbjct: 1 KYVKVKKI-GEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMK 57
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDM----KAIKNWARQILRGL 140
H NI+++ S+ ++ N I M + G Y+K + + I +W QI L
Sbjct: 58 HPNIVQYQESFEENGNLYIVMD---YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE 198
H H+ I+HRD+K NIF+ +G +K+GD G+A V+ AR+ IGTP +++PE
Sbjct: 115 K--HVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE 171
Query: 199 LYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 246
+ E YN DI++ G + EM T ++ + E N + K+ G P
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 69/238 (28%), Positives = 105/238 (44%), Gaps = 53/238 (22%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYS----EVHLL 80
+ LG G+F V +G W+ V+ D+L + E ++
Sbjct: 1 KKLGDGSFGVVRRG---------EWSTSG-GKVIPVAVKCLKSDKLSDIMDDFLKEAAIM 50
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKN-VDMKAIKNWARQIL 137
SL HEN+I+ Y + + M+TEL GSL R RK + + ++A QI
Sbjct: 51 HSLDHENLIRLYGVVLTH---PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA 107
Query: 138 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------IVMQQ----PT 184
G+ YL S IHRDL NI + ++ +VKIGD GL VM++ P
Sbjct: 108 NGMRYLESKR--FIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164
Query: 185 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 240
A + APE L ++ D++ FG+ + EM T E P+ + +QI KK+
Sbjct: 165 A--------WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 32 ILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LG GAF TVYKG +G I VA + E SP + + E +++ S+ H +
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE---TSPKANKEILDEAYVMASVDHPH 70
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHK-NVDMKAIKNWARQILRGLHYLHS 145
+++ + + + +IT+L G L Y + HK N+ + + NW QI +G+ YL
Sbjct: 71 VVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT----P-EFMAPE-L 199
++HRDL N+ V VKI D GLA + + P ++MA E +
Sbjct: 128 KR--LVHRDLAARNVLVKTPQ-HVKITDFGLA-KLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 200 YEEEYNELVDIYSFGMCILEMVT 222
Y D++S+G+ + E++T
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 62/204 (30%), Positives = 114/204 (55%), Gaps = 22/204 (10%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 84
+Y+++ +G+G + TV+K + VA +V ++D + P R E+ LLK LK
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELK 57
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKK-HKNVDMKAIKNWARQILRGLHYL 143
H+NI++ Y+ V +++ + ++ E +Y + ++D + +K++ Q+L+GL +
Sbjct: 58 HKNIVRLYD--VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPE- 198
HSHN ++HRDLK N+ +N NGE+K+ D GLA I ++ +A V T + P+
Sbjct: 116 HSHN--VLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDV 170
Query: 199 -LYEEEYNELVDIYSFGMCIL-EM 220
+ Y+ +D++S G CI E+
Sbjct: 171 LFGAKLYSTSIDMWSAG-CIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 75/266 (28%), Positives = 129/266 (48%), Gaps = 19/266 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENII 89
E LG+GA+ V K G +A + I + S +Q +RL ++ + ++S+ +
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKR--IRATVNSQEQ-KRLLMDLDISMRSVDCPYTV 63
Query: 90 KFYNSWVDDTNRTINMITELF-TSGSLRYRKKHK---NVDMKAIKNWARQILRGLHYLHS 145
FY + + + I M E+ TS Y+K + + + A I++ L YLHS
Sbjct: 64 TFYGALFREGDVWICM--EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYEEE- 203
+IHRD+K N+ +N NG+VK+ D G++ + A+++ G +MAPE E
Sbjct: 122 -KLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL 179
Query: 204 ----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
Y+ D++S G+ ++E+ T +PY+ K P Q K+V P ++ P+ +
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQD 239
Query: 260 FIEKCIVPASLRLPAL-ELLKDPFLV 284
F+ KC+ P ELL+ PF
Sbjct: 240 FVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 64/195 (32%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG+G + TV+KG ++ VA ++ +E +P R EV LLK+LKH NI+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKNLKHANIVTLH 69
Query: 93 NSWVDDTNRTINMITELFTSGSLRYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPII 151
+ + T R + ++ E S +Y N+ M +K + Q+LRGL Y H I+
Sbjct: 70 D--IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--IL 125
Query: 152 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEYNEL 207
HRDLK N+ +N GE+K+ D GLA PT + + T + P+ L EY+
Sbjct: 126 HRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP 184
Query: 208 VDIYSFGMCILEMVT 222
+D++ G + EM T
Sbjct: 185 IDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG+G++ TVYKG ++ G VA ++ +E +P R E LLK LKH NI+
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVT 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPP 149
++ + T +T+ ++ E + +Y + M ++ + Q+LRGL Y H
Sbjct: 68 LHD--IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR-- 123
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEYN 205
++HRDLK N+ ++ GE+K+ D GLA P T + + T + P+ L EY+
Sbjct: 124 VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 206 ELVDIYSFGMCILEMVT 222
+D++ G EM T
Sbjct: 183 TSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 9e-19
Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 19/208 (9%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHE 86
+LGKG+F V KG +E I+ V +ED D +E E +L + +H
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED-----DDVECTMVERRVLALAWEHP 56
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHS 145
+ + ++ T + + E G L + + D + +A +I+ GL +LH
Sbjct: 57 FLTHLFCTF--QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-E 202
II+RDLK DN+ ++ +G +KI D G+ + + A + GTP+++APE+ + +
Sbjct: 115 KG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 203 EYNELVDIYSFGMCILEMVTCEYPYNEC 230
+YNE VD +SFG+ + EM+ + P++
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 74/248 (29%), Positives = 121/248 (48%), Gaps = 23/248 (9%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA+ +V FD G+ VA +++ QS +R Y E+ LLK +KH
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 75
Query: 86 ENIIKFYNSWVDDTN----RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLH 141
EN+I + + + + ++T L + K K D ++ QILRGL
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD-DHVQFLIYQILRGLK 134
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAPE 198
Y+HS + IIHRDLK N+ VN + E+KI D GLA + T + G T + APE
Sbjct: 135 YIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA----RHTDDEMTGYVATRWYRAPE 187
Query: 199 LYEE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTD 254
+ YN+ VDI+S G + E++T +P + + ++ ++ L K++
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247
Query: 255 PQVKQFIE 262
+ +I+
Sbjct: 248 ESARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 31/268 (11%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQV--NIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
+G GA TVYK G A + N ED ++ Q+ R E+ +L+ + H N++
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR--QICR---EIEILRDVNHPNVV 135
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
K ++ + D N I ++ E GSL + D + + + ARQIL G+ YLH +
Sbjct: 136 KCHDMF--DHNGEIQVLLEFMDGGSL---EGTHIADEQFLADVARQILSGIAYLHRRH-- 188
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---PTARSVIGTPEFMAPELYEEEYNE 206
I+HRD+K N+ +N VKI D G++ ++ Q P SV GT +M+PE + N
Sbjct: 189 IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNH 246
Query: 207 LV------DIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSGIKPASLSKVTDPQVK 258
DI+S G+ ILE +P+ + A + + P + + + + +
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS-REFR 305
Query: 259 QFIEKCIV--PASLRLPALELLKDPFLV 284
FI C+ PA R A++LL+ PF++
Sbjct: 306 HFISCCLQREPAK-RWSAMQLLQHPFIL 332
|
Length = 353 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG+G + TVYKG ++ VA ++ +E +P R EV LLK LKH NI+ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVTLH 70
Query: 93 NSWVDDTNRTINMITELFTSGSLRYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPII 151
+ + T +++ ++ E +Y N ++M +K + Q+LRGL+Y H ++
Sbjct: 71 D--IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VL 126
Query: 152 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEYNEL 207
HRDLK N+ +N GE+K+ D GLA PT + + T + P+ L +Y+
Sbjct: 127 HRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 208 VDIYSFGMCILEMVT 222
+D++ G EM T
Sbjct: 186 IDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIK 90
+G+G + VYK D+ G VA +V +++ + P R E+ +L+ L H NI+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIVN 70
Query: 91 FYNSWVDDTN--------RTINMITE--------LFTSGSLRYRKKHKNVDMKAIKNWAR 134
D + ++ E L SG + + + H IK++ +
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-------IKSFMK 123
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIG 190
Q+L GL+Y H N +HRD+KC NI +N N G++K+ D GLA + +P VI
Sbjct: 124 QLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVI- 179
Query: 191 TPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 222
T + PEL EE Y +D++S G CIL E+ T
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 72/256 (28%), Positives = 118/256 (46%), Gaps = 20/256 (7%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G G + VYK + G A + +E D + E+ ++K KH NI+ ++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE----PGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 93 NSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 150
S++ I M E GSL+ Y +++ I R+ L+GL YLHS
Sbjct: 73 GSYLSREKLWICM--EYCGGGSLQDIYHVTGPLSELQ-IAYVCRETLQGLAYLHSKGK-- 127
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE----Y 204
+HRD+K NI + +NG+VK+ D G+A + A+ S IGTP +MAPE+ E Y
Sbjct: 128 MHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQFIE 262
N+L DI++ G+ +E+ + P + ++ S +P L T F++
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVK 246
Query: 263 KCIVPASLRLPALELL 278
+ + P E L
Sbjct: 247 ISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
E +G+G + VYK +++ G VA ++ ++ + P R E+ LLK L H NI+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 62
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRYRK--KHKNVDMKAIKNWARQILRGLHYLHSHN 147
K + V T + ++ E ++ + + IK++ Q+L+GL + HSH
Sbjct: 63 KLLD--VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEE 203
++HRDLK N+ +N G +K+ D GLA P T + T + APE L +
Sbjct: 121 --VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 204 YNELVDIYSFGMCILEMVT 222
Y+ VDI+S G EMVT
Sbjct: 178 YSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 41/220 (18%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQL--ERLYSEVHLLK 81
RY +G+GA+ V + G++VA ++ SP Q +R E+ +L+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFEHQTFCQRTLREIKILR 58
Query: 82 SLKHENIIKFYNSWVDDTNRTIN--------MITELFTSGSLRYRK-KHKNVDMKAIKNW 132
KHENII + + + N M T+L Y+ K +++ I+ +
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDL-------YKLIKTQHLSNDHIQYF 111
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS----- 187
QILRGL Y+HS N ++HRDLK N+ +N N ++KI D GLA + +
Sbjct: 112 LYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 188 VIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTCE 224
+ T + APE L + Y + +DI+S G CIL EM++
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVG-CILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 63/196 (32%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG+G++ TVYKG +V+G VA + +++ +P R E LLK LKH NI+
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLKGLKHANIVL 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPP 149
++ + T T+ ++ E + +Y KH + + +K + Q+LRGL Y+H
Sbjct: 68 LHD--IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY-- 123
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEYN 205
I+HRDLK N+ ++ + GE+K+ D GLA P T + + T + P+ L EY+
Sbjct: 124 ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 206 ELVDIYSFGMCILEMV 221
+D++ G +EM+
Sbjct: 183 TCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 69/275 (25%), Positives = 123/275 (44%), Gaps = 25/275 (9%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G +V K G +A V+I Q+ R E+ ++ + I+ FY
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR---ELQIMHECRSPYIVSFY 69
Query: 93 NSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPI 150
+++++ N I M E GSL R KK + ++ + A ++ GL YL++ H I
Sbjct: 70 GAFLNENN--ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--I 125
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVD 209
+HRD+K NI VN G++K+ D G++ + A + +GT +M+PE + +Y D
Sbjct: 126 MHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 210 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------KPASLSKVTDPQV-K 258
++S G+ I+E+ ++P+ N + GI P L P+ +
Sbjct: 185 VWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243
Query: 259 QFIEKCIV--PASLRLPALELLKDPFLVTDNPKDL 291
F++ C++ P P PF+ ++
Sbjct: 244 DFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 73/262 (27%), Positives = 124/262 (47%), Gaps = 23/262 (8%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G G + VYK + G A + +E + + E+ ++K KH NI+ ++
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLE----PGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 93 NSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 150
S++ I M E GSL+ Y + + I +R+ L+GL+YLHS
Sbjct: 73 GSYLRRDKLWICM--EFCGGGSLQDIYHVTGPLSESQ-IAYVSRETLQGLYYLHSKGK-- 127
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE----Y 204
+HRD+K NI + +NG VK+ D G++ + A+ S IGTP +MAPE+ E Y
Sbjct: 128 MHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS---KVTDPQVKQFI 261
N+L DI++ G+ +E+ + P + ++ S +P L K ++ F+
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN-SFHHFV 245
Query: 262 EKCIVPASLRLPALE-LLKDPF 282
+ + + P E LL+ PF
Sbjct: 246 KMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQV-NIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
E +G GA+ V D G +VA ++ + DV +R E+ +L+ KH+NI
Sbjct: 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA---KRTLRELKILRHFKHDNI 66
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKA--IKNWARQILRGLHYLHSH 146
I + ++ + S + H + + I+ + Q+LRGL Y+HS
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA 126
Query: 147 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSV-----IGTPEFMAPELY 200
N +IHRDLK N+ VN + E++IGD G+A + PT + T + APEL
Sbjct: 127 N--VIHRDLKPSNLLVNE-DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 201 --EEEYNELVDIYSFGMCIL-EMV 221
EY +D++S G CI EM+
Sbjct: 184 LSLPEYTTAIDMWSVG-CIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 74/340 (21%), Positives = 135/340 (39%), Gaps = 59/340 (17%)
Query: 27 GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY ++ LG G+ V+ D VA ++ V+ P ++ E+ +++ L
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI----VLTDPQSVKHALREIKIIRRLD 60
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGS-----------LRYRKKHKNVDMKAIKNWA 133
H+NI+K Y + + L S L + + + + +
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM 120
Query: 134 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----V 188
Q+LRGL Y+HS N ++HRDLK N+F+N + +KIGD GLA ++ +
Sbjct: 121 YQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 189 IGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTC---------------------- 223
+ T + +P L Y + +D+++ G CI EM+T
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKPLFAGAHELEQMQLILESVPV 237
Query: 224 --EYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIVPASL-RLPALEL 277
E NE N + + G L + +P+ F+E+ + + RL A E
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA 297
Query: 278 LKDPFL-VTDNPKD--LVCDPLRLPNLVPEVMNLAHSEPH 314
L P++ P D + P + + + +++ +
Sbjct: 298 LMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 58/177 (32%), Positives = 87/177 (49%), Gaps = 11/177 (6%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDM---KAIKNW 132
E LL +KH NI+ F S+ D + I M E G L + K + + I W
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVM--EYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IG 190
Q+ G+ H H ++HRD+K NIF+ NG+VK+GD G A ++ P A + +G
Sbjct: 106 FVQMCLGVQ--HIHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVG 162
Query: 191 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 246
TP ++ PE++E YN DI+S G + E+ T ++P+ I K KP
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 21/202 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
E +G+G + VYK D++ G VA ++ +E + P R E+ LLK L H NI+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIV 61
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRY--RKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
+ + + + ++ E +Y +D IK++ Q+L+G+ Y HSH
Sbjct: 62 RLLDVVHSENK--LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPE--LYE 201
++HRDLK N+ ++ G +K+ D GLA + ++ T V T + APE L
Sbjct: 120 --VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGS 174
Query: 202 EEYNELVDIYSFGMCIL-EMVT 222
+Y+ VDI+S G CI EMV
Sbjct: 175 RQYSTPVDIWSIG-CIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 5e-18
Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
+Y+ + LGKGA+ V+K D VA + I D ++ +R + E+ L+ L
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKK--IFDAFRNATDAQRTFREIMFLQELGD 65
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKH--KNVDMKAIKNWARQILRGLHY 142
H NI+K N + ++ I ++ E + + + ++V + I Q+L+ L Y
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYI---MYQLLKALKY 122
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQQPTARSVIGTPEFM 195
+HS N +IHRDLK NI +N ++ VK+ D GLA + P + T +
Sbjct: 123 IHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 196 APE--LYEEEYNELVDIYSFGMCIL-EMVTC 223
APE L Y + VD++S G CIL EM+
Sbjct: 180 APEILLGSTRYTKGVDMWSVG-CILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 64/255 (25%), Positives = 123/255 (48%), Gaps = 19/255 (7%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G F V++G + + + VA + +D+++ + EV LK L+H+++I +
Sbjct: 14 LGSGYFGEVWEGLWK-NRVRVAIKILKSDDLLK----QQDFQKEVQALKRLRHKHLISLF 68
Query: 93 NSWVDDTNRTINMITELFTSGSLRY---RKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
V + +ITEL GSL + + + + ++ + A Q+ G+ YL N
Sbjct: 69 A--VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN-- 124
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNE 206
IHRDL NI V G + K+ D GLA ++++ + ++ APE ++
Sbjct: 125 SIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 207 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265
D++SFG+ + EM T + PY N ++Y ++T+G + +K ++ + + +C
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGYRMPCPAKCP-QEIYKIMLECW 241
Query: 266 VPASLRLPALELLKD 280
P+ + L++
Sbjct: 242 AAEPEDRPSFKALRE 256
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 83/289 (28%), Positives = 142/289 (49%), Gaps = 32/289 (11%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY + E++GKG++ V D G +VA ++N DV + R+ E+ LL+ L+
Sbjct: 1 RY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN--DVFEHVSDATRILREIKLLRLLR 57
Query: 85 HENIIKFYNSWVDDTNRT---INMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLH 141
H +I++ + + + R I ++ EL S + K + ++ + + + Q+LR L
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-----IGTPEFMA 196
Y+H+ N + HRDLK NI N + ++KI D GLA V T ++ + T + A
Sbjct: 118 YIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 197 PEL---YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLS 250
PEL + +Y +DI+S G CI V P KN +T + P ++S
Sbjct: 175 PELCGSFFSKYTPAIDIWSIG-CIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233
Query: 251 KVTDPQVKQFI----EKCIVPASLRLP-----ALELLKDPFLVTDNPKD 290
+V + + ++++ +K VP S + P AL LL+ L+ +PKD
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLER--LLAFDPKD 280
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
++G+GA+ V K ++ G VA + + D + EV +L+ L+HENI+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLRHENIVN 64
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPP 149
++ + ++ E L + + A++++ Q+L+ + Y HSHN
Sbjct: 65 LKEAFRRK--GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN-- 120
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELY--EEEY 204
IIHRD+K +NI V+ +G +K+ D G A ++ A + T + APEL + Y
Sbjct: 121 IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 205 NELVDIYSFGMCIL-EMVT 222
+ VD+++ G CI+ E++
Sbjct: 180 GKPVDVWAIG-CIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 9e-18
Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 28 RYDEIL--GKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY ++ G GA+ TV D G +VA + + QS +R Y E+ LLK +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHMKH 73
Query: 86 ENIIKFYNSWVDDTNRTINMITEL-----FTSGSLRYRKKHKNVDMKAIKNWARQILRGL 140
EN+I + + D + ++ + F L KH+ + I+ Q+L+GL
Sbjct: 74 ENVIGLLDVFTPDLS--LDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-- 198
Y+H+ IIHRDLK N+ VN + E+KI D GLA V+ T + APE
Sbjct: 132 KYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSEMTGYVV-TRWYRAPEVI 187
Query: 199 LYEEEYNELVDIYSFGMCILEMVT 222
L Y + VDI+S G + EM+T
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-18
Identities = 46/138 (33%), Positives = 75/138 (54%), Gaps = 11/138 (7%)
Query: 98 DTNRTINMITELFTSGSLRYRKKHKNVDMKAIKN-----WARQILRGLHYLHSHNPPIIH 152
T + ++ + G LRY + + + + QI+ GL +LH II+
Sbjct: 63 QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIY 120
Query: 153 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EEYNELVD 209
RDLK +N+ ++ N+G V+I DLGLA+ ++ Q + GTP FMAPEL + EEY+ VD
Sbjct: 121 RDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVD 179
Query: 210 IYSFGMCILEMVTCEYPY 227
++ G+ + EM+ P+
Sbjct: 180 YFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 32 ILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK---SLK 84
+LG+G F V YK E+ I+ + D++ + D++E L E + + S +
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKA----LKKGDII-ARDEVESLMCEKRIFETANSER 60
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNV-DMKAIKNWARQILRGLHYL 143
H ++ + + T + + E + +G H +V +A ++ GL YL
Sbjct: 61 HPFLVNLFACF--QTEDHVCFVME-YAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYL 117
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPE-LY 200
H + I++RDLK DN+ ++ G VKI D GL R+ GTPEF+APE L
Sbjct: 118 HENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYPY 227
E Y VD + G+ I EM+ E P+
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 22/200 (11%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
D +G GAF V+ D DG VA + + +V Q+ +R++ E+ +L KH+N++
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKK--MPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62
Query: 90 KFYNSWVD-------DTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHY 142
S +D D I ++TEL S + + + +K + QILRGL Y
Sbjct: 63 ----SALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV---IGTPEFMAPEL 199
LHS I+HRD+K N+ VN +N +KI D GLA V + ++ + + T + APE+
Sbjct: 119 LHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEI 175
Query: 200 Y--EEEYNELVDIYSFGMCI 217
Y VDI+S G CI
Sbjct: 176 LMGSRHYTSAVDIWSVG-CI 194
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 74/269 (27%), Positives = 114/269 (42%), Gaps = 49/269 (18%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQ---VNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
LG G F V++G WN V ++ + + +E ++K L+H +I
Sbjct: 14 LGAGQFGEVWEGL---------WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLI 64
Query: 90 KFYNSWVDDTNRTINMITELFTSGSL---------RYRKKHKNVDMKAIKNWARQILRGL 140
+ Y V I ++TEL GSL R K + +DM A Q+ G+
Sbjct: 65 QLYA--VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA------QVASGM 116
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAP 197
YL + N IHRDL N+ V G N K+ D GLA V+++ AR P ++ AP
Sbjct: 117 AYLEAQN--YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAP 173
Query: 198 ELYEEEYNELV---DIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---PASLS 250
E YN D++SFG+ + E+VT PY N A++ ++V G + P
Sbjct: 174 E--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQGYRMPCPPG-- 228
Query: 251 KVTDPQVKQFIEKCIVPASLRLPALELLK 279
++ + C P E L+
Sbjct: 229 --CPKELYDIMLDCWKEDPDDRPTFETLQ 255
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG+G + TV+KG ++ VA ++ +E +P R EV LLK LKH NI+
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPP 149
++ + T++++ ++ E +Y N+ M +K + QILRGL Y H
Sbjct: 69 LHD--IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK-- 124
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEYN 205
++HRDLK N+ +N GE+K+ D GLA PT + + T + P+ L EY+
Sbjct: 125 VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 206 ELVDIYSFGMCILEMVT 222
+D++ G EM +
Sbjct: 184 TQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 46/233 (19%)
Query: 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--- 75
S RY + LG+G + V K +D + G VA +V I ++ + +L
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 76 -------EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKA 128
E+ ++ +KHENI+ + +V+ IN++ ++ + L+ K VD K
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGD--FINLVMDIM-ASDLK-----KVVDRKI 114
Query: 129 ------IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----- 177
+K QIL GL+ LH +HRDL NIF+N + G KI D GLA
Sbjct: 115 RLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGY 171
Query: 178 ------IVMQQPTARSVIGTPE-----FMAPELY--EEEYNELVDIYSFGMCI 217
+ + R T + + APEL E+Y+ VD++S G CI
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG-CI 223
|
Length = 335 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 14/196 (7%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKF 91
+G+G F V K G A + +S +Q+ L E+ L+ L H NI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK--KHFKSLEQVNNL-REIQALRRLSPHPNILRL 63
Query: 92 YNSWVDDTNRTINMITELFTSGSLRYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPI 150
D + ++ EL K K + K +K++ Q+L+ L ++H + I
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--I 121
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE--LYEEEYNE 206
HRD+K +NI + + +K+ D G I + P I T + APE L + Y
Sbjct: 122 FHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYT-EYISTRWYRAPECLLTDGYYGP 178
Query: 207 LVDIYSFGMCILEMVT 222
+DI++ G E+++
Sbjct: 179 KMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 25 RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
RY + +LG+G F V Y ++ G VA + E E+++L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINIL 60
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRG 139
K+L HENI+K+ + + + +I E GSLR Y KH +++ + +A+QI G
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEG 119
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------RSVIGTPE 193
+ YLHS + IHRDL N+ ++ N+ VKIGD GLA + P R +P
Sbjct: 120 MAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAV--PEGHEYYRVREDGDSPV 174
Query: 194 F-MAPE-LYEEEYNELVDIYSFGMCILEMVT 222
F A E L E +++ D++SFG+ + E++T
Sbjct: 175 FWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 27 GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYSEVHLLK 81
Y+ + LG+G F VYK G VA ++ N +D P R E+ +LK
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PITALR---EIKILK 62
Query: 82 SLKHENIIKFYNSWVDDTNRTINMITELFT---------SGSLRYRKKHKNVDMKAIKNW 132
LKH N++ + V+ +++ ++ SG L + IK +
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCY 120
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSV 188
Q+L G++YLH ++ I+HRD+K NI ++ N G +KI D GLA P
Sbjct: 121 MLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 189 IGTPEFM---------APELY--EEEYNELVDIYSFGMCIL-EMVT 222
GT ++ PEL E Y VDI+ G C+ EM T
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
E +G+G + VYK D V +A ++ +E + P R E+ LLK ++H NI+
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR---EISLLKEMQHGNIV 64
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNV------DMKAIKNWARQILRGLHYL 143
+ + V + + + ++ E + L KKH + + + IK + QILRG+ Y
Sbjct: 65 RLQD--VVHSEKRLYLVFE-YLDLDL---KKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--L 199
HSH ++HRDLK N+ ++ +K+ D GLA P T + T + APE L
Sbjct: 119 HSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176
Query: 200 YEEEYNELVDIYSFGMCILEMVT 222
Y+ VDI+S G EMV
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 33/203 (16%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--EVHLLKSLKHENII 89
+G+G + VY+ D G VA +V ++ D + + S E+ LL +L+H NI+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMD---NERDGIP-ISSLREITLLLNLRHPNIV 69
Query: 90 KFYNSWVDDTNRTINMITELFTS--GSLRYRKKHKNVDMKA------IKNWARQILRGLH 141
+ V +I ++ E SL +M +K Q+LRGL
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLD-------NMPTPFSESQVKCLMLQLLRGLQ 122
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAP 197
YLH + IIHRDLK N+ + G +KI D GLA P T + V T + AP
Sbjct: 123 YLHENF--IIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAP 177
Query: 198 ELY--EEEYNELVDIYSFGMCIL 218
EL Y +D+++ G CIL
Sbjct: 178 ELLLGCTTYTTAIDMWAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 68/244 (27%), Positives = 120/244 (49%), Gaps = 22/244 (9%)
Query: 31 EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKH 85
++LGKG+F V KG DEV I+V V ++D D ++ +E +L + KH
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD-----DDVDCTMTEKRILALAAKH 55
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLH 144
+ + + T + + E G L ++ ++ + D + +A ++ L +LH
Sbjct: 56 PFLTALHCCF--QTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYE 201
H +I+RDLK DNI ++ G K+ D G+ ++ T + GTP+++APE L E
Sbjct: 114 RHG--VIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 202 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQ 259
EY VD ++ G+ + EM+ + P+ E N +++ + + P LSK +K
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKA 229
Query: 260 FIEK 263
F+ K
Sbjct: 230 FMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 77/276 (27%), Positives = 128/276 (46%), Gaps = 36/276 (13%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENII 89
E +GKG + VYK ++ DG A V I D + D E + +E ++L+SL H N++
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAA---VKILDPISDVD--EEIEAEYNILQSLPNHPNVV 82
Query: 90 KFYNSWVDDTNRT---INMITELFTSGSLR-----YRKKHKNVDMKAIKNWARQILRGLH 141
KFY + + ++ EL GS+ + +D I L GL
Sbjct: 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 199
+LH N IIHRD+K +NI + G VK+ D G++ + R + +GTP +MAPE+
Sbjct: 143 HLH--NNRIIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 199
Query: 200 ------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253
Y+ Y+ D++S G+ +E+ + P + +P + K+ P L
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVKTLFKIPRNPPPTLL---- 254
Query: 254 DPQ-----VKQFIEKCIVPASLRLPAL-ELLKDPFL 283
P+ FI +C++ P++ LL+ PF+
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 32 ILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHE 86
+LGKG+F V KG DE+ ++V V ++D D +E +E +L + KH
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD-----DDVECTMTEKRVLALAGKHP 56
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHS 145
+ + ++ + T + + E G L + ++ D + +A +I+ GL +LH
Sbjct: 57 FLTQLHSCF--QTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEE 202
II+RDLK DN+ ++ G +KI D G+ ++ T + GTP+++APE L +
Sbjct: 115 RG--IIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 203 EYNELVDIYSFGMCILEMVTCEYPY 227
Y VD ++ G+ + EM+ + P+
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 38/206 (18%)
Query: 36 GAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNS 94
G + VY+ D+ G VA ++ +E + P R E+++L L+H NI+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR---EINILLKLQHPNIVTVKEV 72
Query: 95 WVDDTNRTINMITELFTSGSLRYRKKHKNVDMKA-------------IKNWARQILRGLH 141
V I M+ E +H D+K+ +K Q+L G+
Sbjct: 73 VVGSNLDKIYMVMEYV---------EH---DLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 199
+LH + I+HRDLK N+ +N N G +KI D GLA P ++ T + APEL
Sbjct: 121 HLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPEL 177
Query: 200 Y--EEEYNELVDIYSFGMCIL-EMVT 222
+EY+ +D++S G CI E++T
Sbjct: 178 LLGAKEYSTAIDMWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG+G++ TVYKG ++G VA ++++ P R E LLK LKH NI+
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVL 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPP 149
++ + T T+ + E + +Y +H + ++ + Q+LRGL Y+H +
Sbjct: 68 LHD--IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH-- 123
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEYN 205
I+HRDLK N+ ++ GE+K+ D GLA P T S + T + P+ L +Y+
Sbjct: 124 ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182
Query: 206 ELVDIYSFGMCILEMV 221
+DI+ G +EM+
Sbjct: 183 SALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 58/262 (22%), Positives = 110/262 (41%), Gaps = 18/262 (6%)
Query: 35 KGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYN 93
KGAF +VY G A + D M + +Q+ + +E ++ + K Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSD-MIAKNQVTNVKAERAIMMIQGESPYVAKLY- 63
Query: 94 SWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 152
+ + + ++ E G K + K + +++ G+ LH IIH
Sbjct: 64 -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIH 120
Query: 153 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIY 211
RD+K +N+ ++ G +K+ D GL+ + + +GTP+++APE +++ D +
Sbjct: 121 RDIKPENLLID-QTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETILGVGDDKMSDWW 177
Query: 212 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVP-A 268
S G I E + YP + P ++ + S P + + P+ I + +
Sbjct: 178 SLGCVIFEFLF-GYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 269 SLRLPA---LELLKDPFLVTDN 287
+ RL A E+ PF + N
Sbjct: 237 AKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 49/141 (34%), Positives = 73/141 (51%), Gaps = 6/141 (4%)
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSH 146
I+ FY ++ D +I M E GSL + KK + + + +LRGL YL
Sbjct: 61 IVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE- 117
Query: 147 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYN 205
I+HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y
Sbjct: 118 KHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYT 176
Query: 206 ELVDIYSFGMCILEMVTCEYP 226
DI+S G+ ++EM YP
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 71/276 (25%), Positives = 129/276 (46%), Gaps = 36/276 (13%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 89
E +GKG + V+K ++ +G + A V I D + D E + +E ++LK+L H N++
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAA---VKILDPIHDID--EEIEAEYNILKALSDHPNVV 78
Query: 90 KFYNSWVDDTNRT---INMITELFTSGSLR-----YRKKHKNVDMKAIKNWARQILRGLH 141
KFY + + + ++ EL GS+ + K+ + ++ I + L GL
Sbjct: 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 199
+LH IHRD+K +NI + G VK+ D G++ + R + +GTP +MAPE+
Sbjct: 139 HLH--VNKTIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 200 ------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253
+ Y+ D++S G+ +E+ + P + +P + K+ P +
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPRNPPP----TLH 250
Query: 254 DPQV-----KQFIEKCIVPA-SLRLPALELLKDPFL 283
P++ FI KC+ R +LL+ F+
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 55/205 (26%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD--QLERL-YSEVHLLKS 82
+Y+++ +G+G++ V+K + G VA I+ ++S D ++++ E+ +LK
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVA-----IKKFVESEDDPVIKKIALREIRMLKQ 56
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKH-KNVDMKAIKNWARQILRGLH 141
LKH N++ V R ++++ E L +K+ + V IK Q L+ ++
Sbjct: 57 LKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 199
+ H HN IHRD+K +NI + G++K+ D G A ++ P + T + APEL
Sbjct: 115 FCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL 171
Query: 200 Y--EEEYNELVDIYSFGMCILEMVT 222
+ +Y VD+++ G E++T
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 42/133 (31%), Positives = 69/133 (51%), Gaps = 10/133 (7%)
Query: 105 MITELFTSGSLRYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 161
++ L G L+Y + +A QI+ GL +LH I++RDLK +N+
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVL 127
Query: 162 VNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 218
++ ++G V+I DLGLA+ + + GTP +MAPE L E Y+ VD ++ G +
Sbjct: 128 LD-DHGNVRISDLGLAVELKGGKKIKGRA-GTPGYMAPEVLQGEVYDFSVDWFALGCTLY 185
Query: 219 EMVTCEYPYNECK 231
EM+ P+ + K
Sbjct: 186 EMIAGRSPFRQRK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 20/202 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
E +G+G + VYKG ++ G VA ++ +E + P R E+ LLK L+H NI+
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR---EISLLKELQHPNIV 62
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRYR---KKHKNVDMKAIKNWARQILRGLHYLHSH 146
+ + + +R + +I E + +Y K + +D + +K++ QIL+G+ + HS
Sbjct: 63 CLQDVLMQE-SR-LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 147 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPE--LY 200
++HRDLK N+ ++ N G +K+ D GLA P T V T + APE L
Sbjct: 121 R--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLG 175
Query: 201 EEEYNELVDIYSFGMCILEMVT 222
Y+ VDI+S G EM T
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHEN-I 88
E +G+G + VYK D+ G VA + +E D P R E+ LL+ L I
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR---EISLLQMLSESIYI 63
Query: 89 IKFYN-SWVDDTNRTIN-------MITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGL 140
++ + V++ N + + ++L R + + K IK++ Q+L+G+
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IGTPEFMAPE 198
+ H H ++HRDLK N+ V+ G +KI DLGL P I T + APE
Sbjct: 124 AHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181
Query: 199 --LYEEEYNELVDIYSFGMCILEMVT 222
L Y+ VDI+S G EM
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 68/266 (25%), Positives = 119/266 (44%), Gaps = 24/266 (9%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G+GAF TV K + G +A ++ + +L + +V +++S I+KFY
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRL-LMDLDV-VMRSSDCPYIVKFY 69
Query: 93 NSWVDDTNRTINMITELFTSGSLR------YRKKHKNVDMKAIKNWARQILRGLHYL-HS 145
+ + + I M EL SL Y + + + A ++ L+YL
Sbjct: 70 GALFREGDCWICM--ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYEEE- 203
IIHRD+K NI ++ NG +K+ D G++ + A++ G +MAPE +
Sbjct: 127 LK--IIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 183
Query: 204 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQV 257
Y+ D++S G+ + E+ T ++PY + + +V G I S + P
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF 243
Query: 258 KQFIEKCIVPASLRLPAL-ELLKDPF 282
FI C++ + P ELL+ PF
Sbjct: 244 VNFINLCLIKDESKRPKYKELLEHPF 269
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 75/327 (22%), Positives = 137/327 (41%), Gaps = 48/327 (14%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G+GA+ V + +VA + I + + +R E+ LL+ L HEN+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKK--IANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 93 NSWVDDTNRTIN---MITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
+ N ++ EL + + + + + + + Q+LRGL Y+HS N
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN-- 128
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----------APEL 199
++HRDLK N+ +N N ++KI D GL AR+ +FM APEL
Sbjct: 129 VLHRDLKPSNLLLNANC-DLKICDFGL--------ARTTSEKGDFMTEYVVTRWYRAPEL 179
Query: 200 Y--EEEYNELVDIYSFGMCIL-EMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTD 254
EY +D++S G CI E++ + +P + + ++ ++ L + +
Sbjct: 180 LLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238
Query: 255 PQVKQFIEKCIVPASLRLP-----------ALELLKDPFLVTDNPKDL-VCDPLRLPNLV 302
+ +++I +P + R A++LL + LV D K + V + L P L
Sbjct: 239 EKARRYIRS--LPYTPRQSFARLFPHANPLAIDLL-EKMLVFDPSKRITVEEALAHPYLA 295
Query: 303 P-EVMNLAHSEPHPMDIDLNHKKVSAD 328
+ P D ++ +
Sbjct: 296 SLHDPSDEPVCQTPFSFDFEEDALTEE 322
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (198), Expect = 1e-15
Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 30/202 (14%)
Query: 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-----RYRKKHKNVDM 126
+L EV++++ LKH+NI+++ + +++ N+ + ++ E +G L + K ++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 127 KAIKNWARQILRGLHYLHS-----HNPPIIHRDLKCDNIFV--------------NGNNG 167
AI + RQ+L L Y H+ + ++HRDLK NIF+ N NG
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 168 E--VKIGDLGLAI-VMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMV 221
KIGD GL+ + + A S +GTP + +PEL E Y++ D+++ G I E+
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 222 TCEYPYNECKNPAQIYKKVTSG 243
+ + P+++ N +Q+ ++ G
Sbjct: 238 SGKTPFHKANNFSQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER---LYSEVHLLKSLKHEN 87
++G+G++ V K + G VA I+ ++S D E+ +LK L+HEN
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVA-----IKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKN-VDMKAIKNWARQILRGLHYLHSH 146
++ V + + ++ E L +K+ N +D ++ + QILRG+ + HSH
Sbjct: 62 LVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 147 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY--EE 202
N IIHRD+K +NI V+ +G VK+ D G A + P + T + APEL +
Sbjct: 120 N--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 203 EYNELVDIYSFGMCILEMVTCE 224
+Y VDI++ G + EM+T E
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 53/156 (33%), Positives = 84/156 (53%), Gaps = 14/156 (8%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTI---NMITELFTSGSLRYRKKHKNVDMKAIKNW 132
E LL+++ H ++I+ ++ V + + ++L+T + R R + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRP----LPIDQALII 162
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGT 191
+QIL GL YLH+ IIHRD+K +NIF+N + +V IGDLG A + P + GT
Sbjct: 163 EKQILEGLRYLHAQR--IIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGT 219
Query: 192 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 226
E APE L ++YN DI+S G+ + EM+ YP
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YP 253
|
Length = 357 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIK 90
+G+GA+ V+K D +G VA +V ++ + P R + + L++ +H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 91 FYN-SWVDDTNR--TINMITELFTSGSLRYRKK--HKNVDMKAIKNWARQILRGLHYLHS 145
++ V T+R + ++ E Y K V + IK+ Q+LRGL +LHS
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPE-LYEEE 203
H ++HRDLK NI V ++G++K+ D GLA I Q SV+ T + APE L +
Sbjct: 129 HR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 185
Query: 204 YNELVDIYSFGMCILEM 220
Y VD++S G EM
Sbjct: 186 YATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 69/238 (28%), Positives = 116/238 (48%), Gaps = 15/238 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G GA+ +V +D +VA +++ QS R Y E+ LLK +KHEN+I
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLS--RPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 93 NSWVDDTN----RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
+ + T+ + ++T L L K + + + ++ Q+LRGL Y+HS
Sbjct: 81 DVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG- 138
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYNE 206
IIHRDLK N+ VN + E++I D GLA + T + APE L YN+
Sbjct: 139 -IIHRDLKPSNVAVN-EDCELRILDFGLARQADDEMT-GYVATRWYRAPEIMLNWMHYNQ 195
Query: 207 LVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262
VDI+S G + E++ + +P N+ + + +V P L K++ +++I+
Sbjct: 196 TVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 30 DEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
+G+G F VY+G E + I VA SP E+ E ++++ H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHP 67
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKN-VDMKAIKNWARQILRGLHYLH 144
+I+K ++ + ++ EL G LR Y + +K +D+ ++ ++ Q+ L YL
Sbjct: 68 HIVKLIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTP-EFMAPE-LY 200
S +HRD+ N+ V+ + VK+GD GL+ ++ + S P ++MAPE +
Sbjct: 125 SKR--FVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 201 EEEYNELVDIYSFGMCILEM 220
+ D++ FG+C+ E+
Sbjct: 182 FRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 72/208 (34%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 84
+Y+ + +G GA+ TVYK D G VA V ++ P R EV LLK L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR---EVALLKRLE 57
Query: 85 ---HENIIKFYNSWVDDTNRT-----INMITELFTSGSLRYRKK--HKNVDMKAIKNWAR 134
H NI++ + V T+RT + ++ E Y K + + IK+ R
Sbjct: 58 AFDHPNIVRLMD--VCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMR 115
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPE 193
Q LRGL +LH++ I+HRDLK +NI V + G+VK+ D GLA I Q V+ T
Sbjct: 116 QFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLW 172
Query: 194 FMAPE-LYEEEYNELVDIYSFGMCILEM 220
+ APE L + Y VD++S G EM
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 12/164 (7%)
Query: 136 ILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPE 193
I++ LHYL H +IHRD+K NI ++ +G VK+ D G++ + A++ G
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 194 FMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA- 247
+MAPE + +Y+ D++S G+ ++E+ T ++PY CK ++ K+ P+
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239
Query: 248 SLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKD 290
++ P F++ C+ + P ELL+ PF+ +
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 95/333 (28%), Positives = 146/333 (43%), Gaps = 50/333 (15%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY ++ G GA+ +V D+ G +VA +++ QS +R Y E+ LLK ++
Sbjct: 16 RYTSLKQV-GSGAYGSVCSAIDKRTGEKVAIKKLS--RPFQSEIFAKRAYRELTLLKHMQ 72
Query: 85 HENIIKFYNSWV-----DDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRG 139
HEN+I + + D+ ++ + T L+ H + K ++ Q+L G
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDK-VQYLVYQMLCG 129
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE- 198
L Y+HS IIHRDLK N+ VN + E+KI D GLA V+ T + APE
Sbjct: 130 LKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGYVV-TRWYRAPEV 185
Query: 199 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASLSKVTDP 255
L YN+ VDI+S G + EM+T + + Q+ + KVT P + K+ D
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245
Query: 256 QVKQFIEKCIVPA------SLRLP-----ALELLKDPFLVTDNPKDLVC---------DP 295
K +I+ +P S P A++LL + L D K L D
Sbjct: 246 AAKSYIKS--LPKYPRKDFSTLFPKASPQAVDLL-EKMLELDVDKRLTATEALEHPYFDS 302
Query: 296 LRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSAD 328
R + E P D L ++K+S D
Sbjct: 303 FRDADEET--------EQQPYDDSLENEKLSVD 327
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 66/214 (30%), Positives = 96/214 (44%), Gaps = 41/214 (19%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
LG G F V+ G WN +V ++ + E E ++K L+H+ ++
Sbjct: 14 LGAGQFGEVWMGT---------WNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 90 KFYNSWVDDTNRTINMITELFTSGSL---------RYRKKHKNVDMKAIKNWARQILRGL 140
+ Y V I ++TE + GSL + + + VDM A QI G+
Sbjct: 65 QLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA------QIAEGM 116
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAP 197
YL S N IHRDL NI V G N KI D GLA +++ TAR P ++ AP
Sbjct: 117 AYLESRN--YIHRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAP 173
Query: 198 E--LYEEEYNELVDIYSFGMCILEMVT---CEYP 226
E Y + D++SFG+ + E+VT YP
Sbjct: 174 EAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 71/253 (28%), Positives = 124/253 (49%), Gaps = 33/253 (13%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWN 56
M FTK +T + S+ + E LG G+F V +KG E I+
Sbjct: 1 MKAAYMFTKPDTSSWKLSDFE-------MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK 53
Query: 57 QVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT-----ELFT 111
+ ++ M+ Q++ + E +L L H I+ S+ D+ NR ++ ELFT
Sbjct: 54 REILK--MK---QVQHVAQEKSILMELSHPFIVNMMCSFQDE-NRVYFLLEFVVGGELFT 107
Query: 112 SGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 171
LR + N K + +++ YLHS + II+RDLK +N+ ++ N G VK+
Sbjct: 108 H--LRKAGRFPN---DVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKV 159
Query: 172 GDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNEC 230
D G A + T ++ GTPE++APE+ + + + + VD ++ G+ + E + P+ +
Sbjct: 160 TDFGFAKKVPDRTF-TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD- 217
Query: 231 KNPAQIYKKVTSG 243
P +IY+K+ +G
Sbjct: 218 DTPFRIYEKILAG 230
|
Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-15
Identities = 62/229 (27%), Positives = 111/229 (48%), Gaps = 22/229 (9%)
Query: 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
E + K+ + +Y +LG GA TV DG A V++E + S R +
Sbjct: 24 EATAKEQAKKY-WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQA 80
Query: 76 EVHLLKSLKHENIIKFYNSWV--DDTN----RTINMITELFTSGSLRYRKKHKNVDMKAI 129
EV L + +I+K + + D N I ++ + +G LR K + +
Sbjct: 81 EVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF 140
Query: 130 KNWAR-----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----AIVM 180
+ Q+L +H++HS + +IHRD+K NI + +NG VK+GD G A +
Sbjct: 141 REHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILL-CSNGLVKLGDFGFSKMYAATV 197
Query: 181 QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYN 228
R+ GTP ++APE++ + Y++ D++S G+ + E++T + P++
Sbjct: 198 SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 31 EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKH 85
++LGKG+F V+ KG ++ I+ +DV+ D +E E +L + +H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKAL-----KKDVVLMDDDVECTMVEKRVLSLAWEH 55
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKK--HKNVDMKAIKNWARQILRGLHYL 143
+ Y ++ T + + E G L + + HK D+ +A +I+ GL +L
Sbjct: 56 PFLTHLYCTF--QTKENLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFL 112
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LY 200
HS I++RDLK DNI ++ +G +KI D G+ ++ + GTP+++APE L
Sbjct: 113 HSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYPYN 228
++YN VD +SFG+ + EM+ + P++
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 79/307 (25%), Positives = 126/307 (41%), Gaps = 68/307 (22%)
Query: 13 EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLE 71
++ EF D +Y + +I G+G F V+K + VA +V +E+ + P
Sbjct: 1 DQYEFPFCDEVSKYEKLAKI-GQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL 59
Query: 72 RLYSEVHLLKSLKHENIIKFY---NSWVDDTNR---TINMITELFTSGSLRYRKKHKNVD 125
R E+ +L+ LKHEN++ + NR + ++ E F L +KNV
Sbjct: 60 R---EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFE-FCEHDLAGLLSNKNVK 115
Query: 126 MK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183
IK + +L GL+Y+H + I+HRD+K NI + +G +K+ D GLA
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLARAFSLS 172
Query: 184 --------TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT---------- 222
T R V T + PEL E +Y +D++ G CI+ EM T
Sbjct: 173 KNSKPNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWTRSPIMQGNTE 229
Query: 223 ----------C------------EYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
C + + + + P +KV +KP V DP
Sbjct: 230 QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP----YVKDPHALD 285
Query: 260 FIEKCIV 266
I+K +V
Sbjct: 286 LIDKLLV 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 9e-15
Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 33 LGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+G+G + VYK D D E A Q+ + S + E+ LL+ LKH N+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR------EIALLRELKHPNVIA 62
Query: 91 FYNSWVDDTNRTINMITEL----------FTSGSLRYRKKHKNVDMKAIKNWARQILRGL 140
++ ++R + ++ + F S + KK + +K+ QIL G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRAS-KANKKPMQLPRSMVKSLLYQILDGI 121
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-----RSVIGTP 192
HYLH++ ++HRDLK NI V G G VKI D+G A + P V+ T
Sbjct: 122 HYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 193 EFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 231
+ APEL Y + +DI++ G E++T E P C+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 70/244 (28%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LGKG+F V KG DE+ I++ V I+D D +E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD-----DDVECTMVEKRVLALPGKPP 61
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRYRKKH--KNVDMKAIKNWARQILRGLHYLHS 145
+ +S +R + + E G L Y + K + A+ +A +I GL +LHS
Sbjct: 62 FLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGKFKEPHAV-FYAAEIAIGLFFLHS 119
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE--LYE 201
II+RDLK DN+ ++ G +KI D G+ + T R+ GTP+++APE Y
Sbjct: 120 KG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY- 175
Query: 202 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--SGIKPASLSKVTDPQVKQ 259
+ Y + VD ++FG+ + EM+ + P+ + ++ ++++ + + P SLSK K
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234
Query: 260 FIEK 263
+ K
Sbjct: 235 LLTK 238
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 66/256 (25%), Positives = 116/256 (45%), Gaps = 26/256 (10%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G F V+ G I+VA + E M D +E E ++ L H N+++ Y
Sbjct: 12 LGSGQFGVVHLGKWR-GKIDVAIKMIR-EGAMSEDDFIE----EAKVMMKLSHPNLVQLY 65
Query: 93 NSWVDDTNRTINMITELFTSGSLR-YRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPI 150
V R I ++TE +G L Y ++ K + + + + + YL S+
Sbjct: 66 G--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--F 121
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP-EFMAPELYE-EEYNE 206
IHRDL N V G + VK+ D GLA ++ Q T+ P ++ PE+++ ++
Sbjct: 122 IHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 207 LVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIE 262
D++SFG+ + E+ + + PY N +++ + V++G +P K+ +V +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSAGYRLYRP----KLAPTEVYTIMY 235
Query: 263 KCIVPASLRLPALELL 278
C PA + L
Sbjct: 236 SCWHEKPEDRPAFKKL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 54/171 (31%), Positives = 86/171 (50%), Gaps = 15/171 (8%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKK 120
E V+ Q +E H+L+++ H +II+ ++ N+ +I + + Y
Sbjct: 118 EHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFT--YNKFTCLILPRYKTDLYCYLAA 175
Query: 121 HKNV---DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177
+N+ D+ AI+ R +LR + YLH IIHRD+K +NIF+N + G+V +GD G A
Sbjct: 176 KRNIAICDILAIE---RSVLRAIQYLH--ENRIIHRDIKAENIFIN-HPGDVCLGDFGAA 229
Query: 178 ---IVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCE 224
+ + GT APEL + Y VDI+S G+ + EM TC
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 34/219 (15%)
Query: 33 LGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
LG+G+F VY+G VA VN M+ +++E +E ++K +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIE-FLNEASVMKEFNCHH 70
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKA----------IKNWARQI 136
+++ V T+ ++ EL G L+ Y + + A +I
Sbjct: 71 VVRLLGV-VSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 137 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ---QPTARSVIGT 191
G+ YL + +HRDL N V + VKIGD G+ I + + ++
Sbjct: 129 ADGMAYLAAKK--FVHRDLAARNCMVAE-DLTVKIGDFGMTRDIYETDYYRKGGKGLL-- 183
Query: 192 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPY 227
P +MAPE L + + D++SFG+ + EM T E PY
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 70/245 (28%), Positives = 110/245 (44%), Gaps = 48/245 (19%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
LG G F V+ G WN +V ++ + E E ++K L+H+ ++
Sbjct: 14 LGNGQFGEVWMG---------TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 90 KFYNSWVDDTNRTINMITELFTSGSL---------RYRKKHKNVDMKAIKNWARQILRGL 140
+ Y + I ++TE + GSL R K VDM A Q+ G+
Sbjct: 65 QLYAVV---SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA------QVAAGM 115
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAP 197
Y+ N IHRDL+ NI V G+ KI D GLA +++ + TAR P ++ AP
Sbjct: 116 AYIERMN--YIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 198 E--LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK-------PA 247
E LY + D++SFG+ + E+VT PY N ++ ++V G + P
Sbjct: 173 EAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPI 230
Query: 248 SLSKV 252
SL ++
Sbjct: 231 SLHEL 235
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 21/222 (9%)
Query: 33 LGKGAFKTVYKG-FDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
LG G F +V KG + G +EVA + E + + R E ++ L H I+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPCIV 59
Query: 90 KFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
+ + + ++ EL G L +Y KK + + + +K A Q+ G+ YL S +
Sbjct: 60 RLIGVCKGEP---LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH- 115
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTP-EFMAPE-LYEE 202
+HRDL N+ + N + KI D G++ + A + P ++ APE +
Sbjct: 116 -FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 203 EYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+++ D++S+G+ + E + PY E K ++ + SG
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 31 EILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
++LG GAF TVYKG E I VA + I + P E ++ S+ H
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGS-LRYRKKHK-NVDMKAIKNWARQILRGLHYLH 144
++++ + + TI ++T+L G L Y +HK N+ + + NW QI +G+ YL
Sbjct: 70 HLVRLLGVCL---SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPE-L 199
++HRDL N+ V N VKI D GLA +++ + A ++MA E +
Sbjct: 127 ERR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 200 YEEEYNELVDIYSFGMCILEMVT 222
+ ++ D++S+G+ I E++T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 51/201 (25%), Positives = 101/201 (50%), Gaps = 10/201 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
++LGKG F V ++ G A + E V+ + D++ +E +L++ +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPP 149
+ T+ + + E G L + + V + + + +I+ L YLHS +
Sbjct: 60 L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 115
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 206
+++RD+K +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E+ +Y
Sbjct: 116 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 207 LVDIYSFGMCILEMVTCEYPY 227
VD + G+ + EM+ P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 68/265 (25%), Positives = 129/265 (48%), Gaps = 21/265 (7%)
Query: 9 KSETEEGEFSEKDPSCRYGRYDEI--LGKGAF-KTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
K +++ + ++ +Y ++ I LG G+F + + + D VA + +++
Sbjct: 12 KKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK 71
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGS----LRYRKKH 121
Q++ ++SE +L + H + Y S+ D++ + ++ E G LR K+
Sbjct: 72 Q-KQVDHVFSERKILNYINHPFCVNLYGSFKDES--YLYLVLEFVIGGEFFTFLRRNKRF 128
Query: 122 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181
N D+ +A QI+ YL S N I++RDLK +N+ ++ +G +K+ D G A V+
Sbjct: 129 PN-DVGCF--YAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVD 182
Query: 182 QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 240
T ++ GTPE++APE L + + D ++ G+ I E++ P+ P IY+K+
Sbjct: 183 TRT-YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF-YANEPLLIYQKI 240
Query: 241 TSGIKPASLSKVTDPQVKQFIEKCI 265
GI K D K ++K +
Sbjct: 241 LEGI--IYFPKFLDNNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 51/291 (17%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
++G+GAF V+ D+ G A + D+++ Q+ + +E +L I+K
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN-QIAHVRAERDILADADSPWIVKL 66
Query: 92 YNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 150
Y S+ D+ + + ++ E G L + + + + +++ L +H
Sbjct: 67 YYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--F 122
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----------------------------Q 181
IHRD+K DNI + +G +K+ D GL M +
Sbjct: 123 IHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 182 QPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQI 236
Q A S +GTP+++APE L Y D +S G+ + EM+ +P Y++ +
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY-GFPPFYSD--TLQET 238
Query: 237 YKKVTSGIKPASLSKVTDPQV----KQFIEKCIVPASLRL-PALELLKDPF 282
Y K+ + + SL DP V I + + RL E+ PF
Sbjct: 239 YNKIINWKE--SLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 31 EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
++LGKG+F V KG E ++ +DV+ D +E E +L +L E
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKAL-----KKDVVLIDDDVECTMVEKRVL-ALAWE 54
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKN-VDMKAIKNWARQILRGLHYLHS 145
N + T + + E G L + + K D+ +A +I+ GL +LHS
Sbjct: 55 NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS 114
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-E 202
II+RDLK DN+ ++ +G +KI D G+ V A + GTP+++APE+ +
Sbjct: 115 KG--IIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 203 EYNELVDIYSFGMCILEMVTCEYPYN 228
+Y VD +SFG+ + EM+ + P++
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G V K + G+ +A +++E P ++ E+ +L I+ FY
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 93 NSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 151
++ D +I M E GSL + K+ K + + + + +LRGL YL + I+
Sbjct: 70 GAFYSDGEISICM--EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ-IM 126
Query: 152 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 210
HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y+ DI
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 211 YSFGMCILEMVTCEYP 226
+S G+ ++E+ YP
Sbjct: 186 WSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 31/214 (14%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKHENIIK 90
LGKG GF EV + QV M + +L+ RL + +L + I++
Sbjct: 1 LGKG-------GFGEVCAV-----QVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILE 48
Query: 91 FYNS-------WVDDTNRTINMITELFTSGSLRYRKKH---KNVDMKAIKNWARQILRGL 140
NS + ++ + ++ L G L+Y + + ++M+ + +++ QI G+
Sbjct: 49 KVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI 108
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE 198
LH H+ I++RD+K +N+ ++ + G ++ DLGLA+ ++ + + GT +MAPE
Sbjct: 109 --LHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPE 164
Query: 199 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 231
L EE Y+ VD ++ G I EMV P+ + K
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 20/204 (9%)
Query: 30 DEILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKH 85
++LG GAF TVYKG E + +++ V I+++ + SP + + E +++ S+ +
Sbjct: 12 IKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGS-LRYRKKHK-NVDMKAIKNWARQILRGLHYL 143
++ + + T+ +IT+L G L Y ++HK N+ + + NW QI +G++YL
Sbjct: 69 PHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE- 198
++HRDL N+ V VKI D GLA ++ ++ A ++MA E
Sbjct: 126 EERR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 199 LYEEEYNELVDIYSFGMCILEMVT 222
+ Y D++S+G+ + E++T
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 58/196 (29%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G V+K + G+ +A +++E P ++ E+ +L I+ FY
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 93 NSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 151
++ D +I M E GSL + KK + + + + +++GL YL + I+
Sbjct: 70 GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 126
Query: 152 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 210
HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y+ DI
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 211 YSFGMCILEMVTCEYP 226
+S G+ ++EM YP
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 10/201 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
++LGKG F V ++ G A ++ ++V+ + D++ +E +LK+ +H +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAM-KILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPP 149
S+ T + + E G L + + V + + +I+ L YLHS
Sbjct: 60 LKYSF--QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-- 115
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 206
I++RDLK +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E+ +Y
Sbjct: 116 IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 207 LVDIYSFGMCILEMVTCEYPY 227
VD + G+ + EM+ P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 58/214 (27%), Positives = 110/214 (51%), Gaps = 10/214 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++GKG+F V ++DG A + + V+ +Q + LLK++KH ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
+ S+ T + + + G L + ++ ++ + +A +I L YLHS N
Sbjct: 61 LHYSF--QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN-- 116
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNE 206
I++RDLK +NI ++ + G V + D GL + Q T + GTPE++APE + ++ Y+
Sbjct: 117 IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 207 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 240
VD + G + EM+ P+ C++ A++Y +
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPF-YCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 33 LGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+G+G + VYK D D + A Q+ + S + E+ LL+ LKH N+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR------EIALLRELKHPNVIS 62
Query: 91 FYNSWVDDTNRTINMITEL----------FTSGSLRYRKKHKNVDMKAIKNWARQILRGL 140
++ +R + ++ + F S + KK + +K+ QIL G+
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRAS-KANKKPVQLPRGMVKSLLYQILDGI 121
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-----RSVIGTP 192
HYLH++ ++HRDLK NI V G G VKI D+G A + P V+ T
Sbjct: 122 HYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 193 EFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 231
+ APEL Y + +DI++ G E++T E P C+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 58/236 (24%), Positives = 115/236 (48%), Gaps = 12/236 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++GKG+F V + + A + + +++ ++ + LLK++KH ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKA-IKNWARQILRGLHYLHSHNPP 149
+ S+ T + + + G L Y + + ++ + +A +I L YLHS N
Sbjct: 61 LHFSF--QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN-- 116
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNE 206
I++RDLK +NI ++ + G + + D GL + T + GTPE++APE L+++ Y+
Sbjct: 117 IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 207 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262
VD + G + EM+ P+ +N A++Y + + KP L + +E
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILN--KPLQLKPNITNSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G F V+ G+ +V I+ + Q E +E +L+K L+H +++ Y
Sbjct: 14 LGAGQFGEVWMGYYNGH------TKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY 67
Query: 93 NSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIK--NWARQILRGLHYLHSHNPP 149
T I +ITE +GSL + K + + + K + A QI G+ ++ N
Sbjct: 68 AVV---TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN-- 122
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP-EFMAPE-LYEEEYN 205
IHRDL+ NI V+ KI D GLA I + TAR P ++ APE + +
Sbjct: 123 YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 206 ELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 236
D++SFG+ + E+VT PY NP I
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 19/206 (9%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LGKG+F V KG DE+ I++ V I+D D +E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALQDKPP 61
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRYRKKH--KNVDMKAIKNWARQILRGLHYLHS 145
+ +S +R + + E G L Y + K + +A+ +A +I GL +LH
Sbjct: 62 FLTQLHSCFQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKEPQAV-FYAAEISVGLFFLHR 119
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-E 202
II+RDLK DN+ ++ + G +KI D G+ ++ T R+ GTP+++APE+ +
Sbjct: 120 RG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 203 EYNELVDIYSFGMCILEMVTCEYPYN 228
Y + VD +++G+ + EM+ + P++
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 53 VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112
VA ++N++ S + L+ L E+ + L+H NI+ + S++ D+ + +++ L
Sbjct: 28 VAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAY 83
Query: 113 GSLR-YRKKHKNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 169
GS K H + AI + +L L Y+HS IHR +K +I ++G +G+V
Sbjct: 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSG-DGKV 140
Query: 170 KIGDLGLAIVM--QQPTARSVIGTPEF-------MAPELYEEE---YNELVDIYSFGMCI 217
+ L ++ M R V P+ ++PE+ ++ YNE DIYS G+
Sbjct: 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITA 200
Query: 218 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257
E+ P+ + Q+ + G P L K T P
Sbjct: 201 CELANGHVPFKDMP-ATQMLLEKVRGTVPCLLDKSTYPLY 239
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 10/216 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++GKG+F V + DG A + + +++ +Q + LLK+LKH ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
+ S+ T + + + G L + ++ + + +A ++ + YLHS N
Sbjct: 61 LHYSF--QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN-- 116
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNE 206
II+RDLK +NI ++ + G V + D GL +P T + GTPE++APE L +E Y+
Sbjct: 117 IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 207 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 242
VD + G + EM+ P+ ++ +Q+Y +
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
R + LG+G F V+ G WN +V I+ + E E ++K L+
Sbjct: 9 RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 59
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKK---HKNVDMKAIKNWARQILRGLH 141
HE +++ Y ++ I ++TE + GSL K K + + + + A QI G+
Sbjct: 60 HEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 198
Y+ N +HRDL+ NI V G N K+ D GLA +++ + TAR P ++ APE
Sbjct: 117 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 199 --LYEEEYNELVDIYSFGMCILEMVT 222
LY + D++SFG+ + E+ T
Sbjct: 174 AALY-GRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 78/276 (28%), Positives = 123/276 (44%), Gaps = 26/276 (9%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY ++ +G GA V FD V GI VA +++ Q+ +R Y E+ LLK + H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS--RPFQNQTHAKRAYRELVLLKCVNH 79
Query: 86 ENIIKFYNSWVDDTN----RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLH 141
+NII N + + + + ++ EL + + H +D + + Q+L G+
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQV--IHMELDHERMSYLLYQMLCGIK 137
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV-----MQQPTARSVIGTPEFMA 196
+LHS IIHRDLK NI V ++ +KI D GLA M P + T + A
Sbjct: 138 HLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTACTNFMMTP----YVVTRYYRA 190
Query: 197 PE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVTD 254
PE + Y E VDI+S G + E+V + + Q K + G A
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250
Query: 255 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD 290
P V+ ++E P + EL D +++ +D
Sbjct: 251 PTVRNYVEN--RPQYPGISFEELFPDWIFPSESERD 284
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 65/231 (28%), Positives = 117/231 (50%), Gaps = 22/231 (9%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LGKG+F V KG DE+ I++ V I+D D +E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALSGKPP 61
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRYRKKH--KNVDMKAIKNWARQILRGLHYLHS 145
+ +S +R + + E G L Y+ + + + A+ +A +I GL +LHS
Sbjct: 62 FLTQLHSCFQTMDR-LYFVMEYVNGGDLMYQIQQVGRFKEPHAV-FYAAEIAIGLFFLHS 119
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-E 202
II+RDLK DN+ ++ + G +KI D G+ + T ++ GTP+++APE+ +
Sbjct: 120 KG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 203 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSK 251
Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P S+SK
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSK 226
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 67/254 (26%), Positives = 121/254 (47%), Gaps = 17/254 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENII 89
+LGKG+F V + G + +V +DV+ D +E +E +L + H +
Sbjct: 1 RVLGKGSFGKVMLARLKESG-RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
+ Y + T + + E G L + +K + D + +A +I L +LH
Sbjct: 60 QLYCCF--QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYN 205
II+RDLK DN+ ++ + G K+ D G+ + T + GTP+++APE L E Y
Sbjct: 117 -IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 206 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQFIEK 263
VD ++ G+ + EM+ P+ E +N +++ + + + P LS+ +K F+ K
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK 233
Query: 264 CIVPASLRLPALEL 277
++RL +L L
Sbjct: 234 ---NPTMRLGSLTL 244
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
R D LG+G F V+ G WN +V I+ + E E ++K L+
Sbjct: 9 RLDVKLGQGCFGEVWMG---------TWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLR 59
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKH---KNVDMKAIKNWARQILRGLH 141
H+ ++ Y ++ I ++TE GSL K K + + + + A QI G+
Sbjct: 60 HDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 198
Y+ N IHRDL+ NI V G+N KI D GLA +++ + TAR P ++ APE
Sbjct: 117 YIERMN--YIHRDLRAANILV-GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 199 --LYEEEYNELVDIYSFGMCILEMVT 222
LY + D++SFG+ + E+VT
Sbjct: 174 AALY-GRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKH 85
R+ +LGKG F EV QV M + +LE R+ +L
Sbjct: 3 RHYRVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 50
Query: 86 ENIIKFYNS-------WVDDTNRTINMITELFTSGSLR---YRKKHKNVDMKAIKNWARQ 135
+ I++ NS + +T + ++ L G L+ Y + D + +A +
Sbjct: 51 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE 110
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEF 194
I GL LH I++RDLK +NI ++ + G ++I DLGLA+ + + T R +GT +
Sbjct: 111 ITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGY 167
Query: 195 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK 231
MAPE+ + E Y D + G I EM+ + P+ + K
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA V +D V G VA + + Q+ +R Y E+ L+K + H
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKK--LSRPFQNVTHAKRAYRELVLMKLVNH 74
Query: 86 ENIIKFYNSWVDDTN----RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLH 141
+NII N + + + + ++ EL + +L + ++D + + Q+L G+
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NL-CQVIQMDLDHERMSYLLYQMLCGIK 132
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FMA 196
+LHS IIHRDLK NI V ++ +KI D GLA + S + TP + A
Sbjct: 133 HLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRA 185
Query: 197 PE-LYEEEYNELVDIYSFGMCIL-EMV 221
PE + Y E VDI+S G CI+ EM+
Sbjct: 186 PEVILGMGYKENVDIWSVG-CIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 78/294 (26%), Positives = 138/294 (46%), Gaps = 21/294 (7%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
++GKG+F V + DG A + + +++ +Q + LLK++KH ++
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 92 YNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 150
+ S+ T + + + G L + ++ ++ + +A +I L YLHS N I
Sbjct: 62 HYSF--QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--I 117
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNEL 207
I+RDLK +NI ++ + G V + D GL + T + GTPE++APE L ++ Y+
Sbjct: 118 IYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 208 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 267
VD + G + EM+ P+ ++ A++Y + + KP L + +E +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF-YSRDTAEMYDNILN--KPLRLKPNISVSARHLLEGLLQK 233
Query: 268 -ASLRLPA----LELLKDPFLVTDNPKDLVCDPLRLPNLVPEV---MNLAHSEP 313
+ RL A LE+ F + N DLV + P P V M+L H +P
Sbjct: 234 DRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPP-FNPNVSGPMDLKHFDP 286
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 70/235 (29%), Positives = 105/235 (44%), Gaps = 39/235 (16%)
Query: 27 GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RYD I +GKG VY +D V VA ++ ED+ ++P +R E + L
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLI 60
Query: 85 HENIIKFYN--SWVDDTNRTINMITELFTSGSL--RYRKK-------HKNVDMKAIKNWA 133
H I+ Y+ S D T+ I E +T SL +K + + A +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYI-EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 134 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----------P 183
+I + Y+HS ++HRDLK DNI + G GEV I D G AI +
Sbjct: 120 HKICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 184 TARS----------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 227
++GTP++MAPE L +E DIY+ G+ + +M+T +PY
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 62/206 (30%), Positives = 87/206 (42%), Gaps = 19/206 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +GKG F VYKG + EVA PD + E +LK H NI+K
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVK 56
Query: 91 FYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
V + I ++ EL GSL RKK + +K + + G+ YL S N
Sbjct: 57 LIGVCVQ--KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN- 113
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEEE 203
IHRDL N V G N +KI D G++ + G + + APE L
Sbjct: 114 -CIHRDLAARNCLV-GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 204 YNELVDIYSFGMCILEMVT---CEYP 226
Y D++S+G+ + E + YP
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYP 197
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
++LGKG F V ++ G A + E V+ + D++ +E +L++ +H +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKE-VIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPP 149
S+ T+ + + E G L + + V + + +I+ L YLHS
Sbjct: 60 LKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN- 116
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 206
+++RDLK +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E+ +Y
Sbjct: 117 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 207 LVDIYSFGMCILEMVTCEYP-YNE 229
VD + G+ + EM+ P YN+
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 89/340 (26%), Positives = 145/340 (42%), Gaps = 62/340 (18%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII-- 89
I+G G+F VY+ +D E +V I+ V+Q P R E+ ++K+L H NII
Sbjct: 73 IIGNGSFGVVYEAIC-IDTSE----KVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFL 124
Query: 90 --KFYNSWV--DDTNRTINMITELFTSGSLRYRKKH----KNVDMKAIKNWARQILRGLH 141
+Y ++ N +N++ E +Y K + + + +K ++ Q+ R L
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEFMAPELY 200
Y+HS I HRDLK N+ ++ N +K+ D G A ++ + S I + + APEL
Sbjct: 185 YIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELM 242
Query: 201 --EEEYNELVDIYSFGMCILEMVTCEYPYNECKN--------------PAQIYKKVTS-- 242
Y +D++S G I EM+ YP ++ P + K +
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPN 301
Query: 243 -------GIKPASLSKV----TDPQVKQFIEKCIVPASL-RLPALELLKDPFLVTDNPKD 290
+KP L KV T FI + + L RL +E L DPF D
Sbjct: 302 YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF------D 355
Query: 291 LVCDP-LRLPNLV---PEVMNLAHSEPHPMDIDLNHKKVS 326
+ DP ++LP + P++ N +E M K +
Sbjct: 356 DLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIP 395
|
Length = 440 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 30 DEILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHE 86
+ LG+G F V K + G + V ++ + + S +L L SE +LLK + H
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGR-AGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHK---------------------- 122
++IK Y + D + +I E GSLR R+ K
Sbjct: 64 HVIKLYGACSQD--GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 123 -NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181
+ M + ++A QI RG+ YL ++HRDL N+ V ++KI D GL+ +
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLV-AEGRKMKISDFGLSRDVY 178
Query: 182 QPTA---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 222
+ + RS P ++MA E L++ Y D++SFG+ + E+VT
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 54/181 (29%), Positives = 92/181 (50%), Gaps = 20/181 (11%)
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWA- 133
SE+H L + H I+K ++ + D + +I E + G L + K + + + +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171
Query: 134 ----RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----A 185
QI+ L +HS ++HRDLK NIF+ G +K+GD G + A
Sbjct: 172 GLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 186 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ--IYKKVTS 242
S GTP ++APEL+E + Y++ D++S G+ + E++T P+ K P+Q I ++V
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLY 285
Query: 243 G 243
G
Sbjct: 286 G 286
|
Length = 478 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 71/268 (26%), Positives = 120/268 (44%), Gaps = 40/268 (14%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKH 85
R +LGKG F EV QV M + +LE R+ +L
Sbjct: 3 RQYRVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGESMALNE 50
Query: 86 ENIIKFYNS-------WVDDTNRTINMITELFTSGSLRYRKKH---KNVDMKAIKNWARQ 135
+ I++ NS + +T + ++ L G L++ H + +A +
Sbjct: 51 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE 110
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEF 194
I GL LH I++RDLK +NI ++ ++G ++I DLGLA+ V + T + +GT +
Sbjct: 111 ICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 167
Query: 195 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253
MAPE+ + E Y D ++ G + EM+ + P+ + K KK IK + ++
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK------KK----IKREEVERLV 217
Query: 254 DPQVKQFIEKCIVPASLRLPALELLKDP 281
+++ EK P + L + L KDP
Sbjct: 218 KEVQEEYSEK-FSPDARSLCKMLLCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 74/245 (30%), Positives = 112/245 (45%), Gaps = 26/245 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE-RLYSEVHLLKSLKHENII 89
E+LGKG F V+KG + D VA ED+ P +L+ + SE +LK H NI+
Sbjct: 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCK-EDL---PQELKIKFLSEARILKQYDHPNIV 55
Query: 90 KFYNSWVDDTNRTINMITELFTSGS-LRY-RKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
K V + I ++ EL G L + RKK + K + +A G+ YL S N
Sbjct: 56 KLIG--VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEE 202
IHRDL N V G N +KI D G++ + S G + + APE L
Sbjct: 114 --CIHRDLAARNCLV-GENNVLKISDFGMS-RQEDDGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 203 EYNELVDIYSFGMCILEMVT---CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
Y+ D++S+G+ + E + C YP Q ++V G + + K D V +
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYP---GMTNQQAREQVEKGYRMSCPQKCPD-DVYK 225
Query: 260 FIEKC 264
+++C
Sbjct: 226 VMQRC 230
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 26/233 (11%)
Query: 32 ILGKGAFKTVYKG-FDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
LG GAF VY+G ++ G +V ++ + + E+ E HL+ + H NI
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 89 IKFYNSWVDDTNRTINMITELFTSGS----LRYRKKHKN----VDMKAIKNWARQILRGL 140
+K + N +I EL G LR + + + +K + + + +G
Sbjct: 62 VKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIVMQQPTARSVIGTP---- 192
YL + IHRDL N V+ + VKIGD GLA + + G
Sbjct: 120 VYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 193 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+MAPE L + ++ D++SFG+ + E++T + PY N ++ + VT+G
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-12
Identities = 50/182 (27%), Positives = 91/182 (50%), Gaps = 22/182 (12%)
Query: 73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT--------SGSLRYRKKHKNV 124
L +E+ L L HENI+K + N MIT+ + + ++ +
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTY--MITQKYDFDLYSFMYDEAFDWKDRPLLK 267
Query: 125 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 183
+AI +Q+L + Y+H +IHRD+K +NIF+N +G++ +GD G A+ ++
Sbjct: 268 QTRAI---MKQLLCAVEYIHDKK--LIHRDIKLENIFLNC-DGKIVLGDFGTAMPFEKER 321
Query: 184 TARSV--IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY-PYNE-CKNPAQIYK 238
A +GT +PE L + Y E+ DI+S G+ +L+M++ ++ P + P +
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381
Query: 239 KV 240
K+
Sbjct: 382 KI 383
|
Length = 501 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 24/205 (11%)
Query: 31 EILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV--HLLK--SLK 84
++LG G F TV+KG E D I++ I+D +S Q + E+ H+L SL
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQT---FQEITDHMLAMGSLD 67
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDMKAIKNWARQILRGLHY 142
H I++ ++ ++T+L GSL R+ ++D + + NW QI +G++Y
Sbjct: 68 HAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTP-EFMAPE 198
L H ++HR+L NI + ++ V+I D G+A ++ + S TP ++MA E
Sbjct: 125 LEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 199 -LYEEEYNELVDIYSFGMCILEMVT 222
+ Y D++S+G+ + EM++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 13/182 (7%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDMKA 128
+ E ++ L HE +++ Y V R I ++TE ++G L R+ K
Sbjct: 44 DEFIEEAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ 101
Query: 129 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 188
+ + + G+ YL S IHRDL N V+ + G VK+ D GL+ + S
Sbjct: 102 LLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSS 158
Query: 189 IGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+G+ + PE L +++ D+++FG+ + E+ + + PY N ++ +KV+ G
Sbjct: 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQG 217
Query: 244 IK 245
++
Sbjct: 218 LR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
++LGKG F V ++ G A ++ ++V+ + D++ +E +L++ +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAM-KILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPP 149
S+ T+ + + E G L + + V + + +I+ L YLHS +
Sbjct: 60 LKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 206
+++RDLK +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E+ +Y
Sbjct: 116 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 207 LVDIYSFGMCILEMVTCEYPY 227
VD + G+ + EM+ P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 7e-12
Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 24/197 (12%)
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQ 135
VH L + N IK Y S T + +I + G L KK + +K RQ
Sbjct: 61 VHQLMK-DNPNFIKLYYSV--TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ 117
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 195
++ L+ LH HN IIH D+K +N+ + + + D GL ++ P+ GT ++
Sbjct: 118 LVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--GTLDYF 173
Query: 196 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPY----NECKNPAQ----IYKKVTSGIKP 246
+PE + Y+ D ++ G+ E++T ++P+ +E + KK+
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP----- 228
Query: 247 ASLSKVTDPQVKQFIEK 263
K F++
Sbjct: 229 --FIKNVSKNANDFVQS 243
|
Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 33 LGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
+G+G + V+ K E+ VA ++ + ++ +++ + +E +L + K E +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEI----VALKRMK-KSLLFKLNEVRHVLTERDILTTTKSEWL 63
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNV-DMKAIKNWARQILRGLHYLHSHN 147
+K ++ DD + M E G R + V + + ++ + LH
Sbjct: 64 VKLLYAFQDDEYLYLAM--EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEY 204
IHRDLK +N F+ +G +K+ D GL+ IV A SV+G+P++MAPE L + Y
Sbjct: 122 --YIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTY---ANSVVGSPDYMAPEVLRGKGY 175
Query: 205 NELVDIYSFGMCILEMVTCEYP 226
+ VD +S G C+L C +P
Sbjct: 176 DFTVDYWSLG-CMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 36/221 (16%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER----LYSEVHLLKSL-K 84
+ LG+GAF V K E G++ + M D E+ L SE+ ++K + K
Sbjct: 17 GKPLGEGAFGQVVKA--EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDM----------------K 127
H+NII V + ++ E G+LR + + + K
Sbjct: 75 HKNIINLLG--VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 128 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQ 182
+ ++A Q+ RG+ +L S IHRDL N+ V ++ +KI D GLA I +
Sbjct: 133 DLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDH-VMKIADFGLARDIHHIDYYR 189
Query: 183 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 222
T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 190 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 40/129 (31%), Positives = 69/129 (53%), Gaps = 6/129 (4%)
Query: 106 ITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 164
I +L G L Y +H K ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 165 NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 222
+G V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191
Query: 223 CEYPYNECK 231
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 23/223 (10%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G + VY+G + + VA + ED M+ +E E ++K +KH N+++
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 68
Query: 93 NSWVDDTNRTINMITELFTSGSL-RY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
V +ITE T G+L Y + V+ + A QI + YL N
Sbjct: 69 G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 205
IHRDL N V G N VK+ D GL+ +M T + G ++ APE L +++
Sbjct: 125 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 206 ELVDIYSFGMCILEMVT---CEYPYNECKNPAQIYKKVTSGIK 245
D+++FG+ + E+ T YP + +Q+Y+ + G +
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKGYR 223
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 129 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA------IVMQQ 182
+++ QIL GL Y+HS N ++HRDLK N+ VN + E+KI D GLA
Sbjct: 107 FQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNA-DCELKICDFGLARGFSENPGENA 163
Query: 183 PTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL 218
+ T + APE L + Y + +D++S G CIL
Sbjct: 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 39/129 (30%), Positives = 68/129 (52%), Gaps = 6/129 (4%)
Query: 106 ITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 164
I +L G L Y +H ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 165 NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 222
+G V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191
Query: 223 CEYPYNECK 231
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 65/277 (23%), Positives = 130/277 (46%), Gaps = 39/277 (14%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHE 86
++G+G++ V K + + ++V ++ +D + ++ + +E H+ ++ H
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNHP 56
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHS 145
++ ++ + T + + E G L + ++ + + + + ++ +I L+YLH
Sbjct: 57 FLVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-E 202
II+RDLK DN+ ++ + G +K+ D G+ +P T + GTP ++APE+ E
Sbjct: 115 RG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 203 EYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
+Y VD ++ G+ + EM+ P++ NP Q D +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDYLFQV 216
Query: 260 FIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 295
+EK I +P SL + A +LK FL D + L C P
Sbjct: 217 ILEKQIRIPRSLSVKAASVLKS-FLNKDPKERLGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKH 85
R +LGKG F EV QV M + +LE R+ +L
Sbjct: 3 RQYRVLGKGGFG------------EVCACQVRATGKMYACKRLEKKRIKKRKGESMALNE 50
Query: 86 ENIIKFYNS-------WVDDTNRTINMITELFTSGSLR---YRKKHKNVDMKAIKNWARQ 135
+ I++ NS + +T + ++ + G L+ Y + + + +A +
Sbjct: 51 KQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE 110
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEF 194
IL GL LH N ++RDLK +NI ++ + G ++I DLGLA+ + + + R +GT +
Sbjct: 111 ILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGY 167
Query: 195 MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 227
MAPE L + Y D + G I EM+ + P+
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 61/230 (26%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSL-KHENI 88
LG GAF V + A +V ++ + + ER L SE+ ++ L HENI
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSL---RYRKKHKNVDMKAIKNWARQILRGLHYLHS 145
+ + I +ITE G L RK+ + ++ + +++ Q+ +G+ +L S
Sbjct: 102 VNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEV-KIGDLGLAIVMQQPTARSVIGTP----EFMAPE-L 199
N IHRDL N+ + +G++ KI D GLA + + V G ++MAPE +
Sbjct: 160 KN--CIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 200 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 248
+ Y D++S+G+ + E+ + PY ++ YK + G + A
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 50/168 (29%), Positives = 81/168 (48%), Gaps = 20/168 (11%)
Query: 132 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVI 189
++ +I L++LH II+RDLK DN+ ++ G +K+ D G+ +P T +
Sbjct: 101 YSAEISLALNFLHERG--IIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRPGDTTSTFC 157
Query: 190 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 248
GTP ++APE L E+Y VD ++ G+ + EM+ P++ G+
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD------------IVGMSDNP 205
Query: 249 LSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 295
D + +EK I +P SL + A +LK FL D + L C P
Sbjct: 206 DQNTEDYLFQVILEKQIRIPRSLSVKASSVLKG-FLNKDPKERLGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 18/197 (9%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G F V+ G+ +V ++ + ++ E +L+K+L+H+ +++ Y
Sbjct: 14 LGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 67
Query: 93 NSWVDDTNRTINMITELFTSGS-LRYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPP 149
V I +ITE GS L + K + V + + +++ QI G+ Y+ N
Sbjct: 68 A--VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 123
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPELYE-EEYN 205
IHRDL+ N+ V+ + KI D GLA V++ + TAR P ++ APE +
Sbjct: 124 YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 206 ELVDIYSFGMCILEMVT 222
D++SFG+ + E+VT
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 56/230 (24%), Positives = 105/230 (45%), Gaps = 16/230 (6%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
+++G G F V++G ++ G + + + Q + SE ++ H NII
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIK--NWARQILRGLHYLHSHN 147
+ V + +ITE +G+L + + + + + R I G+ YL N
Sbjct: 70 RLEG--VVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFMAPE-LYE 201
+HRDL NI VN +N E K+ D GL+ V++ + + + APE +
Sbjct: 128 --YVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 202 EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK-PASL 249
++ D++SFG+ + E+++ E PY + N ++ K + G + PA +
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPM 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 66/241 (27%), Positives = 98/241 (40%), Gaps = 37/241 (15%)
Query: 31 EILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
LG+GAF V+ G E D VA V S D + E LL + +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVA---VKTLKETASNDARKDFEREAELLTNFQH 67
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKN------------- 131
ENI+KFY + M+ E G L ++ + H
Sbjct: 68 ENIVKFYGVCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 132 -WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 190
A QI G+ YL S + +HRDL N V G + VKIGD G++ + V G
Sbjct: 126 QIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDVYTTDYYRVGG 182
Query: 191 TP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+M PE +Y + E D++SFG+ + E+ T + P+ N ++ + +T G
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIECITQG 240
Query: 244 I 244
Sbjct: 241 R 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 32 ILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LG GAF TVYKG DG I VA + + SP + + E +++ +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVA---IKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGS-LRYRKKHKN-VDMKAIKNWARQILRGLHYLHS 145
+ + + T+ ++T+L G L Y +++K+ + + + NW QI +G+ YL
Sbjct: 71 VCRLLGICL---TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIG--TP-EFMAPE-LY 200
++HRDL N+ V N VKI D GLA ++ T G P ++MA E +
Sbjct: 128 VR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 201 EEEYNELVDIYSFGMCILEMVT 222
+ D++S+G+ + E++T
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 64/273 (23%), Positives = 126/273 (46%), Gaps = 33/273 (12%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
++G+G++ V K D++ ++V ++ +D + ++ + +E H+ +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD-----EDIDWVQTEKHVFEQASSNP 56
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSH 146
+ +S T+R ++ E G L + ++ + + + + +A +I L++LH
Sbjct: 57 FLVGLHSCFQTTSRLF-LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 147 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE 203
II+RDLK DN+ ++ +G +K+ D G+ P T + GTP ++APE+ EE
Sbjct: 116 G--IIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 204 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263
Y VD ++ G+ + EM+ P++ + + D + +EK
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM--------------NTEDYLFQVILEK 218
Query: 264 CI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 295
I +P L + A +LK FL D + L C P
Sbjct: 219 PIRIPRFLSVKASHVLKG-FLNKDPKERLGCQP 250
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 18/223 (8%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
D SC + +E++G G F V +G ++ G + + + Q SE ++
Sbjct: 2 DVSCV--KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 59
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILR 138
H NII V +R + +ITE +G+L R+ + + R I
Sbjct: 60 GQFDHPNIIHLEG--VVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAA 117
Query: 139 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTP-- 192
G+ YL N +HRDL NI VN +N K+ D GL+ ++ PT S +G
Sbjct: 118 GMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174
Query: 193 -EFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKN 232
+ APE + ++ D++S+G+ + E M E PY + N
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 39/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 99 TNRTINMITELFTSGSLRYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 157
T+ + ++T+ + G L + + + K + +++ L +LH ++ I++RDLK
Sbjct: 67 TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKP 124
Query: 158 DNIFVNGNNGEVKIGDLGL--AIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSF 213
+NI ++ G + + D GL A + T + GT E++APE+ +E Y + VD +S
Sbjct: 125 ENILLDA-TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL 183
Query: 214 GMCILEMVTCEYPYNECKNPAQIYKKVTSG 243
G+ + EM P+ ++ Q+Y+ + G
Sbjct: 184 GVLVFEMCCGWSPF-YAEDTQQMYRNIAFG 212
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 76 EVHLLKSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNW 132
E+ L+ + NI+K Y +D D +++I E T G LR K K++ K +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127
Query: 133 ARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 191
A +GL+ L+ N P +++L + V N ++KI GL ++ P ++V
Sbjct: 128 AIDCCKGLYNLYKYTNKP--YKNLTSVSFLVT-ENYKLKIICHGLEKILSSPPFKNV--- 181
Query: 192 PEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 245
FM Y+ EY DIYS G+ + E+ T + P+ +IY + +
Sbjct: 182 -NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYDLIINKNN 239
Query: 246 PASLSKVTDPQVKQFIEKCIVPASLRLPAL 275
L ++K +E C S++ P +
Sbjct: 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269
|
Length = 283 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSV 188
ARQ+L + Y+H IIHRD+K +N+ VNG ++ +GD G A + P +
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGI 322
Query: 189 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 219
GT + APE L + Y VDI+S G+ I E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 108 ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 167
ELFT S R R K + V + ++ +I+ L +LH II+RD+K +NI ++ +NG
Sbjct: 91 ELFTHLSQRERFKEQEVQI-----YSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNG 142
Query: 168 EVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEMV 221
V + D GL+ + A S GT E+MAP++ + +++ VD +S G+ + E++
Sbjct: 143 HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202
Query: 222 TCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRL----- 272
T P+ E + A+I +++ P + K I++ ++ RL
Sbjct: 203 TGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDIIQRLLMKDPKKRLGCGPS 260
Query: 273 PALELLKDPFLVTDNPKDLVCDPLRLP 299
A E+ K PF N DL + P
Sbjct: 261 DADEIKKHPFFQKINWDDLAAKKVPAP 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 33 LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
LG+G F V G D+ V V + + L L SE+ ++K + KH+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLR--------------YRKKH---KNVDMKAIK 130
II + D + +I E + G+LR Y + + K +
Sbjct: 86 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 131 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 185
+ A Q+ RG+ YL S IHRDL N+ V +N +KI D GLA I + T
Sbjct: 144 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 200
Query: 186 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 222
+ ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 201 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 29/218 (13%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKH 85
R+ +LGKG F EV QV M + +LE R+ +L
Sbjct: 3 RHYRVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 50
Query: 86 ENIIKFYNS-------WVDDTNRTINMITELFTSGSLR---YRKKHKNVDMKAIKNWARQ 135
+ I++ NS + +T + ++ + G L+ Y + D + +A +
Sbjct: 51 KRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE 110
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEF 194
+ GL L I++RDLK +NI ++ + G ++I DLGLA+ + + T R +GT +
Sbjct: 111 LCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGY 167
Query: 195 MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 231
MAPE + E+Y D + G I EM+ + P+ + K
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWAR 134
E+ +LK++ H II +++ T+ M+ + Y + + ++ R
Sbjct: 135 REIDILKTISHRAIINLIHAY--RWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQR 192
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIG 190
++L L YLH IIHRD+K +NIF++ +GD G A + P G
Sbjct: 193 RLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 191 TPEFMAPELYE-EEYNELVDIYSFGMCILEM 220
T E +PEL + Y DI+S G+ + EM
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 68/235 (28%), Positives = 102/235 (43%), Gaps = 38/235 (16%)
Query: 20 KDPSCRYGRYDEILGK----GAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLE 71
+DP + R LGK G F V G D+ E V + + L
Sbjct: 6 EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS 65
Query: 72 RLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAI 129
L SE+ ++K + KH+NII + D + +I E + G+LR Y + + M+
Sbjct: 66 DLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYS 123
Query: 130 KNWAR----------------QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 173
+ AR Q+ RG+ YL S IHRDL N+ V NN +KI D
Sbjct: 124 YDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIAD 180
Query: 174 LGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 222
GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 181 FGLARDVNNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 108 ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 167
ELFT R ++ ++ + +I+ L +LH II+RD+K +NI ++ G
Sbjct: 91 ELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDS-EG 142
Query: 168 EVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEMV 221
V + D GL+ A S GT E+MAPE+ +++ VD +S G+ E++
Sbjct: 143 HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202
Query: 222 TCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263
T P+ E + ++I +++ P K + + FI+K
Sbjct: 203 TGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQK 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 42/236 (17%)
Query: 21 DPSCRYGRYDEILGK----GAFKTVYKGFDEVDGIEVAWNQ------VNIEDVMQSPDQL 70
DP + R +LGK G F V + E GI+ + V + + L
Sbjct: 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDL 61
Query: 71 ERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLR------------- 116
L SE+ L+K + KH+NII + + +I E G+LR
Sbjct: 62 ADLISEMELMKLIGKHKNIINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPDY 119
Query: 117 ----YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172
+ + + K + + A Q+ RG+ YL S IHRDL N+ V +N +KI
Sbjct: 120 TFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMKIA 176
Query: 173 DLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 222
D GLA I + T+ + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 177 DFGLARGVHDIDYYKKTSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 58/259 (22%), Positives = 115/259 (44%), Gaps = 28/259 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +GKG F V G + G +VA + + Q+ +E ++ L+H N+++
Sbjct: 12 QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQ 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNV-DMKAIKNWARQILRGLHYLHSHN 147
V++ + ++TE GSL R + ++V + ++ + + YL ++N
Sbjct: 64 LLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEY 204
+HRDL N+ V+ +N K+ D GL Q T + + ++ APE L E+++
Sbjct: 123 --FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKF 176
Query: 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQVKQFI 261
+ D++SFG+ + E+ Y + P K V ++ D P V +
Sbjct: 177 STKSDVWSFGILLWEI----YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM 232
Query: 262 EKCIVPASLRLPALELLKD 280
++C + P+ L++
Sbjct: 233 KQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 48/197 (24%), Positives = 90/197 (45%), Gaps = 23/197 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+GKG F V G + G +VA ++D + +E ++ +L+H N+++
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVK--CLKDDSTAAQAF---LAEASVMTTLRHPNLVQ 64
Query: 91 FYNSWVDDTNRTINMITELFTSGSL----RYRKKHKNVDMKAIKNWARQILRGLHYLHSH 146
+ + ++TE GSL R R + + +A + G+ YL
Sbjct: 65 LLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVIT-LAQQLGFALDVCEGMEYLEEK 121
Query: 147 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEE 203
N +HRDL N+ V+ + K+ D GLA Q + + + ++ APE L E++
Sbjct: 122 N--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKK 175
Query: 204 YNELVDIYSFGMCILEM 220
++ D++SFG+ + E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 53/175 (30%), Positives = 91/175 (52%), Gaps = 14/175 (8%)
Query: 70 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR---YRKKHKNVDM 126
+E +E +++K+L+H+ ++K ++ V T I +ITE GSL + +
Sbjct: 45 VEAFLAEANVMKTLQHDKLVKL-HAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL 101
Query: 127 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPT 184
+ +++ QI G+ ++ N IHRDL+ NI V+ + KI D GLA V++ + T
Sbjct: 102 PKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT 158
Query: 185 ARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 236
AR P ++ APE + + D++SFG+ ++E+VT PY NP I
Sbjct: 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 73/262 (27%), Positives = 117/262 (44%), Gaps = 26/262 (9%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA V +D V VA +++ Q+ +R Y E+ L+K + H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 75
Query: 86 ENIIKFYNSWVDDTN----RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLH 141
+NII N + + + + ++ EL + + + +D + + Q+L G+
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIK 133
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFMA 196
+LHS IIHRDLK NI V ++ +KI D GLA + S + TP + A
Sbjct: 134 HLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRA 186
Query: 197 PE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASLSKVT 253
PE + Y E VDI+S G + EMV + + ++ + KV G K
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 254 DPQVKQFIEKCIVPASLRLPAL 275
P V+ ++E A L P L
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKL 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 36/119 (30%), Positives = 67/119 (56%), Gaps = 7/119 (5%)
Query: 125 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 184
D+ + + ++L L LH N +I+RDLK +NI ++ G + + D GL + +
Sbjct: 91 DLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDD 147
Query: 185 ARS--VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 240
++ GTPE++APEL Y + VD ++ G+ + EM+T P+ + +N ++Y+K+
Sbjct: 148 DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKI 205
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 4/87 (4%)
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE 201
H H+ II+RDLK +NI ++ G +K+ D GL+ + + A S GT E+MAPE+
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 202 EE-YNELVDIYSFGMCILEMVTCEYPY 227
+ + D +SFG+ + EM+T P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 23/220 (10%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G F V+ G I+VA +N E M D +E E ++ L H +++ Y
Sbjct: 12 LGSGQFGVVHLG-KWRAQIKVAIKAIN-EGAMSEEDFIE----EAKVMMKLSHPKLVQLY 65
Query: 93 NSWVDDTNRTINMITELFTSGSL----RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
V + + ++TE +G L R R+ + DM + + + + G+ YL ++
Sbjct: 66 G--VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM--LLSMCQDVCEGMEYLERNS- 120
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP-EFMAPELYE-EEY 204
IHRDL N V+ + G VK+ D G+ ++ + T+ S P ++ PE++ +Y
Sbjct: 121 -FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 205 NELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243
+ D++SFG+ + E+ T + P+ E K+ ++ + ++ G
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA V +D + VA +++ Q+ +R Y E+ L+K + H
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 86 ENIIKFYNSWVDDTN----RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLH 141
+NII N + + + + ++ EL + + + +D + + Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIK 140
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FMA 196
+LHS IIHRDLK NI V ++ +KI D GLA + S + TP + A
Sbjct: 141 HLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRA 193
Query: 197 PE-LYEEEYNELVDIYSFGMCILEMV 221
PE + Y E VDI+S G + EM+
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 50/231 (21%), Positives = 102/231 (44%), Gaps = 51/231 (22%)
Query: 31 EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
++LGKG V+ KG ++ ++V + M ++++R+ +E +L +L H
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVL-----DKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSG----SLRYRKKHKNVDMKAIKNWARQILRGLHY 142
+ Y T + ++ + + G L R+ K + + + +A ++L L Y
Sbjct: 62 FLPTLY--ASFQTETYLCLVMD-YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA------------------------- 177
LH I++RDLK +NI ++ +G + + D L+
Sbjct: 119 LH--LLGIVYRDLKPENILLHE-SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 178 ----IVMQQPTAR--SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMV 221
++P+ R S +GT E++APE+ + + VD ++ G+ + EM+
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 22/234 (9%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEV 77
DPS ++++G G F V +G ++ G I+VA ++ +L+ L +E
Sbjct: 2 DPSYV--TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKAGSSDKQRLDFL-TEA 56
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIK--NWARQ 135
++ H NII+ V +R + +ITE +GSL + + + R
Sbjct: 57 SIMGQFDHPNIIRLEG--VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRG 114
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGT 191
I G+ YL N +HRDL NI VN +N K+ D GL+ ++ T +
Sbjct: 115 IASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171
Query: 192 PEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKNPAQIYKKVTSG 243
+ APE + ++ D++SFG+ + E M E PY + N + K V G
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 50/193 (25%), Positives = 75/193 (38%), Gaps = 19/193 (9%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKK 120
D + Q R E L L H NI+ +S + E +LR
Sbjct: 13 TDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLF-AVFEYVPGRTLREVLA 71
Query: 121 HKNVDMKAIKNWA--RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGL 176
+ A + Q+L L +HN I+HRDLK NI V+ K+ D G+
Sbjct: 72 ADGA-LPAGETGRLMLQVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128
Query: 177 ---------AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 226
A V V+GTP + APE L E D+Y++G+ LE +T +
Sbjct: 129 GTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-R 187
Query: 227 YNECKNPAQIYKK 239
+ + A+I +
Sbjct: 188 VVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 23/207 (11%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G G F V+ G+ +V I+ + + E E ++ L H +++ Y
Sbjct: 12 IGSGQFGLVWLGYWLEK------RKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 93 NSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 150
V I ++ E G L R + + + + G+ YL S N +
Sbjct: 66 G--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--V 121
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPELYE-EEYNE 206
IHRDL N V G N VK+ D G+ + S GT ++ +PE++ +Y+
Sbjct: 122 IHRDLAARNCLV-GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 207 LVDIYSFGMCILEMVTCEYPYNECKNP 233
D++SFG+ + E+ ++E K P
Sbjct: 181 KSDVWSFGVLMWEV------FSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 51/198 (25%), Positives = 99/198 (50%), Gaps = 31/198 (15%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKN---V 124
+Q+++++ E +L ++ ++ + S+ +T R + M+ E G K+ V
Sbjct: 43 NQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLCMVMEYVEGGDCATLLKNIGALPV 100
Query: 125 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV----- 179
DM A +A +L L YLH++ I+HRDLK DN+ + + G +K+ D GL+ +
Sbjct: 101 DM-ARMYFAETVL-ALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSL 155
Query: 180 ------------MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEY 225
++ + V GTPE++APE + + Y + VD ++ G+ + E +V C
Sbjct: 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
Query: 226 PYNECKNPAQIYKKVTSG 243
+ + P +++ +V S
Sbjct: 216 FFGD--TPEELFGQVISD 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 37/223 (16%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV--MQSPDQLERLYSEVHLLKSLKH 85
R+ E LG+ AF +YKG + G++ A V I+ + + +P Q E L+ L H
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHA-QLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR----YRKKHKNV--------------DMK 127
NI+ + + + M+ E G L R H +V D
Sbjct: 67 PNIVCLLGVVTQE--QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 128 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ------ 181
+ A QI G+ YL SH +H+DL NI + G VKI DLGL+ +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHVKISDLGLSREIYSADYYR 181
Query: 182 -QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 222
QP + I +M PE + +++ DI+SFG+ + E+ +
Sbjct: 182 VQPKSLLPI---RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 36/148 (24%), Positives = 77/148 (52%), Gaps = 13/148 (8%)
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
+++ + ++ DD + + M+ E G L + +V K K + +++ L +HS
Sbjct: 105 VVQLFCAFQDD--KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEEE- 203
+IHRD+K DN+ ++ +G +K+ D G + M + + +GTP++++PE+ + +
Sbjct: 163 --LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 204 ----YNELVDIYSFGMCILEMVTCEYPY 227
Y D +S G+ + EM+ + P+
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 37/237 (15%)
Query: 33 LGKGAFKTV-----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHE 86
LG+GAF V Y E D I VA ++ + + D + + E LL +L+HE
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVA-----VKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKH-------------KNVDMKAIKNW 132
+I+KFY V+ + M+ E G L ++ + H + + +
Sbjct: 68 HIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 192
A+QI G+ YL S + +HRDL N V G N VKIGD G++ + V G
Sbjct: 126 AQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 193 ----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+M PE + ++ D++S G+ + E+ T + P+ + N ++ + +T G
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 41/146 (28%), Positives = 77/146 (52%), Gaps = 21/146 (14%)
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 196
+H LH +HRD+K DNI ++ NG +++ D G + +M+ T +S +GTP++++
Sbjct: 118 VHQLH-----YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 197 PELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----P 246
PE+ + +Y D +S G+C+ EM+ E P+ ++ + Y K+ + + P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFP 230
Query: 247 ASLSKVTDPQVKQFIEKCIVPASLRL 272
A ++ V++ K I + I RL
Sbjct: 231 AQVTDVSE-DAKDLIRRLICSREHRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 44/221 (19%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-------QSPDQLER--LYSEVHLLKSL 83
LG+GAF V+ + +N +D M + P R E LL +L
Sbjct: 13 LGEGAFGKVF--------LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 64
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSL-----------------RYRKKHKNVDM 126
+HE+I+KFY D + M+ E G L + R+ + +
Sbjct: 65 QHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 127 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 186
+ + A QI G+ YL S + +HRDL N V G N VKIGD G++ +
Sbjct: 123 SQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSRDVYSTDYY 179
Query: 187 SVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 222
V G +M PE + ++ D++SFG+ + E+ T
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 18/196 (9%)
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAI-KNWA 133
+E ++L+++KH I+ ++ T + +I E + G L + + + M+ +
Sbjct: 49 AERNILEAVKHPFIVDLIYAF--QTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL 106
Query: 134 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL---AIVMQQPTARSVIG 190
+I L +LH II+RDLK +NI ++ G VK+ D GL +I T + G
Sbjct: 107 SEISLALEHLHQQG--IIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVT-HTFCG 162
Query: 191 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPA 247
T E+MAPE L + + VD +S G + +M+T P+ +N + K+ G P
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPP 221
Query: 248 SLSKVTDPQVKQFIEK 263
L+ P+ + ++K
Sbjct: 222 YLT----PEARDLLKK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 54/220 (24%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
EI+G+G F V +G E G +VA + + Q+ E ++ L H+N+++
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQA------FLEETAVMTKLHHKNLVR 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSL----RYRKKHKNVDMKAIKNWARQILRGLHYLHSH 146
+ + + ++ EL + G+L R R + V + + ++ + G+ YL S
Sbjct: 64 LLGVIL---HNGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK 119
Query: 147 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYN 205
++HRDL NI V+ +G K+ D GLA V S + ++ APE L ++++
Sbjct: 120 K--LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPV-KWTAPEALKHKKFS 175
Query: 206 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 245
D++S+G+ + E+ + Y P K+V ++
Sbjct: 176 SKSDVWSYGVLLWEV----FSYGRAPYPKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 40/144 (27%), Positives = 78/144 (54%), Gaps = 17/144 (11%)
Query: 143 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS--VIGTPEFMAPE 198
+HS H +HRD+K DN+ ++ NG +++ D G + M Q T +S +GTP++++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 199 LYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----PAS 248
+ + +Y D +S G+C+ EM+ E P+ ++ + Y K+ + + P+
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHEERFQFPSH 232
Query: 249 LSKVTDPQVKQFIEKCIVPASLRL 272
++ V++ + K I++ I RL
Sbjct: 233 ITDVSE-EAKDLIQRLICSRERRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 61/239 (25%), Positives = 102/239 (42%), Gaps = 43/239 (17%)
Query: 33 LGKGAFKTVYKG-FDEVDGIEVAWNQVNIEDVMQSP---DQLERLYSEVHLLKSLKHENI 88
LG GAF VY+G + DG V QV ++ + +S D+ + L E ++ H+NI
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVEL-QVAVKTLPESCSEQDESDFL-MEALIMSKFNHQNI 71
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVD------MKAIKNWARQILRGL 140
++ + R I + EL G L+ R+ + MK + AR + +G
Sbjct: 72 VRLIGVSFERLPRFI--LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 141 HYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP------ 192
YL ++ IHRD+ N + G KI D G+ AR +
Sbjct: 130 KYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGM--------ARDIYRASYYRKGG 179
Query: 193 ------EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSG 243
++M PE + + + D++SFG+ + E+ + Y PY N ++ + VT G
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGG 237
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 51/177 (28%), Positives = 83/177 (46%), Gaps = 30/177 (16%)
Query: 70 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRY----------- 117
L L SE+ ++K + KH+NII + D + ++ E + G+LR
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 118 ------RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 171
+ + + K + + A Q+ RG+ YL S IHRDL N+ V +N +KI
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDN-VMKI 175
Query: 172 GDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 222
D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 36/148 (24%), Positives = 76/148 (51%), Gaps = 13/148 (8%)
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
+++ + ++ DD R + M+ E G L + +V K + + +++ L +HS
Sbjct: 105 VVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEEE- 203
IHRD+K DN+ ++ +G +K+ D G + M + + +GTP++++PE+ + +
Sbjct: 163 --FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 204 ----YNELVDIYSFGMCILEMVTCEYPY 227
Y D +S G+ + EM+ + P+
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 57/249 (22%), Positives = 110/249 (44%), Gaps = 46/249 (18%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++G+GAF V + G A + D+++ +Q+ + +E +L ++K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-EQVGHIRAERDILVEADSLWVVK 65
Query: 91 FYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
+ S+ D N + +I E G + K + + + + + + + +H
Sbjct: 66 MFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG-- 121
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------------PT----------- 184
IHRD+K DN+ ++ + G VK+ D GL +++ P+
Sbjct: 122 FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 185 ------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 231
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP +
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPPFCSE 239
Query: 232 NPAQIYKKV 240
P + YKKV
Sbjct: 240 TPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 39/218 (17%)
Query: 33 LGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQ-LERLYSEVHLLKSLKHE 86
LG+GAF V+ E D + VA +++ +S Q +R E LL L+H+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQR---EAELLTVLQHQ 67
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKH---------------KNVDMKAIK 130
+I++FY + R + M+ E G L R+ + H + + +
Sbjct: 68 HIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 131 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 190
A QI G+ YL S + +HRDL N V G VKIGD G++ + V G
Sbjct: 126 AIASQIASGMVYLASLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRVGG 182
Query: 191 TP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 222
+M PE LY + E DI+SFG+ + E+ T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 31 EILGKGAFKTVYKG-FDEVDGIEV--AWNQVN-IEDVMQSPDQLERLYSEVHLLKSLKHE 86
++GKG F VY G + DG ++ A +N I D+ +++E+ E ++K H
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL----EEVEQFLKEGIIMKDFSHP 56
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRY--RKKHKNVDMKAIKNWARQILRGLHYLH 144
N++ + + ++ G LR R + N +K + + Q+ +G+ YL
Sbjct: 57 NVLSLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA 115
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------IVMQQPTARSVIGTPEFM 195
S +HRDL N ++ + VK+ D GLA V A+ + ++M
Sbjct: 116 SKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWM 169
Query: 196 APE-LYEEEYNELVDIYSFGMCILEMVT 222
A E L +++ D++SFG+ + E++T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 57/249 (22%), Positives = 110/249 (44%), Gaps = 46/249 (18%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++G+GAF V + G A + D+++ +Q+ + +E +L ++K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-EQVAHIRAERDILVEADGAWVVK 65
Query: 91 FYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
+ S+ D R + +I E G + K + +A + + + + + +H
Sbjct: 66 MFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG-- 121
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------------PT----------- 184
IHRD+K DN+ ++ G VK+ D GL +++ P+
Sbjct: 122 FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 185 ------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 231
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP +
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPPFCSE 239
Query: 232 NPAQIYKKV 240
P + Y+KV
Sbjct: 240 TPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 48/218 (22%), Positives = 91/218 (41%), Gaps = 22/218 (10%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLYSEVHLLKSLKHENII 89
LG+G F V+ + E V ++ + ++ D+ E+ + + L H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 90 KFYNSWVDDTNRTINMITE----------LFTSGSLRYRKKHKNVDMKAIKNWARQILRG 139
+ + MI E L + S + K + K QI G
Sbjct: 72 RLLGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQP--TARSVIGTPEFMA 196
+ +L + +HRDL N V+ EVK+ L L+ V R+ + ++A
Sbjct: 130 MDHLSNAR--FVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186
Query: 197 PE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKN 232
PE + E++++ D++SFG+ + E+ T E P+ +
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 62/218 (28%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKH 85
R+ E LG+GAF VYKG ++ V I+ + + P + E L+ L+H
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR----YRKKHKNV-------------DMKA 128
NI+ V + M+ E G L H +V D
Sbjct: 68 PNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 129 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 188
+ A QI G+ YL SH+ +HRDL N V G VKI D GL+ + V
Sbjct: 126 FLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYYRV 182
Query: 189 IGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEM 220
+M PE LY + E DI+SFG+ + E+
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 36/125 (28%), Positives = 70/125 (56%), Gaps = 13/125 (10%)
Query: 108 ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 167
E+FT Y++ + + D ++ ++ +I+ L +LH I++RD+K +NI ++ + G
Sbjct: 91 EMFTH---LYQRDNFSED--EVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEG 142
Query: 168 EVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVT 222
V + D GL+ + ++ S GT E+MAPE+ + + + VD +S G+ I E++T
Sbjct: 143 HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
Query: 223 CEYPY 227
P+
Sbjct: 203 GASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 64/273 (23%), Positives = 94/273 (34%), Gaps = 79/273 (28%)
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------------------------- 180
H IHRD+K DNI ++ +G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 181 --------------------QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 219
Q+ A S++GTP ++APE+ Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 220 MVTCEYPYNECKNPAQIYKKV-----TSGIKP-ASLSKVTDPQVKQFIEKCIVPASLRL- 272
M+ + P+ PA+ KV T I A LS + I + A RL
Sbjct: 237 MLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLS----REASDLILRLCCGAEDRLG 291
Query: 273 --PALELLKDPFLVTDNPKDLVCDPLRLP-NLVPEVMNLAHSEPHPMDIDLNHKKVSADS 329
A E+ PF D R +P++ HP D N V +
Sbjct: 292 KNGADEIKAHPFFKG---IDFASLIRRQKAPYIPKIT-------HPTDTS-NFDPVDPEK 340
Query: 330 CAKSNTG---TWFLTLELQR-LTENN--EFTLR 356
++G R TE+ EFT R
Sbjct: 341 LRSDDSGESSPDRNVKPNNRKRTEHAFYEFTFR 373
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 35/142 (24%), Positives = 60/142 (42%), Gaps = 45/142 (31%)
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----------------------- 176
+ +H IHRD+K DN+ ++ G +K+ D GL
Sbjct: 114 IDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 177 -AIVMQQPT----------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCIL 218
+ +P A S +GTP+++APE++ + YN+ D +S G+ +
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 219 EMVTCEYPYNECKNPAQIYKKV 240
EM+ YP NP + Y+K+
Sbjct: 231 EMLV-GYPPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 40/234 (17%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLER---------LY 74
R E LG+G F V+ E +G+ + + + V+ + L
Sbjct: 8 RLKEKLGEGQFGEVH--LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL---------RYRKKHKN-- 123
E+ ++ LK+ NII+ V D + MITE +G L H N
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 124 --VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181
V + + A QI G+ YL S N +HRDL N V GN+ +KI D G++ +
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV-GNHYTIKIADFGMSRNLY 180
Query: 182 QPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C-EYPYN 228
+ G +MA E + ++ D+++FG+ + EM T C E PY+
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 17/223 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +G+G F V+ G D VA + + + PD + E +LK H NI++
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVK--SCRETL-PPDLKAKFLQEARILKQYSHPNIVR 57
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
V + I ++ EL G R + + +K + G+ YL S +
Sbjct: 58 LIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH- 114
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEEE 203
IHRDL N V N +KI D G++ + S G + + APE L
Sbjct: 115 -CIHRDLAARNCLVTEKNV-LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 204 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 245
Y+ D++SFG+ + E + PY N Q + + G++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSN-QQTREAIEQGVR 214
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 46/192 (23%), Positives = 100/192 (52%), Gaps = 13/192 (6%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
++G+GA+ V K + VA + +D ++ + E E+ +L++LK ENI++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKK--FKDSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 92 YNSWVDDTNRTINMITELFTSGSLRYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPI 150
++ + ++ E L ++ N V + ++++ Q+++ +H+ H ++ I
Sbjct: 66 KEAF--RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--I 121
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIGTPEFMAPE-LYEEEYNE 206
+HRD+K +N+ ++ N+ +K+ D G A + + + + + T + +PE L Y +
Sbjct: 122 VHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 207 LVDIYSFGMCIL 218
VD++S G CIL
Sbjct: 181 AVDMWSVG-CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 16/221 (7%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
D SC + ++++G G F V G ++ G + + Q SE ++
Sbjct: 2 DASCI--KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIM 59
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHK-NVDMKAIKNWARQILR 138
H NII V ++ + ++TE +GSL + +KH + + R I
Sbjct: 60 GQFDHPNIIHLEG--VVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIAS 117
Query: 139 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPE 193
G+ YL +HRDL NI VN +N K+ D GL+ V++ T R
Sbjct: 118 GMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174
Query: 194 FMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKN 232
+ APE + ++ D++S+G+ + E M E PY E N
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 33 LGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+G+G +VY G V ++E+ + + L+ L +EV L +H NI+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMT 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKH---KNVDMKAIKNWARQILRGLHYLHSHN 147
+ V T + +I+ GS K + + I N LRGL+YLH +
Sbjct: 64 SWT--VFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLG--LAIVMQQPTARSVIGTPEF-------MAPE 198
IHR++K +I ++G+ G V + L ++V A+ V P+F ++PE
Sbjct: 122 --YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 199 LYEEE---YNELVDIYSFGMCILEMVTCEYPYNE 229
L ++ YN DIYS G+ E+ T P+ +
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 30/108 (27%), Positives = 56/108 (51%), Gaps = 15/108 (13%)
Query: 132 WAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ---QPT 184
WAR +++ L +HS IHRD+K DN+ ++ +G +K+ D G + M
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVR 199
Query: 185 ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPY 227
+ +GTP++++PE+ + Y D +S G+ + EM+ + P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 19/155 (12%)
Query: 143 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTPEFMAPE 198
+HS H +HRD+K +N+ ++ G +K+ D G A + + ++ +GTP+++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 199 LYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251
+ Y D +S G+ EM+ P++E A+ Y + + L
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMN--FQRFLKF 230
Query: 252 VTDPQV----KQFIEKCIVPASLRLPALELLKDPF 282
DP+V I+ + RL L PF
Sbjct: 231 PEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 43/136 (31%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGT-- 191
Q+ G+ +L S N +HRDL N+ + VKI D GLA +M+ S T
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 192 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 248
P ++MAPE ++ Y L D++SFG+ + E+ T PY E Q Y + G + A
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK 363
Query: 249 LSKVTDPQVKQFIEKC 264
+ +D ++ + ++KC
Sbjct: 364 PAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 37/231 (16%)
Query: 31 EILGKGAFKTVY-------KGFDEVDGIEVAWNQVNIEDVMQSP------DQLERLYSEV 77
E LG+G F V+ + F E E + ++ + E EV
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKH-----------KNVD 125
+L L NI + D + MI E +G L ++ +KH K++
Sbjct: 71 KILSRLSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 126 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185
+ A QI G+ YL S N +HRDL N V G N +KI D G++ +
Sbjct: 129 FSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLYSSDY 185
Query: 186 RSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C-EYPYNE 229
V G +MA E + ++ D+++FG+ + E++T C E PY
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 30/220 (13%)
Query: 31 EILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHE 86
++L +G F ++ G DE G E +V ++ V S Q+ L E LL L H+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKE---EEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 87 NIIKFYNSWVDDTNRTINMITELFTS-GSLR-YRKKHKNVDM---KAIK-----NWARQI 136
NI+ + ++D + + + G+L+ + ++ + + +A+ + A QI
Sbjct: 69 NILPILHVCIEDGEPP--FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 137 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE--- 193
G+ YLH +IH+D+ N ++ +VKI D L+ + P +G E
Sbjct: 127 ACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNALSRDLF-PMDYHCLGDNENRP 182
Query: 194 --FMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNE 229
+MA E L +EY+ D++SFG+ + E++T + PY E
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 21/146 (14%)
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 196
+H L +HRD+K DN+ ++ NG +++ D G + ++ T +S +GTP++++
Sbjct: 118 VHQLG-----YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 197 PELYEE------EYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASL 249
PE+ + Y D +S G+C+ EM+ E P Y E + + Y K+ + +
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQF 229
Query: 250 -SKVTD--PQVKQFIEKCIVPASLRL 272
VTD + K I + I RL
Sbjct: 230 PPDVTDVSEEAKDLIRRLICSPETRL 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 43/277 (15%)
Query: 32 ILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
+LGKG F +V + ++ +VA + D+ S D +E E +K H N+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSD-IEEFLREAACMKEFDHPNV 63
Query: 89 IKFYNSWVDDTNRT-----INMITELFTS-GSL-------RYRKKHKNVDMKAIKNWARQ 135
IK V +R I M+ F G L R ++ + ++ + +
Sbjct: 64 IKLIG--VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------QQPTARSVI 189
I G+ YL S N IHRDL N +N N V + D GL+ + +Q A +
Sbjct: 122 IASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVADFGLSKKIYSGDYYRQGCASKL- 177
Query: 190 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK-- 245
+++A E L + Y D+++FG+ + E++T + PY +N ++IY + G +
Sbjct: 178 -PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIKGNRLK 235
Query: 246 --PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 280
P L V + + +C P P+ + L+D
Sbjct: 236 QPPDCLEDVYE-----LMCQCWSPEPKCRPSFQHLRD 267
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-----RYRKKHKNVDMKA-- 128
E+ ++ LK NII+ + + MITE +G L R+ +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 129 -----IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183
+ A QI G+ YL S N +HRDL N V G N +KI D G++ +
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLYSG 183
Query: 184 -----TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT-C-EYPYNE 229
R+V+ + ++ D+++FG+ + E++T C E PY++
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
Q+ RG+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 229
Query: 195 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 222
MAPE ++++ Y D++SFG+ + E+ +
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 29/232 (12%)
Query: 33 LGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERL--YSEVHLLKSLKHENI 88
LG+G+F VY+G D + G A +V ++ V +S ER+ +E ++K ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKG--EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLR-----YRKKHKN------VDMKAIKNWARQIL 137
++ V + ++ EL G L+ R + +N ++ + A +I
Sbjct: 72 VRLLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 138 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP----E 193
G+ YL++ +HRDL N V + VKIGD G+ + + G
Sbjct: 130 DGMAYLNAKK--FVHRDLAARNCMVAHDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 194 FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243
+MAPE L + + D++SFG+ + E+ + E PY N Q+ K V G
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFVMDG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 34/182 (18%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMK-------- 127
EV +L LK NII+ VD+ + MITE +G L ++D K
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 128 ------------AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175
++ + A QI G+ YL S N +HRDL N V G N +KI D G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLV-GENLTIKIADFG 183
Query: 176 LAIVM-----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE--MVTCEYPY 227
++ + + R+V+ +MA E + ++ D+++FG+ + E M+ E PY
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPI-RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 228 NE 229
E
Sbjct: 243 GE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 192
Q+ RG+ +L S N +HRDL N+ + VKI D GLA + + G+
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 193 --EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 248
++MAPE +++ Y L D++S+G+ + E+ + PY + Y K+ SG + A
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK 361
Query: 249 LSKVTDPQVKQFIEKCIVPASLRLPALELLKD 280
T +V + KC + P+ L D
Sbjct: 362 PDHATQ-EVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 39/173 (22%), Positives = 62/173 (35%), Gaps = 22/173 (12%)
Query: 132 WA--RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 189
WA Q L L LH L + + +G V + +S
Sbjct: 20 WAVCLQCLGALRELHRQAKS--GNILLTWDGLLK-LDGSV----------AFKTPEQS-R 65
Query: 190 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 248
P FMAPE+ + Y E DIYS G+ + E + E PYNE + + I + + +G +
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG--MPA 123
Query: 249 LSKVTDPQVKQFIEKCIVPASLRLPALELLK---DPFLVTDNPKDLVCDPLRL 298
++ +RL A L + + + L + L L
Sbjct: 124 DDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
Q+ RG+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 230
Query: 195 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 222
MAPE ++++ Y D++SFG+ + E+ +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 61/257 (23%), Positives = 114/257 (44%), Gaps = 27/257 (10%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHE 86
++++++G+G F V + + DG+++ +++ D + E+ +L L H
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-FAGELEVLCKLGHHP 63
Query: 87 NIIKFYNSWVDDTNRTI--------NMITELFTSGSLR----YRKKH---KNVDMKAIKN 131
NII + + I N++ L S L + K+H + + +
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 132 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 191
+A + G+ YL IHRDL N+ V G N KI D GL+ + +++
Sbjct: 124 FASDVATGMQYLSEKQ--FIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVKKTMGRL 180
Query: 192 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGIKPA 247
P +MA E L Y D++SFG+ + E+V+ PY C A++Y+K+ G +
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYR-M 237
Query: 248 SLSKVTDPQVKQFIEKC 264
+ D +V + + +C
Sbjct: 238 EKPRNCDDEVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 26/144 (18%)
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
Q+ +G+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 235
Query: 195 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 240
MAPE +++ Y D++SFG+ + E+ + PY K + +++
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295
Query: 241 TSGIKPASLSKVTDPQVKQFIEKC 264
G + + T P++ Q + C
Sbjct: 296 KEGTRMRA-PDYTTPEMYQTMLDC 318
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 125 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180
D+ IK RQ+L GL LH I+HRD+K +N+ V +G+VKI D G A+ M
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 33 LGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLY--SEVHLLKSLKHENII 89
+G G F V G EV+ G A QV ++++ S E++ E +SL+H N++
Sbjct: 3 IGNGWFGKVILG--EVNSGYTPA--QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 90 KFYNSWVDDTNRTINM----ITELFTSGSLRYRKKHKNV--DMKAIKNWARQILRGLHYL 143
+ + T + M + +L G LR +K + + D ++ A +I GL +L
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDL--KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPEL 199
H +N IH DL N + + VKIGD GL+ + T + ++APEL
Sbjct: 117 HKNN--FIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 200 YEEEYNELV--------DIYSFGMCILEM 220
+E + L+ +++S G+ I E+
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 32/230 (13%)
Query: 33 LGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENII 89
+G G F V G E G+ A +V ++++ S PD+ EV + L H N++
Sbjct: 3 IGNGWFGKVLLG--EAHRGMSKA--RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKA----IKNWARQILRGLHYL 143
+ ++ ++ E G L+ R V A ++ A ++ GL +L
Sbjct: 59 QCLGQCIESI--PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPEL 199
H + IH DL N + + VKIGD GLA+ T ++APEL
Sbjct: 117 HQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 200 YEEEYNELV--------DIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 240
E +L+ +I+S G+ + E+ T + PY + + Q+ K+V
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 27/201 (13%)
Query: 33 LGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G F TV KG ++ E VA + ++ P + L E ++++ L + I++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVR 60
Query: 91 FY-----NSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLH 144
SW+ ++ EL G L ++ +K+K+V K I Q+ G+ YL
Sbjct: 61 MIGICEAESWM--------LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE- 198
N +HRDL N+ + + KI D GL+ + A++ P ++ APE
Sbjct: 113 ETN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 199 LYEEEYNELVDIYSFGMCILE 219
+ +++ D++SFG+ + E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 37/123 (30%), Positives = 52/123 (42%), Gaps = 32/123 (26%)
Query: 127 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----- 181
K I+ RQIL L LHS I+HRD+K NI + +G KI DLG A ++
Sbjct: 255 KIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY 312
Query: 182 QPTARSVIGTPEFMAPE-----------------------LYEEEYNELVDIYSFGMCIL 218
P + + P + APE L++ + DIYS G+ L
Sbjct: 313 IP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 219 EMV 221
+M
Sbjct: 371 QMA 373
|
Length = 566 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 37/262 (14%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHE 86
++ +++G+G F V K + DG+ + +++ S D E+ +L L H
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHP 68
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMK---AIKN----------- 131
NII + + + + E G+L + +K + ++ AI N
Sbjct: 69 NIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 132 --WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 189
+A + RG+ YL IHRDL NI V G N KI D GL+ + +++
Sbjct: 127 LHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMG 183
Query: 190 GTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGI- 244
P +MA E L Y D++S+G+ + E+V+ PY C A++Y+K+ G
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYR 241
Query: 245 --KPASLSKVTDPQVKQFIEKC 264
KP + D +V + +C
Sbjct: 242 LEKPLN----CDDEVYDLMRQC 259
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 17/143 (11%)
Query: 133 ARQILR-------GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185
++Q+L G+ YL IHRDL NI V G N KI D GL+ +
Sbjct: 111 SQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVK 167
Query: 186 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVT 241
+++ P +MA E L Y D++S+G+ + E+V+ PY C A++Y+K+
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLP 225
Query: 242 SGIKPASLSKVTDPQVKQFIEKC 264
G + D +V + +C
Sbjct: 226 QGYR-LEKPLNCDDEVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 28 RYDEILGKGAFKTVYKG--FDEVDGIEVAWNQV-NIEDVMQSPDQLERLYSEVHLLKSLK 84
R+ E LG+ F VYKG F G + + ++D + P + E E + L+
Sbjct: 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR-EEFKHEAMMRSRLQ 66
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLR----YRKKHKNV----DMKAIKNW---- 132
H NI+ + + ++MI + L R H +V D K +K+
Sbjct: 67 HPNIVCLLGVVTKE--QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 133 -----ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 187
QI G+ +L SH+ ++H+DL N+ V + VKI DLGL +
Sbjct: 125 DFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-DKLNVKISDLGLFREVYAADYYK 181
Query: 188 VIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 222
++G +M+PE + +++ DI+S+G+ + E+ +
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 36/238 (15%)
Query: 31 EILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+ILG+G F +V +G D+ ++VA + ++ S ++E SE +K H N
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS--EIEEFLSEAACMKDFDHPN 62
Query: 88 IIKFYNSWVDDTNRTIN------MITELFTSGSL-------RYRKKHKNVDMKAIKNWAR 134
++K V ++ +I G L R + + ++ + +
Sbjct: 63 VMKLIG--VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------QQPTARS 187
I G+ YL + N IHRDL N + + V + D GL+ + Q A+
Sbjct: 121 DIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 188 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243
+ +++A E L + Y D+++FG+ + E+ T + PY +N +IY + G
Sbjct: 178 PV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLRHG 231
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 21/40 (52%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179
L YLH H IIHRDLK DN+ ++ N G +K+ D GL+ V
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 33/132 (25%), Positives = 51/132 (38%), Gaps = 51/132 (38%)
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----------------------------- 176
H IHRD+K DNI ++ +G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 177 --------------------AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 215
A Q+ A S++GTP ++APE L Y +L D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 216 CILEMVTCEYPY 227
+ EM+ + P+
Sbjct: 237 ILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 66/274 (24%), Positives = 103/274 (37%), Gaps = 76/274 (27%)
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-------------------QPT-- 184
H IHRD+K DNI ++ +G +K+ D GL + +P+
Sbjct: 118 HKMGFIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 185 ----------------------------ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 215
A S++GTP ++APE L + Y +L D +S G+
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 216 CILEMVTCEYPYNECKNPAQIYKKVT---SGIKPASLSKVTDPQVKQFIEKCIVPASLRL 272
+ EM+ + P+ P + KV + + K++ P+ I K A RL
Sbjct: 237 ILFEMLVGQPPF-LAPTPTETQLKVINWENTLHIPPQVKLS-PEAVDLITKLCCSAEERL 294
Query: 273 ---PALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADS 329
A ++ PF + D D P P V ++ HPMD N V +S
Sbjct: 295 GRNGADDIKAHPFF---SEVDFSSDIRTQP--APYVPKIS----HPMDTS-NFDPVEEES 344
Query: 330 ----CAKSNTGTW-FLTLELQRLTENN--EFTLR 356
+ +T TW L + E+ EFT R
Sbjct: 345 PWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFR 378
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 56/267 (20%), Positives = 108/267 (40%), Gaps = 70/267 (26%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++GKGAF V + + D ++ + ++ M DQL + +E +L ++
Sbjct: 7 KVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65
Query: 91 FYNSWVDDTNRTINMITELFTSGSL-----RYRKKHKNVDMKAIKNWARQIL--RGLHYL 143
Y S+ D + + +I E G L +Y ++V + A +L +H L
Sbjct: 66 LYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYM---AECVLAIEAVHKL 120
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-------------VMQQPTAR---- 186
IHRD+K DNI ++ G +K+ D GL+ ++Q + +
Sbjct: 121 G-----FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 187 --------------------------------SVIGTPEFMAPELYEEE-YNELVDIYSF 213
S +GTP+++APE++ ++ Y + D +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 214 GMCILEMVTCEYPYNECKNPAQIYKKV 240
G + E + +P +N + Y+K+
Sbjct: 235 GAIMFECL-IGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 31/233 (13%)
Query: 33 LGKGAFKTVYKG-FDEVDGI-EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG+G F +V +G ++ D I +VA + I +S ++E SE +K H N+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS--EMEDFLSEAVCMKEFDHPNVMR 64
Query: 91 FYNSWVDDTNR----TINMITELFTSGSL-------RYRKKHKNVDMKAIKNWARQILRG 139
+ + +I G L R + + + + + I G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------QQPTARSVIGTP 192
+ YL S + IHRDL N +N N V + D GL+ + Q A+ +
Sbjct: 125 MEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV--- 178
Query: 193 EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243
+++A E L + Y D++SFG+ + E+ T + PY +N ++IY + G
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDYLRQG 230
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 31 EILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSE-----VHLLKSL 83
E LG+G F ++KG + D E+ +V +++ D+ R YSE ++ L
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEV----LLKVLDKSHRNYSESFFEAASMMSQL 56
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIK-NWARQILRGLH 141
H++++ Y V M+ E GSL Y KK+KN+ + K A+Q+ LH
Sbjct: 57 SHKHLVLNYGVCVCGDESI--MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALH 114
Query: 142 YLHSHNPPIIHRDLKCDNIFV-------NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
+L + H ++ N+ + GN +K+ D G++I + P + P +
Sbjct: 115 FLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV-LPKEILLERIP-W 170
Query: 195 MAPELYEEEYNELV--DIYSFGMCILEM 220
+ PE E N + D +SFG + E+
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 630 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.89 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.84 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.59 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.56 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 98.35 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.33 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.17 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.17 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.06 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.04 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.97 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.97 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.92 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.87 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.7 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.57 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.54 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.29 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.24 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.24 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.19 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.07 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.04 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.03 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.87 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.76 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.45 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.28 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.22 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.08 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.78 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 95.75 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.58 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.52 | |
| PLN02236 | 344 | choline kinase | 95.48 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.45 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.42 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.22 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.99 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.44 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.7 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.35 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.09 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 91.58 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 90.57 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 90.46 | |
| PTZ00384 | 383 | choline kinase; Provisional | 90.28 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 89.83 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 89.81 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-91 Score=760.26 Aligned_cols=419 Identities=61% Similarity=0.991 Sum_probs=366.0
Q ss_pred CCCccCCccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCee
Q 006810 10 SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89 (630)
Q Consensus 10 ~~~~~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIV 89 (630)
.++++.+++|.||.|||.||.++||+|+|.+||+|+|..+|.+|||+.+++.++.+++..+++|+.|+++|+.|+|||||
T Consensus 25 ~e~~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIi 104 (632)
T KOG0584|consen 25 SEPDESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNII 104 (632)
T ss_pred hccccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCcee
Confidence 44678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc
Q 006810 90 KFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 168 (630)
Q Consensus 90 k~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 168 (630)
+||++|++..+.+++||||+|++|+|+ |++++++++.+.++.|++|||.||.|||++.||||||||||+||||+|+.|.
T Consensus 105 rfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~ 184 (632)
T KOG0584|consen 105 RFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGE 184 (632)
T ss_pred eeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCc
Confidence 999999999999999999999999999 9999999999999999999999999999999999999999999999999999
Q ss_pred EEEcccccceeeccCCCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006810 169 VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 248 (630)
Q Consensus 169 vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~ 248 (630)
|||||+|+|+..+...+..++|||+|||||+++..|+..+||||||||++||+|+++||++|.+++|||++++.|++|..
T Consensus 185 VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 185 VKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred eeecchhHHHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 99999999999999988999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCHHHHhcCCCcccCCCCccccCCCCC------------CCCchhhhccCCCCCCCC
Q 006810 249 LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRL------------PNLVPEVMNLAHSEPHPM 316 (630)
Q Consensus 249 l~~~~s~~lk~~I~kcL~~p~~Rpsa~eLL~hpf~~~~~~~~~~~~~l~~------------p~~~~~~~~~~~~~~~~~ 316 (630)
+.++.+|++++||++||...+.|+||.|||+||||..+.... .+++. .................+
T Consensus 265 l~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g~~---~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~ 341 (632)
T KOG0584|consen 265 LSKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDEDGGIV---ELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQF 341 (632)
T ss_pred hhccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccccccc---cccchhhcccccccccccccchhhcCCcccccccc
Confidence 999999999999999999999999999999999999875421 11111 111111000000111122
Q ss_pred Ccccccccccccccc---ccCCCCcchhhhhhhcccccceeeecccCCCC-ceEEEEEecCCCCCeeeeEeecccCCccH
Q 006810 317 DIDLNHKKVSADSCA---KSNTGTWFLTLELQRLTENNEFTLRGEKNDDD-TVSLTLRIGDKSGHVSNIHFVFYLNADTA 392 (630)
Q Consensus 317 ~~d~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~i~L~Lri~d~~~~~~~i~f~f~~~~Dta 392 (630)
+.+... +.+...+- ....-......+..|...++.+.++|+++++. .++|.|||+|..|+.|||+|+|++..|||
T Consensus 342 ~~~~~~-D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta 420 (632)
T KOG0584|consen 342 DYNLNT-DESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTA 420 (632)
T ss_pred eeecCC-CchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcch
Confidence 222111 01111000 01111222345666777888999999999877 99999999999999999999999999999
Q ss_pred HHHHHHHHHccCCCCcCHHHHHHHHHHHHHHhCCCCCCCC
Q 006810 393 ISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSL 432 (630)
Q Consensus 393 ~~va~EmV~~~~i~~~d~~~ia~~i~~~i~~~~~~~~~~~ 432 (630)
.+||.|||+++.++++++..||+|||..|.+|+|.|+...
T Consensus 421 ~~Va~eMv~el~~~dq~v~~ia~mid~~i~~L~p~~~~~~ 460 (632)
T KOG0584|consen 421 PSVAHEMVEELEITDQPVVNIAEMIDGEISALVPNWKAST 460 (632)
T ss_pred hHHHHHHHhhcCCcccchhhHHHHHhchhhhcCCccCCCC
Confidence 9999999999999999999999999999999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-52 Score=430.54 Aligned_cols=251 Identities=29% Similarity=0.496 Sum_probs=227.2
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
...||+|+.|+||++.|+.||+.+|+|.|... ..+...+++.+|+++++.++|||||+||+.|+.+.. .+.++|||
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mEY 159 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICMEY 159 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehhh
Confidence 47799999999999999999999999999533 245667889999999999999999999999988765 79999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCcc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 187 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~ 187 (630)
|++|+|+ .++..++++|..+..++.+|++||.|||. ++ ||||||||.|||++ ..|.|||||||++..+-+..+.+
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvN-skGeVKicDFGVS~~lvnS~a~t 236 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVN-SKGEVKICDFGVSGILVNSIANT 236 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeec-cCCCEEeccccccHHhhhhhccc
Confidence 9999999 77777999999999999999999999995 77 99999999999999 79999999999999888888899
Q ss_pred ccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCC----CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 188 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 188 ~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~----~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
++||..|||||.+.+ .|+.++||||||+.++||++|++||... .+...++..|..+.+|.......++++++||.
T Consensus 237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~ 316 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVS 316 (364)
T ss_pred ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 999999999999986 5999999999999999999999999873 46778888888876665544469999999999
Q ss_pred Hccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 263 KCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 263 kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+||+ +|.+||++.|||.|||++...
T Consensus 317 ~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 317 CCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9998 799999999999999998644
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=428.20 Aligned_cols=270 Identities=26% Similarity=0.377 Sum_probs=228.8
Q ss_pred CccCCccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH---HHHHHHHHHHHHHHhCCCCCe
Q 006810 12 TEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP---DQLERLYSEVHLLKSLKHENI 88 (630)
Q Consensus 12 ~~~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~---~~~~~l~~Ei~iL~~L~HpNI 88 (630)
.++....+.. ...||-+.+.||+|+||.|.+|+.+.||+.||+|+++........ .....+.+|+++|++|+||||
T Consensus 160 ~d~~~~~pks-~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~I 238 (475)
T KOG0615|consen 160 RDSSKVPPKS-FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNI 238 (475)
T ss_pred chhccCccch-hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCE
Confidence 3344444444 445568889999999999999999999999999999876543321 233446799999999999999
Q ss_pred eEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCC-
Q 006810 89 IKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN- 166 (630)
Q Consensus 89 Vk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~- 166 (630)
|+++++|...+ ..||||||+.||.|. .+..++.+.+..-+.+++|++.|+.|||++| |+||||||+|||++ .+
T Consensus 239 V~~~d~f~~~d--s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~-~~~ 313 (475)
T KOG0615|consen 239 VRIKDFFEVPD--SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLS-NDA 313 (475)
T ss_pred EEEeeeeecCC--ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEec-cCC
Confidence 99999986554 579999999999998 8889999999999999999999999999999 99999999999997 44
Q ss_pred --CcEEEcccccceeeccC-CCccccCCCCCCCccccccc----cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHH
Q 006810 167 --GEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 239 (630)
Q Consensus 167 --g~vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~~----ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~ 239 (630)
-.+||+|||+|+..+.. ..++.||||.|.|||++... |..++||||+||++|-+++|.+||++...+..+.+.
T Consensus 314 e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ 393 (475)
T KOG0615|consen 314 EDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ 393 (475)
T ss_pred cceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH
Confidence 68999999999887643 46789999999999998642 456999999999999999999999987666668888
Q ss_pred HHcCCCC--CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 240 VTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 240 i~~g~~p--~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
|..|..+ +..+..++.++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 394 I~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 394 ILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 8888553 23445568999999999997 999999999999999998643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=439.84 Aligned_cols=257 Identities=33% Similarity=0.543 Sum_probs=229.5
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
.||..++|..++.||+|||++||.+.+..+|+.||+|+|....+. ...+.+++.+||++.++|+|||||+||++|.|..
T Consensus 13 ~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~-k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 13 EDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK-KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN 91 (592)
T ss_pred ecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc-CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence 444556668899999999999999999999999999999876543 4567889999999999999999999999997664
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.+|||.|+|..|+|. +.+..+.++|.+++.+++||+.||.|||+++ |+|||||..|+|++ .+-+|||||||+|+
T Consensus 92 --nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~-~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 92 --NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLN-ENMNVKIGDFGLAT 166 (592)
T ss_pred --ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeec-CcCcEEecccceee
Confidence 599999999999998 7888999999999999999999999999999 99999999999998 78899999999998
Q ss_pred eeccC--CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 179 VMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 179 ~~~~~--~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
..... ...+.||||.|.|||++. .+++..+||||+||++|-||+|++||.. .+..+.+.+|..... .++...++
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y--~~P~~ls~ 243 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEY--SMPSHLSA 243 (592)
T ss_pred eecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCc--ccccccCH
Confidence 87644 456889999999999876 4699999999999999999999999986 667788888876533 34557889
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
++++||.++|. +|.+|||++++|.|+||+.
T Consensus 244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 244 EAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 99999999998 8999999999999999954
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=423.63 Aligned_cols=266 Identities=27% Similarity=0.436 Sum_probs=225.8
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
+--+...-|.+.++||.|..++||+|++..+++.||||+++++++.. .++.+.+|++.|+.++||||+++|.+|+.+
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~---~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN---DLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh---hHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 33445555688999999999999999999999999999999988743 377899999999999999999999999876
Q ss_pred CCCEEEEEEcccCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 99 TNRTINMITELFTSGSLRYRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~~~---~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
. .+|+||.||.+|++..+.+ ...++|..|..++++++.||.|||.+| .||||||+.||||+ .+|.|||+|||
T Consensus 97 ~--~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkLadFg 171 (516)
T KOG0582|consen 97 S--ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKLADFG 171 (516)
T ss_pred c--eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEEcCce
Confidence 4 6999999999999974332 345999999999999999999999999 99999999999998 89999999999
Q ss_pred cceeeccC-----CC-ccccCCCCCCCccccc---cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-
Q 006810 176 LAIVMQQP-----TA-RSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK- 245 (630)
Q Consensus 176 la~~~~~~-----~~-~~~~GTp~Y~APEvl~---~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~- 245 (630)
++..+... .. .+++|||+|||||++. .+|+.|+|||||||++.||++|..||........+..++....+
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT 251 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence 88544322 11 5678999999999954 36999999999999999999999999987766777666665433
Q ss_pred ------CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCCccc
Q 006810 246 ------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 292 (630)
Q Consensus 246 ------p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~~~~ 292 (630)
+..-.+..+..++.||..||+ +|.+||||++||+|+||+....+...
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~ 305 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYL 305 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhc
Confidence 112223456789999999998 89999999999999999988776643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=402.86 Aligned_cols=265 Identities=25% Similarity=0.445 Sum_probs=233.7
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+.+.++||+|+||.||.++.+.||+.+|+|++++...... ...+....|..+|.+++||.||+++..|++.. .+|||
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~--kLylV 103 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTEE--KLYLV 103 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccCC--eEEEE
Confidence 4778999999999999999999999999999988776543 56678899999999999999999999997664 59999
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--C
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--P 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~ 183 (630)
+||+.||.|. .+.+.+.+++..++.|+.+|+.||.|||++| ||||||||+|||++ .+|+++|+|||+++..-. .
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhcccCCC
Confidence 9999999999 6778999999999999999999999999999 99999999999998 899999999999975432 3
Q ss_pred CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
...++|||++|||||++. .+|+.++|.||||+++|||++|.+||.. .+...+++++..+.. ...+...+.+++++|+
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~-~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKL-PLPPGYLSEEARDLLK 258 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcC-CCCCccCCHHHHHHHH
Confidence 556789999999999775 5699999999999999999999999987 677788888887652 3345667899999999
Q ss_pred Hccc-CCCCCC----CHHHHhcCCCcccCCCCccccCCCCCC
Q 006810 263 KCIV-PASLRL----PALELLKDPFLVTDNPKDLVCDPLRLP 299 (630)
Q Consensus 263 kcL~-~p~~Rp----sa~eLL~hpf~~~~~~~~~~~~~l~~p 299 (630)
++|. +|.+|. .+.++-+||||...+|..+....+..|
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~Pp 300 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPP 300 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCC
Confidence 9997 899995 688999999999999988766555443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=418.96 Aligned_cols=260 Identities=32% Similarity=0.569 Sum_probs=230.6
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
-.||..+|..+ +.||+|+.|.||.|....++..||+|++.+... ...+-+.+|+.+|+..+|+|||+|++.|...
T Consensus 268 ~~dP~~~y~~~-~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 268 QGDPRSKYTDF-KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred CCChhhhhcch-hhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 37999999665 669999999999999999999999999987653 2335589999999999999999999998766
Q ss_pred CCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 99 TNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+|+||||++||+|..+...-.++|.+++.+|+++++||+|||.++ |+|||||.+|||+. .+|.+||+|||++.
T Consensus 343 --deLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGFca 417 (550)
T KOG0578|consen 343 --DELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGFCA 417 (550)
T ss_pred --ceeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeeeee
Confidence 45999999999999987777788999999999999999999999999 99999999999997 89999999999997
Q ss_pred eeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 179 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 179 ~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
.+... ...+.+|||.|||||++.. .|++++||||||++++||+-|++||-.......++.+-..|.+....+...++
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~ 497 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSP 497 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCH
Confidence 76543 4667899999999998865 69999999999999999999999998745555666667777777777788899
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
.+++|+.+||+ ++.+|++|.|||.||||+.+.+
T Consensus 498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 498 ELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP 531 (550)
T ss_pred HHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence 99999999997 9999999999999999976554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=397.56 Aligned_cols=258 Identities=28% Similarity=0.518 Sum_probs=223.1
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
-.|.| -+.+.||+|+||+||+|.++.+|.+||||.|....+ .+...+.+..|+.+|+.++|||||.++++..+. .
T Consensus 8 ~~~~y-~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~--~ 82 (429)
T KOG0595|consen 8 VVGDY-ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD--D 82 (429)
T ss_pred ccccc-eehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC--C
Confidence 34566 566779999999999999999999999999987654 467778899999999999999999999987554 4
Q ss_pred EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC--C---CcEEEcccc
Q 006810 102 TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--N---GEVKIGDLG 175 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~---g~vKL~DFG 175 (630)
.+|+|||||.||+|. |+..++.+++..++.++.||+.||++||+++ ||||||||+|||++.. + -.+||+|||
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 799999999999998 9999999999999999999999999999999 9999999999999842 1 468999999
Q ss_pred cceeeccC-CCccccCCCCCCCcccc-ccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Q 006810 176 LAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKV 252 (630)
Q Consensus 176 la~~~~~~-~~~~~~GTp~Y~APEvl-~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p~~l~~~ 252 (630)
+|+.+... ...+.||+|.|||||++ .++|+.|+|+||+|+|+|+|++|+.||.. .++.++...+..+.. .+.++..
T Consensus 161 fAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 161 FARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAE 239 (429)
T ss_pred hhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhh
Confidence 99988765 45688999999999988 57799999999999999999999999987 566777777776644 3344455
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.++.+.+++-..|. ++..|.+..+-+.|+|+....
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 56677788888886 899999999999999997644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=391.50 Aligned_cols=244 Identities=30% Similarity=0.506 Sum_probs=216.7
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+++.+.||+|+||.||++.+..+|..||+|.|++... +....+.+..|+.+|++|+|||||++|+.-+..++..+++|
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3778999999999999999999999999999997654 45677889999999999999999999994445566679999
Q ss_pred EcccCCCCHH-----HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCC--EEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 107 TELFTSGSLR-----YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP--IIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 107 ~Ey~~gGsL~-----~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~--IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
||||.+|+|. +.+.++.++++.++.++.|++.||..+|++-|. |+||||||.|||++ .+|.|||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhHhH
Confidence 9999999996 344567899999999999999999999995444 99999999999998 899999999999998
Q ss_pred eccC--CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 180 MQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
+... .+.+.+|||.||+||++. .+|+.++||||+||++|||+..++||.+ .+-.++-++|..+-.|+-+...++..
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS~~ 256 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYSTD 256 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhhhH
Confidence 8665 357889999999999876 5699999999999999999999999998 48889999999986665555788999
Q ss_pred HHHHHHHccc-CCCCCCCH
Q 006810 257 VKQFIEKCIV-PASLRLPA 274 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa 274 (630)
++.+|.-|+. +|..||+.
T Consensus 257 l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHccCCcccCCCc
Confidence 9999999997 89999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=397.55 Aligned_cols=257 Identities=33% Similarity=0.555 Sum_probs=216.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| +.++.||+|+||+||++.+..+|...|+|.+.... .. ..+.+.+|+.+|++|+|||||++++.........+
T Consensus 17 ~~~-~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 17 SNW-SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred chh-hhhccccCccceEEEEEEecCCCcceeeeeeeccc---ch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 345 56799999999999999999999999999998662 12 26779999999999999999999996433322478
Q ss_pred EEEEcccCCCCHH-HHhhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++.|||+++|+|. ++.+.+ .+++..++++.+||+.||+|||++| ||||||||+|||++..+|.+||+|||++....
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999998 666666 7999999999999999999999999 99999999999998337999999999997665
Q ss_pred c-----CCCccccCCCCCCCccccccccC--cccceeehhHHHHHHhhCCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 182 Q-----PTARSVIGTPEFMAPELYEEEYN--ELVDIYSFGMCILEMVTCEYPYNE-CKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 182 ~-----~~~~~~~GTp~Y~APEvl~~~ys--~~sDIWSLGvil~ELltG~~Pf~~-~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
. .....+.|||.|||||++...+. .++|||||||+++||+||..||.+ ......++........| .++...
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~l 248 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSL 248 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCccc
Confidence 2 22346789999999999885433 499999999999999999999987 33344455555555334 777889
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
++++++||.+|++ +|..||||.+||.|||++....
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999999997 8999999999999999987544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=382.12 Aligned_cols=265 Identities=27% Similarity=0.459 Sum_probs=237.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.+.||.|+||.|.+++++.+|..+|+|++++.++.. ..+.+...+|..+|+.+.||.+++++++|.+. ..+||||
T Consensus 47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~--~~lymvm 123 (355)
T KOG0616|consen 47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN--SNLYMVM 123 (355)
T ss_pred hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEeeccC--CeEEEEE
Confidence 34588999999999999999999999999998877654 56678889999999999999999999998665 5699999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCc
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 186 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~ 186 (630)
||++||.|. ++++.+++++..++.++.||+.||+|||+++ |++|||||+|||++ .+|.+||+|||+|...... ..
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~r-T~ 199 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGR-TW 199 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEecCc-EE
Confidence 999999998 8999999999999999999999999999999 99999999999998 8999999999999877665 56
Q ss_pred cccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHcc
Q 006810 187 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL 265 (630)
+.||||.|+|||++. .+|+.++|.|+|||++|||+.|.+||.. .++.++|.+|..+.. .++...++++++||.++|
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL 276 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKLL 276 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCcc--cCCcccCHHHHHHHHHHH
Confidence 789999999999876 5699999999999999999999999987 677999999998743 467788999999999999
Q ss_pred c-CCCCC-----CCHHHHhcCCCcccCCCCccccCCCCCCCCc
Q 006810 266 V-PASLR-----LPALELLKDPFLVTDNPKDLVCDPLRLPNLV 302 (630)
Q Consensus 266 ~-~p~~R-----psa~eLL~hpf~~~~~~~~~~~~~l~~p~~~ 302 (630)
+ |-++| .-..++-.||||+..+|..+....+..|..+
T Consensus 277 ~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 277 QVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred hhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 7 77777 3577899999999999988777666666554
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=404.43 Aligned_cols=259 Identities=27% Similarity=0.541 Sum_probs=223.8
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH-HHHHHHHHHHHHHHhCC-CCCeeEEEeEEEc
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLK-HENIIKFYNSWVD 97 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~-~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d 97 (630)
....|+| ++++.||+|+||+|++|.+..+|..||+|+++........ ...+.+.+|+.+++.++ ||||+++++++..
T Consensus 13 ~~~~g~y-~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 13 QLSIGKY-ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccccCce-eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 4556788 8899999999999999999999999999988765332122 34456779999999999 9999999999876
Q ss_pred CCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 98 DTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
.. .+|+||||+.||+|. ++...+++.+..++.+++||+.|++|||++| |+||||||+|||++.+.+.+||+|||+
T Consensus 92 ~~--~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 92 PT--KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred CC--eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 54 499999999999998 7777899999999999999999999999999 999999999999984339999999999
Q ss_pred ceee--ccCCCccccCCCCCCCcccccc-c-c-CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 177 AIVM--QQPTARSVIGTPEFMAPELYEE-E-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 177 a~~~--~~~~~~~~~GTp~Y~APEvl~~-~-y-s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
+... ......+.+|||.|+|||++.+ . | +.++||||+||+||.|++|+.||.+ .+...++.++..+.. .++.
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~--~~p~ 244 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEF--KIPS 244 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCc--cCCC
Confidence 9887 3456788999999999999876 4 6 4889999999999999999999988 566667777776633 3444
Q ss_pred CC-cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 252 VT-DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 252 ~~-s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.. +++++.+|.+||+ +|.+|+++.+++.||||+..
T Consensus 245 ~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 245 YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 44 9999999999998 89999999999999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=403.68 Aligned_cols=257 Identities=27% Similarity=0.477 Sum_probs=226.4
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~l 105 (630)
+.++++||.|+|++|++|.++.++.+||||++.++-+.. +....-+..|-.+|.+| .||.|+++|..|.|+. .+||
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~--sLYF 151 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE--SLYF 151 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc--ceEE
Confidence 578999999999999999999999999999987655433 23345577899999999 8999999999998775 5999
Q ss_pred EEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-
Q 006810 106 ITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 106 V~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 183 (630)
|+||+++|+|. ++++.+.|++...+.++.||+.||+|||++| ||||||||+|||++ .+|++||+|||.|..+...
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd-~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLD-KDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEc-CCCcEEEeeccccccCChhh
Confidence 99999999998 9999999999999999999999999999999 99999999999998 8999999999999765321
Q ss_pred ------------C--CccccCCCCCCCccccccc-cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006810 184 ------------T--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 248 (630)
Q Consensus 184 ------------~--~~~~~GTp~Y~APEvl~~~-ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~ 248 (630)
. ..+++||..|.+||++... .+..+|||+||||+|+|+.|.+||.+ .|+-.++++|..- .-.
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l--~y~ 305 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQAL--DYE 305 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHh--ccc
Confidence 1 1468999999999998765 68899999999999999999999987 6777888887753 334
Q ss_pred CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCCccc
Q 006810 249 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 292 (630)
Q Consensus 249 l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~~~~ 292 (630)
++...++.+++||+++|+ +|.+|+++.+|-.||||...++..+-
T Consensus 306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw 350 (604)
T KOG0592|consen 306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW 350 (604)
T ss_pred CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence 666778999999999998 89999999999999999999988743
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=400.01 Aligned_cols=262 Identities=31% Similarity=0.556 Sum_probs=227.7
Q ss_pred CccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEE
Q 006810 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (630)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f 95 (630)
.-...+|...|.++ +.||+|+||.||+|+|..+++.||+|++.++. .++..+.+.+|+.+|.++++|||.++|++|
T Consensus 5 ~~~~~~~~~~~~~~-~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsy 80 (467)
T KOG0201|consen 5 DVLKIDPELLYTKL-ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSY 80 (467)
T ss_pred hhhcCCcccccccc-hhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhhe
Confidence 34556788888554 89999999999999999999999999998775 467788899999999999999999999999
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
+... .++++||||.||++. .++....+++..+..++++++.||.|||.++ .+|||||+.|||+. .+|.+||+||
T Consensus 81 l~g~--~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s-~~g~vkl~Df 155 (467)
T KOG0201|consen 81 LKGT--KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLS-ESGDVKLADF 155 (467)
T ss_pred eecc--cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEe-ccCcEEEEec
Confidence 8764 589999999999998 5555555699999999999999999999999 99999999999998 6799999999
Q ss_pred ccceeeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 175 GLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 175 Gla~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
|++..+... ...+++|||.|||||++.+ .|+.++||||||+++|||++|++||..+..+..++ +.....|+.+..
T Consensus 156 gVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--lIpk~~PP~L~~ 233 (467)
T KOG0201|consen 156 GVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--LIPKSAPPRLDG 233 (467)
T ss_pred ceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--eccCCCCCcccc
Confidence 999887654 3468899999999998876 69999999999999999999999999865432222 222345667777
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
..++.+++||+.||. +|..||+|.+||+|+|++....
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k 271 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKK 271 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCC
Confidence 889999999999997 7999999999999999998543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=401.92 Aligned_cols=259 Identities=24% Similarity=0.464 Sum_probs=232.2
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
..+.+|=| ++++.||.|+.|.|.+|++..||+.+|||+|.... .........+.+||-+|+.+.||||+++|++|...
T Consensus 7 ~~~tiGpw-kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~-~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~ 84 (786)
T KOG0588|consen 7 HKNTIGPW-KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS-ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK 84 (786)
T ss_pred ccccccce-eccccccCCCCceehhhhcccccceeEEEeecccc-ccccccccchhhhhHHHHHhcCCCeeeeeeeeccC
Confidence 45667888 99999999999999999999999999999998663 23445567789999999999999999999999654
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 99 TNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+|+|.||++||.|. |+..++++++.++.++++||+.|+.|||..+ |+||||||+|+|++ ..+.|||+|||+|
T Consensus 85 --~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd-~~~nIKIADFGMA 159 (786)
T KOG0588|consen 85 --QHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLD-VKNNIKIADFGMA 159 (786)
T ss_pred --ceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhh-cccCEeeecccee
Confidence 5699999999999998 9999999999999999999999999999999 99999999999998 6667999999999
Q ss_pred eee-ccCCCccccCCCCCCCccccccc-c-CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 178 IVM-QQPTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 178 ~~~-~~~~~~~~~GTp~Y~APEvl~~~-y-s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
... ......+.||+|+|.|||++.+. | +.++||||.|||||.|+||..||.+ .|...++.++..|... ++..++
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is 236 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNIS 236 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCC
Confidence 754 34456788999999999998864 5 6899999999999999999999986 7899999999999653 457789
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+++++||.+||. ||++|.|..|+++|||+..-.
T Consensus 237 ~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 237 SEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 999999999996 999999999999999998643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=374.42 Aligned_cols=253 Identities=26% Similarity=0.460 Sum_probs=213.6
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+|.++ -.+|+|+||+||+++++.||+.||||++.-. ..++...+-..+|+++|++|+|||+|.+.++|- ....+
T Consensus 2 ekYE~L-gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr--rkrkl 76 (396)
T KOG0593|consen 2 EKYEKL-GKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVFR--RKRKL 76 (396)
T ss_pred cHHhhh-hccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHHH--hccee
Confidence 356555 4589999999999999999999999998533 234555667889999999999999999999884 44579
Q ss_pred EEEEcccCCCCHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++|+|||+..-|..+ .....++.+.++.+++|++.|+.|+|+++ +|||||||+||||+ .+|.+||||||+|+.+..
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSA 153 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEe-cCCcEEeccchhhHhhcC
Confidence 999999999999844 44567999999999999999999999999 99999999999998 899999999999988764
Q ss_pred CC--CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc----------------
Q 006810 183 PT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---------------- 242 (630)
Q Consensus 183 ~~--~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~---------------- 242 (630)
+. -+.++.|.+|+|||++-+ +|+..+|||++||++.||++|++.|.+..+.+|++.+...
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 32 345678999999998765 6999999999999999999999999999999999876643
Q ss_pred ---CCC---C---CCCC---CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 243 ---GIK---P---ASLS---KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 243 ---g~~---p---~~l~---~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
|+. | ..+. ...+.-+.+|+++||. +|.+|++.++||.||||.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 111 1 1111 1234578999999997 999999999999999994
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=391.10 Aligned_cols=259 Identities=23% Similarity=0.410 Sum_probs=224.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+..+||+||||.||+|+-+.||..+|+|++++.... ...+.+.++.|-.+|...++|+||++|.+|++. .++|+||
T Consensus 144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~--~~LYLiM 220 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK--EYLYLIM 220 (550)
T ss_pred hhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC--CeeEEEE
Confidence 4568999999999999999999999999999877654 467788899999999999999999999999766 4699999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc----
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---- 182 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~---- 182 (630)
||++||++. .+.+.+.|++..++.++.+++.|++.||++| +|||||||+|+||+ ..|++||.|||++..+..
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccchhhhhhhh
Confidence 999999999 7888899999999999999999999999999 99999999999998 899999999999742100
Q ss_pred -----------C---------C-------------------------CccccCCCCCCCcccccc-ccCcccceeehhHH
Q 006810 183 -----------P---------T-------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMC 216 (630)
Q Consensus 183 -----------~---------~-------------------------~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvi 216 (630)
. . +.+.+|||.|||||++.+ +|+..+|.||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 0 0 014579999999998865 59999999999999
Q ss_pred HHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHcccCCCCCCC---HHHHhcCCCcccCCCCcc
Q 006810 217 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 217 l~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~--~~~s~~lk~~I~kcL~~p~~Rps---a~eLL~hpf~~~~~~~~~ 291 (630)
+||||.|.+||.. .++.+.+++|......-.++ ...++++++||.+||.+|.+|.- +.|+-.||||+..+|..+
T Consensus 378 myEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l 456 (550)
T KOG0605|consen 378 MYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHL 456 (550)
T ss_pred HHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchh
Confidence 9999999999998 67888888877654322222 23569999999999999999885 889999999999999876
Q ss_pred cc
Q 006810 292 VC 293 (630)
Q Consensus 292 ~~ 293 (630)
..
T Consensus 457 ~~ 458 (550)
T KOG0605|consen 457 RE 458 (550)
T ss_pred hc
Confidence 54
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=387.73 Aligned_cols=250 Identities=27% Similarity=0.357 Sum_probs=212.6
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
++||+|.||.||+|++..+|+.||+|+|.+... .+.......+||.+|++|+|||||++.+..++.....+|||+|||
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM 200 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM 200 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc
Confidence 789999999999999999999999999987653 234455678999999999999999999998877667899999999
Q ss_pred CCCCHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC---Cc
Q 006810 111 TSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---AR 186 (630)
Q Consensus 111 ~gGsL~~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~---~~ 186 (630)
+......+ ...-.|++.+++.+++||+.||+|||++| |+|||||+.||||| ++|.+||+|||+|+.+.... .+
T Consensus 201 dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~~~~T 277 (560)
T KOG0600|consen 201 DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFYTPSGSAPYT 277 (560)
T ss_pred cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeeccCCCCcccc
Confidence 99665543 34568999999999999999999999999 99999999999998 89999999999999775443 34
Q ss_pred cccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-C------CC--------
Q 006810 187 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-A------SL-------- 249 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~------~l-------- 249 (630)
..+.|.+|+|||++-+ .|+.++|+||.||||.||++|++.|.+....+|+..+....-.| . .+
T Consensus 278 ~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp 357 (560)
T KOG0600|consen 278 SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKP 357 (560)
T ss_pred cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCC
Confidence 5577999999998765 59999999999999999999999999977777776665431111 0 00
Q ss_pred -----------CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 250 -----------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 250 -----------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.+..++.+.+|+.++|. +|.+|.||.++|.|+||..
T Consensus 358 ~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 358 QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 12346788999999997 9999999999999999943
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=358.61 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=211.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.||.+ .+.||+|.||+||+|.|..||+.||||+|+..+... .......+||+.|+.++||||+.+.++|...+ .+
T Consensus 2 ~rY~~-~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~--~l 76 (318)
T KOG0659|consen 2 DRYEK-LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--GINRTALREIKLLQELKHPNIIELIDVFPHKS--NL 76 (318)
T ss_pred chhhh-hhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--CccHHHHHHHHHHHHccCcchhhhhhhccCCC--ce
Confidence 47755 478999999999999999999999999999875432 22355789999999999999999999996554 58
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
.+|+||++...-. ...+...++...++.|+.++++||+|||++. |+||||||.|+|++ .+|.+||+|||+|+.+..
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccCC
Confidence 8899999874333 3445567899999999999999999999998 99999999999997 899999999999998765
Q ss_pred CCC--ccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCC--------
Q 006810 183 PTA--RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PAS-------- 248 (630)
Q Consensus 183 ~~~--~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~-------- 248 (630)
+.. ...+-|.+|+|||++.+ .|+..+||||.|||+.||+.|.+-|.+..+.+|+...+..--. +..
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 532 22367999999998765 5999999999999999999999989988888887766653111 111
Q ss_pred ---------------CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 249 ---------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 249 ---------------l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
+....+.++.+|+.++|. +|.+|++|.|+|+|+||++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 122345678999999998 8999999999999999987
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=376.03 Aligned_cols=257 Identities=24% Similarity=0.432 Sum_probs=220.7
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
.| ++.+.||+|+||.||+|.++.+|..||+|++...... .....+.+.+|+.+|++++||||++++++|.+. ..++
T Consensus 19 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 94 (329)
T PTZ00263 19 DF-EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVY 94 (329)
T ss_pred he-EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEEE
Confidence 35 7889999999999999999999999999999754432 234456788999999999999999999998754 4689
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+||||+.+|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCceEcCCC
Confidence 999999999998 7777888999999999999999999999999 99999999999998 7899999999999765443
Q ss_pred CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
.....||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+ .+....+..+..+.. .++...+..+++||.
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRL--KFPNWFDGRARDLVK 247 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCc--CCCCCCCHHHHHHHH
Confidence 234679999999998865 488999999999999999999999976 556667777766532 345567899999999
Q ss_pred Hccc-CCCCCCC-----HHHHhcCCCcccCCCCccc
Q 006810 263 KCIV-PASLRLP-----ALELLKDPFLVTDNPKDLV 292 (630)
Q Consensus 263 kcL~-~p~~Rps-----a~eLL~hpf~~~~~~~~~~ 292 (630)
+||. +|.+|++ +.+++.||||...++..+.
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~ 283 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 9997 8999997 7999999999987665543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=387.70 Aligned_cols=260 Identities=27% Similarity=0.386 Sum_probs=218.0
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDT 99 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~ 99 (630)
+-..|| .+.+.||.|.||.||+|+.+.+|+.||||.++.+- ..-++ -.-+||++.|++|+ |||||++++++.+.+
T Consensus 7 ~~m~RY-~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf--~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 7 IFMDRY-TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF--YSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred hHHHHH-HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh--ccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 345688 56688999999999999999999999999986432 12222 23468999999998 999999999998776
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
. .+|||||||+..... ...+++.|++..++.|+.||++||+|+|.+| +.||||||+|||+.+ +..|||+|||+|+
T Consensus 83 ~-~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~-~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 83 R-ILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISG-NDVIKIADFGLAR 158 (538)
T ss_pred c-eEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecc-cceeEeccccccc
Confidence 5 899999999997776 4445778999999999999999999999999 999999999999984 6699999999999
Q ss_pred eeccCC-CccccCCCCCCCccccc--cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC------------
Q 006810 179 VMQQPT-ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG------------ 243 (630)
Q Consensus 179 ~~~~~~-~~~~~GTp~Y~APEvl~--~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g------------ 243 (630)
...... -+.++.|.+|+|||++- +-|+.++|||++|||++|+.+.++.|.+....+|++++..--
T Consensus 159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 877654 45568899999999764 459999999999999999999999999988888988875420
Q ss_pred ------------CCCC---CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 244 ------------IKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 244 ------------~~p~---~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
..+. .+....++++.++|.+||. ||.+||||.++|+||||+....
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 0011 1223367899999999999 9999999999999999987543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=375.55 Aligned_cols=255 Identities=24% Similarity=0.442 Sum_probs=216.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
++||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+|+.++||||++++++|... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEeCC
Confidence 469999999999999999999999999975432 2234556788999999999999999999988654 4799999999
Q ss_pred CCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--CCCcc
Q 006810 111 TSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARS 187 (630)
Q Consensus 111 ~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~~ 187 (630)
++|+|. ++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccc
Confidence 999997 7777888999999999999999999999999 99999999999998 789999999999865322 22345
Q ss_pred ccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc
Q 006810 188 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 266 (630)
Q Consensus 188 ~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~ 266 (630)
.+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.. .+...+...+..+. ..++...++++++||++||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 679999999998864 589999999999999999999999976 45555656555442 24456678999999999997
Q ss_pred -CCCCCC-----CHHHHhcCCCcccCCCCccccC
Q 006810 267 -PASLRL-----PALELLKDPFLVTDNPKDLVCD 294 (630)
Q Consensus 267 -~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~~ 294 (630)
+|.+|| ++.++++||||...++......
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~ 265 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQK 265 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence 899999 8999999999998776665433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=394.66 Aligned_cols=265 Identities=24% Similarity=0.431 Sum_probs=234.3
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l~l 105 (630)
+++..+||+|+||+|++|..+.+++.+|||.+++..+.. .++.+.++.|.+++.... ||.++.+|..|+.. .++|+
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~--~~l~f 446 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTK--EHLFF 446 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccC--CeEEE
Confidence 577899999999999999999999999999999888766 467788999999998885 99999999999755 56999
Q ss_pred EEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee--ccC
Q 006810 106 ITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQP 183 (630)
Q Consensus 106 V~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~--~~~ 183 (630)
||||+.||++..+...+.+++..++.++..|+.||.|||++| |||||||.+|||++ ..|.+||+|||+++.- ...
T Consensus 447 vmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred EEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEecccccccccCCCCC
Confidence 999999999767777789999999999999999999999999 99999999999998 8999999999999753 344
Q ss_pred CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
...++||||.|||||++.+ .|+.++|.|||||+||||++|+.||.+ .+.++++..|... ...++...+.++..+++
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d--~~~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVND--EVRYPRFLSKEAIAIMR 600 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC--CCCCCCcccHHHHHHHH
Confidence 5678999999999998875 599999999999999999999999998 6788888877754 33466678899999999
Q ss_pred Hccc-CCCCCCC-----HHHHhcCCCcccCCCCccccCCCCCCC
Q 006810 263 KCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPN 300 (630)
Q Consensus 263 kcL~-~p~~Rps-----a~eLL~hpf~~~~~~~~~~~~~l~~p~ 300 (630)
++|. +|.+|.- +.++..||||+..+|..+....++.|.
T Consensus 601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf 644 (694)
T KOG0694|consen 601 RLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPF 644 (694)
T ss_pred HHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCC
Confidence 9997 7999986 478999999999999988766665543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=371.29 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=218.1
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||+||+|.+..+|+.||+|++...... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 2 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 77 (291)
T cd05612 2 DL-ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ--RFLY 77 (291)
T ss_pred Cc-eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC--CeEE
Confidence 45 7789999999999999999999999999999765432 233456788999999999999999999987644 5799
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC
Confidence 999999999998 7778888999999999999999999999999 99999999999998 7899999999998765432
Q ss_pred CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...++..+..+. ..++...++.+++||+
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~ 230 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGK--LEFPRHLDLYAKDLIK 230 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--cCCCccCCHHHHHHHH
Confidence 234679999999998764 488999999999999999999999987 45666666666553 2345566899999999
Q ss_pred Hccc-CCCCCCC-----HHHHhcCCCcccCCCCc
Q 006810 263 KCIV-PASLRLP-----ALELLKDPFLVTDNPKD 290 (630)
Q Consensus 263 kcL~-~p~~Rps-----a~eLL~hpf~~~~~~~~ 290 (630)
+||+ +|.+|++ +.+++.||||...++..
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 264 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD 264 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence 9998 8999995 99999999998765543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=387.08 Aligned_cols=250 Identities=29% Similarity=0.502 Sum_probs=220.4
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| -+-+.||+|+||.||+|+.+.++..||+|.+.+.. ..+.++..+.+|+++++.|+|||||.++++|... ..+
T Consensus 2 e~y-hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~--~~~ 76 (808)
T KOG0597|consen 2 EQY-HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFETS--AHL 76 (808)
T ss_pred cch-hHHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc--ceE
Confidence 355 34488999999999999999999999999987544 4567888999999999999999999999998544 569
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
|+|+||+.| +|+ ++...+.++++.++.++.|++.||.|||+++ |+|||+||.|||+. .+|.+|+||||+|+.+..
T Consensus 77 ~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMST 152 (808)
T ss_pred EEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhccc
Confidence 999999999 777 8899999999999999999999999999999 99999999999997 899999999999988765
Q ss_pred C--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 183 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 183 ~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
. ...+.-|||.|||||++++ .|+..+|+||||||+|||++|++||.. ....++.+.|... |..++...+..++.
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d--~v~~p~~~S~~f~n 229 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKD--PVKPPSTASSSFVN 229 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcC--CCCCcccccHHHHH
Confidence 4 3456779999999998875 599999999999999999999999986 4556666666654 44455578899999
Q ss_pred HHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 260 FIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
|++.+|. ||..|.+..+|+.|||.+.
T Consensus 230 fl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 230 FLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred HHHHHhhcChhhcccHHHHhcChHHhh
Confidence 9999997 8999999999999999975
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=376.80 Aligned_cols=259 Identities=23% Similarity=0.391 Sum_probs=214.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||+||+|.+..+|..||+|++...... .......+.+|+.+++.++||||++++++|.+. ..+|+||
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~~~lv~ 80 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LNLYLIM 80 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CeEEEEE
Confidence 6789999999999999999999999999999754322 234456788999999999999999999998654 4689999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC---
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--- 183 (630)
||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCCEEEeeccCcccccccccc
Confidence 999999998 7777889999999999999999999999999 99999999999998 7899999999998643211
Q ss_pred ----------------------------------CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCC
Q 006810 184 ----------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYN 228 (630)
Q Consensus 184 ----------------------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~ 228 (630)
.....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0124579999999998764 58999999999999999999999998
Q ss_pred CCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHcccC---CCCCCCHHHHhcCCCcccCCCCcccc
Q 006810 229 ECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKDLVC 293 (630)
Q Consensus 229 ~~~~~~~i~~~i~~g~~p~~l~--~~~s~~lk~~I~kcL~~---p~~Rpsa~eLL~hpf~~~~~~~~~~~ 293 (630)
. .+....+..+........++ ...++++++||.+++.+ +..||++.|+++||||+..++..+..
T Consensus 238 ~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~ 306 (363)
T cd05628 238 S-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRE 306 (363)
T ss_pred C-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHh
Confidence 6 45566666665532222222 23578999999997764 34678999999999999887766533
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=375.24 Aligned_cols=242 Identities=36% Similarity=0.597 Sum_probs=205.1
Q ss_pred eeEecccCceEEEEEEEccCCeE-EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEc
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~-VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~E 108 (630)
.+.||+|+||+||+|... |.. ||+|.+...+.. ....+.|.+|+.+|.+|+|||||+|++++..... .+.+|||
T Consensus 46 ~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~--~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVtE 120 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFD--DESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVTE 120 (362)
T ss_pred hhhcccCCceeEEEEEeC--CceeEEEEEecchhcC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEEE
Confidence 466999999999999765 556 999999865532 2237789999999999999999999998865542 5889999
Q ss_pred ccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC-cEEEcccccceeeccC-
Q 006810 109 LFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 109 y~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g-~vKL~DFGla~~~~~~- 183 (630)
|+++|+|. ++.. .+.++...+..|+.||+.|++|||+++| ||||||||+|||++ .++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~-~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVD-LKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEc-CCCCEEEECCCccceeecccc
Confidence 99999998 5555 6889999999999999999999999997 99999999999998 676 9999999999877653
Q ss_pred -CCccccCCCCCCCccccccc---cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 184 -TARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 184 -~~~~~~GTp~Y~APEvl~~~---ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
......||+.|||||++.+. |+.++|||||||++|||+||+.||.+... .++...+..+...+.++...++.+..
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~~ 277 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLSS 277 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 33447899999999999854 99999999999999999999999998766 55555554444444556668899999
Q ss_pred HHHHccc-CCCCCCCHHHHhc
Q 006810 260 FIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+|++||. +|..||+..+++.
T Consensus 278 l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 278 LMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHhCCCCCCcCCCHHHHHH
Confidence 9999997 8999999998765
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=371.68 Aligned_cols=263 Identities=24% Similarity=0.430 Sum_probs=221.0
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG-~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
...| .+.+.||+|+||.||+|.+..++ ..||+|.+...... .....+.+.+|+.+++.++||||++++++|.+. .
T Consensus 29 ~~~y-~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~ 104 (340)
T PTZ00426 29 YEDF-NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--S 104 (340)
T ss_pred hhhc-EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--C
Confidence 3445 77899999999999999877665 78999998754432 234556788999999999999999999998654 4
Q ss_pred EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 102 TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
.+++||||+.+|+|. ++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeec
Confidence 699999999999998 7777888999999999999999999999999 99999999999997 7899999999999765
Q ss_pred ccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 181 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 181 ~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .++..++..+..+.. .++...++.+++
T Consensus 182 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 257 (340)
T PTZ00426 182 DTR-TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKH 257 (340)
T ss_pred CCC-cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence 432 345679999999998865 488999999999999999999999986 456666777766533 345567899999
Q ss_pred HHHHccc-CCCCCC-----CHHHHhcCCCcccCCCCccccCCC
Q 006810 260 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 296 (630)
Q Consensus 260 ~I~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~~~l 296 (630)
+|++||. +|.+|+ ++.++++||||...++.......+
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~ 300 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNV 300 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence 9999997 799985 899999999999877655444333
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=373.47 Aligned_cols=256 Identities=23% Similarity=0.434 Sum_probs=213.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||+||+|.+..+|..||+|++...... .......+.+|+.+|+.++||||++++++|.+. ..+++||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv~ 80 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDE--NYLYLIM 80 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CeEEEEE
Confidence 6789999999999999999999999999999754332 234556688999999999999999999998754 4799999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC---
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--- 183 (630)
||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceeccccccc
Confidence 999999998 7777788999999999999999999999999 99999999999998 7899999999998643211
Q ss_pred -------------------------------------CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCC
Q 006810 184 -------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEY 225 (630)
Q Consensus 184 -------------------------------------~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~ 225 (630)
.....+||+.|+|||++. ..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 011346999999999875 458999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHcccCCCCCCC---HHHHhcCCCcccCCCCc
Q 006810 226 PYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKD 290 (630)
Q Consensus 226 Pf~~~~~~~~i~~~i~~g~~p~~l~--~~~s~~lk~~I~kcL~~p~~Rps---a~eLL~hpf~~~~~~~~ 290 (630)
||... +....+..+........++ ...++.+++||.+||.+|.+|++ +.++|.||||+..++..
T Consensus 238 Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~ 306 (364)
T cd05599 238 PFCSD-NPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEH 306 (364)
T ss_pred CCCCC-CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 99874 4555555555433222222 24588999999999998999997 99999999998765543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=358.48 Aligned_cols=251 Identities=27% Similarity=0.482 Sum_probs=220.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.++||+|.|+.||++.+..+|..+|+|+|+...+... ..+.+.+|+++-+.|+||||+++++++. ...+.|+|+
T Consensus 14 ~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti~--~~~~~ylvF 89 (355)
T KOG0033|consen 14 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHYLVF 89 (355)
T ss_pred hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhhc--ccceeEEEE
Confidence 556899999999999999999999999999998776543 5678999999999999999999999874 345799999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCcEEEcccccceeeccC-
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGla~~~~~~- 183 (630)
|+++||+|. .+.....+++..+-.+++||+.+|.|+|.++ |||||+||+|+++-+ ...-+||+|||+|...+..
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE 167 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence 999999997 5666678899999999999999999999999 999999999999953 3347999999999887743
Q ss_pred CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQF 260 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~lk~~ 260 (630)
....++|||.|||||+++. .|+..+|||+.|+++|-|+.|++||.+ .+...+|+.|..+.. +.......+++++++
T Consensus 168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 3456789999999998874 699999999999999999999999987 577889999988743 444556678999999
Q ss_pred HHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 261 IEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 261 I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
|++||. +|++|.||.|+|+|||+..
T Consensus 247 vrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHhccChhhhccHHHHhCCchhcc
Confidence 999996 9999999999999999975
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=369.41 Aligned_cols=258 Identities=21% Similarity=0.360 Sum_probs=215.5
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 1 ~~y-~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~ 76 (333)
T cd05600 1 KDF-QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD--EYL 76 (333)
T ss_pred CCc-EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC--CEE
Confidence 356 778999999999999999999999999999975432 2234456788999999999999999999988654 479
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
|+||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc
Confidence 9999999999998 7777788999999999999999999999999 99999999999998 789999999999975544
Q ss_pred CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC---CCC---CCCCcH
Q 006810 183 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---ASL---SKVTDP 255 (630)
Q Consensus 183 ~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p---~~l---~~~~s~ 255 (630)
......||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+....+..+...... +.. ....++
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~ 231 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSD 231 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCH
Confidence 3345679999999998764 589999999999999999999999986 4555555555432211 111 124578
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCCc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 290 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~~ 290 (630)
++.+||.+||. +|.+||++.++++||||....+..
T Consensus 232 ~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~ 267 (333)
T cd05600 232 EAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNE 267 (333)
T ss_pred HHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence 99999999997 688999999999999998765433
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=365.90 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=211.9
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCC
Q 006810 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (630)
Q Consensus 33 LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~g 112 (630)
||+|+||+||+|.+..+|..||+|++..... ........+.+|+.+|++++||||++++++|.+. ..+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCC
Confidence 7999999999999999999999999975432 2344566788999999999999999999988654 578999999999
Q ss_pred CCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--CCCcccc
Q 006810 113 GSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVI 189 (630)
Q Consensus 113 GsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~~~~ 189 (630)
|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ......+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCcccccc
Confidence 9997 7777888999999999999999999999999 99999999999997 789999999999875322 2234467
Q ss_pred CCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-C
Q 006810 190 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 267 (630)
Q Consensus 190 GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~ 267 (630)
||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...++..+..+ +..++...++.+++||.+||. +
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCC
Confidence 9999999998765 589999999999999999999999986 4555666666544 334556678999999999998 8
Q ss_pred CCCCC---CHHHHhcCCCcccCCCCc
Q 006810 268 ASLRL---PALELLKDPFLVTDNPKD 290 (630)
Q Consensus 268 p~~Rp---sa~eLL~hpf~~~~~~~~ 290 (630)
|.+|| ++.++|.||||...+...
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~~~~ 257 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLSWKK 257 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCCHHH
Confidence 99997 589999999998865544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=371.05 Aligned_cols=257 Identities=23% Similarity=0.416 Sum_probs=215.4
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||+||+|.+..+|..||+|++....... ......+.+|+.++..++||||++++++|.+. ..++
T Consensus 2 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 77 (350)
T cd05573 2 DF-EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQIAHVRAERDILADADSPWIVKLYYSFQDE--EHLY 77 (350)
T ss_pred Cc-eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhcCCCCccchhhheecC--CeEE
Confidence 56 77899999999999999999999999999997654322 24456788999999999999999999988654 4699
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCccc
Confidence 999999999998 6667788999999999999999999999998 99999999999998 7899999999998755432
Q ss_pred C-------------------------------CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC
Q 006810 184 T-------------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK 231 (630)
Q Consensus 184 ~-------------------------------~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~ 231 (630)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 234579999999998765 58999999999999999999999998744
Q ss_pred CHHHHHHHHHcCCCCCCC--CCCCcHHHHHHHHHcccCCCCCCC-HHHHhcCCCcccCCCC
Q 006810 232 NPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDNPK 289 (630)
Q Consensus 232 ~~~~i~~~i~~g~~p~~l--~~~~s~~lk~~I~kcL~~p~~Rps-a~eLL~hpf~~~~~~~ 289 (630)
....+..+........+ ....++.+++||.+||.+|.+|++ +.++|.||||+...+.
T Consensus 235 -~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 235 -LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred -HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHH
Confidence 45555555542221122 223589999999999999999999 9999999999875543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=374.64 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=211.2
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||+||+|.+..+|+.||+|++...... .......+.+|+.+++.++||||++++++|.+. ..+|
T Consensus 2 ~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~ 77 (377)
T cd05629 2 DF-HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA--QYLY 77 (377)
T ss_pred Cc-eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CeeE
Confidence 45 7789999999999999999999999999998754322 234567788999999999999999999998754 4699
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+||||+++|+|. ++...+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+++.....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeecccccccccc
Confidence 999999999998 7777888999999999999999999999999 99999999999997 7899999999998532110
Q ss_pred -------------------------------------------------CCccccCCCCCCCcccccc-ccCcccceeeh
Q 006810 184 -------------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSF 213 (630)
Q Consensus 184 -------------------------------------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSL 213 (630)
.....+||+.|+|||++.+ .|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0013579999999998764 58999999999
Q ss_pred hHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHcccCCCC---CCCHHHHhcCCCcccCCC
Q 006810 214 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNP 288 (630)
Q Consensus 214 Gvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~--~~~s~~lk~~I~kcL~~p~~---Rpsa~eLL~hpf~~~~~~ 288 (630)
||++|||+||..||.. .+....+..+........++ ...++++++||.+||.+|.+ |+++.++|.||||...++
T Consensus 235 Gvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 235 GAIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred chhhhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9999999999999976 34555555555432222222 24678999999999986554 569999999999987554
Q ss_pred C
Q 006810 289 K 289 (630)
Q Consensus 289 ~ 289 (630)
.
T Consensus 314 ~ 314 (377)
T cd05629 314 D 314 (377)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=372.60 Aligned_cols=255 Identities=23% Similarity=0.438 Sum_probs=215.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH----------HHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP----------DQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~----------~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
++.+.||+|.||.|.+|++..+|..||+|++...++.... ...+++++||.+|++|+|||||+++++.-+
T Consensus 100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD 179 (576)
T KOG0585|consen 100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD 179 (576)
T ss_pred ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence 5567899999999999999999999999999765543211 124689999999999999999999998766
Q ss_pred CCCCEEEEEEcccCCCCHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 98 DTNRTINMITELFTSGSLRYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~~~~~~-lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
.....+|||+|||..|.+......+. +++.+++.++++++.||+|||.+| ||||||||.|+|++ .+|+|||+|||+
T Consensus 180 P~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~-~~g~VKIsDFGV 256 (576)
T KOG0585|consen 180 PESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLS-SDGTVKISDFGV 256 (576)
T ss_pred cccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEc-CCCcEEeeccce
Confidence 66678999999999999986666666 999999999999999999999999 99999999999998 789999999999
Q ss_pred ceeeccC-------CCccccCCCCCCCccccccc-----cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC
Q 006810 177 AIVMQQP-------TARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 244 (630)
Q Consensus 177 a~~~~~~-------~~~~~~GTp~Y~APEvl~~~-----ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~ 244 (630)
+...... .....+|||.|||||.+.++ .+.+.||||+||+||.|+.|+.||.+ .....++.+|....
T Consensus 257 s~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 257 SNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVNDP 335 (576)
T ss_pred eeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhcCc
Confidence 9766322 12346899999999987652 36789999999999999999999987 55667777777653
Q ss_pred CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 245 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 245 ~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
......+.....++++|.++|. +|..|.+..++-.|||....
T Consensus 336 L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 336 LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 3222223457899999999997 89999999999999999764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=363.85 Aligned_cols=252 Identities=29% Similarity=0.442 Sum_probs=210.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc---CCCCEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD---DTNRTIN 104 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d---~~~~~l~ 104 (630)
...+.||+|+||.|..|.++.+|+.||+|++. +.....-..++.++|+++|+.++|+||+.+++.+.. +.-.-+|
T Consensus 25 ~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 25 VLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred cccccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 43588999999999999999999999999986 223456677889999999999999999999999866 2234699
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-- 181 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~-- 181 (630)
+|+|+|+. +|. .++.+..++...+..++.|||.||.|+|+.+ |+||||||.|+|++ .+..+||+|||+|+...
T Consensus 103 iV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n-~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 103 LVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLN-ADCDLKICDFGLARYLDKF 178 (359)
T ss_pred EehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeec-cCCCEEeccccceeecccc
Confidence 99999954 555 6667777999999999999999999999999 99999999999998 78899999999999874
Q ss_pred --cCCCccccCCCCCCCccccc--cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc---------------
Q 006810 182 --QPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------------- 242 (630)
Q Consensus 182 --~~~~~~~~GTp~Y~APEvl~--~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~--------------- 242 (630)
....+..+-|.+|.|||++. ..|+.++||||.|||+.||++|++-|.+.....|+...+..
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 33345667899999999764 46999999999999999999999999886555554332211
Q ss_pred ---------CC-CCC---CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 243 ---------GI-KPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 243 ---------g~-~p~---~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.. ++. .+.+..++.+.+|+++||+ +|.+|+|++|+|.||||..
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 01 111 2234668999999999998 9999999999999999976
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=372.90 Aligned_cols=258 Identities=23% Similarity=0.363 Sum_probs=211.8
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| .+.++||+|+||+||+|.+..++..||+|++...... .......+.+|+.++++++||||++++++|.+. ..++
T Consensus 2 ~f-~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~ 77 (382)
T cd05625 2 MF-VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLY 77 (382)
T ss_pred Cc-EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEE
Confidence 45 6678999999999999999999999999999754322 234567788999999999999999999998754 4699
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc-
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 182 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~- 182 (630)
+||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCcccccc
Confidence 999999999998 6667778999999999999999999999999 99999999999998 789999999999743210
Q ss_pred ------------------------------------------------CCCccccCCCCCCCccccc-cccCcccceeeh
Q 006810 183 ------------------------------------------------PTARSVIGTPEFMAPELYE-EEYNELVDIYSF 213 (630)
Q Consensus 183 ------------------------------------------------~~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSL 213 (630)
......+||+.|+|||++. ..|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0012357999999999875 468999999999
Q ss_pred hHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCcHHHHHHHHHcccCCCCCCC---HHHHhcCCCcccCCC
Q 006810 214 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNP 288 (630)
Q Consensus 214 Gvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l--~~~~s~~lk~~I~kcL~~p~~Rps---a~eLL~hpf~~~~~~ 288 (630)
||++|||++|+.||... ++......+........+ ....+++++++|.+|+.+|.+|++ +.+++.||||+..++
T Consensus 235 Gvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 235 GVILYEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred hHHHHHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 99999999999999874 444444444332222222 234689999999998888999987 999999999987654
Q ss_pred Cc
Q 006810 289 KD 290 (630)
Q Consensus 289 ~~ 290 (630)
..
T Consensus 314 ~~ 315 (382)
T cd05625 314 SS 315 (382)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=357.61 Aligned_cols=260 Identities=22% Similarity=0.358 Sum_probs=213.0
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
|++.+.||+|+||.||+|.+..+|..||+|.+....... ......+.+|+.+++.++|+||++++++|.+. ..+++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEE
Confidence 367799999999999999999999999999987654322 23345578899999999999999999988654 468999
Q ss_pred EcccCCCCHH-HHh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 107 TELFTSGSLR-YRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
|||+++|+|. ++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCC
Confidence 9999999997 433 3346899999999999999999999999 99999999999997 7889999999999765432
Q ss_pred -CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 184 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 184 -~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~---~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...... ..+...+.. .+..++...++++.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~ 233 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAK 233 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHH
Confidence 2344579999999998864 5899999999999999999999999864332 222222222 22344556789999
Q ss_pred HHHHHccc-CCCCCCC-----HHHHhcCCCcccCCCCccccC
Q 006810 259 QFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCD 294 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rps-----a~eLL~hpf~~~~~~~~~~~~ 294 (630)
+||.+||. +|.+||+ +.++++||||...+++.+...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 275 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN 275 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence 99999997 8999997 899999999998877665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=371.78 Aligned_cols=260 Identities=23% Similarity=0.419 Sum_probs=215.3
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||+||+|.++.+|..||+|++...... .......+.+|+.++..++||||++++++|.+. ..+++||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv~ 80 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RNLYLIM 80 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEEE
Confidence 6779999999999999999999999999999754332 234567788999999999999999999998654 4699999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC---
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--- 183 (630)
||+++|+|. ++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCccccccccc
Confidence 999999998 6777888999999999999999999999999 99999999999997 7899999999998643211
Q ss_pred ----------------------------------CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCC
Q 006810 184 ----------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYN 228 (630)
Q Consensus 184 ----------------------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~ 228 (630)
.....+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0123579999999998764 58999999999999999999999998
Q ss_pred CCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHcccCCCCCC---CHHHHhcCCCcccCCCCccccC
Q 006810 229 ECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKDLVCD 294 (630)
Q Consensus 229 ~~~~~~~i~~~i~~g~~p~~l~--~~~s~~lk~~I~kcL~~p~~Rp---sa~eLL~hpf~~~~~~~~~~~~ 294 (630)
. .++...+..+........++ ...+++++++|.+|+.+|.+|+ ++.+++.||||...++..+...
T Consensus 238 ~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~ 307 (360)
T cd05627 238 S-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRER 307 (360)
T ss_pred C-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhcC
Confidence 6 45555666555432222222 2357899999999888888888 4799999999998877665433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=371.67 Aligned_cols=256 Identities=22% Similarity=0.350 Sum_probs=209.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||+||+|.+..+|..||+|++...... .......+.+|+.+++.++||||++++++|.+. ..+++||
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~lv~ 80 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFVM 80 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEEEEEE
Confidence 6678899999999999999999999999999765432 234567789999999999999999999998754 4699999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC---
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--- 183 (630)
||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCccccccccc
Confidence 999999998 7777888999999999999999999999999 99999999999998 7899999999987432100
Q ss_pred ----------------------------------------------CCccccCCCCCCCcccccc-ccCcccceeehhHH
Q 006810 184 ----------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMC 216 (630)
Q Consensus 184 ----------------------------------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvi 216 (630)
...+.+||+.|+|||++.+ .|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0124579999999998764 58999999999999
Q ss_pred HHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCcHHHHHHHHHccc---CCCCCCCHHHHhcCCCcccCCCCc
Q 006810 217 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV---PASLRLPALELLKDPFLVTDNPKD 290 (630)
Q Consensus 217 l~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l--~~~~s~~lk~~I~kcL~---~p~~Rpsa~eLL~hpf~~~~~~~~ 290 (630)
+|||+||+.||..... ......+........+ ....++++++||.+|+. ++..|+++.+++.||||....+..
T Consensus 238 l~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 238 LFEMLVGQPPFLAPTP-TETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS 315 (381)
T ss_pred HHHHHhCCCCCcCCCH-HHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhH
Confidence 9999999999987443 3333333322111112 22468999999999664 355699999999999998866544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=366.37 Aligned_cols=252 Identities=24% Similarity=0.455 Sum_probs=213.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
++||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+|+.++||||++++++|... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEeCC
Confidence 469999999999999999999999999975432 2344567788999999999999999999988654 4689999999
Q ss_pred CCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--CCCcc
Q 006810 111 TSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARS 187 (630)
Q Consensus 111 ~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~~ 187 (630)
++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCccccccc
Confidence 999998 6777788999999999999999999999999 99999999999998 789999999999865322 22345
Q ss_pred ccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc
Q 006810 188 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 266 (630)
Q Consensus 188 ~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~ 266 (630)
.+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+..+ ...++...++++++||.+||+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME--DIKFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccC--CccCCCCCCHHHHHHHHHHcC
Confidence 679999999998864 589999999999999999999999976 3455555555433 234556678999999999997
Q ss_pred -CCCCCC-----CHHHHhcCCCcccCCCCcc
Q 006810 267 -PASLRL-----PALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 267 -~p~~Rp-----sa~eLL~hpf~~~~~~~~~ 291 (630)
+|.+|+ ++.++++||||...++...
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~ 262 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQDV 262 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 899997 8999999999988766544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=370.36 Aligned_cols=261 Identities=28% Similarity=0.529 Sum_probs=221.6
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
+..-|..-| -+.+.||+|+||.||+|+++.+|..||||++..+ ..++.+.+|+.+|++++.|++|+||++|+.
T Consensus 27 L~K~PEEVF-Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK 99 (502)
T KOG0574|consen 27 LNKPPEEVF-DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFK 99 (502)
T ss_pred hcCChHHHH-HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhcc
Confidence 334444444 4567899999999999999999999999999754 356779999999999999999999999876
Q ss_pred CCCCEEEEEEcccCCCCHH--HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 98 DTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~--~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
.. -+|+|||||..|+.. .+.+++++++.++..+++..|.||+|||... -||||||+.|||++ ..|..||+|||
T Consensus 100 ~s--DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLN-T~G~AKLADFG 174 (502)
T KOG0574|consen 100 HS--DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLN-TDGIAKLADFG 174 (502)
T ss_pred CC--ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEc-ccchhhhhhcc
Confidence 54 489999999999997 5667899999999999999999999999987 89999999999998 89999999999
Q ss_pred cceeeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC--C
Q 006810 176 LAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--S 250 (630)
Q Consensus 176 la~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l--~ 250 (630)
+|..+... ...+++|||.|||||+++. +|+.++||||||++..||+.|++||.+-.....++..-+ .+|+.+ +
T Consensus 175 VAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT--~PPPTF~KP 252 (502)
T KOG0574|consen 175 VAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT--KPPPTFKKP 252 (502)
T ss_pred ccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC--CCCCCCCCh
Confidence 99877654 3567899999999999986 699999999999999999999999987433333332222 233333 3
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCCccc
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 292 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~~~~ 292 (630)
..++.++.+||++||. +|.+|.||.+|+.|||++.+....++
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~ 295 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIM 295 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHH
Confidence 4578899999999997 79999999999999999998776654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=365.71 Aligned_cols=253 Identities=23% Similarity=0.446 Sum_probs=213.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
++||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+++.++||||++++++|... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCC
Confidence 469999999999999999999999999975432 2334556788999999999999999999988654 4799999999
Q ss_pred CCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--CCCcc
Q 006810 111 TSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARS 187 (630)
Q Consensus 111 ~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~~ 187 (630)
++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCcccc
Confidence 999998 6677778999999999999999999999999 99999999999998 789999999999865322 22345
Q ss_pred ccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc
Q 006810 188 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 266 (630)
Q Consensus 188 ~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~ 266 (630)
..||+.|+|||++. +.++.++|||||||++|+|++|+.||.. .+.......+.... ..++...++.++++|.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 67999999999876 4589999999999999999999999976 44555555554332 23455678999999999997
Q ss_pred -CCCCCC-----CHHHHhcCCCcccCCCCccc
Q 006810 267 -PASLRL-----PALELLKDPFLVTDNPKDLV 292 (630)
Q Consensus 267 -~p~~Rp-----sa~eLL~hpf~~~~~~~~~~ 292 (630)
+|.+|+ ++.+++.||||....+....
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 263 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 263 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 899998 89999999999987665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=371.01 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=210.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||+||+|.+..+|..||+|++...... .......+.+|+.+|+.++||||+++++.|.+. ..+++||
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv~ 80 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFVM 80 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CEEEEEE
Confidence 7789999999999999999999999999998654322 123456688999999999999999999998654 4799999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc----
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---- 182 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~---- 182 (630)
||+++|+|. ++...+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCccccccccc
Confidence 999999998 7777788999999999999999999999999 99999999999998 789999999999742210
Q ss_pred -----------------------------------------CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHH
Q 006810 183 -----------------------------------------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEM 220 (630)
Q Consensus 183 -----------------------------------------~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~EL 220 (630)
......+||+.|||||++.+ .++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00123579999999998764 589999999999999999
Q ss_pred hhCCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCcHHHHHHHHHcccCCCCCC---CHHHHhcCCCcccCCCCc
Q 006810 221 VTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKD 290 (630)
Q Consensus 221 ltG~~Pf~~~~~~~~i~~~i~~g~~p~--~l~~~~s~~lk~~I~kcL~~p~~Rp---sa~eLL~hpf~~~~~~~~ 290 (630)
+||+.||.... +......+....... ......++.++++|.+|+.+|.+|+ ++.++++||||+......
T Consensus 238 l~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~ 311 (376)
T cd05598 238 LVGQPPFLADT-PAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFAS 311 (376)
T ss_pred hhCCCCCCCCC-HHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHH
Confidence 99999998743 444333443322211 1223468899999999888999999 999999999998765443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=364.34 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=211.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
++||+|+||+||+|.+..+|..||+|++....... ......+.+|.. +++.++||||++++++|.+. ..+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEEcC
Confidence 46999999999999999999999999997654322 223344555544 56889999999999988654 468999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--cCCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 186 (630)
+.+|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCccc
Confidence 9999998 7777788999999999999999999999999 99999999999998 78999999999986432 22234
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHcc
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL 265 (630)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+. ..+....++.+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKP--LRLKPNISVSARHLLEGLL 231 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHh
Confidence 5679999999998764 588999999999999999999999986 45666666666542 2344456899999999999
Q ss_pred c-CCCCCCCH----HHHhcCCCcccCCCCccccCCC
Q 006810 266 V-PASLRLPA----LELLKDPFLVTDNPKDLVCDPL 296 (630)
Q Consensus 266 ~-~p~~Rpsa----~eLL~hpf~~~~~~~~~~~~~l 296 (630)
+ +|.+||++ .+++.||||....+..+....+
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~ 267 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKI 267 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccC
Confidence 7 89999998 5999999998876655544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=361.98 Aligned_cols=249 Identities=29% Similarity=0.437 Sum_probs=211.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC---EEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR---TIN 104 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~---~l~ 104 (630)
+-.+++|+|+||+||+|....++++||||++-.+... -.+|+.+|+.++|||||++..+|...... ++.
T Consensus 27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~--------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 27 EAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY--------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc--------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 5569999999999999999999999999999655432 23799999999999999999888765443 778
Q ss_pred EEEcccCCCCHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 105 MITELFTSGSLRYRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 105 lV~Ey~~gGsL~~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
+||||++....++++ .+..++...++-+..||++||.|||+++ |+||||||.|+|+|..+|.+||||||.|+.+
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 899999997665444 4788999999999999999999999999 9999999999999988899999999999876
Q ss_pred ccC-CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-C-------------
Q 006810 181 QQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G------------- 243 (630)
Q Consensus 181 ~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g------------- 243 (630)
... ...+++.|..|+|||++.+ .|+.++||||.||++.||+-|++-|.+.....|+..++.- |
T Consensus 177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 543 3456778999999998764 6999999999999999999999999997777777666542 0
Q ss_pred --------CCCCC----CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 244 --------IKPAS----LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 244 --------~~p~~----l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..+.. +.+..++++.+|+.++|+ +|.+|.++.|+|.||||...
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 11111 345568999999999999 89999999999999999764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=355.31 Aligned_cols=251 Identities=20% Similarity=0.348 Sum_probs=204.9
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|| ++.+.||+|+||+||+|.++.+|..||+|++..... .....+.+.+|+.+++.++||||++++++|... ..++
T Consensus 2 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 76 (287)
T cd07848 2 KF-EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKLY 76 (287)
T ss_pred Cc-eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecC--CEEE
Confidence 56 778999999999999999999999999999875432 233456688999999999999999999988654 4789
Q ss_pred EEEcccCCCCHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLRY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~~-~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+||||++++++.. ......+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCccccccc
Confidence 9999999998884 444567999999999999999999999998 99999999999997 7899999999999765432
Q ss_pred ---CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CC--------------
Q 006810 184 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI-------------- 244 (630)
Q Consensus 184 ---~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~-------------- 244 (630)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............... +.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 2234578999999998764 5899999999999999999999999875443333221110 00
Q ss_pred -----CCC---------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 245 -----KPA---------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 245 -----~p~---------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.+. .+....++++++||.+||. +|.+|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0112357789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=362.00 Aligned_cols=256 Identities=26% Similarity=0.446 Sum_probs=211.6
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
..+| ++.+.||+|+||.||+|.+..+|..||+|.+.... ......++.+|+++|++++||||+++++++.+. ..
T Consensus 4 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 77 (331)
T cd06649 4 DDDF-ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GE 77 (331)
T ss_pred cccc-eEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CE
Confidence 3566 66788999999999999999999999999987542 244567799999999999999999999998765 46
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+++||||+++|+|. ++...+.+++..+..++.||+.||.|||+.+ +|+||||||+|||++ .+|.+||+|||++....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEc-CCCcEEEccCccccccc
Confidence 89999999999998 7777788999999999999999999999853 399999999999998 78999999999997665
Q ss_pred cCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHH-------------------
Q 006810 182 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT------------------- 241 (630)
Q Consensus 182 ~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~------------------- 241 (630)
........||+.|+|||++.+ .++.++|||||||++|+|+||+.||... +...+...+.
T Consensus 156 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCcccc
Confidence 555556679999999998764 5899999999999999999999999753 2222222211
Q ss_pred ---------------------------cCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 242 ---------------------------SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 242 ---------------------------~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
....+.......++++++||.+||+ +|.+||++.++|+||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 1111111122457899999999998 899999999999999998644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=358.71 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=203.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 5 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 78 (303)
T cd07869 5 DSY-EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTK--ETL 78 (303)
T ss_pred ccc-eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecC--CeE
Confidence 456 677999999999999999999999999999875432 12234567899999999999999999998654 468
Q ss_pred EEEEcccCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLRYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+.++.+.++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKSV 155 (303)
T ss_pred EEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceeccC
Confidence 99999998665555444 467899999999999999999999999 99999999999998 789999999999865432
Q ss_pred C--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc--CC------------
Q 006810 183 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GI------------ 244 (630)
Q Consensus 183 ~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~--g~------------ 244 (630)
. ......||+.|+|||++.+ .++.++|||||||++|+|+||..||.+..+.......+.. +.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 2 2334578999999998754 4788999999999999999999999875554333332211 00
Q ss_pred ---CCCCCC-------------CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 245 ---KPASLS-------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 245 ---~p~~l~-------------~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
.+..+. ...++.+++||.+||+ +|.+|||+.++|.||||+...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 000000 0134678999999998 8999999999999999987543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=363.34 Aligned_cols=252 Identities=23% Similarity=0.421 Sum_probs=212.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
++||+|+||+||+|.++.+|..||+|++...... .....+.+..|..++..+ +||||++++++|.+. ..+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcC
Confidence 4699999999999999999999999999754322 234456677888888876 799999999988654 468999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--cCCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 186 (630)
+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCccc
Confidence 9999998 6777888999999999999999999999999 99999999999998 78999999999986532 22334
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHcc
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL 265 (630)
...||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+.. .++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L 231 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence 5679999999998864 588999999999999999999999986 456666666665432 344567899999999999
Q ss_pred c-CCCCCCCH------HHHhcCCCcccCCCCcc
Q 006810 266 V-PASLRLPA------LELLKDPFLVTDNPKDL 291 (630)
Q Consensus 266 ~-~p~~Rpsa------~eLL~hpf~~~~~~~~~ 291 (630)
. +|.+|+++ .++++||||....+..+
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~ 264 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 7 89999998 89999999987665443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=362.45 Aligned_cols=255 Identities=28% Similarity=0.436 Sum_probs=203.6
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC---C
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---R 101 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~---~ 101 (630)
|| ++.+.||+|+||.||+|.+..+|..||+|.+.... .......++.+|+.+++.++||||+++++++..... .
T Consensus 1 ry-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred Ce-EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 56 78899999999999999999999999999986432 122344568899999999999999999998865432 3
Q ss_pred EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 102 TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
.+|+||||+.+ +|. .+.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 78 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 78 DIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVA 153 (338)
T ss_pred eEEEEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCcccccc
Confidence 58999999965 565 7777788999999999999999999999999 99999999999998 7899999999999754
Q ss_pred ccCC-----CccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHH--------------H
Q 006810 181 QQPT-----ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY--------------K 238 (630)
Q Consensus 181 ~~~~-----~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~--------------~ 238 (630)
.... .....||+.|+|||++.+ .++.++|||||||++|+|+||++||.+.....++. .
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3211 134579999999998753 58899999999999999999999997643222111 0
Q ss_pred HHHc-----------CCCCCC---CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 239 KVTS-----------GIKPAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 239 ~i~~-----------g~~p~~---l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.+.. ...+.. .....++.+.++|.+||. +|.+||++.++|.||||+..
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 0000 001111 112356889999999997 89999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=368.06 Aligned_cols=258 Identities=21% Similarity=0.370 Sum_probs=213.2
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||.||+|.+..+|..||+|++...... .......+.+|+.+++.++||||++++++|.+. ..+
T Consensus 43 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~--~~~ 118 (370)
T cd05596 43 EDF-DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD--KYL 118 (370)
T ss_pred HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CEE
Confidence 455 6779999999999999999999999999999754322 123345577899999999999999999988654 479
Q ss_pred EEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 104 NMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 104 ~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
++||||+++|+|..+.....+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceeeccCC
Confidence 99999999999985445567999999999999999999999999 99999999999998 7899999999999765432
Q ss_pred ---CCccccCCCCCCCcccccc-----ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CC
Q 006810 184 ---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VT 253 (630)
Q Consensus 184 ---~~~~~~GTp~Y~APEvl~~-----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~--~~ 253 (630)
.....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.. .+....+..+........++. ..
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 2235679999999998753 378899999999999999999999987 455556666655433333333 46
Q ss_pred cHHHHHHHHHccc-CCCC--CCCHHHHhcCCCcccCCCC
Q 006810 254 DPQVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPK 289 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~--Rpsa~eLL~hpf~~~~~~~ 289 (630)
+.++++||.+||. +|.+ |+++.+++.||||+...+.
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 8999999999998 5665 9999999999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=367.17 Aligned_cols=258 Identities=21% Similarity=0.376 Sum_probs=211.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||.||+|.+..+|..||+|++...... .......+.+|+.+++.++||||++++++|.+. ..
T Consensus 42 ~~~y-~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~ 117 (370)
T cd05621 42 AEDY-DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD--KY 117 (370)
T ss_pred HHHC-eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CE
Confidence 3566 7789999999999999999999999999999754322 223345678899999999999999999998654 57
Q ss_pred EEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 103 INMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 103 l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+|+||||+++|+|........+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceeccc
Confidence 999999999999984445557999999999999999999999999 99999999999998 789999999999976543
Q ss_pred CC---CccccCCCCCCCcccccc-----ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC--C
Q 006810 183 PT---ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--V 252 (630)
Q Consensus 183 ~~---~~~~~GTp~Y~APEvl~~-----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~--~ 252 (630)
.. ....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||... +....+..+........++. .
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD-SLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCcccCCCCccc
Confidence 22 245679999999998753 2788999999999999999999999874 44555555554332222222 4
Q ss_pred CcHHHHHHHHHcccCC---CCCCCHHHHhcCCCcccCCC
Q 006810 253 TDPQVKQFIEKCIVPA---SLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 253 ~s~~lk~~I~kcL~~p---~~Rpsa~eLL~hpf~~~~~~ 288 (630)
.++.++++|.+||.++ ..|+++.++++||||+...+
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 5889999999999743 34889999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=361.03 Aligned_cols=256 Identities=25% Similarity=0.431 Sum_probs=211.5
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHH---HhCCCCCeeEEEeEEEcCCCCEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL---KSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL---~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
|++.+.||+|+||.||+|.+..+|..||+|+++..... .....+.+.+|++++ +.++||||++++++|... ..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEE
Confidence 37789999999999999999999999999999755422 233455677776655 567899999999988654 468
Q ss_pred EEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc-
Q 006810 104 NMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~- 182 (630)
|+||||+++|+|......+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 ~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCCC
Confidence 99999999999985555678999999999999999999999999 99999999999998 789999999999864322
Q ss_pred -CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006810 183 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260 (630)
Q Consensus 183 -~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~ 260 (630)
......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+..+.. .++...++.+.+|
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 231 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAISI 231 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHH
Confidence 22345679999999998764 588999999999999999999999986 455555555554422 2445678999999
Q ss_pred HHHccc-CCCCCC-----CHHHHhcCCCcccCCCCcc
Q 006810 261 IEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 261 I~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~ 291 (630)
|.+||. +|.+|| ++.++++||||....+...
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~ 268 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHH
Confidence 999997 899999 6999999999987665543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=363.51 Aligned_cols=251 Identities=24% Similarity=0.444 Sum_probs=211.6
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
++||+|+||.||+|.+..+|..||+|++..... ........+.+|+++++.++||||++++++|... ..+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 469999999999999999999999999975432 2334556778899999999999999999988654 4799999999
Q ss_pred CCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--CCCc
Q 006810 111 TSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR 186 (630)
Q Consensus 111 ~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~ 186 (630)
++|+|. ++...+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccc
Confidence 999998 66677789999999999999999999997 67 99999999999998 789999999999865322 2234
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHcc
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL 265 (630)
...||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...+...+... ...++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME--EIRFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHh
Confidence 5679999999998864 589999999999999999999999976 4455555555443 23345567899999999999
Q ss_pred c-CCCCCC-----CHHHHhcCCCcccCCCCc
Q 006810 266 V-PASLRL-----PALELLKDPFLVTDNPKD 290 (630)
Q Consensus 266 ~-~p~~Rp-----sa~eLL~hpf~~~~~~~~ 290 (630)
+ +|.+|+ ++.++|+||||....+..
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~ 262 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVWQD 262 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 7 899997 899999999998765544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=374.75 Aligned_cols=254 Identities=30% Similarity=0.552 Sum_probs=222.2
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| -+.+++|+|+||.+++++++..+..|+||+|..... +....+...+|+.++++++|||||.|+++|++++ ..+
T Consensus 4 ~~Y-e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~--t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l 79 (426)
T KOG0589|consen 4 DNY-EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL--TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLL 79 (426)
T ss_pred chh-hhhhhcCccccchhhhhhhccCCceEEEEEEecccc--CchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceE
Confidence 355 456899999999999999999999999999998764 3445557889999999999999999999998654 459
Q ss_pred EEEEcccCCCCHH-HHh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 104 NMITELFTSGSLR-YRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
++||+||+||+|. .++ +...++++.+..|+.||+.|+.|||+.. |+||||||.|||++ .++.|||+|||+|+.+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLT-KDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcc-ccCceeecchhhhhhc
Confidence 9999999999998 332 3356899999999999999999999888 99999999999998 7788899999999988
Q ss_pred ccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 181 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 181 ~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
+.. .+.+++|||.||.||++.+ +|+.++||||||||+|||++-+++|.. .+...+..++..+. -.+++..++.++
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~-~~Plp~~ys~el 234 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGL-YSPLPSMYSSEL 234 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhcc-CCCCCccccHHH
Confidence 776 5678899999999999986 599999999999999999999999988 56666666666655 344667788999
Q ss_pred HHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 258 KQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+.+|+.||. +|..||+|.+||.+|.++..
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 999999997 79999999999999988754
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=379.14 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=206.2
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC-
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD- 98 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~- 98 (630)
..+.++| ++.++||+|+||+||+|.+..+|..||+|++.... ....+|+.+|+.++|||||+++++|...
T Consensus 62 ~~~~~~y-~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~ 132 (440)
T PTZ00036 62 RSPNKSY-KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTEC 132 (440)
T ss_pred cCcCCeE-EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecc
Confidence 3456677 88899999999999999999999999999885321 1234799999999999999999987542
Q ss_pred -----CCCEEEEEEcccCCCCHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcE
Q 006810 99 -----TNRTINMITELFTSGSLRYR----KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 169 (630)
Q Consensus 99 -----~~~~l~lV~Ey~~gGsL~~~----~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 169 (630)
....+++||||++++...++ .....+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+
T Consensus 133 ~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 133 FKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred cccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCce
Confidence 22367899999997654433 34577999999999999999999999999 99999999999998555689
Q ss_pred EEcccccceeeccC-CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC
Q 006810 170 KIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 246 (630)
Q Consensus 170 KL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p 246 (630)
||+|||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|||+||.+||.+.....++...+.....|
T Consensus 211 kL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred eeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99999999765432 3345678999999998754 58999999999999999999999998866555555443311000
Q ss_pred --------------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 --------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 --------------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..++...++++++||.+||+ +|.+|||+.|+|.||||...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 01223356899999999998 89999999999999999764
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=384.06 Aligned_cols=261 Identities=28% Similarity=0.465 Sum_probs=220.1
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
-+|..-|..+ ..||-|+||.||+|..+.++...|.|.|... +...++.+.-||.||..|+||+||++++.|+-+.
T Consensus 28 lnP~d~WeIi-GELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 28 LNPRDHWEII-GELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred CCHHHHHHHH-hhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 4566667444 4489999999999999999999999998743 4678899999999999999999999999776554
Q ss_pred CCEEEEEEcccCCCCHH--HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 100 NRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~--~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
.+||+.|||.||-.+ .+.-...+++.++..+|+|++.||.|||+++ |||||||+.|||++ -+|.|+|+|||++
T Consensus 103 --kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADFGVS 177 (1187)
T KOG0579|consen 103 --KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADFGVS 177 (1187)
T ss_pred --ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeeccccc
Confidence 488899999999998 4556788999999999999999999999999 99999999999998 8999999999998
Q ss_pred eeecc--CCCccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006810 178 IVMQQ--PTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249 (630)
Q Consensus 178 ~~~~~--~~~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l 249 (630)
..... ....+++|||+|||||++. .+|+.++||||||++|+||+.+++|.++......+.+.-....+...-
T Consensus 178 AKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 178 AKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ 257 (1187)
T ss_pred ccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC
Confidence 64432 2456899999999999763 369999999999999999999999998854444444444444333344
Q ss_pred CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCCc
Q 006810 250 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 290 (630)
Q Consensus 250 ~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~~ 290 (630)
+..++..+++|+.+||+ +|..||++.+||+||||+....++
T Consensus 258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcch
Confidence 66788999999999998 799999999999999999765544
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=359.94 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=211.7
Q ss_pred eEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 31 EILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~---~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
+.||+|+||.||+|.+. .+|..||+|.+..............+.+|+.+|+.++||||++++++|... ..+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence 57999999999999864 578999999997654333334456678999999999999999999998654 4689999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--CC
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PT 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~ 184 (630)
||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCc
Confidence 999999998 7777888999999999999999999999999 99999999999998 789999999999864322 22
Q ss_pred CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006810 185 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263 (630)
Q Consensus 185 ~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~k 263 (630)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||.. .+.......+..+. ..++...++.+++||.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGK--LNLPPYLTPEARDLLKK 233 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence 344679999999998764 578999999999999999999999987 44445555555443 23455678999999999
Q ss_pred ccc-CCCCCC-----CHHHHhcCCCcccCCCCcc
Q 006810 264 CIV-PASLRL-----PALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 264 cL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~ 291 (630)
||+ +|.+|| ++.+++.||||....+..+
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~ 267 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL 267 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 997 899999 8999999999987665444
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.13 Aligned_cols=252 Identities=22% Similarity=0.368 Sum_probs=212.4
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
++||+|+||.||+|.+..+|..||+|++...... ..+..+.+..|..++..+ +||||++++++|... ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeC
Confidence 4699999999999999999999999999754322 234556677899999866 899999999998654 468999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--CCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~ 186 (630)
+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccCCcccc
Confidence 9999998 7777888999999999999999999999999 99999999999998 789999999999865322 2234
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHcc
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL 265 (630)
...||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+....+..+..+.. .++...+++++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 5679999999998765 589999999999999999999999987 456666666665432 234456899999999999
Q ss_pred c-CCCCCC-------CHHHHhcCCCcccCCCCcc
Q 006810 266 V-PASLRL-------PALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 266 ~-~p~~Rp-------sa~eLL~hpf~~~~~~~~~ 291 (630)
. +|.+|+ ++.+++.||||...++..+
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~ 265 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL 265 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHH
Confidence 8 899999 8999999999987665543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.46 Aligned_cols=256 Identities=19% Similarity=0.331 Sum_probs=213.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.+.||+|+||+||+|.+..+|..||+|+++.... ........+.+|+.+++.++||||+++++++.+. ..+++||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~lv~ 80 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYLVM 80 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEEEEE
Confidence 778999999999999999999999999999985432 2234556788999999999999999999988654 4689999
Q ss_pred cccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC-
Q 006810 108 ELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 184 (630)
||+++|+|. ++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCCCCc
Confidence 999999998 55554 68999999999999999999999999 99999999999998 78999999999997654332
Q ss_pred --CccccCCCCCCCccccc-------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCC
Q 006810 185 --ARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVT 253 (630)
Q Consensus 185 --~~~~~GTp~Y~APEvl~-------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~--~~~ 253 (630)
.....||+.|+|||++. ..++.++|||||||++|+|++|+.||... +....+..+........++ ...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCCccCCCCCCCC
Confidence 23347899999999875 34788999999999999999999999874 4444555554433222222 246
Q ss_pred cHHHHHHHHHcccCCCCCCCHHHHhcCCCcccCCCCc
Q 006810 254 DPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD 290 (630)
Q Consensus 254 s~~lk~~I~kcL~~p~~Rpsa~eLL~hpf~~~~~~~~ 290 (630)
++.+++||.+||.+|.+||++.+++.||||...++..
T Consensus 237 ~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 237 SSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred CHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHHH
Confidence 7899999999999999999999999999998765544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=379.27 Aligned_cols=269 Identities=28% Similarity=0.487 Sum_probs=229.7
Q ss_pred cCCccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEe
Q 006810 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 93 (630)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~ 93 (630)
..-|...||..+|.-+ +.||.|+||.||.|.|..+.+.||||++..... ++....+.+.+|++.|++|+|||+|.|.+
T Consensus 16 A~LF~k~DPEklf~dL-rEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkg 93 (948)
T KOG0577|consen 16 ADLFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKG 93 (948)
T ss_pred HHHHccCCHHHHHHHH-HHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccc
Confidence 3557889999999665 559999999999999999999999999988764 44556688999999999999999999999
Q ss_pred EEEcCCCCEEEEEEcccCCCCHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEc
Q 006810 94 SWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172 (630)
Q Consensus 94 ~f~d~~~~~l~lV~Ey~~gGsL~~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 172 (630)
+|..+. +.|+|||||-|.--+.+ .-.+++.+-.|..|+.+.|.||+|||+++ .||||||+.|||++ +.|.|||+
T Consensus 94 CyLre~--TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKLa 168 (948)
T KOG0577|consen 94 CYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKLA 168 (948)
T ss_pred eeeccc--hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeeec
Confidence 998654 57899999988655533 34567999999999999999999999999 99999999999998 89999999
Q ss_pred ccccceeeccCCCccccCCCCCCCcccc----ccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006810 173 DLGLAIVMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 248 (630)
Q Consensus 173 DFGla~~~~~~~~~~~~GTp~Y~APEvl----~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~ 248 (630)
|||.|..... +.+++|||.|||||++ .|.|+-++|||||||+.+||+..++|+..+.....+|.+-... .|.-
T Consensus 169 DFGSAsi~~P--AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-sPtL 245 (948)
T KOG0577|consen 169 DFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTL 245 (948)
T ss_pred cccchhhcCc--hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-CCCC
Confidence 9999876543 5789999999999976 3679999999999999999999999998866666666655443 3333
Q ss_pred CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCCccc
Q 006810 249 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 292 (630)
Q Consensus 249 l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~~~~ 292 (630)
....++..++.||..||+ .|.+|||+.+||+|+|.....+..++
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi 290 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVI 290 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHH
Confidence 345578999999999998 58999999999999999887665544
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=366.71 Aligned_cols=254 Identities=27% Similarity=0.452 Sum_probs=218.5
Q ss_pred ceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEEE
Q 006810 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l~ 104 (630)
+|.+.+.||+|.||+||+|.++.+|..+|+|.+....... ....+.+.+|+.+|+++. |||||.++++|.+.. .++
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--~~~ 112 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--SVY 112 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--eEE
Confidence 3488899999999999999999999999999998766543 335577999999999998 999999999997654 799
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC---CCcEEEcccccceee
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVM 180 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~---~g~vKL~DFGla~~~ 180 (630)
+|||++.||.|. .+... .+++..+..+++||+.++.|||+.| |+||||||+|+|+... ++.+|++|||++...
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 999999999997 44333 5999999999999999999999999 9999999999999743 358999999999877
Q ss_pred cc-CCCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHH
Q 006810 181 QQ-PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQ 256 (630)
Q Consensus 181 ~~-~~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~ 256 (630)
.. ......+|||.|+|||++. ..|+..+||||+|+++|.|++|..||.+. +.......+..+.. +.......+..
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~-~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE-TEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC-ChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 65 3456789999999999988 68999999999999999999999999884 44455556666533 33444556899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+++||.+||. +|.+|+||.++|.|||++..
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999997 89999999999999999875
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.81 Aligned_cols=256 Identities=21% Similarity=0.369 Sum_probs=211.1
Q ss_pred eeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEE
Q 006810 28 RYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~---~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l 103 (630)
++.+.||+|+||+||+|.+. .+|..||+|++............+.+.+|+.+++.+ +||||++++++|... ..+
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~~ 80 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--AKL 80 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--CEE
Confidence 77899999999999998764 578999999997544333344556788999999999 599999999988644 468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+.+|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEEC-CCCCEEEeeCcCCccccc
Confidence 9999999999997 7777888999999999999999999999999 99999999999998 789999999999975432
Q ss_pred C---CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCC---CCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 183 P---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC---KNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 183 ~---~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~---~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
. .....+||+.|+|||++.+ .++.++|||||||++|+|+||..||... .....+...+... ...++...+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--DPPFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC--CCCCCCCCC
Confidence 2 2234679999999998864 3788999999999999999999999642 2333444444432 223455678
Q ss_pred HHHHHHHHHccc-CCCCCC-----CHHHHhcCCCcccCCCCc
Q 006810 255 PQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKD 290 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~ 290 (630)
+.+++||.+||. +|.+|| ++.++++||||+...+..
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 277 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEA 277 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999999999997 899999 888999999998765443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=357.90 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=214.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC-CeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp-NIVk~~~~f~d~~~~~l~lV 106 (630)
++.+.||+|+||.||+|.+..++..||+|++...... .....+.+..|+.++..++|+ +|++++++|.+. ..+|+|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv 79 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYFV 79 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEEE
Confidence 7789999999999999999999999999999754332 234556788899999999775 578888887654 469999
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--cC
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QP 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~ 183 (630)
|||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... ..
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCCCC
Confidence 9999999998 6777788999999999999999999999999 99999999999998 78999999999986432 22
Q ss_pred CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
.....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...++..+.... ..++...++.++++|.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~ 233 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSICK 233 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHH
Confidence 3345679999999998765 589999999999999999999999986 45666666666543 2345667899999999
Q ss_pred Hccc-CCCCCCCH-----HHHhcCCCcccCCCCcc
Q 006810 263 KCIV-PASLRLPA-----LELLKDPFLVTDNPKDL 291 (630)
Q Consensus 263 kcL~-~p~~Rpsa-----~eLL~hpf~~~~~~~~~ 291 (630)
+||. +|.+|+++ .+++.||||...++..+
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~ 268 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKL 268 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 9997 89999976 89999999998766544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=359.57 Aligned_cols=251 Identities=18% Similarity=0.374 Sum_probs=208.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
++||+|+||.||+|.+..+|..||+|+++.... ........+.+|..+++.+ +||||++++++|.+. ..+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeC
Confidence 469999999999999999999999999976432 2334556788999999998 799999999998654 468999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--cCCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 186 (630)
+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccCCCccc
Confidence 9999998 6677789999999999999999999999999 99999999999998 78999999999986422 22334
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~--------~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
..+||+.|+|||++.+ .++.++|||||||++|+|+||+.||... .....+.+.+... ...++...++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCCCCCCHHH
Confidence 5689999999998865 5889999999999999999999999631 1122344444443 223455678999
Q ss_pred HHHHHHccc-CCCCCCC------HHHHhcCCCcccCCCC
Q 006810 258 KQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPK 289 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rps------a~eLL~hpf~~~~~~~ 289 (630)
+++|.+||+ +|.+|++ +.++++||||....+.
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 999999997 8999987 7899999999775543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.77 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=200.2
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 5 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 78 (288)
T cd07871 5 ETY-VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCL 78 (288)
T ss_pred ccc-eEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeE
Confidence 346 667899999999999999999999999999975432 12234577899999999999999999988654 478
Q ss_pred EEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||+.+ +|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKS 154 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeecc
Confidence 999999986 665 5544 345799999999999999999999999 99999999999998 78999999999987543
Q ss_pred cC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCC-----------
Q 006810 182 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK----------- 245 (630)
Q Consensus 182 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~----------- 245 (630)
.. ......|++.|+|||++.+ .++.++|||||||++|+|+||++||......+.+...... +.+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 32 2234568999999998754 4899999999999999999999999874433333222211 000
Q ss_pred --------CC-------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 246 --------PA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 246 --------p~-------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
+. ......++++++||.+||+ +|.+|||+.|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 0012357889999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=350.68 Aligned_cols=258 Identities=23% Similarity=0.310 Sum_probs=213.5
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+..-|.++ ..|++|+||.||+|+|+.|++.||+|.++.+.-. ...--...+||.+|.+++|||||.+-.+.+.....
T Consensus 74 sv~efe~l-nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek--~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 74 SVEEFEKL-NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK--EGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred cHHHHHHH-hhcccCcceeEEEeccCCcceeEEeeeccccccc--CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 33445443 5699999999999999999999999999876521 12223467999999999999999999999888878
Q ss_pred EEEEEEcccCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 102 TINMITELFTSGSLRYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
.+|||||||+...-..+. ...++.+.+++.++.|+|.||+|||.+. |+|||||++|+|++ +.|.+||+|||+|+.+
T Consensus 151 ~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREY 227 (419)
T ss_pred eeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhh
Confidence 899999999985333333 3468999999999999999999999998 99999999999998 8999999999999988
Q ss_pred ccCC--CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC----------
Q 006810 181 QQPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---------- 246 (630)
Q Consensus 181 ~~~~--~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p---------- 246 (630)
..+. .+..+-|.+|+|||++-+ .|++++|+||+|||+.||+++++.|.+....+|+.+++..--.|
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 7663 344567999999997764 59999999999999999999999999988888887776531000
Q ss_pred ----------C--------CCCCC-CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 247 ----------A--------SLSKV-TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 247 ----------~--------~l~~~-~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
. .+... .+....+|+..+|. +|.+|.||.|.|+|.||..
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 0 01111 34678899999998 9999999999999999986
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=362.11 Aligned_cols=257 Identities=20% Similarity=0.370 Sum_probs=213.2
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||.||+|.+..++..||+|++...... .......+.+|+.+++.++||||+++++.|.+. ..+
T Consensus 43 ~~y-~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~ 118 (371)
T cd05622 43 EDY-EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RYL 118 (371)
T ss_pred hhc-EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEE
Confidence 566 7789999999999999999999999999999754322 223445678899999999999999999998654 579
Q ss_pred EEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 104 NMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 104 ~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
++||||+++|+|..+.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCcC
Confidence 99999999999984445567999999999999999999999999 99999999999998 7899999999999765432
Q ss_pred ---CCccccCCCCCCCcccccc-----ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCC
Q 006810 184 ---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVT 253 (630)
Q Consensus 184 ---~~~~~~GTp~Y~APEvl~~-----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~--~~~ 253 (630)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+........++ ...
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDI 274 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcCCC
Confidence 2235679999999998753 278899999999999999999999986 55666667666543322222 356
Q ss_pred cHHHHHHHHHcccCCC---CCCCHHHHhcCCCcccCCC
Q 006810 254 DPQVKQFIEKCIVPAS---LRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 254 s~~lk~~I~kcL~~p~---~Rpsa~eLL~hpf~~~~~~ 288 (630)
++.++++|.+||.+|. .|+++.++++||||+...+
T Consensus 275 s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 275 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred CHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 8999999999998543 3789999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=376.85 Aligned_cols=251 Identities=33% Similarity=0.559 Sum_probs=220.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
-+||+|.||+||.|+|..|...+|||.|..++ ....+-+..||.+.++|+|.|||+|.+++ ..+.++-+.||-+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD----SREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc----chhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecC
Confidence 47999999999999999999999999997443 45567789999999999999999999986 3445788899999
Q ss_pred CCCCHH--HHhhcCCC--CHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--CC
Q 006810 111 TSGSLR--YRKKHKNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PT 184 (630)
Q Consensus 111 ~gGsL~--~~~~~~~l--se~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~ 184 (630)
+||+|. .+.+.+++ ++.++..+.+||+.||.|||.+. |||||||-+||||+.-.|.+||.|||.++.+.. +.
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 999998 56678888 89999999999999999999999 999999999999998899999999999976643 45
Q ss_pred CccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 185 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 185 ~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
..++.||..|||||++.. +|+.++|||||||++.||+||++||.+..++...+-++---..-+.++...+.+++.||
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 678899999999999863 59999999999999999999999999887776665555444445567777889999999
Q ss_pred HHccc-CCCCCCCHHHHhcCCCcccCCCC
Q 006810 262 EKCIV-PASLRLPALELLKDPFLVTDNPK 289 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~ 289 (630)
.+|+. +|.+||+|.+||.+||++..+.+
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccCCCC
Confidence 99998 79999999999999999986433
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=355.55 Aligned_cols=259 Identities=22% Similarity=0.342 Sum_probs=215.8
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~l 105 (630)
+++.+.||+|+||.||+|.+..++..||+|++...... .....+.+..|..++..+ +||+|+++++++.+. ..+++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF 78 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence 36789999999999999999999999999999754322 233445677788888877 588999999988654 47999
Q ss_pred EEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--c
Q 006810 106 ITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--Q 182 (630)
Q Consensus 106 V~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~ 182 (630)
||||+++|+|. ++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCCC
Confidence 99999999998 6777788999999999999999999999999 99999999999998 78999999999987543 2
Q ss_pred CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 183 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 183 ~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
......+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...++..+.... ..++...+++++++|
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~li 232 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN--VAYPKSMSKEAVAIC 232 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCcCCHHHHHHH
Confidence 23345679999999998764 589999999999999999999999987 45566666666543 234556789999999
Q ss_pred HHccc-CCCCCCC-----HHHHhcCCCcccCCCCccccC
Q 006810 262 EKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCD 294 (630)
Q Consensus 262 ~kcL~-~p~~Rps-----a~eLL~hpf~~~~~~~~~~~~ 294 (630)
.+||+ +|.+|++ ..+++.||||+..++......
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~ 271 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK 271 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence 99997 8999998 489999999998776554433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=349.06 Aligned_cols=251 Identities=26% Similarity=0.428 Sum_probs=205.5
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCC
Q 006810 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (630)
Q Consensus 33 LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~g 112 (630)
||+|+||+||+|.+..+|..||+|.+...... .....+.+..|+.+++.++||||++++++|... ..+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCCCC
Confidence 79999999999999999999999998754432 223446678899999999999999999988544 468999999999
Q ss_pred CCHH-HHh----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--CC
Q 006810 113 GSLR-YRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 185 (630)
Q Consensus 113 GsL~-~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~~ 185 (630)
|+|. ++. ....+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++...... ..
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccc
Confidence 9997 332 3457999999999999999999999999 99999999999997 7899999999999765432 23
Q ss_pred ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 186 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 186 ~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~---~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+...+.. .+..++...++.+++++
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN--DSVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc--cCCCCcccCCHHHHHHH
Confidence 34579999999998764 5889999999999999999999999763322 222222222 23344556789999999
Q ss_pred HHccc-CCCCCC-----CHHHHhcCCCcccCCCCcc
Q 006810 262 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 262 ~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~ 291 (630)
.+||. +|.+|| ++.++++||||+..++..+
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 268 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL 268 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence 99997 899999 8899999999988665554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=357.96 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=208.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHH-HHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV-HLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei-~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
+.||+|+||+||+|.+..++..||+|++........ .....+.+|. .+++.++||||++++++|... ..+++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeC
Confidence 469999999999999999999999999975433222 2223344444 457889999999999988654 468999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--cCCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 186 (630)
+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcc
Confidence 9999998 6777788999999999999999999999999 99999999999998 78999999999986532 22334
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHcc
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL 265 (630)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+... +..+....++.++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNK--PLQLKPNITNSARHLLEGLL 231 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHc
Confidence 5679999999998765 588999999999999999999999986 4555565655543 23344567899999999999
Q ss_pred c-CCCCCCCHH----HHhcCCCcccCCCCccc
Q 006810 266 V-PASLRLPAL----ELLKDPFLVTDNPKDLV 292 (630)
Q Consensus 266 ~-~p~~Rpsa~----eLL~hpf~~~~~~~~~~ 292 (630)
+ +|.+|+++. ++++|+||...++..+.
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~ 263 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSPINWDDLI 263 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCCCCHHHHH
Confidence 8 899999876 89999999887765544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.40 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=208.9
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHH-HHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV-HLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei-~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
++||+|+||.||+|.+..+|..||+|++....... ......+.+|. .+++.++||||++++++|.+. ..+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEEcC
Confidence 46999999999999999999999999997544322 22334455555 468899999999999988654 478999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--CCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~ 186 (630)
+++|+|. .+...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccc
Confidence 9999997 6667788999999999999999999999998 99999999999998 789999999999865322 2234
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHcc
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL 265 (630)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+... +..++...+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHc
Confidence 5679999999998764 588999999999999999999999987 4566666666654 33455567889999999999
Q ss_pred c-CCCCCCCH----HHHhcCCCcccCCCCccc
Q 006810 266 V-PASLRLPA----LELLKDPFLVTDNPKDLV 292 (630)
Q Consensus 266 ~-~p~~Rpsa----~eLL~hpf~~~~~~~~~~ 292 (630)
+ +|.+|+++ .++++||||...++..+.
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSPINWDDLY 263 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHh
Confidence 8 89999876 499999999877655443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=355.35 Aligned_cols=251 Identities=24% Similarity=0.432 Sum_probs=208.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh-CCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
++||+|+||.||+|.+..+|..||+|.++..... .....+.+..|..++.. ++||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence 4699999999999999999999999999754322 22344556667777765 4899999999988654 479999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--CCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~ 186 (630)
+++|+|. ++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCccc
Confidence 9999998 6667788999999999999999999999998 99999999999998 789999999999975432 2334
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHcc
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL 265 (630)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+ .+..+++..+.... ..++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDR--PHFPRWISKEAKDCLSKLF 231 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHc
Confidence 5679999999998764 589999999999999999999999987 45566666665432 2345667899999999999
Q ss_pred c-CCCCCCCH-HHHhcCCCcccCCCCc
Q 006810 266 V-PASLRLPA-LELLKDPFLVTDNPKD 290 (630)
Q Consensus 266 ~-~p~~Rpsa-~eLL~hpf~~~~~~~~ 290 (630)
. +|.+||++ .+++.||||....+..
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~ 258 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGIDWER 258 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCCHHH
Confidence 7 89999986 4899999998866544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=355.35 Aligned_cols=251 Identities=25% Similarity=0.432 Sum_probs=209.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh-CCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
++||+|+||.||+|.++.+|..||+|.++..... .......+..|..++.. ++||||++++++|.+. ..+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECC
Confidence 4699999999999999999999999999754322 12344556778888875 4999999999998654 479999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--cCCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 186 (630)
+.+|+|. ++...+.+++..+..++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCcee
Confidence 9999998 6777788999999999999999999999999 99999999999998 78899999999986432 22344
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHcc
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL 265 (630)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+..+. ..++...+++++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHc
Confidence 5679999999998864 589999999999999999999999976 45566666665442 3345567899999999999
Q ss_pred c-CCCCCCCH-HHHhcCCCcccCCCCc
Q 006810 266 V-PASLRLPA-LELLKDPFLVTDNPKD 290 (630)
Q Consensus 266 ~-~p~~Rpsa-~eLL~hpf~~~~~~~~ 290 (630)
. +|.+|+++ .+++.||||...++..
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~~~~ 258 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTINWTA 258 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCCHHH
Confidence 7 89999998 5888999998865543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=355.50 Aligned_cols=251 Identities=22% Similarity=0.396 Sum_probs=211.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
+.||+|+||+||+|.+..++..||+|++...... .......+.+|+.+++.+ +||||++++++|.+. ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence 4699999999999999999999999999754322 234556678899999888 799999999988654 469999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--cCCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 186 (630)
+++|+|. ++...+.+++..+..++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCccc
Confidence 9999998 6667778999999999999999999999999 99999999999998 78999999999986432 22234
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHcc
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL 265 (630)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+..... .++...++.+++||++||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSFL 231 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHc
Confidence 4579999999998864 589999999999999999999999976 455666666654422 344567899999999999
Q ss_pred c-CCCCCCCH-----HHHhcCCCcccCCCCc
Q 006810 266 V-PASLRLPA-----LELLKDPFLVTDNPKD 290 (630)
Q Consensus 266 ~-~p~~Rpsa-----~eLL~hpf~~~~~~~~ 290 (630)
. +|.+||++ .+++.||||...++..
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~ 262 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDWDK 262 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 7 89999999 9999999998866543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=357.16 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=207.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
++||+|+||+||+|.+..+|..||+|++....... ......+..|.. +++.++||||++++++|... ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEEcC
Confidence 46999999999999999999999999997543322 233344555554 57889999999999988654 468999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--cCCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 186 (630)
+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcc
Confidence 9999998 7777888999999999999999999999999 99999999999997 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHcc
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL 265 (630)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+.... ..+....+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKP--LVLRPGASLTAWSILEELL 231 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHh
Confidence 5679999999998765 588999999999999999999999986 45556666665442 2333456889999999999
Q ss_pred c-CCCCCCCH----HHHhcCCCcccCCCCcc
Q 006810 266 V-PASLRLPA----LELLKDPFLVTDNPKDL 291 (630)
Q Consensus 266 ~-~p~~Rpsa----~eLL~hpf~~~~~~~~~ 291 (630)
. +|.+||++ .+++.||||....+..+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~ 262 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESLSWTDL 262 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 7 79999876 58999999987665443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=355.34 Aligned_cols=251 Identities=19% Similarity=0.381 Sum_probs=207.7
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
++||+|+||.||+|.+..+|..||+|++..... ........+.+|+.++.++ +||||++++++|.+. ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeC
Confidence 469999999999999999999999999976533 2344556788899988777 899999999998654 468999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--CCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~ 186 (630)
+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCccc
Confidence 9999998 6777788999999999999999999999999 99999999999998 789999999999865322 2234
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~--------~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
...||+.|+|||++.+ .++.++|||||||++|+|+||+.||... .....+...+... ...++...+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCCCCCHHH
Confidence 5679999999998764 5889999999999999999999999521 1122334444433 223556678999
Q ss_pred HHHHHHccc-CCCCCCC------HHHHhcCCCcccCCCC
Q 006810 258 KQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPK 289 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rps------a~eLL~hpf~~~~~~~ 289 (630)
+++|.+||. +|.+|++ ..+++.||||...++.
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 999999997 8999998 4799999999876553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=353.80 Aligned_cols=251 Identities=24% Similarity=0.440 Sum_probs=209.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh-CCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
+.||+|+||.||+|.+..+|..||+|.++..... ..........|..+++. ++||||++++++|.+. ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeC
Confidence 4699999999999999999999999999754321 12334556678888876 5999999999998654 468999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--cCCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 186 (630)
+++|+|. ++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCcee
Confidence 9999998 6666778999999999999999999999999 99999999999998 78899999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHcc
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL 265 (630)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+.... ..++...+..+++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDN--PCYPRWLTREAKDILVKLF 231 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHh
Confidence 5679999999998765 589999999999999999999999986 45566666665442 2344567889999999999
Q ss_pred c-CCCCCCCHH-HHhcCCCcccCCCCc
Q 006810 266 V-PASLRLPAL-ELLKDPFLVTDNPKD 290 (630)
Q Consensus 266 ~-~p~~Rpsa~-eLL~hpf~~~~~~~~ 290 (630)
. +|.+|+++. +++.||||...++..
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~ 258 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREIDWSA 258 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCCCHHH
Confidence 7 899999997 899999998876544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=356.30 Aligned_cols=252 Identities=23% Similarity=0.483 Sum_probs=223.6
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
..|| .+.+.||+|.||.|-+|.+...|+.||||.|+...+ .+++.+-.+.+||++|..|+||||+.+|++|... .-
T Consensus 52 kHRy-E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI-kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk--dK 127 (668)
T KOG0611|consen 52 KHRY-EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI-KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK--DK 127 (668)
T ss_pred hhHH-HHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc-ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC--ce
Confidence 4566 667899999999999999999999999999987765 4577788899999999999999999999999654 45
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+++||||..+|.|. |+...+.+++.+++.+++||+.|+.|||.++ ++|||||.+|||++ .|+.+||+|||++..+.
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD-~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLD-QNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeec-CCCCeeeeccchhhhhc
Confidence 99999999999997 9999999999999999999999999999999 99999999999998 89999999999998876
Q ss_pred cC-CCccccCCCCCCCccccccc-c-CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 182 QP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 182 ~~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
.. ..+++||+|-|.+||++.+. | ++.+|-||||++||-|+.|..||.+ .+-..+++.|..|.... ...+..+.
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrE---P~~PSdA~ 280 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYRE---PETPSDAS 280 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccC---CCCCchHH
Confidence 54 46789999999999999874 5 6899999999999999999999987 56677788888875432 12345788
Q ss_pred HHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 259 QFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
-+|+.||. +|.+|.|+.++-.|.|+.=
T Consensus 281 gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 281 GLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred HHHHHHHhcCcccchhHHHHhhhheeec
Confidence 99999995 9999999999999999853
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=358.45 Aligned_cols=256 Identities=29% Similarity=0.413 Sum_probs=204.6
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC-
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~- 100 (630)
...|| ++.+.||+|+||.||+|.+..+|..||+|++.... .......++.+|+.+++.++||||++++++|.....
T Consensus 19 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 19 VLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhce-EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 35677 77899999999999999999999999999986442 223445678899999999999999999999865432
Q ss_pred ---CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 101 ---RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 101 ---~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+++||||+.++.+..+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~a 170 (359)
T cd07876 96 EEFQDVYLVMELMDANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 170 (359)
T ss_pred cccceeEEEEeCCCcCHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCCc
Confidence 3579999999887555442 45899999999999999999999999 99999999999998 7899999999999
Q ss_pred eeeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------------
Q 006810 178 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------- 242 (630)
Q Consensus 178 ~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~------------- 242 (630)
...... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+......+...+..
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 754332 2344578999999998765 5899999999999999999999999865433222111110
Q ss_pred --------CC-C-C----------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 243 --------GI-K-P----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 243 --------g~-~-p----------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.. . + .......++.+++||.+||+ +|.+|||+.|+|.||||..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00 0 0 01112346789999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=353.43 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=219.7
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+|+.+.||+|..|+||+|....++..+|+|++..+... ....+.++..|-+||+.++||.++.+|..|.. ..+++++
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~-~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~cl~ 155 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA-SRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYSCLV 155 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh-hhhHHHHHHHHHHHHHhcCCCccchhhheeec--cceeEEE
Confidence 34557899999999999999999999999999876653 35667888899999999999999999999854 4689999
Q ss_pred EcccCCCCHH---HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee---
Q 006810 107 TELFTSGSLR---YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--- 180 (630)
Q Consensus 107 ~Ey~~gGsL~---~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~--- 180 (630)
||||+||+|. ..+.++.+++..++.++.+|+.||+|||..| ||+|||||+||||. ++|+|-|.||.++...
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccCCCC
Confidence 9999999997 3345678999999999999999999999999 99999999999998 8999999999886311
Q ss_pred ----c---------------------------c-C-----------------------CCccccCCCCCCCccccccc-c
Q 006810 181 ----Q---------------------------Q-P-----------------------TARSVIGTPEFMAPELYEEE-Y 204 (630)
Q Consensus 181 ----~---------------------------~-~-----------------------~~~~~~GTp~Y~APEvl~~~-y 204 (630)
. . . ...+++||-+|.|||++.+. .
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0 01246799999999999864 8
Q ss_pred CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCC----HHHHhc
Q 006810 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP----ALELLK 279 (630)
Q Consensus 205 s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rps----a~eLL~ 279 (630)
+.++|.|+|||.+|||+.|..||.+..+.+.+...+.....-+..+ ..+..+++||+++|+ +|.+|.. |.|+-+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 9999999999999999999999999888888888887654433222 457899999999998 7999998 999999
Q ss_pred CCCcccCCCC
Q 006810 280 DPFLVTDNPK 289 (630)
Q Consensus 280 hpf~~~~~~~ 289 (630)
||||+..+|.
T Consensus 392 HpFF~gVnWa 401 (459)
T KOG0610|consen 392 HPFFEGVNWA 401 (459)
T ss_pred CccccCCChh
Confidence 9999999987
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.40 Aligned_cols=252 Identities=28% Similarity=0.445 Sum_probs=197.0
Q ss_pred cceeeeeEecccCceEEEEEEEcc-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCeeEEEeEEEc---
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVD--- 97 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~-tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpNIVk~~~~f~d--- 97 (630)
|| ++.+.||+|+||+||+|.+.. +|..||+|.+....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 2 ~Y-~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 2 QY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred Cc-ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 56 778999999999999999864 57889999987543221 2223455677666655 79999999998753
Q ss_pred CCCCEEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 98 DTNRTINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
.....+++||||+.+ +|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+||
T Consensus 79 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Df 154 (290)
T cd07862 79 DRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADF 154 (290)
T ss_pred CCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEccc
Confidence 233568999999985 554 5543 346899999999999999999999999 99999999999998 7899999999
Q ss_pred ccceeeccC-CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CC---
Q 006810 175 GLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PA--- 247 (630)
Q Consensus 175 Gla~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~--- 247 (630)
|++...... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+......+...+..... +.
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 999765433 234557899999999875 45889999999999999999999999875544444333321100 00
Q ss_pred -------------------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 248 -------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 248 -------------------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.+....++.+++||.+||+ +|.+|||+.++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112357788999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=354.47 Aligned_cols=254 Identities=26% Similarity=0.448 Sum_probs=209.6
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
..+| ++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|++++++++||||++++++|.+. ..
T Consensus 4 ~~~y-~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 77 (333)
T cd06650 4 DDDF-EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GE 77 (333)
T ss_pred hhhh-heeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CE
Confidence 3566 77899999999999999999999999999987542 234556789999999999999999999998765 47
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
+++||||+++|+|. ++...+.+++..+..++.||+.||.|||+. + |+||||||+|||++ .+|.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhh
Confidence 89999999999998 777778899999999999999999999974 5 99999999999998 7899999999998765
Q ss_pred ccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHH---------------------
Q 006810 181 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--------------------- 238 (630)
Q Consensus 181 ~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~--------------------- 238 (630)
.........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ...+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 155 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCcccCCccccccCcccCC
Confidence 5444455679999999998865 58899999999999999999999997532 222211
Q ss_pred -----------------------HHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 239 -----------------------KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 239 -----------------------~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.+.....+.......+.++++||.+||+ +|.+||++.|+|.||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 1111111111122357889999999998 89999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.78 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=210.4
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.++||+|+||+||+|.+..+|..||+|++...... .......+.+|+.+++.++||||+++++.+.+. ..+++||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 79 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVL 79 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEEE
Confidence 6678999999999999999999999999998754332 122345577899999999999999999988654 4689999
Q ss_pred cccCCCCHH-HHh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-
Q 006810 108 ELFTSGSLR-YRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 183 (630)
||+.+|+|. .+. ....+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCCCC
Confidence 999999997 333 2356999999999999999999999998 99999999999997 7899999999999765432
Q ss_pred CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHH---HHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 184 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~---i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
.....+|++.|+|||++. ..++.++|||||||++|+|++|+.||.+...... +...+.. .+..++...++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 234 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE--DQEEYSEKFSEAARS 234 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh--cccccCcccCHHHHH
Confidence 223457899999999876 4588999999999999999999999986433221 2222222 123344557889999
Q ss_pred HHHHccc-CCCCCC-----CHHHHhcCCCcccCCCCcccc
Q 006810 260 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVC 293 (630)
Q Consensus 260 ~I~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~ 293 (630)
||.+||. +|.+|| ++.+++.||||...+++.+..
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~ 274 (285)
T cd05605 235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA 274 (285)
T ss_pred HHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhh
Confidence 9999997 899999 899999999999877666543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=353.52 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=209.3
Q ss_pred eEecccCceEEEEEEE---ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 31 EILGKGAFKTVYKGFD---EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d---~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
+.||+|+||.||++.+ ..+|..||+|++...... .....++.+|+.+|++++||||++++++|.+. ..+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK--VRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEE
Confidence 5799999999999876 457899999999754321 22345677899999999999999999998654 4689999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--C
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~ 184 (630)
||+++|+|. ++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...... .
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCc
Confidence 999999997 7777788999999999999999999999999 99999999999998 7899999999998755432 2
Q ss_pred CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006810 185 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263 (630)
Q Consensus 185 ~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~k 263 (630)
.....||+.|+|||++.+ .++.++|||||||++|+|+||+.||... +.......+.... ..++...++.++++|.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK-DRKETMTMILKAK--LGMPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC-CHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence 345679999999998764 5789999999999999999999999864 4555555554432 23445678999999999
Q ss_pred ccc-CCCCCCC-----HHHHhcCCCcccCCCCcc
Q 006810 264 CIV-PASLRLP-----ALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 264 cL~-~p~~Rps-----a~eLL~hpf~~~~~~~~~ 291 (630)
||+ +|.+||+ ..+++.||||....+..+
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL 265 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHH
Confidence 997 8999999 677999999988655443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=351.30 Aligned_cols=252 Identities=19% Similarity=0.368 Sum_probs=209.9
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
+.||+|+||.||+|.+..++..||+|++..... ........+.+|+.++.++ +||||++++++|.+. ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeC
Confidence 469999999999999999999999999975432 2334566788999999888 699999999988654 469999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--cCCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 186 (630)
+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCcee
Confidence 9999998 6777788999999999999999999999999 99999999999998 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCC------CCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 187 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC------KNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~------~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
..+||+.|+|||++.+ .++.++|||||||++|+|+||..||... .....+...+... +..++...++.+++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~ 232 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASH 232 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHH
Confidence 5679999999998764 5899999999999999999999999532 2233444444433 33456677899999
Q ss_pred HHHHccc-CCCCCCC------HHHHhcCCCcccCCCCc
Q 006810 260 FIEKCIV-PASLRLP------ALELLKDPFLVTDNPKD 290 (630)
Q Consensus 260 ~I~kcL~-~p~~Rps------a~eLL~hpf~~~~~~~~ 290 (630)
+|.+||. +|.+|++ ..+++.||||...++..
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~ 270 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDL 270 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHH
Confidence 9999997 8999998 46999999999876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=337.00 Aligned_cols=251 Identities=24% Similarity=0.444 Sum_probs=222.5
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+.+++.||+|-||.||+|+.+.++-.||+|++.++.... ......+.+|+++-+.|+||||+++|++|.+.. .+|++
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~--riyLi 100 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK--RIYLI 100 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhheeccc--eeEEE
Confidence 356799999999999999999999999999998776543 234466889999999999999999999998764 69999
Q ss_pred EcccCCCCHH-HHh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 107 TELFTSGSLR-YRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+||.+.|++. .+. ..+++++...+.+++|++.||.|+|.++ ||||||||+|+|+. ..|.+||+|||-+......
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccC-CCCCeeccCCCceeecCCC
Confidence 9999999997 666 7788999999999999999999999999 99999999999996 8999999999999877777
Q ss_pred CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
...+.|||..|.|||+.++ .++..+|+|++|++.||++.|.+||... +....|+.+..- ...++..++..++++|.
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~-~~~etYkrI~k~--~~~~p~~is~~a~dlI~ 254 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ-SHSETYKRIRKV--DLKFPSTISGGAADLIS 254 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh-hhHHHHHHHHHc--cccCCcccChhHHHHHH
Confidence 7788999999999998876 5899999999999999999999999874 477778877653 22344677899999999
Q ss_pred Hccc-CCCCCCCHHHHhcCCCcccC
Q 006810 263 KCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 263 kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+||. +|.+|++..|++.|||+...
T Consensus 255 ~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 255 RLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHhccCccccccHHHHhhhHHHHhc
Confidence 9998 89999999999999998753
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=349.44 Aligned_cols=258 Identities=19% Similarity=0.358 Sum_probs=209.2
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||+||+|.+..+|..||+|++...... .....+.+.+|+.+++.++||||++++++|.+. ..+|
T Consensus 2 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 77 (331)
T cd05597 2 DF-EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLY 77 (331)
T ss_pred Cc-eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEE
Confidence 45 7789999999999999999999999999999754322 233456688999999999999999999988654 4799
Q ss_pred EEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 105 MITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+||||+++|+|. ++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCC
Confidence 999999999998 5544 567999999999999999999999999 99999999999997 789999999999865543
Q ss_pred CC---CccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Q 006810 183 PT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLS 250 (630)
Q Consensus 183 ~~---~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~---~l~ 250 (630)
.. .....||+.|+|||++. +.++.++|||||||++|+|++|+.||.. .+..+.+..+....... ...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 22 12346999999999875 2478899999999999999999999976 34455555554432211 122
Q ss_pred CCCcHHHHHHHHHcccC---CCCCCCHHHHhcCCCcccCCCCc
Q 006810 251 KVTDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKD 290 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~~---p~~Rpsa~eLL~hpf~~~~~~~~ 290 (630)
...++.+++||.+||.. +..|+++.++|.||||....+..
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 34688999999999863 34478999999999998765443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=349.96 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=213.3
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l~lV 106 (630)
++.+.||+|+||+||+|.++.+|..||+|++...... .....+.+..|+.+++.+. ||+|++++++|.+. ..+|+|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv 79 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYFV 79 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEEE
Confidence 6678999999999999999999999999999754322 2344566788999998886 56778898887654 469999
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 183 (630)
|||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCCCc
Confidence 9999999998 7777788999999999999999999999999 99999999999998 7899999999998654322
Q ss_pred CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...++..+.... ..++...+++++++|.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~ 233 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSICK 233 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHHH
Confidence 2345679999999998764 589999999999999999999999987 45566666665542 2345567899999999
Q ss_pred Hccc-CCCCCCC-----HHHHhcCCCcccCCCCccc
Q 006810 263 KCIV-PASLRLP-----ALELLKDPFLVTDNPKDLV 292 (630)
Q Consensus 263 kcL~-~p~~Rps-----a~eLL~hpf~~~~~~~~~~ 292 (630)
+||. +|.+|++ ..++++||||...++..+.
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~ 269 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLE 269 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHh
Confidence 9997 8999997 5789999999987665543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=353.90 Aligned_cols=249 Identities=24% Similarity=0.400 Sum_probs=205.8
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 33 LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
||+|+||+||+|.+..+|..||+|++....... .........|..++..+ +||||++++++|... ..+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcC
Confidence 799999999999999999999999997544322 23344456677777665 799999999988654 468999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--cCCCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 186 (630)
+.+|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCcc
Confidence 9999997 7777888999999999999999999999999 99999999999998 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHc
Q 006810 187 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kc 264 (630)
..+||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+..+++..+..+.... .....++.+++||.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHH
Confidence 5679999999998754 478999999999999999999999976 45666666666553321 1234688999999999
Q ss_pred cc-CCCCCC----CHHHHhcCCCcccCCCC
Q 006810 265 IV-PASLRL----PALELLKDPFLVTDNPK 289 (630)
Q Consensus 265 L~-~p~~Rp----sa~eLL~hpf~~~~~~~ 289 (630)
|. +|.+|| ++.+++.||||....+.
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~ 262 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADIDWD 262 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCCHH
Confidence 97 899998 68999999999875543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=369.18 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=219.1
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
.....+.+|| ++.+.||+|+||+||+|.+..+|..||+|.+..... ......++.+|+.+|..++|+||++++..|.
T Consensus 25 ~~~~~~~~rY-~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~ 101 (496)
T PTZ00283 25 ATAKEQAKKY-WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101 (496)
T ss_pred ccccccCCCE-EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence 3445566788 889999999999999999999999999999976543 3456677889999999999999999998775
Q ss_pred cCCC------CEEEEEEcccCCCCHH-HHhh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC
Q 006810 97 DDTN------RTINMITELFTSGSLR-YRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 165 (630)
Q Consensus 97 d~~~------~~l~lV~Ey~~gGsL~-~~~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 165 (630)
.... ..+++||||+++|+|. ++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .
T Consensus 102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~-~ 178 (496)
T PTZ00283 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLC-S 178 (496)
T ss_pred cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEe-C
Confidence 4322 2478999999999997 4432 356899999999999999999999998 99999999999998 7
Q ss_pred CCcEEEcccccceeeccC----CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 006810 166 NGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 240 (630)
Q Consensus 166 ~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i 240 (630)
++.+||+|||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+...++..+
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~ 257 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKT 257 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHH
Confidence 899999999999765432 2345679999999998865 589999999999999999999999986 4555666666
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 241 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 241 ~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
..+..+ .++...+++++++|.+||. +|.+||++.++|.|||++.
T Consensus 258 ~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 258 LAGRYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred hcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 555332 3456678999999999997 8999999999999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=341.25 Aligned_cols=250 Identities=26% Similarity=0.460 Sum_probs=213.8
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH----HHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEE
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP----DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~----~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~ 104 (630)
.++||+|..++|.++.++.+|.++|+|++.......+. .-++.-.+|+.+|+++ -||+|+++.++|.. +..++
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes--~sF~F 99 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES--DAFVF 99 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--cchhh
Confidence 48899999999999999999999999999764433322 2345566899999999 69999999999854 45788
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+|+|+|+.|.|. |+...-.++++..+++++|++.|++|||.++ |+||||||+|||++ ++-++||.|||+++.+...
T Consensus 100 lVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILld-dn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLD-DNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeec-cccceEEeccceeeccCCc
Confidence 999999999998 9999999999999999999999999999999 99999999999998 7889999999999887654
Q ss_pred -CCccccCCCCCCCccccc-------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCC
Q 006810 184 -TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVT 253 (630)
Q Consensus 184 -~~~~~~GTp~Y~APEvl~-------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~ 253 (630)
..+..||||.|+|||.+. .+|+..+|+|++|+|+|-|+.|.+||... ....+.+.+..|... .+-....
T Consensus 177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-kQmlMLR~ImeGkyqF~speWadi 255 (411)
T KOG0599|consen 177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-KQMLMLRMIMEGKYQFRSPEWADI 255 (411)
T ss_pred hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-HHHHHHHHHHhcccccCCcchhhc
Confidence 467789999999999774 25889999999999999999999999752 233445666666542 2223456
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
+..++++|.+||+ +|.+|.|++|+|.||||.+
T Consensus 256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred cccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 7899999999997 9999999999999999965
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=332.34 Aligned_cols=250 Identities=34% Similarity=0.587 Sum_probs=210.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~-~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
.+.+.||+|++|.||+|.+..+|..||+|.+....... .......+.+|+.++++++||||+++++++.+. ..+++|
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 82 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETLSIF 82 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeEEEE
Confidence 67899999999999999999999999999987543221 123456788999999999999999999998655 479999
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC-
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 184 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 184 (630)
+||+++++|. .+...+.+++..++.++.||+.||.|||+.+ ++||||+|+||+++ .++.++|+|||++.......
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecccccc
Confidence 9999999998 6777788999999999999999999999999 99999999999998 78999999999986543221
Q ss_pred --C--ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 185 --A--RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 185 --~--~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
. ....|++.|+|||++.+ .++.++||||||+++|+|++|+.||........... +........++...+..+++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH-HhccCCCCCCCccCCHHHHH
Confidence 1 33567889999998765 488999999999999999999999987544444433 33333344566677899999
Q ss_pred HHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 260 FIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
+|.+||. +|.+||++.++|+||||
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999997 79999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.83 Aligned_cols=256 Identities=28% Similarity=0.391 Sum_probs=204.3
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC-
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~- 100 (630)
..+|| ++.+.||+|+||.||+|.+..+|..||+|.+.... .......++.+|+.+++.++||||++++++|.....
T Consensus 15 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 15 VLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhce-eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 34678 77799999999999999999999999999986432 234455678899999999999999999998865432
Q ss_pred ---CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 101 ---RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 101 ---~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+++||||+.++.+..+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 92 ~~~~~~~lv~e~~~~~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~~ 166 (355)
T cd07874 92 EEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 166 (355)
T ss_pred cccceeEEEhhhhcccHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCccc
Confidence 3579999999886555443 35899999999999999999999999 99999999999998 7899999999999
Q ss_pred eeeccCC-CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------------
Q 006810 178 IVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------- 242 (630)
Q Consensus 178 ~~~~~~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~------------- 242 (630)
+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+..
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 7654432 344678999999998765 5899999999999999999999999864432222211110
Q ss_pred ---------CCC------C-----------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 243 ---------GIK------P-----------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 243 ---------g~~------p-----------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
... + .......+..+++||.+||. +|.+|||+.|+|+||||..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 000 0 00112235678999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=339.01 Aligned_cols=252 Identities=30% Similarity=0.442 Sum_probs=196.5
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCeeEEEeEEEcC---
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDD--- 98 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpNIVk~~~~f~d~--- 98 (630)
|| ++.+.||+|+||+||+|.+..+|..||+|.+....... .....+.+|+.+++.+ +||||++++++|...
T Consensus 1 ~y-~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred Cc-eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 45 77899999999999999999999999999987543211 1112344566666554 799999999988643
Q ss_pred CCCEEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 99 TNRTINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
....+++|+||+.+ +|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||
T Consensus 78 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg 153 (288)
T cd07863 78 RETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFG 153 (288)
T ss_pred CCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccC
Confidence 23468999999986 554 5443 345899999999999999999999999 99999999999998 78999999999
Q ss_pred cceeeccC-CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-C-C----C-
Q 006810 176 LAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-I-K----P- 246 (630)
Q Consensus 176 la~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g-~-~----p- 246 (630)
++...... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||........+.+.+... . . +
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 99766433 223457899999999875 458999999999999999999999998754443333322210 0 0 0
Q ss_pred -----------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 247 -----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 247 -----------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.......+..++++|.+||+ +|.+||++.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01112356788999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=347.19 Aligned_cols=258 Identities=19% Similarity=0.367 Sum_probs=209.9
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||+||+|.++.++..||+|.+...... .......+.+|+.++..++||||++++++|.+. ..+|
T Consensus 2 ~y-~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~ 77 (331)
T cd05624 2 DF-EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDE--NYLY 77 (331)
T ss_pred Cc-eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEE
Confidence 45 7789999999999999999999999999998753321 233455678899999999999999999988654 5799
Q ss_pred EEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 105 MITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+||||+++|+|. ++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccC
Confidence 999999999998 5554 568999999999999999999999999 99999999999998 789999999999976543
Q ss_pred CC---CccccCCCCCCCcccccc------ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---
Q 006810 183 PT---ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--- 250 (630)
Q Consensus 183 ~~---~~~~~GTp~Y~APEvl~~------~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~--- 250 (630)
.. ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+........++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 32 123579999999998763 478899999999999999999999986 34455555554432211222
Q ss_pred CCCcHHHHHHHHHcccCCCC---CCCHHHHhcCCCcccCCCCc
Q 006810 251 KVTDPQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNPKD 290 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~~p~~---Rpsa~eLL~hpf~~~~~~~~ 290 (630)
...++.++++|.+||..+.+ |+++.++++||||+..++..
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 23578999999999974333 56899999999998766544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=356.46 Aligned_cols=256 Identities=24% Similarity=0.423 Sum_probs=220.3
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.|-| -+++.||+|.|++|.+|++..||+.||+|+|...+. +.-....+.+|++.|+.++|||||++|++. +...-
T Consensus 17 AGLY-DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTK 91 (864)
T KOG4717|consen 17 AGLY-DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTK 91 (864)
T ss_pred eeee-hhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccce
Confidence 3445 667899999999999999999999999999987654 233445689999999999999999999964 44456
Q ss_pred EEEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 103 INMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
+|+|+|+-++|+|. |+.++ ..+.+..++.+++||+.|+.|+|+.. +|||||||+||.+....|.|||.|||++..+
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccC
Confidence 99999999999998 77665 57999999999999999999999998 9999999999987768999999999999766
Q ss_pred cc-CCCccccCCCCCCCcccccc-ccC-cccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 181 QQ-PTARSVIGTPEFMAPELYEE-EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 181 ~~-~~~~~~~GTp~Y~APEvl~~-~ys-~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
.. ....+.||+..|.|||++-+ .|+ +++||||||||||-|++|++||....+.+.+..++... -..+...+.++
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK---YtvPshvS~eC 246 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK---YTVPSHVSKEC 246 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc---ccCchhhhHHH
Confidence 54 45678899999999998765 475 78999999999999999999999877666665555433 23566788999
Q ss_pred HHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 258 KQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+++|..||+ +|.+|.+.+++..|+|++..+.
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 999999998 8999999999999999997654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.01 Aligned_cols=257 Identities=28% Similarity=0.430 Sum_probs=210.6
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-eeEEEeEEEcCC----
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDT---- 99 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN-IVk~~~~f~d~~---- 99 (630)
.|.++ +.||+|+||+||+|+++.+|..||+|++.++.-. +..-....+|+.+|+.|+|+| ||++++++....
T Consensus 12 ~~~~~-eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 12 DYEKV-EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHH-HHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 35454 5599999999999999999999999999876431 122345789999999999999 999999987654
Q ss_pred CCEEEEEEcccCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 100 NRTINMITELFTSGSLRYRKKHK----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~~~~~----~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
...+++|+||+....-.|+.... .++...++.+++||+.||+|||+++ |+||||||+||+|+ .+|.+||+|||
T Consensus 89 ~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDFG 165 (323)
T KOG0594|consen 89 IGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLIS-SSGVLKLADFG 165 (323)
T ss_pred cceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEEC-CCCcEeeeccc
Confidence 23799999999885444665544 6888999999999999999999999 99999999999998 79999999999
Q ss_pred cceeeccC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-----
Q 006810 176 LAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----- 246 (630)
Q Consensus 176 la~~~~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p----- 246 (630)
+|+...-+ .....++|.+|+|||++-+ .|+..+||||+|||++||+++++.|.+..+.+++..+...--.|
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 99866533 2445678999999998765 49999999999999999999999999988888877766531111
Q ss_pred -------------------CCCC---CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 247 -------------------ASLS---KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 247 -------------------~~l~---~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
..+. +..++...+++.+||+ +|.+|.||..+|.||||....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 0000 1123588999999998 899999999999999998753
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=350.24 Aligned_cols=248 Identities=27% Similarity=0.474 Sum_probs=202.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.+.||+|+||+||+|.+..+|..||+|++.... .......+.+|+.+|+.++||||++++++|.+. ..+++||
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 151 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN--GEIQVLL 151 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC--CeEEEEE
Confidence 45678999999999999999999999999986432 344557789999999999999999999988544 4689999
Q ss_pred cccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--CC
Q 006810 108 ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 185 (630)
Q Consensus 108 Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~~ 185 (630)
||+.+|+|.. ....++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...... ..
T Consensus 152 e~~~~~~L~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 152 EFMDGGSLEG---THIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred ecCCCCcccc---cccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceecccccccc
Confidence 9999999862 234578889999999999999999999 99999999999998 7899999999999766433 22
Q ss_pred ccccCCCCCCCcccccc-----c-cCcccceeehhHHHHHHhhCCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 186 RSVIGTPEFMAPELYEE-----E-YNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 186 ~~~~GTp~Y~APEvl~~-----~-ys~~sDIWSLGvil~ELltG~~Pf~~~~~--~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
....||+.|+|||++.. . ++.++|||||||++|||++|+.||..... ...+...+... .+.......++++
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 304 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-QPPEAPATASREF 304 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-CCCCCCCccCHHH
Confidence 45679999999998742 2 34689999999999999999999974322 12222223222 2233445678899
Q ss_pred HHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 258 KQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
++||.+||. +|.+||++.|+|+||||....
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 999999997 899999999999999998753
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.98 Aligned_cols=253 Identities=34% Similarity=0.579 Sum_probs=211.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
++.+.||+|+||.||+|.+..+|..||+|.+...... ......+.+.+|+.+++.++||||++++++|.+.....+++|
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 7789999999999999999999999999998754322 223456788999999999999999999999877656678999
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 183 (630)
|||+++|+|. ++...+.+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCccccccccccc
Confidence 9999999998 6677778999999999999999999999999 99999999999998 7899999999998754321
Q ss_pred ---CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 184 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 184 ---~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
......|+..|+|||++.+ .++.++|||||||++|+|++|+.||........+.. ..........+...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH-HhcCCCCCCCchhhCHHHHH
Confidence 2234568999999998754 578999999999999999999999987544444433 33332233344556788999
Q ss_pred HHHHcccCCCCCCCHHHHhcCCCcc
Q 006810 260 FIEKCIVPASLRLPALELLKDPFLV 284 (630)
Q Consensus 260 ~I~kcL~~p~~Rpsa~eLL~hpf~~ 284 (630)
+|.+|+.+|.+||++.+++.|||+.
T Consensus 241 ~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhcChhhCCCHHHHhcCcccC
Confidence 9999999999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=359.31 Aligned_cols=246 Identities=27% Similarity=0.380 Sum_probs=196.3
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|++|+||||++++++|... ...
T Consensus 92 ~~y-~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~ 158 (391)
T PHA03212 92 AGF-SILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYN--KFT 158 (391)
T ss_pred CCc-EEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEEC--Cee
Confidence 466 778999999999999999999999999996431 2367899999999999999999998654 468
Q ss_pred EEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc-
Q 006810 104 NMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~- 182 (630)
++|+|++.+..+.++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 159 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCcccccccc
Confidence 89999997543347777788999999999999999999999999 99999999999998 789999999999965322
Q ss_pred --CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC-------CHHHHHHHHHc-CCCC-----
Q 006810 183 --PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-------NPAQIYKKVTS-GIKP----- 246 (630)
Q Consensus 183 --~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~-------~~~~i~~~i~~-g~~p----- 246 (630)
......+||+.|+|||++.+ .|+.++|||||||++|||+||..||.... ...++...+.. +..|
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 22334679999999998764 58999999999999999999998875421 11111111110 1000
Q ss_pred ---------------------CCCC-----CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 247 ---------------------ASLS-----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 247 ---------------------~~l~-----~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
...+ ...+.++++||.+||. +|.+||||.|+|.||||+.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 0000 0134678999999998 8999999999999999976
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=352.33 Aligned_cols=255 Identities=28% Similarity=0.381 Sum_probs=203.6
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC---
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~--- 99 (630)
.+|| ++.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++.++||||++++++|....
T Consensus 23 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 23 LKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hcce-eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 4677 77899999999999999999999999999986432 22344567889999999999999999999876432
Q ss_pred -CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 -NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 -~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
...+|+||||+.++.+..+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~ 174 (364)
T cd07875 100 EFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 174 (364)
T ss_pred ccCeEEEEEeCCCCCHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCCcc
Confidence 23589999999876555543 35889999999999999999999999 99999999999998 78999999999997
Q ss_pred eeccCC-CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-----------
Q 006810 179 VMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----------- 245 (630)
Q Consensus 179 ~~~~~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~----------- 245 (630)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+..-..
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 654432 344578999999998765 5899999999999999999999999874433332222210000
Q ss_pred ---------C-------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 246 ---------P-------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 246 ---------p-------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
| .......+..+++||.+||+ +|.+|||+.++|.||||..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 00111234678999999998 8999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=335.39 Aligned_cols=254 Identities=30% Similarity=0.537 Sum_probs=208.4
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~ 98 (630)
.+|.|+| ++.+.||+|+||.||+|.+..++..||+|.+.... .....+.+|+.+++.+ +||||++++++|...
T Consensus 2 ~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 2 RDPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred CChhhhh-hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 4789999 77789999999999999999999999999987432 1234578899999998 799999999998754
Q ss_pred C----CCEEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEE
Q 006810 99 T----NRTINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 171 (630)
Q Consensus 99 ~----~~~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 171 (630)
. ...+++||||+.+|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~-~~~~~~l 152 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKL 152 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEEC-CCCCEEE
Confidence 3 24689999999999998 4443 346899999999999999999999998 99999999999998 7889999
Q ss_pred cccccceeeccC--CCccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Q 006810 172 GDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 243 (630)
Q Consensus 172 ~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g 243 (630)
+|||++...... ......|++.|+|||++. ..|+.++|||||||++|+|++|+.||...... .....+...
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-~~~~~~~~~ 231 (272)
T cd06637 153 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-RALFLIPRN 231 (272)
T ss_pred ccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-HHHHHHhcC
Confidence 999999765432 234467899999999874 24788999999999999999999999764333 222233332
Q ss_pred CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 244 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 244 ~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
..+.......+..+++||.+||. +|.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 22333334567899999999997 89999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.67 Aligned_cols=255 Identities=29% Similarity=0.448 Sum_probs=203.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC---
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 100 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~--- 100 (630)
.|| ++.+.||+|+||+||+|.+..++..||+|.+.... ........+.+|+.+|++++||||++++++|.....
T Consensus 15 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 15 ERY-QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhh-hhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 577 66789999999999999999999999999986432 122344667899999999999999999998864321
Q ss_pred -CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 -RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..++++++++ +++|..+.....+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQ 167 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcCCcccee
Confidence 3578999987 678875556678999999999999999999999999 99999999999998 789999999999976
Q ss_pred eccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCC-----------
Q 006810 180 MQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK----------- 245 (630)
Q Consensus 180 ~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~----------- 245 (630)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...... +..
T Consensus 168 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 168 ADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred cCCC-cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 5443 345678999999998765 4889999999999999999999999764332222221110 000
Q ss_pred ------------C-C---CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 246 ------------P-A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 246 ------------p-~---~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+ . ......++.+.+||.+||. +|.+|||+.++|.||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0 0 0012345778999999998 89999999999999999763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.62 Aligned_cols=261 Identities=26% Similarity=0.469 Sum_probs=219.4
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+.+|++++++++||||+++++++.+. ..++
T Consensus 2 ~y-~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 77 (290)
T cd05580 2 DF-EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLY 77 (290)
T ss_pred ce-EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEE
Confidence 45 7789999999999999999999999999998754332 234567788999999999999999999998654 4689
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+||||+++|+|. ++...+.+++..+..++.||+.||.|||+++ ++||||+|.|||++ .+|.+||+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC
Confidence 999999999998 7777788999999999999999999999998 99999999999998 7899999999998765443
Q ss_pred CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
.....|++.|+|||.+.+ .++.++||||||+++|+|++|..||... +.......+..+. ..++...++.++++|.
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~--~~~~~~~~~~l~~li~ 230 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGK--VRFPSFFSPDAKDLIR 230 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCC--ccCCccCCHHHHHHHH
Confidence 344578999999997754 5788999999999999999999999764 3555555555443 2344556899999999
Q ss_pred Hccc-CCCCCC-----CHHHHhcCCCcccCCCCccccCCC
Q 006810 263 KCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 296 (630)
Q Consensus 263 kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~~~l 296 (630)
+||. +|.+|+ ++.+++.||||....+..+....+
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 270 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKI 270 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccC
Confidence 9997 899999 899999999998877655544333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.85 Aligned_cols=256 Identities=18% Similarity=0.355 Sum_probs=208.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.++||+|+||+||++.++.++..||+|++...... .......+.+|+.++..++||||+++++.+.+. ..+++||
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 80 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYLVM 80 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEEEE
Confidence 7789999999999999999999999999998653321 223345578899999999999999999988654 4689999
Q ss_pred cccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC-
Q 006810 108 ELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 184 (630)
||+.+|+|. ++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheecccCCc
Confidence 999999998 5554 467999999999999999999999999 99999999999998 78999999999986543221
Q ss_pred --CccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCC
Q 006810 185 --ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL---SKVT 253 (630)
Q Consensus 185 --~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l---~~~~ 253 (630)
....+||+.|+|||++. +.++.++|||||||++|||++|+.||.. .+....+..+........+ ....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCccccC
Confidence 22357999999999875 3478999999999999999999999987 4555556665544322122 2346
Q ss_pred cHHHHHHHHHcccC---CCCCCCHHHHhcCCCcccCCCCc
Q 006810 254 DPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKD 290 (630)
Q Consensus 254 s~~lk~~I~kcL~~---p~~Rpsa~eLL~hpf~~~~~~~~ 290 (630)
++++++||.+||.. +..|+++.++++||||...++..
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~ 276 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence 89999999999963 33478999999999998766544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=362.91 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=211.9
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccC-CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~t-G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
+|..+-|++.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++|||||+++++|...
T Consensus 63 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~- 137 (478)
T PTZ00267 63 NPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSD- 137 (478)
T ss_pred CCcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-
Confidence 34444458889999999999999998887 889999977543 244556678899999999999999999998755
Q ss_pred CCEEEEEEcccCCCCHH-HHh----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 100 NRTINMITELFTSGSLR-YRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
..+|+||||+++|+|. ++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+||
T Consensus 138 -~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DF 213 (478)
T PTZ00267 138 -DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDF 213 (478)
T ss_pred -CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeC
Confidence 4699999999999997 332 3457899999999999999999999998 99999999999998 7899999999
Q ss_pred ccceeeccC----CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006810 175 GLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249 (630)
Q Consensus 175 Gla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l 249 (630)
|++...... .....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...++..+..+..+ .+
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~-~~ 291 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYD-PF 291 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC-CC
Confidence 999765432 2345679999999998864 589999999999999999999999976 4455555555544332 23
Q ss_pred CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 250 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 250 ~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
+...++.+++||.+||. +|.+||++.++|.|||++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 45567899999999997 8999999999999999964
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=342.62 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=202.3
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||+||+|.+..++..||+|.+...... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 79 (309)
T cd07872 6 ETY-IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSL 79 (309)
T ss_pred Cce-EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC---CcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeE
Confidence 456 7778999999999999999999999999999754322 2234567899999999999999999998654 468
Q ss_pred EEEEcccCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLRYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+.++.+.++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSV 156 (309)
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECccccceecCC
Confidence 99999998754445544 445899999999999999999999999 99999999999998 789999999999875433
Q ss_pred C--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc--CC------------
Q 006810 183 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GI------------ 244 (630)
Q Consensus 183 ~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~--g~------------ 244 (630)
. ......+|+.|+|||++.+ .++.++|||||||++|+|+||+.||......+.+...... ..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 2 2234568999999998754 4789999999999999999999999874433222111110 00
Q ss_pred ------CCC-------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 245 ------KPA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 245 ------~p~-------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.+. ......++++++||.+||. +|.+|||+.|+|.||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000 0112357889999999998 899999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=334.84 Aligned_cols=250 Identities=33% Similarity=0.589 Sum_probs=205.1
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
|++.+.||+|+||+||+|.+..+|..||+|.+...... ........+|+.++++++||||+++++++.+. ..+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE--EEEREENIREIKILRRLRHPNIVQILDVFQDD--NYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH--HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES--SEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc--ccccchhhhhhhcccccccccccccccccccc--cccccc
Confidence 48899999999999999999999999999999865431 22233445699999999999999999998763 568899
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee--ccC
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQP 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~--~~~ 183 (630)
|||+.+++|. ++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||.+... ...
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccccccccccccccccccccc
Confidence 9999999998 6667899999999999999999999999999 99999999999998 8999999999999753 223
Q ss_pred CCccccCCCCCCCccccc--cccCcccceeehhHHHHHHhhCCCCCCCCC--CHHHHHHHHHcCCCCCCCC--CCCcHHH
Q 006810 184 TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLS--KVTDPQV 257 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~--~~ys~~sDIWSLGvil~ELltG~~Pf~~~~--~~~~i~~~i~~g~~p~~l~--~~~s~~l 257 (630)
......+++.|+|||++. ..++.++||||||+++|+|++|..||.... +.............+.... ....+.+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 344567899999999887 458999999999999999999999998742 1222222222111111111 1123899
Q ss_pred HHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 258 KQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
+++|.+||. +|.+||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 999999997 89999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=333.66 Aligned_cols=254 Identities=27% Similarity=0.492 Sum_probs=209.2
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
...+.++| ++.+.||+|+||.||+|.+..++..||+|.++... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~ 78 (267)
T cd06645 4 RRNPQEDF-ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR 78 (267)
T ss_pred ccCcHHHH-HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence 34556677 67789999999999999999999999999987543 23345678899999999999999999998754
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 99 TNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 79 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~ 153 (267)
T cd06645 79 --DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVS 153 (267)
T ss_pred --CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceee
Confidence 4689999999999998 6777888999999999999999999999999 99999999999997 7889999999998
Q ss_pred eeeccC--CCccccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-
Q 006810 178 IVMQQP--TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS- 250 (630)
Q Consensus 178 ~~~~~~--~~~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~- 250 (630)
...... ......|++.|+|||++. +.++.++|+|||||++|+|++|..||........+.........+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06645 154 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233 (267)
T ss_pred eEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc
Confidence 755432 223457899999999863 3488899999999999999999999976443333333333332232222
Q ss_pred -CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCC
Q 006810 251 -KVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 282 (630)
Q Consensus 251 -~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf 282 (630)
...+..+++||.+||. +|.+||++.+++.|||
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 1356789999999997 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.11 Aligned_cols=262 Identities=30% Similarity=0.501 Sum_probs=217.4
Q ss_pred CccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEE
Q 006810 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (630)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f 95 (630)
.+.-.+|..|| ++.+.||+|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++.|
T Consensus 12 ~~~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~ 86 (296)
T cd06654 12 IVSVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSY 86 (296)
T ss_pred ccccCCcccce-eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 35567888999 667889999999999999999999999999876442 2346688999999999999999999998
Q ss_pred EcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 96 VDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
.+. ..+++||||+++|+|........+++..+..++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||
T Consensus 87 ~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~dfg 161 (296)
T cd06654 87 LVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFG 161 (296)
T ss_pred EeC--CEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECccc
Confidence 754 47899999999999984445567899999999999999999999999 99999999999997 78999999999
Q ss_pred cceeeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006810 176 LAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 252 (630)
Q Consensus 176 la~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~ 252 (630)
++...... ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||........++.....+..+...+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06654 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (296)
T ss_pred cchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence 98654332 2234578999999998765 47899999999999999999999998754434444444333333334455
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.++.++++|.+||. +|.+||++.+++.||||....
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 67889999999997 899999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=330.68 Aligned_cols=253 Identities=34% Similarity=0.569 Sum_probs=210.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
++.+.||+|+||.||+|.+..+|..||+|.+...... ........+.+|+.++++++||||+++++++.+.....++++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 5679999999999999999999999999998754322 123456778899999999999999999998876656788999
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 183 (630)
+||+++++|. ++...+.+++..++.++.||+.||+|||+++ |+||||+|+||+++ .++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCCCccccccccc
Confidence 9999999998 6667778999999999999999999999998 99999999999998 7889999999998654321
Q ss_pred ---CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 184 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 184 ---~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
......++..|+|||.+.+ .++.++|||||||++|+|++|+.||........+..... ......++...++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-QPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-CCCCCCCchhcCHHHHH
Confidence 1223458899999998764 478899999999999999999999987544444443333 22334455667889999
Q ss_pred HHHHcccCCCCCCCHHHHhcCCCcc
Q 006810 260 FIEKCIVPASLRLPALELLKDPFLV 284 (630)
Q Consensus 260 ~I~kcL~~p~~Rpsa~eLL~hpf~~ 284 (630)
+|..|+.+|.+||++.|+++||||+
T Consensus 241 li~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FLGCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHhcCChhhCcCHHHHhcCcccc
Confidence 9954445999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=347.18 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=201.4
Q ss_pred CCCcceeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d-----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f 95 (630)
|..|| ++.+.||+|+||.||+|.+ ..++..||+|++.... .......+.+|+.+|+.+ +||||+++++++
T Consensus 5 ~~~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 5 PRDRL-RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred chhHc-eeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 55678 8889999999999999975 3456789999986332 234456789999999999 899999999987
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhhc-----------------------------------------------------
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKKH----------------------------------------------------- 121 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~~----------------------------------------------------- 121 (630)
... +..+++||||+++|+|. ++...
T Consensus 81 ~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 81 TKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred cCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 643 34688999999999997 54321
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC----Cccc
Q 006810 122 ---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSV 188 (630)
Q Consensus 122 ---------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~ 188 (630)
..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++...... ....
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCC
Confidence 34788899999999999999999998 99999999999998 78899999999997543221 1233
Q ss_pred cCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc
Q 006810 189 IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 266 (630)
Q Consensus 189 ~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~ 266 (630)
.+++.|+|||++. ..++.++|||||||++|||++ |..||........+...+..+..+ ..+...++.++++|.+||.
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQ 315 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcc
Confidence 4578899999775 458999999999999999997 999998755555555555554332 3345678899999999997
Q ss_pred -CCCCCCCHHHHhc
Q 006810 267 -PASLRLPALELLK 279 (630)
Q Consensus 267 -~p~~Rpsa~eLL~ 279 (630)
+|.+||++.+++.
T Consensus 316 ~dp~~RPs~~el~~ 329 (338)
T cd05102 316 GDPKERPTFSALVE 329 (338)
T ss_pred CChhhCcCHHHHHH
Confidence 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=342.76 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=190.9
Q ss_pred eeEecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 30 DEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~--~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.||+|+||+||+|.++ .++..||+|.+..... ...+.+|+.+|+.++||||++++++|.......+++|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 467999999999999865 4778999999864322 13467899999999999999999999877677899999
Q ss_pred cccCCCCHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe---CCCCcEEEcccc
Q 006810 108 ELFTSGSLRYRKK---------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDLG 175 (630)
Q Consensus 108 Ey~~gGsL~~~~~---------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~---~~~g~vKL~DFG 175 (630)
||+.++...++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+. ..++.+||+|||
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 9997654334321 235899999999999999999999999 99999999999994 256789999999
Q ss_pred cceeeccC-----CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCH---------HHHHHH
Q 006810 176 LAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------AQIYKK 239 (630)
Q Consensus 176 la~~~~~~-----~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~---------~~i~~~ 239 (630)
++...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|++||...... .++...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 99765432 2234678999999998764 4889999999999999999999999643221 111111
Q ss_pred HHcCCCC-----------------------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 240 VTSGIKP-----------------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 240 i~~g~~p-----------------------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
+.....| .......+..+.+||.+||. +|.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1100000 00001235678999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.24 Aligned_cols=259 Identities=29% Similarity=0.491 Sum_probs=213.9
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
+|.++| ++.+.||+|+||.||+|.+..+|..||+|.+... .....+.+.+|+.+++.++||||+++++.+...
T Consensus 9 ~~~~~y-~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 81 (292)
T cd06644 9 DPNEVW-EIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-- 81 (292)
T ss_pred Ccchhh-hhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--
Confidence 566777 8889999999999999999999999999998643 345667788999999999999999999988654
Q ss_pred CEEEEEEcccCCCCHH-HH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 101 RTINMITELFTSGSLR-YR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++||||+++++|. .+ .....+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~ 158 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSA 158 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEc-CCCCEEEccCccce
Confidence 4689999999999997 33 34567999999999999999999999998 99999999999997 78999999999886
Q ss_pred eeccC--CCccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-CCC
Q 006810 179 VMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASL 249 (630)
Q Consensus 179 ~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l 249 (630)
..... ......+++.|+|||++. ..++.++|||||||++|+|++|..||... +....+..+.....+ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~ 237 (292)
T cd06644 159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLSQ 237 (292)
T ss_pred eccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhcCCCccCCC
Confidence 54322 223456899999999874 23678999999999999999999999764 344444444433322 223
Q ss_pred CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCCc
Q 006810 250 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 290 (630)
Q Consensus 250 ~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~~ 290 (630)
+...+..+.++|.+||. +|.+||++.+++.||||....+.+
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 44567899999999997 899999999999999998755443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=380.71 Aligned_cols=261 Identities=25% Similarity=0.456 Sum_probs=217.8
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||+||+|.+..++..||+|++..... .......+..|+.+|++|+|||||+++++|.+.....
T Consensus 12 l~~Y-eIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 12 LNEY-EVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cCCE-EEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3566 788999999999999999999999999999976543 3445677899999999999999999999998877778
Q ss_pred EEEEEcccCCCCHH-HHhh----cCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCEEeccCCcCceEEeC--------
Q 006810 103 INMITELFTSGSLR-YRKK----HKNVDMKAIKNWARQILRGLHYLHSHN-----PPIIHRDLKCDNIFVNG-------- 164 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~----~~~lse~~i~~i~~QIl~gL~yLHs~~-----~~IiHrDLKp~NILl~~-------- 164 (630)
+|+||||+++|+|. ++.. .+.+++..++.|+.||+.||.|||+.+ .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 99999999999997 4433 467999999999999999999999854 34999999999999962
Q ss_pred --------CCCcEEEcccccceeeccC-CCccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCC
Q 006810 165 --------NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKN 232 (630)
Q Consensus 165 --------~~g~vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~ 232 (630)
..+.+||+|||++...... .....+||+.|+|||++.+ .++.++|||||||++|+|+||..||....+
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 1345899999999765433 2345679999999998743 478999999999999999999999987677
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 233 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 233 ~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
..++...+..+... .....++++.+||.+||. +|.+||++.++|.||||+...+
T Consensus 249 ~~qli~~lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 249 FSQLISELKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHHHHHHhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 77777666654321 223457899999999997 8999999999999999975543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=351.86 Aligned_cols=253 Identities=29% Similarity=0.410 Sum_probs=204.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC---CEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTIN 104 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~---~~l~ 104 (630)
.+.+.||+|+||+||+|.+..+|..||+|.+... ........++.+|+.+|+.++||||+++++++..... ..+|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5678899999999999999999999999988532 1233445678899999999999999999998865431 2689
Q ss_pred EEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-
Q 006810 105 MITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 105 lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 183 (630)
+||||+.++.+..+...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeecccCc
Confidence 9999998644447777788999999999999999999999999 99999999999998 7899999999999765432
Q ss_pred --CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-----------------
Q 006810 184 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----------------- 242 (630)
Q Consensus 184 --~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~----------------- 242 (630)
......+|+.|+|||++.+ .++.++|||||||++|||++|+.||.+.... .....+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 1233468999999998765 3789999999999999999999999864333 22222211
Q ss_pred -------CCCCC------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 243 -------GIKPA------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 243 -------g~~p~------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
...+. .+....++++++||.+||. +|.+|||+.++|.||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 11111 1223457899999999998 89999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.88 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=200.8
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCC
Q 006810 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (630)
Q Consensus 33 LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~g 112 (630)
||+|+||.||++.+..+|..||+|.+....... ......+..|+.+++.++||||++++++|... ..+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEecCCC
Confidence 799999999999999999999999997543322 22234456799999999999999999988654 468999999999
Q ss_pred CCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC-Cccc
Q 006810 113 GSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSV 188 (630)
Q Consensus 113 GsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~-~~~~ 188 (630)
|+|. .+.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.++|+|||++....... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeecc
Confidence 9997 3332 345899999999999999999999999 99999999999998 78999999999987654332 2345
Q ss_pred cCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHc
Q 006810 189 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264 (630)
Q Consensus 189 ~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~---~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kc 264 (630)
.|++.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+.........+ ......+++++++|.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHHHHHHH
Confidence 68999999998754 589999999999999999999999975332 22333333322211 12235688999999999
Q ss_pred cc-CCCCCCCH----HHHhcCCCcccCCCCc
Q 006810 265 IV-PASLRLPA----LELLKDPFLVTDNPKD 290 (630)
Q Consensus 265 L~-~p~~Rpsa----~eLL~hpf~~~~~~~~ 290 (630)
|+ +|.+||++ .++++||||+..++..
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~ 264 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTINFPR 264 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence 97 89999999 6788999998765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=361.60 Aligned_cols=254 Identities=19% Similarity=0.312 Sum_probs=195.3
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC------CCeeEEEeEEE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH------ENIIKFYNSWV 96 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H------pNIVk~~~~f~ 96 (630)
.+|| ++.+.||+|+||+||+|.+..++..||+|+++... .....+..|+.+++.++| ++|++++++|.
T Consensus 128 ~~~y-~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 128 TQRF-KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCcE-EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3566 78899999999999999999999999999986321 222335567777766654 46889999886
Q ss_pred cCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCCC--------
Q 006810 97 DDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNG-------- 167 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g-------- 167 (630)
... ..+++|||++.+..+.++.+++.+++..++.++.||+.||.|||+ .+ ||||||||+|||++ .++
T Consensus 202 ~~~-~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~-~~~~~~~~~~~ 277 (467)
T PTZ00284 202 NET-GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILME-TSDTVVDPVTN 277 (467)
T ss_pred cCC-ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEe-cCCcccccccc
Confidence 543 468899999855444577788899999999999999999999997 47 99999999999997 343
Q ss_pred --------cEEEcccccceeeccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHH
Q 006810 168 --------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 238 (630)
Q Consensus 168 --------~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~ 238 (630)
.+||+|||.+..... .....+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.+..+...+..
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 599999998754322 2345689999999998765 599999999999999999999999987544333221
Q ss_pred HHHc-CCCCCC-------------------------------------C-CCCCcHHHHHHHHHccc-CCCCCCCHHHHh
Q 006810 239 KVTS-GIKPAS-------------------------------------L-SKVTDPQVKQFIEKCIV-PASLRLPALELL 278 (630)
Q Consensus 239 ~i~~-g~~p~~-------------------------------------l-~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL 278 (630)
.... +..|.. + ....++.+.+||.+||+ +|.+|||+.|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 1110 100000 0 01124678899999998 899999999999
Q ss_pred cCCCcccCC
Q 006810 279 KDPFLVTDN 287 (630)
Q Consensus 279 ~hpf~~~~~ 287 (630)
+||||....
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998643
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.99 Aligned_cols=262 Identities=31% Similarity=0.524 Sum_probs=216.7
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
+...++.+|| ++.+.||+|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||++++++|.
T Consensus 12 ~~~~~~~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 86 (297)
T cd06656 12 VSVGDPKKKY-TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYL 86 (297)
T ss_pred cccCChhhhc-eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4567888999 677999999999999999999999999999875432 23456889999999999999999999986
Q ss_pred cCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 97 DDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
.. ..+++||||+++++|........+++..+..++.|++.||.|||+.+ ++||||||+|||++ .+|.++|+|||+
T Consensus 87 ~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Dfg~ 161 (297)
T cd06656 87 VG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGF 161 (297)
T ss_pred cC--CEEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcCcc
Confidence 54 46899999999999984445567899999999999999999999998 99999999999997 789999999999
Q ss_pred ceeeccCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 177 AIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 177 a~~~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
+....... .....+++.|+|||.+.+ .++.++|+|||||++|+|++|..||........+......+..+...+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T cd06656 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241 (297)
T ss_pred ceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcccc
Confidence 87654322 234568999999998764 478999999999999999999999976443333333222233333344556
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
++.+++||.+||. +|.+||++.++|.||||+...+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 7889999999997 8999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=332.35 Aligned_cols=249 Identities=28% Similarity=0.509 Sum_probs=207.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.++||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.++++++||||+++++++... ...++||
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 78 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISICT 78 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEEE
Confidence 66789999999999999999999999999987542 234456788999999999999999999998765 4688999
Q ss_pred cccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCcc
Q 006810 108 ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 187 (630)
Q Consensus 108 Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~ 187 (630)
||+++|+|... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.++|+|||++..........
T Consensus 79 e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~~~~ 152 (279)
T cd06619 79 EFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKT 152 (279)
T ss_pred ecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceecccccccC
Confidence 99999999732 35789999999999999999999998 99999999999998 78999999999997765555556
Q ss_pred ccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCC------HHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006810 188 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN------PAQIYKKVTSGIKPASLSKVTDPQVKQF 260 (630)
Q Consensus 188 ~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~------~~~i~~~i~~g~~p~~l~~~~s~~lk~~ 260 (630)
..||+.|+|||++.+ .++.++|+||||+++|+|++|..||..... .......+.....+.......++++++|
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 789999999998764 588999999999999999999999964221 1223333333322222233467899999
Q ss_pred HHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 261 IEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 261 I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
|.+||. +|.+||++.+++.||||+..+
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcCccccccc
Confidence 999997 899999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=335.52 Aligned_cols=256 Identities=22% Similarity=0.367 Sum_probs=207.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
+..++||+|+||+||+|.+..+|+.||+|.+...... .......+.+|+.+++.++|+||+++++.+.+. ..+++||
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~ 79 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVL 79 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEEE
Confidence 5668899999999999999999999999998754432 223345577899999999999999999988654 4689999
Q ss_pred cccCCCCHH-HHh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-
Q 006810 108 ELFTSGSLR-YRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 183 (630)
||+.+|+|. ++. ....+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.++|+|||++......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecCCCc
Confidence 999999997 443 2346899999999999999999999998 99999999999998 7889999999998755332
Q ss_pred CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA--QIYKKVTSGIKPASLSKVTDPQVKQF 260 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~--~i~~~i~~g~~p~~l~~~~s~~lk~~ 260 (630)
......|++.|+|||++.+ .++.++||||||+++|+|++|+.||....... .....+... .+..+....++.+++|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 235 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSL 235 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHH
Confidence 2234578999999998764 58899999999999999999999998643221 111111111 1223455678899999
Q ss_pred HHHccc-CCCCCCC-----HHHHhcCCCcccCCCCc
Q 006810 261 IEKCIV-PASLRLP-----ALELLKDPFLVTDNPKD 290 (630)
Q Consensus 261 I~kcL~-~p~~Rps-----a~eLL~hpf~~~~~~~~ 290 (630)
|.+||+ +|.+||+ +.++++||||...+...
T Consensus 236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05630 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKR 271 (285)
T ss_pred HHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHH
Confidence 999998 8999999 99999999998765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=336.58 Aligned_cols=251 Identities=26% Similarity=0.452 Sum_probs=200.9
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|| ++.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++.+. ..++
T Consensus 1 ~y-~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (284)
T cd07839 1 KY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLT 75 (284)
T ss_pred Cc-eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceE
Confidence 56 667899999999999999999999999999976432 122334577899999999999999999998654 4689
Q ss_pred EEEcccCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLRYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+|+||+.++.+.++. ..+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGIP 152 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEc-CCCcEEECccchhhccCCC
Confidence 999999865445544 3567999999999999999999999999 99999999999998 7899999999998755432
Q ss_pred --CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--------------
Q 006810 184 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-------------- 245 (630)
Q Consensus 184 --~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-------------- 245 (630)
......+++.|+|||++.+ .++.++|||||||++|+|+||..||....+....+..+.....
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 2233467899999998754 3789999999999999999999986554444433333321100
Q ss_pred ----C---------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 246 ----P---------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 246 ----p---------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
. .......++++++||.+||. +|.+|||+.++|.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 01112357889999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=335.25 Aligned_cols=241 Identities=22% Similarity=0.317 Sum_probs=203.6
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc--CCCCEEEEEEc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD--DTNRTINMITE 108 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d--~~~~~l~lV~E 108 (630)
..||+|+++.||+|.. +|..||+|.+..... ......+.+.+|+.+|++++||||+++++++.+ .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5699999999999976 799999999875432 233445778899999999999999999999877 44457899999
Q ss_pred ccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCc
Q 006810 109 LFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 186 (630)
Q Consensus 109 y~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~ 186 (630)
|+++|+|. ++...+.+++.....++.|++.||.|||+. + ++||||||+||+++ .+|.+||+|||++....... .
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~~-~ 178 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSPP-F 178 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhcccc-c
Confidence 99999998 777778899999999999999999999984 6 88999999999998 78999999999987654322 3
Q ss_pred cccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006810 187 SVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~k 263 (630)
...|++.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+...++..+..+.....++...++.+++||.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999998864 689999999999999999999999987 455666666654434444555678999999999
Q ss_pred ccc-CCCCCCCHHHHhc
Q 006810 264 CIV-PASLRLPALELLK 279 (630)
Q Consensus 264 cL~-~p~~Rpsa~eLL~ 279 (630)
||+ +|.+||++.+++.
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 998 8999999999985
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=328.83 Aligned_cols=254 Identities=29% Similarity=0.535 Sum_probs=208.0
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~ 98 (630)
.+|.+|| ++.+.||+|++|+||+|.++.++..|++|.+.... ...+.+.+|+.+++++ +||||++++++|.+.
T Consensus 2 ~~~~~~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 2 PDPTGIF-ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred CCchhhe-eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 4688999 77899999999999999999999999999987543 2335688999999999 799999999998764
Q ss_pred C----CCEEEEEEcccCCCCHH-HHhh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcE
Q 006810 99 T----NRTINMITELFTSGSLR-YRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 169 (630)
Q Consensus 99 ~----~~~l~lV~Ey~~gGsL~-~~~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 169 (630)
. ...+++||||+++++|. .... ...+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~-~~~~~ 152 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEV 152 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEc-cCCeE
Confidence 3 45689999999999997 3322 467999999999999999999999999 99999999999998 78999
Q ss_pred EEcccccceeeccC--CCccccCCCCCCCcccccc------ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 006810 170 KIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 241 (630)
Q Consensus 170 KL~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~~------~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~ 241 (630)
||+|||++...... ......|++.|+|||++.. .++.++|||||||++|+|++|..||........+.. +.
T Consensus 153 ~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~ 231 (275)
T cd06608 153 KLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK-IP 231 (275)
T ss_pred EECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH-hh
Confidence 99999998654332 2234568999999998742 367899999999999999999999976443333333 33
Q ss_pred cCCCCCC-CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 242 SGIKPAS-LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 242 ~g~~p~~-l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.+..+.. .....+..+++||.+||. +|.+|||+.+++.|||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 3322221 122256789999999997 89999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=323.14 Aligned_cols=248 Identities=28% Similarity=0.553 Sum_probs=208.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|++|.||+|.++.+|..||+|.+..... .....+.+.+|+.++++++||||+++++.|... ...+++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 788999999999999999999999999999975432 234556788999999999999999999987533 34689999
Q ss_pred cccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-
Q 006810 108 ELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 183 (630)
||+++++|. ++.. ...+++.+++.++.|++.||.|||+.+ ++||||||+||+++ .++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEecccC
Confidence 999999997 4443 456899999999999999999999999 99999999999998 7899999999999766432
Q ss_pred -CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 184 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 184 -~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
......|++.|+|||++.+ .++.++||||||+++|+|++|+.||... +.......+..+..+ ..+...++.+.+||
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 234 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEGKLP-PMPKDYSPELGELI 234 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCC-CCccccCHHHHHHH
Confidence 2334568999999998764 4788999999999999999999999763 444444445444332 34456789999999
Q ss_pred HHccc-CCCCCCCHHHHhcCCCc
Q 006810 262 EKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.+||+ +|.+||++.++++||||
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 235 ATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHhccCcccCCCHHHHhcCCCC
Confidence 99997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=336.27 Aligned_cols=259 Identities=32% Similarity=0.550 Sum_probs=214.1
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
.+|..|| ++.+.||.|+||+||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 15 ~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 88 (296)
T cd06655 15 GDPKKKY-TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKELIINEILVMKELKNPNIVNFLDSFLVG- 88 (296)
T ss_pred CCCcceE-EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHHHHHHHHHHHHhcCCCceeeeeeeEecC-
Confidence 3466777 667889999999999999999999999999875432 2345688999999999999999999988654
Q ss_pred CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 100 NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++|+||+++|+|........+++..+..++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||++..
T Consensus 89 -~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~~ 164 (296)
T cd06655 89 -DELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFGFCAQ 164 (296)
T ss_pred -ceEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccchh
Confidence 46899999999999985445567999999999999999999999999 99999999999997 789999999999865
Q ss_pred eccCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 180 MQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 180 ~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
..... .....|++.|+|||.+.+ .++.++|||||||++|+|++|+.||........+.........+...+...++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06655 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI 244 (296)
T ss_pred cccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHH
Confidence 44322 234568999999998764 488999999999999999999999987544344333333333333344557889
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+++||++||. +|.+||++.+++.||||+...+
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 9999999997 8999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=323.63 Aligned_cols=249 Identities=31% Similarity=0.542 Sum_probs=213.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.+.||.|+||.||+|.+..+|..||+|.+..... .....+++.+|+.+++.++||||+++++++.......++++|
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 667899999999999999999999999999876543 345567788999999999999999999998877777899999
Q ss_pred cccCCCCHH-HHhh----cCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 108 ELFTSGSLR-YRKK----HKNVDMKAIKNWARQILRGLHYLH-----SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 108 Ey~~gGsL~-~~~~----~~~lse~~i~~i~~QIl~gL~yLH-----s~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
||+++++|. ++.. ...+++..++.++.||+.||.||| +.+ ++||||+|+||+++ .++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEeccccc
Confidence 999999997 4433 467999999999999999999999 777 99999999999998 7899999999999
Q ss_pred eeeccCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 178 IVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 178 ~~~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
....... .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||... +...+...+..+.. ..++...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~ 235 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKF-RRIPYRYS 235 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCC-CCCccccC
Confidence 7665433 344578999999998764 4788999999999999999999999874 45666666666543 34555678
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
..+.+++.+||. +|.+||++.++|+|||+
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999997 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=326.13 Aligned_cols=252 Identities=31% Similarity=0.558 Sum_probs=212.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
++.+.||+|+||.||+|.+..+|..||+|.+...... ........+.+|+.++++++||||+++++++.+.....++++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 7889999999999999999999999999998654321 234456788999999999999999999999877666678999
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 183 (630)
+||+++++|. ++...+.+++..++.|+.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 85 VEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECccccccccccccc
Confidence 9999999998 6666778999999999999999999999999 99999999999998 7889999999999754321
Q ss_pred ---CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 184 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 184 ---~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
......|++.|+|||++.+ .++.++|+|||||++|+|++|+.||........+.+. .....+..++...++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI-ATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH-HcCCCCCCCCcccCHHHHH
Confidence 1234568999999998764 4788999999999999999999999875444444433 3333344566677899999
Q ss_pred HHHHcccCCCCCCCHHHHhcCCCc
Q 006810 260 FIEKCIVPASLRLPALELLKDPFL 283 (630)
Q Consensus 260 ~I~kcL~~p~~Rpsa~eLL~hpf~ 283 (630)
||.+||++|..||++.++|.|||.
T Consensus 241 ~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhcCcccCccHHHHhcCCCC
Confidence 999999989999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=336.36 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=207.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|++++++++||||++++++|.+. ..+++||
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 78 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISICM 78 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEEEe
Confidence 77899999999999999999999999999987432 244556788999999999999999999998754 4789999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 185 (630)
||+++|+|. ++.+.+.+++..+..++.||+.||.|||+ ++ ++||||||+|||++ .++.+||+|||++........
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~ 155 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 155 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEe-cCCcEEEccCCCccccccccc
Confidence 999999998 77777889999999999999999999997 56 99999999999998 788999999999876554445
Q ss_pred ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc----------------------
Q 006810 186 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---------------------- 242 (630)
Q Consensus 186 ~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~---------------------- 242 (630)
....|++.|+|||++.+ .++.++||||||+++|+|+||+.||.... .......+..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 56688999999998764 47889999999999999999999996532 2222222211
Q ss_pred --------------CCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 243 --------------GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 243 --------------g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
...|.......++++++||.+||. +|.+||++.+++.||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 111111112357789999999997 89999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=333.29 Aligned_cols=255 Identities=31% Similarity=0.561 Sum_probs=212.7
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
+|..+| .+.+.||.|+||+||+|.+..++..||+|.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 74 (280)
T cd06611 2 NPNDIW-EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-- 74 (280)
T ss_pred CchhHH-HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--
Confidence 578888 7778899999999999999999999999998743 345567788999999999999999999998754
Q ss_pred CEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 101 RTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++||||+++|+|. ++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~~ 151 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSA 151 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEC-CCCCEEEccCccch
Confidence 4689999999999998 4443 457999999999999999999999999 99999999999997 78999999999886
Q ss_pred eeccC--CCccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-CCC
Q 006810 179 VMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASL 249 (630)
Q Consensus 179 ~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l 249 (630)
..... ......|++.|+|||++. ..++.++||||||+++|+|++|+.||... +.......+..+..+ ...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~ 230 (280)
T cd06611 152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQ 230 (280)
T ss_pred hhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCC
Confidence 54322 223456899999999864 23677999999999999999999999864 444444444444332 223
Q ss_pred CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 250 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 250 ~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+...+..+.+||.+||. +|.+||++.++|+||||...
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 44567899999999997 89999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=327.47 Aligned_cols=250 Identities=32% Similarity=0.527 Sum_probs=206.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc--CCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~--~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~l 105 (630)
++.+.||+|+||.||+|.+ .+|..+|+|.+...... ........+.+|+.+|+.++|+||+++++++.+. ..+++
T Consensus 3 ~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 79 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTISI 79 (265)
T ss_pred cccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEEE
Confidence 6788999999999999986 47899999998754321 1233456788999999999999999999998654 57899
Q ss_pred EEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--
Q 006810 106 ITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-- 182 (630)
Q Consensus 106 V~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~-- 182 (630)
|+||+++++|. ++.....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ .++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhcc
Confidence 99999999998 6777788999999999999999999999998 99999999999998 789999999999864321
Q ss_pred ------CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 183 ------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 183 ------~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
.......|++.|+|||++.+ .++.++|+|||||++|+|++|..||.....................++...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 11234568999999998764 47899999999999999999999998654444443333221222335556789
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.+++||.+||. +|.+||++.++|.||||
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999997 89999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=332.68 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=201.5
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH---HHHhCCCCCeeEEEeEEEcCCCCEEEEEEc
Q 006810 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH---LLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (630)
Q Consensus 32 ~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~---iL~~L~HpNIVk~~~~f~d~~~~~l~lV~E 108 (630)
+||+|+||.||+|.+..+|..||+|.+........ .......+|.. ++...+||||+.++++|... ..+++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEe
Confidence 48999999999999999999999999875543222 11222334443 44455899999999988654 46889999
Q ss_pred ccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCcc
Q 006810 109 LFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 187 (630)
Q Consensus 109 y~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~ 187 (630)
|+++|+|. ++..++.+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.++|+|||++..........
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccCccC
Confidence 99999998 7777888999999999999999999999999 99999999999998 78999999999987655444445
Q ss_pred ccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006810 188 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263 (630)
Q Consensus 188 ~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~--~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~k 263 (630)
..|++.|+|||.+.+ .++.++|||||||++|+|++|..||..... ...+.... . ..+..++...++.++++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-L-TVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-h-cCCcCCccccCHHHHHHHHH
Confidence 579999999998753 478999999999999999999999975332 22221111 1 12334455678999999999
Q ss_pred ccc-CCCCCC-----CHHHHhcCCCcccCCCCcc
Q 006810 264 CIV-PASLRL-----PALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 264 cL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~ 291 (630)
||. +|.+|+ ++.++++||||+..+....
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence 997 899999 6999999999998765554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=329.72 Aligned_cols=256 Identities=27% Similarity=0.474 Sum_probs=208.3
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
+.+..|.+.| ++.+.||+|+||.||+|.+..+|..||+|++.... ......+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~ 76 (267)
T cd06646 2 ILRRNPQHDY-ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76 (267)
T ss_pred ccccCchhhc-chhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEE
Confidence 3456677778 77899999999999999999999999999987442 223345788999999999999999999987
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 97 DDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
.. ..+++||||+++|+|. .+...+.+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||
T Consensus 77 ~~--~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg 151 (267)
T cd06646 77 SR--EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFG 151 (267)
T ss_pred eC--CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCc
Confidence 55 4689999999999998 6666778999999999999999999999998 99999999999997 78899999999
Q ss_pred cceeeccCC--CccccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006810 176 LAIVMQQPT--ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249 (630)
Q Consensus 176 la~~~~~~~--~~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l 249 (630)
++....... .....|++.|+|||.+. ..++.++|||||||++|+|++|+.||..................+..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06646 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL 231 (267)
T ss_pred cceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC
Confidence 997654322 23456899999999763 347789999999999999999999996543222222222222222222
Q ss_pred --CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCC
Q 006810 250 --SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 282 (630)
Q Consensus 250 --~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf 282 (630)
....+..+++||.+||. +|.+||++.++|.|+|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 12357899999999997 8999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=327.15 Aligned_cols=253 Identities=30% Similarity=0.511 Sum_probs=207.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~--~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~l 105 (630)
+..+.||+|+||.||+|.+..+|..||+|.+........ ......+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~ 80 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED--SHFNL 80 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--CeEEE
Confidence 667899999999999999999999999999875432221 23457789999999999999999999988654 46889
Q ss_pred EEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC
Q 006810 106 ITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 184 (630)
Q Consensus 106 V~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 184 (630)
|+||+.+++|. .+...+.+++..+..|+.||+.||.|||+++ ++||||+|+||+++..+..+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999998 6667788999999999999999999999999 99999999999997444479999999986654321
Q ss_pred ------CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcH
Q 006810 185 ------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 185 ------~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~--~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
.....|+..|+|||++.+ .++.++||||||+++|+|++|+.||..... .......+.........+...++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 123468899999998764 588999999999999999999999965332 22222222223334455566789
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
+++++|.+||. +|.+||++.++|+||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999997 899999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=330.92 Aligned_cols=254 Identities=30% Similarity=0.539 Sum_probs=208.2
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~ 98 (630)
..|.|+| ++.+.||+|+||.||+|.+..++..||+|++.... .....+..|+.+++.+ +||||++++++|+..
T Consensus 12 ~~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 12 RDPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred cChhhhh-hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4678888 77799999999999999999999999999986432 3345678899999998 799999999998643
Q ss_pred ----CCCEEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEE
Q 006810 99 ----TNRTINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 171 (630)
Q Consensus 99 ----~~~~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 171 (630)
....++++|||+.+|+|. ++.. ...+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEE
Confidence 245789999999999998 4433 345889999999999999999999999 99999999999997 7899999
Q ss_pred cccccceeeccC--CCccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Q 006810 172 GDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 243 (630)
Q Consensus 172 ~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g 243 (630)
+|||++...... ......|++.|+|||++. ..++.++|||||||++|+|++|..||........+. .+...
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~ 241 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRN 241 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-hHhhC
Confidence 999998654322 234467899999999764 347889999999999999999999997654333333 23333
Q ss_pred CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 244 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 244 ~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
..+.......+.++.+||.+||. +|.+||++.++|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 242 PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 33333344578899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.99 Aligned_cols=247 Identities=31% Similarity=0.570 Sum_probs=209.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.+.||+|++|.||+|.+..+|..|++|.+..... .......+.+|+.+++.++||||+++++++.+. ..+++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVM 78 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEE
Confidence 667899999999999999999999999999876543 244567789999999999999999999998654 5789999
Q ss_pred cccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC
Q 006810 108 ELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 184 (630)
||+++++|. ++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++ .++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEe-CCCCEEEcccccceeccCcc
Confidence 999999998 5544 367899999999999999999999998 99999999999998 78899999999987654332
Q ss_pred --CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 185 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 185 --~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
.....|++.|+|||++.+ .++.++|||||||++|+|++|+.||... +.......+..+..+. +....+..++++|
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i 233 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFPP-VSQMYSQQLAQLI 233 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC-CccccCHHHHHHH
Confidence 234568999999998764 5789999999999999999999999764 4555555555554332 3446788999999
Q ss_pred HHccc-CCCCCCCHHHHhcCCCc
Q 006810 262 EKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.+||+ +|.+||++.+++.|||+
T Consensus 234 ~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 234 DQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHccCCcccCcCHHHHhhCCCC
Confidence 99997 89999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=325.88 Aligned_cols=251 Identities=33% Similarity=0.599 Sum_probs=208.2
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC-----HHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~-----~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
|| .+...||+|+||.||+|.+..++..||+|.+........ ....+.+.+|+.++++++||||+++++++.+.
T Consensus 1 ~~-~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 78 (267)
T cd06628 1 KW-IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA- 78 (267)
T ss_pred Cc-cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-
Confidence 45 677899999999999999999999999999875433221 12346688999999999999999999988664
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
...++||||+++++|. ++...+.+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.++|+|||++.
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg~~~ 154 (267)
T cd06628 79 -DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISK 154 (267)
T ss_pred -CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccCCCc
Confidence 4688999999999998 7777788999999999999999999999998 99999999999997 78999999999987
Q ss_pred eeccC--------CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006810 179 VMQQP--------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249 (630)
Q Consensus 179 ~~~~~--------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l 249 (630)
..... ......|++.|+|||.+.+ .++.++|+|||||++|+|++|+.||........+. .+.... ...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~-~~~~ 232 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENA-SPEI 232 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH-HHhccC-CCcC
Confidence 55421 1123458899999998764 57889999999999999999999998754444333 333332 2334
Q ss_pred CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 250 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 250 ~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
+...+..++++|++||+ +|.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 55678899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=330.38 Aligned_cols=252 Identities=23% Similarity=0.402 Sum_probs=203.1
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHH---HHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEc
Q 006810 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE---VHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (630)
Q Consensus 32 ~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~E---i~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~E 108 (630)
+||+|+||.||+|.+..+|+.||+|.+.......... ......| +.+++...||||++++++|.+. ..+++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh-HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEe
Confidence 4899999999999999999999999997654332221 1122233 4455667899999999988654 46899999
Q ss_pred ccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCcc
Q 006810 109 LFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 187 (630)
Q Consensus 109 y~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~ 187 (630)
|+.||+|. ++...+.+++..++.|+.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..........
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC-CCCCEEEccCcCccccCccCCcC
Confidence 99999998 6767788999999999999999999999998 99999999999998 78899999999987655444455
Q ss_pred ccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCC--CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006810 188 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263 (630)
Q Consensus 188 ~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~--~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~k 263 (630)
..|++.|+|||++.+ .++.++||||||+++|+|++|+.||.... ........... .+..++...++.++++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHH
Confidence 679999999998863 48899999999999999999999997642 22222222221 2334455568999999999
Q ss_pred ccc-CCCCCC-----CHHHHhcCCCcccCCCCcc
Q 006810 264 CIV-PASLRL-----PALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 264 cL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~ 291 (630)
||. +|.+|| ++.+++.||||....+...
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 997 799999 9999999999988765544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=329.69 Aligned_cols=250 Identities=28% Similarity=0.516 Sum_probs=206.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||.||+|.+..++..+++|.+... .....+.+.+|+.+++.++||||++++++|... ...++|+
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v~ 81 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILI 81 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEEE
Confidence 6678899999999999999999999999998643 245567788999999999999999999998764 4688999
Q ss_pred cccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--
Q 006810 108 ELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 183 (630)
||+++|+|. .+. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++ .++.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEcccccccccccccc
Confidence 999999998 333 3567999999999999999999999998 99999999999997 7899999999998654322
Q ss_pred CCccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcHH
Q 006810 184 TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQ 256 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p~~l~~~~s~~ 256 (630)
......+++.|+|||++. ..++.++|||||||++|+|++|+.||.... .......+..... ....+...+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSE 237 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCHH
Confidence 223456899999999873 236789999999999999999999998643 3333333333322 22334556789
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+++||.+||. +|.+||++.++++||||....
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 9999999997 899999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=335.87 Aligned_cols=246 Identities=27% Similarity=0.429 Sum_probs=190.8
Q ss_pred eeEecccCceEEEEEEEcc--CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 30 DEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~--tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
+..||+|+||+||+|.+.. ++..||+|.+..... ...+.+|+.+|+.++||||++++++|.......+++|+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 4689999999999998654 678999998864321 23467899999999999999999999877777899999
Q ss_pred cccCCCCHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe---CCCCcEEEcccc
Q 006810 108 ELFTSGSLRYRKK---------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDLG 175 (630)
Q Consensus 108 Ey~~gGsL~~~~~---------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~---~~~g~vKL~DFG 175 (630)
||+.++.+.++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+. ..+|.+||+|||
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 9998765544321 235889999999999999999999999 99999999999994 256799999999
Q ss_pred cceeeccCC-----CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCH---------HHHHHH
Q 006810 176 LAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------AQIYKK 239 (630)
Q Consensus 176 la~~~~~~~-----~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~---------~~i~~~ 239 (630)
+++...... .....||+.|+|||++.+ .++.++|||||||++|||+||++||...... .++...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 997654321 234578999999998764 4789999999999999999999999643211 111111
Q ss_pred HHc-CCC---------------------------C-------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 240 VTS-GIK---------------------------P-------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 240 i~~-g~~---------------------------p-------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
+.. +.. . .......+..++++|.+||+ +|.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 110 000 0 00011235678899999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=334.58 Aligned_cols=253 Identities=27% Similarity=0.445 Sum_probs=201.7
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~y-~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~ 79 (301)
T cd07873 6 ETY-IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSL 79 (301)
T ss_pred cce-EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc---CchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeE
Confidence 355 6778999999999999999999999999999755322 2234567899999999999999999998654 468
Q ss_pred EEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||+.+ +|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 80 TLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKS 155 (301)
T ss_pred EEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccC
Confidence 999999985 565 5443 457899999999999999999999999 99999999999998 78899999999986543
Q ss_pred cC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-------------
Q 006810 182 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI------------- 244 (630)
Q Consensus 182 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~------------- 244 (630)
.. ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||.......++ ..+....
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL-HFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCChhhchhhhc
Confidence 22 2233467899999998754 4788999999999999999999999874433322 2211100
Q ss_pred ----C----C-------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 245 ----K----P-------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 245 ----~----p-------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
. + .......++.+++||.+||. +|.+|||+.|+|.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 0 00112457889999999998 899999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=323.59 Aligned_cols=251 Identities=29% Similarity=0.534 Sum_probs=208.5
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
|..+| .+.+.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+.++++++||||+++++++.+. .
T Consensus 1 ~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~ 73 (262)
T cd06613 1 PQEDY-ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR--D 73 (262)
T ss_pred Cccce-EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC--C
Confidence 56778 77899999999999999999999999999997543 23557788999999999999999999988654 4
Q ss_pred EEEEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 102 TINMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
.++++|||+.+++|. +.... ..+++..++.++.|++.||.|||+++ ++||||+|+||+++ .+|.+||+|||++..
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~ 150 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQ 150 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchh
Confidence 689999999999998 55554 78999999999999999999999999 99999999999998 789999999999875
Q ss_pred eccC--CCccccCCCCCCCcccccc----ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC--CC
Q 006810 180 MQQP--TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SK 251 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~~----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l--~~ 251 (630)
.... ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||..................+..+ ..
T Consensus 151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (262)
T cd06613 151 LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKE 230 (262)
T ss_pred hhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchh
Confidence 5432 2334578999999998753 57889999999999999999999998755444443333332222221 22
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPF 282 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf 282 (630)
..+.++++||++||. +|..||++.+++.|||
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 346789999999997 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=354.21 Aligned_cols=253 Identities=26% Similarity=0.463 Sum_probs=207.2
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-C-----CCeeEEEeEEE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-H-----ENIIKFYNSWV 96 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-H-----pNIVk~~~~f~ 96 (630)
..|| .+.++||+|+||.|-+|.|..||+.||||+|+-. +....+...|+.+|..|+ | -|||+++++|.
T Consensus 185 ~~rY-~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 185 AYRY-EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred EEEE-EEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 3355 5579999999999999999999999999999743 455666788999999997 4 39999999997
Q ss_pred cCCCCEEEEEEcccCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC-CCCcEEEcc
Q 006810 97 DDTNRTINMITELFTSGSLRYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGD 173 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~D 173 (630)
-.. .+++|+|++.-....+++.+ .+++...++.+++||+.||.+||+.+ |||+||||+|||+.. ....|||+|
T Consensus 259 fr~--HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 259 FRN--HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred ccc--ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEe
Confidence 654 58899999988666676654 46899999999999999999999999 999999999999962 234899999
Q ss_pred cccceeeccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCCC-----
Q 006810 174 LGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP----- 246 (630)
Q Consensus 174 FGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p----- 246 (630)
||.|+....... +++-+..|+|||++-+ +|+.+.||||||||++||+||.+.|.+....+|+..++.. |.+|
T Consensus 335 FGSSc~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 335 FGSSCFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred cccccccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 999987776554 7788999999997765 7999999999999999999999999886666666544421 1000
Q ss_pred ----------------------------------------------C-C-------CCCCCcHHHHHHHHHccc-CCCCC
Q 006810 247 ----------------------------------------------A-S-------LSKVTDPQVKQFIEKCIV-PASLR 271 (630)
Q Consensus 247 ----------------------------------------------~-~-------l~~~~s~~lk~~I~kcL~-~p~~R 271 (630)
+ . +....+..+.+||++||. +|.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 0 0 001123568999999998 99999
Q ss_pred CCHHHHhcCCCcccC
Q 006810 272 LPALELLKDPFLVTD 286 (630)
Q Consensus 272 psa~eLL~hpf~~~~ 286 (630)
+|+.++|+||||...
T Consensus 494 ~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 494 ITPAQALNHPFLTGT 508 (586)
T ss_pred CCHHHHhcCcccccc
Confidence 999999999999853
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.84 Aligned_cols=252 Identities=35% Similarity=0.597 Sum_probs=211.0
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~-~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
|| +..+.||+|+||.||+|.+..+|..|++|.+...... ...+..+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 1 ~~-~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~ 77 (258)
T cd06632 1 RW-RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNL 77 (258)
T ss_pred Cc-cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeE
Confidence 56 6789999999999999999989999999998764322 2344567789999999999999999999987644 468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++|+||+++++|. ++...+.+++..+..++.||+.||.|||+.+ ++||||+|+||+++ .++.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccceeccc
Confidence 8999999999998 7777778999999999999999999999998 99999999999998 789999999999876544
Q ss_pred CC-CccccCCCCCCCcccccc-c-cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 183 PT-ARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 183 ~~-~~~~~GTp~Y~APEvl~~-~-ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
.. .....|++.|+|||.+.. . ++.++|+||||+++|+|++|+.||........... +........++...++.+++
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HHhcccCCCcCCCcCHHHHH
Confidence 32 345678999999997653 3 78999999999999999999999987553333333 33322333455567899999
Q ss_pred HHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 260 FIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
||.+||. +|.+||++.++|.|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999997 89999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.45 Aligned_cols=256 Identities=24% Similarity=0.387 Sum_probs=208.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
+..+.||+|+||+||+|.+..+|..||+|.+...... .......+.+|+.+|+.++|+||+++++.|... ..+++||
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~ 79 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLVL 79 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEEE
Confidence 5568899999999999999999999999998755432 223345578899999999999999999988654 4689999
Q ss_pred cccCCCCHH-HHh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-
Q 006810 108 ELFTSGSLR-YRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 183 (630)
||+.+|+|. .+. ....+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEC-CCCCEEEecCCcceecCCCC
Confidence 999999997 433 3446999999999999999999999999 99999999999998 7789999999998654332
Q ss_pred CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHH---HHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 184 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~---i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
......|++.|+|||++. ..++.++|+|||||++|+|++|..||........ +...+... ...+....++.+.+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 234 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAKS 234 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHHH
Confidence 223457899999999875 4588999999999999999999999986433222 22222221 22344556789999
Q ss_pred HHHHccc-CCCCCCC-----HHHHhcCCCcccCCCCcc
Q 006810 260 FIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 260 ~I~kcL~-~p~~Rps-----a~eLL~hpf~~~~~~~~~ 291 (630)
||.+||+ +|.+||+ +.+++.||||.....+..
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 272 (285)
T cd05632 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL 272 (285)
T ss_pred HHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHH
Confidence 9999998 8999999 889999999998765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=339.88 Aligned_cols=250 Identities=22% Similarity=0.427 Sum_probs=199.0
Q ss_pred eeeEeccc--CceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 29 YDEILGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 29 ~~e~LG~G--~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+.++||+| +|++||++.+..+|+.||+|.+..... .....+.+.+|+.+++.++||||++++++|..+ ..+++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEE
Confidence 45789999 789999999999999999999875532 234456688899999999999999999999765 468999
Q ss_pred EcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 107 TELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
|||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++++||+........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhccccc
Confidence 9999999998 4443 346899999999999999999999999 99999999999998 7889999999865332111
Q ss_pred ---------CCccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-----
Q 006810 184 ---------TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----- 246 (630)
Q Consensus 184 ---------~~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p----- 246 (630)
......++..|+|||++.+ .|+.++|||||||++|+|++|+.||.............. +..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 233 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCLLDT 233 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-CCccccccc
Confidence 1122356778999998864 488999999999999999999999976443332222221 1110
Q ss_pred ---------------------------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 ---------------------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 ---------------------------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.......++.+++||.+||+ +|.+|||+.++|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00112346789999999998 89999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.94 Aligned_cols=255 Identities=29% Similarity=0.507 Sum_probs=212.9
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|| ++.+.||.|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 2 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (274)
T cd06609 2 LF-TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLW 75 (274)
T ss_pred hh-hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEE
Confidence 56 66788999999999999999999999999987543 234456688999999999999999999998765 5789
Q ss_pred EEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-
Q 006810 105 MITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 105 lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 183 (630)
+|+||+++++|.......++++..++.++.||+.||.|||+++ ++||||+|+||+++ .+|.++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEcccccceeecccc
Confidence 9999999999984334448999999999999999999999998 99999999999998 7899999999999776543
Q ss_pred -CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 184 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 184 -~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
......|++.|+|||.+.+ .++.++||||||+++|+|+||..||... ++......+..+..+.......++.+.++|
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCCCCcccccCHHHHHHH
Confidence 2334578999999998764 5899999999999999999999999763 344444445444433322222788999999
Q ss_pred HHccc-CCCCCCCHHHHhcCCCcccCCCC
Q 006810 262 EKCIV-PASLRLPALELLKDPFLVTDNPK 289 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~ 289 (630)
.+||. +|.+||++.++++||||+.....
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 99997 89999999999999999876544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=317.26 Aligned_cols=251 Identities=38% Similarity=0.626 Sum_probs=216.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|++|.||+|.+..+|..|++|++..... .....+.+.+|+.++++++||||+++++.+.+.....+++|+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 677999999999999999999999999999876543 245678899999999999999999999988765446799999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC--
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~-- 184 (630)
||+++++|. ++.....+++..++.++.|++.||.|||+.+ ++||||+|+||+++ .++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEcccccEEeccccccc
Confidence 999999998 6666669999999999999999999999998 99999999999998 68999999999997665543
Q ss_pred --CccccCCCCCCCccccccc-cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 185 --ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 185 --~~~~~GTp~Y~APEvl~~~-ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
.....+++.|+|||.+.+. ++.++||||||+++|+|++|..||....+.......+........++...++.+++||
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 3455789999999987654 8899999999999999999999998765455555555443344455666789999999
Q ss_pred HHccc-CCCCCCCHHHHhcCCCc
Q 006810 262 EKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.+||. +|.+||++.+++.||||
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHhCcCChhhCCCHHHHhhCCCC
Confidence 99998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.91 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=205.8
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 99 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~ 99 (630)
++.++| .+.+.||+|+||.||+|.+..+|..+|+|.+.... .....+.+|+.+++.+ +||||++++++|...+
T Consensus 19 ~~~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 19 DPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 478888 77789999999999999999999999999986432 2234577899999999 8999999999987543
Q ss_pred ---CCEEEEEEcccCCCCHH-HHh----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEE
Q 006810 100 ---NRTINMITELFTSGSLR-YRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 171 (630)
Q Consensus 100 ---~~~l~lV~Ey~~gGsL~-~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 171 (630)
...+++||||+++|+|. ++. ....+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEE
Confidence 24689999999999997 432 3467899999999999999999999998 99999999999997 7889999
Q ss_pred cccccceeeccCC--CccccCCCCCCCcccccc------ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Q 006810 172 GDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 243 (630)
Q Consensus 172 ~DFGla~~~~~~~--~~~~~GTp~Y~APEvl~~------~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g 243 (630)
+|||++....... .....|++.|+|||++.. .++.++|||||||++|+|++|+.||........+. .+..+
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~ 248 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-KIPRN 248 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-HHhcC
Confidence 9999987544322 234568999999998753 26789999999999999999999998744333333 33333
Q ss_pred CCC-CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 244 IKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 244 ~~p-~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
..+ ...+......++++|.+||+ +|.+||++.++|.||||+
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 222 11223356789999999997 899999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=328.05 Aligned_cols=248 Identities=28% Similarity=0.455 Sum_probs=199.3
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|++|.||+|.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++.+. ..+++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLYLIF 78 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEEEEE
Confidence 678899999999999999999999999999875432 122335678899999999999999999998754 4689999
Q ss_pred cccCCCCHH-HHhh---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 108 ELFTSGSLR-YRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~---~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
||+.+ +|. ++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++......
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeecCCC
Confidence 99985 554 4432 356899999999999999999999998 99999999999998 7899999999998755432
Q ss_pred C--CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 006810 184 T--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------- 246 (630)
Q Consensus 184 ~--~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p------------- 246 (630)
. .....+++.|+|||++.+ .++.++|||||||++|+|+||+.||.+................+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 2 223467899999998754 47889999999999999999999998754444333322110000
Q ss_pred -------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 247 -------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 247 -------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.......++++++||.+||. +|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01123357899999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.24 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=210.9
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCC
Q 006810 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (630)
Q Consensus 33 LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~g 112 (630)
||.|+||.||+|.+..+|..||+|.+...... .....+.+.+|+.+++.++||||+++++++.+. ..+++|+||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCC
Confidence 69999999999999999999999999755432 234457799999999999999999999988654 468899999999
Q ss_pred CCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-CCccccC
Q 006810 113 GSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIG 190 (630)
Q Consensus 113 GsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-~~~~~~G 190 (630)
|+|. ++.+...+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...... ......|
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccC
Confidence 9998 6667778999999999999999999999998 99999999999998 7899999999999766543 2234578
Q ss_pred CCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-C
Q 006810 191 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 267 (630)
Q Consensus 191 Tp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~-~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~ 267 (630)
++.|+|||.+.+ .++.++|+||||+++|+|++|..||.... ++...+..+..+.....++...++.+++||.+||. +
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 999999998754 58899999999999999999999997644 25555566654444444555558899999999997 8
Q ss_pred CCCCCC-----HHHHhcCCCcccCCC
Q 006810 268 ASLRLP-----ALELLKDPFLVTDNP 288 (630)
Q Consensus 268 p~~Rps-----a~eLL~hpf~~~~~~ 288 (630)
|.+||+ +.|+++||||...++
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCCCC
Confidence 999999 999999999987543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.04 Aligned_cols=255 Identities=26% Similarity=0.472 Sum_probs=205.8
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~ 98 (630)
.++..+| .+.+.||+|+||.||+|.+..+|..||+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 14 PDPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred CCcccce-eeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 4577888 77799999999999999999999999999875321 1224577899999999 799999999987542
Q ss_pred ---CCCEEEEEEcccCCCCHH-HHh----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEE
Q 006810 99 ---TNRTINMITELFTSGSLR-YRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 170 (630)
Q Consensus 99 ---~~~~l~lV~Ey~~gGsL~-~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 170 (630)
....+++||||+++|+|. .+. ....+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC-CCCCEE
Confidence 335789999999999997 332 3456899999999999999999999998 99999999999998 788999
Q ss_pred EcccccceeeccC--CCccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Q 006810 171 IGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 242 (630)
Q Consensus 171 L~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~ 242 (630)
|+|||++...... ......|++.|+|||++. ..++.++|||||||++|+|++|+.||........+......
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 9999998765432 223456899999999874 34788999999999999999999999875443433322221
Q ss_pred CCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 243 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 243 g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.......+...+..++++|.+||. +|.+||++.++|.|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 112222344567889999999997 89999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=327.18 Aligned_cols=250 Identities=28% Similarity=0.496 Sum_probs=209.4
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++.+... ..+++|+
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICM 78 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEE
Confidence 55688999999999999999999999999987543 234556788999999999999999999988765 5789999
Q ss_pred cccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC
Q 006810 108 ELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 184 (630)
||+.+++|. ++... ..+++..+..++.||+.||.|||+ .+ ++||||||+||+++ .+|.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhHHHH
Confidence 999999998 55554 789999999999999999999999 88 99999999999998 78999999999987654433
Q ss_pred CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCC----CCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 185 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 185 ~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~----~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
.....+++.|+|||.+.+ .++.++||||||+++|+|++|..||... .......+.+..+..+.......++.+++
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 334778999999998754 5889999999999999999999999764 23334444444443333223337889999
Q ss_pred HHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 260 FIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
||.+||. +|.+||++.+++.||||+.
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 9999997 8999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.76 Aligned_cols=251 Identities=25% Similarity=0.436 Sum_probs=204.2
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|| ++.+.||+|+||.||+|.+..+|..||+|.+..... .....+.+.+|+.++++++||||++++++|... ..++
T Consensus 2 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 76 (286)
T cd07847 2 KY-EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLH 76 (286)
T ss_pred ce-eeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEE
Confidence 56 677899999999999999999999999999865432 122334578899999999999999999998654 4688
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+||||+++++|. .......+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++......
T Consensus 77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGP 153 (286)
T ss_pred EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCC
Confidence 999999999998 4455667999999999999999999999998 99999999999998 7889999999999765443
Q ss_pred C--CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--C-------------
Q 006810 184 T--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I------------- 244 (630)
Q Consensus 184 ~--~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g--~------------- 244 (630)
. .....++..|+|||++.+ .++.++||||||+++|+|++|+.||.+..+.+.+....... .
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 2 233467889999998754 47889999999999999999999998765554443322110 0
Q ss_pred -----CCC--C------CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 245 -----KPA--S------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 245 -----~p~--~------l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.+. . .....+..+.+||.+||. +|.+||++.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0 012346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=329.69 Aligned_cols=262 Identities=27% Similarity=0.465 Sum_probs=213.7
Q ss_pred CccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEE
Q 006810 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (630)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f 95 (630)
.+...+|..|| ++.+.||+|+||+||+|.+..+|..||+|.+..... ........+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~ 84 (307)
T cd06607 7 LFSKDDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY 84 (307)
T ss_pred hhcCCCcchhh-hhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 35567888898 667999999999999999999999999999875432 2344556788999999999999999999998
Q ss_pred EcCCCCEEEEEEcccCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 96 VDDTNRTINMITELFTSGSLRYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
.+. ...++|+||+.++.+..+. ..+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .+|.+||+||
T Consensus 85 ~~~--~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~-~~~~~kL~df 159 (307)
T cd06607 85 LRE--HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADF 159 (307)
T ss_pred EeC--CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEC-CCCCEEEeec
Confidence 765 3588999999865555433 4567999999999999999999999998 99999999999997 7899999999
Q ss_pred ccceeeccCCCccccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006810 175 GLAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 250 (630)
Q Consensus 175 Gla~~~~~~~~~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~ 250 (630)
|++...... ....+++.|+|||++. +.++.++||||||+++|+|+||+.||........++ .+.....+....
T Consensus 160 g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~ 236 (307)
T cd06607 160 GSASLVSPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLSS 236 (307)
T ss_pred CcceecCCC--CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-HHhcCCCCCCCc
Confidence 998654332 3456889999999763 458889999999999999999999997643333333 333333333233
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
...+..++++|.+||. +|.+||++.+++.||||....
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 3467889999999997 899999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.78 Aligned_cols=258 Identities=22% Similarity=0.330 Sum_probs=205.4
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
++..+| ++.+.||+|+||.||+|.+..+|..||+|.+....... .....+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 4 RSVTEF-EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD--GIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred ccccce-eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC--CCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 456677 77789999999999999999999999999997654221 222345679999999999999999999887666
Q ss_pred CEEEEEEcccCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 RTINMITELFTSGSLRYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++||||+.++...++. ....+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 81 ~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~~ 157 (309)
T cd07845 81 DSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLART 157 (309)
T ss_pred CeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceeee
Confidence 6789999999864333443 3467999999999999999999999999 99999999999998 789999999999976
Q ss_pred eccC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC----------
Q 006810 180 MQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---------- 245 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~---------- 245 (630)
.... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||..... ...+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCChhhchhh
Confidence 6543 2223346888999998754 478999999999999999999999987443 333333222100
Q ss_pred -----------C-CCC------CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 246 -----------P-ASL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 246 -----------p-~~l------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
+ ..+ ....++.+++||.+||. +|.+||++.++|.||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0 000 01247889999999998 8999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.78 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=198.9
Q ss_pred CcceeeeeEecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~--~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
.+| ++.+.||+|+||.||+|... .++..||+|.+.... ...+|+.+|++++||||++++++|... .
T Consensus 92 ~~y-~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---------~~~~E~~il~~l~h~~iv~~~~~~~~~--~ 159 (392)
T PHA03207 92 MQY-NILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---------TPGREIDILKTISHRAIINLIHAYRWK--S 159 (392)
T ss_pred Cce-EEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---------cHHHHHHHHHhcCCCCccceeeeEeeC--C
Confidence 356 77899999999999999753 467889999875321 245799999999999999999988654 4
Q ss_pred EEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 102 TINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
.+++|||++.++.+.++.....+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 160 ~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 160 TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLD 236 (392)
T ss_pred EEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCccccccC
Confidence 6899999998655557777788999999999999999999999999 99999999999998 78999999999997554
Q ss_pred cC----CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCC---HHHHHHHHHc-C---------
Q 006810 182 QP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTS-G--------- 243 (630)
Q Consensus 182 ~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~---~~~i~~~i~~-g--------- 243 (630)
.. ......||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+... ..++...+.. +
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 32 1234579999999998864 589999999999999999999999976432 1122111110 0
Q ss_pred ---------------CCC-CCCC-----CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCC
Q 006810 244 ---------------IKP-ASLS-----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 289 (630)
Q Consensus 244 ---------------~~p-~~l~-----~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~ 289 (630)
..+ ...+ ...+.++++||.+||. +|.+||++.++|.||||....+.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 000 0011 1245688999999997 89999999999999999875443
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=331.03 Aligned_cols=258 Identities=22% Similarity=0.375 Sum_probs=209.4
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||+||+|.+..+|..||+|.+...... .......+.+|+.+++.++||||+++++.+.+. ..++
T Consensus 2 ~y-~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 77 (316)
T cd05574 2 HF-KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASFQTE--TYLC 77 (316)
T ss_pred ce-EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHHHHHHHHHHHHHhCCCCCchhheeeeecC--CEEE
Confidence 34 6778999999999999999999999999999765432 234567789999999999999999999988554 5789
Q ss_pred EEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 105 MITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+||||+.+++|. ++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++ .+|.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc-CCCCEEEeecchhhccc
Confidence 999999999998 4443 357899999999999999999999998 99999999999998 78999999999875432
Q ss_pred cC-------------------------------CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCC
Q 006810 182 QP-------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNE 229 (630)
Q Consensus 182 ~~-------------------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~ 229 (630)
.. ......||..|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 11 1123468999999998764 478899999999999999999999987
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCC----HHHHhcCCCcccCCCCc
Q 006810 230 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP----ALELLKDPFLVTDNPKD 290 (630)
Q Consensus 230 ~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rps----a~eLL~hpf~~~~~~~~ 290 (630)
.............. .........++.+++||.+||. +|.+||+ +.++|.||||+...+..
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~ 299 (316)
T cd05574 235 SNRDETFSNILKKE-VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL 299 (316)
T ss_pred CchHHHHHHHhcCC-ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence 54444443333222 2211222268899999999997 8999999 99999999998765443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=321.47 Aligned_cols=249 Identities=32% Similarity=0.573 Sum_probs=205.7
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
|..+| ++.+.||+|+||.||+|.+..++..|++|.+.... ..+.+.+|+++++.++||||+++++++.+. .
T Consensus 1 ~~~~y-~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~ 71 (256)
T cd06612 1 PEEVF-DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKN--T 71 (256)
T ss_pred Ccccc-hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--C
Confidence 55677 77889999999999999999999999999986432 256789999999999999999999998765 5
Q ss_pred EEEEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 102 TINMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
.+++++||+.+++|. ++. ....+++..++.++.||+.||.|||+.+ ++||||+|+||+++ .++.++|+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEC-CCCcEEEcccccchh
Confidence 689999999999998 444 3567899999999999999999999998 99999999999998 788999999999876
Q ss_pred eccCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCcH
Q 006810 180 MQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKPASLSKVTDP 255 (630)
Q Consensus 180 ~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g-~~p~~l~~~~s~ 255 (630)
..... .....|++.|+|||++.+ .++.++||||||+++|+|++|+.||......... ..+... ......+...+.
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd06612 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FMIPNKPPPTLSDPEKWSP 227 (256)
T ss_pred cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-hhhccCCCCCCCchhhcCH
Confidence 54432 234568899999998764 5888999999999999999999999764332222 222221 111222334678
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.+.+||.+||+ +|.+||++.++|.||||
T Consensus 228 ~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999997 89999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=324.94 Aligned_cols=256 Identities=27% Similarity=0.477 Sum_probs=209.5
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| +..+.||.|++|.||+|.+..++..||+|.+.... ......++.+|+++++.++||||++++++|.+.....++
T Consensus 2 ~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 2 KI-VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred ce-EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 45 56788999999999999999999999999987543 234557789999999999999999999999877767899
Q ss_pred EEEcccCCCCHH-HHh----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 105 MITELFTSGSLR-YRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
+||||+++++|. ++. ....+++..+..++.||+.||.|||+.+ ++||||+|+||+++ .++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-cCCeEEEeecccccc
Confidence 999999999996 322 3456899999999999999999999999 99999999999998 788999999999876
Q ss_pred eccCCCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCC----CCHHHHHHHHHcCCCCC---CCC-
Q 006810 180 MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPA---SLS- 250 (630)
Q Consensus 180 ~~~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~----~~~~~i~~~i~~g~~p~---~l~- 250 (630)
..........++..|+|||.+. ..++.++|||||||++|+|++|..||... .........+.....+. ...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 155 LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred ccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 5544444556888999999775 45889999999999999999999999764 22333444433321111 111
Q ss_pred -CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 251 -KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 251 -~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
...++.+++||.+||. +|.+||++.|++.||||+...
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 2246789999999997 899999999999999996644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.47 Aligned_cols=245 Identities=26% Similarity=0.390 Sum_probs=192.0
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||.||+|.+..++..||+|..... ....|+.++++++||||++++++|... ...+
T Consensus 67 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 133 (357)
T PHA03209 67 GY-TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSG--AITC 133 (357)
T ss_pred Cc-EEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeC--CeeE
Confidence 45 7889999999999999999999999999975322 134689999999999999999998765 4688
Q ss_pred EEEcccCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc-
Q 006810 105 MITELFTSGSLRYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 182 (630)
Q Consensus 105 lV~Ey~~gGsL~~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~- 182 (630)
+|+||+.+..+.++. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 134 lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 134 MVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEecCccccccccC
Confidence 999999765555543 4567999999999999999999999999 99999999999998 788999999999865332
Q ss_pred CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCC----------HHHHHHHHHc-CCCCCCCC
Q 006810 183 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN----------PAQIYKKVTS-GIKPASLS 250 (630)
Q Consensus 183 ~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~----------~~~i~~~i~~-g~~p~~l~ 250 (630)
.......||+.|+|||++.+ .|+.++|||||||++|||+++..|+..... ...+...+.. +..|..++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 23345679999999998764 589999999999999999996655432111 1112222211 11111111
Q ss_pred ------------------------------CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 251 ------------------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 251 ------------------------------~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
...+.++.+||.+||+ +|.+||||.|+|+||||+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1235567789999998 8999999999999999975
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=316.87 Aligned_cols=249 Identities=29% Similarity=0.507 Sum_probs=210.4
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|| ++.++||.|+||.||.+.+..+|..|++|.+..... .......+.+|+.++++++|+||++++++|.+. ..++
T Consensus 1 ~y-~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08221 1 HY-IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLL 75 (256)
T ss_pred Cc-eEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEE
Confidence 56 677999999999999999999999999999876543 234556788999999999999999999999764 5789
Q ss_pred EEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 105 MITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++|||+++|+|. ++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++ .++.+||+|||++....
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEcc
Confidence 999999999998 55443 56899999999999999999999998 99999999999998 78899999999987654
Q ss_pred cCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 182 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 182 ~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
... .....|++.|+|||++.+ .++.++|+||||+++|+|++|+.||.. .+.......+..+..+. .....+..++
T Consensus 153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd08221 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELI 230 (256)
T ss_pred cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHH
Confidence 332 344578999999998764 478899999999999999999999976 45555555555543332 3355688999
Q ss_pred HHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 259 QFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
++|.+||. +|.+||++.++|+|||+
T Consensus 231 ~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHcccCcccCCCHHHHhhCcCC
Confidence 99999997 79999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.67 Aligned_cols=248 Identities=26% Similarity=0.434 Sum_probs=209.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.++||.|+||.||+|.+..+|..||+|.+...... .......+.+|+.++++++||||++++++|.+. ..+++|+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 79 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPFLVNLWYSFQDE--ENMYLVV 79 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC--CeEEEEE
Confidence 7789999999999999999999999999999755432 234567899999999999999999999988543 5689999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-CC
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TA 185 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-~~ 185 (630)
||+.+++|. ++.....+++..+..|+.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...... ..
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCccc
Confidence 999999998 6666678999999999999999999999998 99999999999998 7899999999998765443 23
Q ss_pred ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 186 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 186 ~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~--~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
....|+..|+|||++.+ .++.++|+||||+++|+|++|..||..... ...+...... .....+...+..+.++|.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHH
Confidence 34568899999998764 478999999999999999999999987543 3444433332 233444556789999999
Q ss_pred Hccc-CCCCCCCH--HHHhcCCCc
Q 006810 263 KCIV-PASLRLPA--LELLKDPFL 283 (630)
Q Consensus 263 kcL~-~p~~Rpsa--~eLL~hpf~ 283 (630)
+||. +|.+||++ .|++.||||
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHccCChhHcCCccHHHHhcCCCC
Confidence 9997 89999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.36 Aligned_cols=262 Identities=23% Similarity=0.440 Sum_probs=227.2
Q ss_pred eeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEc
Q 006810 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (630)
Q Consensus 29 ~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~E 108 (630)
|.++||+|.||.|-+++.+.+|+.+|+|+++.+-+. .+++...-..|-++|+.++||.+..+..+|+. +.++++|||
T Consensus 172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevii-akdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drlCFVMe 248 (516)
T KOG0690|consen 172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVII-AKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRLCFVME 248 (516)
T ss_pred HHHHhcCCccceEEEEeecccCceeehhhhhhhhee-ehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceEEEEEE
Confidence 357899999999999999999999999999866544 46677778889999999999999999888854 457999999
Q ss_pred ccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee--ccCCC
Q 006810 109 LFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTA 185 (630)
Q Consensus 109 y~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~--~~~~~ 185 (630)
|..||.|. .+...+.+++...+.+...|+.||.|||+++ ||.||||.+|+|++ .+|++||+|||+.+.- .....
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhccccccee
Confidence 99999998 6777888999999999999999999999999 99999999999998 8999999999998643 23456
Q ss_pred ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHc
Q 006810 186 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264 (630)
Q Consensus 186 ~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kc 264 (630)
.++||||+|+|||++.. .|+.++|.|.+|+++|||++|+.||.. .+-+.++..|..+ ...++...+++++.++..+
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~e--d~kFPr~ls~eAktLLsGL 402 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILME--DLKFPRTLSPEAKTLLSGL 402 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhh--hccCCccCCHHHHHHHHHH
Confidence 78999999999999975 699999999999999999999999987 4455555555443 3356777899999999999
Q ss_pred cc-CCCCCCC-----HHHHhcCCCcccCCCCccccCCCCCC
Q 006810 265 IV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 299 (630)
Q Consensus 265 L~-~p~~Rps-----a~eLL~hpf~~~~~~~~~~~~~l~~p 299 (630)
|. +|.+|.. |.|+..|+||...+|...+.+.+..|
T Consensus 403 L~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PP 443 (516)
T KOG0690|consen 403 LKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPP 443 (516)
T ss_pred hhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCC
Confidence 97 8999985 88999999999999988776666544
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=324.23 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=203.8
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|| ++.+.||+|+||.||+|.+..+|..||+|++...... ......+.+|+.++++++||||+++++++.+. ..++
T Consensus 1 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 75 (286)
T cd07832 1 RY-KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE--GGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFV 75 (286)
T ss_pred Cc-eEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc--chhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeE
Confidence 45 7889999999999999999999999999998765431 23456788999999999999999999998654 5789
Q ss_pred EEEcccCCCCHH-HH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 105 MITELFTSGSLR-YR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+|+||+ +++|. .+ .....+++..++.++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++.....
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLIS-ADGVLKIADFGLARLFSE 151 (286)
T ss_pred EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEc-CCCcEEEeeeeecccccC
Confidence 999999 99997 44 34567999999999999999999999999 99999999999998 789999999999876654
Q ss_pred CC---CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Q 006810 183 PT---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------- 246 (630)
Q Consensus 183 ~~---~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p----------- 246 (630)
.. .....|++.|+|||++.+ .++.++||||||+++|+|+||.+||....+...+...+..-..+
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 32 234568999999998753 36899999999999999999988887654443333222210000
Q ss_pred ----------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 247 ----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 247 ----------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
.......+..+.+||.+||. +|.+||++.++|.||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00112346889999999998 899999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=318.88 Aligned_cols=248 Identities=29% Similarity=0.512 Sum_probs=203.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||.|+||+||+|.+..+|..||+|++..... ......+.+|+.+|+.++||||+++++.+... ..+++||
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~ 78 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELWLVM 78 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEEEEE
Confidence 778999999999999999999999999999875432 22567789999999999999999999988654 4689999
Q ss_pred cccCCCCHH-HHhhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 108 ELFTSGSLR-YRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~---~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
||+++++|. ++... ..+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLG-EDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccchHHHhccC
Confidence 999999998 54442 46899999999999999999999999 99999999999998 7889999999998655432
Q ss_pred C------CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCC
Q 006810 184 T------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL---SKV 252 (630)
Q Consensus 184 ~------~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l---~~~ 252 (630)
. .....|++.|+|||++.. .++.++|+||||+++|+|++|+.||..........+.+......... ...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 1 234568999999998754 48899999999999999999999998754433333333322111111 124
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.++.+++||.+||. +|.+||++.+++.||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 57889999999998 89999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=317.52 Aligned_cols=250 Identities=34% Similarity=0.616 Sum_probs=209.1
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|| .+.+.||+|+||.||+|.+..+|..||+|.+...... ....+.+.+|+.+++.++||||+++++.+... ..++
T Consensus 1 ~y-~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~ 75 (264)
T cd06626 1 RW-QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVY 75 (264)
T ss_pred Cc-eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEE
Confidence 56 7789999999999999999999999999999765432 45678899999999999999999999986543 5789
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+|+||+++++|. ++.....+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEcccccccccCCC
Confidence 999999999998 6666667899999999999999999999999 99999999999998 6899999999998765432
Q ss_pred CC------ccccCCCCCCCcccccc-c---cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC-
Q 006810 184 TA------RSVIGTPEFMAPELYEE-E---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV- 252 (630)
Q Consensus 184 ~~------~~~~GTp~Y~APEvl~~-~---ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~- 252 (630)
.. ....+++.|+|||++.+ . ++.++||||||+++|+|++|+.||....+.......+..+. +..++..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSL 231 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC-CCCCCccc
Confidence 11 13467889999998764 2 68899999999999999999999976545544444444432 2233333
Q ss_pred -CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 253 -TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 253 -~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.++.+.+||.+||+ +|.+||++.+++.|||+
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 47899999999997 89999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.54 Aligned_cols=249 Identities=29% Similarity=0.544 Sum_probs=206.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.++++++||||+++++++... ..+++||
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYMCM 78 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEEEE
Confidence 66789999999999999999999999999986431 344457788999999999999999999988654 5789999
Q ss_pred cccCCCCHH-HHhh---cCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 108 ELFTSGSLR-YRKK---HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 108 Ey~~gGsL~-~~~~---~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
||+++++|. ++.. ...+++..+..++.||+.||.|||+ ++ |+||||||+||+++ .++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEEC-CCCCEEEeecCCcccccC
Confidence 999999998 4443 2379999999999999999999996 57 99999999999998 689999999999976655
Q ss_pred CCCccccCCCCCCCcccccc-------ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHH---HHHcCCCCCCCCCC
Q 006810 183 PTARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK---KVTSGIKPASLSKV 252 (630)
Q Consensus 183 ~~~~~~~GTp~Y~APEvl~~-------~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~---~i~~g~~p~~l~~~ 252 (630)
.......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.... ...... .+..+ .+..++..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~-~~~~~~~~ 233 (286)
T cd06622 156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDG-DPPTLPSG 233 (286)
T ss_pred CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhc-CCCCCCcc
Confidence 55555678999999998743 25789999999999999999999997532 222222 23333 23344555
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.++++++||.+||. +|.+||++.+++.||||...
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 78999999999997 89999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=322.12 Aligned_cols=251 Identities=28% Similarity=0.473 Sum_probs=199.4
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHH-HHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~i-L~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
++.+.||+|+||.||+|.+..+|..||+|.++.... ... ...+..|+.+ ++.++||||+++++++... ..+++|
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv 78 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQE-QKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC 78 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence 677899999999999999999999999999875432 122 2345556554 6778999999999998654 358999
Q ss_pred EcccCCCCHH-HHh----hcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 107 TELFTSGSLR-YRK----KHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
|||+++ +|. ++. ....+++..++.++.||+.||.|||++ + ++||||||+||+++ .++.+||+|||++...
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeeccccccc
Confidence 999985 553 332 335789999999999999999999987 7 99999999999998 7899999999998765
Q ss_pred ccCCC-ccccCCCCCCCcccccc-----ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 181 QQPTA-RSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 181 ~~~~~-~~~~GTp~Y~APEvl~~-----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
..... ....|++.|+|||++.+ .++.++|+|||||++|+|++|+.||............+..+..+.......+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 43322 23568999999998753 4688999999999999999999999764444333333333333332233467
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.++++||.+||. +|.+||++.+++.||||....
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 899999999997 899999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=315.67 Aligned_cols=250 Identities=30% Similarity=0.525 Sum_probs=208.0
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|| ++.+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+.+|+.++||||+++++.+... ..++
T Consensus 1 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08220 1 KY-EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALM 75 (256)
T ss_pred Cc-eEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEE
Confidence 45 678999999999999999999999999999976543 234567789999999999999999999988644 5789
Q ss_pred EEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 105 MITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+||||+++++|. ++.. ...+++..++.++.|++.||.|||+++ ++||||+|+||+++..++.+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 999999999998 5544 345899999999999999999999998 99999999999998556678999999997665
Q ss_pred cCC-CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 182 QPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 182 ~~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... .....+..+.. ..++...++.+++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~l~~ 231 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-ALVLKIMSGTF-APISDRYSPDLRQ 231 (256)
T ss_pred CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-HHHHHHHhcCC-CCCCCCcCHHHHH
Confidence 432 234568999999998864 4788999999999999999999999875443 44444443322 2344456889999
Q ss_pred HHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 260 FIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
+|.+||. +|.+||++.++|.||||
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=319.94 Aligned_cols=245 Identities=32% Similarity=0.519 Sum_probs=201.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
..||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..+++|+||+
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 87 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIFMEQV 87 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEEEecC
Confidence 57999999999999999999999999886432 34556789999999999999999999987654 5789999999
Q ss_pred CCCCHH-HHhh-cCCC--CHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--C
Q 006810 111 TSGSLR-YRKK-HKNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 184 (630)
Q Consensus 111 ~gGsL~-~~~~-~~~l--se~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~ 184 (630)
++++|. .+.. ...+ ++..+..++.||+.||.|||+++ |+||||||.||+++..++.++|+|||++...... .
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 999998 4443 3455 88999999999999999999998 9999999999999755789999999998655322 2
Q ss_pred CccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 185 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 185 ~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
.....|++.|+|||++.+ .++.++||||||+++|+|++|+.||.....................++...++++++||
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence 233468999999998753 37889999999999999999999997654433332222211223345566788999999
Q ss_pred HHccc-CCCCCCCHHHHhcCCCc
Q 006810 262 EKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.+||. +|.+||++.+++.||||
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCCHHHHHhCCCC
Confidence 99997 79999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=317.41 Aligned_cols=250 Identities=30% Similarity=0.542 Sum_probs=213.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.+.||+|++|.||+|.+..+|..||+|++..... ......+.+|+..+..++||||+++++++... ..+++|+
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVL 78 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEE
Confidence 667999999999999999999999999999875532 24567789999999999999999999998655 5689999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 185 (630)
||+++++|. ++.....+++..++.++.||+.||.|||+ .+ ++||||+|+||+++ .++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEEC-CCCCEEEccCccceecccCCC
Confidence 999999998 66667889999999999999999999999 88 99999999999998 789999999999876654332
Q ss_pred c--cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC--CHHHHHHHHHcCCCCCCCCCC-CcHHHHH
Q 006810 186 R--SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLSKV-TDPQVKQ 259 (630)
Q Consensus 186 ~--~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~--~~~~i~~~i~~g~~p~~l~~~-~s~~lk~ 259 (630)
. ...++..|+|||.+.+ .++.++|+||||+++|+|+||..||.... ...+....+.....+. +... .+..+.+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 234 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS-LPAEEFSPEFRD 234 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC-CCcccCCHHHHH
Confidence 2 4568899999998764 47889999999999999999999998764 5555566665443333 3334 7889999
Q ss_pred HHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 260 FIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+|.+||. +|.+||++.+++.||||+..
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999997 79999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=327.07 Aligned_cols=257 Identities=22% Similarity=0.387 Sum_probs=211.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.+.||+|+||.||+|.+..++..||+|.+..... ........+.+|+.+++.++||||+++++.+... ..+++||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 80 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETK--RHLCMVM 80 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CEEEEEE
Confidence 677999999999999999999999999999875432 2234456788999999999999999999988644 4789999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC---
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--- 183 (630)
||+++|+|. ++...+.+++..+..++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcCccc
Confidence 999999998 7777788999999999999999999999998 99999999999997 7899999999987531110
Q ss_pred --------------CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-CC
Q 006810 184 --------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PA 247 (630)
Q Consensus 184 --------------~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p~ 247 (630)
......|++.|+|||.+. ..++.++|||||||++|+|++|..||.+. ...++...+..+.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDIEWP 236 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccCCC
Confidence 011245788999999765 46889999999999999999999999864 45555555554422 22
Q ss_pred CCCCCCcHHHHHHHHHccc-CCCCCCC---HHHHhcCCCcccCCCCcc
Q 006810 248 SLSKVTDPQVKQFIEKCIV-PASLRLP---ALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 248 ~l~~~~s~~lk~~I~kcL~-~p~~Rps---a~eLL~hpf~~~~~~~~~ 291 (630)
......++.++++|.+||+ +|.+||+ +.++|.||||........
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~ 284 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL 284 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHH
Confidence 2223567899999999998 8999998 799999999987655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=325.50 Aligned_cols=251 Identities=24% Similarity=0.434 Sum_probs=207.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||+||+|.+..+|..||+|++.... .......+.+|+++++.++||||+++++++... ..+++||
T Consensus 8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 82 (284)
T cd06620 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMCM 82 (284)
T ss_pred HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEEE
Confidence 67789999999999999999999999999987542 234456789999999999999999999998765 4789999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 185 (630)
||+++|+|. ++...+.+++..+..++.|++.||.|||+ ++ ++||||+|+||+++ .++.++|+|||++........
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchhhhcc
Confidence 999999998 66677789999999999999999999997 56 99999999999997 789999999999865544444
Q ss_pred ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCH-------H---HHHHHHHcCCCCCCCCCCCc
Q 006810 186 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP-------A---QIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 186 ~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~-------~---~i~~~i~~g~~p~~l~~~~s 254 (630)
....|++.|+|||++. +.++.++|||||||++|+|+||+.||...... . .....+.....+.......+
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence 4567899999999765 46889999999999999999999999753321 1 12222222222221122367
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..+.+||.+||. +|.+||++.|+++||||...
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 889999999998 89999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=350.07 Aligned_cols=245 Identities=22% Similarity=0.329 Sum_probs=195.2
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||.||+|.+..++..||+|.... ..+.+|+++|++|+|||||++++++... ...+
T Consensus 170 gy-~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~ 236 (461)
T PHA03211 170 GF-AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLTC 236 (461)
T ss_pred Ce-EEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEE
Confidence 55 788999999999999999999999999996432 2256899999999999999999988654 4688
Q ss_pred EEEcccCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLRYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+|||++.+..+.++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 237 lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 237 LVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVN-GPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEEC-CCCCEEEcccCCceecccc
Confidence 8999997544445544 457999999999999999999999999 99999999999997 7889999999999765432
Q ss_pred C----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC-------CHHHHHHHHHcCCCC-CC--
Q 006810 184 T----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-------NPAQIYKKVTSGIKP-AS-- 248 (630)
Q Consensus 184 ~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~-------~~~~i~~~i~~g~~p-~~-- 248 (630)
. .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ...++.+.+...... ..
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 1 224579999999998765 58999999999999999999886643211 123444444332110 00
Q ss_pred ---------------------------CC--CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 249 ---------------------------LS--KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 249 ---------------------------l~--~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
+. ...++.+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 1235689999999998 8999999999999999974
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=382.00 Aligned_cols=257 Identities=30% Similarity=0.533 Sum_probs=221.4
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
..+=||+| +-.||.|.||.||.|.+..+|+..|+|.+++-+.. ......+.+|..+|..|+|||+|++|++=+..
T Consensus 1232 nV~~rWqr-g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-- 1306 (1509)
T KOG4645|consen 1232 NVTFRWQR-GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-- 1306 (1509)
T ss_pred cceeeecc-ccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecH--
Confidence 34457744 67899999999999999999999999999876543 34456678999999999999999999965544
Q ss_pred CEEEEEEcccCCCCHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 RTINMITELFTSGSLRYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~~~~~~-lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++.||||++|+|..+..+++ .++...+.+..|++.||+|||++| ||||||||.|||++ .+|.+|++|||.|..
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld-~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD-FNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee-cCCcEEeecccceeE
Confidence 45788899999999996555554 667777788899999999999999 99999999999998 899999999999976
Q ss_pred eccCC------CccccCCCCCCCcccccc----ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006810 180 MQQPT------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249 (630)
Q Consensus 180 ~~~~~------~~~~~GTp~Y~APEvl~~----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l 249 (630)
...+. .+...|||-|||||++.+ +...+.|||||||+++||+||+.||....+..+|+-.+..|..|+..
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P 1463 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP 1463 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc
Confidence 65442 345689999999999864 35679999999999999999999999999999999999999888654
Q ss_pred CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 250 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 250 ~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
...+++-++||++||+ ||.+|.++.|||.|.|-+..
T Consensus 1464 -~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1464 -ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred -hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 4488999999999997 99999999999999987654
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.47 Aligned_cols=249 Identities=27% Similarity=0.497 Sum_probs=208.1
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|| ++.+.||+|+||.||++.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y-~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08218 1 KY-VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLY 75 (256)
T ss_pred Cc-eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEE
Confidence 45 778999999999999999999999999999876543 234456788999999999999999999988544 4789
Q ss_pred EEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 105 MITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+|+||+++++|. ++... ..+++..+..|+.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecC
Confidence 999999999997 44432 35899999999999999999999998 99999999999997 78899999999987654
Q ss_pred cCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 182 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 182 ~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
... .....|++.|+|||++.+ .++.++|+|||||++|+|++|..||... +...++..+..+..+. .+...+..++
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd08218 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKIIRGSYPP-VSSHYSYDLR 230 (256)
T ss_pred cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHhcCCCCC-CcccCCHHHH
Confidence 322 234568899999998754 5788999999999999999999999864 4455555555554332 3445678999
Q ss_pred HHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 259 QFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
++|.+||. +|.+||++.++|.||||
T Consensus 231 ~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999997 79999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=331.78 Aligned_cols=261 Identities=26% Similarity=0.370 Sum_probs=207.5
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHH----------HHHHHHHHHHHHHhCCCCCee
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD----------QLERLYSEVHLLKSLKHENII 89 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~----------~~~~l~~Ei~iL~~L~HpNIV 89 (630)
.+..+||..+.+.||+|+||+||+|.+..+|..||+|++.......... ....+.+|+.++++++||||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 4677899888899999999999999999999999999987543321110 012477899999999999999
Q ss_pred EEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc
Q 006810 90 KFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 168 (630)
Q Consensus 90 k~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 168 (630)
+++++|... ..+++||||+.+ +|. ++.....+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.
T Consensus 84 ~~~~~~~~~--~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~~ 157 (335)
T PTZ00024 84 GLVDVYVEG--DFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGI 157 (335)
T ss_pred eeeEEEecC--CcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCCC
Confidence 999998654 468999999985 565 7777778999999999999999999999999 99999999999997 7899
Q ss_pred EEEcccccceeecc----------------CCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCC
Q 006810 169 VKIGDLGLAIVMQQ----------------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC 230 (630)
Q Consensus 169 vKL~DFGla~~~~~----------------~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~ 230 (630)
++|+|||++..... .......+++.|+|||.+.+ .++.++|||||||++|+|+||..||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999875541 11122356889999998764 3688999999999999999999999875
Q ss_pred CCHHHHHHHHHcCCCCC-------------------------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 231 KNPAQIYKKVTSGIKPA-------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 231 ~~~~~i~~~i~~g~~p~-------------------------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
.....+.........+. ......+..+.+||.+||. +|.+||++.++|.||||+
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 44433322221100000 0012346789999999998 899999999999999998
Q ss_pred cC
Q 006810 285 TD 286 (630)
Q Consensus 285 ~~ 286 (630)
..
T Consensus 318 ~~ 319 (335)
T PTZ00024 318 SD 319 (335)
T ss_pred CC
Confidence 64
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=322.81 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=204.8
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCC
Q 006810 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (630)
Q Consensus 33 LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~g 112 (630)
||+|+||+||+|.+..+|..||+|.+...... .......+.+|+.+|+.++||||++++++|... ..+++||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecCCC
Confidence 69999999999999999999999998754322 223445677899999999999999999988654 468999999999
Q ss_pred CCHH-HHhhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-CCccc
Q 006810 113 GSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSV 188 (630)
Q Consensus 113 GsL~-~~~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-~~~~~ 188 (630)
++|. ++...+ .+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.++|+|||++...... .....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccc
Confidence 9998 555544 7999999999999999999999999 99999999999998 7899999999998755432 22345
Q ss_pred cCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHc
Q 006810 189 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264 (630)
Q Consensus 189 ~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~---~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kc 264 (630)
.+++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ...+...+.. .+...+...++.++++|++|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence 67889999998754 588899999999999999999999976432 2222222221 23345556789999999999
Q ss_pred cc-CCCCCC-----CHHHHhcCCCcccCCCCcc
Q 006810 265 IV-PASLRL-----PALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 265 L~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~ 291 (630)
|+ +|.+|| ++.+++.||||...++...
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~ 265 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL 265 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence 97 899999 8999999999987666543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=318.76 Aligned_cols=249 Identities=23% Similarity=0.417 Sum_probs=201.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHH-HHhCCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~i-L~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
+.||+|+||.||+|.+..+|..||+|.+....... ......+..|..+ ...++||||++++++|... ..+++|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEec
Confidence 46899999999999999999999999986543211 2223334455444 4566999999999998654 468999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCccc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 188 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~ 188 (630)
+++|+|. ++...+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++..... ....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~--~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE--NKKF 153 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEeecccceeccc--cccC
Confidence 9999998 6667788999999999999999999999998 99999999999998 788999999999865433 2345
Q ss_pred cCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHcc
Q 006810 189 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 189 ~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~lk~~I~kcL 265 (630)
.|++.|+|||.+.+ .++.++||||||+++|+|+||..||... +....+..+..+.. +.......++.++++|.+||
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 68999999998765 4789999999999999999999999764 44555555443322 33334456899999999999
Q ss_pred c-CCCCCCCH---HHHhcCCCcccCCC
Q 006810 266 V-PASLRLPA---LELLKDPFLVTDNP 288 (630)
Q Consensus 266 ~-~p~~Rpsa---~eLL~hpf~~~~~~ 288 (630)
. +|.+||++ .|+|.||||...++
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 7 89999955 79999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=327.66 Aligned_cols=262 Identities=32% Similarity=0.535 Sum_probs=212.9
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
..-.++.+|| ++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~ 86 (293)
T cd06647 12 VSVGDPKKKY-TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYL 86 (293)
T ss_pred eeccCchhhc-eeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheee
Confidence 3456777888 67799999999999999999999999999986432 233466889999999999999999999987
Q ss_pred cCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 97 DDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
.. ...++|+||+++|+|........+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||+
T Consensus 87 ~~--~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg~ 161 (293)
T cd06647 87 VG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGF 161 (293)
T ss_pred eC--CcEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCcc
Confidence 65 35889999999999984444556899999999999999999999999 99999999999998 788999999998
Q ss_pred ceeeccC--CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 177 AIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 177 a~~~~~~--~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
+...... ......|++.|+|||.+. +.++.++|+||||+++|+|++|+.||.......++......+..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd06647 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241 (293)
T ss_pred eecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCcccc
Confidence 8654332 223456899999999775 4588999999999999999999999976443333322222222222233345
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+..++++|.+||. +|.+||++.+++.||||+..++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 7889999999997 8999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.11 Aligned_cols=252 Identities=26% Similarity=0.443 Sum_probs=198.8
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||.||+|.+..+|..||+|.+...... .....+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~ 77 (291)
T cd07870 4 ATSY-LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE---GVPFTAIREASLLKGLKHANIVLLHDIIHTK--ET 77 (291)
T ss_pred ccee-EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC---CCcHHHHHHHHHHHhcCCCCEeEEEEEEecC--Ce
Confidence 3566 7789999999999999999999999999998754321 2223467899999999999999999988654 46
Q ss_pred EEEEEcccCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLRYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
.++|+||+.++.+.++. ....+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++....
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 78 LTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKS 154 (291)
T ss_pred EEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEeccccccccC
Confidence 88999999755555443 3466889999999999999999999998 99999999999997 78999999999986543
Q ss_pred cC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc--CCC----------
Q 006810 182 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIK---------- 245 (630)
Q Consensus 182 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~---------- 245 (630)
.. ......+++.|+|||++.+ .++.++||||||+++|+|+||..||............+.. +.+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 22 2234467999999998754 4788999999999999999999999765444333222211 000
Q ss_pred -------------CCCC----C-CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 246 -------------PASL----S-KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 246 -------------p~~l----~-~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
+..+ . ...++.+.++|.+||+ +|.+|||+.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 0 0125789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.80 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=194.4
Q ss_pred CCCcceeeeeEecccCceEEEEEEEc----------------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDE----------------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~----------------~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H 85 (630)
|.+|| ++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+|++++|
T Consensus 3 ~~~~~-~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h 78 (304)
T cd05096 3 PRGHL-LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKD 78 (304)
T ss_pred chhhC-eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCC
Confidence 56788 88999999999999999753 245579999986432 34455678999999999999
Q ss_pred CCeeEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHc
Q 006810 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKH-------------------KNVDMKAIKNWARQILRGLHYLHS 145 (630)
Q Consensus 86 pNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~-------------------~~lse~~i~~i~~QIl~gL~yLHs 145 (630)
|||+++++++.+.. .+++||||+.+|+|. ++... ..+++..+..++.||+.||.|||+
T Consensus 79 ~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 79 PNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCeeEEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 99999999987653 589999999999997 44322 246778899999999999999999
Q ss_pred CCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHH
Q 006810 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 220 (630)
Q Consensus 146 ~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~EL 220 (630)
++ |+||||||+|||++ .++.+||+|||++....... .....+++.|+|||++. +.++.++|||||||++|+|
T Consensus 157 ~~--ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 157 LN--FVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred CC--ccccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 99 99999999999998 78999999999997553322 12234578899999765 5689999999999999999
Q ss_pred hh--CCCCCCCCCCHHHHHHHHHc----C--CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 221 VT--CEYPYNECKNPAQIYKKVTS----G--IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 221 lt--G~~Pf~~~~~~~~i~~~i~~----g--~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
++ +..||..... .+....+.. . ......+...+..+++||.+||. +|.+|||+.++..
T Consensus 234 ~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 234 LMLCKEQPYGELTD-EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHccCCCCCCcCCH-HHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 87 5678876433 333322221 1 11112234567899999999998 8999999999843
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.53 Aligned_cols=232 Identities=31% Similarity=0.467 Sum_probs=195.6
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
+-||.|+.|.||+|+ ..+++||||+|+-- -..+|+-|++|+|||||.|.+++.. ..+++||||||
T Consensus 130 eWlGSGaQGAVF~Gr--l~netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVCtq--sPcyCIiMEfC 194 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGR--LHNETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVCTQ--SPCYCIIMEFC 194 (904)
T ss_pred hhhccCcccceeeee--ccCceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeeecC--CceeEEeeecc
Confidence 459999999999995 56899999988521 1247899999999999999998853 46899999999
Q ss_pred CCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-CCccc
Q 006810 111 TSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSV 188 (630)
Q Consensus 111 ~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-~~~~~ 188 (630)
..|.|. .++....++......|.++|+.|+.|||.+. |||||||.-||||+ .+..|||+|||.++..... +..++
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs-~~d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILIS-YDDVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEee-ccceEEeccccchHhhhhhhhhhhh
Confidence 999998 8888899999999999999999999999999 99999999999998 7789999999999866543 45678
Q ss_pred cCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-
Q 006810 189 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV- 266 (630)
Q Consensus 189 ~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~- 266 (630)
+||..|||||+++. ..+.|+|||||||+||||+||+.||.+-.. ..|..-+-....-...+...+.-++-||+.||.
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-heeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence 99999999999875 579999999999999999999999976322 222222222222334556677889999999997
Q ss_pred CCCCCCCHHHHhcCC
Q 006810 267 PASLRLPALELLKDP 281 (630)
Q Consensus 267 ~p~~Rpsa~eLL~hp 281 (630)
+|.+||+..++|.|-
T Consensus 351 KpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 351 KPRNRPSFRQILLHL 365 (904)
T ss_pred CCCCCccHHHHHHHH
Confidence 899999999999884
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=321.94 Aligned_cols=252 Identities=25% Similarity=0.430 Sum_probs=206.3
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
+|| ++.+.||+|+||.||+|.+..+|..||+|.++.... .......+.+|+++++.++||||+++++++... ..+
T Consensus 1 ~~y-~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 75 (288)
T cd07833 1 NKY-EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRL 75 (288)
T ss_pred Cce-eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEE
Confidence 366 778999999999999999999999999999875432 233456789999999999999999999998763 468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++|+||++++.+. .......+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++.....
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRA 152 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEEeeecccccCC
Confidence 9999999998887 4555667999999999999999999999998 99999999999998 789999999999876544
Q ss_pred C---CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--CC----------
Q 006810 183 P---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IK---------- 245 (630)
Q Consensus 183 ~---~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g--~~---------- 245 (630)
. ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||........+....... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 3 2234568899999998753 57899999999999999999999998754444333221100 00
Q ss_pred ---------C--------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 246 ---------P--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 246 ---------p--------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
+ ..++...++++++||.+||. +|.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01223347889999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=324.08 Aligned_cols=254 Identities=27% Similarity=0.436 Sum_probs=203.5
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~-~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
|| .+.+.||+|+||.||+|.+..+|..||+|.+........ ......+..|+.+++.++||||+++++++.+ ...+
T Consensus 1 ~y-~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~ 77 (298)
T cd07841 1 RY-EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNI 77 (298)
T ss_pred Cc-eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEE
Confidence 45 567889999999999999999999999999976543211 2233557789999999999999999999876 3578
Q ss_pred EEEEcccCCCCHH-HHhhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||+ +|+|. ++.... .+++..++.++.||+.||.|||+++ ++||||+|+|||++ .+|.++|+|||++....
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFG 153 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEc-CCCCEEEccceeeeecc
Confidence 9999999 88997 555554 7999999999999999999999999 99999999999998 78999999999997665
Q ss_pred cC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-CC----------
Q 006810 182 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-KP---------- 246 (630)
Q Consensus 182 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~-~p---------- 246 (630)
.. ......+++.|+|||.+.+ .++.++|||||||++|+|++|.+||........+ ..+.... .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL-GKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH-HHHHHHcCCCchhhhhhccc
Confidence 43 2233456889999998753 4788999999999999999998888764443332 2222110 00
Q ss_pred ---------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 ---------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 ---------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.......+..+++||.+||. +|.+||++.++|.||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 00112346789999999998 89999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=322.79 Aligned_cols=248 Identities=27% Similarity=0.458 Sum_probs=199.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||.|++|.||+|.++.+|..||+|.+..... .......+.+|++++++++||||+++++++.+. ..+++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLVF 78 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccC--CcEEEEe
Confidence 677899999999999999999999999999875432 223345688999999999999999999988644 4689999
Q ss_pred cccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-
Q 006810 108 ELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 183 (630)
||+.+ +|. ++.. ...+++..++.++.||+.||+|||+++ ++||||+|+||+++ .++.+||+|||++......
T Consensus 79 e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred ecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEeeccchhhcccCc
Confidence 99974 565 4433 467899999999999999999999998 99999999999998 7899999999998655432
Q ss_pred -CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Q 006810 184 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA------------- 247 (630)
Q Consensus 184 -~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~------------- 247 (630)
......+++.|+|||++.+ .++.++||||||+++|+|+||+.||..........+.+.....+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2233457889999998764 368899999999999999999999987554444443332111100
Q ss_pred -------------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 248 -------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 248 -------------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
......++.++++|.+||. +|.+||++.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 1122457889999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=317.22 Aligned_cols=248 Identities=26% Similarity=0.466 Sum_probs=206.4
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCC
Q 006810 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (630)
Q Consensus 33 LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~g 112 (630)
||+|+||.||+|.+..+|..||+|.+..... ........+.+|+.+++.++||||+++++.+.. ...+++|+||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCC
Confidence 6899999999999999999999999875433 224556778999999999999999999998754 3578999999999
Q ss_pred CCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--------
Q 006810 113 GSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------- 183 (630)
Q Consensus 113 GsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-------- 183 (630)
++|. ++...+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc-CCCCEEEEecccchhcccCcccccccc
Confidence 9998 6666678999999999999999999999998 99999999999998 7899999999998644322
Q ss_pred --CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006810 184 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260 (630)
Q Consensus 184 --~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~ 260 (630)
......+++.|+|||.+.. .++.++|+||||+++|+|++|..||.. .........+..+..+.......++.+.+|
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 2233567889999997654 478899999999999999999999976 445556666655433222222247899999
Q ss_pred HHHccc-CCCCCCCH---HHHhcCCCcccCC
Q 006810 261 IEKCIV-PASLRLPA---LELLKDPFLVTDN 287 (630)
Q Consensus 261 I~kcL~-~p~~Rpsa---~eLL~hpf~~~~~ 287 (630)
|.+||. +|.+||++ .++|+||||...+
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 999997 89999999 9999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=333.63 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=204.1
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
++.+|| ++.+.||.|+||.||+|.+..+|..||+|++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~y-~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 2 DLGSRY-MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred CcCcce-EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 456788 778999999999999999999999999999876542 344668899999999999999999987654432
Q ss_pred ------------CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc
Q 006810 101 ------------RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 168 (630)
Q Consensus 101 ------------~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 168 (630)
..+++|+||+.+ +|........+++..++.++.||+.||.|||+++ |+||||||+||+++..++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~ 153 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccccccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCce
Confidence 357899999984 7764444567999999999999999999999999 9999999999999756778
Q ss_pred EEEcccccceeeccCC-----CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 006810 169 VKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 241 (630)
Q Consensus 169 vKL~DFGla~~~~~~~-----~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~ 241 (630)
+||+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||............+.
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999997653221 122357889999997643 478899999999999999999999976443333222211
Q ss_pred cC-----------------------CCC----CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 242 SG-----------------------IKP----ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 242 ~g-----------------------~~p----~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.. ..+ ..+....+.++++||.+||+ +|.+||++.++|.||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 10 000 01122456889999999998 8999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=326.42 Aligned_cols=254 Identities=28% Similarity=0.466 Sum_probs=199.5
Q ss_pred cceeeeeEecccCceEEEEEEEcc--CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~--tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
|| ++.+.||+|+||.||+|.+.. +|..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.....
T Consensus 1 ~y-~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KY-EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred Cc-eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 45 677889999999999999988 899999999976431 12233456788999999999999999999998776678
Q ss_pred EEEEEcccCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC----CCcEEEcc
Q 006810 103 INMITELFTSGSLRYRKK-----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----NGEVKIGD 173 (630)
Q Consensus 103 l~lV~Ey~~gGsL~~~~~-----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~----~g~vKL~D 173 (630)
+++||||+.++.+..+.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ . +|.+||+|
T Consensus 79 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~-~~~~~~~~~kl~D 155 (316)
T cd07842 79 VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVM-GEGPERGVVKIGD 155 (316)
T ss_pred EEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEc-CCCCccceEEECC
Confidence 999999998765543321 236899999999999999999999999 99999999999997 6 88999999
Q ss_pred cccceeeccCC-----CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHH--------HHHH
Q 006810 174 LGLAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------QIYK 238 (630)
Q Consensus 174 FGla~~~~~~~-----~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~--------~i~~ 238 (630)
||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||....... ....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 99987653321 234567899999997754 47899999999999999999999997533211 0000
Q ss_pred HHHc------------------------CCCCCCCC-----------CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCC
Q 006810 239 KVTS------------------------GIKPASLS-----------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 282 (630)
Q Consensus 239 ~i~~------------------------g~~p~~l~-----------~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf 282 (630)
.+.. ......+. ...+..+.++|.+||. +|.+|||+.+++.|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 0000 00000011 1456789999999998 8999999999999999
Q ss_pred c
Q 006810 283 L 283 (630)
Q Consensus 283 ~ 283 (630)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.71 Aligned_cols=253 Identities=30% Similarity=0.520 Sum_probs=205.4
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC------CHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~------~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
|| .+.+.||+|+||.||+|.+..+|..||+|.+....... .....+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~-~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KW-VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred ce-eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 45 66789999999999999999999999999986532211 112345688899999999999999999987544
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 99 TNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~~~~ 155 (272)
T cd06629 81 --EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGIS 155 (272)
T ss_pred --CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeecccc
Confidence 5689999999999998 6667788999999999999999999999998 99999999999998 7899999999998
Q ss_pred eeeccC----CCccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC---CCC
Q 006810 178 IVMQQP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPA 247 (630)
Q Consensus 178 ~~~~~~----~~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~---~p~ 247 (630)
...... ......|+..|+|||++.. .++.++|+||||+++|+|++|..||........+........ .+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence 654322 1223468899999998753 378899999999999999999999976444433333222221 122
Q ss_pred CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 248 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 248 ~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
......+..+++||.+||. +|.+||++.++|.||||
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 2334467899999999997 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.71 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=200.0
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCC---
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN--- 100 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~--- 100 (630)
+| ++.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 2 ~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 2 AY-EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred Cc-eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 56 677899999999999999999999999999875432 1223356788999999995 6999999998865432
Q ss_pred CEEEEEEcccCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 101 RTINMITELFTSGSLRYRKK-----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~~~-----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
..+|+||||++++...++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++..++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 79 PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred ceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecc
Confidence 24889999999743334432 345899999999999999999999998 99999999999998438899999999
Q ss_pred cceeeccCC--CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-----
Q 006810 176 LAIVMQQPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----- 246 (630)
Q Consensus 176 la~~~~~~~--~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p----- 246 (630)
++....... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...............-..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 987543321 223357889999997753 47899999999999999999999998755554443332210000
Q ss_pred --------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 247 --------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 247 --------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
.......++.+++||.+||. +|.+||++.++|.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00112357889999999997 899999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.19 Aligned_cols=255 Identities=28% Similarity=0.393 Sum_probs=200.9
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC--
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~-- 100 (630)
..|| ++.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||++++++|.....
T Consensus 15 ~~~y-~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 15 LKRY-QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hcce-EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 3677 66799999999999999999999999999986432 223445668899999999999999999998864432
Q ss_pred --CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 101 --RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+|+||||+.++.+..+... +++..+..++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.
T Consensus 92 ~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~ 166 (353)
T cd07850 92 EFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 166 (353)
T ss_pred ccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccce
Confidence 357899999976433444433 999999999999999999999998 99999999999998 78999999999997
Q ss_pred eeccCC-CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-----------
Q 006810 179 VMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----------- 245 (630)
Q Consensus 179 ~~~~~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~----------- 245 (630)
...... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||.......+....+..-..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 654432 234568999999998764 5899999999999999999999999764433222111110000
Q ss_pred ---------C----CCC----------------CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 246 ---------P----ASL----------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 246 ---------p----~~l----------------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
+ ..+ ....++.+++||.+||. +|.+||++.|+|.||||..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0 000 11345678999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.49 Aligned_cols=261 Identities=24% Similarity=0.376 Sum_probs=201.5
Q ss_pred CccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEE
Q 006810 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (630)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f 95 (630)
++.-.+..++| ++.+.||+|+||.||+|.+..+|..||+|.+...... ......+.+|+.++++++||||+++++++
T Consensus 4 ~~~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 80 (310)
T cd07865 4 EFPFCDEVSKY-EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEIC 80 (310)
T ss_pred cCcccchhhhe-EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc--CCchhHHHHHHHHHHhCCCCCccceEEEE
Confidence 34455667788 6778999999999999999999999999998654321 22233466899999999999999999987
Q ss_pred EcCC------CCEEEEEEcccCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc
Q 006810 96 VDDT------NRTINMITELFTSGSLRYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 168 (630)
Q Consensus 96 ~d~~------~~~l~lV~Ey~~gGsL~~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 168 (630)
.... ...+++||||+.++....+.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~ 157 (310)
T cd07865 81 RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGI 157 (310)
T ss_pred ecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCc
Confidence 6543 235799999998643344433 347899999999999999999999998 99999999999997 7899
Q ss_pred EEEcccccceeeccCC------CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 006810 169 VKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 240 (630)
Q Consensus 169 vKL~DFGla~~~~~~~------~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i 240 (630)
+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|+||..||.... .......+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~-~~~~~~~~ 236 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT-EQHQLTLI 236 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Confidence 9999999987553321 123457889999998754 36889999999999999999999997643 22221111
Q ss_pred Hc---CCCCC------------------C---------CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 241 TS---GIKPA------------------S---------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 241 ~~---g~~p~------------------~---------l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.. ...+. . .....++.+++||.+||. +|.+||++.++|.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 11 10000 0 011235778899999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=309.32 Aligned_cols=249 Identities=31% Similarity=0.561 Sum_probs=211.3
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|| ++.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+++++.++|||++++++.+... ..++
T Consensus 1 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~ 75 (258)
T cd08215 1 KY-EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLC 75 (258)
T ss_pred Cc-eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEE
Confidence 35 778999999999999999999999999999876542 235566788999999999999999999998765 5789
Q ss_pred EEEcccCCCCHH-HHhh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 105 MITELFTSGSLR-YRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
+|+||+++++|. ++.. ...+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceee
Confidence 999999999998 4443 377999999999999999999999998 99999999999998 789999999999976
Q ss_pred eccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 180 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
.... ......|++.|+|||.+.+ .++.++|+||||+++++|++|..||... +...+........ ...++...+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~ 230 (258)
T cd08215 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQ-YPPIPSQYSSE 230 (258)
T ss_pred cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCC-CCCCCCCCCHH
Confidence 5443 2334578999999997654 5788999999999999999999999764 4555555555443 33455567889
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
+.++|.+||. +|.+||++.++|.||||
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=320.74 Aligned_cols=257 Identities=30% Similarity=0.551 Sum_probs=212.1
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
+|.++| +..+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++.+.
T Consensus 1 ~~~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 74 (277)
T cd06640 1 DPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-- 74 (277)
T ss_pred ChHHhh-hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--
Confidence 355667 44577999999999999999999999999987543 244567789999999999999999999998764
Q ss_pred CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 101 RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
..+++||||+++|+|......+++++..+..++.|++.||.|||+.+ ++|+||+|+||+++ .++.++|+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQL 151 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEcccccceec
Confidence 47999999999999984444567999999999999999999999998 99999999999998 7889999999999655
Q ss_pred ccCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 181 QQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 181 ~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
.... .....++..|+|||++.+ .++.++|+|||||++|+|+||..||.... +......+..+. +..+....+..+
T Consensus 152 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~ 229 (277)
T cd06640 152 TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPKNN-PPTLTGEFSKPF 229 (277)
T ss_pred cCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhhhcCC-CCCCchhhhHHH
Confidence 4322 233467889999998754 57889999999999999999999998743 333333333332 334445567899
Q ss_pred HHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 258 KQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
.++|.+||. +|.+||++.+++.||||.....
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 230 KEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 999999997 7999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=314.97 Aligned_cols=250 Identities=28% Similarity=0.492 Sum_probs=206.1
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|+||.||+|.+..+|..||+|.+..... ........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 77 (267)
T cd08228 2 ANF-QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NEL 77 (267)
T ss_pred cce-eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeE
Confidence 355 788999999999999999999999999999875433 2345556788999999999999999999998765 468
Q ss_pred EEEEcccCCCCHH-HHh----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 104 NMITELFTSGSLR-YRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
++|+||+++|+|. .+. ....+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc-CCCCEEECccccce
Confidence 8999999999997 332 3455899999999999999999999998 99999999999997 78899999999987
Q ss_pred eeccCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCc
Q 006810 179 VMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 179 ~~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~-~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
...... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... +...+...+.....+.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 654322 234568899999997754 57889999999999999999999996533 33455555555444444444567
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..++++|.+||. +|.+||++.++|+.
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 889999999997 89999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.37 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=201.4
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||.||+|.+..+|..||+|.++..... ......+.+|+.++++++||||+++++++.+.....+++||
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 6678999999999999999999999999999765432 22334567899999999999999999998877556899999
Q ss_pred cccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--
Q 006810 108 ELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 183 (630)
||+.+ +|. .+.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++ .+|.+||+|||++......
T Consensus 86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCcEEEeecCceeeccCCcc
Confidence 99986 665 4433 346899999999999999999999999 99999999999998 7899999999998766543
Q ss_pred CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC----------------
Q 006810 184 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---------------- 245 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~---------------- 245 (630)
......+++.|+|||.+.+ .++.++||||||+++|+|++|..||........+.+....-..
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 2233467899999998764 3688999999999999999999999875443333222111000
Q ss_pred ------------CCCCCCC-CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 246 ------------PASLSKV-TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 246 ------------p~~l~~~-~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
...++.. .++.++++|.+||+ +|.+||++.|+|.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0112222 47889999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=354.88 Aligned_cols=246 Identities=22% Similarity=0.410 Sum_probs=197.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEE-EcC---C-CC
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSW-VDD---T-NR 101 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f-~d~---~-~~ 101 (630)
+++++|.+|||+.||+|.+...|.+||+|++-.. ++..++.+.+||.+|++|+ |||||.|+++. ... . ..
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 6679999999999999999999899999988643 5778889999999999997 99999999943 221 1 23
Q ss_pred EEEEEEcccCCCCHH-HHh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.+.+.||||.||.|- ++. ...+|++.++++|+.|++.|+.+||.+.|||||||||-+||||+ .+|..||||||.++
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCcccccc
Confidence 578899999987764 443 34559999999999999999999999999999999999999997 88999999999985
Q ss_pred eec-cC-CCc---------cccCCCCCCCccccc---c-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Q 006810 179 VMQ-QP-TAR---------SVIGTPEFMAPELYE---E-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 243 (630)
Q Consensus 179 ~~~-~~-~~~---------~~~GTp~Y~APEvl~---~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g 243 (630)
..- .. ... ...-||.|+|||++. + ..++|+|||+|||+||-|+....||.+....+ |..+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-----Ilng 269 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-----ILNG 269 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----EEec
Confidence 321 11 111 123599999999764 3 58999999999999999999999998742211 2233
Q ss_pred CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 244 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 244 ~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
....+....++..+++||+.||+ +|.+||++.+++.+-+.
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 22222234567899999999998 89999999998865443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=336.96 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=201.1
Q ss_pred CCCcceeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d-----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f 95 (630)
|..+| ++.+.||+|+||+||+|.+ ..++..||+|+++... .....+.+.+|+.+|+.+ +||||++++++|
T Consensus 33 ~~~~~-~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 33 PRNRL-SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred chHHe-ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 44456 7889999999999999964 4567799999986432 233456788999999999 899999999988
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhhc-----------------------------------------------------
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKKH----------------------------------------------------- 121 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~~----------------------------------------------------- 121 (630)
.+. ...++||||+++|+|. ++...
T Consensus 109 ~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 109 TVG--GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred ccC--CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 654 4588999999999996 44321
Q ss_pred ----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 122 ----------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 122 ----------------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~ 263 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARD 263 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEE-CCCcEEEecCcccee
Confidence 24788899999999999999999998 99999999999998 788999999999976
Q ss_pred eccCCCc----cccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 180 MQQPTAR----SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 180 ~~~~~~~----~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
....... ...+++.|+|||++.+ .++.++|||||||++|+|++ |..||........+.+.+..+..+. .+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 342 (375)
T cd05104 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-SPECA 342 (375)
T ss_pred ccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-CCCCC
Confidence 5432211 2234567999998764 58999999999999999998 8999987655666666666654332 33456
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+.+++++|.+||. +|.+||++.+++..
T Consensus 343 ~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 343 PSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 7899999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=326.05 Aligned_cols=257 Identities=29% Similarity=0.552 Sum_probs=209.7
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
.|...|.. ...||+|+||.||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||+++++.+...
T Consensus 19 ~~~~~~~~-~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-- 91 (292)
T cd06658 19 DPREYLDS-FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-- 91 (292)
T ss_pred chHHHHhh-hhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--
Confidence 34444433 467999999999999999999999999986432 34456688999999999999999999988654
Q ss_pred CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 101 RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
...++||||+++++|......+.+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.++|+|||++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 92 DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQV 168 (292)
T ss_pred CeEEEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEccCcchhhc
Confidence 46899999999999985556677999999999999999999999998 99999999999997 7899999999998654
Q ss_pred ccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHH
Q 006810 181 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQ 256 (630)
Q Consensus 181 ~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~-~l~~~~s~~ 256 (630)
... ......|++.|+|||++.+ .++.++||||||+++|||++|+.||... +....+..+.....+. ......+..
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06658 169 SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLPPRVKDSHKVSSV 247 (292)
T ss_pred ccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCccccccccCHH
Confidence 322 2234578999999998764 5889999999999999999999999763 4444444444332221 122346789
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+++||.+||. +|.+||++.++|.||||....+
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 9999999997 8999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.26 Aligned_cols=248 Identities=21% Similarity=0.316 Sum_probs=196.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l~lV 106 (630)
++.+.||+|+||.||+|.+..++..||+|.+..... .... ....+|+.+++++. ||||+++++++.+.....+++|
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 678899999999999999999999999998864321 2222 23457888998885 9999999999987655679999
Q ss_pred EcccCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC-
Q 006810 107 TELFTSGSLRYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 184 (630)
Q Consensus 107 ~Ey~~gGsL~~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 184 (630)
|||+.++.+..+.. ...+++..++.++.||+.||.|||+++ ++||||+|+||+++ . |.+||+|||++.......
T Consensus 79 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~-~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 79 FELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIK-D-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEc-C-CCeEEEecccccccccCCC
Confidence 99998755555443 467899999999999999999999998 99999999999998 4 999999999997654332
Q ss_pred CccccCCCCCCCccccc--cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--C--------------CC
Q 006810 185 ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I--------------KP 246 (630)
Q Consensus 185 ~~~~~GTp~Y~APEvl~--~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g--~--------------~p 246 (630)
.....+++.|+|||++. +.++.++|||||||++|+|++|..||.... ....+..+... . ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN-ELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC-HHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 23456899999999764 346889999999999999999999997643 32222222110 0 00
Q ss_pred CC-----------CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 247 AS-----------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 247 ~~-----------l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.. +....+..++++|.+||. +|.+||++.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00 112457899999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.36 Aligned_cols=254 Identities=30% Similarity=0.538 Sum_probs=208.7
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+...| +..+.||+|+||.||+|.+..+|..||+|.+.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 2 ~~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 75 (277)
T cd06642 2 PEELF-TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--T 75 (277)
T ss_pred hHHHH-HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccC--C
Confidence 34455 44577999999999999999999999999987443 234557789999999999999999999988654 4
Q ss_pred EEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 102 TINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
.+++||||+++++|........+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLT 152 (277)
T ss_pred ceEEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEcccccccccc
Confidence 6899999999999984445567999999999999999999999998 99999999999997 78999999999987554
Q ss_pred cCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 182 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 182 ~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
... .....|+..|+|||.+.+ .++.++|+|||||++|+|+||..||... .+......+..+. +..+....+..+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~ 230 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLEGQYSKPFK 230 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCC-CCCCCcccCHHHH
Confidence 322 223468899999998765 4788999999999999999999999763 3333333333332 2334455678899
Q ss_pred HHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 259 QFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
++|.+||. +|.+||++.++|.||||..-
T Consensus 231 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 231 EFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 99999997 89999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=314.94 Aligned_cols=243 Identities=20% Similarity=0.327 Sum_probs=198.4
Q ss_pred eeeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~---~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
+++.++||+|+||.||+|.+. ..+..||+|.++... .......+.+|+..+++++||||+++++++... ..+
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 81 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTM 81 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCc
Confidence 388999999999999999765 456799999987432 234456788999999999999999999988654 468
Q ss_pred EEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||+++|+|. ++.. ...+++..++.++.||+.||+|||+++ ++||||||+|||++ .++.+||+|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~-~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVN-SDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEc-CCCcEEECCCccccccc
Confidence 8999999999998 5554 457899999999999999999999998 99999999999998 78999999999875432
Q ss_pred cCC---CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 182 QPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 182 ~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
... .....+++.|+|||.+. +.++.++|||||||++|||++ |+.||... +...+.+.+..+..+ ..+...+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 236 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-SGQDVIKAVEDGFRL-PAPRNCPNL 236 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHH
Confidence 221 11223567899999775 468899999999999999775 99999864 445555666655433 345567889
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhc
Q 006810 257 VKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+.+++.+||+ +|.+||++.++++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999998 7999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=325.93 Aligned_cols=253 Identities=28% Similarity=0.525 Sum_probs=208.4
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+++.....||+|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||++++++|... ..++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~ 94 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELW 94 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEE
Confidence 344455679999999999999999999999999875432 2345688999999999999999999988654 4689
Q ss_pred EEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-
Q 006810 105 MITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 105 lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 183 (630)
+|+||+++++|........+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 95 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 95 VLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhccccc
Confidence 9999999999985556677999999999999999999999999 99999999999997 7899999999998654332
Q ss_pred -CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHHHHHH
Q 006810 184 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQF 260 (630)
Q Consensus 184 -~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~~~s~~lk~~ 260 (630)
......|++.|+|||++.+ .++.++|||||||++|+|++|+.||... ........+.....+ .......++.+.+|
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 250 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPVLRDF 250 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCccccCCCCHHHHHH
Confidence 2234578999999998764 5889999999999999999999999763 444444444433221 12233457889999
Q ss_pred HHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 261 IEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 261 I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
|.+||. +|.+||++.+++.||||....
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 999997 899999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=328.36 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=201.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC--
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~-- 100 (630)
.++| ++.+.||+|+||.||+|.+..+|..||+|++.... ......++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y-~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 4 GPRY-QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred ccce-EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 3566 78899999999999999999999999999986422 23345668889999999999999999998754432
Q ss_pred -CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 -RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++|+||+.+ +|......+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~ 155 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARI 155 (336)
T ss_pred cceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECcccceee
Confidence 358999999986 5553445568999999999999999999999999 99999999999998 789999999999875
Q ss_pred eccCC-----CccccCCCCCCCccccc--cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHH-----------
Q 006810 180 MQQPT-----ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT----------- 241 (630)
Q Consensus 180 ~~~~~-----~~~~~GTp~Y~APEvl~--~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~----------- 241 (630)
..... .....||+.|+|||.+. ..++.++|||||||++|+|++|+.||.+......+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 53221 12356899999999764 3588999999999999999999999976432221111100
Q ss_pred ---cC-------CCC----C---CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 242 ---SG-------IKP----A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 242 ---~g-------~~p----~---~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.. ..+ . ......++++.+||.+||. +|.+||++.+++.||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00 000 0 0112346789999999998 89999999999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=317.83 Aligned_cols=257 Identities=29% Similarity=0.573 Sum_probs=210.7
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
.++..+|..+ ..||+|++|.||+|.+..+|..|++|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~- 88 (285)
T cd06648 15 GDPRSYLDNF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG- 88 (285)
T ss_pred CcchHhhhcc-eEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-
Confidence 4555556443 78999999999999999999999999986432 23445688999999999999999999988754
Q ss_pred CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 100 NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
...++|+||+++++|......+++++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++..
T Consensus 89 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~ 164 (285)
T cd06648 89 -DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQ 164 (285)
T ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc-CCCcEEEcccccchh
Confidence 46889999999999984333478999999999999999999999999 99999999999998 789999999998764
Q ss_pred eccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCcH
Q 006810 180 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTDP 255 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~-l~~~~s~ 255 (630)
.... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.. .++......+..+..+.. .....+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
T cd06648 165 VSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSP 243 (285)
T ss_pred hccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCH
Confidence 4322 2234568999999998764 588999999999999999999999976 445555556655532221 1223678
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.+.+||.+||. +|.+||++.++|.||||....
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 99999999997 899999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=365.43 Aligned_cols=257 Identities=21% Similarity=0.387 Sum_probs=220.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.++||+|+||.|.+++++.++..||.|+++.-+.... .....|..|-.+|..-+.+.|+.++..|.|+ .++||||
T Consensus 78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr-~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~--~~LYlVM 154 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR-AETACFREERDIMVFGNSEWIVQLHYAFQDE--RYLYLVM 154 (1317)
T ss_pred HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc-hhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc--cceEEEE
Confidence 566899999999999999999999999999986554432 2345588899999999999999999999765 5799999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC--
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~-- 184 (630)
||++||+|- .+.+..+++++-++.++..|+.||.-||+.| +|||||||+|||++ ..|+|||+|||.+..+....
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcCCCCcE
Confidence 999999998 7777778999999999999999999999999 99999999999998 89999999999987666432
Q ss_pred -CccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcH
Q 006810 185 -ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDP 255 (630)
Q Consensus 185 -~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~--~~~s~ 255 (630)
....+|||-|.+||++. +.|+..+|.||+||++|||+.|+.||+. .....-|.+|..-.....+| ..++.
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccCH
Confidence 23568999999999884 3599999999999999999999999987 44555566666543333333 34789
Q ss_pred HHHHHHHHcccCCCCCCC---HHHHhcCCCcccCCCCcc
Q 006810 256 QVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 256 ~lk~~I~kcL~~p~~Rps---a~eLL~hpf~~~~~~~~~ 291 (630)
++++||.+.|.+|..|.. +.++-.||||...+|..+
T Consensus 311 eakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~i 349 (1317)
T KOG0612|consen 311 EAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNI 349 (1317)
T ss_pred HHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhh
Confidence 999999999999999888 999999999999998553
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=317.33 Aligned_cols=250 Identities=27% Similarity=0.463 Sum_probs=196.4
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|++|+||+|.++.+|..||+|.+...... .....+.+|+.++++++||||+++++++.+. ...
T Consensus 5 ~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 78 (291)
T cd07844 5 ETY-KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHTK--KTL 78 (291)
T ss_pred cce-eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEecC--CeE
Confidence 345 6779999999999999999999999999998754321 1123466899999999999999999998654 578
Q ss_pred EEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||+.+ +|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKS 154 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEc-CCCCEEECccccccccC
Confidence 999999986 666 4443 457899999999999999999999999 99999999999998 78999999999986543
Q ss_pred cC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-------------
Q 006810 182 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI------------- 244 (630)
Q Consensus 182 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~------------- 244 (630)
.. ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||............+....
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 22 1223356889999998754 478999999999999999999999976543333222221100
Q ss_pred ------------CCCC---CCCCCc--HHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 245 ------------KPAS---LSKVTD--PQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 245 ------------~p~~---l~~~~s--~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.+.. .....+ ..+.++|.+||. +|.+||++.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 001123 788999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=341.23 Aligned_cols=261 Identities=28% Similarity=0.479 Sum_probs=223.6
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
.+..-.|-| .+...||+|.|+.|.+|.+..+|.+||+|.+..... +...++.+.+|+++|+.|+|||||++|.+...
T Consensus 50 ~~~~~vg~y-~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t 126 (596)
T KOG0586|consen 50 DDSNSVGLY-VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIET 126 (596)
T ss_pred cccccccce-eeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence 344445555 788999999999999999999999999999876543 44556679999999999999999999998754
Q ss_pred CCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 98 DTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
. ..+|+||||+.+|.+. |+.+++++.+..++.++.|++.|++|||+++ |+|||||++|||++ .+-.+||+|||+
T Consensus 127 ~--~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~-~~mnikIaDfgf 201 (596)
T KOG0586|consen 127 E--ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLD-ENMNIKIADFGF 201 (596)
T ss_pred c--ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccc-cccceeeecccc
Confidence 4 5799999999999998 9999999999999999999999999999999 99999999999998 677899999999
Q ss_pred ceeecc-CCCccccCCCCCCCccccccc-c-CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 177 AIVMQQ-PTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 177 a~~~~~-~~~~~~~GTp~Y~APEvl~~~-y-s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
+..+.. ....+++|+|.|.|||++.+. | ++.+|+||+|+++|-|+.|..||.+ .+...+...+..+... ++-..
T Consensus 202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~r--Ip~~m 278 (596)
T KOG0586|consen 202 STFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYR--IPFYM 278 (596)
T ss_pred ceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeec--cccee
Confidence 988764 356789999999999999864 4 6899999999999999999999987 4444454555554332 33345
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 289 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~ 289 (630)
+-+++++|.++|+ +|.+|++..++..|+|.......
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 7789999999998 89999999999999999765443
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=317.19 Aligned_cols=250 Identities=33% Similarity=0.557 Sum_probs=205.1
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCeeEEEeEEEcCCCCEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpNIVk~~~~f~d~~~~~l 103 (630)
|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++ ||||+++++++.+. ..+
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~~ 77 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PRL 77 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CEE
Confidence 356788999999999999999999999999986532 2344566889999999997 99999999988654 468
Q ss_pred EEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 104 NMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 104 ~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
++||||+++++|......+.+++..+..++.||+.||.|||+.+ ++||||+|+||+++ .++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEc-CCCCEEEccCCceeecCCC
Confidence 89999999999984444568999999999999999999999999 99999999999998 6899999999998765443
Q ss_pred C--CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC-CCcHHHH
Q 006810 184 T--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK-VTDPQVK 258 (630)
Q Consensus 184 ~--~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~-~~s~~lk 258 (630)
. .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.... .......+... .+..+.. ..++++.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIPKS-KPPRLEDNGYSKLLR 232 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhccccC-CCCCCCcccCCHHHH
Confidence 2 234568999999998754 36889999999999999999999997643 32222222222 2233333 3678999
Q ss_pred HHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 259 QFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+||.+||. +|.+||++.+++.||||+..
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 99999997 89999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=317.10 Aligned_cols=257 Identities=36% Similarity=0.618 Sum_probs=211.5
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
.++...| .+.+.||+|++|.||+|.+..++..|++|.+..... ....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 87 (286)
T cd06614 15 GDPRELY-KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVG- 87 (286)
T ss_pred CCccccc-hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-
Confidence 4555555 677899999999999999999999999999875432 456688999999999999999999998765
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 100 NRTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+++|+||+++++|. ++.... .++...+..++.||+.||.|||+.+ ++|+||+|+||+++ .+|.++|+|||++
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d~~~~ 163 (286)
T cd06614 88 -DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFA 163 (286)
T ss_pred -CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECccchh
Confidence 5789999999999998 555555 8999999999999999999999998 99999999999998 7899999999988
Q ss_pred eeeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCC
Q 006810 178 IVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 253 (630)
Q Consensus 178 ~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p~~l~~~~ 253 (630)
...... ......+++.|+|||++.+ .++.++|+||||+++|+|++|..||... ++......+.. ...+.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEKW 242 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchhhC
Confidence 644332 2234467899999997764 5889999999999999999999999864 33333333333 22222223336
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+..+++||.+||. +|.+||++.++|.||||....+
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 7899999999998 7999999999999999988544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=309.63 Aligned_cols=243 Identities=27% Similarity=0.464 Sum_probs=204.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||.||++.+..+|..||+|.++... .....+.+.+|+.+++.++||||++++++|.+. ..+++|+
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 77 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIVM 77 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEE
Confidence 67899999999999999999999999999987543 234556788999999999999999999998654 4789999
Q ss_pred cccCCCCHH-HHh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC
Q 006810 108 ELFTSGSLR-YRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 184 (630)
||+++|+|. ++. ....+++..++.|+.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||.+.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeecccc
Confidence 999999997 443 3456899999999999999999999999 99999999999997 78999999999997654332
Q ss_pred --CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 185 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 185 --~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
.....|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..+..+ .++...+..+++||
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 232 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYK-PLPSHYSYELRSLI 232 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCC-CCCcccCHHHHHHH
Confidence 234578999999998864 488999999999999999999999986 4555555555544332 24455678999999
Q ss_pred HHccc-CCCCCCCHHHHhcC
Q 006810 262 EKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+||. +|.+||++.+++.-
T Consensus 233 ~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 233 KQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHhCCcccCCCHHHHhhc
Confidence 99997 89999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=318.69 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=201.7
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|++|+||+|.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 76 (294)
T PLN00009 2 DQY-EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRL 76 (294)
T ss_pred Cce-EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeE
Confidence 356 677899999999999999999999999999865432 223345678899999999999999999998654 468
Q ss_pred EEEEcccCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLRYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~~~~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||++++.+....... .+++..++.++.||+.||+|||+++ ++||||+|+||+++..++.+||+|||++....
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 9999999764444544433 3588999999999999999999998 99999999999998556789999999996543
Q ss_pred cC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Q 006810 182 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------- 246 (630)
Q Consensus 182 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p----------- 246 (630)
.. ......+++.|+|||.+.+ .++.++|||||||++|+|+||+.||........+.+.+..-..+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 22 2233467899999998754 47889999999999999999999998754444444332210000
Q ss_pred ------------C---CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 ------------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 ------------~---~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
. ......++.+++||.+||. +|.+||++.++|.||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0112356889999999997 89999999999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.85 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=199.0
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCC-----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG-----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f 95 (630)
|..+| .+.+.||+|+||.||+|.+...| ..||+|.+.... ..+..+.+.+|+.+++.+ +|||||+++++|
T Consensus 36 ~~~~~-~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 36 PRDNL-QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cHHHc-eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 44456 77899999999999999865444 579999986442 234567788999999999 899999999988
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhhc-----------------------------------------------------
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKKH----------------------------------------------------- 121 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~~----------------------------------------------------- 121 (630)
... ..+++||||+++|+|. ++...
T Consensus 112 ~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 112 THG--GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred cCC--CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 655 4689999999999997 43221
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC
Q 006810 122 -----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 184 (630)
Q Consensus 122 -----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 184 (630)
.++++..+.+++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDS 266 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccCCc
Confidence 24788899999999999999999998 99999999999998 78899999999997654332
Q ss_pred Cc----cccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 185 AR----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 185 ~~----~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
.. ...+++.|||||++. ..++.++|||||||++|+|++ |..||........+...+..+..+ ..+...+++++
T Consensus 267 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 345 (374)
T cd05106 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-SRPDFAPPEIY 345 (374)
T ss_pred ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-cCCCCCCHHHH
Confidence 21 223456899999775 468999999999999999997 999998754444455555544332 33445689999
Q ss_pred HHHHHccc-CCCCCCCHHHHhc
Q 006810 259 QFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
++|.+||+ +|.+||++.++++
T Consensus 346 ~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 346 SIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 99999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=312.52 Aligned_cols=249 Identities=22% Similarity=0.439 Sum_probs=210.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
..||.|+-|+|++++.+.+|...|+|.+.... +..+..+++..++++... +.|+||+.|++|+.+.. +++.||.
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V~IcMel 172 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--VFICMEL 172 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--HHHHHHH
Confidence 45999999999999999999999999997543 567888999999987766 49999999999987765 5667788
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC-cc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RS 187 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~-~~ 187 (630)
|.-.--+ ..+..++++|..+-.+...++.||.||..+. +|+|||+||.|||++ ..|.|||||||++..+-...+ ..
T Consensus 173 Ms~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSkAhtr 250 (391)
T KOG0983|consen 173 MSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKAHTR 250 (391)
T ss_pred HHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-cCCCEEeecccccceeeccccccc
Confidence 7654333 3445677999999999999999999997754 499999999999998 899999999999976655443 34
Q ss_pred ccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHHHHHH
Q 006810 188 VIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFI 261 (630)
Q Consensus 188 ~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~--~~s~~lk~~I 261 (630)
..|-+.|||||.+. ..|+..+||||||++++||+||++||.++....+...++....+ +.++. ..++++.+|+
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~~~gFSp~F~~fv 329 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPGHMGFSPDFQSFV 329 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCcccCcCHHHHHHH
Confidence 46899999999885 35999999999999999999999999999888888777776544 33432 3799999999
Q ss_pred HHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 262 EKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
..||. ++.+||...+||+|||+....
T Consensus 330 ~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 330 KDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHhhcCcccCcchHHHhcCcceeecc
Confidence 99997 899999999999999997643
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=316.34 Aligned_cols=248 Identities=28% Similarity=0.483 Sum_probs=198.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||.|++|.||+|.+..+|..||+|++..... ......+.+|+.++++++||||+++++++.+. ..+++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 77 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVF 77 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEE
Confidence 677999999999999999999999999999976542 22234577899999999999999999998765 3578999
Q ss_pred cccCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-
Q 006810 108 ELFTSGSLRYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 108 Ey~~gGsL~~~~~~---~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 183 (630)
||++++.+.++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFGIPV 154 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhcCCc
Confidence 99997444454433 46899999999999999999999999 99999999999998 7899999999998654332
Q ss_pred -CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Q 006810 184 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------------- 246 (630)
Q Consensus 184 -~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-------------- 246 (630)
......+++.|+|||++.+ .++.++||||||+++|+|++|+.||.+................|
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 2233467899999998754 46889999999999999999999998755444333222110000
Q ss_pred ------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 247 ------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 247 ------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
..+....++.++++|.+||+ +|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00112346789999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.24 Aligned_cols=251 Identities=27% Similarity=0.453 Sum_probs=202.1
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||.||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++||||++++++|.+ ...++
T Consensus 2 ~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 76 (286)
T cd07846 2 KY-ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLY 76 (286)
T ss_pred ce-eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEE
Confidence 45 677999999999999999999999999998864332 22344567889999999999999999999854 35789
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+|+||+++++|. .......+++..++.++.||+.||.|||+.+ ++||||+|+||+++ .++.++|+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCC
Confidence 999999999998 4445567999999999999999999999998 99999999999997 7899999999998765432
Q ss_pred --CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-----------------
Q 006810 184 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----------------- 242 (630)
Q Consensus 184 --~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~----------------- 242 (630)
......+++.|+|||++.+ .++.++||||||+++|+|++|+.||...............
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 2234568899999998754 3778999999999999999999999764433332222210
Q ss_pred --CCC-CC--------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 243 --GIK-PA--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 243 --g~~-p~--------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
+.. +. ...+..+..+++||.+||. +|.+||++.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 00 0112346789999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.77 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=199.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC--
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~-- 100 (630)
.++| ++.+.||+|+||.||+|.+..+|..||+|++....... .....+.+|+.+++.++||||+++++++.+...
T Consensus 7 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDY-EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 4677 78899999999999999999999999999987543221 122346789999999999999999998765432
Q ss_pred ----CEEEEEEcccCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 101 ----RTINMITELFTSGSLRYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 101 ----~~l~lV~Ey~~gGsL~~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
..+++|+||+.+..+..+. ....+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||
T Consensus 84 ~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg 160 (311)
T cd07866 84 KRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFG 160 (311)
T ss_pred cccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECcCc
Confidence 3689999999876555433 4567999999999999999999999999 99999999999998 78999999999
Q ss_pred cceeeccCC-------------CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 006810 176 LAIVMQQPT-------------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 240 (630)
Q Consensus 176 la~~~~~~~-------------~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i 240 (630)
++....... .....|++.|+|||++.+ .++.++|||||||++|+|++|++||.+...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 986543221 123357889999997754 47899999999999999999999997644333222221
Q ss_pred HcC--CCCCC------------------C-------CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 241 TSG--IKPAS------------------L-------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 241 ~~g--~~p~~------------------l-------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
... ..+.. . .....+.+.+||.+||. +|.+||++.++|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 110 00000 0 01234678999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=310.95 Aligned_cols=250 Identities=28% Similarity=0.502 Sum_probs=204.6
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|| .+.+.||+|+||.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++||||+++++.+... ..++
T Consensus 1 ~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~ 75 (257)
T cd08225 1 RY-EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLF 75 (257)
T ss_pred Cc-eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEE
Confidence 45 778999999999999999999999999999976533 223446688999999999999999999987544 5789
Q ss_pred EEEcccCCCCHH-HHhhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 105 MITELFTSGSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+|+||+++++|. ++.... .+++..+..|+.||+.||.|||+++ ++||||||+||+++..+..+||+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 999999999998 444432 5799999999999999999999999 99999999999998443467999999987654
Q ss_pred cCC--CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 182 QPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 182 ~~~--~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
... .....|++.|+|||++. ..++.++|+||||+++|+|++|..||... +.......+..+..+ ......+..++
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFA-PISPNFSRDLR 231 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCC-CCCCCCCHHHH
Confidence 332 22346899999999775 45889999999999999999999999764 344444444443322 23345678999
Q ss_pred HHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 259 QFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
++|.+||. +|.+||++.++++||||
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 232 SLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHhccChhhCcCHHHHhhCCCC
Confidence 99999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.82 Aligned_cols=247 Identities=33% Similarity=0.588 Sum_probs=204.2
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+.+.+.||+|++|.||+|.+..+|..|++|.+..... .....+.+|+.+++.++||||+++++.+... ...+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~ 75 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIV 75 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEE
Confidence 3677899999999999999999999999999875432 3556788999999999999999999988665 468899
Q ss_pred EcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC
Q 006810 107 TELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 184 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 184 (630)
+||+++++|. .+... ..+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.++|+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc-cCCeEEEeeccccccccccc
Confidence 9999999998 44443 58999999999999999999999988 99999999999998 78999999999987665433
Q ss_pred -CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 185 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 185 -~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
.....++..|+|||.+.+ .++.++|+||||+++|+|++|+.||........+.................+..+.+||.
T Consensus 153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence 345678999999998764 478899999999999999999999987533333333332221111112223789999999
Q ss_pred Hccc-CCCCCCCHHHHhcCCC
Q 006810 263 KCIV-PASLRLPALELLKDPF 282 (630)
Q Consensus 263 kcL~-~p~~Rpsa~eLL~hpf 282 (630)
+||. +|.+||++.++|.|||
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 9997 8999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=315.21 Aligned_cols=243 Identities=25% Similarity=0.379 Sum_probs=201.7
Q ss_pred eeeeEecccCceEEEEEEEccCC-----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG-----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~ 82 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--QP 82 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--Cc
Confidence 77899999999999999876655 789999886432 344556789999999999999999999988654 45
Q ss_pred EEEEEcccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC
Q 006810 103 INMITELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 165 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 165 (630)
++++|||+++|+|. ++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~-~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG-E 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc-C
Confidence 88999999999997 55443 56889999999999999999999999 99999999999998 7
Q ss_pred CCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHH
Q 006810 166 NGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 239 (630)
Q Consensus 166 ~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~ 239 (630)
++.+||+|||++....... .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ .+...+...
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~~ 238 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIEM 238 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 8899999999987543221 22345688999999765 568999999999999999998 9999987 455667777
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 240 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 240 i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+..+..+ ..+...++++.+++.+||. +|.+||++.+++++
T Consensus 239 i~~~~~~-~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLL-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcC-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7665443 3345678999999999998 79999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=315.09 Aligned_cols=249 Identities=32% Similarity=0.558 Sum_probs=208.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.++++++||||++++++|.+. ..+++||
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 81 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIM 81 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEE
Confidence 55688999999999999999999999999886543 234456788999999999999999999998654 4688999
Q ss_pred cccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC--C
Q 006810 108 ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--A 185 (630)
Q Consensus 108 Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~--~ 185 (630)
||+++|+|........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++ .+|.++|+|||++....... .
T Consensus 82 e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 82 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecccchhhh
Confidence 9999999984444567999999999999999999999998 99999999999998 78899999999986554322 2
Q ss_pred ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHc
Q 006810 186 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264 (630)
Q Consensus 186 ~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kc 264 (630)
....++..|+|||.+.+ .++.++|+|||||++|+|++|..||.. .+.......+..+. +..+....+..+.++|.+|
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~ 236 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEAC 236 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhcCC-CCCCCcccCHHHHHHHHHH
Confidence 33568899999998764 478899999999999999999999976 34444444444332 3345556788999999999
Q ss_pred cc-CCCCCCCHHHHhcCCCcccC
Q 006810 265 IV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 265 L~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
|. +|.+||++.++++||||...
T Consensus 237 l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 237 LNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ccCChhhCcCHHHHHhCHHHhhh
Confidence 97 89999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.88 Aligned_cols=249 Identities=31% Similarity=0.531 Sum_probs=205.5
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|+||.||+|.+..+|..||+|.++..... .......+.+|+.++++++|+||++++++|.+. ...
T Consensus 2 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~ 77 (267)
T cd08224 2 GNF-KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NEL 77 (267)
T ss_pred Cce-eeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeE
Confidence 466 7889999999999999999999999999998764432 234467789999999999999999999998765 468
Q ss_pred EEEEcccCCCCHH-HHhh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 104 NMITELFTSGSLR-YRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
++||||+++|+|. ++.. ...+++..++.|+.||+.||.|||+++ ++||||+|+||+++ .+|.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC-CCCcEEEeccceee
Confidence 9999999999997 4432 345899999999999999999999999 99999999999998 78999999999987
Q ss_pred eeccCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCc
Q 006810 179 VMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 179 ~~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~-~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
...... .....+++.|+|||.+.+ .++.++|||||||++|+|++|..||.... +.......+..+..+.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 554322 234568999999997754 58899999999999999999999996532 33344455555544433333567
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..++++|.+||. +|.+||++.+++.
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 899999999997 7999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=321.71 Aligned_cols=262 Identities=28% Similarity=0.464 Sum_probs=212.6
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
+-..++..+|. ..+.||+|+||+||+|.+..+|..||+|.+..... ........+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~~~~~-~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 91 (313)
T cd06633 14 FYKDDPEEIFV-GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL 91 (313)
T ss_pred hccCCHHHHhh-cceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 34567777774 45779999999999999999999999999875433 23445567889999999999999999999987
Q ss_pred cCCCCEEEEEEcccCCCCHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 97 DDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
+. ...|+||||+.++.+..+ .....+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||
T Consensus 92 ~~--~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~dfg 166 (313)
T cd06633 92 KE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFG 166 (313)
T ss_pred eC--CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEeecC
Confidence 65 468899999976555543 34567899999999999999999999999 99999999999997 78899999999
Q ss_pred cceeeccCCCccccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 176 LAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 176 la~~~~~~~~~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
++..... .....|++.|+|||++. +.++.++|||||||++|+|++|..||............ .....+.....
T Consensus 167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 243 (313)
T cd06633 167 SASKSSP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-AQNDSPTLQSN 243 (313)
T ss_pred CCcccCC--CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HhcCCCCCCcc
Confidence 8854322 23457899999999873 45788999999999999999999999875444444433 33333333344
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
..+..+++||.+||+ +|.+||++.++|.||||.....
T Consensus 244 ~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 244 EWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 567789999999997 8999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=314.54 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=198.4
Q ss_pred CCcceeeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~----d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
.+||+++.+.||+|+||+||++. ...++..||+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 47998999999999999998764 34578899999986432 233456788999999999999999999988766
Q ss_pred CCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 99 TNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
....+++||||+++|+|........+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~ 155 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAK 155 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEc-CCCcEEEeeccccc
Confidence 6667999999999999984444457999999999999999999999999 99999999999997 78899999999987
Q ss_pred eeccCCC-----ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHH--------------HHHH
Q 006810 179 VMQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------------QIYK 238 (630)
Q Consensus 179 ~~~~~~~-----~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~--------------~i~~ 238 (630)
....... ....++..|+|||.+. ..++.++||||||+++|+|+||..||....... .+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 6543211 1223566799999775 458899999999999999999999986432110 0111
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 239 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 239 ~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+..+.. ...+...+..+++++.+||. +|++||++.+++.
T Consensus 236 ~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 LLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111111 12234567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=317.98 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=199.4
Q ss_pred eeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEEEEEE
Q 006810 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 29 ~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
..+.||+|+||.||++.+..+|..||+|.+..... ......+.+|+.++.++. ||||+++++++... ...+++|
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~~ 82 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWICM 82 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEEE
Confidence 35779999999999999999999999999875432 244567889999999996 99999999988754 3577899
Q ss_pred cccCCCCHH---H--HhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 108 ELFTSGSLR---Y--RKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 108 Ey~~gGsL~---~--~~~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
||+...... + ......+++..+..++.|++.||+|||+. + ++||||||+||+++ .++.+||+|||++....
T Consensus 83 e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGISGQLV 159 (288)
T ss_pred ecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchhHHhc
Confidence 998763222 1 22356799999999999999999999974 7 99999999999998 78899999999986544
Q ss_pred cC-CCccccCCCCCCCcccccc----ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Q 006810 182 QP-TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVT 253 (630)
Q Consensus 182 ~~-~~~~~~GTp~Y~APEvl~~----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~---~l~~~~ 253 (630)
.. ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||.......+....+..+..+. ......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd06616 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239 (288)
T ss_pred cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence 32 2234468999999998764 488999999999999999999999976543333333333332222 112236
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
++++.+||.+||. +|.+||++.+++.||||+...
T Consensus 240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 7899999999998 899999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=307.38 Aligned_cols=240 Identities=25% Similarity=0.421 Sum_probs=203.0
Q ss_pred eEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~t---G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
+.||+|+||.||+|.+... +..||+|.+..... ....+.+.+|+.+++.++||||+++++++.+ ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence 4699999999999999866 99999999875432 2246778999999999999999999998876 45789999
Q ss_pred cccCCCCHH-HHhhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 108 ELFTSGSLR-YRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~---------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
||+++|+|. ++... ..+++..++.++.||+.||+|||+++ ++||||||+||+++ .++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~-~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVG-EDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEEC-CCCcEEEcccccc
Confidence 999999998 55554 78999999999999999999999998 99999999999998 7899999999999
Q ss_pred eeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 178 IVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 178 ~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
....... .....+++.|+|||.+.. .++.++||||||+++|+|++ |..||... ...++...+..+... ..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 230 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-PKPE 230 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCc
Confidence 7665432 334567889999998764 68899999999999999999 69999874 566666777664433 3445
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..++++.++|.+||. +|.+||++.+++.+
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 568999999999997 89999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.50 Aligned_cols=249 Identities=35% Similarity=0.614 Sum_probs=210.5
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|| ++.+.||+|++|.||+|.+..+|..|++|.+..... .......+.+|+.++++++||||+++++++.+. ..++
T Consensus 1 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (254)
T cd06627 1 NY-QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLY 75 (254)
T ss_pred Cc-eeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEE
Confidence 35 678999999999999999999999999999976543 235667899999999999999999999988654 5789
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
++|||+++++|. ++.....+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTT-KDGVVKLADFGVATKLNDV 152 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEC-CCCCEEEeccccceecCCC
Confidence 999999999998 6667788999999999999999999999998 99999999999998 6899999999999766543
Q ss_pred CC--ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006810 184 TA--RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260 (630)
Q Consensus 184 ~~--~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~ 260 (630)
.. ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||............. ... ...++...+..++++
T Consensus 153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~ 230 (254)
T cd06627 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDD-HPPLPEGISPELKDF 230 (254)
T ss_pred cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccC-CCCCCCCCCHHHHHH
Confidence 32 34568999999997754 47889999999999999999999997654333333333 222 234555678999999
Q ss_pred HHHccc-CCCCCCCHHHHhcCCCc
Q 006810 261 IEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 261 I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
|.+||. +|.+||++.+++.||||
T Consensus 231 i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 231 LMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHhCChhhCcCHHHHhcCCCC
Confidence 999997 89999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=319.83 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=213.4
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEEEEc
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITE 108 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~lV~E 108 (630)
.++||+|+|+.|--+....+|.+||+|+|.+. ......++.+|++++.++ .|+||+.++++|.+++ .+|+|+|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYLVfE 156 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYLVFE 156 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEEEEe
Confidence 47899999999999999999999999999754 234567899999999999 5999999999997664 5899999
Q ss_pred ccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCC--CcEEEcccccceeecc---
Q 006810 109 LFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQ--- 182 (630)
Q Consensus 109 y~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~--g~vKL~DFGla~~~~~--- 182 (630)
-|.||.|. .+.+++.+++.++.++.++|+.||.+||.+| |.||||||+|||-...+ .-||||||.++.....
T Consensus 157 Km~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred cccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999987 8899999999999999999999999999999 99999999999986333 2589999988743321
Q ss_pred ------CCCccccCCCCCCCccccc---c---ccCcccceeehhHHHHHHhhCCCCCCCCCC--------------HHHH
Q 006810 183 ------PTARSVIGTPEFMAPELYE---E---EYNELVDIYSFGMCILEMVTCEYPYNECKN--------------PAQI 236 (630)
Q Consensus 183 ------~~~~~~~GTp~Y~APEvl~---~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~--------------~~~i 236 (630)
+...+.+|+.+|||||+.. + .|+.++|.||||||+|-|+.|++||.+.=. ...+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 2234567888999999753 2 489999999999999999999999976211 3567
Q ss_pred HHHHHcCCC--CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCC
Q 006810 237 YKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 289 (630)
Q Consensus 237 ~~~i~~g~~--p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~ 289 (630)
+..|..|.. |..-+..++.+++++|.++|. ++..|.+|.+.|+|||++...+.
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 888888854 444455678999999999997 89999999999999999875544
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=327.16 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=203.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC---
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 100 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~--- 100 (630)
.|| ++.+.||+|+||+||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y-~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKY-VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cce-eEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 466 778899999999999999999999999999864321 22334567789999999999999999998765432
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++|+||+.+ +|. ++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcCccccc
Confidence 358999999975 555 7777788999999999999999999999998 99999999999998 789999999999976
Q ss_pred eccC--CCccccCCCCCCCccccc--cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc--C----------
Q 006810 180 MQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--G---------- 243 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~--~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~--g---------- 243 (630)
.... ......++..|+|||++. ..++.++|||||||++|+|++|+.||.+.... .....+.. +
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhc
Confidence 5432 223456889999999775 35889999999999999999999999763221 11111110 0
Q ss_pred -----------C----CC--CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 244 -----------I----KP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 244 -----------~----~p--~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
. .+ .......++.+++||.+||. +|.+||++.++|+||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 00 01123467889999999998 89999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.24 Aligned_cols=249 Identities=31% Similarity=0.511 Sum_probs=209.8
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|| ++.+.||+|+||.||++.+..+|..+|+|.+..... .......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y-~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08530 1 DF-KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLC 75 (256)
T ss_pred Cc-eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEE
Confidence 35 678999999999999999999999999999875543 234556788999999999999999999988765 5789
Q ss_pred EEEcccCCCCHH-HHhh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 105 MITELFTSGSLR-YRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
+|+||+++++|. ++.. ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++ .++.+||+|||++..
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLV-ANDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEe-cCCcEEEeeccchhh
Confidence 999999999997 4433 367899999999999999999999999 99999999999998 688999999999976
Q ss_pred eccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 180 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 180 ~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
..........+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||... +...+...+..+..+ ......+.+++
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 230 (256)
T cd08530 153 LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGKYP-PIPPIYSQDLQ 230 (256)
T ss_pred hccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCC-CCchhhCHHHH
Confidence 65554445568999999998754 4788999999999999999999999874 444455555544333 23346778999
Q ss_pred HHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 259 QFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
++|.+||. +|.+||++.++|.||++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 99999997 89999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=316.06 Aligned_cols=256 Identities=23% Similarity=0.384 Sum_probs=208.6
Q ss_pred eeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEE
Q 006810 28 RYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~---~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l 103 (630)
++.+.||.|+||.||+|.+. .+|..||+|.+............+.+.+|+.+++++ +||||+++++.|... ..+
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~~ 80 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--TKL 80 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--CeE
Confidence 67899999999999999874 489999999987543323334456688899999999 699999999988644 478
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+++++|. ++.....+++..+..++.||+.||.|||+.+ ++||||+|+|||++ .++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEC-CCCCEEEeeCccceeccc
Confidence 8999999999998 7777788999999999999999999999998 99999999999998 789999999999876543
Q ss_pred C---CCccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCC
Q 006810 183 P---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 183 ~---~~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~---~~~i~~~i~~g~~p~~l~~~~ 253 (630)
. ......|++.|+|||.+.. .++.++||||||+++|+|++|..||..... ...+...+.... ..++...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 235 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEM 235 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--CCCCccC
Confidence 2 1234568999999998753 467899999999999999999999964222 223333333322 2344567
Q ss_pred cHHHHHHHHHccc-CCCCCC-----CHHHHhcCCCcccCCCCc
Q 006810 254 DPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKD 290 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~ 290 (630)
++.+.++|.+||. +|.+|+ ++.+++.||||+..++..
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 8999999999998 799997 899999999999877544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=327.65 Aligned_cols=250 Identities=23% Similarity=0.393 Sum_probs=200.6
Q ss_pred CCCcceeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~-----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f 95 (630)
|-.|| ++.+.||+|+||.||+|.+. .+++.||+|+++... .......+.+|+.+++++ +||||+++++++
T Consensus 5 ~~~~~-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 5 PRDRL-KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CHHHh-hhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 45577 88999999999999999743 356899999986432 234456788999999999 899999999988
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhh------------------------------------------------------
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKK------------------------------------------------------ 120 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~------------------------------------------------------ 120 (630)
.... ..+++++||+++|+|. ++..
T Consensus 81 ~~~~-~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 81 TKPG-GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred ecCC-CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 6543 4688999999999997 4432
Q ss_pred -------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC----Ccccc
Q 006810 121 -------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVI 189 (630)
Q Consensus 121 -------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~ 189 (630)
...+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..+.... .....
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccCCC
Confidence 126889999999999999999999998 99999999999998 68899999999997653221 12334
Q ss_pred CCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-
Q 006810 190 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV- 266 (630)
Q Consensus 190 GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~- 266 (630)
+++.|+|||++. ..++.++|||||||++|+|++ |..||.+....+.+...+..+..+ ..+...++++.+++.+||+
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccC
Confidence 567899999765 568999999999999999998 999997644444444555544332 2344567899999999997
Q ss_pred CCCCCCCHHHHhcC
Q 006810 267 PASLRLPALELLKD 280 (630)
Q Consensus 267 ~p~~Rpsa~eLL~h 280 (630)
+|.+||++.++++|
T Consensus 316 ~p~~RPs~~ell~~ 329 (337)
T cd05054 316 NPEDRPTFSELVEI 329 (337)
T ss_pred ChhhCcCHHHHHHH
Confidence 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=334.79 Aligned_cols=254 Identities=27% Similarity=0.454 Sum_probs=215.7
Q ss_pred Ccceee-eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 24 CRYGRY-DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 24 gRy~r~-~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.-|+-+ .++||+|-||+||-|+++.+|+.||+|+|.+..+. ..+...+++|+.+|++++||.||.+.-.|.. ...
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp--~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~er 637 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP--TKQESQLRNEVAILQNLHHPGIVNLECMFET--PER 637 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCC--CchHHHHHHHHHHHHhcCCCCeeEEEEeecC--Cce
Confidence 334333 48999999999999999999999999999866543 3344778999999999999999999987744 457
Q ss_pred EEEEEcccCCCCHHH--HhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC--CCcEEEcccccce
Q 006810 103 INMITELFTSGSLRY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAI 178 (630)
Q Consensus 103 l~lV~Ey~~gGsL~~--~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKL~DFGla~ 178 (630)
+++|||-+.|.-|.. -...+++++...+.++.||+.||.|||-++ |+|.||||+|||+... -.++||||||+|+
T Consensus 638 vFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 638 VFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeecccccee
Confidence 999999999998883 345688999999999999999999999999 9999999999999733 3489999999999
Q ss_pred eeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCCc
Q 006810 179 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTD 254 (630)
Q Consensus 179 ~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g--~~p~~l~~~~s 254 (630)
..... ..++++|||.|+|||++.. +|+..-|+||.|+|+|--+.|..||.+..+. ...|... ..|+...+.++
T Consensus 716 iIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI---ndQIQNAaFMyPp~PW~eis 792 (888)
T KOG4236|consen 716 IIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI---NDQIQNAAFMYPPNPWSEIS 792 (888)
T ss_pred ecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch---hHHhhccccccCCCchhhcC
Confidence 88765 4578899999999998875 6999999999999999999999999875443 3334432 34555566778
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+++.+||..+|+ +-.+|.|....|.|||++..
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 999999999997 78999999999999999874
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.12 Aligned_cols=264 Identities=28% Similarity=0.475 Sum_probs=213.9
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
+-..+|...| ...+.||+|+||.||+|.+..+|..||+|.+..... ...+....+.+|+.+++.++|||++++++++.
T Consensus 18 ~~~~~~~~~f-~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (317)
T cd06635 18 FFKEDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95 (317)
T ss_pred hcCCCchhhh-hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3567777776 567889999999999999999999999999875433 23445567889999999999999999999987
Q ss_pred cCCCCEEEEEEcccCCCCHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 97 DDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
+. ...++||||+.+..+..+ .....+++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.+||+|||
T Consensus 96 ~~--~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~dfg 170 (317)
T cd06635 96 RE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFG 170 (317)
T ss_pred eC--CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEecCC
Confidence 65 358899999987544443 34567899999999999999999999999 99999999999997 78899999999
Q ss_pred cceeeccCCCccccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 176 LAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 176 la~~~~~~~~~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
++..... .....|++.|+|||++. +.++.++|||||||++|+|++|..||........+......+ .+.....
T Consensus 171 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 247 (317)
T cd06635 171 SASIASP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQSN 247 (317)
T ss_pred CccccCC--cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcc-CCCCCCc
Confidence 8865432 23456899999999763 358889999999999999999999998754444444433333 3333344
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCCc
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 290 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~~ 290 (630)
..++.++++|.+||+ +|.+||++.+++.|+|+....+..
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 567889999999997 899999999999999997755433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.77 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=201.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++.+.....+++|+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 56788999999999999999999999999998653 2233445678899999999999999999998765346799999
Q ss_pred cccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC-
Q 006810 108 ELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 184 (630)
||+++ +|. .+... ..+++..++.++.||+.||+|||+++ ++|+||+|+||+++ .+|.+||+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc-CCCCEEEccccceeeccCCCc
Confidence 99986 665 44433 58999999999999999999999998 99999999999998 78999999999997665432
Q ss_pred --CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CC-----------
Q 006810 185 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PA----------- 247 (630)
Q Consensus 185 --~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~----------- 247 (630)
.....+++.|+|||.+.+ .++.++||||||+++|+|+||+.||........+......... +.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 233456889999997653 4789999999999999999999999875433332222211000 00
Q ss_pred ---------------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 248 ---------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 248 ---------------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.+....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0111237889999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.95 Aligned_cols=258 Identities=31% Similarity=0.426 Sum_probs=207.7
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC-
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~- 100 (630)
..+|| ++.+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+|+.++||||+++++++.....
T Consensus 13 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRY-RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccce-EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 46678 66789999999999999999999999999986432 233445668899999999999999999998865432
Q ss_pred ---CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 101 ---RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 101 ---~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+++||||+ +++|........+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~kl~dfg~~ 165 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLA 165 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccc
Confidence 2468999998 678875555678999999999999999999999999 99999999999998 7899999999998
Q ss_pred eeeccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC----------
Q 006810 178 IVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---------- 245 (630)
Q Consensus 178 ~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~---------- 245 (630)
...... .....+++.|+|||++.+ .++.++|+||||+++|+|++|..||..................
T Consensus 166 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 166 RQTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred cccccC-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 755432 234567999999998764 4788999999999999999999999875443333222211100
Q ss_pred ---------------C---CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 246 ---------------P---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 246 ---------------p---~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+ ..+....++.+.++|.+||. +|.+||++.+++.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 01123457789999999998 899999999999999998643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=326.10 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=204.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC--CCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TNR 101 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~--~~~ 101 (630)
.+| .+.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.+|+.++||||++++++|... ...
T Consensus 5 ~~y-~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRY-KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hce-eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 455 778999999999999999999999999999875422 223456678899999999999999999987543 234
Q ss_pred EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 102 TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
.+++|+||+.+ +|. .+...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++...
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEecccccceee
Confidence 78999999975 666 6666777999999999999999999999998 99999999999998 7899999999998755
Q ss_pred ccCC------CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCC------
Q 006810 181 QQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK------ 245 (630)
Q Consensus 181 ~~~~------~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~------ 245 (630)
.... .....|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.......++...... +..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 3321 123468999999998753 4889999999999999999999999764433222111110 000
Q ss_pred ------------------CC---CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 246 ------------------PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 246 ------------------p~---~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+. .+....++.+++||.+||+ +|.+||++.++|.||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 00 0113357889999999997 89999999999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=312.98 Aligned_cols=249 Identities=30% Similarity=0.509 Sum_probs=207.5
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l 103 (630)
+| .+.+.||+|+||.||+|.+..+|..||+|++...... .......+.+|+.++++++ ||||+++++++.+. ..+
T Consensus 2 ~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~ 77 (280)
T cd05581 2 DF-KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENL 77 (280)
T ss_pred Cc-eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceE
Confidence 45 7789999999999999999999999999998764432 2344467889999999998 99999999987544 468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+.+++|. ++.+.+.+++..++.|+.||+.||.|||+++ ++|+||+|+||+++ .+|.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCC
Confidence 9999999999998 7777778999999999999999999999999 99999999999997 789999999999865433
Q ss_pred CC----------------------CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHH
Q 006810 183 PT----------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 239 (630)
Q Consensus 183 ~~----------------------~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~ 239 (630)
.. .....+++.|+|||++.. .++.++||||||+++++|++|+.||.... ..+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~ 233 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQK 233 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHH
Confidence 21 123457899999997654 47889999999999999999999998743 3344444
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCH----HHHhcCCCc
Q 006810 240 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELLKDPFL 283 (630)
Q Consensus 240 i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa----~eLL~hpf~ 283 (630)
+... ...++...++.+.+||.+||. +|.+||++ .++|+||||
T Consensus 234 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKL--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhc--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 4322 223344558899999999997 89999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.24 Aligned_cols=260 Identities=28% Similarity=0.477 Sum_probs=210.7
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
+-..+|..+| ...+.||+|+||.||+|.+..+|..||+|.+..... .......++.+|+.+++.++|||++++++++.
T Consensus 8 ~~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 8 FFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred hhcCCcHHHH-HHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 4456677777 445779999999999999999999999999875432 23344567889999999999999999999987
Q ss_pred cCCCCEEEEEEcccCCCCHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 97 DDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
.. ...++|+||+.++.+..+ .....+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||
T Consensus 86 ~~--~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg 160 (308)
T cd06634 86 RE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFG 160 (308)
T ss_pred cC--CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC-CCCcEEECCcc
Confidence 65 468899999985443443 34566899999999999999999999998 99999999999997 78999999999
Q ss_pred cceeeccCCCccccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 176 LAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 176 la~~~~~~~~~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
++...... ....|++.|+|||.+. +.++.++|||||||++|+|++|..||........... +..+..+.....
T Consensus 161 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (308)
T cd06634 161 SASIMAPA--NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPALQSG 237 (308)
T ss_pred cceeecCc--ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH-HhhcCCCCcCcc
Confidence 98765432 3456899999999864 3578899999999999999999999976443333333 333333433344
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..+..+++||++||. +|.+||++.+++.|||+...
T Consensus 238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred cccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 677899999999997 89999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=314.41 Aligned_cols=248 Identities=27% Similarity=0.443 Sum_probs=199.4
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||.|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.++||||+++++++.+. ...++|+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~ 77 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED--EGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVF 77 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc--ccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEE
Confidence 5678899999999999999999999999998765321 22335678899999999999999999988654 5789999
Q ss_pred cccCCCCHH-HHhhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-
Q 006810 108 ELFTSGSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 183 (630)
||+. ++|. ++.... .+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPV 153 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCcEEEeecccccccCCCc
Confidence 9996 5676 555554 7899999999999999999999998 99999999999998 6899999999998654332
Q ss_pred -CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC---------------
Q 006810 184 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--------------- 245 (630)
Q Consensus 184 -~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--------------- 245 (630)
......+++.|+|||++.+ .++.++||||||+++|+|++|+.||.......++.+.+.....
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1223356889999997754 3688999999999999999999999875443333332221000
Q ss_pred -----------CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 246 -----------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 246 -----------p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
........+..+.++|.+||+ +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 011123456889999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=307.84 Aligned_cols=246 Identities=21% Similarity=0.362 Sum_probs=199.4
Q ss_pred eeeeEecccCceEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC----
Q 006810 28 RYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---- 100 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~---tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~---- 100 (630)
++.+.||+|+||.||+|.+.. ++..||+|.++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 678899999999999998765 348899999875432 34556778999999999999999999998765432
Q ss_pred CEEEEEEcccCCCCHH-HHhh------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcc
Q 006810 101 RTINMITELFTSGSLR-YRKK------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 173 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 173 (630)
...++|+||+++|+|. ++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEEC-CCCeEEECC
Confidence 3478999999999997 4322 236899999999999999999999998 99999999999998 788999999
Q ss_pred cccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCC
Q 006810 174 LGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 247 (630)
Q Consensus 174 FGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~ 247 (630)
||+++...... .....+++.|+|||.+.+ .++.++|||||||++|||++ |..||.+. ....++..+..+..+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~- 234 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHGNRL- 234 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-
Confidence 99997654321 112234678999998764 58899999999999999999 88999764 445566666655433
Q ss_pred CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 248 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 248 ~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..+...++.+.++|.+||+ +|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3455678899999999998 89999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=338.09 Aligned_cols=240 Identities=34% Similarity=0.533 Sum_probs=205.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.+.||+|.||+||+|++- ..||||.++.... ++++++.|++|+.++++-+|.||+-|.+++..+. +.+|+
T Consensus 395 ~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~AIiT 466 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LAIIT 466 (678)
T ss_pred hccceeccccccceeecccc---cceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---eeeee
Confidence 45788999999999999775 3799999987764 5678999999999999999999999999986443 58999
Q ss_pred cccCCCCHH-HH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc---
Q 006810 108 ELFTSGSLR-YR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--- 182 (630)
Q Consensus 108 Ey~~gGsL~-~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--- 182 (630)
-+|+|.+|. ++ .....|.+.+...|++||++|+.|||.++ |||||||..|||+. +++.|||+|||++..-..
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCCcEEEecccceeeeeeecc
Confidence 999999997 33 34567999999999999999999999999 99999999999997 779999999999964322
Q ss_pred -CCCccccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCc
Q 006810 183 -PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PASLSKVTD 254 (630)
Q Consensus 183 -~~~~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~---p~~l~~~~s 254 (630)
.......|...|||||+++ .+|++.+|||||||++|||+||..||. ..+.+++.-.+..|.. ........+
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCH
Confidence 2233445788999999875 358999999999999999999999999 6899999888888843 334445566
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.++++|+..||. ++.+||...+||.
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHH
Confidence 799999999998 8999999999876
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.43 Aligned_cols=236 Identities=23% Similarity=0.346 Sum_probs=189.2
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh-CCCCCeeEEEeEEEcCCCCEEEEEEcccC
Q 006810 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDTNRTINMITELFT 111 (630)
Q Consensus 33 LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~-L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~ 111 (630)
||+|+||.||++.++.+|..+|+|.+........ |+..... .+||||++++++|.... .+++||||++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~---------e~~~~~~~~~h~~iv~~~~~~~~~~--~~~iv~e~~~ 92 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI---------EPMVHQLMKDNPNFIKLYYSVTTLK--GHVLIMDYIK 92 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh---------hHHHHHHhhcCCCEEEEEEEEecCC--eeEEEEEcCC
Confidence 6999999999999999999999999875432111 2222221 27999999999987653 6899999999
Q ss_pred CCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC-cEEEcccccceeeccCCCcccc
Q 006810 112 SGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQPTARSVI 189 (630)
Q Consensus 112 gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g-~vKL~DFGla~~~~~~~~~~~~ 189 (630)
+|+|. ++.....+++..++.|+.||+.||.|||+.+ ++||||||+||+++ .++ .++|+|||++...... ....
T Consensus 93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~~l~dfg~~~~~~~~--~~~~ 167 (267)
T PHA03390 93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYD-RAKDRIYLCDYGLCKIIGTP--SCYD 167 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEe-CCCCeEEEecCccceecCCC--ccCC
Confidence 99998 6667679999999999999999999999999 99999999999998 555 9999999998765432 2346
Q ss_pred CCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-
Q 006810 190 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV- 266 (630)
Q Consensus 190 GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~-i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~- 266 (630)
|++.|+|||++.+ .++.++||||||+++|+|++|+.||........ ..........+....+..++.+++||.+||+
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 247 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKY 247 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhcc
Confidence 8999999998764 588999999999999999999999975332211 1111111122334445678999999999998
Q ss_pred CCCCCCC-HHHHhcCCCcc
Q 006810 267 PASLRLP-ALELLKDPFLV 284 (630)
Q Consensus 267 ~p~~Rps-a~eLL~hpf~~ 284 (630)
+|.+|++ ..++|+||||.
T Consensus 248 ~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 248 NINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ChhhCCchHHHHhcCCccc
Confidence 8999997 59999999996
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=322.83 Aligned_cols=254 Identities=30% Similarity=0.440 Sum_probs=206.7
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC---CC
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---NR 101 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~---~~ 101 (630)
|| ++.+.||+|++|.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++.+.. ..
T Consensus 1 ~y-~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RY-ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred Cc-eeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 56 78899999999999999999999999999986432 22345567889999999999999999999886653 23
Q ss_pred EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 102 TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
.+|+||||+.+ +|. .+.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++|+|||++...
T Consensus 78 ~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~-~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 78 DVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVN-SNCDLKICDFGLARGV 153 (330)
T ss_pred ceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccCceEee
Confidence 68999999986 565 6667778999999999999999999999999 99999999999998 7899999999999766
Q ss_pred ccCC-----CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--C-----
Q 006810 181 QQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P----- 246 (630)
Q Consensus 181 ~~~~-----~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p----- 246 (630)
.... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||..... ...+..+..... +
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-IDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHhcCCCChhHhh
Confidence 5432 334568999999998764 478999999999999999999999987443 333333322110 0
Q ss_pred ----------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 ----------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 ----------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.......++.+.+||.+||. +|.+||++.++|.||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 00112346789999999998 89999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=330.09 Aligned_cols=241 Identities=26% Similarity=0.428 Sum_probs=198.0
Q ss_pred ceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEE
Q 006810 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~l 105 (630)
..++.+.||+|-||.||+|.... ...||+|.++.... ..+.+.+|+++|++|+|+|||++|+++..+. .++|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyI 278 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYI 278 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEE
Confidence 34566889999999999997653 33899999875432 1244779999999999999999999886543 6999
Q ss_pred EEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 106 ITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 106 V~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
|||||+.|+|. |++. +..++..+...++.||+.|++||++++ +|||||.+.||||+ +++.+||+|||+|+....
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEcccccccccCC
Confidence 99999999998 7765 577999999999999999999999999 99999999999997 888999999999995433
Q ss_pred CCCccccC---CCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 183 PTARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 183 ~~~~~~~G---Tp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
..-....| ...|.|||.+. +.++.++|||||||+|+||+| |+.||.+. +..+....+..|..-+. +..+++++
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-sn~ev~~~le~GyRlp~-P~~CP~~v 433 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-SNEEVLELLERGYRLPR-PEGCPDEV 433 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-CHHHHHHHHhccCcCCC-CCCCCHHH
Confidence 22111111 34699999775 679999999999999999999 88999885 45566677888765432 44578999
Q ss_pred HHHHHHccc-CCCCCCCHHHHhc
Q 006810 258 KQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
-+++..|+. +|.+|||...|..
T Consensus 434 Y~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 434 YELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHHHHHhhCCcccCCCHHHHHH
Confidence 999999997 8999999986543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=305.83 Aligned_cols=239 Identities=23% Similarity=0.409 Sum_probs=194.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
+.||+|+||+||+|.+..+|..||+|.+... ...+....+.+|+.+++.++||||+++++++... ..+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeec
Confidence 4699999999999999999999999987532 2344557789999999999999999999988654 4688999999
Q ss_pred CCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCcc-
Q 006810 111 TSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS- 187 (630)
Q Consensus 111 ~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~- 187 (630)
.+++|. ++.. ...+++..++.++.|++.||.|||+++ ++||||||+|||++ .++.+||+|||++..........
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCccccccccccc
Confidence 999998 5544 446899999999999999999999998 99999999999998 78899999999986543321111
Q ss_pred ---ccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 188 ---VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 188 ---~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
..++..|+|||.+. +.++.++||||||+++|+|++ |..||... ........+..... ...+...+..+.+||.
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 230 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGVR-LPCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCC-CCCcccCCHHHHHHHH
Confidence 12245699999875 458899999999999999998 88898753 44444444444332 2345566889999999
Q ss_pred Hccc-CCCCCCCHHHHhc
Q 006810 263 KCIV-PASLRLPALELLK 279 (630)
Q Consensus 263 kcL~-~p~~Rpsa~eLL~ 279 (630)
+||+ +|.+||++.+++.
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9998 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.78 Aligned_cols=245 Identities=27% Similarity=0.458 Sum_probs=198.8
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeE----EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIE----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~----VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
.+| ++.+.||+|+||+||+|.+..+|.. ||+|.++.. ......+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~f-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 7 TEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred hhc-eeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 345 7789999999999999998766654 899988632 2344556788999999999999999999988653
Q ss_pred CCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 100 NRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..++|+||+.+|+|. ++.. ...++...+..|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 82 --~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a 156 (316)
T cd05108 82 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFGLA 156 (316)
T ss_pred --CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEcccccc
Confidence 367899999999997 5554 446899999999999999999999999 99999999999997 7889999999999
Q ss_pred eeeccCCC----ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 178 IVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 178 ~~~~~~~~----~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
+....... ....+++.|+|||++. ..++.++|||||||++|||++ |+.||.+ ....++...+..+..+. .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 234 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPP 234 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCCC-CCC
Confidence 76543221 1223466899999775 458999999999999999998 9999976 34555555555543332 344
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..+..+.++|.+||. +|.+||++.+++.+
T Consensus 235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 235 ICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 567899999999997 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.56 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=199.8
Q ss_pred cceeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~-----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
+| .+.+.||+|+||.||+|.+. .++..||+|.+.... ..+....+.+|+++|+.++||||+++++++...
T Consensus 6 ~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 80 (280)
T cd05049 6 TI-VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG- 80 (280)
T ss_pred Hh-hHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-
Confidence 44 66789999999999999874 346889999886432 233457789999999999999999999998765
Q ss_pred CCEEEEEEcccCCCCHH-HHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC
Q 006810 100 NRTINMITELFTSGSLR-YRKKH--------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 164 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~--------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 164 (630)
..+++||||+++|+|. ++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~- 156 (280)
T cd05049 81 -DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG- 156 (280)
T ss_pred -CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc-
Confidence 4689999999999998 55433 34789999999999999999999999 99999999999998
Q ss_pred CCCcEEEcccccceeeccC----CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHH
Q 006810 165 NNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 238 (630)
Q Consensus 165 ~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~ 238 (630)
.++.+||+|||++...... ......+++.|+|||++. +.++.++|||||||++|+|++ |..||... +......
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~~ 235 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIE 235 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHH
Confidence 7899999999998754322 122334678899999876 458899999999999999998 99999764 4555566
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 239 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 239 ~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+..+..+. .+...+..++++|.+||+ +|.+||++.|++.
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 666554432 344578899999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.47 Aligned_cols=246 Identities=22% Similarity=0.351 Sum_probs=199.0
Q ss_pred eeeeEecccCceEEEEEEEccCCe--EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC----CC
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NR 101 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~--~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~----~~ 101 (630)
.+++.||+|+||.||+|.+..++. .||+|.++... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 467889999999999999887775 69999886542 23455678899999999999999999999765422 23
Q ss_pred EEEEEEcccCCCCHH-HHh------hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 102 TINMITELFTSGSLR-YRK------KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~------~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
..++||||+.+|+|. ++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCC
Confidence 578899999999997 332 2245899999999999999999999998 99999999999997 7899999999
Q ss_pred ccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006810 175 GLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 248 (630)
Q Consensus 175 Gla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 248 (630)
|++....... .....+++.|+|||.+.+ .++.++|||||||++|+|++ |+.||.. .....++..+..+..+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~- 234 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK- 234 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-
Confidence 9997654321 122345778999998764 58999999999999999999 8899976 45566667676654332
Q ss_pred CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 249 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 249 l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.....+..++++|.+||+ +|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 334567889999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.83 Aligned_cols=248 Identities=32% Similarity=0.541 Sum_probs=203.2
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||.||+|.+..+|..||+|.+...... .......+.+|+.+++.++||||++++++|.+. ..++
T Consensus 3 ~y-~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08229 3 NF-RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELN 78 (267)
T ss_pred hh-hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh-hHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEE
Confidence 45 6778999999999999999999999999988754432 334556788999999999999999999998765 4688
Q ss_pred EEEcccCCCCHH-HHh----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 105 MITELFTSGSLR-YRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
++|||+++++|. ++. ....+++..++.++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++..
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~ 155 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhc
Confidence 999999999997 433 2456899999999999999999999999 99999999999998 788999999999876
Q ss_pred eccCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCcH
Q 006810 180 MQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN-PAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 180 ~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~-~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
..... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||..... .....+.+.....+.......++
T Consensus 156 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred cccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccH
Confidence 54322 234578999999998754 578899999999999999999999975332 23444444444334333445788
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.++++|.+||. +|.+||++.+++.
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999997 8999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.87 Aligned_cols=242 Identities=28% Similarity=0.514 Sum_probs=195.7
Q ss_pred eeeeEecccCceEEEEEEEc----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 28 RYDEILGKGAFKTVYKGFDE----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+.+.||.|+||.||+|... ..+..|++|.++.. ......+.+.+|++.+++++||||+++++++.... .+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeecccccccccccccccccccccccc--cc
Confidence 45789999999999999887 56789999998532 23555788999999999999999999999998433 48
Q ss_pred EEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 104 NMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
++|+||+++|+|. ++... ..+++..+..|+.||+.||.|||+++ ++||+|+++|||++ .++.+||+|||++...
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~-~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLD-SNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEE-TTTEEEEESTTTGEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-cccccccccccccccc
Confidence 8999999999998 66665 78999999999999999999999998 99999999999998 7889999999999766
Q ss_pred ccC----CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 181 QQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 181 ~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
... ......+...|+|||.+.. .++.++||||||+++|||++ |+.||... +...+...+..+..+ ..+...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 231 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRL-PIPDNCP 231 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEET-TSBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccc-eeccchh
Confidence 221 1123346778999998864 48999999999999999999 78999875 667777777665443 3455678
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..+.++|.+||. +|.+||++.++++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 899999999997 8999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=314.89 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=211.1
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f 95 (630)
+.+..-+.-|..-.++||-|-.|.|..++++.||+.+|+|++.- ..+.++|+++.-.. .|||||.++++|
T Consensus 54 ~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---------s~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 54 FKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---------SPKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred hhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---------CHHHHhHhhhhhhhcCCCceEEeehhh
Confidence 44444555563334899999999999999999999999998741 13467888876555 799999999988
Q ss_pred Ec--CCCCEEEEEEcccCCCCHH-HHhhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCc
Q 006810 96 VD--DTNRTINMITELFTSGSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGE 168 (630)
Q Consensus 96 ~d--~~~~~l~lV~Ey~~gGsL~-~~~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~ 168 (630)
.. ....++.+|||.++||.|. .+..++ .++++++..|++||..|+.|||+.+ |.||||||+|+|..+ .|..
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~ 202 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAP 202 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcc
Confidence 54 2346899999999999998 444444 5999999999999999999999999 999999999999973 4568
Q ss_pred EEEcccccceeecc-CCCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCC---HHHHHHHHHcC
Q 006810 169 VKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSG 243 (630)
Q Consensus 169 vKL~DFGla~~~~~-~~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~---~~~i~~~i~~g 243 (630)
+||+|||+|+.... ....+.+-||.|.|||++. +.|+..+|+||+||++|-|++|.+||..... ...+..+|..|
T Consensus 203 lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 203 LKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred eEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 99999999987653 3456778899999999886 4699999999999999999999999976332 22344556655
Q ss_pred CC--CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 244 IK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 244 ~~--p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.. |..-+...+..++++|+++|. +|++|.|+.+++.|||+...
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 43 444445568999999999997 89999999999999999764
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.28 Aligned_cols=256 Identities=26% Similarity=0.381 Sum_probs=204.9
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~ 101 (630)
.+|| .+.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++++ +||||++++++|......
T Consensus 6 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKY-EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHH-HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 3456 67799999999999999999999999999885322 1233445678899999999 999999999998766666
Q ss_pred EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 102 TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
.+++||||+.+ +|. ++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchhcc
Confidence 78999999985 776 44444 8899999999999999999999998 99999999999998 8899999999998654
Q ss_pred ccC-------CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-------
Q 006810 181 QQP-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI------- 244 (630)
Q Consensus 181 ~~~-------~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~------- 244 (630)
... ......|++.|+|||++.+ .++.++||||||+++|+|+||+.||.......+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 322 2234568999999997743 478899999999999999999999976544433322211110
Q ss_pred ---------------------CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 245 ---------------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 245 ---------------------~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
......+..+.++.+||.+||+ +|.+||++.++|.||||+.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0111223357889999999998 89999999999999999763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.83 Aligned_cols=256 Identities=31% Similarity=0.468 Sum_probs=205.2
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC--
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~-- 100 (630)
.++| ++.+.||+|++|.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y-~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 14 PDRY-QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cCce-EEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4567 67899999999999999999999999999886432 223345668889999999999999999987754432
Q ss_pred --CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 101 --RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++|+||+ +++|........+++..++.++.||+.||.|||+.+ |+||||||+||+++ .+|.+||+|||++.
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~~~ 166 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGLAR 166 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEccccccc
Confidence 3588999998 568875445578999999999999999999999998 99999999999998 78999999999997
Q ss_pred eeccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC--CC--------
Q 006810 179 VMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KP-------- 246 (630)
Q Consensus 179 ~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~--~p-------- 246 (630)
..... .....+++.|+|||.+.+ .++.++|||||||++|+|++|+.||........ +..+.... .+
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 167 HTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCHHHHhhcc
Confidence 65433 344568999999998754 478899999999999999999999986443333 33222111 00
Q ss_pred ----------------C---CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 247 ----------------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 247 ----------------~---~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
. ......++.+.+||.+||. +|.+||++.++|.||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0 0112347899999999997 899999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=308.87 Aligned_cols=246 Identities=24% Similarity=0.411 Sum_probs=196.2
Q ss_pred CcceeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~-----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
+|| ++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~-~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 6 EKI-TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred HHc-eeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 455 88899999999999999864 346789999875332 233456688999999999999999999987543
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC
Q 006810 99 TNRTINMITELFTSGSLR-YRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 167 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~----------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 167 (630)
..+++||||+++|+|. ++... ..++...+..++.|++.||.|||+.+ ++||||||+||+++ .++
T Consensus 82 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~-~~~ 156 (277)
T cd05062 82 --QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDF 156 (277)
T ss_pred --CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc-CCC
Confidence 4688999999999998 54432 23577889999999999999999998 99999999999998 789
Q ss_pred cEEEcccccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHH
Q 006810 168 EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 241 (630)
Q Consensus 168 ~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~ 241 (630)
.++|+|||++....... .....+++.|+|||++.+ .++.++|||||||++|||++ |..||.+. +.......+.
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~-~~~~~~~~~~ 235 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-SNEQVLRFVM 235 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHH
Confidence 99999999986443221 112345778999998764 58999999999999999999 78899763 4455555554
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 242 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 242 ~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+.. ...+...++.++++|.+||+ +|.+||++.|++.+
T Consensus 236 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 EGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4432 23445567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=309.87 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=200.8
Q ss_pred CcceeeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~-----tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
.|| ++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~-~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 6 EKI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred HHc-eeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 467 778999999999999997652 35689999876432 233445678899999999999999999987654
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC
Q 006810 99 TNRTINMITELFTSGSLR-YRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 167 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~----------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 167 (630)
...++||||+++|+|. ++... ..++...+..++.||+.||.|||+++ |+||||||+||+++ .++
T Consensus 82 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~-~~~ 156 (288)
T cd05061 82 --QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA-HDF 156 (288)
T ss_pred --CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc-CCC
Confidence 4589999999999998 55432 23467788999999999999999998 99999999999998 789
Q ss_pred cEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHH
Q 006810 168 EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 241 (630)
Q Consensus 168 ~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~ 241 (630)
.+||+|||+++...... .....++..|+|||.+. +.++.++|||||||++|||++ |+.||.. .....+.+.+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~ 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVM 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 99999999987543221 12234567899999876 458999999999999999999 7889976 45555655555
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc------CCCcccCC
Q 006810 242 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK------DPFLVTDN 287 (630)
Q Consensus 242 ~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~------hpf~~~~~ 287 (630)
.+..+ ..+...++.++++|.+||. +|.+||++.+++. ||||....
T Consensus 236 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 236 DGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 44332 2334557899999999997 8999999999986 88887654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=305.00 Aligned_cols=241 Identities=26% Similarity=0.421 Sum_probs=200.4
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+.+.+.||+|+||.||+|.+..++..||+|.+... ......+.+|+.+++.++||||+++++++... ..+++|
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII 80 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEE
Confidence 36789999999999999999999999999988632 22345688999999999999999999987654 458899
Q ss_pred EcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 107 TELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
|||+++|+|. ++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCccccccccc
Confidence 9999999998 5543 346899999999999999999999998 99999999999997 7899999999998765443
Q ss_pred CCc---cccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 184 TAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 184 ~~~---~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
... ...+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. .+.......+..+..+ ..+...++++.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKVY 235 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHH
Confidence 221 123466899999776 458899999999999999998 9999976 4566666666665433 34556789999
Q ss_pred HHHHHccc-CCCCCCCHHHHhc
Q 006810 259 QFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
++|.+||. +|.+||++.++++
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHH
Confidence 99999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=304.93 Aligned_cols=238 Identities=23% Similarity=0.371 Sum_probs=197.2
Q ss_pred EecccCceEEEEEEE--ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 32 ILGKGAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 32 ~LG~G~fg~Vy~A~d--~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
.||+|+||.||+|.+ ..++..||+|++.... ......+.+.+|+.+++.++||||+++++++.. ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEec
Confidence 589999999999964 5678999999886443 234556778999999999999999999997643 346889999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC---
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 185 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~--- 185 (630)
+++|+|. ++...+.+++..+..++.||+.||.|||+++ ++||||||.||+++ .++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc-CCCeEEECCCccccccCCCCCeee
Confidence 9999998 7777778999999999999999999999999 99999999999998 788999999999876543221
Q ss_pred --ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 186 --RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 186 --~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
....+++.|+|||.+.. .++.++|||||||++|||++ |..||.. .+...+...+..+..+ ..+...+++++++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERM-ECPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 12234578999998764 57889999999999999998 9999976 4556667777766443 34556789999999
Q ss_pred HHccc-CCCCCCCHHHHhc
Q 006810 262 EKCIV-PASLRLPALELLK 279 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+||+ +|.+||++.++..
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99997 8999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=313.53 Aligned_cols=248 Identities=30% Similarity=0.565 Sum_probs=205.9
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
..||+|+||.||+|.+..+|..||+|++.... ......+.+|+.+++.++||||++++++|... ...++||||+
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 99 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVMEFL 99 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEecC
Confidence 67999999999999999999999999885432 23456688999999999999999999998754 4689999999
Q ss_pred CCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--CCccc
Q 006810 111 TSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSV 188 (630)
Q Consensus 111 ~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~~~~~ 188 (630)
++++|........+++..+..++.|++.||+|||+++ ++||||+|.||+++ .++.++|+|||++...... .....
T Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 100 EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEcccccceeccccccccccc
Confidence 9999985556677999999999999999999999998 99999999999998 7889999999988654332 22345
Q ss_pred cCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHHHHHHccc
Q 006810 189 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV 266 (630)
Q Consensus 189 ~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~-~l~~~~s~~lk~~I~kcL~ 266 (630)
.|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.. .........+.....+. ......++.+.++|.+||.
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 68999999997754 578899999999999999999999976 34444444444433221 1223467899999999997
Q ss_pred -CCCCCCCHHHHhcCCCcccCCC
Q 006810 267 -PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 267 -~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+|.+||++.++|.||||....+
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCC
Confidence 8999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=321.40 Aligned_cols=254 Identities=30% Similarity=0.445 Sum_probs=201.7
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC----
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---- 99 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~---- 99 (630)
.|| .+.+.||+|+||.||+|.+..+|..||+|++.... ......+.+.+|+.++++++||||+++++++....
T Consensus 17 ~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 17 ERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred Cce-EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 566 67799999999999999999999999999986432 12334566889999999999999999999886432
Q ss_pred CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 100 NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
...++++++++ +++|........+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++..
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg~~~~ 169 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARH 169 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEeccccccc
Confidence 13477888876 778875555667999999999999999999999999 99999999999998 789999999999875
Q ss_pred eccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--------------
Q 006810 180 MQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-------------- 243 (630)
Q Consensus 180 ~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g-------------- 243 (630)
.... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||........+ ..+...
T Consensus 170 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 170 TDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLKKISS 247 (345)
T ss_pred cccc-ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHhhccc
Confidence 4332 234568999999998754 4788999999999999999999999764332222 211110
Q ss_pred ------------CCC---CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 244 ------------IKP---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 244 ------------~~p---~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
... .......++.+++||.+||. +|.+||++.++|.||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 000 00111347889999999998 89999999999999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=309.74 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=198.7
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCC----------------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDG----------------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG----------------~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H 85 (630)
+.++| ++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++++++|
T Consensus 3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~ 78 (296)
T cd05051 3 PRQPL-NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSD 78 (296)
T ss_pred chhhC-cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCC
Confidence 34577 88899999999999999876544 568999887443 23556778899999999999
Q ss_pred CCeeEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEec
Q 006810 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHK-----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR 153 (630)
Q Consensus 86 pNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~-----------~lse~~i~~i~~QIl~gL~yLHs~~~~IiHr 153 (630)
|||++++++|... ..+++|+||+.+++|. ++.... .+++..++.++.||+.||.|||+++ ++||
T Consensus 79 ~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~ 154 (296)
T cd05051 79 PNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHR 154 (296)
T ss_pred CCEeEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccc
Confidence 9999999998665 4688999999999998 555544 6899999999999999999999999 9999
Q ss_pred cCCcCceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh--CCCC
Q 006810 154 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT--CEYP 226 (630)
Q Consensus 154 DLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt--G~~P 226 (630)
||||+||+++ .++.++|+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++ +..|
T Consensus 155 dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 155 DLATRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred ccchhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 9999999998 77999999999987543321 223456788999997764 68999999999999999998 7788
Q ss_pred CCCCCCHHHHHHHHHcC------CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 227 YNECKNPAQIYKKVTSG------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 227 f~~~~~~~~i~~~i~~g------~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
|..... .++...+... ......+...+.++.++|.+||+ +|.+||++.+++.
T Consensus 234 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 234 YEHLTD-QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCcCh-HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 876433 3333333322 11112234456899999999997 8999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.59 Aligned_cols=249 Identities=24% Similarity=0.408 Sum_probs=195.9
Q ss_pred eEeccc--CceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEc
Q 006810 31 EILGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (630)
Q Consensus 31 e~LG~G--~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~E 108 (630)
+.||+| +|++||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||++++++|... ..+++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEEe
Confidence 456766 999999999999999999999876532 344567889999999999999999999999765 46889999
Q ss_pred ccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--
Q 006810 109 LFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 183 (630)
Q Consensus 109 y~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 183 (630)
|+.+|+|. ++... ..+++..++.++.||+.||+|||+++ ++||||||+||+++ .++.++++||+.+......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCc
Confidence 99999998 44432 45899999999999999999999998 99999999999998 7889999999865322111
Q ss_pred C-------CccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-C------
Q 006810 184 T-------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P------ 246 (630)
Q Consensus 184 ~-------~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p------ 246 (630)
. .....++..|+|||++.+ .++.++|||||||++|+|++|..||............+..... |
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence 0 111234567999998864 3788999999999999999999999875544443333221100 0
Q ss_pred -------------------------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 -------------------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 -------------------------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.......++.+++||.+||. +|.+|||+.++|+||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00112245678999999997 89999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=311.83 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=198.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC--------
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-------- 99 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~-------- 99 (630)
.+.+.||+|+||+||+|.+..+|..||+|.++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 10 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred heeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 6789999999999999999999999999999765422 222345778999999999999999999886543
Q ss_pred CCEEEEEEcccCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 NRTINMITELFTSGSLRYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
...+++|+||++++.+..+.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++ .++.+||+|||++.
T Consensus 88 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~ 164 (302)
T cd07864 88 KGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLAR 164 (302)
T ss_pred CCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEEeCcccccc
Confidence 337899999999855554443 457999999999999999999999998 99999999999998 78999999999987
Q ss_pred eeccCCC---ccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc---CCCCCC--
Q 006810 179 VMQQPTA---RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKPAS-- 248 (630)
Q Consensus 179 ~~~~~~~---~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~---g~~p~~-- 248 (630)
....... ....+++.|+|||++.+ .++.++|||||||++|+|++|++||........+ ..+.. +..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL-ELISRLCGSPCPAVWP 243 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChhhcc
Confidence 6543221 22346788999998753 3688999999999999999999999764333322 22211 111100
Q ss_pred -----------------------CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 249 -----------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 249 -----------------------l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.....++.++++|.+||. +|.+||++.++|.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 112357899999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.25 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=201.0
Q ss_pred CCCcceeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d-----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f 95 (630)
|.+|| ++.+.||+|+||.||+|.+ ..++..||+|.++... .......+.+|+.+|.++ +||||+++++++
T Consensus 5 ~~~~~-~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 5 PRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred chhHh-cccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 56788 8899999999999999984 4568899999986432 234456788999999999 789999999987
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhhc-----------------------------------------------------
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKKH----------------------------------------------------- 121 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~~----------------------------------------------------- 121 (630)
.... ..+++||||+++|+|. ++...
T Consensus 81 ~~~~-~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 81 TKPG-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred ecCC-CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 6543 4688999999999997 44321
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC---
Q 006810 122 --------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--- 184 (630)
Q Consensus 122 --------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~--- 184 (630)
..+++..+..|+.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEc-CCCcEEEEecccccccccCcchh
Confidence 23678888999999999999999998 99999999999998 78899999999987543221
Q ss_pred -CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 185 -ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 185 -~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
.....+++.|+|||.+. ..++.++||||||+++|+|++ |..||........+...+..+..+ ..+...++.+.+++
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 315 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTM 315 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHH
Confidence 11233567899999775 458999999999999999997 999998755555555555554332 23345678999999
Q ss_pred HHccc-CCCCCCCHHHHhcC
Q 006810 262 EKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+||. +|.+||++.++++|
T Consensus 316 ~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99997 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=329.80 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=201.7
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~ 101 (630)
.||-|.+.+.||+||.+.||++..... ..||+|.+.... .+...+..+.+|+.+|.+| .|.+||++|+|-+. +.
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~ 433 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DG 433 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--Cc
Confidence 466667778999999999999976543 466777665443 3566788899999999999 48999999998765 46
Q ss_pred EEEEEEcccCCCCHH-HHhhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 102 TINMITELFTSGSLR-YRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~-lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
++||||||-+. +|. .+++... ++.-.++.+.+|+|.++.++|.+| |||.||||.|+|+- .|.+||+|||+|..
T Consensus 434 ~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 434 YLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFGIANA 508 (677)
T ss_pred eEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeechhcc
Confidence 89999998665 454 5554444 344589999999999999999999 99999999999985 78999999999987
Q ss_pred eccCC----CccccCCCCCCCcccccc------------ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Q 006810 180 MQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 243 (630)
Q Consensus 180 ~~~~~----~~~~~GTp~Y~APEvl~~------------~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g 243 (630)
....+ ..+.+||+.||+||.+.. ..+.++||||||||||+|+.|+.||....+....+..++..
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP 588 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence 76543 345689999999997631 15678999999999999999999998765555555555543
Q ss_pred CCCCCCCCCCcHH-HHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 244 IKPASLSKVTDPQ-VKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 244 ~~p~~l~~~~s~~-lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.....++....+. +.++++.||+ +|.+||+..+||+|||++.
T Consensus 589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 3333455544444 9999999997 9999999999999999975
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=308.97 Aligned_cols=242 Identities=26% Similarity=0.410 Sum_probs=198.1
Q ss_pred eeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 27 GRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d-----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+++.+.||+|+||.||++.+ ..++..||+|.+... .......+.+|+.++++++||||+++++++... .
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--D 80 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence 47889999999999999985 345677999988632 244566789999999999999999999988654 4
Q ss_pred EEEEEEcccCCCCHH-HHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC
Q 006810 102 TINMITELFTSGSLR-YRKKHK-------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 167 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~-------------~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 167 (630)
.+++|+||+++|+|. ++...+ .+++..++.++.||+.||+|||+++ ++||||||+||+++ .++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~-~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCC
Confidence 688999999999997 554433 4899999999999999999999998 99999999999998 789
Q ss_pred cEEEcccccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHH
Q 006810 168 EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 241 (630)
Q Consensus 168 ~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~ 241 (630)
.+||+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|+| |..||... +.......+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~~~i~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECIT 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHH
Confidence 99999999987543221 122345778999998764 58899999999999999998 89999764 4555556666
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 242 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 242 ~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+..+ ..+...++.+++||.+||+ +|.+||++.+++.
T Consensus 237 ~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 65433 2344577899999999998 8999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=328.27 Aligned_cols=247 Identities=27% Similarity=0.402 Sum_probs=198.9
Q ss_pred CCcceeeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWV 96 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~-----tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~ 96 (630)
.++| ++.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+.+|+.+|+.+. ||||++++++|.
T Consensus 36 ~~~~-~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 36 RDGL-VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccce-ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3455 677999999999999998643 34579999986432 2344567899999999996 999999999986
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHhhc------------------------------------------------------
Q 006810 97 DDTNRTINMITELFTSGSLR-YRKKH------------------------------------------------------ 121 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~~~------------------------------------------------------ 121 (630)
+. ..+++||||+++|+|. ++...
T Consensus 112 ~~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 112 KS--GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred cC--CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 54 4689999999999997 43221
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCc
Q 006810 122 ------------------------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 159 (630)
Q Consensus 122 ------------------------------------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~N 159 (630)
..+++..+..++.||+.||.|||+.+ |+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~N 267 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHh
Confidence 24788889999999999999999998 9999999999
Q ss_pred eEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCH
Q 006810 160 IFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNP 233 (630)
Q Consensus 160 ILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~ 233 (630)
||++ .++.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||......
T Consensus 268 ill~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 268 VLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EEEe-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9998 78899999999997653321 22345678899999775 458999999999999999997 99999875555
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 234 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 234 ~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..++..+..+..+ ..+...++.++++|.+||. +|.+||++.++.+
T Consensus 347 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 5566666665433 2345567899999999997 8999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=307.25 Aligned_cols=245 Identities=22% Similarity=0.372 Sum_probs=197.0
Q ss_pred eeeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 27 GRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~-----tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 82 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-- 82 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--
Confidence 4778999999999999999987 78899999876432 2334456889999999999999999999886553
Q ss_pred EEEEEEcccCCCCHH-HHhhcC-------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC--CCcEEE
Q 006810 102 TINMITELFTSGSLR-YRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKI 171 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~-------~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKL 171 (630)
..++||||+.+|+|. ++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++.. +..+||
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEe
Confidence 578999999999998 554432 5899999999999999999999999 9999999999999732 236999
Q ss_pred cccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCC
Q 006810 172 GDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 245 (630)
Q Consensus 172 ~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~ 245 (630)
+|||++....... ......++.|+|||++. ..++.++|||||||++|+|++ |..||... +...+...+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~~~~~~~~~~~ 239 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEFVTGGGR 239 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCc
Confidence 9999987653221 11223356899999875 458999999999999999997 99999864 44455555554433
Q ss_pred CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 246 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 246 p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+ ..+...++.+.+||.+||+ +|.+||++.++|+|
T Consensus 240 ~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2 3345567899999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=350.60 Aligned_cols=250 Identities=27% Similarity=0.417 Sum_probs=197.4
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
||| ++.+.||+|+||.||+|.+..+|..||+|++.... .......+++.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 grY-eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~l 77 (932)
T PRK13184 2 QRY-DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPV 77 (932)
T ss_pred CCe-EEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEE
Confidence 688 78899999999999999999999999999987432 23345567799999999999999999999988654 468
Q ss_pred EEEEcccCCCCHH-HHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEE
Q 006810 104 NMITELFTSGSLR-YRKK-----------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 171 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~-----------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 171 (630)
++||||++||+|. ++.. ...++...+..++.||+.||.|||+++ |+||||||+||+++ .+|.+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEE
Confidence 9999999999997 4332 234567788999999999999999998 99999999999997 7899999
Q ss_pred cccccceeeccC--------------------CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCC
Q 006810 172 GDLGLAIVMQQP--------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC 230 (630)
Q Consensus 172 ~DFGla~~~~~~--------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~ 230 (630)
+|||++...... .....+||+.|||||++.+ .++.++|||||||++|||+||..||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999755210 1123569999999998764 5889999999999999999999999763
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 231 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 231 ~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.......................++.+.+++.+||. +|.+|+++.+.|.+
T Consensus 235 ~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 332222221111111111123467889999999998 89999887765543
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=307.65 Aligned_cols=244 Identities=25% Similarity=0.372 Sum_probs=198.6
Q ss_pred eeeeeEecccCceEEEEEEE----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 27 GRYDEILGKGAFKTVYKGFD----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
+++.+.||+|+||+||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 81 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QP 81 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cc
Confidence 37889999999999999985 3456889999986432 344556788999999999999999999988654 35
Q ss_pred EEEEEcccCCCCHH-HHhh-----------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC
Q 006810 103 INMITELFTSGSLR-YRKK-----------------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 164 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~-----------------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 164 (630)
.++||||+++|+|. ++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~- 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG- 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc-
Confidence 88999999999997 4432 124788999999999999999999998 99999999999998
Q ss_pred CCCcEEEcccccceeeccC----CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHH
Q 006810 165 NNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 238 (630)
Q Consensus 165 ~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~ 238 (630)
.++.+||+|||++...... ......++..|+|||.+. +.++.++|||||||++|||++ |..||.+ .....+..
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~ 237 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIE 237 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence 7889999999999755322 122344577899999875 458999999999999999998 9999976 34556666
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 239 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 239 ~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+.....+ ..+...++.++++|.+||+ +|.+||++.+++++
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66654433 3455678999999999998 89999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=303.08 Aligned_cols=238 Identities=24% Similarity=0.402 Sum_probs=195.7
Q ss_pred eEecccCceEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG---~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
+.||+|+||.||+|++..++ ..||+|.+..... ....+.+.+|+.+++.++||||+++++++.. ..+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEE
Confidence 46999999999999876655 8999999875432 2345678899999999999999999997643 2478999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCc
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 186 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~ 186 (630)
||+.+|+|. ++...+.+++..+..|+.|++.||.|||.++ ++||||||+|||++ .++.+||+|||+++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecCCcc
Confidence 999999998 7777778999999999999999999999998 99999999999998 7899999999998765432211
Q ss_pred -----cccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 187 -----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 187 -----~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
...++..|+|||.+. ..++.++|||||||++|+|++ |..||... +..++...+..+.. ...+...++.+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 229 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGER-LPRPEECPQEIYS 229 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCc-CCCCCCCCHHHHH
Confidence 112345799999775 458899999999999999998 99999774 45556666655433 3344566789999
Q ss_pred HHHHccc-CCCCCCCHHHHhc
Q 006810 260 FIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+|.+||. +|.+||++.+++.
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=325.07 Aligned_cols=268 Identities=25% Similarity=0.402 Sum_probs=220.7
Q ss_pred ceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEE
Q 006810 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~l 105 (630)
+++.-++||+||||.||-+.-..||+.+|.|.+..+.+.. .........|-.+|.+++.+.||.+-..|... ..+++
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAfeTk--d~LCl 262 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAFETK--DALCL 262 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeeecCC--CceEE
Confidence 4455688999999999999999999999999987655433 23345577899999999999999997777544 45899
Q ss_pred EEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 106 ITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 106 V~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
|+..|.||+|. .+... ..+++..+..++.+|+.||++||... ||+|||||+|||+| +.|+|+|.|+|+|..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEecCC
Confidence 99999999998 44444 48999999999999999999999999 99999999999998 899999999999987765
Q ss_pred CC-CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 183 PT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 183 ~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~---~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
.. ....+||.+|||||++.+ .|+..+|.|||||++|||+.|+.||...... +++-+.+.. .+..++...++++
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEEA 417 (591)
T ss_pred CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHHH
Confidence 43 345599999999998875 5999999999999999999999999764322 223233332 3556677789999
Q ss_pred HHHHHHccc-CCCCCC-----CHHHHhcCCCcccCCCCccccCCCCCCCC
Q 006810 258 KQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPNL 301 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~~~l~~p~~ 301 (630)
+++.+.+|. +|++|. .+.++-.||||+..+++.+....+..|..
T Consensus 418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfi 467 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFI 467 (591)
T ss_pred HHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCC
Confidence 999999997 788876 57799999999999998875554544433
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=316.50 Aligned_cols=254 Identities=31% Similarity=0.474 Sum_probs=202.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.+|| ++.+.||.|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||++++++|.... ..
T Consensus 9 ~~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 84 (328)
T cd07856 9 TNRY-VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-ED 84 (328)
T ss_pred ccce-EEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-Cc
Confidence 4566 778999999999999999999999999998864322 2234466889999999999999999999986543 35
Q ss_pred EEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 103 INMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 103 l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
.++|+||+ +++|........+++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.++|+|||++.....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCccccccccCC
Confidence 78999998 457775555667899999999999999999999999 99999999999998 789999999999875433
Q ss_pred CCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc------------------
Q 006810 183 PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------------ 242 (630)
Q Consensus 183 ~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~------------------ 242 (630)
. .....+++.|+|||.+.+ .++.++|||||||++|+|+||+.||.... .......+..
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 161 Q-MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD-HVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred C-cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 2 234567899999998754 58899999999999999999999997633 2111111100
Q ss_pred ------CC--CC---CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 243 ------GI--KP---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 243 ------g~--~p---~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.. .+ .......++.++++|.+||+ +|.+||++.++|.||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00 00 01113456899999999997 89999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=306.41 Aligned_cols=243 Identities=25% Similarity=0.421 Sum_probs=198.1
Q ss_pred ceeeeeEecccCceEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 26 YGRYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~A~d~~tG~----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
.+++.++||+|+||+||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--- 81 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---
Confidence 34778999999999999999877776 48999886432 344556788999999999999999999988643
Q ss_pred EEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 102 TINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..++++||+++|+|. ++.. .+.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGLARL 158 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCceee
Confidence 367899999999998 5544 456999999999999999999999998 99999999999997 788999999999976
Q ss_pred eccCCC----ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 180 MQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 180 ~~~~~~----~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
...... ....+++.|+|||.+. ..++.++|||||||++|||++ |..||.. .....+...+..+..+ ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 236 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERL-PQPPIC 236 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcC-CCCccC
Confidence 643221 1123467899999775 458999999999999999998 8999975 3455555556555433 234456
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
++.+.++|.+||. +|..||++.+++.
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8899999999997 8999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=304.89 Aligned_cols=246 Identities=24% Similarity=0.399 Sum_probs=199.5
Q ss_pred CCcceeeeeEecccCceEEEEEEEccC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~t-----G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
..+| ++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+|+.++||||+++++++..
T Consensus 5 ~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 5 REKI-TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred hHHe-eEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 3456 7789999999999999988644 4899999975432 23445668899999999999999999998865
Q ss_pred CCCCEEEEEEcccCCCCHH-HHhh----------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCC
Q 006810 98 DTNRTINMITELFTSGSLR-YRKK----------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 166 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~-~~~~----------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~ 166 (630)
. ...++||||+++|+|. ++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++ .+
T Consensus 81 ~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~-~~ 155 (277)
T cd05032 81 G--QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA-ED 155 (277)
T ss_pred C--CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc-CC
Confidence 5 4688999999999998 4432 234788899999999999999999998 99999999999998 78
Q ss_pred CcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHH
Q 006810 167 GEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 240 (630)
Q Consensus 167 g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i 240 (630)
|.+||+|||+++...... .....++..|+|||.+. +.++.++|||||||++|+|+| |..||.. .+.....+.+
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~ 234 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFV 234 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHH
Confidence 999999999986543321 22335678899999775 458899999999999999998 9999976 4556666666
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 241 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 241 ~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..+..+ ..+...+..+.++|.+||. +|.+|||+.+++.
T Consensus 235 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 235 IDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred hcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 644332 3344568899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=311.34 Aligned_cols=257 Identities=23% Similarity=0.376 Sum_probs=206.4
Q ss_pred eeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEE
Q 006810 28 RYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~---~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l 103 (630)
++.+.||+|+||.||+|.+. .++..||+|.+..............+.+|+.++.++ +||||+++++.|... ..+
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~~~ 80 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--TKL 80 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--CEE
Confidence 67899999999999999864 467899999987544333334456788999999999 699999999988543 468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+.+|+|. ++.....+++..++.|+.|++.||.|||+.+ ++||||+|+||+++ .++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLD-SEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEEECcccccccc
Confidence 8999999999998 6666778999999999999999999999998 99999999999997 788999999999865433
Q ss_pred CC---CccccCCCCCCCccccccc---cCcccceeehhHHHHHHhhCCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCC
Q 006810 183 PT---ARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 183 ~~---~~~~~GTp~Y~APEvl~~~---ys~~sDIWSLGvil~ELltG~~Pf~~~~---~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
.. .....|++.|+|||.+.+. ++.++||||||+++|+|++|..||.... ....+.+.+..... ..+...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCccc
Confidence 21 2234689999999987543 6789999999999999999999996422 12233333333322 334456
Q ss_pred cHHHHHHHHHccc-CCCCCCC---HHHHhcCCCcccCCCCcc
Q 006810 254 DPQVKQFIEKCIV-PASLRLP---ALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rps---a~eLL~hpf~~~~~~~~~ 291 (630)
++.++++|.+||+ +|.+||| +.++|+||||+...+..+
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~ 277 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL 277 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHH
Confidence 7899999999997 8999998 568899999988766444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.31 Aligned_cols=243 Identities=24% Similarity=0.426 Sum_probs=193.6
Q ss_pred CceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCCCCHH
Q 006810 37 AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR 116 (630)
Q Consensus 37 ~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~ 116 (630)
+++.||.+.+..+|..||+|+++.... .......+.+|+.+++.++||||++++++|.+. ...+++|||+++|+|.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYGSCE 87 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEeccCCCCHH
Confidence 556677777788999999999986532 345667899999999999999999999998765 4588999999999998
Q ss_pred -HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC---------C
Q 006810 117 -YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---------T 184 (630)
Q Consensus 117 -~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~---------~ 184 (630)
++.. ...+++..++.+++||+.||+|||+++ |+||||||+||+++ .+|.+||+|||.+...... .
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeeccccccccccccc
Confidence 5443 346899999999999999999999999 99999999999998 7899999999988644221 1
Q ss_pred CccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC----------------
Q 006810 185 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---------------- 245 (630)
Q Consensus 185 ~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~---------------- 245 (630)
.....++..|+|||++.. .|+.++|||||||++|+|++|..||............+.....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 123457788999998764 4889999999999999999999999875544444444332110
Q ss_pred ---------------CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 246 ---------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 246 ---------------p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+.......+.++.+||.+||. +|.+||++.++|.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 000111234678999999997 89999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=308.41 Aligned_cols=249 Identities=27% Similarity=0.442 Sum_probs=200.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|++|.||+|.+..+|..+++|.+..... .......+.+|+.+|+.++||||+++++++.+. ..+++|+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 77 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVF 77 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEE
Confidence 456889999999999999999999999999875432 223456788999999999999999999987654 5688999
Q ss_pred cccCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC--
Q 006810 108 ELFTSGSLRYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 184 (630)
Q Consensus 108 Ey~~gGsL~~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~-- 184 (630)
||+.+..+..+.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.++|+|||.+.......
T Consensus 78 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 78 EFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred eccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCccc
Confidence 9998744444433 468999999999999999999999999 99999999999998 78999999999997665432
Q ss_pred CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC----------------
Q 006810 185 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---------------- 246 (630)
Q Consensus 185 ~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p---------------- 246 (630)
.....+++.|+|||.+.+ .++.++||||||+++|+|+||+.||.......++.........+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 223457889999997753 47889999999999999999999998755544443332221110
Q ss_pred -----------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 247 -----------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 247 -----------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.......+..+++||.+||. +|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 01112356789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=304.89 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=199.5
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC---C
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD---T 99 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~---~ 99 (630)
..|| |+.+.||.|||+-||++....++..+|+|+|.... .++.+...+|++..++++||||++++++.+.+ .
T Consensus 20 ~~Ry-ri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 20 NKRY-RIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred CceE-EEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 4677 99999999999999999999999999999997543 56778899999999999999999999876543 3
Q ss_pred CCEEEEEEcccCCCCHH-HH---h-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 100 NRTINMITELFTSGSLR-YR---K-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~---~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
...+|+++.|+..|+|. .+ + +...+++.++..|+.+|++||.+||+..||++||||||.||++. ..+.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-DSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec-CCCceEEEec
Confidence 35799999999999885 32 2 33469999999999999999999999999999999999999997 6899999999
Q ss_pred ccceeeccCC-----C------ccccCCCCCCCcccccc----ccCcccceeehhHHHHHHhhCCCCCCCCCC-HHHHHH
Q 006810 175 GLAIVMQQPT-----A------RSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKN-PAQIYK 238 (630)
Q Consensus 175 Gla~~~~~~~-----~------~~~~GTp~Y~APEvl~~----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~-~~~i~~ 238 (630)
|.++...-.. . .....|..|+|||++.- ..++++|||||||++|.|+.|..||..-.. ...+.-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 9986543210 0 11235889999999863 368899999999999999999999963100 000000
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 239 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 239 ~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+..+....+-...++..+.++|+.||+ +|.+||++.+|+.+
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0111111111123378899999999997 89999999999874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=301.32 Aligned_cols=242 Identities=27% Similarity=0.478 Sum_probs=205.6
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCC
Q 006810 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (630)
Q Consensus 33 LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~g 112 (630)
||+|+||.||+|.+..+|..||+|.+..... ........+..|+.+++.++||||+++++.+.. ...+++||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCC
Confidence 6999999999999999999999999876543 233456778999999999999999999998754 3578999999999
Q ss_pred CCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--CCcccc
Q 006810 113 GSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVI 189 (630)
Q Consensus 113 GsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~~~~~~ 189 (630)
++|. ++.....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ .++.++|+|||++...... ......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCc
Confidence 9998 7777778999999999999999999999998 99999999999998 7889999999998765443 234456
Q ss_pred CCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-C
Q 006810 190 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 267 (630)
Q Consensus 190 GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~ 267 (630)
++..|+|||.+.+ .++.++|+||||+++|+|++|..||.. .+.......+... ...++...+..+.+||++||. +
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~--~~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKD--PLRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhcCC
Confidence 8899999998764 478899999999999999999999976 3445555555542 233555568899999999997 8
Q ss_pred CCCCCCH---HHHhcCCCc
Q 006810 268 ASLRLPA---LELLKDPFL 283 (630)
Q Consensus 268 p~~Rpsa---~eLL~hpf~ 283 (630)
|.+||++ .+++.||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=307.61 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=199.2
Q ss_pred CcceeeeeEecccCceEEEEEEE----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFD----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
+|++++.+.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 57778889999999999999974 4678999999986432 2445567899999999999999999999987765
Q ss_pred CCEEEEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 100 NRTINMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
...+++||||+++++|. ++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~~ 156 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLT 156 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCccc
Confidence 56789999999999998 55443 46899999999999999999999999 99999999999998 7889999999998
Q ss_pred eeeccCC-----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCC--------------CHHHHH
Q 006810 178 IVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--------------NPAQIY 237 (630)
Q Consensus 178 ~~~~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~--------------~~~~i~ 237 (630)
....... .....++..|+|||.+. +.++.++|||||||++|+|+|+..|+.... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 7654321 12345677899999765 458899999999999999999877653211 111222
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 238 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 238 ~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..+..+.. .......+..+.+||.+||. +|.+||++.+++++
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 RVLEEGKR-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHcCcc-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 22223322 22334567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=302.21 Aligned_cols=239 Identities=28% Similarity=0.444 Sum_probs=195.4
Q ss_pred eEecccCceEEEEEEEcc-CC--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEV-DG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~-tG--~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++||+|++|+||+|.+.. .+ ..||+|.+...... ...+.+.+|+.++++++||||+++++++.+ ..+++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence 468999999999998865 33 36999998765432 566789999999999999999999999876 5789999
Q ss_pred cccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC
Q 006810 108 ELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 184 (630)
||+++|+|. ++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEe-cCCEEEeccccccccccccc
Confidence 999999998 55444 46899999999999999999999998 99999999999998 77999999999987654321
Q ss_pred -----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 185 -----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 185 -----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
.....++..|+|||.+.. .++.++|||||||++|+|++ |..||... +..++...+.........+...+..+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDI 230 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHH
Confidence 112346778999998764 58899999999999999999 99999764 44555555543222223344567899
Q ss_pred HHHHHHccc-CCCCCCCHHHHhc
Q 006810 258 KQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.++|.+||. +|.+||++.+++.
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.18 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=200.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEccC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV 96 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~t-----G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~ 96 (630)
.++| ++.+.||+|+||.||+|.+... ...||+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~-~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 11 RDRL-TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred HhHe-EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3456 7779999999999999987644 3789999886432 234556788999999999 8999999999885
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCc
Q 006810 97 DDTNRTINMITELFTSGSLR-YRKK----------------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 159 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~~----------------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~N 159 (630)
.. ..+++||||+++|+|. ++.. ...+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 87 ~~--~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 87 QE--GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred CC--CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 44 4689999999999998 5432 356899999999999999999999998 9999999999
Q ss_pred eEEeCCCCcEEEcccccceeeccCCC----ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCH
Q 006810 160 IFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNP 233 (630)
Q Consensus 160 ILl~~~~g~vKL~DFGla~~~~~~~~----~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~ 233 (630)
||++ .++.+||+|||++........ ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. ...
T Consensus 163 il~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~ 240 (293)
T cd05053 163 VLVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPV 240 (293)
T ss_pred EEEc-CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCH
Confidence 9997 789999999999976543211 1123456799999765 458899999999999999997 9999976 455
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 234 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 234 ~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+.+..+..+..+. .+...+..+.+||.+||. +|.+|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 241 EELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 56666666654332 344567899999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=352.59 Aligned_cols=245 Identities=33% Similarity=0.572 Sum_probs=204.4
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC------------
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD------------ 98 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~------------ 98 (630)
++||+||||.||+++.+-+|..||||+|.+.. +.....++.+|+.+|.+|+|||||+||..|++.
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~ 561 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS 561 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence 68999999999999999999999999998764 455678899999999999999999999999630
Q ss_pred ------------------------------------------C-------------------------------------
Q 006810 99 ------------------------------------------T------------------------------------- 99 (630)
Q Consensus 99 ------------------------------------------~------------------------------------- 99 (630)
.
T Consensus 562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~ 641 (1351)
T KOG1035|consen 562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI 641 (1351)
T ss_pred chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence 0
Q ss_pred ------------------C--------CEEEEEEcccCCCCHHHHhhcCCC--CHHHHHHHHHHHHHHHHHHHcCCCCEE
Q 006810 100 ------------------N--------RTINMITELFTSGSLRYRKKHKNV--DMKAIKNWARQILRGLHYLHSHNPPII 151 (630)
Q Consensus 100 ------------------~--------~~l~lV~Ey~~gGsL~~~~~~~~l--se~~i~~i~~QIl~gL~yLHs~~~~Ii 151 (630)
+ .++||-||||+..+++++.....+ .....+++++||+.||.|+|++| ||
T Consensus 642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--iI 719 (1351)
T KOG1035|consen 642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--II 719 (1351)
T ss_pred cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--ee
Confidence 0 357888999999999855444444 47889999999999999999999 99
Q ss_pred eccCCcCceEEeCCCCcEEEcccccceeec----------c----------CCCccccCCCCCCCcccccc----ccCcc
Q 006810 152 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----------Q----------PTARSVIGTPEFMAPELYEE----EYNEL 207 (630)
Q Consensus 152 HrDLKp~NILl~~~~g~vKL~DFGla~~~~----------~----------~~~~~~~GTp~Y~APEvl~~----~ys~~ 207 (630)
||||||.|||++ .++.|||+|||+|+... . ...++.+||.-|+|||++.+ .|+.|
T Consensus 720 HRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 720 HRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999998 78899999999997511 0 02335689999999999863 59999
Q ss_pred cceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 208 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 208 sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~---l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
+|||||||+++||+. ||........+...+..+..|.. +.+. -+.-+.+|+.||+ +|++||||.|||++.||
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~-~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ll 874 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPE-HPEEASLIRWLLSHDPSKRPTATELLNSELL 874 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCccccccc-chHHHHHHHHHhcCCCccCCCHHHHhhccCC
Confidence 999999999999984 78776666677777777766655 2222 3567889999998 89999999999999999
Q ss_pred cc
Q 006810 284 VT 285 (630)
Q Consensus 284 ~~ 285 (630)
..
T Consensus 875 pp 876 (1351)
T KOG1035|consen 875 PP 876 (1351)
T ss_pred Cc
Confidence 74
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=318.13 Aligned_cols=256 Identities=29% Similarity=0.409 Sum_probs=201.3
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC--
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~-- 100 (630)
..|| .+.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||++++++|.....
T Consensus 14 ~~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 14 PERY-TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccce-EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 3577 667999999999999999999999999999864321 22334567899999999999999999998865432
Q ss_pred --CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 101 --RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++|+||+.. +|.... ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~-~~~~~kL~dfg~~~ 165 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLAR 165 (342)
T ss_pred CCceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCCCCc
Confidence 357899999875 555322 346899999999999999999999999 99999999999998 78999999999986
Q ss_pred eeccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC------------
Q 006810 179 VMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI------------ 244 (630)
Q Consensus 179 ~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~------------ 244 (630)
.... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+ ..+....
T Consensus 166 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 166 HADA-EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL-TQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCC-CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCCHHHHHHhc
Confidence 5433 2234567899999998754 4788999999999999999999999864322222 2221100
Q ss_pred ----------CC----CC---CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 245 ----------KP----AS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 245 ----------~p----~~---l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
.+ .. .....++.+++||.+||+ +|.+||++.++|.||||.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 00 112356789999999997 8999999999999999987543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=309.44 Aligned_cols=255 Identities=24% Similarity=0.440 Sum_probs=200.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~ 102 (630)
+.| ++.+.||+|+||.||+|.+..+|..||+|.++.... ......+.+|+.++..+ .||||+++++++.+. ..
T Consensus 15 ~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~ 88 (296)
T cd06618 15 NDL-ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SD 88 (296)
T ss_pred chh-eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCchHhhheeeecC--Ce
Confidence 334 778999999999999999999999999999875432 23345566777766666 599999999998764 46
Q ss_pred EEEEEcccCCCCHH-HH-hhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 103 INMITELFTSGSLR-YR-KKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~-~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
+++||||+.+ +|. .+ .....+++..+..++.||+.||.|||+ ++ |+||||+|+||+++ .++.+||+|||++..
T Consensus 89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~~ 164 (296)
T cd06618 89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGR 164 (296)
T ss_pred EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEECccccchh
Confidence 8999999865 554 33 335679999999999999999999997 46 99999999999998 789999999999875
Q ss_pred eccCC-CccccCCCCCCCcccccc-----ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC-CCCCC
Q 006810 180 MQQPT-ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKV 252 (630)
Q Consensus 180 ~~~~~-~~~~~GTp~Y~APEvl~~-----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~-~l~~~ 252 (630)
..... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......+....+.....+. .....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 54322 223357889999998753 378899999999999999999999976444444444444332221 22224
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
.+.++++||.+||. +|.+||++.+++.||||+....
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 67899999999997 8999999999999999986443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=300.16 Aligned_cols=240 Identities=25% Similarity=0.416 Sum_probs=195.6
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+++.+.||+|++|.||+|.+. .+..||+|.++.... ..+.+.+|+.++++++||||+++++++... ..+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (261)
T cd05068 8 IQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYIV 79 (261)
T ss_pred eeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecC--CCeeee
Confidence 388899999999999999875 457899999865432 234578899999999999999999987654 458899
Q ss_pred EcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 107 TELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
|||+++++|. ++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGLARVIKED 156 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEc-CCCCEEECCcceEEEccCC
Confidence 9999999998 55443 36899999999999999999999998 99999999999998 7899999999999766543
Q ss_pred CCccccC---CCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 184 TARSVIG---TPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 184 ~~~~~~G---Tp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
......| +..|+|||.+.+ .++.++||||||+++|+|+| |+.||.+. +.......+...... ..+...+..++
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM-TNAEVLQQVDQGYRM-PCPPGCPKELY 234 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHH
Confidence 2222223 357999997764 58899999999999999999 99999764 455555555554332 23445678999
Q ss_pred HHHHHccc-CCCCCCCHHHHhc
Q 006810 259 QFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
++|.+||. +|.+||++.+++.
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHH
Confidence 99999997 8999999999865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=299.63 Aligned_cols=239 Identities=23% Similarity=0.434 Sum_probs=194.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||.||+|..+ .+..+|+|.+..... ....+.+|+.+|+.++||||+++++++... ..+++||
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~ 78 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLYIVT 78 (256)
T ss_pred EEeeEecCCcCceEEEEEec-cCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEEEEE
Confidence 67789999999999999765 456899998764322 124578899999999999999999987544 4689999
Q ss_pred cccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC
Q 006810 108 ELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185 (630)
Q Consensus 108 Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 185 (630)
||+++|+|. ++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEc-CCCeEEECCCCCccccCCCce
Confidence 999999998 4443 456899999999999999999999999 99999999999998 788999999999875432211
Q ss_pred ---ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006810 186 ---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260 (630)
Q Consensus 186 ---~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~ 260 (630)
....++..|+|||++. ..++.++||||||+++|+|++ |+.||.. .+..+....+..+..+ ..+...+..+.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~~l 233 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRL-YRPKLASMTVYEV 233 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence 1223456899999876 458899999999999999999 8999976 4555666666665433 2344567899999
Q ss_pred HHHccc-CCCCCCCHHHHhc
Q 006810 261 IEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 261 I~kcL~-~p~~Rpsa~eLL~ 279 (630)
|.+||. +|.+||++.+++.
T Consensus 234 i~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 234 MYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 999997 7999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.31 Aligned_cols=240 Identities=25% Similarity=0.425 Sum_probs=196.0
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+. ...++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIYII 79 (261)
T ss_pred eEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCcEEE
Confidence 488899999999999999865 56779999876432 2346788999999999999999999987544 458899
Q ss_pred EcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 107 TELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+||+++|+|. ++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCccceecCCC
Confidence 9999999998 5443 456899999999999999999999998 99999999999998 7899999999999765432
Q ss_pred C---CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 184 T---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 184 ~---~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
. .....++..|+|||.+. +.++.++|||||||++|+|+| |..||.. .+.......+..+...+ .....+..+.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRMP-RMENCPDELY 234 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHH
Confidence 2 12234567899999875 458889999999999999998 9999976 34455555555554332 3345678999
Q ss_pred HHHHHccc-CCCCCCCHHHHhc
Q 006810 259 QFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
++|.+||. +|.+||++.+++.
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 99999997 8999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.21 Aligned_cols=243 Identities=23% Similarity=0.389 Sum_probs=198.4
Q ss_pred eeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCC
Q 006810 28 RYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d-----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~ 101 (630)
.+.+.||+|+||.||+|.+ ..++..||+|.++... .....+.+.+|+.+++++ +||||+++++++... .
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~ 112 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTIG--G 112 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--C
Confidence 7789999999999999975 3456789999886432 234456789999999999 899999999988654 4
Q ss_pred EEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.+++||||+.+|+|. ++... ..+++.++..++.||+.||.|||+++ |+||||||+||+++ .++.++|+|||++.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeEEECCCcccc
Confidence 589999999999998 55433 33899999999999999999999998 99999999999997 78899999999987
Q ss_pred eeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006810 179 VMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 252 (630)
Q Consensus 179 ~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~ 252 (630)
...... .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||..........+.+..+..+ ..+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 268 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPEH 268 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCCC
Confidence 553321 11234577899999765 458899999999999999998 999998755555555555555433 33445
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.++.+++||.+||. +|.+||++.+++.
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 67899999999997 7999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.00 Aligned_cols=240 Identities=22% Similarity=0.326 Sum_probs=187.7
Q ss_pred EecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 32 ILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 32 ~LG~G~fg~Vy~A~d~--~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
.||+|+||.||+|... .++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+. ..+++||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVMEF 76 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEEC
Confidence 5899999999999754 456789999886543 223345688899999999999999999988654 357899999
Q ss_pred cCCCCHH-HHhhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 110 FTSGSLR-YRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 110 ~~gGsL~-~~~~~-----~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+++|+|. ++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEECCccccccccCc
Confidence 9999997 44332 24567888999999999999999998 99999999999998 7889999999998643322
Q ss_pred C----CccccCCCCCCCcccccc--------ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCC---CC
Q 006810 184 T----ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---PA 247 (630)
Q Consensus 184 ~----~~~~~GTp~Y~APEvl~~--------~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~---p~ 247 (630)
. .....+++.|+|||++.+ .++.++||||||+++|||++ |+.||............+..... .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 1 223457888999998753 25789999999999999996 99999875544443333332211 22
Q ss_pred CCCCCCcHHHHHHHHHcccCCCCCCCHHHHhc
Q 006810 248 SLSKVTDPQVKQFIEKCIVPASLRLPALELLK 279 (630)
Q Consensus 248 ~l~~~~s~~lk~~I~kcL~~p~~Rpsa~eLL~ 279 (630)
.+....++.+++++++|+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 23334578899999999989999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.81 Aligned_cols=238 Identities=23% Similarity=0.411 Sum_probs=196.2
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+++.+.||+|+||.||+|.. .|..||+|.+... ...+.+.+|+.+++.++||||+++++++.... ..+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~lv 78 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIV 78 (256)
T ss_pred CeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-CceEEE
Confidence 37789999999999999965 4888999987532 22456889999999999999999999765443 468899
Q ss_pred EcccCCCCHH-HHhhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 107 TELFTSGSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+||+++|+|. ++...+ .+++..+..++.||+.||+|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCccceecccc
Confidence 9999999998 554433 4889999999999999999999998 99999999999998 7899999999998754332
Q ss_pred CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
. ....++..|+|||++.+ .++.++|||||||++|+|++ |+.||.. .+...+...+..+..+ ......++.++++|
T Consensus 156 ~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 232 (256)
T cd05082 156 Q-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYDVM 232 (256)
T ss_pred C-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHH
Confidence 2 23345678999998764 58899999999999999998 9999975 4566666666665433 34456789999999
Q ss_pred HHccc-CCCCCCCHHHHhc
Q 006810 262 EKCIV-PASLRLPALELLK 279 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+||. +|.+||++.+++.
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 233 KQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHhcCChhhCcCHHHHHH
Confidence 99997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.78 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=199.7
Q ss_pred CCcceeeeeEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~-------tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~ 94 (630)
.++| .+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.+ +||||++++++
T Consensus 17 ~~~~-~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 17 RDRL-VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred hHHe-EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4566 888999999999999998643 33579999886432 234456788999999999 79999999998
Q ss_pred EEcCCCCEEEEEEcccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCc
Q 006810 95 WVDDTNRTINMITELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 157 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp 157 (630)
+... ..+++||||+.+|+|. ++..+ ..++..++..++.||+.||+|||+++ ++||||||
T Consensus 93 ~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 93 CTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred EecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 8654 4688999999999998 55443 24888999999999999999999998 99999999
Q ss_pred CceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCC
Q 006810 158 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECK 231 (630)
Q Consensus 158 ~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~ 231 (630)
+||+++ .++.+||+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.. .
T Consensus 169 ~Nill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~ 246 (307)
T cd05098 169 RNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-V 246 (307)
T ss_pred HheEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-C
Confidence 999998 78899999999986543211 111234578999997754 58899999999999999998 8889875 5
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 232 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 232 ~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+...+...+..+..+ ..+...+.+++++|.+||. +|.+||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 247 PVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 666777766665432 3445668899999999997 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.72 Aligned_cols=243 Identities=23% Similarity=0.406 Sum_probs=195.4
Q ss_pred eeeeEecccCceEEEEEEEccCCe--EEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~--~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~ 104 (630)
++.++||+|+||.||+|.++.+|. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++... ..++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 79 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLY 79 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccce
Confidence 788999999999999999887775 4688876521 1234456788999999999 799999999988654 4588
Q ss_pred EEEcccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC
Q 006810 105 MITELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 167 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 167 (630)
+|+||+++|+|. ++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++ .++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG-ENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-CCC
Confidence 999999999997 55432 25889999999999999999999998 99999999999997 788
Q ss_pred cEEEcccccceeeccCCCcc-ccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCC
Q 006810 168 EVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 244 (630)
Q Consensus 168 ~vKL~DFGla~~~~~~~~~~-~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~ 244 (630)
.+||+|||++.......... ...+..|+|||++.. .++.++|||||||++|+|++ |..||.. .....+...+..+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~~ 235 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY 235 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCC
Confidence 99999999986432221111 223457999998754 58999999999999999997 9999976 45555666665554
Q ss_pred CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 245 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 245 ~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+ ..+...++.+++||.+||. +|.+||++.++++.
T Consensus 236 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32 2345578899999999997 89999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.91 Aligned_cols=247 Identities=28% Similarity=0.395 Sum_probs=197.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l~lV 106 (630)
++.+.||+|++|+||+|.+..+|+.||+|.+..... . .......+|+..+++++ ||||+++++++.+ ....++|
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv 76 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFV 76 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEE
Confidence 678899999999999999999999999999864321 1 12233567999999999 9999999998866 3568999
Q ss_pred EcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 107 TELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
|||+ +|+|. ++... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++ .++.++|+|||++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS-GPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCCEEEeecccceeccCC
Confidence 9999 66775 55544 37899999999999999999999999 99999999999998 7899999999999766543
Q ss_pred C-CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Q 006810 184 T-ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------------- 246 (630)
Q Consensus 184 ~-~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-------------- 246 (630)
. .....++..|+|||++.+ .++.++|+||||+++++|++|++||..........+.......+
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 2 234568899999998743 47899999999999999999999997755444443332211000
Q ss_pred -------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 247 -------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 247 -------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
..+....++.+++||.+||+ +|.+||++.|++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00111235789999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.93 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=194.5
Q ss_pred eeeeeEecccCceEEEEEEEccCCeE--EEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~--VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l 103 (630)
+.+.+.||+|+||.||+|.+..+|.. +|+|.+... ........+.+|+.++.++ +||||+++++++... ..+
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~~ 83 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYL 83 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CCc
Confidence 37789999999999999999888865 466665421 2345556788999999999 899999999988554 468
Q ss_pred EEEEcccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCC
Q 006810 104 NMITELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 166 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~ 166 (630)
++||||+++|+|. ++... ..+++..++.++.||+.||+|||+++ ++||||||+|||++ .+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~-~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-EN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec-CC
Confidence 9999999999997 54432 35789999999999999999999998 99999999999998 78
Q ss_pred CcEEEcccccceeeccCC-CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcC
Q 006810 167 GEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243 (630)
Q Consensus 167 g~vKL~DFGla~~~~~~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g 243 (630)
+.+||+|||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|+| |..||.. .+.......+..+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~ 239 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQG 239 (303)
T ss_pred CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhcC
Confidence 899999999986432211 111234567999998764 47899999999999999998 9999976 3445555655544
Q ss_pred CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 244 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 244 ~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..+ ..+...++.+.++|.+||+ +|.+||++.++|.+
T Consensus 240 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 YRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 322 2333467899999999997 89999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=300.55 Aligned_cols=243 Identities=24% Similarity=0.411 Sum_probs=197.9
Q ss_pred eeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~t---G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
++.+.||+|+||+||+|.+..+ ...||+|.+.... .......+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 81 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RPVM 81 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--CceE
Confidence 7889999999999999988654 4689999886432 344556788999999999999999999987644 4588
Q ss_pred EEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 105 MITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+||||+++|+|. ++.. .+.+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.++|+|||++.....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCCEEECccchhhcccc
Confidence 999999999998 5544 457899999999999999999999998 99999999999998 788999999999976642
Q ss_pred CC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 183 PT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 183 ~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
.. .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.... ...+...+..+..+ ..+...++.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~ 236 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-NQDVIKAVEDGYRL-PPPMDCPSA 236 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHcCCCC-CCCCCCCHH
Confidence 11 11223467899999876 458899999999999999998 999997643 44455555554332 223456789
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+.+++.+||. +|.+||++.+++++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.21 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=198.3
Q ss_pred eeeeEecccCceEEEEEEEccC--CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcC--CCCE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVD--GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD--TNRT 102 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~t--G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~--~~~~ 102 (630)
++.+.||+|+||.||+|.+..+ |..||+|.+.... ........+.+|+.+++.+ +||||+++++.+... ....
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 7889999999999999999888 9999999986422 1223345678899999999 599999999875432 2245
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++++++|+.+ +|. .+.....+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++....
T Consensus 81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVN-ADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEc-CCCCEEeCcCCCceecc
Confidence 7888999875 665 7777888999999999999999999999999 99999999999998 78999999999997543
Q ss_pred cC------CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHH------------
Q 006810 182 QP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT------------ 241 (630)
Q Consensus 182 ~~------~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~------------ 241 (630)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||........+...+.
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 22 1233578999999997654 588999999999999999999999976432221111110
Q ss_pred --c-----------CCCCC---CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 242 --S-----------GIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 242 --~-----------g~~p~---~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
. ..... ......+..+++||.+||. +|.+||++.+++.||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 0 00001 1122347899999999997 8999999999999999965
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.49 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=196.8
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
.|.+|| ++.+.||+|+||+||+|.+..++ .||+|.+..... ..+.+.+|+.+++.++||||+++++.+.+
T Consensus 3 ~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--- 72 (262)
T cd05071 3 IPRESL-RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--- 72 (262)
T ss_pred CChHHe-eEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC---
Confidence 356787 88999999999999999887664 599999874332 12457889999999999999999997632
Q ss_pred CEEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 101 RTINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
...++||||+++|+|. ++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++ .++.+||+|||.+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~~ 149 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLA 149 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCce
Confidence 3478999999999998 5544 345899999999999999999999998 99999999999998 7889999999999
Q ss_pred eeeccCCC---ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006810 178 IVMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 252 (630)
Q Consensus 178 ~~~~~~~~---~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~ 252 (630)
........ ....++..|+|||+.. ..++.++|||||||++|+|+| |..||... ....+...+..+... .....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~ 227 (262)
T cd05071 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPE 227 (262)
T ss_pred eeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCC-CCccc
Confidence 76543321 1234567899999765 468999999999999999999 88899764 344555555444322 23445
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+..+.++|.+|+. +|.+||++.+++.
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 67899999999998 8999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.14 Aligned_cols=240 Identities=23% Similarity=0.359 Sum_probs=187.6
Q ss_pred EecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 32 ILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 32 ~LG~G~fg~Vy~A~d~--~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
.||+|+||.||+|... .....+|+|.+.... .......+.+|+.+++.++||||+++++++... ..+++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEEe
Confidence 5899999999999643 245678888765332 334456688999999999999999999988654 458999999
Q ss_pred cCCCCHH-HHhhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 110 FTSGSLR-YRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 110 ~~gGsL~-~~~~~-----~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+++|+|. ++... ...++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEec-CCCcEEEeccccccccccc
Confidence 9999998 55443 23467888999999999999999999 99999999999998 7889999999998643221
Q ss_pred ----CCccccCCCCCCCcccccc--------ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCC---CC
Q 006810 184 ----TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---PA 247 (630)
Q Consensus 184 ----~~~~~~GTp~Y~APEvl~~--------~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~---p~ 247 (630)
......+++.|+|||++.. .++.++|||||||++|+|++ |..||....+...+...+..+.. .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 1122345778999998642 36789999999999999999 78899875554444444444322 22
Q ss_pred CCCCCCcHHHHHHHHHcccCCCCCCCHHHHhc
Q 006810 248 SLSKVTDPQVKQFIEKCIVPASLRLPALELLK 279 (630)
Q Consensus 248 ~l~~~~s~~lk~~I~kcL~~p~~Rpsa~eLL~ 279 (630)
.+....++.+++++..|+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 34456778899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=299.36 Aligned_cols=240 Identities=23% Similarity=0.397 Sum_probs=199.3
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+.+++.+.||+|+||.||+|... |..||+|.+.... ...+++.+|+.+++.++||||+++++++.+ ....+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 76 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLY 76 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeE
Confidence 34478899999999999999764 8899999986442 145778999999999999999999998865 34688
Q ss_pred EEEcccCCCCHH-HHhhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 105 MITELFTSGSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+||||+++++|. ++.... .+++..++.++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEAS 153 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEcccccccccc
Confidence 999999999998 555444 6999999999999999999999999 99999999999998 78999999999997664
Q ss_pred cCCCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 182 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 182 ~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
.... ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...++.+.+
T Consensus 154 ~~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (256)
T cd05039 154 QGQD-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVYK 230 (256)
T ss_pred cccc-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHHH
Confidence 3222 233456799999775 458889999999999999997 9999976 4556666666655433 334556899999
Q ss_pred HHHHccc-CCCCCCCHHHHhc
Q 006810 260 FIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+|.+||. +|.+||++.+++.
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 9999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.17 Aligned_cols=241 Identities=24% Similarity=0.417 Sum_probs=194.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeE----EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIE----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~----VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++.+.||+|+||+||+|.+..+|.. |++|.+... ........+..|+.+++.++||||+++++++.. ..+
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~ 83 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASL 83 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Ccc
Confidence 6778999999999999999877764 666666422 223445678889999999999999999998643 347
Q ss_pred EEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++|+||+++|+|. ++.. .+.+++..+..|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||+++...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEEcCCccceecc
Confidence 7899999999998 5544 467899999999999999999999998 99999999999998 78999999999997553
Q ss_pred cCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 182 QPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 182 ~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
... .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+ ..+..+...+..+..+ ..+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 238 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG-MRPHEVPDLLEKGERL-AQPQICTI 238 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcC-CCCCCCCH
Confidence 221 12345677899999875 468999999999999999998 9999976 3455555556555433 23445678
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+.+++.+|+. +|.+||++.|++.
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 89999999997 8999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.34 Aligned_cols=250 Identities=30% Similarity=0.419 Sum_probs=195.3
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCeeEEEeEEEcCCC---C
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDDTN---R 101 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpNIVk~~~~f~d~~~---~ 101 (630)
++.+.||+|+||.||+|.++.+|..||+|.+..... .......+.+|+.+++++ +||||+++++++.+... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 678899999999999999998999999999975432 122234466777776665 69999999999876543 2
Q ss_pred EEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.++++|||+.+ +|. ++... ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||++.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~-~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEc-cCCCEEEeccCcce
Confidence 48899999986 565 54443 35899999999999999999999998 99999999999998 67999999999987
Q ss_pred eeccCC-CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC----------
Q 006810 179 VMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---------- 246 (630)
Q Consensus 179 ~~~~~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p---------- 246 (630)
...... .....+++.|+|||++.+ .++.++|||||||++|+|++|.+||......+.+.+.......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 664332 234457889999997764 57889999999999999999999998754443333322211000
Q ss_pred --------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 247 --------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 247 --------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.......++.+.+||.+||. +|.+||++.++|.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00011235778999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=303.12 Aligned_cols=250 Identities=31% Similarity=0.516 Sum_probs=201.3
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~-~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
|| .+.+.||+|+||.||+|.+..++..+++|.++...... .......+.+|+.+++.++||||+++++++.+.. ..
T Consensus 1 ~y-~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 77 (260)
T cd08222 1 RY-ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD--AF 77 (260)
T ss_pred Cc-eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--ce
Confidence 56 77899999999999999998887777777665422211 1223445778999999999999999999886553 58
Q ss_pred EEEEcccCCCCHH-HHh----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 104 NMITELFTSGSLR-YRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
++|+||+++++|. .+. ....+++..++.++.|++.||.|||+++ ++||||+|+||+++ ++.+||+|||++.
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~--~~~~~l~d~g~~~ 153 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLK--NNLLKIGDFGVSR 153 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEee--cCCEeecccCcee
Confidence 8999999999997 332 3467999999999999999999999998 99999999999996 4679999999987
Q ss_pred eeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 179 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 179 ~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
..... ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||... ........+..+.. ..++...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~ 231 (260)
T cd08222 154 LLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-NFLSVVLRIVEGPT-PSLPETYSR 231 (260)
T ss_pred ecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHcCCC-CCCcchhcH
Confidence 65332 2234568899999997754 5788999999999999999999999763 34444444444433 334556788
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
++.++|.+||. +|.+||++.+++.||||
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999997 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=308.51 Aligned_cols=248 Identities=26% Similarity=0.410 Sum_probs=199.3
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEc-------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEE
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 92 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~-------~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~ 92 (630)
.|.+|| .+.+.||+|+||.||+|.+. ..+..||+|.+.... .......+.+|+.+++++ +||||++++
T Consensus 9 ~~~~~~-~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 9 FPRDRL-VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccHHHe-eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 345677 68899999999999999763 245679999876432 244566788999999999 699999999
Q ss_pred eEEEcCCCCEEEEEEcccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccC
Q 006810 93 NSWVDDTNRTINMITELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 155 (630)
Q Consensus 93 ~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 155 (630)
+++.+. ..+++||||+++|+|. ++... ..+++..+..++.||+.||.|||+++ ++||||
T Consensus 85 ~~~~~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dl 160 (314)
T cd05099 85 GVCTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDL 160 (314)
T ss_pred EEEccC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccc
Confidence 988654 4689999999999998 55432 35889999999999999999999998 999999
Q ss_pred CcCceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCC
Q 006810 156 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNE 229 (630)
Q Consensus 156 Kp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~ 229 (630)
||+|||++ .++.+||+|||+++...... .....+++.|+|||++. +.++.++|||||||++|+|++ |..||..
T Consensus 161 kp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 161 AARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred cceeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 99999997 78999999999997554321 11123456799999775 458899999999999999999 8899976
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 230 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 230 ~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+...++..+..+..+ ..+...+.+++++|.+||. +|.+||++.+++.
T Consensus 240 -~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 240 -IPVEELFKLLREGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred -CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 4556666666655432 2344567899999999997 8999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=336.22 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=189.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCC-eEEEEEEee-------------cccccCCHHHHHHHHHHHHHHHhCCCCCee
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVN-------------IEDVMQSPDQLERLYSEVHLLKSLKHENII 89 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG-~~VAiK~i~-------------~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIV 89 (630)
++| ++.+.||+|+||+||+|..+... ..++.|.+. .............+.+|+.+|++++||||+
T Consensus 148 ~~Y-~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 148 AHF-RVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hcc-EEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 456 78899999999999998764332 222222111 011112233456688999999999999999
Q ss_pred EEEeEEEcCCCCEEEEEEcccCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC
Q 006810 90 KFYNSWVDDTNRTINMITELFTSGSLRYRKK-----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 164 (630)
Q Consensus 90 k~~~~f~d~~~~~l~lV~Ey~~gGsL~~~~~-----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 164 (630)
++++++... ...|+|++++.+..+.++.. ........++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 227 ~l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~- 301 (501)
T PHA03210 227 KIEEILRSE--ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN- 301 (501)
T ss_pred cEeEEEEEC--CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-
Confidence 999998655 45889999997765554432 223456788899999999999999999 99999999999998
Q ss_pred CCCcEEEcccccceeeccCC---CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCC-CCCCC-CH-HHHH
Q 006810 165 NNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP-YNECK-NP-AQIY 237 (630)
Q Consensus 165 ~~g~vKL~DFGla~~~~~~~---~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~P-f~~~~-~~-~~i~ 237 (630)
.+|.+||+|||++..+.... ....+||+.|+|||++.+ .|+.++|||||||++|||++|..| |.... ++ .++.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 78999999999997664332 234679999999998764 589999999999999999998864 43221 22 2333
Q ss_pred HHHHcCC-C----C-------------------CCC-----CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 238 KKVTSGI-K----P-------------------ASL-----SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 238 ~~i~~g~-~----p-------------------~~l-----~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+.+.... . | ..+ ....+..+.++|.+||. +|.+|||+.|+|.||||....
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 3222100 0 0 000 01235677888999998 899999999999999998754
Q ss_pred C
Q 006810 288 P 288 (630)
Q Consensus 288 ~ 288 (630)
.
T Consensus 462 ~ 462 (501)
T PHA03210 462 E 462 (501)
T ss_pred c
Confidence 3
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=304.95 Aligned_cols=242 Identities=26% Similarity=0.400 Sum_probs=196.5
Q ss_pred eeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 27 GRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~-----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+.+.+.||+|+||.||+|.+. .++..|++|.+... .......+.+|+.++++++||||+++++++... .
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--D 80 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC--C
Confidence 377899999999999999753 35667999887532 234446688999999999999999999988654 4
Q ss_pred EEEEEEcccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC
Q 006810 102 TINMITELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 164 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 164 (630)
.+++||||+++++|. ++..+ +.+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~- 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG- 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-
Confidence 689999999999998 55433 34889999999999999999999999 99999999999998
Q ss_pred CCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHH
Q 006810 165 NNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 238 (630)
Q Consensus 165 ~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~ 238 (630)
.++.++|+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|+| |..||... +......
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~ 236 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIE 236 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH
Confidence 78899999999986543321 22345678999999775 458899999999999999999 99999763 4445555
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 239 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 239 ~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+..+..+ ......+..++++|.+||. +|.+||++.++++
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 55554333 3345567899999999997 8999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.56 Aligned_cols=241 Identities=23% Similarity=0.409 Sum_probs=196.1
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++... ..+++|
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIFIV 77 (256)
T ss_pred cchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceEEE
Confidence 477899999999999999876 567899998863322 123577899999999999999999987544 468899
Q ss_pred EcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC
Q 006810 107 TELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 184 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 184 (630)
|||+++++|. ++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++ .+|.+||+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceeccccc
Confidence 9999999998 5544 457899999999999999999999999 99999999999998 78999999999987654332
Q ss_pred Cccc---cCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 185 ARSV---IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 185 ~~~~---~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
.... .++..|+|||.+. ..++.++||||||+++|+|+| |..||... +.......+..+..+ ..+...++.+++
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF-SNSEVVESVSAGYRL-YRPKLAPTEVYT 232 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHH
Confidence 2222 2345799999876 468899999999999999999 89999763 455556666655332 334567899999
Q ss_pred HHHHccc-CCCCCCCHHHHhcC
Q 006810 260 FIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
++.+||. +|.+||++.+++..
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHH
Confidence 9999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=302.55 Aligned_cols=245 Identities=25% Similarity=0.437 Sum_probs=200.4
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
|...| ++.+.||.|+||.||+|.+.. +..||+|.+.... ......+.+|+.+++.++||||+++++++.+. .
T Consensus 4 ~~~~y-~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 75 (261)
T cd05148 4 PREEF-TLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--E 75 (261)
T ss_pred cHHHH-HHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecC--C
Confidence 34445 678999999999999999987 8999999986443 23345688999999999999999999987654 4
Q ss_pred EEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.+++||||+++|+|. ++.. ...+++..+..|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~ 152 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLAR 152 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchh
Confidence 588999999999998 5543 356899999999999999999999998 99999999999998 78899999999997
Q ss_pred eeccCC--CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 179 VMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 179 ~~~~~~--~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
...... .....+++.|+|||.+. +.++.++||||||+++|+|++ |+.||.. .+....+..+..+..+ ..+...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 230 (261)
T cd05148 153 LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCP 230 (261)
T ss_pred hcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCC
Confidence 654322 12234567899999775 458899999999999999998 8999976 3455555666554333 3345667
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+.+.++|.+||. +|.+||++.+++.
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.31 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=194.4
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccC--------------CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVD--------------GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~t--------------G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN 87 (630)
|..|| ++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|++++++++|||
T Consensus 3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~ 78 (295)
T cd05097 3 PRQQL-RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPN 78 (295)
T ss_pred chHhC-eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCC
Confidence 56778 8889999999999999987543 2358999986432 2445567899999999999999
Q ss_pred eeEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhc------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEecc
Q 006810 88 IIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKH------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 154 (630)
Q Consensus 88 IVk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrD 154 (630)
|+++++++... ..+++||||+.+++|. ++... ..+++..+..++.||+.||.|||+++ ++|||
T Consensus 79 i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~d 154 (295)
T cd05097 79 IIRLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRD 154 (295)
T ss_pred cCeEEEEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccc
Confidence 99999998654 4688999999999997 44332 23688999999999999999999999 99999
Q ss_pred CCcCceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh--CCCCC
Q 006810 155 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--CEYPY 227 (630)
Q Consensus 155 LKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt--G~~Pf 227 (630)
|||+||+++ .++.+||+|||++....... .....+++.|+|||++. +.++.++|||||||++|+|++ +..||
T Consensus 155 lkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 155 LATRNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred cChhhEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 999999998 78899999999986543221 12234567899999765 568999999999999999998 67788
Q ss_pred CCCCCHHHHHHHHHc------CCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 228 NECKNPAQIYKKVTS------GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 228 ~~~~~~~~i~~~i~~------g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.... ..++...+.. .......+...++.+++||.+||+ +|.+||++.++++
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 234 SLLS-DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cccC-hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7633 3333332211 111122344567899999999998 8999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=298.36 Aligned_cols=240 Identities=23% Similarity=0.418 Sum_probs=194.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||+||+|.+.. +..||+|.+..... ..+.+.+|+.++++++||||+++++++... ..+++||
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIVT 78 (256)
T ss_pred EEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcEEEE
Confidence 778899999999999997653 45699998864322 124588999999999999999999988544 4578999
Q ss_pred cccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC
Q 006810 108 ELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185 (630)
Q Consensus 108 Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 185 (630)
||+.+|+|. ++.. ...+++..++.++.||+.||.|||+++ ++||||||.||+++ .++.+||+|||.+........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecCCCce
Confidence 999999998 5544 347899999999999999999999998 99999999999998 788999999999875543321
Q ss_pred c---cccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006810 186 R---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260 (630)
Q Consensus 186 ~---~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~ 260 (630)
. ...++..|+|||.+. ..++.++|||||||++|+|++ |..||... +.......+..+..+ ..+...+..++++
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 233 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVSQGLRL-YRPHLASEKVYAI 233 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHhcCCCC-CCCCCCCHHHHHH
Confidence 1 123456799999886 458899999999999999999 99999764 344455555554333 2344567899999
Q ss_pred HHHccc-CCCCCCCHHHHhcC
Q 006810 261 IEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 261 I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+.+||. +|.+||++.+++.+
T Consensus 234 i~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 234 MYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHcCCCcccCCCHHHHHHh
Confidence 999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=298.82 Aligned_cols=243 Identities=26% Similarity=0.414 Sum_probs=195.0
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
|.+|| ++.+.||+|+||.||+|.+..++ .||+|.+..... ..+.+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~-~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 73 (260)
T cd05069 4 PRESL-RLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---E 73 (260)
T ss_pred ChHHe-eeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---C
Confidence 34566 88899999999999999876554 699998764321 23567889999999999999999997632 3
Q ss_pred EEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..++||||+.+|+|. ++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++ .++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~ 150 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCccce
Confidence 478999999999997 5543 234889999999999999999999998 99999999999997 78999999999997
Q ss_pred eeccCCC---ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 179 VMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 179 ~~~~~~~---~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
....... ....++..|+|||... +.++.++||||||+++|+|+| |..||.+.. .......+..+..+ ..+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~ 228 (260)
T cd05069 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-NREVLEQVERGYRM-PCPQGC 228 (260)
T ss_pred EccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC-CCCccc
Confidence 6543221 2234567899999775 458899999999999999999 999998743 44445555554332 334456
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+..++++|.+||. +|.+||++.+++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 7899999999998 8999999998865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=300.11 Aligned_cols=245 Identities=24% Similarity=0.407 Sum_probs=198.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG---~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
+|| ++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 4 ~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 77 (267)
T cd05066 4 SCI-KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-- 77 (267)
T ss_pred HHe-EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 356 78899999999999999886544 479999886432 234556789999999999999999999988644
Q ss_pred CEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 101 RTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++||||+++|+|. ++.. .+.+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~ 154 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSR 154 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEEC-CCCeEEeCCCCccc
Confidence 4688999999999998 5544 356899999999999999999999999 99999999999997 78899999999987
Q ss_pred eeccCCC-----ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 179 VMQQPTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 179 ~~~~~~~-----~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
....... ....+++.|+|||.+.+ .++.++|+||||+++|+|++ |..||... ........+..+..+ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 232 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRL-PAPM 232 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcC-CCCC
Confidence 6543211 11223568999998864 68999999999999999886 99999764 345555666655332 2334
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..++.+++++.+||. +|.+||++.+++.
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 233 DCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=302.94 Aligned_cols=242 Identities=25% Similarity=0.406 Sum_probs=196.0
Q ss_pred eeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 27 GRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d-----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+++.+.||+|+||.||+|.. ..++..+|+|.+... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--R 80 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--C
Confidence 36779999999999999964 346778999987532 345567799999999999999999999988654 4
Q ss_pred EEEEEEcccCCCCHH-HHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC
Q 006810 102 TINMITELFTSGSLR-YRKKH---------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 165 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~---------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 165 (630)
.+++||||+++|+|. ++..+ ..+++..+..++.||+.||+|||+++ ++||||||+|||++ .
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~-~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVG-Q 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEc-C
Confidence 588999999999998 55443 24889999999999999999999999 99999999999998 7
Q ss_pred CCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHH
Q 006810 166 NGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 239 (630)
Q Consensus 166 ~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~ 239 (630)
++.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.... .......
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~ 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-NTEAIEC 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC-HHHHHHH
Confidence 8899999999987543321 12234578899999775 458999999999999999998 899997643 4444455
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 240 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 240 i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+..+..+ ..+...++.+.+||.+||+ +|.+||++.+++.
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5554333 2344567899999999997 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=301.95 Aligned_cols=244 Identities=27% Similarity=0.428 Sum_probs=192.9
Q ss_pred eeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 28 RYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~----d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++.+.||+|+||+||+|. +..+|..||+|.+... .....+.+.+|+.+++.++||||+++++++.......+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 778999999999999987 4568899999998643 24556778999999999999999999998766555678
Q ss_pred EEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||+++|+|. ++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCccccccc
Confidence 9999999999998 5544 356899999999999999999999999 99999999999997 78899999999997654
Q ss_pred cCCC-----ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCH---------------HHHHHHH
Q 006810 182 QPTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------------AQIYKKV 240 (630)
Q Consensus 182 ~~~~-----~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~---------------~~i~~~i 240 (630)
.... ....++..|+|||++.+ .++.++|||||||++|||++|..|+...... ..+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3221 11123446999998764 5889999999999999999988776432110 0111122
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 241 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 241 ~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..+.. .......+..+.+||.+||. +|.+|||+.+++.
T Consensus 240 ~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 22211 12234567899999999997 8999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=340.68 Aligned_cols=148 Identities=26% Similarity=0.427 Sum_probs=131.6
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||+||+|.+..+|..||+|++...... .......+.+|+.+++.++||||++++.++... ..+
T Consensus 4 ~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~ 79 (669)
T cd05610 4 EEF-VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-NKNMVHQVQAERDALALSKSPFIVHLYYSLQSA--NNV 79 (669)
T ss_pred CCE-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--CEE
Confidence 355 7889999999999999999999999999999765432 345567788999999999999999999887654 469
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
|+||||+.+|+|. ++...+.+++..++.|+.||+.||.|||.++ |+||||||+|||++ .+|.+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 9999999999998 7777788999999999999999999999998 99999999999998 78999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=297.88 Aligned_cols=242 Identities=24% Similarity=0.404 Sum_probs=196.3
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
..+| ++.++||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.++++++||||+++++++.. ..
T Consensus 5 ~~~~-~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 74 (260)
T cd05067 5 RETL-KLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EP 74 (260)
T ss_pred hHHc-eeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CC
Confidence 3445 78899999999999999864 678899999864332 23468899999999999999999998632 35
Q ss_pred EEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 103 INMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
++++|||+.+|+|. ++.. ...++...+..++.|++.||+|||+++ ++||||||+||+++ .++.++|+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~ 151 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcceee
Confidence 78999999999997 4433 346899999999999999999999998 99999999999998 789999999999976
Q ss_pred eccCCC---ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 180 MQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 180 ~~~~~~---~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
...... ....++..|+|||++. ..++.++||||||+++|+|++ |+.||.+. +.......+..+..+ ..+...+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 229 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCP 229 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCC
Confidence 542221 2234567899999876 457889999999999999999 99999874 445555555554333 3344567
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+++++|.+||. +|.+||++.+++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 230 EELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 899999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=297.83 Aligned_cols=241 Identities=22% Similarity=0.377 Sum_probs=191.2
Q ss_pred eEecccCceEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~---tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
+.||+|+||.||+|.+.. .+..||+|.+... ......+.+.+|+.+++.++||||+++++++.... ...++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEE
Confidence 468999999999998653 3468999987532 23445677889999999999999999999775433 3577899
Q ss_pred cccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--
Q 006810 108 ELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 183 (630)
||+.+|+|. ++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++ .++.+||+|||+++.....
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCccccccccCCcc
Confidence 999999998 5543 345788889999999999999999998 99999999999998 7889999999998754321
Q ss_pred ----CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhC-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 184 ----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 184 ----~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG-~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
......+++.|+|||.+. ..++.++|||||||++|||++| .+||.. .+...+...+..+..+ ..+...++.+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRL-LQPEYCPDPL 231 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCcCCHHH
Confidence 112334577899999775 4688999999999999999995 556654 4555666666555333 2344567899
Q ss_pred HHHHHHccc-CCCCCCCHHHHhcC
Q 006810 258 KQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+++.+||. +|.+||++.+++..
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999997 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=297.89 Aligned_cols=242 Identities=24% Similarity=0.404 Sum_probs=195.1
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
..+| ++.+.||+|+||.||+|.+. .+..||+|.+..... . .+.+.+|+.++++++||||+++++++.. ..
T Consensus 5 ~~~~-~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~ 74 (260)
T cd05070 5 RESL-QLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--S---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EP 74 (260)
T ss_pred hHHh-hhhheeccccCceEEEEEec-CCceeEEEEecCCCC--C---HHHHHHHHHHHHhcCCCceEEEEeEECC---CC
Confidence 3466 77899999999999999766 566799999875432 1 2458899999999999999999997632 34
Q ss_pred EEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 103 INMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
++++|||+++++|. ++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~-~~~~~~l~dfg~~~~ 151 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVG-DGLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEe-CCceEEeCCceeeee
Confidence 78999999999998 5443 345899999999999999999999998 99999999999998 788999999999976
Q ss_pred eccCCC---ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 180 MQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 180 ~~~~~~---~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
...... ....++..|+|||++. ..++.++||||||+++|+|++ |..||... +.......+..+..+ ..+...+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 229 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRM-PCPQDCP 229 (260)
T ss_pred ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCC
Confidence 543221 1223456799999765 458899999999999999999 89999764 444455555544332 3345667
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..+++||.+||. +|.+|||+.+++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 899999999997 8999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=297.65 Aligned_cols=236 Identities=20% Similarity=0.393 Sum_probs=192.4
Q ss_pred ecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 33 LGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 33 LG~G~fg~Vy~A~d~--~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++.. ..+++||||+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~ 76 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMA 76 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeC
Confidence 899999999999765 456789999886432 24455678999999999999999999998742 3578999999
Q ss_pred CCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC---
Q 006810 111 TSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 185 (630)
Q Consensus 111 ~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~--- 185 (630)
++|+|. ++. ....+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccCCcccee
Confidence 999998 544 3567999999999999999999999998 99999999999997 788999999999865432211
Q ss_pred --ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 186 --RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 186 --~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
....+++.|+|||.+. +.++.++|||||||++|+|++ |..||... ....+...+..+..+ ..+...+++++++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 231 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYALM 231 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 1112357899999876 458899999999999999996 99999874 445555666665433 45566789999999
Q ss_pred HHccc-CCCCCCCHHHHhc
Q 006810 262 EKCIV-PASLRLPALELLK 279 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+||. +|.+||++.++.+
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 99998 8999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=300.18 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=200.5
Q ss_pred cceeeeeEecccCceEEEEEEEcc----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~----tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
|| ++.++||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+++.++||||+++++++... +
T Consensus 7 ~~-~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~ 81 (280)
T cd05043 7 RV-TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-G 81 (280)
T ss_pred he-EEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-C
Confidence 44 788999999999999999876 3688999987522 2345567789999999999999999999987654 3
Q ss_pred CEEEEEEcccCCCCHH-HHhhc--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEE
Q 006810 101 RTINMITELFTSGSLR-YRKKH--------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 171 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~--------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 171 (630)
...+++++|+++|+|. ++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEc-CCCcEEE
Confidence 4678899999999998 55432 45899999999999999999999998 99999999999997 7899999
Q ss_pred cccccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCC
Q 006810 172 GDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 245 (630)
Q Consensus 172 ~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~ 245 (630)
+|||+++.+.... .....++..|+|||++.+ .++.++|||||||++|+|++ |+.||.. .++..+...+..+..
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDGYR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHcCCC
Confidence 9999997553221 112345667999998764 58899999999999999999 9999976 466667666666544
Q ss_pred CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 246 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 246 p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+. .....++.+++++.+||. +|.+||++.+++.
T Consensus 238 ~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 33 234467899999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=303.55 Aligned_cols=242 Identities=26% Similarity=0.420 Sum_probs=196.0
Q ss_pred eeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 28 RYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~-----tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
++.+.||+|+||+||+|.+.. .+..||+|.+.... .......+.+|+.+++.++||||+++++.+... ..
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 77 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GP 77 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CC
Confidence 677899999999999998753 33678888876432 234457788999999999999999999988654 35
Q ss_pred EEEEEcccCCCCHH-HHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCc
Q 006810 103 INMITELFTSGSLR-YRKKH------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 157 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~------------------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp 157 (630)
.++++||+.+|+|. ++... ..+++..+..++.|++.||.|||+++ ++||||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp 155 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAA 155 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhh
Confidence 78899999999997 44321 35789999999999999999999998 99999999
Q ss_pred CceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCC
Q 006810 158 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECK 231 (630)
Q Consensus 158 ~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~ 231 (630)
+|||++ .++.+||+|||++....... .....++..|+|||.+. ..++.++||||||+++|+|+| |..||.+ .
T Consensus 156 ~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~ 233 (290)
T cd05045 156 RNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-I 233 (290)
T ss_pred heEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-C
Confidence 999997 78899999999987543221 12234567899999765 458899999999999999999 9999976 4
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 232 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 232 ~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+..+...+..+..+. .+...+..+++||.+||+ +|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 234 APERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 5666667666554332 345567899999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=302.96 Aligned_cols=246 Identities=22% Similarity=0.314 Sum_probs=197.7
Q ss_pred CCcceeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~-----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
..+| ++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNI-EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhc-eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 4455 77889999999999999874 367899999886432 23445668899999999999999999998765
Q ss_pred CCCCEEEEEEcccCCCCHH-HHhhc----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEecc
Q 006810 98 DTNRTINMITELFTSGSLR-YRKKH----------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 154 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~-~~~~~----------------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrD 154 (630)
. ..+++|+||+++|+|. ++... ..+++..++.++.||+.||.|||+++ ++|||
T Consensus 80 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~d 155 (288)
T cd05050 80 G--KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRD 155 (288)
T ss_pred C--CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eeccc
Confidence 4 3578999999999997 55432 24788899999999999999999998 99999
Q ss_pred CCcCceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCC
Q 006810 155 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYN 228 (630)
Q Consensus 155 LKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~ 228 (630)
|||+|||++ .++.++|+|||++....... ......++.|+|||.+. ..++.++|||||||++|+|++ |..||.
T Consensus 156 l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 156 LATRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred ccHhheEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999997 78999999999986543221 12223466799999765 468999999999999999998 888987
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 229 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 229 ~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+ .+...+...+..+..+ ..+...+..+.+||.+||+ +|.+||++.|+++
T Consensus 235 ~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 G-MAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred C-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6 4455666666555432 2234567899999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.90 Aligned_cols=262 Identities=23% Similarity=0.404 Sum_probs=233.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
-.||-||||.|=++........+|+|+++...+.. .++.+.++.|-++|..++.|.||++|..|-+ .+++||+||-|
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~kyvYmLmEaC 502 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SKYVYMLMEAC 502 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--chhhhhhHHhh
Confidence 56999999999999776666679999998877655 4566889999999999999999999999854 46899999999
Q ss_pred CCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-CCccc
Q 006810 111 TSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSV 188 (630)
Q Consensus 111 ~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-~~~~~ 188 (630)
-||.|. .++..+.|++.+.+.++.-++.|++|||++| ||+|||||+|++++ .+|-+||.|||+|+..... ...++
T Consensus 503 lGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~KTwTF 579 (732)
T KOG0614|consen 503 LGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGRKTWTF 579 (732)
T ss_pred cCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhccCCceeee
Confidence 999998 8889999999999999999999999999999 99999999999998 8999999999999877654 56789
Q ss_pred cCCCCCCCccc-cccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-
Q 006810 189 IGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV- 266 (630)
Q Consensus 189 ~GTp~Y~APEv-l~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~- 266 (630)
||||+|.|||+ +..+.+.++|.||||+++|||+||.+||++ .++...|..|.+|+.-..+++.+...+.++|+++-.
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~ 658 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRD 658 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhc
Confidence 99999999995 456799999999999999999999999998 789999999999999888999999999999998765
Q ss_pred CCCCCCC-----HHHHhcCCCcccCCCCccccCCCCCC
Q 006810 267 PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 299 (630)
Q Consensus 267 ~p~~Rps-----a~eLL~hpf~~~~~~~~~~~~~l~~p 299 (630)
.|.+|.. +.++-+|.||..-+|..+....++.|
T Consensus 659 ~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pP 696 (732)
T KOG0614|consen 659 NPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPP 696 (732)
T ss_pred CcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCC
Confidence 7999886 78999999999988887655444433
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=294.41 Aligned_cols=242 Identities=28% Similarity=0.469 Sum_probs=200.3
Q ss_pred eeeeEecccCceEEEEEEEccCC----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--Cee
Confidence 45688999999999999998776 899999986442 223567789999999999999999999988665 468
Q ss_pred EEEEcccCCCCHH-HHhhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 104 NMITELFTSGSLR-YRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~--lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
+++|||+++++|. ++..... +++..+..++.||+.||+|||+++ ++||||||+||+++ .++.++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCceec
Confidence 9999999999998 5544333 999999999999999999999998 99999999999998 7889999999999765
Q ss_pred ccCCCc---cccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 181 QQPTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 181 ~~~~~~---~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
...... ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .+...+...+..+..+. .+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPP 231 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCH
Confidence 433111 123678999999775 458899999999999999998 7888876 55666666666654433 3444788
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+.+++.+||. +|.+||++.+++.
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999998 8999999999885
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=303.30 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=193.1
Q ss_pred CCCcceeeeeEecccCceEEEEEEEcc----------------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEV----------------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~----------------tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H 85 (630)
|.+|| ++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++|
T Consensus 3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~ 78 (296)
T cd05095 3 PRKRL-TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKD 78 (296)
T ss_pred Chhhc-eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCC
Confidence 66787 889999999999999985432 45579999886432 24455678899999999999
Q ss_pred CCeeEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEec
Q 006810 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKH-----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHR 153 (630)
Q Consensus 86 pNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~-----------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHr 153 (630)
|||+++++++.... .+++||||+++|+|. ++... ..+++..+..++.||+.||+|||+++ ++||
T Consensus 79 ~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~ 154 (296)
T cd05095 79 PNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHR 154 (296)
T ss_pred CCcceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence 99999999986653 588999999999998 54432 24677899999999999999999999 9999
Q ss_pred cCCcCceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh--CCCC
Q 006810 154 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--CEYP 226 (630)
Q Consensus 154 DLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt--G~~P 226 (630)
||||+|||++ .++.++|+|||++....... .....+++.|+|||... +.++.++|||||||++|||++ |..|
T Consensus 155 dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 155 DLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred cCChheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 9999999997 78999999999987553322 11223467899999654 568999999999999999998 7789
Q ss_pred CCCCCCHHHHHHHHHc----CC--CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 227 YNECKNPAQIYKKVTS----GI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 227 f~~~~~~~~i~~~i~~----g~--~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
|.... ...+...... .. .....+...++.+++||.+||+ +|.+||++.+++.
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 234 YSQLS-DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccccC-hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 97633 3333322211 10 1111233456899999999998 8999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.52 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=200.5
Q ss_pred eeeeeEecccCceEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
|.....||+|.||.||+|..+.++. .+|||.++-++- ........-+|+.+++.|+|||||.+..+|+.. +..
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~ 102 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK 102 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence 3455779999999999998766654 789999875532 122335577999999999999999999999865 568
Q ss_pred EEEEEcccCCCCHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC---CCcEEEccc
Q 006810 103 INMITELFTSGSLRYRK-----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGDL 174 (630)
Q Consensus 103 l~lV~Ey~~gGsL~~~~-----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~---~g~vKL~DF 174 (630)
+++++||.+...+..++ +.+.++...++.++.||+.|+.|||++- |+||||||.||||.++ .|.|||+||
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999998776443 2356899999999999999999999987 9999999999999842 489999999
Q ss_pred ccceeeccCC-----CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCC------CH---HHHHH
Q 006810 175 GLAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECK------NP---AQIYK 238 (630)
Q Consensus 175 Gla~~~~~~~-----~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~------~~---~~i~~ 238 (630)
|+++.++.+. ...++.|.+|+|||++-+ .|+.++|||++|||+.||+|.++.|.+.. ++ .|+.+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999887653 334677999999998764 59999999999999999999998886521 11 22222
Q ss_pred HHHc-CCC-----------CC-----------C-----------CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 239 KVTS-GIK-----------PA-----------S-----------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 239 ~i~~-g~~-----------p~-----------~-----------l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
++.- |.+ |. . ..+..++...+++.++|. ||-+|.||+++|.|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 2110 100 00 0 012345678899999998 99999999999999999
Q ss_pred ccCC
Q 006810 284 VTDN 287 (630)
Q Consensus 284 ~~~~ 287 (630)
..+.
T Consensus 341 ~~d~ 344 (438)
T KOG0666|consen 341 TEDP 344 (438)
T ss_pred ccCC
Confidence 8753
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.76 Aligned_cols=239 Identities=27% Similarity=0.413 Sum_probs=193.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
++||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++... ...++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECC
Confidence 46999999999999854 68899999876432 234445688999999999999999999988654 3588999999
Q ss_pred CCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC---
Q 006810 111 TSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 185 (630)
Q Consensus 111 ~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~--- 185 (630)
++|+|. ++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccccccccC
Confidence 999998 4433 456899999999999999999999998 99999999999997 789999999999865433211
Q ss_pred ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006810 186 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263 (630)
Q Consensus 186 ~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~k 263 (630)
....+++.|+|||++. +.++.++||||||+++|+|++ |..||... +.......+..+... ..+...+..+.+++.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 229 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQR 229 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 1223466799999876 458889999999999999998 99999864 444555555544332 3344567899999999
Q ss_pred ccc-CCCCCCCHHHHhcC
Q 006810 264 CIV-PASLRLPALELLKD 280 (630)
Q Consensus 264 cL~-~p~~Rpsa~eLL~h 280 (630)
|+. +|.+||++.++++.
T Consensus 230 ~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 230 CWDYKPENRPKFSELQKE 247 (250)
T ss_pred HcccCcccCCCHHHHHHH
Confidence 997 89999999998763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=303.58 Aligned_cols=244 Identities=27% Similarity=0.424 Sum_probs=198.2
Q ss_pred eeeeeEecccCceEEEEEEEc-------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcC
Q 006810 27 GRYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~-------~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~ 98 (630)
+++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 17 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred eeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 378899999999999999752 245689999886331 234557789999999999 899999999988654
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceE
Q 006810 99 TNRTINMITELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 161 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NIL 161 (630)
..+++||||+.+|+|. ++... ..++...+..++.||+.||.|||+++ ++||||||+||+
T Consensus 94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil 169 (304)
T cd05101 94 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVL 169 (304)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEE
Confidence 4688999999999998 55432 34788899999999999999999999 999999999999
Q ss_pred EeCCCCcEEEcccccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHH
Q 006810 162 VNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 235 (630)
Q Consensus 162 l~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~ 235 (630)
++ .++.+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.. .+...
T Consensus 170 i~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~ 247 (304)
T cd05101 170 VT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEE 247 (304)
T ss_pred Ec-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-CCHHH
Confidence 97 78999999999997654321 122345678999997754 58999999999999999998 7888876 45666
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 236 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 236 i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+...+..+..+ ..+...+..+++||.+||. +|.+||++.+++..
T Consensus 248 ~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 248 LFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 77777655432 3345567899999999997 79999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=302.65 Aligned_cols=243 Identities=21% Similarity=0.298 Sum_probs=197.3
Q ss_pred eeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 28 RYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~-----tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
++.+.||+|+||.||+|.+.. .+..||+|.++... .....+.+.+|+.+++.++||||+++++++.... .
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~ 82 (283)
T cd05091 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ--P 82 (283)
T ss_pred HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--c
Confidence 677889999999999998754 36889999987432 2344567889999999999999999999886553 5
Q ss_pred EEEEEcccCCCCHH-HHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC
Q 006810 103 INMITELFTSGSLR-YRKK----------------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 165 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~----------------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 165 (630)
+++++||+.+++|. ++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++ .
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~-~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-D 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec-C
Confidence 88999999999997 4321 235888999999999999999999999 99999999999998 7
Q ss_pred CCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHH
Q 006810 166 NGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 239 (630)
Q Consensus 166 ~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~ 239 (630)
++.+||+|||+++...... .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ .....+...
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~ 238 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIEM 238 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 8899999999987543321 12334578999999765 568999999999999999998 8888876 455566666
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 240 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 240 i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+..+..+ ..+...+..+.++|.+||+ +|.+||++.+++..
T Consensus 239 i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 6655432 3345678899999999997 89999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=283.99 Aligned_cols=249 Identities=25% Similarity=0.429 Sum_probs=201.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
+.||+|.||+||+|+...+++.||+|.+++.+- ++..-....+|+-+|+.|+|.|||+++++...+ ..+-+|+|||
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlhsd--kkltlvfe~c 83 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLVFEFC 83 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhccC--ceeEEeHHHh
Confidence 679999999999999999999999999998653 333445688999999999999999999976443 4577899999
Q ss_pred CCCCHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC--Ccc
Q 006810 111 TSGSLRY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARS 187 (630)
Q Consensus 111 ~gGsL~~-~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~--~~~ 187 (630)
....-.| -.-++.++.+.++.++.|++.||.++|+++ +.||||||+|++|+ .||.+||+|||+++.+..+. ...
T Consensus 84 dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin-~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 84 DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEec-cCCcEEecccchhhhcCCceEeeec
Confidence 8754444 456889999999999999999999999999 99999999999998 89999999999998777654 233
Q ss_pred ccCCCCCCCccccccc--cCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHc-CCC-CCCC-------------
Q 006810 188 VIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS-GIK-PASL------------- 249 (630)
Q Consensus 188 ~~GTp~Y~APEvl~~~--ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~-g~~-p~~l------------- 249 (630)
.+.|.+|.+|.++.+. |+...|+||.|||+.|+.. |++.|.+..-.+|+.++... |.+ ...+
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 4669999999988653 9999999999999999997 66667775555555554432 110 0000
Q ss_pred --C---------CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 250 --S---------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 250 --~---------~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+ +..+..-+++++++|. +|..|.+|+++|+||||...
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 0 1112345899999997 99999999999999999753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.36 Aligned_cols=262 Identities=28% Similarity=0.455 Sum_probs=211.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS---PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~---~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
..|| -+..+||+|||+.||+|+|....+.||+|+-.+.+--.+ .......-+|.++.+.|+||.||++|++|.-+.
T Consensus 462 n~RY-LlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 462 NDRY-LLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHH-HHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3567 456899999999999999999999999998765431111 112344668999999999999999999996544
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCcEEEccccc
Q 006810 100 NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGL 176 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGl 176 (630)
..++-|+|||+|.+|+ |++.++-+++++++.|+.||+.||.||....|||||=||||.|||+-. .-|.+||.|||+
T Consensus 541 -dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 541 -DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred -ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 4678899999999999 999999999999999999999999999999999999999999999841 347899999999
Q ss_pred ceeeccCCC---------ccccCCCCCCCccccc-c----ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHH-
Q 006810 177 AIVMQQPTA---------RSVIGTPEFMAPELYE-E----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT- 241 (630)
Q Consensus 177 a~~~~~~~~---------~~~~GTp~Y~APEvl~-~----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~- 241 (630)
+.++....- ....||-+|++||.|- + ..+.++||||+|||+|..+.|+.||........+...-+
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 988765421 2356899999999653 2 368899999999999999999999987554444433221
Q ss_pred -c-CCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 242 -S-GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 242 -~-g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
. .....+..++.++++++||++||+ .-.+|....+|-.||+|...
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 1 111112235678999999999999 57899999999999999763
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=297.14 Aligned_cols=232 Identities=23% Similarity=0.415 Sum_probs=185.4
Q ss_pred eEecccCceEEEEEEEccCC----------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 31 EILGKGAFKTVYKGFDEVDG----------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG----------~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR--- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence 46999999999999998777 457888765332 115678899999999999999999998876
Q ss_pred CEEEEEEcccCCCCHH-HHhhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC-------cEEE
Q 006810 101 RTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-------EVKI 171 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g-------~vKL 171 (630)
...++||||+++|+|. ++.... .++...+..++.||+.||.|||+++ |+||||||+|||++ .++ .+||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~-~~~~~~~~~~~~kl 149 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVA-RYGLNEGYVPFIKL 149 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEe-cCccccCCceeEEe
Confidence 3468899999999998 665555 7999999999999999999999998 99999999999998 555 7999
Q ss_pred cccccceeeccCCCccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCC
Q 006810 172 GDLGLAIVMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 247 (630)
Q Consensus 172 ~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~ 247 (630)
+|||++..... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.... ........... .
T Consensus 150 ~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~---~ 223 (259)
T cd05037 150 SDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQ---H 223 (259)
T ss_pred CCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcC---C
Confidence 99999876543 223456788999998764 47899999999999999999 588887643 32222222211 1
Q ss_pred CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 248 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 248 ~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..+......+.++|.+||. +|.+||++.++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1122223789999999997 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.35 Aligned_cols=243 Identities=23% Similarity=0.400 Sum_probs=196.4
Q ss_pred eeeeeEecccCceEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~---~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
+++.+.||+|+||.||+|.++.+|. .||+|.+... ........+..|+.+++.++||||+++++++.+. ..+
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~ 80 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--RPV 80 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--Cce
Confidence 4889999999999999999887765 6999988643 2345567899999999999999999999987544 458
Q ss_pred EEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||+++|+|. ++.. .+.+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEc-CCCcEEECCCccccccc
Confidence 8999999999998 5443 466899999999999999999999998 99999999999998 78899999999986543
Q ss_pred cCCC----c-ccc--CCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006810 182 QPTA----R-SVI--GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 252 (630)
Q Consensus 182 ~~~~----~-~~~--GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~ 252 (630)
.... . ... .+..|+|||.+. ..++.++|||||||++|||++ |..||... +.......+..... ...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i~~~~~-~~~~~~ 235 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAIEQDYR-LPPPMD 235 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCc-CCCccc
Confidence 3211 1 111 235799999876 458899999999999999886 99999763 44455555544332 222345
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+..+.+++.+||. +|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 57899999999998 7999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.60 Aligned_cols=242 Identities=24% Similarity=0.427 Sum_probs=196.4
Q ss_pred eeeeEecccCceEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~---~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+..+.||+|+||.||+|.++.++. .||+|.+.... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 82 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KPAM 82 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CCcE
Confidence 668999999999999999876654 79999886432 234556788999999999999999999988654 4588
Q ss_pred EEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 105 MITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+||||+++|+|. ++.. .+.+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCccceeccc
Confidence 999999999998 5543 467899999999999999999999998 99999999999998 788999999999875543
Q ss_pred CCCc-----cccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 183 PTAR-----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 183 ~~~~-----~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
.... ....++.|+|||++. +.++.++|||||||++|+|++ |..||... +...+...+..+... ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~ 237 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRL-PAPMDCPS 237 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCC-CCCCCCCH
Confidence 2211 112345799999876 458899999999999999998 99999763 445566666554332 22334678
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+.++|.+|+. +|.+||++.++++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=294.13 Aligned_cols=238 Identities=26% Similarity=0.425 Sum_probs=194.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
++||+|+||.||+|.+.. |..||+|.+..... ......+.+|+.++++++||||+++++++.+. ...++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcC
Confidence 469999999999999887 99999998875432 24556789999999999999999999988655 4588999999
Q ss_pred CCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC---
Q 006810 111 TSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 185 (630)
Q Consensus 111 ~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~--- 185 (630)
.+++|. ++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcceec
Confidence 999998 5533 457899999999999999999999998 99999999999998 788999999999875442111
Q ss_pred -ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 186 -RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 186 -~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
....++..|+|||.+. +.++.++||||||+++|+|+| |..||... ........+.... ....+...+..+.++|.
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 229 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGY-RMPAPQLCPEEIYRLML 229 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCC-CCCCCccCCHHHHHHHH
Confidence 1122356799999776 458899999999999999999 88999763 3444555554432 22334566789999999
Q ss_pred Hccc-CCCCCCCHHHHhc
Q 006810 263 KCIV-PASLRLPALELLK 279 (630)
Q Consensus 263 kcL~-~p~~Rpsa~eLL~ 279 (630)
+||. +|.+||++.++|.
T Consensus 230 ~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 230 QCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9997 7999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=295.27 Aligned_cols=244 Identities=26% Similarity=0.423 Sum_probs=196.7
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+..+| ++.++||+|+||+||+|.+. .+..||+|.+..... ....+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~-~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 74 (261)
T cd05034 4 PRESL-KLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--E 74 (261)
T ss_pred chhhe-eeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecC--C
Confidence 34456 88899999999999999876 557899999874432 235588999999999999999999987543 4
Q ss_pred EEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.+++||||+++++|. ++... ..+++..+..|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~ 151 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVG-ENLVCKIADFGLAR 151 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEc-CCCCEEECccccce
Confidence 689999999999998 55443 46899999999999999999999998 99999999999997 78999999999987
Q ss_pred eeccCC---CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 179 VMQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 179 ~~~~~~---~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
...... .....++..|+|||.+.+ .++.++||||||+++|+|+| |+.||.+. +.......+..+..+ ..+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 229 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERGYRM-PRPPNC 229 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCC
Confidence 654321 112234578999998764 58889999999999999999 99999764 444555555554322 223344
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+..++++|.+||. +|.+||++.+++.
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7899999999997 8999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=298.60 Aligned_cols=247 Identities=20% Similarity=0.344 Sum_probs=198.6
Q ss_pred CcceeeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~-----tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
.+| ++.+.||+|+||.||+|+.+. ....|++|.+.... .......+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNL-QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred Hhc-eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 455 667889999999999998754 34678888775322 233567789999999999999999999987543
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhcC---------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc
Q 006810 99 TNRTINMITELFTSGSLR-YRKKHK---------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 168 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~~---------~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 168 (630)
...++||||+++|+|. ++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~ 155 (275)
T cd05046 81 --EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQRE 155 (275)
T ss_pred --CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEe-CCCc
Confidence 4688999999999998 555444 6899999999999999999999999 99999999999998 7889
Q ss_pred EEEcccccceeeccC---CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcC
Q 006810 169 VKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243 (630)
Q Consensus 169 vKL~DFGla~~~~~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g 243 (630)
++|+|||++...... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||... .....+..+..+
T Consensus 156 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~~ 234 (275)
T cd05046 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAG 234 (275)
T ss_pred EEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHcC
Confidence 999999998643221 122345677899999765 457889999999999999999 88899763 444555555544
Q ss_pred CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 244 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 244 ~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..+.......+..+.++|.+||. +|.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 43333445567899999999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.91 Aligned_cols=244 Identities=27% Similarity=0.450 Sum_probs=200.1
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
++| ++.+.||+|+||+||+|.++.+|. .||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~-~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 80 (279)
T cd05057 7 TEL-EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS-- 80 (279)
T ss_pred HHc-EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 455 788999999999999999877765 58888776442 24556778899999999999999999998875
Q ss_pred CCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 100 NRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+++|+||+++|+|. ++.. ...+++..+..|+.||+.||+|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg~~ 156 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGLA 156 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCccc
Confidence 4688999999999998 5544 456999999999999999999999998 99999999999997 7889999999999
Q ss_pred eeeccCCC----ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 178 IVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 178 ~~~~~~~~----~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
........ ....+++.|+|||.+. ..++.++||||||+++|||++ |..||.. .....+...+..+.. ...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~ 234 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGER-LPQPP 234 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhCCCC-CCCCC
Confidence 76543211 1122356899999775 468899999999999999999 9999987 456666666665533 23345
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..+..+.+++.+||. +|..||++.+++.
T Consensus 235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 235 ICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 577899999999997 8999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.27 Aligned_cols=248 Identities=31% Similarity=0.473 Sum_probs=198.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|++|.||+|.+..+|..||+|.+.... ......+.+.+|+.+++.++||||+++++++.+. ..+++|+
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~ 77 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVF 77 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEe
Confidence 56788999999999999999999999999997653 1223345677899999999999999999988654 5689999
Q ss_pred cccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC-
Q 006810 108 ELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 184 (630)
||+.+ +|. ++... ..+++..+..++.|++.||.|||+++ |+||||+|+||+++ .++.++|+|||++.......
T Consensus 78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc-CCCCEEEecCCcccccCCCcc
Confidence 99985 777 55554 58999999999999999999999999 99999999999998 78999999999987654332
Q ss_pred -CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC------------------
Q 006810 185 -ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG------------------ 243 (630)
Q Consensus 185 -~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g------------------ 243 (630)
.....+++.|+|||.+.+ .++.++|||||||++|+|++|.+||........+.+.....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 223456788999997753 57889999999999999999999997744333322221100
Q ss_pred -CCCC-------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 244 -IKPA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 244 -~~p~-------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
..+. ......+..+++||++||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000 0011236789999999997 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=295.24 Aligned_cols=242 Identities=24% Similarity=0.452 Sum_probs=195.3
Q ss_pred eeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~t---G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
.+.+.||+|+||.||+|.+... ...||+|.+.... .....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~~ 82 (270)
T cd05056 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PVW 82 (270)
T ss_pred eeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---CcE
Confidence 6789999999999999987644 4568999876432 245567789999999999999999999987543 467
Q ss_pred EEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 105 MITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+||||+++|+|. ++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS-SPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe-cCCCeEEccCceeeeccc
Confidence 999999999998 5544 346899999999999999999999998 99999999999998 788999999999876543
Q ss_pred CCC---ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 183 PTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 183 ~~~---~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
... ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||...... .....+..+..+ ..+...++.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~ 237 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGRIENGERL-PMPPNCPPTL 237 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCcC-CCCCCCCHHH
Confidence 321 1223456899999775 458899999999999999996 99999875443 444555544333 3445667899
Q ss_pred HHHHHHccc-CCCCCCCHHHHhcC
Q 006810 258 KQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+++|.+|+. +|.+||++.+++..
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999997 89999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=297.54 Aligned_cols=239 Identities=25% Similarity=0.394 Sum_probs=190.7
Q ss_pred eEecccCceEEEEEEEccCCe--EEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~--~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++||+|+||.||+|.+..+|. .+|+|.+... ......+.+.+|+.+++++ +||||+++++++... ..+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEE
Confidence 468999999999999988876 4688877522 2344556788999999999 899999999988654 4588999
Q ss_pred cccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEE
Q 006810 108 ELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 170 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 170 (630)
||+++|+|. ++... ..+++..++.++.|++.||+|||+++ ++||||||+||+++ .++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCCeEE
Confidence 999999997 54432 24789999999999999999999998 99999999999998 789999
Q ss_pred EcccccceeeccCCC-ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCC
Q 006810 171 IGDLGLAIVMQQPTA-RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 247 (630)
Q Consensus 171 L~DFGla~~~~~~~~-~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~ 247 (630)
|+|||++........ .....++.|+|||++. ..++.++|||||||++|+|++ |..||.. .+....+..+..+..+
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~- 230 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL- 230 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCC-
Confidence 999999853322111 1122356799999875 458899999999999999997 9999976 4445555656554332
Q ss_pred CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 248 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 248 ~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..+...+.++.++|.+|+. +|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2344567899999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=293.22 Aligned_cols=243 Identities=23% Similarity=0.398 Sum_probs=196.0
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+.++| ++.+.||+|+||.||+|.+. .+..+|+|.+... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 4 ~~~~~-~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~ 73 (260)
T cd05073 4 PRESL-KLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---E 73 (260)
T ss_pred cccce-eEEeEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---C
Confidence 44566 88999999999999999755 4567999987633 2334678899999999999999999998765 4
Q ss_pred EEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++|||+++|+|. ++.. ...+++..+..|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||.+.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~ 150 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLAR 150 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCccee
Confidence 578999999999997 5543 346788999999999999999999998 99999999999998 78999999999987
Q ss_pred eeccCCC---ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 179 VMQQPTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 179 ~~~~~~~---~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
....... ....++..|+|||++.. .++.++|||||||++|+|+| |..||... +...+...+..+... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 228 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRM-PRPENC 228 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCC-CCcccC
Confidence 6543221 12235667999998764 57889999999999999999 99999864 444455555554332 233456
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+.++.+++.+|+. +|.+||++.+++.
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 7899999999997 8999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=297.95 Aligned_cols=240 Identities=20% Similarity=0.328 Sum_probs=185.3
Q ss_pred EecccCceEEEEEEEccC--CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 32 ILGKGAFKTVYKGFDEVD--GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 32 ~LG~G~fg~Vy~A~d~~t--G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
.||+|+||+||+|..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+. ..+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEec
Confidence 599999999999975433 2356666655332 234557789999999999999999999988754 458999999
Q ss_pred cCCCCHH-HHhhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--
Q 006810 110 FTSGSLR-YRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-- 182 (630)
Q Consensus 110 ~~gGsL~-~~~~~----~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~-- 182 (630)
+++|+|. ++... ..+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc-CCccEEecccccccccCcch
Confidence 9999998 55432 34677888999999999999999998 99999999999998 788999999998753221
Q ss_pred --CCCccccCCCCCCCcccccc--------ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCC---CCCC
Q 006810 183 --PTARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI---KPAS 248 (630)
Q Consensus 183 --~~~~~~~GTp~Y~APEvl~~--------~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~---~p~~ 248 (630)
.......+++.|+|||++.. .++.++|||||||++|||++ |..||........+...+..+. ..+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 12234567899999998742 35678999999999999997 5678876444443333333321 1233
Q ss_pred CCCCCcHHHHHHHHHcccCCCCCCCHHHHhc
Q 006810 249 LSKVTDPQVKQFIEKCIVPASLRLPALELLK 279 (630)
Q Consensus 249 l~~~~s~~lk~~I~kcL~~p~~Rpsa~eLL~ 279 (630)
+....++.+++++..|+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 234 LELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred cCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 3445678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.86 Aligned_cols=235 Identities=20% Similarity=0.371 Sum_probs=185.5
Q ss_pred eEecccCceEEEEEEEccCCeE-------EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIE-------VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~-------VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
+.||+|+||+||+|.+...+.. ||+|.+... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--Cc
Confidence 4699999999999988665543 888876532 2344567889999999999999999999987654 47
Q ss_pred EEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc--------EEEcc
Q 006810 104 NMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--------VKIGD 173 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~--------vKL~D 173 (630)
++||||+.+|+|. ++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++ .++. ++++|
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLI-REEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEe-cccccccCCCceEEecc
Confidence 8999999999998 55443 45899999999999999999999998 99999999999997 3433 79999
Q ss_pred cccceeeccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCC-CCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006810 174 LGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCE-YPYNECKNPAQIYKKVTSGIKPASLS 250 (630)
Q Consensus 174 FGla~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~-~Pf~~~~~~~~i~~~i~~g~~p~~l~ 250 (630)
||++..... .....+++.|+|||++.+ .++.++||||||+++|+|++|. .||.. ............ ...++
T Consensus 152 ~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~~~---~~~~~ 225 (258)
T cd05078 152 PGISITVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFYED---RHQLP 225 (258)
T ss_pred cccccccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHHHc---cccCC
Confidence 998865433 233567899999998864 4788999999999999999984 66654 333322222222 12234
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
...+.++.++|.+||+ +|.+||++.++++.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 4456889999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.39 Aligned_cols=244 Identities=26% Similarity=0.413 Sum_probs=201.0
Q ss_pred eeeEecccCceEEEEEEEccCCe---E-EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 29 YDEILGKGAFKTVYKGFDEVDGI---E-VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 29 ~~e~LG~G~fg~Vy~A~d~~tG~---~-VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+.+.||+|+||.||+|.-+..+. . ||+|..+.+. ....+++..+.+|+++|++++|||||++|++.++.. .++
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--Pl~ 237 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--PLM 237 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--ccE
Confidence 34789999999999998766432 3 8999887533 235678888999999999999999999999877654 599
Q ss_pred EEEcccCCCCHH-HHhhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 105 MITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+|||+|.||+|. ++++.+ .++..+...++.+.+.||+|||+++ +|||||-.+|+|++ .++.+||+|||+++.-..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~-~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS-KKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec-CCCeEEeCccccccCCcc
Confidence 999999999998 888877 4999999999999999999999999 99999999999997 677889999999865432
Q ss_pred CCCcc-c-cCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 183 PTARS-V-IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 183 ~~~~~-~-~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
-.... . --...|+|||.+.. .|+.++|||||||++||+.+ |..||.+. ...++...+.....+...+...++++.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~-~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM-KNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC-CHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 11111 1 13468999998864 59999999999999999999 88899985 455666666444344455557788999
Q ss_pred HHHHHccc-CCCCCCCHHHHhc
Q 006810 259 QFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.++.+|+. +|..||++.++.+
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH
Confidence 99999997 8999999998765
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=318.31 Aligned_cols=244 Identities=25% Similarity=0.409 Sum_probs=198.0
Q ss_pred eeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCC
Q 006810 28 RYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNR 101 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~-----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~ 101 (630)
.+.+.||+|+||.||+|.+. .++..||+|+++... .....+.+.+|+.+|..+. |||||+++++|... .
T Consensus 40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~--~ 114 (401)
T cd05107 40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG--G 114 (401)
T ss_pred ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--C
Confidence 45689999999999999853 456789999997432 2334456889999999997 99999999998655 4
Q ss_pred EEEEEEcccCCCCHH-HHhhc-----------------------------------------------------------
Q 006810 102 TINMITELFTSGSLR-YRKKH----------------------------------------------------------- 121 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~----------------------------------------------------------- 121 (630)
.+++||||+.+|+|. ++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 689999999999997 44322
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEE
Q 006810 122 ---------------------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 162 (630)
Q Consensus 122 ---------------------------------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 162 (630)
..+++..+..++.||+.||.|||+.+ ++||||||+|||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl 272 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLI 272 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEE
Confidence 13567788999999999999999988 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccC----CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHH
Q 006810 163 NGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 236 (630)
Q Consensus 163 ~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i 236 (630)
+ .++.+||+|||++...... ......+++.|+|||.+. ..++.++|||||||++|||++ |..||......+..
T Consensus 273 ~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 C-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred e-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 8 7889999999999754321 122345788999999775 458899999999999999998 89999876666666
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 237 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 237 ~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
...+..+..+ ..+...+.++.++|.+||. +|.+||++.+++..
T Consensus 352 ~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6666665433 2345568999999999997 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=328.97 Aligned_cols=259 Identities=29% Similarity=0.478 Sum_probs=214.7
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEE
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV 96 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~ 96 (630)
...||+.-| .|.++||.|.+|.||++..+.+|..+|+|+...... .-+.+..|..+|+.+ +|||++.+|++|.
T Consensus 13 ~lpdp~d~~-ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-----~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 13 SLPDPADIF-EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-----EEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred hCCCCCCcc-EEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-----ccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 346788888 678999999999999999999999999999875432 224466788888887 7999999999986
Q ss_pred cCC---CCEEEEEEcccCCCCHHH-Hh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEE
Q 006810 97 DDT---NRTINMITELFTSGSLRY-RK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 170 (630)
Q Consensus 97 d~~---~~~l~lV~Ey~~gGsL~~-~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 170 (630)
-.+ .+.+|||||||.||+.-. .+ +..++.|..+..|++.++.||.+||.+. ++|||||-.|||++ .+|.||
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT-~e~~VK 163 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT-ENAEVK 163 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe-ccCcEE
Confidence 432 357999999999999863 22 2678999999999999999999999998 99999999999998 899999
Q ss_pred EcccccceeeccC--CCccccCCCCCCCcccccc------ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Q 006810 171 IGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 242 (630)
Q Consensus 171 L~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~~------~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~ 242 (630)
|+|||++..+... ...+++|||.|||||++.. .|+..+|+||||+++.||.-|.+|+.++.....++.+..
T Consensus 164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR- 242 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR- 242 (953)
T ss_pred EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC-
Confidence 9999999887654 4567899999999998853 378899999999999999999999988554444443332
Q ss_pred CCCCCCC-CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 243 GIKPASL-SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 243 g~~p~~l-~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..+|.-. ++.++.++-+||..||. +-.+||+..++|+|||++..
T Consensus 243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 2222222 45678899999999997 78999999999999999843
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.66 Aligned_cols=263 Identities=22% Similarity=0.392 Sum_probs=225.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
.+..+||+|+||.|.+|..+.+.+.+|||+++..-+.++ +.++.-..|-++|... +-|.+++++..|+.- .++|+|
T Consensus 352 nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTm--DRLyFV 428 (683)
T KOG0696|consen 352 NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTM--DRLYFV 428 (683)
T ss_pred ceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhh--hheeeE
Confidence 356899999999999999999999999999987766554 4455566788888777 567888999888654 469999
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee--eccC
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV--MQQP 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~--~~~~ 183 (630)
|||+.||+|- .+..-+++.+..+..++..|+-||-+||++| ||+||||.+|||++ ..|+|||+|||+... ....
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd-~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEec-cCCceEeeecccccccccCCc
Confidence 9999999998 6778899999999999999999999999999 99999999999998 789999999999863 4555
Q ss_pred CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
+.++++|||.|+|||++. .+|+.++|.||||++||||+.|++||.+ .+.+++++.|... ...+++..+.++.++.+
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~eh--nvsyPKslSkEAv~ick 582 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEH--NVSYPKSLSKEAVAICK 582 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHc--cCcCcccccHHHHHHHH
Confidence 678899999999999775 6799999999999999999999999987 6788888888764 34577888999999999
Q ss_pred Hccc-CCCCCCCH-----HHHhcCCCcccCCCCccccCCCCCC
Q 006810 263 KCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLRLP 299 (630)
Q Consensus 263 kcL~-~p~~Rpsa-----~eLL~hpf~~~~~~~~~~~~~l~~p 299 (630)
..|. .|.+|..+ .++-.||||+..+|.++....++.|
T Consensus 583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPP 625 (683)
T KOG0696|consen 583 GLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPP 625 (683)
T ss_pred HHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCC
Confidence 9997 69998753 5788999999999887655555444
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.50 Aligned_cols=244 Identities=26% Similarity=0.417 Sum_probs=196.8
Q ss_pred eeeeeEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcC
Q 006810 27 GRYDEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~-------tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~ 98 (630)
+++.+.||+|+||.||+|.+.. .+..||+|.+... ........+.+|+.+++++ +||||+++++++...
T Consensus 14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 4889999999999999998643 2347899987632 2334567789999999999 899999999988654
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceE
Q 006810 99 TNRTINMITELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 161 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NIL 161 (630)
..+++|+||+++|+|. ++... ..++...+..++.||+.||.|||+++ ++||||||+|||
T Consensus 91 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil 166 (334)
T cd05100 91 --GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVL 166 (334)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEE
Confidence 4688999999999998 55432 24778899999999999999999998 999999999999
Q ss_pred EeCCCCcEEEcccccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHH
Q 006810 162 VNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 235 (630)
Q Consensus 162 l~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~ 235 (630)
++ .++.+||+|||+++...... .....+++.|+|||++.+ .++.++||||||+++|||++ |..||.. .+...
T Consensus 167 l~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~ 244 (334)
T cd05100 167 VT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEE 244 (334)
T ss_pred Ec-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCHHH
Confidence 97 78899999999987654321 112234567999998754 58899999999999999998 8899976 45566
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 236 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 236 i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+...+..+..+ ..+...+.++.++|.+||. +|.+||++.+++.+
T Consensus 245 ~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 245 LFKLLKEGHRM-DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66666655433 2334567899999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=291.73 Aligned_cols=240 Identities=21% Similarity=0.424 Sum_probs=196.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.++++++||||+++++++... ..+++|+
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPICLVF 78 (256)
T ss_pred EEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceEEEE
Confidence 77899999999999999875 477899998864332 124578899999999999999999987654 4588999
Q ss_pred cccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC
Q 006810 108 ELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185 (630)
Q Consensus 108 Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 185 (630)
||+++|+|. ++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeecccCcc
Confidence 999999998 5443 456899999999999999999999999 99999999999997 788999999999875533221
Q ss_pred ---ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006810 186 ---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260 (630)
Q Consensus 186 ---~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~ 260 (630)
....++..|+|||++. +.++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+...+..+.+|
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 233 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRL-YKPRLASQSVYEL 233 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCC-CCCCCCCHHHHHH
Confidence 1223466899999876 458889999999999999998 9999976 4455566666655333 2234567899999
Q ss_pred HHHccc-CCCCCCCHHHHhcC
Q 006810 261 IEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 261 I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+.+||. +|.+||++.++++.
T Consensus 234 ~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 234 MQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHcccChhhCCCHHHHHHh
Confidence 999998 79999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=296.45 Aligned_cols=226 Identities=17% Similarity=0.263 Sum_probs=185.3
Q ss_pred cCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCCCCH
Q 006810 36 GAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL 115 (630)
Q Consensus 36 G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL 115 (630)
|.||.||+|.+..+|..||+|.+.... ...+|...+....||||+++++++.+. ..+++||||+++|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCH
Confidence 899999999999999999999986532 123455556667899999999988654 468999999999999
Q ss_pred H-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCccccCCCCC
Q 006810 116 R-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194 (630)
Q Consensus 116 ~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y 194 (630)
. ++.+...+++..+..|+.|++.||.|||+++ ++||||||+||+++ .++.++|+|||.+....... ....+++.|
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~~-~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDSC-DGEAVENMY 148 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEecccchhcccccc-ccCCcCccc
Confidence 7 6667778999999999999999999999998 99999999999998 78899999999876554332 334567889
Q ss_pred CCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCC
Q 006810 195 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL 272 (630)
Q Consensus 195 ~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rp 272 (630)
+|||.+. +.++.++||||||+++|+|++|+.|+..... .+ .......++...++.++++|.+||. +|.+|+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS--GI-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch--hc-----ccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 9999876 4588999999999999999999988764211 11 1111123445578899999999997 899999
Q ss_pred CH-----HHHhcCCCc
Q 006810 273 PA-----LELLKDPFL 283 (630)
Q Consensus 273 sa-----~eLL~hpf~ 283 (630)
++ .++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 96 899999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.96 Aligned_cols=253 Identities=21% Similarity=0.240 Sum_probs=186.5
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHH-------HHHHHHHHHHHHhCCCCCee
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQ-------LERLYSEVHLLKSLKHENII 89 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~t---G~~VAiK~i~~~~~~~~~~~-------~~~l~~Ei~iL~~L~HpNIV 89 (630)
....+|| ++.++||+|+||+||+|.+..+ +..+|+|...........+. ......+...+..++|+||+
T Consensus 8 ~i~~~~y-~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 8 DITGKEW-KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred ccCCCce-EEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 3444566 8999999999999999998877 67778776544321110000 01123344566778999999
Q ss_pred EEEeEEEcCCC--CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC
Q 006810 90 KFYNSWVDDTN--RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 167 (630)
Q Consensus 90 k~~~~f~d~~~--~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 167 (630)
++++.+..... ...+++++++.......+......++..++.++.||+.||.|||+++ |+||||||+|||++ .++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~-~~~ 163 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD-GNN 163 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCC
Confidence 99987654432 24467788776543334444555788999999999999999999998 99999999999997 788
Q ss_pred cEEEcccccceeeccC---------CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHH
Q 006810 168 EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 237 (630)
Q Consensus 168 ~vKL~DFGla~~~~~~---------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~ 237 (630)
.++|+|||+++..... ......||+.|+|||++.+ .++.++|||||||++|||++|..||........+.
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999765321 1223469999999998765 58999999999999999999999998753332222
Q ss_pred --------HHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 238 --------KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 238 --------~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..+..+. ......++.+.++++.|+. +|.+||+..++++
T Consensus 244 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2222221 1123457899999999997 8999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.44 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=197.7
Q ss_pred CcceeeeeEecccCceEEEEEEEc----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDE----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
.|++++.+.||+|+||.||+|... .++..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 456678899999999999999864 3589999999875432 135677899999999999999999999887766
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 100 NRTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
....++||||+++|+|. ++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~ 156 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLA 156 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccccc
Confidence 66789999999999998 554433 6999999999999999999999998 99999999999998 7899999999999
Q ss_pred eeeccCCC-----ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHH--------------HHH
Q 006810 178 IVMQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------------QIY 237 (630)
Q Consensus 178 ~~~~~~~~-----~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~--------------~i~ 237 (630)
........ ....++..|+|||.+. ..++.++||||||+++|+|+||..|+....... .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 76552211 1123456799999765 458889999999999999999999986532211 122
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 238 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 238 ~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..+..+.. ...+...+.++.+++.+||. +|.+||++.+++.
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22222222 12233456889999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.05 Aligned_cols=235 Identities=20% Similarity=0.370 Sum_probs=183.1
Q ss_pred eEecccCceEEEEEEEcc------------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 31 EILGKGAFKTVYKGFDEV------------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~------------tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
+.||+|+||.||+|.... ....|++|.+... ..+....+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 468999999999997432 2346888886543 233455688899999999999999999988755
Q ss_pred CCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc-------E
Q 006810 99 TNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-------V 169 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~-------v 169 (630)
. ..++||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++. +
T Consensus 77 ~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~~~~~~~~ 151 (262)
T cd05077 77 V--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLA-REGIDGECGPFI 151 (262)
T ss_pred C--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEe-cCCccCCCCcee
Confidence 3 468999999999998 5443 467999999999999999999999998 99999999999997 4443 8
Q ss_pred EEcccccceeeccCCCccccCCCCCCCccccc--cccCcccceeehhHHHHHHh-hCCCCCCCCCCHHHHHHHHHcCCCC
Q 006810 170 KIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQIYKKVTSGIKP 246 (630)
Q Consensus 170 KL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~--~~ys~~sDIWSLGvil~ELl-tG~~Pf~~~~~~~~i~~~i~~g~~p 246 (630)
|++|||++..... .....+++.|+|||.+. ..++.++|||||||++|+|+ +|..||... ...... ....+...
T Consensus 152 ~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~-~~~~~~~~ 227 (262)
T cd05077 152 KLSDPGIPITVLS--RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-RFYEGQCM 227 (262)
T ss_pred EeCCCCCCccccC--cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHH-HHHhcCcc
Confidence 9999999865432 23346788999999875 45889999999999999998 588888753 222222 22222111
Q ss_pred CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 247 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 247 ~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.....+++++++|.+||. +|.+||+..++|.+
T Consensus 228 --~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 --LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 222335789999999997 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.52 Aligned_cols=242 Identities=28% Similarity=0.469 Sum_probs=185.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
.+||+|+||.||+|.-. +|..||||.+....... ...|.+|+.+|.+++|||+|++++|+.+... ..++|+||+
T Consensus 81 ~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEym 154 (361)
T KOG1187|consen 81 NLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEYM 154 (361)
T ss_pred cceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEcc
Confidence 58999999999999754 45899999776443211 3349999999999999999999999987653 578999999
Q ss_pred CCCCHH-HHhhcC--CCCHHHHHHHHHHHHHHHHHHHcC-CCCEEeccCCcCceEEeCCCCcEEEcccccceeecc-CCC
Q 006810 111 TSGSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTA 185 (630)
Q Consensus 111 ~gGsL~-~~~~~~--~lse~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~-~~~ 185 (630)
+.|+|. .+.... .+++....+|+.+++.||+|||.. .|||||||||+.|||+| .+...||+|||+|+.... ...
T Consensus 155 ~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~~~~ 233 (361)
T KOG1187|consen 155 PNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEGDTS 233 (361)
T ss_pred CCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCccccc
Confidence 999997 444333 889999999999999999999994 45899999999999998 899999999999965543 222
Q ss_pred -ccc-cCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCC--CHHHHH----HHHHcCCC----CCCCC-C
Q 006810 186 -RSV-IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIY----KKVTSGIK----PASLS-K 251 (630)
Q Consensus 186 -~~~-~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~--~~~~i~----~~i~~g~~----p~~l~-~ 251 (630)
.+. .||..|+|||.+. +..+.++|||||||+++||+||+.|..... ....+. ..+..+.. .+.+. .
T Consensus 234 ~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~ 313 (361)
T KOG1187|consen 234 VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG 313 (361)
T ss_pred eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence 222 7999999999876 578999999999999999999998876422 111111 12222211 11221 2
Q ss_pred CCc--HHH---HHHHHHccc-CCCCCCCHHHHhc
Q 006810 252 VTD--PQV---KQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 252 ~~s--~~l---k~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..+ ..+ ..+..+|+. +|..||+..+++.
T Consensus 314 ~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 314 EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 222 233 455668997 6899999998644
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=290.52 Aligned_cols=237 Identities=22% Similarity=0.427 Sum_probs=193.8
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
.| ++.+.||+|+||.||++. .+|..||+|.+.... ..+.+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~-~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~ 74 (254)
T cd05083 7 KL-TLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLY 74 (254)
T ss_pred Hc-eeeeeeccCCCCceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcE
Confidence 45 778999999999999985 578899999986432 235688999999999999999999988643 368
Q ss_pred EEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 105 MITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+||||+.+|+|. ++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGS 151 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCcEEECCCccceecc
Confidence 999999999998 54433 35899999999999999999999998 99999999999997 78899999999987543
Q ss_pred cCCCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 182 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 182 ~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
.. ......+..|+|||.+. +.++.++|+|||||++|+|++ |..||... +.......+..+..+. .....++.+++
T Consensus 152 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (254)
T cd05083 152 MG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKGYRME-PPEGCPADVYV 228 (254)
T ss_pred cc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhCCCCCC-CCCcCCHHHHH
Confidence 32 22233467899999775 468899999999999999998 99999764 4455555565554333 34456789999
Q ss_pred HHHHccc-CCCCCCCHHHHhc
Q 006810 260 FIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+|.+||. +|..||++.+++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 9999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=292.51 Aligned_cols=247 Identities=26% Similarity=0.453 Sum_probs=199.4
Q ss_pred eeeeEecccCceEEEEEEEcc-CCeEEEEEEeeccccc------CCHHHHHHHHHHHHHHHh-CCCCCeeEEEeEEEcCC
Q 006810 28 RYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVM------QSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDT 99 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~-tG~~VAiK~i~~~~~~------~~~~~~~~l~~Ei~iL~~-L~HpNIVk~~~~f~d~~ 99 (630)
.+.+.||+|+||.||+|.+.. ++..+|+|.+...... .......++.+|+.++.+ ++||||+++++++.+.
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~- 81 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN- 81 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC-
Confidence 567889999999999999988 7889999998654321 223455667889988865 7999999999988654
Q ss_pred CCEEEEEEcccCCCCHH-HH----hhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCCCcEEEcc
Q 006810 100 NRTINMITELFTSGSLR-YR----KKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGD 173 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~----~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~D 173 (630)
..+++||||+++++|. .+ .....+++..++.++.|++.||.|||+ .+ ++||||+|+||+++ .++.+||+|
T Consensus 82 -~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~d 157 (269)
T cd08528 82 -DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTITD 157 (269)
T ss_pred -CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEEec
Confidence 4689999999999996 33 234578999999999999999999996 56 99999999999997 788999999
Q ss_pred cccceeeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 174 LGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 174 FGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
||++...... ......|+..|+|||.+.+ .++.++||||||+++|+|++|+.||.. .+.......+..+..++....
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCcc
Confidence 9999765543 3344568999999998764 488999999999999999999999976 344444444544433333334
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..++.+.+||.+||+ +|.+||++.|+..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 567899999999997 89999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=293.08 Aligned_cols=246 Identities=22% Similarity=0.336 Sum_probs=195.4
Q ss_pred eeeeEecccCceEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC----
Q 006810 28 RYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---- 100 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~---tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~---- 100 (630)
++.++||+|+||.||+|.+.. +|..||+|++.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 677899999999999998653 67999999986443 234456778899999999999999999998865432
Q ss_pred CEEEEEEcccCCCCHH-HHhh------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcc
Q 006810 101 RTINMITELFTSGSLR-YRKK------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 173 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 173 (630)
...+++++|+.+|+|. ++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++ .++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEECc
Confidence 2357889999999996 3321 125789999999999999999999998 99999999999997 788999999
Q ss_pred cccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCC
Q 006810 174 LGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 247 (630)
Q Consensus 174 FGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~ 247 (630)
||+++...... .....+++.|++||.+.. .++.++|||||||++|+|++ |..||.. .+...++..+..+...
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~- 234 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL- 234 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC-
Confidence 99987553221 122345678999997754 57889999999999999999 8899976 4445555555544322
Q ss_pred CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 248 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 248 ~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
......+..+.+++.+||. +|.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2234567899999999997 89999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=296.57 Aligned_cols=235 Identities=20% Similarity=0.328 Sum_probs=182.8
Q ss_pred EecccCceEEEEEEEccC------------------------CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC
Q 006810 32 ILGKGAFKTVYKGFDEVD------------------------GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87 (630)
Q Consensus 32 ~LG~G~fg~Vy~A~d~~t------------------------G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN 87 (630)
.||+|+||.||+|....+ ...||+|.+.... ......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 489999999999975322 2468888875432 234466888999999999999
Q ss_pred eeEEEeEEEcCCCCEEEEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC
Q 006810 88 IIKFYNSWVDDTNRTINMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 165 (630)
Q Consensus 88 IVk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 165 (630)
|+++++++.+.. ..++||||+++|+|. ++. ..+.+++..+..++.||+.||+|||+++ |+||||||+||+++..
T Consensus 78 iv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 999999987653 578999999999998 443 3567899999999999999999999998 9999999999999721
Q ss_pred ------CCcEEEcccccceeeccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHh-hCCCCCCCCCCHHHH
Q 006810 166 ------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQI 236 (630)
Q Consensus 166 ------~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELl-tG~~Pf~~~~~~~~i 236 (630)
.+.+||+|||++...... ....+++.|+|||.+.+ .++.++|||||||++|||+ +|+.||.... +...
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-PSEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-hHHH
Confidence 234899999987543221 22357888999998754 4789999999999999995 6999997643 3332
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 237 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 237 ~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
........ .++....+.+.++|.+||. +|.+||++.++|++
T Consensus 231 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222211 1223345789999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=321.08 Aligned_cols=238 Identities=24% Similarity=0.409 Sum_probs=200.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
.+...+|.|+|+.|..+.+..++...++|++..... ...+|+.++... +||||+++++.+.+. ..+|+|
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~--------~~~~e~~~~~~~~~h~niv~~~~v~~~~--~~~~~v 394 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD--------DNQDEIPISLLVRDHPNIVKSHDVYEDG--KEIYLV 394 (612)
T ss_pred ccccccCCCCccceeeeeccccccchhheecccccc--------ccccccchhhhhcCCCcceeecceecCC--ceeeee
Confidence 456679999999999999999999999999975421 133566555444 899999999988554 569999
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 185 (630)
||++.||.+. .+...+.+. ..+..|++||+.|+.|||++| ||||||||+|||+.+..|+++|+|||.++..+.. .
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-C 470 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh-h
Confidence 9999999886 444444444 888899999999999999999 9999999999999547899999999999877665 3
Q ss_pred ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHc
Q 006810 186 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264 (630)
Q Consensus 186 ~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kc 264 (630)
.+.+-|..|.|||++.. +|++++||||||++||+|++|+.||....+..+++..+..+ .+....|..+|++|.+|
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~----~~s~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP----KFSECVSDEAKDLLQQL 546 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC----ccccccCHHHHHHHHHh
Confidence 34456889999998874 69999999999999999999999999877776777777654 33467899999999999
Q ss_pred cc-CCCCCCCHHHHhcCCCc
Q 006810 265 IV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 265 L~-~p~~Rpsa~eLL~hpf~ 283 (630)
|+ +|.+|+++.+++.||||
T Consensus 547 L~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCChhhCcChhhhccCcch
Confidence 98 99999999999999999
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=298.83 Aligned_cols=242 Identities=28% Similarity=0.476 Sum_probs=194.1
Q ss_pred eeeeEecccCceEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
+..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~~ 83 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---TI 83 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---Cc
Confidence 667889999999999999988776 46888775332 233445688999999999999999999988643 35
Q ss_pred EEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++++||+++|+|. ++..+ ..+++..+..|+.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEcccccccccc
Confidence 6899999999998 55443 46899999999999999999999998 99999999999997 78899999999997654
Q ss_pred cCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 182 QPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 182 ~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
... .....+++.|+|||.+. ..++.++|||||||++|||++ |..||.+. ........+..+..+ ..+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 238 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERL-PQPPICTI 238 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCC-CCCCCCCH
Confidence 321 12234567899999876 458899999999999999997 89999763 344455555544333 23445678
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+.++|.+|+. +|.+||++.+++..
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999997 89999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=292.24 Aligned_cols=238 Identities=27% Similarity=0.434 Sum_probs=190.1
Q ss_pred EecccCceEEEEEEEccCC------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEE
Q 006810 32 ILGKGAFKTVYKGFDEVDG------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 32 ~LG~G~fg~Vy~A~d~~tG------~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~l 105 (630)
.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeEE
Confidence 5899999999999876544 789999875432 123456788999999999999999999988654 45889
Q ss_pred EEcccCCCCHH-HHhh-------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC-----cEEEc
Q 006810 106 ITELFTSGSLR-YRKK-------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-----EVKIG 172 (630)
Q Consensus 106 V~Ey~~gGsL~-~~~~-------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g-----~vKL~ 172 (630)
||||+++|+|. ++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++ .++ .++|+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~~~~~~l~ 153 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVS-EKGYDADRVVKIG 153 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEe-cCCCCCCcceEEC
Confidence 99999999997 5432 234789999999999999999999998 99999999999998 555 89999
Q ss_pred ccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCC
Q 006810 173 DLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 246 (630)
Q Consensus 173 DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p 246 (630)
|||++....... .....+++.|+|||.+. +.++.++|||||||++|+|+| |..||... +.......+..+..+
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~ 232 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAGGRL 232 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-CHHHHHHHHhcCCcc
Confidence 999986543221 11234578899999776 458899999999999999998 99999764 444555555544322
Q ss_pred CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 247 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 247 ~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..+...+..+.++|.+||. +|.+||++.+++.
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 -QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2334567899999999997 8999999999865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=321.76 Aligned_cols=205 Identities=34% Similarity=0.539 Sum_probs=174.0
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC---
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~--- 99 (630)
.+-|. ..+.||+||||.||+++++.+|+.||+|.++... .....++.-+|+++|++|+|||||+++++=.+..
T Consensus 12 ~y~W~-~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 12 NYLWE-MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGL 87 (732)
T ss_pred Cccee-ehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCc
Confidence 35553 3689999999999999999999999999998654 3456677889999999999999999999643333
Q ss_pred -CCEEEEEEcccCCCCHH-HHh---hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe-CCCC--cEEE
Q 006810 100 -NRTINMITELFTSGSLR-YRK---KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNG--EVKI 171 (630)
Q Consensus 100 -~~~l~lV~Ey~~gGsL~-~~~---~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~-~~~g--~vKL 171 (630)
...-.+|||||.||+|+ .+. ...++++.++..++..+..||.|||++| |+||||||.||++. +.+| .-||
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEee
Confidence 23457899999999998 443 4568999999999999999999999999 99999999999985 3334 3699
Q ss_pred cccccceeeccC-CCccccCCCCCCCccccc--cccCcccceeehhHHHHHHhhCCCCCCCCCCH
Q 006810 172 GDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNP 233 (630)
Q Consensus 172 ~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~--~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~ 233 (630)
+|||.|+.+... ...+++||+.|.+||+++ +.|+..+|.|||||++|+.+||..||.....+
T Consensus 166 tDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 166 TDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999999987654 567889999999999998 46899999999999999999999999765444
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.30 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=211.8
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
+.||-|+||.|-++....|...||.|-+.+.++.. ..+...+..|-.||..-+.+.||++|.+|.|++ ++||||+|+
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDkd--nLYFVMdYI 711 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYFVMDYI 711 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--ceEEEEecc
Confidence 67999999999999999999999999998777654 456677888999999999999999999998775 599999999
Q ss_pred CCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec--------
Q 006810 111 TSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-------- 181 (630)
Q Consensus 111 ~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~-------- 181 (630)
+||++- .+.+-+-|.|..++.++.++..|+++.|..| +|||||||+||||+ .+|+|||.|||+.+-++
T Consensus 712 PGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 712 PGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred CCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeeccccccceeccccccc
Confidence 999998 7788889999999999999999999999999 99999999999998 89999999999974221
Q ss_pred -cC-----------------------------------CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCC
Q 006810 182 -QP-----------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 224 (630)
Q Consensus 182 -~~-----------------------------------~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~ 224 (630)
.. .....+||+.|+|||++. .+|+..+|.||.|||||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 00 011356999999999875 57999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcHHHHHHHHHcccCCCCCCC---HHHHhcCCCcccCCCCc
Q 006810 225 YPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKD 290 (630)
Q Consensus 225 ~Pf~~~~~~~~i~~~i~~g~~-p~~l~~~~s~~lk~~I~kcL~~p~~Rps---a~eLL~hpf~~~~~~~~ 290 (630)
+||......+..++.+.-... ....-...++++.++|.++...+..|.. ++++-.||||+..++..
T Consensus 869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHh
Confidence 999886555544443322111 1223345789999999998887777764 67899999999887655
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=330.06 Aligned_cols=242 Identities=24% Similarity=0.404 Sum_probs=198.3
Q ss_pred eeeeEecccCceEEEEEEEccC-C----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVD-G----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~t-G----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.+.+.||+|+||.||.|..... | ..||+|.+... .+.+....|.+|..+|+.++|||||+++++.++. ..
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--~~ 769 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--GP 769 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--CC
Confidence 5679999999999999976543 3 24888877533 3467778899999999999999999999998874 34
Q ss_pred EEEEEcccCCCCHH-HHhhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 103 INMITELFTSGSLR-YRKKH-------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~-------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
.++++|||++|+|. +++.. ..++...+..++.||++|++||++++ +|||||.+.|+|++ ..+.|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~-~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLD-ERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeec-ccCcEEEccc
Confidence 77899999999998 66554 46899999999999999999999999 99999999999998 6799999999
Q ss_pred ccceeeccCCCcc----ccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006810 175 GLAIVMQQPTARS----VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 248 (630)
Q Consensus 175 Gla~~~~~~~~~~----~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 248 (630)
|+|+......-.. ..-...|||||.+. +.++.++|||||||++||++| |..||....+.+.+......| .-.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--RL~ 924 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--RLD 924 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--ccC
Confidence 9998433221111 11235799999876 679999999999999999999 889998865555554455555 334
Q ss_pred CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 249 LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 249 l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+..++..+-+++..||. +|.+||+...|++
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 566778888899999997 8999999999988
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=323.06 Aligned_cols=240 Identities=25% Similarity=0.386 Sum_probs=197.3
Q ss_pred eeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 28 RYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~-----tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
++.+.||+|+||.||+|.... ....||||.++-.. +.+..+.|.+|+.+|..|+|||||++++++... +.
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--~P 563 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCREG--DP 563 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC--Ce
Confidence 456889999999999996532 34579999986432 344678899999999999999999999988654 46
Q ss_pred EEEEEcccCCCCHH-HHhhc----------C----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC
Q 006810 103 INMITELFTSGSLR-YRKKH----------K----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 167 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~----------~----~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 167 (630)
++||+|||..|+|. +++.+ . +++..+...++.||+.|+.||-++. +|||||...|+||. .+-
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg-e~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG-ENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec-cce
Confidence 99999999999997 55432 1 2888999999999999999999999 99999999999996 889
Q ss_pred cEEEcccccceeeccCCCc----cccCCCCCCCcc-ccccccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHH
Q 006810 168 EVKIGDLGLAIVMQQPTAR----SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 241 (630)
Q Consensus 168 ~vKL~DFGla~~~~~~~~~----~~~GTp~Y~APE-vl~~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~ 241 (630)
.|||+|||+++..-...-. ...-..+||||| ++.++|++++|||||||+|||+++ |..||.+..|.+ ..+.++
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-VIe~i~ 719 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-VIECIR 719 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-HHHHHH
Confidence 9999999999744222111 112256899999 566889999999999999999999 899999866655 456666
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHH
Q 006810 242 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL 277 (630)
Q Consensus 242 ~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eL 277 (630)
.|.. -.-+...+.++.+++..|++ .|.+||+.+|+
T Consensus 720 ~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 720 AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 6655 44567788999999999998 79999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=318.46 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=174.6
Q ss_pred CcceeeeeEecccCceEEEEEEEccC----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc--
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVD----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD-- 97 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~t----G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d-- 97 (630)
++| .+.+.||+|+||.||+|.+..+ |..||+|.+.... .. +....+ .++...+.++..+...|..
T Consensus 132 ~~y-~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 132 DDF-VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AV--EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CCe-EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hh--HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 345 7789999999999999999998 9999999875321 11 111111 1222233333333322211
Q ss_pred --CCCCEEEEEEcccCCCCHH-HHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEecc
Q 006810 98 --DTNRTINMITELFTSGSLR-YRKKHK--------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 154 (630)
Q Consensus 98 --~~~~~l~lV~Ey~~gGsL~-~~~~~~--------------------~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrD 154 (630)
.....+++|+||+.+++|. ++.... ......+..++.||+.||.|||+++ |+|||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRD 280 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRD 280 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCc
Confidence 3345789999999999997 333221 1123457789999999999999998 99999
Q ss_pred CCcCceEEeCCCCcEEEcccccceeeccC---CCccccCCCCCCCcccccc-----------------------ccCccc
Q 006810 155 LKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE-----------------------EYNELV 208 (630)
Q Consensus 155 LKp~NILl~~~~g~vKL~DFGla~~~~~~---~~~~~~GTp~Y~APEvl~~-----------------------~ys~~s 208 (630)
|||+|||++..++.+||+|||+++.+... ....+++||.|||||.+.. .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 99999999855789999999999755332 2345789999999996531 234567
Q ss_pred ceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC----------CC---CC------CCCCCcHHHHHHHHHccc-CC
Q 006810 209 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------KP---AS------LSKVTDPQVKQFIEKCIV-PA 268 (630)
Q Consensus 209 DIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~----------~p---~~------l~~~~s~~lk~~I~kcL~-~p 268 (630)
|||||||++|||+++..|+.. +..+....+.... .+ .. .....+....+||.+||+ +|
T Consensus 361 DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999999998766542 2233322222110 00 00 011123345689999998 89
Q ss_pred CCCCCHHHHhcCCCcccCCCC
Q 006810 269 SLRLPALELLKDPFLVTDNPK 289 (630)
Q Consensus 269 ~~Rpsa~eLL~hpf~~~~~~~ 289 (630)
.+|||+.++|+||||+.....
T Consensus 439 ~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 439 RQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred ccCCCHHHHhCCcCcCCCCcc
Confidence 999999999999999876543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=275.07 Aligned_cols=239 Identities=34% Similarity=0.593 Sum_probs=201.9
Q ss_pred CceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCCCCHH
Q 006810 37 AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR 116 (630)
Q Consensus 37 ~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~ 116 (630)
+||.||+|.+..+|..||+|++...... ...+.+.+|++.+++++|+||+++++++... ...++++||+.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHH
Confidence 6899999999999999999998754321 1157789999999999999999999988654 4688999999999998
Q ss_pred -HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-CCccccCCCCC
Q 006810 117 -YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEF 194 (630)
Q Consensus 117 -~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-~~~~~~GTp~Y 194 (630)
++.....++...+..++.+++.+|.|||+.+ ++|+||+|+||+++ .++.++|+|||.+...... ......+++.|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLD-EDGHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEEC-CCCcEEEccccceeeeccccccccccCCcCC
Confidence 5555555999999999999999999999998 99999999999998 6799999999999766543 34456789999
Q ss_pred CCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC-CcHHHHHHHHHccc-CCCCC
Q 006810 195 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV-TDPQVKQFIEKCIV-PASLR 271 (630)
Q Consensus 195 ~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~-~s~~lk~~I~kcL~-~p~~R 271 (630)
+|||.+. ..++.++||||||+++++|++|..||....+...+...+..+......... .+..+.+++.+||. +|.+|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999775 458889999999999999999999998756667777766655443322221 67899999999997 89999
Q ss_pred CCHHHHhcCCCc
Q 006810 272 LPALELLKDPFL 283 (630)
Q Consensus 272 psa~eLL~hpf~ 283 (630)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=292.02 Aligned_cols=247 Identities=28% Similarity=0.437 Sum_probs=203.7
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHH-HHhCCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~i-L~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
..||.|+||+|++..++.+|+..|+|+|.... ...+..+++.|.+. ++.-+.||||+||+..+.+.. .|+.||+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--cWiCMEL 144 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--CWICMEL 144 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--eeeeHHH
Confidence 46999999999999999999999999998654 34566778888875 455689999999998776544 6778899
Q ss_pred cCCCCHH------HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 110 FTSGSLR------YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 110 ~~gGsL~------~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
|+- +|+ |-.+...++|..+-.+.--++.||.||...- .|||||+||+|||++ ..|.|||||||++..+...
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILld-r~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLD-RHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEe-cCCCEeeecccchHhHHHH
Confidence 975 343 3356778999999999999999999997642 399999999999998 7899999999999877665
Q ss_pred CCccc-cCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-C---CCcH
Q 006810 184 TARSV-IGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-K---VTDP 255 (630)
Q Consensus 184 ~~~~~-~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~-~---~~s~ 255 (630)
.+.+. .|-..|||||.+.. +|+.++|+||||++|||++||.+||....+..+....+..|-+|.-.. . ..+.
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 54443 68889999998853 499999999999999999999999988766665666666665554322 1 2578
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.++.||.-||. +.+.||...+|+++||++.
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 99999999997 7899999999999999975
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=317.46 Aligned_cols=265 Identities=28% Similarity=0.496 Sum_probs=228.9
Q ss_pred cCCccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEe
Q 006810 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 93 (630)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~ 93 (630)
..++...+|.-.|+- ...+|.|.||.||+|+|+.+|+..|+|.|+++.. +...-+.+|+-+++.++|||||.||+
T Consensus 5 ~~disrrnP~ddyel-lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~----dd~~~iqqei~~~~dc~h~nivay~g 79 (829)
T KOG0576|consen 5 KSDISRRNPQDDYEL-LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG----DDFSGIQQEIGMLRDCRHPNIVAYFG 79 (829)
T ss_pred cchhhhcCCccchhh-eeeecCCcccchhhhcccccCchhhheeeeccCC----ccccccccceeeeecCCCcChHHHHh
Confidence 456677799999954 5779999999999999999999999999998753 34456788999999999999999999
Q ss_pred EEEcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEc
Q 006810 94 SWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172 (630)
Q Consensus 94 ~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 172 (630)
.|...+. +|+.||||.+|+|. ...-.+.+++.++...++..++||+|||+.+ -+|||||-.||+++ ..|.+|++
T Consensus 80 sylr~dk--lwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvkla 154 (829)
T KOG0576|consen 80 SYLRRDK--LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLA 154 (829)
T ss_pred hhhhhcC--cEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeec
Confidence 9976654 88899999999998 5567889999999999999999999999999 89999999999998 89999999
Q ss_pred ccccceeeccC--CCccccCCCCCCCcccc----ccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC
Q 006810 173 DLGLAIVMQQP--TARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 246 (630)
Q Consensus 173 DFGla~~~~~~--~~~~~~GTp~Y~APEvl----~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p 246 (630)
|||.+..+... ..++++|||.|||||+- .+.|+.++|||++|+.+.|+...++|.........++-..+++..|
T Consensus 155 Dfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp 234 (829)
T KOG0576|consen 155 DFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP 234 (829)
T ss_pred ccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC
Confidence 99999776654 45689999999999974 3679999999999999999999999977655555566666677777
Q ss_pred CCCCC--CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 247 ASLSK--VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 247 ~~l~~--~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+.+.. ..++.+.+|++.+|. .|.+||+++.+|.|||......
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~ 279 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLS 279 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchh
Confidence 66543 367899999999997 7999999999999999976533
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=290.82 Aligned_cols=265 Identities=23% Similarity=0.355 Sum_probs=205.3
Q ss_pred CccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEE
Q 006810 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (630)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f 95 (630)
.+.-.+..+.|.|+ ..||+|.||.||+|..+.+|+.||+|++..+.-. ...-....+|+++|..|+|+|++.+++.+
T Consensus 9 ~~P~~~~~~~yek~-~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK--eGfpitalreikiL~~lkHenv~nliEic 85 (376)
T KOG0669|consen 9 YEPFCDEVSKYEKL-AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEIC 85 (376)
T ss_pred cCCceecchHHHHH-HhcCCchHHHHHHHhhcCccchhHHHHHHHhccc--cCCcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence 34456677788775 6699999999999999999999999988653311 12234577999999999999999887654
Q ss_pred Ec------CCCCEEEEEEcccCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc
Q 006810 96 VD------DTNRTINMITELFTSGSLRYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 168 (630)
Q Consensus 96 ~d------~~~~~l~lV~Ey~~gGsL~~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 168 (630)
-. .....+|+|+.+|+....-.+.. ..+++..++++++++++.||.|+|... |+|||+||.|+||+ .+|.
T Consensus 86 ~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt-~dgi 162 (376)
T KOG0669|consen 86 RTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLIT-KDGI 162 (376)
T ss_pred hhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEc-CCce
Confidence 22 22346999999999854444433 368999999999999999999999999 99999999999998 7899
Q ss_pred EEEcccccceeeccCCC------ccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 006810 169 VKIGDLGLAIVMQQPTA------RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 240 (630)
Q Consensus 169 vKL~DFGla~~~~~~~~------~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i 240 (630)
+||+|||+++.+..... ...+.|.+|++||.+-+ .|+++.|||..|||+.||+|+.+-+.+..+..++..+-
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 99999999976543221 12345999999997754 69999999999999999999999998755544432211
Q ss_pred --HcCCCCCC-----------------C-------------CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 241 --TSGIKPAS-----------------L-------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 241 --~~g~~p~~-----------------l-------------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.....+.. + +-+.++++.++++++|. ||.+|+.+.++|+|.||.++
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 11111100 1 11235688999999998 99999999999999999764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=273.02 Aligned_cols=257 Identities=21% Similarity=0.376 Sum_probs=210.1
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEE
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWV 96 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~ 96 (630)
+..--...| .+.+.+|+|-|+.||.|+...+.+.+++|+++.- ...++.+|+++|+.|. |||||+++++..
T Consensus 32 i~wg~~ddY-eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-------kkkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 32 IDWGNQDDY-EIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-------KKKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred eeccccchH-HHHHHHcCccHhhHhcccccCCCceEEEeeechH-------HHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 333344445 4557899999999999999999999999998743 3466999999999997 999999999988
Q ss_pred cCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 97 DDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
+.......+|+||+.+.+.+. -...++...++.++.|++.||.|||+.| |+|||+||.|++|+.....++|+|+|+
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~--ly~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQ--LYPTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred CccccCchhHhhhhccccHHH--HhhhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecch
Confidence 888888889999999887662 3456888899999999999999999999 999999999999997788999999999
Q ss_pred ceeeccCCCcc-ccCCCCCCCccccc--cccCcccceeehhHHHHHHhhCCCCC-CCCCCHHHHHHHHHc----------
Q 006810 177 AIVMQQPTARS-VIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTS---------- 242 (630)
Q Consensus 177 a~~~~~~~~~~-~~GTp~Y~APEvl~--~~ys~~sDIWSLGvil~ELltG~~Pf-~~~~~~~~i~~~i~~---------- 242 (630)
|..+....... .+.+..|--||++- ..|+..-|+|||||++..|+..+-|| .+..|.+|++++..-
T Consensus 180 AEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 180 AEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred HhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 98776654333 34577788999775 46999999999999999999988775 556777887665431
Q ss_pred -----CCCC-------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 243 -----GIKP-------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 243 -----g~~p-------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
...| ..-....++++.+|+.++|. |-.+|+||.|++.||||...
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 0000 11112346999999999998 89999999999999999753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=281.77 Aligned_cols=261 Identities=18% Similarity=0.323 Sum_probs=211.7
Q ss_pred ceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEE
Q 006810 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~ 104 (630)
-+++.++||+|+|+.|.++..+.|.+.+|+|+++.+-+ +..+.++-...|-.+..+- +||.+|-++..|..+ .+++
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~-nddedidwvqtek~vfe~asn~pflvglhscfqte--srlf 327 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE--SRLF 327 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhc-CCcccchhHHhhHHHHHhccCCCeEEehhhhhccc--ceEE
Confidence 35788999999999999999999999999999986544 4445566677788877666 899999999998655 5699
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee--c
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--Q 181 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~--~ 181 (630)
+|.||++||+|- ......+++++.++.+...|..||.|||++| ||.||||.+|+|++ ..|++||.|+|+.+.- .
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlld-aeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEc-cCCceeecccchhhcCCCC
Confidence 999999999997 7778889999999999999999999999999 99999999999998 7899999999998643 2
Q ss_pred cCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCC--CC-----CHHHHHHHHHcCCCCCCCCCCC
Q 006810 182 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNE--CK-----NPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 182 ~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~--~~-----~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
.....+++|||.|.|||++.+ .|+..+|.|+||++++||+.|+.||.- .. +.+-+++.+..... .++...
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--riprsl 482 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPRSL 482 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--ccccee
Confidence 335668999999999999986 599999999999999999999999952 22 23345555554322 233334
Q ss_pred cHHHHHHHHHccc-CCCCCCC------HHHHhcCCCcccCCCCccccC
Q 006810 254 DPQVKQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPKDLVCD 294 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rps------a~eLL~hpf~~~~~~~~~~~~ 294 (630)
+-.+..+++..|. +|.+|.. ..++-.|+||+..+|.-+..+
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk 530 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQK 530 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhc
Confidence 4455666677675 7887764 578899999998887655433
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=295.40 Aligned_cols=248 Identities=26% Similarity=0.472 Sum_probs=201.6
Q ss_pred cCCCCcceeee-------eEecccCceEEEEEEEcc----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCe
Q 006810 20 KDPSCRYGRYD-------EILGKGAFKTVYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88 (630)
Q Consensus 20 ~dp~gRy~r~~-------e~LG~G~fg~Vy~A~d~~----tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI 88 (630)
..|.+|-|++. +.||.|-||.||+|.... ....||+|..+... ..+..+.|..|.-+|++++||||
T Consensus 377 ~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphI 453 (974)
T KOG4257|consen 377 STPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHI 453 (974)
T ss_pred cCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcch
Confidence 45788887774 679999999999997643 23468888776443 35567889999999999999999
Q ss_pred eEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCC
Q 006810 89 IKFYNSWVDDTNRTINMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 166 (630)
Q Consensus 89 Vk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~ 166 (630)
|++++++.+. .+|+|||+++-|.|+ |+..+ ..++......++.||..||+|||+.. +|||||...|||+. ..
T Consensus 454 ikLIGv~~e~---P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVs-Sp 527 (974)
T KOG4257|consen 454 IKLIGVCVEQ---PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVS-SP 527 (974)
T ss_pred hheeeeeecc---ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeec-Cc
Confidence 9999998654 489999999999999 77655 46999999999999999999999999 99999999999997 66
Q ss_pred CcEEEcccccceeeccCCC---ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHH
Q 006810 167 GEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 241 (630)
Q Consensus 167 g~vKL~DFGla~~~~~~~~---~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~ 241 (630)
..|||+|||+++.+....- ....-..-|||||-+. ..++.++|||-||+|+||++. |..||.+-.|.+.+.. +.
T Consensus 528 ~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-iE 606 (974)
T KOG4257|consen 528 QCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-IE 606 (974)
T ss_pred ceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-ec
Confidence 7999999999987655421 1111234699999665 679999999999999999876 8899998776665533 33
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHh
Q 006810 242 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 278 (630)
Q Consensus 242 ~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL 278 (630)
.|. ..+.+..++|.+-.++.+||+ +|.+||...++-
T Consensus 607 nGe-RlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 607 NGE-RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred CCC-CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 332 234567788999999999998 899999988754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=285.38 Aligned_cols=257 Identities=20% Similarity=0.368 Sum_probs=199.5
Q ss_pred ccccCC-CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--C----Cee
Q 006810 17 FSEKDP-SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--E----NII 89 (630)
Q Consensus 17 ~~e~dp-~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H--p----NIV 89 (630)
+...|- .+|| .+...||+|.||.|-.+.|..++..||+|+++-- ....+...-|+++|.++.+ | -+|
T Consensus 81 ~~~gD~l~~Ry-~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 81 YQVGDILTNRY-EIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred EEeccccccce-ehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 444454 7788 6678999999999999999999999999998622 3445667789999999943 2 356
Q ss_pred EEEeEEEcCCCCEEEEEEcccCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC---
Q 006810 90 KFYNSWVDDTNRTINMITELFTSGSLRYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--- 164 (630)
Q Consensus 90 k~~~~f~d~~~~~l~lV~Ey~~gGsL~~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--- 164 (630)
.+.++| +-...+++|+|.+...+.+++..+ .+++..+++.+++|++.+++|||+.+ ++|-||||+|||+..
T Consensus 155 ~m~~wF--dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 155 QMRDWF--DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEY 230 (415)
T ss_pred eeehhh--hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccce
Confidence 666665 234568899999866566666654 46899999999999999999999999 999999999999831
Q ss_pred ----------------CCCcEEEcccccceeeccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCC
Q 006810 165 ----------------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY 227 (630)
Q Consensus 165 ----------------~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf 227 (630)
.+-.|+|+|||.|+...... .+.+.|..|.|||++-+ +++..+||||+||||+||.||...|
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 13468999999998665543 56678999999998765 7999999999999999999999999
Q ss_pred CCCCCHHHH--HHHHHcCCCCC-----------------CCC----------------------CCC---cHHHHHHHHH
Q 006810 228 NECKNPAQI--YKKVTSGIKPA-----------------SLS----------------------KVT---DPQVKQFIEK 263 (630)
Q Consensus 228 ~~~~~~~~i--~~~i~~g~~p~-----------------~l~----------------------~~~---s~~lk~~I~k 263 (630)
....+.+.+ ++.+.. ..|. .++ ... ..++.+||++
T Consensus 310 qtHen~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred ccCCcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 876665533 222221 1110 000 001 1357899999
Q ss_pred ccc-CCCCCCCHHHHhcCCCccc
Q 006810 264 CIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 264 cL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
||. ||++|+|+.|+|.||||..
T Consensus 389 mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HHccCccccccHHHHhcCHHhhc
Confidence 998 9999999999999999975
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=294.10 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=181.0
Q ss_pred CCcceeeeeEecccCceEEEEEEEc----------------cCCeEEEEEEeecccccCCHH----------HHHHHHHH
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDE----------------VDGIEVAWNQVNIEDVMQSPD----------QLERLYSE 76 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~----------------~tG~~VAiK~i~~~~~~~~~~----------~~~~l~~E 76 (630)
...| ++.++||+|+||+||+|.+. ..+..||+|.+.........+ ..+....|
T Consensus 144 ~d~F-~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 144 SDDF-QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred ccCc-eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3345 77899999999999999752 345689999986532110000 11223357
Q ss_pred HHHHHhCCCCCe-----eEEEeEEEcC------CCCEEEEEEcccCCCCHH-HHhhc-----------------------
Q 006810 77 VHLLKSLKHENI-----IKFYNSWVDD------TNRTINMITELFTSGSLR-YRKKH----------------------- 121 (630)
Q Consensus 77 i~iL~~L~HpNI-----Vk~~~~f~d~------~~~~l~lV~Ey~~gGsL~-~~~~~----------------------- 121 (630)
+.++.+++|.++ ++++++|... .....++|+||+++|+|. ++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888877655 5677766432 123578999999999996 33211
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC-Cc--cccCCCCCCCc
Q 006810 122 -KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-AR--SVIGTPEFMAP 197 (630)
Q Consensus 122 -~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~-~~--~~~GTp~Y~AP 197 (630)
..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....... .. ...+||.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12456788999999999999999998 99999999999998 77899999999996543321 11 22458999999
Q ss_pred cccccc---------------------cC--cccceeehhHHHHHHhhCCC-CCCCCCCH----------HHHHHHHHcC
Q 006810 198 ELYEEE---------------------YN--ELVDIYSFGMCILEMVTCEY-PYNECKNP----------AQIYKKVTSG 243 (630)
Q Consensus 198 Evl~~~---------------------ys--~~sDIWSLGvil~ELltG~~-Pf~~~~~~----------~~i~~~i~~g 243 (630)
|++... |+ .+.||||+||++|+|++|.. ||...... ...+..+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 976421 22 34799999999999999985 77532111 1111112222
Q ss_pred CCCCCCCCCCcHHHHHHHHHccc-CC---CCCCCHHHHhcCCCccc
Q 006810 244 IKPASLSKVTDPQVKQFIEKCIV-PA---SLRLPALELLKDPFLVT 285 (630)
Q Consensus 244 ~~p~~l~~~~s~~lk~~I~kcL~-~p---~~Rpsa~eLL~hpf~~~ 285 (630)
..........++..++||.+||. +| .+|+|+.|+|.||||..
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 11222234467899999999997 33 68999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=278.19 Aligned_cols=253 Identities=28% Similarity=0.408 Sum_probs=204.6
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC--
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~-- 100 (630)
..||..+ ..+|.|+- .|-.|+|..++..||+|.+... ........+.++|..++..++|+||++++.+|.....
T Consensus 16 ~~Ry~nL-~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 16 PKRYVNL-KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeee-cccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 4577554 77999998 8899999999999999998655 3334556789999999999999999999999865432
Q ss_pred --CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 101 --RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+|+|||||....-..+. -.++-..+..++.|++.|+.|||+.+ |+||||||+||+++ ..+.+||.|||+|+
T Consensus 92 ~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~-~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 92 EFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDFGLAR 166 (369)
T ss_pred HHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceec-chhheeeccchhhc
Confidence 3588999999875544433 45778899999999999999999999 99999999999998 78999999999998
Q ss_pred eeccC-CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-------------
Q 006810 179 VMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG------------- 243 (630)
Q Consensus 179 ~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g------------- 243 (630)
..... ....++.|..|.|||++- ..|.+.+||||+||++.||++|...|.+....+|..+.+..-
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 66555 345567899999999764 459999999999999999999999998755555544443210
Q ss_pred -------------------CCCC-CC------CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 244 -------------------IKPA-SL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 244 -------------------~~p~-~l------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
..|. .+ .+.....+++++.+||+ +|.+|.++.++|+|||++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0010 01 12234578999999997 999999999999999997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=291.52 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=199.1
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC------CCeeEEEeEEE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH------ENIIKFYNSWV 96 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H------pNIVk~~~~f~ 96 (630)
.+|| .+.-..|+|-|++|.+|.|...|.+||||+|...+++. ..=+.|+.+|++|+. -++++++..|.
T Consensus 431 D~RY-~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 431 DSRY-EVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-----KTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred ccee-EEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 3455 44456899999999999999999999999998655443 234579999999953 48889988875
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHhhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEc
Q 006810 97 DDTNRTINMITELFTSGSLR-YRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~~~---~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 172 (630)
- ...+|||+|.+.- .|+ .+++. -.|.+.+++.++.|++.||..|-.+| |+|.||||+||||+.....+|||
T Consensus 505 h--knHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 505 H--KNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred h--cceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeec
Confidence 3 4569999998765 455 56554 45899999999999999999999999 99999999999999777789999
Q ss_pred ccccceeeccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHH-HcCCCCC---
Q 006810 173 DLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV-TSGIKPA--- 247 (630)
Q Consensus 173 DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i-~~g~~p~--- 247 (630)
|||.|..........+..+..|.|||++-+ .|+...|+||.||+||||.||+..|.+.+|...+.-.. ..|..|.
T Consensus 580 DfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 580 DFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 999998777666655666789999998766 69999999999999999999999999877655442111 1111110
Q ss_pred ----------------------------------------CCC-------CCC------cHHHHHHHHHccc-CCCCCCC
Q 006810 248 ----------------------------------------SLS-------KVT------DPQVKQFIEKCIV-PASLRLP 273 (630)
Q Consensus 248 ----------------------------------------~l~-------~~~------s~~lk~~I~kcL~-~p~~Rps 273 (630)
.+. ... -.++++|+.+||. +|.+|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 000 000 1368999999997 9999999
Q ss_pred HHHHhcCCCccc
Q 006810 274 ALELLKDPFLVT 285 (630)
Q Consensus 274 a~eLL~hpf~~~ 285 (630)
..++|+||||+.
T Consensus 740 ~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQALKHPFITE 751 (752)
T ss_pred HHHHhcCCcccC
Confidence 999999999974
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=289.19 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=200.6
Q ss_pred CccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEE
Q 006810 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (630)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f 95 (630)
..+.+-|..+- ++++.||+|-||.|.++.-. .+..||+|.++.... ......|.+|+++|.+|+|||||++++++
T Consensus 530 ~al~EfPRs~L-~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~---~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 530 PALVEFPRSRL-RFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT---KNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred cchhhcchhhe-ehhhhhcCcccceeEEEEec-CceEEEEeecCcccc---hhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 34455566565 77899999999999999543 369999999876542 34567799999999999999999999999
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEc
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 172 (630)
+.++ .+++||||++.|+|+ ++..+. ...-....++|.||+.|++||.+.+ +|||||.+.|+|++ .++++||+
T Consensus 605 ~~De--PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~-~e~~iKia 679 (807)
T KOG1094|consen 605 VQDD--PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVD-GEFTIKIA 679 (807)
T ss_pred ecCC--chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeec-CcccEEec
Confidence 7664 589999999999999 777774 3345566779999999999999999 99999999999998 78999999
Q ss_pred ccccceeeccCCC----ccccCCCCCCCcc-ccccccCcccceeehhHHHHHHhh--CCCCCCCCCCHHHHHHHHHc---
Q 006810 173 DLGLAIVMQQPTA----RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTS--- 242 (630)
Q Consensus 173 DFGla~~~~~~~~----~~~~GTp~Y~APE-vl~~~ys~~sDIWSLGvil~ELlt--G~~Pf~~~~~~~~i~~~i~~--- 242 (630)
|||+++-+-...- ...+-..+||||| ++.++++.++|+|+||+++||+++ .+.||+... .+++.+....
T Consensus 680 dfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-~e~vven~~~~~~ 758 (807)
T KOG1094|consen 680 DFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-DEQVVENAGEFFR 758 (807)
T ss_pred CcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-HHHHHHhhhhhcC
Confidence 9999974433221 1233467899999 667899999999999999999776 779998754 4444443332
Q ss_pred CCCC---CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 243 GIKP---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 243 g~~p---~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
...+ ...+...+..+.+++.+|+. +..+|||.++|-.
T Consensus 759 ~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 759 DQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1111 22345677889999999997 8899999999743
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=293.10 Aligned_cols=255 Identities=25% Similarity=0.430 Sum_probs=208.7
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccC-C--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVD-G--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~t-G--~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
|.+.. ++.|.||+|.||+|++|.++.. | ..||+|.+...... ..+..|++|+.+|.+|+|||+|++|++..+.
T Consensus 108 pee~i-~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~q 183 (1039)
T KOG0199|consen 108 PEEQI-KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLDQ 183 (1039)
T ss_pred cHHHH-HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeeccc
Confidence 44433 4558899999999999977643 3 57999999765542 2677899999999999999999999987763
Q ss_pred CCCEEEEEEcccCCCCHH-HHh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 99 TNRTINMITELFTSGSLR-YRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
-+.||+|+++.|+|. .+. ....|....+..++.||+.|+.||.+++ +|||||...|+++- .-..|||+|||
T Consensus 184 ---p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNllla-sprtVKI~DFG 257 (1039)
T KOG0199|consen 184 ---PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLA-SPRTVKICDFG 257 (1039)
T ss_pred ---hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheec-ccceeeeeccc
Confidence 488999999999996 333 3556889999999999999999999999 99999999999997 57799999999
Q ss_pred cceeeccCCCccccC-----CCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006810 176 LAIVMQQPTARSVIG-----TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 248 (630)
Q Consensus 176 la~~~~~~~~~~~~G-----Tp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 248 (630)
+.+.+.........+ ...|+|||.++ ..++.++|+|+|||++|||+| |+.||.++ ...+|.+.+..+.. ..
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~er-Lp 335 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGER-LP 335 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhcccccc-CC
Confidence 998876654433332 34699999776 579999999999999999999 88999984 67888888875533 33
Q ss_pred CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 249 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 249 l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
-++.++..+-+++..||. .|.+||+...|...-++....+
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp 376 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQP 376 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCC
Confidence 456788999999999998 8999999999876655554433
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-33 Score=275.80 Aligned_cols=251 Identities=27% Similarity=0.457 Sum_probs=201.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC---CEEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINMIT 107 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~---~~l~lV~ 107 (630)
+.||.|+||+||.+.|..+|+.||+|++. ...++-....++.+|+++|..++|.|++...+......- ..+|+|+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 77999999999999999999999999874 333444556789999999999999999998886543322 2478899
Q ss_pred cccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC---
Q 006810 108 ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--- 184 (630)
Q Consensus 108 Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~--- 184 (630)
|++.+..-+.+..-..++...++-++.||+.||.|||+.+ |.||||||.|+|++ .|..+||||||+++......
T Consensus 137 ELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 137 ELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVN-SNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEec-cCceEEecccccccccchhhhhh
Confidence 9998865567778889999999999999999999999999 99999999999998 78899999999998765432
Q ss_pred CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc--------------------
Q 006810 185 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------------- 242 (630)
Q Consensus 185 ~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-------------------- 242 (630)
....+-|..|+|||++.+ .|+.++||||.|||+.||+..+..|.. .++.+....|+.
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA-q~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA-AGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc-cChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 223356889999998875 599999999999999999999999976 444444333321
Q ss_pred ----CCCCCCCCC---C-----CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 243 ----GIKPASLSK---V-----TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 243 ----g~~p~~l~~---~-----~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+.+++.+.. . ...+...++.++|. +|.+|.+..+.+.|+++....
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 223333321 1 22456677777787 899999999999999987644
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=256.09 Aligned_cols=208 Identities=27% Similarity=0.464 Sum_probs=177.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
+.||+|+||.|-+.++..+|...|+|.+...- +.+...++++|+.+.... ..|.+|.||+.+.+..+ +|+.||.
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd--vwIcME~ 126 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD--VWICMEL 126 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc--EEEeHHH
Confidence 46999999999999999999999999997542 245567788899876554 89999999998876654 8888999
Q ss_pred cCCCCHH-----HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC
Q 006810 110 FTSGSLR-----YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 184 (630)
Q Consensus 110 ~~gGsL~-----~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 184 (630)
|.- +|+ .+++.+.++|..+-+++..++.||.|||++= .+||||+||.|||++ ..|+|||||||++..+....
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILIN-YDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEc-cCCcEEEcccccceeehhhh
Confidence 875 443 3467788999999999999999999999973 499999999999998 89999999999998887776
Q ss_pred Ccc-ccCCCCCCCcccccc-----ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC
Q 006810 185 ARS-VIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 246 (630)
Q Consensus 185 ~~~-~~GTp~Y~APEvl~~-----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p 246 (630)
+.+ -.|-..|||||.+.. .|+.++||||||++++||+++++||....++.+..+.+.....|
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 665 468889999998752 58999999999999999999999999988998888888776444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=300.06 Aligned_cols=241 Identities=27% Similarity=0.395 Sum_probs=186.5
Q ss_pred eeEecccCceE-EEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 30 DEILGKGAFKT-VYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 30 ~e~LG~G~fg~-Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+++|.|+-|+ ||+|. ..|++||+|.+-. .......+||.+|+.. +|||||+||. .+.+...+|+..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-------e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIal 582 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLE-------EFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIAL 582 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhh-------HhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEe
Confidence 47899999986 79995 4588999998742 2334578999999998 6999999999 456667899999
Q ss_pred cccCCCCHHHHhhc-CCC---CHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC----CCcEEEccccccee
Q 006810 108 ELFTSGSLRYRKKH-KNV---DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----NGEVKIGDLGLAIV 179 (630)
Q Consensus 108 Ey~~gGsL~~~~~~-~~l---se~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~----~g~vKL~DFGla~~ 179 (630)
|+|....-+++... ..+ .....+..+.|++.||++||+.+ ||||||||+||||... ...++|.|||+++.
T Consensus 583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 99987443455543 111 11345788999999999999999 9999999999999852 24789999999987
Q ss_pred eccC-----CCccccCCCCCCCccccccc-cCcccceeehhHHHHHHhhC-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006810 180 MQQP-----TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLSKV 252 (630)
Q Consensus 180 ~~~~-----~~~~~~GTp~Y~APEvl~~~-ys~~sDIWSLGvil~ELltG-~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~ 252 (630)
+... ......||-+|+|||++... -..++|||||||++|+.++| .+||.. +-+....++........+...
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--~~~R~~NIl~~~~~L~~L~~~ 738 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--SLERQANILTGNYTLVHLEPL 738 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--hHHhhhhhhcCccceeeeccC
Confidence 6543 23356799999999998754 46689999999999999996 899975 333333334333333334344
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.+.+++++|.+||. +|..||+|.++|.||||=.
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 44489999999998 8999999999999999943
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=292.78 Aligned_cols=245 Identities=25% Similarity=0.444 Sum_probs=204.2
Q ss_pred ceeeeeEecccCceEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 26 YGRYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~A~d~~tG---~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
|.+++++||.|.||.|++|.-+..| ..||||.++.. ..+.+...|+.|+.||-+++||||+++.++.. ..+.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G---ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT--ks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG---YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT--KSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccC---ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe--cCce
Confidence 6688999999999999999888776 57999988743 35677888999999999999999999999753 3457
Q ss_pred EEEEEcccCCCCHH-H-HhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 103 INMITELFTSGSLR-Y-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~-~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
+++|+|||++|+|+ + +...+.|+..++..+++-|+.|+.||-+.+ +|||||.+.||||+ .+-..|++|||+++.+
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVN-snLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVL 781 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeec-cceEEEeccccceeec
Confidence 99999999999998 4 455678999999999999999999999999 99999999999998 7889999999999987
Q ss_pred ccCCC--ccccC---CCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 181 QQPTA--RSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 181 ~~~~~--~~~~G---Tp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
..... .+..| ..+|.|||.+. ++++.++|||||||+|||.+. |+.||-+..|.+.+ +.|..+...+ .+-..
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI-kaIe~gyRLP-pPmDC 859 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-KAIEQGYRLP-PPMDC 859 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH-HHHHhccCCC-CCCCC
Confidence 65432 12222 35899999775 679999999999999999665 99999998777665 4444554322 23356
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+..+.+|+..|++ +-..||...+|+.+
T Consensus 860 P~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred cHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 7889999999998 68999999998873
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=311.88 Aligned_cols=236 Identities=21% Similarity=0.325 Sum_probs=176.4
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
+..++||+|+||.||+|.+..+|..||+|.+..... ....|++.+++++|||||++++++.+.. ..++||
T Consensus 693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv~ 762 (968)
T PLN00113 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLIH 762 (968)
T ss_pred CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEEE
Confidence 345689999999999999999999999998863221 1124688999999999999999987653 578999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 185 (630)
||+++|+|. ++. .+++..+..++.||+.||+|||.+ .++|+||||||+||+++ .++..++. ||....... .
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~--~ 835 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLCT--D 835 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC-CCCceEEE-ecccccccc--C
Confidence 999999998 443 489999999999999999999954 34599999999999998 56666665 555433222 1
Q ss_pred ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCC----HHHHHHHHHcCC-----CCCCCCC----
Q 006810 186 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN----PAQIYKKVTSGI-----KPASLSK---- 251 (630)
Q Consensus 186 ~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~----~~~i~~~i~~g~-----~p~~l~~---- 251 (630)
....||+.|||||++.+ .|+.++|||||||++|||+||+.||..... .....+...... ..+.+..
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 23468999999998764 589999999999999999999999853211 111111111100 0011110
Q ss_pred --CCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 252 --VTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 252 --~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
....++.+++.+|++ +|.+||++.|+++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 112356788999997 89999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=271.90 Aligned_cols=133 Identities=27% Similarity=0.482 Sum_probs=113.1
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----C---CCeeEEEeE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----H---ENIIKFYNS 94 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-----H---pNIVk~~~~ 94 (630)
.||| -+.+.||-|.|+|||+|.|+.+.+.||+|+++- .....+....||++|++++ | ..||++++.
T Consensus 77 ~gRY-~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 77 GGRY-HVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred CceE-EEEEeccccccceeEEEeeccCCeEEEEEEEeh-----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 3788 667899999999999999999999999999873 2344567889999999983 3 379999999
Q ss_pred EEc--CCCCEEEEEEcccCCCCHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEE
Q 006810 95 WVD--DTNRTINMITELFTSGSLRYRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 162 (630)
Q Consensus 95 f~d--~~~~~l~lV~Ey~~gGsL~~~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 162 (630)
|.- .....++||+|++....|..++ ..+.++...++.|++|||.||.|||..- +|||-||||+|||+
T Consensus 151 FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred ceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 854 3346899999999888888443 4678999999999999999999999853 49999999999999
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=276.29 Aligned_cols=237 Identities=26% Similarity=0.430 Sum_probs=202.3
Q ss_pred eeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEc
Q 006810 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (630)
Q Consensus 29 ~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~E 108 (630)
....||-|.||.||.|.++.-...||+|.++- +.-.++.|+.|..+|+.++|||+|++++++..+ ..+|||+|
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E--pPFYIiTE 343 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--PPFYIITE 343 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhh-----cchhHHHHHHHHHHHHhhcCccHHHHhhhhccC--CCeEEEEe
Confidence 35789999999999999999999999998762 234668899999999999999999999988544 45899999
Q ss_pred ccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC
Q 006810 109 LFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185 (630)
Q Consensus 109 y~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 185 (630)
||..|.|. |++.. .-++.-.+..++.||..|++||..++ +|||||.+.|+|+. .+..||++|||+++.+....-
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVg-EnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccc-ccceEEeeccchhhhhcCCce
Confidence 99999886 76654 34677788999999999999999999 99999999999995 888999999999999877654
Q ss_pred ccccC---CCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006810 186 RSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260 (630)
Q Consensus 186 ~~~~G---Tp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~ 260 (630)
....| ..-|.|||-+. ..++.++|||+||++|||++| |-.||.+ .+..+.|..+..+..- .-+..+++.+-+|
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM-~~PeGCPpkVYeL 498 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRM-DGPEGCPPKVYEL 498 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhccccc-cCCCCCCHHHHHH
Confidence 44444 34699999665 568999999999999999999 7789987 7888999988887543 2345678999999
Q ss_pred HHHccc-CCCCCCCHHHH
Q 006810 261 IEKCIV-PASLRLPALEL 277 (630)
Q Consensus 261 I~kcL~-~p~~Rpsa~eL 277 (630)
+..||+ .|++||+..|+
T Consensus 499 MraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 499 MRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HHHHhcCCcccCccHHHH
Confidence 999999 89999998875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=268.45 Aligned_cols=238 Identities=28% Similarity=0.436 Sum_probs=180.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCeeEEEeEEEcCC--CCEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDDT--NRTI 103 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpNIVk~~~~f~d~~--~~~l 103 (630)
.+.++||+|.||.||+|. -.++.||||++... +.+.+..|-.+.+. ++|+||++|++.--..+ ...+
T Consensus 213 ~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~-------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQ-------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred hhHHHhhcCccceeehhh--ccCceeEEEecCHH-------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 556899999999999995 55799999998743 34556666666554 58999999998532222 3368
Q ss_pred EEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcC-------CCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 104 NMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSH-------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 104 ~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~-------~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
++|++|.+.|+|....+...+++....+++..+++||+|||+- +|+|+|||||..||||. ++++.-|+|||+
T Consensus 284 wLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDFGL 362 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADFGL 362 (534)
T ss_pred eEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeeccce
Confidence 9999999999999555666899999999999999999999963 47899999999999997 899999999999
Q ss_pred ceeeccCC----CccccCCCCCCCccccccccC-------cccceeehhHHHHHHhhCCC------------CCCC----
Q 006810 177 AIVMQQPT----ARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVTCEY------------PYNE---- 229 (630)
Q Consensus 177 a~~~~~~~----~~~~~GTp~Y~APEvl~~~ys-------~~sDIWSLGvil~ELltG~~------------Pf~~---- 229 (630)
|..+.... ....+||.+|||||++++..+ .+.||||+|.++|||++... ||..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 98765432 234689999999999987533 25899999999999998532 3321
Q ss_pred CCCHHHHHHHHHcCCCC----CCCCCCC-cHHHHHHHHHccc-CCCCCCCHH
Q 006810 230 CKNPAQIYKKVTSGIKP----ASLSKVT-DPQVKQFIEKCIV-PASLRLPAL 275 (630)
Q Consensus 230 ~~~~~~i~~~i~~g~~p----~~l~~~~-s~~lk~~I~kcL~-~p~~Rpsa~ 275 (630)
....+++...+...... ..+.+.. -..+++.|+.|+. ||..|.||.
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 11223333333333222 2232332 3568999999997 899999975
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=281.72 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=202.3
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEc----c---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCe
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDE----V---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENI 88 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~----~---tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNI 88 (630)
..|.+..++ .+.+.||+|+||.|++|.-. . ....||+|..+... ...+.+.+..|+.+|+.+ +||||
T Consensus 290 ~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~ni 364 (609)
T KOG0200|consen 290 KWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNI 364 (609)
T ss_pred ceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcch
Confidence 444444444 45569999999999999642 1 25679999876432 236678899999999999 69999
Q ss_pred eEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCEE
Q 006810 89 IKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPII 151 (630)
Q Consensus 89 Vk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~----------------~lse~~i~~i~~QIl~gL~yLHs~~~~Ii 151 (630)
+.+.+.... ...+++|+||+..|+|. +++..+ .++...+..++.||+.|++||++.. +|
T Consensus 365 v~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~v 440 (609)
T KOG0200|consen 365 VNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CV 440 (609)
T ss_pred hhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--cc
Confidence 999998765 45689999999999998 555444 3899999999999999999999998 99
Q ss_pred eccCCcCceEEeCCCCcEEEcccccceeeccCCCcc---ccC--CCCCCCcccccc-ccCcccceeehhHHHHHHhh-CC
Q 006810 152 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIG--TPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CE 224 (630)
Q Consensus 152 HrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~---~~G--Tp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~ 224 (630)
||||.+.|||+. .+..+||+|||+++......... ..| ...|||||.+.. .|+.++|||||||++||++| |.
T Consensus 441 HRDLAaRNVLi~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~ 519 (609)
T KOG0200|consen 441 HRDLAARNVLIT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG 519 (609)
T ss_pred chhhhhhhEEec-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC
Confidence 999999999997 77899999999998544332221 122 235999997764 69999999999999999999 88
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 225 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 225 ~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.||.+......+++.+..|.... .+...++++-++++.|+. +|.+||+..++..
T Consensus 520 ~PYp~~~~~~~l~~~l~~G~r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 520 TPYPGIPPTEELLEFLKEGNRME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 99988554666788888886643 455668999999999997 8999999998765
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=263.00 Aligned_cols=248 Identities=31% Similarity=0.502 Sum_probs=186.5
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCeeEEEeEEEc
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVD 97 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpNIVk~~~~f~d 97 (630)
+-...|-.++.+.||+|.||.||+|.. .|+.||+|++.-.+ .+...+|.++.+. |+|+||+.|++.=..
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd-------E~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD-------ERSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc-------hhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 334556678889999999999999965 49999999986332 2346666666654 599999999985332
Q ss_pred CCC--CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHc------CCCCEEeccCCcCceEEeCCCCc
Q 006810 98 DTN--RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGE 168 (630)
Q Consensus 98 ~~~--~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs------~~~~IiHrDLKp~NILl~~~~g~ 168 (630)
+.+ ..+|+|++|-+.|+|. |+.. ..++.+...+++..++.||++||. .+|.|.|||||..||||. .+|.
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~ 354 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGT 354 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCc
Confidence 222 3699999999999998 5554 889999999999999999999994 357799999999999997 8999
Q ss_pred EEEcccccceeeccC------CCccccCCCCCCCccccccccC-------cccceeehhHHHHHHhhC----------CC
Q 006810 169 VKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVTC----------EY 225 (630)
Q Consensus 169 vKL~DFGla~~~~~~------~~~~~~GTp~Y~APEvl~~~ys-------~~sDIWSLGvil~ELltG----------~~ 225 (630)
.-|+|+|+|...... .....+||.+|||||++....+ ..+||||||.++||++.. ++
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 999999999655433 2345689999999999976432 358999999999999862 57
Q ss_pred CCCCCC----CHHHHHHHHHcCCCCCCCCCCC--cH---HHHHHHHHccc-CCCCCCCHHHHh
Q 006810 226 PYNECK----NPAQIYKKVTSGIKPASLSKVT--DP---QVKQFIEKCIV-PASLRLPALELL 278 (630)
Q Consensus 226 Pf~~~~----~~~~i~~~i~~g~~p~~l~~~~--s~---~lk~~I~kcL~-~p~~Rpsa~eLL 278 (630)
||.+.. ..+++.+.+......+.++... ++ .+..+++.|+- +|..|.||-.+-
T Consensus 435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 886532 2344444443332222222221 23 34567889995 899999987653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=233.83 Aligned_cols=207 Identities=38% Similarity=0.651 Sum_probs=180.5
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCC
Q 006810 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (630)
Q Consensus 33 LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~g 112 (630)
||+|++|.||++.+..+|.++++|.+....... ....+.+|+..++.+.|++|+++++++... ...++++||+.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCC
Confidence 689999999999998889999999987543211 456789999999999999999999988654 568899999999
Q ss_pred CCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC-CCcEEEcccccceeeccCC--Ccc
Q 006810 113 GSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPT--ARS 187 (630)
Q Consensus 113 GsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~-~g~vKL~DFGla~~~~~~~--~~~ 187 (630)
++|. ++... ..++...+..++.+++.+|.|||+++ ++|+||+|.||+++ . ++.++|+|||.+....... ...
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~-~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLD-SDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEe-CCCCcEEEecCCceEEccCCcchhhc
Confidence 9998 44443 47999999999999999999999998 99999999999998 5 7899999999998765543 444
Q ss_pred ccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHcc
Q 006810 188 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 188 ~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL 265 (630)
..+...|++||.+.. .++.+.|+|+||+++++| ..+.+++.+|+
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l 198 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKML 198 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHh
Confidence 567889999998865 678899999999999999 67899999999
Q ss_pred c-CCCCCCCHHHHhcCC
Q 006810 266 V-PASLRLPALELLKDP 281 (630)
Q Consensus 266 ~-~p~~Rpsa~eLL~hp 281 (630)
. +|.+||++.++++|+
T Consensus 199 ~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 199 QKDPEKRPSAKEILEHL 215 (215)
T ss_pred hCCcccCcCHHHHhhCC
Confidence 7 899999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=271.72 Aligned_cols=197 Identities=29% Similarity=0.462 Sum_probs=173.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHH----HHHHHHHHHHHHhCC---CCCeeEEEeEEEcCCC
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ----LERLYSEVHLLKSLK---HENIIKFYNSWVDDTN 100 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~----~~~l~~Ei~iL~~L~---HpNIVk~~~~f~d~~~ 100 (630)
...+.||.|+||.|++|.++.+..+|++|.|.++...-+... +-.+-.||.+|..|+ |+||++++++|.++
T Consensus 564 ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd-- 641 (772)
T KOG1152|consen 564 TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD-- 641 (772)
T ss_pred eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC--
Confidence 335789999999999999999999999999987765543221 223567999999998 99999999999655
Q ss_pred CEEEEEEcccCCC-CHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 101 RTINMITELFTSG-SLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 101 ~~l~lV~Ey~~gG-sL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.++|++||--..| +|. ++..+..++|.+++.+++||+.|+++||++| |||||||-+|+.++ .+|-+||+|||.|.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd-~~g~~klidfgsaa 718 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVD-SNGFVKLIDFGSAA 718 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEe-cCCeEEEeeccchh
Confidence 5799999986555 565 8888999999999999999999999999999 99999999999998 79999999999998
Q ss_pred eeccCCCccccCCCCCCCccccccc-c-CcccceeehhHHHHHHhhCCCCCCC
Q 006810 179 VMQQPTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNE 229 (630)
Q Consensus 179 ~~~~~~~~~~~GTp~Y~APEvl~~~-y-s~~sDIWSLGvil~ELltG~~Pf~~ 229 (630)
.........++||..|.|||++.+. | +..-|||+||+++|-++..+.||..
T Consensus 719 ~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8888888899999999999999875 4 6789999999999999999999963
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-28 Score=235.98 Aligned_cols=210 Identities=34% Similarity=0.554 Sum_probs=178.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||.|++|+||+|.+..++..+|+|.+...... .....+.+|+..++.++|+|++++++++... ...++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~ 76 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVM 76 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEE
Confidence 6788999999999999999988999999998754321 2567788999999999999999999987654 4588999
Q ss_pred cccCCCCHH-HHhhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--
Q 006810 108 ELFTSGSLR-YRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~-lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 183 (630)
||+.+++|. .+..... +++..+..++.|++.+|.|||+++ ++|+||+|.||+++ .++.++|+|||.+......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLG-MDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeCceeeEecCccc
Confidence 999999998 5555555 899999999999999999999998 99999999999998 6799999999999776543
Q ss_pred -CCccccCCCCCCCcccc-c-cccCcccceeehhHHHHHHhhCCCCCCC-CCCHHHHHHHHHcCCC
Q 006810 184 -TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTCEYPYNE-CKNPAQIYKKVTSGIK 245 (630)
Q Consensus 184 -~~~~~~GTp~Y~APEvl-~-~~ys~~sDIWSLGvil~ELltG~~Pf~~-~~~~~~i~~~i~~g~~ 245 (630)
......++..|++||.+ . ..++.++|+|+||+++++|++|+.||.. ..+...+.+.+..+..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 23445688899999987 3 3467799999999999999999999976 5666677777777653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=275.49 Aligned_cols=240 Identities=30% Similarity=0.469 Sum_probs=196.6
Q ss_pred eeeEecccCceEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 29 YDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 29 ~~e~LG~G~fg~Vy~A~d~~tG~----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
..++||+|+||+||+|.....|+ +||+|++... ........+..|+-+|.+|+|||+++++++..... +.
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~q 773 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST---LQ 773 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---HH
Confidence 35789999999999999877765 6788877533 23344567899999999999999999999876543 78
Q ss_pred EEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 105 MITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+|++|+++|.|. |.+. ..++..+....|+.||++|+.|||.+. ++||||-..||||. .-..+||.|||+++.+..
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVk-sP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVK-SPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeec-CCCeEEEEecchhhccCc
Confidence 899999999997 5554 567999999999999999999999998 99999999999998 566999999999987754
Q ss_pred CCCcc----ccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 183 PTARS----VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 183 ~~~~~----~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
..... ..-.+-|||-|.+. ..|+.++|||||||++||++| |..||.+ ...++|-+.+..|.. -.-+...+.+
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCtiD 928 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTID 928 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccHH
Confidence 43221 11245688888654 679999999999999999999 8899987 567777777777755 3446677889
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhc
Q 006810 257 VKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+-.++.+||. |+..||++++|-.
T Consensus 929 Vy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHhccCcccCccHHHHHH
Confidence 9999999997 8999999888653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=258.59 Aligned_cols=250 Identities=26% Similarity=0.430 Sum_probs=194.8
Q ss_pred ceeeeeEecccCceEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCC
Q 006810 26 YGRYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~A~d~~---tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~ 101 (630)
+++..++||.|.|++||+|++.. ....||+|.|.... ...++..|+++|..+ -+.||+++.+.+- .+.
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~r--nnd 108 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCFR--NND 108 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhhc--cCC
Confidence 45778999999999999999987 88999999987543 235689999999999 5899999999874 445
Q ss_pred EEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 102 TINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
.+.+|+||++....+.+.. .++...++.+++.++.||.++|.+| ||||||||.|++.+...+.-.|+|||+|....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~--~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR--SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred eeEEEecccCccCHHHHHh--cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHH
Confidence 6889999999988773332 4568999999999999999999999 99999999999999888899999999985110
Q ss_pred ---------c------CC----------------C---------------ccccCCCCCCCcccccc--ccCcccceeeh
Q 006810 182 ---------Q------PT----------------A---------------RSVIGTPEFMAPELYEE--EYNELVDIYSF 213 (630)
Q Consensus 182 ---------~------~~----------------~---------------~~~~GTp~Y~APEvl~~--~ys~~sDIWSL 213 (630)
. .. . ....|||+|.|||++.. .-++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 0 00 0 01249999999998753 46889999999
Q ss_pred hHHHHHHhhCCCCCCCCCCHHH-HHHHHH-------------cCC-----------------------------------
Q 006810 214 GMCILEMVTCEYPYNECKNPAQ-IYKKVT-------------SGI----------------------------------- 244 (630)
Q Consensus 214 Gvil~ELltG~~Pf~~~~~~~~-i~~~i~-------------~g~----------------------------------- 244 (630)
|+|++-++++.+||....+... +...++ .|.
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 9999999999999965443211 111110 010
Q ss_pred CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 245 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 245 ~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.+.......+..+.+|+.+||. +|.+|.+|+++|+||||....
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 0011122345688999999997 999999999999999998543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=233.60 Aligned_cols=258 Identities=20% Similarity=0.301 Sum_probs=193.1
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f 95 (630)
+...+-...| .+.+.||+|.||.+.+|.++.+...+++|.+.... .....|.+|++---.| .|.||+.-|++-
T Consensus 17 l~kv~l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~va 90 (378)
T KOG1345|consen 17 LKKVDLEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVA 90 (378)
T ss_pred ccccchhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHH
Confidence 3344445556 77899999999999999999999999999997543 2346688998876666 689999988864
Q ss_pred EcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe-CCCCcEEEccc
Q 006810 96 VDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDL 174 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~-~~~g~vKL~DF 174 (630)
+.. ...+++++||++.|+|+.-.....+.+...+.++.|+++|+.|+|+.+ +||||||.+||||- .+.-.||||||
T Consensus 91 Fqt-~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 91 FQT-SDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred hhc-CceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeec
Confidence 433 347889999999999996556678999999999999999999999999 99999999999985 34458999999
Q ss_pred ccceeeccCCCccccCCCCCCCcccccc----c--cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHH---HHHHcCCC
Q 006810 175 GLAIVMQQPTARSVIGTPEFMAPELYEE----E--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY---KKVTSGIK 245 (630)
Q Consensus 175 Gla~~~~~~~~~~~~GTp~Y~APEvl~~----~--ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~---~~i~~g~~ 245 (630)
|+.+...... ...-.+..|.|||++.. . .++.+|||.||+++|..+||.+||.......+-| .....+..
T Consensus 168 G~t~k~g~tV-~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 168 GLTRKVGTTV-KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred ccccccCcee-hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 9986544332 22233667999997642 2 4788999999999999999999997432222222 12222222
Q ss_pred --CCCCCCCCcHHHHHHHHHccc-CCCCC---CCHHHHhcCCCcc
Q 006810 246 --PASLSKVTDPQVKQFIEKCIV-PASLR---LPALELLKDPFLV 284 (630)
Q Consensus 246 --p~~l~~~~s~~lk~~I~kcL~-~p~~R---psa~eLL~hpf~~ 284 (630)
.+...+..++.+..+.++-|. .+.+| .++....+..|..
T Consensus 247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 247 PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 222334567788888889887 56666 5666666666653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=276.81 Aligned_cols=198 Identities=19% Similarity=0.232 Sum_probs=144.2
Q ss_pred HhCCC-CCeeEEEeEEEc----C-CCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEe
Q 006810 81 KSLKH-ENIIKFYNSWVD----D-TNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 152 (630)
Q Consensus 81 ~~L~H-pNIVk~~~~f~d----~-~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiH 152 (630)
+.+.| +||++++++|.. . ....+++++||+ +++|. ++.. ...+++..++.+++||+.||.|||+++ |+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 34455 577788887611 1 124577888987 55777 5543 456999999999999999999999999 999
Q ss_pred ccCCcCceEEeC------------------CCCcEEEcccccceeeccC------------------CCccccCCCCCCC
Q 006810 153 RDLKCDNIFVNG------------------NNGEVKIGDLGLAIVMQQP------------------TARSVIGTPEFMA 196 (630)
Q Consensus 153 rDLKp~NILl~~------------------~~g~vKL~DFGla~~~~~~------------------~~~~~~GTp~Y~A 196 (630)
|||||+||||+. .++.+||+|||+++..... .....+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999951 3456777788877532110 0012468999999
Q ss_pred ccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCH
Q 006810 197 PELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA 274 (630)
Q Consensus 197 PEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa 274 (630)
||++. ..|+.++|||||||++|||++|..|+... ......+.....+.... ...+...+++.+||. +|.+||++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcCh
Confidence 99875 46999999999999999999999887532 22222232222222221 124567889999997 79999999
Q ss_pred HHHhcCCCccc
Q 006810 275 LELLKDPFLVT 285 (630)
Q Consensus 275 ~eLL~hpf~~~ 285 (630)
.|+|.||||..
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 99999999975
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-27 Score=243.75 Aligned_cols=272 Identities=32% Similarity=0.551 Sum_probs=210.1
Q ss_pred CCCccCCccccCCCCcceeeeeEecccC---ceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC
Q 006810 10 SETEEGEFSEKDPSCRYGRYDEILGKGA---FKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86 (630)
Q Consensus 10 ~~~~~~~~~e~dp~gRy~r~~e~LG~G~---fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp 86 (630)
...++.+|++.+|++||++-++..|+.. .-.||+|.++..|.+|+|..|.+........+.++...-++.|-++.|.
T Consensus 48 ~s~~~~eIleesp~~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHs 127 (458)
T KOG1266|consen 48 DSEDESEILEESPCGRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHS 127 (458)
T ss_pred cccchhhhhccCchhhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHH
Confidence 4466788999999999999989888743 4578999999999999999998877666555666666778899999999
Q ss_pred CeeEEEeEEEcCC---CCEEEEEEcccCCCCHH-HHh----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcC
Q 006810 87 NIIKFYNSWVDDT---NRTINMITELFTSGSLR-YRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 158 (630)
Q Consensus 87 NIVk~~~~f~d~~---~~~l~lV~Ey~~gGsL~-~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~ 158 (630)
|||+++.||.+.+ ..++.|++||+..|++. +++ .+..+....+++|+.||+.||.|||+..|||+|+++.|+
T Consensus 128 nlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~ 207 (458)
T KOG1266|consen 128 NLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCD 207 (458)
T ss_pred HHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchh
Confidence 9999999997643 24688999999999997 443 456799999999999999999999999999999999999
Q ss_pred ceEEeCCCCcEEEcccccceeecc------CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC
Q 006810 159 NIFVNGNNGEVKIGDLGLAIVMQQ------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK 231 (630)
Q Consensus 159 NILl~~~~g~vKL~DFGla~~~~~------~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~ 231 (630)
.||+. ++|.|||+--........ .......+-|+|.|||.-.. ..+.++|||+||+|+++|..++.--....
T Consensus 208 tifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnse 286 (458)
T KOG1266|consen 208 TIFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSE 286 (458)
T ss_pred heeec-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCc
Confidence 99998 999999975443321110 01112346789999996543 45678999999999999999987644322
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 232 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 232 ~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.....-..+.. ......+..-+++|.+||. .|..||++.++|+||.+....
T Consensus 287 S~~~~ee~ia~-----~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 287 SKVEVEENIAN-----VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred ceeehhhhhhh-----heeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 21111111111 1112234556889999998 799999999999999887643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=218.46 Aligned_cols=159 Identities=26% Similarity=0.346 Sum_probs=125.8
Q ss_pred CCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCccccC
Q 006810 113 GSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 190 (630)
Q Consensus 113 GsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~G 190 (630)
|+|. ++.. .+.+++..++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||++....... ..|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~~---~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPEQ---SRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeecccc---CCC
Confidence 6776 5554 456999999999999999999999987 99999997 7889999 99987654432 368
Q ss_pred CCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC-----CCCCCcH--HHHHHHH
Q 006810 191 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-----LSKVTDP--QVKQFIE 262 (630)
Q Consensus 191 Tp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~-----l~~~~s~--~lk~~I~ 262 (630)
|+.|||||++.+ .|+.++|||||||++|||+||+.||............+.....+.. .....+. .+++||.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999998764 5899999999999999999999999765444444444443322221 1111222 6999999
Q ss_pred Hccc-CCCCCCCHHHHhcCCCccc
Q 006810 263 KCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 263 kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
+||. +|.+||++.+++.|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 9997 8999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-23 Score=210.82 Aligned_cols=251 Identities=30% Similarity=0.449 Sum_probs=201.8
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC-CeeEEEeEEEcCCCCEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp-NIVk~~~~f~d~~~~~l~l 105 (630)
+++.+.||.|+|+.||++.+. ..+++|.+....... ......+.+|+.+++.+.|+ +|+++++.+... ...++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEE
Confidence 377889999999999999888 788999987654322 23567789999999999988 799999998433 34789
Q ss_pred EEcccCCCCHH-HHhhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC-cEEEcccccceee
Q 006810 106 ITELFTSGSLR-YRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVM 180 (630)
Q Consensus 106 V~Ey~~gGsL~-~~~~~~---~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g-~vKL~DFGla~~~ 180 (630)
+++|+.++++. ...... .++......++.|++.++.|+|+.+ ++|||+||+||+++ ..+ .++++|||++...
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~-~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLD-RDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-CCCCeEEEeccCcceec
Confidence 99999999998 444443 7999999999999999999999999 99999999999998 555 7999999999755
Q ss_pred ccC--------CCccccCCCCCCCcccccc----ccCcccceeehhHHHHHHhhCCCCCCCCCC---HHHHHHHHHcCCC
Q 006810 181 QQP--------TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIK 245 (630)
Q Consensus 181 ~~~--------~~~~~~GTp~Y~APEvl~~----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~---~~~i~~~i~~g~~ 245 (630)
... ......||+.|+|||.+.+ .+....|+||+|++++++++|..||..... .......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 433 2356689999999998764 578899999999999999999999877553 4555555555443
Q ss_pred C-CCCCCCC------cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 246 P-ASLSKVT------DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 246 p-~~l~~~~------s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+ ....... ...+.+++.+++. +|..|.+..+...++|....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 3 1111111 2578999999997 79999999998888666543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=223.25 Aligned_cols=172 Identities=22% Similarity=0.290 Sum_probs=132.7
Q ss_pred CcceeeeeEecccCceEEEEEEEcc-CCeEEEEEEeecccc-cCCHHHHHHHHHHHHHHHhCCCCCeeE-EEeEEEcCCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDV-MQSPDQLERLYSEVHLLKSLKHENIIK-FYNSWVDDTN 100 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~-tG~~VAiK~i~~~~~-~~~~~~~~~l~~Ei~iL~~L~HpNIVk-~~~~f~d~~~ 100 (630)
++| ++.+.||+|+||+||+|.+.. +|..||+|++..... .........+.+|+++|++|+|+||++ +++.
T Consensus 18 ~~Y-~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------ 90 (365)
T PRK09188 18 ARF-VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------ 90 (365)
T ss_pred CCc-eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------
Confidence 456 888999999999999998876 788889998752211 012334567899999999999999985 5442
Q ss_pred CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccC-CcCceEEeCCCCcEEEccccccee
Q 006810 101 RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL-KCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDL-Kp~NILl~~~~g~vKL~DFGla~~ 179 (630)
...|+||||++|++|...... . ...|+.|++.||.|||+++ |+|||| ||+|||++ .++.+||+|||+++.
T Consensus 91 ~~~~LVmE~~~G~~L~~~~~~---~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLARPH---G---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQLASV 161 (365)
T ss_pred CCcEEEEEccCCCCHHHhCcc---c---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEECcccee
Confidence 237899999999999733211 1 2578999999999999998 999999 99999997 778999999999986
Q ss_pred eccCC----------CccccCCCCCCCccccccc-------cCccccee
Q 006810 180 MQQPT----------ARSVIGTPEFMAPELYEEE-------YNELVDIY 211 (630)
Q Consensus 180 ~~~~~----------~~~~~GTp~Y~APEvl~~~-------ys~~sDIW 211 (630)
..... .....+++.|+|||.+... .+...|-|
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 54332 1345688899999988532 33457777
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-25 Score=250.03 Aligned_cols=260 Identities=24% Similarity=0.378 Sum_probs=200.8
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecc--cccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~--~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
..|++..+++|.|++|.|+.+.........++|.+... ...........+..|+-+-..|.|||++.....+.+...
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~- 395 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG- 395 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-
Confidence 45777789999999999999988888877777766532 111222222336778888899999999887765544332
Q ss_pred EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 102 TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
+.-+||||++ +|. .+...+.++...+..+++|++.||.|+|++| |.|||||++|++++ .+|.+||+|||.+...
T Consensus 396 -~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~-~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 396 -ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVT-ENGILKIIDFGAASVF 470 (601)
T ss_pred -chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEe-cCCceEEeecCcceee
Confidence 3334999999 888 5555568999999999999999999999999 99999999999998 8999999999999766
Q ss_pred ccC------CCccccCCCCCCCcccccc-ccC-cccceeehhHHHHHHhhCCCCCCCCCCHHHHH-HHHHcC-----CCC
Q 006810 181 QQP------TARSVIGTPEFMAPELYEE-EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIY-KKVTSG-----IKP 246 (630)
Q Consensus 181 ~~~------~~~~~~GTp~Y~APEvl~~-~ys-~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~-~~i~~g-----~~p 246 (630)
..+ ....++|+..|+|||++.+ .|+ ..+||||.|++++.|++|+.||.......+.+ ...... ..+
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 543 2345689999999998865 576 47999999999999999999997644333321 111111 112
Q ss_pred CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCC
Q 006810 247 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 289 (630)
Q Consensus 247 ~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~ 289 (630)
..+....+...+.+|.++|+ +|.+|.|+.++++++||+.....
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 33344566788999999998 89999999999999999986543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=215.93 Aligned_cols=243 Identities=22% Similarity=0.324 Sum_probs=193.0
Q ss_pred eeeeEecccCceEEEEEEEccCCe-----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGI-----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~-----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
|+..++-+|.||.||.|+...+.. .|-+|-++. ..++-+...+..|.-+|..+.|||+..+.++.+.+.. .
T Consensus 287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~---~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~-~ 362 (563)
T KOG1024|consen 287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ---HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA-T 362 (563)
T ss_pred echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh---cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC-c
Confidence 555678899999999997664432 334443331 1245567889999999999999999999998876543 4
Q ss_pred EEEEEcccCCCCHH-HHhh--------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcc
Q 006810 103 INMITELFTSGSLR-YRKK--------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 173 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~--------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 173 (630)
.+.++.+..-|+|+ ++.. ...++..++..++.|+..|++|||.++ |||.||...|.+|+ +.-+|||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEEecc
Confidence 56678899999998 5541 234677788899999999999999999 99999999999998 778999999
Q ss_pred cccceeeccCC---C-ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCC
Q 006810 174 LGLAIVMQQPT---A-RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 247 (630)
Q Consensus 174 FGla~~~~~~~---~-~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~ 247 (630)
=.+++.+-... . ........||+||.+. ..|+.++|+||||+++|||+| |+.||.+ .+|.++...+..|....
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyRla 518 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYRLA 518 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhccceec
Confidence 99987542211 1 1112245799999775 569999999999999999999 8899987 78999999999986643
Q ss_pred CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 248 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 248 ~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+-..++++..++..||+ .|.+||+..++..
T Consensus 519 -QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 519 -QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 345678899999999997 8999999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-22 Score=223.61 Aligned_cols=245 Identities=19% Similarity=0.290 Sum_probs=196.9
Q ss_pred EecccCceEEEEEE---EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEEEEEE
Q 006810 32 ILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 32 ~LG~G~fg~Vy~A~---d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++|+|+||.|+++. ....|.-+|.|+.+.......... .-..|-.++..++ ||.+|+++..|..+. .+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDG--KLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeecccc--chhHhh
Confidence 47999999998753 345677889888765544333222 4556778888887 999999999886654 477889
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCc
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 186 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~ 186 (630)
++..+|.|. ...+...+.+...+.+...++.+++++|+.+ ++|||+|++||+++ .+|.+++.|||+++..-.....
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeec-ccCccccCCchhhhHhHhhhhc
Confidence 999999998 6667778899999999999999999999999 99999999999998 8999999999999765443333
Q ss_pred cccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc
Q 006810 187 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 266 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~ 266 (630)
|||..|||||++. .+..++|.||||++++||+||..||.. .+...|.... ...+...+..+++++..++.
T Consensus 154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE--LEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHh
Confidence 8999999999998 678899999999999999999999976 3344443321 22445567888999999886
Q ss_pred -CCCCCCC-----HHHHhcCCCcccCCCCcccc
Q 006810 267 -PASLRLP-----ALELLKDPFLVTDNPKDLVC 293 (630)
Q Consensus 267 -~p~~Rps-----a~eLL~hpf~~~~~~~~~~~ 293 (630)
+|.+|.- +.++++|+||+..++..+..
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~ 256 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDWNELEA 256 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeHhhHhh
Confidence 7887775 47899999999988876543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-20 Score=196.11 Aligned_cols=246 Identities=22% Similarity=0.236 Sum_probs=175.7
Q ss_pred cceeeeeEecccCceEEEEEEEccCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC----CCeeEEEeEEEcCC
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH----ENIIKFYNSWVDDT 99 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG-~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H----pNIVk~~~~f~d~~ 99 (630)
+| ++.+.||+|+||.||++.+..++ ..+|+|.......... ..+..|+.++..+.. +++..+++... ..
T Consensus 19 ~~-~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~ 92 (322)
T KOG1164|consen 19 RY-KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-ST 92 (322)
T ss_pred ce-EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CC
Confidence 67 88999999999999999998875 7889888765432211 147778888888863 68888888764 34
Q ss_pred CCEEEEEEcccCCCCHH-HHh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCC----CcEEEc
Q 006810 100 NRTINMITELFTSGSLR-YRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN----GEVKIG 172 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~----g~vKL~ 172 (630)
..+-|+||+++.. +|. .+. ..+.++..++.+++.|++.+|.+||+.| ++||||||+|+.+.... ..+.|.
T Consensus 93 ~~~~~iVM~l~G~-sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 93 EDFNFIVMSLLGP-SLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred CceeEEEEeccCc-cHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEE
Confidence 4567888988755 554 332 2468999999999999999999999999 99999999999996332 469999
Q ss_pred ccccce--eeccC---------C-CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHH--HH
Q 006810 173 DLGLAI--VMQQP---------T-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ--IY 237 (630)
Q Consensus 173 DFGla~--~~~~~---------~-~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~--i~ 237 (630)
|||+++ .+... . ...+.||..|+++....+ +.+.+-|+||++.++.+|+.|..||........ .+
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999998 32111 1 223569999999997765 578999999999999999999999976443322 22
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 238 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 238 ~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
...........+....+.++..+...+-. +-..+|....+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 22222111111222334555555554443 4566676655443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-21 Score=192.92 Aligned_cols=182 Identities=16% Similarity=0.117 Sum_probs=138.5
Q ss_pred CccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHH------HHHHHHHHHhCCCCCee
Q 006810 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER------LYSEVHLLKSLKHENII 89 (630)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~------l~~Ei~iL~~L~HpNIV 89 (630)
++.+.--.+|| |..++||.|+||.||++.+ ++..+|+|++..... ..+....+ +.+|++.+.+|.||+|.
T Consensus 23 ~~~~~~l~~~y-~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~-~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~ 98 (232)
T PRK10359 23 EIFDDFLSYNI-KTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVK-RTERFLKSFVKGDYYENLIVQTDRVRSEGLA 98 (232)
T ss_pred HHHHHHhhCce-EEEEEecCCCceEEEEEec--CCCcEEEEEechhcC-chHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence 44455557899 8899999999999999744 477899999865432 33344344 57899999999999999
Q ss_pred EEEeEEEcCCC------CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe
Q 006810 90 KFYNSWVDDTN------RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 163 (630)
Q Consensus 90 k~~~~f~d~~~------~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 163 (630)
...+++.+... ...++||||++|.+|... ..+++ ....+|+.+|..||.+| ++|||+||.||+++
T Consensus 99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~---~~~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~ 169 (232)
T PRK10359 99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDM---PEISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVS 169 (232)
T ss_pred cceEeeeecccccccccCCeEEEEEEECCccHHHh---hhccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEe
Confidence 99998775432 347899999999999743 12333 34669999999999999 99999999999998
Q ss_pred CCCCcEEEcccccceeeccCCCccccCCCCCCCccccccccCcccceeehhHHHHHHh
Q 006810 164 GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV 221 (630)
Q Consensus 164 ~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELl 221 (630)
.+| ++|+|||............. =+++..|+.++|||+||+++..+.
T Consensus 170 -~~g-i~liDfg~~~~~~e~~a~d~---------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 -KNG-LRIIDLSGKRCTAQRKAKDR---------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -CCC-EEEEECCCcccccchhhHHH---------HHHHhHhcccccccceeEeehHHH
Confidence 677 99999998765432221110 023456888999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=185.95 Aligned_cols=144 Identities=16% Similarity=0.170 Sum_probs=112.0
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHH----------------------HHHHHHHHHHHHHhCCCCC
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD----------------------QLERLYSEVHLLKSLKHEN 87 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~----------------------~~~~l~~Ei~iL~~L~HpN 87 (630)
...||+|+||.||+|.+. +|+.||+|+++......... ......+|+++|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 367999999999999987 89999999997643211000 0122345999999998887
Q ss_pred eeEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHH-HcCCCCEEeccCCcCceEEeCC
Q 006810 88 IIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGN 165 (630)
Q Consensus 88 IVk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yL-Hs~~~~IiHrDLKp~NILl~~~ 165 (630)
+...+.+.. .. .++||||++|+++. .....+.+++..+..++.||+.+|.|+ |+.+ |+||||||+|||++
T Consensus 81 v~~p~~~~~--~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-- 152 (190)
T cd05147 81 IPCPEPILL--KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-- 152 (190)
T ss_pred CCCCcEEEe--cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE--
Confidence 744333221 11 27999999998876 445567899999999999999999999 7988 99999999999997
Q ss_pred CCcEEEcccccceeecc
Q 006810 166 NGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 166 ~g~vKL~DFGla~~~~~ 182 (630)
++.++|+|||+|.....
T Consensus 153 ~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCcEEEEEccccccCCC
Confidence 47899999999975444
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-20 Score=181.18 Aligned_cols=144 Identities=18% Similarity=0.211 Sum_probs=114.3
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccC--------------------CHH--HHHHHHHHHHHHHhCCCCC
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--------------------SPD--QLERLYSEVHLLKSLKHEN 87 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~--------------------~~~--~~~~l~~Ei~iL~~L~HpN 87 (630)
...||+|+||.||+|.+. +|..||+|+++...... ... ....+.+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 89999999998652110 000 1233468999999999998
Q ss_pred eeEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCC
Q 006810 88 IIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGN 165 (630)
Q Consensus 88 IVk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~ 165 (630)
|.....++... .++||||++|+++. .......++...+..++.|++.+|.++|+ +| |+||||||+||+++
T Consensus 81 i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-- 152 (190)
T cd05145 81 VPVPEPILLKK----NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-- 152 (190)
T ss_pred CCCceEEEecC----CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--
Confidence 85544433322 37999999998664 33455678899999999999999999999 88 99999999999997
Q ss_pred CCcEEEcccccceeecc
Q 006810 166 NGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 166 ~g~vKL~DFGla~~~~~ 182 (630)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 68999999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-20 Score=189.16 Aligned_cols=238 Identities=18% Similarity=0.188 Sum_probs=147.2
Q ss_pred CCCCcc--eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC----------CCe
Q 006810 21 DPSCRY--GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH----------ENI 88 (630)
Q Consensus 21 dp~gRy--~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H----------pNI 88 (630)
.+.+++ .+.+++||.|+++.||.+.|..||+++|+|++.... .......+.+.+|.-....+.+ -.+
T Consensus 6 ~~~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~ 84 (288)
T PF14531_consen 6 ELGQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRF 84 (288)
T ss_dssp SSS--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred cCCCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence 334444 344689999999999999999999999999997766 3444567777777766555433 122
Q ss_pred eEEEeEEE---------cCCCC------EEEEEEcccCCCCHH-H---HhhcC----CCCHHHHHHHHHHHHHHHHHHHc
Q 006810 89 IKFYNSWV---------DDTNR------TINMITELFTSGSLR-Y---RKKHK----NVDMKAIKNWARQILRGLHYLHS 145 (630)
Q Consensus 89 Vk~~~~f~---------d~~~~------~l~lV~Ey~~gGsL~-~---~~~~~----~lse~~i~~i~~QIl~gL~yLHs 145 (630)
+.-++... ...+. ..+++|.-+. ++|. . +.... .+.......+..|+++.+++||.
T Consensus 85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~ 163 (288)
T PF14531_consen 85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS 163 (288)
T ss_dssp ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeeEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh
Confidence 22222111 11111 1345666664 4554 2 22222 23344455667999999999999
Q ss_pred CCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCccccCCCCCCCcccccc---------ccCcccceeehhHH
Q 006810 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE---------EYNELVDIYSFGMC 216 (630)
Q Consensus 146 ~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~---------~ys~~sDIWSLGvi 216 (630)
+| ++|+||+|+|+|++ .+|.++|+||+.....+..... ...+..|.+||+... .++.+.|.|+||++
T Consensus 164 ~G--lVHgdi~~~nfll~-~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 164 YG--LVHGDIKPENFLLD-QDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp TT--EEEST-SGGGEEE--TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred cc--eEecccceeeEEEc-CCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 99 99999999999998 7999999999877554443222 334678999997632 37889999999999
Q ss_pred HHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCC
Q 006810 217 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLR 271 (630)
Q Consensus 217 l~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~R 271 (630)
+|.|++|+.||..... ...... .-..-. ..+..++.+|..+|+ +|.+|
T Consensus 240 ly~lWC~~lPf~~~~~-~~~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSP-EADPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGG-GSTSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCc-cccccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999975321 110000 001112 567889999999998 67666
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.5e-21 Score=217.19 Aligned_cols=241 Identities=20% Similarity=0.272 Sum_probs=176.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
-+.+.||++.|=.|.+|++. .|. |++|++-..+-.-+-....+..+|++ ....+|||.++|..+- ...+..|||.
T Consensus 26 ~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAAylvR 100 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAAYLVR 100 (1431)
T ss_pred eeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHHHHHH
Confidence 56899999999999999765 455 88898754442222233333445556 7777999999998753 3445678899
Q ss_pred cccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee--eccCCC
Q 006810 108 ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV--MQQPTA 185 (630)
Q Consensus 108 Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~--~~~~~~ 185 (630)
+|+.....+.+..+.-+..-+.+.++.||+.||.-+|..| |+|||||++||||+ .-.-+.|.||..-+. +.....
T Consensus 101 qyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 101 QYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEe-eechhhhhcccccCCccCCCCCc
Confidence 9998876666667777888999999999999999999999 99999999999998 666899999976532 111111
Q ss_pred ---cccc----CCCCCCCcccccc-----------c-cCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCC-
Q 006810 186 ---RSVI----GTPEFMAPELYEE-----------E-YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI- 244 (630)
Q Consensus 186 ---~~~~----GTp~Y~APEvl~~-----------~-ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~- 244 (630)
..+. .-.+|.|||.|-. . ..++-||||+||+++||++ |++||. -.|+...-..+.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCcc
Confidence 1112 2348999997632 1 3568899999999999998 688884 344444333321
Q ss_pred CCC-CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 245 KPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 245 ~p~-~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+. -+.+..+..++.+|..|++ +|++|.+|++.|+-
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111 1234456789999999998 99999999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.6e-20 Score=211.23 Aligned_cols=227 Identities=25% Similarity=0.418 Sum_probs=166.1
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
..-|+.--+...+.|..|+||-||+..|+.+-..+|+ .++.... +.+- +|.....|.+|
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l---------ilRn--ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL---------ILRN--ILTFAGNPFVV--------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhh-cccccch---------hhhc--cccccCCccee---------
Confidence 3344444445568899999999999999999999998 4443221 1110 22222222222
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 99 TNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
|+.. .++.-+.++... +.+++|||+.+ |+|||+||+|++|+ .-|++|+.|||++
T Consensus 136 --------------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 136 --------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLS 190 (1205)
T ss_pred --------------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhh
Confidence 5554 444445565544 78999999998 99999999999998 8899999999997
Q ss_pred eee--cc---------------CCCccccCCCCCCCcccc-ccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHH
Q 006810 178 IVM--QQ---------------PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 239 (630)
Q Consensus 178 ~~~--~~---------------~~~~~~~GTp~Y~APEvl-~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~ 239 (630)
... .. -..+.++|||.|.|||++ ..+|+..+|.|++|+|+||.+.|..||.+ .++++++..
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~ 269 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQ 269 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhh
Confidence 421 10 012356899999999965 56799999999999999999999999987 567777777
Q ss_pred HHcC-CCCCCCCCCCcHHHHHHHHHccc-CCCCCC---CHHHHhcCCCcccCCCCccc
Q 006810 240 VTSG-IKPASLSKVTDPQVKQFIEKCIV-PASLRL---PALELLKDPFLVTDNPKDLV 292 (630)
Q Consensus 240 i~~g-~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rp---sa~eLL~hpf~~~~~~~~~~ 292 (630)
+... +....-..-..++++++|.++|+ .|..|. .+-++-+|+||+..+++.++
T Consensus 270 visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~ll 327 (1205)
T KOG0606|consen 270 VISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLL 327 (1205)
T ss_pred hhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhh
Confidence 6653 22222244567999999999996 777765 56788999999998887544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=176.92 Aligned_cols=236 Identities=22% Similarity=0.321 Sum_probs=177.6
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCeeEEEeEEE
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWV 96 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pNIVk~~~~f~ 96 (630)
.+.--.|.| ++.+.||.|+||.+|+|.....|++||||.-... ... ..+..|.++.+.|++ ..|..+..++.
T Consensus 9 ~~~iv~gky-~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 9 EELIVGGKY-KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKH-----PQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred hhheeccce-EEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCC-----cchhHHHHHHHHhccCCCCchhhhhcc
Confidence 334445667 8899999999999999999999999999975422 211 237788899999975 56766666554
Q ss_pred cCCCCEEEEEEcccCCCCHH--HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe--CCCCcEEEc
Q 006810 97 DDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIG 172 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~--~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKL~ 172 (630)
+. .+-.+||++.. -+|. +-.....++.+++.-++-|++.-++|+|.++ +|||||||+|+|+- .+...+.|+
T Consensus 82 e~--~ynvlVMdLLG-PsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 82 EK--DYNVLVMDLLG-PSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred cc--ccceeeeeccC-ccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEE
Confidence 33 45668999874 4665 4456778999999999999999999999999 99999999999983 234579999
Q ss_pred ccccceeeccC---------CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC--CHHHHHHHH
Q 006810 173 DLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKV 240 (630)
Q Consensus 173 DFGla~~~~~~---------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~--~~~~i~~~i 240 (630)
|||+|+.+... ..+...||..|.+--...+ +-+..-|+=|+|.++..+..|..||.+.. +..|.+++|
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 99999765432 2234568999987654332 35677899999999999999999998743 445677777
Q ss_pred HcCCC---CCCCCCCCcHHHHHHHHHcc
Q 006810 241 TSGIK---PASLSKVTDPQVKQFIEKCI 265 (630)
Q Consensus 241 ~~g~~---p~~l~~~~s~~lk~~I~kcL 265 (630)
..... +..+-+-.+.++.-.+.-|-
T Consensus 237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R 264 (341)
T KOG1163|consen 237 SEKKMSTPIEVLCKGFPAEFAMYLNYCR 264 (341)
T ss_pred HHhhcCCCHHHHhCCCcHHHHHHHHHHh
Confidence 65432 33344556777777777774
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=176.83 Aligned_cols=184 Identities=15% Similarity=0.098 Sum_probs=137.8
Q ss_pred eeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEEEEEE
Q 006810 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 29 ~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
....|++|+||+||++.. .+.+++.+.+.....-...-....+.+|+++|++|. |++|++++++ ...+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 357899999999998854 677888776654432111112235789999999995 5889999885 2368999
Q ss_pred cccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccC-CcCceEEeCCCCcEEEcccccceeeccCCC-
Q 006810 108 ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL-KCDNIFVNGNNGEVKIGDLGLAIVMQQPTA- 185 (630)
Q Consensus 108 Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDL-Kp~NILl~~~~g~vKL~DFGla~~~~~~~~- 185 (630)
||+.|.+|...... ....++.|++.+|.++|++| |+|||| ||+|||++ .+|.++|+|||++........
T Consensus 78 eyI~G~~L~~~~~~------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcchH
Confidence 99999998632211 12457899999999999999 999999 79999997 788999999999975443221
Q ss_pred ----c----------cccCCCCCCCccccc--cccC-cccceeehhHHHHHHhhCCCCCCC
Q 006810 186 ----R----------SVIGTPEFMAPELYE--EEYN-ELVDIYSFGMCILEMVTCEYPYNE 229 (630)
Q Consensus 186 ----~----------~~~GTp~Y~APEvl~--~~ys-~~sDIWSLGvil~ELltG~~Pf~~ 229 (630)
. -..++|.|+.|+.-. ...+ ...+.++.|.-+|.++|+..|+.+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 112688999998432 2333 677888999999999999988765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=174.04 Aligned_cols=137 Identities=19% Similarity=0.211 Sum_probs=106.8
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-----CCCCeeEEEeEEEcCCC-CE-
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-----KHENIIKFYNSWVDDTN-RT- 102 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-----~HpNIVk~~~~f~d~~~-~~- 102 (630)
.+.||+|+|+.||. +..++.. +||++..... ...+.+.+|+.+++.| +||||+++|+++.++.. ..
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 36899999999995 7777766 6998876432 2345689999999999 67999999999877643 34
Q ss_pred EEEEEcc--cCCCCHHHHhhcCCCCHHHHHHHHHHHHHHH-HHHHcCCCCEEeccCCcCceEEeC---CCCcEEEccccc
Q 006810 103 INMITEL--FTSGSLRYRKKHKNVDMKAIKNWARQILRGL-HYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGL 176 (630)
Q Consensus 103 l~lV~Ey--~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL-~yLHs~~~~IiHrDLKp~NILl~~---~~g~vKL~DFGl 176 (630)
+.+|+|| +.+|+|....+.+.+++. ..++.|++.++ +|||+++ |+||||||+|||++. .++.++|+||+.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 3378999 668999843344567666 46788988888 9999999 999999999999973 234899999554
Q ss_pred c
Q 006810 177 A 177 (630)
Q Consensus 177 a 177 (630)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-18 Score=174.83 Aligned_cols=211 Identities=21% Similarity=0.327 Sum_probs=163.9
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN 100 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~ 100 (630)
-.|--+|+++.||.|+||..+.|....+++.||||.-..+ . ....+.-|.+..+.|. .++|...|.+- ...
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S---~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG 96 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---S---EAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEG 96 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc---C---CcchHHHHHHHHHHHcCCCCCCceeeec--ccc
Confidence 3455569999999999999999999999999999964322 1 2234667778777774 68888887643 344
Q ss_pred CEEEEEEcccCCCCHH--HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC----CCCcEEEccc
Q 006810 101 RTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDL 174 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~--~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~----~~g~vKL~DF 174 (630)
.+=.||+|++. -+|. +--...+|+.+++.-++.|++.-++|+|+++ +|.|||||+|+||.. ....|.|+||
T Consensus 97 ~~NiLVidLLG-PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 97 KYNILVIDLLG-PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred chhhhhhhhhC-cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEec
Confidence 44557889874 4665 4456778999999999999999999999999 999999999999942 2236899999
Q ss_pred ccceeeccCC---------CccccCCCCCCCcccc-ccccCcccceeehhHHHHHHhhCCCCCCCCC--CHHHHHHHHHc
Q 006810 175 GLAIVMQQPT---------ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTS 242 (630)
Q Consensus 175 Gla~~~~~~~---------~~~~~GTp~Y~APEvl-~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~--~~~~i~~~i~~ 242 (630)
|+|+.+..+. .++..||.+||+--.. ..+-+..-|+=|||-++...+.|..||.+.. +..+.|++|-.
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 9998776543 2356799999997743 3456788999999999999999999998754 34566666654
Q ss_pred C
Q 006810 243 G 243 (630)
Q Consensus 243 g 243 (630)
.
T Consensus 254 ~ 254 (449)
T KOG1165|consen 254 T 254 (449)
T ss_pred c
Confidence 3
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.9e-18 Score=172.84 Aligned_cols=152 Identities=18% Similarity=0.165 Sum_probs=117.9
Q ss_pred CCCcceeeeeEecccCceEEEEEE-EccCCeEEEEEEeecccccC------------------CHH--HHHHHHHHHHHH
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGF-DEVDGIEVAWNQVNIEDVMQ------------------SPD--QLERLYSEVHLL 80 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~-d~~tG~~VAiK~i~~~~~~~------------------~~~--~~~~l~~Ei~iL 80 (630)
-.||-+++.+.||+|+||.||+|. +..+|..||+|++....... ... ....+.+|+.++
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 356677889999999999999998 77899999999997543110 000 113466899999
Q ss_pred HhCCCC--CeeEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCc
Q 006810 81 KSLKHE--NIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 157 (630)
Q Consensus 81 ~~L~Hp--NIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp 157 (630)
+++.+. .+++++++ . ..++||||+.|++|. .......+....+..++.||+.+|.+||.++ .|+||||||
T Consensus 105 ~~L~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp 177 (237)
T smart00090 105 QRLYEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSE 177 (237)
T ss_pred HHHHhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCCh
Confidence 999763 34455542 1 247999999999886 4434556777788999999999999999987 499999999
Q ss_pred CceEEeCCCCcEEEcccccceeecc
Q 006810 158 DNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 158 ~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+||+++ ++.++|+|||.+.....
T Consensus 178 ~NIli~--~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH--DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE--CCCEEEEEChhhhccCC
Confidence 999997 67999999999865443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=174.21 Aligned_cols=188 Identities=20% Similarity=0.339 Sum_probs=138.1
Q ss_pred CCCCeeEEEeEEEc-------------------------CCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHH
Q 006810 84 KHENIIKFYNSWVD-------------------------DTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILR 138 (630)
Q Consensus 84 ~HpNIVk~~~~f~d-------------------------~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~ 138 (630)
+|||||+++..|.+ ..+.++|+||.-... +|+........+.....-++.|++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 69999999998875 133568888887765 5663344556778888899999999
Q ss_pred HHHHHHcCCCCEEeccCCcCceEEeC-CCC--cEEEcccccceeeccC-----CC---ccccCCCCCCCccccccc----
Q 006810 139 GLHYLHSHNPPIIHRDLKCDNIFVNG-NNG--EVKIGDLGLAIVMQQP-----TA---RSVIGTPEFMAPELYEEE---- 203 (630)
Q Consensus 139 gL~yLHs~~~~IiHrDLKp~NILl~~-~~g--~vKL~DFGla~~~~~~-----~~---~~~~GTp~Y~APEvl~~~---- 203 (630)
|+.|||.|| |.|||||.+|||+.- +++ .+.|+|||.+---... .. -..-|.-.-||||+....
T Consensus 353 av~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 353 AVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 999999999 999999999999852 233 6889999976322211 11 122477889999988632
Q ss_pred ---cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHH
Q 006810 204 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL 275 (630)
Q Consensus 204 ---ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~ 275 (630)
.-.++|.|+.|.+.||+++...||..... ..+-...-..-..+.++...++.++++|..+|+ +|++|+++.
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccch-heechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 23589999999999999999999986221 111111111222345677788999999999998 899999854
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.1e-18 Score=169.26 Aligned_cols=234 Identities=18% Similarity=0.297 Sum_probs=178.9
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
..|.....|..|+|+.. |-.++.|+++..++. ....+.|..|...|+-+.||||..+++.+... ..+.+|..||
T Consensus 196 tkl~e~hsgelwrgrwq--gndivakil~vr~~t--~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~isq~m 269 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ--GNDIVAKILNVREVT--ARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVIISQYM 269 (448)
T ss_pred hhhccCCCccccccccc--Ccchhhhhhhhhhcc--hhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceEeeeec
Confidence 45777888999999765 556777887766653 33446688999999999999999999987544 4588899999
Q ss_pred CCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEE--EcccccceeeccCCC
Q 006810 111 TSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK--IGDLGLAIVMQQPTA 185 (630)
Q Consensus 111 ~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK--L~DFGla~~~~~~~~ 185 (630)
+-|+|. .+... -.++..++.+++.+|+.|++|||+..|-|.---|....++|+ ++-+.+ .+|--++.. .
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid-edltarismad~kfsfq--e--- 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFSFQ--E--- 343 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceeeee--c---
Confidence 999997 44433 346788999999999999999999986444556889999998 554444 445433321 1
Q ss_pred ccccCCCCCCCccccccc----cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 186 RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 186 ~~~~GTp~Y~APEvl~~~----ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
......|.||+||.+... .-.++|+|||++++|||.|.+.||.+..+.+--++....|..+ .+++..++.+..++
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv-~ippgis~hm~klm 422 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV-HIPPGISRHMNKLM 422 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc-cCCCCccHHHHHHH
Confidence 122358999999988643 3468999999999999999999999877666666666666544 45566788999999
Q ss_pred HHccc-CCCCCCCHHHH
Q 006810 262 EKCIV-PASLRLPALEL 277 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eL 277 (630)
.-|+. +|.+||....+
T Consensus 423 ~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMI 439 (448)
T ss_pred HHHhcCCCCcCCCccee
Confidence 99996 89999976653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.4e-18 Score=185.06 Aligned_cols=253 Identities=19% Similarity=0.321 Sum_probs=167.8
Q ss_pred CccccCCCCcceeeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEE
Q 006810 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKF 91 (630)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~t---G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~ 91 (630)
+..+..+.+.+ ++.+..++.+++.++...-... .+.++-+...... -.......+++-.+... .|++.+..
T Consensus 236 ~~~~~~~~~s~-~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~----~~~~~~~~r~~~~l~~~~~~~~s~~~ 310 (516)
T KOG1033|consen 236 ESSRHEESGSS-SISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS----LCACKYTFRQLGVLVDSSHSNRSILE 310 (516)
T ss_pred Ccccccccccc-cccccccccccCCchhhhhcccchhhhhccchhhhccc----hhhhhhhhhhhhheeccccCCccccc
Confidence 34444444444 4456677777777776543322 2233322222221 12223344455555444 44444432
Q ss_pred E------eEEEcC---CCCEEEEEEcccCCCCHH-HHhh---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcC
Q 006810 92 Y------NSWVDD---TNRTINMITELFTSGSLR-YRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 158 (630)
Q Consensus 92 ~------~~f~d~---~~~~l~lV~Ey~~gGsL~-~~~~---~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~ 158 (630)
- ..+... ...++|+.|++|..++|. .+.. ....+....+.|+.|+..|+.| ++ .+|||+||.
T Consensus 311 d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~ 385 (516)
T KOG1033|consen 311 DLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPS 385 (516)
T ss_pred CCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhcccc
Confidence 1 122111 123689999999999998 4332 2346778899999999999999 66 999999999
Q ss_pred ceEEeCCCCcEEEcccccceeeccCC--------CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCC
Q 006810 159 NIFVNGNNGEVKIGDLGLAIVMQQPT--------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYN 228 (630)
Q Consensus 159 NILl~~~~g~vKL~DFGla~~~~~~~--------~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~ 228 (630)
||++. .+..+||+|||+........ .....||+.||+||.+. ..|+.++||||||++|+||+. -..+|.
T Consensus 386 nif~~-~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e 464 (516)
T KOG1033|consen 386 NIFFS-DDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE 464 (516)
T ss_pred ccccc-cchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH
Confidence 99997 78899999999987554322 23457999999999887 469999999999999999998 444443
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 229 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 229 ~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
. ...+..+..+..|+.+... .|+-..|+.++|. .|.+||++.+.-.|+|++
T Consensus 465 r----~~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 465 R----IATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred H----HHhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 2 2233445566555443333 3667789999997 799999888877777753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.7e-16 Score=154.65 Aligned_cols=137 Identities=22% Similarity=0.264 Sum_probs=108.8
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~----~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+.||+|++|.||+|.+ .|..|++|+......... .....++.+|+.++..+.|++|+....++.+.. ..++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEE
Confidence 5799999999999976 788899997653322111 112356788999999999999877666655443 46789
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
|||++|++|. .+..... ....++.+++.+|.++|+++ ++|||++|.|||++ ++.++|+|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 9999999998 4433221 88899999999999999999 99999999999997 67899999998854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.5e-18 Score=191.99 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=200.0
Q ss_pred CCCcceeeeeEecccCceEEEEEEEc-cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDT 99 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~-~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~ 99 (630)
|..-| ++.+.||+|+|+.|-++... .....+|.|.+.... ........+..|..+-+.+. |+|++++++.+...
T Consensus 18 ~~~~~-~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~- 93 (601)
T KOG0590|consen 18 PNSQY-KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP- 93 (601)
T ss_pred ccccc-cccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCC-
Confidence 45555 67788999999999988663 344566777665543 34556667778888888887 99999999976443
Q ss_pred CCEEEEEEcccCCCCHH-HH-hhcC-CCCHHHHHHHHHHHHHHHHHHH-cCCCCEEeccCCcCceEEeCCCC-cEEEccc
Q 006810 100 NRTINMITELFTSGSLR-YR-KKHK-NVDMKAIKNWARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNG-EVKIGDL 174 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~-~~~~-~lse~~i~~i~~QIl~gL~yLH-s~~~~IiHrDLKp~NILl~~~~g-~vKL~DF 174 (630)
...+++++|..||++. .+ .... ..+.....+++.|+..+|.|+| ..+ +.||||||+|.+++ .++ .++++||
T Consensus 94 -~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~-~s~~~l~~~df 169 (601)
T KOG0590|consen 94 -RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLD-ESGSALKIADF 169 (601)
T ss_pred -cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhc-cCCCcccCCCc
Confidence 5678899999999997 44 4444 6788899999999999999999 888 99999999999998 777 9999999
Q ss_pred ccceeecc-CC----CccccC-CCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-
Q 006810 175 GLAIVMQQ-PT----ARSVIG-TPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK- 245 (630)
Q Consensus 175 Gla~~~~~-~~----~~~~~G-Tp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~- 245 (630)
|+|..+.. .. ....+| ++.|+|||.+.+ -.....|+||.|+++.-|++|..|+.........+........
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~ 249 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR 249 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc
Confidence 99977655 22 234578 999999998876 3578899999999999999999999764433333222222211
Q ss_pred -CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 246 -PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 246 -p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
........+....+++.++|. +|..|.+..++-.+||+..
T Consensus 250 ~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 250 FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 133345567889999999995 8999999999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3e-16 Score=154.66 Aligned_cols=144 Identities=21% Similarity=0.186 Sum_probs=109.6
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC-----CH-------------HHHHHHHHHHHHHHhCCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-----SP-------------DQLERLYSEVHLLKSLKH 85 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~-----~~-------------~~~~~l~~Ei~iL~~L~H 85 (630)
|+-+++.+.||+|+||.||+|... +|..||+|++....... .. .......+|+.++..+.|
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 343477899999999999999874 89999999987543100 00 011236789999999988
Q ss_pred CC--eeEEEeEEEcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe
Q 006810 86 EN--IIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 163 (630)
Q Consensus 86 pN--IVk~~~~f~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 163 (630)
++ +++.++. ...++||||++|++|..... ......++.+|+.++.++|+++ |+||||||+||+++
T Consensus 93 ~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~-----~~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~ 159 (198)
T cd05144 93 EGFPVPKPIDW------NRHAVVMEYIDGVELYRVRV-----LEDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVD 159 (198)
T ss_pred cCCCCCceeec------CCceEEEEEeCCcchhhccc-----cccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEc
Confidence 74 4444431 23578999999999874322 1456789999999999999998 99999999999998
Q ss_pred CCCCcEEEcccccceeecc
Q 006810 164 GNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 164 ~~~g~vKL~DFGla~~~~~ 182 (630)
.++.++|+|||.+.....
T Consensus 160 -~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 -DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred -CCCcEEEEECCccccCCC
Confidence 689999999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.3e-16 Score=186.32 Aligned_cols=187 Identities=22% Similarity=0.301 Sum_probs=145.5
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCeeEEEeEEEcCCCCEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpNIVk~~~~f~d~~~~~l 103 (630)
+-+.+.||+|+||+||+|.+.. |..||+|+=+.... .+ ++==.+++.+|+ -+.|+.++..++-.+ .-
T Consensus 700 ~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~--~S 769 (974)
T KOG1166|consen 700 FCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--WE-----FYICLQVMERLKPQMLPSIMHISSAHVFQN--AS 769 (974)
T ss_pred EEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--ee-----eeehHHHHHhhchhhhcchHHHHHHHccCC--cc
Confidence 4667899999999999998876 99999998654331 11 111123344444 234555555444333 35
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe------CCCCcEEEccccc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------GNNGEVKIGDLGL 176 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~------~~~g~vKL~DFGl 176 (630)
++|+||.+.|+|. ++...+.+++..+..+..|++..++.||.++ ||||||||+|+||. ..+--++|+|||.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 6799999999997 7778889999999999999999999999999 99999999999995 1234689999999
Q ss_pred ceeecc----CCCccccCCCCCCCccccccc-cCcccceeehhHHHHHHhhCCC
Q 006810 177 AIVMQQ----PTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEY 225 (630)
Q Consensus 177 a~~~~~----~~~~~~~GTp~Y~APEvl~~~-ys~~sDIWSLGvil~ELltG~~ 225 (630)
+..+.. ......++|-.|-.+|+..+. ++..+|.|.|+.+++-||.|++
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 965532 244567789999999998864 8899999999999999999973
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=150.33 Aligned_cols=134 Identities=23% Similarity=0.267 Sum_probs=102.2
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 32 ~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~----~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.||+|+||.||+|. .+|..|++|.......... .....++.+|+.+++.+.|+++....-++.... ..++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEE
Confidence 38999999999997 4678899998654322211 122466789999999999886554443334333 357899
Q ss_pred cccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 108 ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 108 Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
||++|++|......... .++.|++.+|.+||+.+ ++|||++|.||+++ ++.++++|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999999733222111 88999999999999999 99999999999997 68999999998854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.2e-16 Score=170.00 Aligned_cols=194 Identities=27% Similarity=0.417 Sum_probs=148.0
Q ss_pred HHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCE-EeccCC
Q 006810 80 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPI-IHRDLK 156 (630)
Q Consensus 80 L~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~I-iHrDLK 156 (630)
|+.+.|.|+.+|++..++. ..++.|.+||..|+|..... .-.++..-...++++|+.||.|||... | .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999998877 46888999999999983333 456777788889999999999999875 5 999999
Q ss_pred cCceEEeCCCCcEEEcccccceeeccC----CCccccCCCCCCCccccccc--------cCcccceeehhHHHHHHhhCC
Q 006810 157 CDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEEE--------YNELVDIYSFGMCILEMVTCE 224 (630)
Q Consensus 157 p~NILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~~--------ys~~sDIWSLGvil~ELltG~ 224 (630)
..|.+++ ....+||.|||+....... ......-...|.|||++... .+.+.|||||||+++|+++..
T Consensus 77 s~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 77 SSNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred cccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999998 7889999999998665321 11111224469999988652 456799999999999999999
Q ss_pred CCCCCCC---CHHHHHHHHHcCCCCC---CCC-C-CCcHHHHHHHHHccc-CCCCCCCHHHHh
Q 006810 225 YPYNECK---NPAQIYKKVTSGIKPA---SLS-K-VTDPQVKQFIEKCIV-PASLRLPALELL 278 (630)
Q Consensus 225 ~Pf~~~~---~~~~i~~~i~~g~~p~---~l~-~-~~s~~lk~~I~kcL~-~p~~Rpsa~eLL 278 (630)
.||.... .+.++...+..+..+. .+. . ...+++..++++|+. +|.+||+...+-
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 9997632 3345666666622211 111 1 234578999999997 899999988753
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.3e-15 Score=170.67 Aligned_cols=136 Identities=21% Similarity=0.236 Sum_probs=106.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~----~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
...+.||+|+||+||+|... +..+++|+........ .....+++.+|+++++.++|++|+..+.++.+.. ..
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~ 411 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--EK 411 (535)
T ss_pred CccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CC
Confidence 55789999999999999764 3345555432221111 1123467889999999999999988776665543 36
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
++||||+++++|. ++. ....++.|++.+|.|||+++ ++||||||+||+++ ++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCccccc
Confidence 7899999999998 443 45789999999999999999 99999999999994 67899999999865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-15 Score=146.78 Aligned_cols=141 Identities=23% Similarity=0.219 Sum_probs=100.7
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHH--------------------HHHHHHHHHHHhCCCCC--
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL--------------------ERLYSEVHLLKSLKHEN-- 87 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~--------------------~~l~~Ei~iL~~L~HpN-- 87 (630)
.+.||+|+||+||+|.+. +|..||+|++............ .....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999887 8999999998754321111000 01135677777765443
Q ss_pred eeEEEeEEEcCCCCEEEEEEcccCCCCHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCC
Q 006810 88 IIKFYNSWVDDTNRTINMITELFTSGSLRY-RKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGN 165 (630)
Q Consensus 88 IVk~~~~f~d~~~~~l~lV~Ey~~gGsL~~-~~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~ 165 (630)
+.+.+... ..++||||++++.+.+ ........ ..+..++.+++.++.++|. ++ |+||||||+||+++
T Consensus 81 ~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-- 149 (187)
T cd05119 81 VPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-- 149 (187)
T ss_pred CCceEecC------CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE--
Confidence 45555431 2579999999965431 11111111 6788999999999999999 88 99999999999997
Q ss_pred CCcEEEcccccceeecc
Q 006810 166 NGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 166 ~g~vKL~DFGla~~~~~ 182 (630)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 78999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.5e-14 Score=145.88 Aligned_cols=141 Identities=14% Similarity=0.177 Sum_probs=106.3
Q ss_pred eeEec-ccCceEEEEEEEccCCeEEEEEEeecccc----cC-----CHHHHHHHHHHHHHHHhCCCCCe--eEEEeEEEc
Q 006810 30 DEILG-KGAFKTVYKGFDEVDGIEVAWNQVNIEDV----MQ-----SPDQLERLYSEVHLLKSLKHENI--IKFYNSWVD 97 (630)
Q Consensus 30 ~e~LG-~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~----~~-----~~~~~~~l~~Ei~iL~~L~HpNI--Vk~~~~f~d 97 (630)
..+|| .||.|+||++... |..+++|.+..... .. ......++.+|+.++..|.|++| ++.+.+...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 46788 8999999999654 78899998864321 00 11234668899999999998875 666665443
Q ss_pred CCCC--EEEEEEcccCC-CCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 98 DTNR--TINMITELFTS-GSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 98 ~~~~--~l~lV~Ey~~g-GsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
.... ..++||||++| .+|........+++.. +.||+.+|.+||++| |+||||||.|||++ .++.++|+||
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~-~~~~v~LIDf 186 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLD-PDGKFWLIDF 186 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEc-CCCCEEEEEC
Confidence 3222 23589999998 6887444445666553 578999999999999 99999999999997 6789999999
Q ss_pred cccee
Q 006810 175 GLAIV 179 (630)
Q Consensus 175 Gla~~ 179 (630)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-13 Score=125.70 Aligned_cols=133 Identities=20% Similarity=0.104 Sum_probs=108.0
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCeeEEEeEEEcCCCCEEEEEE
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.||+|.++.||++.+.. ..+++|.+..... ...+.+|+.+++.+.| +++++++.++... ...++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~ 72 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLM 72 (155)
T ss_pred ceecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEE
Confidence 4679999999999998753 7899998754321 3458889999999976 5889988866433 4688999
Q ss_pred cccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 108 ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 108 Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~-~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
||+.++.+... +......++.+++.+|.+||... .+++||||+|.||+++ ..+.++++|||.+..
T Consensus 73 e~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-CCcEEEEEecccccC
Confidence 99999887632 66778889999999999999852 2499999999999998 578999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.8e-13 Score=150.97 Aligned_cols=248 Identities=23% Similarity=0.261 Sum_probs=188.4
Q ss_pred eeEecc--cCceEEEEEEE--ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEEE
Q 006810 30 DEILGK--GAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 30 ~e~LG~--G~fg~Vy~A~d--~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l~ 104 (630)
...+|. |.+|.||.+.. ..++..+|+|.-+..- ..+....+=++|+...+.+ .|+|.++.+..|... ..++
T Consensus 119 ~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~--s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~--~~lf 194 (524)
T KOG0601|consen 119 SSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF--SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS--GILF 194 (524)
T ss_pred ccccccCCCCCceeecccCCcccCCcccccccccCCC--CCccccccccchhhcccccCccccccccCcccccC--Ccce
Confidence 467999 99999999988 8899999998733211 1122223345677777777 499999999988654 4588
Q ss_pred EEEcccCCCCHHHHhhcCC-CCHHHHHHHHHHHHH----HHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 105 MITELFTSGSLRYRKKHKN-VDMKAIKNWARQILR----GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 105 lV~Ey~~gGsL~~~~~~~~-lse~~i~~i~~QIl~----gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
+-+|+|....+.+...... ++...++..+.+... ||.++|+.+ ++|-|+||+||++..+....+++|||+...
T Consensus 195 iqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 195 IQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeEE
Confidence 8899998544456555444 899999999999999 999999998 999999999999973338899999999877
Q ss_pred eccCCCc-------cccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006810 180 MQQPTAR-------SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 252 (630)
Q Consensus 180 ~~~~~~~-------~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~ 252 (630)
+...... ...|...|++||+.++-++.+.|||+||.++.+..++-.++....+.. ...+..+..|..+-..
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--WSQLRQGYIPLEFCEG 350 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC--ccccccccCchhhhcC
Confidence 6554311 124677899999999999999999999999999999988776542211 1112222334444444
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.+..+...+..++. ++..|+++..++.|+++..
T Consensus 351 ~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 351 GSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 55666778888887 7899999999999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.9e-13 Score=157.68 Aligned_cols=254 Identities=19% Similarity=0.320 Sum_probs=194.9
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
+.+-+|+++.++.+.-..+|...+.+.......... ...+.+.++-.++-...||-++..+..|... ..++++++|.
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r--sP~~L~~~~~ 886 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSFPCR--SPLPLVGHYL 886 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCCCCC--CCcchhhHHh
Confidence 567789999999997777776666666544332221 1233444555555556778888877765333 4588999999
Q ss_pred CCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee---------
Q 006810 111 TSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--------- 180 (630)
Q Consensus 111 ~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~--------- 180 (630)
.+|+|. .+..-+..+....+.....+.++++|||+.. +.|||++|+|+++. .+|..++.|||.....
T Consensus 887 ~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 887 NGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred ccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCccccccccccccCcCCc
Confidence 999998 6666677888899999999999999999987 89999999999997 8999999999832100
Q ss_pred ----c------------c--------CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHH
Q 006810 181 ----Q------------Q--------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 235 (630)
Q Consensus 181 ----~------------~--------~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~ 235 (630)
+ . .......||+.|.|||...+ ....++|.|++|++++|.++|.+||.. ..+.+
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~tpq~ 1042 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-ETPQQ 1042 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-cchhh
Confidence 0 0 00123468999999997654 578899999999999999999999987 66777
Q ss_pred HHHHHHcCCC-CCCCCCCCcHHHHHHHHHccc-CCCCCCCHH---HHhcCCCcccCCCCcc
Q 006810 236 IYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPAL---ELLKDPFLVTDNPKDL 291 (630)
Q Consensus 236 i~~~i~~g~~-p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~---eLL~hpf~~~~~~~~~ 291 (630)
+++.+..+.. +..-+...++++++++.+.|. .|.+|..+. ++-.||||+..++..+
T Consensus 1043 ~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1043 IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence 7777766544 344455678999999999997 799999988 8899999999877654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.3e-11 Score=134.57 Aligned_cols=143 Identities=20% Similarity=0.165 Sum_probs=94.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCH--------------------------HH----------HHHHH
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--------------------------DQ----------LERLY 74 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~--------------------------~~----------~~~l~ 74 (630)
+.||.|++|.||+|... +|+.||||+.+..-...-. .. .-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999754 7999999998643110000 00 01244
Q ss_pred HHHHHHHhCC----CCCeeEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHH-HHHHHHcCC
Q 006810 75 SEVHLLKSLK----HENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILR-GLHYLHSHN 147 (630)
Q Consensus 75 ~Ei~iL~~L~----HpNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~-gL~yLHs~~ 147 (630)
+|.+.+..+. |.+-+.+-.++.+-. ..-++||||++|++|. .... ....+ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 5666666652 333333333332222 2357899999999997 3221 12222 3445666655 467889998
Q ss_pred CCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 148 ~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++|+|++|.||+++ .+|.++|+|||++..+.
T Consensus 278 --~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 --FFHADLHPGNIFVL-KDGKIIALDFGIVGRLS 308 (437)
T ss_pred --ceeCCCCcccEEEC-CCCcEEEEeCCCeeECC
Confidence 99999999999997 78999999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1e-10 Score=115.67 Aligned_cols=143 Identities=16% Similarity=0.162 Sum_probs=104.8
Q ss_pred eEecccCceEEEEEEEcc------CCeEEEEEEeecccc--cC-------C---------HHHHHHHH----HHHHHHHh
Q 006810 31 EILGKGAFKTVYKGFDEV------DGIEVAWNQVNIEDV--MQ-------S---------PDQLERLY----SEVHLLKS 82 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~------tG~~VAiK~i~~~~~--~~-------~---------~~~~~~l~----~Ei~iL~~ 82 (630)
..||.|-=+.||.|.... .+..+|+|+.+..-. .. . ......+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998654 358999998754210 00 0 01122233 89999999
Q ss_pred CCC--CCeeEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHH-HcCCCCEEeccCCcC
Q 006810 83 LKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCD 158 (630)
Q Consensus 83 L~H--pNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yL-Hs~~~~IiHrDLKp~ 158 (630)
|.. -++++.+.+ . .-++||||+.++.+. ...+...++...+..+..|++.+|.+| |..+ ++||||++.
T Consensus 83 l~~~Gv~vP~pi~~---~---~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL---K---KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe---c---CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 953 566677763 1 246799999887554 333444566777888899999999999 8898 999999999
Q ss_pred ceEEeCCCCcEEEcccccceeeccC
Q 006810 159 NIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 159 NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
||++. +|.+.|+|||.+.....+
T Consensus 155 NIL~~--~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 155 NMLWH--DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred HEEEE--CCcEEEEECCCceeCCCC
Confidence 99996 578999999988765443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=2e-11 Score=137.30 Aligned_cols=141 Identities=14% Similarity=0.156 Sum_probs=94.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeeccccc--------------------------CCH----HHHHH------HH
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--------------------------QSP----DQLER------LY 74 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~--------------------------~~~----~~~~~------l~ 74 (630)
+.||+|++|.||+|..+.+|++||+|+++..-.. ... +..+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 6899999999999999888999999998743100 000 11112 33
Q ss_pred HHHHHHHhCC----CCCeeEEEeEEEcCCCCEEEEEEcccCCCCHHH---HhhcC----CCCHHHHHHHHHHHHHHHHHH
Q 006810 75 SEVHLLKSLK----HENIIKFYNSWVDDTNRTINMITELFTSGSLRY---RKKHK----NVDMKAIKNWARQILRGLHYL 143 (630)
Q Consensus 75 ~Ei~iL~~L~----HpNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~~---~~~~~----~lse~~i~~i~~QIl~gL~yL 143 (630)
+|+..+.++. +.+.+.+-.+|.+-. ..-++||||+.|+.+.. +...+ .+.+..+..++.||+
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s-t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------ 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYC-SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------ 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccC-CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH------
Confidence 4555555542 344444434332222 23568999999999862 22222 245555666677765
Q ss_pred HcCCCCEEeccCCcCceEEeCCCC----cEEEcccccceeecc
Q 006810 144 HSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVMQQ 182 (630)
Q Consensus 144 Hs~~~~IiHrDLKp~NILl~~~~g----~vKL~DFGla~~~~~ 182 (630)
..| ++|+|+||.||+++ .+| .++++|||++..+..
T Consensus 278 -~~G--ffHaDpHPGNIlv~-~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -RDG--FFHADMHPGNIFVS-YDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -hCC--eeeCCCChHHeEEe-cCCCCCCeEEEEecceEEECCH
Confidence 367 99999999999998 566 999999999876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.18 E-value=8.1e-11 Score=112.01 Aligned_cols=128 Identities=20% Similarity=0.057 Sum_probs=93.8
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCee-EEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII-KFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIV-k~~~~f~d~~~~~l~lV~Ey 109 (630)
+.|+.|.++.||++... |..|++|....... ....+.+|+.+++.+.+.+++ +++.+. ... -++||||
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~--~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFD--PET--GVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCC--CeEEEEe
Confidence 56899999999999754 88999998753321 112356789999988655544 455432 222 3689999
Q ss_pred cCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCC---CEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 110 FTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP---PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 110 ~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~---~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
++|.++... ......++.+++.+|..||..+. .++|||++|.||+++ ++.++++|||.+.
T Consensus 73 i~G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG 135 (170)
T ss_pred cCCCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence 999987632 11124567899999999999872 259999999999997 5689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2e-10 Score=128.38 Aligned_cols=168 Identities=24% Similarity=0.314 Sum_probs=123.7
Q ss_pred EEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCCCCHHHHhhcC
Q 006810 43 KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHK 122 (630)
Q Consensus 43 ~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~~~~~~~ 122 (630)
.|..+.+|.+|.+...+... ....+.+.+-++.|+.++||||++|++.+..+ .++|+|||-+.--.. +++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~--~~~ylvTErV~Pl~~-~lk~-- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEEE--GTLYLVTERVRPLET-VLKE-- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhccc--CceEEEeeccccHHH-HHHH--
Confidence 56778889999998887543 24456677889999999999999999998655 479999998754321 2222
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC--ccccCCCCCCCcccc
Q 006810 123 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPELY 200 (630)
Q Consensus 123 ~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~--~~~~GTp~Y~APEvl 200 (630)
+....+..-+.||+.||.+||..+ .++|++|.-+.|||+ ..|..||++|-++........ +...---.|..|+.+
T Consensus 101 -l~~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 101 -LGKEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEI 177 (690)
T ss_pred -hHHHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChhhc
Confidence 226677788999999999998543 399999999999998 899999999988765443221 111112235555533
Q ss_pred ccccCcccceeehhHHHHHHhhC
Q 006810 201 EEEYNELVDIYSFGMCILEMVTC 223 (630)
Q Consensus 201 ~~~ys~~sDIWSLGvil~ELltG 223 (630)
... .-..|.|-|||++++++.|
T Consensus 178 ~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Ccc-ccchhhhhHHHHHHHHhCc
Confidence 211 1457999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.2e-11 Score=131.64 Aligned_cols=249 Identities=20% Similarity=0.193 Sum_probs=171.9
Q ss_pred CCCcceeeeeEecccCceEEEEEEEc-cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 99 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~-~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~ 99 (630)
+.+++. +...||.|.|+.|+...-. .++..|++|.+... .....++ ..-..|+-+...+ -|.+++.++..|....
T Consensus 263 ~~~df~-~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 263 KLTDFG-LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ecCCcc-eeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhh-hcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 334443 3477999999999987544 67888999887533 2222222 3344677777666 5999999999997655
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
+ .|+=.|||.++++. ....-..+++...+++..|++.++.++|+.. ++|+|+||.||++....+.-+++|||.+.
T Consensus 340 ~--~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 340 Q--GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred c--ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccc
Confidence 4 45778999999998 4445566889999999999999999999998 99999999999997223788999999986
Q ss_pred eeccCCCccccCCCCCC-Ccccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 179 VMQQPTARSVIGTPEFM-APELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 179 ~~~~~~~~~~~GTp~Y~-APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
.+.-... .....-+++ .+|++.. .+..++|++|||..+.+.+++..--... +....+..+..+. .+.. ..
T Consensus 416 ~~~~~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----~~~~~i~~~~~p~-~~~~-~~ 488 (524)
T KOG0601|consen 416 RLAFSSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----VQSLTIRSGDTPN-LPGL-KL 488 (524)
T ss_pred ccceecc-cccccccccccchhhccccccccccccccccccccccccCcccCccc----ccceeeecccccC-CCch-HH
Confidence 4322211 122233444 3555443 4678999999999999999997432221 1122233332221 1222 25
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
++..+.+.++. ++..|+.+.++..|.-|.
T Consensus 489 ~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 489 QLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 66667777775 678889999988876554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=3e-09 Score=105.16 Aligned_cols=144 Identities=19% Similarity=0.202 Sum_probs=105.9
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCeeEEEeEEEcCC-CCEEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDT-NRTINMIT 107 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pNIVk~~~~f~d~~-~~~l~lV~ 107 (630)
+.|+.|.++.||++... +|..+++|........ .....+.+|+.+++.+.+ .++.+++.+..... ....++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 66899999999999764 3689999987643321 123457889999999976 34566666543221 12467999
Q ss_pred cccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 006810 108 ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHN---------------------------------------- 147 (630)
Q Consensus 108 Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~---------------------------------------- 147 (630)
||++|+++........+++.....++.+++.+|.+||+..
T Consensus 80 e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 80 ERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999998873322256788888889999999999998531
Q ss_pred --------------CCEEeccCCcCceEEeCC-CCcEEEcccccce
Q 006810 148 --------------PPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAI 178 (630)
Q Consensus 148 --------------~~IiHrDLKp~NILl~~~-~g~vKL~DFGla~ 178 (630)
..++|+|+++.||+++.. ++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 237999999999999832 5678999998774
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.5e-08 Score=96.47 Aligned_cols=145 Identities=21% Similarity=0.265 Sum_probs=104.0
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEE
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~----~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~l 105 (630)
..+|-+|+-+.|+++. ..|+.+.||.=..+..... .-...+..+|+++|.++.--.|.---=+|+|.....+
T Consensus 12 l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i-- 87 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI-- 87 (229)
T ss_pred ceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE--
Confidence 4788999999999995 4588888886544433321 1234667889999999965555443334566655555
Q ss_pred EEcccCCC-CHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcE--EEccccccee
Q 006810 106 ITELFTSG-SLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV--KIGDLGLAIV 179 (630)
Q Consensus 106 V~Ey~~gG-sL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v--KL~DFGla~~ 179 (630)
+|||++|- +++ ++... ..........++++|=..+.-||..+ ||||||..+||++..+++++ .++|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 66999884 444 54433 22333344789999999999999999 99999999999998655555 8999999854
Q ss_pred e
Q 006810 180 M 180 (630)
Q Consensus 180 ~ 180 (630)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.2e-08 Score=106.38 Aligned_cols=213 Identities=18% Similarity=0.269 Sum_probs=150.0
Q ss_pred CceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC--CCEEEEEEcccCCC-
Q 006810 37 AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--NRTINMITELFTSG- 113 (630)
Q Consensus 37 ~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~--~~~l~lV~Ey~~gG- 113 (630)
--.+.|+|+...+|..|++|+++....... .+...-+++++++.|+|||+|.++|.... ...+++|++|.++.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 346789999999999999999954332221 12345688999999999999999987432 34799999998874
Q ss_pred CHH--HH--------------hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 114 SLR--YR--------------KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 114 sL~--~~--------------~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
+|- +. ..+...++..+|.++.|+..||.++|+.| +.-+-|.+.+|+++| +.+++|...|+.
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G-~~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTG-KMRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeC-cceEEEecccce
Confidence 442 21 12345789999999999999999999999 888999999999985 448899888877
Q ss_pred eeeccCCCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCcHH
Q 006810 178 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 178 ~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i-~~~i~~g~~p~~l~~~~s~~ 256 (630)
........ +.+++ -.+-|.=.||.+++.|+||..--......... .+.+ ...++.+
T Consensus 441 Dvl~~d~~------------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I---------~~~yS~D 497 (655)
T KOG3741|consen 441 DVLQEDPT------------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI---------TTTYSTD 497 (655)
T ss_pred eeecCCCC------------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh---------hhhhhHH
Confidence 65544321 11111 12457777999999999996432221111111 2222 2345678
Q ss_pred HHHHHHHcccC-CCCCCCHHHHhcC
Q 006810 257 VKQFIEKCIVP-ASLRLPALELLKD 280 (630)
Q Consensus 257 lk~~I~kcL~~-p~~Rpsa~eLL~h 280 (630)
++++|.-+... +.+ .+..+++.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 89999887763 443 788888764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.6e-08 Score=94.87 Aligned_cols=131 Identities=22% Similarity=0.309 Sum_probs=93.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHH-----HHHHHHHHHHHHHhCCCCCe--eEEEeEEEcCCCCEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD-----QLERLYSEVHLLKSLKHENI--IKFYNSWVDDTNRTI 103 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~-----~~~~l~~Ei~iL~~L~HpNI--Vk~~~~f~d~~~~~l 103 (630)
..+++|+-+.+|.+.. -|..+++|.=-.+... .+. ..++-.+|+++|.+++--.| +.+|+ ++..+ -
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR-~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d--vD~~~--~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYR-HPELDEKLRRERTRREARILAKAREAGVPVPIVYD--VDPDN--G 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccC-ChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE--EcCCC--C
Confidence 3578999999999944 4556666643222222 222 23556689999999865444 44555 55554 3
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
.++|||++|-.|+ ++... ...+++.+=.-+.-||..| |+||||.+.||++. ++.+.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~--~~~i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILS--GGRIYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEe--CCcEEEEECCcccc
Confidence 4688999999998 55444 2456777777788899999 99999999999997 44599999999964
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.7e-08 Score=94.68 Aligned_cols=131 Identities=27% Similarity=0.279 Sum_probs=83.5
Q ss_pred EEEEEEEccCCeEEEEEEeeccccc---------------------CC-HHHHHHHHHHHHHHHhCCCC--CeeEEEeEE
Q 006810 40 TVYKGFDEVDGIEVAWNQVNIEDVM---------------------QS-PDQLERLYSEVHLLKSLKHE--NIIKFYNSW 95 (630)
Q Consensus 40 ~Vy~A~d~~tG~~VAiK~i~~~~~~---------------------~~-~~~~~~l~~Ei~iL~~L~Hp--NIVk~~~~f 95 (630)
.||.|.. ..|..||+|+.+..... .. ........+|+++|..+..- ++++.+++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899976 47889999987652110 00 01234567899999999765 56777754
Q ss_pred EcCCCCEEEEEEcccC--CCCHHHHhhcCCCCHHHHHHHHHHHHHHHHH-HHcCCCCEEeccCCcCceEEeCCCCcEEEc
Q 006810 96 VDDTNRTINMITELFT--SGSLRYRKKHKNVDMKAIKNWARQILRGLHY-LHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~--gGsL~~~~~~~~lse~~i~~i~~QIl~gL~y-LHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 172 (630)
.. -++||||++ |..+..+.. ..++......++.+++..+.. +|..| |+||||.+.||+++ .+.+.|+
T Consensus 79 -~~----~~ivME~I~~~G~~~~~l~~-~~~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~--~~~~~iI 148 (188)
T PF01163_consen 79 -NR----NVIVMEYIGEDGVPLPRLKD-VDLSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVD--DGKVYII 148 (188)
T ss_dssp -ET----TEEEEE--EETTEEGGCHHH-CGGGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEE--TTCEEE-
T ss_pred -eC----CEEEEEecCCCccchhhHHh-ccccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEee--cceEEEE
Confidence 22 257999999 655543222 222245567788888885555 57888 99999999999997 3489999
Q ss_pred ccccceeecc
Q 006810 173 DLGLAIVMQQ 182 (630)
Q Consensus 173 DFGla~~~~~ 182 (630)
|||.+.....
T Consensus 149 Df~qav~~~~ 158 (188)
T PF01163_consen 149 DFGQAVDSSH 158 (188)
T ss_dssp -GTTEEETTS
T ss_pred ecCcceecCC
Confidence 9998865543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.3e-09 Score=119.12 Aligned_cols=242 Identities=21% Similarity=0.265 Sum_probs=168.6
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-eeEEEeEEEc
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVD 97 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN-IVk~~~~f~d 97 (630)
..|+. ||+.+-.-+++|+++.+||++...+...+ .+.|... ....-++++|.+++||| .+.+++.+
T Consensus 237 lkDk~-kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~-- 303 (829)
T KOG0576|consen 237 LKDKT-KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY-- 303 (829)
T ss_pred ccCCc-cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--
Confidence 34444 44444466899999999999888776665 6666432 23456889999999999 55555543
Q ss_pred CCCCEEEEEEcccCCC-CHH--HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 98 DTNRTINMITELFTSG-SLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gG-sL~--~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
+.+...+++++++.+| +-. .....-.+.+-+....++.=+.+|+|+|+.. -+||| ||+.. ++..|.+||
T Consensus 304 ~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s--~~~~~~~~~ 375 (829)
T KOG0576|consen 304 DGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGS--EEEVKLLDF 375 (829)
T ss_pred CcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccccc--ccccccccc
Confidence 3345788999999988 222 1122223445566677888889999999875 58998 77764 678999999
Q ss_pred ccceeeccC-CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC--CC
Q 006810 175 GLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LS 250 (630)
Q Consensus 175 Gla~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~--l~ 250 (630)
+....+... ..++..+|+.++|||+.. +.+....|.|++|.-..+|.-|.+|-... +.+. ...+..|.. +.
T Consensus 376 ~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~---~~~g~~p~s~~L~ 450 (829)
T KOG0576|consen 376 AVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVL---PMIGNGPNSPMLT 450 (829)
T ss_pred cCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--cccc---CCCCCCCCccccc
Confidence 998766554 456788999999999654 56899999999999999999998887541 1111 111111100 00
Q ss_pred --CCCcHHH-HHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 251 --KVTDPQV-KQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 251 --~~~s~~l-k~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
...++.. ++|...|+. .|..|+.+..+++|.+|..-
T Consensus 451 ~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 451 DKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred hhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 0111222 358888997 69999999999999999653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.9e-08 Score=110.72 Aligned_cols=146 Identities=20% Similarity=0.312 Sum_probs=105.4
Q ss_pred HHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCc-----------cccCCCCCCCcccccc-ccC
Q 006810 138 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-----------SVIGTPEFMAPELYEE-EYN 205 (630)
Q Consensus 138 ~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~-----------~~~GTp~Y~APEvl~~-~ys 205 (630)
.||.|+|.+- .+||++|.|++|.++ .+|..||+.|+++.....+... ...-...|.|||++.. ..+
T Consensus 110 dgl~flh~sA-k~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~ 187 (700)
T KOG2137|consen 110 DGLAFLHRSA-KVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNT 187 (700)
T ss_pred chhhhhccCc-ceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccc
Confidence 8999999874 699999999999998 7999999999987544332110 1123557999997765 467
Q ss_pred cccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCC
Q 006810 206 ELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT--SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 281 (630)
Q Consensus 206 ~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~--~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hp 281 (630)
.++|+||||+.+|.+.. |..-+.. .+....+.... .+..........+.++++-+.++|. ++..||++.+++..|
T Consensus 188 ~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 188 PASDVFSLGVLIYTIYNGGKSIIAA-NGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred ccccceeeeeEEEEEecCCcchhhc-cCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence 89999999999999994 5444433 22222221111 1112223345677899999999996 899999999999999
Q ss_pred CcccC
Q 006810 282 FLVTD 286 (630)
Q Consensus 282 f~~~~ 286 (630)
||...
T Consensus 267 ff~D~ 271 (700)
T KOG2137|consen 267 FFSDP 271 (700)
T ss_pred ccCCc
Confidence 99754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-06 Score=94.25 Aligned_cols=242 Identities=17% Similarity=0.222 Sum_probs=151.5
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHH-hCCCCCeeEEEeEEE---
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWV--- 96 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~-~L~HpNIVk~~~~f~--- 96 (630)
++.|--...++.||+|+-+.+|-.- .-+.. +.|+...... .... +.+..|. .-.||-+-. -=.|-
T Consensus 7 ~~~ge~i~~gr~LgqGgea~ly~l~--e~~d~-VAKIYh~Ppp----a~~a---qk~a~la~~p~~p~~~~-rvaWPqa~ 75 (637)
T COG4248 7 DVYGEPIPPGRPLGQGGEADLYTLG--EVRDQ-VAKIYHAPPP----AAQA---QKVAELAATPDAPLLNY-RVAWPQAT 75 (637)
T ss_pred cccCcccCCCccccCCccceeeecc--hhhch-hheeecCCCc----hHHH---HHHHHhccCCCCcchhh-hhcccHHH
Confidence 4444444456779999999999652 22223 3466543321 1111 1122233 335664332 11121
Q ss_pred ---cCCCCEEEEEEcccCCCCH-H--H-----HhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC
Q 006810 97 ---DDTNRTINMITELFTSGSL-R--Y-----RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 165 (630)
Q Consensus 97 ---d~~~~~l~lV~Ey~~gGsL-~--~-----~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 165 (630)
.+....+-|+|..+.+..= . | +.......+.-+.+.++.|+.+.+-||.+| .+-||+.++|+|+. +
T Consensus 76 L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-d 152 (637)
T COG4248 76 LHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-D 152 (637)
T ss_pred hhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-c
Confidence 1223347888888877522 1 1 122344678889999999999999999999 89999999999997 8
Q ss_pred CCcEEEcccccceee-ccCCCccccCCCCCCCccccc-c-----ccCcccceeehhHHHHHHhhC-CCCCCCCC----CH
Q 006810 166 NGEVKIGDLGLAIVM-QQPTARSVIGTPEFMAPELYE-E-----EYNELVDIYSFGMCILEMVTC-EYPYNECK----NP 233 (630)
Q Consensus 166 ~g~vKL~DFGla~~~-~~~~~~~~~GTp~Y~APEvl~-~-----~ys~~sDIWSLGvil~ELltG-~~Pf~~~~----~~ 233 (630)
++.|.|.|=..-..- +.......+|.++|.+||+-. + +-+...|.|.||+++++++.| ++||++-. .+
T Consensus 153 ~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap 232 (637)
T COG4248 153 DSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP 232 (637)
T ss_pred CceEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC
Confidence 899999885433222 222223457899999999643 2 246789999999999999987 99998621 01
Q ss_pred HHHHHHHHc-----------CCCC--CCC-CCCCcHHHHHHHHHcccC---CCCCCCHHH
Q 006810 234 AQIYKKVTS-----------GIKP--ASL-SKVTDPQVKQFIEKCIVP---ASLRLPALE 276 (630)
Q Consensus 234 ~~i~~~i~~-----------g~~p--~~l-~~~~s~~lk~~I~kcL~~---p~~Rpsa~e 276 (630)
.-....|.. +..| ..+ ....++.+..+..+|+.+ +.-||+++.
T Consensus 233 ~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 233 NPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred CcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 111112222 2222 122 234578999999999974 568999753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.5e-06 Score=90.39 Aligned_cols=105 Identities=18% Similarity=0.130 Sum_probs=76.9
Q ss_pred HHHHHHHHHHhCCCCCee--EEEeEEEcCC---CCEEEEEEcccCCC-CHH-HHhh--cCCCCHHHHHHHHHHHHHHHHH
Q 006810 72 RLYSEVHLLKSLKHENII--KFYNSWVDDT---NRTINMITELFTSG-SLR-YRKK--HKNVDMKAIKNWARQILRGLHY 142 (630)
Q Consensus 72 ~l~~Ei~iL~~L~HpNIV--k~~~~f~d~~---~~~l~lV~Ey~~gG-sL~-~~~~--~~~lse~~i~~i~~QIl~gL~y 142 (630)
.+.+|...+..|..-+|. +...+..... ...-++|||++++. +|. +... ....+......++.++...+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 367888888887433222 2333332211 23467899999986 787 4322 3456677888999999999999
Q ss_pred HHcCCCCEEeccCCcCceEEeC------CCCcEEEcccccce
Q 006810 143 LHSHNPPIIHRDLKCDNIFVNG------NNGEVKIGDLGLAI 178 (630)
Q Consensus 143 LHs~~~~IiHrDLKp~NILl~~------~~g~vKL~DFGla~ 178 (630)
||..| |+||||++.|||++. .++.+.|+||+.+.
T Consensus 154 LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99999 999999999999973 24689999999775
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.7e-07 Score=93.49 Aligned_cols=139 Identities=21% Similarity=0.215 Sum_probs=100.3
Q ss_pred ceeeeeEecccCceEEEEEEEccCCeEEEEEEeeccc-----ccCCH-------------HHHHHHHHHHHHHHhCCCC-
Q 006810 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIED-----VMQSP-------------DQLERLYSEVHLLKSLKHE- 86 (630)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~-----~~~~~-------------~~~~~l~~Ei~iL~~L~Hp- 86 (630)
+..++..||-|--+.||.|.+. .|.++|+|.-+... ..... -......+|+++|..|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 4467889999999999999876 78999999754321 11111 1134467899999999655
Q ss_pred -CeeEEEeEEEcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC
Q 006810 87 -NIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 165 (630)
Q Consensus 87 -NIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 165 (630)
.|++-+++ .+..+||||++|-.|.... ++.+....++..|+.-+.-+-..| +||||+++-||+++ .
T Consensus 171 ~~VP~P~~~------nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~-~ 237 (304)
T COG0478 171 VKVPKPIAW------NRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVT-E 237 (304)
T ss_pred CCCCCcccc------ccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEe-c
Confidence 77777763 3467899999997775221 134445555666666555555667 99999999999998 8
Q ss_pred CCcEEEcccccce
Q 006810 166 NGEVKIGDLGLAI 178 (630)
Q Consensus 166 ~g~vKL~DFGla~ 178 (630)
+|.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999996553
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.1e-07 Score=63.77 Aligned_cols=32 Identities=38% Similarity=0.523 Sum_probs=27.4
Q ss_pred eEEEEEecCCCC------CeeeeEeecccCCccHHHHH
Q 006810 365 VSLTLRIGDKSG------HVSNIHFVFYLNADTAISIA 396 (630)
Q Consensus 365 i~L~Lri~d~~~------~~~~i~f~f~~~~Dta~~va 396 (630)
|.|+||++|+.+ ++++|+|+|++++|+|++||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 679999999998 89999999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.8e-06 Score=82.45 Aligned_cols=107 Identities=21% Similarity=0.214 Sum_probs=80.2
Q ss_pred HHHHHHHHHHHHhCCCCC--eeEEEeEEEcCC--CCEEEEEEcccCCC-CHH-HHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 006810 70 LERLYSEVHLLKSLKHEN--IIKFYNSWVDDT--NRTINMITELFTSG-SLR-YRKKHKNVDMKAIKNWARQILRGLHYL 143 (630)
Q Consensus 70 ~~~l~~Ei~iL~~L~HpN--IVk~~~~f~d~~--~~~l~lV~Ey~~gG-sL~-~~~~~~~lse~~i~~i~~QIl~gL~yL 143 (630)
..+..+|...+..|..-. +++.+.+..... ...-++|||++++. +|. .......++......++.++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 346778888888774332 333444333222 13468899999985 687 555545578888999999999999999
Q ss_pred HcCCCCEEeccCCcCceEEeCCCC---cEEEccccccee
Q 006810 144 HSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDLGLAIV 179 (630)
Q Consensus 144 Hs~~~~IiHrDLKp~NILl~~~~g---~vKL~DFGla~~ 179 (630)
|..| |+|+|+++.|||++ .++ .+.|+||+-+..
T Consensus 135 H~~g--i~H~Dl~~~NILv~-~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVD-PDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEe-CCCCceeEEEEcchhcee
Confidence 9999 99999999999998 454 799999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.4e-05 Score=78.25 Aligned_cols=140 Identities=14% Similarity=0.135 Sum_probs=95.6
Q ss_pred cccCceEEEEEEEccCCeEEEEEEee--cccccCCHHHHHHHHHHHHHHHhCCCCC--eeEEE--eEEEcCCCCEEEEEE
Q 006810 34 GKGAFKTVYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFY--NSWVDDTNRTINMIT 107 (630)
Q Consensus 34 G~G~fg~Vy~A~d~~tG~~VAiK~i~--~~~~~~~~~~~~~l~~Ei~iL~~L~HpN--IVk~~--~~f~d~~~~~l~lV~ 107 (630)
|+||.+.|+... ..|..+-+|+-. .......+-....+.+|+..|..|..-+ +.+.. +.--......-+|||
T Consensus 27 ~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 578999999874 334567777653 1111111234567999999999985322 33333 211122233577899
Q ss_pred cccCC-CCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc--EEEcccccce
Q 006810 108 ELFTS-GSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAI 178 (630)
Q Consensus 108 Ey~~g-GsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~--vKL~DFGla~ 178 (630)
|-+.+ -+|. .+.. -.+.+......++.+|...+.-||..| +.|+|+-+.|||++ .+|. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~-~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVK-TEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeec-CCCCeeEEEEEhhccc
Confidence 97764 4676 3333 235578888899999999999999999 99999999999997 4556 9999997553
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.3e-06 Score=99.03 Aligned_cols=204 Identities=23% Similarity=0.350 Sum_probs=143.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE--EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 006810 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT--INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLH 144 (630)
Q Consensus 68 ~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~--l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLH 144 (630)
.++....-|+..+..+.|+|++.++.|-+...... +.+..++|+.-++. .+..-+.++....+.|..+++.||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 34455556778889999999999999876544322 33456889998888 5566678899999999999999999999
Q ss_pred cCCCCEEeccCCcC---ceEEeCCCCcEEEc--ccccceeeccCC-CccccCCCCCCCccccccc-c--CcccceeehhH
Q 006810 145 SHNPPIIHRDLKCD---NIFVNGNNGEVKIG--DLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE-Y--NELVDIYSFGM 215 (630)
Q Consensus 145 s~~~~IiHrDLKp~---NILl~~~~g~vKL~--DFGla~~~~~~~-~~~~~GTp~Y~APEvl~~~-y--s~~sDIWSLGv 215 (630)
+.. ..|.-|... +--.+ ..+.+.+. ||+.+..+.... .....-+..+.|||..... + ....|+|.+|.
T Consensus 304 ~~~--l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 SLS--LEHVVLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred Hhc--cceeEEecccccccccC-ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 986 666666555 33333 34456666 888776554432 2233446678888877643 2 34479999999
Q ss_pred HHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 216 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 216 il~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~-~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.+..+..|..+-..... +..+. ........+++.+|+. ++.+|+++.++|.|||.+...
T Consensus 381 l~~~~~~~~~i~~~~~~-------------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV-------------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred HHhhhhhcCcccccccc-------------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 99999998755432111 11111 1122267888999996 799999999999999997643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00013 Score=72.21 Aligned_cols=140 Identities=21% Similarity=0.239 Sum_probs=79.8
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CeeEEEeEEEc-CCCCEEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNSWVD-DTNRTINMIT 107 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--NIVk~~~~f~d-~~~~~l~lV~ 107 (630)
+.|+.|..+.||+..... ..+++|..... .....+.+|..+++.|... .+.+++.+... ......+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 679999999999997654 48889986422 3456677888888888533 34566653322 2234578999
Q ss_pred cccCCCCHHH------H--------------hhc----CCCCHHH---------HHHH------------HHHHHH-HHH
Q 006810 108 ELFTSGSLRY------R--------------KKH----KNVDMKA---------IKNW------------ARQILR-GLH 141 (630)
Q Consensus 108 Ey~~gGsL~~------~--------------~~~----~~lse~~---------i~~i------------~~QIl~-gL~ 141 (630)
++++|..+.. . ... ..+.... ...+ ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999986643 0 000 1111000 0000 011111 233
Q ss_pred HHHc-----CCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 142 YLHS-----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 142 yLHs-----~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.++. ..+.++|+|+.|.||+++..++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 223499999999999998556677899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.7e-05 Score=89.41 Aligned_cols=150 Identities=14% Similarity=0.160 Sum_probs=92.2
Q ss_pred cceeee-eEecccCceEEEEEEEccCCeEEEEEEeecccccC--------------------------CHHH--------
Q 006810 25 RYGRYD-EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--------------------------SPDQ-------- 69 (630)
Q Consensus 25 Ry~r~~-e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~--------------------------~~~~-------- 69 (630)
.|..+. +.|+.++.|.||+|.-. +|++||||+.++.-... -...
T Consensus 124 ~F~eF~~~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l 202 (517)
T COG0661 124 LFSEFEPEPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL 202 (517)
T ss_pred HHHHcCCCchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence 344444 78999999999999765 49999999865421100 0000
Q ss_pred --HHHHHHHHHHHHhCC-----CCCeeEEEeEEEcCCCCEEEEEEcccCCCCHH-H-HhhcCCCCHHHHHHHHHHHHHHH
Q 006810 70 --LERLYSEVHLLKSLK-----HENIIKFYNSWVDDTNRTINMITELFTSGSLR-Y-RKKHKNVDMKAIKNWARQILRGL 140 (630)
Q Consensus 70 --~~~l~~Ei~iL~~L~-----HpNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~-~~~~~~lse~~i~~i~~QIl~gL 140 (630)
.-.+.+|...+.++. .|+|. +=.+|.+-+. .-+++|||+.|-.+. . ..+...++.+.+.....++..--
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~-VP~V~we~t~-~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q 280 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPDVY-VPKVYWEYTT-RRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQ 280 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCCeE-eceeehhccC-CcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 111345666666552 33322 2122212122 245899999998886 2 23335666555544443332221
Q ss_pred HHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 141 ~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+=..| ++|.|.+|.||+++ .+|.+.+.|||+...+..
T Consensus 281 --~~~dg--ffHaDpHpGNi~v~-~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 --LLRDG--FFHADPHPGNILVR-SDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --HHhcC--ccccCCCccceEEe-cCCcEEEEcCcceecCCH
Confidence 22256 99999999999998 789999999999865544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.97 E-value=6.7e-05 Score=76.04 Aligned_cols=134 Identities=13% Similarity=0.119 Sum_probs=78.7
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC--eeEEEeEEEcCCCCEEEEEEc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNSWVDDTNRTINMITE 108 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN--IVk~~~~f~d~~~~~l~lV~E 108 (630)
+.||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-. +.+.+.+.. ......+|||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~--~~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLVE--DGGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEEe--cCCeeeeeee
Confidence 56899999999984 25577888775321 1234678999998886433 355565432 2345678999
Q ss_pred ccCCCC-HH------------H-------H-hhcC----CCCHHH-HHHHHHH----------HHHH-HHHH--HcCCCC
Q 006810 109 LFTSGS-LR------------Y-------R-KKHK----NVDMKA-IKNWARQ----------ILRG-LHYL--HSHNPP 149 (630)
Q Consensus 109 y~~gGs-L~------------~-------~-~~~~----~lse~~-i~~i~~Q----------Il~g-L~yL--Hs~~~~ 149 (630)
+++|.. +. . + .-|. ..+... ...+..+ +... ..+| +...+.
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 999963 10 0 0 0111 111111 1111111 1111 1122 223345
Q ss_pred EEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 150 IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
++|+|+.|.||+++ .+| +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~-~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITS-GKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEc-CCC-cEEEechhcC
Confidence 79999999999997 566 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.97 E-value=8.8e-05 Score=75.53 Aligned_cols=142 Identities=20% Similarity=0.208 Sum_probs=98.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeeccccc------------------CCHHHH--HHHHHHHHHHHhCC--CCCe
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM------------------QSPDQL--ERLYSEVHLLKSLK--HENI 88 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~------------------~~~~~~--~~l~~Ei~iL~~L~--HpNI 88 (630)
-.|..|--+.||+|.. .++..||+|+....-.. .+...+ .=..+|+..|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 4566777889999964 56889999988642211 000111 11346888888884 3445
Q ss_pred eEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCC
Q 006810 89 IKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNN 166 (630)
Q Consensus 89 Vk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~ 166 (630)
.+-+.++ . -.+||||+...... -..+.-++....+..+..+++..+.-|-. .+ +||+||+.=|||+. .
T Consensus 133 P~Pi~~~---~---nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~--~ 202 (268)
T COG1718 133 PEPIAFR---N---NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH--D 202 (268)
T ss_pred CCceeec---C---CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE--C
Confidence 5555533 1 25799999876443 23344445555788889999999988876 67 99999999999996 7
Q ss_pred CcEEEcccccceeeccC
Q 006810 167 GEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 167 g~vKL~DFGla~~~~~~ 183 (630)
|.+.|+|||-|.....+
T Consensus 203 ~~p~iID~~QaV~~~hp 219 (268)
T COG1718 203 GEPYIIDVSQAVTIDHP 219 (268)
T ss_pred CeEEEEECccccccCCC
Confidence 79999999988655543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.7e-05 Score=75.92 Aligned_cols=143 Identities=16% Similarity=0.177 Sum_probs=85.2
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHH------HHHHHHHHHhCCCC---CeeEE
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER------LYSEVHLLKSLKHE---NIIKF 91 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~------l~~Ei~iL~~L~Hp---NIVk~ 91 (630)
--.+.| ++.+++-......|.+. ..+|..+++|....+... ....... ..+.+..+..+... .+..+
T Consensus 28 i~~~~~-~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 28 ILDNNY-KIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHhCCc-eEEEeecCCCccEEEEE--EECCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 334555 55566666555555444 667889999987643321 1111111 22344444444322 22222
Q ss_pred EeEEEcCCC---CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc
Q 006810 92 YNSWVDDTN---RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 168 (630)
Q Consensus 92 ~~~f~d~~~---~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 168 (630)
|-.-.-... ...++||||++|-.|.... .+++ .+...|..++.-||..| +.|||..|.|++++ ++.
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~---~i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~--~~~ 172 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIE---DIDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS--NNG 172 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccch---hcCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE--CCc
Confidence 222111111 2356899999998875211 1222 34566778899999999 99999999999997 456
Q ss_pred EEEcccccce
Q 006810 169 VKIGDLGLAI 178 (630)
Q Consensus 169 vKL~DFGla~ 178 (630)
++++||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00014 Score=73.79 Aligned_cols=75 Identities=16% Similarity=0.054 Sum_probs=48.9
Q ss_pred eEecccCc-eEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEEEEEEc
Q 006810 31 EILGKGAF-KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITE 108 (630)
Q Consensus 31 e~LG~G~f-g~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l~lV~E 108 (630)
+.|..|.. ..||+... .+..+.+|...... ...+.+|+++++.+. +--+.+++.+.... ..-++|||
T Consensus 4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e 72 (244)
T cd05150 4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTS 72 (244)
T ss_pred eecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEE
Confidence 33555655 88999954 34677888764321 234667888888873 34456677755433 34678999
Q ss_pred ccCCCCHH
Q 006810 109 LFTSGSLR 116 (630)
Q Consensus 109 y~~gGsL~ 116 (630)
+++|.++.
T Consensus 73 ~i~G~~l~ 80 (244)
T cd05150 73 AVPGVPAA 80 (244)
T ss_pred eeCCccHh
Confidence 99998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00044 Score=82.93 Aligned_cols=147 Identities=20% Similarity=0.289 Sum_probs=90.3
Q ss_pred eeEecccCceEEEEEEEccCC--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCe--eEEEeEEEcCC-CCEE
Q 006810 30 DEILGKGAFKTVYKGFDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENI--IKFYNSWVDDT-NRTI 103 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG--~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNI--Vk~~~~f~d~~-~~~l 103 (630)
.+.|+.|.+..+|+......+ ..+++|+......... ...+.+|+++|+.|. |++| ++++.++.+.. ....
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~---~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS---AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc---HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 366899999999998654332 4677887654332211 235778999999995 6665 67776554432 1356
Q ss_pred EEEEcccCCCCHH---------------------HHh-hcC------------C---CCHHHHHHHHHHH----------
Q 006810 104 NMITELFTSGSLR---------------------YRK-KHK------------N---VDMKAIKNWARQI---------- 136 (630)
Q Consensus 104 ~lV~Ey~~gGsL~---------------------~~~-~~~------------~---lse~~i~~i~~QI---------- 136 (630)
|+||||++|..+. .+. -|. . .-...+.+|..|.
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 7999999986431 000 000 0 1123454444332
Q ss_pred -----HHHHHHHHcCCC---------CEEeccCCcCceEEeCCCCc-EEEccccccee
Q 006810 137 -----LRGLHYLHSHNP---------PIIHRDLKCDNIFVNGNNGE-VKIGDLGLAIV 179 (630)
Q Consensus 137 -----l~gL~yLHs~~~---------~IiHrDLKp~NILl~~~~g~-vKL~DFGla~~ 179 (630)
...+.+|..+-| .+||+|++++||+++..++. +-|.||.++..
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 233566744322 39999999999999743444 57999988753
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00038 Score=70.51 Aligned_cols=74 Identities=8% Similarity=0.017 Sum_probs=44.2
Q ss_pred eEecccCce-EEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC---CeeEEEeEEEcCCC-CEEEE
Q 006810 31 EILGKGAFK-TVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE---NIIKFYNSWVDDTN-RTINM 105 (630)
Q Consensus 31 e~LG~G~fg-~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp---NIVk~~~~f~d~~~-~~l~l 105 (630)
+.|+.|+.. .||+. |..+++|..... .....+.+|.++|+.|... .+.+.+........ ...++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc------chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 457877776 48976 235677754321 1234688899999888532 34444443211111 23478
Q ss_pred EEcccCCCCH
Q 006810 106 ITELFTSGSL 115 (630)
Q Consensus 106 V~Ey~~gGsL 115 (630)
||++++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 8999999766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00041 Score=78.30 Aligned_cols=147 Identities=16% Similarity=0.149 Sum_probs=90.6
Q ss_pred ceeee-eEecccCceEEEEEEEccCCeEEEEEEeecccccCC-H---------------------------HHHHH----
Q 006810 26 YGRYD-EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-P---------------------------DQLER---- 72 (630)
Q Consensus 26 y~r~~-e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~-~---------------------------~~~~~---- 72 (630)
|..+. +.||.-+.|.||+|.-+. |+.||+|+=+..- ... . +-.+.
T Consensus 161 f~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l-~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E 238 (538)
T KOG1235|consen 161 FSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGL-EKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE 238 (538)
T ss_pred HHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcCh-HHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence 33443 789999999999997665 9999999643211 100 0 00111
Q ss_pred --HHHHHHHHHhC----CCCC------eeEEEeEEEcCCCCEEEEEEcccCCCCHH---HHhhcCCCCHHHHHHHHHHHH
Q 006810 73 --LYSEVHLLKSL----KHEN------IIKFYNSWVDDTNRTINMITELFTSGSLR---YRKKHKNVDMKAIKNWARQIL 137 (630)
Q Consensus 73 --l~~Ei~iL~~L----~HpN------IVk~~~~f~d~~~~~l~lV~Ey~~gGsL~---~~~~~~~lse~~i~~i~~QIl 137 (630)
+.+|.+...++ .|-+ |.++|-.+. ..-+++||||+|..+. ++.+ ..++...+..-+.+..
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~ 313 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAY 313 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHH
Confidence 33444443333 4555 555554332 2356899999998775 4443 3455554444444433
Q ss_pred HHHHHHHcCCCCEEeccCCcCceEEeC---CCCcEEEcccccceeeccC
Q 006810 138 RGLHYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 138 ~gL~yLHs~~~~IiHrDLKp~NILl~~---~~g~vKL~DFGla~~~~~~ 183 (630)
.-.- =..| ++|+|=+|.||++.. .++.+.+.|||+.......
T Consensus 314 ~~qI--f~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 314 LEQI--FKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHH--HhcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2222 2346 999999999999983 3678999999998655443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0054 Score=61.09 Aligned_cols=131 Identities=21% Similarity=0.258 Sum_probs=88.0
Q ss_pred cceeeeeEecccCc-eEEEEEEEccCCeEEEEEEeecccccC----------CH-------HHHHHHHHHHHHHHhC---
Q 006810 25 RYGRYDEILGKGAF-KTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SP-------DQLERLYSEVHLLKSL--- 83 (630)
Q Consensus 25 Ry~r~~e~LG~G~f-g~Vy~A~d~~tG~~VAiK~i~~~~~~~----------~~-------~~~~~l~~Ei~iL~~L--- 83 (630)
.-.++.+.||.|.- |.||++ +..|..+|+|.+..-.... .. ....-|..|-+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv--~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKV--EIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEE--EECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 34467799999999 999999 4678899999943211100 00 1233466777766555
Q ss_pred CCCCe--eEEEeEEEcCC----------------CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHc
Q 006810 84 KHENI--IKFYNSWVDDT----------------NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHS 145 (630)
Q Consensus 84 ~HpNI--Vk~~~~f~d~~----------------~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs 145 (630)
.+.++ |++|+|..-.. .....||-||++... .+.. .-+.+|++-|..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~----~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQI----RDIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccch----hHHHHHHHHHHHHHH
Confidence 55666 99999874321 112356777766643 2232 345667777888999
Q ss_pred CCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 146 ~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
.| |+-+|+++.|.. + -||+|||.+
T Consensus 183 ~g--I~~~Dv~~~ny~-~-----G~lvDfs~~ 206 (207)
T PF13095_consen 183 LG--IVPRDVKPRNYR-G-----GKLVDFSSS 206 (207)
T ss_pred CC--eeeccCcccccc-C-----CEEEecccC
Confidence 99 999999999965 3 289999854
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00093 Score=65.88 Aligned_cols=98 Identities=26% Similarity=0.186 Sum_probs=78.6
Q ss_pred HHHHHHHHhCCC-CCeeEEEeEEEcCCCCEEEEEEcccCCCCHH----HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 006810 74 YSEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLR----YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148 (630)
Q Consensus 74 ~~Ei~iL~~L~H-pNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~----~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~ 148 (630)
..|.-+|+.+.+ ++++++++++ + -++|+||...+++. .+......++..+.+++.+++..+.+|+....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G-~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----G-RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----C-CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888999976 6999999986 1 24588999988664 23334457899999999999999999987321
Q ss_pred -CEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 149 -PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 149 -~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
++.-.|++++|+-++ .+|.+|++|...+.
T Consensus 81 ~~~~lcDv~~~nfgv~-~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVN-DDGRLKLIDLDDVF 110 (188)
T ss_pred CcEEEeecchHHeEEe-CCCcEEEEechhcc
Confidence 277799999999998 78999999998764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0041 Score=65.68 Aligned_cols=77 Identities=12% Similarity=0.107 Sum_probs=51.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC---CCeeEEEeEEEcCC-CCEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDDT-NRTINMI 106 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H---pNIVk~~~~f~d~~-~~~l~lV 106 (630)
+.||.|..+.||+.... +| .+.+|..+ .. . ....+..|...|+.|.- -.+++++++..+.. ...-++|
T Consensus 20 ~~i~~G~~~~vy~~~~~-~~-~~~~k~~~-~~--~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 20 ECISEQPYAALWALYDS-QG-NPMPLMAR-SF--S---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eecCCccceeEEEEEcC-CC-CEEEEEec-cc--c---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 67999999999998432 23 56667643 11 0 11347789999988843 36777887654322 2447899
Q ss_pred EcccCCCCH
Q 006810 107 TELFTSGSL 115 (630)
Q Consensus 107 ~Ey~~gGsL 115 (630)
||+++|+++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0012 Score=64.17 Aligned_cols=129 Identities=26% Similarity=0.236 Sum_probs=86.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeE-EEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK-FYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk-~~~~f~d~~~~~l~lV 106 (630)
+..+.||+|.+|.||++. ..|.++|+|+=..+ .....+..|+++|..++-.++.+ +|.| +. .++.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~d------s~r~~l~kEakiLeil~g~~~~p~vy~y--g~----~~i~ 90 (201)
T COG2112 25 RVEKELAKGTTSVVYLGE--WRGGEVALKVRRRD------SPRRNLEKEAKILEILAGEGVTPEVYFY--GE----DFIR 90 (201)
T ss_pred hhhhhhhcccccEEEEee--ccCceEEEEEecCC------cchhhHHHHHHHHHHhhhcCCCceEEEe--ch----hhhh
Confidence 345789999999999995 45779999875432 23456889999999998877764 4443 22 3456
Q ss_pred EcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCc-C-ceEEeCCCCcEEEcccccceee
Q 006810 107 TELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC-D-NIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 107 ~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp-~-NILl~~~~g~vKL~DFGla~~~ 180 (630)
|||+.|-.|....... +-++ ...++..---|-..| |-|+.|.- . ||+++ ++.+.|+||.-|+.-
T Consensus 91 me~i~G~~L~~~~~~~--~rk~----l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~--~~~~~iIDFd~At~k 156 (201)
T COG2112 91 MEYIDGRPLGKLEIGG--DRKH----LLRVLEKAYKLDRLG--IEHGELSRPWKNVLVN--DRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhcCcchhhhhhcc--cHHH----HHHHHHHHHHHHHhc--cchhhhcCCceeEEec--CCcEEEEEccchhhc
Confidence 9999997776322221 2222 333444433455566 89998874 3 66664 559999999988643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0038 Score=62.80 Aligned_cols=74 Identities=15% Similarity=0.137 Sum_probs=45.9
Q ss_pred eEecccCceEEEEEEEcc-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC-CeeEEEeEEEcCCCCEEEEEEc
Q 006810 31 EILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINMITE 108 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~-tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp-NIVk~~~~f~d~~~~~l~lV~E 108 (630)
+.|..|-...+|+..... .+..|++|....... ......+|+.+++.+... -.++++..+ .. .+|||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-----~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-----LIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-----ceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEE
Confidence 567888888999985432 356888897653211 111234688888888433 344555432 21 26999
Q ss_pred ccCCCCH
Q 006810 109 LFTSGSL 115 (630)
Q Consensus 109 y~~gGsL 115 (630)
|++|-++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.013 Score=64.39 Aligned_cols=80 Identities=21% Similarity=0.217 Sum_probs=54.7
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeeccccc--C-CHHHHHHHHHHHHHHHhCC---CCCeeEEEeEEEcCCCCEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--Q-SPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~--~-~~~~~~~l~~Ei~iL~~L~---HpNIVk~~~~f~d~~~~~l~ 104 (630)
+.||.|.+..||++.+...++.|++|+-...... . .+-..++...|.+.|+.+. -.+++++|.+ +.. .-+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~--~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEE--LAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCC--CCE
Confidence 6799999999999988644468999986422111 1 1224567778888888762 3467788875 332 356
Q ss_pred EEEcccCCCC
Q 006810 105 MITELFTSGS 114 (630)
Q Consensus 105 lV~Ey~~gGs 114 (630)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 8999998744
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.04 E-value=6.1e-05 Score=91.26 Aligned_cols=214 Identities=14% Similarity=0.028 Sum_probs=140.9
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhh----cCCCCHHHHHHHHHHHHHHHHH
Q 006810 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKK----HKNVDMKAIKNWARQILRGLHY 142 (630)
Q Consensus 68 ~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~----~~~lse~~i~~i~~QIl~gL~y 142 (630)
...+.+..|...++...|+++...+.-..+......|.+++|+.+|.+. .+.+ ...++..-+....++.+.+..-
T Consensus 1271 Plkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1271 PLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred HHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccch
Confidence 3445566777788889999999988866555666788899999999997 3322 3345555555555665777777
Q ss_pred HHcCC---CCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHH
Q 006810 143 LHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMC 216 (630)
Q Consensus 143 LHs~~---~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvi 216 (630)
+|+.. --.+|++||+-|.+|. .+-.+|++++|+.+..... ......++|.|++|++... .++.++|||..|+-
T Consensus 1351 ~ls~tnlg~T~v~~~Lkf~lpmIV-tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIV-TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred hhhcccCCccchhhhhhhhcccee-cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 66542 2369999999999998 5668999999999843322 2345677889999998765 47777999999999
Q ss_pred HHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHc-ccCCCCCCCHHHHhcCCCcc
Q 006810 217 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLV 284 (630)
Q Consensus 217 l~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kc-L~~p~~Rpsa~eLL~hpf~~ 284 (630)
+|++.-|..||-.. ..-..+.+........++...+.+.-.....+ +.+-..||+-...+.-+.+.
T Consensus 1430 ly~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHhcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 99999998777431 01111111112222223333222222222222 23556777777777766654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0089 Score=59.53 Aligned_cols=132 Identities=20% Similarity=0.339 Sum_probs=84.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeeccccc------------CCHHHHHHHHHHHHHHHhCC------CCCeeEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM------------QSPDQLERLYSEVHLLKSLK------HENIIKFY 92 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~------------~~~~~~~~l~~Ei~iL~~L~------HpNIVk~~ 92 (630)
..||+|+.=.||.- .......||++...... ..........+|+.-...+. +..|.++|
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57999999999975 33445678887655400 00112234556666555555 78999999
Q ss_pred eEEEcCCCCEEEEEEcccCC--C----CHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC-
Q 006810 93 NSWVDDTNRTINMITELFTS--G----SLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN- 165 (630)
Q Consensus 93 ~~f~d~~~~~l~lV~Ey~~g--G----sL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~- 165 (630)
++... +..+.+|+|.+.. | +|......+.++. .+...+.++ ..||-.++ |+.+||+|.||++...
T Consensus 84 G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~~L~~f---~~~l~~~~--Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 84 GFVET--NLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQALDEF---KRYLLDHH--IVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEEec--CCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHHHHHHH---HHHHHHcC--CeecCCCcccEEEEecC
Confidence 97644 4456777787643 2 4554456666776 455444444 45566667 9999999999999622
Q ss_pred CC--cEEEcc
Q 006810 166 NG--EVKIGD 173 (630)
Q Consensus 166 ~g--~vKL~D 173 (630)
+| .+.|+|
T Consensus 156 ~~~~~lvlID 165 (199)
T PF10707_consen 156 SGEFRLVLID 165 (199)
T ss_pred CCceEEEEEe
Confidence 22 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.007 Score=62.01 Aligned_cols=132 Identities=19% Similarity=0.191 Sum_probs=73.5
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCe-eEEEeEEEcCCCCEEEEEEcccC
Q 006810 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMITELFT 111 (630)
Q Consensus 33 LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI-Vk~~~~f~d~~~~~l~lV~Ey~~ 111 (630)
+..|-...+|+.. .+|..+++|....... ...-...+|..+++.+..-.+ .+++.. +. -++|+||++
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~----~~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPILV--NE----HWLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEEE--eC----CEEEEEecc
Confidence 5567778899885 4577888886542211 100124578888888854333 334432 22 157899999
Q ss_pred CCCHHH---------------Hh-hc------CCCCH-HHHHHHHHHH---------HHHHHHHHcC------CCCEEec
Q 006810 112 SGSLRY---------------RK-KH------KNVDM-KAIKNWARQI---------LRGLHYLHSH------NPPIIHR 153 (630)
Q Consensus 112 gGsL~~---------------~~-~~------~~lse-~~i~~i~~QI---------l~gL~yLHs~------~~~IiHr 153 (630)
|..+.. +. -| .+++. ..+..+..++ ...+..+-.. .+-++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 876520 00 01 11221 1222222222 1112222111 1238999
Q ss_pred cCCcCceEEeCCCCcEEEcccccce
Q 006810 154 DLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 154 DLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
|+.|.||+++ .++ +.|+||..+.
T Consensus 152 Dl~~~Nil~~-~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 152 DVHAYNLVVT-PQG-LKLIDWEYAS 174 (256)
T ss_pred CCCcCcEEEe-CCC-CEEEeccccC
Confidence 9999999998 455 7899998774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.012 Score=63.18 Aligned_cols=144 Identities=18% Similarity=0.248 Sum_probs=99.4
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccc--------------------cCCHHHHHH--HHHHHHHHHhCCCCC
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV--------------------MQSPDQLER--LYSEVHLLKSLKHEN 87 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~--------------------~~~~~~~~~--l~~Ei~iL~~L~HpN 87 (630)
...|..|--+.||.|. ...|..+|||+++..-+ ..++..+-+ ...|++.|++|+.-.
T Consensus 149 nGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 149 NGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred ccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 3457778889999996 45788899998753211 112222222 346888999887655
Q ss_pred eeEEEeEEEcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHH-HcCCCCEEeccCCcCceEEeCC
Q 006810 88 IIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGN 165 (630)
Q Consensus 88 IVk~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yL-Hs~~~~IiHrDLKp~NILl~~~ 165 (630)
|.----..+ ..-++||+++.....- -..+...++...+..+-.|++.-+.-| |.++ +||.||+-=|+|+.
T Consensus 228 IP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh-- 299 (520)
T KOG2270|consen 228 IPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH-- 299 (520)
T ss_pred CCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE--
Confidence 442222112 1246899999755443 455667788888888888888888777 4566 99999999999995
Q ss_pred CCcEEEcccccceeecc
Q 006810 166 NGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 166 ~g~vKL~DFGla~~~~~ 182 (630)
.|.+.|+|.+-+.....
T Consensus 300 dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred CCEEEEEEccccccCCC
Confidence 79999999998765433
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.027 Score=58.74 Aligned_cols=138 Identities=17% Similarity=0.110 Sum_probs=77.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CeeEEEeE----EEcCCCCEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNS----WVDDTNRTIN 104 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--NIVk~~~~----f~d~~~~~l~ 104 (630)
+.|..|....+|+... .+..+++|+... .. ...+..|+.++..|.+- .+.+.+.. +........+
T Consensus 20 ~~i~~G~~n~~y~v~~--~~~~~vLr~~~~----~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 20 EGISAGIENTNYFVTT--DSGRYVLTLFEK----VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred ecccCccccceEEEEe--CCCcEEEEEcCC----CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 5677888889998743 345788887653 11 23466677777777432 24444432 1111123568
Q ss_pred EEEcccCCCCHHH-----H--------hhc---CCCC-------H-H----HH--------HHHHHHHHHHHHHHHc---
Q 006810 105 MITELFTSGSLRY-----R--------KKH---KNVD-------M-K----AI--------KNWARQILRGLHYLHS--- 145 (630)
Q Consensus 105 lV~Ey~~gGsL~~-----~--------~~~---~~ls-------e-~----~i--------~~i~~QIl~gL~yLHs--- 145 (630)
+|++|++|..+.. . +-| ..+. . . .. ......+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 8999999876410 0 000 0000 0 0 00 0011112233444443
Q ss_pred --CCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 146 --HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 146 --~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
....++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~-~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFD-GDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEe-CCceEEEeehhhhc
Confidence 112389999999999998 55566899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.064 Score=56.70 Aligned_cols=29 Identities=28% Similarity=0.322 Sum_probs=23.8
Q ss_pred CEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 149 ~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.+||+|+.|+||+++ .+...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~-~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFE-GDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEE-CCceEEEEeccccc
Confidence 499999999999997 44445799998763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.027 Score=59.09 Aligned_cols=74 Identities=20% Similarity=0.201 Sum_probs=45.0
Q ss_pred eEecccCceEEEEEEEcc------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCe-eEEEeEEEcCCCCEE
Q 006810 31 EILGKGAFKTVYKGFDEV------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTI 103 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~------tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI-Vk~~~~f~d~~~~~l 103 (630)
+.|..|-...+|+..... .+..+++|+..... .......+|+++++.+....+ .+++.++ ..
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~---- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIF--PN---- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEe--CC----
Confidence 456677777899886432 25789999864321 112235678888888743333 3455543 22
Q ss_pred EEEEcccCCCCH
Q 006810 104 NMITELFTSGSL 115 (630)
Q Consensus 104 ~lV~Ey~~gGsL 115 (630)
.+|+||++|..+
T Consensus 73 ~~v~e~i~G~~l 84 (302)
T cd05156 73 GRIEEFIPSRTL 84 (302)
T ss_pred CchhheeCCCcC
Confidence 247899888765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.052 Score=58.81 Aligned_cols=79 Identities=15% Similarity=0.128 Sum_probs=52.1
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeeccccc---CCHHHHHHHHHHHHHHHhCC--CC-CeeEEEeEEEcCCCCEEEE
Q 006810 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM---QSPDQLERLYSEVHLLKSLK--HE-NIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 32 ~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~---~~~~~~~~l~~Ei~iL~~L~--Hp-NIVk~~~~f~d~~~~~l~l 105 (630)
.||-|....||++.+...+..|+||+-...-.. ..+-..+|..-|...|+... -| .++++|.+ +.. ...+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e--~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTE--MAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccc--ccee
Confidence 479999999999997644478999986432211 12344566778888887763 24 56667763 333 3558
Q ss_pred EEcccCCCC
Q 006810 106 ITELFTSGS 114 (630)
Q Consensus 106 V~Ey~~gGs 114 (630)
|||+++...
T Consensus 78 vMEdL~~~~ 86 (370)
T TIGR01767 78 VMEDLSHHK 86 (370)
T ss_pred hHhhCccch
Confidence 999996643
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.0062 Score=64.43 Aligned_cols=136 Identities=18% Similarity=0.210 Sum_probs=93.4
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeeccc-----ccCCHH---------H----HHHHHHHHHHHHhCCC--CC
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIED-----VMQSPD---------Q----LERLYSEVHLLKSLKH--EN 87 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~-----~~~~~~---------~----~~~l~~Ei~iL~~L~H--pN 87 (630)
-++..||-|--+.||.+-+. .|.+.++|.-.+.. +....+ + .-...+|+..|+.|.. --
T Consensus 95 svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 45688999999999999765 68888988654422 111111 1 1224578999998843 33
Q ss_pred eeEEEeEEEcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC
Q 006810 88 IIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 167 (630)
Q Consensus 88 IVk~~~~f~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 167 (630)
|++-++. .+.++|||++.|-.|...... ..+..+...+..-+.-|..+| +||+|+.-=||++. .++
T Consensus 174 VPkpiD~------~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~-dd~ 239 (465)
T KOG2268|consen 174 VPKPIDH------NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVK-DDD 239 (465)
T ss_pred CCCcccc------cceeeHHHhhcccceeeeeec-----CChHHHHHHHHHHHHHHHHcC--ceecccchheeEEe-cCC
Confidence 4444442 356789999999887632221 223345556666667778888 99999999999998 788
Q ss_pred cEEEcccccce
Q 006810 168 EVKIGDLGLAI 178 (630)
Q Consensus 168 ~vKL~DFGla~ 178 (630)
.++++||--..
T Consensus 240 ~i~vIDFPQmv 250 (465)
T KOG2268|consen 240 KIVVIDFPQMV 250 (465)
T ss_pred CEEEeechHhh
Confidence 99999996543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.28 Score=52.62 Aligned_cols=136 Identities=16% Similarity=0.207 Sum_probs=75.4
Q ss_pred eEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCe-eEEEeEEEcCCCCEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~t---G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI-Vk~~~~f~d~~~~~l~lV 106 (630)
+.|..|=.-.+|+...... +..|++|+..... . ..-.-.+|..+++.+..-++ ++++.++ .. . +|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t----~-~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~-G---~i 88 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT----D-YVIDRERELQAIKYLSAAGFGAKLLGVF--GN-G---MI 88 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc----C-eEechHHHHHHHHHHHhcCCCCceeEEe--CC-c---Ee
Confidence 4455577778898854322 3478888764321 1 11113468888888865444 3455544 22 1 47
Q ss_pred EcccCCCCHHH---------------H-hhcC-------CCC-HHHHHHHHHHH-------------------------H
Q 006810 107 TELFTSGSLRY---------------R-KKHK-------NVD-MKAIKNWARQI-------------------------L 137 (630)
Q Consensus 107 ~Ey~~gGsL~~---------------~-~~~~-------~ls-e~~i~~i~~QI-------------------------l 137 (630)
.+|++|-.|.. + +-|. ..+ ...+..|..++ +
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 89987765520 0 0011 011 22333333332 1
Q ss_pred HHHHHHH-cCC--CCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 138 RGLHYLH-SHN--PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 138 ~gL~yLH-s~~--~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+..+. ..+ .-++|.||.+.||+++..++.++++||..|
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 1122221 112 127999999999999745678999999876
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.0056 Score=69.04 Aligned_cols=69 Identities=30% Similarity=0.450 Sum_probs=58.1
Q ss_pred CCceEEEEEecCCCC----CeeeeEeecccCCccHHHHHHHHHHccCCCCcCHHHHHHHHHHHHHHhCCCCCC
Q 006810 362 DDTVSLTLRIGDKSG----HVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNP 430 (630)
Q Consensus 362 ~~~i~L~Lri~d~~~----~~~~i~f~f~~~~Dta~~va~EmV~~~~i~~~d~~~ia~~i~~~i~~~~~~~~~ 430 (630)
+..++|.+|..|.++ ..|.|+|.|+++.|+++.||+|||+++++++.|...+|..|...+.++--....
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~ 388 (632)
T KOG0584|consen 316 DPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRND 388 (632)
T ss_pred cccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhc
Confidence 345667788877763 356899999999999999999999999999999999999999988887765543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.13 Score=54.15 Aligned_cols=138 Identities=17% Similarity=0.152 Sum_probs=75.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CeeEEEeE----EEcCCCCEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNS----WVDDTNRTIN 104 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--NIVk~~~~----f~d~~~~~l~ 104 (630)
+.|+.|....+|+... .+| .+++|+..... ..+ .+..|+.++..|... .+++++.. ++.......+
T Consensus 28 ~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~---~~~---~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 28 KGIAEGVENSNYLLTT-DVG-RYILTLYEKRV---KAE---ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred cccCCccccceEEEEe-CCC-cEEEEEecCCC---CHH---HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 5577787789998853 334 67788765321 122 344566666666322 23444331 1111234578
Q ss_pred EEEcccCCCCHH-----H-H-------hhc---CCC--------CHHHHH---------------HHHHHHHHHHHHHHc
Q 006810 105 MITELFTSGSLR-----Y-R-------KKH---KNV--------DMKAIK---------------NWARQILRGLHYLHS 145 (630)
Q Consensus 105 lV~Ey~~gGsL~-----~-~-------~~~---~~l--------se~~i~---------------~i~~QIl~gL~yLHs 145 (630)
++++|++|..+. . . .-| ..+ ...... .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 899999986431 0 0 000 000 011100 001122334555532
Q ss_pred -----CCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 146 -----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 146 -----~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+.++|+|+.+.||+++ .++.+.|+||+.+
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~-~~~~~~vIDfd~~ 215 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFD-GDSVKGVIDFYFA 215 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEE-CCceEEEeecccc
Confidence 223599999999999998 5666789999866
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.072 Score=58.42 Aligned_cols=79 Identities=19% Similarity=0.178 Sum_probs=53.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccc--cCCHHHHHHHHHHHHHHHhCC--CC-CeeEEEeEEEcCCCCEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV--MQSPDQLERLYSEVHLLKSLK--HE-NIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~--~~~~~~~~~l~~Ei~iL~~L~--Hp-NIVk~~~~f~d~~~~~l~l 105 (630)
+.||-|.-..||++.+...+..|+||+-...-. ...+-..+|..-|...|+.+. -| .++++|.+ +. ....+
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~--e~~~~ 110 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DS--VMNCC 110 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--Cc--HHhhH
Confidence 678999999999998854466899998642211 122445677788888888773 24 56667763 33 23567
Q ss_pred EEcccCCC
Q 006810 106 ITELFTSG 113 (630)
Q Consensus 106 V~Ey~~gG 113 (630)
|||+++..
T Consensus 111 vMEdL~~~ 118 (409)
T PRK12396 111 VMEDLSDH 118 (409)
T ss_pred HHHhCccc
Confidence 99998654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.086 Score=56.86 Aligned_cols=137 Identities=14% Similarity=0.168 Sum_probs=78.0
Q ss_pred eEecccCceEEEEEEEcc----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCee-EEEeEEEcCCCCEEEE
Q 006810 31 EILGKGAFKTVYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII-KFYNSWVDDTNRTINM 105 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~----tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIV-k~~~~f~d~~~~~l~l 105 (630)
+.|-.|-.-.+|++.... .+..|++|+..... ..... -.+|+.+++.+..-++. ++++.+ ... .
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~id-R~~E~~~~~~l~~~gl~P~~~~~~--~~g----~ 110 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFD-RDDEIRTFECMSRHGQGPRLLGRF--PNG----R 110 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeec-hHHHHHHHHHHHHcCCCCceEEEE--CCc----e
Confidence 446567788899985322 34688888765321 12222 25688888888543333 455554 221 4
Q ss_pred EEcccCCCCHHH--H-------------h-hcC--------CCCHHHHHHHHHHHHH-----------------HHHH--
Q 006810 106 ITELFTSGSLRY--R-------------K-KHK--------NVDMKAIKNWARQILR-----------------GLHY-- 142 (630)
Q Consensus 106 V~Ey~~gGsL~~--~-------------~-~~~--------~lse~~i~~i~~QIl~-----------------gL~y-- 142 (630)
|++|+++.++.. + . -|. ......+..|..++.. .+..
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 788888766631 0 0 010 1113344455433321 1111
Q ss_pred --HHc--CCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 143 --LHS--HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 143 --LHs--~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
+.. ....++|+|+++.||+++..++.+.|+||..+.
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 121 112389999999999998446789999998663
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.035 Score=61.96 Aligned_cols=162 Identities=19% Similarity=0.264 Sum_probs=99.0
Q ss_pred HHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEE
Q 006810 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 151 (630)
Q Consensus 72 ~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~Ii 151 (630)
.+.-.+..++.+.|+|...+.+.- .....+..+|+|++.-..-++.+.+. +-..... .++ +.
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~-r~~~~r~IVV~e~~~~Sled~~~~~~-l~~~s~~--------------~~~--~~ 89 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFS-RGKHERVIVVMEHYTMSLEDILKTGN-LKDESLL--------------AHG--VL 89 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeee-cCccceEEEEehhhccchHHHHHhcc-cchhhhc--------------ccc--cc
Confidence 466778999999999999999853 34445688999998764444443333 2111111 122 22
Q ss_pred eccCCcCceEEeCCCCcEEEcccccceeeccCCCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCC
Q 006810 152 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 231 (630)
Q Consensus 152 HrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~ 231 (630)
|- +.++++| .++. .. .+.+| +++||||+|.++.++..|...+..-.
T Consensus 90 ~~-------------~~~~~td-~~~t---~~--~~~~~---------------pKsdVwsl~~i~~el~L~~~l~~~~~ 135 (725)
T KOG1093|consen 90 HL-------------NIIYITD-HFLT---KY--PSPIG---------------PKSDVWSLGFIILELYLGISLEAELT 135 (725)
T ss_pred ee-------------hhhhccc-cccc---cC--CCCCC---------------cchhhhhHHHHHHHHHHhhHHHHHHH
Confidence 21 2233333 1110 00 11111 39999999999999999988776644
Q ss_pred CHHHHHHHHHcCCCCCCC---------CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 232 NPAQIYKKVTSGIKPASL---------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 232 ~~~~i~~~i~~g~~p~~l---------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
+.++.....+-...+... ....+..+.++..+|+- .|..||...++.+++-|..
T Consensus 136 ~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 136 ESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 444433333322222211 12245667888899995 7999999999999999865
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.11 Score=54.31 Aligned_cols=29 Identities=21% Similarity=0.340 Sum_probs=23.7
Q ss_pred CEEeccCCcCceEEeCCCCc-EEEcccccce
Q 006810 149 PIIHRDLKCDNIFVNGNNGE-VKIGDLGLAI 178 (630)
Q Consensus 149 ~IiHrDLKp~NILl~~~~g~-vKL~DFGla~ 178 (630)
-++|+|++|.|||++ .++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~-~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILID-EDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEe-CCCCEEEEECcHhcc
Confidence 489999999999998 4354 5699999774
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.25 Score=54.52 Aligned_cols=78 Identities=17% Similarity=0.093 Sum_probs=51.1
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCC---HHHHHHHHHHHHHHHhCC---CCCeeEEEeEEEcCCCCEE
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS---PDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~---~~~~~~l~~Ei~iL~~L~---HpNIVk~~~~f~d~~~~~l 103 (630)
.+.||-|....||+..+. +..|+||+-........ +-...+...|...|+.+. -.+++++|.+. .+ .-
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--ed--~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--RT--MA 110 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--CC--CC
Confidence 367899999999998763 45688998653222111 123455666777777664 24788888854 32 24
Q ss_pred EEEEcccCCC
Q 006810 104 NMITELFTSG 113 (630)
Q Consensus 104 ~lV~Ey~~gG 113 (630)
+++|||++++
T Consensus 111 vlvME~L~~~ 120 (418)
T PLN02756 111 LIGMRYLEPP 120 (418)
T ss_pred EEEEeecCCc
Confidence 6789999873
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.24 Score=52.92 Aligned_cols=139 Identities=13% Similarity=0.195 Sum_probs=77.0
Q ss_pred ccCce-EEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CeeEEEeEEEcCCCCEEEEEEcccC
Q 006810 35 KGAFK-TVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNSWVDDTNRTINMITELFT 111 (630)
Q Consensus 35 ~G~fg-~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--NIVk~~~~f~d~~~~~l~lV~Ey~~ 111 (630)
+||++ .+|...+. +.+++++ ... .........+..+|+++++.+.-- -+...+..+.+......|+||+|++
T Consensus 34 ~~G~sn~t~~~~~~--~~~~vlR-~P~--~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 34 SGGWSNDTFRLGDT--GQKYVLR-KPP--RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred cCCcccceEEEecC--CceEEEe-cCC--ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 34433 34555333 7788887 321 111223445567788888877432 2333444443333246788999999
Q ss_pred CCCHH-----------HHh----------------------hcCCCCHHHHHHHHHHH--------------HHHHHHHH
Q 006810 112 SGSLR-----------YRK----------------------KHKNVDMKAIKNWARQI--------------LRGLHYLH 144 (630)
Q Consensus 112 gGsL~-----------~~~----------------------~~~~lse~~i~~i~~QI--------------l~gL~yLH 144 (630)
|..+. +.. +.......++.+|..+. ..-..||+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 84321 000 00011223333333333 12234555
Q ss_pred cCCC------CEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 145 SHNP------PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 145 s~~~------~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
.+-| .++|||+.+.||+++ ..+.+=+.||+++..
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~-~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIID-PGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEe-CCCeeEEEecccccc
Confidence 4433 489999999999998 566689999998853
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.2 Score=52.91 Aligned_cols=29 Identities=10% Similarity=0.124 Sum_probs=25.2
Q ss_pred CEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 149 ~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.++|+|+.++||+++ .++.+-++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~-~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD-ETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEc-CCCCEEEEEhhhcc
Confidence 499999999999997 67789999998664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.70 E-value=0.32 Score=51.24 Aligned_cols=73 Identities=19% Similarity=0.128 Sum_probs=42.3
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCeeEEEeEEEcCCCCEEEEE
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpNIVk~~~~f~d~~~~~l~lV 106 (630)
.+.|+.|....+|+.. .++..+.+|.-. .. ....+..|..-|+.|. --.+++.+.+...... -++|
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~fLl 90 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS-ES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--AFLL 90 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEE-GG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--CEEE
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecC-hh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--ceEE
Confidence 3678889999999985 678889999765 21 1134667887777773 3356677776544433 3789
Q ss_pred EcccCCC
Q 006810 107 TELFTSG 113 (630)
Q Consensus 107 ~Ey~~gG 113 (630)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999887
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.35 E-value=0.41 Score=48.62 Aligned_cols=85 Identities=22% Similarity=0.334 Sum_probs=59.1
Q ss_pred HHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEe
Q 006810 73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 152 (630)
Q Consensus 73 l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiH 152 (630)
++.+.+++.++. .|+++.. +.+..+-+|.|+|---... ...++..=+.+|.-+|+.++..+|
T Consensus 105 y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i~------------~~N~i~agi~~L~~fH~~~~~~lH 166 (308)
T PF07387_consen 105 YFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKIN------------FSNFITAGIKDLMDFHSENQHCLH 166 (308)
T ss_pred hhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCcccc------------hhHHHHHhHHHHHHhhccCCCeec
Confidence 567888888775 5777764 2334567788887542211 111222224567788977778999
Q ss_pred ccCCcCceEEeCCCCcEEEccccc
Q 006810 153 RDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 153 rDLKp~NILl~~~~g~vKL~DFGl 176 (630)
||-.|+||+-+ ..|-+||.|-+.
T Consensus 167 GD~np~NiM~D-~~G~lKlVDP~~ 189 (308)
T PF07387_consen 167 GDCNPDNIMCD-KFGYLKLVDPVC 189 (308)
T ss_pred CCCChhheeec-CCCCEEecChhh
Confidence 99999999998 899999999763
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.09 E-value=0.41 Score=52.50 Aligned_cols=63 Identities=19% Similarity=0.164 Sum_probs=44.8
Q ss_pred EEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-cCCCCEEeccCCcCceEEeCCCC
Q 006810 103 INMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNG 167 (630)
Q Consensus 103 l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLH-s~~~~IiHrDLKp~NILl~~~~g 167 (630)
..++-+|..|-++....+....+++..+.++.-...||-.+- -.+ ++|.|+.|.||++...++
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNKT 383 (565)
T ss_pred ceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecCC
Confidence 446667888877775556677777777777776666655443 334 999999999999974333
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.58 E-value=0.72 Score=50.03 Aligned_cols=103 Identities=18% Similarity=0.260 Sum_probs=64.9
Q ss_pred CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 100 NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+.|++|++- |+.+..+ +.-..+++..++.+.+..|.-+... .+.-||++..+||+|+ .|.|-|+||-+++.
T Consensus 298 ~~y~yl~~kdh-gt~is~i---k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId--~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII---KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID--EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecC-Cceeeee---ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee--cCceEEEEeeeeec
Confidence 35677777763 3344322 2335677788888877777666555 4699999999999997 89999999999973
Q ss_pred eccCCCccccCCCCCCCccccccccCcccceee
Q 006810 180 MQQPTARSVIGTPEFMAPELYEEEYNELVDIYS 212 (630)
Q Consensus 180 ~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIWS 212 (630)
. .... .+--..+--|-+|.|.-+..-+||-
T Consensus 371 ~-~~q~--~isy~rldhp~lF~G~dd~QFeIYr 400 (488)
T COG5072 371 S-YSQG--IISYNRLDHPDLFNGVDDYQFEIYR 400 (488)
T ss_pred c-cCCc--eeeccccCchhhhcCccceeeeHHH
Confidence 2 2111 1111223344455554444555554
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=90.57 E-value=1.7 Score=44.48 Aligned_cols=73 Identities=19% Similarity=0.225 Sum_probs=44.1
Q ss_pred eEecccCceEEEEEEEccCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC---CCeeEEEeEEEcCCCCEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG-~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H---pNIVk~~~~f~d~~~~~l~lV 106 (630)
+.+.-|..-..|.. .+| .++-+|.= .......+..|+.-|..|.- -++.+++. ....+...|+|
T Consensus 22 ~~v~gG~inea~~v---~dg~~~~FvK~n-------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~--~G~~~~~sylV 89 (286)
T COG3001 22 EEVSGGDINEAWRL---RDGTDPFFVKCN-------QREQLSMFTAEADGLELLARSNTITVPKVIA--VGASRDHSYLV 89 (286)
T ss_pred cccCCccccceeEe---ecCCcceEEEec-------chhhHHHHHHHHHHHHHHHhcCCccccceEE--ecCCCCeeEEE
Confidence 33444444444444 444 45666542 23445667788877777743 45666666 34555678999
Q ss_pred EcccCCCCH
Q 006810 107 TELFTSGSL 115 (630)
Q Consensus 107 ~Ey~~gGsL 115 (630)
+||++-|.+
T Consensus 90 le~L~~~~~ 98 (286)
T COG3001 90 LEYLPTGPL 98 (286)
T ss_pred EeeccCCCC
Confidence 999988766
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=90.46 E-value=0.06 Score=59.96 Aligned_cols=66 Identities=21% Similarity=0.531 Sum_probs=56.8
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
+..+|+|+||+|+.+..+..+-.+|||.|..... .....+..+|+.-+..+.|++|++++..|...
T Consensus 54 ~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~---e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 54 GQCLGRGGFGVVFSAQNKADENKYAVKRITLKNR---EESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred cccccccCccccCCccccccchhhHHHHhcccch---hhhhhhhhccccchhhhcccchhhheeceecC
Confidence 4789999999999999988888999999987653 44556788999999999999999999988654
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.28 E-value=1.4 Score=48.26 Aligned_cols=75 Identities=13% Similarity=0.069 Sum_probs=42.4
Q ss_pred eEecccCceEEEEEEEccC-CeE-----EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCe-eEEEeEEEcCCCCEE
Q 006810 31 EILGKGAFKTVYKGFDEVD-GIE-----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTI 103 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~t-G~~-----VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI-Vk~~~~f~d~~~~~l 103 (630)
+.|..|-...+|++..... +.. |.++... ......-.-.+|+.+++.|...++ .++++.|. -
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-----~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~------~ 124 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-----TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG------D 124 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEecc-----CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC------C
Confidence 4565688888999864322 222 3333221 111111112468889999865544 45666552 1
Q ss_pred EEEEcccCCCCHH
Q 006810 104 NMITELFTSGSLR 116 (630)
Q Consensus 104 ~lV~Ey~~gGsL~ 116 (630)
++|.||++|-.|.
T Consensus 125 g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 FTIQEWVEGNTMG 137 (383)
T ss_pred EEEEEEeccccCC
Confidence 4788999988763
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=89.83 E-value=2.9 Score=43.50 Aligned_cols=29 Identities=31% Similarity=0.480 Sum_probs=23.4
Q ss_pred EEeccCCcCceEEeCC-CC---cEEEcccccce
Q 006810 150 IIHRDLKCDNIFVNGN-NG---EVKIGDLGLAI 178 (630)
Q Consensus 150 IiHrDLKp~NILl~~~-~g---~vKL~DFGla~ 178 (630)
++|||+++.|||+... +| .+++.||-.++
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 8999999999999633 33 68999997653
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=89.81 E-value=4.2 Score=50.35 Aligned_cols=30 Identities=30% Similarity=0.531 Sum_probs=23.9
Q ss_pred CEEeccCCcCceEEeCCC-CcEE-Ecccccce
Q 006810 149 PIIHRDLKCDNIFVNGNN-GEVK-IGDLGLAI 178 (630)
Q Consensus 149 ~IiHrDLKp~NILl~~~~-g~vK-L~DFGla~ 178 (630)
.+||+|+.+.||++++.. +.+. |+|||-+.
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 499999999999998432 2565 99999774
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 630 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-74 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-29 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-29 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-27 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-27 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-27 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-27 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-27 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-26 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-26 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-25 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-24 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-24 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-24 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-24 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-24 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-24 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-24 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-24 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-24 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-23 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-23 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-23 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-22 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-22 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-22 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-22 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-22 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-22 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-22 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-22 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-22 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-21 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-21 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-21 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-21 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-21 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-21 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-21 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-21 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-20 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-20 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-18 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-17 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-17 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-17 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-15 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-14 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-14 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-08 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 4e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 4e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 9e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-04 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 6e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 442 bits (1140), Expect = e-153
Identities = 136/281 (48%), Positives = 188/281 (66%), Gaps = 6/281 (2%)
Query: 10 SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
E E + R+ ++D +G+G+FKTVYKG D +EVAW ++ + +
Sbjct: 11 IEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSE 68
Query: 70 LERLYSEVHLLKSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLR-YRKKHKNVDM 126
+R E +LK L+H NI++FY+SW + I ++TEL TSG+L+ Y K+ K + +
Sbjct: 69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI 128
Query: 127 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 186
K +++W RQIL+GL +LH+ PPIIHRDLKCDNIF+ G G VKIGDLGLA + + A+
Sbjct: 129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188
Query: 187 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 246
+VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+LEM T EYPY+EC+N AQIY++VTSG+KP
Sbjct: 189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 248
Query: 247 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD 286
AS KV P+VK+ IE CI R +LL F +
Sbjct: 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 6e-67
Identities = 72/267 (26%), Positives = 133/267 (49%), Gaps = 19/267 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+G G++ K + DG + W +++ + + + L SEV+LL+ LKH NI++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 91 FYNSWVDDTNRTINMITELFTSGSL-----RYRKKHKNVDMKAIKNWARQILRGLHYLHS 145
+Y+ +D TN T+ ++ E G L + K+ + +D + + Q+ L H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 146 HNPP---IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY 200
+ ++HRDLK N+F++G VK+GD GLA ++ T A++ +GTP +M+PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 201 EEE-YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258
YNE DI+S G C+L E+ P+ + ++ K+ G K + ++
Sbjct: 189 NRMSYNEKSDIWSLG-CLLYELCALMPPFTA-FSQKELAGKIREG-KFRRIPYRYSDELN 245
Query: 259 QFIEKCIVP-ASLRLPALELLKDPFLV 284
+ I + + R E+L++P ++
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-65
Identities = 71/293 (24%), Positives = 133/293 (45%), Gaps = 17/293 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +G+G+F DG + ++NI S + E EV +L ++KH NI++
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKHPNIVQ 87
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDM--KAIKNWARQILRGLHYLHSHN 147
+ S+ ++ + + ++ + G L R K V I +W QI L ++H
Sbjct: 88 YRESFEENGS--LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-Y 204
I+HRD+K NIF+ +G V++GD G+A V+ AR+ IGTP +++PE+ E + Y
Sbjct: 146 --ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264
N DI++ G + E+ T ++ + E + + K+ SG +S ++ + +
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQL 260
Query: 265 IVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPM 316
R +L+ F + + + L + + S+P P
Sbjct: 261 FKRNPRDRPSVNSILEKGF-IAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPA 312
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 1e-65
Identities = 78/289 (26%), Positives = 132/289 (45%), Gaps = 18/289 (6%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
+ + + +G+G F VY+ +DG+ VA +V I D+M
Sbjct: 13 VPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM- 71
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-----RYRKK 120
E+ LLK L H N+IK+Y S+++D +N++ EL +G L ++K+
Sbjct: 72 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQ 129
Query: 121 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180
+ + + + + Q+ L ++HS ++HRD+K N+F+ G VK+GDLGL
Sbjct: 130 KRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFF 186
Query: 181 QQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYN-ECKNPAQI 236
T A S++GTP +M+PE E YN DI+S G + EM + P+ + N +
Sbjct: 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 246
Query: 237 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 284
KK+ P S +++Q + CI P R + +
Sbjct: 247 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 5e-65
Identities = 64/284 (22%), Positives = 113/284 (39%), Gaps = 20/284 (7%)
Query: 8 TKSETEEGEFSEKDPSCRYG-RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
+ + P + + + LG G++ V+K + DG A +
Sbjct: 37 ASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF-- 94
Query: 65 QSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKN 123
+ P R +EV + + +H ++ +W + + + TE SL+ +
Sbjct: 95 RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI--LYLQTE-LCGPSLQQHCEAWG 151
Query: 124 VDM--KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181
+ + + R L L +LHS ++H D+K NIF+ G G K+GD GL + +
Sbjct: 152 ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL-GPRGRCKLGDFGLLVELG 208
Query: 182 QPT-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 240
G P +MAPEL + Y D++S G+ ILE+ + + Q+ +
Sbjct: 209 TAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY 268
Query: 241 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
A LS +++ + + P LR A LL P L
Sbjct: 269 LPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-64
Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 30/299 (10%)
Query: 10 SETEEGEFSEKDPSCRYGRYD----EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
TEEG+ Y + +LGKG + VY G D + + +A ++ D
Sbjct: 3 RSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--- 59
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKN 123
+ L+ E+ L K LKH+NI+++ S+ ++ I + E GSL R K
Sbjct: 60 -SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG--FIKIFMEQVPGGSLSALLRSKWGP 116
Query: 124 VDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IV 179
+ I + +QIL GL YLH + I+HRD+K DN+ +N +G +KI D G + +
Sbjct: 117 LKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174
Query: 180 MQQPTARSVIGTPEFMAPE---LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 236
P + GT ++MAPE Y + DI+S G I+EM T + P+ E P
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA 234
Query: 237 YKKVTSGIK----PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 290
KV P S+S + K FI KC P R A +LL D FL + K
Sbjct: 235 MFKVGMFKVHPEIPESMS----AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-62
Identities = 73/275 (26%), Positives = 119/275 (43%), Gaps = 27/275 (9%)
Query: 4 GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVA---WNQVNI 60
GS F KS +E + Y++ +GKG F V+KG D VA +
Sbjct: 5 GSEFPKSRLPTLADNEIE-------YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRY--R 118
E + ++ + EV ++ +L H NI+K Y + M+ E G L +
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL----MHNPPRMVMEFVPCGDLYHRLL 113
Query: 119 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDL 174
K + I G+ Y+ + NPPI+HRDL+ NIF+ + K+ D
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 175 GLAIVMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECK 231
GL+ + ++G ++MAPE E Y E D YSF M + ++T E P++E
Sbjct: 174 GLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232
Query: 232 NP--AQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264
I G++P ++ + P+++ IE C
Sbjct: 233 YGKIKFINMIREEGLRP-TIPEDCPPRLRNVIELC 266
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-61
Identities = 65/284 (22%), Positives = 114/284 (40%), Gaps = 40/284 (14%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+ EI +G G F V+K +DG +V + E+ EV L L H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDH 63
Query: 86 ENIIKFYNSWVDD--------------TNRTINMITELFTSGSLRY---RKKHKNVDMKA 128
NI+ + W + + + E G+L +++ + +D
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 129 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-S 187
QI +G+ Y+HS +I+RDLK NIF+ + +VKIGD GL ++ R
Sbjct: 124 ALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTR 180
Query: 188 VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 246
GT +M+PE + Y + VD+Y+ G+ + E++ E + + GI
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRDGIIS 237
Query: 247 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 289
+ K ++K + R E+L+ + +P+
Sbjct: 238 DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 3e-61
Identities = 73/243 (30%), Positives = 123/243 (50%), Gaps = 15/243 (6%)
Query: 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
E +G G+F TV++ E G +VA + +D +++ EV ++K L+H NI
Sbjct: 41 IKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNI 96
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRY----RKKHKNVDMKAIKNWARQILRGLHYLH 144
+ F + N +I +TE + GSL + +D + + A + +G++YLH
Sbjct: 97 VLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE- 201
+ NPPI+HR+LK N+ V+ VK+ D GL+ + +++S GTPE+MAPE+
Sbjct: 155 NRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 202 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261
E NE D+YSFG+ + E+ T + P+ + + + + +PQV I
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL-EIPRNLNPQVAAII 272
Query: 262 EKC 264
E C
Sbjct: 273 EGC 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-60
Identities = 65/292 (22%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 25 RY-GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 81
RY ++ I LG+G F V++ ++VD A ++ + + E++ EV L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALA 58
Query: 82 SLKHENIIKFYNSWVDDTN----------RTINMITELFTSGSL----RYRKKHKNVDMK 127
L+H I++++N+W++ + + +L +L R + +
Sbjct: 59 KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 128 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR- 186
+ QI + +LHS ++HRDLK NIF + VK+GD GL M Q
Sbjct: 119 VCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 187 -------------SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKN 232
+GT +M+PE Y+ VDI+S G+ + E++ YP++
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQME 232
Query: 233 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
+ V + K L P ++ + P R A+ ++++
Sbjct: 233 RVRTLTDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-59
Identities = 67/243 (27%), Positives = 115/243 (47%), Gaps = 21/243 (8%)
Query: 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
+E++G+GAF V K + +VA I+ ++S + + E+ L + H NI
Sbjct: 12 VEEVVGRGAFGVVCKA--KWRAKDVA-----IK-QIESESERKAFIVELRQLSRVNHPNI 63
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRY----RKKHKNVDMKAIKNWARQILRGLHYLH 144
+K Y + + ++ E GSL + +W Q +G+ YLH
Sbjct: 64 VKLYGA----CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 145 SHNP-PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E 202
S P +IHRDLK N+ + +KI D G A +Q + G+ +MAPE++E
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-HMTNNKGSAAWMAPEVFEGS 178
Query: 203 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVTDPQVKQFI 261
Y+E D++S+G+ + E++T P++E PA I V +G +P L K ++ +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIESLM 237
Query: 262 EKC 264
+C
Sbjct: 238 TRC 240
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-59
Identities = 87/298 (29%), Positives = 132/298 (44%), Gaps = 48/298 (16%)
Query: 23 SCRYG-RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
S RY ++EI LG+GAF V K + +D A ++ + ++L + SEV L
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVML 55
Query: 80 LKSLKHENIIKFYNSWVDDTNR-----------TINMITELFTSGSLRYR--KKHKNVDM 126
L SL H+ ++++Y +W++ N T+ + E +G+L ++ N
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 127 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 186
RQIL L Y+HS IIHRDLK NIF++ + VKIGD GLA + +
Sbjct: 116 DEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDI 172
Query: 187 ----------------SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYN 228
S IGT ++A E+ + YNE +D+YS G+ EM+ YP++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFS 229
Query: 229 ECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
I KK+ S P K+ I I + R A LL +L
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 4e-58
Identities = 70/243 (28%), Positives = 105/243 (43%), Gaps = 14/243 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
EI+G G F VY+ G EVA + +E + E L LKH NII
Sbjct: 13 EIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP-P 149
+ + N + + E G L K + + NWA QI RG++YLH P
Sbjct: 71 LRGVCLKEPNLCL--VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 150 IIHRDLKCDNIFVN-------GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE- 201
IIHRDLK NI + +N +KI D GLA + T S G +MAPE+
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRA 188
Query: 202 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261
+++ D++S+G+ + E++T E P+ A Y + + + + +
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL-PIPSTCPEPFAKLM 247
Query: 262 EKC 264
E C
Sbjct: 248 EDC 250
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-57
Identities = 65/305 (21%), Positives = 115/305 (37%), Gaps = 31/305 (10%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI 60
+ G +E + E + + +G+G+F V++ D+ G + A +V +
Sbjct: 34 TEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL 93
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRK 119
E E+ L I+ Y + + +N+ EL GSL K
Sbjct: 94 EVFRVE---------ELVACAGLSSPRIVPLYGAVREGP--WVNIFMELLEGGSLGQLIK 142
Query: 120 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179
+ + + Q L GL YLH+ I+H D+K DN+ ++ + + D G A+
Sbjct: 143 QMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALC 200
Query: 180 MQQ-------PTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 231
+Q T + GT MAPE+ + + VDI+S +L M+ +P+ +
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260
Query: 232 NPAQIYKKVTSGI----KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD 286
K + P S + P Q I++ + R A+EL +
Sbjct: 261 RGPLCLKIASEPPPIREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316
Query: 287 NPKDL 291
L
Sbjct: 317 EVGGL 321
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-57
Identities = 47/243 (19%), Positives = 95/243 (39%), Gaps = 16/243 (6%)
Query: 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
+ L + ++KG G ++ + + D S + E L+ H N+
Sbjct: 14 FLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNV 69
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLR---YRKKHKNVDMKAIKNWARQILRGLHYLHS 145
+ + +IT GSL + + VD +A + RG+ +LH+
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-- 203
P I L ++ ++ + +I + Q P + P ++APE +++
Sbjct: 130 LEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPG---RMYAPAWVAPEALQKKPE 185
Query: 204 --YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261
D++SF + + E+VT E P+ + N K G++P ++ P V + +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-TIPPGISPHVSKLM 244
Query: 262 EKC 264
+ C
Sbjct: 245 KIC 247
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-57
Identities = 58/281 (20%), Positives = 113/281 (40%), Gaps = 40/281 (14%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENII 89
E +G G F +V+K +DG A + + EV+ L +H +++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL--AGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 90 KFYNSWVDDTNRTINMITELFTSGSL-----RYRKKHKNVDMKAIKNWARQILRGLHYLH 144
+++++W +D + + + E GSL + +K+ Q+ RGL Y+H
Sbjct: 75 RYFSAWAEDDH--MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 145 SHNPPIIHRDLKCDNIFVNGNN------------------GEVKIGDLGLAIVMQQPTAR 186
S + ++H D+K NIF++ + KIGDLG + P +
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--Q 188
Query: 187 SVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 244
G F+A E+ +E + DI++ + ++ E + ++ G
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQGR 244
Query: 245 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 284
P + +V + + ++ I P R A+ L+K L+
Sbjct: 245 LP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-56
Identities = 65/253 (25%), Positives = 116/253 (45%), Gaps = 31/253 (12%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E++GKG F VY G G EVA ++IE + DQL+ EV + +HEN++
Sbjct: 39 ELIGKGRFGQVYHGR--WHG-EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVL 93
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
F + + + I IT L +L R +D+ + A++I++G+ YLH+
Sbjct: 94 FMGACMSPPHLAI--ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG- 150
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------QQPTARSVIGTPEFMAPEL-- 199
I+H+DLK N+F + NG+V I D GL + ++ R G +APE+
Sbjct: 151 -ILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 200 --------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251
+ +++ D+++ G E+ E+P+ + I ++ +G+KP
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQI 266
Query: 252 VTDPQVKQFIEKC 264
++ + C
Sbjct: 267 GMGKEISDILLFC 279
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-55
Identities = 79/248 (31%), Positives = 128/248 (51%), Gaps = 24/248 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +G G+F TVYKG + G +VA +N+ +P QL+ +EV +L+ +H NI+
Sbjct: 30 QRIGSGSFGTVYKG--KWHG-DVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
F + I +T+ SL + +MK + + ARQ RG+ YLH+ +
Sbjct: 85 FM-GYSTAPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS- 140
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYEEE- 203
IIHRDLK +NIF+ + VKIGD GLA + + G+ +MAPE+ +
Sbjct: 141 -IIHRDLKSNNIFL-HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 204 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQV 257
Y+ D+Y+FG+ + E++T + PY+ N QI + V G LSKV ++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 258 KQFIEKCI 265
K+ + +C+
Sbjct: 259 KRLMAECL 266
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 61/279 (21%), Positives = 115/279 (41%), Gaps = 30/279 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENI 88
+ +G G V++ +E A VN+E+ L+ +E+ L L+ + I
Sbjct: 15 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
I+ Y+ + D I M+ E + L + KK K++D K++ + +L +H +H H
Sbjct: 72 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPEL---- 199
I+H DLK N + +G +K+ D G+A MQ T S +GT +M PE
Sbjct: 129 --IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 200 --------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251
+ + + D++S G + M + P+ + N +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 252 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 289
+ + ++ ++ C+ R+ ELL P++
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 8e-54
Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 32/274 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENI 88
+ +G G V++ +E A VN+E+ L+ +E+ L L+ + I
Sbjct: 34 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
I+ Y+ + D I M+ E + L + KK K++D K++ + +L +H +H H
Sbjct: 91 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEEE 203
I+H DLK N + +G +K+ D G+A MQ T S +GT +M PE ++
Sbjct: 148 --IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 204 ------------YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 250
+ D++S G CIL M + P+ + N +
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262
Query: 251 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
+ + ++ ++ C+ R+ ELL P++
Sbjct: 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 6e-53
Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 32/280 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENI 88
+ +G G V++ +E A VN+E+ L+ +E+ L L+ + I
Sbjct: 62 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
I+ Y+ + D I M+ E + L + KK K++D K++ + +L +H +H H
Sbjct: 119 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEEE 203
I+H DLK N + +G +K+ D G+A MQ T S +G +M PE ++
Sbjct: 176 --IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 204 ------------YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 250
+ D++S G CIL M + P+ + N +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290
Query: 251 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 289
+ + ++ ++ C+ R+ ELL P++
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-50
Identities = 88/297 (29%), Positives = 145/297 (48%), Gaps = 23/297 (7%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP 67
+S + + DP + + ++I GKG+F V+KG D VA +++E ++
Sbjct: 6 VQSGLPGMQNLKADPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLE---EAE 61
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMK 127
D++E + E+ +L + K+Y S++ DT I M E GS + +D
Sbjct: 62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM--EYLGGGSALDLLEPGPLDET 119
Query: 128 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR- 186
I R+IL+GL YLHS IHRD+K N+ ++ +GEVK+ D G+A + +
Sbjct: 120 QIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKR 176
Query: 187 -SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA----QIYKKV 240
+ +GTP +MAPE+ ++ Y+ DI+S G+ +E+ E P++E +P I K
Sbjct: 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKN- 234
Query: 241 TSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPL 296
P +L +K+F+E C S R A ELLK F++ + K L
Sbjct: 235 ----NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTEL 287
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-49
Identities = 88/275 (32%), Positives = 140/275 (50%), Gaps = 24/275 (8%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
S DP +Y R+++I G+GA TVY D G EVA Q+N++ + E + +E+
Sbjct: 14 SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEI 68
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQIL 137
+++ K+ NI+ + +S++ + M E GSL +D I R+ L
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVM--EYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 138 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFM 195
+ L +LHS+ +IHRD+K DNI + +G VK+ D G I +Q +++GTP +M
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183
Query: 196 APEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGI----KPASL 249
APE+ + Y VDI+S G+ +EM+ E PY +NP + +Y T+G P L
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKL 242
Query: 250 SKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFL 283
S + F+ +C + R A ELL+ FL
Sbjct: 243 S----AIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 5e-49
Identities = 77/275 (28%), Positives = 131/275 (47%), Gaps = 24/275 (8%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
+ DP Y +I G+G+ V ++ G +VA +++ + E L++EV
Sbjct: 39 DQGDPRLLLDSYVKI-GEGSTGIVCLAREKHSGRQVAVKMMDLR----KQQRRELLFNEV 93
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQIL 137
+++ +H N+++ Y S++ + M E G+L ++ + I +L
Sbjct: 94 VIMRDYQHFNVVEMYKSYLVGEELWVLM--EFLQGGALTDIVSQVRLNEEQIATVCEAVL 151
Query: 138 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFM 195
+ L YLH+ +IHRD+K D+I + +G VK+ D G I P +S++GTP +M
Sbjct: 152 QALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM 208
Query: 196 APEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGI----KPASL 249
APE+ Y VDI+S G+ ++EMV E PY +P Q + + S +
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKV 267
Query: 250 SKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFL 283
S P ++ F+E+ + R A ELL PFL
Sbjct: 268 S----PVLRDFLERMLVRDPQERATAQELLDHPFL 298
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 9e-49
Identities = 86/312 (27%), Positives = 144/312 (46%), Gaps = 27/312 (8%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
F + DP + EI G G+F VY D + VA +++ QS ++ + + E
Sbjct: 47 FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKE 104
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWAR 134
V L+ L+H N I++ ++ + + M E + GS K + I
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWLVM--E-YCLGSASDLLEVHKKPLQEVEIAAVTH 161
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
L+GL YLHSHN +IHRD+K NI ++ G VK+GD G A +M A S +GTP +
Sbjct: 162 GALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYW 216
Query: 195 MAPE----LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ----IYKKVTSGIKP 246
MAPE + E +Y+ VD++S G+ +E+ + P N I + + ++
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQS 275
Query: 247 ASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPE 304
S + F++ C R + LLK F++ + P ++ D + R + V E
Sbjct: 276 GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRE 331
Query: 305 VMNLAHSEPHPM 316
+ NL + + +
Sbjct: 332 LDNLQYRKMKKI 343
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-48
Identities = 71/292 (24%), Positives = 117/292 (40%), Gaps = 49/292 (16%)
Query: 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
+ +GKG + V+ G + G +VA + E E++ ++HENI
Sbjct: 41 MVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEAS--WFRET---EIYQTVLMRHENI 93
Query: 89 IKFYNSWVDDTNRTINM--ITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHS- 145
+ F + + T + IT+ +GSL K +D K++ A + GL +LH+
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 146 -----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGTPEF 194
P I HRDLK NI V NG I DLGLA+ T + +GT +
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 195 MAPELYEE-------EYNELVDIYSFGMCILEMVTC----------EYPYNECKNPAQIY 237
M PE+ +E + + D+YSFG+ + E+ + PY++ Y
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 238 KKVTSG---------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
+ + S Q+ + + +C + RL AL + K
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-48
Identities = 78/301 (25%), Positives = 137/301 (45%), Gaps = 27/301 (8%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP 67
KS E + DP+ + E+ G GAF VYK ++ G A + + S
Sbjct: 3 RKSREYEHVRRDLDPNEVWEIVGEL-GDGAFGKVYKAKNKETGALAAAKVIETK----SE 57
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVD 125
++LE E+ +L + H I+K ++ D I + E G++ + + +
Sbjct: 58 EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI--EFCPGGAVDAIMLELDRGLT 115
Query: 126 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQP 183
I+ RQ+L L++LHS IIHRDLK N+ + G++++ D G++ +
Sbjct: 116 EPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQ 172
Query: 184 TARSVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-I 236
S IGTP +MAPE + + Y+ DI+S G+ ++EM E P++E NP + +
Sbjct: 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVL 231
Query: 237 YKKVTSGIKPASLSKVTD--PQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVC 293
K S P +L + + + F++ R A +LL+ PF+ + +
Sbjct: 232 LKIAKSD--PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289
Query: 294 D 294
+
Sbjct: 290 E 290
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 39/301 (12%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
+ Y + I G GA V + +VA ++N+E + +
Sbjct: 2 SEDSSALPWSINRDDYELQEVI-GSGATAVVQAAYCAPKKEKVAIKRINLE---KCQTSM 57
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM-------ITELFTSGSLRYRKKHKN 123
+ L E+ + H NI+ +Y S+V + M + ++ + K
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117
Query: 124 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA------ 177
+D I R++L GL YLH + IHRD+K NI + +G V+I D G++
Sbjct: 118 LDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFGVSAFLATG 174
Query: 178 -IVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC---- 230
+ + ++ +GTP +MAPE+ E+ Y+ DI+SFG+ +E+ T PY++
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234
Query: 231 -------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPF 282
+P + V K ++ I C R A ELL+ F
Sbjct: 235 VLMLTLQNDPPSLETGVQDKEMLKKYGKS----FRKMISLCLQKDPEKRPTAAELLRHKF 290
Query: 283 L 283
Sbjct: 291 F 291
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 79/288 (27%), Positives = 136/288 (47%), Gaps = 28/288 (9%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
K P + +++ G+G++ +VYK + G VA QV +E L+ + E+
Sbjct: 23 LTKQPEEVFDVLEKL-GEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEI 75
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQ 135
+++ +++K+Y S+ +T+ I M E +GS+ R ++K + I +
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVM--EYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 193
L+GL YLH IHRD+K NI +N G K+ D G+A + +VIGTP
Sbjct: 134 TLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPF 190
Query: 194 FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ----IYKKVTSGIK-PA 247
+MAPE + E YN + DI+S G+ +EM + PY + +P + I + P
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTNPPPTFRKPE 249
Query: 248 SLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCD 294
S F+++C + R A +LL+ PF+ + ++ D
Sbjct: 250 LWS----DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRD 293
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 8e-47
Identities = 83/289 (28%), Positives = 135/289 (46%), Gaps = 27/289 (9%)
Query: 20 KDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
DP RY LGKG F ++ D A V + ++ P Q E++ E+
Sbjct: 9 VDPR-SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQREKMSMEI 66
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQI 136
+ +SL H++++ F+ + D+ + ++ EL SL K+ K + + + RQI
Sbjct: 67 SIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 137 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEF 194
+ G YLH + +IHRDLK N+F+N + EVKIGD GLA ++ R + GTP +
Sbjct: 125 VLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181
Query: 195 MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSK 251
+APE L ++ ++ VD++S G CI+ + P E + Y ++ P ++
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN- 239
Query: 252 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 299
P I+K + + R ELL D F + P RLP
Sbjct: 240 ---PVAASLIQKMLQTDPTARPTINELLNDEFFTSG------YIPARLP 279
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 74/290 (25%), Positives = 115/290 (39%), Gaps = 49/290 (16%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +GKG + V++G G VA + D E E++ L+HENI+
Sbjct: 14 ECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKS--WFRET---ELYNTVMLRHENILG 66
Query: 91 FYNSWVDDTNRTINM--ITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHS--- 145
F S + + + + IT GSL + +D + I GL +LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 146 ---HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGTPEFMA 196
P I HRDLK NI V NG+ I DLGLA++ Q T + +GT +MA
Sbjct: 127 GTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 197 PELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG------ 243
PE+ +E + + VDI++FG+ + E+ ++ + V
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 244 -------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
I S T + + +++C S RL AL + K
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 72/292 (24%), Positives = 111/292 (38%), Gaps = 49/292 (16%)
Query: 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
E +GKG F V++G + G EVA + + E E++ L+HENI
Sbjct: 46 LQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERS--WFREA---EIYQTVMLRHENI 98
Query: 89 IKFYNSWVDDTNRTINM--ITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHS- 145
+ F + D + +++ GSL V ++ + A GL +LH
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 146 -----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEF 194
P I HRDLK NI V NG I DLGLA+ T +GT +
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 195 MAPELYEE-------EYNELVDIYSFGMCILEMVTC----------EYPYNECKNP---- 233
MAPE+ ++ E + DIY+ G+ E+ + PY +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 234 AQIYKKVTSG-----IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
++ K V I S + + + +C + RL AL + K
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-46
Identities = 56/276 (20%), Positives = 93/276 (33%), Gaps = 34/276 (12%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG+G F V DG A ++ E E + + H NI++
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILC----HEQQDREEAQREADMHRLFNHPNILR 90
Query: 91 FYNSWVDDTNRT--INMITELFTSGSL-----RYRKKHKNVDMKAIKNWARQILRGLHYL 143
+ + ++ F G+L R + K + I I RGL +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----------VIGTP 192
H+ HRDLK NI + + G+ + DLG S T
Sbjct: 151 HA--KGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 193 EFMAPELYEEE----YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYK-KVTSGIKP 246
+ APEL+ + +E D++S G C+L M+ E PY+ V + +
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 247 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDP 281
+ + + Q + + R LL
Sbjct: 267 PQSPRHS-SALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-46
Identities = 80/310 (25%), Positives = 139/310 (44%), Gaps = 35/310 (11%)
Query: 9 KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD 68
+S E + +DP+ + + + G G + VYKG G A +++ D
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELV-GNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----D 62
Query: 69 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN----MITELFTSGSLR---YRKK 120
+ E + E+++LK H NI +Y +++ ++ ++ E +GS+ K
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 121 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180
+ + I R+ILRGL +LH H +IHRD+K N+ + N EVK+ D G++ +
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQL 179
Query: 181 QQPTAR--SVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKN 232
+ R + IGTP +MAPE + Y+ D++S G+ +EM P + +
Sbjct: 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MH 238
Query: 233 PA----QIYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDN 287
P I + +K SK + + FIE C + S R +L+K PF+
Sbjct: 239 PMRALFLIPRNPAPRLKSKKWSK----KFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294
Query: 288 PKDLVCDPLR 297
+ V L+
Sbjct: 295 NERQVRIQLK 304
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 9e-46
Identities = 61/274 (22%), Positives = 111/274 (40%), Gaps = 29/274 (10%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
+ILG+GA V++G + G A + + + + ++ E +LK L H+NI+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDM---KAIKNWARQILRGLHYLHS 145
K + + T R +I E GSL ++ N R ++ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 146 HNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE 201
+ I+HR++K NI K+ D G A ++ S+ GT E++ P++YE
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 202 ---------EEYNELVDIYSFGMCIL-EMVTCE---YPYNECKNPAQIYKKVTSGIKPAS 248
++Y VD++S G T P+ + ++ K+ +G +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 249 LSKVTDPQ--VKQFIEKCIVPASLRLPALELLKD 280
+S V + + V SL LL
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-45
Identities = 81/282 (28%), Positives = 133/282 (47%), Gaps = 26/282 (9%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY LGKG F ++ D A V + ++ P Q E++ E+ + +SL
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQREKMSMEISIHRSLA 99
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYL 143
H++++ F+ + D+ + ++ EL SL K+ K + + + RQI+ G YL
Sbjct: 100 HQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE-LY 200
H + +IHRDLK N+F+N + EVKIGD GLA ++ R + GTP ++APE L
Sbjct: 158 HRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVK 258
++ ++ VD++S G CI+ + P E + Y ++ P ++ P
Sbjct: 215 KKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAA 269
Query: 259 QFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 299
I+K + + R ELL D F + P RLP
Sbjct: 270 SLIQKMLQTDPTARPTINELLNDEFFTSG------YIPARLP 305
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 6e-45
Identities = 65/253 (25%), Positives = 98/253 (38%), Gaps = 28/253 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E+LGKG F K G + E + + EV +++ L+H N++K
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMV----MKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
F D +N ITE G+LR + ++A+ I G+ YLHS N
Sbjct: 72 FIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN- 128
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----------------PTARSVIGTP 192
IIHRDL N V N V + D GLA +M +V+G P
Sbjct: 129 -IIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 193 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251
+MAPE + Y+E VD++SFG+ + E++ + + G
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246
Query: 252 VTDPQVKQFIEKC 264
P +C
Sbjct: 247 NCPPSFFPITVRC 259
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 65/290 (22%), Positives = 118/290 (40%), Gaps = 32/290 (11%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
+ILG+GA V++G + G A + + + + ++ E +LK L H+NI+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDM---KAIKNWARQILRGLHYLHS 145
K + + T R +I E GSL ++ N R ++ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 146 HNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE 201
+ I+HR++K NI K+ D G A ++ S+ GT E++ P++YE
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 202 ---------EEYNELVDIYSFGMCIL-EMVTCE---YPYNECKNPAQIYKKVTSGIKPAS 248
++Y VD++S G T P+ + ++ K+ +G +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 249 LSKVTDPQVKQFIEKCIVPASLRLPA-LELLKDPFLVTDNPKDLVCDPLR 297
+S V + +P S L L++L P L L D +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA----NILEADQEK 293
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 65/281 (23%), Positives = 125/281 (44%), Gaps = 18/281 (6%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
++ LGKG F VY ++ +A + + ++ +L EV + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-GVEHQLRREVEIQSHLR 67
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYL 143
H NI++ Y + D T + +I E G++ R +K D + + ++ L Y
Sbjct: 68 HPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE- 202
HS +IHRD+K +N+ + G+ GE+KI D G ++ + GT +++ PE+ E
Sbjct: 126 HSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 203 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQF 260
++E VD++S G+ E + P E + YK+++ P ++ +
Sbjct: 183 MHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEFTFPDFVT----EGARDL 237
Query: 261 IEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 300
I + + S R E+L+ P++ ++ K C +
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-43
Identities = 56/272 (20%), Positives = 124/272 (45%), Gaps = 20/272 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENII 89
+G G V+K G +A Q+ + ++ +R+ ++ +LKS I+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVLKSHDCPYIV 87
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
+ + +++ +T+ + + EL + + + ++ + + + I++ L+YL +
Sbjct: 88 QCFGTFITNTD--VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE------LYE 201
+IHRD+K NI ++ G++K+ D G++ + A+ G +MAPE +
Sbjct: 146 -VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 202 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD--PQVKQ 259
+Y+ D++S G+ ++E+ T ++PY CK ++ KV +P L +
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQS 262
Query: 260 FIEKCIV-PASLRLPALELLKDPFLVTDNPKD 290
F++ C+ R +LL+ F+ +
Sbjct: 263 FVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 6e-43
Identities = 71/395 (17%), Positives = 128/395 (32%), Gaps = 74/395 (18%)
Query: 5 SGFTKSETEEGEFSEKDPSCRYGRYDEILGKGA--FKTVYKGFDEVDGIEVAWNQVNIED 62
++ +G S Y I GKG TV + G V ++N+E
Sbjct: 6 HHHMENLYFQGMSSFLPEGGCYELLTVI-GKGFEDLMTVNLARYKPTGEYVTVRRINLEA 64
Query: 63 VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKH 121
S + + L E+H+ K H NI+ + +++ D + ++T GS + H
Sbjct: 65 --CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTH 120
Query: 122 KNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179
M AI + +L+ L Y+H +HR +K +I ++ +G+V + L +
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLS 177
Query: 180 MQQPTAR---------SVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPY 227
M R + +++PE+ ++ Y+ DIYS G+ E+ P+
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 228 ---------------------------NECKNPAQIYKKVTSGIKPASLSKVTDPQV--- 257
E + SG+ + + P
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 258 -------------KQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 303
F+E+C R A LL F + LP L+
Sbjct: 298 PSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEA----LPELLR 353
Query: 304 EVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTW 338
V + + E D + + + W
Sbjct: 354 PVTPITNFEGSQSQ-DHSGIFGLVTNLEELEVDDW 387
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 52/272 (19%), Positives = 104/272 (38%), Gaps = 29/272 (10%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
+ A+ + + E+ + + + SP ++ ++ + +N +
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 92 YNSWVDDTNRTINMITELFTSGSLR----YRKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
I M +L +L+ R ++ + + QI + +LHS
Sbjct: 127 LQPSSPKVYLYIQM--QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--------------SVIGTPE 193
++HRDLK NIF + VK+GD GL M Q +GT
Sbjct: 185 --LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 194 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 252
+M+PE Y+ VDI+S G+ + E++ Y ++ +I V + P ++
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIITDVRNLKFPLLFTQ- 297
Query: 253 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
PQ ++ + P + R A +++++
Sbjct: 298 KYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 162 bits (410), Expect = 2e-42
Identities = 93/400 (23%), Positives = 142/400 (35%), Gaps = 41/400 (10%)
Query: 22 PSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
P+ G ++ E LG G F V + + G +VA + SP ER E+ +
Sbjct: 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQI 65
Query: 80 LKSLKHENIIKFYNSWVDDTNRTIN------MITELFTSGSLR-YRKKHKNVDM---KAI 129
+K L H N++ V D + + + E G LR Y + +N I
Sbjct: 66 MKKLNHPNVVSARE--VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNI--FVNGNNGEVKIGDLGLAIVMQQPT-AR 186
+ I L YLH + IIHRDLK +NI KI DLG A + Q
Sbjct: 124 RTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
Query: 187 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 245
+GT +++APEL E ++Y VD +SFG E +T P+ P Q + KV
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241
Query: 246 PASLSKVTDPQVKQFIEKCIVPASL---------RLPALELLKDP-----FLVTDNPKDL 291
+ +F P L R L+ N
Sbjct: 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301
Query: 292 VCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENN 351
L + VMN+ H + N + S + +TG + E Q L + +
Sbjct: 302 QALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTG---IPEEEQELLQAS 358
Query: 352 EFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADT 391
L + V + + D ++ F+F
Sbjct: 359 GLALNSAQPLTQYV-IDCTVIDGRQGEGDLIFLFDNRKTV 397
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 66/312 (21%), Positives = 133/312 (42%), Gaps = 35/312 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENII 89
+G+GA+ +V K + G +A ++ + ++L ++ +++S I+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 90 KFYNSWVDDTNRTINMITELFTSGSL------RYRKKHKNVDMKAIKNWARQILRGLHYL 143
+FY + + + + E S S Y + + + ++ L++L
Sbjct: 85 QFYGALFREGD--CWICME-LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 144 HS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPE--- 198
IIHRD+K NI ++ +G +K+ D G++ + A++ G +MAPE
Sbjct: 142 KENLK--IIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198
Query: 199 --LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD-- 254
+ Y+ D++S G+ + E+ T +PY + + +V G P LS +
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEERE 257
Query: 255 --PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 311
P F+ C+ S R ELLK PF++ + + + V ++++ +
Sbjct: 258 FSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA-----VEVACYVCKILDQMPA 312
Query: 312 EP-HPMDIDLNH 322
P PM +D +H
Sbjct: 313 TPSSPMYVDHHH 324
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-42
Identities = 62/274 (22%), Positives = 119/274 (43%), Gaps = 23/274 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENII 89
LG+GA+ V K G +A ++ + + +RL ++ ++++ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 90 KFYNSWVDDTNRTINMITELFTSGSL-----RYRKKHKNVDMKAIKNWARQILRGLHYLH 144
FY + + + + + E SL + K + + + A I++ L +LH
Sbjct: 70 TFYGALFREGD--VWICME-LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 145 S-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE---- 198
S + +IHRD+K N+ +N G+VK+ D G++ + A+ G +MAPE
Sbjct: 127 SKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183
Query: 199 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257
L ++ Y+ DI+S G+ ++E+ +PY+ P Q K+V P + +
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEF 243
Query: 258 KQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 290
F +C+ + R EL++ PF K
Sbjct: 244 VDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-42
Identities = 69/276 (25%), Positives = 129/276 (46%), Gaps = 23/276 (8%)
Query: 25 RYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
+ + +LGKG+F VY+ G+EVA ++ + M ++R+ +EV +
Sbjct: 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA-MYKAGMVQRVQNEVKIHCQ 67
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDMKAIKNWARQILRGL 140
LKH +I++ YN + D + ++ E+ +G + + + K +++ QI+ G+
Sbjct: 68 LKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE 198
YLHSH I+HRDL N+ + N +KI D GLA ++ P + ++ GTP +++PE
Sbjct: 126 LYLHSHG--ILHRDLTLSNLLL-TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182
Query: 199 -LYEEEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTD 254
+ D++S G C+ ++ P+ + KV P+ LS
Sbjct: 183 IATRSAHGLESDVWSLG-CMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPSFLS---- 236
Query: 255 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 289
+ K I + + + RL +L PF+ ++
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 68/300 (22%), Positives = 112/300 (37%), Gaps = 32/300 (10%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP 67
+ + +E + ++LG GA T+ D +VA ++ E
Sbjct: 8 EQDDGDEETSVVIVGKISFCP-KDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF---- 61
Query: 68 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNV 124
+R EV LL+ +H N+I+++ + D + EL + +L +K
Sbjct: 62 SFADR---EVQLLRESDEHPNVIRYFCTEKDRQF--QYIAIEL-CAATLQEYVEQKDFAH 115
Query: 125 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIVM 180
+Q GL +LHS N I+HRDLK NI ++ N I D GL +
Sbjct: 116 LGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 181 QQP-----TARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEY-PYNEC 230
V GT ++APE+ E+ VDI+S G +++ P+ +
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233
Query: 231 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 289
+ K D ++ IEK I R A +LK PF + +
Sbjct: 234 LQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 65/279 (23%), Positives = 128/279 (45%), Gaps = 18/279 (6%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
+D LGKG F VY ++ + +A + + + +L
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-GVEHQLRR 63
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWAR 134
E+ + L+H NI++ YN + D I ++ E G L + +KH D + +
Sbjct: 64 EIEIQSHLRHPNILRMYNYFHDRKR--IYLMLEFAPRGELYKELQKHGRFDEQRSATFME 121
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
++ LHY H +IHRD+K +N+ + G GE+KI D G ++ R++ GT ++
Sbjct: 122 ELADALHYCHERK--VIHRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRTMCGTLDY 178
Query: 195 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSK 251
+ PE+ E + ++E VD++ G+ E + P+ + + + ++++ + +K P LS
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFLS- 236
Query: 252 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 289
K I K + RLP +++ P++ ++ +
Sbjct: 237 ---DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-41
Identities = 79/280 (28%), Positives = 127/280 (45%), Gaps = 15/280 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+LGKG+F V D++ G E A ++ ++ E L EV LLK L H NI+K
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
Y + D ++ E++T G L K RQ+L G+ Y+H +
Sbjct: 91 LYEFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 150 IIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYNE 206
I+HRDLK +N+ + + ++I D GL+ + + IGT ++APE+ Y+E
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 206
Query: 207 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEK 263
D++S G IL ++ P N I KKV G + KV++ K I K
Sbjct: 207 KCDVWSTG-VILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE-SAKDLIRK 264
Query: 264 CIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 302
+ S+R+ A + L ++ T + + D L N +
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAI 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-41
Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 49/293 (16%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+ E+ +G F V+K ++ VA V I +Q + EV+ L +KHEN
Sbjct: 27 QLLEVKARGRFGCVWKA--QLLNEYVA---VKIFP-IQDKQSWQNE-YEVYSLPGMKHEN 79
Query: 88 IIKFYNSWVDDTNRTINM--ITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHS 145
I++F + T+ +++ IT GSL K V + + A + RGL YLH
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHE 139
Query: 146 --------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPE 193
H P I HRD+K N+ + NN I D GLA+ +GT
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 194 FMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI----------- 236
+MAPE+ ++ + +D+Y+ G+ + E+ + + + +
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258
Query: 237 ---------YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
+KK ++ + + IE+C A RL A + +
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-41
Identities = 70/333 (21%), Positives = 130/333 (39%), Gaps = 62/333 (18%)
Query: 5 SGFTKSETEEGEFSEKDPSCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIED 62
F + + GE + D +++I LG G V+K + G+ +A +++E
Sbjct: 18 EAFLTQKQKVGELKDDD-------FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 70
Query: 63 VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKH 121
P ++ E+ +L I+ FY ++ D I++ E GSL + KK
Sbjct: 71 ---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKA 125
Query: 122 KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180
+ + + + +++GL YL H I+HRD+K NI VN + GE+K+ D G++ +
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQL 182
Query: 181 QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 239
A S +GT +M+PE L Y+ DI+S G+ ++EM YP
Sbjct: 183 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 240 VTSGIKPASLSKVTD-----------------------------------------PQVK 258
A+ + + +
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302
Query: 259 QFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 290
F+ KC++ + R +L+ F+ + ++
Sbjct: 303 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 76/301 (25%), Positives = 132/301 (43%), Gaps = 25/301 (8%)
Query: 7 FTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVN----IED 62
F ++ K Y + LG GA V F+ +VA ++
Sbjct: 118 FFDLTVDDQSVYPKALRDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG 176
Query: 63 VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKH 121
+ D + +E+ +LK L H IIK N D + ++ EL G L + +
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAED--YYIVLELMEGGELFDKVVGN 233
Query: 122 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIV 179
K + K + Q+L + YLH + IIHRDLK +N+ + + +KI D G + +
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 180 MQQPTA-RSVIGTPEFMAPE----LYEEEYNELVDIYSFGMCILEMVTCEY-PYNECKNP 233
+ + + R++ GTP ++APE + YN VD +S G IL + Y P++E +
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEHRTQ 350
Query: 234 AQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 289
+ ++TSG P ++V++ ++K +V R E L+ P+L ++ K
Sbjct: 351 VSLKDQITSGKYNFIPEVWAEVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409
Query: 290 D 290
Sbjct: 410 R 410
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 83/283 (29%), Positives = 131/283 (46%), Gaps = 21/283 (7%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
+ + RY +LGKG+F V K D + E A +N + EV
Sbjct: 16 FQGTFAERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREV 72
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQI 136
LLK L H NI+K + D ++ ++ EL+T G L K K +Q+
Sbjct: 73 ELLKKLDHPNIMKLFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 137 LRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIGTPE 193
G+ Y+H HN I+HRDLK +NI + + ++KI D GL+ QQ T + IGT
Sbjct: 131 FSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 194 FMAPELYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPAS 248
++APE+ Y+E D++S G IL ++ P Y + N I K+V +G
Sbjct: 189 YIAPEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQ 245
Query: 249 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 290
++D K I K + SLR+ A + L+ P++ + ++
Sbjct: 246 WRTISD-DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 61/315 (19%), Positives = 110/315 (34%), Gaps = 43/315 (13%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 89
+L +G F VY+ D G E A ++ ++ + EV +K L H NI+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLS----NEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 90 KFYNSWVD-----DTNRTINMITELFTSGSL----RYRKKHKNVDMKAIKNWARQILRGL 140
+F ++ DT + ++ G L + + + + Q R +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV------------ 188
++H PPIIHRDLK +N+ + N G +K+ D G A + S
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLL-SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 189 --IGTPEFMAPELYE----EEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVT 241
TP + PE+ + E DI++ G CIL + ++P+ + +I
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED-GAKLRIVNGKY 266
Query: 242 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 300
S + I + RL E++ + P +
Sbjct: 267 SIPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP--ITE 320
Query: 301 LVPEVMNLAHSEPHP 315
L+ + +
Sbjct: 321 LLEQNGGYGSATLSR 335
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 64/277 (23%), Positives = 119/277 (42%), Gaps = 30/277 (10%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVN---IEDVMQSPDQLERLYSEVHLLKS 82
Y +G+G++ V + I A ++ +EDV +R E+ ++KS
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-------DRFKQEIEIMKS 62
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLH 141
L H NII+ Y ++ D+T+ I ++ EL T G L R + + +L +
Sbjct: 63 LDHPNIIRLYETFEDNTD--IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA 120
Query: 142 YLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 198
Y H N + HRDLK +N + + +K+ D GLA + R+ +GTP +++P+
Sbjct: 121 YCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 199 LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVT 253
+ E Y D +S G ++ ++ C YP +++ K+ G V+
Sbjct: 179 VLEGLYGPECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVS 235
Query: 254 DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 289
Q + I + + R+ +L+ L+ +
Sbjct: 236 P-QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-39
Identities = 81/280 (28%), Positives = 125/280 (44%), Gaps = 16/280 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+LGKG+F V K D + E A +N + EV LLK L H NI+K
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMK 85
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
+ D ++ ++ EL+T G L K K +Q+ G+ Y+H HN
Sbjct: 86 LFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 150 IIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYNE 206
I+HRDLK +NI + + ++KI D GL+ QQ + IGT ++APE+ Y+E
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 207 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEK 263
D++S G IL ++ P KN I K+V +G ++D K I K
Sbjct: 202 KCDVWSAG-VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD-DAKDLIRK 259
Query: 264 CIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 302
+ SLR+ A + L+ P++ + + L
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESA 299
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 75/298 (25%), Positives = 130/298 (43%), Gaps = 26/298 (8%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVN----IEDVMQSPDQLERLYSEVHLLKSLKH 85
+ LG GA V F+ +VA ++ + D + +E+ +LK L H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLH 144
IIK N + D + ++ EL G L + +K + K + Q+L + YLH
Sbjct: 75 PCIIKIKN-FFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 145 SHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE--- 198
+ IIHRDLK +N+ + + +KI D G + ++ + + R++ GTP ++APE
Sbjct: 132 ENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 199 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 252
+ YN VD +S G IL + YP + + ++TSG P ++V
Sbjct: 190 SVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEH-RTQVSLKDQITSGKYNFIPEVWAEV 247
Query: 253 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLA 309
++ ++K +V R E L+ P+L ++ K D L N + +
Sbjct: 248 SEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVL 304
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 62/281 (22%), Positives = 123/281 (43%), Gaps = 27/281 (9%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
+ + + + LG GAF V+ + G+E + + +S +E++ +E
Sbjct: 15 YFQGTIDDLF-IFKRKLGSGAFGDVHLVEERSSGLERV---IKTINKDRSQVPMEQIEAE 70
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-----RYRKKHKNVDMKAIKN 131
+ +LKSL H NIIK + + D N + ++ E G L + + K + +
Sbjct: 71 IEVLKSLDHPNIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 132 WARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSV 188
+Q++ L Y HS + ++H+DLK +NI F + + +KI D GLA + + +
Sbjct: 129 LMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA 186
Query: 189 IGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---- 244
GT +MAPE+++ + DI+S G ++ + + ++ +K T
Sbjct: 187 AGTALYMAPEVFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA 245
Query: 245 -KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
+ L+ PQ +++ + R A ++L +
Sbjct: 246 VECRPLT----PQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-39
Identities = 80/294 (27%), Positives = 127/294 (43%), Gaps = 23/294 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVA---------WNQVNIEDVMQSPDQLERLYSEVHLLK 81
LG GA+ V ++ E A +D E +Y+E+ LLK
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 82 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGL 140
SL H NIIK ++ + D ++TE + G L + D N +QIL G+
Sbjct: 102 SLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159
Query: 141 HYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAP 197
YLH HN I+HRD+K +NI N + +KI D GL+ + R +GT ++AP
Sbjct: 160 CYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 198 ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTD 254
E+ +++YNE D++S G I+ ++ C YP +N I KKV G ++
Sbjct: 218 EVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNIS- 275
Query: 255 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 307
+ K+ I+ + + R A E L ++ D L + +
Sbjct: 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRK 329
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-39
Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 16/281 (5%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
+ LG GA+ V D+V +E A + V S +L EV +LK L H NI+
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV--STSSNSKLLEEVAVLKLLDHPNIM 99
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
K Y+ + D N ++ E + G L + +Q+L G+ YLH HN
Sbjct: 100 KLYDFFEDKRN--YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN- 156
Query: 149 PIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYN 205
I+HRDLK +N+ + + +KI D GL+ V + + +GT ++APE+ ++Y+
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYD 215
Query: 206 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIE 262
E D++S G IL ++ YP + +I +KV G V++ K I+
Sbjct: 216 EKCDVWSIG-VILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE-GAKDLIK 273
Query: 263 KCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 302
+ + + R+ A + L+ P++ K L
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANA 314
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 72/276 (26%), Positives = 131/276 (47%), Gaps = 23/276 (8%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
YD E LGKGAF V + + G+E A +N + + S ++L E + + L+H
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQH 64
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLH 144
NI++ ++S +++ ++ +L T G L + + +QIL + Y H
Sbjct: 65 PNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 145 SHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPE-LY 200
S+ I+HR+LK +N+ + VK+ D GLAI + GTP +++PE L
Sbjct: 123 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 255
++ Y++ VDI++ G IL ++ YP ++E + ++Y ++ +G VT
Sbjct: 181 KDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTP- 236
Query: 256 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 290
+ K I+ + R+ A + LK P++
Sbjct: 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-38
Identities = 72/294 (24%), Positives = 126/294 (42%), Gaps = 29/294 (9%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-LERLYSEVHLLKSLK 84
Y+ E++GKG F V + + G + A V++ SP E L E + LK
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYR---KKHKNVDM--KAIKNWARQILRG 139
H +I++ ++ D + M+ E L + + ++ RQIL
Sbjct: 85 HPHIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 140 LHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFM 195
L Y H +N IIHRD+K + + N+ VK+G G+AI + + A +GTP FM
Sbjct: 143 LRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 196 APE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASL 249
APE + E Y + VD++ G IL ++ Y ++++ + G P
Sbjct: 201 APEVVKREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQW 256
Query: 250 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK-DLVCDPLRLPNL 301
S +++ K + + ++ + R+ E L P+L + + P + L
Sbjct: 257 SHISE-SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQL 309
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 66/294 (22%), Positives = 118/294 (40%), Gaps = 24/294 (8%)
Query: 7 FTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS 66
+ K + E + Y E LG GAF V++ ++ G +N
Sbjct: 34 WKKYVPQPVEVKQGSVYDYY-DILEELGSGAFGVVHRCVEKATGRVFVAKFINT----PY 88
Query: 67 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDM 126
P + +E+ ++ L H +I ++++ D + +I E + G L R ++ M
Sbjct: 89 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKM 146
Query: 127 --KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQP 183
+ N+ RQ GL ++H H+ I+H D+K +NI VKI D GLA +
Sbjct: 147 SEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204
Query: 184 TA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKK 239
+ T EF APE + E D+++ G + ++ E + + +
Sbjct: 205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQN 261
Query: 240 VTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 289
V + S V+ + K FI+ + RL + L+ P+L D+
Sbjct: 262 VKRCDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 69/287 (24%), Positives = 128/287 (44%), Gaps = 26/287 (9%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+ E+LG GAF V+ + G A + + L +E+ +LK +KH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD----SSLENEIAVLKKIKH 65
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDMKAIKNWARQILRGLHYL 143
ENI+ + + T+ ++ +L + G L R ++ + A +Q+L + YL
Sbjct: 66 ENIVTLEDIYESTTH--YYLVMQLVSGGELFDRILERGVYTEKDA-SLVIQQVLSAVKYL 122
Query: 144 HSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LY 200
H + I+HRDLK +N+ N ++ I D GL+ + Q + GTP ++APE L
Sbjct: 123 HENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLA 180
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 255
++ Y++ VD +S G I ++ C YP Y E +++++K+ G + +++
Sbjct: 181 QKPYSKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKEGYYEFESPFWDDISE- 236
Query: 256 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 301
K FI + + R + L P++ + P +
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQI 283
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 68/278 (24%), Positives = 128/278 (46%), Gaps = 23/278 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
EILG G F V+K + G+++A + + E + +E+ ++ L H N+I+
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKT----RGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDM--KAIKNWARQILRGLHYLHSHNP 148
Y+++ + I ++ E G L R ++ ++ + +QI G+ ++H
Sbjct: 151 LYDAFESKND--IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY- 207
Query: 149 PIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LYEEEYN 205
I+H DLK +NI VN + ++KI D GLA + + GTPEF+APE + + +
Sbjct: 208 -ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266
Query: 206 ELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQF 260
D++S G+ I M+ + N A+ + + + +++ + K+F
Sbjct: 267 FPTDMWSVGV-IAYMLLSGLSPFLGD--NDAETLNNILACRWDLEDEEFQDISE-EAKEF 322
Query: 261 IEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLR 297
I K ++ S R+ A E LK P+L + +
Sbjct: 323 ISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 73/274 (26%), Positives = 132/274 (48%), Gaps = 23/274 (8%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
YD E LGKGAF V + + G+E A +N + + S ++L E + + L+H
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQH 87
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLH 144
NI++ ++S +++ ++ +L T G L + + +QIL + Y H
Sbjct: 88 PNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 145 SHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LY 200
S+ I+HR+LK +N+ + VK+ D GLAI + A GTP +++PE L
Sbjct: 146 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 203
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 255
++ Y++ VDI++ G IL ++ YP ++E + ++Y ++ +G VT
Sbjct: 204 KDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTP- 259
Query: 256 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 288
+ K I+ + R+ A + LK P++
Sbjct: 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 58/317 (18%), Positives = 117/317 (36%), Gaps = 47/317 (14%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVY-----------KGFDEVDGIEVAWNQVNIEDVM 64
K+ Y L +G F + K +++ + + D +
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKI 81
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKN 123
+ + +E+ ++ +K+E + + + +I E + S+ ++ +
Sbjct: 82 SIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFV 139
Query: 124 VDMKA--------IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175
+D IK + +L Y+H+ I HRD+K NI + NG VK+ D G
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILM-DKNGRVKLSDFG 197
Query: 176 LAIVMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKN 232
+ M + GT EFM PE + E VDI+S G+C+ M P++ +
Sbjct: 198 ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257
Query: 233 PAQIYKKVTSG-----------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA 274
+++ + + K + + F++ + + R+ +
Sbjct: 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317
Query: 275 LELLKDPFLVTDNPKDL 291
+ LK +L N +DL
Sbjct: 318 EDALKHEWLADTNIEDL 334
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 24/290 (8%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSL 83
YD E LG G F V K ++ G+E A + S + R + EV +L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDM-KAIKNWARQILRGLHY 142
H N+I ++ + + T+ + +I EL + G L K + ++ +QIL G++Y
Sbjct: 73 LHHNVITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 143 LHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 198
LH+ I H DLK +NI + N +K+ D GLA ++ +++ GTPEF+APE
Sbjct: 131 LHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 199 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 252
+ E D++S G I ++ + + +TS S
Sbjct: 189 IVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITSVSYDFDEEFFSHT 245
Query: 253 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 301
++ K FI K +V RL E L+ P++ + + + + NL
Sbjct: 246 SE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNL 294
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 55/275 (20%), Positives = 113/275 (41%), Gaps = 26/275 (9%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+Y E LG+G F V++ + + V + E+ +L +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYM-----AKFVKVKGTDQVLVKKEISILNIARH 60
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDM--KAIKNWARQILRGLHYL 143
NI+ + S+ + MI E + + R ++ + I ++ Q+ L +L
Sbjct: 61 RNILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 144 HSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LY 200
HSHN I H D++ +NI + + +KI + G A ++ R + PE+ APE
Sbjct: 119 HSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 255
+ + D++S G ++ ++ E QI + + + + +++
Sbjct: 177 HDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISI- 232
Query: 256 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 289
+ F+++ +V R+ A E L+ P+L +
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 42/224 (18%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLY---SEVHLLKSLKHE 86
E++G+G + VYKG +D VA V + + ++ + ++H+
Sbjct: 18 LELIGRGRYGAVYKG--SLDERPVA--------VKVFSFANRQNFINEKNIYRVPLMEHD 67
Query: 87 NIIKFYNSWVDDTNRTIN---MITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYL 143
NI +F T ++ E + +GSL D + A + RGL YL
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 144 HS-------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----------QQPTAR 186
H+ + P I HRDL N+ V N+G I D GL++ + + A
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 187 SVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT 222
S +GT +MAPE+ E E + VD+Y+ G+ E+
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 67/320 (20%), Positives = 116/320 (36%), Gaps = 64/320 (20%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLK 84
+Y +G+G++ V + A +N + Q +P +ER+ +EV L+K L
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWA----------- 133
H NI + Y + D+ I ++ EL G L + D
Sbjct: 87 HPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 134 ------------------------------RQILRGLHYLHSHNPPIIHRDLKCDNI-FV 162
RQI LHYLH+ I HRD+K +N F
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFS 202
Query: 163 NGNNGEVKIGDLGLAIVMQQPTA------RSVIGTPEFMAPEL---YEEEYNELVDIYSF 213
+ E+K+ D GL+ + + GTP F+APE+ E Y D +S
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262
Query: 214 GMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVP-AS 269
G +L ++ N A +V + + + + ++ + + +
Sbjct: 263 G-VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSP-LARDLLSNLLNRNVD 320
Query: 270 LRLPALELLKDPFLVTDNPK 289
R A+ L+ P++ + K
Sbjct: 321 ERFDAMRALQHPWISQFSDK 340
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 26/291 (8%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL--ERLYSEVHLLKSL 83
YD E LG G F V K ++ G+E A + S + E + EV +L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDMKAIKNWARQILRGLH 141
H NII ++ + + T+ + +I EL + G L +K + +A ++ +QIL G++
Sbjct: 73 LHPNIITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEAT-SFIKQILDGVN 129
Query: 142 YLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAP 197
YLH+ I H DLK +NI + N +K+ D GLA ++ +++ GTPEF+AP
Sbjct: 130 YLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 198 E-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSK 251
E + E D++S G I ++ + + +T+ S+
Sbjct: 188 EIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITAVSYDFDEEFFSQ 244
Query: 252 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 301
++ K FI K +V RL E L+ P++ + + + + NL
Sbjct: 245 TSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNL 294
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 5e-36
Identities = 38/297 (12%), Positives = 80/297 (26%), Gaps = 56/297 (18%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVA------------------------WNQVNIEDVMQS 66
+LG+ + D+ G + +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 67 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-------RYRK 119
R L+K + + +I+ D + + S +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 120 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179
HK++ A Q++R L LH + ++H L+ +I ++ G V + +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQ-RGGVFLTGFEHLVR 255
Query: 180 MQQPTARSVIGTPEFMAPELYEEE------------YNELVDIYSFGMCILEMVTCEYPY 227
+ F PEL D ++ G+ I + + P
Sbjct: 256 DGARV--VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313
Query: 228 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
+ + + K V+ +E + RL L+ ++ P
Sbjct: 314 TK-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 139 bits (350), Expect = 6e-36
Identities = 42/337 (12%), Positives = 92/337 (27%), Gaps = 58/337 (17%)
Query: 27 GRY-----DEILGKGAFKTVYKGFDEVDGIEVA------WNQVNIEDV------------ 63
R +LG+ + D+ G + +
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 64 ---MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF--TSGSL--- 115
+++ Q + + +K K +D+ + + L+ +L
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 116 -----RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 170
+ HK++ A Q++R L LH + ++H L+ +I + G V
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVL-DQRGGVF 251
Query: 171 IGDLGLAIVMQQPT---ARSVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMV 221
+ + PE A + D ++ G+ I +
Sbjct: 252 LTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 222 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 280
+ P + + + K V+ +E + RL L+ ++
Sbjct: 312 CADLPNTD-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMET 364
Query: 281 PFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMD 317
P + + + L L E + P
Sbjct: 365 PEY--EQLRTELSAALPLYQTDGEPTREGGAPPSGTS 399
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 69/280 (24%), Positives = 127/280 (45%), Gaps = 24/280 (8%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSL 83
Y+ E LG G F V K + G E A + + S + R + EV++L+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHY 142
+H NII ++ + + T+ + +I EL + G L + +++ + +QIL G+HY
Sbjct: 66 RHPNIITLHDIFENKTD--VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 143 LHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 198
LHS I H DLK +NI + N N +K+ D G+A ++ +++ GTPEF+APE
Sbjct: 124 LHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 199 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 252
+ E D++S G I ++ E + +++ S
Sbjct: 182 IVNYEPLGLEADMWSIG-VITYILLSGASPFLGE--TKQETLTNISAVNYDFDEEYFSNT 238
Query: 253 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 291
++ K FI + +V R+ + L+ ++ +++
Sbjct: 239 SE-LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-35
Identities = 73/289 (25%), Positives = 133/289 (46%), Gaps = 25/289 (8%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
Y E LGKGAF V + + G E A +N + + S ++L E + + LKH
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKH 69
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLH 144
NI++ ++S ++ + +I +L T G L + + +QIL + + H
Sbjct: 70 PNIVRLHDSISEEGH--HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 145 SHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE-L 199
++HR+LK +N+ + VK+ D GLAI ++ GTP +++PE L
Sbjct: 128 QMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 200 YEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTD 254
++ Y + VD+++ G IL ++ YP ++E + ++Y+++ +G VT
Sbjct: 186 RKDPYGKPVDLWACG-VILYILLVGYPPFWDE--DQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 255 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP-KDLVCDPLRLPNL 301
+ K I K + S R+ A E LK P++ + + + L
Sbjct: 243 -EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCL 290
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 68/289 (23%), Positives = 122/289 (42%), Gaps = 27/289 (9%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
YD E LG GAF V++ + G A V E + E+ + L+H
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT----PHESDKETVRKEIQTMSVLRH 213
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDMKAIKNWARQILRGLHYL 143
++ ++++ DD + MI E + G L + +H + + RQ+ +GL ++
Sbjct: 214 PTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 144 HSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LY 200
H +N +H DLK +NI F + E+K+ D GL + + + GT EF APE
Sbjct: 272 HENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 255
+ D++S G + ++ E N + + V S ++ S +++
Sbjct: 330 GKPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISE- 385
Query: 256 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN--PKDLVCDPLRLPNL 301
K FI K ++ + R+ + L+ P+L N +D R +
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 434
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 48/308 (15%), Positives = 89/308 (28%), Gaps = 48/308 (15%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
S R + E L G V+ D + A +V S +LERL+
Sbjct: 55 SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFAL-KVFTMGAENSRSELERLHEAT 113
Query: 78 HLLKSLKHENIIKFYN-----------------------SWVDDTNRTINMITELFTSGS 114
L E+ + + DD ++ S
Sbjct: 114 FAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVD 173
Query: 115 L--------RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 166
L + + A+ Q++R L S ++H DN+F+ +
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFI-MPD 230
Query: 167 GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVT 222
G + +GD+ + T P AP + + ++ + G+ I +
Sbjct: 231 GRLMLGDVSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 223 CEYPYNEC-KNPAQIYKKVTSGIK-----PASLSKVTDPQVKQFIEKCIVP-ASLRLPAL 275
P+ +K+ + + VK I + + RL L
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348
Query: 276 ELLKDPFL 283
E ++ P
Sbjct: 349 EAMETPEF 356
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 70/279 (25%), Positives = 124/279 (44%), Gaps = 24/279 (8%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL--ERLYSEVHLLKSL 83
YD E LG G F V K ++ G++ A + S + E + EV +LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHY 142
+H N+I + + + T+ + +I EL G L + +++ + + +QIL G++Y
Sbjct: 72 QHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 143 LHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 198
LHS I H DLK +NI + N +KI D GLA + +++ GTPEF+APE
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 199 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 252
+ E D++S G I ++ + + V++ + S
Sbjct: 188 IVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFSNT 244
Query: 253 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 290
+ K FI + +V R+ + L+ P++ + +
Sbjct: 245 SA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 70/298 (23%), Positives = 124/298 (41%), Gaps = 30/298 (10%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
T S + + ++ LG+GA VY+ + A +
Sbjct: 34 TASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK- 92
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNV 124
+ + +E+ +L L H NIIK + T I+++ EL T G L R +
Sbjct: 93 -----KIVRTEIGVLLRLSHPNIIKLKEIFETPTE--ISLVLELVTGGELFDRIVEKGYY 145
Query: 125 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 182
+ + +QIL + YLH + I+HRDLK +N+ + + +KI D GL+ +++
Sbjct: 146 SERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
Query: 183 PTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFG--MCILEMVTCEYP--YNECKNPAQI 236
++V GTP + APE L Y VD++S G IL C + Y+E + +
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYIL---LCGFEPFYDE-RGDQFM 259
Query: 237 YKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 290
++++ + +V+ K + K IV RL + L+ P++
Sbjct: 260 FRRILNCEYYFISPWWDEVSL-NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 62/310 (20%), Positives = 130/310 (41%), Gaps = 24/310 (7%)
Query: 25 RYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
G+Y ++LG+G++ V + D A + + + + P+ + E+ LL+
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGS---LRYRKKHKNVDMKAIKNWARQILRG 139
L+H+N+I+ + ++ + + M+ E G L + + +A + Q++ G
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG-YFCQLIDG 121
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFM 195
L YLHS I+H+D+K N+ + G +KI LG+A + A G+P F
Sbjct: 122 LEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 196 APELY--EEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLS 250
PE+ + ++ VDI+S G+ + + T YP+ N ++++ + G P
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSYAIPGDCG 237
Query: 251 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLA 309
P + ++ + + R ++ + + +P P+ +
Sbjct: 238 ----PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSM 293
Query: 310 HSEPHPMDID 319
P+ D+
Sbjct: 294 TVVPYLEDLH 303
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 48/276 (17%), Positives = 100/276 (36%), Gaps = 34/276 (12%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENI 88
+LG+GAF VY+ + ++ + P + + LK
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSL------RYRKKHKNVDMKAIKNWARQILRGLHY 142
+KFY++ + ++ EL++ G+L K + + ++A ++L +
Sbjct: 130 MKFYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 143 LHSHNPPIIHRDLKCDNIFVNG----------NNGEVKIGDLGLAIVMQQP----TARSV 188
+H IIH D+K DN + + + + DLG +I M+ +
Sbjct: 188 VHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 189 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 247
T F E L + +N +D + + M+ Y + + + + +
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHL 305
Query: 248 SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPF 282
+ +F + +P LP+L+LL+
Sbjct: 306 DMW-------NEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 69/308 (22%), Positives = 123/308 (39%), Gaps = 37/308 (12%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVA--------WNQVN 59
T+ G S Y EILG+G V + + E A +
Sbjct: 1 TRDAALPGSHSTHGFYENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59
Query: 60 IEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRYR 118
E+V + + + EV +L+ + H NII+ +++ +T ++ +L G L
Sbjct: 60 AEEVQELREATLK---EVDILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDY 114
Query: 119 -KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177
+ + K + R +L + LH N I+HRDLK +NI ++ ++ +K+ D G +
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFS 171
Query: 178 IVMQQPTA-RSVIGTPEFMAPE-------LYEEEYNELVDIYSFGMCILEMVTCEYP--Y 227
+ R V GTP ++APE Y + VD++S G I+ + P +
Sbjct: 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTLLAGSPPFW 230
Query: 228 NECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
+ + + + SG +D VK + + +V R A E L PF
Sbjct: 231 HR--KQMLMLRMIMSGNYQFGSPEWDDYSDT-VKDLVSRFLVVQPQKRYTAEEALAHPFF 287
Query: 284 VTDNPKDL 291
+++
Sbjct: 288 QQYVVEEV 295
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 64/306 (20%), Positives = 114/306 (37%), Gaps = 32/306 (10%)
Query: 10 SETEEGEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP 67
T KD Y +LGKG F TV+ G D ++VA + V+
Sbjct: 14 PGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS 73
Query: 68 --DQLERLYSEVHLLKSL----KHENIIKFYNSWVDDTNRTINMITELFTSGS--LRYRK 119
EV LL + H +I+ + +T ++ E Y
Sbjct: 74 PLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD--WFETQEGFMLVLERPLPAQDLFDYIT 131
Query: 120 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179
+ + + + Q++ + + HS ++HRD+K +NI ++ G K+ D G +
Sbjct: 132 EKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGAL 189
Query: 180 MQQPTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCIL-EMVTCEYPYNECKNPAQI 236
+ GT + PE +Y+ ++S G+ +L +MV + P+
Sbjct: 190 LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGI-LLYDMVCGDIPFER------- 241
Query: 237 YKKVTSGI--KPASLSKVTDPQVKQFIEKCIVPA-SLRLPALELLKDPFLVTDNPKDLVC 293
+++ PA +S P I +C+ P S R E+L DP++ T +
Sbjct: 242 DQEILEAELHFPAHVS----PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
Query: 294 DPLRLP 299
P
Sbjct: 298 PSKGGP 303
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 78/296 (26%), Positives = 142/296 (47%), Gaps = 24/296 (8%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLY 74
S D G Y + +GKG F V + G EVA + I D Q +P L++L+
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVA---IKIIDKTQLNPTSLQKLF 62
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWA 133
EV ++K L H NI+K + V +T +T+ +I E + G + Y H + K ++
Sbjct: 63 REVRIMKILNHPNIVKLFE--VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF 120
Query: 134 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTP 192
RQI+ + Y H I+HRDLK +N+ + + +KI D G + + G P
Sbjct: 121 RQIVSAVQYCHQKR--IVHRDLKAENLLL-DADMNIKIADFGFSNEFTVGGKLDAFCGAP 177
Query: 193 EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPAS 248
+ APEL++ ++Y+ VD++S G+ + +V+ P++ +N ++ ++V G P
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYRIPFY 236
Query: 249 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 303
+S + +++ +V R +++KD ++ + +D + P P L
Sbjct: 237 MS----TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL-KPFVEPELDI 287
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 66/327 (20%), Positives = 126/327 (38%), Gaps = 40/327 (12%)
Query: 7 FTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS 66
F E ++ ++ Y ++LG G V + F G + A ++
Sbjct: 16 FQGPEPKKYAVTDD-----YQLSKQVLGLGVNGKVLECFHRRTGQKCA---------LKL 61
Query: 67 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN--RTINMITELFTSGSLRYR---KK 120
+ EV +I+ + + + + R + +I E G L R +
Sbjct: 62 LYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG 121
Query: 121 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAI 178
+ + R I + +LHSHN I HRD+K +N+ + + + +K+ D G A
Sbjct: 122 DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 179 VMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKN--P 233
Q ++ TP ++APE L E+Y++ D++S G I+ ++ C +P Y+
Sbjct: 180 ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQAIS 238
Query: 234 AQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL-----V 284
+ +++ G S+V++ KQ I + + RL + + P++ V
Sbjct: 239 PGMKRRIRLGQYGFPNPEWSEVSE-DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297
Query: 285 TDNPKDLVCDPLRLPNLVPEVMNLAHS 311
P + EV S
Sbjct: 298 PQTPLHTARVLQEDKDHWDEVKEEMTS 324
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 64/282 (22%), Positives = 116/282 (41%), Gaps = 24/282 (8%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
Y + LG+G F V + + G E A + D + E+ +L+ K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAK 86
Query: 85 H-ENIIKFYNSWVDDTNRTINMITELFTSGSLRYR---KKHKNVDMKAIKNWARQILRGL 140
+I + + + + I +I E G + + + V + +QIL G+
Sbjct: 87 SCPRVINLHEVYENTSE--IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 141 HYLHSHNPPIIHRDLKCDNI-FVNGN-NGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAP 197
+YLH +N I+H DLK NI + G++KI D G++ + R ++GTPE++AP
Sbjct: 145 YYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
Query: 198 E-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSK 251
E L + D+++ G+ I M+ E + + Y ++ + S
Sbjct: 203 EILNYDPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQETYLNISQVNVDYSEETFSS 259
Query: 252 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLV 292
V+ FI+ +V R A L +L + ++L
Sbjct: 260 VSQ-LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-34
Identities = 68/319 (21%), Positives = 114/319 (35%), Gaps = 53/319 (16%)
Query: 10 SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
S E+ ++ILG G+ TV G VA ++ D
Sbjct: 1 SRIANIPNFEQSLKNLV-VSEKILGYGSSGTVVFQ-GSFQGRPVAVKRML-------IDF 51
Query: 70 LERLYSEVHLL-KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--------RYRKK 120
+ E+ LL +S H N+I++Y S D + + EL + +L +
Sbjct: 52 CDIALMEIKLLTESDDHPNVIRYYCSETTDRF--LYIALEL-CNLNLQDLVESKNVSDEN 108
Query: 121 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------------GNNGE 168
K + RQI G+ +LHS IIHRDLK NI V+ N
Sbjct: 109 LKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166
Query: 169 VKIGDLGLAIVMQ------QPTARSVIGTPEFMAPEL--------YEEEYNELVDIYSFG 214
+ I D GL + + + GT + APEL + +DI+S G
Sbjct: 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226
Query: 215 MCILEMVTCEYP--YNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCIVP-ASL 270
+++ ++ + I + + S + L + + I + I
Sbjct: 227 CVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK 286
Query: 271 RLPALELLKDPFLVTDNPK 289
R A+++L+ P + K
Sbjct: 287 RPTAMKVLRHPLFWPKSKK 305
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 58/259 (22%), Positives = 112/259 (43%), Gaps = 34/259 (13%)
Query: 15 GEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVA------------------ 54
G + +Y + +GKG++ V ++E D A
Sbjct: 1 GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRR 60
Query: 55 ----WNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110
+ +Q +E++Y E+ +LK L H N++K D + M+ EL
Sbjct: 61 PPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELV 120
Query: 111 TSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 170
G + K + + + + +++G+ YLH IIHRD+K N+ V G +G +K
Sbjct: 121 NQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLV-GEDGHIK 177
Query: 171 IGDLGLAIVMQQPTA--RSVIGTPEFMAPEL---YEEEYN-ELVDIYSFGMCILEMVTCE 224
I D G++ + A + +GTP FMAPE + ++ + +D+++ G+ + V +
Sbjct: 178 IADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
Query: 225 YPYNECKNPAQIYKKVTSG 243
P+ + + ++ K+ S
Sbjct: 238 CPFMD-ERIMCLHSKIKSQ 255
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 67/304 (22%), Positives = 122/304 (40%), Gaps = 33/304 (10%)
Query: 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
D+ LG+G+F K + A ++ E+ LK +
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-------KRMEANTQKEITALKLCEG 64
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYL 143
H NI+K + + D + ++ EL G L R KK K+ R+++ + ++
Sbjct: 65 HPNIVKLHEVFHDQLH--TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 144 HSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE- 198
H ++HRDLK +N+ F + +N E+KI D G A + ++ T + APE
Sbjct: 123 HDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 199 LYEEEYNELVDIYSFGMCILEMVTCEYP-------YNECKNPAQIYKKVTSG---IKPAS 248
L + Y+E D++S G IL + C + +I KK+ G + +
Sbjct: 181 LNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 249 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 307
V+ + K I+ + + RL L + +L + +PL P+++
Sbjct: 240 WKNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS--NPLMTPDILGSSGA 296
Query: 308 LAHS 311
H+
Sbjct: 297 AVHT 300
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 87/370 (23%), Positives = 148/370 (40%), Gaps = 74/370 (20%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI 60
+D + K +G+ E+ Y +++G G+F V++ EVA I
Sbjct: 18 LDDPNKVIKVLASDGKTGEQREI-AYTNC-KVIGNGSFGVVFQAKLVESD-EVA-----I 69
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTSGSL- 115
+ V+Q E+ +++ +KH N++ FY++ +N++ E ++
Sbjct: 70 KKVLQDK---RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY 125
Query: 116 ----RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 171
Y K + + M IK + Q+LR L Y+HS I HRD+K N+ ++ +G +K+
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKL 183
Query: 172 GDLGLA-IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE--- 224
D G A I++ S I + + APEL Y +DI+S G C++ E++ +
Sbjct: 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQGQPLF 242
Query: 225 -----------------YPYNE---CKNPAQIYKKVTSGIKPASLSKV----TDPQVKQF 260
P E NP + K I+P SKV T P
Sbjct: 243 PGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDL 301
Query: 261 IEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDI 318
I + + P S RL A+E L PF D LR + + P
Sbjct: 302 ISRLLEYTP-SARLTAIEALCHPFF----------DELRTGE-----ARMPNGRELPPLF 345
Query: 319 DLNHKKVSAD 328
+ +++S
Sbjct: 346 NWTKEELSVR 355
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 58/300 (19%), Positives = 116/300 (38%), Gaps = 29/300 (9%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERL 73
K+ +Y +LG G F +VY G D + VA V + + R+
Sbjct: 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 74 YSEVHLLKSLKHE--NIIKFYNSWVDDTNRTINMITELFT-SGSL-RYRKKHKNVDMKAI 129
EV LLK + +I+ + + + +I E L + + + +
Sbjct: 94 PMEVVLLKKVSSGFSGVIRLLD--WFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 189
+++ Q+L + + H+ ++HRD+K +NI ++ N GE+K+ D G +++
Sbjct: 152 RSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 209
Query: 190 GTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--K 245
GT + PE Y+ ++S G+ + +MV + P+ +++ G
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQVFF 262
Query: 246 PASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLPNLVPE 304
+S + + I C+ P E+ P++ + L +L P
Sbjct: 263 RQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA-EIHLHSLSPG 317
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 25 RYGRYDEILGKGAFKTVYKG--FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
+ +G+G + VYK D D + A Q+ + S E+ LL+
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRE 74
Query: 83 LKHENIIKFYNSWVDDTNRTINMITE---------LFTSGSLRYRKKHKNVDMKAIKNWA 133
LKH N+I ++ +R + ++ + + + + KK + +K+
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 134 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLAIVMQQPTARSVIG 190
QIL G+HYLH++ ++HRDLK NI V G G VKI D+G A + P
Sbjct: 135 YQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 191 TPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 222
P + APEL Y + +DI++ G CI E++T
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIG-CIFAELLT 231
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 36/253 (14%)
Query: 28 RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDV----MQSPDQLERLYSEVHL 79
+Y LGKG F +V + G VA V PDQ E+ +
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVA--------VKQLQHSGPDQQRDFQREIQI 77
Query: 80 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQIL 137
LK+L + I+K+ +++ ++ E SG LR + ++H+ +D + ++ QI
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 138 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPE 193
+G+ YL S +HRDL NI V + VKI D GLA ++ R +P
Sbjct: 138 KGMEYLGSRR--CVHRDLAARNILV-ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 194 F-MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 250
F APE L + ++ D++SFG+ + E+ T C+ + ++
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP------ 248
Query: 251 KVTDPQVKQFIEK 263
++ + +E+
Sbjct: 249 --ALSRLLELLEE 259
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-33
Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 18/275 (6%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+D + LG+GA+ V + V VA V+++ + P+ +++ E+ + K L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLN 63
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYL 143
HEN++KFY + E + G L + + + + Q++ G+ YL
Sbjct: 64 HENVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPE- 198
H I HRD+K +N+ ++ +KI D GLA V + ++ GT ++APE
Sbjct: 122 HGIG--ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 199 LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257
L E++ E VD++S G+ + M+ E P+++ + Q Y + K D
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 258 KQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 291
+ K +V S R+ ++ KD + K
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 64/278 (23%), Positives = 123/278 (44%), Gaps = 31/278 (11%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL----ERLYSEVHLLK 81
+YD +++G+G V + G E A + + SP+QL E E H+L+
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 82 SLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRG 139
+ H +II +S+ + + ++ +L G L + + K ++ R +L
Sbjct: 155 QVAGHPHIITLIDSYESSSF--MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 198
+ +LH++N I+HRDLK +NI ++ +N ++++ D G + ++ R + GTP ++APE
Sbjct: 213 VSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
Query: 199 -------LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KP 246
Y + VD+++ G IL + P ++ + + + G
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACG-VILFTLLAGSPPFWHR--RQILMLRMIMEGQYQFSS 326
Query: 247 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
+ VK I + + RL A + L+ PF
Sbjct: 327 PEWDDRSST-VKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 78/340 (22%), Positives = 135/340 (39%), Gaps = 69/340 (20%)
Query: 4 GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV 63
GS T G+ ++ Y +++G G+F VY+ G VA I+ V
Sbjct: 34 GSKVTTVVATPGQGPDRPQEVSY-TDTKVIGNGSFGVVYQAKLCDSGELVA-----IKKV 87
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTSGSL---- 115
+Q E+ +++ L H NI++ FY+S +N++ + ++
Sbjct: 88 LQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA 143
Query: 116 -RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174
Y + + + + +K + Q+ R L Y+HS I HRD+K N+ ++ + +K+ D
Sbjct: 144 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 201
Query: 175 GLA-IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE------ 224
G A +++ S I + + APEL +Y +D++S G C+L E++ +
Sbjct: 202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG-CVLAELLLGQPIFPGD 260
Query: 225 --------------YPYNE---CKNPAQIYKKVT-SGIKPASLSKV----TDPQVKQFIE 262
P E NP Y + IK +KV T P+
Sbjct: 261 SGVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIKAHPWTKVFRPRTPPEAIALCS 318
Query: 263 KCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 300
+ + P + RL LE F D LR PN
Sbjct: 319 RLLEYTP-TARLTPLEACAHSFF----------DELRDPN 347
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 68/304 (22%), Positives = 128/304 (42%), Gaps = 20/304 (6%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+D + LG+GA+ V + V VA V+++ + P+ +++ E+ + K L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLN 63
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYL 143
HEN++KFY + E + G L + + + + Q++ G+ YL
Sbjct: 64 HENVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPEL 199
H I HRD+K +N+ ++ +KI D GLA V + ++ GT ++APEL
Sbjct: 122 HGIG--ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 200 YE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIY-KKVTSGIKPASLSKVTDPQ 256
+ E++ E VD++S G+ + M+ E P+++ + Q Y K+ D
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSA 237
Query: 257 VKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHP 315
+ K +V S R+ ++ KD + K + + +
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSN 297
Query: 316 MDID 319
+D
Sbjct: 298 LDFS 301
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 66/312 (21%), Positives = 122/312 (39%), Gaps = 31/312 (9%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVN----IE 61
+ E E +Y LG GAF V+ D+ EV + +E
Sbjct: 5 EPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE 64
Query: 62 DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGS--LRYRK 119
D +L ++ E+ +L ++H NIIK + + + ++ E SG +
Sbjct: 65 DCWIEDPKLGKVTLEIAILSRVEHANIIKVLD--IFENQGFFQLVMEKHGSGLDLFAFID 122
Query: 120 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179
+H +D RQ++ + YL + IIHRD+K +NI + + +K+ D G A
Sbjct: 123 RHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAE-DFTIKLIDFGSAAY 179
Query: 180 MQQ-PTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQI 236
+++ + GT E+ APE+ Y ++++S G+ L + E NP
Sbjct: 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGV-TLYTLVFEE------NPFCE 232
Query: 237 YKKVTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD-NPKDLV 292
++ P +S ++ + + P R +L+ DP++ N D
Sbjct: 233 LEETVEAAIHPPYLVS----KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYT 288
Query: 293 CDPLRLPNLVPE 304
+ + N
Sbjct: 289 WEEVFRVNKPES 300
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 68/248 (27%), Positives = 109/248 (43%), Gaps = 25/248 (10%)
Query: 28 RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
++ + LGKG F +V + G VA ++ + + L E+ +LKSL
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSL 68
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLH 141
+H+NI+K+ R + +I E GSLR Y +KHK +D + + QI +G+
Sbjct: 69 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--PEF-MA 196
YL + IHRDL NI V N VKIGD GL + + + P F A
Sbjct: 129 YLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 197 PE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255
PE L E +++ D++SFG+ + E+ T Y E G ++
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDK--QGQMIVF 239
Query: 256 QVKQFIEK 263
+ + ++
Sbjct: 240 HLIELLKN 247
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 68/248 (27%), Positives = 109/248 (43%), Gaps = 25/248 (10%)
Query: 28 RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
++ + LGKG F +V + G VA ++ + + L E+ +LKSL
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSL 99
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLH 141
+H+NI+K+ R + +I E GSLR Y +KHK +D + + QI +G+
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--PEF-MA 196
YL + IHRDL NI V N VKIGD GL + + + P F A
Sbjct: 160 YLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216
Query: 197 PE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255
PE L E +++ D++SFG+ + E+ T Y E G ++
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDK--QGQMIVF 270
Query: 256 QVKQFIEK 263
+ + ++
Sbjct: 271 HLIELLKN 278
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 58/281 (20%), Positives = 117/281 (41%), Gaps = 31/281 (11%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL- 83
Y ++LG G V + F++ + A ++D + EV L
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--LQDC-------PKARREVELHWRAS 112
Query: 84 KHENIIKFYNSWVD--DTNRTINMITELFTSGSLRYR---KKHKNVDMKAIKNWARQILR 138
+ +I++ + + + + + ++ E G L R + + + + I
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 139 GLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFM 195
+ YLHS N I HRD+K +N+ + + N +K+ D G A + + TP ++
Sbjct: 173 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 230
Query: 196 APE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQ--IYKKVTSGI---KPA 247
APE L E+Y++ D++S G I+ ++ C YP Y+ + ++ G
Sbjct: 231 APEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289
Query: 248 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 287
S+V++ +VK I + + R+ E + P+++
Sbjct: 290 EWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 22/284 (7%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
S+ D + G Y + LG G F V G ++ G +VA +N ++S D + ++
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKR 60
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWAR 134
E+ LK +H +IIK Y V T M+ E + G L Y KH V+ + +
Sbjct: 61 EIQNLKLFRHPHIIKLYQ--VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ 118
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPE 193
QIL + Y H H ++HRDLK +N+ ++ + KI D GL+ +M R+ G+P
Sbjct: 119 QILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPN 175
Query: 194 FMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSGI--KPAS 248
+ APE+ Y VDI+S G+ IL + C P+++ ++ ++KK+ G+ P
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGV-ILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEY 233
Query: 249 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 291
L+ V + + R ++ + + D P L
Sbjct: 234 LN----RSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 33/278 (11%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLK 84
Y+ E +G G++ + + +E A V I + +S E+ LL+ +
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFA---VKI--IDKSKRDPTE---EIEILLRYGQ 74
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDMKAIKNWARQILRGLHY 142
H NII + V D + + ++TEL G L + ++ + +A I + + Y
Sbjct: 75 HPNIITLKD--VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA-SAVLFTITKTVEY 131
Query: 143 LHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAP 197
LH+ ++HRDLK NI +GN ++I D G A ++ + T F+AP
Sbjct: 132 LHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
Query: 198 E-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECK-NPAQIYKKVTSG---IKPASLS 250
E L + Y+ DI+S G +L + Y N P +I ++ SG + +
Sbjct: 190 EVLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248
Query: 251 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 287
V+D K + K + RL A +L+ P++V +
Sbjct: 249 SVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 22/226 (9%)
Query: 30 DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
++LG GAF TVYKG E I VA + SP + + E +++ S+ +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDN 76
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHYL 143
++ + + T+ +IT+L G L Y ++HK N+ + + NW QI +G++YL
Sbjct: 77 PHVCRLLG--IC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGT--P-EFMAPE- 198
++HRDL N+ V VKI D GLA ++ + G P ++MA E
Sbjct: 134 EDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 199 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+ Y D++S+G+ + E++T PY+ ++I + G
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 28 RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
+ LG+G F V + G +VA V + + L E+ +L++L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVA---VKSLKPESGGNHIADLKKEIEILRNL 80
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLH 141
HENI+K+ +D I +I E SGSL+ Y K+K +++K +A QI +G+
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MA 196
YL S +HRDL N+ V + +VKIGD GL ++ T + +P F A
Sbjct: 141 YLGSRQ--YVHRDLAARNVLV-ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 197 PE-LYEEEYNELVDIYSFGMCILEMVT 222
PE L + ++ D++SFG+ + E++T
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 27/270 (10%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKS 82
RY + LG G TVY D + I+VA + + + L+R EVH
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSSQ 67
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLH 141
L H+NI+ + +D + M E +L Y + H + + N+ QIL G+
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVM--EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPE 198
+ H I+HRD+K NI + +N +KI D G+A + + + V+GT ++ +PE
Sbjct: 126 HAHDMR--IVHRDIKPQNILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 199 LYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQ 256
+ E +E DIYS G+ + EM+ E P+N + I K + + P + V
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQDSV-PNVTTDV-RKD 239
Query: 257 VKQFIEKCIVPASLRLP------ALELLKD 280
+ Q + I+ A+ + E+ D
Sbjct: 240 IPQSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 28 RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
+ LG+G F V ++ G VA V P E+ +L++L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVA---VKALKADAGPQHRSGWKQEIDILRTL 90
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHY 142
HE+IIK+ D ++ ++ E GSLR Y +H + + + +A+QI G+ Y
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAY 149
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MAP 197
LH+ + IHRDL N+ + N+ VKIGD GLA + + R +P F AP
Sbjct: 150 LHAQH--YIHRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206
Query: 198 E-LYEEEYNELVDIYSFGMCILEMVT 222
E L E ++ D++SFG+ + E++T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 69/328 (21%), Positives = 132/328 (40%), Gaps = 55/328 (16%)
Query: 10 SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
+++ G F + Y +++LG+GA V + + E A V I + +
Sbjct: 3 TDSFSGRFEDV-----YQLQEDVLGEGAHARVQTCINLITSQEYA---VKIIEKQPGHIR 54
Query: 70 LERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDM 126
R++ EV +L + H N+++ + ++ ++ E GS+ K+ ++
Sbjct: 55 -SRVFREVEMLYQCQGHRNVLELIEFFEEEDR--FYLVFEKMRGGSILSHIHKRRHFNEL 111
Query: 127 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ--- 181
+A + + L +LH+ I HRDLK +NI + VKI D L ++
Sbjct: 112 EA-SVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 182 ------QPTARSVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYP--Y 227
P + G+ E+MAPE Y++ D++S G IL ++ YP
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYILLSGYPPFV 227
Query: 228 NECK-------------NPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASL 270
C +++ + G + ++ K I K +V A
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC-AAKDLISKLLVRDAKQ 286
Query: 271 RLPALELLKDPFLVTDNPKDLVCDPLRL 298
RL A ++L+ P++ P++ + P+ L
Sbjct: 287 RLSAAQVLQHPWVQGCAPENTLPTPMVL 314
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 32/216 (14%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLK 81
+Y+ E +G+G + TV+K + VA +V ++ D E + S E+ LLK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD------DDDEGVPSSALREICLLK 56
Query: 82 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNV-DMKAIKNWARQILRG 139
LKH+NI++ ++ V +++ + ++ E F L +Y D + +K++ Q+L+G
Sbjct: 57 ELKHKNIVRLHD--VLHSDKKLTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM---- 195
L + HS N ++HRDLK N+ +N NGE+K+ + GLA P R + E +
Sbjct: 114 LGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPV-RCY--SAEVVTLWY 167
Query: 196 -APELY--EEEYNELVDIYSFGMCIL-EMVTCEYPY 227
P++ + Y+ +D++S G CI E+ P
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPL 202
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 71/323 (21%), Positives = 130/323 (40%), Gaps = 39/323 (12%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
+ RYD + +G G F D++ VA + + E +
Sbjct: 11 LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-----ENVQR 65
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWAR 134
E+ +SL+H NI++F V T + +I E + G L + + +
Sbjct: 66 EIINHRSLRHPNIVRFKE--VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ 123
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTA-RSVIGTP 192
Q+L G+ Y HS I HRDLK +N ++G+ +KI D G + + +S +GTP
Sbjct: 124 QLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 181
Query: 193 EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-- 248
++APE+ +EY+ ++ D++S G+ + M+ YP+ E + Y+K I
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYS 240
Query: 249 ------LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 301
+S P+ I + V + R+ E+ + + + P DL+ +
Sbjct: 241 IPDDIRIS----PECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQF 296
Query: 302 ---------VPEVMNLAHSEPHP 315
+ +M + P
Sbjct: 297 QEPEQPMQSLDTIMQIISEATIP 319
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 58/221 (26%), Positives = 87/221 (39%), Gaps = 17/221 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +G+G F V+ G D VA E + PD + E +LK H NI++
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLP--PDLKAKFLQEARILKQYSHPNIVR 176
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-Y-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
V + I ++ EL G + R + + +K + G+ YL S
Sbjct: 177 LIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEE 203
IHRDL N V N +KI D G++ + G + APE L
Sbjct: 234 -CIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 204 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
Y+ D++SFG+ + E + PY N Q + V G
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKG 331
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 68/221 (30%), Positives = 104/221 (47%), Gaps = 35/221 (15%)
Query: 22 PSCRY-GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--- 75
PS RY LG+G + VYK D V VA ++ +E + E +
Sbjct: 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE------HEEEGVPGTAI 81
Query: 76 -EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWA 133
EV LLK L+H NII+ + V N +++I E + L +Y K+ +V M+ IK++
Sbjct: 82 REVSLLKELQHRNIIELKS--VIHHNHRLHLIFE-YAENDLKKYMDKNPDVSMRVIKSFL 138
Query: 134 RQILRGLHYLHSHNPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQQPTARSVI 189
Q++ G+++ HS +HRDLK N+ ++ +KIGD GLA P +
Sbjct: 139 YQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-- 194
Query: 190 GTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 222
T E + PE+ Y+ VDI+S CI EM+
Sbjct: 195 -THEIITLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEMLM 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 88/341 (25%), Positives = 151/341 (44%), Gaps = 30/341 (8%)
Query: 25 RYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIED--VMQSPDQLERLYSEVHLL 80
G Y E LG+G+F V +VA + +++ D R+ E+ L
Sbjct: 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVA---LKFISRQLLKKSDMHMRVEREISYL 63
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRG 139
K L+H +IIK Y+ V T I M+ E + G L Y + K + + + +QI+
Sbjct: 64 KLLRHPHIIKLYD--VITTPTDIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPE 198
+ Y H H I+HRDLK +N+ ++ +N VKI D GL+ +M ++ G+P + APE
Sbjct: 121 IEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177
Query: 199 LYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTD 254
+ + Y VD++S G+ + M+ P+++ + ++KKV S + P LS
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLS---- 232
Query: 255 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEP 313
P + I + IV R+ E+ +DP+ + P L + + E
Sbjct: 233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEA 292
Query: 314 HPMDIDLNHKKVSADSCAKSN--TGTWFLTLELQRLTENNE 352
D + + +D ++N + L E Q + E E
Sbjct: 293 MGFSEDYIVEALRSD---ENNEVKEAYNLLHENQVIQEKLE 330
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 30 DEILGKGAFKTVYKGF---DEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLK 84
E LG G+F V +G + VA V DV+ P+ ++ EV+ + SL
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVA---VKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHY 142
H N+I+ Y V + M+TEL GSL +KH+ + + + +A Q+ G+ Y
Sbjct: 80 HRNLIRLYG--V-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAP 197
L S IHRDL N+ + + VKIGD GL + P + AP
Sbjct: 137 LESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 198 E-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 240
E L ++ D + FG+ + EM T + P+ +QI K+
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKI 237
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-29
Identities = 80/287 (27%), Positives = 135/287 (47%), Gaps = 20/287 (6%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
+ D + G Y + LG G F V G E+ G +VA +N ++S D + ++
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRR 65
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWAR 134
E+ LK +H +IIK Y V T I M+ E + G L Y K+ +D K + +
Sbjct: 66 EIQNLKLFRHPHIIKLYQ--VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ 123
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPE 193
QIL G+ Y H H ++HRDLK +N+ ++ + KI D GL+ +M R+ G+P
Sbjct: 124 QILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPN 180
Query: 194 FMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASL 249
+ APE+ Y VDI+S G+ + ++ P+++ + ++KK+ GI P L
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYL 239
Query: 250 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDP 295
+ P V ++ + R ++ + + D PK L +
Sbjct: 240 N----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPED 282
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 66/307 (21%), Positives = 120/307 (39%), Gaps = 60/307 (19%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + LG G V+ D VA ++ + D + E+ +++ L H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV----KHALREIKIIRRLDH 67
Query: 86 ENIIKFYN------------SWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWA 133
+NI+K + ++ ++ E + L + + + + +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFM 126
Query: 134 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 193
Q+LRGL Y+HS N ++HRDLK N+F+N + +KIGD GLA +M + +
Sbjct: 127 YQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 194 -----FMAPE--LYEEEYNELVDIYSFGMCIL-EMVT----------------------- 222
+ +P L Y + +D+++ G CI EM+T
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQLILESIPV 243
Query: 223 -CEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIV--PASLRLPALE 276
E E + +Y + L+++ + F+E+ + P RL A E
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD-RLTAEE 302
Query: 277 LLKDPFL 283
L P++
Sbjct: 303 ALSHPYM 309
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
Y + LG+G + TVYKG ++ VA ++ +E +P R EV LLK LKH
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKH 59
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNV-DMKAIKNWARQILRGLHYL 143
NI+ ++ + T +++ ++ E + L +Y N+ +M +K + Q+LRGL Y
Sbjct: 60 ANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APE 198
H ++HRDLK N+ +N GE+K+ D GLA PT E + P+
Sbjct: 117 HRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY---DNEVVTLWYRPPD 170
Query: 199 LY--EEEYNELVDIYSFGMCIL-EMVT 222
+ +Y+ +D++ G CI EM T
Sbjct: 171 ILLGSTDYSTQIDMWGVG-CIFYEMAT 196
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE----RLYSEVHLLK 81
RY+ + LG+G F TVYK D+ VA ++ + ++ D + R E+ LL+
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKLLQ 67
Query: 82 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNV-DMKAIKNWARQILRG 139
L H NII +++ +N I+++ + F L K + V IK + L+G
Sbjct: 68 ELSHPNIIGLLDAFGHKSN--ISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM---- 195
L YLH H I+HRDLK +N+ ++ NG +K+ D GLA P R+ T + +
Sbjct: 125 LEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPN-RAY--THQVVTRWY 178
Query: 196 -APELY--EEEYNELVDIYSFGMCIL-EMVT 222
APEL Y VD+++ G CIL E++
Sbjct: 179 RAPELLFGARMYGVGVDMWAVG-CILAELLL 208
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 26/206 (12%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG G + TVYKG ++ G+ VA +V ++ +P R E+ L+K LKHENI++
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKELKHENIVR 67
Query: 91 FYNSWVDDTNRTINMITELFTS------GSLRYRKKHKNVDMKAIKNWARQILRGLHYLH 144
Y+ V T + ++ E + S + +++ +K + Q+L+GL + H
Sbjct: 68 LYD--VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APEL 199
+ I+HRDLK N+ +N G++K+GD GLA P + E + AP++
Sbjct: 126 ENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTF---SSEVVTLWYRAPDV 179
Query: 200 Y--EEEYNELVDIYSFGMCIL-EMVT 222
Y+ +DI+S G CIL EM+T
Sbjct: 180 LMGSRTYSTSIDIWSCG-CILAEMIT 204
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLK 84
+Y+ +G+G++ V+K + G VA + D R E+ +LK LK
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLK 60
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKN-VDMKAIKNWARQILRGLHYL 143
H N++ V R ++++ E L +++ V +K+ Q L+ +++
Sbjct: 61 HPNLVNLLE--VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APE 198
H HN IHRD+K +NI + + +K+ D G A ++ P+ E +PE
Sbjct: 119 HKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYY---DDEVATRWYRSPE 172
Query: 199 LY--EEEYNELVDIYSFGMCIL-EMVT 222
L + +Y VD+++ G C+ E+++
Sbjct: 173 LLVGDTQYGPPVDVWAIG-CVFAELLS 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 31/206 (15%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHE 86
E +G+G + VYK D I VA ++ ++ + E + S E+ LLK L H
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRI-VALKRIRLD------AEDEGIPSTAIREISLLKELHHP 79
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNV-DMKAIKNWARQILRGLHYLH 144
NI+ + V + R + ++ E F L + ++K IK + Q+LRG+ + H
Sbjct: 80 NIVSLID--VIHSERCLTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APEL 199
H I+HRDLK N+ +N ++G +K+ D GLA P T E + AP++
Sbjct: 137 QHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSY---THEVVTLWYRAPDV 190
Query: 200 Y--EEEYNELVDIYSFGMCIL-EMVT 222
++Y+ VDI+S G CI EM+T
Sbjct: 191 LMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHE 86
E +G+G + VYK + A ++ +E + E + S E+ +LK LKH
Sbjct: 8 EKIGEGTYGVVYKAQNNYGET-FALKKIRLE------KEDEGIPSTTIREISILKELKHS 60
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNV-DMKAIKNWARQILRGLHYLH 144
NI+K Y+ V T + + ++ E L + + + K++ Q+L G+ Y H
Sbjct: 61 NIVKLYD--VIHTKKRLVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APEL 199
++HRDLK N+ +N GE+KI D GLA P R T E + AP++
Sbjct: 118 DRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPV-RKY--THEIVTLWYRAPDV 171
Query: 200 Y--EEEYNELVDIYSFGMCIL-EMVT 222
++Y+ +DI+S G CI EMV
Sbjct: 172 LMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 76/327 (23%), Positives = 128/327 (39%), Gaps = 58/327 (17%)
Query: 18 SEKDPSCRY-GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERL 73
++ + +Y+ ++G+G++ V K ++ G VA + D + R
Sbjct: 15 GTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR- 73
Query: 74 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKN-VDMKAIKNW 132
E+ LLK L+HEN++ V + ++ E L + N +D + ++ +
Sbjct: 74 --EIKLLKQLRHENLVNLLE--VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKY 129
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 192
QI+ G+ + HSHN IIHRD+K +NI V+ +G VK+ D G A + P
Sbjct: 130 LFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY---DD 183
Query: 193 EFM-----APELY--EEEYNELVDIYSFGMCIL-EMVTCEYPY----------------- 227
E APEL + +Y + VD+++ G C++ EM E P
Sbjct: 184 EVATRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSDIDQLYHIMMCL 241
Query: 228 ---NE------CKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIV--PASLRLP 273
KNP ++ + L + V +KC+ P R
Sbjct: 242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK-RPF 300
Query: 274 ALELLKDPFLVTDNPKDLVCDPLRLPN 300
ELL F D + L+L
Sbjct: 301 CAELLHHDFFQMDGFAERFSQELQLKV 327
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 75/351 (21%), Positives = 126/351 (35%), Gaps = 82/351 (23%)
Query: 4 GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV 63
GS + + + + R+ + + + G+G F TV G ++ G+ VA I+ V
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRF-QVERMAGQGTFGTVQLGKEKSTGMSVA-----IKKV 56
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRT-INMITELFTSGSL--- 115
+Q P R + L L H NI++ FY D +N++ E +L
Sbjct: 57 IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRC 115
Query: 116 --RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 173
Y ++ IK + Q++R + LH + + HRD+K N+ VN +G +K+ D
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175
Query: 174 LGLAIVMQQPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL-EM 220
G A+ + + E APEL + Y VDI+S G CI EM
Sbjct: 176 FGS--------AKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG-CIFAEM 225
Query: 221 VTCE--YPYNECKN------------PAQIYKKVTSG--------IKPASLSKV------ 252
+ E + + ++ +K+ K S V
Sbjct: 226 MLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSL 285
Query: 253 -TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 300
+ + + P R+ E L P+ D L P
Sbjct: 286 KDAKEAYDLLSALLQYLP-EERMKPYEALCHPYF----------DELHDPA 325
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 22/226 (9%)
Query: 30 DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
++LG GAF TVYKG E I VA + SP + + E +++ S+ +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDN 76
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHYL 143
++ + T+ +IT+L G L Y ++HK N+ + + NW QI +G++YL
Sbjct: 77 PHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG-TP-EFMAPE- 198
++HRDL N+ V VKI D GLA + ++ + G P ++MA E
Sbjct: 134 EDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 199 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+ Y D++S+G+ + E++T PY+ ++I + G
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 61/226 (26%), Positives = 91/226 (40%), Gaps = 50/226 (22%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+ +LG+GA+ V + G VA ++ P R E+ +LK KH
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKH 68
Query: 86 ENIIKFYNSWVDDTNRTIN---MITELFTSGSLRYRKKHKNVDMKAI-----------KN 131
ENII +N D+ N +I EL + D+ + +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT------------DLHRVISTQMLSDDHIQY 116
Query: 132 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVI 189
+ Q LR + LH N +IHRDLK N+ +N N ++K+ D GLA I
Sbjct: 117 FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPT 173
Query: 190 GTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 222
G M APE L +Y+ +D++S G CIL E+
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFL 218
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 7e-28
Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 22/211 (10%)
Query: 27 GRY--DEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
G+Y + G +Y D V+G V + + +E L +
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVV---LKGLVHSGDAEAQAMAMAERQFLAEV 136
Query: 84 KHENIIKFYNSWVDDTNRTINMIT----ELFTSGSLR-YRKKHKNVDMKAIKNWARQILR 138
H +I++ +N +V+ T+R + + E SL+ + + V +AI + +IL
Sbjct: 137 VHPSIVQIFN-FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA-EAI-AYLLEILP 193
Query: 139 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE 198
L YLHS +++ DLK +NI + ++K+ DLG + + GTP F APE
Sbjct: 194 ALSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAVSRINSFGY--LYGTPGFQAPE 247
Query: 199 LYEEEYNELVDIYSFGMCIL-EMVTCEYPYN 228
+ DIY+ G L + N
Sbjct: 248 IVRTGPTVATDIYTVG-RTLAALTLDLPTRN 277
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 72/380 (18%), Positives = 131/380 (34%), Gaps = 108/380 (28%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG G+F V + FD G A ++ V+Q P E+ ++K L H NIIK
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFA-----LKKVLQDP---RYKNRELDIMKVLDHVNIIK 64
Query: 91 ----FYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDM-------------------- 126
FY + ++ G H +
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 127 -KAIKNWAR---------------QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 170
K +K++ R Q+ R + ++HS I HRD+K N+ VN + +K
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLK 182
Query: 171 IGDLGLAIVMQQPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL 218
+ D G A+ +I + E APEL EY +D++S G C+
Sbjct: 183 LCDFGS--------AKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVF 232
Query: 219 -EMVTCE--YPYNECKN------------PAQIYKKVTSG--------IKPASLSKV--- 252
E++ + + + + ++ +K K+
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292
Query: 253 -TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVT-DNPKDL-VCDPLRLPNL----VP 303
T +E+ + P LR+ E + PF N + V + P+ +P
Sbjct: 293 GTPSLAIDLLEQILRYEP-DLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIP 351
Query: 304 EVMNLAHSEPHPMDIDLNHK 323
++ N + E + ++ ++
Sbjct: 352 QLFNFSPYELSIIPGNVLNR 371
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 46/241 (19%), Positives = 96/241 (39%), Gaps = 42/241 (17%)
Query: 28 RYDEILGKGAFKTVYKG-------FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
++E LG+G F ++KG + ++ EV ++ + E + ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA----HRNYSESFFEAASMM 66
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKN-VDMKAIKNWARQILR 138
L H++++ Y V ++ E GSL Y KK+KN +++ A+Q+
Sbjct: 67 SKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 139 GLHYLHSHNPPIIHRDLKCDNIFVN-------GNNGEVKIGDLGLAIVMQQPTARSVIGT 191
+H+L + +IH ++ NI + GN +K+ D G+ + +V+
Sbjct: 125 AMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI--------SITVLPK 174
Query: 192 PEF------MAPE--LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTS 242
+ PE + N D +SFG + E+ + + P + + + +
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYED 233
Query: 243 G 243
Sbjct: 234 R 234
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 52/226 (23%), Positives = 108/226 (47%), Gaps = 22/226 (9%)
Query: 30 DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
++LG G F TV+KG E I V + + + + + + + SL H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVC---IKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHYL 143
+I++ ++ ++T+ GSL + ++H+ + + + NW QI +G++YL
Sbjct: 75 AHIVRLLGLC---PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTP-EFMAPE- 198
H ++HR+L N+ + + +V++ D G+A ++ S TP ++MA E
Sbjct: 132 EEHG--MVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 199 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
++ +Y D++S+G+ + E++T PY + A++ + G
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-AEVPDLLEKG 233
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 50/217 (23%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
Y + LG+G + V++ + + +V + P + +++ E+ +L++L+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRG 89
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKA---------IKNWARQ 135
NII + D +RT ++ E N D K I+ + +
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHV-----------NNTDFKQLYQTLTDYDIRFYMYE 138
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTP 192
IL+ L Y HS I+HRD+K N+ ++ + ++++ D GLA Q+ R + +
Sbjct: 139 ILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--VASR 194
Query: 193 EFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTCEYP 226
F PE + + Y+ +D++S G C+L M+ + P
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLG-CMLASMIFRKEP 230
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
Y +G GA+ +V D+ G +VA + + QS +R Y E+ LLK ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK--LSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 86 ENIIKFYN----SWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLH 141
EN+I + + ++ + L + + I+ Q+L+GL
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DL-QKIMGLKFSEEKIQYLVYQMLKGLK 140
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--L 199
Y+HS ++HRDLK N+ VN + E+KI D GLA V+ T + APE L
Sbjct: 141 YIHSAG--VVHRDLKPGNLAVNE-DCELKILDFGLARHADAEMTGYVV-TRWYRAPEVIL 196
Query: 200 YEEEYNELVDIYSFGMCIL-EMVT 222
YN+ VDI+S G CI+ EM+T
Sbjct: 197 SWMHYNQTVDIWSVG-CIMAEMLT 219
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 55/236 (23%), Positives = 97/236 (41%), Gaps = 43/236 (18%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY+ ++G G++ V + +D+++ VA + I V + +R+ E+ +L L H
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK--ILRVFEDLIDCKRILREIAILNRLNH 111
Query: 86 ENIIKFYN---SWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHY 142
++++K + + + ++ E+ S + + + IK +L G+ Y
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------------------IVMQQP 183
+HS I+HRDLK N VN + VK+ D GLA M
Sbjct: 172 VHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 184 TARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVTCEYP 226
T + APE L +E Y E +D++S G CI E++
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKE 283
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 51/228 (22%), Positives = 100/228 (43%), Gaps = 27/228 (11%)
Query: 30 DEILGKGAFKTVYKGF--DEVDGIEVAWNQVNI----EDVMQSPDQLERLYSEVHLLKSL 83
D+ LG G F TV KG+ + VA + + P + L +E ++++ L
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVA-----VKILKNEAN-DPALKDELLAEANVMQQL 75
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHY 142
+ I++ + + ++ E+ G L Y +++++V K I Q+ G+ Y
Sbjct: 76 DNPYIVRMIG--IC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAP 197
L N +HRDL N+ + KI D GL+ + + ++ P ++ AP
Sbjct: 133 LEESN--FVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189
Query: 198 E-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
E + +++ D++SFG+ + E + + PY K ++ + G
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKG 236
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 62/325 (19%), Positives = 116/325 (35%), Gaps = 74/325 (22%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVA------ 54
M + + + Y + G++ V G D +GI VA
Sbjct: 2 MQAKGEAAMRDLIAELHAMQS---PY-TVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFN 56
Query: 55 -WNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN---SWVDDTNRTINMITEL- 109
+ +++ +R+ E+ LL H NI+ + + + + ++TEL
Sbjct: 57 TVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM 116
Query: 110 -------FTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 162
+ +H I+ + IL GLH LH ++HRDL NI +
Sbjct: 117 RTDLAQVIHDQRIVISPQH-------IQYFMYHILLGLHVLHEAG--VVHRDLHPGNILL 167
Query: 163 NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----------APE--LYEEEYNELVDI 210
NN ++ I D L AR APE + + + +LVD+
Sbjct: 168 ADNN-DITICDFNL--------ARE-DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDM 217
Query: 211 YSFGMCIL-EMVTCE--YPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKC 264
+S G C++ EM + + + N Q+ K+ + K + + P + ++
Sbjct: 218 WSAG-CVMAEMFNRKALFRGSTFYN--QL-NKIVEVVGTPKIEDVVMFSSPSARDYLRNS 273
Query: 265 I-----VPASLRLP-----ALELLK 279
+ + +P AL+L+
Sbjct: 274 LSNVPARAWTAVVPTADPVALDLIA 298
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G+GA+ V +D ++ + VA +++ + +R E+ +L +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRH 84
Query: 86 ENIIKFYNSWVDDTNRTIN---MITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHY 142
ENII + T + ++ +L + L K +++ I + QILRGL Y
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FMAP 197
+HS N ++HRDLK N+ +N ++KI D GLA V + T + AP
Sbjct: 144 IHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 198 E--LYEEEYNELVDIYSFGMCIL-EMVT 222
E L + Y + +DI+S G CIL EM++
Sbjct: 201 EIMLNSKGYTKSIDIWSVG-CILAEMLS 227
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 41/228 (17%)
Query: 22 PSCRY-GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEV 77
P C +Y+ +G+G F V+K G +VA +V +E+ + P R E+
Sbjct: 11 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EI 67
Query: 78 HLLKSLKHENIIKFY------NSWVDDTNRTINMITE--------LFTSGSLRYRKKHKN 123
+L+ LKHEN++ S + +I ++ + L ++ +++
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-- 125
Query: 124 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183
IK + +L GL+Y+H + I+HRD+K N+ + +G +K+ D GLA
Sbjct: 126 -----IKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLA 177
Query: 184 TARSVIG-TPE-----FMAPELY--EEEYNELVDIYSFGMCIL-EMVT 222
T + PEL E +Y +D++ G CI+ EM T
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWT 224
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLK-- 84
+G GA+ TVYK D G VA V + L EV LL+ L+
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVREVALLRRLEAF 71
Query: 85 -HENIIKFYN---SWVDDTNRTINMITELFTSGSLRY---RKKHKNVDMKAIKNWARQIL 137
H N+++ + + D + ++ E LR + + + IK+ RQ L
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 138 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-- 195
RGL +LH++ I+HRDLK +NI V + G VK+ D GLA + A TP +
Sbjct: 131 RGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL----TPVVVTL 183
Query: 196 ---APE-LYEEEYNELVDIYSFGMCIL-EMVT 222
APE L + Y VD++S G CI EM
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVG-CIFAEMFR 214
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 69/284 (24%), Positives = 128/284 (45%), Gaps = 21/284 (7%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCR-YGRYD----EILGKGAFKTVYKGFDEVDGIEVAW 55
MD + + + ++ P R D +ILG+G+F TV + E A
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAI 60
Query: 56 NQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL 115
+ +++ +++ + E ++ L H +K Y ++ DD + +G L
Sbjct: 61 KILEKRHIIKE-NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGEL 117
Query: 116 -RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174
+Y +K + D + + +I+ L YLH IIHRDLK +NI +N + ++I D
Sbjct: 118 LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDF 174
Query: 175 GLA----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 229
G A +Q A S +GT ++++PE L E+ + D+++ G I ++V P+
Sbjct: 175 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-R 233
Query: 230 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRL 272
N I++K+ + P+ + +EK +V A+ RL
Sbjct: 234 AGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRL 275
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 57/224 (25%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 30 DEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
+ ILG+G F VY+G + + I VA +D D E+ SE ++K+L H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCT--LDNKEKFMSEAVIMKNLDHP 73
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLR-Y-RKKHKNVDMKAIKNWARQILRGLHYLH 144
+I+K + +I EL+ G L Y + ++ + + ++ QI + + YL
Sbjct: 74 HIVKLIG--II-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT--P-EFMAPE-LY 200
S N +HRD+ NI V + VK+GD GL+ ++ T P ++M+PE +
Sbjct: 131 SIN--CVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 187
Query: 201 EEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+ D++ F +C+ E+++ + P+ +N + + G
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKG 230
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 67/276 (24%), Positives = 110/276 (39%), Gaps = 34/276 (12%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKS 82
RY EILG G V+ D D +VA V + D+ + P R E +
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 83 LKHENIIKFYNSWVDDTNRT----INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQIL 137
L H I+ Y++ +T I M E +LR + K
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVM--EYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 138 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-----SVIGTP 192
+ L++ H + IIHRD+K NI + VK+ D G+A + +VIGT
Sbjct: 127 QALNFSHQNG--IIHRDVKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 193 EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLS 250
++++PE + + D+YS G + E++T E P+ +P + Y+ V P S
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPIPPS-- 240
Query: 251 KVTDPQVKQFIEKCIVPASLRLP------ALELLKD 280
+ ++ ++ A + P A E+ D
Sbjct: 241 -ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 53/227 (23%), Positives = 96/227 (42%), Gaps = 38/227 (16%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
Y ++G+G++ VY +D+ VA + + + + +R+ E+ +L LK
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKK--VNRMFEDLIDCKRILREITILNRLKS 84
Query: 86 ENIIKFYNSWVDDTNRTIN---MITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHY 142
+ II+ Y+ + D + ++ E+ S + K + + IK +L G ++
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--------------IVMQQPTARSV 188
+H IIHRDLK N +N + VK+ D GLA + +
Sbjct: 145 IHESG--IIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 189 IGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 222
+ + APE L +E Y + +DI+S G CI E++
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLN 247
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 20/223 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+G+G F V++G + VA E+ E ++ H +
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTS--DSVREKFLQEALTMRQFDHPH 77
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHYLHS 145
I+K V T + +I EL T G LR + + K ++D+ ++ +A Q+ L YL S
Sbjct: 78 IVKLIG--V-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT--P-EFMAPE-LYE 201
+HRD+ N+ V+ N+ VK+GD GL+ M+ T P ++MAPE +
Sbjct: 135 KR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 202 EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+ D++ FG+C+ E++ P+ KN + ++ +G
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENG 233
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 72/214 (33%), Positives = 104/214 (48%), Gaps = 37/214 (17%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA+ +V FD G+ VA + QS +R Y E+ LLK +KH
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 86 ENIIKFYN----SWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLH 141
EN+I + + + + ++T L + L K + + ++ QILRGL
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM------ 195
Y+HS + IIHRDLK N+ VN + E+KI D GL AR T + M
Sbjct: 147 YIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGL--------ARH---TADEMTGYVAT 192
Query: 196 ----APE--LYEEEYNELVDIYSFGMCIL-EMVT 222
APE L YN+ VDI+S G CI+ E++T
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLT 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G + VY+G + + VA + ED M+ +E E ++K +KH N+++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAV-KTLKEDTME----VEEFLKEAAVMKEIKHPNLVQ 280
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 147
V +ITE T G+L Y ++ + V + A QI + YL N
Sbjct: 281 LLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 203
IHR+L N V G N VK+ D GL+ +M TA + P ++ APE L +
Sbjct: 339 --FIHRNLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 204 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
++ D+++FG+ + E+ T PY +Q+Y+ +
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 435
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 52/232 (22%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
+Y+ + LGKGA+ V+K D G VA + I D Q+ +R + E+ +L L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKK--IFDAFQNSTDAQRTFREIMILTELSG 67
Query: 85 HENIIKFYNSWVDDTNRTINMITEL--------FTSGSLRYRKKHKNVDMKAIKNWARQI 136
HENI+ N D +R + ++ + + L H + Q+
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL--EPVH-------KQYVVYQL 118
Query: 137 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------------IVMQQP 183
++ + YLHS ++HRD+K NI +N VK+ D GL+ +
Sbjct: 119 IKVIKYLHSGG--LLHRDMKPSNILLNA-ECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 184 TARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 222
+ + APE L +Y + +D++S G CIL E++
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILC 226
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 21/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG G F V G + +VA + E M + + E + L H ++K
Sbjct: 14 KELGSGQFGVVKLGKWK-GQYDVAVKMIK-EGSMSEDEFFQ----EAQTMMKLSHPKLVK 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-Y-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
FY V I ++TE ++G L Y R K ++ + + G+ +L SH
Sbjct: 68 FYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ- 124
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEE 203
IHRDL N V+ + VK+ D G+ + S +GT +F APE + +
Sbjct: 125 -FIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVSSVGT-KFPVKWSAPEVFHYFK 181
Query: 204 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
Y+ D+++FG+ + E+ + + PY+ N +++ KV+ G
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQG 221
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 19 EKDPSCRY-GRYD--EILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLY 74
EKD CR +Y+ +G+GA+ V+K D G VA +V ++ E +
Sbjct: 2 EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT------GEEGMP 55
Query: 75 S----EVHLLKSLK---HENIIKFYN---SWVDDTNRTINMITELFTSGSL-RYRKKHKN 123
EV +L+ L+ H N+++ ++ D + ++ E L Y K
Sbjct: 56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPE 114
Query: 124 V--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181
+ IK+ Q+LRGL +LHSH ++HRDLK NI V ++G++K+ D GLA +
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYS 171
Query: 182 QPTARSVIGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 222
A T + APE L + Y VD++S G CI EM
Sbjct: 172 FQMAL----TSVVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 21/222 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G + VY+G + + VA + ED M+ E E ++K +KH N+++
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEV----EEFLKEAAVMKEIKHPNLVQ 73
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 147
V +ITE T G+L Y ++ + V + A QI + YL N
Sbjct: 74 LLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEE 202
IHRDL N V N+ VK+ D GL+ +M T + G +F APE L
Sbjct: 132 --FIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGA-KFPIKWTAPESLAYN 187
Query: 203 EYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+++ D+++FG+ + E+ T PY +Q+Y+ +
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +G G F V+ G+ + +VA + E M D +E E ++ L H +++
Sbjct: 14 QEIGSGQFGLVHLGYWL-NKDKVAIKTIR-EGAMSEEDFIE----EAEVMMKLSHPKLVQ 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKKHKN-VDMKAIKNWARQILRGLHYLHSHNP 148
Y V I ++TE G L Y + + + + + G+ YL
Sbjct: 68 LYG--VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 124
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEE 203
+IHRDL N V G N +K+ D G+ + S GT +F +PE
Sbjct: 125 -VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSR 181
Query: 204 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
Y+ D++SFG+ + E+ + + PY N +++ + +++G
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
Y ++ +G GA+ V D G +VA + + QS +R Y E+ LLK ++H
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 86 ENIIKFYNSWVDDTNRT----INMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLH 141
EN+I + + D ++ + L KH+ + I+ Q+L+GL
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLKGLR 142
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--L 199
Y+H+ IIHRDLK N+ VN + E+KI D GLA V+ T + APE L
Sbjct: 143 YIHAAG--IIHRDLKPGNLAVNE-DCELKILDFGLARQADSEMTGYVV-TRWYRAPEVIL 198
Query: 200 YEEEYNELVDIYSFGMCIL-EMVT 222
Y + VDI+S G CI+ EM+T
Sbjct: 199 NWMRYTQTVDIWSVG-CIMAEMIT 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA V +D + VA + + Q+ +R Y E+ L+K + H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKK--LSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 86 ENIIKFYNSWVDDTNRT----INMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLH 141
+NII N + + + ++ EL + +L + +D + + Q+L G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NL-CQVIQMELDHERMSYLLYQMLCGIK 141
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FMA 196
+LHS IIHRDLK NI V ++ +KI D GLA + S + TP + A
Sbjct: 142 HLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRA 194
Query: 197 PE-LYEEEYNELVDIYSFGMCIL-EMVT 222
PE + Y E VDI+S G CI+ EM+
Sbjct: 195 PEVILGMGYKENVDIWSVG-CIMGEMIK 221
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 21/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG G F V G +VA + E M + +E E ++ +L HE +++
Sbjct: 30 KELGTGQFGVVKYGKWR-GQYDVAIKMIK-EGSMSEDEFIE----EAKVMMNLSHEKLVQ 83
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-Y-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
Y V R I +ITE +G L Y R+ + + + + + YL S
Sbjct: 84 LYG--VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 140
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEE 203
+HRDL N VN VK+ D GL+ + S +G+ +F PE L +
Sbjct: 141 -FLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVLMYSK 197
Query: 204 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
++ DI++FG+ + E+ + + PY N ++ + + G
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQG 237
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-26
Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 20/224 (8%)
Query: 30 DEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
+G+G F V++G + VA S E+ E ++ H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHP 451
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKN-VDMKAIKNWARQILRGLHYLH 144
+I+K T + +I EL T G LR + + K +D+ ++ +A Q+ L YL
Sbjct: 452 HIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT--P-EFMAPE-LY 200
S +HRD+ N+ V+ N+ VK+GD GL+ M+ T P ++MAPE +
Sbjct: 509 SKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 201 EEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+ D++ FG+C+ E++ P+ KN + ++ +G
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENG 608
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 21/238 (8%)
Query: 19 EKDPSCRYGRYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
PS ++E++G+G F VY G ++ I A V + + ++ + +
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFLT 75
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-Y-RKKHKNVDMKAIKNWA 133
E ++K H N++ + + ++ G LR + R + N +K + +
Sbjct: 76 EGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134
Query: 134 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 193
Q+ +G+ YL S +HRDL N ++ VK+ D GLA M SV
Sbjct: 135 LQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTG 191
Query: 194 F------MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243
MA E L +++ D++SFG+ + E++T PY + I + G
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG 248
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 52/228 (22%), Positives = 116/228 (50%), Gaps = 21/228 (9%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDM 126
+++ ++ E+ +++ L+H ++ + S+ D+ + + M+ +L G LRY +++ +
Sbjct: 57 NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED--MFMVVDLLLGGDLRYHLQQNVHFKE 114
Query: 127 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-A 185
+ +K + +++ L YL + IIHRD+K DNI ++ +G V I D +A ++ + T
Sbjct: 115 ETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQI 171
Query: 186 RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKK 239
++ GT +MAPE++ Y+ VD +S G+ E++ PY + +I
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
Query: 240 VTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD-PFL 283
+ + P++ S ++ ++K + P R L +++ P++
Sbjct: 232 FETTVVTYPSAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 52/279 (18%), Positives = 107/279 (38%), Gaps = 48/279 (17%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL- 83
Y ++LG G V + F++ + A ++D + EV L
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--LQDC-------PKARREVELHWRAS 68
Query: 84 KHENIIKFYNSWVD--DTNRTINMITELFTSGSLRYR---KKHKNVDMKAIKNWARQILR 138
+ +I++ + + + + + ++ E G L R + + + + I
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 139 GLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMA 196
+ YLHS N I HRD+K +N+ + + N +K+ D G A
Sbjct: 129 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------A 167
Query: 197 PELYEEEYNELVDIYSFGMCILEMVTCEYP----YNECKNPAQIYKKVTSGI---KPASL 249
E E+Y++ D++S G I+ ++ C YP + + ++ G
Sbjct: 168 KETTGEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 250 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 287
S+V++ +VK I + + R+ E + P+++
Sbjct: 227 SEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG+G F V+ G VA M E E ++K L+HE +++
Sbjct: 190 VKLGQGCFGEVWMGTWN-GTTRVAIK-TLKPGTMSP----EAFLQEAQVMKKLRHEKLVQ 243
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 147
Y + I ++TE + GSL + K K + + + + A QI G+ Y+ N
Sbjct: 244 LYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 203
+HRDL+ NI V N K+ D GLA +++ TAR P ++ APE
Sbjct: 301 --YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 204 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+ D++SFG+ + E+ T PY N ++ +V G
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 397
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 21/229 (9%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
D ++GKG F VY G I+ A ++ + Q+E E L++ L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLN 80
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLR-Y-RKKHKNVDMKAIKNWARQILRGLHY 142
H N++ + +++ G L + R +N +K + ++ Q+ RG+ Y
Sbjct: 81 HPNVLALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEF----MA 196
L +HRDL N ++ + VK+ D GLA I+ ++ + A
Sbjct: 140 LAEQK--FVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 197 PE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
E L + D++SFG+ + E++T PY + + G
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQG 244
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 4e-25
Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 35/213 (16%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA V +D V VA + + Q+ +R Y E+ L+K + H
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK--LSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 86 ENIIKFYN----SWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLH 141
+NII N + + + ++ EL + + +D + + Q+L G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM------ 195
+LHS IIHRDLK NI V + +KI D GL AR+ GT M
Sbjct: 179 HLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGL--------ART-AGTSFMMTPYVVT 226
Query: 196 ----APE-LYEEEYNELVDIYSFGMCIL-EMVT 222
APE + Y E VDI+S G CI+ EMV
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVG-CIMGEMVR 258
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 52/245 (21%), Positives = 96/245 (39%), Gaps = 44/245 (17%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI----EDVMQSPDQLERLYSEVHLLKSL 83
+LGKG F +V + ++ + ++ +V + D++ + +E E +K
Sbjct: 26 TLGRMLGKGEFGSVREA--QLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEF 82
Query: 84 KHENIIKFY----NSWVDDTNRTINMITELFTSGSL-------RYRKKHKNVDMKAIKNW 132
H ++ K S +I G L R + N+ ++ + +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 192
I G+ YL S N IHRDL N + + V + D GL+ R +
Sbjct: 143 MVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM-TVCVADFGLS--------RKIYSGD 191
Query: 193 EF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 238
+ +A E L + Y D+++FG+ + E++T + PY +N A+IY
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYN 250
Query: 239 KVTSG 243
+ G
Sbjct: 251 YLIGG 255
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 55/267 (20%), Positives = 97/267 (36%), Gaps = 31/267 (11%)
Query: 25 RYGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLL 80
++G Y ++G+G VY+ D V VA + + E + P R+ E
Sbjct: 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVA---LKLMSETLSSDPVFRTRMQREARTA 88
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRG 139
L+ +++ ++ D ++M L L ++ + RQI
Sbjct: 89 GRLQEPHVVPIHDFGEIDGQLYVDM--RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMA 196
L H+ HRD+K +NI V + + D G+A + +GT +MA
Sbjct: 147 LDAAHAAG--ATHRDVKPENILV-SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMA 203
Query: 197 PELYE-EEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254
PE + DIY+ C+L E +T PY + + + + I S
Sbjct: 204 PERFSESHATYRADIYALT-CVLYECLTGSPPY-QGDQLSVMGAHINQAIPRPS---TVR 258
Query: 255 PQVKQFIEKCIVPASLRLPALELLKDP 281
P + + I + K+P
Sbjct: 259 PGIPVAFDAVIARG--------MAKNP 277
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-25
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG+G F V+ G VA M E E ++K L+HE +++
Sbjct: 273 VKLGQGCFGEVWMGTWN-GTTRVAIK-TLKPGTMSP----EAFLQEAQVMKKLRHEKLVQ 326
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 147
Y + I ++TE + GSL + K K + + + + A QI G+ Y+ N
Sbjct: 327 LYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 203
+HRDL+ NI V N K+ D GLA +++ TAR P ++ APE
Sbjct: 384 --YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 204 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+ D++SFG+ + E+ T PY N ++ +V G
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 480
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 21/226 (9%)
Query: 30 DEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
++I+G G V G V G + VA + + + L SE ++ H
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYT-ERQRRDFL-SEASIMGQFDHP 110
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKN-VDMKAIKNWARQILRGLHYLH 144
NII+ V R ++TE +GSL + + H + + R + G+ YL
Sbjct: 111 NIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAPE- 198
+HRDL N+ V+ N K+ D GL+ + A + G P + APE
Sbjct: 169 DLG--YVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 199 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+ ++ D++SFG+ + E++ E PY N + V G
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEG 270
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 46/225 (20%), Positives = 93/225 (41%), Gaps = 21/225 (9%)
Query: 30 DEILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
D LG G F +V +G I+VA + + E + E ++ L +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLR-Y-RKKHKNVDMKAIKNWARQILRGLHYLHS 145
I++ V + ++ E+ G L + K + + + + Q+ G+ YL
Sbjct: 72 IVRLIG--VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAPE-L 199
N +HRDL N+ + + KI D GL+ + + P ++ APE +
Sbjct: 129 KN--FVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 200 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+++ D++S+G+ + E ++ + PY + K ++ + G
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQG 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 66/248 (26%), Positives = 120/248 (48%), Gaps = 34/248 (13%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G+F V + G A ++ + V++ Q+E +E +L+++ ++K
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 93 NSWVDDTNRTINMIT------ELFTSGSLRYRKKHKNVDMKAIKNWAR----QILRGLHY 142
S+ D++N + M+ E+F+ LR + AR QI+ Y
Sbjct: 108 FSFKDNSN--LYMVMEYVAGGEMFSH--LRRIGRFSE-------PHARFYAAQIVLTFEY 156
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYE 201
LHS + +I+RDLK +N+ ++ G +++ D G A ++ T ++ GTPE +APE +
Sbjct: 157 LHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILS 212
Query: 202 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQ 259
+ YN+ VD ++ G+ I EM P+ P QIY+K+ SG ++ P+ S +K
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHFS----SDLKD 267
Query: 260 FIEKCIVP 267
+ +
Sbjct: 268 LLRNLLQV 275
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 22/227 (9%)
Query: 30 DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+++G G F VYKG + VA + +++ L E ++ H
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYT-EKQRVDFL-GEAGIMGQFSH 105
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKN-VDMKAIKNWARQILRGLHYL 143
NII+ V + + +ITE +G+L + ++ + + R I G+ YL
Sbjct: 106 HNIIRLEG--VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT--P-EFMAPE 198
+ N +HRDL NI VN N K+ D GL+ V++ + G P + APE
Sbjct: 164 ANMN--YVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 199 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+ ++ D++SFG+ + E++T E PY E N ++ K + G
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDG 266
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 54/238 (22%), Positives = 100/238 (42%), Gaps = 21/238 (8%)
Query: 19 EKDPSCRYGRYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
PS ++E++G+G F VY G ++ I A V + + ++ + +
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFLT 139
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-Y-RKKHKNVDMKAIKNWA 133
E ++K H N++ + + ++ G LR + R + N +K + +
Sbjct: 140 EGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198
Query: 134 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 193
Q+ +G+ +L S +HRDL N ++ VK+ D GLA M SV
Sbjct: 199 LQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 194 ------FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243
+MA E L +++ D++SFG+ + E++T PY + I + G
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG 312
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 51/243 (20%), Positives = 102/243 (41%), Gaps = 41/243 (16%)
Query: 28 RYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+ILG+G F +V +G ++ ++VA + +++ S ++E SE +K
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFS 94
Query: 85 HENIIKFYNSWVDDTNRTIN---MITELFTSGSL-------RYRKKHKNVDMKAIKNWAR 134
H N+I+ ++ +++ I +I G L R K++ ++ + +
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
I G+ YL + N +HRDL N + + V + D GL ++ + +
Sbjct: 155 DIALGMEYLSNRN--FLHRDLAARNCMLRDDM-TVCVADFGL--------SKKIYSGDYY 203
Query: 195 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 240
+A E L + Y D+++FG+ + E+ T PY +N ++Y +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYL 262
Query: 241 TSG 243
G
Sbjct: 263 LHG 265
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 49/219 (22%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +GKG F V G + G +VA + D + +E ++ L+H N+++
Sbjct: 27 QTIGKGEFGDVMLG--DYRGNKVAVKCIK-NDATA-----QAFLAEASVMTQLRHSNLVQ 78
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 147
+ + + ++TE GSL Y + + + ++ + + YL +N
Sbjct: 79 LLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-EFMAPE-LYEEEYN 205
+HRDL N+ V+ +N K+ D GL + P ++ APE L E++++
Sbjct: 138 --FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFS 192
Query: 206 ELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
D++SFG+ + E+ + PY + +V G
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 230
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-24
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 21/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG G F V+ +VA M L E +++K+L+H+ ++K
Sbjct: 194 KKLGAGQFGEVWMATYN-KHTKVAVK-TMKPGSMSVEAFLA----EANVMKTLQHDKLVK 247
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSHN 147
+ T I +ITE GSL + K + + + +++ QI G+ ++ N
Sbjct: 248 LHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 203
IHRDL+ NI V+ + KI D GLA V++ TAR P ++ APE +
Sbjct: 305 --YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 204 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243
+ D++SFG+ ++E+VT PY NP ++ + + G
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERG 401
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 21/226 (9%)
Query: 30 DEILGKGAFKTVYKG---FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
D+++G G F V G I VA + + + L E ++ H
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYT-EKQRRDFL-GEASIMGQFDHP 106
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKN-VDMKAIKNWARQILRGLHYLH 144
NII+ V ++ + ++TE +GSL + +KH + + R I G+ YL
Sbjct: 107 NIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT--P-EFMAPE- 198
+HRDL NI +N N K+ D GL V++ A + G P + +PE
Sbjct: 165 DMG--YVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 199 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+ ++ D++S+G+ + E+++ E PY E N + K V G
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEG 266
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 56/243 (23%), Positives = 93/243 (38%), Gaps = 41/243 (16%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
LG+G+F VY+G VA V E + S + +E
Sbjct: 28 TMSRELGQGSFGMVYEG--------VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 79
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-----------YRKKHKNVDM 126
++K ++++ V + +I EL T G L+ +
Sbjct: 80 SVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 127 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 186
+ A +I G+ YL+++ +HRDL N V + VKIGD G+ + +
Sbjct: 138 SKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYY 194
Query: 187 SVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 240
G M+PE L + + D++SFG+ + E+ T E PY N Q+ + V
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRFV 253
Query: 241 TSG 243
G
Sbjct: 254 MEG 256
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 45/225 (20%), Positives = 93/225 (41%), Gaps = 21/225 (9%)
Query: 30 DEILGKGAFKTVYKGFDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
D LG G F +V +G + I+VA + + E + E ++ L +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 397
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHYLHS 145
I++ + ++ E+ G L + + + + + Q+ G+ YL
Sbjct: 398 IVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAPE-L 199
N +HR+L N+ + N KI D GL+ + + P ++ APE +
Sbjct: 455 KN--FVHRNLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 200 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+++ D++S+G+ + E ++ + PY + K P ++ + G
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQG 555
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 21/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG G F V+ G+ +VA + + M L E +L+K L+H+ +++
Sbjct: 19 ERLGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLA----EANLMKQLQHQRLVR 72
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSHN 147
Y T I +ITE +GSL + K + + + + A QI G+ ++ N
Sbjct: 73 LYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 203
IHRDL+ NI V+ KI D GLA +++ TAR P ++ APE +
Sbjct: 130 --YIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 204 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+ D++SFG+ + E+VT PY NP ++ + + G
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERG 226
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 55/254 (21%), Positives = 100/254 (39%), Gaps = 54/254 (21%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLLK 81
+ + LG+GAF V + + GI+ + E S + L SE+ +L
Sbjct: 30 KLGKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILI 85
Query: 82 SL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLR-----------------YRKKHKN 123
+ H N++ + + +I E G+L
Sbjct: 86 HIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 124 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183
+ ++ + ++ Q+ +G+ +L S IHRDL NI ++ N VKI D GL
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVKICDFGL------- 194
Query: 184 TARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNE 229
AR + P++ MAPE +++ Y D++SFG+ + E+ + PY
Sbjct: 195 -ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 230 CKNPAQIYKKVTSG 243
K + +++ G
Sbjct: 254 VKIDEEFCRRLKEG 267
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 61/256 (23%), Positives = 99/256 (38%), Gaps = 62/256 (24%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---------SPDQLERLYSEVH 78
LG+GAF V+ +N +D M + + E
Sbjct: 18 VLKRELGEGAFGKVFLA--------ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE 69
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-----------------YRKKH 121
LL +L+HE+I+KFY V + M+ E G L R+
Sbjct: 70 LLTNLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 122 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181
+ + + + A QI G+ YL S + +HRDL N V N VKIGD G+
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGM----- 179
Query: 182 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPY 227
+R V T + M PE + ++ D++SFG+ + E+ T + P+
Sbjct: 180 ---SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236
Query: 228 NECKNPAQIYKKVTSG 243
+ N ++ + +T G
Sbjct: 237 FQLSN-TEVIECITQG 251
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 57/237 (24%), Positives = 93/237 (39%), Gaps = 29/237 (12%)
Query: 28 RYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
LG GAF VY+G ++ ++VA + + S E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISK 89
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGS----LRYRKKHKNVD----MKAIKNWAR 134
H+NI++ V + ++ EL G LR + + M + + AR
Sbjct: 90 FNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP 192
I G YL ++ IHRD+ N + G KIGD G+A + + + G
Sbjct: 148 DIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 193 EF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243
M PE E + D +SFG+ + E+ + PY N ++ + VTSG
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG 261
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-23
Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 33/225 (14%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +GKG F V G + G +VA + D + +E ++ L+H N+++
Sbjct: 199 QTIGKGEFGDVMLG--DYRGNKVAVKCIK-NDATA-----QAFLAEASVMTQLRHSNLVQ 250
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 147
+ + + ++TE GSL Y + + + ++ + + YL +N
Sbjct: 251 LLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-------FMAPE-L 199
+HRDL N+ V+ +N K+ D GL + T + + APE L
Sbjct: 310 --FVHRDLAARNVLVSEDN-VAKVSDFGL--------TKEASSTQDTGKLPVKWTAPEAL 358
Query: 200 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
E++++ D++SFG+ + E+ + PY + +V G
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 402
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-22
Identities = 60/247 (24%), Positives = 107/247 (43%), Gaps = 27/247 (10%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LG+G F V+ K ++ + + + + E +L +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-----KGYQGAMVEKKILAKVHSRF 246
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRY-----RKKHKNVDMKAIKNWARQILRGLHY 142
I+ ++ +T + ++ + G +RY + + + QI+ GL +
Sbjct: 247 IVSLAYAF--ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-L 199
LH N II+RDLK +N+ ++ ++G V+I DLGLA + Q + GTP FMAPE L
Sbjct: 305 LHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 200 YEEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQ 256
EEY+ VD ++ G+ + EM+ P+ E ++ ++V + P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKFSPA 419
Query: 257 VKQFIEK 263
K F E
Sbjct: 420 SKDFCEA 426
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 54/276 (19%), Positives = 118/276 (42%), Gaps = 31/276 (11%)
Query: 16 EFSEKDPSCRYGRYD----EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSP 67
+ K R D +++G+GAF V K +V +++ ++ ++++
Sbjct: 56 DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL----LSKFEMIKR- 110
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMK 127
+ E ++ +++ + ++ DD + M+ E G L + +V K
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYDVPEK 168
Query: 128 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---T 184
+ + +++ L +HS IHRD+K DN+ ++ +G +K+ D G + M +
Sbjct: 169 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVR 225
Query: 185 ARSVIGTPEFMAPEL-----YEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYK 238
+ +GTP++++PE+ + Y D +S G+ + EM+ + P Y + + Y
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYS 283
Query: 239 KVTSGIKPASLSKVTD--PQVKQFIEKCIVPASLRL 272
K+ + + D + K I + +RL
Sbjct: 284 KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRL 319
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 68/246 (27%), Positives = 116/246 (47%), Gaps = 30/246 (12%)
Query: 33 LGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
LG G+F V+ + ++V + E V++ Q+E E +L + H I
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKV----LKKEIVVRL-KQVEHTNDERLMLSIVTHPFI 68
Query: 89 IKFYNSWVDDTNRTINMIT------ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHY 142
I+ + ++ D I MI ELF+ +K + K +A ++ L Y
Sbjct: 69 IRMWGTFQDAQQ--IFMIMDYIEGGELFS-----LLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYE 201
LHS + II+RDLK +NI ++ NG +KI D G A + T ++ GTP+++APE +
Sbjct: 122 LHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVST 177
Query: 202 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261
+ YN+ +D +SFG+ I EM+ P+ N + Y+K+ + + VK +
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNA--ELRFPPFFNEDVKDLL 234
Query: 262 EKCIVP 267
+ I
Sbjct: 235 SRLITR 240
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 55/247 (22%), Positives = 91/247 (36%), Gaps = 45/247 (18%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---------SPDQLERLYSEVH 78
LG+GAF V+ N + +D M S + E
Sbjct: 44 VLKWELGEGAFGKVFLA--------ECHNLLPEQDKMLVAVKALKEASESARQDFQREAE 95
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR----------------YRKKHK 122
LL L+H++I++F+ V R + M+ E G L
Sbjct: 96 LLTMLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153
Query: 123 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182
+ + + A Q+ G+ YL + +HRDL N V VKIGD G++ +
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYS 210
Query: 183 PTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 236
V G M PE + ++ D++SFG+ + E+ T + P+ + N +
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEA 269
Query: 237 YKKVTSG 243
+T G
Sbjct: 270 IDCITQG 276
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 29/237 (12%)
Query: 28 RYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
LG GAF VY+G ++ ++VA + + S E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISK 130
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGS----LRYRKKHKNVD----MKAIKNWAR 134
H+NI++ V + ++ EL G LR + + M + + AR
Sbjct: 131 FNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP 192
I G YL ++ IHRD+ N + G KIGD G+A + + G
Sbjct: 189 DIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246
Query: 193 EF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243
M PE E + D +SFG+ + E+ + PY N ++ + VTSG
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG 302
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 55/244 (22%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 28 RYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
R+ E LG+ F VYKG VA + + E E L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAE--GPLREEFRHEAMLRAR 68
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-----------------YRKKHKNVD 125
L+H N++ V ++ ++MI + G L R ++
Sbjct: 69 LQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 126 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185
+ QI G+ YL SH+ ++H+DL N+ V VKI DLGL +
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-NVKISDLGLFREVYAADY 183
Query: 186 RSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 239
++G MAPE + +++ DI+S+G+ + E+ + PY N + +
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVEM 242
Query: 240 VTSG 243
+ +
Sbjct: 243 IRNR 246
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 56/260 (21%), Positives = 94/260 (36%), Gaps = 65/260 (25%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
+ + LG GAF V + A+ + + M + E L SE+
Sbjct: 26 SFGKTLGAGAFGKVVEA--------TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 77
Query: 78 HLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLR-------------------Y 117
+L L H NI+ +ITE G L
Sbjct: 78 KVLSYLGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 118 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177
+D++ + +++ Q+ +G+ +L S N IHRDL NI + + KI D GL
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL-THGRITKICDFGL- 191
Query: 178 IVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC- 223
AR + + MAPE ++ Y D++S+G+ + E+ +
Sbjct: 192 -------ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 224 EYPYNECKNPAQIYKKVTSG 243
PY ++ YK + G
Sbjct: 245 SSPYPGMPVDSKFYKMIKEG 264
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 33/226 (14%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
ILG+G F VYKG DG VA ++ E Q + +EV ++ H N
Sbjct: 33 SNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHRN 88
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNW-ARQ-----ILRGLH 141
+++ + T R + + +GS+ + + + +W RQ RGL
Sbjct: 89 LLRLRGFCMTPTERLL--VYPYMANGSVASCL-RERPESQPPLDWPKRQRIALGSARGLA 145
Query: 142 YLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFM 195
YLH H +P IIHRD+K NI ++ E +GD GLA +M + V GT +
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHI 202
Query: 196 APELYEEEY------NELVDIYSFGMCILEMVTCEYPYNECKNPAQ 235
AP EY +E D++ +G+ +LE++T + ++ +
Sbjct: 203 AP-----EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 5e-22
Identities = 42/170 (24%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 99 TNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 157
T ++ I +L G L Y +H ++ +A +I+ GL ++H+ +++RDLK
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKP 320
Query: 158 DNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGM 215
NI ++ +G V+I DLGLA + + +GT +MAPE Y+ D +S G
Sbjct: 321 ANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 216 CILEMVTCEYPY--NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263
+ +++ P+ ++ K+ +I + + L P+++ +E
Sbjct: 380 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLEG 427
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 57/256 (22%), Positives = 102/256 (39%), Gaps = 61/256 (23%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
++ + LG GAF V + A+ + V++ D+ E L SE+
Sbjct: 49 QFGKTLGAGAFGKVVEA--------TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSEL 100
Query: 78 HLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLR---------------YRKKH 121
++ L +HENI+ + +ITE G L + +
Sbjct: 101 KIMSHLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 122 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181
+ + +++ Q+ +G+ +L S N IHRD+ N+ + N KIGD GL
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVAKIGDFGL----- 210
Query: 182 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPY 227
AR ++ + MAPE +++ Y D++S+G+ + E+ + PY
Sbjct: 211 ---ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267
Query: 228 NECKNPAQIYKKVTSG 243
++ YK V G
Sbjct: 268 PGILVNSKFYKLVKDG 283
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 8e-22
Identities = 62/302 (20%), Positives = 125/302 (41%), Gaps = 44/302 (14%)
Query: 2 DCGSGFTKSETEEGEFSEKD-------PSCRYGRYD----EILGKGAFKTVY----KGFD 46
+C + + E E+ E R R D +++G+GAF V K D
Sbjct: 40 ECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD 99
Query: 47 EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106
+V +++ + M + E +L + + I + ++ DD N + ++
Sbjct: 100 KVFAMKIL-----NKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN--LYLV 152
Query: 107 TELFTSGSLRY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 164
+ + G L K + + + + +++ + +H + +HRD+K DNI ++
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD- 209
Query: 165 NNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELYEEE------YNELVDIYSFGM 215
NG +++ D G + + +GTP++++PE+ + Y D +S G+
Sbjct: 210 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGV 269
Query: 216 CILEMVTCEYP-YNECKNPAQIYKKVTSGIK----PASLSKVTDPQVKQFIEKCIVPASL 270
C+ EM+ E P Y E + + Y K+ + + P ++ V K I + I
Sbjct: 270 CMYEMLYGETPFYAE--SLVETYGKIMNHKERFQFPTQVTDV-SENAKDLIRRLICSREH 326
Query: 271 RL 272
RL
Sbjct: 327 RL 328
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYS 75
F E+ S +G+G F VYKG+ V+ VA ++ + + +L++
Sbjct: 27 FDERPIS----VGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTE-ELKQQFDQ 79
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRY----RKKHKNVD----MK 127
E+ ++ +HEN+++ D + ++ +GSL + K
Sbjct: 80 EIKVMAKCQHENLVELLGFSSDGDDLC--LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 128 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTA 185
+ A G+++LH IHRD+K NI ++ KI D GLA T
Sbjct: 138 IAQGAAN----GINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTV 190
Query: 186 RS--VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT 222
+ ++GT +MAPE E DIYSFG+ +LE++T
Sbjct: 191 MTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 61/265 (23%), Positives = 99/265 (37%), Gaps = 71/265 (26%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
+ LG+G F V K A++ SP +L L SE
Sbjct: 26 VLGKTLGEGEFGKVVKA--------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEF 77
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--------------------- 116
++LK + H ++IK Y + + +I E GSLR
Sbjct: 78 NVLKQVNHPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 117 ----YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172
+ + M + ++A QI +G+ YL ++HRDL NI V ++KI
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGR-KMKIS 192
Query: 173 DLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILE 219
D GL +R V + MA E L++ Y D++SFG+ + E
Sbjct: 193 DFGL--------SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 220 MVTC-EYPYNECKNPAQIYKKVTSG 243
+VT PY +++ + +G
Sbjct: 245 IVTLGGNPYPGIPP-ERLFNLLKTG 268
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 51/265 (19%), Positives = 84/265 (31%), Gaps = 71/265 (26%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
Y +G+GAF V++ A + E S D E
Sbjct: 50 EYVRDIGEGAFGRVFQA--------RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA 101
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGS----LRYRKKH------------ 121
L+ + NI+K + + ++ E G LR H
Sbjct: 102 ALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 122 ---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172
+ ARQ+ G+ YL +HRDL N V N VKI
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIA 216
Query: 173 DLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILE 219
D GL+ R++ + M PE ++ Y D++++G+ + E
Sbjct: 217 DFGLS--------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268
Query: 220 MVT-CEYPYNECKNPAQIYKKVTSG 243
+ + PY + ++ V G
Sbjct: 269 IFSYGLQPYYGMAH-EEVIYYVRDG 292
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 59/261 (22%), Positives = 96/261 (36%), Gaps = 62/261 (23%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLLK 81
+ ++LG GAF V GI + + E S + E L SE+ ++
Sbjct: 48 EFGKVLGSGAFGKVMNA--TAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMT 103
Query: 82 SL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLR------------------------ 116
L HENI+ + I +I E G L
Sbjct: 104 QLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 117 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176
+ + + + +A Q+ +G+ +L + +HRDL N+ V VKI D GL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGK-VVKICDFGL 218
Query: 177 AIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC 223
AR ++ + MAPE L+E Y D++S+G+ + E+ +
Sbjct: 219 --------ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270
Query: 224 -EYPYNECKNPAQIYKKVTSG 243
PY A YK + +G
Sbjct: 271 GVNPYPGIPVDANFYKLIQNG 291
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 51/244 (20%), Positives = 103/244 (42%), Gaps = 24/244 (9%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LGKG F V + ++ + + + +E +L+ +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----KGEAMALNEKQILEKVNSRF 245
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRY---RKKHKNVDMKAIKNWARQILRGLHYLH 144
++ ++ +T + ++ L G L++ +A +I GL LH
Sbjct: 246 VVSLAYAY--ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPE-LYEE 202
I++RDLK +NI ++ ++G ++I DLGLA+ + + T + +GT +MAPE + E
Sbjct: 304 RER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 203 EYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
Y D ++ G + EM+ + P+ + ++ + V P S+ PQ +
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSERFSPQARS 418
Query: 260 FIEK 263
+
Sbjct: 419 LCSQ 422
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 15/228 (6%)
Query: 33 LGKGAFKTVY---KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
LGKG + V+ K G A + ++++ +E ++L+ +KH I+
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
++ T + +I E + G L + ++ + +I L +LH
Sbjct: 85 DLIYAF--QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG- 141
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYN 205
II+RDLK +NI +N + G VK+ D GL + + GT E+MAPE L +N
Sbjct: 142 -IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199
Query: 206 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSK 251
VD +S G + +M+T P+ +N + K+ + P L++
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYLTQ 246
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 52/302 (17%), Positives = 118/302 (39%), Gaps = 42/302 (13%)
Query: 2 DCGSGFTKSETEEGEFSEK-------DPSCRYGRYD----EILGKGAFKTVY----KGFD 46
+ G+ + +F + R R D +++G+GAF V K
Sbjct: 27 ELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTG 86
Query: 47 EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106
+V +++ + M ++ E +L + I + + ++ D+ + ++
Sbjct: 87 QVYAMKIM-----NKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY--LYLV 139
Query: 107 TELFTSGSLRY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 164
E + G L K + + + + + +I+ + +H +HRD+K DNI ++
Sbjct: 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD- 196
Query: 165 NNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPEL--------YEEEYNELVDIYSF 213
G +++ D G + +GTP++++PE+ Y D ++
Sbjct: 197 RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256
Query: 214 GMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVPASL 270
G+ EM + P+ + A+ Y K+ + + + + + FI++ + P
Sbjct: 257 GVFAYEMFYGQTPF-YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPET 315
Query: 271 RL 272
RL
Sbjct: 316 RL 317
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 64/256 (25%), Positives = 102/256 (39%), Gaps = 58/256 (22%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--------EDVMQSPDQLERLYSEVHL 79
+ LG+G F V E GI+ + + +D + L L SE+ +
Sbjct: 84 TLGKPLGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEM 139
Query: 80 LKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLR-----------------YRKKH 121
+K + KH+NII + + +I E + G+LR R
Sbjct: 140 MKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 122 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181
+ + K + + Q+ RG+ YL S IHRDL N+ V NN +KI D GLA
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLA---- 250
Query: 182 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPY 227
R + + MAPE L++ Y D++SFG+ + E+ T PY
Sbjct: 251 ----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
Query: 228 NECKNPAQIYKKVTSG 243
+++K + G
Sbjct: 307 PGIPV-EELFKLLKEG 321
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 65/256 (25%), Positives = 103/256 (40%), Gaps = 58/256 (22%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--------EDVMQSPDQLERLYSEVHL 79
+ LG+GAF V E GI+ + + +D + L L SE+ +
Sbjct: 38 TLGKPLGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEM 93
Query: 80 LKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLR-----------------YRKKH 121
+K + KH+NII + + +I E + G+LR R
Sbjct: 94 MKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 122 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181
+ + K + + Q+ RG+ YL S IHRDL N+ V NN +KI D GL
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGL----- 203
Query: 182 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPY 227
AR + + MAPE L++ Y D++SFG+ + E+ T PY
Sbjct: 204 ---ARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 228 NECKNPAQIYKKVTSG 243
+++K + G
Sbjct: 261 PGIPV-EELFKLLKEG 275
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 38/124 (30%), Positives = 69/124 (55%), Gaps = 9/124 (7%)
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 190
A +I L YLHS N I++RDLK +NI ++ + G + + D GL + T + G
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCG 201
Query: 191 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PA 247
TPE++APE L+++ Y+ VD + G + EM+ P+ +N A++Y + + ++
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKP 260
Query: 248 SLSK 251
+++
Sbjct: 261 NITN 264
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 62/254 (24%), Positives = 99/254 (38%), Gaps = 54/254 (21%)
Query: 28 RYDEILGKGAFKTVYKG--FDEVDGIEVAWNQVNI----EDVMQSPDQLERLYSEVHLLK 81
+ LG+GAF V +V + D + L L SE+ ++K
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMK 129
Query: 82 SL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLR-----------------YRKKHKN 123
+ KH+NII + + +I E + G+LR +
Sbjct: 130 MIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 124 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183
+ K + + A Q+ RG+ YL S IHRDL N+ V +N +KI D GLA
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLA------ 238
Query: 184 TARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNE 229
R + + MAPE L++ Y D++SFG+ + E+ T PY
Sbjct: 239 --RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 230 CKNPAQIYKKVTSG 243
+++K + G
Sbjct: 297 VPV-EELFKLLKEG 309
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 54/229 (23%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 33 LGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
LGKG F V K +++ +V I D++ +E +L++ +H +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVAHTVTESRVLQNTRHPFL 67
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNV-DMKAIKNWARQILRGLHYLHSHN 147
++ T+ + + E G L + + V + + + +I+ L YLHS +
Sbjct: 68 TALKYAF--QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEY 204
+++RD+K +N+ ++ +G +KI D GL + T ++ GTPE++APE L + +Y
Sbjct: 126 --VVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSK 251
VD + G+ + EM+ P+ ++ ++++ + I+ P +LS
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPRTLSP 230
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 64/276 (23%), Positives = 123/276 (44%), Gaps = 28/276 (10%)
Query: 2 DCGSGFTKSETEEGEFSEKDPSCRYGRYD----EILGKGAFKTVY----KGFDEVDGIEV 53
GS S EE E S P R + ++LGKG F V K +++
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI 180
Query: 54 AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSG 113
+V + D++ +E +L++ +H + S+ T+ + + E G
Sbjct: 181 LKKEVIVAK-----DEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYANGG 233
Query: 114 SLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172
L + + + + + +I+ L YLHS +++RDLK +N+ ++ + G +KI
Sbjct: 234 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKIT 291
Query: 173 DLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 229
D GL + T ++ GTPE++APE L + +Y VD + G+ + EM+ P+
Sbjct: 292 DFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-Y 350
Query: 230 CKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQFIEK 263
++ ++++ + I+ P +L P+ K +
Sbjct: 351 NQDHEKLFELILMEEIRFPRTLG----PEAKSLLSG 382
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 38/122 (31%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 192
++ L +LHS II+RDLK +NI ++ G +K+ D GL+ + + A S GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 193 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 249
E+MAPE + + + D +SFG+ + EM+T P+ + K+ + + P L
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFL 249
Query: 250 SK 251
S
Sbjct: 250 SP 251
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 14/128 (10%)
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGT 191
+I+ L +LH II+RD+K +NI ++ +NG V + D GL+ + + A GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 192 PEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSG-I 244
E+MAP++ +++ VD +S G+ + E++T P+ E + A+I +++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283
Query: 245 K-PASLSK 251
P +S
Sbjct: 284 PYPQEMSA 291
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHENIIK 90
++G G F VYKG DG +VA + E Q +E+ L +H +++
Sbjct: 46 LIGHGVFGKVYKGVLR-DGAKVALKRRTPESS-----QGIEEFETEIETLSFCRHPHLVS 99
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR---YRKKHKNVDMKAIKNWAR--QIL----RGLH 141
+ + I + +G+L+ Y + M +W + +I RGLH
Sbjct: 100 LIGFCDERNEMIL--IYKYMENGNLKRHLYGSDLPTMSM----SWEQRLEICIGAARGLH 153
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFM 195
YLH IIHRD+K NI ++ N KI D G++ + T V GT ++
Sbjct: 154 YLH--TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTV--VKGTLGYI 208
Query: 196 APELYEEEY-NELVDIYSFGMCILEMVT 222
PE + + E D+YSFG+ + E++
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 190
+ +I L+YLH II+RDLK DN+ ++ G +K+ D G+ + T + G
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 191 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 239
TP ++APE L E+Y VD ++ G+ + EM+ P++ + +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 192
+I+ GL +LHS I++RDLK DNI ++ +G +KI D G+ ++ + GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 193 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 249
+++APE L ++YN VD +SFG+ + EM+ + P+ ++ +++ + P L
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWL 241
Query: 250 SKVTDPQVKQFIEKCIVPASLRLPALELLKD-PF 282
K + + + RL ++ P
Sbjct: 242 EKEAKDLLVKLFVRE---PEKRLGVRGDIRQHPL 272
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 36/122 (29%), Positives = 64/122 (52%), Gaps = 9/122 (7%)
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 192
+I+ L +LH II+RDLK DN+ ++ G K+ D G+ + T + GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 193 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 249
+++APE L E Y VD ++ G+ + EM+ P+ E +N +++ + + + P L
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWL 247
Query: 250 SK 251
+
Sbjct: 248 HE 249
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 38/122 (31%), Positives = 71/122 (58%), Gaps = 9/122 (7%)
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 192
+I GL +L S II+RDLK DN+ ++ + G +KI D G+ + T ++ GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 193 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 249
+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P S+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM 244
Query: 250 SK 251
SK
Sbjct: 245 SK 246
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 190
+ +I L+YLH II+RDLK DN+ ++ G +K+ D G+ + T + G
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 191 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 239
TP ++APE L E+Y VD ++ G+ + EM+ P++ + +
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 32/223 (14%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY LG G F TV+ D V+ VA ++ V E E+ LL+ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVA-----MKIVRGDKVYTEAAEDEIKLLQRVN 73
Query: 85 -----------HENIIKFYNS--WVDDTNRTINMITELFTSGSLR-YRKKHKNV--DMKA 128
+I+K + + M+ E+ +L KK+++ +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV-LGENLLALIKKYEHRGIPLIY 132
Query: 129 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-----NGNNGEVKIGDLGLAIVMQQP 183
+K ++Q+L GL Y+H IIH D+K +N+ + N ++KI DLG A +
Sbjct: 133 VKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE- 190
Query: 184 TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY 225
+ I T E+ +PE L + DI+S I E++T ++
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 32/239 (13%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-K 84
++ +++G+G F V K + DG ++ A ++ E + E+ +L L
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKD--DHRDFAGELEVLCKLGH 84
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNW----------- 132
H NII + + + E G+L + +K + ++
Sbjct: 85 HPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 133 -----ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 187
A + RG+ YL IHRDL NI V N KI D GL+ + ++
Sbjct: 143 QLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKT 199
Query: 188 VIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
+ P +MA E L Y D++S+G+ + E+V+ PY A++Y+K+ G
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG 257
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 32/261 (12%), Positives = 65/261 (24%), Gaps = 49/261 (18%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
GRY G ++ D +VA V+ + D L+ S L +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVD-PQGVLPDDVLQETLSRTLRLSRID 89
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLH 144
+ + + + E GSL+ + AI+ + + H
Sbjct: 90 KPGVARVLDVVHTRAGGLVVA--EWIRGGSLQEVADTSPSPVGAIR-AMQSLAAAADAAH 146
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 204
+ + V +G+V + M +
Sbjct: 147 RAG--VALSIDHPSRVRV-SIDGDVVLAYPA---TMPDANPQD----------------- 183
Query: 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQI---YKKVTSGIKPASLSKVTDPQVKQFI 261
DI G + ++ +P E + + + + D
Sbjct: 184 ----DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA---DIDRD----- 231
Query: 262 EKCIVPASLRLPALELL-KDP 281
+P + A + D
Sbjct: 232 ----IPFQISAVAARSVQGDG 248
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 3e-18
Identities = 39/124 (31%), Positives = 71/124 (57%), Gaps = 9/124 (7%)
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 190
A +I GL +L S II+RDLK DN+ ++ G +KI D G+ + T ++ G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTFCG 504
Query: 191 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPA 247
TP+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPK 563
Query: 248 SLSK 251
S+SK
Sbjct: 564 SMSK 567
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY +++GKG+F V K +D VA ++ V + E+ +L+ L+
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVA-----LKMVRNEKRFHRQAAEEIRILEHLR 151
Query: 85 HE------NIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNV--DMKAIKNWARQ 135
+ N+I N M EL S +L KK+K + ++ +A
Sbjct: 152 KQDKDNTMNVIHMLE-NFTFRNHIC-MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
IL+ L LH + IIH DLK +NI +K+ D G + Q + I + +
Sbjct: 209 ILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-TYIQSRFY 265
Query: 195 MAPE-LYEEEYNELVDIYSFGMCIL-EMVT 222
APE + Y +D++S G CIL E++T
Sbjct: 266 RAPEVILGARYGMPIDMWSLG-CILAELLT 294
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY+ ++GKG+F V K +D V+ VA I+ + L + EV LL+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVA-----IKIIKNKKAFLNQAQIEVRLLELMN 108
Query: 85 HE------NIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKN--VDMKAIKNWARQ 135
I+ N ++ E+ S +L + V + + +A+Q
Sbjct: 109 KHDTEMKYYIVHLKR-HFMFRNHLC-LVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 194
+ L +L + IIH DLK +NI N +KI D G + + Q I + +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-QYIQSRFY 224
Query: 195 MAPE-LYEEEYNELVDIYSFGMCIL-EMVT 222
+PE L Y+ +D++S G CIL EM T
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLG-CILVEMHT 253
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 33/119 (27%), Positives = 57/119 (47%), Gaps = 9/119 (7%)
Query: 131 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVI 189
++ Q+ +G+ +L S IHRDL NI + VKI D GLA + + P
Sbjct: 197 CYSFQVAKGMEFLASRK--CIHRDLAARNILL-SEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 190 GTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 243
++MAPE +++ Y D++SFG+ + E+ + PY K + +++ G
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 39/205 (19%), Positives = 70/205 (34%), Gaps = 28/205 (13%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLER--LYSEVHLLKSL-K 84
+ LG+GAF V + + GI+ + M + E L SE+ +L +
Sbjct: 27 GKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLH 144
H N++ + +I E G+L + K + K + +G Y+
Sbjct: 85 HLNVVNLL-GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY 204
+ I DLK + + G + +S+ E APE +++
Sbjct: 144 A-----IPVDLKRRLDSITSSQSSASSGFVE---------EKSLSDVEEEEAPEDLYKDF 189
Query: 205 NELVDIYSF------GMCILEMVTC 223
L + + GM L C
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKC 214
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 72.6 bits (177), Expect = 2e-13
Identities = 107/705 (15%), Positives = 209/705 (29%), Gaps = 229/705 (32%)
Query: 16 EFSEKDPSCRYGRYDEILG--KGAFKTVYKGFD--EV-DGIEVAWNQVNIEDVMQSPDQL 70
E E + +IL + AF FD +V D + ++ I+ ++ S D +
Sbjct: 10 ETGEHQYQYK-----DILSVFEDAFV---DNFDCKDVQDMPKSILSKEEIDHIIMSKDAV 61
Query: 71 ERLYSEVHLLKSLKHENIIK-F--------YNSWVDDTNRTINMITELFTSGSLRYRKKH 121
L S K E +++ F Y ++ +T + T + R +
Sbjct: 62 SGTLRLFWTLLS-KQEEMVQKFVEEVLRINYK-FLMSPIKTEQRQPSMMTRMYIEQRDRL 119
Query: 122 KNVDMKAIK-NWAR-----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175
N + K N +R ++ + L L N+ ++G G G
Sbjct: 120 YNDNQVFAKYNVSRLQPYLKLRQALLELRPA-----------KNVLIDGVLG---SGKTW 165
Query: 176 LAIVMQQPTARS--VIGTPEFMAPELYEEEYNELVDIY--SFGMC-----ILEMVT---- 222
+A+ S V +F I+ + C +LEM+
Sbjct: 166 VALD----VCLSYKVQCKMDF--------------KIFWLNLKNCNSPETVLEMLQKLLY 207
Query: 223 ---------CEYPYNECKNPAQIYKKVTSGIK----PASL---SKVTDPQV-KQFIEKC- 264
++ N I ++ +K L V + + F C
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK 267
Query: 265 -------------IVPASLRLPALELLKDPFLVTDNPKDLV-----CDPLRLPNLVPEVM 306
+ A+ +L+ D K L+ C P LP EV+
Sbjct: 268 ILLTTRFKQVTDFLSAATTTHISLDHHSMTL-TPDEVKSLLLKYLDCRPQDLP---REVL 323
Query: 307 NLAHSEPHPMDIDLNHKKVSADSCAKSNTGTW--FLTLELQRLTENNEFTLRGEKNDDDT 364
+P + + A+S + TW + + +LT E +L + +
Sbjct: 324 TT-----NPRRLSI-----IAESI-RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 365 ---VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQL--DLSHEDVVSIAELIDN 419
L VF +A I ++ + D+ DV ++ N
Sbjct: 373 KMFDRL---------------SVFPPSAH----IPTILLSLIWFDVIKSDV----MVVVN 409
Query: 420 LIMK--LVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGV 477
+ K LV ST S + L+ + +K E + + +
Sbjct: 410 KLHKYSLVEKQPKE--STISIPSIYLE---------LKVKLENEYALHRSIVD------- 451
Query: 478 LSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKAD 537
Y + D+ + D Y + + H + +
Sbjct: 452 -------HYNIPKTFDSDDLIPPYL---------------DQYFYSHIGH-HLKNIEHPE 488
Query: 538 EVSLGESILFNESTQNSETSFIDS---CSGMSKNLSFSSISSLS--------LADKE-HS 585
++L + + F++ + N S S +++L + D +
Sbjct: 489 RMTLFRMVFLD-------FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY 541
Query: 586 DGL---------KLELDAINSKYQQCFQELLRQREDEM--ENARK 619
+ L K+E + I SKY + L ++ + E ++
Sbjct: 542 ERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 1e-04
Identities = 41/304 (13%), Positives = 85/304 (27%), Gaps = 115/304 (37%)
Query: 6 GFTKSETEE----------------------------GEFSEKDPSCRYGRYD------- 30
T E + E S +D + +
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE-SIRDGLATWDNWKHVNCDKL 355
Query: 31 --------EILGKGAFKTVYKGF----DEVDGI-----EVAWNQVNIEDVMQSPDQL--- 70
+L ++ ++ I + W V DVM ++L
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSVFPPSAH-IPTILLSLIWFDVIKSDVMVVVNKLHKY 414
Query: 71 --------ERLYS--EVHLLKSLK-------HENIIKFYNSW--VDDTNRTINMITELFT 111
E S ++L +K H +I+ YN D + + + F
Sbjct: 415 SLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFY 474
Query: 112 SGSLRYRKKHKNVDMKAIK---------------NWARQILRGLHYLHSHNPPIIH--RD 154
S + + H +K I+ + Q +R + + I++ +
Sbjct: 475 S-HIGH---H----LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQ 526
Query: 155 LKC--DNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-------FMAPE--LYEEE 203
LK I N E + + L + + ++I + MA + ++EE
Sbjct: 527 LKFYKPYICDNDPKYERLVNAI-LDFLPK--IEENLICSKYTDLLRIALMAEDEAIFEEA 583
Query: 204 YNEL 207
+ ++
Sbjct: 584 HKQV 587
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 46/185 (24%), Positives = 71/185 (38%), Gaps = 27/185 (14%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY +G G+F +Y G D G EVA + +E V QL E + K ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVA---IKLECVKTKHPQLHI---ESKIYKMMQ 62
Query: 85 H-ENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLH 141
I + M+ EL SL + + +K + A Q++ +
Sbjct: 63 GGVGIPTIRWCGAEGDYNV--MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 142 YLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQP---------TARSVIG 190
Y+HS N IHRD+K DN + V I D GLA + +++ G
Sbjct: 120 YIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
Query: 191 TPEFM 195
T +
Sbjct: 178 TARYA 182
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 34/193 (17%), Positives = 66/193 (34%), Gaps = 40/193 (20%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G G F +Y F + A + V +E + L+SE+ + + ++ I
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVE-----YQENGPLFSELKFYQRVAKKDCI--- 96
Query: 93 NSWVDDTNRTINMITELFTSGSLRYRKKHKNV--------------------DMKAIKNW 132
W++ I + SG ++ + +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQQ 182
++L L Y+H + +H D+K N+ + N +V + D GL+ Q+
Sbjct: 157 GIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 183 PTARSVIGTPEFM 195
+ GT EF
Sbjct: 215 NPRKGHNGTIEFT 227
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 47/232 (20%), Positives = 89/232 (38%), Gaps = 48/232 (20%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+ +G G F V + A ++ V E +LK ++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYA-----VKVVRNIKKYTRSAKIEADILKKIQ 89
Query: 85 HE-----NIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNV--DMKAIKNWARQI 136
++ NI+K++ + + +I E SL ++ ++ IK + +I
Sbjct: 90 NDDINNNNIVKYHG-KFMYYDH-MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEI 146
Query: 137 LRGLHYLHSHNPPIIHRDLKCDNIFVN------------------------GNNGEVKIG 172
L+ L+YL + + H DLK +NI ++ + +K+
Sbjct: 147 LKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 173 DLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 222
D G A S+I T ++ APE + ++ D++SFG C+L E+ T
Sbjct: 205 DFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFG-CVLAELYT 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 46/227 (20%), Positives = 88/227 (38%), Gaps = 42/227 (18%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY LG+G F V + D G QV ++ + E E+++LK +K
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKS----QVALKIIRNVGKYREAARLEINVLKKIK 74
Query: 85 HE------NIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNV--DMKAIKNWARQ 135
+ + + W + + + EL + + K++ + +++ A Q
Sbjct: 75 EKDKENKFLCVLMSD-WFNFHGH-MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NGEVKIGDLGLA 177
+ L +LH + + H DLK +NI + N +++ D G A
Sbjct: 132 LCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 178 IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 222
+ +++ T + PE + E + + D++S G CIL E
Sbjct: 190 TFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIG-CILFEYYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 66/334 (19%), Positives = 122/334 (36%), Gaps = 92/334 (27%)
Query: 27 GRYD--EILGKGAFKTVYKGFD-EVDGIEVAWNQVNI---EDVMQSPDQLERLYSEVHLL 80
RY+ + LG+GAF V + D + G VA V I D + E+ +L
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVA---VKIVKNVDRYCEAARS-----EIQVL 65
Query: 81 KSLKHE------NIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNV--DMKAIKN 131
+ L ++ W + I ++ EL S + K++ + + I+
Sbjct: 66 EHLNTTDPNSTFRCVQMLE-WFEHHGH-ICIVFELL-GLSTYDFIKENGFLPFRLDHIRK 122
Query: 132 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NGEVKIGD 173
A QI + +++LHS+ + H DLK +NI + N ++K+ D
Sbjct: 123 MAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 174 LGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-------------- 218
G A + +++ T + APE + +++ D++S G CIL
Sbjct: 181 FGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIG-CILIEYYLGFTVFPTHD 238
Query: 219 --EMVTC-------------------------EYPYNECKNPAQIYKKVTSGIKPASLSK 251
E + ++E + + + +K LS+
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298
Query: 252 -VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
V ++ I+K + + R+ E LK PF
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 2e-11
Identities = 53/331 (16%), Positives = 94/331 (28%), Gaps = 71/331 (21%)
Query: 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIED----VMQSPDQLE 71
FS P+ + R ++I G+G F V++ D VA + IE E
Sbjct: 12 PFSHCLPTEKLQRCEKI-GEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 72 RLYSEVHLLKSL---------KHENIIKFYNSWV-------------------------- 96
+ E+ + K L + E I +
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 97 --DDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 154
+ + ++ E G + + K + K+ Q+ L + HRD
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE-ASLRFEHRD 187
Query: 155 LKCDNIFVN----------GNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFM----APE 198
L N+ + N I GL + + T G F +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247
Query: 199 LYEEEYNELVDIYSFGMCILEMVTCEY-PYNECK-----NPAQIYKKVTSGIKPASLSKV 252
L+ + + DIY EY PY+ + + K
Sbjct: 248 LFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQ 307
Query: 253 TDPQVKQFIEKCIVPASLRLPALELLKDPFL 283
++++F + +S A +LL L
Sbjct: 308 IKRKIQEFHRTMLNFSS----ATDLLCQHSL 334
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 36/158 (22%), Positives = 67/158 (42%), Gaps = 18/158 (11%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
++ +G G+F +Y G + EVA + +E+V QL E + + L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLLY---ESKIYRILQ 60
Query: 85 -HENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLH 141
I V+ ++ +L SL + + + +K + A Q++ +
Sbjct: 61 GGTGIPNVRWFGVEGDYNV--LVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
Query: 142 YLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLA 177
++HS + +HRD+K DN + +V I D GLA
Sbjct: 118 FVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 36/160 (22%), Positives = 61/160 (38%), Gaps = 20/160 (12%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+ + +G G F + G + VA + +E + QL E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVA---IKLEPMKSRAPQLHL---EYRFYKQLG 62
Query: 85 H-ENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLH 141
+ I + Y M+ EL SL + + +K + A Q++ +
Sbjct: 63 SGDGIPQVYYFGPCGKYNA--MVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 142 YLHSHNPPIIHRDLKCDNIFV----NGNNGEVKIGDLGLA 177
Y+HS N +I+RD+K +N + N + I D LA
Sbjct: 120 YVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 26/193 (13%), Positives = 57/193 (29%), Gaps = 37/193 (19%)
Query: 33 LGKGAFKTVYKGFDEVDGI--------EVA----------WNQVNIEDVMQSPDQLERLY 74
+ +Y+ + + +N+ N P Q+ +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS--GSLRYRKKHKNVDMKAIKNW 132
L S I V ++ S + +++
Sbjct: 110 K----LYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLGRSLQSALDVSPKHVLSERSVLQV 164
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQQ 182
A ++L L +LH + +H ++ +NIFV+ + +V + G A + +
Sbjct: 165 ACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 183 PTARSVIGTPEFM 195
+ G EF+
Sbjct: 223 GSRSPHEGDLEFI 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 38/202 (18%), Positives = 62/202 (30%), Gaps = 41/202 (20%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+ +G+G F +Y D V + + V P L++E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVE--PSDNGPLFTELKFYQRAA 91
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNV-------------------- 124
I W+ + + + SG K
Sbjct: 92 KPEQI---QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR 148
Query: 125 -DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA----- 177
K + + +IL L Y+H H +H D+K N+ +N N +V + D GLA
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 178 ----IVMQQPTARSVIGTPEFM 195
R GT EF
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFT 228
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 62/266 (23%), Positives = 98/266 (36%), Gaps = 76/266 (28%)
Query: 27 GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
GRY I LG G F TV+ +D VA + + V + E E+ LLKS++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVA---MKV--VKSAEHYTETALDEIRLLKSVR 91
Query: 85 --------HENIIKFYNS-WVDDTNRT-INMITE-----LFTSGSLRYRKKHKNVDMKAI 129
E +++ + + N T I M+ E L + ++ + + +
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLK---WIIKSNYQGLPLPCV 148
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--------------------------- 162
K +Q+L+GL YLH+ IIH D+K +NI +
Sbjct: 149 KKIIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 163 ---------------------NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LY 200
N +VKI DLG A + + I T ++ + E L
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-TEDIQTRQYRSLEVLI 266
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYP 226
YN DI+S E+ T +Y
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDYL 292
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 31/160 (19%), Positives = 64/160 (40%), Gaps = 20/160 (12%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
Y +G+G+F +++G + ++ +VA + E QL E K L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRD---EYRTYKLLA 63
Query: 85 H-ENIIKFYNSWVDDTNRTINMITELFTSGSLRY--RKKHKNVDMKAIKNWARQILRGLH 141
I Y + + ++ +L SL + +K + A+Q+L +
Sbjct: 64 GCTGIPNVYYFGQEGLHNV--LVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLA 177
+H + +++RD+K DN + N + + + D G+
Sbjct: 121 SIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 7e-06
Identities = 20/73 (27%), Positives = 33/73 (45%), Gaps = 6/73 (8%)
Query: 358 EKNDDDTVSLTLRIGD----KSGHVSN--IHFVFYLNADTAISIAEEMVEQLDLSHEDVV 411
+ + + L LRI D K + N I F F L D +A+EMVE + D
Sbjct: 19 DDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHK 78
Query: 412 SIAELIDNLIMKL 424
++A+ I + + +
Sbjct: 79 TMAKAIKDRVSLI 91
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 630 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 99.57 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 99.04 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.97 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.79 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.27 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.16 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.12 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.68 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.54 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.13 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.05 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.81 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.62 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.53 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.38 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.27 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.23 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.22 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.21 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.81 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.54 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.73 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.61 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 90.96 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-62 Score=510.69 Aligned_cols=271 Identities=50% Similarity=0.933 Sum_probs=244.8
Q ss_pred cCCccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEe
Q 006810 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 93 (630)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~ 93 (630)
+...+...+.|||+++.+.||+|+||+||+|.++.+|..||+|++..... .....+++.+|+.+|++|+|||||++|+
T Consensus 15 ~~~~~~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~ 92 (290)
T 3fpq_A 15 ETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYD 92 (290)
T ss_dssp --CEEEECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhcCcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 34456677899999999999999999999999999999999999976543 4556788999999999999999999999
Q ss_pred EEEcC--CCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEE
Q 006810 94 SWVDD--TNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 170 (630)
Q Consensus 94 ~f~d~--~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 170 (630)
+|.+. ....+|||||||+||+|. ++.+.+.+++..++.|++||+.||+|||+++++||||||||+|||+++.+|.+|
T Consensus 93 ~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vK 172 (290)
T 3fpq_A 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEE
T ss_pred EEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEE
Confidence 98653 345799999999999998 788889999999999999999999999999988999999999999986689999
Q ss_pred EcccccceeeccCCCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006810 171 IGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 250 (630)
Q Consensus 171 L~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~ 250 (630)
|+|||+|+........+.+|||.|||||++.+.|+.++|||||||++|||+||++||.+..+..+++..+..+..|..++
T Consensus 173 l~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 173 IGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp ECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred EEeCcCCEeCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC
Confidence 99999998766666678899999999999998999999999999999999999999998888899999999888887788
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
...++++++||.+||+ +|.+|||+.|+|+||||++.
T Consensus 253 ~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 8889999999999997 89999999999999999863
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=482.64 Aligned_cols=259 Identities=30% Similarity=0.536 Sum_probs=224.1
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
..||..+| ++.+.||+|+||+||+|.++.+|+.||+|+++..... ..+.+.+|+.+|++|+|||||++|++|.+.
T Consensus 69 ~~dp~~~y-~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 143 (346)
T 4fih_A 69 PGDPRSYL-DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVG 143 (346)
T ss_dssp SSCGGGTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS----SGGGGHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCChhHhc-EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 45677777 6678899999999999999999999999999865432 234588999999999999999999999765
Q ss_pred CCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 99 TNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+|||||||+||+|..+..++++++..++.|++||+.||+|||+++ ||||||||+|||++ .+|.+||+|||+|+
T Consensus 144 --~~~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~ 218 (346)
T 4fih_A 144 --DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCA 218 (346)
T ss_dssp --TEEEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCE
T ss_pred --CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEC-CCCCEEEecCcCce
Confidence 46999999999999995555678999999999999999999999999 99999999999998 88999999999998
Q ss_pred eeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCc
Q 006810 179 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTD 254 (630)
Q Consensus 179 ~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~~~s 254 (630)
..... ...+.+|||.|||||++.+ .|+.++|||||||++|||+||++||.+ .+...++..+..+..+ .......+
T Consensus 219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s 297 (346)
T 4fih_A 219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVS 297 (346)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSC
T ss_pred ecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCC
Confidence 76543 3457899999999998875 599999999999999999999999987 5666677777665443 22334578
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+++++||.+||+ +|.+|||+.|+|+||||+...+
T Consensus 298 ~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 298 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 999999999997 8999999999999999987543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=476.73 Aligned_cols=257 Identities=27% Similarity=0.445 Sum_probs=226.2
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
|++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+++|++|+|||||++|++|.+. ..+|+|
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~yiv 110 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFG 110 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEE
Confidence 488999999999999999999999999999998654322 23456799999999999999999999999765 579999
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 183 (630)
||||+||+|. ++.+.+.+++..++.|++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEc-CCCCEEEEEcCCceecCCCCC
Confidence 9999999998 7888899999999999999999999999999 99999999999998 7899999999999876432
Q ss_pred --CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006810 184 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260 (630)
Q Consensus 184 --~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~ 260 (630)
...+.+|||.|||||++.+ .|+.++|||||||++|+|+||++||.+ .+..+++..+..+.. .++...++++++|
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dl 264 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKARDL 264 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHHHHH
Confidence 3456799999999999875 599999999999999999999999987 567777777776533 3556789999999
Q ss_pred HHHccc-CCCCCCCHHH------HhcCCCcccCCCCccc
Q 006810 261 IEKCIV-PASLRLPALE------LLKDPFLVTDNPKDLV 292 (630)
Q Consensus 261 I~kcL~-~p~~Rpsa~e------LL~hpf~~~~~~~~~~ 292 (630)
|.+||+ +|.+|||+.| +++||||+..++..+.
T Consensus 265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 303 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence 999998 8999999988 5899999998887754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-57 Score=464.96 Aligned_cols=257 Identities=26% Similarity=0.506 Sum_probs=207.4
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
.-.||| ++.+.||+|+||+||+|.++.+|+.||+|+++..... ......++.+|+.+|++|+|||||+++++|.+.
T Consensus 10 ~~ig~Y-~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-- 85 (275)
T 3hyh_A 10 AHIGNY-QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-- 85 (275)
T ss_dssp ----CC-EEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred CEeeCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--
Confidence 345788 8889999999999999999999999999999865432 234456799999999999999999999998754
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+|+||||+. |+|. ++.+++.+++..++.|++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+.
T Consensus 86 ~~~~ivmEy~~-g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~ 161 (275)
T 3hyh_A 86 DEIIMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNI 161 (275)
T ss_dssp SEEEEEEECCC-EEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTCCEEECCSSCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEEC-CCCCEEEeecCCCee
Confidence 57999999995 5665 8888899999999999999999999999999 99999999999998 789999999999976
Q ss_pred eccC-CCccccCCCCCCCccccccc-c-CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 180 MQQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 180 ~~~~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
.... ...+.+|||.|||||++.+. | +.++|||||||++|+|+||+.||.+ .+...+++.+..+.. .++...+++
T Consensus 162 ~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~ 238 (275)
T 3hyh_A 162 MTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVY--TLPKFLSPG 238 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTSCHH
T ss_pred cCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHH
Confidence 6543 34567899999999998764 4 6899999999999999999999987 567778888877643 355678999
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+++||.+||+ +|.+|||+.|+|+||||+..-+
T Consensus 239 ~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p 271 (275)
T 3hyh_A 239 AAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLP 271 (275)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCC
T ss_pred HHHHHHHHccCChhHCcCHHHHHcCcccccCCC
Confidence 9999999998 8999999999999999986544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=486.76 Aligned_cols=259 Identities=30% Similarity=0.536 Sum_probs=225.0
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
..||..+| ++.+.||+|+||+||+|.++.+|+.||+|++...... ..+.+.+|+.+|++|+|||||++|++|.+.
T Consensus 146 ~~dp~~~y-~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 146 PGDPRSYL-DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp SSCGGGTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS----SGGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCChhHhc-EeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh----HHHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 45777777 7778899999999999999999999999999865432 235588999999999999999999999865
Q ss_pred CCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 99 TNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+|||||||+||+|..+...+++++..++.|++||+.||+|||+++ ||||||||+||||+ .+|.+||+|||+|+
T Consensus 221 --~~~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~-~~g~vKl~DFGla~ 295 (423)
T 4fie_A 221 --DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCA 295 (423)
T ss_dssp --TEEEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEEC-TTCCEEECCCTTCE
T ss_pred --CEEEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEecCccce
Confidence 46999999999999995556778999999999999999999999999 99999999999998 88999999999998
Q ss_pred eeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCc
Q 006810 179 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTD 254 (630)
Q Consensus 179 ~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~~~s 254 (630)
..... ...+.+|||.|||||++.+ .|+.++|||||||++|||++|++||.+ .+...++..+..+..+ .......+
T Consensus 296 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s 374 (423)
T 4fie_A 296 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVS 374 (423)
T ss_dssp ECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSSC
T ss_pred ECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccCC
Confidence 76543 3457899999999998875 599999999999999999999999987 5666666777665443 23345678
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+++++||.+||+ +|.+|||+.|+|+||||+...+
T Consensus 375 ~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 375 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 999999999997 8999999999999999987543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=475.17 Aligned_cols=254 Identities=26% Similarity=0.454 Sum_probs=215.8
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
-.|| ++.+.||+|+||+||+|.++.+|+.||+|+++.... .....+++.+|+.+|++|+|||||++|++|.+. ..
T Consensus 23 me~Y-~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~ 97 (350)
T 4b9d_A 23 MEKY-VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEEN--GS 97 (350)
T ss_dssp CCCE-EEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred ccce-EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CE
Confidence 3578 778999999999999999999999999999986543 455678899999999999999999999999765 47
Q ss_pred EEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 103 INMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
+|||||||+||+|. ++.. ...+++..++.|+.||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+.
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~ 174 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARV 174 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEEC-TTCCEEECSTTEESC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCCEEEccccccee
Confidence 99999999999998 5543 345799999999999999999999999 99999999999998 789999999999987
Q ss_pred eccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 180 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
.... ...+.+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+..+ .++...+++
T Consensus 175 ~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~-~~~~~~s~~ 252 (350)
T 4b9d_A 175 LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFP-PVSLHYSYD 252 (350)
T ss_dssp CCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSCHH
T ss_pred ecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCC-CCCccCCHH
Confidence 6543 2345789999999999875 599999999999999999999999987 5666666666666544 345567899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999998 89999999999999999763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=467.67 Aligned_cols=265 Identities=23% Similarity=0.353 Sum_probs=219.5
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~---~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
.+| .+| ++.+.||+|+||+||+|.+. .+|+.||+|+++...... ....++.+|+.+|++|+|||||++|++|.
T Consensus 21 ~~p-~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 21 ADP-SQF-ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp CCG-GGE-EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEE
T ss_pred CCc-ccc-EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 345 356 88899999999999999884 478999999997644321 12235788999999999999999999997
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 97 DDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
+. ..+|+|||||+||+|. ++.+.+.+++..++.|++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 97 ~~--~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFG 171 (304)
T 3ubd_A 97 TE--GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFG 171 (304)
T ss_dssp ET--TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTSCEEEESSE
T ss_pred EC--CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEc-CCCCEEecccc
Confidence 65 4699999999999998 7888899999999999999999999999999 99999999999998 78999999999
Q ss_pred cceeecc--CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006810 176 LAIVMQQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 252 (630)
Q Consensus 176 la~~~~~--~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~ 252 (630)
+|+.... ....+.+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+.. .++..
T Consensus 172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~ 248 (304)
T 3ubd_A 172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKL--GMPQF 248 (304)
T ss_dssp EEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTT
T ss_pred cceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCc
Confidence 9986533 33456799999999998874 599999999999999999999999987 566777777766533 35567
Q ss_pred CcHHHHHHHHHccc-CCCCCCCH-----HHHhcCCCcccCCCCccccCCC
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPL 296 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa-----~eLL~hpf~~~~~~~~~~~~~l 296 (630)
.++++++||.+||+ +|.+|||| +|+|+||||+..++..+....+
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~ 298 (304)
T 3ubd_A 249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREI 298 (304)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCC
Confidence 89999999999998 89999984 7999999999988766544433
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=459.96 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=209.7
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
.++++.+.||+|+||+||+|.++.+|..||+|+++.+.. ..+|+.+|+.|+|||||++|++|.+. ..+|
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~--~~~~ 126 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREG--PWVN 126 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEET--TEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 356888999999999999999999999999999986543 24699999999999999999999765 4799
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC-cEEEcccccceeecc
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQ 182 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g-~vKL~DFGla~~~~~ 182 (630)
||||||+||+|. ++...+.+++..++.|+.||+.||.|||+++ ||||||||+||||+ .+| .+||+|||+|+....
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLS-SDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEC-TTSCCEEECCCTTCEEC--
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEe-CCCCEEEEeeCCCCeEccC
Confidence 999999999998 7788889999999999999999999999999 99999999999998 566 699999999987643
Q ss_pred C-------CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCC
Q 006810 183 P-------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVT 253 (630)
Q Consensus 183 ~-------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p~~l~~~~ 253 (630)
. ....++|||.|||||++.+ .|+.++|||||||++|||+||++||.+.... .++..+..+.. ...++...
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 282 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-PLCLKIASEPPPIREIPPSC 282 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS-CCHHHHHHSCCGGGGSCTTS
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHHcCCCCchhcCccC
Confidence 2 1234689999999998875 5999999999999999999999999874443 34444444433 34566778
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHH-------------hcCCCccc
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALEL-------------LKDPFLVT 285 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eL-------------L~hpf~~~ 285 (630)
++.+++||.+||+ +|.+|||+.|+ |+|||+..
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 9999999999997 89999999997 57888865
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=446.96 Aligned_cols=254 Identities=24% Similarity=0.434 Sum_probs=200.5
Q ss_pred Ccc---eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 24 CRY---GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 24 gRy---~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
||| |++.+.||+|+||+||+|.++.+|..||+|+++... .....+++.+|+.+|++|+|||||++|++|.+...
T Consensus 1 GR~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 1 GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp CHHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred CCcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 566 688899999999999999999999999999997543 35566789999999999999999999999976442
Q ss_pred ----------CEEEEEEcccCCCCHH-HHhhcCC---CCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCC
Q 006810 101 ----------RTINMITELFTSGSLR-YRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 166 (630)
Q Consensus 101 ----------~~l~lV~Ey~~gGsL~-~~~~~~~---lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~ 166 (630)
..+|+|||||++|+|. ++..... .+...++.|+.||+.||+|||+++ |+||||||+|||++ .+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~-~~ 154 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MD 154 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TT
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC-CC
Confidence 3589999999999998 6655554 345678999999999999999999 99999999999998 78
Q ss_pred CcEEEcccccceeeccCC--------------CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC
Q 006810 167 GEVKIGDLGLAIVMQQPT--------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK 231 (630)
Q Consensus 167 g~vKL~DFGla~~~~~~~--------------~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~ 231 (630)
|.+||+|||+|+...... ..+.+|||.|||||++.+ .|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 999999999997654321 234579999999998875 59999999999999999996 886532
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 232 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 232 ~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+.......+.....|+.+ ...++.+++||.+||+ +|.+|||+.|+|+||||+..+
T Consensus 232 ~~~~~~~~~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 232 ERVRTLTDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHHHHHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHHHHHhcCCCCCCC-cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 333334444444333222 2235778999999998 899999999999999998654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=456.20 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=212.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC----C
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----T 99 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~----~ 99 (630)
.|| ++.+.||+|+||+||+|.++.+|+.||||+++... ......+++.+|+.+|+.|+|||||+++++|... +
T Consensus 54 ~~Y-~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 54 DEY-EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp SSE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCe-EEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 467 78899999999999999999999999999996443 3455667889999999999999999999987643 2
Q ss_pred CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 100 NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
...+|+|||||.|+.+.++...+.+++..++.|++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+.
T Consensus 131 ~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~-~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 131 FKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMARG 207 (398)
T ss_dssp CCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccC-CCCCEEEeecceeee
Confidence 357999999997553348888899999999999999999999999999 99999999999998 889999999999976
Q ss_pred ecc------CCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCCCC---
Q 006810 180 MQQ------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA--- 247 (630)
Q Consensus 180 ~~~------~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p~--- 247 (630)
+.. ....+.+||+.|||||++.+ .|+.++||||+||++|||+||++||.+.....++...+.. +.++.
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 532 23456799999999998764 4799999999999999999999999885444444333321 11110
Q ss_pred ------------------------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 248 ------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 248 ------------------------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.+....++++++||.+||+ +|.+||||.|+|+||||+..
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0112457899999999998 89999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=468.97 Aligned_cols=266 Identities=21% Similarity=0.358 Sum_probs=227.0
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~--~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
|++.++||+|+||+||+|.++.+|..||+|+++...... ..........++.+++.++|||||+++++|.+. ..+|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--~~ly 268 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLS 268 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--SEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--CEEE
Confidence 488899999999999999999999999999997654321 222333344557788889999999999999765 4699
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
||||||+||+|. ++.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+ .+|.+||+|||+|+.....
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld-~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEe-CCCCEEecccceeeecCCC
Confidence 999999999998 7888899999999999999999999999999 99999999999998 8999999999999988777
Q ss_pred CCccccCCCCCCCccccc-c-ccCcccceeehhHHHHHHhhCCCCCCCC--CCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 184 TARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~-~-~ys~~sDIWSLGvil~ELltG~~Pf~~~--~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
...+.+|||.|||||++. + .|+.++|||||||++|||+||++||.+. .+...+...+... +..++...++++++
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~~~~p~~~S~~a~d 423 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRS 423 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--CCCCCTTSCHHHHH
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--CCCCCccCCHHHHH
Confidence 777889999999999885 3 5999999999999999999999999753 2344555555544 23456678999999
Q ss_pred HHHHccc-CCCCCCC-----HHHHhcCCCcccCCCCccccCCCCCC
Q 006810 260 FIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 299 (630)
Q Consensus 260 ~I~kcL~-~p~~Rps-----a~eLL~hpf~~~~~~~~~~~~~l~~p 299 (630)
||.+||+ +|.+|++ +.|+++||||+..++..+....+..|
T Consensus 424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP 469 (689)
T 3v5w_A 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPP 469 (689)
T ss_dssp HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcC
Confidence 9999998 8999998 79999999999999887765545444
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=434.98 Aligned_cols=251 Identities=18% Similarity=0.341 Sum_probs=203.0
Q ss_pred CCcceeeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~---~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~ 98 (630)
.+|| ++.+.||+|+||+||+|.++ .+++.||+|.+.... ...++.+|+++|+.+ +|||||+++++|.+.
T Consensus 20 ~~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 20 SNVF-KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGTC-EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred cCcE-EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 4677 88999999999999999875 468999999986432 234578999999998 699999999999765
Q ss_pred CCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 99 TNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+|+||||+++|+|.... +.+++..++.+++||+.||+|||++| |+||||||+|||++...|.+||+|||+|+
T Consensus 93 --~~~~lvmE~~~g~~L~~~~--~~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 93 --DHVVIAMPYLEHESFLDIL--NSLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp --TEEEEEEECCCCCCHHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred --CEEEEEEeCCCcccHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 4799999999999998333 46999999999999999999999999 99999999999998555899999999997
Q ss_pred eeccC------------------------------CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCC
Q 006810 179 VMQQP------------------------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYP 226 (630)
Q Consensus 179 ~~~~~------------------------------~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~P 226 (630)
..... ...+.+|||.|||||++.+ .|+.++||||+||++|||+||+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 54321 1234579999999998864 489999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHc--C--------------------------------------------------CCCCCCCCCCc
Q 006810 227 YNECKNPAQIYKKVTS--G--------------------------------------------------IKPASLSKVTD 254 (630)
Q Consensus 227 f~~~~~~~~i~~~i~~--g--------------------------------------------------~~p~~l~~~~s 254 (630)
|....+.......+.. | ..........+
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 9765554433322211 0 00001123467
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+++++||.+||+ +|.+|+||.|+|+||||+..
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 899999999998 89999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=424.90 Aligned_cols=242 Identities=31% Similarity=0.493 Sum_probs=203.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||+||+|... ..||+|+++... .+....+.+.+|+.+|++|+|||||++++++.+ ..+++||
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iVm 110 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAIVT 110 (307)
T ss_dssp CEEEECCCCSSSEEEEEESS---SEEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEE
T ss_pred EEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEEE
Confidence 67899999999999999754 359999987543 356677889999999999999999999997643 2478999
Q ss_pred cccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--
Q 006810 108 ELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 183 (630)
|||++|+|. ++.. ...+++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEE-TTEEEEECCCSSCBC------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEEC-CCCcEEEeeccCceecccCCc
Confidence 999999998 5544 467999999999999999999999998 99999999999998 7899999999999765432
Q ss_pred --CCccccCCCCCCCcccccc----ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCc
Q 006810 184 --TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTD 254 (630)
Q Consensus 184 --~~~~~~GTp~Y~APEvl~~----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~---~l~~~~s 254 (630)
.....+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+..+...+...+..+..++ .++...+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 267 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence 2345689999999998853 489999999999999999999999998777888888887775543 3445678
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+.+++||.+||+ +|.+|||+.|++.+
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999997 89999999987543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=423.73 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=210.1
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEE
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~-----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~ 92 (630)
+...+...| .+.+.||+|+||+||+|.+. .+|..||+|.++.. .....+.+.+|+.+|++|+|||||++|
T Consensus 7 ~~~I~r~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~ 81 (299)
T 4asz_A 7 VQHIKRHNI-VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFY 81 (299)
T ss_dssp CCBCCGGGE-EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hcccCHHHe-EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEE
Confidence 334444455 78899999999999999864 46889999998632 355677899999999999999999999
Q ss_pred eEEEcCCCCEEEEEEcccCCCCHH-HHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcC
Q 006810 93 NSWVDDTNRTINMITELFTSGSLR-YRKKH-------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 158 (630)
Q Consensus 93 ~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~-------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~ 158 (630)
+++.+. ..+++|||||++|+|. ++..+ ..+++..+..|+.||+.||.|||+++ ||||||||+
T Consensus 82 g~~~~~--~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~ 157 (299)
T 4asz_A 82 GVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATR 157 (299)
T ss_dssp EEECSS--SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred EEEeeC--CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHh
Confidence 998765 4589999999999998 66543 46999999999999999999999998 999999999
Q ss_pred ceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCC
Q 006810 159 NIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKN 232 (630)
Q Consensus 159 NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~ 232 (630)
|||++ .++.+||+|||+|+...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+
T Consensus 158 NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~ 235 (299)
T 4asz_A 158 NCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LS 235 (299)
T ss_dssp GEEEC-GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SC
T ss_pred hEEEC-CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CC
Confidence 99998 78999999999997654321 23356899999999886 569999999999999999999 8999987 46
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 233 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 233 ~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
..++...+..+..+ ..+...++++.+||.+||+ +|.+|||+.++ ++||+
T Consensus 236 ~~~~~~~i~~~~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 236 NNEVIECITQGRVL-QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp HHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred HHHHHHHHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 67777777777544 3456778999999999997 89999999998 44664
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=421.41 Aligned_cols=243 Identities=23% Similarity=0.375 Sum_probs=200.9
Q ss_pred eeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 27 GRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~-----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+.+.+.||+|+||+||+|.+. .+|..||+|+++.. +....+.|.+|+.+|++|+|||||++|+++.+. .
T Consensus 43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~ 116 (329)
T 4aoj_A 43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEG--R 116 (329)
T ss_dssp EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--S
T ss_pred eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence 467899999999999999864 47899999998632 456678899999999999999999999998654 4
Q ss_pred EEEEEEcccCCCCHH-HHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC
Q 006810 102 TINMITELFTSGSLR-YRKKH---------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 165 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~---------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 165 (630)
.+++|||||++|+|. ++..+ +++++..+..|+.||+.||.|||+++ ||||||||+|||++ .
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~-~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG-Q 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-T
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC-C
Confidence 589999999999998 55443 46899999999999999999999998 99999999999998 8
Q ss_pred CCcEEEcccccceeeccC----CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHH
Q 006810 166 NGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 239 (630)
Q Consensus 166 ~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~ 239 (630)
++.+||+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+| |+.||.+ .+..+++..
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~ 272 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTEAIDC 272 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 899999999999865432 2234679999999998865 59999999999999999999 8999987 456667777
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 240 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 240 i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+..+..+ ..+...++++.+||.+||. +|.+|||+.|++.+
T Consensus 273 i~~g~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGREL-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCCC-CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCCC-CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 7776543 3456778999999999997 89999999999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=451.91 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=220.7
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
..+| ++.+.||+|+||+||+|.++.+|+.||+|++.... ....+.+.+|+.+|+.|+|||||+++++|.+. ..
T Consensus 156 l~~Y-~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 228 (573)
T 3uto_A 156 LDHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NE 228 (573)
T ss_dssp GGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--SE
T ss_pred cccc-EEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CE
Confidence 3567 78899999999999999999999999999997542 44567789999999999999999999999754 57
Q ss_pred EEEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC-CCCcEEEccccccee
Q 006810 103 INMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIV 179 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~DFGla~~ 179 (630)
+|||||||+||+|. ++. ..+.+++..++.+++||+.||.|||+++ |+||||||+|||++. ..|.+||+|||+|+.
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999999999997 554 4568999999999999999999999999 999999999999973 248999999999987
Q ss_pred eccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcH
Q 006810 180 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDP 255 (630)
Q Consensus 180 ~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~ 255 (630)
+... .....+|||.|||||++.+ .|+.++|||||||++|+|++|+.||.+ .+..+.+..+..+.. +.......++
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 7543 3456789999999998875 599999999999999999999999987 456666666665532 3334456789
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
++++||.+||+ +|.+||++.|+|+||||+..+.
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 99999999998 8999999999999999987543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=418.43 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=206.9
Q ss_pred CCCcceeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d-----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
+...+ ++.+.||+|+||+||+|.. ..++..||||.++... .....+.|.+|+.+|++|+|||||++++++.
T Consensus 24 ~~~~~-~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 24 SLSAV-RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CGGGE-EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHC-eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 44455 8889999999999999985 3578899999986432 2334567999999999999999999999986
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCc
Q 006810 97 DDTNRTINMITELFTSGSLR-YRKK----------------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 159 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~~----------------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~N 159 (630)
+. ..+++|||||++|+|. ++.. ...+++..+..|+.||+.||+|||+++ ||||||||+|
T Consensus 100 ~~--~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~N 175 (308)
T 4gt4_A 100 KD--QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRN 175 (308)
T ss_dssp SS--SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred EC--CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccc
Confidence 54 3588999999999998 6543 245899999999999999999999999 9999999999
Q ss_pred eEEeCCCCcEEEcccccceeeccC----CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCH
Q 006810 160 IFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNP 233 (630)
Q Consensus 160 ILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~ 233 (630)
|||+ .++.+||+|||+++..... .....+||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+.
T Consensus 176 ILl~-~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~ 253 (308)
T 4gt4_A 176 VLVY-DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSN 253 (308)
T ss_dssp EEEC-GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCH
T ss_pred eEEC-CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCH
Confidence 9998 7899999999999765432 234567999999999876 569999999999999999998 8999987 466
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 234 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 234 ~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.++...+..+..++ .+...++.+.++|.+||. +|.+|||+.|++.+
T Consensus 254 ~~~~~~i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 254 QDVVEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77777787765443 456678999999999997 89999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=399.44 Aligned_cols=271 Identities=50% Similarity=0.933 Sum_probs=241.6
Q ss_pred cCCccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEe
Q 006810 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 93 (630)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~ 93 (630)
+...+..+..++|+++.+.||+|+||+||+|.+..++..||+|.+..... .....+.+.+|+.+|++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 92 (290)
T 1t4h_A 15 ETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYD 92 (290)
T ss_dssp ---CCEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhhhhhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence 34556677889999999999999999999999999999999999975543 4566788999999999999999999999
Q ss_pred EEEcC--CCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEE
Q 006810 94 SWVDD--TNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 170 (630)
Q Consensus 94 ~f~d~--~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 170 (630)
+|... ....+++||||+++|+|. ++...+.+++..++.|+.||+.||.|||+++++|+||||||+|||++..++.+|
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred eeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEE
Confidence 98653 346789999999999998 777778999999999999999999999999878999999999999976788999
Q ss_pred EcccccceeeccCCCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006810 171 IGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 250 (630)
Q Consensus 171 L~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~ 250 (630)
|+|||++............||+.|+|||++.+.++.++|||||||++|+|++|+.||....+...+...+..+..+..+.
T Consensus 173 l~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 173 IGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp ECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred EeeCCCcccccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC
Confidence 99999997766666666789999999999988899999999999999999999999999888899999888888777777
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 8888999999999998 89999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=421.74 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=211.8
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCeeEEEeEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSW 95 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~t-----G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pNIVk~~~~f 95 (630)
|..+| ++.+.||+|+||+||+|.+..+ ++.||+|.++... .....+.+.+|+.+|++++| ||||++++++
T Consensus 62 ~~~~~-~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 62 PRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp CGGGE-EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHe-EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 44566 8899999999999999987654 4789999986432 34566789999999999965 8999999988
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcC
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 158 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~ 158 (630)
.... ..+++|||||++|+|. +++.. ..+++..+..|+.||+.||+|||+++ ||||||||+
T Consensus 138 ~~~~-~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~ 214 (353)
T 4ase_A 138 TKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR 214 (353)
T ss_dssp CCTT-SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred EecC-CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCcc
Confidence 6543 4588999999999998 65432 34899999999999999999999999 999999999
Q ss_pred ceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCC
Q 006810 159 NIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKN 232 (630)
Q Consensus 159 NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~ 232 (630)
|||++ .++.+||+|||+|+...... ....+||+.|||||++. +.|+.++|||||||++|||+| |+.||.+...
T Consensus 215 NILl~-~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 215 NILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ceeeC-CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 99998 78999999999998654322 23457899999999876 469999999999999999998 8999998777
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 233 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 233 ~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
...+...+..+..+ ..+...++++.++|.+||. +|.+|||+.++++|
T Consensus 294 ~~~~~~~i~~g~~~-~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 294 DEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp SHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 77788888877654 3456678999999999997 89999999999987
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=395.49 Aligned_cols=261 Identities=31% Similarity=0.515 Sum_probs=222.5
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
.-.++.+|| ++.+.||+|+||+||+|.+..+|..||+|++...... ..+.+.+|+.+++.++||||++++++|..
T Consensus 14 ~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (297)
T 3fxz_A 14 SVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLV 88 (297)
T ss_dssp BSSCGGGTB-CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CcCChhhce-eeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc----HHHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence 345678888 7789999999999999999999999999999765432 23568899999999999999999999876
Q ss_pred CCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 98 DTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
. ..+++||||+++|+|........+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 89 ~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 89 G--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFC 163 (297)
T ss_dssp T--TEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTC
T ss_pred C--CEEEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEC-CCCCEEEeeCCCc
Confidence 5 46899999999999995555567999999999999999999999999 99999999999998 7899999999999
Q ss_pred eeeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 178 IVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 178 ~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
...... .....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||...............+......+...+
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T 3fxz_A 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (297)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSC
T ss_pred eecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Confidence 766543 2345689999999998764 5899999999999999999999999875555555555555544444556678
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+.+++||.+||. +|.+|||+.|+|+||||+...+
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 999999999998 8999999999999999986543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=396.84 Aligned_cols=254 Identities=26% Similarity=0.497 Sum_probs=221.7
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||.||+|.+..+|..||+|++..... .....+++.+|+.+|+.++||||+++++++... ..
T Consensus 14 ~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~ 88 (328)
T 3fe3_A 14 IGNY-RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE--KT 88 (328)
T ss_dssp ETTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred cCCE-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CE
Confidence 4567 888999999999999999999999999999976542 456678899999999999999999999998654 57
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLD-ADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTCCGGGS
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEc-CCCCEEEeeccCceecC
Confidence 99999999999998 7778889999999999999999999999999 99999999999998 78999999999997654
Q ss_pred cC-CCccccCCCCCCCccccccc-c-CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 182 QP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 182 ~~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
.. .....+||+.|+|||++.+. + +.++|||||||++|+|+||+.||.+ .+...+...+..+... ++...++++.
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 242 (328)
T 3fe3_A 166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDCE 242 (328)
T ss_dssp SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHH
T ss_pred CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHH
Confidence 33 34567899999999988754 4 4799999999999999999999987 5667777777666432 3456789999
Q ss_pred HHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 259 QFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+||.+||. +|.+|||+.|+|+||||+...
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999998 899999999999999998643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=399.89 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=193.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC--C
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--R 101 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~--~ 101 (630)
.|.+.+.+.||+|+||+||+|.+ +|..||||+++... ........|+..+.+++|||||++++++.+... .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 35568899999999999999976 69999999986432 122223457777788999999999999876543 3
Q ss_pred EEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcC------CCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 102 TINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~------~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
.+|+|||||++|+|.......++++..+.+++.|++.||+|||++ .++||||||||+|||++ .+|.+||+|||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DFG 153 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred EEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeCC
Confidence 689999999999999444566799999999999999999999987 33599999999999998 78999999999
Q ss_pred cceeeccCC------CccccCCCCCCCcccccc-------ccCcccceeehhHHHHHHhhCCCCCCCC------------
Q 006810 176 LAIVMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNEC------------ 230 (630)
Q Consensus 176 la~~~~~~~------~~~~~GTp~Y~APEvl~~-------~ys~~sDIWSLGvil~ELltG~~Pf~~~------------ 230 (630)
+|+...... ....+||+.|||||++.+ .|+.++|||||||++|||+||..||...
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 998765432 234579999999998864 3678999999999999999997765321
Q ss_pred --CCHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 231 --KNPAQIYKKVTSGIKPASLSKV-----TDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 231 --~~~~~i~~~i~~g~~p~~l~~~-----~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.....+...+......+.++.. ..+.+.++|.+||. +|.+|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1234444545443332233222 22468899999997 89999999998763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=387.60 Aligned_cols=257 Identities=23% Similarity=0.444 Sum_probs=213.8
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC----------------------HHHHHHHHHHHHHH
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----------------------PDQLERLYSEVHLL 80 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~----------------------~~~~~~l~~Ei~iL 80 (630)
.++| ++.+.||+|+||+||+|.+..+|..||+|++........ ....+.+.+|+.+|
T Consensus 12 ~~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 12 LNQY-TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp ETTE-EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred ecce-EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4677 888999999999999999999999999999976542211 12345688999999
Q ss_pred HhCCCCCeeEEEeEEEcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCce
Q 006810 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 160 (630)
Q Consensus 81 ~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NI 160 (630)
++++||||+++++++.+.....+++||||+++|+|......+.+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Ni 168 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNL 168 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHE
Confidence 9999999999999998766678999999999999985556678999999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCC--CccccCCCCCCCccccccc----cCcccceeehhHHHHHHhhCCCCCCCCCCHH
Q 006810 161 FVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPA 234 (630)
Q Consensus 161 Ll~~~~g~vKL~DFGla~~~~~~~--~~~~~GTp~Y~APEvl~~~----ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~ 234 (630)
|++ .+|.+||+|||++....... .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.. .+..
T Consensus 169 l~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~ 246 (298)
T 2zv2_A 169 LVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIM 246 (298)
T ss_dssp EEC-TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHH
T ss_pred EEC-CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHH
Confidence 998 78999999999998765432 2456799999999988653 47889999999999999999999987 4555
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 235 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 235 ~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
.+...+.....+.......++.+++||.+||. +|.+||++.|+|+||||+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 55666655544333345678999999999997 899999999999999995
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=398.97 Aligned_cols=263 Identities=23% Similarity=0.444 Sum_probs=224.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|+||+||+|.++.+|..||+|+++...... ......+.+|+.+|+.++||||++++++|.+. ..+
T Consensus 5 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~ 80 (337)
T 1o6l_A 5 NDF-DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRL 80 (337)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEE
T ss_pred HHe-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEE
Confidence 456 78899999999999999999999999999997543211 22346688999999999999999999998755 479
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec-
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ- 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~- 181 (630)
++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEEC-CCCCEEEeeccchhhccc
Confidence 9999999999998 7777889999999999999999999999999 99999999999998 78999999999997532
Q ss_pred -cCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 182 -QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 182 -~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+...++..+..+. ..++...++++++
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~ 234 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKS 234 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHH
Confidence 233456789999999998864 589999999999999999999999987 45666666666542 2345667899999
Q ss_pred HHHHccc-CCCCCC-----CHHHHhcCCCcccCCCCccccCCC
Q 006810 260 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 296 (630)
Q Consensus 260 ~I~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~~~l 296 (630)
||.+||. +|.+|| ++.++++||||...++..+....+
T Consensus 235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~ 277 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 277 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence 9999997 899999 899999999999988776654433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=403.54 Aligned_cols=264 Identities=22% Similarity=0.406 Sum_probs=221.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~ 102 (630)
++| ++.++||+|+||+||+|.++.+|..||+|++...... .....+.+.+|..+|+.+ +||||++++++|.+. ..
T Consensus 23 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~ 98 (353)
T 3txo_A 23 DNF-EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DR 98 (353)
T ss_dssp CCE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hhe-EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CE
Confidence 456 7889999999999999999999999999999754321 123456688999999988 799999999998754 46
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+|+||||+++|+|. ++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEEC-CCCCEEEccccceeecc
Confidence 99999999999998 7777889999999999999999999999999 99999999999998 78999999999997533
Q ss_pred --cCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 182 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 182 --~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+...++..+..+.. .++...++.++
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~ 252 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLHEDAT 252 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 223456789999999998865 599999999999999999999999987 566677777766533 34556789999
Q ss_pred HHHHHccc-CCCCCCCH------HHHhcCCCcccCCCCccccCCCC
Q 006810 259 QFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVCDPLR 297 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa------~eLL~hpf~~~~~~~~~~~~~l~ 297 (630)
+||.+||. +|.+||++ .++++||||+..++..+....+.
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~ 298 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIE 298 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCC
Confidence 99999998 89999999 89999999999887765444443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=398.72 Aligned_cols=264 Identities=26% Similarity=0.414 Sum_probs=222.9
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEeEE
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLKHENIIKFYNSW 95 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~--~~~~~l~~Ei~iL~~L~HpNIVk~~~~f 95 (630)
...+..++| ++.+.||+|+||+||+|.++.+|..||+|++......... ...+.+.+|+.+|++++||||++++++|
T Consensus 6 ~~~~~~~~y-~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 6 KQQKVEDFY-DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp BCSCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCChhhce-EEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 344555666 8899999999999999999999999999999865432211 1346688999999999999999999998
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC----cEE
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVK 170 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vK 170 (630)
.+. ..+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+|
T Consensus 85 ~~~--~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~~~~vk 159 (361)
T 2yab_A 85 ENR--TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLL-DKNIPIPHIK 159 (361)
T ss_dssp ECS--SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CTTSSSCCEE
T ss_pred EeC--CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-CCCCCccCEE
Confidence 654 5799999999999998 7777788999999999999999999999999 99999999999997 444 799
Q ss_pred EcccccceeeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--
Q 006810 171 IGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-- 246 (630)
Q Consensus 171 L~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-- 246 (630)
|+|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+...
T Consensus 160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~ 238 (361)
T 2yab_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFD 238 (361)
T ss_dssp ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCC
T ss_pred EEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCC
Confidence 9999999876543 3456789999999998875 589999999999999999999999987 4566666666665332
Q ss_pred CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 247 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 247 ~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
..+....++.+++||.+||. +|.+|||+.|+|+||||+..++
T Consensus 239 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 22335678999999999998 8999999999999999986543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=391.58 Aligned_cols=265 Identities=28% Similarity=0.444 Sum_probs=225.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||+||+|.++.+|..||+|++....... ....+.+.+|+.+|+.++||||++++++|.+. ..+
T Consensus 6 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~ 81 (318)
T 1fot_A 6 QDF-QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQI 81 (318)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEE
T ss_pred HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--CEE
Confidence 456 78899999999999999999999999999997543211 12346688999999999999999999998754 479
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
|+||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSS
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEc-CCCCEEEeecCcceecCC
Confidence 9999999999998 7777889999999999999999999999999 99999999999998 789999999999976544
Q ss_pred CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 183 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 183 ~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
. ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.. .+....+..+..+. ..++...+++++++|
T Consensus 159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li 234 (318)
T 1fot_A 159 V-TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAE--LRFPPFFNEDVKDLL 234 (318)
T ss_dssp C-BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred c-cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHH
Confidence 2 345789999999998764 589999999999999999999999987 45556666665543 234566789999999
Q ss_pred HHccc-CCCCCC-----CHHHHhcCCCcccCCCCccccCCCCCC
Q 006810 262 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 299 (630)
Q Consensus 262 ~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~~~l~~p 299 (630)
.+||. +|.+|| ++.++++||||+..++..+....+..|
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p 278 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 278 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCS
T ss_pred HHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCC
Confidence 99997 899999 899999999999888776654444433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=402.28 Aligned_cols=264 Identities=18% Similarity=0.352 Sum_probs=221.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~ 102 (630)
.+| ++.++||+|+||+||+|.++.+|..||+|+++..... .....+.+.+|..+|+++ +||||++++++|.+. ..
T Consensus 52 ~~y-~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~ 127 (396)
T 4dc2_A 52 QDF-DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR 127 (396)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred hHc-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CE
Confidence 355 7889999999999999999999999999999865432 334456688899999887 899999999998754 47
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCC
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEC-CCCCEEEeecceeeecc
Confidence 99999999999998 7777889999999999999999999999999 99999999999998 78999999999997532
Q ss_pred --cCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCC--------CCHHHHHHHHHcCCCCCCCC
Q 006810 182 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLS 250 (630)
Q Consensus 182 --~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~--------~~~~~i~~~i~~g~~p~~l~ 250 (630)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||... .....++..+.... ..++
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p 282 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIP 282 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--CCCC
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--cCCC
Confidence 234556789999999998865 5899999999999999999999999642 22344555555542 3355
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCH------HHHhcCCCcccCCCCccccCCC
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVCDPL 296 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa------~eLL~hpf~~~~~~~~~~~~~l 296 (630)
...++++++||.+||+ +|.+||++ .|+++||||+..++..+....+
T Consensus 283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~ 335 (396)
T 4dc2_A 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQV 335 (396)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCS
T ss_pred CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCC
Confidence 6678999999999998 89999995 7999999999988776544433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=378.79 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=212.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.|| ++.+.||+|+||+||+|.+..+|..||+|++..... .......+.+|+.++++++||||++++++|.+. ..+
T Consensus 2 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 76 (292)
T 3o0g_A 2 QKY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKL 76 (292)
T ss_dssp CSE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred CCc-eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEE
Confidence 466 788999999999999999999999999999986543 334556788999999999999999999998764 468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+.++.+. .....+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecCC
Confidence 9999999987777 4445788999999999999999999999999 99999999999998 789999999999987653
Q ss_pred C--CCccccCCCCCCCcccccc-c-cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--CCC----------
Q 006810 183 P--TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP---------- 246 (630)
Q Consensus 183 ~--~~~~~~GTp~Y~APEvl~~-~-ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g--~~p---------- 246 (630)
. ......||+.|+|||++.+ . ++.++|||||||++|+|+||..||....+.......+... ..+
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 3 3345678999999998764 3 7999999999999999999988866556665555544321 000
Q ss_pred ---------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 ---------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 ---------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.......++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01122467899999999998 89999999999999999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=395.28 Aligned_cols=266 Identities=23% Similarity=0.393 Sum_probs=227.3
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||.||+|.+..+|..||+|++....... ....+.+.+|+.+|+.++||||++++++|.+. ..
T Consensus 40 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 115 (350)
T 1rdq_E 40 LDQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SN 115 (350)
T ss_dssp GGGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred HHHC-EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CE
Confidence 3566 77899999999999999999999999999997543211 12346788999999999999999999998754 47
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+|+||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECS
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEEC-CCCCEEEcccccceecc
Confidence 99999999999998 7777788999999999999999999999999 99999999999998 78999999999998665
Q ss_pred cCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006810 182 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260 (630)
Q Consensus 182 ~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~ 260 (630)
.. ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+..+++..+..+.. .++...++.++++
T Consensus 193 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 268 (350)
T 1rdq_E 193 GR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDL 268 (350)
T ss_dssp SC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHH
T ss_pred CC-cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 43 345689999999998764 589999999999999999999999987 566777777776632 3456678999999
Q ss_pred HHHccc-CCCCCCC-----HHHHhcCCCcccCCCCccccCCCCCC
Q 006810 261 IEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 299 (630)
Q Consensus 261 I~kcL~-~p~~Rps-----a~eLL~hpf~~~~~~~~~~~~~l~~p 299 (630)
|.+||. +|.+||+ +.++++||||...++..+....+..|
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p 313 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCC
Confidence 999997 8999998 99999999999887766544444333
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=390.34 Aligned_cols=260 Identities=18% Similarity=0.362 Sum_probs=221.5
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~ 102 (630)
.+| ++.+.||+|+||.||+|.++.+|..||+|++..... ......+.+.+|+.+++++ +||||++++++|.+. ..
T Consensus 9 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~ 84 (345)
T 3a8x_A 9 QDF-DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR 84 (345)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hhe-EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CE
Confidence 456 788999999999999999999999999999986543 3456677889999999988 899999999998754 57
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+|+||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCGGGCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEEecccccccc
Confidence 99999999999998 7777788999999999999999999999999 99999999999998 78999999999997532
Q ss_pred --cCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCC--------CCHHHHHHHHHcCCCCCCCC
Q 006810 182 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLS 250 (630)
Q Consensus 182 --~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~--------~~~~~i~~~i~~g~~p~~l~ 250 (630)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||... .....++..+.... ..++
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIP 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--CCCC
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--CCCC
Confidence 223456789999999998765 5899999999999999999999999642 23344555555542 2355
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCH------HHHhcCCCcccCCCCccc
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLV 292 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa------~eLL~hpf~~~~~~~~~~ 292 (630)
...++.+++||.+||. +|.+||++ .+++.||||+..++..+.
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~ 288 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 288 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHH
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHH
Confidence 6678999999999998 89999995 799999999987765543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=396.71 Aligned_cols=264 Identities=23% Similarity=0.422 Sum_probs=224.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~ 101 (630)
.++| ++.++||+|+||+||+|.++.+|..||+|+++...... ....+.+..|..+|+.+ +||||++++++|.+. .
T Consensus 16 ~~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~ 91 (345)
T 1xjd_A 16 IEDF-ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--E 91 (345)
T ss_dssp CTTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--S
T ss_pred hHHe-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--C
Confidence 3556 78899999999999999999999999999997543211 12345678899999876 999999999998764 4
Q ss_pred EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 102 TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
.+|+||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEEC-CCCCEEEeEChhhhhc
Confidence 699999999999998 7777789999999999999999999999999 99999999999998 7899999999999754
Q ss_pred c--cCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 181 Q--QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 181 ~--~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
. .......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+ .+...++..+..+.. .++...++++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 245 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEA 245 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCC--CCCcccCHHH
Confidence 3 234456789999999998765 589999999999999999999999987 566677777766532 3456678999
Q ss_pred HHHHHHccc-CCCCCCCHH-HHhcCCCcccCCCCccccCCC
Q 006810 258 KQFIEKCIV-PASLRLPAL-ELLKDPFLVTDNPKDLVCDPL 296 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~-eLL~hpf~~~~~~~~~~~~~l 296 (630)
++||.+||. +|.+||++. ++++||||+..++..+....+
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~ 286 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI 286 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCS
T ss_pred HHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCC
Confidence 999999998 899999998 999999999888766544433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=386.12 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=215.0
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 6 ~~~y-~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 79 (323)
T 3tki_A 6 VEDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NI 79 (323)
T ss_dssp TTCE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhhc-eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC--Ce
Confidence 3567 888999999999999999999999999999975432 22345688999999999999999999988654 57
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+++||||+++|+|. ++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECE
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEe-CCCCEEEEEeeccceec
Confidence 89999999999998 6777778999999999999999999999999 99999999999998 78999999999997654
Q ss_pred cC----CCccccCCCCCCCccccccc--cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 182 QP----TARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 182 ~~----~~~~~~GTp~Y~APEvl~~~--ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
.. .....+||+.|+|||++.+. ++.++|||||||++|+|+||+.||.........+................++
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCH
Confidence 32 23456899999999988653 3778999999999999999999998766555555555554333333355689
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
.+++||.+||. +|.+|||+.|+|+||||+....
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 99999999998 8999999999999999986543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=405.47 Aligned_cols=261 Identities=20% Similarity=0.351 Sum_probs=217.1
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.++||+|+||+||+|.++.+|..||+|++....... ....+.+.+|+.+++.++||||++++++|.+. ..+
T Consensus 69 ~~y-~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~ 144 (410)
T 3v8s_A 69 EDY-EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RYL 144 (410)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred ccc-EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEE
Confidence 455 78899999999999999999999999999997532211 11123477899999999999999999999754 579
Q ss_pred EEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 104 NMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 104 ~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
|+||||++||+|........+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 145 ~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeEC-CCCCEEEeccceeEeeccC
Confidence 99999999999985445668999999999999999999999999 99999999999998 7899999999999876543
Q ss_pred C---CccccCCCCCCCccccccc-----cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCC
Q 006810 184 T---ARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVT 253 (630)
Q Consensus 184 ~---~~~~~GTp~Y~APEvl~~~-----ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~ 253 (630)
. ..+.+||+.|+|||++.+. |+.++|||||||++|||+||+.||.+ .+....+..+..+.. ........
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~ 300 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDI 300 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTTCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCcccc
Confidence 2 3467899999999987632 78999999999999999999999987 566666666655321 11222357
Q ss_pred cHHHHHHHHHccc-CCCC--CCCHHHHhcCCCcccCCCCccc
Q 006810 254 DPQVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPKDLV 292 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~--Rpsa~eLL~hpf~~~~~~~~~~ 292 (630)
++++++||.+||. +|.+ |+++.|+++||||+..++..+.
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~ 342 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWET 342 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTT
T ss_pred cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHh
Confidence 8999999999998 5666 9999999999999988776543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=385.49 Aligned_cols=264 Identities=24% Similarity=0.347 Sum_probs=210.9
Q ss_pred CCCcceeeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~---~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
..++| ++.+.||+|+||.||+|.+. .+|..||+|+++.............+.+|+.+|+.++||||++++++|.+.
T Consensus 15 ~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 15 RPECF-ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CGGGE-EEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CHHHe-EEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 34566 88899999999999999985 689999999997654433344556688999999999999999999998764
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 99 TNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 94 --GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLC 168 (327)
T ss_dssp --SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTSCEEECCCSCC
T ss_pred --CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEEC-CCCcEEEEeCCcc
Confidence 4689999999999998 7777888999999999999999999999999 99999999999998 7899999999998
Q ss_pred eeecc--CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 178 IVMQQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 178 ~~~~~--~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+..... .++...+
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~ 245 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKL--NLPPYLT 245 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCC--CCCTTSC
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCC
Confidence 75432 23345689999999998764 589999999999999999999999987 455555555554422 3445678
Q ss_pred HHHHHHHHHccc-CCCCCC-----CHHHHhcCCCcccCCCCccccC
Q 006810 255 PQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCD 294 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~~ 294 (630)
+.+++||.+||. +|.+|| ++.++|.||||+..++..+...
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~ 291 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 291 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTT
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhc
Confidence 999999999997 899999 8899999999998776655433
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=382.63 Aligned_cols=259 Identities=24% Similarity=0.402 Sum_probs=207.4
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
.-.+|| ++.+.||+|+||+||+|.+. +|..||+|++..... .......+.+|+.+|++++||||+++++++.+.
T Consensus 18 ~l~~~y-~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 91 (311)
T 3niz_A 18 GLMEKY-QKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-- 91 (311)
T ss_dssp CSSCEE-EEEEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS--
T ss_pred chHhhh-HhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC--
Confidence 345677 78899999999999999985 599999999975432 233456788999999999999999999998644
Q ss_pred CEEEEEEcccCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 RTINMITELFTSGSLRYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++||||++++.+.++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARA 168 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEEC-CCCCEEEccCcCcee
Confidence 4689999999975555444 4456999999999999999999999999 99999999999998 789999999999987
Q ss_pred eccC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc--CCCCCC-----
Q 006810 180 MQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPAS----- 248 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~p~~----- 248 (630)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...... ...+..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 6533 2344578999999998764 4899999999999999999999999876555444433321 111111
Q ss_pred --------------------CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 249 --------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 249 --------------------l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+....++++++||.+||+ +|.+|||+.|+|+||||+..++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 112356889999999998 8999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=398.52 Aligned_cols=266 Identities=21% Similarity=0.406 Sum_probs=224.9
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||.||+|.+..+|..||+|++....... ....+.+.+|+.+|+.++|||||+++++|.+. ..
T Consensus 14 ~~~y-~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~ 89 (384)
T 4fr4_A 14 FDHF-EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--ED 89 (384)
T ss_dssp GGGE-EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred hHHe-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 3556 88899999999999999999999999999997543221 22346788999999999999999999999765 46
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+|+||||+.+|+|. ++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEC-CCCCEEEeccceeeecc
Confidence 89999999999998 7777788999999999999999999999999 99999999999998 78999999999998764
Q ss_pred cC-CCccccCCCCCCCcccccc----ccCcccceeehhHHHHHHhhCCCCCCCC--CCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 182 QP-TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 182 ~~-~~~~~~GTp~Y~APEvl~~----~ys~~sDIWSLGvil~ELltG~~Pf~~~--~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
.. .....+||+.|+|||++.. .|+.++|||||||++|+|++|+.||... .....++..+.... ..++...+
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~~~s 244 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWS 244 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CCCCTTSC
T ss_pred CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cCCCCcCC
Confidence 43 3456789999999998852 4899999999999999999999999753 33455555555432 33455678
Q ss_pred HHHHHHHHHccc-CCCCCCC-HHHHhcCCCcccCCCCccccCCCC
Q 006810 255 PQVKQFIEKCIV-PASLRLP-ALELLKDPFLVTDNPKDLVCDPLR 297 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rps-a~eLL~hpf~~~~~~~~~~~~~l~ 297 (630)
+.+++||.+||. +|.+||+ +.+++.||||...++..+....+.
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~ 289 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLI 289 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCC
Confidence 999999999998 8999998 899999999999888766554443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=385.91 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=216.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~--~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
..+| ++.+.||+|+||+||+|.+..+|..||+|++......... ...+.+.+|+.+|+.++||||++++++|.+.
T Consensus 10 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 86 (326)
T 2y0a_A 10 DDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-- 86 (326)
T ss_dssp HHHE-EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred ccce-EeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence 3455 8899999999999999999999999999999865432211 1346688999999999999999999998654
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC----cEEEcccc
Q 006810 101 RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLG 175 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKL~DFG 175 (630)
..+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+|||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~-~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLL-DRNVPKPRIKIIDFG 163 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEES-CSSSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEe-cCCCCCCCEEEEECC
Confidence 4689999999999998 7777788999999999999999999999999 99999999999997 555 89999999
Q ss_pred cceeeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCC
Q 006810 176 LAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSK 251 (630)
Q Consensus 176 la~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~ 251 (630)
++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. +.......+..... +.....
T Consensus 164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 164 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp TCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHTCCCCCHHHHT
T ss_pred CCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHHhcCCCcCccccc
Confidence 99876532 3445679999999998864 5899999999999999999999999874 44445454544322 222234
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
..++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 568899999999997 899999999999999998654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=392.98 Aligned_cols=265 Identities=21% Similarity=0.340 Sum_probs=224.7
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~ 101 (630)
.++| ++.++||+|+||+||+|.++.+|..||+|+++...... ....+.+.+|..+|..+ +||||++++++|.+. .
T Consensus 19 ~~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~ 94 (353)
T 2i0e_A 19 LTDF-NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--D 94 (353)
T ss_dssp CTTE-EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--S
T ss_pred hHHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--C
Confidence 3456 78899999999999999999999999999997643221 22346688999999988 899999999998754 4
Q ss_pred EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 102 TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
.+|+||||++||+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEc-CCCcEEEEeCCccccc
Confidence 799999999999998 7777788999999999999999999999999 99999999999998 7899999999999754
Q ss_pred c--cCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 181 Q--QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 181 ~--~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
. .......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+ .+...++..+..+.. .++...++++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 248 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEA 248 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHH
Confidence 2 233456789999999998764 589999999999999999999999987 566677777766532 3456778999
Q ss_pred HHHHHHccc-CCCCCCC-----HHHHhcCCCcccCCCCccccCCCC
Q 006810 258 KQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLR 297 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rps-----a~eLL~hpf~~~~~~~~~~~~~l~ 297 (630)
++||.+||. +|.+||+ +.+++.||||+..++..+....+.
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~ 294 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQ 294 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCC
Confidence 999999997 8999994 699999999998887665444443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=400.67 Aligned_cols=254 Identities=26% Similarity=0.448 Sum_probs=217.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||+||+|.+..+|..||+|++..... .....+.+.+|+.+|+.++||||++++++|.+. ..+
T Consensus 11 ~~Y-~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 85 (444)
T 3soa_A 11 EEY-QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEE--GHH 85 (444)
T ss_dssp HHE-EEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS--SEE
T ss_pred CCe-EEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC--CEE
Confidence 355 888999999999999999999999999999986543 344567789999999999999999999998654 578
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCcEEEcccccceee
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVM 180 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGla~~~ 180 (630)
++||||+.+|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||++...
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999997 7778889999999999999999999999999 999999999999974 3578999999999766
Q ss_pred ccCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcH
Q 006810 181 QQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDP 255 (630)
Q Consensus 181 ~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~ 255 (630)
.... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+.. +.......++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp CTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred cCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCCH
Confidence 5432 345689999999998875 599999999999999999999999987 556667777766543 2333346789
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 99999999998 8999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=392.88 Aligned_cols=257 Identities=24% Similarity=0.390 Sum_probs=203.2
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNR 101 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~ 101 (630)
.+|| ++.+.||+|+||+||+|.+..+|..||+|++... ........++.+|+.+|+.+. ||||++++++|......
T Consensus 8 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 8 LRKY-ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HTTE-EEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cCce-EEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc--ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3567 7889999999999999999999999999998633 234566778899999999997 99999999999876666
Q ss_pred EEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 102 TINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
.+|+||||+.+ +|........+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 85 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 85 DVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLN-AECHVKVADFGLSRSFV 160 (388)
T ss_dssp CEEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEESS
T ss_pred EEEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEc-CCCCEEecCCccccccc
Confidence 79999999985 6764444568999999999999999999999999 99999999999998 78999999999997543
Q ss_pred c-----------------------CCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHH
Q 006810 182 Q-----------------------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 236 (630)
Q Consensus 182 ~-----------------------~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i 236 (630)
. ......+||+.|+|||++.+ .|+.++|||||||++|||++|++||.+.....++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 2 11234679999999998764 5899999999999999999999999885554444
Q ss_pred HHHHHcCCCCC--------------------------------------------CCCCCCcHHHHHHHHHccc-CCCCC
Q 006810 237 YKKVTSGIKPA--------------------------------------------SLSKVTDPQVKQFIEKCIV-PASLR 271 (630)
Q Consensus 237 ~~~i~~g~~p~--------------------------------------------~l~~~~s~~lk~~I~kcL~-~p~~R 271 (630)
...+.....|. ......++++++||.+||+ +|.+|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 43332111110 0012457899999999998 89999
Q ss_pred CCHHHHhcCCCcccC
Q 006810 272 LPALELLKDPFLVTD 286 (630)
Q Consensus 272 psa~eLL~hpf~~~~ 286 (630)
||+.|+|+||||+..
T Consensus 321 ~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 321 ISANDALKHPFVSIF 335 (388)
T ss_dssp CCHHHHTTSTTTTTT
T ss_pred CCHHHHhCCHHHHHh
Confidence 999999999999763
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=390.51 Aligned_cols=254 Identities=26% Similarity=0.471 Sum_probs=218.2
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|+||.||+|.+..+|..||+|++..... .....+.+.+|+.+++.|+||||++++++|.+. ..+
T Consensus 29 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~ 103 (362)
T 2bdw_A 29 DNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFH 103 (362)
T ss_dssp HHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred cCe-EEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEE
Confidence 355 888999999999999999999999999999986543 355667899999999999999999999998654 568
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC--CCcEEEcccccceee
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVM 180 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKL~DFGla~~~ 180 (630)
++||||+.+|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.. ++.+||+|||++...
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999997 7777788999999999999999999999999 9999999999999732 356999999999766
Q ss_pred ccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHH
Q 006810 181 QQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQ 256 (630)
Q Consensus 181 ~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~s~~ 256 (630)
... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+... .......+++
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 260 (362)
T 2bdw_A 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPE 260 (362)
T ss_dssp TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 543 2345689999999998875 589999999999999999999999987 4566666666665432 2223456899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
+++||.+||. +|.+||++.++|+||||..
T Consensus 261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 261 AKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999997 8999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=373.84 Aligned_cols=263 Identities=24% Similarity=0.398 Sum_probs=212.8
Q ss_pred cCCccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEe
Q 006810 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 93 (630)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~ 93 (630)
++--...+-.++| ++.+.||+|+||+||+|.+..+|..||+|.+...... ...+.+.+|+.+|++++||||+++++
T Consensus 12 ~~~~~~g~i~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~ 87 (285)
T 3is5_A 12 ENLYFQGTIDDLF-IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ---VPMEQIEAEIEVLKSLDHPNIIKIFE 87 (285)
T ss_dssp -CCEESSCHHHHE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC---SCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccCCCCCChhhhe-eecceeccCCCeEEEEEEEccCCceEEEEEeeccccc---hhHHHHHHHHHHHHhCCCchHHhHHH
Confidence 3334444555677 8899999999999999999999999999999865432 23466889999999999999999999
Q ss_pred EEEcCCCCEEEEEEcccCCCCHH-HHh----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CC
Q 006810 94 SWVDDTNRTINMITELFTSGSLR-YRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NN 166 (630)
Q Consensus 94 ~f~d~~~~~l~lV~Ey~~gGsL~-~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~ 166 (630)
++.+. ..+++||||+++|+|. ++. ....+++..++.++.||+.||.|||+++ |+||||||+||+++. .+
T Consensus 88 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~ 163 (285)
T 3is5_A 88 VFEDY--HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPH 163 (285)
T ss_dssp EEECS--SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTT
T ss_pred heecC--CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCC
Confidence 98654 5689999999999997 432 3478999999999999999999999999 999999999999952 45
Q ss_pred CcEEEcccccceeeccC-CCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC
Q 006810 167 GEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 245 (630)
Q Consensus 167 g~vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~ 245 (630)
+.+||+|||++...... ......||+.|+|||++.+.++.++|||||||++|+|++|+.||.+. +...+...+.....
T Consensus 164 ~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~ 242 (285)
T 3is5_A 164 SPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT-SLEEVQQKATYKEP 242 (285)
T ss_dssp CCEEECCCCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCC
T ss_pred CCEEEEeeecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCC-CHHHHHhhhccCCc
Confidence 78999999999765443 33456799999999999888999999999999999999999999874 44555444444332
Q ss_pred C-CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 246 P-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 246 p-~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
. .......++.+++||.+||. +|.+||++.|+|+||||++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 243 NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 2 22223468999999999998 8999999999999999985
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=384.79 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=215.1
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
-.+|| ++.+.||+|+||+||+|.+..+|..||+|.+... ......+.+|+.+|+.++||||++++++|.+. .
T Consensus 3 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~ 74 (321)
T 1tki_A 3 LYEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESM--E 74 (321)
T ss_dssp CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--T
T ss_pred hhhce-EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--C
Confidence 34677 8889999999999999999999999999998743 23446688999999999999999999998765 4
Q ss_pred EEEEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC-CCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~-~g~vKL~DFGla~ 178 (630)
.+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.. ++.+||+|||++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 699999999999998 55443 47999999999999999999999999 9999999999999732 7899999999998
Q ss_pred eeccC-CCccccCCCCCCCccccccc-cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCc
Q 006810 179 VMQQP-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTD 254 (630)
Q Consensus 179 ~~~~~-~~~~~~GTp~Y~APEvl~~~-ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~--~l~~~~s 254 (630)
..... ......|||.|+|||++.+. ++.++|||||||++|+|++|..||.. .+...+...+..+.... ......+
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T 1tki_A 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCC
Confidence 76543 23456799999999988754 79999999999999999999999987 45555666665543321 1224568
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 232 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999997 89999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=402.53 Aligned_cols=263 Identities=23% Similarity=0.425 Sum_probs=213.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+|+.++||||++++++|.+. ..+
T Consensus 148 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 223 (446)
T 4ejn_A 148 NEF-EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRL 223 (446)
T ss_dssp GGE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEET--TEE
T ss_pred HHc-EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--CEE
Confidence 455 788999999999999999999999999999975432 2234556788999999999999999999998765 468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||+++|+|. ++...+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEEC-SSSCEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEEC-CCCCEEEccCCCceecc
Confidence 9999999999998 77778899999999999999999999998 88 99999999999998 78999999999997533
Q ss_pred c--CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 182 Q--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 182 ~--~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
. ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.. .+...+...+..... .++...+++++
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~ 377 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLGPEAK 377 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHH
Confidence 2 23456789999999998864 589999999999999999999999987 455666666655432 34556789999
Q ss_pred HHHHHccc-CCCCCC-----CHHHHhcCCCcccCCCCccccCCC
Q 006810 259 QFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 296 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~~~l 296 (630)
+||.+||. +|.+|| ++.|+|+||||...++..+....+
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~ 421 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL 421 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcC
Confidence 99999998 899999 999999999999887766544433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=388.21 Aligned_cols=257 Identities=22% Similarity=0.421 Sum_probs=210.6
Q ss_pred CCcceeeeeEeccc--CceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 23 SCRYGRYDEILGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G--~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
.+|| ++.+.||+| +||+||+|.+..+|..||+|++..... .....+.+.+|+.+|+.++|||||+++++|.+.
T Consensus 24 ~~~y-~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 98 (389)
T 3gni_B 24 GGCY-ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-- 98 (389)
T ss_dssp GGGE-EEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred CCcE-EEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC--
Confidence 3556 889999999 999999999999999999999986543 356677889999999999999999999999765
Q ss_pred CEEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 101 RTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccccc
Confidence 4699999999999998 55544 67999999999999999999999999 99999999999998 7899999999988
Q ss_pred eeecc---------CCCccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC
Q 006810 178 IVMQQ---------PTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 245 (630)
Q Consensus 178 ~~~~~---------~~~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~ 245 (630)
..... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+......+...+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 54321 12233578999999998865 5899999999999999999999999875554444333221100
Q ss_pred -------------------------------------------CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCC
Q 006810 246 -------------------------------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 281 (630)
Q Consensus 246 -------------------------------------------p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hp 281 (630)
...+....++.+++||.+||+ +|.+|||+.|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 112334567899999999998 899999999999999
Q ss_pred CcccCC
Q 006810 282 FLVTDN 287 (630)
Q Consensus 282 f~~~~~ 287 (630)
||+...
T Consensus 336 ~f~~~~ 341 (389)
T 3gni_B 336 FFKQIK 341 (389)
T ss_dssp GGGGC-
T ss_pred HHHHHh
Confidence 998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=365.09 Aligned_cols=258 Identities=26% Similarity=0.473 Sum_probs=219.7
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
-.++| ++.+.||+|+||+||+|.+..+|..||+|++..... .....+.+.+|+.++++++||||+++++++.+. .
T Consensus 4 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 78 (284)
T 3kk8_A 4 FSDNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--S 78 (284)
T ss_dssp TTTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred hhhhh-hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--C
Confidence 45677 888999999999999999999999999999976543 455667899999999999999999999998654 4
Q ss_pred EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGla~ 178 (630)
..++||||+++|+|. ++.....+++..++.++.||+.||.|||+++ |+||||||+||+++. .++.+||+|||++.
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 689999999999997 7777888999999999999999999999999 999999999999972 23459999999997
Q ss_pred eeccCC-CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCc
Q 006810 179 VMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD 254 (630)
Q Consensus 179 ~~~~~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s 254 (630)
...... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+.......+..+.. +.......+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T 3kk8_A 157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVT 235 (284)
T ss_dssp ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhcccC
Confidence 665433 345679999999998765 589999999999999999999999987 455566666655533 223334678
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 999999999998 899999999999999998644
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=401.79 Aligned_cols=260 Identities=19% Similarity=0.363 Sum_probs=216.2
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.++||+|+||+||+|.++.+|+.||+|++....... ......+.+|+.++..++||||++++++|.+. ..+
T Consensus 74 ~~y-~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~~ 149 (437)
T 4aw2_A 74 EDF-EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDD--NNL 149 (437)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS--SEE
T ss_pred hhe-EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CEE
Confidence 455 78899999999999999999999999999997532211 11223478899999999999999999998764 469
Q ss_pred EEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
|+||||+++|+|. ++.. .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~-~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEc-CCCCEEEcchhhhhhcc
Confidence 9999999999998 5555 578999999999999999999999999 99999999999998 78999999999997654
Q ss_pred cCC---CccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC---CCCCCC
Q 006810 182 QPT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASL 249 (630)
Q Consensus 182 ~~~---~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g---~~p~~l 249 (630)
... ....+||+.|+|||++. +.|+.++|||||||++|||+||+.||.+ .+....+..+... ...+..
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~ 305 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQ 305 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCSS
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCCcc
Confidence 332 23468999999999875 3589999999999999999999999987 4566666665432 122223
Q ss_pred CCCCcHHHHHHHHHccc-CCCC--CCCHHHHhcCCCcccCCCCcc
Q 006810 250 SKVTDPQVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 250 ~~~~s~~lk~~I~kcL~-~p~~--Rpsa~eLL~hpf~~~~~~~~~ 291 (630)
....++++++||.+||. +|.+ |+++.|+++||||+..++..+
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 34578999999999997 4555 899999999999999888765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=374.45 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=202.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
+|| ++.+.||+|+||+||+|.+ .+|..||+|++...... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~y-~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 75 (288)
T 1ob3_A 2 EKY-HGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRL 75 (288)
T ss_dssp CSE-EEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCE
T ss_pred ccc-hhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc--cccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeE
Confidence 467 7789999999999999998 68999999999754321 22235678999999999999999999998755 468
Q ss_pred EEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||+.+ +|. ++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFG 151 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHC
T ss_pred EEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEeECccccccC
Confidence 999999997 565 4443 478999999999999999999999999 99999999999998 78999999999997654
Q ss_pred cC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCC-C---------
Q 006810 182 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-P--------- 246 (630)
Q Consensus 182 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~-p--------- 246 (630)
.. ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+......+...... +.. .
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 32 2334578999999998854 4899999999999999999999999875544444433321 100 0
Q ss_pred ---------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 ---------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 ---------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..+....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 01123467899999999998 89999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=385.47 Aligned_cols=262 Identities=29% Similarity=0.488 Sum_probs=219.6
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
+...+|..+| ++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+.+|+.+|++++||||++++++|.
T Consensus 47 ~~~~~~~~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 47 FFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp CCCSCHHHHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcccchhhhe-eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4456677777 777899999999999999999999999999976532 23445577899999999999999999999987
Q ss_pred cCCCCEEEEEEcccCCCCHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 97 DDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
+. ..+++||||+.|+.+..+ .....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 125 ~~--~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG 199 (348)
T 1u5q_A 125 RE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFG 199 (348)
T ss_dssp ET--TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCT
T ss_pred EC--CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEeecc
Confidence 65 468999999986544544 45678999999999999999999999999 99999999999998 78999999999
Q ss_pred cceeeccCCCccccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 176 LAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 176 la~~~~~~~~~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
++..... .....||+.|+|||++. +.++.++|||||||++|||+||+.||........+. .+..+..+.....
T Consensus 200 ~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 276 (348)
T 1u5q_A 200 SASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSG 276 (348)
T ss_dssp TCBSSSS--BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCCCCCCT
T ss_pred CceecCC--CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCCC
Confidence 9976543 24567999999999873 468999999999999999999999998754444444 4444444444556
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
..++.+++||.+||. +|.+|||+.++|+||||....+
T Consensus 277 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 277 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 678999999999998 8999999999999999986543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=383.60 Aligned_cols=264 Identities=26% Similarity=0.396 Sum_probs=205.1
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
.......+|| ++.+.||+|+||+||+|.+..+|..||+|++..... .......+.+|+.+|++++||||+++++++.
T Consensus 27 ~~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 27 APSATSIDRY-RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp -----CGGGE-EEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred CCcccchhhE-EEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3455566788 788999999999999999999999999999975532 2334566789999999999999999999987
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe----CCCCcEEE
Q 006810 97 DDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN----GNNGEVKI 171 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~----~~~g~vKL 171 (630)
+. ..+++||||+.+ +|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..++.+||
T Consensus 104 ~~--~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 104 HN--HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp ET--TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEE
T ss_pred cC--CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEE
Confidence 65 468999999996 665 8888889999999999999999999999999 99999999999995 24556999
Q ss_pred cccccceeeccC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CCC
Q 006810 172 GDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKP 246 (630)
Q Consensus 172 ~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g-~~p 246 (630)
+|||++...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...+... ..+
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 179 GDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258 (329)
T ss_dssp CCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence 999999765432 2344578999999998864 48999999999999999999999998865555554444321 111
Q ss_pred C-CC-------------------------CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 247 A-SL-------------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 247 ~-~l-------------------------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
. .+ ....++++++||.+||. +|.+|||+.|+|+||||+..++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 0 00 01157899999999998 8999999999999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=378.43 Aligned_cols=257 Identities=29% Similarity=0.530 Sum_probs=216.7
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
.+|..+| ...+.||+|+||+||+|.+..+|..||+|++..... ...+.+.+|+.+++.++||||++++++|...
T Consensus 41 ~~~~~~~-~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 114 (321)
T 2c30_A 41 GDPRLLL-DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVG- 114 (321)
T ss_dssp SCHHHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-
T ss_pred CCchhhh-hccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-
Confidence 3444445 566899999999999999999999999999975432 2345688999999999999999999998765
Q ss_pred CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 100 NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++||||+++|+|........+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 115 -~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~ 190 (321)
T 2c30_A 115 -EELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQ 190 (321)
T ss_dssp -TEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEE
T ss_pred -CEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCcEEEeeeeeeee
Confidence 46899999999999995556678999999999999999999999999 99999999999998 789999999999976
Q ss_pred eccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcH
Q 006810 180 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDP 255 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~-~l~~~~s~ 255 (630)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..+....+.....+. ......++
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2c30_A 191 ISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSP 269 (321)
T ss_dssp CCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSCH
T ss_pred cccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCCH
Confidence 6543 2345689999999998864 589999999999999999999999987 45556666665554332 22334678
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.+++||.+||. +|.+||++.++|.||||....
T Consensus 270 ~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 270 VLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 99999999998 899999999999999998654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=385.40 Aligned_cols=258 Identities=24% Similarity=0.401 Sum_probs=203.2
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
....+|| ++.+.||+|+||+||+|.+..+|+.||+|++...... .+.+.+|+.+++.++||||++++++|.+.
T Consensus 16 ~~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 88 (361)
T 3uc3_A 16 MHDSDRY-DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQREIINHRSLRHPNIVRFKEVILTP- 88 (361)
T ss_dssp CCCTTTE-EEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-----CHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred CCCCCcE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-----cHHHHHHHHHHHhCCCCCCCcEEEEEeeC-
Confidence 3445788 8889999999999999999999999999999754321 24578999999999999999999998754
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC--cEEEccccc
Q 006810 100 NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGL 176 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g--~vKL~DFGl 176 (630)
..+++||||+++|+|. ++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++ .+||+|||+
T Consensus 89 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~-~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 89 -THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLD-GSPAPRLKICDFGY 164 (361)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEEC-SSSSCCEEECCCCC
T ss_pred -CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCceEEEeecCc
Confidence 4689999999999998 7777788999999999999999999999999 99999999999997 444 499999999
Q ss_pred ceeecc-CCCccccCCCCCCCcccccc-ccCc-ccceeehhHHHHHHhhCCCCCCCCCCH---HHHHHHHHcCCCCCCCC
Q 006810 177 AIVMQQ-PTARSVIGTPEFMAPELYEE-EYNE-LVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLS 250 (630)
Q Consensus 177 a~~~~~-~~~~~~~GTp~Y~APEvl~~-~ys~-~sDIWSLGvil~ELltG~~Pf~~~~~~---~~i~~~i~~g~~p~~l~ 250 (630)
++.... ......+||+.|+|||++.+ .++. ++|||||||++|+|++|+.||...... ..+...+..........
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (361)
T 3uc3_A 165 SKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244 (361)
T ss_dssp C---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT
T ss_pred cccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc
Confidence 974432 23345679999999998764 4554 489999999999999999999764332 33444444433322233
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
...++.+++||.+||+ +|.+|||+.|+|+||||....+
T Consensus 245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 3568999999999998 8999999999999999976543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=392.46 Aligned_cols=264 Identities=24% Similarity=0.428 Sum_probs=216.4
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHH-HHhCCCCCeeEEEeEEEcCCCCE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~i-L~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
++| ++.++||+|+||.||+|.++.+|..||+|++....... ......+.+|..+ ++.++||||++++++|.+. ..
T Consensus 38 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--~~ 113 (373)
T 2r5t_A 38 SDF-HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DK 113 (373)
T ss_dssp GGE-EEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECS--SE
T ss_pred hhe-EEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--CE
Confidence 345 78899999999999999999999999999998765432 3344556777776 5788999999999998764 47
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+|+||||++||+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCBCGGGB
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEeeCccccccc
Confidence 99999999999998 7777888999999999999999999999999 99999999999998 78999999999997532
Q ss_pred --cCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 182 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 182 --~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.. .+...++..+..+ +..++...++.++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~ 267 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNK--PLQLKPNITNSAR 267 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHS--CCCCCSSSCHHHH
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhc--ccCCCCCCCHHHH
Confidence 234456789999999998865 589999999999999999999999987 5666677766654 2334566789999
Q ss_pred HHHHHccc-CCCCCCCH----HHHhcCCCcccCCCCccccCCCC
Q 006810 259 QFIEKCIV-PASLRLPA----LELLKDPFLVTDNPKDLVCDPLR 297 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa----~eLL~hpf~~~~~~~~~~~~~l~ 297 (630)
+||.+||+ +|.+||++ .+++.||||+..++..+....+.
T Consensus 268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~ 311 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKIT 311 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred HHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCC
Confidence 99999997 89999997 68999999999888776554443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=398.27 Aligned_cols=260 Identities=20% Similarity=0.373 Sum_probs=216.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.++||+|+||.||+|.++.+|+.||+|+++..... .....+.+.+|..+|..++||||++++++|.+. ..+
T Consensus 61 ~~f-~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~~ 136 (412)
T 2vd5_A 61 DDF-EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQDE--NYL 136 (412)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS--SEE
T ss_pred hhE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEE
Confidence 455 7889999999999999999999999999999753321 122334578899999999999999999998765 479
Q ss_pred EEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
|+||||+++|+|. ++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld-~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeec-CCCCEEEeechhheecc
Confidence 9999999999998 55554 58999999999999999999999999 99999999999998 78999999999998765
Q ss_pred cCC---CccccCCCCCCCccccc--------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC---CCCC
Q 006810 182 QPT---ARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPA 247 (630)
Q Consensus 182 ~~~---~~~~~GTp~Y~APEvl~--------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g---~~p~ 247 (630)
... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.. .+....+..+... ...+
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCC
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCCC
Confidence 432 23468999999999886 3589999999999999999999999987 4556666555532 2222
Q ss_pred CCCCCCcHHHHHHHHHcccCCCCC---CCHHHHhcCCCcccCCCCcc
Q 006810 248 SLSKVTDPQVKQFIEKCIVPASLR---LPALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 248 ~l~~~~s~~lk~~I~kcL~~p~~R---psa~eLL~hpf~~~~~~~~~ 291 (630)
.+....++++++||.+||.+|.+| +++.|+++||||+..++..+
T Consensus 293 ~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp ----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred ccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 234567899999999999988777 59999999999999888765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=387.25 Aligned_cols=255 Identities=25% Similarity=0.449 Sum_probs=210.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~-~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
++| ++.+.||+|+||+||+|.++.+|..||+|++........ ....+.+.+|+.+++.++||||++++++|.+. ..
T Consensus 24 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 100 (351)
T 3c0i_A 24 DVY-ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GM 100 (351)
T ss_dssp HHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred cce-EEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 456 888999999999999999999999999999975432211 11346688999999999999999999998764 46
Q ss_pred EEEEEcccCCCCHH-HHhh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCcEEEcccc
Q 006810 103 INMITELFTSGSLR-YRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLG 175 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFG 175 (630)
+|+||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999996 3332 345899999999999999999999999 999999999999972 23359999999
Q ss_pred cceeeccCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC--CCC
Q 006810 176 LAIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLS 250 (630)
Q Consensus 176 la~~~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~--~l~ 250 (630)
++....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ ....++..+..+.... ...
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCCHHHH
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCCcccc
Confidence 998765432 345689999999998865 589999999999999999999999986 3455556555543321 112
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
...++.+++||.+||. +|.+||++.++|+||||+.
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 4568899999999997 8999999999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=366.44 Aligned_cols=252 Identities=23% Similarity=0.408 Sum_probs=215.9
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.+|| ++.+.||+|+||+||+|.+..++..||+|.+..... ...+.+.+|+.++++++||||++++++|.+. ..
T Consensus 8 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (277)
T 3f3z_A 8 NQYY-TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDN--TD 80 (277)
T ss_dssp HHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred hhhE-EeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Ce
Confidence 3455 889999999999999999999999999999975432 2245688999999999999999999998654 56
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEE---eCCCCcEEEcccccce
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAI 178 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl---~~~~g~vKL~DFGla~ 178 (630)
+++||||+++++|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+||++ + .++.+||+|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDS-PDSPLKLIDFGLAA 157 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSS-TTCCEEECCCTTCE
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCC-CCCcEEEEecccce
Confidence 89999999999997 7777888999999999999999999999999 9999999999999 4 67899999999997
Q ss_pred eeccC-CCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcH
Q 006810 179 VMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDP 255 (630)
Q Consensus 179 ~~~~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~--l~~~~s~ 255 (630)
..... ......||+.|+|||++.+.++.++||||||+++|+|+||+.||... +.......+..+..+.. .....++
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAP-TDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred eccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 66543 34556799999999999888999999999999999999999999874 45555555555433221 1225678
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.+++||.+||. +|.+||++.++|+||||+.
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 99999999998 8999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=400.94 Aligned_cols=255 Identities=27% Similarity=0.380 Sum_probs=204.2
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC---
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~--- 99 (630)
.+|| ++.+.||+|+||+||+|.+..+|..||+|++.... .......++.+|+.+|+.++||||++++++|....
T Consensus 61 ~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 61 LKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp ETTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred cCCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 3567 77899999999999999999999999999997542 34566778999999999999999999999986543
Q ss_pred -CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 -NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 -~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
...+|+||||+.++.+..+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++
T Consensus 138 ~~~~~~lv~E~~~~~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~-~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 138 EFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 212 (464)
T ss_dssp TCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCCC-
T ss_pred cCCeEEEEEeCCCCCHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEe-CCCCEEEEEEEeee
Confidence 24689999999988666543 35999999999999999999999999 99999999999998 78999999999998
Q ss_pred eeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCCCC--------
Q 006810 179 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA-------- 247 (630)
Q Consensus 179 ~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p~-------- 247 (630)
..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.. +.++.
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred ecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 66543 3455789999999998764 6999999999999999999999999885544444433321 11000
Q ss_pred ----------CCCC--------------------CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 248 ----------SLSK--------------------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 248 ----------~l~~--------------------~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.... ..++++++||.+||+ +|.+|||+.|+|+||||..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 0000 015679999999998 8999999999999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=391.85 Aligned_cols=255 Identities=28% Similarity=0.462 Sum_probs=211.4
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
-.|+| ++.+.||+|+||+||+|.+..+|..||+|++....... .....++.+|+.+|+.++||||+++++++... .
T Consensus 7 ~i~~Y-~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~ 82 (336)
T 3h4j_B 7 HIGPY-IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVEREISYLKLLRHPHIIKLYDVITTP--T 82 (336)
T ss_dssp EETTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--S
T ss_pred ccCCE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc-hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--C
Confidence 45788 88999999999999999999999999999997532211 12235688999999999999999999998754 4
Q ss_pred EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 102 TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
.+++||||+ +|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEEC-TTCCEEECCSSCTBTT
T ss_pred EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEc-CCCCEEEEEeccceec
Confidence 689999999 45665 7888889999999999999999999999999 99999999999998 7899999999999765
Q ss_pred ccC-CCccccCCCCCCCccccccc-c-CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 181 QQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 181 ~~~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
... .....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+... ..+...+..+ ...++...++.+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~i~~~--~~~~p~~~s~~~ 235 (336)
T 3h4j_B 159 TDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-PNLFKKVNSC--VYVMPDFLSPGA 235 (336)
T ss_dssp TTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS-TTCBCCCCSS--CCCCCTTSCHHH
T ss_pred cCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH-HHHHHHHHcC--CCCCcccCCHHH
Confidence 443 34566899999999988754 3 7899999999999999999999976322 2222222211 223455678999
Q ss_pred HHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 258 KQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
++||.+||. +|.+|||+.|+++||||+...
T Consensus 236 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 236 QSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 999999997 899999999999999998643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=371.99 Aligned_cols=257 Identities=22% Similarity=0.394 Sum_probs=207.7
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
+|| ++.+.||+|+||+||+|.+..+|..||+|++.... ......+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 3 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 77 (311)
T 4agu_A 3 EKY-EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRL 77 (311)
T ss_dssp CCE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred ccc-eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeE
Confidence 567 78899999999999999999999999999986543 3345567788999999999999999999998754 468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+++++|. +....+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC-
T ss_pred EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEc-CCCCEEEeeCCCchhccC
Confidence 9999999999998 6666788999999999999999999999999 99999999999998 789999999999976653
Q ss_pred C--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc--C-------------
Q 006810 183 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--G------------- 243 (630)
Q Consensus 183 ~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~--g------------- 243 (630)
. ......||+.|+|||++.+ .++.++|||||||++|+|+||..||.+............. .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 3 2345678999999998764 5799999999999999999999999875544443322211 0
Q ss_pred ----CC---CCCC------CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 244 ----IK---PASL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 244 ----~~---p~~l------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
.. +... ....++.+.+||.+||. +|.+|||+.++|+||||+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 00 0000 13467889999999998 8999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=369.29 Aligned_cols=254 Identities=23% Similarity=0.423 Sum_probs=212.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|+||+||+|.+..+|..||+|++...... .......+.+|+.+++.++||||++++++|.+. ..+
T Consensus 9 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 84 (279)
T 3fdn_A 9 EDF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRV 84 (279)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred ccE-EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CEE
Confidence 566 8889999999999999999999999999998654321 112245688999999999999999999998654 468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+++|+|. ++.....+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEEC-TTSCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEc-CCCCEEEEeccccccCCc
Confidence 9999999999998 7777788999999999999999999999999 99999999999997 789999999999876655
Q ss_pred CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 183 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 183 ~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+.... ..++...++.+++||
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 238 (279)
T 3fdn_A 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVE--FTFPDFVTEGARDLI 238 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTC--CCCCTTSCHHHHHHH
T ss_pred ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCC--CCCCCcCCHHHHHHH
Confidence 55556789999999998865 478899999999999999999999986 45555666655542 234556789999999
Q ss_pred HHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 262 EKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.+||. +|.+||++.++|+||||+...
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHhccChhhCCCHHHHhhCccccCCc
Confidence 99997 899999999999999998643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=387.11 Aligned_cols=273 Identities=23% Similarity=0.331 Sum_probs=213.1
Q ss_pred CCCccCCccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCee
Q 006810 10 SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89 (630)
Q Consensus 10 ~~~~~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIV 89 (630)
+...+..+....-.+|| ++.+.||+|+||+||+|.+..+|..||+|++... ........++.+|+.+|+.++||||+
T Consensus 12 ~~~~~Q~~~~~~i~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv 88 (432)
T 3n9x_A 12 ENLYFQGIKNVHVPDNY-IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--FEDLIDCKRILREITILNRLKSDYII 88 (432)
T ss_dssp CCCCTTCGGGCCCCTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECST--TTSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhcCCCcceecCCE-EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch--hcChHHHHHHHHHHHHHHHcCCCCcc
Confidence 34444555566667788 8899999999999999999999999999999643 23456678899999999999999999
Q ss_pred EEEeEEEcCCC---CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC
Q 006810 90 KFYNSWVDDTN---RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 165 (630)
Q Consensus 90 k~~~~f~d~~~---~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 165 (630)
++++++..... ..+|+||||+.+ +|. ++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .
T Consensus 89 ~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~ 164 (432)
T 3n9x_A 89 RLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN-Q 164 (432)
T ss_dssp CEEEECCCSCTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-T
T ss_pred eEEEEEecCCCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEEC-C
Confidence 99999876532 468999999885 676 7777788999999999999999999999999 99999999999998 7
Q ss_pred CCcEEEcccccceeeccC------------------------CCccccCCCCCCCcccc-c-cccCcccceeehhHHHHH
Q 006810 166 NGEVKIGDLGLAIVMQQP------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILE 219 (630)
Q Consensus 166 ~g~vKL~DFGla~~~~~~------------------------~~~~~~GTp~Y~APEvl-~-~~ys~~sDIWSLGvil~E 219 (630)
+|.+||+|||+++..... .....+||+.|+|||++ . ..|+.++|||||||++||
T Consensus 165 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~e 244 (432)
T 3n9x_A 165 DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244 (432)
T ss_dssp TCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHH
Confidence 899999999999765432 12456899999999975 3 459999999999999999
Q ss_pred HhhCCC-----------CCCCCCC-----------------HHHHHHH-----------------------HHcCCC--C
Q 006810 220 MVTCEY-----------PYNECKN-----------------PAQIYKK-----------------------VTSGIK--P 246 (630)
Q Consensus 220 LltG~~-----------Pf~~~~~-----------------~~~i~~~-----------------------i~~g~~--p 246 (630)
|++|.. +|.+... ..++... +..... +
T Consensus 245 ll~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (432)
T 3n9x_A 245 LLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324 (432)
T ss_dssp HHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCC
T ss_pred HHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCC
Confidence 998433 3333110 1111111 111000 0
Q ss_pred CC---CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCC
Q 006810 247 AS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 289 (630)
Q Consensus 247 ~~---l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~ 289 (630)
.. .....++++++||.+||+ +|.+|||+.|+|+||||+.....
T Consensus 325 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred CCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 00 113468999999999998 89999999999999999876543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=401.90 Aligned_cols=258 Identities=31% Similarity=0.490 Sum_probs=222.1
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.+|| ++.++||+|+||+||+|.+..+|..||+|++....... ....+.+.+|+.+|++++||||++++++|.+. ..
T Consensus 25 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 100 (484)
T 3nyv_A 25 SDRY-KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--GY 100 (484)
T ss_dssp HHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred cCce-EEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 4566 88899999999999999999999999999997654322 23456789999999999999999999998654 57
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe--CCCCcEEEccccccee
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIV 179 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKL~DFGla~~ 179 (630)
+++||||+.+|+|. ++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ ..++.+||+|||++..
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999997 7778889999999999999999999999999 99999999999995 2578999999999976
Q ss_pred eccC-CCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHH
Q 006810 180 MQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQ 256 (630)
Q Consensus 180 ~~~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~--l~~~~s~~ 256 (630)
.... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+...+...+..+..... .....++.
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred cccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 5543 3345679999999999998999999999999999999999999987 556666777766644322 22456899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+++||.+||+ +|.+|||+.++|+||||+...
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 9999999998 899999999999999998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=398.98 Aligned_cols=254 Identities=28% Similarity=0.469 Sum_probs=213.9
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||+||+|.++.+|..||+|++....... .....+.+|+.+|+.++||||++++++|.+. ..++
T Consensus 38 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 112 (494)
T 3lij_A 38 MY-QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK--RNYY 112 (494)
T ss_dssp HE-EEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred Ce-EEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEE
Confidence 45 78899999999999999999999999999997654322 2245688999999999999999999998654 5689
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCcEEEcccccceeec
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGla~~~~ 181 (630)
+||||+++|+|. ++.....+++..++.|++||+.||.|||+++ |+||||||+|||++. .++.+||+|||++....
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999997 7777788999999999999999999999999 999999999999973 24569999999998765
Q ss_pred cC-CCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHHHH
Q 006810 182 QP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVK 258 (630)
Q Consensus 182 ~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~s~~lk 258 (630)
.. .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+...+...+..+..+ .......++.++
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred CCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 43 3455689999999999988899999999999999999999999987 4566666766665433 222345789999
Q ss_pred HHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 259 QFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+||.+||+ +|.+|||+.++|+||||+..
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 99999998 89999999999999999763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=401.13 Aligned_cols=260 Identities=31% Similarity=0.498 Sum_probs=220.4
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
..-.+|| ++.+.||+|+||+||+|.+..+|..||+|++....... .....+.+|+.+|++++||||+++++++.+.
T Consensus 18 g~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 93 (486)
T 3mwu_A 18 GTFAERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDS- 93 (486)
T ss_dssp CHHHHHE-EEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred CChhcce-EEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-
Confidence 3445667 88899999999999999999999999999997543322 2346688999999999999999999998654
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCcEEEccccc
Q 006810 100 NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGL 176 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGl 176 (630)
..+++||||+.+|+|. .+...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||+
T Consensus 94 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 94 -SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred -CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 5799999999999997 7777789999999999999999999999999 999999999999962 456899999999
Q ss_pred ceeeccC-CCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCC
Q 006810 177 AIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVT 253 (630)
Q Consensus 177 a~~~~~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l--~~~~ 253 (630)
+...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|+.||.+ .+...+...+..+..+... ....
T Consensus 171 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 249 (486)
T 3mwu_A 171 STCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTI 249 (486)
T ss_dssp TTTBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGS
T ss_pred CeECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCC
Confidence 9765443 3345689999999999999999999999999999999999999987 5566666777666443322 2456
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 250 s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 8999999999998 899999999999999998643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=384.45 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=215.2
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
+..++| ++.+.||+|+||+||+|.+..+|..||+|++.... ......+.+|+.+|+.++||||++++++|.+.
T Consensus 48 ~~~~~y-~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-- 120 (387)
T 1kob_A 48 SVYDYY-DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-- 120 (387)
T ss_dssp CGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--
T ss_pred ccccce-EEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--
Confidence 334455 88899999999999999999999999999997432 34456788999999999999999999998654
Q ss_pred CEEEEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC-CCCcEEEcccccc
Q 006810 101 RTINMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLA 177 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~DFGla 177 (630)
..+++||||+.+|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||++
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccc
Confidence 5799999999999998 44433 47999999999999999999999999 999999999999973 3578999999999
Q ss_pred eeeccCC-CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCC
Q 006810 178 IVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVT 253 (630)
Q Consensus 178 ~~~~~~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~ 253 (630)
....... .....||+.|+|||++.+ .++.++|||||||++|+|+||..||.+. +.......+..... +.......
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 277 (387)
T 1kob_A 199 TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-DDLETLQNVKRCDWEFDEDAFSSV 277 (387)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHCCCCCCSSTTTTS
T ss_pred eecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCccccccC
Confidence 8765432 344579999999998865 5899999999999999999999999874 44455555554322 23334567
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 278 s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 8999999999997 899999999999999998643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=373.16 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=202.5
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC-HHHHHHHHHHHHHHHhC---CCCCeeEEEeEEEc
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSL---KHENIIKFYNSWVD 97 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~-~~~~~~l~~Ei~iL~~L---~HpNIVk~~~~f~d 97 (630)
..+|| ++.+.||+|+||+||+|.+..+|..||+|++........ ......+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 7 ATSRY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ---CC-EEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred cccce-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 35678 888999999999999999999999999999975432111 11123355666666655 59999999999876
Q ss_pred CCCC---EEEEEEcccCCCCHH-HHhhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEE
Q 006810 98 DTNR---TINMITELFTSGSLR-YRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 171 (630)
Q Consensus 98 ~~~~---~l~lV~Ey~~gGsL~-~~~~~~~--lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 171 (630)
.... .+++||||+.+ +|. ++..... +++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEEC-TTSCEEE
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEE
Confidence 5432 58899999985 776 6555443 999999999999999999999999 99999999999997 7899999
Q ss_pred cccccceeeccC-CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCCC-C
Q 006810 172 GDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP-A 247 (630)
Q Consensus 172 ~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p-~ 247 (630)
+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+...+.. +..+ .
T Consensus 162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 999999765543 334568999999999875 46899999999999999999999999875444443333321 1111 1
Q ss_pred C----------------------CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 248 S----------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 248 ~----------------------l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
. .....++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 1 113467899999999998 899999999999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=399.01 Aligned_cols=258 Identities=29% Similarity=0.442 Sum_probs=217.0
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC---------HHHHHHHHHHHHHHHhCCCCCeeEEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS---------PDQLERLYSEVHLLKSLKHENIIKFY 92 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~---------~~~~~~l~~Ei~iL~~L~HpNIVk~~ 92 (630)
-.++| ++.+.||+|+||+||+|.++.+|..||+|++........ ....+.+.+|+.+|++++||||++++
T Consensus 34 i~~~Y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 34 IGESY-FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp GGGTE-EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cccce-EEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34556 788999999999999999999999999999976543211 12346788999999999999999999
Q ss_pred eEEEcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC---c
Q 006810 93 NSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---E 168 (630)
Q Consensus 93 ~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g---~ 168 (630)
++|.+. ..+++||||+++|+|. ++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ .++ .
T Consensus 113 ~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~~~ 187 (504)
T 3q5i_A 113 DVFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLE-NKNSLLN 187 (504)
T ss_dssp EEEECS--SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES-STTCCSS
T ss_pred EEEEcC--CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEe-cCCCCcc
Confidence 998654 5799999999999997 7777888999999999999999999999999 99999999999997 444 6
Q ss_pred EEEcccccceeeccC-CCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC
Q 006810 169 VKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 247 (630)
Q Consensus 169 vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~ 247 (630)
+||+|||++...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+...+...+..+....
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCC
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCC
Confidence 999999999876543 3456689999999999988899999999999999999999999987 56667777777664432
Q ss_pred C--CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 248 S--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 248 ~--l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
. .....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 2 224568999999999998 89999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=362.66 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=215.1
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|+||.||+|.+..+|..||+|++..... ....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 7 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (276)
T 2yex_A 7 EDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQ 80 (276)
T ss_dssp HHE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred cce-EEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEE
Confidence 355 788999999999999999999999999999976542 23456789999999999999999999998654 468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+++|+|. ++.....+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEc-cCCCEEEeeCCCccccCC
Confidence 9999999999998 6666778999999999999999999999999 99999999999998 789999999999976543
Q ss_pred C----CCccccCCCCCCCcccccc-c-cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 183 P----TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 183 ~----~~~~~~GTp~Y~APEvl~~-~-ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
. ......||+.|+|||++.+ . ++.++||||||+++|+|++|+.||.........+..+.............++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 237 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHH
Confidence 2 2345679999999998865 3 36789999999999999999999987655545555555443332233456899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+++||.+||. +|.+|||+.++++||||+..
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 238 PLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 9999999997 89999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=384.20 Aligned_cols=257 Identities=30% Similarity=0.442 Sum_probs=207.6
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC-
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~- 100 (630)
-.+|| ++.+.||+|+||+||+|.+..+|..||+|++.... ......+++.+|+.+|+.++||||+++++++.....
T Consensus 23 ~~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 23 VRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99 (367)
T ss_dssp CBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred ecceE-EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence 34667 78899999999999999999999999999986432 345566789999999999999999999999865432
Q ss_pred ---CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 101 ---RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 101 ---~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+|+||||+ +++|..+.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 100 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLA 175 (367)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred ccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEc-CCCCEEEEeeecc
Confidence 3578999999 788985455578999999999999999999999999 99999999999998 7899999999999
Q ss_pred eeeccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCCC--------
Q 006810 178 IVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP-------- 246 (630)
Q Consensus 178 ~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p-------- 246 (630)
+..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.. +..+
T Consensus 176 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 176 RQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp EECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred cccccc-cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 875443 345688999999998764 5899999999999999999999999875544444333221 1110
Q ss_pred -------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 -------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 -------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..+....++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 11234568999999999998 89999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=372.27 Aligned_cols=258 Identities=22% Similarity=0.362 Sum_probs=205.7
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 100 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~ 100 (630)
-..+|...+++||+|+||+||+|.+..+|..||+|++.... .....++.+|+.+|+++ +||||++++++|.+.
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-- 83 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-- 83 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--
Confidence 34567333588999999999999999999999999997542 22345688999999985 799999999998765
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc---EEEccccc
Q 006810 101 RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE---VKIGDLGL 176 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~---vKL~DFGl 176 (630)
..+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++. +||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCE-HPNQVSPVKICDFDL 160 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEES-CSSSSCSEEECCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEc-cCCCcCceEEEEccC
Confidence 4799999999999998 7777788999999999999999999999999 99999999999997 4444 99999999
Q ss_pred ceeeccC---------CCccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCC---------
Q 006810 177 AIVMQQP---------TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKN--------- 232 (630)
Q Consensus 177 a~~~~~~---------~~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~--------- 232 (630)
+...... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 8654321 123456999999999875 3489999999999999999999999976432
Q ss_pred -----HHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 233 -----PAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 233 -----~~~i~~~i~~g~~p~~--l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
...+...+..+..... .....++.+++||.+||. +|.+|||+.|+|+||||+...+
T Consensus 241 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 2345555555433211 113467899999999998 8999999999999999986543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=378.83 Aligned_cols=265 Identities=24% Similarity=0.373 Sum_probs=211.9
Q ss_pred CccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEE
Q 006810 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (630)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f 95 (630)
.....+..+|| ++.+.||+|+||+||+|.+..+|..||+|++...... ......+.+|+.+|+.++||||+++++++
T Consensus 9 ~~~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 85 (351)
T 3mi9_A 9 ECPFCDEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEIC 85 (351)
T ss_dssp CCTTSCBGGGE-EEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SSSCHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccccce-eEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--ccchHHHHHHHHHHHhccCCCcccHhhee
Confidence 34445667888 7789999999999999999999999999998655432 22334578999999999999999999998
Q ss_pred EcCC------CCEEEEEEcccCCCCHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc
Q 006810 96 VDDT------NRTINMITELFTSGSLRY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 168 (630)
Q Consensus 96 ~d~~------~~~l~lV~Ey~~gGsL~~-~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 168 (630)
.... ...+++||||+.++.+.. ......+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.
T Consensus 86 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~-~~~~ 162 (351)
T 3mi9_A 86 RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGV 162 (351)
T ss_dssp EEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSC
T ss_pred eccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCC
Confidence 7653 357899999999865554 344567999999999999999999999999 99999999999998 7899
Q ss_pred EEEcccccceeeccC------CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 006810 169 VKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 240 (630)
Q Consensus 169 vKL~DFGla~~~~~~------~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i 240 (630)
+||+|||++...... ......||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+......+....
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999999999765421 2234578999999998764 48999999999999999999999998754333332222
Q ss_pred H--cCCCCCCCCCC---------------------------CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 241 T--SGIKPASLSKV---------------------------TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 241 ~--~g~~p~~l~~~---------------------------~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
. ....+..++.. .++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 1 12222211111 26789999999998 89999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=376.51 Aligned_cols=254 Identities=24% Similarity=0.422 Sum_probs=213.1
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCeeEEEeEEEcCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTN 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pNIVk~~~~f~d~~~ 100 (630)
.++.|++.+.||+|+||+||+|.+. +|..||+|++.... ......+.+.+|+.+|+.++| |||+++++++.+.
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-- 81 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-- 81 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC--
Confidence 4555699999999999999999884 68999999998654 245666789999999999987 9999999998754
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++||| +.+|+|. ++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ +|.+||+|||++..
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~--~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQ 156 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSSCC
T ss_pred CEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE--CCcEEEeecccccc
Confidence 57999999 5677887 7788889999999999999999999999999 99999999999996 67999999999976
Q ss_pred eccCC----CccccCCCCCCCccccc------------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Q 006810 180 MQQPT----ARSVIGTPEFMAPELYE------------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 243 (630)
Q Consensus 180 ~~~~~----~~~~~GTp~Y~APEvl~------------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g 243 (630)
..... ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||....+.......+...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 64332 23567999999999875 457889999999999999999999998766665656666655
Q ss_pred CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 244 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 244 ~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.....++...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 55556677778999999999998 89999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=379.16 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=202.4
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|+||+||+|.+..+|+.||+|++.... ..+.+.+|+.+|++++||||++++++|.+. ..+
T Consensus 53 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 123 (349)
T 2w4o_A 53 DFF-EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TEI 123 (349)
T ss_dssp GTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred CcE-EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecC--CeE
Confidence 445 88899999999999999999999999999987432 234578899999999999999999998654 468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCcEEEcccccceee
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVM 180 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGla~~~ 180 (630)
++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||++...
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999997 7777788999999999999999999999999 999999999999962 3789999999999765
Q ss_pred ccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHH
Q 006810 181 QQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQ 256 (630)
Q Consensus 181 ~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~ 256 (630)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........++..+..+.. +..+....++.
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 443 2345679999999998875 5899999999999999999999999887666667776665533 22334567899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+++||.+||. +|.+||++.++|+||||....
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999998 899999999999999998643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=382.73 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=206.9
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC---
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--- 98 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~--- 98 (630)
..+|| ++.+.||+|+||+||+|.+..+|+.||+|++...... ..+|+.+|+.++||||++++++|...
T Consensus 5 ~~~~y-~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 5 SSKKY-SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp -CTTE-EEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccceE-EEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 35677 8899999999999999999999999999998644321 23799999999999999999998653
Q ss_pred ---------------------------------CCCEEEEEEcccCCCCHH-----HHhhcCCCCHHHHHHHHHHHHHHH
Q 006810 99 ---------------------------------TNRTINMITELFTSGSLR-----YRKKHKNVDMKAIKNWARQILRGL 140 (630)
Q Consensus 99 ---------------------------------~~~~l~lV~Ey~~gGsL~-----~~~~~~~lse~~i~~i~~QIl~gL 140 (630)
...++++||||+++ +|. +......+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 23468999999996 443 334567899999999999999999
Q ss_pred HHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-CCccccCCCCCCCcccccc--ccCcccceeehhHHH
Q 006810 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCI 217 (630)
Q Consensus 141 ~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil 217 (630)
.|||+++ |+||||||+|||++..++.+||+|||++...... ......||+.|+|||++.+ .|+.++|||||||++
T Consensus 155 ~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 155 GFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999999 9999999999999867899999999999866433 3445688999999998764 489999999999999
Q ss_pred HHHhhCCCCCCCCCCHHHHHHHHHcCCCC------------------C--------CCCCCCcHHHHHHHHHccc-CCCC
Q 006810 218 LEMVTCEYPYNECKNPAQIYKKVTSGIKP------------------A--------SLSKVTDPQVKQFIEKCIV-PASL 270 (630)
Q Consensus 218 ~ELltG~~Pf~~~~~~~~i~~~i~~g~~p------------------~--------~l~~~~s~~lk~~I~kcL~-~p~~ 270 (630)
|+|++|+.||.+.....++...+.....| . .++...++++++||.+||+ +|.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999999866555555544321110 0 1234467899999999998 8999
Q ss_pred CCCHHHHhcCCCccc
Q 006810 271 RLPALELLKDPFLVT 285 (630)
Q Consensus 271 Rpsa~eLL~hpf~~~ 285 (630)
|||+.|+|+||||+.
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=378.14 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=212.2
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~ 101 (630)
.++| ++.+.||+|+||+||+|.++.+|..||+|++..... ...+|+.+|.++ +||||++++++|.+. .
T Consensus 21 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~ 89 (342)
T 2qr7_A 21 TDGY-EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDG--K 89 (342)
T ss_dssp HHHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECS--S
T ss_pred cccE-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcC--C
Confidence 3456 788999999999999999999999999999975432 134678888777 799999999998654 5
Q ss_pred EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCC---CcEEEcccccc
Q 006810 102 TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLA 177 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~---g~vKL~DFGla 177 (630)
.+|+||||+.+|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+...+ +.+||+|||++
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 799999999999998 7777888999999999999999999999999 99999999999985333 35999999999
Q ss_pred eeeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCC--CCHHHHHHHHHcCCCC--CCCC
Q 006810 178 IVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKP--ASLS 250 (630)
Q Consensus 178 ~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~--~~~~~i~~~i~~g~~p--~~l~ 250 (630)
...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||... .+...+...+..+..+ ....
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 866443 3345689999999998875 4899999999999999999999999763 4567777777766443 2234
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
...++++++||.+||. +|.+||++.++|+||||..
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 5678999999999997 8999999999999999964
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=375.50 Aligned_cols=254 Identities=28% Similarity=0.524 Sum_probs=194.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||+||+|.+..+|..||+|++..... ....+.+.+|+.+|++++||||+++++++.+. ..
T Consensus 4 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 77 (317)
T 2pmi_A 4 SSQF-KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVIHTE--NK 77 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT--TE
T ss_pred ccce-eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC--Ce
Confidence 4567 778999999999999999999999999999976542 22235578999999999999999999998654 57
Q ss_pred EEEEEcccCCCCHH-HHhhc------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 103 INMITELFTSGSLR-YRKKH------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
+++||||+++ +|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 78 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg 153 (317)
T 2pmi_A 78 LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFG 153 (317)
T ss_dssp EEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCS
T ss_pred EEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEc-CCCCEEECcCc
Confidence 9999999995 665 54332 46999999999999999999999999 99999999999998 78999999999
Q ss_pred cceeeccC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCCCC---
Q 006810 176 LAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA--- 247 (630)
Q Consensus 176 la~~~~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p~--- 247 (630)
++...... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+......+...... +..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 154 LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 99876432 2345678999999998864 4899999999999999999999999875444333322221 11100
Q ss_pred ---------------------------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 248 ---------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 248 ---------------------------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
......++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 0112467899999999998 89999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=371.62 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=216.9
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~--~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
.++| ++.+.||+|+||.||+|.+..+|..||+|.+......... ...+.+.+|+.++++++||||++++++|.+.
T Consensus 11 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 87 (321)
T 2a2a_A 11 EDFY-DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-- 87 (321)
T ss_dssp HHHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred hccE-EEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 3445 8899999999999999999999999999999865432211 1346688999999999999999999998654
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC----cEEEcccc
Q 006810 101 RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLG 175 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKL~DFG 175 (630)
..+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~-~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLL-DKNIPIPHIKLIDFG 164 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CTTSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEe-cCCCCcCCEEEccCc
Confidence 5689999999999998 7777788999999999999999999999999 99999999999997 555 79999999
Q ss_pred cceeeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCC
Q 006810 176 LAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSK 251 (630)
Q Consensus 176 la~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~ 251 (630)
++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||... +.......+...... ..+..
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp TCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHTTCCCCCHHHHT
T ss_pred cceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcccccChhhhc
Confidence 99766543 3345679999999998864 5899999999999999999999999874 455555555554322 22234
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
..++.+++||.+||. +|.+|||+.++|+||||....
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 568899999999998 899999999999999998644
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=393.29 Aligned_cols=261 Identities=23% Similarity=0.376 Sum_probs=196.1
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC---
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~--- 99 (630)
.+|| ++.+.||+|+||+||+|.+..+|..||+|++... .......+++.+|+.+|+.++|||||+++++|....
T Consensus 52 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRY-EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTE-EECCC-------CEEEEEECC--CEEEEEEECST--TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCe-EEeeEeeecCCeEEEEEEECCCCcEEEEEEechh--hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 3677 8889999999999999999999999999998643 234566788999999999999999999999986543
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
...+|+||||+.+ +|. ++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++
T Consensus 129 ~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCB
T ss_pred CceEEEEEecccc-chhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEEC-CCCCEeecccccch
Confidence 2469999999865 565 7777788999999999999999999999999 99999999999998 78999999999997
Q ss_pred eeccC-----------------------------CCccccCCCCCCCcccc-c-cccCcccceeehhHHHHHHhh-----
Q 006810 179 VMQQP-----------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVT----- 222 (630)
Q Consensus 179 ~~~~~-----------------------------~~~~~~GTp~Y~APEvl-~-~~ys~~sDIWSLGvil~ELlt----- 222 (630)
..... .....+||+.|+|||++ . ..|+.++|||||||++|||+|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 65321 12345789999999975 3 459999999999999999999
Q ss_pred ------CCCCCCCCCC--------------------HHHHHHHHHc-CCC---------------------------CCC
Q 006810 223 ------CEYPYNECKN--------------------PAQIYKKVTS-GIK---------------------------PAS 248 (630)
Q Consensus 223 ------G~~Pf~~~~~--------------------~~~i~~~i~~-g~~---------------------------p~~ 248 (630)
|++||.+... ..++...+.. +.. ...
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 6677755321 1111111100 000 011
Q ss_pred CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCCc
Q 006810 249 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 290 (630)
Q Consensus 249 l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~~ 290 (630)
.....++++++||.+||+ +|.+|||+.|+|+||||+......
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 123458999999999998 899999999999999999765433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=397.90 Aligned_cols=255 Identities=28% Similarity=0.478 Sum_probs=219.8
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||.||+|.+..+|..||+|++...... ..+....+.+|+.+|+.++||||+++++++... ..
T Consensus 15 ~~~Y-~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~ 90 (476)
T 2y94_A 15 IGHY-ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SD 90 (476)
T ss_dssp ETTE-EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred ecCE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence 4667 8899999999999999999999999999999754321 122346789999999999999999999998654 46
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~-~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEe-cCCCeEEEeccchhhcc
Confidence 99999999999998 7777889999999999999999999999999 99999999999998 78999999999998765
Q ss_pred cC-CCccccCCCCCCCccccccc-c-CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 182 QP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 182 ~~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
.. .....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+ .+...++..+..+... .+...++.++
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 244 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFY--TPQYLNPSVI 244 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-SSSHHHHHHHHTTCCC--CCTTCCHHHH
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCcC--CCccCCHHHH
Confidence 43 34567899999999988764 4 6899999999999999999999987 4555666777666432 3456789999
Q ss_pred HHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 259 QFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+||.+||. +|.+|||+.+++.||||+...
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred HHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 99999997 899999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=384.62 Aligned_cols=254 Identities=24% Similarity=0.419 Sum_probs=214.6
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC--CCCeeEEEeEEEcCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDTN 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~--HpNIVk~~~~f~d~~~ 100 (630)
.++.|++.+.||+|+||+||+|.+.. |..||+|++..... .....+.+.+|+.+|+.|+ ||||+++++++...
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-- 128 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-- 128 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--
Confidence 35556889999999999999999875 99999999986543 4566788999999999996 59999999988754
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++||| +.+|+|. ++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++..
T Consensus 129 ~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~--~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 129 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQ 203 (390)
T ss_dssp SEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES--SSCEEECCCSSSCC
T ss_pred CEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE--CCeEEEEecCcccc
Confidence 46999999 5777887 7777889999999999999999999999999 99999999999995 58999999999976
Q ss_pred eccCC----CccccCCCCCCCcccccc------------ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Q 006810 180 MQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 243 (630)
Q Consensus 180 ~~~~~----~~~~~GTp~Y~APEvl~~------------~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g 243 (630)
..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||....+.......+...
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 64322 345679999999998754 58899999999999999999999998766665566666655
Q ss_pred CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 244 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 244 ~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.....++...++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 55555666678999999999998 89999999999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=378.08 Aligned_cols=260 Identities=26% Similarity=0.438 Sum_probs=208.9
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~-~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
-.+|| ++.+.||+|+||+||+|.+..+|..||+|++....... .....+.+.+|+.++++++||||++++++|.+.
T Consensus 24 ~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 100 (345)
T 3hko_A 24 LQKKY-HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE-- 100 (345)
T ss_dssp HHHHE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred hhhhe-eecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC--
Confidence 34566 88899999999999999999999999999997653221 234567899999999999999999999998654
Q ss_pred CEEEEEEcccCCCCHH-HHhh----------------------------------------cCCCCHHHHHHHHHHHHHH
Q 006810 101 RTINMITELFTSGSLR-YRKK----------------------------------------HKNVDMKAIKNWARQILRG 139 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~----------------------------------------~~~lse~~i~~i~~QIl~g 139 (630)
..+++||||+++|+|. ++.. ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 5799999999999997 4321 1124688899999999999
Q ss_pred HHHHHcCCCCEEeccCCcCceEEeCCCC--cEEEcccccceeeccC------CCccccCCCCCCCccccc---cccCccc
Q 006810 140 LHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYE---EEYNELV 208 (630)
Q Consensus 140 L~yLHs~~~~IiHrDLKp~NILl~~~~g--~vKL~DFGla~~~~~~------~~~~~~GTp~Y~APEvl~---~~ys~~s 208 (630)
|.|||+++ |+||||||+|||++ .++ .+||+|||++...... ......||+.|+|||++. ..++.++
T Consensus 181 l~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG--ICHRDIKPENFLFS-TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT--EECCCCCGGGEEES-CSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC--ccccCCChhhEEEe-cCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999997 455 8999999999765332 123567999999999885 4588999
Q ss_pred ceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 209 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 209 DIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
|||||||++|+|++|+.||.+......+...+..... +.......++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 9999999999999999999875544444444443322 122223468999999999998 89999999999999999864
Q ss_pred C
Q 006810 287 N 287 (630)
Q Consensus 287 ~ 287 (630)
.
T Consensus 338 ~ 338 (345)
T 3hko_A 338 S 338 (345)
T ss_dssp S
T ss_pred h
Confidence 3
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=371.44 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=202.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~ 102 (630)
++| ++.+.||+|+||+||+|.+..+|..||+|++.... .......+...|+..+..+ +||||++++++|.+. ..
T Consensus 57 ~~y-~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~ 131 (311)
T 3p1a_A 57 QSF-QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GI 131 (311)
T ss_dssp HHE-EEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC--CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred hhe-eeeheeccCCCeEEEEEEECCCCeEEEEEEecccc--cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CE
Confidence 445 77899999999999999999999999999876432 2334444555566555544 999999999998654 56
Q ss_pred EEEEEcccCCCCHH-HH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 103 INMITELFTSGSLR-YR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
+++||||+. |+|. ++ .....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 132 LYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLG-PRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEEEECCC-CBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-GGGCEEECCCTTCEEC
T ss_pred EEEEEeccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEccceeeeec
Confidence 899999994 5665 44 34557999999999999999999999999 99999999999997 7899999999999766
Q ss_pred ccCC-CccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 181 QQPT-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 181 ~~~~-~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
.... .....||+.|+|||++.+.++.++|||||||++|||++|..||.. ......+..+..+..+....++.+++
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~ 283 (311)
T 3p1a_A 208 GTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRS 283 (311)
T ss_dssp C------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCHHHHTTSCHHHHH
T ss_pred ccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCcccccCCCHHHHH
Confidence 5432 344579999999999988999999999999999999999777654 22334455555555556677899999
Q ss_pred HHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 260 FIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
||.+||. +|.+|||+.++|+||||++
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 284 VLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999998 8999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=365.11 Aligned_cols=254 Identities=23% Similarity=0.432 Sum_probs=217.1
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|+||+||+|.+..+|..||+|++....... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 14 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 89 (284)
T 2vgo_A 14 DDF-DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--KRI 89 (284)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred hhc-eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC--CEE
Confidence 456 88899999999999999999999999999997543211 12235688999999999999999999998654 578
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMG-YKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECSS
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEc-CCCCEEEecccccccCcc
Confidence 9999999999998 7777788999999999999999999999999 99999999999997 789999999999977665
Q ss_pred CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 183 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 183 ~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||... +.......+.... ..++...++.+++||
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~li 243 (284)
T 2vgo_A 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-SHTETHRRIVNVD--LKFPPFLSDGSKDLI 243 (284)
T ss_dssp SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTC--CCCCTTSCHHHHHHH
T ss_pred cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC-CHhHHHHHHhccc--cCCCCcCCHHHHHHH
Confidence 55566789999999998865 5899999999999999999999999874 4444555554432 234456789999999
Q ss_pred HHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 262 EKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.+||. +|.+||++.++|+||||+...
T Consensus 244 ~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 99997 899999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=374.24 Aligned_cols=250 Identities=24% Similarity=0.431 Sum_probs=203.3
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC----
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---- 100 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~---- 100 (630)
+| ++.+.||+|+||.||+|.+..+|..||+|++.... .....+.+.+|+.+|++++||||++++++|.+...
T Consensus 7 ~y-~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 7 DF-EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HE-EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred cC-ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 45 78899999999999999999999999999997643 23456779999999999999999999999876432
Q ss_pred ---------------------------------------------------CEEEEEEcccCCCCHH-HHhhcCC---CC
Q 006810 101 ---------------------------------------------------RTINMITELFTSGSLR-YRKKHKN---VD 125 (630)
Q Consensus 101 ---------------------------------------------------~~l~lV~Ey~~gGsL~-~~~~~~~---ls 125 (630)
..+++||||+++|+|. ++..... .+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 2489999999999998 5554433 45
Q ss_pred HHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--------------CCccccCC
Q 006810 126 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--------------TARSVIGT 191 (630)
Q Consensus 126 e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--------------~~~~~~GT 191 (630)
+..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...... .....+||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 6679999999999999999999 99999999999998 7899999999999766543 12345799
Q ss_pred CCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCC
Q 006810 192 PEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PAS 269 (630)
Q Consensus 192 p~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~ 269 (630)
+.|+|||++.+ .++.++|||||||++|+|++|..|+. ........+.....+.. ....++.+++||.+||. +|.
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~ 315 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPLL-FTQKYPQEHMMVQDMLSPSPT 315 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCHH-HHHHCHHHHHHHHHHHCSSGG
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCcc-cccCChhHHHHHHHHccCCCC
Confidence 99999998865 58999999999999999999877763 23344444444433221 12235788999999998 899
Q ss_pred CCCCHHHHhcCCCccc
Q 006810 270 LRLPALELLKDPFLVT 285 (630)
Q Consensus 270 ~Rpsa~eLL~hpf~~~ 285 (630)
+||++.|+|+||||+.
T Consensus 316 ~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 316 ERPEATDIIENAIFEN 331 (332)
T ss_dssp GSCCHHHHHHSTTCCC
T ss_pred cCCCHHHHhhchhhhc
Confidence 9999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=368.38 Aligned_cols=259 Identities=22% Similarity=0.433 Sum_probs=216.2
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.+|| ++.+.||+|+||.||+|.+..+|..||+|++..............+.+|+.++++++||||+++++++.......
T Consensus 4 ~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKY-LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCB-CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred ccce-eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3677 888999999999999999999999999999976543322345677999999999999999999999987666667
Q ss_pred EEEEEcccCCCCHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 103 INMITELFTSGSLRYRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 103 l~lV~Ey~~gGsL~~~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
+++||||+.+|.+.++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-CCCcEEeecccccccc
Confidence 99999999998544443 3567999999999999999999999999 99999999999998 7899999999999765
Q ss_pred ccC----CCccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 181 QQP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 181 ~~~----~~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+..+.. .++...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~~ 236 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGDC 236 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSSS
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCcc
Confidence 422 2234568999999998864 247899999999999999999999986 456666666665532 345567
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
++.+.+||.+||. +|.+||++.++|+||||+...+
T Consensus 237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 8999999999998 8999999999999999987543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=368.10 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=215.7
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||+||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||++++++|.+. ..
T Consensus 8 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (304)
T 2jam_A 8 RKTF-IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDSSLENEIAVLKKIKHENIVTLEDIYEST--TH 80 (304)
T ss_dssp HHHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hccc-eeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchHHHHHHHHHHHhCCCCCeeehhhhcccC--CE
Confidence 3456 889999999999999999999999999999975432 2235688999999999999999999998654 46
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe--CCCCcEEEccccccee
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIV 179 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKL~DFGla~~ 179 (630)
+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+||++. ..++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 89999999999997 7777788999999999999999999999999 99999999999992 2678999999999976
Q ss_pred eccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHH
Q 006810 180 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQ 256 (630)
Q Consensus 180 ~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~ 256 (630)
..........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+..+.. +.......++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 159 EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp CCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred cCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 65544555679999999998865 589999999999999999999999987 455666666666543 23344567899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+++||.+||. +|.+||++.++|+||||...
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999998 89999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=379.88 Aligned_cols=257 Identities=25% Similarity=0.447 Sum_probs=214.7
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
-..++| ++.+.||+|+||+||+|.+..+|..||+|++.... .....+.+.+|+.+|+.++||||++++++|.+.
T Consensus 30 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 103 (360)
T 3eqc_A 30 LKDDDF-EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-- 103 (360)
T ss_dssp CCGGGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--
T ss_pred cccccc-eeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--
Confidence 345567 78899999999999999999999999999997542 355667899999999999999999999998765
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 101 RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+. + |+||||||+|||++ .+|.+||+|||++.
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSG 180 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEEC-CCCCEEEEECCCCc
Confidence 4689999999999998 777778899999999999999999999995 8 99999999999998 78999999999997
Q ss_pred eeccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHH---------------------
Q 006810 179 VMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI--------------------- 236 (630)
Q Consensus 179 ~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i--------------------- 236 (630)
...........||+.|+|||++.+ .++.++|||||||++|+|+||+.||... +...+
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC-CHHHHHHHHC----------------
T ss_pred ccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccCCCCCCCccc
Confidence 665545556789999999998865 5899999999999999999999999763 32222
Q ss_pred ---------------------HHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 237 ---------------------YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 237 ---------------------~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
...+.....+.......++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 122222333333334568899999999998 899999999999999998644
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=403.13 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=219.9
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+++.++||+|+||.||+|.+..+|..||+|++....... ......+.+|+.+|+.++||||++++++|.+. ..+|+|
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~lV 262 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 262 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--CEEEEE
Confidence 478899999999999999999999999999997643321 12345678999999999999999999998754 479999
Q ss_pred EcccCCCCHH-HHhhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 107 TELFTSGSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
|||++||+|. ++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld-~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEe-CCCCeEEEecccceecccC
Confidence 9999999998 554433 4999999999999999999999999 99999999999998 7899999999999876543
Q ss_pred -CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 184 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 184 -~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~---~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
.....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.... ....+...+... +..++...+++++
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~s~~~~ 417 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERFSPQAR 417 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTSCHHHH
T ss_pred ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccCCHHHH
Confidence 3345689999999998865 59999999999999999999999998643 345566666543 3445667899999
Q ss_pred HHHHHccc-CCCCCC-----CHHHHhcCCCcccCCCCcccc
Q 006810 259 QFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVC 293 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~ 293 (630)
+||.+||. +|.+|| ++.|+++||||+..++..+..
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~ 458 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGA 458 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhc
Confidence 99999998 899999 799999999999988766543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=366.68 Aligned_cols=259 Identities=27% Similarity=0.474 Sum_probs=211.4
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
..++.++| ++.+.||+|+||.||+|.+..+|..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 14 DLDPNEVW-EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp SSCGGGTE-EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccCCccce-eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 45788888 88899999999999999999999999999986542 23456788999999999999999999998765
Q ss_pred CCCEEEEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 99 TNRTINMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
..+++||||+++|+|. ++. ....+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||+
T Consensus 89 --~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 163 (302)
T 2j7t_A 89 --GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGV 163 (302)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTSCEEECCCHH
T ss_pred --CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEC-CCCCEEEEECCC
Confidence 4689999999999998 443 3577999999999999999999999999 99999999999998 789999999998
Q ss_pred ceeecc--CCCccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-C
Q 006810 177 AIVMQQ--PTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-A 247 (630)
Q Consensus 177 a~~~~~--~~~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~ 247 (630)
+..... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||.... .......+.....+ .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~ 242 (302)
T 2j7t_A 164 SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSDPPTL 242 (302)
T ss_dssp HHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCC
T ss_pred CccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-HHHHHHHHhccCCccc
Confidence 754321 1234467999999999873 357889999999999999999999998744 44444444443332 2
Q ss_pred CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 248 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 248 ~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
..+...++.++++|.+||. +|.+|||+.++|+||||+....
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 3345568899999999997 8999999999999999987544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=368.64 Aligned_cols=260 Identities=20% Similarity=0.343 Sum_probs=211.4
Q ss_pred CccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeE
Q 006810 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNS 94 (630)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~ 94 (630)
..++....++| ++.+.||+|+||+||+|.+..+|..||+|++.... ...+.+|+.+|++++ ||||++++++
T Consensus 28 ~~~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~ 99 (330)
T 3nsz_A 28 HVVEWGNQDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADI 99 (330)
T ss_dssp CCCCCEEGGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred hhhcccCCCce-EEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeee
Confidence 34444456677 88899999999999999999999999999986322 256889999999997 9999999999
Q ss_pred EEcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 95 WVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
+.+.....+++||||+.+++|.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||+||
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 100 VKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp EECTTTCCEEEEEECCCCCCHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCC
T ss_pred eccCCCCceEEEEeccCchhHHHHH--HhCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 9876667899999999999998433 24899999999999999999999999 9999999999999844448999999
Q ss_pred ccceeeccC-CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHH----------
Q 006810 175 GLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT---------- 241 (630)
Q Consensus 175 Gla~~~~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~---------- 241 (630)
|++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....+.......+.
T Consensus 176 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 176 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp TTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence 999866543 3445679999999998764 589999999999999999999999965444433222211
Q ss_pred ---cCCC----------------------CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 242 ---SGIK----------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 242 ---~g~~----------------------p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.... +.......++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 1100 011112268999999999998 899999999999999998753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=367.40 Aligned_cols=258 Identities=29% Similarity=0.528 Sum_probs=211.7
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEc
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d 97 (630)
..++.++| ++.+.||+|+||.||+|.+..+|..||+|++..... ..+.+.+|+.+++++ +||||++++++|..
T Consensus 19 l~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 19 LRDPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCCTTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccCCCCcE-EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 34678888 888999999999999999999999999999975432 235688999999999 89999999999976
Q ss_pred CC----CCEEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEE
Q 006810 98 DT----NRTINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 170 (630)
Q Consensus 98 ~~----~~~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 170 (630)
.. ...+++||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEc-CCCCEE
Confidence 43 46799999999999998 5543 357999999999999999999999999 99999999999998 789999
Q ss_pred EcccccceeeccC--CCccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Q 006810 171 IGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 242 (630)
Q Consensus 171 L~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~ 242 (630)
|+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+||..||... +.......+..
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~ 248 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPR 248 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHH
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhc
Confidence 9999999765432 234567999999999874 35889999999999999999999999874 44444444544
Q ss_pred CCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 243 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 243 g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
...+.......++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 444444556678999999999997 89999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=389.94 Aligned_cols=259 Identities=26% Similarity=0.419 Sum_probs=208.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~----~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
.++| ++.+.||+|+||+||+|.+..+|..||+|++....... .......+.+|+.+|++++||||++++++|..
T Consensus 134 ~~~y-~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hccE-EEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4566 78899999999999999999999999999998654321 12223457899999999999999999998743
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCcEEEcccc
Q 006810 99 TNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLG 175 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFG 175 (630)
..+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||
T Consensus 212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecc
Confidence 3478999999999997 7777889999999999999999999999999 999999999999972 23469999999
Q ss_pred cceeeccC-CCccccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC--C
Q 006810 176 LAIVMQQP-TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--S 248 (630)
Q Consensus 176 la~~~~~~-~~~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~--~ 248 (630)
++...... .....+||+.|+|||++. ..|+.++|||||||++|+|+||+.||........+...+..+..+. .
T Consensus 288 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 288 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp TTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred cceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence 99766543 334568999999999874 4578899999999999999999999987655555666666554321 2
Q ss_pred CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 249 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 249 l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.....++.+++||.+||+ +|.+||++.++|+||||+...
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 224568899999999998 899999999999999998644
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=372.10 Aligned_cols=244 Identities=24% Similarity=0.366 Sum_probs=190.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
+.||+|+||+||+|.+..+|..||+|++... ....+.+|+.+++.+. ||||++++++|.+. ..+++||||
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e~ 87 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVMEL 87 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEECC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEEEc
Confidence 6799999999999999999999999998642 2345778999999997 99999999998654 568999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC---cEEEcccccceeeccC--
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDLGLAIVMQQP-- 183 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g---~vKL~DFGla~~~~~~-- 183 (630)
+++|+|. ++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++ .+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 88 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFT-DENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEE-C----CEEEECCCTTCEECCC---
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEe-cCCCcccEEEeccccceecCCCCC
Confidence 9999998 7778889999999999999999999999999 99999999999997 344 8999999999765432
Q ss_pred CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC------CHHHHHHHHHcCCCCCC--CCCCCc
Q 006810 184 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK------NPAQIYKKVTSGIKPAS--LSKVTD 254 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~------~~~~i~~~i~~g~~p~~--l~~~~s 254 (630)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.... ....+...+..+..+.. .....+
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 2345678999999998864 58999999999999999999999997532 33556666666543221 113468
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+++++||.+||. +|.+|||+.++|+||||+..
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 999999999997 89999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=381.10 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=205.5
Q ss_pred ceee--eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 26 YGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 26 y~r~--~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++++ .++||+|+||.||+|.+..+|..||+|++.... ....+.+.+|+.+|++++||||++++++|.+. ..+
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 161 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESK--NDI 161 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEE
Confidence 3455 478999999999999999999999999997543 34557789999999999999999999998654 468
Q ss_pred EEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe-CCCCcEEEcccccceee
Q 006810 104 NMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~-~~~g~vKL~DFGla~~~ 180 (630)
++||||+++|+|. ++. ....+++..++.++.||+.||.|||+++ |+||||||+|||+. ..++.+||+|||++...
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 9999999999996 443 4457999999999999999999999999 99999999999984 25679999999999876
Q ss_pred ccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcHHH
Q 006810 181 QQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQV 257 (630)
Q Consensus 181 ~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p~~l~~~~s~~l 257 (630)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+..... +.......++++
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 543 2345579999999998864 5889999999999999999999999875444444344433322 222234568999
Q ss_pred HHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 258 KQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
++||.+||. +|.+||++.|+|+||||+..
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999998 89999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=374.21 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=213.0
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
-.+|| ++.+.||+|+||+||+|.+..+|..||+|++.... ........++.+|+.++++++||||+++++++......
T Consensus 10 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 10 LSDRY-ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp ETTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT-TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ecCcE-EEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc-cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 34677 88999999999999999999999999999997643 23456677899999999999999999999998765432
Q ss_pred --EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 --TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 --~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTSCEEECCCSCC-
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEc-CCCCEEEeeccCcc
Confidence 568999999999998 7777888999999999999999999999999 99999999999998 78999999999997
Q ss_pred eeccC-----CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC-CCCC
Q 006810 179 VMQQP-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSK 251 (630)
Q Consensus 179 ~~~~~-----~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~-~l~~ 251 (630)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||............+.....+. ....
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence 65432 2234579999999998865 589999999999999999999999987554444445554443322 2234
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..++.+++||.+||. +|.+||++.++|.|+|++..
T Consensus 245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 578999999999997 89999999999999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=409.11 Aligned_cols=265 Identities=21% Similarity=0.349 Sum_probs=226.3
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~ 102 (630)
++| ++.++||+|+||.||+|.++.+|+.||+|+++...... ....+.+..|..+|..+ +||||++++++|.+. ..
T Consensus 341 ~~f-~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--~~ 416 (674)
T 3pfq_A 341 TDF-NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR 416 (674)
T ss_dssp TTE-EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS--SE
T ss_pred cce-EEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC--CE
Confidence 345 77899999999999999999999999999997543211 22346678899999988 799999999988644 57
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+|+||||+++|+|. ++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~-~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEEC-SSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEc-CCCcEEEeecceeeccc
Confidence 99999999999998 7777789999999999999999999999999 99999999999998 78999999999997543
Q ss_pred --cCCCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 182 --QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 182 --~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
.......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+ .+...++..+..+. ..++...+++++
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~ 570 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN--VAYPKSMSKEAV 570 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSC--CCCCTTSCHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHH
Confidence 23445678999999999886 4699999999999999999999999987 56777777777653 345567899999
Q ss_pred HHHHHccc-CCCCCCCH-----HHHhcCCCcccCCCCccccCCCCC
Q 006810 259 QFIEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLRL 298 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa-----~eLL~hpf~~~~~~~~~~~~~l~~ 298 (630)
+||.+||. +|.+|+++ .|++.||||+..++..+....+..
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~p 616 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQP 616 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCC
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCC
Confidence 99999998 89999997 999999999998887765544433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=370.87 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=211.8
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~ 101 (630)
.+||....+.||+|+||+||+|.+..+|..||+|++..... .......+.+|+.+++.+ +||||++++++|.+. .
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~--~ 102 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYENT--S 102 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--S
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC--C
Confidence 45664444899999999999999999999999999975432 223356788999999999 569999999998654 5
Q ss_pred EEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCcEEEccccc
Q 006810 102 TINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGL 176 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGl 176 (630)
.+++||||+.+|+|. ++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .+|.+||+|||+
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 689999999999998 4433 467999999999999999999999999 999999999999973 268999999999
Q ss_pred ceeeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC--CCCCCCCC
Q 006810 177 AIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKV 252 (630)
Q Consensus 177 a~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~--~p~~l~~~ 252 (630)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....+..+.... .+......
T Consensus 181 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 259 (327)
T 3lm5_A 181 SRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED-NQETYLNISQVNVDYSEETFSS 259 (327)
T ss_dssp CEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCTTTTTT
T ss_pred ccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHhcccccCchhhcc
Confidence 9876543 2345679999999998864 58999999999999999999999998744 444444444332 23334456
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCCcc
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~~~ 291 (630)
.++.+++||.+||+ +|.+|||+.++|+||||+..++..+
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 78999999999998 8999999999999999998766554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=362.57 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=201.0
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
..++| ++.+.||+|+||+||+|.+..+|..||+|++.... ......+.+.++...++.++||||+++++++.+. .
T Consensus 5 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~ 79 (290)
T 3fme_A 5 KADDL-EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--G 79 (290)
T ss_dssp CGGGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--S
T ss_pred cHHhh-hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--C
Confidence 34566 88899999999999999999999999999987542 2233344455666678999999999999998765 3
Q ss_pred EEEEEEcccCCCCHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 102 TINMITELFTSGSLRYR----KKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~----~~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
.+++||||++++...++ .....+++..++.++.||+.||.|||++ + |+||||||+||+++ .++.+||+|||+
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 156 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGI 156 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEEC-TTCCEEBCCC--
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecCC
Confidence 58899999986432332 3467899999999999999999999998 8 99999999999998 788999999999
Q ss_pred ceeeccCC-CccccCCCCCCCccccc-----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006810 177 AIVMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 250 (630)
Q Consensus 177 a~~~~~~~-~~~~~GTp~Y~APEvl~-----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~ 250 (630)
+....... .....||+.|+|||++. ..++.++|||||||++|+|+||+.||..................+....
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 97655432 33457999999999862 3588999999999999999999999987666666555555554454445
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 5678999999999998 89999999999999999753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=384.15 Aligned_cols=250 Identities=21% Similarity=0.311 Sum_probs=205.0
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC----CCCE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----TNRT 102 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~----~~~~ 102 (630)
|++.++||+|+||+||+|.+..+|..||+|++..... ...+|+.+|+.|+|||||+++++|... ...+
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4778999999999999999999999999999864432 134699999999999999999988642 2345
Q ss_pred EEEEEcccCCCCHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 103 INMITELFTSGSLRYR----KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 103 l~lV~Ey~~gGsL~~~----~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
+++||||+.++.+..+ .....+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||+|||+++
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 7899999998655432 34678999999999999999999999999 99999999999998556789999999998
Q ss_pred eeccC-CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-----------
Q 006810 179 VMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------- 244 (630)
Q Consensus 179 ~~~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~----------- 244 (630)
..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++...+....
T Consensus 206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 65433 3445689999999998754 589999999999999999999999988655555555443200
Q ss_pred ---CCCC------------CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 245 ---KPAS------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 245 ---~p~~------------l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.... +....++++++||.+||+ +|.+||++.|+|.||||...
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0000 223457899999999998 89999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=374.56 Aligned_cols=255 Identities=24% Similarity=0.464 Sum_probs=214.6
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH----HHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP----DQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~----~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~ 98 (630)
++| ++.+.||+|+||.||+|.+..+|..||+|++......... ...+.+.+|+.+++.+ +||||++++++|...
T Consensus 94 ~~y-~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 94 QKY-DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhc-ccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 456 7789999999999999999999999999999765432222 2246688999999999 899999999998654
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 99 TNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+++||||+++|+|. ++.....+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++
T Consensus 173 --~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~-~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 173 --SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFS 247 (365)
T ss_dssp --SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTC
T ss_pred --CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEEecCcc
Confidence 5789999999999998 7777788999999999999999999999999 99999999999998 7899999999999
Q ss_pred eeeccC-CCccccCCCCCCCcccccc-------ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC-
Q 006810 178 IVMQQP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS- 248 (630)
Q Consensus 178 ~~~~~~-~~~~~~GTp~Y~APEvl~~-------~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~- 248 (630)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+.......+..+.....
T Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCH
T ss_pred cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCC
Confidence 766543 3455689999999998753 478899999999999999999999987 445555555655533221
Q ss_pred -CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 249 -LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 249 -l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.....++.+++||.+||. +|.+||++.++|+||||+.
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 123467889999999997 8999999999999999963
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=374.61 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=199.5
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
+|| ++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+|+.+|+.++||||+++++++.+. ..+
T Consensus 2 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 75 (324)
T 3mtl_A 2 ETY-IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSL 75 (324)
T ss_dssp CSE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCE
T ss_pred Cce-EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEE
Confidence 467 788999999999999999999999999999975432 11222355799999999999999999998755 458
Q ss_pred EEEEcccCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLRYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+.++.+.++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSI 152 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEEC-TTCCEEECSSSEEECC--
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEEC-CCCCEEEccCcccccccC
Confidence 89999999644445544 456999999999999999999999999 99999999999998 789999999999976543
Q ss_pred C--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc--CCCCCCC-------
Q 006810 183 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASL------- 249 (630)
Q Consensus 183 ~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~p~~l------- 249 (630)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.....++...... ...+..+
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 2 2344578999999998764 5899999999999999999999999875443333322221 1111111
Q ss_pred ------------------CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 250 ------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 250 ------------------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
....++++++||.+||+ +|.+|||+.|+|+||||.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 12357889999999998 8999999999999999987543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=361.24 Aligned_cols=258 Identities=27% Similarity=0.483 Sum_probs=217.1
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||+||+|.+..+|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.+.....
T Consensus 5 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 5 AEDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred hhhe-eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 4567 888999999999999999999999999999976543 3556778999999999999999999999988766678
Q ss_pred EEEEEcccCCCCHH-HHhh----cCCCCHHHHHHHHHHHHHHHHHHHcCC---CCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 103 INMITELFTSGSLR-YRKK----HKNVDMKAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~----~~~lse~~i~~i~~QIl~gL~yLHs~~---~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
+++||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~df 160 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDF 160 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC-SSSCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecC
Confidence 99999999999997 4433 345999999999999999999999987 3499999999999998 7899999999
Q ss_pred ccceeeccCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 175 GLAIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 175 Gla~~~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
|++....... .....||+.|+|||++.+ .++.++||||||+++|+|+||+.||.. .+...+...+..+..+ .++.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~ 238 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPY 238 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC-CCCT
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhcccc-cCCc
Confidence 9997654332 234578999999998765 588999999999999999999999987 4566666667666443 3455
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..++.++++|.+||. +|.+||++.++|+|+|+...
T Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 678999999999997 89999999999999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=368.21 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=218.8
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
...+|| ++.+.||+|+||.||+|.+..+|..||+|++..... ......+.+.+|+.+++.++||||++++++|.+.
T Consensus 38 ~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 113 (335)
T 2owb_A 38 RSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-- 113 (335)
T ss_dssp TTTEEE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred ccCCce-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 334555 888999999999999999999999999999975543 3456677899999999999999999999998654
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++||||+.+++|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATK 190 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEc-CCCCEEEeeccCcee
Confidence 5799999999999998 6677788999999999999999999999999 99999999999998 789999999999976
Q ss_pred eccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 180 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||... +....+..+..+.. .++...++.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~--~~~~~~~~~ 267 (335)
T 2owb_A 191 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNEY--SIPKHINPV 267 (335)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCC--CCCTTSCHH
T ss_pred cccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHhcCCC--CCCccCCHH
Confidence 6432 2345679999999998865 4889999999999999999999999874 44445555544322 344567899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+++||.+||. +|.+||++.++|+||||...
T Consensus 268 ~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 268 AASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 9999999998 89999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=370.93 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=209.2
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc----CCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~----~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
++| ++.+.||+|+||.||+|.+..+|..||+|++...... ........+.+|+.+|++++||||+++++++...
T Consensus 10 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 10 DEY-IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hce-eEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 456 8889999999999999999999999999999754321 1122345588999999999999999999988543
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC---cEEEcccc
Q 006810 100 NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDLG 175 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g---~vKL~DFG 175 (630)
.+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+|||
T Consensus 88 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 --DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLS-SQEEDCLIKITDFG 162 (322)
T ss_dssp --SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-SSSSSCCEEECCCT
T ss_pred --ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-cCCCCCeEEEccCc
Confidence 278999999999997 7777889999999999999999999999999 99999999999997 333 59999999
Q ss_pred cceeeccCC-CccccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--CC
Q 006810 176 LAIVMQQPT-ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--AS 248 (630)
Q Consensus 176 la~~~~~~~-~~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~ 248 (630)
++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||........+...+..+... ..
T Consensus 163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 163 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp TCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred cceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 997665432 23457999999999873 458899999999999999999999998765554555555554322 12
Q ss_pred CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 249 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 249 l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.....++.+++||.+||. +|.+||++.++|+||||+...
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 224567899999999998 899999999999999998644
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=359.23 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=218.6
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
...+|| ++.+.||+|+||+||+|.+..+|..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 12 ~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 87 (294)
T 2rku_A 12 RSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-- 87 (294)
T ss_dssp TTTEEE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred Ccccce-EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC--
Confidence 334455 888999999999999999999999999999976543 3456677899999999999999999999998654
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++||||+++++|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++..
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATK 164 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEc-CCCCEEEEeccCcee
Confidence 5789999999999998 6677788999999999999999999999999 99999999999998 789999999999976
Q ss_pred eccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 180 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
.... ......||+.|+|||++.+ .++.++||||||+++|+|+||+.||... .....+..+..+. ..++...++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~--~~~~~~~~~~ 241 (294)
T 2rku_A 165 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNE--YSIPKHINPV 241 (294)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTC--CCCCTTSCHH
T ss_pred cccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhhcc--CCCccccCHH
Confidence 5432 2345679999999998765 4889999999999999999999999874 4445555555442 2345567899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
++++|.+||. +|.+||++.++|+||||...
T Consensus 242 ~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 242 AASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 9999999998 89999999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=372.59 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=202.7
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----CCCeeEEEeEEEcC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----HENIIKFYNSWVDD 98 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-----HpNIVk~~~~f~d~ 98 (630)
+|| ++.+.||+|+||+||+|.+..+|..||+|++.. .......+..|+.+++.+. ||||++++++|...
T Consensus 35 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 35 NAF-LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred CEE-EEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 556 888999999999999999999999999999863 2345566788999999996 99999999998765
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC-----------
Q 006810 99 TNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----------- 164 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~----------- 164 (630)
..+++||||+ +++|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 109 --~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 109 --DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp --TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred --CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchh
Confidence 4689999999 88887 55443 35999999999999999999999999 999999999999962
Q ss_pred -------------CCCcEEEcccccceeeccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCC
Q 006810 165 -------------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC 230 (630)
Q Consensus 165 -------------~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~ 230 (630)
.++.+||+|||++..... ......||+.|+|||++.+ .|+.++|||||||++|+|+||+.||...
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 378999999999976443 3345689999999998764 5899999999999999999999999874
Q ss_pred CCHHHHHHHHHcCCCCCC------------------------C--------------------CCCCcHHHHHHHHHccc
Q 006810 231 KNPAQIYKKVTSGIKPAS------------------------L--------------------SKVTDPQVKQFIEKCIV 266 (630)
Q Consensus 231 ~~~~~i~~~i~~g~~p~~------------------------l--------------------~~~~s~~lk~~I~kcL~ 266 (630)
. .......+.....+.. + ....++.+.+||.+||+
T Consensus 263 ~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 263 E-HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp S-HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred c-HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 4 3333333322111100 0 01123778899999998
Q ss_pred -CCCCCCCHHHHhcCCCcc
Q 006810 267 -PASLRLPALELLKDPFLV 284 (630)
Q Consensus 267 -~p~~Rpsa~eLL~hpf~~ 284 (630)
+|.+|||+.|+|+||||+
T Consensus 342 ~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 342 IDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGC
T ss_pred CChhhCCCHHHHhcCcccC
Confidence 899999999999999995
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=374.11 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=210.3
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC---
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~--- 99 (630)
.+|| ++.+.||+|+||.||+|.+..+|..||+|++... ......+++.+|+.+|++++||||+++++++....
T Consensus 26 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 26 GPRY-TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cccE-EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 3577 8889999999999999999999999999998743 23556678999999999999999999999986543
Q ss_pred CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 100 NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
...+++||||+.+ +|......+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 102 ~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 102 MKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARV 177 (364)
T ss_dssp CCCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred cceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEEC-CCCCEEEEeCcceEe
Confidence 2468999999986 6764445567999999999999999999999999 99999999999998 789999999999976
Q ss_pred eccCC-----CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC------
Q 006810 180 MQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------ 246 (630)
Q Consensus 180 ~~~~~-----~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p------ 246 (630)
..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.....|
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 64321 244589999999997643 48999999999999999999999998755444443332110000
Q ss_pred ----------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 ----------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 ----------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..+....++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 01123467899999999998 89999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=369.48 Aligned_cols=252 Identities=23% Similarity=0.389 Sum_probs=206.1
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.+|| ++.++||+|+||+||+|.+..+|..||+|++....... ..+.+.+|+.+|++++||||+++++++.......
T Consensus 8 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 8 NHLW-LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp SEEE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS---CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCE-EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc---hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 3455 88999999999999999999999999999997544322 2456789999999999999999999998777668
Q ss_pred EEEEEcccCCCCHH-HHhhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEE----eCCCCcEEEccc
Q 006810 103 INMITELFTSGSLR-YRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVKIGDL 174 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~---~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl----~~~~g~vKL~DF 174 (630)
+++||||+++|+|. ++.... .+++..++.++.||+.||.|||+++ |+||||||+|||+ + .++.+||+||
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~Df 160 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDF 160 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTT-SCEEEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCC-CCceEEEccC
Confidence 89999999999998 554332 3999999999999999999999999 9999999999998 5 5678999999
Q ss_pred ccceeeccC-CCccccCCCCCCCccccc---------cccCcccceeehhHHHHHHhhCCCCCCCCCCH---HHHHHHHH
Q 006810 175 GLAIVMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVT 241 (630)
Q Consensus 175 Gla~~~~~~-~~~~~~GTp~Y~APEvl~---------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~---~~i~~~i~ 241 (630)
|++...... ......||+.|+|||++. ..++.++|||||||++|+|+||+.||...... ..+...+.
T Consensus 161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 999876543 334567999999999875 45889999999999999999999999753322 33333333
Q ss_pred cCCCCC-----------------------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCC
Q 006810 242 SGIKPA-----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 281 (630)
Q Consensus 242 ~g~~p~-----------------------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hp 281 (630)
.+.++. .+....++.+.+||.+||+ +|.+|||+.|+|+||
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 332211 1122335688999999998 899999999999997
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=366.11 Aligned_cols=255 Identities=31% Similarity=0.546 Sum_probs=205.9
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
-+.++| ++.+.||+|+||+||+|.+ +|..||+|++..... .....+.+.+|+.+|++++||||+++++++.+..
T Consensus 34 i~~~~y-~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 107 (309)
T 3p86_A 34 IPWCDL-NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP- 107 (309)
T ss_dssp CCGGGE-EEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred CChhHc-eeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 445666 8889999999999999976 689999999875432 4556678999999999999999999999986543
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCC---CCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 101 RTINMITELFTSGSLR-YRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~---lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
.+++||||+++|+|. ++...+. +++..++.++.||+.||.|||+++++|+||||||+|||++ .++.+||+|||+
T Consensus 108 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~ 185 (309)
T 3p86_A 108 -NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGL 185 (309)
T ss_dssp -CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC-TTCCEEECCCC-
T ss_pred -ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe-CCCcEEECCCCC
Confidence 578999999999998 5554443 9999999999999999999999988899999999999998 789999999999
Q ss_pred ceeeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 177 AIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 177 a~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+..+....+........++...
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNL 264 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCCCTTS
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCccC
Confidence 9755433 2345679999999998865 488999999999999999999999987 45666666665454555667778
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhc--CCCcc
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLK--DPFLV 284 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~--hpf~~ 284 (630)
++.+++||.+||. +|.+||++.++++ .++++
T Consensus 265 ~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999997 8999999999987 44443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=358.06 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=205.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~ 102 (630)
++| ++.+.||+|+||+||+|.+..+|..||+|.+..... .......+.+|+..+..+ +||||++++++|.+. ..
T Consensus 11 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~ 85 (289)
T 1x8b_A 11 TEF-HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DH 85 (289)
T ss_dssp HHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TE
T ss_pred chh-hhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--Ce
Confidence 455 788999999999999999999999999999975432 234456788999999999 999999999998765 47
Q ss_pred EEEEEcccCCCCHH-HHhhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC-------------
Q 006810 103 INMITELFTSGSLR-YRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------------- 164 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~----~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~------------- 164 (630)
+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC--------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccc
Confidence 89999999999998 55443 77999999999999999999999999 999999999999972
Q ss_pred -----CCCcEEEcccccceeeccCCCccccCCCCCCCccccccc--cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHH
Q 006810 165 -----NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 237 (630)
Q Consensus 165 -----~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~--ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~ 237 (630)
..+.+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+|+... ...
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~ 237 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQW 237 (289)
T ss_dssp ------CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHH
T ss_pred ccccCCceEEEEcccccccccCCc--cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHH
Confidence 2347999999999766543 334699999999988754 557999999999999999999877542 223
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 238 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 238 ~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
..+..+.. ..++...++.+++||.+||. +|.+||++.++|+||||+...
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 238 HEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHHHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 34444433 34456678999999999998 899999999999999998753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=356.92 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=216.8
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC-----HHHHHHHHHHHHHHHhCC-CCCeeEEEeEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-----PDQLERLYSEVHLLKSLK-HENIIKFYNSW 95 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~-----~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f 95 (630)
-.++| ++.+.||+|+||.||+|.+..+|..||+|++........ ....+.+.+|+.+++++. ||||+++++++
T Consensus 15 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 15 FYENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhcc-ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34567 778999999999999999999999999999976542111 233467889999999995 99999999998
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
.+. ..+++||||+++|+|. ++.....+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+||
T Consensus 94 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~df 168 (298)
T 1phk_A 94 ETN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDF 168 (298)
T ss_dssp ECS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCC
T ss_pred ccC--CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEc-CCCcEEEecc
Confidence 654 5799999999999998 7777788999999999999999999999999 99999999999998 7899999999
Q ss_pred ccceeeccC-CCccccCCCCCCCccccc-------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC
Q 006810 175 GLAIVMQQP-TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 246 (630)
Q Consensus 175 Gla~~~~~~-~~~~~~GTp~Y~APEvl~-------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p 246 (630)
|++...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||... +.......+..+...
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQ 247 (298)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCC
T ss_pred cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc-cHHHHHHHHhcCCcc
Confidence 999766543 344567999999999874 24788999999999999999999999874 455555555554332
Q ss_pred C--CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 247 A--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 247 ~--~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
. ......++.+++||.+||. +|.+||++.++|+||||+....
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 2 2223467899999999998 8999999999999999987543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=360.33 Aligned_cols=255 Identities=26% Similarity=0.501 Sum_probs=190.2
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||+||+|.+..+|..||+|.+....... ....+++.+|+.++++++||||+++++++.+. ..
T Consensus 10 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 85 (278)
T 3cok_A 10 IEDF-KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQRVQNEVKIHCQLKHPSILELYNYFEDS--NY 85 (278)
T ss_dssp GGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS--SE
T ss_pred cccc-eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC--Ce
Confidence 3566 88899999999999999999999999999997543211 12246788999999999999999999998654 57
Q ss_pred EEEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 103 INMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLT-RNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEEeecceeec
Confidence 89999999999998 55443 67999999999999999999999999 99999999999998 7899999999999766
Q ss_pred ccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 181 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 181 ~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||........+ ..+.. ....++...++++
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~ 239 (278)
T 3cok_A 163 KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-NKVVL--ADYEMPSFLSIEA 239 (278)
T ss_dssp C----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCS--SCCCCCTTSCHHH
T ss_pred cCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-HHHhh--cccCCccccCHHH
Confidence 432 2334679999999998765 5789999999999999999999999864433222 21111 1223445678999
Q ss_pred HHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 258 KQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+++|.+||. +|.+||++.++|.||||....
T Consensus 240 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 999999997 899999999999999998643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=396.40 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=218.7
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+++.++||+|+||.||+|.++.+|+.||+|++....... ....+.+.+|+.+|+.++||||++++++|.+. ..+|+|
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~lV 263 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TDLCLV 263 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--CEEEEE
Confidence 477899999999999999999999999999997543321 12346688999999999999999999998754 469999
Q ss_pred EcccCCCCHH-HHhh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 107 TELFTSGSLR-YRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
|||++||+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~-~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEe-CCCCEEEeecceeeecc
Confidence 9999999998 4443 346999999999999999999999999 99999999999998 78999999999998765
Q ss_pred cCC--CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 182 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 182 ~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~---~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
... ....+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.... ....+...+.... ..++...++
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~--~~~p~~~s~ 418 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYPDKFSP 418 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--CCCCTTSCH
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--cCCCcccCH
Confidence 432 344689999999998865 59999999999999999999999997643 3456666666543 234566789
Q ss_pred HHHHHHHHccc-CCCCCCC-----HHHHhcCCCcccCCCCcccc
Q 006810 256 QVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVC 293 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rps-----a~eLL~hpf~~~~~~~~~~~ 293 (630)
.+++||.+||. +|.+||+ +.+++.||||+..++..+..
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~ 462 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEA 462 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHc
Confidence 99999999998 8999996 58999999999887766543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=378.73 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=206.2
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC----
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---- 99 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~---- 99 (630)
+|| ++.++||+|+||+||+|.+..++. ||+|++...... ..+|+.+|+.++||||++++++|....
T Consensus 40 ~~Y-~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 40 IAY-TNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEE-EEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ceE-EEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 456 788999999999999999887766 888888643321 236999999999999999999986533
Q ss_pred CCEEEEEEcccCCCCHHH----HhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 100 NRTINMITELFTSGSLRY----RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~----~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
...+++||||++++.+.. ......+++..++.|+.||+.||.|||+++ |+||||||+|||++..+|.+||+|||
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 235889999999987652 334678999999999999999999999999 99999999999998668999999999
Q ss_pred cceeeccC-CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-------
Q 006810 176 LAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------- 245 (630)
Q Consensus 176 la~~~~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~------- 245 (630)
+++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.....
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp TCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99866433 3446689999999998754 4899999999999999999999999886555555544432100
Q ss_pred -----------C--------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 246 -----------P--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 246 -----------p--------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+ ..+....++++++||.+||+ +|.+|||+.|+|.||||+....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 0 01233467899999999998 8999999999999999987543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=362.04 Aligned_cols=262 Identities=31% Similarity=0.543 Sum_probs=223.1
Q ss_pred CCccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeE
Q 006810 15 GEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (630)
Q Consensus 15 ~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~ 94 (630)
.+.+..+|..+| ++.+.||+|+||.||+|.+..+|..||+|++..... ....+.+.+|+.+++.++||||++++++
T Consensus 13 ~~~~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 88 (303)
T 3a7i_A 13 MQNLKADPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGS 88 (303)
T ss_dssp CTTCEECGGGTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhcCCCChHHHH-HHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 445566788888 778999999999999999999999999999976543 2345678999999999999999999999
Q ss_pred EEcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 95 WVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
|.+. ..+++||||+++++|......+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+||
T Consensus 89 ~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Df 163 (303)
T 3a7i_A 89 YLKD--TKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADF 163 (303)
T ss_dssp EEET--TEEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCC
T ss_pred EecC--CeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEEC-CCCCEEEeec
Confidence 8765 46899999999999995556678999999999999999999999999 99999999999998 7899999999
Q ss_pred ccceeeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 175 GLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 175 Gla~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
|++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||... +.......+..+. +..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~~~~~ 241 (303)
T 3a7i_A 164 GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNN-PPTLEG 241 (303)
T ss_dssp TTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSC-CCCCCS
T ss_pred ccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc-CHHHHHHHhhcCC-CCCCcc
Confidence 999766543 2345679999999998764 5889999999999999999999999874 4555555554443 334556
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
..++.+++||.+||. +|.+||++.++|+||||....
T Consensus 242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 678999999999997 899999999999999997643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=381.05 Aligned_cols=256 Identities=30% Similarity=0.435 Sum_probs=194.5
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC---
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~--- 99 (630)
.+|| ++.+.||+|+||+||+|.+..+|..||+|++.... .......++.+|+.+|+.++||||++++++|....
T Consensus 28 ~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 28 PERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp ETTE-EEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCce-EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 3677 77899999999999999999999999999986432 34556678899999999999999999999986532
Q ss_pred -CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 -NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 -~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
...+++|+||+ +++|........+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLAR 180 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECC-----
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEEC-CCCCEEEeeccccc
Confidence 24578999999 678874445578999999999999999999999999 99999999999998 78999999999997
Q ss_pred eeccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCC----------
Q 006810 179 VMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK---------- 245 (630)
Q Consensus 179 ~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~---------- 245 (630)
..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.. +.+
T Consensus 181 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 181 HTADE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccccc-CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 65433 345689999999998764 5899999999999999999999999875544444333221 100
Q ss_pred --------------CC---CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 246 --------------PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 246 --------------p~---~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.. ......++.+++||.+||+ +|.+|||+.++|.||||...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 00 0112357899999999998 89999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=377.59 Aligned_cols=262 Identities=22% Similarity=0.358 Sum_probs=215.1
Q ss_pred CcceeeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 99 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~---~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~ 99 (630)
++| ++.+.||+|+||+||+|.+. .+|..||+|+++...........+.+.+|+.+|+.+ +||||++++++|...
T Consensus 54 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 54 ENF-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGE-EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred cce-EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 566 88899999999999999984 589999999987543222222334567899999999 699999999998665
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++||||+++|+|. ++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++
T Consensus 132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 132 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSK 207 (355)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEE
T ss_pred -ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCcEEEeeCCCCe
Confidence 4689999999999998 7777788999999999999999999999999 99999999999998 78999999999997
Q ss_pred eeccC---CCccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCC---CCHHHHHHHHHcCCCCCCC
Q 006810 179 VMQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNEC---KNPAQIYKKVTSGIKPASL 249 (630)
Q Consensus 179 ~~~~~---~~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~---~~~~~i~~~i~~g~~p~~l 249 (630)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||... .....+...+.... ..+
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~ 285 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPY 285 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--CCC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC--CCC
Confidence 65332 2334679999999998864 3789999999999999999999999753 23444555554432 234
Q ss_pred CCCCcHHHHHHHHHccc-CCCCCC-----CHHHHhcCCCcccCCCCcccc
Q 006810 250 SKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVC 293 (630)
Q Consensus 250 ~~~~s~~lk~~I~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~ 293 (630)
+...++.+++||.+||. +|.+|| ++.++++||||+..++..+..
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~ 335 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA 335 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhh
Confidence 55678999999999997 899999 999999999999877655443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=372.99 Aligned_cols=259 Identities=26% Similarity=0.407 Sum_probs=211.2
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
...+|| ++.+.||+|+||+||+|.+..+|..||+|++.... ......+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 96 (331)
T 4aaa_A 22 QSMEKY-ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-- 96 (331)
T ss_dssp BCGGGE-EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred hhhhhh-eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--
Confidence 345677 78899999999999999999999999999986543 3445567788999999999999999999998754
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++||||+++++|. +......+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFART 173 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCTTC--
T ss_pred CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEc-CCCcEEEEeCCCcee
Confidence 4689999999999998 5566778999999999999999999999999 99999999999998 788999999999976
Q ss_pred eccC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------------
Q 006810 180 MQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------- 242 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~------------- 242 (630)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...+..
T Consensus 174 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 174 LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 5432 2345679999999998865 5889999999999999999999999886555544443321
Q ss_pred ------CCCCCC---------CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 243 ------GIKPAS---------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 243 ------g~~p~~---------l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+..... .....++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 000000 012457899999999998 899999999999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=358.66 Aligned_cols=254 Identities=26% Similarity=0.463 Sum_probs=209.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
+|| ++.+.||+|+||.||+|.+..+|..||+|.+...... .....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 11 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 86 (276)
T 2h6d_A 11 GHY-VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--TDF 86 (276)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred ccE-EEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CeE
Confidence 567 8889999999999999999999999999999754321 122346788999999999999999999998654 578
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+++++|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEEC-TTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEEC-CCCCEEEeecccccccCC
Confidence 9999999999998 7777888999999999999999999999999 99999999999998 788999999999976544
Q ss_pred C-CCccccCCCCCCCccccccc-c-CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 183 P-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 183 ~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
. ......||+.|+|||++.+. + +.++||||||+++|+|++|+.||.. .+...+...+..+.. .++...++.+++
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVF--YIPEYLNRSVAT 240 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHH
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCcc--cCchhcCHHHHH
Confidence 3 23455789999999988764 3 6799999999999999999999987 456666666666533 234566899999
Q ss_pred HHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 260 FIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+|.+||. +|.+||++.++|+||||+...
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 9999998 899999999999999998654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=358.68 Aligned_cols=250 Identities=32% Similarity=0.519 Sum_probs=204.6
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEccc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey~ 110 (630)
.+||+|+||+||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||++++++|.+. ..+++||||+
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 101 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFMEQV 101 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEECC
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEEEEeC
Confidence 48999999999999999999999999997543 23456788999999999999999999998754 4689999999
Q ss_pred CCCCHH-HHhhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--C
Q 006810 111 TSGSLR-YRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 184 (630)
Q Consensus 111 ~gGsL~-~~~~~---~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~ 184 (630)
++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++..++.+||+|||++...... .
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 999998 44433 25679999999999999999999999 9999999999999854899999999999765432 2
Q ss_pred CccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 185 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 185 ~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
.....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.....................++...++.+++||
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 345679999999998864 27899999999999999999999997654444333332222233345667789999999
Q ss_pred HHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 262 EKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
.+||. +|.+||++.++|.||||+....
T Consensus 260 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 260 LKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHccCChhhCCCHHHHhcChhhhhccc
Confidence 99998 8999999999999999986543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=373.20 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=201.4
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH-HHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~-~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
..+|| ++.+.||+|+||+||+|.+..+|..||+|++......... ...+.+.+|+.+++.++||||++++++|.+.
T Consensus 8 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (346)
T 1ua2_A 8 RAKRY-EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-- 84 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred Hhccc-EEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--
Confidence 35677 7789999999999999999999999999999754322211 1234678999999999999999999998654
Q ss_pred CEEEEEEcccCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 RTINMITELFTSGSLRYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+++||||+.++...++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 85 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 85 SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKS 161 (346)
T ss_dssp TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGST
T ss_pred CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEc-CCCCEEEEeccccee
Confidence 45889999999843335444 356999999999999999999999999 99999999999998 789999999999976
Q ss_pred eccC--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCC-CCCC----
Q 006810 180 MQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-PASL---- 249 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~-p~~l---- 249 (630)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+...+.. +.. +..+
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 5432 2345679999999998754 4889999999999999999999999875544444333322 111 1111
Q ss_pred -------------------CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 250 -------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 250 -------------------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
....++.+++||.+||. +|.+|||+.|+|+||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13456899999999998 89999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=362.56 Aligned_cols=260 Identities=28% Similarity=0.526 Sum_probs=208.8
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
....+..+| ++.+.||+|+||+||+|.+..+|..||+|.+.... ..+.+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 23 LTKQPEEVF-DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp -------CE-EEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred hhhcchhhh-hhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 345567777 77899999999999999999999999999997543 23458899999999999999999999876
Q ss_pred CCCCEEEEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 98 DTNRTINMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
. ..+++||||+++|+|. ++. ....+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||
T Consensus 96 ~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg 170 (314)
T 3com_A 96 N--TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFG 170 (314)
T ss_dssp T--TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCT
T ss_pred C--CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEEC-CCCCEEEeecc
Confidence 4 4689999999999998 443 4678999999999999999999999999 99999999999998 78999999999
Q ss_pred cceeeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCC
Q 006810 176 LAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSK 251 (630)
Q Consensus 176 la~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p~~l~~ 251 (630)
++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||........+ ..+..... ....+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 249 (314)
T 3com_A 171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-FMIPTNPPPTFRKPE 249 (314)
T ss_dssp TCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSCCCCCSSGG
T ss_pred cchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhcCCCcccCCcc
Confidence 99766543 2345679999999998765 5899999999999999999999999874433333 33333322 222344
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCCc
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 290 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~~ 290 (630)
..++.+++||.+||. +|.+||++.++|.||||+......
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~ 289 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence 568899999999997 899999999999999998765433
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=378.91 Aligned_cols=254 Identities=20% Similarity=0.338 Sum_probs=200.1
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHH-HhCCCCCeeEEEeEEEc--C
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWVD--D 98 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL-~~L~HpNIVk~~~~f~d--~ 98 (630)
-.++|..+.++||+|+||+||+|.+..+|+.||+|++... ..+.+|+.++ +.++||||++++++|.. .
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 3456655558999999999999999999999999998622 2466788887 55689999999998854 2
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC--CCcEEEcc
Q 006810 99 TNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGD 173 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKL~D 173 (630)
....+|+||||+++|+|. ++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++.. ++.+||+|
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECC
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEe
Confidence 345799999999999998 55543 35999999999999999999999999 9999999999999832 78999999
Q ss_pred cccceeeccC-CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHH---HHHHHHHcCCC--C
Q 006810 174 LGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIK--P 246 (630)
Q Consensus 174 FGla~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~---~i~~~i~~g~~--p 246 (630)
||++...... .....+||+.|+|||++. ..|+.++|||||||++|+|++|+.||....... .+...+..+.. +
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp CTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred cccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 9999865433 345668999999999886 468999999999999999999999997643211 13333443322 2
Q ss_pred CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 ~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.......++++++||.+||. +|.+|||+.++|+||||...
T Consensus 288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 22234578999999999997 89999999999999999763
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=357.48 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=211.7
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~--~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
+| ++.+.||+|+||+||+|.+..+|..||+|.+......... ...+.+.+|+.++++++||||+++++++.+. ..
T Consensus 6 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 82 (283)
T 3bhy_A 6 HY-EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--TD 82 (283)
T ss_dssp HE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hh-hhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--Ce
Confidence 55 8889999999999999999999999999999865433221 1356788999999999999999999998654 46
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC----cEEEcccccc
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGLA 177 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKL~DFGla 177 (630)
+++||||+++++|. ++.....+++..++.++.||+.||.|||+++ |+||||||+||+++ .++ .+||+|||++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLL-DKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES-CSSSSSCCEEECCCTTC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEe-cCCCCCCceEEEecccc
Confidence 89999999999998 7777788999999999999999999999999 99999999999997 455 8999999999
Q ss_pred eeeccC-CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCC
Q 006810 178 IVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVT 253 (630)
Q Consensus 178 ~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~ 253 (630)
...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.. .+.......+...... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 160 HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp EECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred eeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhcccCCcchhcccC
Confidence 766443 234557999999999886 4589999999999999999999999987 4455555555544321 1223456
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
++.+++||.+||. +|.+||++.++|.||||+..
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 7899999999997 89999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=363.57 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=209.5
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
..-.+|| ++.+.||+|+||+||+|.+..+|..||+|.+..... ......+++.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~- 83 (294)
T 4eqm_A 7 KIINERY-KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED- 83 (294)
T ss_dssp SCEETTE-EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-
T ss_pred hHhhccE-EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-
Confidence 3445677 888999999999999999999999999999975543 3456678899999999999999999999988644
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 84 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 84 -DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILID-SNKTLKIFDFGIAK 159 (294)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCSSST
T ss_pred -CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEEeCCCcc
Confidence 5799999999999998 7777889999999999999999999999999 99999999999998 78999999999997
Q ss_pred eeccC---CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCC
Q 006810 179 VMQQP---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKV 252 (630)
Q Consensus 179 ~~~~~---~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~ 252 (630)
..... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+..........+...... ......
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T 4eqm_A 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239 (294)
T ss_dssp TC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTT
T ss_pred ccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccC
Confidence 65432 2334579999999998765 47899999999999999999999998754444444444433221 234456
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
.++.+.++|.+||. +|.+||++.+.+.+.|.
T Consensus 240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 78999999999998 89999966666666554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=360.73 Aligned_cols=262 Identities=31% Similarity=0.496 Sum_probs=220.6
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
.....-.+|| ++.+.||+|+||+||+|.+..+|..||+|++...... ....+.+.+|+.++++++||||+++++++.
T Consensus 15 ~~~~~~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (287)
T 2wei_A 15 YFQGTFAERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILE 91 (287)
T ss_dssp HHTHHHHHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHHHHHhhcc-eeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence 3344445677 8889999999999999999999999999999765432 234567889999999999999999999986
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC--CCcEEEcc
Q 006810 97 DDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGD 173 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKL~D 173 (630)
+. ..+++||||+.+++|. ++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++.. ++.+||+|
T Consensus 92 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~D 167 (287)
T 2wei_A 92 DS--SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIID 167 (287)
T ss_dssp CS--SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred CC--CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEec
Confidence 54 5789999999999997 7777788999999999999999999999999 9999999999999732 34799999
Q ss_pred cccceeeccC-CCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC--C
Q 006810 174 LGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--S 250 (630)
Q Consensus 174 FGla~~~~~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l--~ 250 (630)
||++...... ......||+.|+|||++.+.++.++||||||+++|+|++|..||.. .+...+...+..+..+... .
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T 2wei_A 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQW 246 (287)
T ss_dssp TTGGGTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGG
T ss_pred cCcceeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhh
Confidence 9999765443 2344568999999999988899999999999999999999999987 4556666666665443322 2
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
...++.+++||.+||. +|.+||++.++|.||||+..
T Consensus 247 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred hhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 4568999999999998 89999999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=373.02 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=209.1
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~----~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
-.+|| ++.+.||+|+||+||+|.+..+|..||+|++........ ......+.+|+.+|++++||||++++++|.+
T Consensus 22 ~~~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKY-STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHE-EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccce-EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34566 788999999999999999999999999999986543221 1123457789999999999999999999865
Q ss_pred CCCCEEEEEEcccCCC-CHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 98 DTNRTINMITELFTSG-SLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gG-sL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
. ..+++||||+.+| +|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 101 ~--~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg 175 (335)
T 3dls_A 101 Q--GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIA-EDFTIKLIDFG 175 (335)
T ss_dssp S--SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCT
T ss_pred C--CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEc-CCCcEEEeecc
Confidence 4 5789999999777 887 7777888999999999999999999999999 99999999999998 78999999999
Q ss_pred cceeeccC-CCccccCCCCCCCccccccc-c-CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006810 176 LAIVMQQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 252 (630)
Q Consensus 176 la~~~~~~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~ 252 (630)
++...... .....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||..... .+. .....+..
T Consensus 176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~---~~~~~~~~ 246 (335)
T 3dls_A 176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVE---AAIHPPYL 246 (335)
T ss_dssp TCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTT---TCCCCSSC
T ss_pred cceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHh---hccCCCcc
Confidence 99876543 33456799999999987653 4 7899999999999999999999975211 011 11223445
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.++++++||.+||. +|.+||++.++|+||||+..
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 78999999999998 89999999999999999763
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=378.47 Aligned_cols=254 Identities=25% Similarity=0.400 Sum_probs=202.9
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC------CCCCeeEEEeEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL------KHENIIKFYNSW 95 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L------~HpNIVk~~~~f 95 (630)
...|| ++.+.||+|+||+||+|.+..+|..||+|++... ......+.+|+.+++.+ +|+||++++++|
T Consensus 95 ~~~ry-~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 95 VAYRY-EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp ETTTE-EEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred ccCcE-EEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 34566 8889999999999999999999999999998642 34456677888888877 677999999998
Q ss_pred EcCCCCEEEEEEcccCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc--EEE
Q 006810 96 VDDTNRTINMITELFTSGSLRYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKI 171 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~--vKL 171 (630)
... ..+++||||+.++.+.++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++. +||
T Consensus 169 ~~~--~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~-~~~~~~vkL 243 (429)
T 3kvw_A 169 TFR--NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLK-QQGRSGIKV 243 (429)
T ss_dssp EET--TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEES-STTSCCEEE
T ss_pred ccC--CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-cCCCcceEE
Confidence 765 468999999975433455443 45999999999999999999999999 99999999999998 6666 999
Q ss_pred cccccceeeccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCCCC--
Q 006810 172 GDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA-- 247 (630)
Q Consensus 172 ~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p~-- 247 (630)
+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|||+||..||.+.....++...+.. +..+.
T Consensus 244 ~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 244 IDFGSSCYEHQ-RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CCCTTCEETTC-CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eecccceecCC-cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 99999976543 3345689999999998765 5999999999999999999999999875544444333321 10000
Q ss_pred -----------------------------------------------------CCCCCCcHHHHHHHHHccc-CCCCCCC
Q 006810 248 -----------------------------------------------------SLSKVTDPQVKQFIEKCIV-PASLRLP 273 (630)
Q Consensus 248 -----------------------------------------------------~l~~~~s~~lk~~I~kcL~-~p~~Rps 273 (630)
.+....++.+++||.+||+ +|.+|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 0112347889999999998 8999999
Q ss_pred HHHHhcCCCcccCC
Q 006810 274 ALELLKDPFLVTDN 287 (630)
Q Consensus 274 a~eLL~hpf~~~~~ 287 (630)
+.|+|+||||+...
T Consensus 403 a~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 403 PGQALRHPWLRRRL 416 (429)
T ss_dssp HHHHHTSTTTC---
T ss_pred HHHHhCChhhccCC
Confidence 99999999998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=360.86 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=205.1
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC--
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD-- 98 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~-- 98 (630)
+..+|| ++.+.||+|+||+||+|.+..+|..||+|.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 8 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 8 DLGSRY-MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp EETTTE-EEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred ccCCce-eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 445777 7889999999999999999999999999998743 355677899999999999999999999987432
Q ss_pred ----------CCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc
Q 006810 99 ----------TNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 168 (630)
Q Consensus 99 ----------~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 168 (630)
....+++||||+. |+|......+.+++..++.++.||+.||.|||+++ |+||||||+|||++..++.
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTE
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCe
Confidence 2357899999998 57874445678999999999999999999999999 9999999999999856789
Q ss_pred EEEcccccceeeccC-----CCccccCCCCCCCccccc--cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 006810 169 VKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 241 (630)
Q Consensus 169 vKL~DFGla~~~~~~-----~~~~~~GTp~Y~APEvl~--~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~ 241 (630)
+||+|||++...... ......+|+.|+|||++. ..++.++|||||||++|+|+||+.||........ ...+.
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~ 238 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLIL 238 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence 999999999765422 223456799999999775 4589999999999999999999999987543333 33322
Q ss_pred cCCC------------------------C----CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 242 SGIK------------------------P----ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 242 ~g~~------------------------p----~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.... + ..+....++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 2110 0 01123468899999999998 89999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=363.05 Aligned_cols=261 Identities=28% Similarity=0.509 Sum_probs=189.4
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
..++| ++.+.||+|+||+||+|.+..+|..||+|.+..... ....+.+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 86 (303)
T 2vwi_A 13 NRDDY-ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-- 86 (303)
T ss_dssp CCCCC-EEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSS--
T ss_pred chhhh-hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--
Confidence 34566 888999999999999999999999999999875432 234566889999999999999999999987654
Q ss_pred EEEEEEcccCCCCHH-HHh--------hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEc
Q 006810 102 TINMITELFTSGSLR-YRK--------KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~--------~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 172 (630)
.+++||||+++|+|. ++. ....+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEc-CCCCEEEE
Confidence 588999999999997 443 2456999999999999999999999999 99999999999998 78999999
Q ss_pred ccccceeeccC-------CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Q 006810 173 DLGLAIVMQQP-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 243 (630)
Q Consensus 173 DFGla~~~~~~-------~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g 243 (630)
|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||................
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 99998654321 1234579999999998864 58999999999999999999999998755444444333322
Q ss_pred CC-------CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCCcc
Q 006810 244 IK-------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL 291 (630)
Q Consensus 244 ~~-------p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~~~ 291 (630)
.. ........++.++++|.+||. +|.+||++.++|+||||+....+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~ 299 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEF 299 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--------
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCcc
Confidence 11 112234567899999999998 8999999999999999987655443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=375.32 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=198.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC---
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~--- 99 (630)
.+|| ++.+.||+|+||+||+|.+..+|..||+|++.... ........+.+|+.+++.++||||++++++|....
T Consensus 24 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 24 LKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp ETTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhhe-eEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 3567 78899999999999999999999999999997542 34556678899999999999999999999986543
Q ss_pred -CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 -NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 -~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
...+++||||+.++.+..+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 101 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 101 EFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 175 (371)
T ss_dssp TCCEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCC--
T ss_pred cccceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEEEeeccc
Confidence 23789999999975444543 46999999999999999999999999 99999999999998 78999999999997
Q ss_pred eeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Q 006810 179 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--------- 247 (630)
Q Consensus 179 ~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~--------- 247 (630)
..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.... ..+..+.......
T Consensus 176 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHHhh
Confidence 66443 2345689999999998765 5899999999999999999999999875433 3333333221100
Q ss_pred -----------CC--------------CC------CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 248 -----------SL--------------SK------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 248 -----------~l--------------~~------~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.+ +. ..++++++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00 00 014678999999998 8999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=363.65 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=208.0
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC--
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-- 99 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~-- 99 (630)
-.++| ++.+.||+|+||+||+|.+..+|..||+|.+... .......++.+|+.+++.++||||+++++++....
T Consensus 9 i~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 9 ISSDF-QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp SCTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred cccce-EEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 45667 8899999999999999999999999999998643 23556677889999999999999999999875432
Q ss_pred -CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 -NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 -~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
...+++||||+.+ +|......+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 85 ~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 85 NFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGLAR 160 (353)
T ss_dssp TCCCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred ccceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-CCCcEEEEeccccc
Confidence 2568999999985 6764444568999999999999999999999999 99999999999998 78999999999997
Q ss_pred eeccCC------------CccccCCCCCCCccccc--cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-C
Q 006810 179 VMQQPT------------ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G 243 (630)
Q Consensus 179 ~~~~~~------------~~~~~GTp~Y~APEvl~--~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g 243 (630)
...... ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.....++...... +
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 654221 22357899999999765 45899999999999999999999999875433333222211 1
Q ss_pred CCC----------------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 244 IKP----------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 244 ~~p----------------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
..+ .......++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 000 00123567899999999998 899999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=368.76 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=216.3
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH-------------HHHHHHHHHHHHHHhCCCCCeeE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-------------DQLERLYSEVHLLKSLKHENIIK 90 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~-------------~~~~~l~~Ei~iL~~L~HpNIVk 90 (630)
++| ++.+.||+|+||.||+|.+ +|..||+|.+......... ...+.+.+|+.++++++||||++
T Consensus 31 ~~y-~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 31 NDY-RIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp TTE-EEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred Cce-EEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 566 8889999999999999998 8999999999764432211 11267899999999999999999
Q ss_pred EEeEEEcCCCCEEEEEEcccCCCCHH-H------Hhh--cCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCce
Q 006810 91 FYNSWVDDTNRTINMITELFTSGSLR-Y------RKK--HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNI 160 (630)
Q Consensus 91 ~~~~f~d~~~~~l~lV~Ey~~gGsL~-~------~~~--~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NI 160 (630)
+++++.+. ..+++||||+++|+|. + +.. ...+++..++.++.||+.||.|||+ ++ |+||||||+||
T Consensus 108 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGE
T ss_pred EEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhE
Confidence 99998764 4799999999999997 5 444 6789999999999999999999999 88 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCCccccCCCCCCCccccccc--cCc-ccceeehhHHHHHHhhCCCCCCCCCCHHHHH
Q 006810 161 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNE-LVDIYSFGMCILEMVTCEYPYNECKNPAQIY 237 (630)
Q Consensus 161 Ll~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~--ys~-~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~ 237 (630)
|++ .++.+||+|||++............||+.|+|||++.+. ++. ++|||||||++|+|++|+.||........+.
T Consensus 184 l~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 184 LMD-KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp EEC-TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EEc-CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 998 789999999999987665555567899999999988754 555 9999999999999999999998866656777
Q ss_pred HHHHcCCCCCCC-----------------CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 238 KKVTSGIKPASL-----------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 238 ~~i~~g~~p~~l-----------------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
..+..+..+... ....++.+++||.+||. +|.+||++.++|+||||+..+.
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 777665332211 14578999999999998 8999999999999999987554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=373.19 Aligned_cols=253 Identities=27% Similarity=0.396 Sum_probs=201.9
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC--------CCCeeEEEeE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--------HENIIKFYNS 94 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~--------HpNIVk~~~~ 94 (630)
.+|| ++.+.||+|+||+||+|.+..+|..||+|++... ....+.+.+|+.+|+.++ ||||++++++
T Consensus 36 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 36 NGRY-HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred CCeE-EEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 3677 8889999999999999999999999999998632 445677889999999995 7889999999
Q ss_pred EEcC--CCCEEEEEEcccCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEeccCCcCceEEeCCCC--
Q 006810 95 WVDD--TNRTINMITELFTSGSLRYRKKH--KNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNG-- 167 (630)
Q Consensus 95 f~d~--~~~~l~lV~Ey~~gGsL~~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g-- 167 (630)
|... ....+++||||+.++++.++... ..+++..++.++.||+.||.|||++ + |+||||||+|||++ .+|
T Consensus 110 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~-~~~~~ 186 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLS-VNEQY 186 (397)
T ss_dssp EEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEEC-CCHHH
T ss_pred eeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEe-ccchh
Confidence 8632 34579999999976666644433 5799999999999999999999998 8 99999999999997 444
Q ss_pred -----------------------------------------------cEEEcccccceeeccCCCccccCCCCCCCcccc
Q 006810 168 -----------------------------------------------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 200 (630)
Q Consensus 168 -----------------------------------------------~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl 200 (630)
.+||+|||++...... ....+||+.|+|||++
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhh
Confidence 7999999999876543 3456799999999987
Q ss_pred cc-ccCcccceeehhHHHHHHhhCCCCCCCCCC------HHHHHHHHH-cCCCCC-------------------------
Q 006810 201 EE-EYNELVDIYSFGMCILEMVTCEYPYNECKN------PAQIYKKVT-SGIKPA------------------------- 247 (630)
Q Consensus 201 ~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~------~~~i~~~i~-~g~~p~------------------------- 247 (630)
.+ .|+.++|||||||++|+|+||+.||..... ...+..... .+..|.
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 65 589999999999999999999999976432 111111111 011110
Q ss_pred -------------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 248 -------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 248 -------------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.+....++.+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0111224678999999998 8999999999999999963
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=383.70 Aligned_cols=250 Identities=16% Similarity=0.188 Sum_probs=196.5
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHH---HHHHhCCCCCeeEEE-----
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV---HLLKSLKHENIIKFY----- 92 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei---~iL~~L~HpNIVk~~----- 92 (630)
.+.++| ++.+.||+|+||+||+|.+..+|..||+|++...... .....+.+.+|+ ++|++++|||||+++
T Consensus 70 ~~~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 70 ERPRTL-VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp CCCEEE-EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred CCCceE-EEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 344555 8889999999999999999999999999999865432 344567789999 566666899999998
Q ss_pred --eEEEcCCC------------C---EEEEEEcccCCCCHH-HHhhcCCCCH-------HHHHHHHHHHHHHHHHHHcCC
Q 006810 93 --NSWVDDTN------------R---TINMITELFTSGSLR-YRKKHKNVDM-------KAIKNWARQILRGLHYLHSHN 147 (630)
Q Consensus 93 --~~f~d~~~------------~---~l~lV~Ey~~gGsL~-~~~~~~~lse-------~~i~~i~~QIl~gL~yLHs~~ 147 (630)
+++.+... . ..++||||+ +|+|. ++...+.+++ ..++.|+.||+.||+|||+++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 55543311 1 378999999 57887 6665555555 888899999999999999999
Q ss_pred CCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCccccCCCCCCCcccccc------------ccCcccceeehhH
Q 006810 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE------------EYNELVDIYSFGM 215 (630)
Q Consensus 148 ~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~------------~ys~~sDIWSLGv 215 (630)
|+||||||+|||++ .+|.+||+|||+++.... .....+| +.|+|||++.+ .|+.++|||||||
T Consensus 227 --ivHrDikp~NIll~-~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 --LVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp --EECSCCCGGGEEEC-TTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred --eecCCCCHHHEEEc-CCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999998 789999999999985433 3345678 99999998764 4899999999999
Q ss_pred HHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 216 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 216 il~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
++|+|+||+.||..... ......+.. .....++.+++||.+||. +|.+||++.++|+||||+.
T Consensus 302 il~elltg~~Pf~~~~~-~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 302 VIYWIWCADLPITKDAA-LGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHSSCCC-------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHCCCCCccccc-ccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999999976321 111111111 124568999999999998 8999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=355.81 Aligned_cols=252 Identities=32% Similarity=0.501 Sum_probs=205.2
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC----
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---- 99 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~---- 99 (630)
++| ++.+.||+|+||+||+|.+..+|..||+|.+... ....+.+.+|+.++++++||||++++++|.+..
T Consensus 6 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 6 SDF-EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccc-hhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 355 7889999999999999999999999999998642 345677899999999999999999999987632
Q ss_pred -------CCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEE
Q 006810 100 -------NRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 170 (630)
Q Consensus 100 -------~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 170 (630)
...+++||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~-~~~~~k 156 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVK 156 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEE
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEc-CCCCEE
Confidence 35789999999999998 5543 446889999999999999999999999 99999999999997 789999
Q ss_pred EcccccceeeccC----------------CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCC
Q 006810 171 IGDLGLAIVMQQP----------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN 232 (630)
Q Consensus 171 L~DFGla~~~~~~----------------~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~ 232 (630)
|+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++ ||....+
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 9999998754321 2234578999999998864 58999999999999999998 6654334
Q ss_pred HHHHHHHHHcCC--CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 233 PAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 233 ~~~i~~~i~~g~--~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
...+...+.... .|..+....++.++++|.+||. +|.+|||+.++|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 445555555432 2445556677889999999998 899999999999999997643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=350.83 Aligned_cols=252 Identities=28% Similarity=0.446 Sum_probs=197.8
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||+||+|.+. |..||+|++............+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 6 ~~~~-~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (271)
T 3dtc_A 6 FAEL-TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--PN 80 (271)
T ss_dssp TTSE-EEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----
T ss_pred hhhe-eeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--Cc
Confidence 4677 88899999999999999874 8999999987654333334457789999999999999999999998654 45
Q ss_pred EEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEEeccCCcCceEEeC-------CCCcEEEccc
Q 006810 103 INMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVNG-------NNGEVKIGDL 174 (630)
Q Consensus 103 l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~-~IiHrDLKp~NILl~~-------~~g~vKL~DF 174 (630)
+++||||+++|+|......+.+++..++.++.||+.||.|||+++. +|+||||||+|||++. .++.+||+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred eEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 8899999999999965667789999999999999999999999983 3889999999999973 2678999999
Q ss_pred ccceeeccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 175 GLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 175 Gla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
|++............||+.|+|||++.+ .++.++||||||+++|+|++|+.||... +.......+.........+...
T Consensus 161 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 161 GLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp CC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHTSCCCCCCCTTC
T ss_pred CcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhhcCCCCCCCCccc
Confidence 9998766655556789999999998765 4899999999999999999999999874 4444444455444445566677
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
++.++++|.+||. +|.+||++.+++++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 8999999999998 89999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=366.89 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=201.1
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc-------CCHHHHHHHHHHHHHHHhCCCCCeeEEEeE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-------QSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~-------~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~ 94 (630)
..++| ++.+.||+|+||.||+|.+.. |..||+|++...... ......+.+.+|+.+|++++||||++++++
T Consensus 20 ~~~~y-~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 20 MQSPY-TVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp TTCSC-EEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred hccce-EEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 35677 888999999999999999865 999999998653321 223445789999999999999999999999
Q ss_pred EEcC---CCCEEEEEEcccCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEE
Q 006810 95 WVDD---TNRTINMITELFTSGSLRYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 170 (630)
Q Consensus 95 f~d~---~~~~l~lV~Ey~~gGsL~~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 170 (630)
|... ....+++||||+.++.+.++. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA-DNNDIT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEE
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc-CCCCEE
Confidence 8653 334789999999965555443 4457999999999999999999999999 99999999999997 789999
Q ss_pred EcccccceeeccC-CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-
Q 006810 171 IGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP- 246 (630)
Q Consensus 171 L~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p- 246 (630)
|+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.....+
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999999754433 3345678999999998764 58999999999999999999999998754333333222110000
Q ss_pred ----------------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 ----------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 ----------------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.......++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 01123457889999999998 89999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=368.93 Aligned_cols=256 Identities=25% Similarity=0.331 Sum_probs=196.3
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC---
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~--- 99 (630)
.+|| ++.+.||+|+||+||+|.+..+|..||+|++...... ..+..++++.++.++||||++++++|....
T Consensus 22 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 22 MDRF-QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HTTE-EEC----------CEEEEETTTCCEEEEEEEECCTTC-----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred ccce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 4577 7889999999999999999999999999998654322 234667888899999999999999986532
Q ss_pred --CCEEEEEEcccCCCCHH----HHhhcCCCCHHHHHHHHHHHHHHHHHHH--cCCCCEEeccCCcCceEEeCCCCcEEE
Q 006810 100 --NRTINMITELFTSGSLR----YRKKHKNVDMKAIKNWARQILRGLHYLH--SHNPPIIHRDLKCDNIFVNGNNGEVKI 171 (630)
Q Consensus 100 --~~~l~lV~Ey~~gGsL~----~~~~~~~lse~~i~~i~~QIl~gL~yLH--s~~~~IiHrDLKp~NILl~~~~g~vKL 171 (630)
...+++||||+.++.+. +......+++..++.++.||+.||.||| +++ |+||||||+|||++..++.+||
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEE
Confidence 23588999999987654 2346778999999999999999999999 777 9999999999999844899999
Q ss_pred cccccceeeccC-CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--
Q 006810 172 GDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-- 246 (630)
Q Consensus 172 ~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-- 246 (630)
+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||........+...+.....+
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 999999866543 3345678999999998753 38999999999999999999999998754444433333211000
Q ss_pred ---------------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 ---------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 ---------------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.......++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 01112246789999999998 89999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=350.47 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=209.1
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHH---HHHHHHHHHHHhCCCCCeeEEEeEE
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL---ERLYSEVHLLKSLKHENIIKFYNSW 95 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~---~~l~~Ei~iL~~L~HpNIVk~~~~f 95 (630)
..-..++| ++.+.||+|+||+||+|.+..+|..||+|.+............ +.+.+|+.++++++||||+++++++
T Consensus 14 ~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 14 PTLADNEI-EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CBCCSTTE-EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhccc-eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 33445777 8889999999999999999999999999999765543333322 6788999999999999999999988
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc-----
Q 006810 96 VDDTNRTINMITELFTSGSLR-YR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----- 168 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~----- 168 (630)
.+.. ++||||+++|+|. ++ .....+++..++.++.||+.||.|||+++++|+||||||+|||++ .++.
T Consensus 93 ~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~-~~~~~~~~~ 167 (287)
T 4f0f_A 93 HNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ-SLDENAPVC 167 (287)
T ss_dssp TTTT----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES-CCCTTCSCC
T ss_pred cCCC----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe-ccCCCCcee
Confidence 5432 5899999999996 44 445679999999999999999999999988899999999999997 5555
Q ss_pred EEEcccccceeeccCCCccccCCCCCCCccccc---cccCcccceeehhHHHHHHhhCCCCCCCCCCHHH-HHHHHHcCC
Q 006810 169 VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGI 244 (630)
Q Consensus 169 vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~---~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~-i~~~i~~g~ 244 (630)
+||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||........ ....+....
T Consensus 168 ~kl~Dfg~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 168 AKVADFGLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp EEECCCTTCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred EEeCCCCccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 99999999975433 234567999999999883 3478999999999999999999999987544333 334444444
Q ss_pred CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 245 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 245 ~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
....++...++.++++|.+||. +|.+||++.++++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4455667788999999999998 8999999999886
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=370.00 Aligned_cols=254 Identities=28% Similarity=0.402 Sum_probs=203.6
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC--
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR-- 101 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~-- 101 (630)
+|| ++.+.||+|+||+||+|.+..+|..||+|++.... .......++.+|+.+++.++||||++++++|......
T Consensus 42 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 42 KTY-VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccE-EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 456 77899999999999999999999999999987542 3455667899999999999999999999998765432
Q ss_pred --EEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 102 --TINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 102 --~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
.+++||||+.+ +|.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 119 ~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 119 FYDFYLVMPFMQT-DLQKIM-GMEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARH 193 (371)
T ss_dssp CCCCEEEEECCCE-EHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECSTTCC--
T ss_pred ceeEEEEEccccc-cHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEEC-CCCCEEEEecCcccc
Confidence 34899999985 565222 345999999999999999999999999 99999999999998 789999999999976
Q ss_pred eccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Q 006810 180 MQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------- 246 (630)
Q Consensus 180 ~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p----------- 246 (630)
.... ....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+......+...+.....+
T Consensus 194 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 194 ADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred cccC-cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 5443 345678999999998765 58999999999999999999999998754444433332211100
Q ss_pred -----------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 -----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 -----------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..+....++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 01123457899999999998 89999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=378.98 Aligned_cols=255 Identities=25% Similarity=0.413 Sum_probs=189.7
Q ss_pred cceeeeeEecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~--~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
+|.-.+++||+|+||+||+|.++ .++..||+|++..... ...+.+|+.+|+.|+||||++++++|.......
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 44223578999999999999965 5789999999864432 134778999999999999999999998777778
Q ss_pred EEEEEcccCCCCHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe---CCCCcEE
Q 006810 103 INMITELFTSGSLRYRKK---------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVK 170 (630)
Q Consensus 103 l~lV~Ey~~gGsL~~~~~---------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~---~~~g~vK 170 (630)
+++||||+.++.+.++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||+. ..++.+|
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence 999999998765544331 225999999999999999999999999 99999999999993 2678999
Q ss_pred EcccccceeeccC-----CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCC---------HH
Q 006810 171 IGDLGLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN---------PA 234 (630)
Q Consensus 171 L~DFGla~~~~~~-----~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~---------~~ 234 (630)
|+|||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||..... ..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 9999999765432 2345689999999998865 489999999999999999999999975332 13
Q ss_pred HHHHHHHc-CCCCCC-C---------------------------------CCCCcHHHHHHHHHccc-CCCCCCCHHHHh
Q 006810 235 QIYKKVTS-GIKPAS-L---------------------------------SKVTDPQVKQFIEKCIV-PASLRLPALELL 278 (630)
Q Consensus 235 ~i~~~i~~-g~~p~~-l---------------------------------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL 278 (630)
++...+.. +.++.. + ....++.+++||.+||. +|.+|||+.|+|
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 33322221 111110 0 01126788999999998 899999999999
Q ss_pred cCCCcccCC
Q 006810 279 KDPFLVTDN 287 (630)
Q Consensus 279 ~hpf~~~~~ 287 (630)
+||||....
T Consensus 333 ~hp~f~~~~ 341 (405)
T 3rgf_A 333 QDPYFLEDP 341 (405)
T ss_dssp TSGGGTSSS
T ss_pred cChhhccCC
Confidence 999998743
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=362.19 Aligned_cols=255 Identities=28% Similarity=0.409 Sum_probs=204.2
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC--
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~-- 100 (630)
.++| ++.+.||+|+||+||+|.+..+|..||+|++.... .......++.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 23 PKTY-VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp ETTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CceE-EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 3567 78899999999999999999999999999986532 345566788999999999999999999999876543
Q ss_pred --CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 101 --RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++||||+.+ +|.... ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 100 NFYDFYLVMPFMQT-DLQKIM-GLKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLAR 174 (353)
T ss_dssp GCCCCEEEEECCSE-EGGGTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTCCEEECSTTCTT
T ss_pred cceeEEEEeccccC-CHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeEC-CCCcEEEeeccccc
Confidence 235899999985 665222 235999999999999999999999999 99999999999998 78999999999997
Q ss_pred eeccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CC-----------
Q 006810 179 VMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI----------- 244 (630)
Q Consensus 179 ~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~----------- 244 (630)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.. +.
T Consensus 175 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 175 HADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp C---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCCCC-ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 65432 345678999999998764 5899999999999999999999999875433333222211 00
Q ss_pred ----------------CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 245 ----------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 245 ----------------~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
....+....++.+++||.+||. +|.+|||+.++|.||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0112234568999999999998 89999999999999999764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=356.53 Aligned_cols=259 Identities=28% Similarity=0.444 Sum_probs=204.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEc-cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCeeEEEeEEEc-
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVD- 97 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~-~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpNIVk~~~~f~d- 97 (630)
.++| ++.+.||+|+||+||+|.+. .+|..||+|++....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 10 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 10 DQQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred hhce-eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 3566 88899999999999999995 789999999997543221 1112355666666655 89999999998863
Q ss_pred --CCCCEEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEc
Q 006810 98 --DTNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172 (630)
Q Consensus 98 --~~~~~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 172 (630)
.....+++||||+.+ +|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~-~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEEC
T ss_pred ccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEc-CCCCEEEe
Confidence 234578999999995 776 55543 35999999999999999999999999 99999999999998 78999999
Q ss_pred ccccceeeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCC----
Q 006810 173 DLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK---- 245 (630)
Q Consensus 173 DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~---- 245 (630)
|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+......+...+.. +..
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 99999765432 2345678999999998764 5899999999999999999999999875544444333321 100
Q ss_pred -------------------CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 246 -------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 246 -------------------p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
...+....++.+++||.+||. +|.+||++.++|.||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 011234568899999999998 8999999999999999987543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=363.46 Aligned_cols=267 Identities=21% Similarity=0.314 Sum_probs=186.6
Q ss_pred CCCCccCCccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCe
Q 006810 9 KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88 (630)
Q Consensus 9 ~~~~~~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI 88 (630)
..++..+......-.++|..+.++||+|+||+||+|.+..+|..||+|++... ... ..+....++.+.||||
T Consensus 13 ~~~~~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~---~~e~~~~~~~~~h~~i 84 (336)
T 3fhr_A 13 EVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKA---RQEVDHHWQASGGPHI 84 (336)
T ss_dssp -------CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHH---HHHHHHHHHHTTSTTB
T ss_pred cccccCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHH---HHHHHHHHHhcCCCCh
Confidence 34455566666677788955577899999999999999999999999998632 121 2223345677899999
Q ss_pred eEEEeEEEcC--CCCEEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe
Q 006810 89 IKFYNSWVDD--TNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 163 (630)
Q Consensus 89 Vk~~~~f~d~--~~~~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 163 (630)
++++++|... ....+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 85 ~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~ 162 (336)
T 3fhr_A 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYT 162 (336)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES
T ss_pred HHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEE
Confidence 9999998652 235689999999999998 55444 36999999999999999999999999 99999999999997
Q ss_pred C--CCCcEEEcccccceeeccCCCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHH---HH
Q 006810 164 G--NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IY 237 (630)
Q Consensus 164 ~--~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~---i~ 237 (630)
. .++.+||+|||++............||+.|+|||++. ..++.++|||||||++|+|++|..||........ ..
T Consensus 163 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 242 (336)
T 3fhr_A 163 SKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242 (336)
T ss_dssp CSSTTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred ecCCCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH
Confidence 3 2456999999999877666566678999999999885 4588999999999999999999999976432211 11
Q ss_pred HHHHcCC--CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 238 KKVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 238 ~~i~~g~--~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
..+..+. .+.......++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 243 RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 1121111 1222334578999999999997 8999999999999999976
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=346.04 Aligned_cols=248 Identities=19% Similarity=0.302 Sum_probs=206.7
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
.-++| ++.+.||+|+||+||+|.+. |..||+|++.... ......+.+.+|+.++++++||||+++++++.+....
T Consensus 8 ~~~~y-~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 8 DFKQL-NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CGGGC-EEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CHHHh-HHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 34566 78899999999999999875 8999999997653 2455667899999999999999999999999776556
Q ss_pred EEEEEEcccCCCCHH-HHhhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.+++||||+++|+|. ++.... .+++..++.|+.||+.||.|||+++++++||||||+||+++ .+|.++|+|||++.
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKF 161 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGSCC
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc-CCcceeEEecccee
Confidence 789999999999998 555544 48999999999999999999999988899999999999998 78899999888875
Q ss_pred eeccCCCccccCCCCCCCccccccc-c---CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 179 VMQQPTARSVIGTPEFMAPELYEEE-Y---NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 179 ~~~~~~~~~~~GTp~Y~APEvl~~~-y---s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
.... ....||+.|+|||++.+. + +.++|||||||++|+|+||+.||..... ......+........++...+
T Consensus 162 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3kmu_A 162 SFQS---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-MEIGMKVALEGLRPTIPPGIS 237 (271)
T ss_dssp TTSC---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-HHHHHHHHHSCCCCCCCTTCC
T ss_pred eecc---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-HHHHHHHHhcCCCCCCCCCCC
Confidence 4322 345789999999988643 3 3479999999999999999999987544 444444443334445666788
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+.+.++|.+||. +|.+|||+.++++
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 238 PHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999998 8999999999886
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=361.09 Aligned_cols=242 Identities=27% Similarity=0.440 Sum_probs=200.8
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||+||+|.+..+|..||+|.+.. ......+.+.+|+.++++++||||+++++++.+. ..
T Consensus 9 ~~~~-~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 81 (310)
T 3s95_A 9 PSDL-IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KR 81 (310)
T ss_dssp GGGE-EEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TE
T ss_pred hhHe-eccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--Ce
Confidence 3566 788999999999999999999999999998843 2456678899999999999999999999998765 46
Q ss_pred EEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 103 INMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
+++||||+++|+|. ++.. ...+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR-ENKNVVVADFGLARLM 158 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEC-TTSCEEECCCTTCEEC
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEEC-CCCCEEEeecccceec
Confidence 89999999999998 5544 578999999999999999999999999 99999999999998 7899999999999765
Q ss_pred ccCCC----------------ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHH-----HHHH
Q 006810 181 QQPTA----------------RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA-----QIYK 238 (630)
Q Consensus 181 ~~~~~----------------~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~-----~i~~ 238 (630)
..... ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 43211 15679999999998875 58999999999999999999999987532211 0111
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 239 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 239 ~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.... ..+...++.+.++|.+||. +|.+||++.+++.
T Consensus 239 ~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 239 FLDR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHH-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccc-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 1234556789999999998 8999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=364.89 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=210.4
Q ss_pred CCCCcceeeeeEecccCceEEEEEE-----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeE
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~-----d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~ 94 (630)
-+.+|| ++.+.||+|+||.||+|. +..+|..||+|++... ......+.+.+|+.+|+++ +||||++++++
T Consensus 19 ~~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 19 FPRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp CCGGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccce-eeceeecCCCCceEEEEEeccccccccceEEEEEEecCc---CCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 456777 888999999999999998 5677899999999743 2355667899999999999 89999999999
Q ss_pred EEcCCCCEEEEEEcccCCCCHH-HHhhcCC--------------------------------------------------
Q 006810 95 WVDDTNRTINMITELFTSGSLR-YRKKHKN-------------------------------------------------- 123 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~-------------------------------------------------- 123 (630)
|.+.. ..+++||||+++|+|. ++.....
T Consensus 95 ~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 95 CTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp ECSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 86543 4578999999999998 5544332
Q ss_pred ----------------CCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC----
Q 006810 124 ----------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---- 183 (630)
Q Consensus 124 ----------------lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~---- 183 (630)
+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCcEEEEeccceeeecccccch
Confidence 899999999999999999999999 99999999999997 7889999999999755332
Q ss_pred CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
......||+.|+|||++. ..++.++|||||||++|+|+| |..||.+......+...+..+..+ ..+...++++.++|
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 329 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTM 329 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHH
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence 123456889999999875 458999999999999999998 999998876666666666665433 34556789999999
Q ss_pred HHccc-CCCCCCCHHHHhcC
Q 006810 262 EKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 262 ~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+||. +|.+||++.+++.|
T Consensus 330 ~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 330 LDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHH
Confidence 99998 89999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=354.46 Aligned_cols=260 Identities=24% Similarity=0.421 Sum_probs=213.4
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC--CCCeeEEEeE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNS 94 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~--HpNIVk~~~~ 94 (630)
+......++.|++.+.||+|+||.||+|.+. +|..||+|++..... .....+.+.+|+.++++++ ||||++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 3334445555588999999999999999885 589999999976542 4566788999999999997 5999999998
Q ss_pred EEcCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcc
Q 006810 95 WVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 173 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 173 (630)
+... ..+++||| +.+|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ +|.+||+|
T Consensus 97 ~~~~--~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~--~~~~kL~D 169 (313)
T 3cek_A 97 EITD--QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLID 169 (313)
T ss_dssp EECS--SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECC
T ss_pred eecC--CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE--CCeEEEee
Confidence 8654 46899999 6677887 7777889999999999999999999999999 99999999999997 48999999
Q ss_pred cccceeeccCC----CccccCCCCCCCcccccc------------ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHH
Q 006810 174 LGLAIVMQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 237 (630)
Q Consensus 174 FGla~~~~~~~----~~~~~GTp~Y~APEvl~~------------~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~ 237 (630)
||++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||....+.....
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 99997654322 234578999999998754 57889999999999999999999998766665555
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 238 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 238 ~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..+........++...++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 250 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 55555544445666678999999999998 89999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=358.57 Aligned_cols=261 Identities=20% Similarity=0.345 Sum_probs=191.9
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~---~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
.+.++| ++.+.||+|+||+||+|.+..++. .||+|++..... .....+.+.+|+.++++++||||+++++++..
T Consensus 20 i~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 20 IPEQQF-TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp CC---C-EEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred cChhHe-EEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 456677 888999999999999999887775 899999875432 23456789999999999999999999999876
Q ss_pred CCCC----EEEEEEcccCCCCHH-HHhhcC------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCC
Q 006810 98 DTNR----TINMITELFTSGSLR-YRKKHK------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 166 (630)
Q Consensus 98 ~~~~----~l~lV~Ey~~gGsL~-~~~~~~------~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~ 166 (630)
.... ..++||||+.+|+|. ++.... .+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~-~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA-ED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc-CC
Confidence 5432 248999999999997 443322 6999999999999999999999999 99999999999998 78
Q ss_pred CcEEEcccccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHH
Q 006810 167 GEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 240 (630)
Q Consensus 167 g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i 240 (630)
|.+||+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||... +...+...+
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~~ 252 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNYL 252 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-ChHHHHHHH
Confidence 999999999997654322 223456889999998765 58999999999999999999 99999874 445555555
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCC-------HHHHhcCCCcccCCCC
Q 006810 241 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-------ALELLKDPFLVTDNPK 289 (630)
Q Consensus 241 ~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rps-------a~eLL~hpf~~~~~~~ 289 (630)
..+..+ ..+...++.+++||.+||. +|.+||| ..+++.|||+......
T Consensus 253 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 253 IGGNRL-KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp HTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred hcCCCC-CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 554433 3345668999999999997 8999999 7788899999875443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=363.51 Aligned_cols=247 Identities=26% Similarity=0.428 Sum_probs=206.7
Q ss_pred CCcceeeeeEecccCceEEEEEEEc-------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~-------~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~ 94 (630)
..+| ++.+.||+|+||+||+|.+. .++..||+|+++... .....+.+.+|+.+|+.+ +||||++++++
T Consensus 80 ~~~~-~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 80 RDKL-TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp GGGE-EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred HHHC-EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3455 88899999999999999874 456789999987442 355677899999999999 89999999999
Q ss_pred EEcCCCCEEEEEEcccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCc
Q 006810 95 WVDDTNRTINMITELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 157 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp 157 (630)
|.+. ..+|+||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 156 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 231 (370)
T 2psq_A 156 CTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 231 (370)
T ss_dssp ECSS--SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred EccC--CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccch
Confidence 8654 4588999999999998 55443 34899999999999999999999999 99999999
Q ss_pred CceEEeCCCCcEEEcccccceeeccC----CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCC
Q 006810 158 DNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECK 231 (630)
Q Consensus 158 ~NILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~ 231 (630)
+|||++ .+|.+||+|||++...... ......+|+.|+|||++.+ .|+.++|||||||++|||+| |..||.+ .
T Consensus 232 ~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-~ 309 (370)
T 2psq_A 232 RNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-I 309 (370)
T ss_dssp GGEEEC-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-C
T ss_pred hhEEEC-CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-C
Confidence 999998 7899999999999765432 1233457889999998764 58999999999999999999 9999987 4
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 232 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 232 ~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+...+...+..+..+ ..+...++.+.++|.+||. +|.+||++.|++.+
T Consensus 310 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 PVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CGGGHHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 556666667666443 3455678999999999997 89999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=355.54 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=207.0
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeE
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~---~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~ 94 (630)
...-..+|| ++.+.||+|+||+||+|.+..+|. .||+|.+.... .....+.+.+|+.+|+.++||||++++++
T Consensus 43 ~~~~~~~~y-~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 43 TREIEASRI-HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp CCBCCGGGE-EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccChhHe-EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 334455677 889999999999999999986554 59999987432 35566789999999999999999999999
Q ss_pred EEcCCCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEc
Q 006810 95 WVDDTNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 172 (630)
|.+. ..+++||||+++|+|. ++.. .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 119 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~ 193 (325)
T 3kul_A 119 VTRG--RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVD-SNLVCKVS 193 (325)
T ss_dssp ECGG--GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEEC
T ss_pred EEeC--CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEC-CCCCEEEC
Confidence 8654 4588999999999998 5543 468999999999999999999999999 99999999999998 78999999
Q ss_pred ccccceeeccCC-----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCC
Q 006810 173 DLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 245 (630)
Q Consensus 173 DFGla~~~~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~ 245 (630)
|||++....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.. .....+...+..+..
T Consensus 194 Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~ 272 (325)
T 3kul_A 194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYR 272 (325)
T ss_dssp CCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCC
T ss_pred CCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCC
Confidence 999998664332 12234678899999886 468999999999999999999 9999987 455666666666543
Q ss_pred CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 246 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 246 p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+ ..+...++.+.++|.+||. +|.+||++.+++.
T Consensus 273 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 273 L-PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3 3445678999999999997 8999999999886
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.30 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=201.3
Q ss_pred CCcceeeeeEecccCceEEEEEEE-ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC------eeEEEeEE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN------IIKFYNSW 95 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d-~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN------IVk~~~~f 95 (630)
.+|| ++.+.||+|+||+||+|.+ ..+|..||+|++... ....+.+.+|+.+++.++|++ |++++++|
T Consensus 13 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 13 SARY-EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp TTTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred cCce-EEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 3577 8889999999999999998 668999999998632 345677889999999997664 99999998
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC-------
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------- 165 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~------- 165 (630)
... ..+++||||+ +++|. ++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++..
T Consensus 87 ~~~--~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 87 EHH--GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EET--TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred ccC--CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccC
Confidence 655 4799999999 67776 555544 6899999999999999999999999 9999999999999732
Q ss_pred -----------CCcEEEcccccceeeccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCH
Q 006810 166 -----------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP 233 (630)
Q Consensus 166 -----------~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~ 233 (630)
++.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred CccccccccccCCCceEeeCcccccCcc-ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 66899999999976443 2345679999999998765 5899999999999999999999999874433
Q ss_pred HHHHHHHHc--CCCCC----------------------------------------CCCCCCcHHHHHHHHHccc-CCCC
Q 006810 234 AQIYKKVTS--GIKPA----------------------------------------SLSKVTDPQVKQFIEKCIV-PASL 270 (630)
Q Consensus 234 ~~i~~~i~~--g~~p~----------------------------------------~l~~~~s~~lk~~I~kcL~-~p~~ 270 (630)
.....+.. +..|. ......++.+.+||.+||. +|.+
T Consensus 241 -~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 241 -EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp -HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred -HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 32222211 11110 0011224678999999998 8999
Q ss_pred CCCHHHHhcCCCcccC
Q 006810 271 RLPALELLKDPFLVTD 286 (630)
Q Consensus 271 Rpsa~eLL~hpf~~~~ 286 (630)
|||+.|+|+||||+..
T Consensus 320 Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 320 RITLREALKHPFFDLL 335 (339)
T ss_dssp SCCHHHHTTSGGGGGG
T ss_pred ccCHHHHhcCHHHHHH
Confidence 9999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=357.06 Aligned_cols=256 Identities=20% Similarity=0.346 Sum_probs=203.1
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC------eeEEEeEE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN------IIKFYNSW 95 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG-~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN------IVk~~~~f 95 (630)
.+|| ++.+.||+|+||+||+|.+..+| ..||+|+++. .....+.+.+|+.+++.++|++ ++.+++++
T Consensus 18 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 18 QERY-EIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp TTTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred cccE-EEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 3566 88899999999999999998877 7999999863 2345567889999999998766 89999988
Q ss_pred EcCCCCEEEEEEcccCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe----------
Q 006810 96 VDDTNRTINMITELFTSGSLRYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---------- 163 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~---------- 163 (630)
... ..+++||||+.++++.++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 92 NFH--GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EET--TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECC
T ss_pred eeC--CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccc
Confidence 654 468999999966666655443 47999999999999999999999999 99999999999993
Q ss_pred --------CCCCcEEEcccccceeeccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHH
Q 006810 164 --------GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA 234 (630)
Q Consensus 164 --------~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~ 234 (630)
..++.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|+||..||.......
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccccCCCcEEEeecCccccccc-cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1578999999999976443 2345689999999998764 68999999999999999999999998754433
Q ss_pred HHHHHHHc-CCCCCC----------------------------------------CCCCCcHHHHHHHHHccc-CCCCCC
Q 006810 235 QIYKKVTS-GIKPAS----------------------------------------LSKVTDPQVKQFIEKCIV-PASLRL 272 (630)
Q Consensus 235 ~i~~~i~~-g~~p~~----------------------------------------l~~~~s~~lk~~I~kcL~-~p~~Rp 272 (630)
.+...... +..|.. .....++++++||.+||. +|.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 32221111 111100 011124578999999998 899999
Q ss_pred CHHHHhcCCCcccCCCC
Q 006810 273 PALELLKDPFLVTDNPK 289 (630)
Q Consensus 273 sa~eLL~hpf~~~~~~~ 289 (630)
|+.++|+||||+...+.
T Consensus 327 t~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 327 TLAEALLHPFFAGLTPE 343 (355)
T ss_dssp CHHHHTTSGGGGGCCHH
T ss_pred CHHHHhcChhhcCCChh
Confidence 99999999999876543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=369.09 Aligned_cols=254 Identities=15% Similarity=0.169 Sum_probs=186.7
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC--CCCCeeEEE-------eEEEc
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL--KHENIIKFY-------NSWVD 97 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L--~HpNIVk~~-------~~f~d 97 (630)
+++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+.+|+.+++.| +||||++++ +++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4788999999999999999999999999999986543 2345566778885544444 699988866 34332
Q ss_pred CCC---------------CEEEEEEcccCCCCHH-HHhh-cCCCCHHHH------HHHHHHHHHHHHHHHcCCCCEEecc
Q 006810 98 DTN---------------RTINMITELFTSGSLR-YRKK-HKNVDMKAI------KNWARQILRGLHYLHSHNPPIIHRD 154 (630)
Q Consensus 98 ~~~---------------~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i------~~i~~QIl~gL~yLHs~~~~IiHrD 154 (630)
... ..+++||||++ |+|. ++.. ...++...+ ..++.||+.||+|||+++ |+|||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrD 219 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGH 219 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETT
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCc
Confidence 221 34899999999 7887 5544 334555555 677799999999999999 99999
Q ss_pred CCcCceEEeCCCCcEEEcccccceeeccCCCccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCC
Q 006810 155 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECK 231 (630)
Q Consensus 155 LKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~ 231 (630)
|||+|||++ .+|.+||+|||+++....... ...+|+.|+|||++.+ .|+.++|||||||++|+|+||+.||....
T Consensus 220 ikp~NIll~-~~~~~kL~DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 220 FTPDNLFIM-PDGRLMLGDVSALWKVGTRGP-ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp CSGGGEEEC-TTSCEEECCGGGEEETTCEEE-GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CCHHHEEEC-CCCCEEEEecceeeecCCCcc-CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 999999998 789999999999986644322 4567799999998864 58999999999999999999999998642
Q ss_pred CHHH-HHHH---HHcCCCC--CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 232 NPAQ-IYKK---VTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 232 ~~~~-i~~~---i~~g~~p--~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.... .+.. ....... .......++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 2100 0000 0000011 11223568999999999997 89999999999999999763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=348.23 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=206.9
Q ss_pred CcceeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d-----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
.+.+++.+.||+|+||.||+|.+ ..+|..||+|++... ......+.+.+|+.+|++++||||++++++|.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN---ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34448899999999999999988 346689999998743 2456678899999999999999999999998654
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhcC------------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEec
Q 006810 99 TNRTINMITELFTSGSLR-YRKKHK------------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR 153 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~~------------------------~lse~~i~~i~~QIl~gL~yLHs~~~~IiHr 153 (630)
..+++||||+++|+|. ++.... .+++..++.++.||+.||.|||+++ |+||
T Consensus 99 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~ 174 (314)
T 2ivs_A 99 --GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHR 174 (314)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred --CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cccc
Confidence 4588999999999998 555433 3899999999999999999999999 9999
Q ss_pred cCCcCceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCC
Q 006810 154 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPY 227 (630)
Q Consensus 154 DLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf 227 (630)
||||+|||++ .++.+||+|||++....... .....+|+.|+|||++.+ .++.++|||||||++|+|+| |..||
T Consensus 175 dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 175 DLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCSGGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccchheEEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999998 78999999999997654322 233457889999998764 58999999999999999999 99999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 228 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 228 ~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.. .+...+...+..+..+ ..+...++.+.++|.+||. +|.+||++.+++.+
T Consensus 254 ~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 254 PG-IPPERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CCHHHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 87 4555666666665433 3455678999999999997 89999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=363.62 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=200.7
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CC-----CeeEEEeEEE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HE-----NIIKFYNSWV 96 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-Hp-----NIVk~~~~f~ 96 (630)
.+|| ++.+.||+|+||+||+|.+..+|..||+|++... ......+.+|+.+++.++ |+ +|++++++|.
T Consensus 53 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 53 MDRY-EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeE-EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 3567 8889999999999999999999999999998632 344566788999988885 55 4999999987
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC-CCCcEEEc
Q 006810 97 DDTNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIG 172 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~ 172 (630)
.. ..+++||||+.+ +|. ++... +.+++..++.++.||+.||.|||++..+|+||||||+|||++. .++.+||+
T Consensus 127 ~~--~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 127 FR--NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ET--TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred cC--CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 65 468999999976 665 55443 5699999999999999999999965445999999999999952 46789999
Q ss_pred ccccceeeccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCCCCCC-
Q 006810 173 DLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASL- 249 (630)
Q Consensus 173 DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p~~l- 249 (630)
|||+++..... ....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+......+...+.. +..+..+
T Consensus 204 DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 204 DFGSSCQLGQR-IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CCTTCEETTCC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCceecccc-cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99999876543 345689999999998765 5899999999999999999999999875444433333221 1111000
Q ss_pred -------------C------------------C----------------------------CCcHHHHHHHHHccc-CCC
Q 006810 250 -------------S------------------K----------------------------VTDPQVKQFIEKCIV-PAS 269 (630)
Q Consensus 250 -------------~------------------~----------------------------~~s~~lk~~I~kcL~-~p~ 269 (630)
+ . ...+++++||.+||+ +|.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 0 0 001478999999998 899
Q ss_pred CCCCHHHHhcCCCcccC
Q 006810 270 LRLPALELLKDPFLVTD 286 (630)
Q Consensus 270 ~Rpsa~eLL~hpf~~~~ 286 (630)
+|||+.|+|+||||+..
T Consensus 363 ~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TSCCHHHHTTSGGGCC-
T ss_pred hCCCHHHHhcCcccccC
Confidence 99999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.89 Aligned_cols=251 Identities=23% Similarity=0.401 Sum_probs=203.5
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhC----CCCCeeEEEeEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSL----KHENIIKFYNSW 95 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~--~~~~~l~~Ei~iL~~L----~HpNIVk~~~~f 95 (630)
-.+|| ++.+.||+|+||.||+|.+..+|..||+|++......... .....+.+|+.+++++ +||||+++++++
T Consensus 29 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 29 FEAEY-RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp ----C-EEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhce-EEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 35667 8889999999999999999999999999999765432211 1233466799999999 899999999988
Q ss_pred EcCCCCEEEEEEcc-cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcc
Q 006810 96 VDDTNRTINMITEL-FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 173 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey-~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 173 (630)
... ..+++|+|| +.+++|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++..+|.+||+|
T Consensus 108 ~~~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 108 ETQ--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp -------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred ecC--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEE
Confidence 654 457889999 7899998 7777888999999999999999999999999 999999999999986688999999
Q ss_pred cccceeeccCCCccccCCCCCCCcccccc-cc-CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 174 LGLAIVMQQPTARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 174 FGla~~~~~~~~~~~~GTp~Y~APEvl~~-~y-s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
||++............||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||... ..+ ... ...++.
T Consensus 184 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~---~~~---~~~~~~ 254 (312)
T 2iwi_A 184 FGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---QEI---LEA---ELHFPA 254 (312)
T ss_dssp CSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HHH---HHT---CCCCCT
T ss_pred cchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---HHH---hhh---ccCCcc
Confidence 99998777666666789999999998764 34 45899999999999999999999652 221 111 123445
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 678999999999997 89999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.59 Aligned_cols=246 Identities=28% Similarity=0.341 Sum_probs=198.2
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC--C
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--N 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~--~ 100 (630)
.++| ++.+.||+|+||+||+|.+. |..||+|++.... .......+|+.+|++++||||+++++++.+.. .
T Consensus 23 ~~~y-~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 23 SMPL-QLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp TEEE-EEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred hhhc-hhhheecccCceEEEEEEEC--CCEEEEEEeecCc-----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 4566 88899999999999999765 8999999986432 33445667999999999999999999997654 3
Q ss_pred CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcC----------CCCEEeccCCcCceEEeCCCCcEE
Q 006810 101 RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSH----------NPPIIHRDLKCDNIFVNGNNGEVK 170 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~----------~~~IiHrDLKp~NILl~~~~g~vK 170 (630)
..+++||||+++|+|........+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+|
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~-~~~~~k 171 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLK-NNLTAC 171 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEEC-TTCCEE
T ss_pred ceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEEC-CCCeEE
Confidence 4689999999999999444556799999999999999999999998 7 99999999999998 789999
Q ss_pred EcccccceeeccCC----CccccCCCCCCCcccccc------ccCcccceeehhHHHHHHhhCCCCCCCCC---------
Q 006810 171 IGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECK--------- 231 (630)
Q Consensus 171 L~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~------~ys~~sDIWSLGvil~ELltG~~Pf~~~~--------- 231 (630)
|+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+..
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 99999997664332 234579999999998864 46778999999999999999999997532
Q ss_pred ------CHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 232 ------NPAQIYKKVTSGIKPASLSKV-----TDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 232 ------~~~~i~~~i~~g~~p~~l~~~-----~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
....+...+......+.+... .++.+.+||.+||. +|.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 223333344333332222221 23569999999998 8999999999886
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=346.63 Aligned_cols=249 Identities=31% Similarity=0.505 Sum_probs=200.2
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
-+-+.+|| ++.+.||+|+||+||+|.+. ..||+|+++... ......+.+.+|+.+|++++||||++++++.. .
T Consensus 19 ~ei~~~~y-~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~ 91 (289)
T 3og7_A 19 WEIPDGQI-TVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-A 91 (289)
T ss_dssp CBCCTTSC-EEEEEEEECSSEEEEEEESS---SEEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred CccCccce-eeeeEecCCCCeEEEEEEEc---CceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-C
Confidence 34567778 88999999999999999754 359999987553 34567788999999999999999999999642 2
Q ss_pred CCCEEEEEEcccCCCCHH-HH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 99 TNRTINMITELFTSGSLR-YR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
..+++||||+.+++|. ++ .....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 92 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~ 166 (289)
T 3og7_A 92 --PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLH-EDNTVKIGDFGL 166 (289)
T ss_dssp --SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTEEEECCCC-
T ss_pred --CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCCCEEEcccee
Confidence 3478999999999997 44 34567999999999999999999999999 99999999999998 789999999999
Q ss_pred ceeecc----CCCccccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006810 177 AIVMQQ----PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 248 (630)
Q Consensus 177 a~~~~~----~~~~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~ 248 (630)
+..... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||....+...+...+..+..+..
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence 975442 1233457999999999874 34788999999999999999999999988888888887777654433
Q ss_pred ---CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 249 ---LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 249 ---l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+....++.+++||.+||. +|.+||++.+++.
T Consensus 247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 344578999999999998 8999999999886
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=349.45 Aligned_cols=255 Identities=21% Similarity=0.374 Sum_probs=195.0
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||+||+|.+..+|..||+|++..... .....+.+.++..+++.++||||+++++++.+. ..
T Consensus 24 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~ 98 (318)
T 2dyl_A 24 INDL-ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TD 98 (318)
T ss_dssp GGGE-EEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hccc-cccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--Cc
Confidence 4566 677899999999999999999999999999975432 223334455566678999999999999998764 47
Q ss_pred EEEEEcccCCCCHH-HH-hhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 103 INMITELFTSGSLR-YR-KKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
+++||||+ ++.+. .. .....+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+||+|||++..
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD-ERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEEC-TTSCEEECCCTTC--
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEEC-CCCCEEEEECCCchh
Confidence 89999999 55555 32 3367899999999999999999999995 8 99999999999998 789999999999976
Q ss_pred eccC-CCccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC-CCCC
Q 006810 180 MQQP-TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSK 251 (630)
Q Consensus 180 ~~~~-~~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~-~l~~ 251 (630)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||............+..+..+. ....
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (318)
T 2dyl_A 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM 254 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence 5433 234457999999999874 3588999999999999999999999988666666666665554332 2223
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 468999999999997 89999999999999999753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.67 Aligned_cols=256 Identities=22% Similarity=0.401 Sum_probs=186.0
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCeeEEEeEEEcCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~-iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
+.++| ++.+.||+|+||.||+|.+..+|..||+|++.... .......+.+|+. +++.++||||+++++++.+.
T Consensus 20 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-- 93 (327)
T 3aln_A 20 TAEDL-KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-- 93 (327)
T ss_dssp CSCSE-EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--
T ss_pred CHHHh-hehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--
Confidence 34566 77899999999999999999999999999997542 2344455666665 77888999999999998765
Q ss_pred CEEEEEEcccCCCCHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 101 RTINMITELFTSGSLRYRK-----KHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~~-----~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
..+++||||+.++...++. ....+++..+..++.||+.||.|||++ + |+||||||+|||++ .+|.+||+||
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~-~~~~~kl~Df 170 (327)
T 3aln_A 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNIKLCDF 170 (327)
T ss_dssp SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEE-TTTEEEECCC
T ss_pred CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEc-CCCCEEEccC
Confidence 4689999999974333433 267899999999999999999999998 8 99999999999998 7899999999
Q ss_pred ccceeeccCC-CccccCCCCCCCccccc-----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--
Q 006810 175 GLAIVMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-- 246 (630)
Q Consensus 175 Gla~~~~~~~-~~~~~GTp~Y~APEvl~-----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-- 246 (630)
|++....... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||............+..+..+
T Consensus 171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 9997654432 23347999999999873 358899999999999999999999998643332222222222221
Q ss_pred -CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 -ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 -~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.......++.+++||.+||. +|.+||++.++|+||||...
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 11224578999999999997 89999999999999999754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=359.94 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=201.0
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----------CCCeeEE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----------HENIIKF 91 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-----------HpNIVk~ 91 (630)
.+|| ++.+.||+|+||+||+|.+..+|..||+|++... ....+.+.+|+.+++.++ ||||+++
T Consensus 18 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 18 DARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCeE-EEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 4677 8889999999999999999999999999998632 344566889999999886 8999999
Q ss_pred EeEEEcCC--CCEEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEeccCCcCceEEe--
Q 006810 92 YNSWVDDT--NRTINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVN-- 163 (630)
Q Consensus 92 ~~~f~d~~--~~~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~-- 163 (630)
+++|.... ...+++||||+ +++|. ++.. ...+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV 168 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEecc
Confidence 99987543 23789999999 77887 5544 45699999999999999999999998 8 99999999999995
Q ss_pred ---CCCCcEEEcccccceeeccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCC------H
Q 006810 164 ---GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN------P 233 (630)
Q Consensus 164 ---~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~------~ 233 (630)
...+.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.||..... .
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCCcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 13448999999999766543 344579999999998865 589999999999999999999999975331 1
Q ss_pred HHHHHHHHc-CCCC--------------------------------------CCCCCCCcHHHHHHHHHccc-CCCCCCC
Q 006810 234 AQIYKKVTS-GIKP--------------------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLP 273 (630)
Q Consensus 234 ~~i~~~i~~-g~~p--------------------------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rps 273 (630)
..+...+.. +..| ..++...++++++||.+||+ +|.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111110 1100 01122335788999999998 8999999
Q ss_pred HHHHhcCCCcccCC
Q 006810 274 ALELLKDPFLVTDN 287 (630)
Q Consensus 274 a~eLL~hpf~~~~~ 287 (630)
+.|+|+||||+...
T Consensus 328 ~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 328 AGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHTCGGGTTCT
T ss_pred HHHHhhChhhhccc
Confidence 99999999998743
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=344.43 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=203.4
Q ss_pred CCCCcceeeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~----d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
.-..+++++.+.||+|+||.||+|. +..+|..||+|.+..... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc---chhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3345566899999999999999998 678999999999975432 234567889999999999999999999998
Q ss_pred cCCCCEEEEEEcccCCCCHH-HH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 97 DDTNRTINMITELFTSGSLR-YR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
+.....+++||||+++|+|. ++ .....+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+||
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Df 170 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDF 170 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEc-CCCCEEECcc
Confidence 77666799999999999998 55 44567999999999999999999999999 99999999999998 7889999999
Q ss_pred ccceeeccCC-----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCC--------------CCHH
Q 006810 175 GLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------------KNPA 234 (630)
Q Consensus 175 Gla~~~~~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~--------------~~~~ 234 (630)
|++....... .....||+.|+|||++.+ .++.++|||||||++|+|+||..|+... ....
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 9997665432 234568889999998764 5889999999999999999999886421 1122
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 235 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 235 ~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+...+..+. ....+...++.+.+||.+||. +|.+|||+.++++
T Consensus 251 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 251 RLVNTLKEGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 3333444433 333455678999999999998 8999999999876
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=357.64 Aligned_cols=251 Identities=22% Similarity=0.395 Sum_probs=209.9
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCC--CCCeeEEEeEEEc
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLK--HENIIKFYNSWVD 97 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~--~~~~~l~~Ei~iL~~L~--HpNIVk~~~~f~d 97 (630)
..+|| ++.+.||+|+||+||+|.+..+|..||+|++......... ....++.+|+.+++.++ ||||+++++++..
T Consensus 41 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 41 LESQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CTTTE-EEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred ccCce-EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34566 8899999999999999999999999999999765432100 11234678999999996 5999999999865
Q ss_pred CCCCEEEEEEcccCC-CCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 98 DTNRTINMITELFTS-GSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~g-GsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
. ..+++|+||+.+ ++|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||+|||
T Consensus 120 ~--~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 120 P--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp S--SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred C--CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 4 468999999986 8887 7777889999999999999999999999999 99999999999998667899999999
Q ss_pred cceeeccCCCccccCCCCCCCcccccc-cc-CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 176 LAIVMQQPTARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 176 la~~~~~~~~~~~~GTp~Y~APEvl~~-~y-s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
++............||+.|+|||++.+ .+ +.++|||||||++|+|+||+.||... .. +..+ ...+....
T Consensus 196 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~---~~----~~~~--~~~~~~~~ 266 (320)
T 3a99_A 196 SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---EE----IIRG--QVFFRQRV 266 (320)
T ss_dssp TCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HH----HHHC--CCCCSSCC
T ss_pred cccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh---hh----hhcc--cccccccC
Confidence 998777665666789999999998764 33 67899999999999999999999652 21 2222 12244567
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 8999999999997 89999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=348.81 Aligned_cols=248 Identities=26% Similarity=0.412 Sum_probs=199.7
Q ss_pred CCcceeeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~----d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
.+|| ++.+.||+|+||+||+|. +..+|..||+|++... .....+.+.+|+.+|++++||||+++++++...
T Consensus 9 ~~~~-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHL-KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGE-EEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHh-hhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3455 899999999999999998 6779999999998633 356667899999999999999999999998765
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 99 TNRTINMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
....+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGL 160 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCS
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEc-CCCeEEEccCcc
Confidence 555688999999999998 55443 45999999999999999999999999 99999999999998 789999999999
Q ss_pred ceeeccCC-----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCH---------------HH
Q 006810 177 AIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---------------AQ 235 (630)
Q Consensus 177 a~~~~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~---------------~~ 235 (630)
+....... .....+++.|+|||++. ..++.++|||||||++|+|+||..||...... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 97654321 22345778899999876 45899999999999999999999998642100 01
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 236 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 236 i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+...+..+. ....+...++++.++|.+||. +|.+|||+.+++.
T Consensus 241 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccC-cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 222233332 223455678999999999998 8999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=353.15 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=206.0
Q ss_pred CCCcceeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d-----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f 95 (630)
+..+| ++.+.||+|+||+||+|.+ ..++..||+|.+.... .....+.+.+|+.+|+++ +||||+++++++
T Consensus 43 ~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 43 PRENL-EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp CGGGE-EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHc-eeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45666 8889999999999999997 3467899999997432 233456789999999999 999999999998
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCEE
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKKHK-----------------------NVDMKAIKNWARQILRGLHYLHSHNPPII 151 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~~~-----------------------~lse~~i~~i~~QIl~gL~yLHs~~~~Ii 151 (630)
... ..+++||||+++|+|. ++.... .+++..++.++.||+.||.|||+++ |+
T Consensus 119 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 194 (344)
T 1rjb_A 119 TLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 194 (344)
T ss_dssp CSS--SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred eeC--CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 654 4588999999999998 554432 3799999999999999999999999 99
Q ss_pred eccCCcCceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCC
Q 006810 152 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEY 225 (630)
Q Consensus 152 HrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~ 225 (630)
||||||+|||++ .++.+||+|||++....... .....||+.|+|||++. +.++.++|||||||++|+|+| |..
T Consensus 195 H~Dikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 195 HRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp ETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred cCCCChhhEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 999999999998 78999999999997654332 22345788999999875 468999999999999999998 999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCC
Q 006810 226 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 281 (630)
Q Consensus 226 Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hp 281 (630)
||.+......+...+..+..+ ..+...++.+.+||.+||. +|.+||++.+++.|-
T Consensus 274 p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcccCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 998876666666666665433 3445678999999999998 899999999999863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=362.21 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=209.2
Q ss_pred CCCCcceeeeeEecccCceEEEEEE-----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEE
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~-----d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f 95 (630)
-+..+| ++.+.||+|+||+||+|. +..++..||+|.+... ........+.+|+.++++++||||+++++++
T Consensus 68 ~~~~~~-~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 68 VPRKNI-TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CCGGGE-EEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCHhHe-EEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc---cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 344566 888999999999999999 5568899999998632 2355566788999999999999999999998
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--C
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKKH-------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--N 165 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~~-------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~ 165 (630)
.+.. .+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 144 ~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 144 LQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp CSSS--SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSST
T ss_pred ecCC--CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCC
Confidence 6543 468999999999998 55443 35899999999999999999999999 999999999999972 2
Q ss_pred CCcEEEcccccceeecc----CCCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHH
Q 006810 166 NGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 239 (630)
Q Consensus 166 ~g~vKL~DFGla~~~~~----~~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~ 239 (630)
+..+||+|||+++.... .......||+.|+|||++. ..++.++|||||||++|||+| |..||.. .+...+...
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~~ 298 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 298 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHH
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHH
Confidence 33599999999975422 2233456899999999875 568999999999999999998 9999987 556667777
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 240 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 240 i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+..+..+ ..+...++.+.+||.+||. +|.+||++.+++++.++...
T Consensus 299 i~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 299 VTSGGRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCC-CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 7766433 3345678899999999998 89999999999999877543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=339.95 Aligned_cols=243 Identities=20% Similarity=0.421 Sum_probs=204.3
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||+||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 10 ~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (269)
T 4hcu_A 10 SEL-TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--API 80 (269)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred hhc-eeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-----CHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Cce
Confidence 355 78899999999999999987 578899999975432 124588999999999999999999998654 458
Q ss_pred EEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||+++|+|. ++. ....+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGGCEEECCTTGGGGBC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEc-CCCCEEecccccccccc
Confidence 8999999999998 543 3456999999999999999999999999 99999999999997 78899999999997554
Q ss_pred cC---CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 182 QP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 182 ~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
.. ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTH 235 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHH
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCHH
Confidence 32 233445788999999886 468999999999999999999 9999987 5566677777665433 344556899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+.++|.+||. +|.+||++.++++|
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999998 89999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.52 Aligned_cols=244 Identities=22% Similarity=0.400 Sum_probs=201.1
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
..+| ++.+.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+. ..
T Consensus 23 ~~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 93 (283)
T 3gen_A 23 PKDL-TFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RP 93 (283)
T ss_dssp GGGE-EEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SS
T ss_pred HHHH-HhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEEecC--CC
Confidence 3455 88899999999999999776 688899999975432 124588999999999999999999988544 45
Q ss_pred EEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 103 INMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
+++||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYV 170 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTSCEEECSTTGGGGB
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEc-CCCCEEEccccccccc
Confidence 88999999999998 5544 567999999999999999999999999 99999999999998 7899999999999755
Q ss_pred ccC---CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 181 QQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 181 ~~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
... ......+|+.|+|||++. ..++.++||||||+++|+|+| |..||.. .+.......+..+..+ ..+...++
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 248 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASE 248 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCH
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccCC-CCCCcCCH
Confidence 432 223345688899999876 468999999999999999998 9999987 4556666666665433 33456689
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+.++|.+||. +|.+||++.+++.|
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999999998 89999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=346.90 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=209.5
Q ss_pred CCCCcceeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeE
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d-----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~ 94 (630)
-+.+|| ++.+.||+|+||+||+|.+ ..++..||+|.+.... .....+.+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 20 FPRNRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp CCGGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cChhhh-hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 456777 8889999999999999985 5678999999997442 345567899999999999 99999999999
Q ss_pred EEcCCCCEEEEEEcccCCCCHH-HHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccC
Q 006810 95 WVDDTNRTINMITELFTSGSLR-YRKKHK------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 155 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~------------------~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 155 (630)
+.+. ..+++||||+++|+|. ++.... .+++..++.++.||+.||.|||+++ |+||||
T Consensus 96 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl 171 (313)
T 1t46_A 96 CTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDL 171 (313)
T ss_dssp ECSS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EecC--CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCC
Confidence 8654 3578999999999998 554433 4899999999999999999999999 999999
Q ss_pred CcCceEEeCCCCcEEEcccccceeeccCCC----ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCC
Q 006810 156 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNE 229 (630)
Q Consensus 156 Kp~NILl~~~~g~vKL~DFGla~~~~~~~~----~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~ 229 (630)
||+|||++ .++.+||+|||++........ ....||+.|+|||++. ..++.++|||||||++|+|+| |..||..
T Consensus 172 kp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 172 AARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp SGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccceEEEc-CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999998 789999999999976654322 2345788999999775 468999999999999999999 9999988
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 230 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 230 ~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..........+..+..+ ..+...++.++++|.+||. +|.+||++.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 251 MPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchhHHHHHhccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 66666666666655443 2345578999999999998 89999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=352.06 Aligned_cols=250 Identities=21% Similarity=0.300 Sum_probs=208.1
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeE
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~-----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~ 94 (630)
..+.++| ++.+.||+|+||.||+|.+. .++..||+|.++... .....+.+.+|+.++++++||||++++++
T Consensus 43 ~~~~~~~-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 43 EYPRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp BCCGGGC-EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred EecHHHC-eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3455677 78899999999999999987 456999999987432 35566789999999999999999999999
Q ss_pred EEcCCCCEEEEEEcccCCCCHH-HHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 006810 95 WVDDTNRTINMITELFTSGSLR-YRKKH------------------------KNVDMKAIKNWARQILRGLHYLHSHNPP 149 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~-~~~~~------------------------~~lse~~i~~i~~QIl~gL~yLHs~~~~ 149 (630)
+.+. ..+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++
T Consensus 119 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-- 194 (343)
T 1luf_A 119 CAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-- 194 (343)
T ss_dssp ECSS--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EccC--CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 8654 4588999999999998 55442 67999999999999999999999999
Q ss_pred EEeccCCcCceEEeCCCCcEEEcccccceeeccC----CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-C
Q 006810 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-C 223 (630)
Q Consensus 150 IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G 223 (630)
|+||||||+|||++ .++.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+| |
T Consensus 195 ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 195 FVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp CCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred eecCCCCcceEEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 99999999999998 7889999999999754322 223456889999999876 468999999999999999999 9
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 224 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 224 ~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..||.+ .+...+...+..+..+ ..+...++.+.++|.+||. +|.+||++.+++++
T Consensus 274 ~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 274 LQPYYG-MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCCC-CChHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 999987 4556666666665433 3455678999999999997 89999999998863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=363.33 Aligned_cols=250 Identities=23% Similarity=0.379 Sum_probs=203.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
+|| ++.++||+|+||+||+|.+..+|..||+|++....... ..+.+.+|+.+|++++||||+++++++.+.....+
T Consensus 9 ~~y-~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 9 HLW-LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp EEE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS---CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred Cce-EEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc---hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 455 89999999999999999999999999999997544322 34567899999999999999999999987766678
Q ss_pred EEEEcccCCCCHH-HHhhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEE----eCCCCcEEEcccc
Q 006810 104 NMITELFTSGSLR-YRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVKIGDLG 175 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~---~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl----~~~~g~vKL~DFG 175 (630)
++||||+++|+|. ++.... .+++..++.++.||+.||.|||+++ |+||||||+|||+ + .++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTT-SCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCC-CceeEEEecCC
Confidence 9999999999998 544332 3999999999999999999999999 9999999999998 5 56789999999
Q ss_pred cceeeccC-CCccccCCCCCCCccccc---------cccCcccceeehhHHHHHHhhCCCCCCCCC---CHHHHHHHHHc
Q 006810 176 LAIVMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTS 242 (630)
Q Consensus 176 la~~~~~~-~~~~~~GTp~Y~APEvl~---------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~---~~~~i~~~i~~ 242 (630)
++...... ......||+.|+|||++. ..++.++|||||||++|+|+||+.||.... ....+...+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 99876443 334567999999999875 357889999999999999999999996432 22334444444
Q ss_pred CCCCC-----------------------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 243 GIKPA-----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 243 g~~p~-----------------------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+.++. .+....++.++++|.+||. +|.+||++.+++.+
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 33221 1112235688999999997 89999999998653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=349.22 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=206.3
Q ss_pred CCcceeeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~----d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
.+||+++.+.||+|+||+||+|. +..+|..||+|++... ......+.+.+|+.+|++++||||+++++++.+.
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 57999999999999999997774 4568999999999754 2456677899999999999999999999999887
Q ss_pred CCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 99 TNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
....+++||||+++|+|........+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAK 182 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCE
T ss_pred CCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEc-CCCCEEECCccccc
Confidence 6778999999999999995555567999999999999999999999999 99999999999998 78999999999998
Q ss_pred eeccCC-----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCH--------------HHHHH
Q 006810 179 VMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--------------AQIYK 238 (630)
Q Consensus 179 ~~~~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~--------------~~i~~ 238 (630)
...... .....||+.|+|||++.+ .++.++|||||||++|+|+||..||...... ..+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 765432 234467889999998865 5889999999999999999999999642111 11222
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 239 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 239 ~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+..+. ....+...++.+.+||.+||. +|.+|||+.+++.
T Consensus 263 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 263 LLERGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 333332 334456678999999999998 8999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.38 Aligned_cols=245 Identities=22% Similarity=0.386 Sum_probs=203.1
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
..++| ++.+.||+|+||+||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+. .
T Consensus 6 ~~~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 76 (268)
T 3sxs_A 6 KREEI-TLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE--Y 76 (268)
T ss_dssp CGGGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred chhhe-eeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEEccC--C
Confidence 34566 88899999999999999766 678899999975432 124588999999999999999999988544 4
Q ss_pred EEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 102 TINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
.+++||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD-RDLCVKVSDFGMTRY 153 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEEC-TTCCEEECCTTCEEE
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEEC-CCCCEEEccCcccee
Confidence 589999999999998 5544 346999999999999999999999999 99999999999998 789999999999976
Q ss_pred eccCCC---ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 180 MQQPTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 180 ~~~~~~---~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
...... ....+|+.|+|||++.+ .++.++||||||+++|+|+| |..||... +.......+..+..+ ..+...+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 231 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-TNSEVVLKVSQGHRL-YRPHLAS 231 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHHHTTCCC-CCCTTSC
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc-ChHHHHHHHHcCCCC-CCCCcCh
Confidence 654332 23346778999998875 58999999999999999999 99999874 455555555554332 3345568
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+.+.++|.+||. +|.+|||+.+++++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 232 DTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999998 89999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=356.53 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=209.8
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEE
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKF 91 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~-------tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~ 91 (630)
.-+.+|| ++.+.||+|+||+||+|.+.. .+..||+|++... .......++.+|+.+++.+ +||||+++
T Consensus 65 ~i~~~~y-~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 65 ELPRDRL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp BCCGGGE-EEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccchhhe-EeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 3445677 888999999999999999753 3468999998744 2456678899999999999 99999999
Q ss_pred EeEEEcCCCCEEEEEEcccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEecc
Q 006810 92 YNSWVDDTNRTINMITELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 154 (630)
Q Consensus 92 ~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrD 154 (630)
++++.+. ..+++||||+++|+|. ++... ..+++..++.|+.||+.||.|||+++ |+|||
T Consensus 141 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~D 216 (382)
T 3tt0_A 141 LGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRD 216 (382)
T ss_dssp EEEECSS--SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred eeeeccC--CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCC
Confidence 9998654 4588999999999998 55443 35999999999999999999999999 99999
Q ss_pred CCcCceEEeCCCCcEEEcccccceeeccC----CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCC
Q 006810 155 LKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYN 228 (630)
Q Consensus 155 LKp~NILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~ 228 (630)
|||+|||++ .++.+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|+| |..||.
T Consensus 217 lkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 217 LAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp CCGGGEEEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCcceEEEc-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999998 7899999999999765432 2233467889999998764 58999999999999999999 999998
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 229 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 229 ~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
. .+...+...+..+..+ ..+...++++.+||.+||. +|.+||++.+++++
T Consensus 296 ~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 296 G-VPVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp T-CCHHHHHHHHHTTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6 5667777777766543 3345678999999999998 89999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.77 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=209.3
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~----d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~ 92 (630)
+.+.-...+| ++.+.||+|+||.||+|. +..+|..||+|++... .....+.+.+|+.++++++||||++++
T Consensus 16 ~~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 16 DPTIFEERHL-KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp -CCBCCGGGE-EEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhhhchhhh-hhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 3333334455 889999999999999998 5789999999998743 355667799999999999999999999
Q ss_pred eEEEcCCCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEE
Q 006810 93 NSWVDDTNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 170 (630)
Q Consensus 93 ~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 170 (630)
+++.......+++||||+++|+|. ++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~-~~~~~k 167 (327)
T 3lxl_A 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVK 167 (327)
T ss_dssp EEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEE
T ss_pred EEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEEC-CCCCEE
Confidence 999877777899999999999998 5544 456999999999999999999999999 99999999999998 789999
Q ss_pred EcccccceeeccCC-----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCC------------
Q 006810 171 IGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN------------ 232 (630)
Q Consensus 171 L~DFGla~~~~~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~------------ 232 (630)
|+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.....
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence 99999998664332 233467888999998764 588999999999999999999999864211
Q ss_pred --HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 233 --PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 233 --~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
...+...+..+. ....+...++.+++||.+||. +|.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 248 PALSRLLELLEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CHHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHhhccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 122333344333 233456678999999999998 89999999999764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=348.08 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=209.7
Q ss_pred CCCCcceeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeE
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d-----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~ 94 (630)
-+.++| ++.+.||+|+||+||+|.+ ..+|..||+|++.... .....+.+.+|+.+++++ +||||++++++
T Consensus 24 ~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 24 FPRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp CCGGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhhe-eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 345677 8899999999999999985 4678999999987432 345567799999999999 79999999998
Q ss_pred EEcCCCCEEEEEEcccCCCCHH-HHhhcCC----------------CCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCc
Q 006810 95 WVDDTNRTINMITELFTSGSLR-YRKKHKN----------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 157 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~----------------lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp 157 (630)
+.... ..+++||||+++|+|. ++..... +++..++.++.||+.||.|||+++ |+||||||
T Consensus 100 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp 176 (316)
T 2xir_A 100 CTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176 (316)
T ss_dssp ECCTT-SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EecCC-CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence 86543 4688999999999998 5554433 899999999999999999999999 99999999
Q ss_pred CceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCC
Q 006810 158 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECK 231 (630)
Q Consensus 158 ~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~ 231 (630)
+|||++ .+|.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|+| |..||....
T Consensus 177 ~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 177 RNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEEC-CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999997 78899999999997654322 223467899999998764 58999999999999999998 999998866
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 232 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 232 ~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
....+...+..+..+ ..+...++.++++|.+||. +|.+||++.+++.|
T Consensus 256 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 256 IDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHhccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 666666666665433 3445678999999999998 89999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=351.84 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=201.4
Q ss_pred CCccccCCCCcceeeeeEecccCceEEEEEEEccCCeEE----EEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeE
Q 006810 15 GEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90 (630)
Q Consensus 15 ~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~V----AiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk 90 (630)
......-..++| ++.+.||+|+||+||+|.+..+|..| |+|.+.... .....+.+.+|+.++++++||||++
T Consensus 6 ~~~~~~l~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~ 81 (327)
T 3poz_A 6 QALLRILKETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCR 81 (327)
T ss_dssp CCSSEECCGGGE-EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCC
T ss_pred HHHHhhcCHHHc-ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeE
Confidence 344455556677 78899999999999999998887765 677664322 2334567899999999999999999
Q ss_pred EEeEEEcCCCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc
Q 006810 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 168 (630)
Q Consensus 91 ~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 168 (630)
+++++.+. ..++|+||+.+|+|. ++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 82 ~~~~~~~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~-~~~~ 155 (327)
T 3poz_A 82 LLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQH 155 (327)
T ss_dssp EEEEEESS---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTE
T ss_pred EEEEEecC---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEEC-CCCC
Confidence 99998754 377899999999998 5544 567999999999999999999999999 99999999999998 7899
Q ss_pred EEEcccccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHc
Q 006810 169 VKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 242 (630)
Q Consensus 169 vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~ 242 (630)
+||+|||+++...... .....||+.|+|||++.+ .++.++|||||||++|+|+| |+.||.. .+...+...+..
T Consensus 156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~ 234 (327)
T 3poz_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEK 234 (327)
T ss_dssp EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHT
T ss_pred EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHHHc
Confidence 9999999997654332 223456889999998764 58999999999999999999 9999986 445556666665
Q ss_pred CCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 243 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 243 g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+..+ ..+...+..+.++|.+||. +|.+||++.+++.+
T Consensus 235 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 235 GERL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TCCC-CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCCC-CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 5433 3445578899999999998 89999999999876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=342.65 Aligned_cols=252 Identities=31% Similarity=0.525 Sum_probs=200.1
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
..++| ++.+.||+|+||.||+|.+..+|..||+|++..... ........+.+|+.++++++||||+++++++... .
T Consensus 30 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 105 (310)
T 2wqm_A 30 TLANF-RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--N 105 (310)
T ss_dssp SGGGE-EEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--T
T ss_pred cccce-EEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--C
Confidence 34566 889999999999999999999999999999976443 2456677899999999999999999999998765 4
Q ss_pred EEEEEEcccCCCCHH-HHh----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 102 TINMITELFTSGSLR-YRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
.+++||||+.+|+|. ++. ....+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||+
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~-~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGL 182 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCC--
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEc-CCCCEEEEeccc
Confidence 689999999999997 443 3567999999999999999999999999 99999999999998 789999999999
Q ss_pred ceeeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC-CHHHHHHHHHcCCCCCCCCCC
Q 006810 177 AIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKV 252 (630)
Q Consensus 177 a~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~-~~~~i~~~i~~g~~p~~l~~~ 252 (630)
+...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.. +...+...+..+..+......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (310)
T 2wqm_A 183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 262 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTT
T ss_pred eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccc
Confidence 8765433 2334578999999998764 58899999999999999999999997543 445566666665555444456
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+++++++|.+||. +|.+||++.+++.+
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 78999999999997 89999999999873
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.31 Aligned_cols=254 Identities=20% Similarity=0.256 Sum_probs=201.1
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
......++| ++.+.||+|+||.||+|.+..+|..||+|++..... ......+.+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 28 REGTQFGPY-RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp ------CCE-EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCcEeccE-EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 344456777 888999999999999999999999999999875432 334556789999999999999999999999876
Q ss_pred CCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 98 DTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
. ..+++||||+++++|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 106 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~ 180 (309)
T 2h34_A 106 D--GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVS-ADDFAYLVDFGI 180 (309)
T ss_dssp T--TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSCCC
T ss_pred C--CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEc-CCCCEEEecCcc
Confidence 4 4789999999999998 7777788999999999999999999999999 99999999999998 789999999999
Q ss_pred ceeeccCC---CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCC
Q 006810 177 AIVMQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSK 251 (630)
Q Consensus 177 a~~~~~~~---~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p~~l~~ 251 (630)
+....... .....||+.|+|||++.+ .++.++||||||+++|+|+||+.||... +...+...+..... +.....
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~ 259 (309)
T 2h34_A 181 ASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-QLSVMGAHINQAIPRPSTVRP 259 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC-HHHHHHHHHHSCCCCGGGTST
T ss_pred CccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc-hHHHHHHHhccCCCCccccCC
Confidence 87654332 234578999999998764 5889999999999999999999999863 34444444444332 334456
Q ss_pred CCcHHHHHHHHHccc-CCCCCC-CHHHHhc
Q 006810 252 VTDPQVKQFIEKCIV-PASLRL-PALELLK 279 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rp-sa~eLL~ 279 (630)
..++.++++|.+||. +|.+|| ++.+++.
T Consensus 260 ~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 260 GIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp TCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 678899999999998 899999 7887765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.47 Aligned_cols=247 Identities=25% Similarity=0.432 Sum_probs=194.8
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~t---G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
..+|| ++.+.||+|+||+||+|.+..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++.+
T Consensus 13 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 87 (281)
T 1mp8_A 13 QRERI-ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 87 (281)
T ss_dssp CGGGE-EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred ehHHe-EEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-
Confidence 44677 8899999999999999998653 567999987643 245566789999999999999999999998732
Q ss_pred CCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 99 TNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
..+++||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 88 --NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGL 162 (281)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC---
T ss_pred --CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEEC-CCCCEEECcccc
Confidence 3478999999999998 5544 347999999999999999999999999 99999999999998 789999999999
Q ss_pred ceeeccCC---CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 177 AIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 177 a~~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
+....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.... ...+...+..+.. ..++.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~-~~~~~~~i~~~~~-~~~~~ 240 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGER-LPMPP 240 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHHTTCC-CCCCT
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC-HHHHHHHHHcCCC-CCCCC
Confidence 97654432 22345688999999886 458999999999999999997 999998744 4445555555433 23456
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..++.+.++|.+||. +|.+||++.+++.+
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 678999999999997 89999999998864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.71 Aligned_cols=257 Identities=20% Similarity=0.346 Sum_probs=200.6
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEe
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 93 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~---tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~ 93 (630)
+.......+.+++.+.||+|+||+||+|.+.. ++..||+|.+.... ......+.+.+|+.++++++||||+++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN--SSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C--CCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc--cchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 33333444555899999999999999998765 66799999987553 24566778999999999999999999999
Q ss_pred EEEcCCCC---EEEEEEcccCCCCHH-HH------hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe
Q 006810 94 SWVDDTNR---TINMITELFTSGSLR-YR------KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 163 (630)
Q Consensus 94 ~f~d~~~~---~l~lV~Ey~~gGsL~-~~------~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 163 (630)
++.+.... ..++||||+++|+|. ++ .....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~ 181 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLR 181 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEEC
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc
Confidence 98765433 468999999999998 44 23467999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEcccccceeeccC----CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHH
Q 006810 164 GNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 237 (630)
Q Consensus 164 ~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~ 237 (630)
.+|.+||+|||++...... ......+++.|+|||++.+ .++.++|||||||++|+|++ |..||... ....+.
T Consensus 182 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~ 259 (313)
T 3brb_A 182 -DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNHEMY 259 (313)
T ss_dssp -TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHH
T ss_pred -CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHH
Confidence 7889999999999765432 1233457889999998764 58999999999999999999 88999874 445555
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 238 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 238 ~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..+..+..+ ..+...++.+.++|.+||. +|.+||++.+++.+
T Consensus 260 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 260 DYLLHGHRL-KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHTTCCC-CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCC-CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 666655433 3445678999999999997 89999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=341.16 Aligned_cols=245 Identities=30% Similarity=0.447 Sum_probs=193.6
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCeeEEEeEEEcC-
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDD- 98 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpNIVk~~~~f~d~- 98 (630)
..++| ++.+.||+|+||+||+|.+ +|..||+|++.... ...+.+|.+++.. ++||||+++++++.+.
T Consensus 6 ~~~~y-~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 6 VARDI-TLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CGGGC-EEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccCcE-EEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34566 8889999999999999976 69999999986432 2345566666666 8999999999987653
Q ss_pred -CCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCEEeccCCcCceEEeCCCCcE
Q 006810 99 -TNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNNGEV 169 (630)
Q Consensus 99 -~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLH--------s~~~~IiHrDLKp~NILl~~~~g~v 169 (630)
....+++||||+++|+|........+++..++.++.||+.||.||| +++ |+||||||+|||++ .++.+
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~-~~~~~ 152 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVK-KNGQC 152 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEEC-TTSCE
T ss_pred CCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEc-CCCCE
Confidence 2356899999999999995556678999999999999999999999 877 99999999999998 78999
Q ss_pred EEcccccceeeccCC------CccccCCCCCCCcccccc-------ccCcccceeehhHHHHHHhhC----------CCC
Q 006810 170 KIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTC----------EYP 226 (630)
Q Consensus 170 KL~DFGla~~~~~~~------~~~~~GTp~Y~APEvl~~-------~ys~~sDIWSLGvil~ELltG----------~~P 226 (630)
||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|||+|| ..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999997654432 233479999999998865 345799999999999999999 888
Q ss_pred CCCCC----CHHHHHHHHHcCCCCCCCC-----CCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 227 YNECK----NPAQIYKKVTSGIKPASLS-----KVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 227 f~~~~----~~~~i~~~i~~g~~p~~l~-----~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
|.... ....+...+........++ ...++.+.+||.+||. +|.+|||+.++++
T Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 86532 2233333333222222222 1234789999999997 8999999999886
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=342.60 Aligned_cols=244 Identities=20% Similarity=0.365 Sum_probs=199.1
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCC-------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDG-------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG-------~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~ 94 (630)
...+| ++.+.||+|+||+||+|.+..+| ..||+|.+.... ....+.+.+|+.++++++||||++++++
T Consensus 6 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 6 RNEDL-IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp CGGGE-EEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred chhHe-eeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 34566 88899999999999999998877 579999986432 3345678999999999999999999999
Q ss_pred EEcCCCCEEEEEEcccCCCCHH-HHhhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc----
Q 006810 95 WVDDTNRTINMITELFTSGSLR-YRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE---- 168 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~~-lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~---- 168 (630)
+.+.. ..++||||+++|+|. ++...+. +++..++.++.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 81 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~~ 155 (289)
T 4fvq_A 81 CVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLI-REEDRKTG 155 (289)
T ss_dssp ECCTT--CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-ECCBGGGT
T ss_pred EEeCC--CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEe-cCCccccc
Confidence 86543 578899999999998 5555443 999999999999999999999999 99999999999998 5555
Q ss_pred ----EEEcccccceeeccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Q 006810 169 ----VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 242 (630)
Q Consensus 169 ----vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~ 242 (630)
+||+|||++..... .....||+.|+|||++.+ .++.++|||||||++|+|+||..|+....+..........
T Consensus 156 ~~~~~kl~Dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~ 233 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLP--KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233 (289)
T ss_dssp BCCEEEECCCCSCTTTSC--HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred ccceeeeccCcccccccC--ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc
Confidence 99999999864432 234568999999998864 4899999999999999999965555444555555544443
Q ss_pred CCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 243 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 243 g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
. ..++...++.+++||.+||. +|.+|||+.++++|
T Consensus 234 ~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 R---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp T---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred c---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2 22334456789999999998 89999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=347.13 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=206.3
Q ss_pred CCCcceeeeeEecccCceEEEEEEEc-------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEe
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN 93 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~-------~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~ 93 (630)
+.++| ++.+.||+|+||+||+|.+. .++..||+|++.... .....+.+.+|+.+++++ +||||+++++
T Consensus 33 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 33 PRDKL-TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp CGGGE-EEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CHhHe-EEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 34566 88899999999999999975 467899999987432 456677899999999999 9999999999
Q ss_pred EEEcCCCCEEEEEEcccCCCCHH-HHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCC
Q 006810 94 SWVDDTNRTINMITELFTSGSLR-YRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 156 (630)
Q Consensus 94 ~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~~----------------~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLK 156 (630)
++.+. ..+++||||+++|+|. ++.... .+++..++.++.||+.||.|||+++ |+|||||
T Consensus 109 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 184 (334)
T 2pvf_A 109 ACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLA 184 (334)
T ss_dssp EECSS--SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred EEccC--CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCc
Confidence 88654 4688999999999998 554433 4899999999999999999999999 9999999
Q ss_pred cCceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCC
Q 006810 157 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNEC 230 (630)
Q Consensus 157 p~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~ 230 (630)
|+|||++ .+|.+||+|||++....... .....+|+.|+|||++. ..++.++|||||||++|+|+| |..||.+
T Consensus 185 p~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~- 262 (334)
T 2pvf_A 185 ARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG- 262 (334)
T ss_dssp GGGEEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-
T ss_pred cceEEEc-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc-
Confidence 9999998 78999999999997665432 23345788999999875 458999999999999999999 9999987
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 231 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 231 ~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+...+...+..+..+ ..+...++.++++|.+||. +|.+||++.+++.+
T Consensus 263 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 263 IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CCHHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4566677777666433 3445678999999999997 89999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=340.51 Aligned_cols=243 Identities=27% Similarity=0.493 Sum_probs=204.6
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc-------
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD------- 97 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d------- 97 (630)
+| ++.+.||+|+||.||+|.+..+|..||+|.+.... +.+.+|+.++++++||||++++++|..
T Consensus 12 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 12 DF-KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HE-EEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred cc-ceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 44 78899999999999999999999999999997542 236789999999999999999998854
Q ss_pred -------CCCCEEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC
Q 006810 98 -------DTNRTINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 167 (630)
Q Consensus 98 -------~~~~~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 167 (630)
.....+++||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~ 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTK 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETT
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEc-CCC
Confidence 1234689999999999998 5543 467999999999999999999999999 99999999999998 788
Q ss_pred cEEEcccccceeeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC
Q 006810 168 EVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 245 (630)
Q Consensus 168 ~vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~ 245 (630)
.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .......+..+.
T Consensus 160 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~- 235 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGI- 235 (284)
T ss_dssp EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTC-
T ss_pred CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhccc-
Confidence 9999999999766543 3345679999999998865 589999999999999999999998853 334444454433
Q ss_pred CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 246 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 246 p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
++...++.++++|.+||. +|.+||++.++++|.+....
T Consensus 236 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 236 ---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred ---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 334568899999999997 89999999999999876543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=338.91 Aligned_cols=246 Identities=21% Similarity=0.335 Sum_probs=204.0
Q ss_pred CCcceeeee-EecccCceEEEEEEE--ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 23 SCRYGRYDE-ILGKGAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 23 ~gRy~r~~e-~LG~G~fg~Vy~A~d--~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
..|| ++.+ .||+|+||+||+|.+ ..++..||+|++.... ......+.+.+|+.+++.++||||+++++++. .
T Consensus 15 ~~~y-~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~- 89 (291)
T 1xbb_A 15 RKLL-TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICE-A- 89 (291)
T ss_dssp GGGE-EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-S-
T ss_pred chhh-hhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-C-
Confidence 4567 5555 999999999999954 6678999999987543 23445678999999999999999999999883 2
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.
T Consensus 90 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 90 -ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSK 165 (291)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCE
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEe-CCCcEEEccCCcce
Confidence 3578999999999998 7777888999999999999999999999999 99999999999998 78899999999997
Q ss_pred eeccCCC-----ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 179 VMQQPTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 179 ~~~~~~~-----~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
....... ....+|+.|+|||++.+ .++.++||||||+++|+|+| |+.||.. .+...+...+..+..+ ..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 243 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPA 243 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCT
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCC
Confidence 6644321 22346789999998864 58899999999999999999 9999987 4566666777665433 3456
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..++.+.++|.+||. +|.+||++.+++.
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 678999999999997 8999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=337.81 Aligned_cols=249 Identities=19% Similarity=0.343 Sum_probs=207.4
Q ss_pred CCCcceeeeeEecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~--~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
+.++|+.+.+.||+|+||+||+|.+. .++..||+|.+... ......+.+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 81 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-- 81 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--
Confidence 34677666669999999999999864 57889999999754 245667889999999999999999999999833
Q ss_pred CCEEEEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 100 NRTINMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+++||||+++|+|. ++. ....+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLS 157 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTC
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEc-CCCCEEECcccce
Confidence 3488999999999998 544 4466999999999999999999999999 99999999999998 7889999999999
Q ss_pred eeeccCC-----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006810 178 IVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 250 (630)
Q Consensus 178 ~~~~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~ 250 (630)
....... .....||+.|+|||++. ..++.++|||||||++|+|+| |+.||... +...+...+..+..+ .++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~i~~~~~~-~~~ 235 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECP 235 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCC-CCC
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHhcCCcC-CCC
Confidence 7664322 22345688999999886 468999999999999999999 99999874 445556666665433 345
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCC
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPALELLKDP 281 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hp 281 (630)
...++.++++|.+||. +|.+||++.+++.+.
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 6678999999999998 899999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=348.17 Aligned_cols=249 Identities=21% Similarity=0.264 Sum_probs=199.8
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC--CC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TN 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~--~~ 100 (630)
.+|| ++.+.||+|+||.||+|.+..+|..||+|++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 28 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 28 NKHY-LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TEEE-EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred CeEE-EEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 4566 8889999999999999999999999999998643 355667899999999999999999999998743 33
Q ss_pred CEEEEEEcccCCCCHH-HHhh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 101 RTINMITELFTSGSLR-YRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
..+++||||+.+|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLG-DEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEc-CCCCEEEEecC
Confidence 4789999999999997 4433 577999999999999999999999999 99999999999997 78999999999
Q ss_pred cceeeccCC-----------CccccCCCCCCCcccccc----ccCcccceeehhHHHHHHhhCCCCCCCCC-CHHHHHHH
Q 006810 176 LAIVMQQPT-----------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKK 239 (630)
Q Consensus 176 la~~~~~~~-----------~~~~~GTp~Y~APEvl~~----~ys~~sDIWSLGvil~ELltG~~Pf~~~~-~~~~i~~~ 239 (630)
++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....+...
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 886543211 123457999999998753 36899999999999999999999995310 00112222
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 240 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 240 i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+.... ........++.++++|.+||. +|.+||++.+++.+
T Consensus 260 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 VQNQL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 33222 222334568999999999998 89999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=347.08 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=183.8
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEc-----
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD----- 97 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d----- 97 (630)
.|| ++.++||+|+||+||+|.+..+|..||+|.+... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 28 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 28 LRL-RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEE-EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred ceE-EEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 466 8899999999999999999999999999998543 3455677899999999996 9999999999853
Q ss_pred -CCCCEEEEEEcccCCCCHH-HHh---hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEc
Q 006810 98 -DTNRTINMITELFTSGSLR-YRK---KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172 (630)
Q Consensus 98 -~~~~~l~lV~Ey~~gGsL~-~~~---~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 172 (630)
.....+++||||+.+ +|. ++. ..+.+++..++.++.||+.||.|||+++++|+||||||+|||++ .++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC-TTSCEEBC
T ss_pred ccCCceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC-CCCCEEEe
Confidence 334568999999975 554 443 35679999999999999999999999988899999999999998 78899999
Q ss_pred ccccceeeccCCC--------------ccccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHH
Q 006810 173 DLGLAIVMQQPTA--------------RSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 234 (630)
Q Consensus 173 DFGla~~~~~~~~--------------~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~ 234 (630)
|||++........ ....||+.|+|||++. ..++.++|||||||++|+|+||+.||......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~- 259 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL- 259 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-
Confidence 9999976543211 1446899999999873 34788999999999999999999999753221
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCC
Q 006810 235 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 281 (630)
Q Consensus 235 ~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hp 281 (630)
.+ ..+..........++.+++||.+||. +|.+||++.++++|-
T Consensus 260 ~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 260 RI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred Hh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 11 11222222334456789999999998 899999999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.41 Aligned_cols=245 Identities=22% Similarity=0.363 Sum_probs=204.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||.||+|.+..+|..||+|.++.. ......+.+.+|+.+|++++||||+++++++.+. ..+
T Consensus 114 ~~~-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 187 (377)
T 3cbl_A 114 EDL-VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPI 187 (377)
T ss_dssp GGE-EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT---SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS--SSC
T ss_pred HHe-EEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc---CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC--CCc
Confidence 344 7889999999999999999999999999998643 2345566788999999999999999999998654 458
Q ss_pred EEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||+++|+|. ++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~-~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVT-EKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECT
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEc-CCCcEEECcCCCceecC
Confidence 8999999999998 5544 346999999999999999999999999 99999999999997 78999999999997644
Q ss_pred cCCC----ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 182 QPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 182 ~~~~----~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
.... ....+++.|+|||++. +.++.++|||||||++|||+| |..||... ...+....+..+..+ ..+...++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 342 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL-SNQQTREFVEKGGRL-PCPELCPD 342 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS-CHHHHHHHHHTTCCC-CCCTTCCH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCH
Confidence 3211 1223577899999876 468999999999999999998 99999874 455566666655433 34556789
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+.++|.+||. +|.+|||+.+++.
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999997 8999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=337.13 Aligned_cols=244 Identities=17% Similarity=0.256 Sum_probs=199.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~ 101 (630)
.++| ++.+.||+|+||+||+|.+..+|..||+|++...... ..+.+|+.+++.+ +||||+++++++.+. .
T Consensus 9 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~ 79 (298)
T 1csn_A 9 GVHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA------PQLRDEYRTYKLLAGCTGIPNVYYFGQEG--L 79 (298)
T ss_dssp TTTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS------CCHHHHHHHHHHTTTCTTCCCEEEEEEET--T
T ss_pred ccce-EEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc------HHHHHHHHHHHHHhcCCCCCeEEeecCCC--c
Confidence 3456 8899999999999999999999999999998644321 2377899999999 899999999988644 4
Q ss_pred EEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc-----EEEccc
Q 006810 102 TINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKIGDL 174 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~-----vKL~DF 174 (630)
.+++||||+ +|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|. +||+||
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIG-RPNSKNANMIYVVDF 155 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-CSSSTTTTCEEECCC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-cCCCCCCCeEEEEEC
Confidence 689999999 99998 5554 346999999999999999999999999 99999999999997 4554 999999
Q ss_pred ccceeeccCC---------CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC--CHHHHHHHHHc
Q 006810 175 GLAIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTS 242 (630)
Q Consensus 175 Gla~~~~~~~---------~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~--~~~~i~~~i~~ 242 (630)
|++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .....+..+..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 9997664431 245579999999998765 58999999999999999999999998643 33444443332
Q ss_pred C---CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 243 G---IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 243 g---~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
. .....+....++.++++|.+||. +|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 2 11222334568999999999997 8999999999876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=347.26 Aligned_cols=242 Identities=21% Similarity=0.268 Sum_probs=197.6
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~ 102 (630)
++| ++.+.||+|+||+||+|.+..+|..||+|.+...... +.+.+|+.+++.| +||||+++++++.+. ..
T Consensus 9 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~ 79 (330)
T 2izr_A 9 PNF-RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA------PQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KY 79 (330)
T ss_dssp TTE-EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS------CCHHHHHHHHHHHCSCTTSCCEEEEEEET--TE
T ss_pred CCe-EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch------HHHHHHHHHHHHhhCCCCCCEEEEEEecC--Cc
Confidence 456 8899999999999999999999999999998754322 2478899999999 999999999988764 47
Q ss_pred EEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCc-----EEEcccc
Q 006810 103 INMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKIGDLG 175 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~-----vKL~DFG 175 (630)
+++||||+ +|+|. ++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++. +||+|||
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~-~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIG-RPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-CGGGTCTTSEEECCCT
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-cCCCCCCceEEEEEcc
Confidence 89999999 89998 4444 578999999999999999999999999 99999999999997 6666 9999999
Q ss_pred cceeeccCC---------CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC--CHHHHHHHHHcC
Q 006810 176 LAIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSG 243 (630)
Q Consensus 176 la~~~~~~~---------~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~--~~~~i~~~i~~g 243 (630)
++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. .....+..+...
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 998654322 245689999999998865 58999999999999999999999998643 333444444322
Q ss_pred CC---CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 244 IK---PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 244 ~~---p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.. +..+.... ++++++|.+||. +|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 236 KRATPIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHSCHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hccCCHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11 11112223 499999999997 8999999998776
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=344.72 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=205.7
Q ss_pred CCccccCCCCcceeeeeEecccCceEEEEEEEccCCeEE--EEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEE
Q 006810 15 GEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEV--AWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKF 91 (630)
Q Consensus 15 ~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~V--AiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~ 91 (630)
..|...+ .++| ++.+.||+|+||.||+|.+..+|..+ |+|.+.... .....+.+.+|+.+|+++ +||||+++
T Consensus 17 ~~~p~~~-~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~ 91 (327)
T 1fvr_A 17 TIYPVLD-WNDI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINL 91 (327)
T ss_dssp CCSSBCC-GGGC-EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCE
T ss_pred ccccccc-HHHc-cceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhh
Confidence 3344333 3566 88899999999999999999999866 999886432 234556788999999999 99999999
Q ss_pred EeEEEcCCCCEEEEEEcccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEecc
Q 006810 92 YNSWVDDTNRTINMITELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 154 (630)
Q Consensus 92 ~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrD 154 (630)
++++.+. ..+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+|||
T Consensus 92 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~d 167 (327)
T 1fvr_A 92 LGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRD 167 (327)
T ss_dssp EEEEEET--TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred ceeeeeC--CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCC
Confidence 9998655 4689999999999998 55443 37999999999999999999999999 99999
Q ss_pred CCcCceEEeCCCCcEEEcccccceeeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCC
Q 006810 155 LKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECK 231 (630)
Q Consensus 155 LKp~NILl~~~~g~vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~ 231 (630)
|||+|||++ .++.+||+|||++...... ......+++.|+|||++.+ .++.++|||||||++|+|+| |..||.. .
T Consensus 168 lkp~NIl~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~ 245 (327)
T 1fvr_A 168 LAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-M 245 (327)
T ss_dssp CSGGGEEEC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-C
T ss_pred CccceEEEc-CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-C
Confidence 999999997 7889999999998744322 2233457889999998864 58999999999999999998 9999987 4
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 232 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 232 ~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+...+...+..+..+ ..+...++.+++||.+||. +|.+||++.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 246 TCAELYEKLPQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CHHHHHHHGGGTCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHhhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 566677777665433 3345568999999999998 89999999999885
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=344.40 Aligned_cols=249 Identities=24% Similarity=0.400 Sum_probs=206.7
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCe-----EEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGI-----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~-----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f 95 (630)
+.++| ++.+.||+|+||+||+|.+..+|. .||+|.+.... .....+.+.+|+.+|+.+ +||||+++++++
T Consensus 44 ~~~~~-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 44 PRNNL-QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp CTTSE-EEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHc-eeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34556 888999999999999999977664 79999986432 345667899999999999 899999999998
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhh--------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCce
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKK--------------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 160 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~--------------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NI 160 (630)
.+. ..+++||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 120 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NI 195 (333)
T 2i1m_A 120 THG--GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNV 195 (333)
T ss_dssp CSS--SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGC
T ss_pred ecC--CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceE
Confidence 654 4588999999999997 4432 346899999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHH
Q 006810 161 FVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPA 234 (630)
Q Consensus 161 Ll~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~ 234 (630)
|++ .++.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+.....
T Consensus 196 l~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 196 LLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EEE-GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred EEC-CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 998 78899999999997654332 22345688999999875 458999999999999999999 999998866666
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 235 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 235 ~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.+...+..+..+ ..+...++.+.++|.+||. +|.+||++.+++.+
T Consensus 275 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 275 KFYKLVKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 666666655433 3445568999999999998 89999999999873
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=341.28 Aligned_cols=247 Identities=23% Similarity=0.401 Sum_probs=205.4
Q ss_pred CCcceeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~-----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
.++| ++.+.||+|+||+||+|.+. .++..||+|.+... ........+.+|+.+++.++||||+++++++.+
T Consensus 24 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 24 REKI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp GGGE-EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hhhe-eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 3456 88899999999999999887 46889999998743 234556778999999999999999999998855
Q ss_pred CCCCEEEEEEcccCCCCHH-HHhhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCC
Q 006810 98 DTNRTINMITELFTSGSLR-YRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 166 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~-~~~~~----------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~ 166 (630)
. ..+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .+
T Consensus 100 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~-~~ 174 (322)
T 1p4o_A 100 G--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-ED 174 (322)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TT
T ss_pred C--CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEc-CC
Confidence 4 4578999999999997 44331 46799999999999999999999999 99999999999998 78
Q ss_pred CcEEEcccccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHH
Q 006810 167 GEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 240 (630)
Q Consensus 167 g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i 240 (630)
|.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|+| |..||.. .+..++...+
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~ 253 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFV 253 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHHHH
Confidence 999999999997554321 223457899999998764 58999999999999999999 8999977 4566666666
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 241 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 241 ~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..+..+ ..+...++.++++|.+||. +|.+||++.+++++
T Consensus 254 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 254 MEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 655432 3345678999999999998 89999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=353.95 Aligned_cols=263 Identities=18% Similarity=0.228 Sum_probs=198.5
Q ss_pred CccCCccccCCCCcceeeeeEecccCceEEEEEEEcc---CCeEEEEEEeecccccCCH--H-----HHHHHHHHHHHHH
Q 006810 12 TEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSP--D-----QLERLYSEVHLLK 81 (630)
Q Consensus 12 ~~~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~---tG~~VAiK~i~~~~~~~~~--~-----~~~~l~~Ei~iL~ 81 (630)
-.+...+.....++| ++.+.||+|+||+||+|.+.. ++..||+|.+......... . ....+.+|+..++
T Consensus 25 l~~g~~~~~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~ 103 (345)
T 2v62_A 25 FPEGKVLDDMEGNQW-VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103 (345)
T ss_dssp CCTTCEEECTTSCEE-EEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred CCCCCeeccccCceE-EEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhc
Confidence 334555555555677 889999999999999999987 8899999998754311000 0 1123667889999
Q ss_pred hCCCCCeeEEEeEEEcC--CCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcC
Q 006810 82 SLKHENIIKFYNSWVDD--TNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 158 (630)
Q Consensus 82 ~L~HpNIVk~~~~f~d~--~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~ 158 (630)
.++||||+++++++... ....+++||||+ +++|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 104 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~ 180 (345)
T 2v62_A 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAA 180 (345)
T ss_dssp TCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred cccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHH
Confidence 99999999999998763 246799999999 99998 6666778999999999999999999999999 999999999
Q ss_pred ceEEeCCCC--cEEEcccccceeeccC---------CCccccCCCCCCCccccccc-cCcccceeehhHHHHHHhhCCCC
Q 006810 159 NIFVNGNNG--EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYP 226 (630)
Q Consensus 159 NILl~~~~g--~vKL~DFGla~~~~~~---------~~~~~~GTp~Y~APEvl~~~-ys~~sDIWSLGvil~ELltG~~P 226 (630)
|||++ .++ .+||+|||+++..... ......||+.|+|||++.+. ++.++|||||||++|+|+||+.|
T Consensus 181 NIll~-~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p 259 (345)
T 2v62_A 181 NLLLG-YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259 (345)
T ss_dssp GEEEE-SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred HEEEc-cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99998 555 9999999999765322 11345799999999988754 89999999999999999999999
Q ss_pred CCCCC-CHHHHHHHHHc--CCCCCC-----CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 227 YNECK-NPAQIYKKVTS--GIKPAS-----LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 227 f~~~~-~~~~i~~~i~~--g~~p~~-----l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
|.... +...+...... ...+.. .....++.++++|.+||. +|.+||++.++++
T Consensus 260 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 260 WEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp TGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 96432 22222211111 111110 012567899999999997 8999999999877
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=336.81 Aligned_cols=243 Identities=25% Similarity=0.399 Sum_probs=205.4
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||+||+|.+..+|..||+|.+... ....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 13 ~~~-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 84 (288)
T 3kfa_A 13 TDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPF 84 (288)
T ss_dssp GGE-EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSE
T ss_pred cce-eEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCE
Confidence 344 8899999999999999999999999999998643 23456788999999999999999999988654 458
Q ss_pred EEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 104 NMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
++||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++...
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEEC-GGGCEEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEc-CCCCEEEccCccceec
Confidence 9999999999998 5554 345999999999999999999999999 99999999999997 7889999999999765
Q ss_pred ccCCC---ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 181 QQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 181 ~~~~~---~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
..... ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...+.....+ ..+...++
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCPE 239 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCCH
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-CCCCCCCH
Confidence 54322 2345688999999876 458999999999999999999 9999976 4555666666655433 34456789
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+++||.+||. +|.+||++.++++
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHH
Confidence 99999999998 8999999999876
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=347.68 Aligned_cols=253 Identities=26% Similarity=0.443 Sum_probs=201.0
Q ss_pred CccccCCCCcceeeeeEecccCceEEEEEEEccCCeEE----EEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEE
Q 006810 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91 (630)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~V----AiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~ 91 (630)
.+...-..++| ++.+.||+|+||+||+|.+..+|..| |+|.+.... .....+.+.+|+.+++.++||||+++
T Consensus 7 ~~~~~l~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~ 82 (327)
T 3lzb_A 7 ALLRILKETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRL 82 (327)
T ss_dssp -CCEECCTTTE-EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCC
T ss_pred hhhcccCHhHc-eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEE
Confidence 44445556777 88899999999999999998888765 666554322 22345678899999999999999999
Q ss_pred EeEEEcCCCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcE
Q 006810 92 YNSWVDDTNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 169 (630)
Q Consensus 92 ~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 169 (630)
++++.... .++|++|+.+|+|. ++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 83 ~~~~~~~~---~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~ 156 (327)
T 3lzb_A 83 LGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHV 156 (327)
T ss_dssp CEEEESSS---EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEE
T ss_pred EEEEecCC---ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEc-CCCCE
Confidence 99987543 77899999999998 5544 567999999999999999999999999 99999999999998 78999
Q ss_pred EEcccccceeeccCC----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcC
Q 006810 170 KIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243 (630)
Q Consensus 170 KL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g 243 (630)
||+|||++....... .....||+.|+|||++.+ .|+.++|||||||++|+|++ |..||.. .+...+...+..+
T Consensus 157 kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~ 235 (327)
T 3lzb_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKG 235 (327)
T ss_dssp EECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTT
T ss_pred EEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcC
Confidence 999999997654322 223456889999998764 58999999999999999999 9999987 4555566666655
Q ss_pred CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 244 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 244 ~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..+ ..+...++.+.++|.+||. +|.+||++.+++..
T Consensus 236 ~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 236 ERL-PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 433 3455678999999999998 89999999999873
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=336.36 Aligned_cols=244 Identities=21% Similarity=0.357 Sum_probs=202.6
Q ss_pred eeeeEecccCceEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~---~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
++.+.||+|+||+||+|.+..++. .||+|.+... ......+.+.+|+.+++.++||||+++++++.+... ..+
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 99 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG-LPH 99 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS-CCE
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC-CcE
Confidence 567999999999999998765544 8999998642 345667889999999999999999999999875543 447
Q ss_pred EEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 105 MITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+||||+.+|+|. ++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLD-ESFTVKVADFGLARDILD 176 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECCTTSSCTTTT
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEeCcCCCcccccC
Confidence 899999999998 5444 567899999999999999999999999 99999999999998 789999999999975432
Q ss_pred ------CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 183 ------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 183 ------~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
.......+|+.|+|||.+.+ .++.++|||||||++|+|+||..|+....+...+...+..+..+ ..+...++
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 255 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQPEYCPD 255 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CCCTTCCH
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CCCccchH
Confidence 12334568899999998865 58999999999999999999666655556677777777665433 34556789
Q ss_pred HHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 256 QVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+.++|.+||. +|.+|||+.+++.
T Consensus 256 ~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 256 SLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999998 8999999999887
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=330.82 Aligned_cols=243 Identities=20% Similarity=0.425 Sum_probs=204.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 8 ~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 78 (267)
T 3t9t_A 8 SEL-TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--API 78 (267)
T ss_dssp GGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSC
T ss_pred hhe-eeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCe
Confidence 455 88899999999999999986 678999999975432 125688999999999999999999998654 458
Q ss_pred EEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-GGGCEEECCTTGGGGBC
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEC-CCCCEEEcccccccccc
Confidence 8999999999998 5544 356899999999999999999999999 99999999999997 78899999999997553
Q ss_pred cC---CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 182 QP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 182 ~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
.. ......+++.|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...++.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~ 233 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTH 233 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHH
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcHH
Confidence 32 223445788999999886 458999999999999999999 8999987 4566666677666433 334567899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
++++|.+||. +|.+||++.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999997 89999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=345.51 Aligned_cols=259 Identities=23% Similarity=0.362 Sum_probs=208.0
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEE-----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEE
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~-----d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~ 92 (630)
+..-+.++| ++.+.||+|+||.||+|. +..+|..||+|.+... ........+.+|+.++++++||||++++
T Consensus 24 ~~~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 24 LKEVPRKNI-TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp SCBCCGGGC-EEEEECC--CSSCEEEEEC--------CCEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCChhhe-EEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc---cchhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence 334566777 888999999999999998 5678899999998633 2355667789999999999999999999
Q ss_pred eEEEcCCCCEEEEEEcccCCCCHH-HHhhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe-
Q 006810 93 NSWVDDTNRTINMITELFTSGSLR-YRKKH-------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN- 163 (630)
Q Consensus 93 ~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~-------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~- 163 (630)
+++.+.. .+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 100 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~ 175 (327)
T 2yfx_A 100 GVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTC 175 (327)
T ss_dssp EEECSSS--SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESC
T ss_pred EEEcCCC--CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEec
Confidence 9986543 578999999999998 55544 34899999999999999999999999 99999999999997
Q ss_pred -CCCCcEEEcccccceeeccC----CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHH
Q 006810 164 -GNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 236 (630)
Q Consensus 164 -~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i 236 (630)
+.++.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+| |..||.. .+...+
T Consensus 176 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~ 254 (327)
T 2yfx_A 176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEV 254 (327)
T ss_dssp SSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHH
T ss_pred CCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHH
Confidence 23446999999998654322 223456899999999875 458999999999999999998 9999986 455666
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 237 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 237 ~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
...+..+..+ ..+...++.++++|.+||. +|.+||++.++++|.|+...
T Consensus 255 ~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 255 LEFVTSGGRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 6666665433 3445678999999999998 89999999999999887543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=340.96 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=202.0
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeE
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~t---G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~ 94 (630)
....|....+++.+.||+|+||+||+|.+..+ +..||+|.+... ......+.+.+|+.++++++||||++++++
T Consensus 18 ~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (298)
T 3f66_A 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94 (298)
T ss_dssp GBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred eecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence 34455555569999999999999999986543 346899988642 345667889999999999999999999998
Q ss_pred EEcCCCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEc
Q 006810 95 WVDDTNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 172 (630)
+.... ...++||||+.+|+|. ++.. ...+++..++.|+.||+.||.|||+++ |+||||||+||+++ .+|.+||+
T Consensus 95 ~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~ 170 (298)
T 3f66_A 95 CLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVA 170 (298)
T ss_dssp ECCSS-SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEEC
T ss_pred EEcCC-CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEC-CCCCEEEC
Confidence 75543 4678999999999998 5543 556899999999999999999999999 99999999999998 78999999
Q ss_pred ccccceeeccC------CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCC
Q 006810 173 DLGLAIVMQQP------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 244 (630)
Q Consensus 173 DFGla~~~~~~------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~ 244 (630)
|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++ |.+||.. .+.......+..+.
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~ 249 (298)
T 3f66_A 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGR 249 (298)
T ss_dssp SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTC
T ss_pred cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCC
Confidence 99999765332 2234467889999998864 58999999999999999999 5566655 44444445555443
Q ss_pred CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 245 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 245 ~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+ ..+...++.+.++|.+||. +|.+||++.++++
T Consensus 250 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 250 RL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 32 3345568899999999998 8999999999886
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=335.96 Aligned_cols=247 Identities=25% Similarity=0.422 Sum_probs=200.6
Q ss_pred CCCcceeeeeEecccCceEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~---tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
..++| ++.+.||+|+||+||+|.+.. ++..||+|.+.... .....+++.+|+.+++.++||||+++++++.+.
T Consensus 10 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 10 AREDV-VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp CGGGE-EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred cccce-EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 34566 888999999999999998654 45679999987542 355667899999999999999999999987533
Q ss_pred CCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 99 TNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
..++||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 86 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 86 ---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVA-SPECVKLGDFGL 159 (281)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-ETTEEEECCCCG
T ss_pred ---CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEC-CCCcEEeCccCC
Confidence 357899999999998 5544 456999999999999999999999999 99999999999998 788999999999
Q ss_pred ceeeccCC---CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 177 AIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 177 a~~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
+....... .....+|+.|+|||++. ..++.++|||||||++|+|+| |+.||..... ......+..+..+ ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~ 237 (281)
T 3cc6_A 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRL-PKPD 237 (281)
T ss_dssp GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-GGHHHHHHHTCCC-CCCT
T ss_pred CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-HHHHHHHhcCCCC-CCCC
Confidence 97654332 23345788999999886 458999999999999999998 9999976433 3444455544332 2345
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..++.+.++|.+||. +|.+||++.+++.+
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 678999999999997 89999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=334.05 Aligned_cols=247 Identities=23% Similarity=0.292 Sum_probs=198.9
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
..+|| ++.+.||+|+||.||+|.+..+|..||+|++...... ..+.+|+.+++.++|++++..+..+.. ...
T Consensus 7 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~ 78 (296)
T 3uzp_A 7 VGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGA-EGD 78 (296)
T ss_dssp ETTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC------CHHHHHHHHHHHHTTSTTCCCEEEEEE-ETT
T ss_pred eccEE-EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch------hHHHHHHHHHHHhhcCCCCCccccccC-CCC
Confidence 45677 8899999999999999999999999999998754321 247899999999999988877766544 345
Q ss_pred EEEEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe--CCCCcEEEcccccc
Q 006810 102 TINMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLA 177 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKL~DFGla 177 (630)
.+++||||+ +|+|. ++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++ ..++.+||+|||++
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred ceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 789999999 88997 444 4567999999999999999999999999 99999999999994 36789999999999
Q ss_pred eeeccCC---------CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCH--HHHHHHHHcC--
Q 006810 178 IVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSG-- 243 (630)
Q Consensus 178 ~~~~~~~---------~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~--~~i~~~i~~g-- 243 (630)
....... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.||...... .+.+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 7665432 245679999999998865 5899999999999999999999999763321 1222222211
Q ss_pred -CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 244 -IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 244 -~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.....+....++.+.++|.+||. +|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11112334567999999999997 8999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=340.15 Aligned_cols=239 Identities=29% Similarity=0.494 Sum_probs=190.4
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
++| ++.+.||+|+||+||+|.+. |..||+|.+.. ....+.+.+|+.+|++++||||+++++++.+ .+
T Consensus 8 ~~~-~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~ 74 (307)
T 2eva_A 8 KEI-EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYGACLN----PV 74 (307)
T ss_dssp GGE-EEEEEEECCSSSEEEEEEET--TEEEEEEECSS------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TT
T ss_pred hHe-eeeeEeecCCCceEEEEEEC--CeeEEEEEecC------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----Cc
Confidence 455 78899999999999999764 88999999853 2345678999999999999999999998752 26
Q ss_pred EEEEcccCCCCHH-HHhhcC---CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEeccCCcCceEEeCCCCc-EEEcccc
Q 006810 104 NMITELFTSGSLR-YRKKHK---NVDMKAIKNWARQILRGLHYLHS---HNPPIIHRDLKCDNIFVNGNNGE-VKIGDLG 175 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~---~lse~~i~~i~~QIl~gL~yLHs---~~~~IiHrDLKp~NILl~~~~g~-vKL~DFG 175 (630)
++||||+++|+|. ++.... .++...+..|+.||+.||.|||+ ++ |+||||||+|||++ .+|. +||+|||
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~~kl~Dfg 151 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLV-AGGTVLKICDFG 151 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEE-TTTTEEEECCCC
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEe-CCCCEEEEcccc
Confidence 8899999999998 555444 47899999999999999999999 66 99999999999998 5565 8999999
Q ss_pred cceeeccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCC
Q 006810 176 LAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 176 la~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~-~~i~~~i~~g~~p~~l~~~~ 253 (630)
++...... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.||...... ..+...+..+..+ ......
T Consensus 152 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 229 (307)
T 2eva_A 152 TACDIQTH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNL 229 (307)
T ss_dssp C-------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTC
T ss_pred cccccccc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-Cccccc
Confidence 99755432 234568999999998865 5899999999999999999999999864333 3344444444333 344567
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
++.++++|.+||. +|.+||++.+++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 8999999999997 89999999999873
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.48 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=194.7
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
....+|| ++.+.||+|+||+||+|.+..+|..||+|++...... ..+.+|+.+++.++|++++..+..+...
T Consensus 5 ~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~- 76 (296)
T 4hgt_A 5 LRVGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAE- 76 (296)
T ss_dssp ------C-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C------CCHHHHHHHHHHHTTSTTCCCEEEEEEE-
T ss_pred cccCCce-EEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc------hHHHHHHHHHHHhcCCCCCCeeeeecCC-
Confidence 3455777 8899999999999999999999999999987654322 2377899999999999888877766543
Q ss_pred CCEEEEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe--CCCCcEEEcccc
Q 006810 100 NRTINMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLG 175 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKL~DFG 175 (630)
....++||||+ +|+|. ++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++ ..++.+||+|||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 35789999999 88997 444 3667999999999999999999999999 99999999999992 268899999999
Q ss_pred cceeeccCC---------CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCH--HHHHHHHHcC
Q 006810 176 LAIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSG 243 (630)
Q Consensus 176 la~~~~~~~---------~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~--~~i~~~i~~g 243 (630)
++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .+.+..+...
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 998664432 235579999999998765 5899999999999999999999999764322 1122222111
Q ss_pred ---CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 244 ---IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 244 ---~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.....+....++.++++|.+||. +|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11112234567899999999998 8999999999876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=352.16 Aligned_cols=253 Identities=23% Similarity=0.407 Sum_probs=197.7
Q ss_pred CccccCCCCcceeeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEE
Q 006810 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92 (630)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~---~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~ 92 (630)
++...-...+| ++.+.||+|+||.||+|.+. .++..||+|.++... .....+.+.+|+.+|++++||||++++
T Consensus 37 ~~~~~~~~~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~ 112 (373)
T 2qol_A 37 EFAKELDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLE 112 (373)
T ss_dssp TTSCBCCGGGC-CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHHhhcCHhhc-eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34444445566 77899999999999999887 567889999987532 455667899999999999999999999
Q ss_pred eEEEcCCCCEEEEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEE
Q 006810 93 NSWVDDTNRTINMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 170 (630)
Q Consensus 93 ~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 170 (630)
+++.+. ..+++||||+++|+|. ++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 113 ~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~k 187 (373)
T 2qol_A 113 GVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCK 187 (373)
T ss_dssp EEECSS--SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEE
T ss_pred EEEeeC--CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEc-CCCCEE
Confidence 998654 4588999999999998 55443 47999999999999999999999999 99999999999998 789999
Q ss_pred EcccccceeeccCC-----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcC
Q 006810 171 IGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 243 (630)
Q Consensus 171 L~DFGla~~~~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g 243 (630)
|+|||+++...... .....+|+.|+|||++. ..++.++|||||||++|||++ |+.||.. .+...+...+..+
T Consensus 188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~i~~~ 266 (373)
T 2qol_A 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKAVDEG 266 (373)
T ss_dssp ECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHHHHTT
T ss_pred ECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcC
Confidence 99999997654321 11224577899999876 458999999999999999998 9999987 4556666666655
Q ss_pred CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 244 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 244 ~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..+. .+...++.+.++|.+||. +|.+||++.+++.
T Consensus 267 ~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 267 YRLP-PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp EECC-CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 3322 234567899999999997 8999999999876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=329.34 Aligned_cols=243 Identities=25% Similarity=0.421 Sum_probs=202.5
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+..+| ++.+.||+|+||+||+|.+. ++..||+|.+..... ..+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 11 ~~~~y-~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 80 (279)
T 1qpc_A 11 PRETL-KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ---E 80 (279)
T ss_dssp CGGGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred CHHhh-hheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-----cHHHHHHHHHHHHhCCCcCcceEEEEEcC---C
Confidence 45677 88899999999999999875 678899999875431 23568899999999999999999998753 2
Q ss_pred EEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.+++||||+++|+|. ++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLAR 157 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEc-CCCCEEECCCcccc
Confidence 478999999999998 54433 37999999999999999999999999 99999999999998 78999999999997
Q ss_pred eeccCC---CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 179 VMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 179 ~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
...... .....+++.|+|||++. +.++.++||||||+++|+|++ |+.||.+ .+...+...+..+..+ ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 235 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRM-VRPDNC 235 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTC
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHHhcccCC-CCcccc
Confidence 665432 22345688999999886 458999999999999999999 9999987 4555666666665433 334567
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
++.+.++|.+||. +|.+||++.+++.
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 8999999999997 8999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.23 Aligned_cols=247 Identities=22% Similarity=0.395 Sum_probs=199.1
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeE----EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIE----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~----VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
...+| ++.+.||+|+||+||+|.+..+|.. ||+|.+..... ......+.+|+.++++++||||+++++++.+
T Consensus 11 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 86 (325)
T 3kex_A 11 KETEL-RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG---RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG 86 (325)
T ss_dssp CTTTE-EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS---CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB
T ss_pred CHhHc-eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 34566 8889999999999999999888875 77776643321 1223446789999999999999999998743
Q ss_pred CCCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 98 DTNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
..+++||||+.+|+|. ++.. .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 87 ---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg 160 (325)
T 3kex_A 87 ---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK-SPSQVQVADFG 160 (325)
T ss_dssp ---SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEES-SSSCEEECSCS
T ss_pred ---CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEEC-CCCeEEECCCC
Confidence 3488999999999997 5544 367999999999999999999999999 99999999999997 78999999999
Q ss_pred cceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006810 176 LAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASL 249 (630)
Q Consensus 176 la~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l 249 (630)
+++...... .....||+.|+|||++. +.++.++|||||||++|+|+| |..||... ....+...+..+..+ ..
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~ 238 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKGERL-AQ 238 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CTTHHHHHHHTTCBC-CC
T ss_pred cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CC
Confidence 997654322 23456788999999886 468999999999999999999 99999874 444555555554332 33
Q ss_pred CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 250 SKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 250 ~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+...++.+.++|.+||. +|.+||++.+++++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 239 PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 44567789999999997 89999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.68 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=202.4
Q ss_pred CccccCCCCcceeeeeEecccCceEEEEEEEccCC----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEE
Q 006810 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91 (630)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~ 91 (630)
.+.......+| ++.+.||+|+||+||+|.+..++ ..||+|.+.... .......+.+|+.++++++||||+++
T Consensus 36 ~~~~~i~~~~~-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~ 111 (333)
T 1mqb_A 36 KFTTEIHPSCV-TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRL 111 (333)
T ss_dssp --CCBCCTTTE-EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hccccCChHHh-hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 44455556677 77899999999999999887553 469999986432 34566779999999999999999999
Q ss_pred EeEEEcCCCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcE
Q 006810 92 YNSWVDDTNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 169 (630)
Q Consensus 92 ~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 169 (630)
++++.+. ..+++||||+++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 112 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~ 186 (333)
T 1mqb_A 112 EGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVC 186 (333)
T ss_dssp EEEECSS--SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCE
T ss_pred EEEEecC--CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEEC-CCCcE
Confidence 9988543 4689999999999998 5544 467999999999999999999999999 99999999999998 78999
Q ss_pred EEcccccceeeccCC-----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHc
Q 006810 170 KIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 242 (630)
Q Consensus 170 KL~DFGla~~~~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~ 242 (630)
||+|||++....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+...+..
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~ 265 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAIND 265 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHT
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHC
Confidence 999999997654321 12234678999999876 458999999999999999999 9999987 455666677766
Q ss_pred CCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 243 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 243 g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+..+. .+...++.+.++|.+||. +|.+||++.+++.+
T Consensus 266 ~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 266 GFRLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TCCCC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 64332 344678999999999997 89999999998874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=357.10 Aligned_cols=241 Identities=22% Similarity=0.408 Sum_probs=200.1
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
..+| ++.+.||+|+||.||+|.+. |..||+|.++... ..+.+.+|+.+|++++||||+++++++.... ..
T Consensus 192 ~~~~-~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 261 (450)
T 1k9a_A 192 MKEL-KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GG 261 (450)
T ss_dssp GGGE-EEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SC
T ss_pred hHHe-EEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-Cc
Confidence 3455 78899999999999999764 8899999987432 2356889999999999999999999887543 36
Q ss_pred EEEEEcccCCCCHH-HHhhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 103 INMITELFTSGSLR-YRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~--lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
+++||||+++|+|. ++...+. +++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++.
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEC-CCCCEEEeeCCCccc
Confidence 89999999999998 6655443 799999999999999999999999 99999999999997 789999999999975
Q ss_pred eccCCCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 180 MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 180 ~~~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
.... .....+++.|+|||++. ..++.++|||||||++|||+| |+.||.... ..++...+..+..+ ..+...++.+
T Consensus 339 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~~~~~~-~~p~~~~~~l 415 (450)
T 1k9a_A 339 ASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKM-DAPDGCPPAV 415 (450)
T ss_dssp CC-------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC-TTTHHHHHHTTCCC-CCCTTCCHHH
T ss_pred cccc-ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC-CCCCcCCHHH
Confidence 5432 22346789999999876 458999999999999999998 999998744 44555666666443 3455678999
Q ss_pred HHHHHHccc-CCCCCCCHHHHhc
Q 006810 258 KQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.++|.+||. +|.+|||+.+++.
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 999999997 8999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=352.50 Aligned_cols=261 Identities=18% Similarity=0.244 Sum_probs=198.9
Q ss_pred cCCccccCCCCcceeeeeEecccCceEEEEEEEccC-----CeEEEEEEeecccccCCHHHH--------HHHHHHHHHH
Q 006810 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQL--------ERLYSEVHLL 80 (630)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~t-----G~~VAiK~i~~~~~~~~~~~~--------~~l~~Ei~iL 80 (630)
..+++.....++| ++.+.||+|+||+||+|.+..+ +..||+|++...... ...+. ..+.+|+..+
T Consensus 25 ~g~~i~~~~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~ 102 (364)
T 3op5_A 25 VGEIITDMAAAAW-KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRT 102 (364)
T ss_dssp TTCEEECTTCCEE-EEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHH
T ss_pred CCcEeeccCCCeE-EEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHH
Confidence 3445555556677 8899999999999999998765 688999998754310 00111 1234566778
Q ss_pred HhCCCCCeeEEEeEEEcCCC--CEEEEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCC
Q 006810 81 KSLKHENIIKFYNSWVDDTN--RTINMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 156 (630)
Q Consensus 81 ~~L~HpNIVk~~~~f~d~~~--~~l~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLK 156 (630)
+.++||||+++++++..... ..+++||||+ +|+|. ++... +.+++..++.|+.||+.||.|||+++ |+|||||
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlk 179 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIK 179 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCC
Confidence 88899999999999876433 5689999999 99998 55444 68999999999999999999999999 9999999
Q ss_pred cCceEEeC-CCCcEEEcccccceeeccCC---------CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCC
Q 006810 157 CDNIFVNG-NNGEVKIGDLGLAIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEY 225 (630)
Q Consensus 157 p~NILl~~-~~g~vKL~DFGla~~~~~~~---------~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~ 225 (630)
|+|||++. .++.+||+|||+++...... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.
T Consensus 180 p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 259 (364)
T 3op5_A 180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL 259 (364)
T ss_dssp GGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999972 46899999999997654321 134569999999998875 48999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCC--------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 226 PYNECKNPAQIYKKVTSGIKP--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 226 Pf~~~~~~~~i~~~i~~g~~p--------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
||.+................+ .-.....++++.+||.+||. +|.+||++.+++.
T Consensus 260 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 260 PWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 998633333322222111000 00114557899999999997 8999999999876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=335.12 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=195.6
Q ss_pred CCcceeeeeEecccCceEEEEEEEcc-CC--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEV-DG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~-tG--~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~ 99 (630)
..+| ++.+.||+|+||+||+|.+.. ++ ..||+|+++.... ......+.+.+|+.++++++||||+++++++....
T Consensus 17 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 17 EKDL-RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp GGGE-EEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhHe-eeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 4456 888999999999999998643 33 4699999875432 23456678999999999999999999999986543
Q ss_pred CCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 100 NRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
+++||||+++|+|. ++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 95 ---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 95 ---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLM 168 (291)
T ss_dssp ---CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTC
T ss_pred ---ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEc-CCCCEEEcccccc
Confidence 78999999999997 4443 467999999999999999999999999 99999999999998 7889999999999
Q ss_pred eeeccCC-----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006810 178 IVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 250 (630)
Q Consensus 178 ~~~~~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~ 250 (630)
....... .....+|+.|+|||++.+ .++.++||||||+++|+|++ |+.||.. .+...+...+.........+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRP 247 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCC
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHccCCCCCCC
Confidence 7664332 223457889999998764 58899999999999999999 9999987 45566666666554444455
Q ss_pred CCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 251 KVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 251 ~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
...++.++++|.+||. +|.+||++.+++.
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 6678999999999997 8999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=335.75 Aligned_cols=242 Identities=19% Similarity=0.320 Sum_probs=192.3
Q ss_pred cCCccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHH-HhCCCCCeeEEE
Q 006810 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFY 92 (630)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL-~~L~HpNIVk~~ 92 (630)
...+....-.++|+.+.++||+|+||.||+|.+..+|..||+|.+... ..+.+|+.++ +.++||||++++
T Consensus 7 ~~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~ 77 (299)
T 3m2w_A 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIV 77 (299)
T ss_dssp CCCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEE
T ss_pred cccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHH
Confidence 345566677788866668999999999999999999999999998632 2366788887 677999999999
Q ss_pred eEEEc--CCCCEEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC--
Q 006810 93 NSWVD--DTNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-- 165 (630)
Q Consensus 93 ~~f~d--~~~~~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~-- 165 (630)
++|.. .....+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++..
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~ 155 (299)
T 3m2w_A 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRP 155 (299)
T ss_dssp EEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSST
T ss_pred hhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCC
Confidence 98865 3345799999999999998 55544 36999999999999999999999999 9999999999999832
Q ss_pred CCcEEEcccccceeeccCCCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC
Q 006810 166 NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 245 (630)
Q Consensus 166 ~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~ 245 (630)
++.+||+|||++..... ..|+.++|||||||++|+|+||+.||...... ...........
T Consensus 156 ~~~~kl~Dfg~a~~~~~-------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~ 215 (299)
T 3m2w_A 156 NAILKLTDFGFAKETTG-------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKTRIR 215 (299)
T ss_dssp TCCEEECCCTTCEECTT-------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSC
T ss_pred CCcEEEecccccccccc-------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcch-hhhHHHHHHHh
Confidence 78999999998864321 34778999999999999999999999763221 11111111111
Q ss_pred --CCCCC----CCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 246 --PASLS----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 246 --p~~l~----~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
...++ ...++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 11111 3468899999999998 89999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=338.80 Aligned_cols=245 Identities=28% Similarity=0.453 Sum_probs=190.0
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCeeEEEeEEEcCCC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpNIVk~~~~f~d~~~ 100 (630)
.++| ++.+.||+|+||.||+|.+. |..||+|++.... .....+|..++.. ++||||+++++++.....
T Consensus 36 ~~~y-~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 36 AKQI-QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHC-EEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccce-EEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 3466 88999999999999999775 9999999986432 1234455555554 499999999999877643
Q ss_pred --CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcC--------CCCEEeccCCcCceEEeCCCCcEE
Q 006810 101 --RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSH--------NPPIIHRDLKCDNIFVNGNNGEVK 170 (630)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~--------~~~IiHrDLKp~NILl~~~~g~vK 170 (630)
..+++||||+++|+|........+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~k 182 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVK-KNGTCC 182 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEEC-TTSCEE
T ss_pred CCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEEC-CCCCEE
Confidence 5789999999999998444556899999999999999999999998 6 99999999999998 789999
Q ss_pred EcccccceeeccCC------CccccCCCCCCCccccccc-cCc------ccceeehhHHHHHHhhC----------CCCC
Q 006810 171 IGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE-YNE------LVDIYSFGMCILEMVTC----------EYPY 227 (630)
Q Consensus 171 L~DFGla~~~~~~~------~~~~~GTp~Y~APEvl~~~-ys~------~sDIWSLGvil~ELltG----------~~Pf 227 (630)
|+|||++....... .....||+.|+|||++.+. +.. ++|||||||++|||+|| +.||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999997654332 1245799999999988654 333 48999999999999999 7777
Q ss_pred CCCC----CHHHHHHHHHcCCCCCCCCC-----CCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 228 NECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 228 ~~~~----~~~~i~~~i~~g~~p~~l~~-----~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.... ........+........++. ..++.+.+||.+||. +|.+||++.++++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 6532 12233333332222222222 335679999999998 89999999999885
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=338.04 Aligned_cols=246 Identities=23% Similarity=0.374 Sum_probs=198.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
..++.||+|+||+||+|.+ +|..||+|++............+.+.+|+.++++++||||+++++++.+. ..+++||
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 109 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG--DDLCLVY 109 (307)
T ss_dssp TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEE
T ss_pred ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC--CceEEEE
Confidence 3468899999999999975 68899999987544333455667899999999999999999999988654 3588999
Q ss_pred cccCCCCHH-HHh---hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 108 ELFTSGSLR-YRK---KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 108 Ey~~gGsL~-~~~---~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
||+++|+|. ++. ....+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD-EAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc-CCCcEEEeecccccccccc
Confidence 999999997 443 3456999999999999999999999999 99999999999998 7899999999999765432
Q ss_pred C----CccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHH---HHHHHHHcCCC---------CC
Q 006810 184 T----ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIK---------PA 247 (630)
Q Consensus 184 ~----~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~---~i~~~i~~g~~---------p~ 247 (630)
. .....||+.|+|||++.+.++.++||||||+++|+|++|..||....... .+...+..... ..
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN 266 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence 1 23457999999999998889999999999999999999999997643322 22222222111 01
Q ss_pred CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 248 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 248 ~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
......+..+.++|.+||. +|.+||++.+++.+
T Consensus 267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1122234678999999997 89999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=339.57 Aligned_cols=254 Identities=26% Similarity=0.333 Sum_probs=190.5
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc---C
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD---D 98 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d---~ 98 (630)
..++| ++.+.||+|+||+||+|.+ +|..||+|++..... .......|+..+..++||||+++++.+.. .
T Consensus 11 ~~~~y-~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 11 DLDNL-KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CTTSE-EEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred ChHHh-heeeecccCCCeEEEEEEE--CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 44667 8889999999999999965 789999999974321 11122344444566899999999975532 3
Q ss_pred CCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcC---------CCCEEeccCCcCceEEeCCCCcE
Q 006810 99 TNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSH---------NPPIIHRDLKCDNIFVNGNNGEV 169 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~---------~~~IiHrDLKp~NILl~~~~g~v 169 (630)
....+++||||+++|+|.........++..++.++.||+.||.|||++ + |+||||||+|||++ .+|.+
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~ 159 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVK-NDGTC 159 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEEC-TTSCE
T ss_pred CCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEc-CCCcE
Confidence 344688999999999998444555679999999999999999999999 7 99999999999998 78999
Q ss_pred EEcccccceeeccC----------CCccccCCCCCCCcccccc--------ccCcccceeehhHHHHHHhhCCCCCCCCC
Q 006810 170 KIGDLGLAIVMQQP----------TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVTCEYPYNECK 231 (630)
Q Consensus 170 KL~DFGla~~~~~~----------~~~~~~GTp~Y~APEvl~~--------~ys~~sDIWSLGvil~ELltG~~Pf~~~~ 231 (630)
||+|||++...... .....+||+.|+|||++.+ .++.++|||||||++|||+||..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 99999999765422 1224579999999998864 46789999999999999999977764322
Q ss_pred C-----------------HHHHHHHHHcCCCCCCCCCC------CcHHHHHHHHHccc-CCCCCCCHHHH------hcCC
Q 006810 232 N-----------------PAQIYKKVTSGIKPASLSKV------TDPQVKQFIEKCIV-PASLRLPALEL------LKDP 281 (630)
Q Consensus 232 ~-----------------~~~i~~~i~~g~~p~~l~~~------~s~~lk~~I~kcL~-~p~~Rpsa~eL------L~hp 281 (630)
. ...+...+........++.. .++.+++||.+||. +|.+|||+.|+ +.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 1 12222222222222222222 34579999999998 89999999999 4466
Q ss_pred CcccC
Q 006810 282 FLVTD 286 (630)
Q Consensus 282 f~~~~ 286 (630)
|-+..
T Consensus 320 ~~~~~ 324 (336)
T 3g2f_A 320 WERNK 324 (336)
T ss_dssp CCC--
T ss_pred HHhcc
Confidence 66654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=348.59 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=196.9
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
..++| ++.+.||+|+||+||+|.+. +|..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. .
T Consensus 37 ~~~~y-~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 108 (321)
T 2qkw_B 37 ATNNF-DHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES----SQGIEEFETEIETLSFCRHPHLVSLIGFCDER--N 108 (321)
T ss_dssp CCCCC-SCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT--T
T ss_pred HHhcc-CccceeecCCCeeEEEEEEC-CCCEEEEEEecccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--C
Confidence 45677 77899999999999999864 78999999886442 34567789999999999999999999988544 4
Q ss_pred EEEEEEcccCCCCHH-HHhhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 102 TINMITELFTSGSLR-YRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~----~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
.+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLD-ENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEEC-TTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEEC-CCCCEEEeeccc
Confidence 588999999999998 44333 25899999999999999999999999 99999999999998 789999999999
Q ss_pred ceeeccC----CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCH-----HHHH-HHHHcCCC
Q 006810 177 AIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP-----AQIY-KKVTSGIK 245 (630)
Q Consensus 177 a~~~~~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~-----~~i~-~~i~~g~~ 245 (630)
+...... ......||+.|+|||++. +.++.++|||||||++|+|+||+.||...... .... .....+..
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 9764322 123456899999999875 56899999999999999999999999753221 1111 11111111
Q ss_pred C----C----CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCC
Q 006810 246 P----A----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 281 (630)
Q Consensus 246 p----~----~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hp 281 (630)
. . .+....+..+.++|.+||. +|.+||++.+++.+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1 1 1112234678999999998 899999999999763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.84 Aligned_cols=241 Identities=22% Similarity=0.416 Sum_probs=193.9
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||+||+|.+ +|..||+|.++... ..+.+.+|+.++++++||||+++++++.... ..
T Consensus 20 ~~~y-~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 89 (278)
T 1byg_A 20 MKEL-KLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GG 89 (278)
T ss_dssp GGGE-EEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC---C
T ss_pred hhhc-eEEeEEecCCCceEEEEEE--cCCEEEEEEecchh------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-Cc
Confidence 4566 8889999999999999976 48999999986432 3466889999999999999999999876543 36
Q ss_pred EEEEEcccCCCCHH-HHhhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 103 INMITELFTSGSLR-YRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
+++||||+++|+|. ++...+ .+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKE 166 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC---
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEe-CCCcEEEeecccccc
Confidence 88999999999998 554443 3899999999999999999999999 99999999999998 789999999999875
Q ss_pred eccCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 180 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 180 ~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
.... .....+++.|+|||++.+ .++.++||||||+++|+|+| |..||... +...+...+..+.. ...+...++.+
T Consensus 167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l 243 (278)
T 1byg_A 167 ASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYK-MDAPDGCPPAV 243 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTTCC-CCCCTTCCHHH
T ss_pred cccc-ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCC-CCCcccCCHHH
Confidence 5433 233467899999998864 58999999999999999998 99999874 44555566655543 33455678999
Q ss_pred HHHHHHccc-CCCCCCCHHHHhc
Q 006810 258 KQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+++|.+||. +|.+||++.+++.
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 999999997 8999999999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=353.30 Aligned_cols=247 Identities=26% Similarity=0.336 Sum_probs=187.1
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~ 102 (630)
++++...++||+|+||+||.+ ...+|..||+|++.... .+.+.+|+.+|+++ +|||||++++++.+. ..
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~ 83 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSETTD--RF 83 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECS--SE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecC--Ce
Confidence 445578899999999999875 56689999999986432 24577899999876 899999999988654 57
Q ss_pred EEEEEcccCCCCHH-HHhhcCCC-------CHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC----------
Q 006810 103 INMITELFTSGSLR-YRKKHKNV-------DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG---------- 164 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~l-------se~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~---------- 164 (630)
+++||||+. |+|. ++...... ++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTT
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccccccc
Confidence 999999996 5887 55444332 23345789999999999999999 999999999999973
Q ss_pred --CCCcEEEcccccceeeccCC------CccccCCCCCCCcccccc--------ccCcccceeehhHHHHHHhh-CCCCC
Q 006810 165 --NNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPY 227 (630)
Q Consensus 165 --~~g~vKL~DFGla~~~~~~~------~~~~~GTp~Y~APEvl~~--------~ys~~sDIWSLGvil~ELlt-G~~Pf 227 (630)
.++.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|||+| |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 23589999999998765432 234579999999998753 48899999999999999999 99999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCC----CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 228 NECKNPAQIYKKVTSGIKPASLSK----VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 228 ~~~~~~~~i~~~i~~g~~p~~l~~----~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
....... ...+........... ..++++++||.+||. +|.+||++.++|+||||..
T Consensus 241 ~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 241 GDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp CSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 7644332 222222222222221 234789999999998 8999999999999999965
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=338.37 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=201.2
Q ss_pred CCcceeeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~----d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
..+.+++.+.||+|+||.||+|. +..+|..||+|++... .....+.+.+|+.++++++||||+++++++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 44555899999999999999998 5678999999998743 345667899999999999999999999998766
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 99 TNRTINMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
....+++||||+++|+|. ++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEc-CCCcEEEecCcc
Confidence 555789999999999998 55544 56999999999999999999999999 99999999999998 789999999999
Q ss_pred ceeeccCC-----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCH---------------HH
Q 006810 177 AIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------------AQ 235 (630)
Q Consensus 177 a~~~~~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~---------------~~ 235 (630)
+....... .....+++.|+|||++.+ .++.++|||||||++|+|+||..||...... ..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 98765432 223456788999998764 5889999999999999999999998632100 01
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 236 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 236 i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+...+..+.. ...+...++++.++|.+||. +|.+||++.+++.
T Consensus 272 ~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2223333322 23445678999999999997 8999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=355.31 Aligned_cols=243 Identities=23% Similarity=0.415 Sum_probs=202.4
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+..+| ++.+.||+|+||+||+|.+. ++..||+|.++.... ..+.+.+|+.+|++++||||+++++++. ..
T Consensus 186 ~~~~~-~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~ 255 (454)
T 1qcf_A 186 PRESL-KLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHAVVT---KE 255 (454)
T ss_dssp CGGGE-EEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHTTCCCTTBCCEEEEEC---SS
T ss_pred chHHe-EEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc-----cHHHHHHHHHHHhhCCCCCEeeEEEEEe---CC
Confidence 44556 78899999999999999875 578899999975431 2467899999999999999999999874 23
Q ss_pred EEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.+++||||+.+|+|. ++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLAR 332 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTCCEEECSTTGGG
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEC-CCCcEEEeeCCCce
Confidence 578999999999998 55433 37899999999999999999999999 99999999999998 78999999999997
Q ss_pred eeccC---CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 179 VMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 179 ~~~~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
..... ......+|+.|+|||++. +.++.++|||||||++|||+| |+.||.+. +..++...+..+.... .+...
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~~-~~~~~ 410 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMP-RPENC 410 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHHHTCCCC-CCTTS
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCC
Confidence 65432 122344678899999886 568999999999999999999 99999874 5556666666664432 34567
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
++.+.++|.+||. +|.+|||+.+++.
T Consensus 411 ~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 411 PEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 8999999999997 8999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=342.20 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=193.3
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
..++| ++.+.||+|+||+||+|.+ .+|..||+|++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 28 ~~~~y-~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 100 (326)
T 3uim_A 28 ASDNF-SNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-- 100 (326)
T ss_dssp TTTSS-CSTTEEECCSSSEEEEECC-SSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS--
T ss_pred Hhhcc-ccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccceEEEEecCC--
Confidence 34566 7789999999999999975 46899999998754321 12235889999999999999999999986554
Q ss_pred EEEEEEcccCCCCHH-HHhhc----CCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEeccCCcCceEEeCCCCcEEEcc
Q 006810 102 TINMITELFTSGSLR-YRKKH----KNVDMKAIKNWARQILRGLHYLHSH---NPPIIHRDLKCDNIFVNGNNGEVKIGD 173 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~----~~lse~~i~~i~~QIl~gL~yLHs~---~~~IiHrDLKp~NILl~~~~g~vKL~D 173 (630)
..++||||+.+|+|. ++... ..+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+||+|
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~-~~~~~kl~D 177 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGD 177 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEEC-TTCCEEECC
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEEC-CCCCEEecc
Confidence 477899999999998 55433 3499999999999999999999998 7 99999999999998 789999999
Q ss_pred cccceeeccCC---CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCC----CCCHHHHHHHHHcCCC
Q 006810 174 LGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNE----CKNPAQIYKKVTSGIK 245 (630)
Q Consensus 174 FGla~~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~----~~~~~~i~~~i~~g~~ 245 (630)
||++....... .....||+.|+|||++. ..++.++|||||||++|+|+||+.||.. ..........+.....
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99998664332 23456999999999875 4589999999999999999999999952 0111111111211111
Q ss_pred CCC------------CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCC
Q 006810 246 PAS------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 281 (630)
Q Consensus 246 p~~------------l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hp 281 (630)
... +....++.+.++|.+||. +|.+|||+.++++|-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 111 111123678999999998 899999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.37 Aligned_cols=242 Identities=16% Similarity=0.275 Sum_probs=194.6
Q ss_pred CCcceeeeeEecccCceEEEEEEEccC--------CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeE----
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVD--------GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK---- 90 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~t--------G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk---- 90 (630)
.++| ++.+.||+|+||+||+|.+..+ |..||+|.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y-~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 41 GRQW-KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp SCEE-EEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred CCeE-EEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhh
Confidence 4555 8899999999999999999874 889999998743 24789999999999999988
Q ss_pred -----------EEeEEEcCCCCEEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCC
Q 006810 91 -----------FYNSWVDDTNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 156 (630)
Q Consensus 91 -----------~~~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLK 156 (630)
+++++.. ....+++||||+ +|+|. ++... ..+++..++.++.||+.||.|||+++ |+|||||
T Consensus 111 ~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dik 186 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVT 186 (352)
T ss_dssp HTTCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCC
T ss_pred hccCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCC
Confidence 5666554 245789999999 99998 66654 78999999999999999999999999 9999999
Q ss_pred cCceEEeCCCC--cEEEcccccceeeccC---------CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCC
Q 006810 157 CDNIFVNGNNG--EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCE 224 (630)
Q Consensus 157 p~NILl~~~~g--~vKL~DFGla~~~~~~---------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~ 224 (630)
|+|||++ .++ .+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|+||+
T Consensus 187 p~NIl~~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 187 AENIFVD-PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp GGGEEEE-TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred HHHEEEc-CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999998 676 8999999999765432 1234579999999998875 5899999999999999999999
Q ss_pred CCCCCCC-CHHHHHHHHHcC-CCCCCCC------CCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 225 YPYNECK-NPAQIYKKVTSG-IKPASLS------KVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 225 ~Pf~~~~-~~~~i~~~i~~g-~~p~~l~------~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.||.... +...+....... ..+..+. ...++.+++||.+||. +|.+||++.++++
T Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 266 LPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 9998754 444443333210 0111111 2457999999999997 8999999999876
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=359.13 Aligned_cols=241 Identities=24% Similarity=0.404 Sum_probs=203.9
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
+++.+.||+|+||.||+|.+..++..||+|.++.... ..+.+.+|+.+|++++||||+++++++.+. ..+++|
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv 294 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII 294 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEE
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-----chHHHHHHHHHHHhcCCCCEeeEEEEEecC--CcEEEE
Confidence 3778999999999999999999999999999874321 246689999999999999999999998654 458899
Q ss_pred EcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 107 TELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
|||+++|+|. ++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEC-CCCcEEEeecccceeccCC
Confidence 9999999998 6554 346899999999999999999999999 99999999999997 7899999999999866443
Q ss_pred C---CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 184 T---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 184 ~---~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
. .....+++.|+|||++. +.++.++|||||||++|||+| |..||.+. +..++...+..+... ..+...++.+.
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~ 449 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRM-ERPEGCPEKVY 449 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence 2 22334678899999876 458999999999999999999 99999874 455666666665433 34456789999
Q ss_pred HHHHHccc-CCCCCCCHHHHhc
Q 006810 259 QFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+||.+||. +|.+||++.++++
T Consensus 450 ~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 450 ELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCcChhHCcCHHHHHH
Confidence 99999997 8999999999876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=337.10 Aligned_cols=244 Identities=27% Similarity=0.427 Sum_probs=197.2
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCeeEEEeEEEcCCC-
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDDTN- 100 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~--L~HpNIVk~~~~f~d~~~- 100 (630)
++| ++.+.||+|+||+||+|.+ +|..||+|++... ....+.+|+.+++. ++||||+++++++.....
T Consensus 42 ~~y-~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 42 RTI-VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHC-EEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccE-EEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 455 8899999999999999987 5999999998633 23457788888887 799999999999876543
Q ss_pred -CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCEEeccCCcCceEEeCCCCcEEE
Q 006810 101 -RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNNGEVKI 171 (630)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLH--------s~~~~IiHrDLKp~NILl~~~~g~vKL 171 (630)
..+++||||+++|+|........+++..++.++.||+.||.||| +++ |+||||||+|||++ .++.+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~-~~~~~kL 188 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK-KNGTCCI 188 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEEC-TTSCEEE
T ss_pred cceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEEC-CCCCEEE
Confidence 26899999999999984444567999999999999999999999 777 99999999999998 7899999
Q ss_pred cccccceeeccCC------CccccCCCCCCCccccccc-------cCcccceeehhHHHHHHhhC----------CCCCC
Q 006810 172 GDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTC----------EYPYN 228 (630)
Q Consensus 172 ~DFGla~~~~~~~------~~~~~GTp~Y~APEvl~~~-------ys~~sDIWSLGvil~ELltG----------~~Pf~ 228 (630)
+|||++....... .....||+.|+|||++.+. ++.++|||||||++|+|+|| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999997665432 2445799999999988653 34689999999999999999 78987
Q ss_pred CCC----CHHHHHHHHHcCCCCCCCCC-----CCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 229 ECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 229 ~~~----~~~~i~~~i~~g~~p~~l~~-----~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
... ....+...+........++. ...+.+.++|.+||. +|.+||++.++++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 532 23445555544333333322 223578999999997 89999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=347.05 Aligned_cols=251 Identities=19% Similarity=0.217 Sum_probs=194.4
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc----CCHHHHHHHHHHHHHHHhCC---------CC
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLK---------HE 86 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~----~~~~~~~~l~~Ei~iL~~L~---------Hp 86 (630)
.-+.++| ++.+.||+|+||+||+|.+ +|..||+|++...... ......+.+.+|+.+|+.++ ||
T Consensus 16 ~~~~~~y-~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ 92 (336)
T 2vuw_A 16 CLPTEKL-QRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE 92 (336)
T ss_dssp HSCHHHH-HTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred hcccccc-hheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence 3455777 7789999999999999987 7899999999865421 12233466888999998886 77
Q ss_pred CeeEEEeEEEcC----------------------------CCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHH
Q 006810 87 NIIKFYNSWVDD----------------------------TNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQIL 137 (630)
Q Consensus 87 NIVk~~~~f~d~----------------------------~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl 137 (630)
|||++++.+... ....+|+||||+++|++. .+ ..+.+++..++.+++||+
T Consensus 93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~-~~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQM-RTKLSSLATAKSILHQLT 171 (336)
T ss_dssp CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGG-TTTCCCHHHHHHHHHHHH
T ss_pred chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHH-HhcCCCHHHHHHHHHHHH
Confidence 777777765421 145799999999999654 44 336799999999999999
Q ss_pred HHHHHHH-cCCCCEEeccCCcCceEEeCCCC--------------------cEEEcccccceeeccCCCccccCCCCCCC
Q 006810 138 RGLHYLH-SHNPPIIHRDLKCDNIFVNGNNG--------------------EVKIGDLGLAIVMQQPTARSVIGTPEFMA 196 (630)
Q Consensus 138 ~gL~yLH-s~~~~IiHrDLKp~NILl~~~~g--------------------~vKL~DFGla~~~~~~~~~~~~GTp~Y~A 196 (630)
.||.||| +++ |+||||||+|||++ .+| .+||+|||+++..... ..+||+.|+|
T Consensus 172 ~aL~~lH~~~~--ivHrDlKp~NILl~-~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~a 245 (336)
T 2vuw_A 172 ASLAVAEASLR--FEHRDLHWGNVLLK-KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHHHC--CBCSCCCGGGEEEE-ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTC
T ss_pred HHHHHHHHhCC--EeECCCCHHHEEEe-ccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccC
Confidence 9999999 899 99999999999998 555 8999999999876543 4589999999
Q ss_pred ccccccccCcccceeehhHH-HHHHhhCCCCCCCCCCHHHHHHHHHcCCC-C----CCCCCCCcHHHHHHHHHcccCCCC
Q 006810 197 PELYEEEYNELVDIYSFGMC-ILEMVTCEYPYNECKNPAQIYKKVTSGIK-P----ASLSKVTDPQVKQFIEKCIVPASL 270 (630)
Q Consensus 197 PEvl~~~ys~~sDIWSLGvi-l~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p----~~l~~~~s~~lk~~I~kcL~~p~~ 270 (630)
||++.+..+.++||||||++ .+++++|..||........+...+..... + .......++++++||.+||+.+
T Consensus 246 PE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 246 EDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp SGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 99998877899999998777 78899999999531111223333332211 1 1112235788999999999843
Q ss_pred CCCHHHHh-cCCCcc
Q 006810 271 RLPALELL-KDPFLV 284 (630)
Q Consensus 271 Rpsa~eLL-~hpf~~ 284 (630)
||.|+| +||||+
T Consensus 324 --sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 --SATDLLCQHSLFK 336 (336)
T ss_dssp --SHHHHHHHCGGGC
T ss_pred --CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=357.94 Aligned_cols=246 Identities=27% Similarity=0.335 Sum_probs=187.4
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l 103 (630)
+| ++.++||+|+||+||. ....+|..||+|++..... ..+.+|+.+|+.+ +|||||++++++.+. ..+
T Consensus 25 ~y-~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~~ 93 (432)
T 3p23_A 25 SF-CPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDR--QFQ 93 (432)
T ss_dssp EE-EEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEET--TEE
T ss_pred EE-ecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecC--CEE
Confidence 45 7789999999999763 3467899999999865432 1256799999999 899999999988654 468
Q ss_pred EEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CC--CcEEEcccccc
Q 006810 104 NMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NN--GEVKIGDLGLA 177 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~--g~vKL~DFGla 177 (630)
|+||||+.+ +|. ++... ..+.+..++.|+.||+.||.|||+++ |+||||||+|||++. .+ ..+||+|||++
T Consensus 94 ~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 94 YIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 999999985 665 55443 34666678899999999999999999 999999999999952 12 35889999999
Q ss_pred eeeccC-----CCccccCCCCCCCccccc----cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCC
Q 006810 178 IVMQQP-----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 247 (630)
Q Consensus 178 ~~~~~~-----~~~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~ 247 (630)
...... .....+||+.|+|||++. ..++.++|||||||++|+|+| |..||.... ..+. ..+.......
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-~~~~-~~~~~~~~~~ 248 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-QRQA-NILLGACSLD 248 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-THHH-HHHTTCCCCT
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-HHHH-HHHhccCCcc
Confidence 765432 234567999999999886 346789999999999999999 999996532 2222 2222221111
Q ss_pred C--CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 248 S--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 248 ~--l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
. .....++.+++||.+||+ +|.+||++.++|+||||...
T Consensus 249 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 1 122345678999999998 89999999999999999764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.75 Aligned_cols=236 Identities=21% Similarity=0.315 Sum_probs=185.3
Q ss_pred cceeeeeEecccCceEEEEE-----EEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCeeEEEeEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWV 96 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A-----~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpNIVk~~~~f~ 96 (630)
+.|++.+.||+|+||+||+| .+..+|..||+|++.... ...+.+|+.+++.++ |+||+++++++.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 33488899999999999999 478899999999986432 234677888888886 999999999987
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHh-----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCC-----
Q 006810 97 DDTNRTINMITELFTSGSLR-YRK-----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----- 165 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~-----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~----- 165 (630)
... ..++||||+++|+|. ++. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++ .
T Consensus 138 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~-~~~~~~ 212 (365)
T 3e7e_A 138 FQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILG-NGFLEQ 212 (365)
T ss_dssp CSS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-GGGTCC
T ss_pred cCC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEec-ccccCc
Confidence 654 578999999999998 444 3567999999999999999999999999 99999999999997 5
Q ss_pred ------CCcEEEcccccceeecc----CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHH
Q 006810 166 ------NGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA 234 (630)
Q Consensus 166 ------~g~vKL~DFGla~~~~~----~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~ 234 (630)
++.+||+|||+++.+.. ......+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 78999999999976542 22345679999999998875 48999999999999999999999996432110
Q ss_pred HHHHHHHcCCCCCCCC-CCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 235 QIYKKVTSGIKPASLS-KVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 235 ~i~~~i~~g~~p~~l~-~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
. .. ...+. ...++.+.+++.+||. +|.+|++..+.|.+
T Consensus 293 ~-------~~-~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 293 C-------KP-EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp E-------EE-CSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred e-------ee-chhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 0 00 01111 1236789999999998 78888765554443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.30 Aligned_cols=243 Identities=25% Similarity=0.398 Sum_probs=198.4
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+..+| ++.+.||+|+||.||+|.+.. +..||+|.++.... ..+.+.+|+.+|++++||||+++++++.+ .
T Consensus 182 ~~~~~-~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~ 251 (452)
T 1fmk_A 182 PRESL-RLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---E 251 (452)
T ss_dssp CGGGE-EEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred ChhHc-eeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC---C
Confidence 44566 888999999999999998874 56799999875431 13568899999999999999999998754 3
Q ss_pred EEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.+++||||+++|+|. ++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLAR 328 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEC-CCCCEEECCCccce
Confidence 478999999999998 5543 356999999999999999999999999 99999999999997 78899999999997
Q ss_pred eeccCC---CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 179 VMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 179 ~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
...... .....+++.|+|||++. +.++.++|||||||++|||+| |+.||.+ ....++...+..+..+ ..+...
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~ 406 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPEC 406 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTS
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCC
Confidence 654322 22345678999999776 568999999999999999999 9999987 4556666677666443 234567
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
++.+.++|.+||. +|.+|||+.+++.
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8999999999997 8999999999886
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=343.78 Aligned_cols=252 Identities=22% Similarity=0.379 Sum_probs=194.5
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~t---G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
..+....+++.+.||+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.++++++||||+++++++.
T Consensus 84 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 160 (373)
T 3c1x_A 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 160 (373)
T ss_dssp CCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC
T ss_pred cChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 334444457889999999999999987543 346899987632 23456778999999999999999999999875
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 97 DDTNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
... ...++||||+++|+|. ++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 161 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DF 236 (373)
T 3c1x_A 161 RSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADF 236 (373)
T ss_dssp CCS-SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC
T ss_pred cCC-CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEEC-CCCCEEEeec
Confidence 443 4578999999999998 5544 356899999999999999999999999 99999999999998 7899999999
Q ss_pred ccceeeccCC------CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCC
Q 006810 175 GLAIVMQQPT------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 246 (630)
Q Consensus 175 Gla~~~~~~~------~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p 246 (630)
|+++...... .....+|+.|+|||++. ..++.++|||||||++|||+| |.+||.... ...+...+..+..+
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-~~~~~~~~~~~~~~ 315 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRRL 315 (373)
T ss_dssp ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-SSCHHHHHHTTCCC
T ss_pred cccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-HHHHHHHHHcCCCC
Confidence 9997553321 22345788999999876 458999999999999999999 677887643 33444455554432
Q ss_pred CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 247 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 247 ~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..+...++.+.++|.+||. +|.+||++.+++++
T Consensus 316 -~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 316 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3345678999999999997 89999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=361.78 Aligned_cols=240 Identities=22% Similarity=0.355 Sum_probs=200.2
Q ss_pred eeEecccCceEEEEEEE--ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 30 DEILGKGAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d--~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
.+.||+|+||+||+|.+ ..++..||+|+++... ......+.+.+|+.+|++++|||||++++++... .+++||
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~ 448 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVM 448 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEE
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEE
Confidence 35899999999999955 4677899999987543 2334557799999999999999999999988532 378999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC--
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~-- 184 (630)
||+.+|+|. ++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++......
T Consensus 449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC----
T ss_pred EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEe-CCCCEEEEEcCCccccccCccc
Confidence 999999998 7778888999999999999999999999999 99999999999998 78899999999997654321
Q ss_pred ---CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 185 ---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 185 ---~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
.....+|+.|+|||++.+ .|+.++|||||||++|||+| |+.||.+ .+...+...+..+..+ ..+...++++.+
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~ 603 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYD 603 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHH
Confidence 223356789999998865 69999999999999999998 9999987 4566677777766543 345567899999
Q ss_pred HHHHccc-CCCCCCCHHHHhc
Q 006810 260 FIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
||.+||. +|.+||++.+++.
T Consensus 604 li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 604 LMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHH
Confidence 9999998 8999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.60 Aligned_cols=245 Identities=27% Similarity=0.461 Sum_probs=199.5
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+.++| ++.+.||+|+||+||+|.+.. .||+|.+..... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 31 ~~~~~-~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 102 (319)
T 2y4i_B 31 PFEQL-EIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-- 102 (319)
T ss_dssp CCSCE-ECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS--
T ss_pred CHHHe-EEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--
Confidence 44666 788999999999999998754 499999876432 1223345778999999999999999999987654
Q ss_pred EEEEEEcccCCCCHH-HHhhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 102 TINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
.+++||||+++|+|. ++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ +|.+||+|||++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~--~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKVVITDFGLFSI 178 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCCC-
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe--CCCEEEeecCCccc
Confidence 588999999999998 554433 6999999999999999999999999 99999999999996 67999999999865
Q ss_pred ecc-------CCCccccCCCCCCCcccccc----------ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Q 006810 180 MQQ-------PTARSVIGTPEFMAPELYEE----------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 242 (630)
Q Consensus 180 ~~~-------~~~~~~~GTp~Y~APEvl~~----------~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~ 242 (630)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .....+...+..
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~ 257 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGT 257 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhcc
Confidence 421 12234468999999998753 378899999999999999999999987 456666667776
Q ss_pred CCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 243 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 243 g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+..+.......++.+.++|.+||. +|.+||++.+++.
T Consensus 258 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 666555445577899999999997 8999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=375.31 Aligned_cols=259 Identities=28% Similarity=0.392 Sum_probs=202.6
Q ss_pred cCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc--
Q 006810 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD-- 97 (630)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d-- 97 (630)
....+|| ++.+.||+|+||+||+|.+..+|..||+|++... ......+++.+|+.+|+.++||||+++++++..
T Consensus 10 g~~~grY-~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 10 TQTCGPW-EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCCCCe-EEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 3445888 8889999999999999999999999999998643 245667789999999999999999999998644
Q ss_pred --CCCCEEEEEEcccCCCCHH-HHhhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC---c
Q 006810 98 --DTNRTINMITELFTSGSLR-YRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---E 168 (630)
Q Consensus 98 --~~~~~l~lV~Ey~~gGsL~-~~~~~~---~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g---~ 168 (630)
......++||||+++|+|. ++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++ .+| .
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~-~~g~~~~ 162 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQ-PGPQRLI 162 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEE-CCSSSCE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEee-cCCCcee
Confidence 1245678999999999998 555433 6999999999999999999999999 99999999999998 444 4
Q ss_pred EEEcccccceeeccC-CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc----
Q 006810 169 VKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---- 242 (630)
Q Consensus 169 vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~---- 242 (630)
+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.....+..+...+..
T Consensus 163 vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp EEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred EEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 999999999866543 234568999999999886 46899999999999999999999999764333221111100
Q ss_pred ---------C--------CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 243 ---------G--------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 243 ---------g--------~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
+ ..+..+....++.+.+||.+||. +|.+|||+.++|.||||+.
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0 00112233356889999999998 8999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=358.72 Aligned_cols=240 Identities=20% Similarity=0.377 Sum_probs=196.4
Q ss_pred eeeEecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 29 YDEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 29 ~~e~LG~G~fg~Vy~A~d~--~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
....||+|+||.||+|.+. .++..||+|+++... .....+.+.+|+.+|++++|||||++++++... .+++|
T Consensus 340 ~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~lv 413 (613)
T 2ozo_A 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALMLV 413 (613)
T ss_dssp EEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---SEEEE
T ss_pred cCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---CeEEE
Confidence 3348999999999999875 456789999987542 233456789999999999999999999998652 48999
Q ss_pred EcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC
Q 006810 107 TELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 184 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 184 (630)
|||+.+|+|. ++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++......
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLV-NRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCSTTTTCC---
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEc-CCCcEEEeeccCcccccCCC
Confidence 9999999998 554 3456999999999999999999999999 99999999999998 78999999999997654321
Q ss_pred -----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 185 -----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 185 -----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
.....+|+.|+|||++. +.|+.++|||||||++|||+| |+.||.+.. ..++...+..+..+ ..+...++++
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-~~~~~~~i~~~~~~-~~p~~~~~~l 568 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRM-ECPPECPPEL 568 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-SHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHHHHcCCCC-CCCCcCCHHH
Confidence 11234578999999886 569999999999999999998 999998754 45566667666433 3455678999
Q ss_pred HHHHHHccc-CCCCCCCHHHHhc
Q 006810 258 KQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.++|.+||. +|.+||++.+++.
T Consensus 569 ~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 569 YALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 999999997 8999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=352.34 Aligned_cols=243 Identities=25% Similarity=0.399 Sum_probs=202.3
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
+..+| ++.+.||+|+||.||+|.+.. +..||+|.++.... ..+.+.+|+.+|++|+||||+++++++.+ .
T Consensus 265 ~~~~~-~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~ 334 (535)
T 2h8h_A 265 PRESL-RLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---E 334 (535)
T ss_dssp CGGGE-EEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred chhhh-hhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEee---c
Confidence 44556 888999999999999998874 56799999975432 13568899999999999999999998754 3
Q ss_pred EEEEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.+++||||+.+|+|. ++.. ...+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLAR 411 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCTTSTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEc-CCCcEEEcccccce
Confidence 578999999999998 5543 356999999999999999999999999 99999999999997 78899999999997
Q ss_pred eeccC---CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 179 VMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 179 ~~~~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
..... ......+++.|+|||++. +.++.++|||||||++|||+| |+.||.+ ....++...+..+... ..+...
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~ 489 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPEC 489 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTC
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCC
Confidence 65432 122345678899999775 568999999999999999999 9999987 4556666677666443 234567
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
++.+.+||.+||. +|.+||++.+|+.
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999997 8999999999876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.84 Aligned_cols=249 Identities=18% Similarity=0.203 Sum_probs=185.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCee-------------
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENII------------- 89 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pNIV------------- 89 (630)
.|.++++++||+|+||+||+|.+..+|+.||+|++...... .....+.+.+|+.+++.+.| +|+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34457789999999999999999999999999998744322 22335778999999999987 2211
Q ss_pred --------EEEeEEEcCC---CCEEEEEEcccCCCCHH-HHh-------hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCE
Q 006810 90 --------KFYNSWVDDT---NRTINMITELFTSGSLR-YRK-------KHKNVDMKAIKNWARQILRGLHYLHSHNPPI 150 (630)
Q Consensus 90 --------k~~~~f~d~~---~~~l~lV~Ey~~gGsL~-~~~-------~~~~lse~~i~~i~~QIl~gL~yLHs~~~~I 150 (630)
.++.++.... ...++++|+++ +|+|. ++. ..+.+++..+..++.||+.||.|||+++ |
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 232 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 232 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 1111111111 22356677765 46665 332 1445788899999999999999999999 9
Q ss_pred EeccCCcCceEEeCCCCcEEEcccccceeeccCCCccccCCCCCCCcccc----------cc-ccCcccceeehhHHHHH
Q 006810 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----------EE-EYNELVDIYSFGMCILE 219 (630)
Q Consensus 151 iHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl----------~~-~ys~~sDIWSLGvil~E 219 (630)
+||||||+|||++ .+|.+||+|||+++..... ....+| +.|+|||++ .+ .|+.++|||||||++|+
T Consensus 233 iHrDiKp~NILl~-~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 233 VHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp ECSCCCGGGEEEC-TTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEe-cCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999998 7889999999998765443 345678 999999987 32 37889999999999999
Q ss_pred HhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 220 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 220 LltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
|+||+.||.... .......+.. .....++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 310 lltg~~Pf~~~~-~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 310 IWCADLPNTDDA-ALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHSSCCCCTTG-GGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHCCCCCCCcc-hhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 999999997632 2211111111 112457899999999998 89999999999999999753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=344.39 Aligned_cols=246 Identities=20% Similarity=0.296 Sum_probs=195.1
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.++| ++.+.||+|+||.||+|.+..+|..||+|++...... ..+.+|+.+++.|+|++++..+..|.. ....
T Consensus 6 ~~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~-~~~~ 77 (483)
T 3sv0_A 6 GNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGV-EGDY 77 (483)
T ss_dssp TTTE-ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEE-ETTE
T ss_pred CCcE-EEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEe-eCCE
Confidence 4566 8899999999999999999999999999998755432 237789999999988655544444333 3357
Q ss_pred EEEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe--CCCCcEEEcccccce
Q 006810 103 INMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAI 178 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKL~DFGla~ 178 (630)
.++||||+ +++|. ++. ..+.+++..++.|+.||+.||.|||+++ |+||||||+||||+ ..++.+||+|||++.
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 89999999 88998 444 3678999999999999999999999999 99999999999993 267899999999998
Q ss_pred eeccCC---------CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCC--HHHHHHHHHcCC--
Q 006810 179 VMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGI-- 244 (630)
Q Consensus 179 ~~~~~~---------~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~--~~~i~~~i~~g~-- 244 (630)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+... ..+.+..+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 665432 125679999999998765 589999999999999999999999987433 233333332211
Q ss_pred -CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 245 -KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 245 -~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
....+....++++.+||.+||. +|.+||++.+|+.
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1112224567899999999997 8999999998764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=354.94 Aligned_cols=244 Identities=25% Similarity=0.430 Sum_probs=200.3
Q ss_pred CcceeeeeEecccCceEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~---tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
++| ++.+.||+|+||+||+|.+.. .+..||+|.+... ......+.+.+|+.+|++++||||+++++++.+
T Consensus 390 ~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 462 (656)
T 2j0j_A 390 ERI-ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 462 (656)
T ss_dssp GGE-EEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred ccE-EEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 455 778999999999999999864 3568999987643 245566789999999999999999999998743
Q ss_pred CEEEEEEcccCCCCHH-HHhhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 101 RTINMITELFTSGSLR-YRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++||||+++|+|. ++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~-~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEe-CCCCEEEEecCCCe
Confidence 3478999999999998 55443 46999999999999999999999999 99999999999998 78999999999997
Q ss_pred eeccCC---CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 179 VMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 179 ~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
...... .....+|+.|+|||++. ..++.++|||||||++|||++ |..||.+. +...+...+..+..+ .++...
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~-~~~~~~~~i~~~~~~-~~~~~~ 617 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERL-PMPPNC 617 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHHTCCC-CCCTTC
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCC-CCCccc
Confidence 654332 22345688999999876 458999999999999999997 99999874 555566666655433 345567
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
++.+.++|.+||. +|.+||++.+++.
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999997 8999999999876
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=362.84 Aligned_cols=241 Identities=20% Similarity=0.277 Sum_probs=198.6
Q ss_pred CcceeeeeEecccCceEEEEEEEcc-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC--
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~-tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~-- 100 (630)
+|| ++.+.||+|+||+||+|.+.. +|..||+|++... ........+.+|+.+|++++||||++++++|.....
T Consensus 80 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 80 GQY-EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp TTE-EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred Cce-EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 677 888999999999999999976 7999999988643 235566778999999999999999999999876543
Q ss_pred -CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 -RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+|+||||+++++|...... .+++..++.|+.||+.||.|||+++ |+||||||+|||++ . +.+||+|||++..
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~-~-~~~kl~DFG~a~~ 230 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLT-E-EQLKLIDLGAVSR 230 (681)
T ss_dssp CEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-S-SCEEECCCTTCEE
T ss_pred CceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEe-C-CcEEEEecccchh
Confidence 236899999999999843333 7999999999999999999999999 99999999999997 3 4899999999976
Q ss_pred eccCCCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 180 MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 180 ~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
.... ...+||+.|+|||++.+.++.++|||||||++|+|++|..||.+... .+..........++.+.+
T Consensus 231 ~~~~--~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l~~ 299 (681)
T 2pzi_A 231 INSF--GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSYGR 299 (681)
T ss_dssp TTCC--SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHHHH
T ss_pred cccC--CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHHHH
Confidence 6543 45679999999999988889999999999999999999998865210 011100000112478999
Q ss_pred HHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 260 FIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
||.+||. +|.+||++.+.+.|+|+.
T Consensus 300 li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 300 LLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHhhhccCChhhCCCHHHHHHHHHHH
Confidence 9999998 899999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=318.55 Aligned_cols=233 Identities=15% Similarity=0.146 Sum_probs=185.6
Q ss_pred CCccccC--CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEE
Q 006810 15 GEFSEKD--PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92 (630)
Q Consensus 15 ~~~~e~d--p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~ 92 (630)
..+...+ -.+|| ++.+.||+|+||.||+|.+..+|..||+|++..... ......+.+.+|+.++++++||||++++
T Consensus 20 ~~~~~g~~~~~~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~ 97 (286)
T 3uqc_A 20 VQLVPGARIANGRY-RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQETLSRTLRLSRIDKPGVARVL 97 (286)
T ss_dssp CCCCTTCEETTTTE-EEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-SCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcCCCCCEEecCcE-EEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc-cCHHHHHHHHHHHHHHhcCCCCCcceee
Confidence 3444444 33788 888999999999999999999999999999975543 3356678899999999999999999999
Q ss_pred eEEEcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEc
Q 006810 93 NSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172 (630)
Q Consensus 93 ~~f~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 172 (630)
+++.+. ..+|+||||++|++|......+ .....+..|+.||+.||.|||++| |+||||||+|||++ .+|.+||+
T Consensus 98 ~~~~~~--~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~-~~g~~kl~ 171 (286)
T 3uqc_A 98 DVVHTR--AGGLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVS-IDGDVVLA 171 (286)
T ss_dssp EEEEET--TEEEEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-TTSCEEEC
T ss_pred EEEEEC--CcEEEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEc-CCCCEEEE
Confidence 998765 4689999999999998433443 466678999999999999999999 99999999999998 78999998
Q ss_pred ccccceeeccCCCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHH---HHHHHcCCC-CCC
Q 006810 173 DLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI---YKKVTSGIK-PAS 248 (630)
Q Consensus 173 DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i---~~~i~~g~~-p~~ 248 (630)
++ .|++| ++.++|||||||++|+|+||+.||.+......+ ...+..... +..
T Consensus 172 ~~------------------~~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T 3uqc_A 172 YP------------------ATMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPAD 227 (286)
T ss_dssp SC------------------CCCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHH
T ss_pred ec------------------cccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhh
Confidence 44 34444 788999999999999999999999874322111 011111111 112
Q ss_pred CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 249 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 249 l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+....++.+++||.+||. +|.+| |+.++++.
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred cccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 334578899999999998 89999 99999873
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-31 Score=299.59 Aligned_cols=189 Identities=13% Similarity=0.051 Sum_probs=135.8
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccC------CHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCCCEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~------~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~~~l 103 (630)
..++.|+.|.+..+.....|+.||+|++....... .+...+.+.+|+.+|+++ .|+||+++++++.++ ..+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEE
Confidence 44677888888888888899999999997543221 233456799999999999 799999999998654 579
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
||||||++||+|. .+...+++++. .+++||+.||+|||++| ||||||||+|||++ .+|.+||+|||+|+....
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~-~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVD-ARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEEC-TTSCEEECCCTTEESCC-
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEEC-CCCCEEEeecccCeeCCC
Confidence 9999999999998 77778888875 47899999999999999 99999999999998 789999999999986654
Q ss_pred C--CCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCC
Q 006810 183 P--TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPY 227 (630)
Q Consensus 183 ~--~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf 227 (630)
. ...+.+|||.|||||++.+.+..++|+||+|+++++|.++..|+
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred CCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence 3 34567899999999999998899999999999998887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=259.33 Aligned_cols=183 Identities=19% Similarity=0.215 Sum_probs=142.3
Q ss_pred eeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 29 ~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~----~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
-.++||+|+||+||+| ...+..+++|.......... ....+++.+|+++|++++||||+++..++..... .+
T Consensus 340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--~~ 415 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--KR 415 (540)
T ss_dssp --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT--TE
T ss_pred CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc--cE
Confidence 3578999999999999 55688999998755332211 1124568999999999999999954444444433 58
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+||||+++|+|. ++.. +..|+.||+.||.|||+++ |+||||||+|||++ . .+||+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~-~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFD-K--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEES-S--SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEEC-C--eEEEEECccCEECCCc
Confidence 999999999998 4443 6799999999999999999 99999999999998 3 9999999999876543
Q ss_pred C---------CccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCC
Q 006810 184 T---------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYN 228 (630)
Q Consensus 184 ~---------~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~ 228 (630)
. ....+||+.|||||++.. .|+..+|+|+..+-.++.+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 235689999999999874 58889999999999999998888874
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=214.69 Aligned_cols=151 Identities=15% Similarity=0.149 Sum_probs=117.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC-----CH---------HHHHHHHHHHHHHHhCCCCCee
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-----SP---------DQLERLYSEVHLLKSLKHENII 89 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~-----~~---------~~~~~l~~Ei~iL~~L~HpNIV 89 (630)
+.++++.+.||+|+||.||+|.+ .+|..||+|.++...... .. .....+.+|+.+|+.++| +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---C
Confidence 44456679999999999999999 889999999986432110 01 235678899999999994 4
Q ss_pred EEEeEEEcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcE
Q 006810 90 KFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 169 (630)
Q Consensus 90 k~~~~f~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 169 (630)
++++++.. ..+++||||++||+|..+ .......++.||+.||.|||+++ |+||||||+|||++ +|.+
T Consensus 165 ~v~~~~~~---~~~~lvmE~~~g~~L~~l------~~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~--~~~v 231 (282)
T 1zar_A 165 AVPKVYAW---EGNAVLMELIDAKELYRV------RVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS--EEGI 231 (282)
T ss_dssp SSCCEEEE---ETTEEEEECCCCEEGGGC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE--TTEE
T ss_pred CcCeEEec---cceEEEEEecCCCcHHHc------chhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE--CCcE
Confidence 55554322 235899999999999752 12345679999999999999999 99999999999998 8899
Q ss_pred EEcccccceeeccCCCccccCCCCCCCcccccc
Q 006810 170 KIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE 202 (630)
Q Consensus 170 KL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~ 202 (630)
||+|||+++ .+..++|||++.+
T Consensus 232 kl~DFG~a~-----------~~~~~~a~e~l~r 253 (282)
T 1zar_A 232 WIIDFPQSV-----------EVGEEGWREILER 253 (282)
T ss_dssp EECCCTTCE-----------ETTSTTHHHHHHH
T ss_pred EEEECCCCe-----------ECCCCCHHHHHHH
Confidence 999999986 2556899998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.8e-19 Score=181.89 Aligned_cols=144 Identities=16% Similarity=0.169 Sum_probs=108.7
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeE--EEEEEeecccccCC--------------------HHHHHHHHHHHHHHH
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQS--------------------PDQLERLYSEVHLLK 81 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~--VAiK~i~~~~~~~~--------------------~~~~~~l~~Ei~iL~ 81 (630)
|.++.+.+.||+|+||.||+|.+..+|.. ||+|+++....... ......+.+|+.+|+
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999889999 99998754321100 012246789999999
Q ss_pred hCCCCCe--eEEEeEEEcCCCCEEEEEEcccCC-C----CHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-cCCCCEEec
Q 006810 82 SLKHENI--IKFYNSWVDDTNRTINMITELFTS-G----SLRYRKKHKNVDMKAIKNWARQILRGLHYLH-SHNPPIIHR 153 (630)
Q Consensus 82 ~L~HpNI--Vk~~~~f~d~~~~~l~lV~Ey~~g-G----sL~~~~~~~~lse~~i~~i~~QIl~gL~yLH-s~~~~IiHr 153 (630)
.|.|++| +..+.. . ..++||||+.+ | +|..... ..++..+..++.||+.||.||| +++ |+||
T Consensus 126 ~l~~~~i~~p~~~~~--~----~~~lVmE~~g~~g~~~~~L~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~g--ivHr 195 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY--M----KNVLLMEFIGEDELPAPTLVELGR--ELKELDVEGIFNDVVENVKRLYQEAE--LVHA 195 (258)
T ss_dssp HHHHTTCCCCCEEEE--E----TTEEEEECCEETTEECCBHHHHGG--GGGGSCHHHHHHHHHHHHHHHHHTSC--EECS
T ss_pred HHHhCCCCCCeEEEc--C----CCEEEEEecCCCCCccccHHHHhh--ccChHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 9988864 444442 1 35789999943 4 5552221 1345678899999999999999 998 9999
Q ss_pred cCCcCceEEeCCCCcEEEcccccceee
Q 006810 154 DLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 154 DLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
||||+|||++ . .++|+|||+|...
T Consensus 196 Dlkp~NILl~-~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYI-D--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEES-S--SEEECCCTTCEET
T ss_pred CCCHHHEEEc-C--cEEEEECcccccC
Confidence 9999999997 3 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-15 Score=162.98 Aligned_cols=139 Identities=16% Similarity=0.151 Sum_probs=100.4
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc-----C--------CH-HH--H--HHHHHHHHHHHhCCCCCe
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-----Q--------SP-DQ--L--ERLYSEVHLLKSLKHENI 88 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~-----~--------~~-~~--~--~~l~~Ei~iL~~L~HpNI 88 (630)
+++...||+|+||.||+|.+. +|..||+|+++..... . .. .. . ....+|+..|.+|.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 488999999999999999885 6999999987643211 0 00 00 1 112467888888865544
Q ss_pred e--EEEeEEEcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCC
Q 006810 89 I--KFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 166 (630)
Q Consensus 89 V--k~~~~f~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~ 166 (630)
. ..++ ... .++||||++|+.|..+.. ......++.||+.+|.|||++| ||||||||.|||++ .+
T Consensus 176 ~vp~p~~--~~~----~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~-~d 241 (397)
T 4gyi_A 176 PVPEPIA--QSR----HTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIR-EE 241 (397)
T ss_dssp SCCCEEE--EET----TEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-EE
T ss_pred CCCeeee--ccC----ceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe-CC
Confidence 3 2232 111 268999999998863321 2245678899999999999999 99999999999997 55
Q ss_pred C----------cEEEcccccceee
Q 006810 167 G----------EVKIGDLGLAIVM 180 (630)
Q Consensus 167 g----------~vKL~DFGla~~~ 180 (630)
| .+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 5 3899999977543
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.3e-15 Score=124.18 Aligned_cols=60 Identities=23% Similarity=0.409 Sum_probs=58.4
Q ss_pred CceEEEEEecCCCCCeeeeEeecccCCccHHHHHHHHHHccCCCCcCHHHHHHHHHHHHH
Q 006810 363 DTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIM 422 (630)
Q Consensus 363 ~~i~L~Lri~d~~~~~~~i~f~f~~~~Dta~~va~EmV~~~~i~~~d~~~ia~~i~~~i~ 422 (630)
.+|+|+|||+|+.+++++|+|+|.+++|||++||+|||.+|+|++.|+.+||++|+++|.
T Consensus 1 ~pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 1 GPISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CCEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CCeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 378999999999999999999999999999999999999999999999999999999997
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.04 E-value=7.1e-14 Score=118.30 Aligned_cols=63 Identities=30% Similarity=0.393 Sum_probs=58.5
Q ss_pred CCceEEEEEecCCC---CCee---eeEeecccCCccHHHHHHHHHHccCCCCcCHHHHHHHHHHHHHHh
Q 006810 362 DDTVSLTLRIGDKS---GHVS---NIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 424 (630)
Q Consensus 362 ~~~i~L~Lri~d~~---~~~~---~i~f~f~~~~Dta~~va~EmV~~~~i~~~d~~~ia~~i~~~i~~~ 424 (630)
..+|.|+|||.|++ |+.| +|+|+|++++|||++||+|||++|+++++|...||++|+.-|..+
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~ 91 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLI 91 (98)
Confidence 36899999999994 7778 999999999999999999999999999999999999999987655
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=5.1e-10 Score=112.56 Aligned_cols=138 Identities=16% Similarity=0.050 Sum_probs=103.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l~lV 106 (630)
++...++.|+.+.||++.. .|..+++|....... .. ...+.+|+.+|+.|. +..+.++++++.+. ...|+|
T Consensus 17 ~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv 88 (263)
T 3tm0_A 17 RCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLL 88 (263)
T ss_dssp EEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-TS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEE
T ss_pred eeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-CC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEEE
Confidence 6778888899999999964 368999999864321 11 124788999999884 67788888876543 568899
Q ss_pred EcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 006810 107 TELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHN--------------------------------------- 147 (630)
Q Consensus 107 ~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~--------------------------------------- 147 (630)
|||++|.+|.... .+......++.++..+|..||+..
T Consensus 89 ~e~i~G~~l~~~~----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 89 MSEADGVLCSEEY----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp EECCSSEEHHHHC----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred EEecCCeehhhcc----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 9999999987331 122334578899999999999811
Q ss_pred ------------------CCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 148 ------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 148 ------------------~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
+.++|||++|.||+++ .++.+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE-CCcEEEEEEchhcc
Confidence 2389999999999997 44456799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.97 E-value=4.2e-09 Score=104.67 Aligned_cols=133 Identities=13% Similarity=0.013 Sum_probs=94.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC--eeEEEeEEEcCCCCEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN--IVk~~~~f~d~~~~~l~l 105 (630)
++..+.+.|..+.||++. ..+|..+++|...... ...+.+|+.+++.+.+.+ +.+++.++.+. ...++
T Consensus 23 ~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~ 92 (264)
T 1nd4_A 23 DWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWL 92 (264)
T ss_dssp EEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEE
T ss_pred ceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEE
Confidence 443433456669999995 4567889999875321 134678999998885544 45688766543 45789
Q ss_pred EEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------
Q 006810 106 ITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-------------------------------------- 147 (630)
Q Consensus 106 V~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~-------------------------------------- 147 (630)
||||++|.+|. . ...+ ...++.++...|..||+..
T Consensus 93 v~e~i~G~~l~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 93 LLGEVPGQDLL-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EEECCSSEETT-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEEecCCcccC-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 99999999884 1 1122 2367788888888888753
Q ss_pred ------------------CCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 148 ------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 148 ------------------~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
+.++|||++|.||+++ .++.+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVE-NGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE-CCcEEEEEcchhcc
Confidence 1199999999999997 45556799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=6.4e-09 Score=109.78 Aligned_cols=144 Identities=15% Similarity=0.178 Sum_probs=102.4
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEee--cccccCCHHHHHHHHHHHHHHHhCC--CCCeeEEEeEEEcCCC-CEEE
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDTN-RTIN 104 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~--~~~~~~~~~~~~~l~~Ei~iL~~L~--HpNIVk~~~~f~d~~~-~~l~ 104 (630)
.+.|+.|.+..||++... +..+++|+.. ..... .....+.+|+.+|+.|. +..+++++.++.+... ...|
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 367899999999998643 4678888765 32211 12245778999999997 4557788886644321 3477
Q ss_pred EEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 006810 105 MITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSH-------------------------------------- 146 (630)
Q Consensus 105 lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~-------------------------------------- 146 (630)
+||||++|..+... ....++......++.++...|..||+.
T Consensus 118 ~vme~v~G~~l~~~-~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ-SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEEECCCCBCCCCT-TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEEecCCeecCCC-ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 89999999887421 123478888999999999999999973
Q ss_pred ------------------CCCEEeccCCcCceEEeCCCC-cEEEccccccee
Q 006810 147 ------------------NPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIV 179 (630)
Q Consensus 147 ------------------~~~IiHrDLKp~NILl~~~~g-~vKL~DFGla~~ 179 (630)
.+.++|||+++.||+++...+ .+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999983332 368999998863
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.79 E-value=1.1e-08 Score=105.65 Aligned_cols=184 Identities=21% Similarity=0.185 Sum_probs=121.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCC--eeEEEeEEEcCCC-CEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN--IIKFYNSWVDDTN-RTINMI 106 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpN--IVk~~~~f~d~~~-~~l~lV 106 (630)
+.++.|....||++. ..+++|.... ......+.+|+.+|+.+ .+.. +.+.+........ ..-|+|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKH------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESS------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCC------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 458999999999872 4588887531 23456788999999888 3332 3344443211111 234789
Q ss_pred EcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 006810 107 TELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHN--------------------------------------- 147 (630)
Q Consensus 107 ~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~--------------------------------------- 147 (630)
|++++|..|.... ...++..+...++.|+...|..||+..
T Consensus 95 m~~i~G~~l~~~~-~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 95 FTKIKGVPLTPLL-LNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCCCEECCHHH-HHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred EcccCCeECCccc-cccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999999886221 145778888888999999999888621
Q ss_pred -----------------CCEEeccCCcCceEEeCC-CCcEEEcccccceeeccCCCccccCCCCC---CCccccc---cc
Q 006810 148 -----------------PPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTARSVIGTPEF---MAPELYE---EE 203 (630)
Q Consensus 148 -----------------~~IiHrDLKp~NILl~~~-~g~vKL~DFGla~~~~~~~~~~~~GTp~Y---~APEvl~---~~ 203 (630)
+.++|+|++|.||+++.. .+.+.|+||+.+..-... ........+ ..|+... ..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--NDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HHHHHHHhhccccCHHHHHHHHHH
Confidence 237999999999999833 456789999988643221 000011111 2333221 12
Q ss_pred cC------------cccceeehhHHHHHHhhCCCCCC
Q 006810 204 YN------------ELVDIYSFGMCILEMVTCEYPYN 228 (630)
Q Consensus 204 ys------------~~sDIWSLGvil~ELltG~~Pf~ 228 (630)
|. ...+.|++|.++|.+.+|..+|.
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 22 22589999999999999988773
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=1e-05 Score=83.75 Aligned_cols=136 Identities=21% Similarity=0.137 Sum_probs=93.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC---CeeEEEeEEEcCCCCEEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE---NIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp---NIVk~~~~f~d~~~~~l~lV~ 107 (630)
+.++.|....||+. |..+++|+-. .......+.+|+.+|+.|.+. .|.+.+.+... .....++||
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~ 92 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGY 92 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEE
T ss_pred eecCCCcceeEEEE-----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEE
Confidence 56788999999998 5678888742 234456789999999999753 35556655432 234567999
Q ss_pred cccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 006810 108 ELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHN---------------------------------------- 147 (630)
Q Consensus 108 Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~---------------------------------------- 147 (630)
||++|..+... .-..++......++.|+...|..||+..
T Consensus 93 e~i~G~~l~~~-~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 93 RKVQGQILGED-GMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECCCSEECHHH-HHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eccCCeECchh-hhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 99999887531 1123455555666666666666666432
Q ss_pred ------------------CCEEeccCCcCceEEeC--CCCc-EEEccccccee
Q 006810 148 ------------------PPIIHRDLKCDNIFVNG--NNGE-VKIGDLGLAIV 179 (630)
Q Consensus 148 ------------------~~IiHrDLKp~NILl~~--~~g~-vKL~DFGla~~ 179 (630)
+.++|+|+++.||+++. .++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 23699999999999973 1345 58999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=2e-05 Score=79.04 Aligned_cols=135 Identities=14% Similarity=0.063 Sum_probs=91.5
Q ss_pred eEecccCce-EEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEEEEEEc
Q 006810 31 EILGKGAFK-TVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITE 108 (630)
Q Consensus 31 e~LG~G~fg-~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l~lV~E 108 (630)
+.+..|..+ .||+......|..+++|.-.. .....+.+|...|+.|. +--+.+++.+..+. ..-++|||
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme 100 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTT 100 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEE
Confidence 335555554 689988777788899997652 23445788999998884 22356777766554 46789999
Q ss_pred ccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCC----------------------------------------
Q 006810 109 LFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP---------------------------------------- 148 (630)
Q Consensus 109 y~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~---------------------------------------- 148 (630)
+++|.++...... .......++.++...|..||...+
T Consensus 101 ~l~G~~~~~~~~~---~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 101 AIPGKTAFQVLEE---YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp CCCSEEHHHHHHH---CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred eeCCccccccccC---CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 9999887522111 112234456666666666664321
Q ss_pred ----------------CEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 149 ----------------PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 149 ----------------~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
-++|+|+.+.||+++ .++.+-|+||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~-~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD-EGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEE-CCeEEEEEECcccc
Confidence 179999999999998 55566799999774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=4.4e-05 Score=81.44 Aligned_cols=80 Identities=15% Similarity=0.145 Sum_probs=48.9
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccc-cCC--HHHHHHHHHHHHHHHhCCC--C-CeeEEEeEEEcCCCCEE
Q 006810 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV-MQS--PDQLERLYSEVHLLKSLKH--E-NIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 30 ~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~-~~~--~~~~~~l~~Ei~iL~~L~H--p-NIVk~~~~f~d~~~~~l 103 (630)
.+.||.|.++.||++.+...|..|++|....... ... .....++..|.++|+.+.. | .+.+++.+ +... .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~--~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM--A 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT--T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc--c
Confidence 3679999999999997766778999998653211 000 0122456778888887742 3 34456643 3332 4
Q ss_pred EEEEcccCCC
Q 006810 104 NMITELFTSG 113 (630)
Q Consensus 104 ~lV~Ey~~gG 113 (630)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 6899999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00013 Score=76.32 Aligned_cols=81 Identities=6% Similarity=-0.079 Sum_probs=50.9
Q ss_pred eEe-cccCceEEEEEEEc--c----CCeEEEEEEeeccc---ccCCHHHHHHHHHHHHHHHhCCC---CCeeEEEeEEEc
Q 006810 31 EIL-GKGAFKTVYKGFDE--V----DGIEVAWNQVNIED---VMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVD 97 (630)
Q Consensus 31 e~L-G~G~fg~Vy~A~d~--~----tG~~VAiK~i~~~~---~~~~~~~~~~l~~Ei~iL~~L~H---pNIVk~~~~f~d 97 (630)
+.| +.|....+|+.... . +|..+++|...... ... ...+.+|+.+|+.|.. -.+.+++.+..+
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~----~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP----TYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS----CCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc----hhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 667 88889999987543 1 26788888765332 101 1236678888877732 356677775533
Q ss_pred CC-CCEEEEEEcccCCCCH
Q 006810 98 DT-NRTINMITELFTSGSL 115 (630)
Q Consensus 98 ~~-~~~l~lV~Ey~~gGsL 115 (630)
.. ....++||||++|..+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 21 1245789999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00037 Score=71.69 Aligned_cols=30 Identities=23% Similarity=0.402 Sum_probs=25.7
Q ss_pred CCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 148 ~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
+.++|||+++.||+++ .++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~-~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLG-ENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEEC-GGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEe-CCCcEEEEehhhcc
Confidence 4599999999999996 46789999998763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0025 Score=68.48 Aligned_cols=29 Identities=21% Similarity=0.454 Sum_probs=24.7
Q ss_pred CCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 148 ~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
+.++|||++|.|||++ .++ +.|+||+.+.
T Consensus 232 ~~liHGDl~~~Nil~~-~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVT-QDS-TQVIDPEFSF 260 (420)
T ss_dssp CEEECSCCSGGGEEEC-SSC-EEECCCTTCE
T ss_pred CeEEecCCCCCcEEEe-CCC-CEEEeCcccc
Confidence 3499999999999997 444 9999998775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0046 Score=64.27 Aligned_cols=74 Identities=15% Similarity=0.043 Sum_probs=54.6
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCeeEEEeEEEcCCCCEEEEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~---HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
+.|+.|.+..+|+... .+..+++|..... ....+.+|+..|+.|. ...+++.+.+.... ...++||
T Consensus 42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvm 110 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND--EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLL 110 (312)
T ss_dssp EEECCSSSSEEEEEES--SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEE
T ss_pred EEeCCccceeeeEEEE--CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEE
Confidence 6689999999999854 4678888876532 2355778988888873 35677777765433 4688999
Q ss_pred cccCCCCH
Q 006810 108 ELFTSGSL 115 (630)
Q Consensus 108 Ey~~gGsL 115 (630)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0096 Score=60.26 Aligned_cols=76 Identities=13% Similarity=-0.008 Sum_probs=50.5
Q ss_pred eeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC---CCeeEEEeEEEcCCCCEEEE
Q 006810 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 29 ~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H---pNIVk~~~~f~d~~~~~l~l 105 (630)
-.+.+|.|..+.||+.. ..+|..|.+|+-..... . ....+.+|+..|+.|.- --+++.+.+ +. -++
T Consensus 19 ~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~-~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~----~~l 87 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAP-A---LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD----RTL 87 (288)
T ss_dssp EEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCC-C---CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET----TEE
T ss_pred EEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCc-c---hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC----ceE
Confidence 34779999999999995 45789999997643321 1 11236789998888842 234455553 22 257
Q ss_pred EEcccCCCCH
Q 006810 106 ITELFTSGSL 115 (630)
Q Consensus 106 V~Ey~~gGsL 115 (630)
||||+.++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 8899987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0055 Score=62.49 Aligned_cols=27 Identities=22% Similarity=0.241 Sum_probs=23.5
Q ss_pred EEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 150 IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
++|+|+.+.||+. .++.+.|+||..+.
T Consensus 175 l~HgDl~~~Nil~--~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 175 ACHCDPLCENFLD--TGERMWIVDWEYSG 201 (301)
T ss_dssp EECSCCCGGGEEE--CSSCEEECCCTTCE
T ss_pred eeccCCCcCCEEE--CCCCEEEEeccccc
Confidence 8999999999995 46788999998775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.015 Score=59.94 Aligned_cols=31 Identities=23% Similarity=0.288 Sum_probs=25.6
Q ss_pred CEEeccCCcCceEEeCC---CCcEEEccccccee
Q 006810 149 PIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIV 179 (630)
Q Consensus 149 ~IiHrDLKp~NILl~~~---~g~vKL~DFGla~~ 179 (630)
.++|||+.+.||+++.. .+.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 49999999999999732 26899999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.38 E-value=0.012 Score=63.55 Aligned_cols=73 Identities=14% Similarity=0.135 Sum_probs=47.2
Q ss_pred eEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCe-eEEEeEEEcCCCCE
Q 006810 31 EILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRT 102 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~-------tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI-Vk~~~~f~d~~~~~ 102 (630)
+.|+.|....||++.... ++..+++|+.... .. ...+.+|+.+++.|...++ +++++.+ ..
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~~--- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHLVAESVIFTLLSERHLGPKLYGIF--SG--- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT---
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC---
Confidence 568888899999996542 3578888887321 11 1234578888888743333 5667654 22
Q ss_pred EEEEEcccCCCCH
Q 006810 103 INMITELFTSGSL 115 (630)
Q Consensus 103 l~lV~Ey~~gGsL 115 (630)
.+|+||++|-.|
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 278999987444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.27 E-value=0.0081 Score=61.47 Aligned_cols=139 Identities=14% Similarity=0.116 Sum_probs=72.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC--eeEEEeEE----EcCCCCEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNSW----VDDTNRTIN 104 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN--IVk~~~~f----~d~~~~~l~ 104 (630)
+.|+.|....+|+.... .| .+++|...... ..+.+..|+.+++.|...+ +.+++..- +.......+
T Consensus 28 ~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTT-KD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEECC---EEEEEEEES-SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eccCCCcccceEEEEeC-Cc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 56788888999998543 33 68889876421 1123456777776663211 23333210 000123568
Q ss_pred EEEcccCCCCHH-----H----------Hhh-cCC--------CCHHHHHHHH---------------HHHHHHHHHHHc
Q 006810 105 MITELFTSGSLR-----Y----------RKK-HKN--------VDMKAIKNWA---------------RQILRGLHYLHS 145 (630)
Q Consensus 105 lV~Ey~~gGsL~-----~----------~~~-~~~--------lse~~i~~i~---------------~QIl~gL~yLHs 145 (630)
++++|++|..+. . +.. ... .........+ ..+...+.+++.
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 899999986531 0 000 001 1111111100 113334455542
Q ss_pred C-----CCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 146 H-----NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 146 ~-----~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
. .+.++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~-~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFL-GDELSGLIDFYFAC 216 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred hCcccCCcccCCCCCCccCEEEe-CCceEEEecchhcc
Confidence 1 12489999999999998 44455799998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.016 Score=61.86 Aligned_cols=137 Identities=15% Similarity=0.192 Sum_probs=79.2
Q ss_pred eEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCE
Q 006810 31 EILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~-------tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~ 102 (630)
+.|..|-...+|++.... ++..|++|+... ... ......+|..+++.|. +.-..+++..+ ..
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~--- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQ---GVDSLVLESVMFAILAERSLGPQLYGVF--PE--- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT---
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC---
Confidence 567778888899986532 357898887522 111 1234558888888774 22235666654 22
Q ss_pred EEEEEcccCCCCHH--HH--------------hhc-------CCCC--HHHHHHHHHHHHH-------------------
Q 006810 103 INMITELFTSGSLR--YR--------------KKH-------KNVD--MKAIKNWARQILR------------------- 138 (630)
Q Consensus 103 l~lV~Ey~~gGsL~--~~--------------~~~-------~~ls--e~~i~~i~~QIl~------------------- 138 (630)
.+|+||++|..|. .+ +-| +... ...+.+|..|+-.
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 2789999986652 00 001 1122 4567777766532
Q ss_pred HHHHH----HcC--CCCEEeccCCcCceEEeCC---CCcEEEcccccce
Q 006810 139 GLHYL----HSH--NPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAI 178 (630)
Q Consensus 139 gL~yL----Hs~--~~~IiHrDLKp~NILl~~~---~g~vKL~DFGla~ 178 (630)
.+..| ... ...++|+|+.+.||+++.. .+.+.|+||..+.
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 12333 222 1238999999999999843 3689999998774
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.22 E-value=0.022 Score=56.18 Aligned_cols=119 Identities=21% Similarity=0.202 Sum_probs=78.0
Q ss_pred CHH--HHhhcCCCCHHHHHHHHHHHHHHHHHH-HcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCCccccC
Q 006810 114 SLR--YRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 190 (630)
Q Consensus 114 sL~--~~~~~~~lse~~i~~i~~QIl~gL~yL-Hs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~G 190 (630)
+|. ......+++++++|.++.|.+.+|.-+ +...+ ..+=+.|..|++. .+|.|-+.+ ..+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVW-RDGAVTLAP-AADD----------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEE-TTSCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEe-cCCceeccc-cccc----------cc
Confidence 555 345678999999999999999998776 22221 2334456889998 788887764 1110 12
Q ss_pred CCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc
Q 006810 191 TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 266 (630)
Q Consensus 191 Tp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~ 266 (630)
...|.|||......+.+.=|||||+++|..+--..|-. .....++.+..||..|..
T Consensus 100 ~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e~--------------------eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 100 EPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKEN--------------------EERELSPPLEQLIDHMAN 155 (229)
T ss_dssp -------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCTT--------------------EEECCCHHHHHHHHHHTT
T ss_pred ccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCcc--------------------cchhhCHHHHHHHHHHHh
Confidence 33567888775556678889999999999987554432 233557889999988875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.21 E-value=0.039 Score=60.26 Aligned_cols=74 Identities=19% Similarity=0.144 Sum_probs=46.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCe-eEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNI-Vk~~~~f~d~~~~~l~lV~Ey 109 (630)
+.|+.|-...+|++.....+..+++|+..... .. ... -.+|..+++.|...++ .+++..+ . + . +|+||
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~---~id-R~~E~~vl~~L~~~gl~P~ll~~~--~-~-G--~v~e~ 182 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE---IIN-REREKKISCILYNKNIAKKIYVFF--T-N-G--RIEEF 182 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS---CSC-HHHHHHHHHHHTTSSSBCCEEEEE--T-T-E--EEEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh---hcC-HHHHHHHHHHHHhcCCCCCEEEEe--C-C-e--EEEEe
Confidence 56888889999999765445889998764321 11 001 1478888888865444 5677765 2 2 2 48999
Q ss_pred cCCCCH
Q 006810 110 FTSGSL 115 (630)
Q Consensus 110 ~~gGsL 115 (630)
++|-.|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.81 E-value=0.02 Score=60.05 Aligned_cols=74 Identities=15% Similarity=0.145 Sum_probs=41.7
Q ss_pred eEecccCceEEEEEEEcc--------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-eeEEEeEEEcCCCC
Q 006810 31 EILGKGAFKTVYKGFDEV--------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDTNR 101 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~--------tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpN-IVk~~~~f~d~~~~ 101 (630)
+.|+.|....+|+..... .+..+++|+..... ........|..+++.|...+ +.+++..+ . .
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-----DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-----cceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 567888889999986543 13678888764321 11111356777777774333 44666543 2 1
Q ss_pred EEEEEEcccCCCCH
Q 006810 102 TINMITELFTSGSL 115 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL 115 (630)
++|+||++|..+
T Consensus 110 --~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 --GRIEEWLYGDPL 121 (369)
T ss_dssp --EEEEECCCSEEC
T ss_pred --cEEEEEecCCcC
Confidence 468999988543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.54 E-value=0.054 Score=55.41 Aligned_cols=76 Identities=11% Similarity=0.011 Sum_probs=45.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CeeEEEeE----EEcCCCCEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNS----WVDDTNRTIN 104 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~Hp--NIVk~~~~----f~d~~~~~l~ 104 (630)
+.|+ |....||+... .+|..+++|....... .. ..+..|..+++.|... .+++++.. +.. .....+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~--~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~-~~g~~~ 103 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW--TA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN-HQGFYF 103 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS--CH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE-ETTEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC--CH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEE-ECCEEE
Confidence 4566 88889998743 3566799998863321 22 3456677777776321 23444432 000 123567
Q ss_pred EEEcccCCCC
Q 006810 105 MITELFTSGS 114 (630)
Q Consensus 105 lV~Ey~~gGs 114 (630)
+|+++++|..
T Consensus 104 ~l~~~i~G~~ 113 (328)
T 1zyl_A 104 AVFPSVGGRQ 113 (328)
T ss_dssp EEEECCCCEE
T ss_pred EEEEecCCCC
Confidence 8999998854
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.73 E-value=0.17 Score=52.51 Aligned_cols=29 Identities=24% Similarity=0.413 Sum_probs=25.3
Q ss_pred CEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 149 ~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~-~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVG-NEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEEC-GGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEe-CCCeEEEEECCCCe
Confidence 489999999999997 56789999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=90.96 E-value=1.1 Score=48.32 Aligned_cols=74 Identities=8% Similarity=0.024 Sum_probs=44.8
Q ss_pred eEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCE
Q 006810 31 EILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~-------tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~ 102 (630)
+.|..|-...+|+..... ++..|++++..... .. .-...+|..+++.|. +.-..++++.+ . +
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~----~idR~~E~~~l~~L~~~gi~P~l~~~~--~-~-- 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GK----FYDSKVELDVFRYLSNINIAPNIIADF--P-E-- 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C----CCCHHHHHHHHHHHHHTTSSCCEEEEE--T-T--
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-ch----hcCHHHHHHHHHHHHhcCCCCCEEEEc--C-C--
Confidence 567778888999987542 15788888754311 01 111246777777773 22234566533 2 1
Q ss_pred EEEEEcccCCCCH
Q 006810 103 INMITELFTSGSL 115 (630)
Q Consensus 103 l~lV~Ey~~gGsL 115 (630)
++|+||++|..|
T Consensus 146 -~~I~efI~G~~l 157 (424)
T 3mes_A 146 -GRIEEFIDGEPL 157 (424)
T ss_dssp -EEEEECCCSEEC
T ss_pred -CEEEEEeCCccC
Confidence 578999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 630 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-82 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-62 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-55 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-49 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-47 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-19 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 256 bits (656), Expect = 7e-82
Identities = 134/263 (50%), Positives = 185/263 (70%), Gaps = 6/263 (2%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
R+ ++D +G+G+FKTVYKG D +EVAW ++ + + + +R E +LK L+
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQ 66
Query: 85 HENIIKFYNSWVD--DTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLH 141
H NI++FY+SW + I ++TEL TSG+L+ Y K+ K + +K +++W RQIL+GL
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE 201
+LH+ PPIIHRDLKCDNIF+ G G VKIGDLGLA + + A++VIGTPEFMAPE+YE
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE 186
Query: 202 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261
E+Y+E VD+Y+FGMC+LEM T EYPY+EC+N AQIY++VTSG+KPAS KV P+VK+ I
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 262 EKCIVP-ASLRLPALELLKDPFL 283
E CI R +LL F
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 209 bits (534), Expect = 2e-63
Identities = 85/303 (28%), Positives = 142/303 (46%), Gaps = 17/303 (5%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
F + DP + EI G G+F VY D + VA +++ QS ++ + + E
Sbjct: 8 FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKE 65
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKN-VDMKAIKNWARQ 135
V L+ L+H N I++ ++ + ++ E + + HK + I
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG 123
Query: 136 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 195
L+GL YLHSHN +IHRD+K NI ++ G VK+GD G A +M A S +GTP +M
Sbjct: 124 ALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYWM 178
Query: 196 APELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251
APE+ E +Y+ VD++S G+ +E+ + P N + PA S
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSG 237
Query: 252 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLA 309
+ F++ C+ R + LLK F++ + P ++ D + R + V E+ NL
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQ 297
Query: 310 HSE 312
+ +
Sbjct: 298 YRK 300
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-62
Identities = 70/265 (26%), Positives = 131/265 (49%), Gaps = 17/265 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+G G++ K + DG + W +++ + + + + L SEV+LL+ LKH NI++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSL-----RYRKKHKNVDMKAIKNWARQILRGLHYLHS 145
+Y+ +D TN T+ ++ E G L + K+ + +D + + Q+ L H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 146 HN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY 200
+ ++HRDLK N+F++G VK+GD GLA ++ T A++ +GTP +M+PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 201 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
YNE DI+S G + E+ P+ + ++ K+ G K + ++ +
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNE 244
Query: 260 FIEKCIVP-ASLRLPALELLKDPFL 283
I + + R E+L++P +
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 7e-62
Identities = 86/293 (29%), Positives = 141/293 (48%), Gaps = 23/293 (7%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
S DP +Y R+++I G+GA TVY D G EVA Q+N++ + E + +E+
Sbjct: 14 SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEI 68
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQIL 137
+++ K+ NI+ + +S++ + ++ E GSL +D I R+ L
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 138 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFM 195
+ L +LHS+ +IHRD+K DNI + +G VK+ D G I +Q +++GTP +M
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183
Query: 196 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254
APE + + Y VDI+S G+ +EM+ E PY +Y T+G +
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 255 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVM 306
+ F+ +C+ R A ELL+ FL P L +L P +
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP---------LSSLTPLIA 287
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 5e-59
Identities = 75/282 (26%), Positives = 132/282 (46%), Gaps = 21/282 (7%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
+P + LG GAF VYK ++ + A ++ +S ++LE E+ +L
Sbjct: 9 NPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVID----TKSEEELEDYMVEIDIL 63
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILR 138
S H NI+K +++ + N + ++ E G++ + + + I+ +Q L
Sbjct: 64 ASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD 121
Query: 139 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMA 196
L+YLH + IIHRDLK NI +G++K+ D G++ + R S IGTP +MA
Sbjct: 122 ALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178
Query: 197 PELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 250
PE+ + Y+ D++S G+ ++EM E P++E + K S +
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238
Query: 251 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 291
K F++KC+ R +LL+ PF+ D+ K +
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 8e-59
Identities = 60/260 (23%), Positives = 118/260 (45%), Gaps = 12/260 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LGKG F VY ++ +A + ++ +L EV + L+H NI++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 91 FYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
Y + D T + +I E G++ R +K D + + ++ L Y HS
Sbjct: 71 LYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-- 126
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 208
+IHRD+K +N+ + + GE+KI D G ++ ++ GT +++ PE + ++E V
Sbjct: 127 VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 185
Query: 209 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP- 267
D++S G+ E + + P+ E + YK+++ + + I + +
Sbjct: 186 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKHN 242
Query: 268 ASLRLPALELLKDPFLVTDN 287
S R E+L+ P++ ++
Sbjct: 243 PSQRPMLREVLEHPWITANS 262
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 9e-56
Identities = 66/267 (24%), Positives = 121/267 (45%), Gaps = 16/267 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG+GA+ V + V VA V+++ + P+ +++ E+ + K L HEN++K
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVK 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
FY + + E + G L R + + + + Q++ G+ YLH
Sbjct: 68 FYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEEE-- 203
I HRD+K +N+ ++ +KI D GLA V ++ + GT ++APEL +
Sbjct: 124 ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 204 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263
+ E VD++S G+ + M+ E P+++ + Q Y + K D + K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 264 CIVP-ASLRLPALELLKDPFLVTDNPK 289
+V S R+ ++ KD + K
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-55
Identities = 66/304 (21%), Positives = 122/304 (40%), Gaps = 51/304 (16%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G V+K + G+ +A +++E P ++ E+ +L I+
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
FY ++ D I++ E GSL KK + + + + +++GL YL +
Sbjct: 69 FYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK- 125
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 208
I+HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y+
Sbjct: 126 IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 209 DIYSFGMCILEMVTCEYPY----------------------------------------- 227
DI+S G+ ++EM YP
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 228 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD 286
++ + + P S V + + F+ KC++ + R +L+ F+
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304
Query: 287 NPKD 290
+ ++
Sbjct: 305 DAEE 308
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-53
Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 27/270 (10%)
Query: 26 YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
G+ + +G G+F TVYKG +VA +N+ +P QL+ +EV +L+
Sbjct: 7 DGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVT--APTPQQLQAFKNEVGVLRKT 61
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRY--RKKHKNVDMKAIKNWARQILRGLH 141
+H NI+ F + ++T+ SL + +M + + ARQ +G+
Sbjct: 62 RHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAP 197
YLH+ + IIHRDLK +NIF++ + VKIGD GLA V + + + G+ +MAP
Sbjct: 119 YLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 198 ELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253
E+ + Y+ D+Y+FG+ + E++T + PY+ N QI V G LSKV
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 254 D---PQVKQFIEKCIVP-ASLRLPALELLK 279
+K+ + +C+ R ++L
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (461), Expect = 2e-52
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 21/301 (6%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
YD E LG GAF V++ + G A V E + E+ + L+H
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRH 82
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRYR--KKHKNVDMKAIKNWARQILRGLHYL 143
++ ++++ DD + MI E + G L + +H + + RQ+ +GL ++
Sbjct: 83 PTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 144 HSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPELYE 201
H +N +H DLK +NI + E+K+ D GL + + + + GT EF APE+ E
Sbjct: 141 HENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198
Query: 202 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVK 258
+ D++S G+ +++ P+ +N + + V S S K
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 259 QFIEKCIVP-ASLRLPALELLKDPFLVTDNP--KDLVCDPLRLPNLVPEVMNLAHSEPHP 315
FI K ++ + R+ + L+ P+L N +D R + + + P P
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEP 317
Query: 316 M 316
+
Sbjct: 318 L 318
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (460), Expect = 3e-52
Identities = 63/273 (23%), Positives = 113/273 (41%), Gaps = 17/273 (6%)
Query: 26 YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
Y YD E LG GAF V++ ++ G +N P + +E+ ++ L
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQL 83
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDMKAIKNWARQILRGLH 141
H +I ++++ D + +I E + G L R + + + N+ RQ GL
Sbjct: 84 HHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPEL 199
++H H+ I+H D+K +NI VKI D GLA + + T EF APE+
Sbjct: 142 HMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 199
Query: 200 YE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQV 257
+ E D+++ G+ +++ P+ + + + P+
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 258 KQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 289
K FI+ + RL + L+ P+L D+
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-51
Identities = 67/263 (25%), Positives = 123/263 (46%), Gaps = 16/263 (6%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
++ +ILG+G+F TV + E A + + +++ + E ++ L H
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRH-IIKENKVPYVTRERDVMSRLDHPF 69
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSL-RYRKKHKNVDMKAIKNWARQILRGLHYLHSH 146
+K Y ++ DD + +G L +Y +K + D + + +I+ L YLH
Sbjct: 70 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 147 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 201
IIHRDLK +NI +N + ++I D G A V+ +Q A S +GT ++++PE L E
Sbjct: 128 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 202 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261
+ + D+++ G I ++V P+ N I++K+ + P+ + +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKL--EYDFPEKFFPKARDLV 241
Query: 262 EKCIVP-ASLRLPALELLKDPFL 283
EK +V A+ RL E+ L
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPL 264
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (447), Expect = 6e-51
Identities = 61/290 (21%), Positives = 121/290 (41%), Gaps = 17/290 (5%)
Query: 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
+D Y + ++LG GAF V D+ VA + + + +E E+ +
Sbjct: 5 EDIRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMEN---EIAV 60
Query: 80 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILR 138
L +KH NI+ + + + + +I +L + G L R + + Q+L
Sbjct: 61 LHKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118
Query: 139 GLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFM 195
+ YLH I+HRDLK +N+ + ++ I D GL+ + + + GTP ++
Sbjct: 119 AVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 176
Query: 196 AP-ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKV 252
AP L ++ Y++ VD +S G+ ++ P+ + +N A++++++ +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDD 235
Query: 253 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 301
K FI + R + L+ P++ D D +
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (438), Expect = 8e-50
Identities = 55/286 (19%), Positives = 107/286 (37%), Gaps = 20/286 (6%)
Query: 7 FTKSETEEG--EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
FT + E EF+++ + ++++G G F V G ++ G + +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHK 122
+ Q SE ++ H N+I T + +ITE +GSL R+
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP--VMIITEFMENGSLDSFLRQNDG 123
Query: 123 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182
+ + R I G+ YL N +HRDL NI VN +N K+ D GL+ ++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLED 180
Query: 183 PTARSV-------IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 234
T+ + APE + ++ D++S+G+ + E+++
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 235 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
+ + + + Q + C + R +++
Sbjct: 241 DVINAIEQDYRLPPPMDC-PSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-49
Identities = 58/268 (21%), Positives = 116/268 (43%), Gaps = 20/268 (7%)
Query: 26 YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
Y +Y E LG+G F V++ + V ++ Q + E+ +L
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-----VLVKKEISILNIA 58
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDMKAIKNWARQILRGLH 141
+H NI+ + S+ + MI E + + R ++ + I ++ Q+ L
Sbjct: 59 RHRNILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 142 YLHSHNPPIIHRDLKCDNIFV-NGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPEL 199
+LHSHN I H D++ +NI + +KI + G A ++ R + PE+ APE+
Sbjct: 117 FLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 200 YEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQ 256
++ + + D++S G + +++ P+ + QI + + + K +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 257 VKQFIEKCIVP-ASLRLPALELLKDPFL 283
F+++ +V R+ A E L+ P+L
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-49
Identities = 71/296 (23%), Positives = 127/296 (42%), Gaps = 17/296 (5%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLY 74
F +++ Y E LG G F V K ++ G++ A + S E +
Sbjct: 3 FRQENVDDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWA 133
EV +LK ++H N+I + + + T+ + +I EL G L + + +++ + +
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 134 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTARS-VI 189
+QIL G++YLHS I H DLK +NI + N +KI D GLA + +
Sbjct: 120 KQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177
Query: 190 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 246
GTPEF+APE+ E D++S G+ +++ P+ + V++
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFE 236
Query: 247 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 301
T K FI + +V R+ + L+ P++ + + + P
Sbjct: 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 169 bits (429), Expect = 1e-48
Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 26/278 (9%)
Query: 26 YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-----QSPDQLERLYSEVH 78
Y Y+ EILG+G V + + E A +++ + + E EV
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 79 LLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQI 136
+L+ + H NII+ +++ +T ++ +L G L Y + + K + R +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 137 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFM 195
L + LH N I+HRDLK +NI ++ ++ +K+ D G + + R V GTP ++
Sbjct: 120 LEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 196 APELYEEE-------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 248
APE+ E Y + VD++S G+ + ++ P+ + + + + SG
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG 235
Query: 249 LSKVTD--PQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
+ D VK + + +V R A E L PF
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 6e-48
Identities = 51/268 (19%), Positives = 105/268 (39%), Gaps = 24/268 (8%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV--MQSPDQLERLYSEVHLLKS 82
+Y +LG G F +VY G D + VA V + + R+ EV LLK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 83 LK--HENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDMKAIKNWARQILR 138
+ +I+ + + + +I E + + + + +++ Q+L
Sbjct: 64 VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 139 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE 198
+ + H+ ++HRD+K +NI ++ N GE+K+ D G +++ GT + PE
Sbjct: 122 AVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 179
Query: 199 LYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256
+ ++S G+ + +MV + P+ + + + +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------SSE 230
Query: 257 VKQFIEKCIVP-ASLRLPALELLKDPFL 283
+ I C+ S R E+ P++
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 168 bits (427), Expect = 6e-48
Identities = 70/285 (24%), Positives = 127/285 (44%), Gaps = 19/285 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G+F V+ +G A + ++++ Q+E E +L + H II+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPP 149
+ ++ D I MI + G L + K +A ++ L YLHS +
Sbjct: 69 MWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-- 124
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 208
II+RDLK +NI ++ NG +KI D G A + T ++ GTP+++APE + + YN+ +
Sbjct: 125 IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNKSI 182
Query: 209 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-- 266
D +SFG+ I EM+ P+ + N + Y+K+ + + VK + + I
Sbjct: 183 DWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRD 239
Query: 267 ----PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 307
+L+ ++ P+ + L+ + P P +
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP-YEPPIQQ 283
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 9e-48
Identities = 53/254 (20%), Positives = 109/254 (42%), Gaps = 19/254 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +GKG F V G + G +VA +++ + +E ++ L+H N+++
Sbjct: 13 QTIGKGEFGDVMLG--DYRGNKVAVK------CIKNDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR---YRKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
V++ + ++TE GSL + + + ++ + + YL +N
Sbjct: 65 LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNE 206
+HRDL N+ V+ + K+ D GL T + ++ APE L E++++
Sbjct: 124 --FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEALREKKFST 179
Query: 207 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 266
D++SFG+ + E+ + + +V G K + P V + ++ C
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCWH 238
Query: 267 P-ASLRLPALELLK 279
A++R L+L +
Sbjct: 239 LDAAMRPSFLQLRE 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (419), Expect = 2e-47
Identities = 60/270 (22%), Positives = 106/270 (39%), Gaps = 17/270 (6%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY+ EILG G V+ D +VA + D+ + P R E +L
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALN 65
Query: 85 HENIIKFYNSWVDDTNR--TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLH 141
H I+ Y++ +T ++ E +LR + K + L+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMA 196
+ H + IIHRD+K NI ++ N VK+ D G+A + +VIGT ++++
Sbjct: 126 FSHQNG--IIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 197 PELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTD 254
PE + + D+YS G + E++T E P+ + Y+ V P S +
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 255 PQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
+ + K + R ++ +
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-47
Identities = 60/285 (21%), Positives = 131/285 (45%), Gaps = 20/285 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
++LGKG F V ++ G A + ++V+ + D++ +E +L++ +H +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 149
++ + + E G L + + + + + + +I+ L YLHS +
Sbjct: 70 LKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 125
Query: 150 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE-EEYNE 206
+++RD+K +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E +Y
Sbjct: 126 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 207 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 266
VD + G+ + EM+ P+ ++ ++++ + + P+ K + +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILME--EIRFPRTLSPEAKSLLAGLLK 241
Query: 267 ------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 305
A E+++ F ++ N +D+V L P P+V
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP-FKPQV 285
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 8e-47
Identities = 59/270 (21%), Positives = 111/270 (41%), Gaps = 24/270 (8%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+ E LG G F V+ G+ +VA ++ + Q + +E +L+K L+H+
Sbjct: 16 KLVERLGAGQFGEVWMGYYN-GHTKVA-----VKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLR---YRKKHKNVDMKAIKNWARQILRGLHYLH 144
+++ Y + I +ITE +GSL + + + + A QI G+ ++
Sbjct: 70 LVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTPEFMAP-ELY 200
N IHRDL+ NI V+ + KI D GLA ++ + ++ AP +
Sbjct: 127 ERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260
+ D++SFG+ + E+VT ++ + + G + ++ Q
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQL 242
Query: 261 IEKCIVP-ASLRLPA---LELLKDPFLVTD 286
+ C R +L+D F T+
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-46
Identities = 47/256 (18%), Positives = 98/256 (38%), Gaps = 19/256 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +G G F V+ G+ + +VA + + E E ++ L H +++
Sbjct: 11 QEIGSGQFGLVHLGYWL-NKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
Y ++ I ++ E G L R + + + + G+ YL
Sbjct: 65 LYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPE-LYEEEY 204
+IHRDL N V N +K+ D G+ + ++ +PE Y
Sbjct: 122 -VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264
+ D++SFG+ + E+ + E ++ +++ + +++G + ++ V Q + C
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHC 238
Query: 265 IVP-ASLRLPALELLK 279
R LL+
Sbjct: 239 WKERPEDRPAFSRLLR 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 6e-46
Identities = 71/301 (23%), Positives = 121/301 (40%), Gaps = 40/301 (13%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL-ERLYSEVHLLKSLKHENII 89
+ LG+G F TVYK D+ VA ++ + ++ D + E+ LL+ L H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDM-KAIKNWARQILRGLHYLHSHNP 148
+++ +N I+++ + + K + V IK + L+GL YLH H
Sbjct: 64 GLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY--EEEY 204
I+HRDLK +N+ ++ NG +K+ D GLA P + T + APEL Y
Sbjct: 121 -ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 205 NELVDIYSFGMCILEMVTCEYPY-------------------------NECKNPAQIYKK 239
VD+++ G + E++ + C P + K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 240 VTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRL 298
GI + + I+ + R+ A + LK + ++ P +L
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRPGP--TPGCQL 295
Query: 299 P 299
P
Sbjct: 296 P 296
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-45
Identities = 67/281 (23%), Positives = 123/281 (43%), Gaps = 17/281 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQ-VNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
++LG GAF TVYKG +G +V + SP + + E +++ S+ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 90 KFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
+ + T + +IT+L G L R+ N+ + + NW QI +G++YL
Sbjct: 75 RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYEE 202
++HRDL N+ V VKI D GLA ++ ++ A ++MA E +
Sbjct: 132 --LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 203 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262
Y D++S+G+ + E++T + ++I + G + + V +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQPPICTIDVYMIMV 247
Query: 263 KCIVP-ASLRLPALELLKDP-FLVTDNPKDLVCDPLRLPNL 301
KC + A R EL+ + + D + LV +L
Sbjct: 248 KCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-45
Identities = 70/282 (24%), Positives = 129/282 (45%), Gaps = 17/282 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENII 89
++LGKG+F V+ + A + +DV+ D +E E +L + +H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
+ ++ N M E G L Y + D+ +A +I+ GL +LHS
Sbjct: 67 HMFCTFQTKENLFFVM--EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE-LYEEEYN 205
I++RDLK DNI ++ +G +KI D G+ A+ + GTP+++APE L ++YN
Sbjct: 124 -IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 206 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265
VD +SFG+ + EM+ + P+ ++ +++ + + + + K + K
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLF 238
Query: 266 VP-ASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 305
V RL ++ + P N ++L + P P+V
Sbjct: 239 VREPEKRLGVRGDIRQHPLFREINWEELERKEID-PPFRPKV 279
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 7e-45
Identities = 51/266 (19%), Positives = 106/266 (39%), Gaps = 22/266 (8%)
Query: 30 DEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
D+ LG G F TV KG+ ++ VA + E P + L +E ++++ L +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPY 69
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSH 146
I++ ++ ++ E+ G L Y +++++V K I Q+ G+ YL
Sbjct: 70 IVRMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 147 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LY 200
N +HRDL N+ + KI D GL+ ++ ++ APE +
Sbjct: 127 N--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260
+++ D++SFG+ + E + +++ + G + + ++
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDL 242
Query: 261 IEKCIVP-ASLRLPA---LELLKDPF 282
+ C R L++ +
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-44
Identities = 70/273 (25%), Positives = 110/273 (40%), Gaps = 23/273 (8%)
Query: 23 SCRYGRYD----EILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYS 75
+C G D E LG G+F V +G + + VA + DV+ P+ ++
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-PDVLSQPEAMDDFIR 60
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RYRKKHKNVDMKAIKNWA 133
EV+ + SL H N+I+ Y + + M+TEL GSL R RK + + + +A
Sbjct: 61 EVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 134 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 188
Q+ G+ YL S IHRDL N+ + VKIGD GL + Q
Sbjct: 118 VQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 189 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 247
+ APE L ++ D + FG+ + EM T N +QI K+ +
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234
Query: 248 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
+ + + +C R + L
Sbjct: 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-44
Identities = 57/262 (21%), Positives = 107/262 (40%), Gaps = 16/262 (6%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
R + +G+G F V++G + S E+ E ++ H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYL 143
+I+K ++ + +I EL T G LR + + ++D+ ++ +A Q+ L YL
Sbjct: 68 PHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 144 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPE-L 199
S +HRD+ N+ V+ N VK+GD GL+ M+ T ++MAPE +
Sbjct: 125 ESKR--FVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 200 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
+ D++ FG+C+ E++ + + ++ +G + + P +
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-PMPPNCPPTLYS 240
Query: 260 FIEKCIVP-ASLRLPALELLKD 280
+ KC S R EL
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (398), Expect = 3e-44
Identities = 57/257 (22%), Positives = 102/257 (39%), Gaps = 19/257 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G + VY+G + + VA + + ++E E ++K +KH N+++
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR---YRKKHKNVDMKAIKNWARQILRGLHYLHSHN 147
+ I E T G+L + V + A QI + YL N
Sbjct: 78 LLGVCTREPPFYIIT--EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT---PEFMAP-ELYEEE 203
IHRDL N V N VK+ D GL+ +M T + G ++ AP L +
Sbjct: 136 --FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 204 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263
++ D+++FG+ + E+ T + +Q+Y+ + + +V + +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP-EKVYELMRA 251
Query: 264 CIVP-ASLRLPALELLK 279
C S R E+ +
Sbjct: 252 CWQWNPSDRPSFAEIHQ 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-44
Identities = 57/272 (20%), Positives = 106/272 (38%), Gaps = 23/272 (8%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
R + LG+G F V+ G VA + + E E ++K L+HE
Sbjct: 20 RLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-----EAFLQEAQVMKKLRHEK 73
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLR---YRKKHKNVDMKAIKNWARQILRGLHYLH 144
+++ Y + I ++TE + GSL + K + + + + A QI G+ Y+
Sbjct: 74 LVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPE-LY 200
N +HRDL+ NI V N K+ D GLA +++ + ++ APE
Sbjct: 131 RMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 201 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260
+ D++SFG+ + E+ T ++ +V G + + +
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHDL 246
Query: 261 IEKCIVP-ASLRLPALELLK--DPFLVTDNPK 289
+ +C R L + + + P+
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-44
Identities = 57/273 (20%), Positives = 103/273 (37%), Gaps = 20/273 (7%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERL 73
+E PSC +++G G F VYKG + + VA + + Q
Sbjct: 2 TEIHPSCV--TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDF 56
Query: 74 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWA 133
E ++ H NII+ I + R+K + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116
Query: 134 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 188
R I G+ YL + N +HRDL NI VN +N K+ D GL+ V++ T
Sbjct: 117 RGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 189 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 247
+ APE + ++ D++SFG+ + E++T + ++ K + G +
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 233
Query: 248 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
+ + Q + +C + R +++
Sbjct: 234 TPMDC-PSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (402), Expect = 5e-44
Identities = 59/284 (20%), Positives = 116/284 (40%), Gaps = 21/284 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENI 88
I+G+G F VY G A ++ + + Q + L+ + I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHSHN 147
+ ++ ++ I +L G L Y +H ++ +A +I+ GL ++H+
Sbjct: 70 VCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 127
Query: 148 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YN 205
+++RDLK NI ++ +G V+I DLGLA + + +GT +MAPE+ ++ Y+
Sbjct: 128 --VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 206 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 265
D +S G + +++ P+ + K + + L P+++ +E +
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 266 V------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 303
L A E+ + PF + L + L P
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFF-----RSLDWQMVFLQKYPP 283
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 7e-44
Identities = 52/257 (20%), Positives = 98/257 (38%), Gaps = 19/257 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG G F V G +VA + + + + E ++ +L HE +++
Sbjct: 10 KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE-----DEFIEEAKVMMNLSHEKLVQ 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 148
Y I +ITE +G L R+ + + + + + YL S
Sbjct: 64 LYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 120
Query: 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIGTPEFMAPELYE-EEY 204
+HRDL N VN + G VK+ D GL+ + S + PE+ ++
Sbjct: 121 -FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 205 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264
+ DI++FG+ + E+ + E ++ + + G++ + +V + C
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKVYTIMYSC 237
Query: 265 IVP-ASLRLPALELLKD 280
A R LL +
Sbjct: 238 WHEKADERPTFKILLSN 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 9e-44
Identities = 45/267 (16%), Positives = 99/267 (37%), Gaps = 24/267 (8%)
Query: 30 DEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
D LG G F +V +G + I+VA + + E + E ++ L +
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 70
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHS 145
I++ + ++ E+ G L K + + + + Q+ G+ YL
Sbjct: 71 IVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 127
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVIGTPEFMAPE-L 199
N +HRDL N+ + N KI D GL+ + + ++ APE +
Sbjct: 128 KN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 200 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259
+++ D++S+G+ + E ++ + ++ + G + P++
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-ECPPECPPELYA 243
Query: 260 FIEKCIVPASLRLP----ALELLKDPF 282
+ C + P + ++ +
Sbjct: 244 LMSDCWIYKWEDRPDFLTVEQRMRACY 270
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-43
Identities = 58/278 (20%), Positives = 111/278 (39%), Gaps = 15/278 (5%)
Query: 12 TEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE 71
+ + PS ++E++G+G F VY G + + V + + ++
Sbjct: 14 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 73
Query: 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--YRKKHKNVDMKAI 129
+ +E ++K H N++ + + ++ G LR R + N +K +
Sbjct: 74 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-- 187
+ Q+ +G+ + +HRDL N ++ VK+ D GLA M S
Sbjct: 133 IGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVH 189
Query: 188 ----VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 242
++MA E L +++ D++SFG+ + E++T P N I +
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 243 GIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
G + DP + + + KC P A +R EL+
Sbjct: 250 GRRLLQPEYCPDP-LYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-43
Identities = 63/284 (22%), Positives = 112/284 (39%), Gaps = 36/284 (12%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +G+G + VYK +++ G VA ++ ++ ++ E+ LLK L H NI+K
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 150
+ + + + + IK++ Q+L+GL + HSH +
Sbjct: 66 LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--V 123
Query: 151 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY--EEEYNE 206
+HRDLK N+ +N G +K+ D GLA P + T + APE+ + Y+
Sbjct: 124 LHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 207 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------------------- 246
VDI+S G EMVT + Q+++ + P
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 247 ------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
+ + D + + + + + R+ A L PF
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-43
Identities = 67/319 (21%), Positives = 117/319 (36%), Gaps = 54/319 (16%)
Query: 22 PSCR-YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 78
P C +Y+ +G+G F V+K G +VA +V +E+ + E+
Sbjct: 4 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIK 61
Query: 79 LLKSLKHENIIKFYNSWVDDT------NRTINMITELFTSGSLRY-RKKHKNVDMKAIKN 131
+L+ LKHEN++ +I ++ + + IK
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 132 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------ 185
+ +L GL+Y+H + I+HRD+K N+ + +G +K+ D GLA
Sbjct: 122 VMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 186 RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY------ 237
+ + T + PE L E +Y +D++ G + EM T Q+
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 238 -----------------------KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 273
K +K + V DP I+K +V + R+
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 274 ALELLKDPFLVTD-NPKDL 291
+ + L F +D P DL
Sbjct: 299 SDDALNHDFFWSDPMPSDL 317
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 9e-43
Identities = 71/348 (20%), Positives = 132/348 (37%), Gaps = 56/348 (16%)
Query: 5 SGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
S T G+ ++ Y +++G G+F VY+ G VA +V +
Sbjct: 1 SKVTTVVATPGQGPDRPQEVSY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-- 57
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTSGSLR---- 116
E+ +++ L H NI++ FY+S +N++ + R
Sbjct: 58 ------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 111
Query: 117 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176
Y + + + + +K + Q+ R L Y+HS I HRD+K N+ ++ + +K+ D G
Sbjct: 112 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 177 AIVMQQPTA-RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 233
A + + S I + + APEL +Y +D++S G + E++ + +
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229
Query: 234 AQIYKKVT----------------------SGIKPASLSKV----TDPQVKQFIEKCIVP 267
Q+ + + IK +KV T P+ + +
Sbjct: 230 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 289
Query: 268 -ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL--VPEVMNLAHSE 312
+ RL LE F +L ++LPN P + N E
Sbjct: 290 TPTARLTPLEACAHSFF-----DELRDPNVKLPNGRDTPALFNFTTQE 332
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (392), Expect = 9e-43
Identities = 65/290 (22%), Positives = 129/290 (44%), Gaps = 21/290 (7%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
++D + LG G+F V + G A ++ + + Q+E +E +L+++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-VVKLKQIEHTLNEKRILQAVNF 100
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLH 144
++K S+ D N + M+ E G + + ++ + +A QI+ YLH
Sbjct: 101 PFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEE 203
S + +I+RDLK +N+ ++ G +++ D G A ++ T ++ GTPE +APE + +
Sbjct: 159 SLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKG 214
Query: 204 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263
YN+ VD ++ G+ I EM P+ P QIY+K+ SG +K +
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRN 271
Query: 264 CIV------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 307
+ +L+ ++ + T + + + P +P+
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP-FIPKFKG 320
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 50/281 (17%), Positives = 108/281 (38%), Gaps = 29/281 (10%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSL 83
Y ++LG G V + F++ + A + + EV ++
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRAS 62
Query: 84 KHENIIKFYNSWVD--DTNRTINMITELFTSGSLR---YRKKHKNVDMKAIKNWARQILR 138
+ +I++ + + + + + ++ E G L + + + + I
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 139 GLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFM 195
+ YLHS N I HRD+K +N+ N +K+ D G A + + TP ++
Sbjct: 123 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 180
Query: 196 APELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------PAS 248
APE+ E+Y++ D++S G+ + ++ P+ + I + + I+ P
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQYEFPNP 239
Query: 249 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 288
+VK I + + R+ E + P+++
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 8e-42
Identities = 66/297 (22%), Positives = 113/297 (38%), Gaps = 46/297 (15%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY +G+GA+ V +D V+ + VA +++ + +R E+ +L +
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFR 64
Query: 85 HENIIKFYNSWVDDTNRTIN--MITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHY 142
HENII + T + + L K +++ I + QILRGL Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 143 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVIGTPEFMAP 197
+HS N ++HRDLK N+ +N ++KI D GLA V + T + AP
Sbjct: 125 IHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 198 ELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--------- 246
E+ Y + +DI+S G + EM++ + Q+ + P
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 247 -------------------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
L D + ++K + R+ + L P+L
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-41
Identities = 57/273 (20%), Positives = 103/273 (37%), Gaps = 28/273 (10%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHE 86
++ +++G+G F V K + DG+ + + S D E+ +L L H
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLR-----------------YRKKHKNVDMKAI 129
NII + + + E G+L + + +
Sbjct: 72 NIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 189
++A + RG+ YL IHRDL NI V N KI D GL+ + +++
Sbjct: 130 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 190 -GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 247
+MA E L Y D++S+G+ + E+V+ A++Y+K+ G +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 248 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
D +V + +C R ++L
Sbjct: 247 KPLNC-DDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-41
Identities = 74/298 (24%), Positives = 125/298 (41%), Gaps = 40/298 (13%)
Query: 23 SCRY-GRYD--EILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQS-PDQLERLYSEV 77
CR +Y+ +G+GA+ V+K D + G VA +V ++ + P R + +
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 78 HLLKSLKHENIIKFYNSWVD---DTNRTINMITELFTSGSLRY--RKKHKNVDMKAIKNW 132
L++ +H N+++ ++ D + ++ E Y + V + IK+
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 133 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGT 191
Q+LRGL +LHSH ++HRDLK NI V ++G++K+ D GLA I Q SV+ T
Sbjct: 122 MFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVT 178
Query: 192 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-- 248
+ APE L + Y VD++S G EM + + + Q+ K + P
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 249 ----------------------LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
D K + KC+ + R+ A L P+
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 8e-41
Identities = 63/283 (22%), Positives = 107/283 (37%), Gaps = 40/283 (14%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLYSEVHLLKSL-KHEN 87
++LG GAF V QV ++ + + D E L SE+ ++ L HEN
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKN------------------------ 123
I+ + I +I E G L + K
Sbjct: 103 IVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 124 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183
+ + + +A Q+ +G+ +L + +HRDL N+ V + VKI D GLA +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVT-HGKVVKICDFGLARDIMSD 217
Query: 184 ----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 237
+ ++MAPE L+E Y D++S+G+ + E+ + PY A Y
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 238 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
K + +G K T ++ ++ C + R L
Sbjct: 278 KLIQNGFKMDQPFYAT-EEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-40
Identities = 63/302 (20%), Positives = 122/302 (40%), Gaps = 46/302 (15%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+Y+ E +G+G + TV+K + VA +V ++D E+ LLK LKH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKH 60
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHS 145
+NI++ ++ D T+ + + ++D + +K++ Q+L+GL + HS
Sbjct: 61 KNIVRLHDVLHSDKKLTLVF-EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPELY--E 201
N ++HRDLK N+ +N NGE+K+ + GLA P + T + P++
Sbjct: 120 RN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 202 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------------- 244
+ Y+ +D++S G E+ P + K++ +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 245 ----------KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVC 293
++ + + ++ + R+ A E L+ P+ D C
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-----SDF-C 290
Query: 294 DP 295
P
Sbjct: 291 PP 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 80/313 (25%), Positives = 126/313 (40%), Gaps = 44/313 (14%)
Query: 5 SGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
SGF + E + + + Y R + +G GA+ V D G +VA ++
Sbjct: 2 SGFYRQEVTKTAWEVRA---VY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--F 55
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRYRKKH 121
QS +R Y E+ LLK ++HEN+I + + D + F L KH
Sbjct: 56 QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 115
Query: 122 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181
+ + I+ Q+L+GL Y+H+ HRDLK N+ VN + E+KI D GLA
Sbjct: 116 EKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVN-EDCELKILDFGLARQAD 172
Query: 182 QPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 239
+ T + APE+ Y + VDI+S G + EM+T + + + Q+ +
Sbjct: 173 SEM-TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231
Query: 240 VTSGIKP----------------------------ASLSKVTDPQVKQFIEKCIVP-ASL 270
+ P AS+ P +EK +V A
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291
Query: 271 RLPALELLKDPFL 283
R+ A E L P+
Sbjct: 292 RVTAGEALAHPYF 304
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 147 bits (371), Expect = 2e-40
Identities = 64/289 (22%), Positives = 107/289 (37%), Gaps = 40/289 (13%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+Y E +G+G + VYK + G A ++ +E + E+ +LK LKH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLE--KEDEGIPSTTIREISILKELKH 59
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHS 145
NI+K Y+ + L ++ K++ Q+L G+ Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKL-LDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE 203
++HRDLK N+ +N GE+KI D GLA P + I T + AP++
Sbjct: 119 RR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 204 --YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK----------------------- 238
Y+ +DI+S G EMV + Q+ +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 239 ---KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 283
V + S K D + K + + R+ A + L+ +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 147 bits (372), Expect = 3e-40
Identities = 54/305 (17%), Positives = 118/305 (38%), Gaps = 54/305 (17%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
Y LG+G + V++ + + +V + P + +++ E+ +L++L+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRG 88
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLH 144
NII + D +RT ++ E + + + ++ + I+ + +IL+ L Y H
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFK--QLYQTLTDYDIRFYMYEILKALDYCH 146
Query: 145 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEE 203
S I+HRD+K N+ ++ + ++++ D GLA + + F PEL +
Sbjct: 147 SMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 204 --YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-------------------- 241
Y+ +D++S G + M+ + P+ + ++
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 242 ---------------SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVT 285
+ + P+ F++K + RL A E ++ P+
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF-Y 323
Query: 286 DNPKD 290
KD
Sbjct: 324 TVVKD 328
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 5e-40
Identities = 54/280 (19%), Positives = 98/280 (35%), Gaps = 33/280 (11%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY +G G+F +Y G D G EVA ++ + +L+ E + K ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQ 60
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRY-RKKHKNVDMKAIKNWARQILRGLHYL 143
I W M+ EL + +K + A Q++ + Y+
Sbjct: 61 GGVGIPTIR-WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 144 HSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQP---------TARSVIGTP 192
HS N IHRD+K DN + V I D GLA + +++ GT
Sbjct: 120 HSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 193 EFMAPELYE-EEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSG---IKP 246
+ + + E + D+ S G ++ + + Q Y++++
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 247 ASLSKVTDPQVKQFIEKCIVPASLRLP----ALELLKDPF 282
L K + ++ C P +L ++ F
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-39
Identities = 68/290 (23%), Positives = 108/290 (37%), Gaps = 49/290 (16%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +GKG F V++G G EVA + + ++ +E++ L+HENI+
Sbjct: 9 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILG 61
Query: 91 FYNSWVDDTNRTINM--ITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHS--- 145
F + D + +++ GSL V ++ + A GL +LH
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 146 ---HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMA 196
P I HRDLK NI V NG I DLGLA+ T +GT +MA
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 197 PELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG------ 243
PE+ ++ E + DIY+ G+ E+ ++ Y +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 244 -------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
I S + + + +C + RL AL + K
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 59/295 (20%), Positives = 124/295 (42%), Gaps = 28/295 (9%)
Query: 31 EILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE- 86
++LG GA+ V+ G A + ++Q E +E +L+ ++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRYR-KKHKNVDMKAIKNWARQILRGLHYLHS 145
++ + ++ +T + + + G L + + ++ + +I+ L +LH
Sbjct: 90 FLVTLHYAFQTETKLHLIL--DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147
Query: 146 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV---MQQPTARSVIGTPEFMAPELY-- 200
II+RD+K +NI ++ +NG V + D GL+ + A GT E+MAP++
Sbjct: 148 LG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 201 -EEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQ 256
+ +++ VD +S G+ + E++T P+ E + A+I +++ P +
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSAL 262
Query: 257 VKQFIEKCIV------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 305
K I++ ++ A E+ + F N DL + P P +
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP-FKPVI 316
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (356), Expect = 2e-38
Identities = 40/259 (15%), Positives = 95/259 (36%), Gaps = 29/259 (11%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
Y +G+G+F +++G + ++ +VA + E QL E K L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRD---EYRTYKLLA 58
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLH 144
I + + + +I L S + +K + A+Q+L + +H
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 145 SHNPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQQP---------TARSVIGT 191
+ +++RD+K DN + N + + D G+ + P +++ GT
Sbjct: 119 EKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 192 PEFMAPELYE-EEYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTSGIKPAS 248
+M+ + E + D+ + G + + + + Q Y+++ +
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236
Query: 249 LSKVTD---PQVKQFIEKC 264
L ++ + +++
Sbjct: 237 LRELCAGFPEEFYKYMHYA 255
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 7e-38
Identities = 49/288 (17%), Positives = 88/288 (30%), Gaps = 45/288 (15%)
Query: 28 RYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
Y +G+GAF V++ VA + E S D E L+
Sbjct: 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAE 72
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLR-------------------------Y 117
+ NI+K + ++ E G L
Sbjct: 73 FDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 118 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177
+ ARQ+ G+ YL +HRDL N V N VKI D GL+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG-ENMVVKIADFGLS 187
Query: 178 IVMQQPTAR----SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKN 232
+ + +M PE ++ Y D++++G+ + E+ +
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 233 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
++ V G + + ++ + C + R + +
Sbjct: 248 HEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-37
Identities = 66/281 (23%), Positives = 113/281 (40%), Gaps = 40/281 (14%)
Query: 31 EILGKGAFKTVYKGFD-------EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
+ LG+GAF V +VA + + + L L SE+ ++K +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMI 75
Query: 84 -KHENIIKFYNSWVDDTNRTINMITELFTSGSLR-----------------YRKKHKNVD 125
KH+NII + D + +I E + G+LR + +
Sbjct: 76 GKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 126 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 183
K + + A Q+ RG+ YL S IHRDL N+ V + +KI D GLA +
Sbjct: 134 SKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 190
Query: 184 --TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 240
+ ++MAPE L++ Y D++SFG+ + E+ T +++K +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 241 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 280
G + S T ++ + C S R +L++D
Sbjct: 251 KEGHRMDKPSNCT-NELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-37
Identities = 55/283 (19%), Positives = 105/283 (37%), Gaps = 39/283 (13%)
Query: 28 RYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
+ + LG GAF V + + VA + + E L SE+ +L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSY 82
Query: 83 LK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKN------------------ 123
L H NI+ + +ITE G L + K
Sbjct: 83 LGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 124 -VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182
+D++ + +++ Q+ +G+ +L S N IHRDL NI + + KI D GLA ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIKN 197
Query: 183 PTARSV----IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 237
+ V ++MAPE ++ Y D++S+G+ + E+ + +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 238 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
K+ + ++ ++ C R ++++
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-37
Identities = 82/327 (25%), Positives = 132/327 (40%), Gaps = 46/327 (14%)
Query: 6 GFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
F + E + + + RY + +G GA+ +V FD G+ VA +++ Q
Sbjct: 3 TFYRQELNKTIWEVPE---RY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQ 56
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---NRTINMITELFTSGSLRYRKKHK 122
S +R Y E+ LLK +KHEN+I + + + L K +
Sbjct: 57 SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 123 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182
+ ++ QILRGL Y+HS + IIHRDLK N+ VN + E+KI D GLA
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDD 173
Query: 183 PTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 240
+ T + APE+ YN+ VDI+S G + E++T + + Q+ +
Sbjct: 174 EM-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232
Query: 241 TSGIKP----------------------------ASLSKVTDPQVKQFIEKCIVP-ASLR 271
P A++ +P +EK +V + R
Sbjct: 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292
Query: 272 LPALELLKDPFLVT-DNPKDL-VCDPL 296
+ A + L + +P D V DP
Sbjct: 293 ITAAQALAHAYFAQYHDPDDEPVADPY 319
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 8e-37
Identities = 52/271 (19%), Positives = 103/271 (38%), Gaps = 25/271 (9%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKH 85
LG+G+F VY+G + + +V I+ + S + +E ++K
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKN-----------VDMKAIKNWAR 134
++++ +I EL T G L+ + + + A
Sbjct: 83 HHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 135 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIG 190
+I G+ YL+++ +HRDL N V + VKIGD G+ + + +
Sbjct: 141 EIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 191 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 249
+M+PE L + + D++SFG+ + E+ T + + Q+ + V G
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 250 SKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
+ + + C +R LE++
Sbjct: 258 DNC-PDMLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-35
Identities = 55/278 (19%), Positives = 106/278 (38%), Gaps = 30/278 (10%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKH 85
+ + LG+GAF V + V ++ + + L SE+ +L + H
Sbjct: 16 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRYRKKHKN-----------------VDMKA 128
+ + +I E G+L + K + ++
Sbjct: 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 129 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----T 184
+ ++ Q+ +G+ +L S IHRDL NI ++ VKI D GLA + +
Sbjct: 136 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVR 192
Query: 185 ARSVIGTPEFMA-PELYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 242
++MA +++ Y D++SFG+ + E+ + PY K + +++
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252
Query: 243 GIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 279
G + T P++ Q + C S R EL++
Sbjct: 253 GTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 72/329 (21%), Positives = 127/329 (38%), Gaps = 61/329 (18%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY + +G GA V +D V VA +++ Q+ +R Y E+ L+K +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVN 74
Query: 85 HENIIKFYNSWVDD----TNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGL 140
H+NII N + + + ++ EL + + + D + + Q+L G+
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--DHERMSYLLYQMLCGI 132
Query: 141 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPE- 198
+LHS IHRDLK NI V ++ +KI D GLA + + T + APE
Sbjct: 133 KHLHSAGI--IHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 199 LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------ 246
+ Y E VDI+S G + EMV + + Q K + P
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 247 ---------------------------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELL 278
+ +K+ Q + + K +V + R+ + L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 279 KDPFLVTDNPKDLVCDPLRLPNLVPEVMN 307
+ P++ ++ DP + P++ +
Sbjct: 310 QHPYI------NVWYDPAEVEAPPPQIYD 332
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 1e-27
Identities = 64/343 (18%), Positives = 119/343 (34%), Gaps = 80/343 (23%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY LG G F TV+ D V+ VA V + V E E+ LL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-----EAAEDEIKLLQRVN 67
Query: 85 HENIIK---------------FYNSWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAI 129
+ K F + + + + +L + +H+ + + +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 130 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI----VMQQPTA 185
K ++Q+L GL Y+H IIH D+K +N+ + + + + +A
Sbjct: 128 KQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 186 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY------NECKNPAQIYK 238
+ I T E+ +PE L + DI+S I E++T ++ + + K+ I +
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 239 KVTSGIKPAS---------------------------------------LSKVTDPQVKQ 259
+ + S SK ++
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 260 FIEKCIVP-ASLRLPALELLKDPFLVTDNPKD-LVCDPLRLPN 300
F+ + R A L+ P+L KD L + +R+P+
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWL-----KDTLGMEEIRVPD 344
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.3 bits (205), Expect = 5e-19
Identities = 30/198 (15%), Positives = 61/198 (30%), Gaps = 21/198 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVA-----WNQVNIEDVMQSPDQLE-RLYSEVHLLKSLK 84
+++G+G V+ + E E + + V + D + +
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 85 HENIIKFYNSWVD---DTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLH 141
+ K V ++ EL K+ V ++ IL +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNA-VLMELI------DAKELYRVRVENPDEVLDMILEEVA 117
Query: 142 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE 201
+ I+H DL N+ V+ + I D ++ + + R ++ +
Sbjct: 118 KFYHRG--IVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173
Query: 202 EEYNELVDIYSFGMCILE 219
Y DI S IL+
Sbjct: 174 RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 630 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.84 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.47 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.35 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.08 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 86.78 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-60 Score=486.72 Aligned_cols=265 Identities=51% Similarity=0.949 Sum_probs=242.5
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
+...+.|||+++.+.||+|+||+||+|.++.+|..||+|.+..... .....+++.+|+++|++++|||||++|++|.+
T Consensus 2 ~g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 79 (270)
T d1t4ha_ 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79 (270)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Confidence 3467889999999999999999999999999999999999976543 45567789999999999999999999999875
Q ss_pred C--CCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccc
Q 006810 98 D--TNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 174 (630)
Q Consensus 98 ~--~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 174 (630)
. ....+|+||||+++|+|. ++.+.+.+++..++.|+.||+.||+|||+++++|+||||||+|||+++.+|.+||+||
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 3 345789999999999998 7888889999999999999999999999999889999999999999766899999999
Q ss_pred ccceeeccCCCccccCCCCCCCccccccccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 175 GLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 175 Gla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
|+|+..........+|||.|||||++.+.|+.++|||||||++|||+||+.||.+..+..++++.+..+..|..++...+
T Consensus 160 Gla~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 160 GLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred CcceeccCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 99987766666778999999999999999999999999999999999999999988889999999998888888888889
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
+++++||.+||. +|.+|||+.|+|+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999998 899999999999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=462.38 Aligned_cols=260 Identities=30% Similarity=0.506 Sum_probs=226.1
Q ss_pred cccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
...||..|| ++.+.||+|+||+||+|.++.+|..||+|+++..... ..+.+.+|+.+|++++|||||+++++|.+
T Consensus 14 ~~~dp~~~Y-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 88 (293)
T d1yhwa1 14 SVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLV 88 (293)
T ss_dssp BSSCTTTTB-CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CCCCccccc-EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh----HHHHHHHHHHHHHhCCCCCEeeEeEEEEE
Confidence 456788999 6668899999999999999999999999999865432 23568899999999999999999999976
Q ss_pred CCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 98 DTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
. ..+|+|||||+||+|..+...+.+++..++.|++||+.||.|||++| |+||||||+|||++ .+|.+||+|||++
T Consensus 89 ~--~~~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~a 163 (293)
T d1yhwa1 89 G--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFC 163 (293)
T ss_dssp T--TEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTC
T ss_pred C--CEEEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEEC-CCCcEeeccchhh
Confidence 5 46899999999999995556678999999999999999999999999 99999999999998 7899999999999
Q ss_pred eeeccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 178 IVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 178 ~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
+..... .....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+......+...+..+..+...+...+
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 243 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSC
T ss_pred eeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCC
Confidence 876433 3456689999999998875 5899999999999999999999999886555666666666655555566778
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
+++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 244 ~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 999999999998 899999999999999998643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=449.75 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=216.2
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||+||+|.++.+|..||+|+++.... .+..+++.+|+.+|++++|||||+++++|.+. ..+|
T Consensus 6 dy-~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~ 79 (271)
T d1nvra_ 6 DW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQY 79 (271)
T ss_dssp EE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred ce-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ceeE
Confidence 45 788999999999999999999999999999986542 23345688999999999999999999999765 4799
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+|||||++|+|. ++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECEET
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEEC-CCCCEEEccchhheeeccC
Confidence 999999999998 7777889999999999999999999999999 99999999999998 7899999999999866432
Q ss_pred ----CCccccCCCCCCCcccccc-cc-CcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 184 ----TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 184 ----~~~~~~GTp~Y~APEvl~~-~y-s~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
.....+|||.|||||++.+ .| +.++|||||||++|||+||++||....+....+................++++
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence 2456789999999998865 44 67899999999999999999999876666666666665544444445668999
Q ss_pred HHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 258 KQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
++||.+||+ +|.+|||+.|+|+||||++.
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 999999998 89999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=448.76 Aligned_cols=252 Identities=23% Similarity=0.431 Sum_probs=222.3
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||+||+|.++.+|..||+|++....... ....+.+.+|+.+|++++|||||+++++|.+. ..+|
T Consensus 7 dy-~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~ 82 (263)
T d2j4za1 7 DF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVY 82 (263)
T ss_dssp GE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred He-EEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC-hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CEEE
Confidence 45 78899999999999999999999999999997543221 22346688999999999999999999999754 4699
Q ss_pred EEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC
Q 006810 105 MITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 183 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 183 (630)
+|||||++|+|. ++...+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCC
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceec-CCCCEeecccceeeecCCC
Confidence 999999999998 7778889999999999999999999999999 99999999999998 7899999999999877666
Q ss_pred CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
.....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. .++...++++++||.
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLIS 236 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHH
Confidence 6667789999999999876 489999999999999999999999976 567777777766532 355678899999999
Q ss_pred Hccc-CCCCCCCHHHHhcCCCcccC
Q 006810 263 KCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 263 kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+||+ +|.+|||+.|+|+||||+..
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCCc
Confidence 9998 89999999999999999753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-55 Score=452.72 Aligned_cols=259 Identities=27% Similarity=0.477 Sum_probs=219.5
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
+.||...| ++.+.||+|+||+||+|.++.+|..||+|+++... ....+.+.+|+.+|++|+|||||+++++|.+.
T Consensus 7 ~~~p~d~Y-~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 81 (288)
T d2jfla1 7 DLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYE 81 (288)
T ss_dssp SSCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCCcccCe-EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 46788888 88899999999999999999999999999997542 33456788999999999999999999999765
Q ss_pred CCCEEEEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 99 TNRTINMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
..+++|||||++|+|. ++. ..+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 82 --~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG~ 156 (288)
T d2jfla1 82 --NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGV 156 (288)
T ss_dssp --TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred --CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeEC-CCCCEEEEechh
Confidence 4689999999999998 544 4567999999999999999999999999 99999999999998 789999999999
Q ss_pred ceeeccC--CCccccCCCCCCCccccc------cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006810 177 AIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 248 (630)
Q Consensus 177 a~~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~ 248 (630)
|+..... .....+||+.|||||++. ..|+.++|||||||++|||+||+.||.+......+............
T Consensus 157 a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (288)
T d2jfla1 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236 (288)
T ss_dssp CEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS
T ss_pred hhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9765432 234578999999999873 34899999999999999999999999875444444444443333334
Q ss_pred CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 249 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 249 l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
.+...++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 455678999999999998 899999999999999998644
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-55 Score=455.28 Aligned_cols=261 Identities=28% Similarity=0.469 Sum_probs=224.8
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
+...||..+| +..+.||+|+||+||+|.+..+|..||+|+++.... ......+.+.+|+.+|++|+|||||+++++|.
T Consensus 8 ~~~~dp~~~y-~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 8 FFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp CCCSCHHHHE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccccCcHHhc-EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 3445788888 566889999999999999999999999999986543 23455677999999999999999999999997
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccc
Q 006810 97 DDTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 175 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 175 (630)
+. ..+|+|||||.+|+|. +....+++++..++.|++||+.||.|||++| |+||||||+|||++ .+|.+||+|||
T Consensus 86 ~~--~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG 160 (309)
T d1u5ra_ 86 RE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFG 160 (309)
T ss_dssp ET--TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCT
T ss_pred EC--CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEC-CCCCEEEeecc
Confidence 65 4699999999999998 6677788999999999999999999999999 99999999999998 78999999999
Q ss_pred cceeeccCCCccccCCCCCCCccccc----cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 176 LAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 176 la~~~~~~~~~~~~GTp~Y~APEvl~----~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
+|..... ....+|||.|||||++. +.|+.++|||||||++|||++|+.||.+.. ..+....+..+..+.....
T Consensus 161 ~a~~~~~--~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~ 237 (309)
T d1u5ra_ 161 SASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSG 237 (309)
T ss_dssp TCBSSSS--BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSCT
T ss_pred cccccCC--CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhCCCCCCCCC
Confidence 9976543 34568999999999874 358999999999999999999999998754 4444555555555555566
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
..++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 778999999999998 899999999999999998643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=443.75 Aligned_cols=251 Identities=26% Similarity=0.477 Sum_probs=207.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||+||+|.++.+|+.||+|.+..... .+...+.+.+|+++|++++|||||++|++|.+..+..+|+||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 778999999999999999999999999999976543 456678899999999999999999999999887777899999
Q ss_pred cccCCCCHH-HHh----hcCCCCHHHHHHHHHHHHHHHHHHHcCC---CCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 108 ELFTSGSLR-YRK----KHKNVDMKAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 108 Ey~~gGsL~-~~~----~~~~lse~~i~~i~~QIl~gL~yLHs~~---~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
|||++|+|. ++. ..+.+++..++.|+.||+.||.|||+++ .+|+||||||+|||++ .+|.+||+|||+++.
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~a~~ 163 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARI 163 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHHHHH
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeeccceee
Confidence 999999997 443 3568999999999999999999999865 2499999999999998 789999999999986
Q ss_pred eccC--CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 180 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 180 ~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
.... .....+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..++...+..+..+ .++...+++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~s~~ 241 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYSDE 241 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSCHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHH
Confidence 6443 3456789999999998865 599999999999999999999999986 5677777777776543 455677899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCc
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFL 283 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~ 283 (630)
+++||.+||+ +|.+|||+.|+|+|||+
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999998 89999999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-54 Score=443.27 Aligned_cols=257 Identities=27% Similarity=0.458 Sum_probs=221.7
Q ss_pred ceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEE
Q 006810 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (630)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~l 105 (630)
| ++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+++|++++|||||+++++|.+. ..+|+
T Consensus 10 y-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~i 85 (288)
T d1uu3a_ 10 F-KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYF 85 (288)
T ss_dssp E-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEEE
T ss_pred C-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC-HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEEE
Confidence 5 88999999999999999999999999999997543221 23346789999999999999999999998754 57999
Q ss_pred EEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC-
Q 006810 106 ITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 183 (630)
Q Consensus 106 V~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 183 (630)
||||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC---
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccC-CCceEEecccccceecccCC
Confidence 99999999997 7788899999999999999999999999999 99999999999998 7899999999999876432
Q ss_pred ---CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006810 184 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 259 (630)
Q Consensus 184 ---~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~ 259 (630)
...+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+...++..+..+. ..++...++++++
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLE--YDFPEKFFPKARD 239 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTC--CCCCTTCCHHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCC--CCCCccCCHHHHH
Confidence 2345689999999998875 589999999999999999999999987 56777777777653 2355677899999
Q ss_pred HHHHccc-CCCCCCCHHH------HhcCCCcccCCCCccc
Q 006810 260 FIEKCIV-PASLRLPALE------LLKDPFLVTDNPKDLV 292 (630)
Q Consensus 260 ~I~kcL~-~p~~Rpsa~e------LL~hpf~~~~~~~~~~ 292 (630)
||.+||+ +|.+|||+.| +++||||+..++..+.
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence 9999998 8999999988 5889999988876654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=441.18 Aligned_cols=265 Identities=25% Similarity=0.398 Sum_probs=221.6
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~--~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
+-..|| ++.+.||+|+||+||+|.++.+|..||+|+++....... ....+.+.+|+.+|++|+|||||+++++|.+.
T Consensus 7 ~i~d~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 7 NVDDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp CGGGTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CcccCE-EEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 344566 889999999999999999999999999999976543322 22356789999999999999999999999755
Q ss_pred CCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCC----cEEEcc
Q 006810 99 TNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGD 173 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKL~D 173 (630)
..+|+|||||++|+|. ++...+.+++..++.+++||+.||+|||+++ |+||||||+|||++ .+| .+||+|
T Consensus 86 --~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~-~~~~~~~~vkl~D 160 (293)
T d1jksa_ 86 --TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLL-DRNVPKPRIKIID 160 (293)
T ss_dssp --SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CSSSSSCCEEECC
T ss_pred --CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEe-cCCCcccceEecc
Confidence 5799999999999998 7778889999999999999999999999999 99999999999997 444 599999
Q ss_pred cccceeeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--CCC
Q 006810 174 LGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASL 249 (630)
Q Consensus 174 FGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l 249 (630)
||++...... ......||+.|+|||++.+ .|+.++|||||||++|||+||+.||.+ .+..+.+..+..+... ...
T Consensus 161 fG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1jksa_ 161 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEY 239 (293)
T ss_dssp CTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHH
T ss_pred hhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchh
Confidence 9999876543 3456789999999998875 589999999999999999999999987 5666666666665432 233
Q ss_pred CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCCCccc
Q 006810 250 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 292 (630)
Q Consensus 250 ~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~~~~~ 292 (630)
....++.+++||.+||. +|.+|||+.|+|+||||+..++...+
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-------
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHhh
Confidence 45678999999999998 89999999999999999976665543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=453.49 Aligned_cols=256 Identities=26% Similarity=0.454 Sum_probs=213.4
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||+||+|.+..+|+.||+|+++... .....+++.+|+.+|++++|||||+++++|.+. ..+
T Consensus 6 d~y-~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 79 (322)
T d1s9ja_ 6 DDF-EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 79 (322)
T ss_dssp GGE-EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SEE
T ss_pred cCC-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 356 66789999999999999999999999999997543 234557789999999999999999999999765 469
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
|+||||+++|+|. ++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||+|+...
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHH
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeEC-CCCCEEEeeCCCccccC
Confidence 9999999999998 77788899999999999999999999997 58 99999999999998 78999999999998776
Q ss_pred cCCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHH-------------------------
Q 006810 182 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ------------------------- 235 (630)
Q Consensus 182 ~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~------------------------- 235 (630)
.....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+......
T Consensus 157 ~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 666677899999999998875 599999999999999999999999976432211
Q ss_pred ----------------HHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 236 ----------------IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 236 ----------------i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
....+.....+.......++++++||.+||+ +|.+||||.|+|+||||+..++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 1111111112222223467899999999998 8999999999999999986443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=447.85 Aligned_cols=261 Identities=23% Similarity=0.441 Sum_probs=227.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.++||+|+||+||+|+++.+|..||+|+++...... ....+.+.+|+.+|++++|||||+++++|.+. ..+|+||
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~iv~ 84 (337)
T d1o6la_ 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVM 84 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc--cccccce
Confidence 78899999999999999999999999999998543321 23456788999999999999999999999765 5799999
Q ss_pred cccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--CC
Q 006810 108 ELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PT 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~ 184 (630)
|||+||+|. ++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+.... ..
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCC
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEec-CCCCEEEeecccccccccCCcc
Confidence 999999998 8888899999999999999999999999999 99999999999998 789999999999986543 34
Q ss_pred CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006810 185 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 263 (630)
Q Consensus 185 ~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~k 263 (630)
....+|||.|||||++.+ .|+.++|||||||++|||+||++||.+ .+...+++.+..+. ..++...++++++||.+
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCC--CCCCccCCHHHHHHHHh
Confidence 456789999999998875 599999999999999999999999987 56777777777654 34567789999999999
Q ss_pred ccc-CCCCCCC-----HHHHhcCCCcccCCCCccccCCCC
Q 006810 264 CIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLR 297 (630)
Q Consensus 264 cL~-~p~~Rps-----a~eLL~hpf~~~~~~~~~~~~~l~ 297 (630)
||+ +|.+|++ +.|+++||||+..++..+....+.
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~ 278 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred hccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCC
Confidence 998 8999994 899999999998877665544443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-53 Score=442.96 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=204.8
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
|-..+| ++.+.||+|+||+||+|.++.+|+.||+|++...... .....+.+|+.+|++|+|||||+++++|.+.
T Consensus 6 di~d~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-- 79 (307)
T d1a06a_ 6 DIRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESG-- 79 (307)
T ss_dssp CGGGTE-EEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred CCccce-EEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence 334556 8899999999999999999999999999999865432 2335678999999999999999999998654
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCcEEEcccccc
Q 006810 101 RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLA 177 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGla 177 (630)
..+|+|||||+||+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+.. .+|.+||+|||++
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEecccee
Confidence 5799999999999998 7778889999999999999999999999999 999999999999952 4789999999999
Q ss_pred eeeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCC
Q 006810 178 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVT 253 (630)
Q Consensus 178 ~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~ 253 (630)
+..... ...+.+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+ .+...+...+..+.. +.......
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCC
Confidence 866543 3456789999999998875 589999999999999999999999987 456666666666543 23344567
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 237 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 8999999999998 89999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9e-53 Score=440.81 Aligned_cols=262 Identities=27% Similarity=0.429 Sum_probs=226.0
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
|++.+.||+|+||+||+|.++.+|..||+|+++...... ....+.+.+|+.+|++++|||||+++++|.+. ..+|+|
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv 82 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIFMI 82 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEEEE
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHhccCcChhheeeeEeeC--CeeeeE
Confidence 488899999999999999999999999999997543211 23356788999999999999999999998754 579999
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCCC
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 185 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 185 (630)
||||.||+|. .+.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+..... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~-~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV-T 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC-B
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEc-CCCCEEEecCccceEeccc-c
Confidence 9999999998 7778888999999999999999999999999 99999999999998 7899999999999876543 3
Q ss_pred ccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHc
Q 006810 186 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 264 (630)
Q Consensus 186 ~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kc 264 (630)
.+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. .++...+++++++|.+|
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 46789999999999876 499999999999999999999999987 566777777766532 34566789999999999
Q ss_pred cc-CCCCCC-----CHHHHhcCCCcccCCCCccccCCCCC
Q 006810 265 IV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRL 298 (630)
Q Consensus 265 L~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~~~l~~ 298 (630)
|+ +|.+|+ ++.++|+||||+..++..+....+..
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~ 275 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIET 275 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCC
T ss_pred hhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCc
Confidence 97 798886 89999999999998877655444433
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-52 Score=445.49 Aligned_cols=264 Identities=22% Similarity=0.366 Sum_probs=220.7
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc--CCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~--~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
.| ++.++||+|+||+||+|.++.+|..||+|++...... .......+..+++.+++.++|||||+++++|.+. ..
T Consensus 5 dy-~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~~ 81 (364)
T d1omwa3 5 DF-SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DK 81 (364)
T ss_dssp TE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--SE
T ss_pred hC-eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--CE
Confidence 45 8889999999999999999999999999999754321 1222233344567888889999999999998765 46
Q ss_pred EEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 103 INMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
+|+|||||+||+|. ++..+..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEc-CCCcEEEeeeceeeecC
Confidence 99999999999998 7788899999999999999999999999999 99999999999998 78999999999999877
Q ss_pred cCCCccccCCCCCCCccccc-c-ccCcccceeehhHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCcHHH
Q 006810 182 QPTARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSGIKPASLSKVTDPQV 257 (630)
Q Consensus 182 ~~~~~~~~GTp~Y~APEvl~-~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~--~~i~~~i~~g~~p~~l~~~~s~~l 257 (630)
.......+||+.|||||++. + .|+.++|||||||++|||+||+.||.+.... ..+...+ ...+..++...++++
T Consensus 159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPEL 236 (364)
T ss_dssp SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS--SSCCCCCCSSSCHHH
T ss_pred CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCCCCHHH
Confidence 76667788999999999885 3 4899999999999999999999999864332 2222222 223445566789999
Q ss_pred HHHHHHccc-CCCCCCC-----HHHHhcCCCcccCCCCccccCCC
Q 006810 258 KQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPL 296 (630)
Q Consensus 258 k~~I~kcL~-~p~~Rps-----a~eLL~hpf~~~~~~~~~~~~~l 296 (630)
++||.+||+ +|.+||| |.|+|+||||+..++..+....+
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~ 281 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY 281 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCC
Confidence 999999998 8999999 89999999999887766544333
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.8e-52 Score=442.04 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=219.8
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
--.|| ++.+.||+|+||+||+|.++.+|..||+|++... .....+.+.+|+.+|++|+|||||+++++|.+. .
T Consensus 24 il~~Y-~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~ 96 (350)
T d1koaa2 24 VLDHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--N 96 (350)
T ss_dssp GGGTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--T
T ss_pred CccCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence 34477 8889999999999999999999999999999643 244567789999999999999999999999765 4
Q ss_pred EEEEEEcccCCCCHH-HH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC-CCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~DFGla~ 178 (630)
.+|+|||||+||+|. ++ ...+.+++..++.|+.||+.||.|||++| |+||||||+|||++. .+|.+||+|||+++
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~ 174 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA 174 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchhe
Confidence 699999999999997 55 35567999999999999999999999999 999999999999963 36899999999998
Q ss_pred eeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCc
Q 006810 179 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD 254 (630)
Q Consensus 179 ~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s 254 (630)
..... ......||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. +.......+
T Consensus 175 ~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 253 (350)
T d1koaa2 175 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGIS 253 (350)
T ss_dssp ECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCC
T ss_pred ecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCC
Confidence 76554 3446789999999998875 589999999999999999999999986 456666666655432 233334578
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCCC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 288 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~~ 288 (630)
+++++||.+||. +|.+|||+.|+|+||||+..+.
T Consensus 254 ~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 999999999998 8999999999999999987654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-52 Score=444.89 Aligned_cols=265 Identities=23% Similarity=0.398 Sum_probs=227.4
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+++|+.++|||||+++++|.+. ..+
T Consensus 41 d~y-~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~ 116 (350)
T d1rdqe_ 41 DQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNL 116 (350)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred cCe-EEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHHcCCCcEeecccccccc--ccc
Confidence 467 67789999999999999999999999999997543221 23456789999999999999999999998754 468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++||||+.+|+|. ++...+.+++..++.|+.||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSS
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccC-CCCCEEeeeceeeeeccc
Confidence 9999999999998 7778889999999999999999999999999 99999999999998 789999999999987654
Q ss_pred CCCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006810 183 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 261 (630)
Q Consensus 183 ~~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I 261 (630)
. ....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+...++..+..+.. .++...++++++||
T Consensus 194 ~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 194 R-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLL 269 (350)
T ss_dssp C-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHH
T ss_pred c-cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHH
Confidence 3 345789999999998875 589999999999999999999999987 567777777766543 34456789999999
Q ss_pred HHccc-CCCCCC-----CHHHHhcCCCcccCCCCccccCCCCCC
Q 006810 262 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 299 (630)
Q Consensus 262 ~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~~~l~~p 299 (630)
.+||. +|.+|+ ++.++|+||||+..++..+....+..|
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p 313 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcC
Confidence 99997 888884 899999999999988766655444444
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-51 Score=439.01 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=217.2
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||+||+|.++.+|..||+|+++... ......+.+|+.+|++|+|||||+++++|.+. ..+
T Consensus 29 d~Y-~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~ 101 (352)
T d1koba_ 29 DYY-DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEM 101 (352)
T ss_dssp GTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEE
T ss_pred cce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 455 88899999999999999999999999999997543 34456788999999999999999999999754 579
Q ss_pred EEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC-CCCcEEEcccccceee
Q 006810 104 NMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVM 180 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~DFGla~~~ 180 (630)
|+|||||+||+|. .+.. ..++++..++.|+.||+.||.|||++| |+||||||+|||++. .+|.+||+|||+|...
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceec
Confidence 9999999999997 4443 457999999999999999999999999 999999999999973 4689999999999877
Q ss_pred ccCC-CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHH
Q 006810 181 QQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQ 256 (630)
Q Consensus 181 ~~~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~ 256 (630)
.... .....||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+. +...++..+..+.. +.......+++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-DDLETLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 6543 445689999999998875 5999999999999999999999999874 45555555555432 34445667899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 259 ~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999998 89999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-52 Score=428.63 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=203.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCH-HHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEEcc
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~-~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~Ey 109 (630)
++||+|+||+||+|.++.+|+.||+|+++........ ...+++.+|+.+|++++|||||+++++|.+.. .+|+||||
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ivmE~ 81 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NISLVFDF 81 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEEEEEC
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--ceeehhhh
Confidence 7899999999999999999999999999765432222 22356889999999999999999999986654 58999999
Q ss_pred cCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccC--CCc
Q 006810 110 FTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 186 (630)
Q Consensus 110 ~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~~~ 186 (630)
+.+|++. .......+++..++.|++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++...... ...
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEec-CCCccccccCccccccCCCccccc
Confidence 9999988 4555678999999999999999999999999 99999999999998 7899999999999765443 334
Q ss_pred cccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCCC-C---------------
Q 006810 187 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP-A--------------- 247 (630)
Q Consensus 187 ~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p-~--------------- 247 (630)
..+||+.|+|||++.+ .|+.++|||||||++|||+||.+||.+..+.+++...... +..+ .
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 5689999999998753 4899999999999999999999999875555544443321 1000 0
Q ss_pred --------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 248 --------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 248 --------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
......++++++||.+||+ +|.+||||.|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0112457899999999998 89999999999999999853
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.5e-51 Score=418.53 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=218.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC-----HHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEc
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-----PDQLERLYSEVHLLKSLK-HENIIKFYNSWVD 97 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~-----~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d 97 (630)
.+| .+.+.||+|+||+||+|.+..+|+.||+|+++....... ....+++.+|+.+|++|+ |||||+++++|.+
T Consensus 3 ~~y-~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 3 ENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ccC-EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 456 888999999999999999999999999999987543321 223456889999999997 9999999999975
Q ss_pred CCCCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 98 DTNRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
+ ..+|+||||+++|+|. ++...+++++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 82 ~--~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 N--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGF 156 (277)
T ss_dssp S--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTT
T ss_pred C--cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEc-CCCCeEEccchh
Confidence 4 5799999999999998 7888889999999999999999999999999 99999999999997 899999999999
Q ss_pred ceeeccC-CCccccCCCCCCCcccccc-------ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--C
Q 006810 177 AIVMQQP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 246 (630)
Q Consensus 177 a~~~~~~-~~~~~~GTp~Y~APEvl~~-------~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p 246 (630)
++..... .....+||+.|+|||++.+ .|+.++||||+||++|+|+||+.||.+ .+.......+..+.. +
T Consensus 157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCC
T ss_pred eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCC
Confidence 9876543 3455689999999998753 368899999999999999999999987 456666666665533 2
Q ss_pred CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 247 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 247 ~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.......++++++||.+||+ +|.+|||+.|+|+||||++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 23334678999999999998 8999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=432.00 Aligned_cols=255 Identities=24% Similarity=0.439 Sum_probs=219.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHH-HhCCCCCeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL-~~L~HpNIVk~~~~f~d~~~~~l~lV 106 (630)
++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.++ +.++|||||+++++|.+. ..+|+|
T Consensus 5 ~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~yiv 81 (320)
T d1xjda_ 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLFFV 81 (320)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEEEE
T ss_pred EEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--CceeEE
Confidence 78899999999999999999999999999997543221 22345566777765 479999999999999765 469999
Q ss_pred EcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc--C
Q 006810 107 TELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--P 183 (630)
Q Consensus 107 ~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~ 183 (630)
|||+++|+|. ++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++.... .
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeec-CCCceeccccchhhhcccccc
Confidence 9999999998 7888899999999999999999999999999 99999999999998 789999999999976543 2
Q ss_pred CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 184 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 184 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
.....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+. ..+++..++++++||.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~ 235 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN--PFYPRWLEKEAKDLLV 235 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCccCCHHHHHHHH
Confidence 3445689999999998875 699999999999999999999999987 56777777777653 3456678999999999
Q ss_pred Hccc-CCCCCCCHH-HHhcCCCcccCCCCcc
Q 006810 263 KCIV-PASLRLPAL-ELLKDPFLVTDNPKDL 291 (630)
Q Consensus 263 kcL~-~p~~Rpsa~-eLL~hpf~~~~~~~~~ 291 (630)
+||+ +|.+||++. ++++||||+..++..+
T Consensus 236 ~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l 266 (320)
T d1xjda_ 236 KLFVREPEKRLGVRGDIRQHPLFREINWEEL 266 (320)
T ss_dssp HHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred HhcccCCCCCcCHHHHHHhCchhccCCHHHH
Confidence 9998 899999996 8999999998765544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=421.15 Aligned_cols=250 Identities=21% Similarity=0.390 Sum_probs=210.9
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCC--CCCeeEEEeEEEcC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLK--HENIIKFYNSWVDD 98 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~--~~~~~l~~Ei~iL~~L~--HpNIVk~~~~f~d~ 98 (630)
.+|| ++.+.||+|+||+||+|.+..+|..||+|+++........ ....++.+|+.+|++++ |||||+++++|.+.
T Consensus 3 ~~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 3 ESQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCeE-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4677 8899999999999999999999999999999765432211 11234668999999997 89999999998655
Q ss_pred CCCEEEEEEcccCC-CCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 99 TNRTINMITELFTS-GSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 99 ~~~~l~lV~Ey~~g-GsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
..+++||||+.+ +++. ++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+++.+||+|||+
T Consensus 82 --~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 82 --DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp --SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred --CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccc
Confidence 468999999986 5665 7777889999999999999999999999999 999999999999985668999999999
Q ss_pred ceeeccCCCccccCCCCCCCcccccc-c-cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 177 AIVMQQPTARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 177 a~~~~~~~~~~~~GTp~Y~APEvl~~-~-ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
|+........+..||+.|+|||++.+ . ++.++|||||||++|+|+||+.||.. ... +..+ ...++...+
T Consensus 158 a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~----i~~~--~~~~~~~~s 228 (273)
T d1xwsa_ 158 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEE----IIRG--QVFFRQRVS 228 (273)
T ss_dssp CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHH----HHHC--CCCCSSCCC
T ss_pred ceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC---chH----Hhhc--ccCCCCCCC
Confidence 98777766677899999999998864 3 46789999999999999999999975 222 2222 223455678
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999998 89999999999999999763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=427.77 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=216.6
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
--+|| ++.+.||+|+||+||+|.++.+|..||+|+++... .....+.+|+++|++++|||||+++++|.+. .
T Consensus 3 ~~~rY-~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~ 74 (321)
T d1tkia_ 3 LYEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESM--E 74 (321)
T ss_dssp CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--T
T ss_pred Cccce-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--C
Confidence 35688 88899999999999999999999999999997542 2345688999999999999999999999765 4
Q ss_pred EEEEEEcccCCCCHH-HHhhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC-CCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~DFGla~ 178 (630)
.+|+|||||+||+|. ++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||+++
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhh
Confidence 699999999999998 565554 7999999999999999999999999 999999999999973 24589999999998
Q ss_pred eeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCc
Q 006810 179 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD 254 (630)
Q Consensus 179 ~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s 254 (630)
..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+.. +.......+
T Consensus 153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T d1tkia_ 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCC
Confidence 76543 3445679999999998764 589999999999999999999999987 566666666665533 222334578
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
+++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 232 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999998 89999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=423.27 Aligned_cols=255 Identities=20% Similarity=0.312 Sum_probs=205.5
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHH-hCCCCCeeEEEeEEEc--
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWVD-- 97 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~-~L~HpNIVk~~~~f~d-- 97 (630)
.-.++|.-++++||+|+||+||+|.+..+|+.||+|+++.. ..+.+|+.++. .++|||||+++++|.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 34567855567899999999999999999999999998632 34678998865 5589999999999865
Q ss_pred CCCCEEEEEEcccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCcEEEc
Q 006810 98 DTNRTINMITELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIG 172 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~ 172 (630)
..+..+|+|||||+||+|. ++... ..+++..++.|++||+.||+|||+++ |+||||||+|||++. ..+.+||+
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccc
Confidence 3346799999999999998 65543 47999999999999999999999999 999999999999973 35689999
Q ss_pred ccccceeeccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHH---HHHHcCCC--
Q 006810 173 DLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY---KKVTSGIK-- 245 (630)
Q Consensus 173 DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~---~~i~~g~~-- 245 (630)
|||+|+..... .....+|||.|||||++.+ .|+.++|||||||++|+|+||++||.+........ ..+..+..
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 99999866543 4456789999999998875 59999999999999999999999997643322221 11111111
Q ss_pred CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 246 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 246 p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
|.......++++++||.+||+ +|.+|||+.|+|.||||+..
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 111112467899999999998 89999999999999999754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=414.67 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=208.0
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||+||+|.+..+|..||+|+++.... .....+++.+|+++|++++|||||+++++|.+. ..+|
T Consensus 3 ~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~ 77 (298)
T d1gz8a_ 3 NF-QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLY 77 (298)
T ss_dssp TE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEE
T ss_pred CC-EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--ccee
Confidence 46 677999999999999999999999999999975432 223346788999999999999999999999765 4699
Q ss_pred EEEcccCCCCHHH--HhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 105 MITELFTSGSLRY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 105 lV~Ey~~gGsL~~--~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+||||+.++.+.+ ....+.+++..++.++.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+|+....
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGV 154 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCC
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeec-ccCcceeccCCcceeccC
Confidence 9999999887763 344667999999999999999999999999 99999999999998 788999999999976643
Q ss_pred C--CCccccCCCCCCCcccccc-c-cCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC----------
Q 006810 183 P--TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---------- 248 (630)
Q Consensus 183 ~--~~~~~~GTp~Y~APEvl~~-~-ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~---------- 248 (630)
. .....+||+.|+|||++.. . ++.++|||||||++|+|++|+.||.+.....++.........+..
T Consensus 155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 3 3445689999999997654 3 578999999999999999999999876555555554432111100
Q ss_pred ----------------CCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 249 ----------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 249 ----------------l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.....++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 012346889999999998 89999999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.2e-50 Score=409.04 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=209.9
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC--
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~-- 100 (630)
.+|| ++.+.||+|+||+||+|.+..+|+.||+|+++.... .+....+++.+|+.+|+.++|||||++++++.....
T Consensus 6 ~drY-~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 6 SDRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred ccee-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 4688 888999999999999999999999999999976543 345667789999999999999999999999876543
Q ss_pred CEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 101 RTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
..+|+||||++||+|. ++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.++|+|||.+..
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTCEE
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccC-ccccceeehhhhhhh
Confidence 4689999999999998 7778889999999999999999999999999 99999999999998 789999999999865
Q ss_pred eccC-----CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCCC
Q 006810 180 MQQP-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKV 252 (630)
Q Consensus 180 ~~~~-----~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~~ 252 (630)
.... .....+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+....+.....+.....+ ......
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 4322 2345689999999998875 58999999999999999999999998754444555555554433 344566
Q ss_pred CcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcc
Q 006810 253 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 284 (630)
Q Consensus 253 ~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~ 284 (630)
.++.+++||.+||+ +|.+||++.+.|.|+|++
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 78999999999998 899999544444566653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=412.90 Aligned_cols=259 Identities=26% Similarity=0.419 Sum_probs=207.0
Q ss_pred CCcceeeeeEecccCceEEEEEEEccC-CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCeeEEEeEEEcC
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDD 98 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~t-G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L---~HpNIVk~~~~f~d~ 98 (630)
..|| ++.+.||+|+||+||+|.+..+ |+.||+|+++...... .....+.+|+.+|+.| +||||++++++|...
T Consensus 6 ~~~Y-~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCE-EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 4678 7788999999999999999765 6789999997643321 1122355666666555 899999999998643
Q ss_pred ---CCCEEEEEEcccCCCCHH--HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcc
Q 006810 99 ---TNRTINMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 173 (630)
Q Consensus 99 ---~~~~l~lV~Ey~~gGsL~--~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 173 (630)
....++++|||+.+|++. .......+++..++.+++||+.||+|||+++ |+||||||+|||++ .+|.+||+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl~d 159 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLAD 159 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEc-CCCCeeecc
Confidence 335789999999999886 3345667999999999999999999999999 99999999999998 789999999
Q ss_pred cccceeeccC-CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CC------
Q 006810 174 LGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI------ 244 (630)
Q Consensus 174 FGla~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~------ 244 (630)
||++...... .....+||+.|||||++. ..|+.++|||||||++|||+||++||.+.....++...+.. +.
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 9998765433 345678999999999875 46999999999999999999999999875444444333321 00
Q ss_pred -----------------CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 245 -----------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 245 -----------------~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
....+....++.+++||.+||+ +|.+||||.|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 0112334568899999999998 899999999999999998643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-49 Score=408.15 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=206.8
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.|| ++.++||+|+||+||+|.++ +|+.||+|+++.... .....+++.+|+.+|++++|||||+++++|.+.. .+
T Consensus 2 ~~Y-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~ 75 (286)
T d1ob3a_ 2 EKY-HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RL 75 (286)
T ss_dssp CSE-EEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CE
T ss_pred CCc-eeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--ce
Confidence 478 66788999999999999986 889999999976543 2233467899999999999999999999997664 58
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++++||+.++++. +....+.+++..++.+++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGI 152 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEc-CCCCEEecccccceeccc
Confidence 8999999999988 5566788999999999999999999999999 99999999999998 789999999999976544
Q ss_pred C--CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCC------------
Q 006810 183 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK------------ 245 (630)
Q Consensus 183 ~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~------------ 245 (630)
. ......|++.|+|||++.+ .++.++|||||||++|||++|++||.+.....++.+.... +..
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 3 2344579999999998753 4789999999999999999999999875444444433221 000
Q ss_pred -------------CCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 246 -------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 246 -------------p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
...+....++.+++||.+||+ +|.+|||+.|+|+||||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 012234467899999999998 8999999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=408.32 Aligned_cols=248 Identities=30% Similarity=0.479 Sum_probs=207.7
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~ 100 (630)
-|.++| ++.+.||+|+||+||+|... ..||+|+++.... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 5 i~~~~~-~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--- 75 (276)
T d1uwha_ 5 IPDGQI-TVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--- 75 (276)
T ss_dssp CCTTCC-CCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred cccccE-EEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---
Confidence 356777 78899999999999999643 3699999875543 34567889999999999999999999997633
Q ss_pred CEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 101 RTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++|||||++|+|. ++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLAT 152 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCSC
T ss_pred cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEc-CCCCEEEcccccee
Confidence 3478999999999998 5544 467999999999999999999999998 99999999999998 78999999999997
Q ss_pred eeccC----CCccccCCCCCCCcccccc----ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCC---
Q 006810 179 VMQQP----TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--- 247 (630)
Q Consensus 179 ~~~~~----~~~~~~GTp~Y~APEvl~~----~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~--- 247 (630)
..... ......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..+..++...+..+..++
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcch
Confidence 65432 2345689999999998853 488999999999999999999999998777888888887775543
Q ss_pred CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 248 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 248 ~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..+...++++++||.+||. +|.+|||+.+++.+
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3455678999999999997 89999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=404.16 Aligned_cols=250 Identities=21% Similarity=0.353 Sum_probs=207.3
Q ss_pred cceeee-eEecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 25 RYGRYD-EILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 25 Ry~r~~-e~LG~G~fg~Vy~A~d~--~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
++..+. +.||+|+||+||+|.+. .+++.||+|+++... .++...+.+.+|+.+|++++|||||++++++.++
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~--- 80 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE--- 80 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---
Confidence 344554 47999999999999864 456899999986443 2345567899999999999999999999988543
Q ss_pred EEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 102 TINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
.+++||||+++|+|. ++.....+++..+..|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++..
T Consensus 81 ~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 81 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKAL 157 (277)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEEC
T ss_pred CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccc-ccCcccccchhhhhhc
Confidence 368999999999998 7788889999999999999999999999999 99999999999998 7899999999999866
Q ss_pred ccCC-----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006810 181 QQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 253 (630)
Q Consensus 181 ~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 253 (630)
.... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+ ..+...
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~ 235 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGC 235 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTC
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccc
Confidence 4332 23356899999999876 458999999999999999998 8999987 4567777888777544 345667
Q ss_pred cHHHHHHHHHccc-CCCCCCCHHHH---hcCCCcc
Q 006810 254 DPQVKQFIEKCIV-PASLRLPALEL---LKDPFLV 284 (630)
Q Consensus 254 s~~lk~~I~kcL~-~p~~Rpsa~eL---L~hpf~~ 284 (630)
++++++||.+||. +|.+|||+.++ |+|+|+.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 8999999999997 89999999987 5676653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=410.08 Aligned_cols=260 Identities=23% Similarity=0.373 Sum_probs=209.3
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
..++.+|| ++.+.||+|+||+||+|.+..+|+.||||++...... .....++.+|+.+|++++||||+++++++...
T Consensus 5 ~~~~~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 5 FCDEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp TSCBGGGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT--TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCCccCCE-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence 46778999 7789999999999999999999999999998765432 23446688999999999999999999998653
Q ss_pred C------CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEE
Q 006810 99 T------NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 171 (630)
Q Consensus 99 ~------~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 171 (630)
. ...+++||||+.++++. .......+++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||
T Consensus 82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~-~~~~~kl 158 (318)
T d3blha1 82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKL 158 (318)
T ss_dssp ---------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEE
T ss_pred cccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeec-CCCcEEe
Confidence 2 34589999999999887 5566778999999999999999999999999 99999999999998 7899999
Q ss_pred cccccceeeccC------CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-
Q 006810 172 GDLGLAIVMQQP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS- 242 (630)
Q Consensus 172 ~DFGla~~~~~~------~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~- 242 (630)
+|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.+. +.......+..
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~i~~~ 237 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQL 237 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-CHHHHHHHHHHh
Confidence 999999755421 2334679999999998753 5899999999999999999999999864 34333333222
Q ss_pred --CCCCCCCCC---------------------------CCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 243 --GIKPASLSK---------------------------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 243 --g~~p~~l~~---------------------------~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
...+..... ..++++++||.+||+ +|.+||||.|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 111111100 126788999999998 8999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=414.87 Aligned_cols=258 Identities=30% Similarity=0.426 Sum_probs=208.7
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC-
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~- 100 (630)
...|| ++.+.||+|+||+||+|.++.+|+.||+|+++... ......+++.+|+.+|++++|||||+++++|.....
T Consensus 16 ~~~~Y-~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 16 VRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp CBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred cCCcE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 45788 67789999999999999999999999999997543 345667889999999999999999999999976532
Q ss_pred ---CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccc
Q 006810 101 ---RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 177 (630)
Q Consensus 101 ---~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 177 (630)
..+|+||||+ +++|....+++++++..++.+++||+.||.|||++| |+||||||+|||++ .++.+||+|||++
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~-~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLA 168 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred cccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcc-cccccccccccce
Confidence 3579999999 567776667788999999999999999999999999 99999999999998 8999999999999
Q ss_pred eeeccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-C-----------
Q 006810 178 IVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G----------- 243 (630)
Q Consensus 178 ~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g----------- 243 (630)
+..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+......+...... +
T Consensus 169 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 169 RQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp EECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred eccCCc-cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 876543 345789999999998754 4689999999999999999999999875443333222211 0
Q ss_pred ----------------CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 244 ----------------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 244 ----------------~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
..........++++++||.+||. +|.+||||.|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00112234568999999999998 899999999999999998643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-49 Score=406.03 Aligned_cols=244 Identities=24% Similarity=0.375 Sum_probs=210.0
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||+||+|.++.+|..||+|+++... ...+.+.+|+.+|++|+|||||++|++|.+. ..+
T Consensus 17 ~~~-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~ 88 (287)
T d1opja_ 17 TDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPF 88 (287)
T ss_dssp GGE-EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSC
T ss_pred HHe-EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccEeeC--Cee
Confidence 455 88899999999999999999999999999986432 2245689999999999999999999998655 458
Q ss_pred EEEEcccCCCCHH-HHhh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 104 NMITELFTSGSLR-YRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
++|||||++|+|. ++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+..
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCCTTTC
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEEC-CCCcEEEccccceeec
Confidence 8999999999998 5433 467899999999999999999999999 99999999999998 7899999999999876
Q ss_pred ccCCC---ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 181 QQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 181 ~~~~~---~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
..... ....||+.|||||++. +.|+.++|||||||++|||++|..||....+..+++..+..+..+ ..+...++.
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~ 244 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-ERPEGCPEK 244 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-CCCTTCCHH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC-CCCccchHH
Confidence 54332 2345789999999876 569999999999999999999888877778888888888877554 345567899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhc
Q 006810 257 VKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+++||.+||. +|.+|||+.++++
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999998 8999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-48 Score=406.27 Aligned_cols=254 Identities=21% Similarity=0.367 Sum_probs=210.8
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN 100 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~ 100 (630)
-..|| ++.+.||+|+||+||+|.++.+|..||+|+++... .+++.+|+.+|+++. ||||++++++|.....
T Consensus 33 ~~d~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 33 NQDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp CGGGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCcCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 34567 88899999999999999999999999999986432 356889999999995 9999999999987777
Q ss_pred CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 101 RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
..+++||||+.+|+|... .+.+++..++.+++||+.||.|||++| |+||||||+|||++..++.+||+|||+|...
T Consensus 105 ~~~~~v~e~~~~~~L~~~--~~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQL--YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp CSEEEEEECCCSCBGGGT--TTSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred CceeEEEeecCCCcHHHH--hcCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceec
Confidence 789999999999999743 357999999999999999999999999 9999999999999855667999999999876
Q ss_pred ccC-CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc--------------C
Q 006810 181 QQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------------G 243 (630)
Q Consensus 181 ~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~--------------g 243 (630)
... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||....+.......+.. .
T Consensus 181 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred cCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 543 4456689999999998754 4899999999999999999999999876554332222210 0
Q ss_pred C---------------------CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccCC
Q 006810 244 I---------------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 287 (630)
Q Consensus 244 ~---------------------~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~~ 287 (630)
. .+.......++++++||++||+ +|.+||||+|+|+||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 0 0011122357899999999998 899999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-48 Score=405.51 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=200.8
Q ss_pred ccccCCCCcceeeeeEecccCceEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEe
Q 006810 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 93 (630)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~---~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~ 93 (630)
+....+.++| ++.++||+|+||+||+|.++.+|. .||+|.+... ......+.+.+|+.+|++|+|||||++++
T Consensus 19 f~~~i~~~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g 94 (299)
T d1jpaa_ 19 FAKEIDISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEG 94 (299)
T ss_dssp HSCBCCGGGE-EEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hchhhChhhc-EEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 4444455666 889999999999999999987765 5888877533 24566778999999999999999999999
Q ss_pred EEEcCCCCEEEEEEcccCCCCHH-HHhh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEE
Q 006810 94 SWVDDTNRTINMITELFTSGSLR-YRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 171 (630)
Q Consensus 94 ~f~d~~~~~l~lV~Ey~~gGsL~-~~~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 171 (630)
++.+. ..+++|||||++|+|. ++.. .+.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .+|.+||
T Consensus 95 ~~~~~--~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl 169 (299)
T d1jpaa_ 95 VVTKS--TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKV 169 (299)
T ss_dssp EECSS--SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEE
T ss_pred EEeeC--CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEEC-CCCcEEE
Confidence 98655 4588999999999998 4444 457999999999999999999999999 99999999999998 7899999
Q ss_pred cccccceeeccCC-------CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHc
Q 006810 172 GDLGLAIVMQQPT-------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 242 (630)
Q Consensus 172 ~DFGla~~~~~~~-------~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~ 242 (630)
+|||+++...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~ 248 (299)
T d1jpaa_ 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQ 248 (299)
T ss_dssp CCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHT
T ss_pred CCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHHc
Confidence 9999998654321 11245799999999876 469999999999999999998 8999987 456677777777
Q ss_pred CCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 243 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 243 g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+..++ .+...++.+++||.+||. +|.+|||+.+++++
T Consensus 249 ~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 249 DYRLP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TCCCC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCCC-CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 65443 345678999999999997 89999999998874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=400.51 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=210.4
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~ 101 (630)
|..+| ++.+.||+|+||+||+|.++ ++..||+|+++.... ..+.+.+|+.+|++++|||||++++++.+.
T Consensus 11 ~~~~~-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--- 80 (272)
T d1qpca_ 11 PRETL-KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQE--- 80 (272)
T ss_dssp CGGGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred CHHHe-EEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC-----CHHHHHHHHHHHHhCCCCCEeEEEeeeccC---
Confidence 44566 88999999999999999875 678999999874331 235689999999999999999999987432
Q ss_pred EEEEEEcccCCCCHH-HHh--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 102 TINMITELFTSGSLR-YRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~-~~~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.+++||||+++|+|. ++. ....+++..+..++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|+
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLAR 157 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeee-cccceeeccccceE
Confidence 468999999999997 332 3346999999999999999999999999 99999999999998 78999999999998
Q ss_pred eeccCC---CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 179 VMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 179 ~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
...... .....||+.|||||++. +.|+.++|||||||++|||+||..|+....+..++...+..+..+. .+...+
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~ 236 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCP 236 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCC
T ss_pred EccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CcccCh
Confidence 765432 33457899999999886 4699999999999999999997666656677888888888775543 355678
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhc--CCCccc
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLK--DPFLVT 285 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~--hpf~~~ 285 (630)
+++++||.+||. +|.+|||+.++++ |+||..
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999997 8999999999988 788753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=409.12 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=205.7
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCC-----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV 96 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG-----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~ 96 (630)
..+| ++.++||+|+||+||+|.+..++ ..||+|.+.... .......+.+|+.+|+++ +|||||+++++|.
T Consensus 36 ~~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 36 RENL-EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GGGE-EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHe-EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 3455 78899999999999999987654 379999886432 233456788999999998 8999999999987
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEe
Q 006810 97 DDTNRTINMITELFTSGSLR-YRKKH-----------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIH 152 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~~~-----------------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiH 152 (630)
+.. .+++|||||++|+|. ++... ..+++..++.++.||+.||+|||+++ |+|
T Consensus 112 ~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiH 187 (325)
T d1rjba_ 112 LSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 187 (325)
T ss_dssp SSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred eCC--eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 654 588999999999998 55433 34899999999999999999999999 999
Q ss_pred ccCCcCceEEeCCCCcEEEcccccceeeccCCC----ccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCC
Q 006810 153 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYP 226 (630)
Q Consensus 153 rDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~----~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~P 226 (630)
|||||+|||++ .+|.+||+|||+|+....... ....||+.|||||++. +.|+.++|||||||++|||+| |+.|
T Consensus 188 RDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 188 RDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp TTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ccCchhccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 99999999998 789999999999976554322 3456899999999775 569999999999999999998 8999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 227 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 227 f~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
|.+......+.+.+..+..+ ..+...++++++||.+||+ +|.+|||+.||++|
T Consensus 267 f~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 98876767777777766543 4556778999999999997 89999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=408.96 Aligned_cols=251 Identities=22% Similarity=0.369 Sum_probs=206.2
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC----CC
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----TN 100 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~----~~ 100 (630)
+| +..++||+|+||+||+|.+..+|+.||+|++...... ..+|+.+|++|+|||||+++++|... ..
T Consensus 21 ~Y-~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred Cc-EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 45 6678999999999999999999999999999754422 34799999999999999999998653 34
Q ss_pred CEEEEEEcccCCCCHH----HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 101 RTINMITELFTSGSLR----YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~----~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
.++++|||||++|++. +......+++..++.|++||+.||+|||++| |+||||||+|||++.++..+||+|||+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccc
Confidence 5789999999988654 2345668999999999999999999999999 999999999999984445899999999
Q ss_pred ceeeccC-CCccccCCCCCCCccccc--cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc-C---------
Q 006810 177 AIVMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G--------- 243 (630)
Q Consensus 177 a~~~~~~-~~~~~~GTp~Y~APEvl~--~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~-g--------- 243 (630)
+...... ...+.+||+.|+|||++. ..|+.++|||||||++|||++|++||.......++...+.. +
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 9876543 345678999999999764 35899999999999999999999999876555554443321 0
Q ss_pred --------CCC--------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 244 --------IKP--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 244 --------~~p--------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
..+ .......++++++||.+||. +|.+||||.|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000 01123468899999999998 89999999999999999763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=394.50 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=215.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.|| ++.+.||+|+||+||+|.++.+|..||||+++.... ......++.+|+.+|+.++||||++++++|.+. ..+
T Consensus 2 ~ry-~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~ 76 (292)
T d1unla_ 2 QKY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKL 76 (292)
T ss_dssp CSE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred CCC-EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeeccccccc--cce
Confidence 477 778999999999999999999999999999976542 345667899999999999999999999999765 468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
++|++++.+++|. +...++.+++..++.+++|++.||+|||+++ |+||||||+|||++ .++.+||+|||.+.....
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccc-cCCceeeeecchhhcccC
Confidence 8999999999998 6677889999999999999999999999999 99999999999998 788999999999987654
Q ss_pred CC--CccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC--------------
Q 006810 183 PT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-------------- 244 (630)
Q Consensus 183 ~~--~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~-------------- 244 (630)
.. .....+++.|+|||++.. .++.++|||||||++|||++|+.||....+..+.+..+....
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 32 334467889999998764 368999999999999999999999877677776666553210
Q ss_pred -------------CCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 245 -------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 245 -------------~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
.........++.+++||.+||+ +|.+||||.|+|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0111233457899999999998 8999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=398.28 Aligned_cols=246 Identities=20% Similarity=0.390 Sum_probs=207.3
Q ss_pred eeeeE-ecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 28 RYDEI-LGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 28 r~~e~-LG~G~fg~Vy~A~d~--~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
.+.++ ||+|+||+||+|.++ .++..||+|+++.. ......+++.+|+.+|++++|||||++++++.++ .+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~ 84 (285)
T d1u59a_ 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALM 84 (285)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEE
T ss_pred EECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---eEE
Confidence 55664 999999999999875 45668999998643 2456678899999999999999999999988543 478
Q ss_pred EEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 105 MITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+||||+++|+|. ++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeec-cCCceeeccchhhhcccc
Confidence 999999999998 544 4567999999999999999999999999 99999999999998 789999999999987643
Q ss_pred CC-----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006810 183 PT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 255 (630)
Q Consensus 183 ~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 255 (630)
.. .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.. ..++...+..+..+ ..+...++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-~~~~~~~i~~~~~~-~~p~~~~~ 239 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRM-ECPPECPP 239 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHHHTTCCC-CCCTTCCH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC-CCCCcCCH
Confidence 32 23456899999999876 569999999999999999998 899998754 55667777777554 34566789
Q ss_pred HHHHHHHHccc-CCCCCCCHHHH---hcCCCcc
Q 006810 256 QVKQFIEKCIV-PASLRLPALEL---LKDPFLV 284 (630)
Q Consensus 256 ~lk~~I~kcL~-~p~~Rpsa~eL---L~hpf~~ 284 (630)
++.+||.+||. +|.+|||+.++ |+|+|+.
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999998 89999999877 6777764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=393.25 Aligned_cols=243 Identities=19% Similarity=0.378 Sum_probs=196.7
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~ 104 (630)
+| ++.+.||+|+||+||+|.+. ++..||+|+++.... ..+.+.+|+.++++++|||||++++++.+.. .++
T Consensus 6 ~~-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~~ 76 (263)
T d1sm2a_ 6 EL-TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PIC 76 (263)
T ss_dssp CE-EEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred Hc-EEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC-----cHHHHHHHHHHHHhcCCCCcccccceeccCC--ceE
Confidence 35 78899999999999999876 678899999874322 2246889999999999999999999987654 588
Q ss_pred EEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeecc
Q 006810 105 MITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 182 (630)
Q Consensus 105 lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 182 (630)
+||||+++|+|. ++. ....+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEEC-GGGCEEECSCC-------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeec-CCCCeEecccchheeccC
Confidence 999999999998 544 4467899999999999999999999999 99999999999998 789999999999976644
Q ss_pred CC---CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006810 183 PT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 258 (630)
Q Consensus 183 ~~---~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk 258 (630)
.. .....||+.|||||++.+ .|+.++|||||||++|||+|+..|+....+..++...+..+..+ ..+...++++.
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~~p~~~~~~l~ 232 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVY 232 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-CCCTTSCHHHH
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-CCccccCHHHH
Confidence 32 234578999999998874 69999999999999999999654544556777888888777544 34566789999
Q ss_pred HHHHHccc-CCCCCCCHHHHhcC
Q 006810 259 QFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 259 ~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+||.+||+ +|.+|||+.++|+|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999998 89999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=392.25 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=204.4
Q ss_pred ccCCCCcceeeeeEecccCceEEEEEEEccCC----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeE
Q 006810 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (630)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~ 94 (630)
|.+|+ .| ++.++||+|+||+||+|.+..++ ..||+|.++... .......+.+|+.+|++|+|||||+++++
T Consensus 3 ei~~~-~~-~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPS-CV-TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTT-TE-EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHH-He-EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 44554 45 67899999999999999987655 579999986432 35566778999999999999999999999
Q ss_pred EEcCCCCEEEEEEcccCCCCHH-HH-hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEc
Q 006810 95 WVDDTNRTINMITELFTSGSLR-YR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 172 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~-~~-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 172 (630)
+.+. ..+++||||+.+|++. .. ...+.+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+
T Consensus 78 ~~~~--~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl~ 152 (283)
T d1mqba_ 78 ISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVS 152 (283)
T ss_dssp ECSS--SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEEC
T ss_pred EecC--CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEEC-CCCeEEEc
Confidence 8654 4588999999999997 33 45578999999999999999999999999 99999999999998 78999999
Q ss_pred ccccceeeccCC-----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC
Q 006810 173 DLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 246 (630)
Q Consensus 173 DFGla~~~~~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p 246 (630)
|||+++...... .....||+.|||||++.+ .|+.++|||||||++|||+||..||....+..+++..+..+..+
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC
Confidence 999997654321 223468999999998764 58999999999999999999777776667888888888887655
Q ss_pred CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 247 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 247 ~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+ .+...++.++++|.+||. +|.+|||+.|+++
T Consensus 233 ~-~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 P-TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp C-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C-CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 4 445678999999999997 8999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=404.74 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=204.1
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC--C
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--R 101 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~--~ 101 (630)
.|| ++.+.||+|+||+||+|.+..+|+.||+|++.... .....+++.+|+.+|++|+||||+++++++..... .
T Consensus 8 ~rY-~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 8 PRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp TTE-EEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCe-EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 477 78899999999999999999999999999997433 35566789999999999999999999999865432 1
Q ss_pred EEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 102 TINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
..+++++|+.+|+|......+++++..++.++.||+.||+|||+++ ||||||||+|||++ .+|.+||+|||++....
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVAD 160 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred ceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEEC-CCCCEEEcccCceeecc
Confidence 2334456677999984445568999999999999999999999999 99999999999998 78999999999997654
Q ss_pred cC-----CCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCC--------
Q 006810 182 QP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------- 246 (630)
Q Consensus 182 ~~-----~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-------- 246 (630)
.. .....+||+.|+|||++.. .|+.++||||+||++|+|++|+.||.......+....+.....+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 32 2345679999999998743 47899999999999999999999998754433333322110000
Q ss_pred --------------------CCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 --------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 --------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
.......++++++||.+||+ +|.+||||.|+|+||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 01123457899999999998 89999999999999999854
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=408.46 Aligned_cols=267 Identities=21% Similarity=0.358 Sum_probs=218.0
Q ss_pred CcceeeeeEecccCceEEEEEEE---ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCeeEEEeEEEcCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFD---EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDT 99 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d---~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pNIVk~~~~f~d~~ 99 (630)
.+| ++.+.||+|+||+||+|.+ +.+|..||+|+++...........+.+.+|+.+|++++| |||++++++|.+.
T Consensus 24 ~~y-~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~- 101 (322)
T d1vzoa_ 24 ENF-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 101 (322)
T ss_dssp GGE-EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred hce-EEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence 345 8889999999999999987 447999999999765433222334568899999999977 8999999998765
Q ss_pred CCEEEEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 100 NRTINMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
..+++||||+.+|+|. ++...+.+++..++.+++||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.
T Consensus 102 -~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 102 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSK 177 (322)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEE
T ss_pred -CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeec-CCCCEEEeeccchh
Confidence 4689999999999998 7888889999999999999999999999999 99999999999998 78999999999997
Q ss_pred eeccC---CCccccCCCCCCCcccccc---ccCcccceeehhHHHHHHhhCCCCCCCCC---CHHHHHHHHHcCCCCCCC
Q 006810 179 VMQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASL 249 (630)
Q Consensus 179 ~~~~~---~~~~~~GTp~Y~APEvl~~---~ys~~sDIWSLGvil~ELltG~~Pf~~~~---~~~~i~~~i~~g~~p~~l 249 (630)
..... ......|++.|+|||.+.+ .++.++|||||||++|+|+||+.||.... ....+....... ...+
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~--~~~~ 255 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPY 255 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--CCCC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC--CCCC
Confidence 65432 2345679999999998753 36889999999999999999999997643 233444444333 2334
Q ss_pred CCCCcHHHHHHHHHccc-CCCCCC-----CHHHHhcCCCcccCCCCccccCCCCC
Q 006810 250 SKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRL 298 (630)
Q Consensus 250 ~~~~s~~lk~~I~kcL~-~p~~Rp-----sa~eLL~hpf~~~~~~~~~~~~~l~~ 298 (630)
+...++++++||.+||+ +|.+|| ++.|+|+||||+..++..+....++.
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~ 310 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCc
Confidence 56689999999999998 899999 48999999999987766655444443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=387.79 Aligned_cols=240 Identities=23% Similarity=0.418 Sum_probs=206.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||+||+|.++ ++..||+|.++.... . .+.+.+|+.++++++||||+++|+++.++ ..+++||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~iv~ 78 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--S---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFIIT 78 (258)
T ss_dssp CCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS--C---HHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEEEEE
T ss_pred EEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC--C---HHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEEE
Confidence 67899999999999999975 788999999985432 1 24588999999999999999999998654 4589999
Q ss_pred cccCCCCHH-H-HhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC-
Q 006810 108 ELFTSGSLR-Y-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 184 (630)
Q Consensus 108 Ey~~gGsL~-~-~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 184 (630)
||+++|+|. + ......+++..+++|+.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+++......
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSSSSC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEc-CCCcEEECcchhheeccCCCc
Confidence 999999987 4 455677999999999999999999999998 99999999999998 78999999999997654332
Q ss_pred --CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006810 185 --ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 260 (630)
Q Consensus 185 --~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~ 260 (630)
.....||+.|+|||++. ..|+.++|||||||++|||+| |+.||... +..++...+..+..+ ..+...++.+++|
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l~~l 233 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRL-YRPHLASEKVYTI 233 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC-CHHHHHHHHHhCCCC-CCcccccHHHHHH
Confidence 23456899999999876 469999999999999999998 89999874 566777778776544 3556788999999
Q ss_pred HHHccc-CCCCCCCHHHHhcC
Q 006810 261 IEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 261 I~kcL~-~p~~Rpsa~eLL~h 280 (630)
|.+||+ +|.+|||+.++|+|
T Consensus 234 i~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 234 MYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHHH
Confidence 999998 79999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=389.46 Aligned_cols=247 Identities=24% Similarity=0.429 Sum_probs=198.9
Q ss_pred CCCcceeeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~t---G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~ 98 (630)
|..+| ++.+.||+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.+|++++|||||++++++.+
T Consensus 5 ~~~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 79 (273)
T d1mp8a_ 5 QRERI-ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 79 (273)
T ss_dssp CGGGE-EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred CHHHe-EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 34566 8899999999999999988654 467888887532 245667789999999999999999999998843
Q ss_pred CCCEEEEEEcccCCCCHH-H-HhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 99 TNRTINMITELFTSGSLR-Y-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~-~-~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
..+++||||+++|+|. + ....+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 80 --~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~-~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 --NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGL 154 (273)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC---
T ss_pred --CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeec-CCCcEEEccchh
Confidence 3578999999999997 4 345667999999999999999999999999 99999999999998 789999999999
Q ss_pred ceeeccC---CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006810 177 AIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 251 (630)
Q Consensus 177 a~~~~~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 251 (630)
++..... ......||+.|+|||++. +.|+.++|||||||++|||+| |.+||.. .+..+++..+..+..+ .++.
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~ 232 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPP 232 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCT
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCC
Confidence 9765432 223456899999999886 469999999999999999998 8899977 4566677777776544 4566
Q ss_pred CCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 252 VTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 252 ~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..++.+++||.+||. +|.+|||+.|+++|
T Consensus 233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 778999999999998 89999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=390.34 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=205.6
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
.+| ++.+.||+|+||+||+|.+..+ ..||+|+++.... . .+.+.+|+.+|++++|||||++|+++.++ .+
T Consensus 17 ~~~-~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~--~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~~---~~ 86 (285)
T d1fmka3 17 ESL-RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--S---PEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PI 86 (285)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SC
T ss_pred HHE-EEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC--C---HHHHHHHHHHHHhcccCCEeEEEEEEecC---Ce
Confidence 456 8999999999999999988754 6799999874432 2 25689999999999999999999987432 36
Q ss_pred EEEEcccCCCCHH-HH--hhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 104 NMITELFTSGSLR-YR--KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~--~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
++||||+++|+|. ++ ...+.+++..+..++.||+.||+|||+++ |+||||||+||||+ .+|.+||+|||+++..
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~-~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLI 163 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC--
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEEC-CCCcEEEcccchhhhc
Confidence 8999999999987 33 33567999999999999999999999999 99999999999998 7899999999999765
Q ss_pred ccC---CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006810 181 QQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 256 (630)
Q Consensus 181 ~~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 256 (630)
... ......||+.|+|||++. +.++.++|||||||++|||+||..||.......++...+..+..++ .+...+++
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 242 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPES 242 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHH
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccCHH
Confidence 432 223457899999999876 4689999999999999999998777766677888888888775543 55677899
Q ss_pred HHHHHHHccc-CCCCCCCHHHHhc--CCCcccC
Q 006810 257 VKQFIEKCIV-PASLRLPALELLK--DPFLVTD 286 (630)
Q Consensus 257 lk~~I~kcL~-~p~~Rpsa~eLL~--hpf~~~~ 286 (630)
+++||.+||+ +|.+||++.+++. ++||...
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999997 8999999999987 8888753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=403.33 Aligned_cols=254 Identities=28% Similarity=0.386 Sum_probs=199.1
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcC----C
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----T 99 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~----~ 99 (630)
.|| ++.++||+|+||+||+|.++.+|..||+|++.... .+.....++.+|+.+|++++|||||+++++|... .
T Consensus 17 ~~Y-~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTE-EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCe-EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh--cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 577 88899999999999999999999999999997543 2456677899999999999999999999999654 2
Q ss_pred CCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEccccccee
Q 006810 100 NRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 179 (630)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 179 (630)
...+|+||||+.+|++... ...+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+|++|||+++.
T Consensus 94 ~~~~~iv~Ey~~~~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~-~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLART 168 (355)
T ss_dssp CCEEEEEEECCSEEHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC---
T ss_pred CceeEEEEeccchHHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccc-cccceeeechhhhhc
Confidence 3689999999998887744 457999999999999999999999999 99999999999998 788999999999876
Q ss_pred eccC-CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHc---------------
Q 006810 180 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------------- 242 (630)
Q Consensus 180 ~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~--------------- 242 (630)
.... .....+||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.....+....+..
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred cccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 5543 3455679999999998765 5899999999999999999999999875433332222210
Q ss_pred ------CCCCC-----------CC-------CCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCccc
Q 006810 243 ------GIKPA-----------SL-------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 285 (630)
Q Consensus 243 ------g~~p~-----------~l-------~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~ 285 (630)
...+. .. ....++++++||.+||. +|.+||||+|+|+||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 00000 00 01125678999999998 8999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=402.08 Aligned_cols=255 Identities=29% Similarity=0.411 Sum_probs=205.3
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCC---C
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---N 100 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~---~ 100 (630)
.|| ++.+.||+|+||+||+|.++.+|+.||+|++.... .+....+++.+|+.+|++|+|||||+++++|.... .
T Consensus 18 ~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 18 ERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp TTE-EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCe-EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 578 77899999999999999999999999999997543 34556678999999999999999999999986432 2
Q ss_pred CEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 101 RTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
...++|++|+.+|+|..+...+++++..++.+++||+.||.|||++| |+||||||+|||++ .+|.+|++|||++...
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHT 171 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC----CC
T ss_pred CceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccc-ccccccccccchhccc
Confidence 23456678889999985556678999999999999999999999999 99999999999998 7899999999999765
Q ss_pred ccCCCccccCCCCCCCcccccc--ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CCC-----------
Q 006810 181 QQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKP----------- 246 (630)
Q Consensus 181 ~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g-~~p----------- 246 (630)
... ..+..||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.... .....+... ..+
T Consensus 172 ~~~-~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 172 DDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp TGG-GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred Ccc-cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChHHhhhccch
Confidence 443 345678999999997654 3688999999999999999999999874333 333222211 000
Q ss_pred ---------C--------CCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcCCCcccC
Q 006810 247 ---------A--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 286 (630)
Q Consensus 247 ---------~--------~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~hpf~~~~ 286 (630)
. ......++++++||.+||. +|.+||||.|+|+||||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0 0113467899999999998 89999999999999999863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=393.39 Aligned_cols=244 Identities=27% Similarity=0.437 Sum_probs=199.9
Q ss_pred eeeeeEecccCceEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG~----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~ 102 (630)
|++.++||+|+||+||+|.+..+|. +||+|.++... .....+.+.+|+.+|++++|||||++++++.+. .
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~ 84 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 84 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 4888999999999999999988876 57888775332 233456799999999999999999999998754 3
Q ss_pred EEEEEcccCCCCHH--HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceee
Q 006810 103 INMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 180 (630)
Q Consensus 103 l~lV~Ey~~gGsL~--~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 180 (630)
.++++||+.+|+|. .......+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~-~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeC-CCCCeEeeccccceec
Confidence 67888999999987 3445678999999999999999999999999 99999999999998 7899999999999765
Q ss_pred ccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 181 QQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 181 ~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
.... .....||+.|||||++. +.|+.++|||||||++|||+| |.+||.+ .+..++...+..+..+ ..+...+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~p~~~~ 239 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICT 239 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCC-CCCTTBC
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccC
Confidence 4322 23346899999999776 468999999999999999999 7888876 4566677777777554 3445678
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcCC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKDP 281 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~hp 281 (630)
+.++++|.+||. +|.+|||+.|++.|.
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 999999999997 899999999999883
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=389.04 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=199.7
Q ss_pred CCCcceeeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~~-----tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f 95 (630)
|..+| ++.+.||+|+||.||+|.+.. +++.||+|+++... .....+.+.+|+.++.++ +|||||.+++++
T Consensus 11 ~~~~y-~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 11 PRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp CGGGE-EEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHE-EEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 34566 889999999999999998754 45789999986432 345566788888888776 689999999987
Q ss_pred EcCCCCEEEEEEcccCCCCHH-HHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcC
Q 006810 96 VDDTNRTINMITELFTSGSLR-YRKK----------------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 158 (630)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~-~~~~----------------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~ 158 (630)
.... ..+++|||||++|+|. ++.. ...+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 87 ~~~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR 163 (299)
T ss_dssp CSTT-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred ccCC-CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCcc
Confidence 6543 4688999999999998 5433 235899999999999999999999999 999999999
Q ss_pred ceEEeCCCCcEEEcccccceeeccC----CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhC-CCCCCCCCC
Q 006810 159 NIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTC-EYPYNECKN 232 (630)
Q Consensus 159 NILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG-~~Pf~~~~~ 232 (630)
|||++ .+|.+||+|||+|+..... ......||+.|||||++.+ .|+.++|||||||++|||+|| .+||.+...
T Consensus 164 NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 164 NILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GEEEC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceeEC-CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 99998 7899999999999765432 2334679999999998764 589999999999999999986 568887767
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 233 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 233 ~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
...+...+..+..+ ..+...++++++||.+||. +|.+|||+.|+++|
T Consensus 243 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 243 DEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp SHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77777778777655 3456678999999999997 89999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=379.72 Aligned_cols=245 Identities=27% Similarity=0.410 Sum_probs=193.1
Q ss_pred eeeeeEecccCceEEEEEEEcc-C--CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEV-D--GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~-t--G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
+++.+.||+|+||.||+|.... + +..||+|+++.... ......+.+.+|+.+|++++|||||++|+++.+. .+
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~~ 85 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---PM 85 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SC
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---ch
Confidence 4889999999999999998643 3 35799999875543 3345567899999999999999999999988543 46
Q ss_pred EEEEcccCCCCHH--HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~--~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++||||+++|++. .....+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~-~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccc-cccceeeccchhhhhcc
Confidence 8999999999987 3445567999999999999999999999999 99999999999998 68899999999998764
Q ss_pred cCC-----CccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 182 QPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 182 ~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
... .....|++.|+|||++.+ .|+.++|||||||++|||+| |+.||.+ .+..++...+.........+...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCccccc
Confidence 432 223457889999998865 58899999999999999998 8999987 455566666655444344556778
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
+.++++|.+||. +|.+|||+.+++.
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999997 8999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-45 Score=383.20 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=207.2
Q ss_pred CCCcceeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEE
Q 006810 22 PSCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (630)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~A~d~-----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~ 96 (630)
|..+| .+.+.||+|+||+||+|.++ .++..||+|+++.. ...+..+++.+|+.+|++++||||++++++|.
T Consensus 11 p~~~~-~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGC-EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHc-EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh---cChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 66777 88899999999999999875 36789999998643 24556678999999999999999999999986
Q ss_pred cCCCCEEEEEEcccCCCCHH-HHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEE
Q 006810 97 DDTNRTINMITELFTSGSLR-YRKKH------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPII 151 (630)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~-~~~~~------------------------~~lse~~i~~i~~QIl~gL~yLHs~~~~Ii 151 (630)
+. ..+++||||+++|+|. ++... ..+++..+..++.||+.||+|||+++ ||
T Consensus 87 ~~--~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iv 162 (301)
T d1lufa_ 87 VG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 162 (301)
T ss_dssp SS--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred cC--CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eE
Confidence 54 3578899999999997 44332 24889999999999999999999999 99
Q ss_pred eccCCcCceEEeCCCCcEEEcccccceeeccC----CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCC-C
Q 006810 152 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCE-Y 225 (630)
Q Consensus 152 HrDLKp~NILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~-~ 225 (630)
||||||+|||++ .++.+||+|||+++..... ...+..||+.|+|||++.+ .|+.++|||||||++|||++|. +
T Consensus 163 HrDlKp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 163 HRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eeEEcccceEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999998 7899999999999755332 2234578999999998765 6999999999999999999996 5
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 226 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 226 Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
||.+ .+..++...+..+..+ ..+...++++.+||.+||. +|.+|||+.|+++
T Consensus 242 p~~~-~~~~e~~~~v~~~~~~-~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 242 PYYG-MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-CCHHHHHHHHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6665 6777788888877654 3456678999999999998 8999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=382.74 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=202.9
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeE--EEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeEEEcCCC
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 100 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~--VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~f~d~~~ 100 (630)
..| ++.++||+|+||+||+|.++.+|.. ||+|.++... ..+..+.+.+|+.+|+++ +|||||++|++|.+.
T Consensus 10 ~~~-~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-- 83 (309)
T d1fvra_ 10 NDI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-- 83 (309)
T ss_dssp GGC-EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--
T ss_pred HHc-EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--
Confidence 344 7889999999999999999999875 6677765322 234556799999999999 799999999999765
Q ss_pred CEEEEEEcccCCCCHH-HHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEe
Q 006810 101 RTINMITELFTSGSLR-YRKK----------------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 163 (630)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-~~~~----------------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 163 (630)
..+++||||+++|+|. ++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG 161 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc
Confidence 4699999999999998 5433 367999999999999999999999998 99999999999998
Q ss_pred CCCCcEEEcccccceeeccC-CCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCC-CCCCCCCHHHHHHHH
Q 006810 164 GNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKV 240 (630)
Q Consensus 164 ~~~g~vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~-Pf~~~~~~~~i~~~i 240 (630)
.++.+||+|||+++..... ......||+.|+|||.+. +.|+.++|||||||++|||++|.. ||.+ .+..+++..+
T Consensus 162 -~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i 239 (309)
T d1fvra_ 162 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKL 239 (309)
T ss_dssp -GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHG
T ss_pred -CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-CCHHHHHHHH
Confidence 7889999999999765433 233557899999999875 569999999999999999999765 5654 6788888888
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 241 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 241 ~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
..+..+. .+...++++++||.+||. +|.+|||+.++|+|
T Consensus 240 ~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 240 PQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8776543 455678999999999998 89999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=379.94 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=204.3
Q ss_pred CCCCcceeeeeEecccCceEEEEEEEccCC-------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEE
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDG-------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 92 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d~~tG-------~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~ 92 (630)
-|..+| ++.+.||+|+||.||+|.+..++ ..||+|.++... .......+.+|+..+.++ +|||||+++
T Consensus 10 i~~~~~-~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 10 LPRDRL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp CCGGGE-EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccHHHe-EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 345677 78899999999999999876554 479999986432 355667788999999888 899999999
Q ss_pred eEEEcCCCCEEEEEEcccCCCCHH-HHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccC
Q 006810 93 NSWVDDTNRTINMITELFTSGSLR-YRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 155 (630)
Q Consensus 93 ~~f~d~~~~~l~lV~Ey~~gGsL~-~~~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 155 (630)
++|.++ ..+++||||+++|+|. ++... ..+++..++.|+.||+.||.|||+++ ||||||
T Consensus 86 ~~~~~~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDi 161 (299)
T d1fgka_ 86 GACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDL 161 (299)
T ss_dssp EEECSS--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred cccccC--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeee
Confidence 999754 4689999999999998 55433 35899999999999999999999999 999999
Q ss_pred CcCceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCC
Q 006810 156 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNE 229 (630)
Q Consensus 156 Kp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~ 229 (630)
||+|||++ .+|.+||+|||+++...... .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+
T Consensus 162 Kp~NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 162 AARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp SGGGEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cccceeec-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 99999998 78999999999998664432 33467899999999775 569999999999999999998 6788865
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 230 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 230 ~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
.+..+++..+..+..+ ..+...++.+++||.+||+ +|.+|||+.|+|+
T Consensus 241 -~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 241 -VPVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp -CCHHHHHHHHHTTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCHHHHHHHHHcCCCC-CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 6777888888877554 4456778999999999998 8999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=380.69 Aligned_cols=246 Identities=22% Similarity=0.363 Sum_probs=203.2
Q ss_pred eeeeeEecccCceEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 27 GRYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~A~d~~tG---~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
..+.++||+|+||+||+|.+..++ ..||+|.++.. ......+++.+|+.+|++|+|||||++++++.+.. ..+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~ 104 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSP 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-Cce
Confidence 345789999999999999986543 46999998632 35667788999999999999999999999987644 468
Q ss_pred EEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeec
Q 006810 104 NMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 181 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 181 (630)
++|||||++|+|. +.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMY 181 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSSGGGCCTT
T ss_pred EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeEC-CCCCEEEecccchhhcc
Confidence 8999999999998 333 4556788999999999999999999999 99999999999998 78999999999997654
Q ss_pred cCC------CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006810 182 QPT------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 254 (630)
Q Consensus 182 ~~~------~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 254 (630)
... .....||+.|+|||.+. +.++.++|||||||++|||+||..||....+..++...+..+..+. .+...+
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~p~~~~ 260 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCP 260 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-CCTTCC
T ss_pred ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-CcccCc
Confidence 321 22356899999999776 5699999999999999999998888877667777777787775543 456678
Q ss_pred HHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 255 PQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 255 ~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
+.+.+||.+||. +|.+||++.|+++|
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999997 89999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=376.24 Aligned_cols=238 Identities=22% Similarity=0.422 Sum_probs=195.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l~lV~ 107 (630)
++.+.||+|+||+||+|.+ .|.+||+|+++.+. ..+.+.+|+++|++++||||+++++++.+.. ..+++||
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~ 80 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVT 80 (262)
T ss_dssp EEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEE
T ss_pred EEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEEEE
Confidence 7889999999999999987 48899999986432 3356889999999999999999999886543 3479999
Q ss_pred cccCCCCHH-HHhhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcccccceeeccCC
Q 006810 108 ELFTSGSLR-YRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 184 (630)
Q Consensus 108 Ey~~gGsL~-~~~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 184 (630)
||+++|+|. ++.+. ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC--------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheec-CCCCEeecccccceecCCC-
Confidence 999999998 55433 45899999999999999999999998 99999999999998 7899999999999865443
Q ss_pred CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006810 185 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 262 (630)
Q Consensus 185 ~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~ 262 (630)
.....+|+.|+|||++. +.|+.++|||||||++|||+| |++||.. .+..++...+..+..+. ++...++.+++||.
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~ 234 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYEVMK 234 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHHHHH
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHH
Confidence 34457899999999875 569999999999999999998 6777765 56777888887776554 45667899999999
Q ss_pred Hccc-CCCCCCCHHHHhcC
Q 006810 263 KCIV-PASLRLPALELLKD 280 (630)
Q Consensus 263 kcL~-~p~~Rpsa~eLL~h 280 (630)
+||. +|.+|||+.+++++
T Consensus 235 ~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 235 NCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcccCHhHCcCHHHHHHH
Confidence 9998 89999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=376.97 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=208.0
Q ss_pred CCCCcceeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEeE
Q 006810 21 DPSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (630)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~A~d-----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L-~HpNIVk~~~~ 94 (630)
-|..+| +++++||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+++.+ +|||||+++++
T Consensus 20 ~~~~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 20 FPRNRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp CCGGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHe-EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 455677 7899999999999999975 3577899999997543 355667799999999999 79999999999
Q ss_pred EEcCCCCEEEEEEcccCCCCHH-HHhhc------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccC
Q 006810 95 WVDDTNRTINMITELFTSGSLR-YRKKH------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 155 (630)
Q Consensus 95 f~d~~~~~l~lV~Ey~~gGsL~-~~~~~------------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 155 (630)
+.+.. .+++|||||++|+|. ++... ..+++..+..++.||+.||+|||+++ ++||||
T Consensus 96 ~~~~~--~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDL 171 (311)
T d1t46a_ 96 CTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDL 171 (311)
T ss_dssp ECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EeeCC--EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccc
Confidence 86553 488999999999998 54433 25899999999999999999999999 999999
Q ss_pred CcCceEEeCCCCcEEEcccccceeeccCC----CccccCCCCCCCccccc-cccCcccceeehhHHHHHHhh-CCCCCCC
Q 006810 156 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNE 229 (630)
Q Consensus 156 Kp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELlt-G~~Pf~~ 229 (630)
||+||+++ .++.+||+|||+++...... ....+||+.|+|||++. +.++.++|||||||++|||+| |.+||..
T Consensus 172 Kp~NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 172 AARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (311)
T ss_dssp SGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccccccc-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC
Confidence 99999998 78999999999998654322 23457899999999876 468999999999999999999 5666666
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 230 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 230 ~~~~~~i~~~i~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
......+.+.+..+..+ ..+...++.+++||.+||. +|.+|||+.++|+
T Consensus 251 ~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 251 MPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHhcCCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 55556666677666544 3455678999999999997 8999999999886
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=374.66 Aligned_cols=246 Identities=23% Similarity=0.389 Sum_probs=205.8
Q ss_pred CCcceeeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEc
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~-----tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d 97 (630)
..+| ++.+.||+|+||+||+|.+.. ++..||+|+++... .......+.+|+.++++++|||||++++++..
T Consensus 19 ~~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 19 REKI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp GGGE-EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred HHHe-EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3577 788999999999999998753 46799999986432 45566779999999999999999999999865
Q ss_pred CCCCEEEEEEcccCCCCHH-HHhh----------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCC
Q 006810 98 DTNRTINMITELFTSGSLR-YRKK----------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 166 (630)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~-~~~~----------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~ 166 (630)
.. .+++||||+.+|+|. ++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .+
T Consensus 95 ~~--~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld-~~ 169 (308)
T d1p4oa_ 95 GQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-ED 169 (308)
T ss_dssp SS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TT
T ss_pred CC--ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeec-CC
Confidence 44 578999999999997 4332 135789999999999999999999998 99999999999998 78
Q ss_pred CcEEEcccccceeeccC----CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCC-CCCCCCCCHHHHHHHH
Q 006810 167 GEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCE-YPYNECKNPAQIYKKV 240 (630)
Q Consensus 167 g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~-~Pf~~~~~~~~i~~~i 240 (630)
+.+||+|||+++..... ......||+.|+|||.+.+ .|+.++|||||||++|||+||. .||.+ .+..+++..+
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i 248 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFV 248 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Confidence 99999999999765432 2234468999999998764 5889999999999999999985 66655 6777777777
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHhc
Q 006810 241 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 279 (630)
Q Consensus 241 ~~g~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL~ 279 (630)
..+..+. .+...++.++++|.+||+ +|.+|||+.++++
T Consensus 249 ~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 249 MEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7765543 445678999999999998 8999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-44 Score=370.00 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=196.1
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCCCEE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~~~l 103 (630)
+|| ++.+.||+|+||+||+|.+..+|+.||+|++...... ..+.+|+++++.++|+|+|..+..+... ....
T Consensus 7 ~rY-~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~ 78 (299)
T d1ckia_ 7 NRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYN 78 (299)
T ss_dssp TTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEE
T ss_pred CEE-EEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEec-CCEE
Confidence 577 8899999999999999999999999999998764322 2377899999999888766655544333 3468
Q ss_pred EEEEcccCCCCHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC--CCCcEEEcccccceee
Q 006810 104 NMITELFTSGSLR-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVM 180 (630)
Q Consensus 104 ~lV~Ey~~gGsL~-~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGla~~~ 180 (630)
++||||+.++.+. .....+.+++..+..++.||+.||+|||+++ |+||||||+|||++. .+..+||+|||+|+..
T Consensus 79 ~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 79 VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 8999999766665 4455678999999999999999999999999 999999999999852 3457999999999876
Q ss_pred ccC---------CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCCCHHHHHH--HHHc---CCC
Q 006810 181 QQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTS---GIK 245 (630)
Q Consensus 181 ~~~---------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~~~i~~--~i~~---g~~ 245 (630)
... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||........... .... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 432 1235679999999998876 489999999999999999999999986443322211 1111 112
Q ss_pred CCCCCCCCcHHHHHHHHHccc-CCCCCCCHH---HHhcCCCcc
Q 006810 246 PASLSKVTDPQVKQFIEKCIV-PASLRLPAL---ELLKDPFLV 284 (630)
Q Consensus 246 p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~---eLL~hpf~~ 284 (630)
+..+....++++.+||.+||. +|.+||++. ++|+|+|.+
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 223445678999999999997 899999987 457777654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=365.74 Aligned_cols=248 Identities=27% Similarity=0.364 Sum_probs=190.5
Q ss_pred cceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCeeEEEeEEEcCCC--CE
Q 006810 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--RT 102 (630)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIVk~~~~f~d~~~--~~ 102 (630)
|-+.+.+.||+|+||+||+|.. +|..||+|+++... ........|+..+++++|||||++++++.+... ..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 4458899999999999999975 69999999986432 222223346666678999999999999986543 36
Q ss_pred EEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcC------CCCEEeccCCcCceEEeCCCCcEEEccccc
Q 006810 103 INMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 176 (630)
Q Consensus 103 l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~------~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 176 (630)
+++||||+++|+|........+++..+..++.|++.||.|||+. .++|+||||||+||||+ .+|.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFGl 154 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCTT
T ss_pred EEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-CCCCeEEEecCc
Confidence 89999999999998433455799999999999999999999974 23499999999999998 789999999999
Q ss_pred ceeeccCC------CccccCCCCCCCccccccc-------cCcccceeehhHHHHHHhhCCCCCCCC-------------
Q 006810 177 AIVMQQPT------ARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTCEYPYNEC------------- 230 (630)
Q Consensus 177 a~~~~~~~------~~~~~GTp~Y~APEvl~~~-------ys~~sDIWSLGvil~ELltG~~Pf~~~------------- 230 (630)
+....... ....+||+.|||||++.+. ++.++|||||||++|||+||..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 97664322 2346799999999988642 677999999999999999998876431
Q ss_pred -CCHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHHHHccc-CCCCCCCHHHHhcC
Q 006810 231 -KNPAQIYKKVTSGIKPASLSKV-----TDPQVKQFIEKCIV-PASLRLPALELLKD 280 (630)
Q Consensus 231 -~~~~~i~~~i~~g~~p~~l~~~-----~s~~lk~~I~kcL~-~p~~Rpsa~eLL~h 280 (630)
.....+...+..+...+.++.. ....+.+++.+||+ +|.+|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1233344444433322222221 12458899999998 89999999998763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.9e-42 Score=352.68 Aligned_cols=243 Identities=17% Similarity=0.259 Sum_probs=195.4
Q ss_pred CcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCeeEEEeEEEcCCCCE
Q 006810 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H-pNIVk~~~~f~d~~~~~ 102 (630)
+|| ++.+.||+|+||+||+|.+..+|+.||+|+++..... ..+.+|++.++.|.| +||+.+++++... ..
T Consensus 5 ~~Y-~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~ 75 (293)
T d1csna_ 5 VHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA------PQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LH 75 (293)
T ss_dssp TTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS------CCHHHHHHHHHHTTTCTTCCCEEEEEEET--TE
T ss_pred Cce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc------HHHHHHHHHHHHhcCCCCCCEEEEEeecC--Cc
Confidence 678 8999999999999999999999999999988654321 236789999999976 8999999988654 46
Q ss_pred EEEEEcccCCCCHH-HHh-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeC----CCCcEEEccccc
Q 006810 103 INMITELFTSGSLR-YRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDLGL 176 (630)
Q Consensus 103 l~lV~Ey~~gGsL~-~~~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~----~~g~vKL~DFGl 176 (630)
.++||||+ +|+|. ++. ....+++..+..++.|++.||.|||++| |+||||||+|||++. ..+.+||+|||+
T Consensus 76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred cEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccce
Confidence 88999999 56766 443 4457999999999999999999999999 999999999999962 357899999999
Q ss_pred ceeeccC---------CCccccCCCCCCCcccccc-ccCcccceeehhHHHHHHhhCCCCCCCCC--CHHHHHHHHHcC-
Q 006810 177 AIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSG- 243 (630)
Q Consensus 177 a~~~~~~---------~~~~~~GTp~Y~APEvl~~-~ys~~sDIWSLGvil~ELltG~~Pf~~~~--~~~~i~~~i~~g- 243 (630)
|+..... .....+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+.. +....+..+...
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence 9865432 2335679999999998875 49999999999999999999999997533 333333333221
Q ss_pred --CCCCCCCCCCcHHHHHHHHHccc-CCCCCCCHHHHh
Q 006810 244 --IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 278 (630)
Q Consensus 244 --~~p~~l~~~~s~~lk~~I~kcL~-~p~~Rpsa~eLL 278 (630)
..+..+.+..++++.+++..|+. +|.+||+...+.
T Consensus 233 ~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 22233445567899999999997 899999877654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-42 Score=364.90 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=195.9
Q ss_pred CCcceeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----------CCCeeEE
Q 006810 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----------HENIIKF 91 (630)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-----------HpNIVk~ 91 (630)
.||| ++.+.||+|+||+||+|.++.+|+.||+|+++.. ....+.+.+|+.+|+.++ ||||+++
T Consensus 12 ~~rY-~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 12 DARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCcE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 4788 8899999999999999999999999999999743 233456788999888875 4789999
Q ss_pred EeEEEcCCCCEEEEEEcccCCCCHH----HHhhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEeccCCcCceEEeCCC
Q 006810 92 YNSWVDDTNRTINMITELFTSGSLR----YRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNN 166 (630)
Q Consensus 92 ~~~f~d~~~~~l~lV~Ey~~gGsL~----~~~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~ 166 (630)
+++|........+++++++..+... .......+++..++.+++||+.||.|||+ +| |+||||||+|||++ .+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~-~~ 162 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLME-IV 162 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEE-EE
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeee-cc
Confidence 9998765555667777776555432 34456789999999999999999999997 77 99999999999997 33
Q ss_pred C------cEEEcccccceeeccCCCccccCCCCCCCccccc-cccCcccceeehhHHHHHHhhCCCCCCCCCCH------
Q 006810 167 G------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP------ 233 (630)
Q Consensus 167 g------~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIWSLGvil~ELltG~~Pf~~~~~~------ 233 (630)
| .++|+|||.+...... ....+||+.|+|||++. ..|+.++||||+||++++|++|+.||......
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcccccceeeEeecccccccccc-cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 3 4999999999765443 35678999999999776 45899999999999999999999999753211
Q ss_pred HHHHHHHHc-CC--------------------CC------------------CCCCCCCcHHHHHHHHHccc-CCCCCCC
Q 006810 234 AQIYKKVTS-GI--------------------KP------------------ASLSKVTDPQVKQFIEKCIV-PASLRLP 273 (630)
Q Consensus 234 ~~i~~~i~~-g~--------------------~p------------------~~l~~~~s~~lk~~I~kcL~-~p~~Rps 273 (630)
..+...+.. +. .+ ..+....++++++||.+||. +|.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 111111100 00 00 00111235789999999998 8999999
Q ss_pred HHHHhcCCCcccC
Q 006810 274 ALELLKDPFLVTD 286 (630)
Q Consensus 274 a~eLL~hpf~~~~ 286 (630)
|.|+|+||||+..
T Consensus 322 a~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 322 AGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHHTCGGGTTC
T ss_pred HHHHhcCcccCCC
Confidence 9999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=5e-24 Score=204.91 Aligned_cols=171 Identities=17% Similarity=0.175 Sum_probs=123.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc-----CC---------HHHHHHHHHHHHHHHhCCCCCeeEEEe
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-----QS---------PDQLERLYSEVHLLKSLKHENIIKFYN 93 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~-----~~---------~~~~~~l~~Ei~iL~~L~HpNIVk~~~ 93 (630)
-++++||+|+||+||+|.+. +|.+||+|+++..... .. ........+|+..+.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46899999999999999885 7999999987542110 00 011234557899999999999999887
Q ss_pred EEEcCCCCEEEEEEcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEeccCCcCceEEeCCCCcEEEcc
Q 006810 94 SWVDDTNRTINMITELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 173 (630)
Q Consensus 94 ~f~d~~~~~l~lV~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 173 (630)
+. . .+++|||++++.+. .++...+..++.||+.+|.|||+++ |+||||||+|||++ + +.++|+|
T Consensus 82 ~~--~----~~lvme~~~~~~~~------~l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~liD 145 (191)
T d1zara2 82 WE--G----NAVLMELIDAKELY------RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWIID 145 (191)
T ss_dssp EE--T----TEEEEECCCCEEGG------GCCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEECC
T ss_pred ec--C----CEEEEEeecccccc------chhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeee-C-CCEEEEE
Confidence 53 2 25799999987664 2455667789999999999999999 99999999999998 4 4599999
Q ss_pred cccceeeccCCCccccCCCCCCCccccccccCcccceeehhH
Q 006810 174 LGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 215 (630)
Q Consensus 174 FGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIWSLGv 215 (630)
||.|.....+........-.-.-.+.+...|+..+|+||+.-
T Consensus 146 FG~a~~~~~~~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 146 FPQSVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp CTTCEETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred CCCcccCCCCCcHHHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 999976654432221100000001334567899999999653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.84 E-value=6.6e-05 Score=72.36 Aligned_cols=138 Identities=15% Similarity=0.036 Sum_probs=84.3
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCEEEEE
Q 006810 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI 106 (630)
Q Consensus 28 r~~e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~l~lV 106 (630)
|+.+..+-++.+.||+.. ..+..+++|......... ...+.+|...++.|. +--+.+++.+..+. ...++|
T Consensus 17 ~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv 88 (263)
T d1j7la_ 17 RCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLL 88 (263)
T ss_dssp EEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEE
T ss_pred EEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc----hhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEE
Confidence 444444444457899873 456677888875432211 123667888877763 33355666654333 467899
Q ss_pred EcccCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHcCCC--------------------------------------
Q 006810 107 TELFTSGSLRYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP-------------------------------------- 148 (630)
Q Consensus 107 ~Ey~~gGsL~~~~~~~~lse~~i~~i~~QIl~gL~yLHs~~~-------------------------------------- 148 (630)
|++++|..+....... .....++.++...|..||+..+
T Consensus 89 ~~~l~G~~~~~~~~~~----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp EECCSSEEHHHHTTTC----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred EEeccccccccccccc----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 9999998875221111 1123344455555555554211
Q ss_pred -------------------CEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 149 -------------------PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 149 -------------------~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
.++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec-CCceEEEeechhcc
Confidence 179999999999998 55555699998774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.72 E-value=5.2e-05 Score=78.80 Aligned_cols=81 Identities=16% Similarity=0.186 Sum_probs=49.7
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeeccccc---CCHHHHHHHHHHHHHHHhCC-C--CCeeEEEeEEEcCCCCEEE
Q 006810 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM---QSPDQLERLYSEVHLLKSLK-H--ENIIKFYNSWVDDTNRTIN 104 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~tG~~VAiK~i~~~~~~---~~~~~~~~l~~Ei~iL~~L~-H--pNIVk~~~~f~d~~~~~l~ 104 (630)
+.||.|....||++.+..+|..|++|+-...-.. ..+....+...|...|+.+. + ..++++|.+ +... -+
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~--~~ 107 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM--AV 107 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT--TE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC--CE
Confidence 5689999999999988888889999976432111 01122345667888887662 2 345666653 3433 35
Q ss_pred EEEcccCCCCH
Q 006810 105 MITELFTSGSL 115 (630)
Q Consensus 105 lV~Ey~~gGsL 115 (630)
+|||++.+..+
T Consensus 108 lvmE~L~~~~~ 118 (392)
T d2pula1 108 TVMEDLSHLKI 118 (392)
T ss_dssp EEECCCTTSEE
T ss_pred EEEeccCCccc
Confidence 79999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.47 E-value=0.00051 Score=65.52 Aligned_cols=75 Identities=9% Similarity=-0.058 Sum_probs=47.6
Q ss_pred eEecccCc-eEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCeeEEEeEEEcCCCCEEEEEE
Q 006810 31 EILGKGAF-KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMIT 107 (630)
Q Consensus 31 e~LG~G~f-g~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~H--pNIVk~~~~f~d~~~~~l~lV~ 107 (630)
+.+..|.. +.||+... ..|..+++|....... ..+..|...|+.|.. -.+.+++.+..+. ...++||
T Consensus 16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~ 85 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-------NELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLL 85 (255)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-------SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEE
T ss_pred EEcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-------hHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEE
Confidence 34555553 68898854 4566788887654321 225677777776643 2355667654433 4578999
Q ss_pred cccCCCCH
Q 006810 108 ELFTSGSL 115 (630)
Q Consensus 108 Ey~~gGsL 115 (630)
++++|-++
T Consensus 86 ~~i~G~~~ 93 (255)
T d1nd4a_ 86 GEVPGQDL 93 (255)
T ss_dssp ECCSSEET
T ss_pred Eeeecccc
Confidence 99988765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.35 E-value=0.022 Score=58.02 Aligned_cols=73 Identities=14% Similarity=0.104 Sum_probs=47.1
Q ss_pred eEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEeEEEcCCCCE
Q 006810 31 EILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT 102 (630)
Q Consensus 31 e~LG~G~fg~Vy~A~d~~-------tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~-HpNIVk~~~~f~d~~~~~ 102 (630)
+.|+.|-.-.+|++.... .+..|.+++..-. .. . ....+|..+++.+. +.-..+++.++ .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~--~-idr~~E~~i~~~ls~~gl~Pkll~~~--~~--- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET--E-SHLVAESVIFTLLSERHLGPKLYGIF--SG--- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC--H-HHHHHHHHHHHHHHHTTSSSCEEEEE--TT---
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---ch--h-hHHHHHHHHHHHHHhCCCCCeEEEEc--CC---
Confidence 668888889999987543 3456777765411 11 2 23457888888874 33345777765 22
Q ss_pred EEEEEcccCCCCH
Q 006810 103 INMITELFTSGSL 115 (630)
Q Consensus 103 l~lV~Ey~~gGsL 115 (630)
.+|+||++|..+
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 468999988655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.08 E-value=0.017 Score=57.28 Aligned_cols=70 Identities=10% Similarity=0.053 Sum_probs=40.8
Q ss_pred eEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCee--EEEe----EEEcCCCCEEEEEEcccCC
Q 006810 39 KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII--KFYN----SWVDDTNRTINMITELFTS 112 (630)
Q Consensus 39 g~Vy~A~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL~~L~HpNIV--k~~~----~f~d~~~~~l~lV~Ey~~g 112 (630)
-.||++.. .+|..|++|+.+.... + .+.+..|...|..|...+|. .... ... ......+.+++++.|
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~--s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~-~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL-NHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE-EETTEEEEEEECCCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCC--C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeee-eeeeEEEEEEeecCC
Confidence 58999954 4788899998764322 2 23466788888777432221 1111 001 112457788899887
Q ss_pred CCH
Q 006810 113 GSL 115 (630)
Q Consensus 113 GsL 115 (630)
..+
T Consensus 109 ~~~ 111 (325)
T d1zyla1 109 RQF 111 (325)
T ss_dssp EEC
T ss_pred cCC
Confidence 543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=86.78 E-value=0.12 Score=50.08 Aligned_cols=29 Identities=31% Similarity=0.355 Sum_probs=24.5
Q ss_pred CEEeccCCcCceEEeCCCCcEEEcccccce
Q 006810 149 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 178 (630)
Q Consensus 149 ~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 178 (630)
++||+|+.++||+++ .++..-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~-~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFL-GDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcc-cccceeEecccccc
Confidence 389999999999998 45556799999774
|